PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agmon, IC				Agmon, Ilana C.			A model for the role of isomerization in nascent peptide movement through the ribosomal tunnel	FASEB JOURNAL			English	Article						translation; translation arrest; origin of life	CIS-TRANS ISOMERIZATION; STRUCTURAL BASIS; CIS/TRANS ISOMERIZATION; TRANSFERASE CENTER; TRANSFER-RNA; TRANSLOCATION; CONFORMATION; NUCLEOTIDES; DYNAMICS	The ribosome is a molecular machine whose manner of controlling the progression of the nascent chain through the ribosomal exit tunnel is currently unknown. A novel model for the mechanism driving the nascent chain motion is hereby presented, in which the similar to 180 degrees rotatory motion performed by each C-terminal amino acid of the nascent chain during its translocation from the A site to the P site, is suggested to twist the newly formed peptide bond into cis conformation. By catalyzing the cis to trans isomerization, the ribosome is proposed to release the potential energy stored within the cis conformer and to utilize it to push the chain down the tunnel, thus operating as a molecular motor. This hypothetical isomerization mechanism is supported by its ability to provide an explanation for the peculiar conduct observed in translational events of nascent chains with C-terminal prolines: the slow peptide bond formation with puromycin, translation arrest, and tmRNA tagging.-Agmon, I. C. A model for the role of isomerization in nascent peptide movement through the ribosomal tunnel. FASEB J. 26, 2277-2282 (2012). www.fasebj.org	[Agmon, Ilana C.] Technion Israel Inst Technol, Inst Adv Studies Theoret Chem, Schulich Fac Chem, IL-32000 Haifa, Israel; [Agmon, Ilana C.] Hebrew Univ Jerusalem, Fritz Haber Res Ctr Mol Dynam, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Hebrew University of Jerusalem	Agmon, IC (corresponding author), Technion Israel Inst Technol, Inst Adv Studies Theoret Chem, Schulich Fac Chem, IL-32000 Haifa, Israel.	chilana@tx.technion.ac.il			Elsa Fendler Research Fund	Elsa Fendler Research Fund	Thanks are due to Noam Adir for the helpful discussion. This work was supported by a Technion Vice President grant from the Elsa Fendler Research Fund.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Agmon I, 2006, ISR J ECOL EVOL, V52, P359, DOI 10.1560/IJEE_52_3-4_359; Agmon I, 2009, INT J MOL SCI, V10, P2921, DOI 10.3390/ijms10072921; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; BIRGE RR, 1981, BIOPHYS J, V34, P517, DOI 10.1016/S0006-3495(81)84865-5; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; Chirkova A, 2010, NUCLEIC ACIDS RES, V38, P4844, DOI 10.1093/nar/gkq213; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Green R, 1997, J MOL BIOL, V266, P40, DOI 10.1006/jmbi.1996.0780; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hugel T, 2002, SCIENCE, V296, P1103, DOI 10.1126/science.1069856; Kern D, 1997, J AM CHEM SOC, V119, P8403, DOI 10.1021/ja970606w; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4; Lu JL, 2007, J MOL BIOL, V371, P1378, DOI 10.1016/j.jmb.2007.06.038; Mankin AS, 2006, TRENDS BIOCHEM SCI, V31, P11, DOI 10.1016/j.tibs.2005.11.007; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Murthy VL, 1999, J MOL BIOL, V291, P313, DOI 10.1006/jmbi.1999.2958; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PICKING WD, 1991, J BIOL CHEM, V266, P1534; Reimer U, 2002, BIOPHYS CHEM, V96, P203, DOI 10.1016/S0301-4622(02)00013-3; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Tchaicheeyan O, 2004, FASEB J, V18, P783, DOI 10.1096/fj.03-1027hyp; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vologodskii A, 2006, PHYS LIFE REV, V3, P119, DOI 10.1016/j.plrev.2006.02.002; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200	41	1	1	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2277	2282		10.1096/fj.11-197657	http://dx.doi.org/10.1096/fj.11-197657			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22389440				2022-12-25	WOS:000305017200006
J	Lorenzato, A; Martino, C; Dani, N; Oligschlager, Y; Ferrero, AM; Biglia, N; Calogero, R; Olivero, M; Di Renzo, MF				Lorenzato, Annalisa; Martino, Cosimo; Dani, Nadia; Oligschlaeger, Yvonne; Ferrero, Anna Maria; Biglia, Nicoletta; Calogero, Raffaele; Olivero, Martina; Di Renzo, Maria Flavia			The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C	FASEB JOURNAL			English	Article						receptor tyrosine kinases; MET receptor; hepatocyte growth factor; nuclear import	HEPATOCYTE GROWTH-FACTOR; CHROMOSOME SEGREGATION; TUMOR-SUPPRESSOR; IMPORTIN-ALPHA; HUMAN HOMOLOG; EXPRESSION; CARCINOMA; CISPLATIN; CSE1; CSE1L/CAS	The cellular apoptosis susceptibility gene CAS/CSE1L is overexpressed in cancer, although it was originally identified as a gene that renders cells vulnerable to apoptotic stimuli. CAS/CSE1L has roles in the nucleocytoplasmic recycling of importin-alpha and in the regulation of gene expression, cell migration, and secretion. We identified CAS/CSE1L as a survival factor for ovarian cancer cells in vitro and in vivo. In 3/3 ovarian cancer cell lines, CAS/CSE1L was down-modulated by the unorthodox proapoptotic signaling of the MET receptor. CAS/CSE1L knockdown with RNA interference committed the ovarian cancer cells to death, but not immortalized normal cells and breast and colon cancer cells. In 70 and 95% of these latter cells, respectively, CAS/CSE1L was localized in the cytoplasm, while it accumulated in the nucleus in >90% of ovarian cancer cells. Nuclear localization depended on AKT, which was constitutively active in ovarian cancer cells. In the nucleus, CAS/CSE1L regulated the expression of the proapoptotic Ras-association domain family 1 gene products RASSF1C and RASSF1A, which mediated death signals evoked by depletion of CAS/CSE1L. Our data show that CAS/CSE1L protects ovarian cancer cells from death through transcriptional suppression of a proapoptotic gene and suggest that the localization of CAS/CSE1L dictates its function.-Lorenzato, A., Martino, C., Dani, N., Oligschlager, Y., Ferrero, A. M., Biglia, N., Calogero, R., Olivero, M., Di Renzo, M. F. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C. FASEB J. 26, 2446-2456 (2012). www.fasebj.org	[Di Renzo, Maria Flavia] Univ Turin, Sch Med, Canc Genet Lab, Dept Oncol Sci,IRCC, I-10060 Turin, Italy; [Ferrero, Anna Maria; Biglia, Nicoletta] Azienda Sanit Osped ASO Ordine Mauriziano, Dept Obstet & Gynaecol, Turin, Italy; [Lorenzato, Annalisa; Martino, Cosimo; Dani, Nadia; Oligschlaeger, Yvonne; Olivero, Martina; Di Renzo, Maria Flavia] Inst Canc Res Candiolo, Candiolo, Italy; [Calogero, Raffaele] ASO San Luigi Gonzaga, Dept Clin & Biol Sci, Genom & Bioinformat Unit, Orbassano, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Fondazione del Piemonte per l'Oncologia	Di Renzo, MF (corresponding author), Univ Turin, Sch Med, Canc Genet Lab, Dept Oncol Sci,IRCC, SP 142,Km 3-95, I-10060 Turin, Italy.	mariaflavia.direnzo@unito.it	Calogero, Raffaele/K-9428-2019; Biglia, Nicoletta/F-8801-2013; DI RENZO, Maria Flavia/B-6091-2012; olivero, martina/J-4811-2018; Ferrero, Annamaria/AAI-6572-2020	Calogero, Raffaele/0000-0002-2848-628X; Biglia, Nicoletta/0000-0003-1009-5309; DI RENZO, Maria Flavia/0000-0002-5093-3373; olivero, martina/0000-0002-6815-3498; Ferrero, Annamaria/0000-0002-2909-3699; Martino, Cosimo/0000-0002-7286-9755; Lorenzato, Annalisa/0000-0002-9324-2337	Italian Association for Cancer Research; Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO); Italian Ministry of Health; Regione Piemonte	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Regione Piemonte(Regione Piemonte)	The authors are extremely grateful to Dr. Simona Pavan, who generously made available the results of her experiments on CAS/CSE1L and chemotherapeutics in ovarian cancer. They also thank Dr. Barbara Canepa for scientific collaboration, and Lidia Giraudo Diego for her enthusiastic help in performing experiments. The authors are indebted to Prof. Guido Serini for help in performing immunofluorescence experiments with confocal microscopy, and to Prof. Luca Primo for advice on expressing active AKT. This study is supported by grants of the Italian Association for Cancer Research and Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO) to M. F. D., of the Italian Ministry of Health to M. F. D. and N.B., and of Regione Piemonte to M. F. D. and R.C.	Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Bagnat M, 2010, CURR BIOL, V20, P1840, DOI 10.1016/j.cub.2010.09.012; Bardella C, 2007, CLIN CANCER RES, V13, P2191, DOI 10.1158/1078-0432.CCR-06-1915; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Bera TK, 2001, MOL CELL BIOL, V21, P7020, DOI 10.1128/MCB.21.20.7020-7024.2001; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Brustmann H, 2004, GYNECOL ONCOL, V92, P268, DOI 10.1016/j.ygyno.2003.10.029; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Calleros L, 2009, CARCINOGENESIS, V30, P1670, DOI 10.1093/carcin/bgp188; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Coltella N, 2006, INT J CANCER, V118, P2981, DOI 10.1002/ijc.21766; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Daskalos A, 2011, CANCER-AM CANCER SOC, V117, P1027, DOI 10.1002/cncr.25531; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Liao CF, 2008, BMB REP, V41, P210, DOI 10.5483/BMBRep.2008.41.3.210; Liao CF, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-15; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Olivero M, 2006, MOL CANCER THER, V5, P1126, DOI 10.1158/1535-7163.MCT-06-0013; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Peiro G, 2002, AM J CLIN PATHOL, V118, P922, DOI 10.1092/JU8YP7MJK2WDT1FY; Rasola A, 2004, CANCER RES, V64, P1744, DOI 10.1158/0008-5472.CAN-03-2383; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Royer B, 2005, ANTI-CANCER DRUG, V16, P1009, DOI 10.1097/01.cad.0000176505.94175.d4; Samouelian V, 2004, CANCER CHEMOTH PHARM, V54, P497, DOI 10.1007/s00280-004-0843-9; Scherf U, 1996, P NATL ACAD SCI USA, V93, P2670, DOI 10.1073/pnas.93.7.2670; Smith JA, 2005, GYNECOL ONCOL, V98, P141, DOI 10.1016/j.ygyno.2005.02.006; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Tai CJ, 2010, EXP CELL RES, V316, P2969, DOI 10.1016/j.yexcr.2010.07.019; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tommasi S, 2005, CANCER RES, V65, P92; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsai CSS, 2010, AM J PATHOL, V176, P1619, DOI 10.2353/ajpath.2010.090467; Tsao TY, 2009, MOL CELL BIOCHEM, V327, P163, DOI 10.1007/s11010-009-0054-0; Tulasne D, 2008, CELL DEATH DIFFER, V15, P427, DOI 10.1038/sj.cdd.4402229; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	49	27	28	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2446	2456		10.1096/fj.11-195982	http://dx.doi.org/10.1096/fj.11-195982			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22389439				2022-12-25	WOS:000305017200022
J	Bansal, S; Srinivasan, S; Anandasadagopan, S; Chowdhury, AR; Selvaraj, V; Kalyanaraman, B; Joseph, J; Avadhani, NG				Bansal, Seema; Srinivasan, Satish; Anandasadagopan, Sureshkumar; Chowdhury, Anindya Roy; Selvaraj, Venkatesh; Kalyanaraman, Balaraman; Joseph, Joy; Avadhani, Narayan G.			Additive Effects of Mitochondrion-targeted Cytochrome CYP2E1 and Alcohol Toxicity on Cytochrome c Oxidase Function and Stability of Respirosome Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC ETHANOL-CONSUMPTION; INDUCED LIVER-INJURY; OXIDATIVE STRESS; FATTY LIVER; HUMAN-CELLS; ENERGY-METABOLISM; REACTIVE OXYGEN; NITRIC-OXIDE; SUBUNIT-VB; DYSFUNCTION	Alcohol treatment induces oxidative stress by a combination of increased production of partially reduced oxygen species and decreased cellular antioxidant pool, including GSH. Recently, we showed that mitochondrion-targeted CYP2E1 augments alcohol-mediated toxicity, causing an increase in reactive oxygen species production and oxidative stress. Here, we show that cytochrome c oxidase (CcO), the terminal oxidase of the mitochondrial respiratory chain, is a critical target of CYP2E1-mediated alcohol toxicity. COS-7 and Hep G2 cell lines expressing predominantly mitochondrion-targeted (Mt(++)) CYP2E1 and livers from alcohol-treated rats showed loss of CcO activity and increased protein carbonylation, which was accompanied by a decline in the steady state levels of subunits I, IVI1, and Vb of the CcO complex. This was also accompanied by reduced mitochondrial DNA content and reduced mitochondrial mRNA. These changes were more prominent in Mt(++) cells in comparison with wild type (WT) CYP2E1-expressing or ER+ (mostly microsome-targeted) cells. In addition, mitochondrion-specific antioxidants, ubiquinol conjugated to triphenyl phosphonium, triphenylphosphonium conjugated carboxyl proxyl, and the CYP2E1 inhibitor diallyl sulfide prevented the loss of CcO activity and the CcO subunits, most likely through reduced oxidative damage to the enzyme complex. Our results suggest that damage to CcO and dissociation of respirosome complexes are critical factors in alcohol-induced toxicity, which is augmented by mitochondrion-targeted CYP2E1. We propose that CcO is one of the direct and immediate targets of alcohol-induced toxicity causing respiratory dysfunction.	[Bansal, Seema; Srinivasan, Satish; Anandasadagopan, Sureshkumar; Chowdhury, Anindya Roy; Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bansal, Seema; Srinivasan, Satish; Anandasadagopan, Sureshkumar; Chowdhury, Anindya Roy; Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Kalyanaraman, Balaraman; Joseph, Joy] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman; Joseph, Joy] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA	University of Pennsylvania; University of Pennsylvania; Medical College of Wisconsin; Medical College of Wisconsin	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu		Ananda Sadagopan, Suresh Kumar/0000-0001-5178-005X	National Institutes of Health [AA-017749]; ARRA [GM-34883]; Harriet Ellison Woodward Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA-017749 and ARRA supplement to GM-34883. This work was also supported by an endowment from the Harriet Ellison Woodward Foundation.	Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016; ARAI M, 1984, BIOCHIM BIOPHYS ACTA, V797, P320, DOI 10.1016/0304-4165(84)90252-6; Aubert J, 2011, CLIN RES HEPATOL GAS, V35, P630, DOI 10.1016/j.clinre.2011.04.015; Bailey SM, 2003, FREE RADICAL RES, V37, P585, DOI 10.1080/1071576031000091711; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bondoc FY, 1999, BIOCHEM PHARMACOL, V58, P461, DOI 10.1016/S0006-2952(99)00111-2; BONDY SC, 1994, EUR J PHARM-ENVIRON, V270, P349, DOI 10.1016/0926-6917(94)90011-6; BOTTENUS RE, 1982, BIOCHEM BIOPH RES CO, V105, P1368, DOI 10.1016/0006-291X(82)90938-X; Butura A, 2009, J HEPATOL, V50, P572, DOI 10.1016/j.jhep.2008.10.020; Cahill A, 1999, HEPATOLOGY, V30, P881, DOI 10.1002/hep.510300434; Cahill A, 1997, BIOCHEM BIOPH RES CO, V235, P286, DOI 10.1006/bbrc.1997.6774; CEDERBAUM AI, 1974, ARCH BIOCHEM BIOPHYS, V165, P560, DOI 10.1016/0003-9861(74)90283-5; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Cifelli PM, 2002, J INHERIT METAB DIS, V25, P411, DOI 10.1023/A:1020112119716; COLEMAN WB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P142, DOI 10.1016/0005-2728(90)90136-R; Conard C. C., 2001, PROTEOMICS, V22, P2046; Corbucci GG, 2006, MINERVA ANESTESIOL, V72, P337; CUNNINGHAM CC, 1990, ALCOHOL ALCOHOLISM, V25, P127, DOI 10.1093/oxfordjournals.alcalc.a044987; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; DIMAURO S, 1986, ANN NY ACAD SCI, V488, P19; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; FIAMINGO FG, 1990, BIOCHEMISTRY-US, V29, P4627, DOI 10.1021/bi00471a018; Fromenty B, 2004, DIABETES METAB, V30, P121, DOI 10.1016/S1262-3636(07)70098-8; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Harman D, 1973, Triangle, V12, P153; HOEK JB, 1994, CURR TOP BIOENERG, V17, P197; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; Kennedy JM, 1998, CARDIOVASC RES, V37, P141, DOI 10.1016/S0008-6363(97)00198-3; Knockaert L, 2011, TOXICOL IN VITRO, V25, P475, DOI 10.1016/j.tiv.2010.11.019; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; KOOP DR, 1986, ALCOHOL CLIN EXP RES, V10, pS44, DOI 10.1111/j.1530-0277.1986.tb05179.x; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Korourian S, 1999, TOXICOL SCI, V47, P110, DOI 10.1093/toxsci/47.1.110; KRAHENBUHL S, 1989, BIOCHEM PHARMACOL, V38, P1583, DOI 10.1016/0006-2952(89)90305-5; Krieg RC, 2004, PROTEOMICS, V4, P2789, DOI 10.1002/pmic.200300796; Kuo WW, 2005, J BIOMED SCI, V12, P601, DOI 10.1007/s11373-005-7373-2; Lands WEM, 1998, ALCOHOL, V15, P147, DOI 10.1016/S0741-8329(97)00110-9; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; LIEBER CS, 1973, RES COMMUN CHEM PATH, V6, P983; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Lu YX, 2008, INT J DIGIT EARTH, V1, P1, DOI 10.1080/17538940801918857; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Mari R, 2000, J BIOL CHEM, V275, P15563; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720; MORIMOTO M, 1995, J NUTR, V125, P2953; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; NOZU F, 1992, HEPATOLOGY, V15, P1099, DOI 10.1002/hep.1840150621; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Ronis MJJ, 1996, CYTOCHROMES P450 MET, P211; Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582; Sayen MR, 2003, AM J PHYSIOL-CELL PH, V284, pC562, DOI 10.1152/ajpcell.00336.2002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1; Shiva S, 2003, IUBMB LIFE, V55, P585, DOI 10.1080/15216540310001640489; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sohn OS, 2001, CANCER RES, V61, P8435; Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9; Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k; Tanji K, 2000, BRAIN PATHOL, V10, P422; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Venkatraman A, 2003, HEPATOLOGY, V38, P141, DOI 10.1053/jhep.2003.50293; Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang S, 2004, CELL MOL LIFE SCI, V61, P220, DOI 10.1007/s00018-003-3357-4; Yu HL, 2003, PROTEOMICS, V3, P2240, DOI 10.1002/pmic.200300475; Yu Q, 2008, AM J PHYSIOL-HEART C, V294, pH2637, DOI 10.1152/ajpheart.91476.2007; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zeng T, 2008, TOXICOLOGY, V252, P86, DOI 10.1016/j.tox.2008.07.062	87	24	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15284	15297		10.1074/jbc.M111.314062	http://dx.doi.org/10.1074/jbc.M111.314062			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22396533	Green Published, hybrid			2022-12-25	WOS:000304006300012
J	Yoboue, ED; Augier, E; Galinier, A; Blancard, C; Pinson, B; Casteilla, L; Rigoulet, M; Devin, A				Yoboue, Edgar D.; Augier, Eric; Galinier, Anne; Blancard, Corinne; Pinson, Benoit; Casteilla, Louis; Rigoulet, Michel; Devin, Anne			cAMP-induced Mitochondrial Compartment Biogenesis ROLE OF GLUTATHIONE REDOX STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GENE-EXPRESSION; GROWTH-YIELD; ACTIVATION; CELLS; SITE; CONSEQUENCES; METABOLISM; MECHANISMS	Cell fate and proliferation are tightly linked to the regulation of the mitochondrial energy metabolism. Hence, mitochondrial biogenesis regulation, a complex process that requires a tight coordination in the expression of the nuclear and mitochondrial genomes, has a major impact on cell fate and is of high importance. Here, we studied the molecular mechanisms involved in the regulation of mitochondrial biogenesis through a nutrient-sensing pathway, the Ras-cAMP pathway. Activation of this pathway induces a decrease in the cellular phosphate potential that alleviates the redox pressure on the mitochondrial respiratory chain. One of the cellular consequences of this modulation of cellular phosphate potential is an increase in the cellular glutathione redox state. The redox state of the glutathione disulfide-glutathione couple is a well known important indicator of the cellular redox environment, which is itself tightly linked to mitochondrial activity, mitochondria being the main cellular producer of reactive oxygen species. The master regulator of mitochondrial biogenesis in yeast (i.e. the transcriptional co-activator Hap4p) is positively regulated by the cellular glutathione redox state. Using a strain that is unable to modulate its glutathione redox state (Delta glr1), we pinpoint a positive feedback loop between this redox state and the control of mitochondrial biogenesis. This is the first time that control of mitochondrial biogenesis through glutathione redox state has been shown.	[Yoboue, Edgar D.; Augier, Eric; Blancard, Corinne; Pinson, Benoit; Rigoulet, Michel; Devin, Anne] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France; [Yoboue, Edgar D.; Augier, Eric; Blancard, Corinne; Pinson, Benoit; Rigoulet, Michel; Devin, Anne] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France; [Galinier, Anne; Casteilla, Louis] UMR UPS CNRS 5273, EFS, INSERM U1031, STROMALab,IFR 150, F-31432 Toulouse 4, France; [Galinier, Anne; Casteilla, Louis] Ctr Hosp Univ Rangueil, Biochim Lab, F-31059 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Devin, A (corresponding author), CNRS, IBGC, Bioenerget & Cell Metab Lab, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.u-bordeaux2.fr	YOBOUE, Edgar D./AAA-7706-2019	Casteilla, Louis/0000-0001-9647-3248; Galinier, Anne/0000-0003-2454-5681; Pinson, Benoit/0000-0003-2936-9058	Agence Nationale de la Recherche [NT05-2_42268]; Conseil Regional d'Aquitaine; Association contre les Maladies Mitochondriales	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Association contre les Maladies Mitochondriales	This work was supported in part by Agence Nationale de la Recherche Grant NT05-2_42268 and the Conseil Regional d'Aquitaine.; Supported in part by the Association contre les Maladies Mitochondriales.	ATZORI L, 1990, J CELL PHYSIOL, V143, P165, DOI 10.1002/jcp.1041430123; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; CAIN K, 1977, BIOCHEM J, V162, P575, DOI 10.1042/bj1620575; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; DANG VD, 1994, YEAST, V10, P1273, DOI 10.1002/yea.320101004; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Dejean L, 2002, BIOCHEM BIOPH RES CO, V293, P1383, DOI 10.1016/S0006-291X(02)00391-1; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Denis V, 1998, MOL MICROBIOL, V30, P557, DOI 10.1046/j.1365-2958.1998.01087.x; Devin A, 2004, TOXICOL MECH METHOD, V14, P271, DOI 10.1080/15376520490479620; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; Fondrat C, 1996, COMPUT APPL BIOSCI, V12, P363; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; FORSBURG SL, 1988, MOL CELL BIOL, V8, P647, DOI 10.1128/MCB.8.2.647; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; Hutter DE, 1997, EXP CELL RES, V232, P435, DOI 10.1006/excr.1997.3527; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Lascaris R, 2003, GENOME BIOL, V4; Leverve X, 1998, MOL CELL BIOCHEM, V184, P53, DOI 10.1023/A:1006810209531; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sumner JB, 1944, SCIENCE, V100, P413, DOI 10.1126/science.100.2601.413; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2197; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; WILSON RB, 1993, FEBS LETT, V325, P191, DOI 10.1016/0014-5793(93)81071-7	47	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14569	14578		10.1074/jbc.M111.302786	http://dx.doi.org/10.1074/jbc.M111.302786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396541	Green Published, hybrid			2022-12-25	WOS:000304003200023
J	Linley, AJ; Mathieu, MG; Miles, AK; Rees, RC; McArdle, SEB; Regad, T				Linley, Adam J.; Mathieu, Morgan G.; Miles, Amanda K.; Rees, Robert C.; McArdle, Stephanie E. B.; Regad, Tarik			The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER/TESTIS ANTIGEN CAGE; RNA HELICASES; MULTIFUNCTIONAL PROTEINS; SIGNALING PATHWAYS; ONCOGENIC RAS; BOX PROTEINS; CANCER; FAMILY; P68; ERK	Malignant melanoma-initiating cells (MMIC) are a subpopulation of cells responsible for melanoma tumor growth and progression. They are defined by the expression of the ATP-binding cassette (ABC) subfamily B member 5 (ABCB5). Here, we identified a critical role for the DEAD-box helicase antigen (HAGE) in ABCB5+ MMIC-dependent tumorigenesis and show that HAGE-specific inactivation inhibits melanoma tumor growth mediated by this tumor-initiating population. Knockdown of HAGE led to a significant decrease in RAS protein expression with a concomitant decrease in activation of the AKT and ERK signaling pathways implicated to play an important role in melanoma progression. To confirm that the reduction in NRAS (Neuroblastoma RAS) expression was dependent on the HAGE helicase activity, we showed that NRAS, effectively silenced by siRNA, could be rescued by reintroduction of HAGE in cells lacking HAGE. Furthermore, we provide a mechanism by which HAGE promotes NRAS unwinding in vitro. We also observed using tumor transplantation in Non-obese diabetic/severe combined immunodeficiency mice that the HAGE knockdown in a ABCB5+ melanoma cell line displayed a significant decrease in tumor growth and compared with the control. Our results suggest that the helicase HAGE is required for ABCB5+ MMIC-dependent tumor growth through promoting RAS protein expression and that cancer therapies targeting HAGE helicase may have broad applications for treating malignant melanoma and potentially other cancer types.	[Linley, Adam J.; Mathieu, Morgan G.; Miles, Amanda K.; Rees, Robert C.; McArdle, Stephanie E. B.; Regad, Tarik] Nottingham Trent Univ, Sch Sci & Technol, John van Geest Canc Res Ctr, Nottingham NG11 8NS, England	Nottingham Trent University	Regad, T (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, John van Geest Canc Res Ctr, Clifton Lane, Nottingham NG11 8NS, England.	tarik.regad@ntu.ac.uk	McArdle, Stephanie EB/I-4712-2015; Regad, Tarik/A-6095-2012	McArdle, Stephanie EB/0000-0001-6929-9782; Regad, Tarik/0000-0003-4028-6368; Miles, Amanda/0000-0002-5388-938X; Linley, Adam/0000-0002-8176-5560	John and Lucille van Geest Foundation	John and Lucille van Geest Foundation	This work was supported by the John and Lucille van Geest Foundation.	AKAO Y, 1995, CANCER RES, V55, P3444; Amler LC, 1996, GENE CHROMOSOME CANC, V15, P134, DOI 10.1002/(SICI)1098-2264(199602)15:2<134::AID-GCC9>3.0.CO;2-4; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; BOS JL, 1989, CANCER RES, V49, P4682; Camats M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002926; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Christensen C, 2005, ONCOGENE, V24, P6292, DOI 10.1038/sj.onc.1208758; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eberle J, 2002, BRIT J CANCER, V86, P1957, DOI 10.1038/sj.bjc.6600351; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P600; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Liggins Amanda P, 2010, Cancer Immun, V10, P8; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Martelange V, 2000, CANCER RES, V60, P3848; Mathieu Morgan G, 2010, Cancer Immun, V10, P2; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Na YR, 2009, CANCER SCI, V100, P1429, DOI 10.1111/j.1349-7006.2009.01218.x; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shim H, 2006, MOL CELLS, V21, P367; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221	42	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13633	13643		10.1074/jbc.M111.308973	http://dx.doi.org/10.1074/jbc.M111.308973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393060	Green Published, hybrid			2022-12-25	WOS:000303996300019
J	He, LL; Yang, NL; Isales, CM; Shi, XM				He, Linlin; Yang, Nianlan; Isales, Carlos M.; Shi, Xing-Ming			Glucocorticoid-Induced Leucine Zipper (GILZ) Antagonizes TNF-alpha Inhibition of Mesenchymal Stem Cell Osteogenic Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; OSTEOBLAST DIFFERENTIATION; PROGENITOR CELLS; DEGRADATION; EXPRESSION; KINASE; GENE; PATHOGENESIS; ARTHRITIS; OSTERIX	Tumor necrosis factor-alpha (TNF-alpha) is a potent proinflammatory cytokine that inhibits osteoblast differentiation while stimulating osteoclast differentiation and bone resorption. TNF-alpha activates MAP kinase pathway leading to inhibition of osterix (Osx) expression. TNF-alpha also induces the expression of E3 ubiquitin ligase protein Smurf1 and Smurf2 and promotes degradation of Runx2, another key transcription factor regulating osteoblast differentiation and bone formation. We showed previously that overexpression of glucocorticoid (GC)-induced leucine zipper (GILZ) enhances osteogenic differentiation of bone marrow mesenchymal stem cells (MSCs). We and others also showed that GILZ is a GC effecter and mediates GC anti-inflammatory activity. In this study, we asked the question whether GILZ retains its osteogenic activity while functioning as an anti-inflammatory mediator. To address this question, we infected mouse bone marrow MSCs with retroviruses expressing GILZ and induced them for osteogenic differentiation in the presence or absence of TNF-alpha. Our results show that overexpression of GILZ antagonized the inhibitory effects of TNF-alpha on MSC osteogenic differentiation and the mRNA and protein expression of Osx and Runx2, two pivotal osteogenic regulators. Further studies show that these antagonistic actions occur via mechanisms involving GILZ inhibition of TNF-alpha-induced ERK MAP kinase activation and protein degradation. These results suggest that GILZ may have therapeutic potential as a novel anti-inflammation therapy.	[He, Linlin; Yang, Nianlan; Isales, Carlos M.; Shi, Xing-Ming] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA; [He, Linlin] Northwestern Polytech Univ, Fac Life Sci, Xian 710072, Peoples R China; [Isales, Carlos M.] Georgia Hlth Sci Univ, Dept Orthopaed Surg, Augusta, GA USA; [Shi, Xing-Ming] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA USA	University System of Georgia; Augusta University; Northwestern Polytechnical University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	He, LL (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA.	xshi@georgiahealth.edu	Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484	National Institutes of Health [DK76045]; National Institute on Aging [P01AG036675]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grant (DK76045 to Dr. Shi), National Institute on Aging (P01AG036675 to Dr. Isales), Scholarship grant from China Scholarship Council (Dr. He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beaulieu E, 2010, ARTHRITIS RHEUM-US, V62, P2651, DOI 10.1002/art.27566; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; Conn DL, 2001, ARTHRIT RHEUM-ARTHR, V45, P462, DOI 10.1002/1529-0131(200110)45:5<462::AID-ART366>3.0.CO;2-V; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Jorgensen C, 2002, ANN RHEUM DIS, V61, P6, DOI 10.1136/ard.61.1.6; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; Li P, 2003, SPRINGER SEMIN IMMUN, V25, P19, DOI 10.1007/s00281-003-0125-3; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; LOCASCIO V, 1990, BONE MINER, V8, P39, DOI 10.1016/0169-6009(91)90139-Q; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Marinova-Mutafchieva L, 2000, ARTHRITIS RHEUM-US, V43, P2046, DOI 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishimura J, 2000, J BONE MINER METAB, V18, P350, DOI 10.1007/s007740070008; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	36	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e31717	10.1371/journal.pone.0031717	http://dx.doi.org/10.1371/journal.pone.0031717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396737	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500007
J	Ge, JY; Ding, ZJ; Song, Y; Wang, FF				Ge, Jiyong; Ding, Zhijian; Song, Yu; Wang, Fangfang			Smoking Dose Modifies the Association between C242T Polymorphism and Prevalence of Metabolic Syndrome in a Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INCREASED OXIDATIVE STRESS; NADPH OXIDASE; CIGARETTE-SMOKE; GENE POLYMORPHISM; SUPEROXIDE ANION; NAD(P)H OXIDASE; OBESITY; RISK; P22PHOX	Background: The C242T polymorphism of the CYBA gene that encodes p22phox, a component of NADPH oxidase, has been found to modulate superoxide production. Oxidase is a major source of the superoxide anion that contributes to individual components of metabolic syndrome. We examined the relationship of the C242T polymorphism with the prevalence of metabolic syndrome in a Chinese population, taking account of consumed cigarette amounts. Methodology/Principal Findings: In 870 participants, we collected biomarkers related to metabolic syndrome and detailed history of smoking and genotyped the C242T polymorphisms. After adjustment for covariates, the CT/TT genotypes were associated with a lower risk of metabolic syndrome (P = 0.0008). The odds of having metabolic syndrome in the CT/TT participants were 0.439 (95%CI: 0.265, 0.726), while for CC participants the odds were 1.110 (95%CI: 0.904, 1.362). There was significant (P = 0.014) interaction between the C242T polymorphism and smoking status in relation to the prevalence of metabolic syndrome. For smokers who smoke no less than 25 pack-years, those with CT/TT genotypes had lower risk of metabolic syndrome as compared with CC polymorphism carriers (P = 0.015). In the multiple regression analysis, the CT/TT genotypes were significantly associated with lower serum concentration of triglycerides both in all subjects and smokers; furthermore, the CT/TT genotypes were also related to smaller waist circumference in smokers. Conclusions: Our study suggests that the C242T gene polymorphism is indeed related to the prevalence of metabolic syndrome and smoking dose might modify this association.	[Ge, Jiyong; Ding, Zhijian; Song, Yu; Wang, Fangfang] Nanjing Med Univ, Changzhou Peoples Hosp 2, Dept Cardiol, Changzhou, Peoples R China	Nanjing Medical University	Ge, JY (corresponding author), Nanjing Med Univ, Changzhou Peoples Hosp 2, Dept Cardiol, Changzhou, Peoples R China.	zhijian_ding@yahoo.com			Health Bureau of Changzhou, China [SN200803]	Health Bureau of Changzhou, China	This study was supported by grants from the Health Bureau of Changzhou, China (SN200803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ARAUJO FB, 1995, ATHEROSCLEROSIS, V117, P61, DOI 10.1016/0021-9150(94)05558-Z; Arca M, 2008, ARTERIOSCL THROM VAS, V28, P752, DOI 10.1161/ATVBAHA.107.154823; Bae JH, 2001, ATHEROSCLEROSIS, V155, P517, DOI 10.1016/S0021-9150(00)00601-8; Brude IR, 1997, ARTERIOSCL THROM VAS, V17, P2576, DOI 10.1161/01.ATV.17.11.2576; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Couillard C, 2005, J CLIN ENDOCR METAB, V90, P6454, DOI 10.1210/jc.2004-2438; Cozma Angela, 2009, Rom J Intern Med, V47, P133; Dutta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010478; Evangelopoulos AA, 2008, NUTR RES, V28, P659, DOI 10.1016/j.nutres.2008.07.001; Fan M, 2007, J HYPERTENS, V25, P1381, DOI 10.1097/HJH.0b013e32810bfe58; Fang SX, 2010, THROMB RES, V125, pE197, DOI 10.1016/j.thromres.2010.01.001; Fricker R, 2004, BRIT J CLIN PHARMACO, V58, P169, DOI 10.1111/j.1365-2125.2004.02130.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Guzik TJ, 2000, CIRCULATION, V102, P1744; He MA, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.002; Hitchman SC, 2011, B WORLD HEALTH ORGAN, V89, P195, DOI 10.2471/BLT.10.079905; Inoue N, 1998, CIRCULATION, V97, P135, DOI 10.1161/01.CIR.97.2.135; Jaimes EA, 2004, ARTERIOSCL THROM VAS, V24, P1031, DOI 10.1161/01.ATV.0000127083.88549.58; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lv J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-40; Macias-Reyes A, 2008, FREE RADICAL RES, V42, P82, DOI 10.1080/10715760701796918; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Niemiec P, 2007, CORONARY ARTERY DIS, V18, P339, DOI 10.1097/MCA.0b013e328241d97a; Raij L, 2001, J HYPERTENS, V19, P891, DOI 10.1097/00004872-200105000-00009; Rao VS, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/295976; Schneider MP, 2003, CLIN SCI, V105, P97, DOI 10.1042/CS20030003; SEVANIAN A, 1988, BIOCHIM BIOPHYS ACTA, V961, P316, DOI 10.1016/0005-2760(88)90079-3; Simao ANC, 2011, BRAZ J MED BIOL RES, V44, P707, DOI [10.1590/S0100-879X2011007500069, 10.1590/S0100-879X2011000700015]; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Wyche KE, 2004, HYPERTENSION, V43, P1246, DOI 10.1161/01.HYP.0000126579.50711.62; Ye SF, 2011, J NANOSCI NANOTECHNO, V11, P3773, DOI 10.1166/jnn.2011.3862; Zafari AM, 2002, ANTIOXID REDOX SIGN, V4, P675, DOI 10.1089/15230860260220184	36	7	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31926	10.1371/journal.pone.0031926	http://dx.doi.org/10.1371/journal.pone.0031926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396743	Green Submitted, gold, Green Published			2022-12-25	WOS:000303005000011
J	Ross, GA; Morris, GM; Biggin, PC				Ross, Gregory A.; Morris, Garrett M.; Biggin, Philip C.			Rapid and Accurate Prediction and Scoring of Water Molecules in Protein Binding Sites	PLOS ONE			English	Article							INHOMOGENEOUS FLUID APPROACH; STRUCTURE-BASED DESIGN; NOVO LIGAND DESIGN; DRUG DESIGN; AUTOMATED DOCKING; FACTOR XA; SOLVATION THERMODYNAMICS; CYTOCHROME-P450 2D6; CRYSTAL-STRUCTURES; POTENT INHIBITORS	Water plays a critical role in ligand-protein interactions. However, it is still challenging to predict accurately not only where water molecules prefer to bind, but also which of those water molecules might be displaceable. The latter is often seen as a route to optimizing affinity of potential drug candidates. Using a protocol we call WaterDock, we show that the freely available AutoDock Vina tool can be used to predict accurately the binding sites of water molecules. WaterDock was validated using data from X-ray crystallography, neutron diffraction and molecular dynamics simulations and correctly predicted 97% of the water molecules in the test set. In addition, we combined data-mining, heuristic and machine learning techniques to develop probabilistic water molecule classifiers. When applied to WaterDock predictions in the Astex Diverse Set of protein ligand complexes, we could identify whether a water molecule was conserved or displaced to an accuracy of 75%. A second model predicted whether water molecules were displaced by polar groups or by non-polar groups to an accuracy of 80%. These results should prove useful for anyone wishing to undertake rational design of new compounds where the displacement of water molecules is being considered as a route to improved affinity.	[Ross, Gregory A.; Biggin, Philip C.] Univ Oxford, Oxford, England; [Morris, Garrett M.] InhibOx, Oxford, England	University of Oxford	Ross, GA (corresponding author), Univ Oxford, Oxford, England.	philip.biggin@bioch.ox.ac.uk	Ross, Gregory/AAA-5568-2021; Morris, Garrett Matthew/F-2465-2019	Morris, Garrett Matthew/0000-0003-1731-8405; Biggin, Philip/0000-0001-5100-8836	Engineering and Physical Sciences Research Council (EPSRC)	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abel R, 2008, J AM CHEM SOC, V130, P2817, DOI 10.1021/ja0771033; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053; Amadasi A, 2008, J MED CHEM, V51, P1063, DOI 10.1021/jm701023h; Barillari C, 2007, J AM CHEM SOC, V129, P2577, DOI 10.1021/ja066980q; Bellocchi D, 2005, BIOORGAN MED CHEM, V13, P1151, DOI 10.1016/j.bmc.2004.11.024; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Carugo O, 1999, ACTA CRYSTALLOGR D, V55, P479, DOI 10.1107/S0907444998012086; Chen DLL, 2005, J COMPUT AID MOL DES, V19, P69, DOI 10.1007/s10822-005-1485-7; Chen JM, 1998, BIOCHEMISTRY-US, V37, P17735, DOI 10.1021/bi981848r; Clarke C, 2001, J AM CHEM SOC, V123, P12238, DOI 10.1021/ja004315q; Davis AM, 2003, ANGEW CHEM INT EDIT, V42, P2718, DOI 10.1002/anie.200200539; de Beer SBA, 2010, CURR TOP MED CHEM, V10, P55, DOI 10.2174/156802610790232288; de Graaf C, 2006, J MED CHEM, V49, P2417, DOI 10.1021/jm0508538; de Graaf C, 2005, J MED CHEM, V48, P2308, DOI 10.1021/jm049650u; ERNST JA, 1995, SCIENCE, V267, P1813, DOI 10.1126/science.7892604; Frydenvang K, 2010, J MED CHEM, V53, P8354, DOI 10.1021/jm101218a; Garcia-Sosa AT, 2010, MOL INFORM, V29, P589, DOI 10.1002/minf.201000007; Garcia-Sosa AT, 2006, J MOL MODEL, V12, P422, DOI 10.1007/s00894-005-0063-1; Garcia-Sosa AT, 2005, J CHEM INF MODEL, V45, P624, DOI 10.1021/ci049694b; Garcia-Sosa AT, 2003, J MOL MODEL, V9, P172, DOI 10.1007/s00894-003-0129-x; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Henchman RH, 2002, J COMPUT CHEM, V23, P861, DOI 10.1002/jcc.10074; Huang N, 2008, J MED CHEM, V51, P4862, DOI 10.1021/jm8006239; Hussain A, 2010, J COMPUT AID MOL DES, V24, P1, DOI 10.1007/s10822-009-9307-y; Imai T, 2007, PROTEINS, V66, P804, DOI 10.1002/prot.21311; Imai T, 2009, J AM CHEM SOC, V131, P12430, DOI 10.1021/ja905029t; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; KELLOGG GE, 1991, J COMPUT AID MOL DES, V5, P545, DOI 10.1007/BF00135313; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Lazaridis T, 1998, J PHYS CHEM B, V102, P3531, DOI 10.1021/jp9723574; Lazaridis T, 1998, J PHYS CHEM B, V102, P3542, DOI 10.1021/jp972358w; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Li Z, 2006, J PHYS CHEM B, V110, P1464, DOI 10.1021/jp056020a; Li Z, 2005, J PHYS CHEM B, V109, P662, DOI 10.1021/jp0477912; Li Z, 2003, J AM CHEM SOC, V125, P6636, DOI 10.1021/ja0299203; Lloyd DG, 2004, J COMPUT AID MOL DES, V18, P89, DOI 10.1023/B:jcam.0000030032.81753.b4; Lu YP, 2007, J CHEM INF MODEL, V47, P668, DOI 10.1021/ci6003527; Luccarelli J, 2010, J CHEM THEORY COMPUT, V6, P3850, DOI 10.1021/ct100504h; Mancera RL, 2007, CURR OPIN DRUG DISC, V10, P275; Mancera RL, 2002, J COMPUT AID MOL DES, V16, P479, DOI 10.1023/A:1021273501447; Michel J, 2010, J COMPUT AID MOL DES, V24, P639, DOI 10.1007/s10822-010-9363-3; Michel J, 2009, J AM CHEM SOC, V131, P15403, DOI 10.1021/ja906058w; MIKOL V, 1995, J MED CHEM, V38, P3361, DOI 10.1021/jm00017a020; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NARTEN AH, 1971, J CHEM PHYS, V55, P2263, DOI 10.1063/1.1676403; Pastor M, 1997, J MED CHEM, V40, P4089, DOI 10.1021/jm970273d; PITT WR, 1991, PROTEIN ENG, V4, P531, DOI 10.1093/protein/4.5.531; Rarey M, 1999, PROTEINS, V34, P17, DOI 10.1002/(SICI)1097-0134(19990101)34:1<17::AID-PROT3>3.0.CO;2-1; Raymer ML, 1997, J MOL BIOL, V265, P445, DOI 10.1006/jmbi.1996.0746; Resat H, 1996, BIOPHYS J, V71, P1179, DOI 10.1016/S0006-3495(96)79322-0; Roberts BC, 2008, J CHEM INF MODEL, V48, P397, DOI 10.1021/ci700285e; Robinson DD, 2010, CHEMMEDCHEM, V5, P618, DOI 10.1002/cmdc.200900501; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rossato G, 2011, J CHEM INF MODEL, V51, P1867, DOI 10.1021/ci200150p; Santos R, 2010, J CHEM INF MODEL, V50, P146, DOI 10.1021/ci900293e; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Setny P, 2010, J PHYS CHEM B, V114, P8667, DOI 10.1021/jp102462s; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Taha MO, 2011, J CHEM INF MODEL, V51, P647, DOI 10.1021/ci100368t; Team RCD, 2011, R LANG ENV STAT COMP; THANKI N, 1988, J MOL BIOL, V202, P637, DOI 10.1016/0022-2836(88)90292-6; Thilagavathi R, 2010, J CHEM INF MODEL, V50, P415, DOI 10.1021/ci900345h; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Rossum G., 1995, PYTHON TUTORIAL, V620; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 1999, J MOL BIOL, V289, P1093, DOI 10.1006/jmbi.1999.2809; Wallnoefer HG, 2011, J COMPUT CHEM, V32, P1743, DOI 10.1002/jcc.21758; Wallnoefer HG, 2010, J PHYS CHEM B, V114, P7405, DOI 10.1021/jp101654g; Wissner A, 2000, J MED CHEM, V43, P3244, DOI 10.1021/jm000206a; Wong SE, 2011, EXPERT OPIN DRUG DIS, V6, P65, DOI 10.1517/17460441.2011.534452; Young RJ, 2006, BIOORG MED CHEM LETT, V16, P5953, DOI 10.1016/j.bmcl.2006.09.001	77	130	131	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32036	10.1371/journal.pone.0032036	http://dx.doi.org/10.1371/journal.pone.0032036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396746	gold, Green Submitted, Green Published			2022-12-25	WOS:000303005000013
J	Auburn, S; Campino, S; Miotto, O; Djimde, AA; Zongo, I; Manske, M; Maslen, G; Mangano, V; Alcock, D; MacInnis, B; Rockett, KA; Clark, TG; Doumbo, OK; Ouedraogo, JB; Kwiatkowski, DP				Auburn, Sarah; Campino, Susana; Miotto, Olivo; Djimde, Abdoulaye A.; Zongo, Issaka; Manske, Magnus; Maslen, Gareth; Mangano, Valentina; Alcock, Daniel; MacInnis, Bronwyn; Rockett, Kirk A.; Clark, Taane G.; Doumbo, Ogobara K.; Ouedraogo, Jean Bosco; Kwiatkowski, Dominic P.			Characterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence Data	PLOS ONE			English	Article							GENETICALLY DIVERSE; MALARIA INFECTIONS; CLINICAL MALARIA; DRUG-TREATMENT; GENOME; EVOLUTION; VIRULENCE; PARASITES; CHILDREN; SURFACE	Our understanding of the composition of multi-clonal malarial infections and the epidemiological factors which shape their diversity remain poorly understood. Traditionally within-host diversity has been defined in terms of the multiplicity of infection (MOI) derived by PCR-based genotyping. Massively parallel, single molecule sequencing technologies now enable individual read counts to be derived on genome-wide datasets facilitating the development of new statistical approaches to describe within-host diversity. In this class of measures the FWS metric characterizes within-host diversity and its relationship to population level diversity. Utilizing P. falciparum field isolates from patients in West Africa we here explore the relationship between the traditional MOI and F-WS approaches. F-WS statistics were derived from read count data at 86,158 SNPs in 64 samples sequenced on the Illumina GA platform. MOI estimates were derived by PCR at the msp-1 and -2 loci. Significant correlations were observed between the two measures, particularly with the msp-1 locus (P=5.92x10(-5)). The F-WS metric should be more robust than the PCR-based approach owing to reduced sensitivity to potential locus-specific artifacts. Furthermore the F-WS metric captures information on a range of parameters which influence out-crossing risk including the number of clones (MOI), their relative proportions and genetic divergence. This approach should provide novel insights into the factors which correlate with, and shape within-host diversity.	[Auburn, Sarah; Campino, Susana; Manske, Magnus; Maslen, Gareth; Alcock, Daniel; MacInnis, Bronwyn; Rockett, Kirk A.; Clark, Taane G.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, S Cambs, England; [Auburn, Sarah] Charles Darwin Univ, Global Hlth Div, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Miotto, Olivo; Kwiatkowski, Dominic P.] Univ Oxford, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok 10700, Thailand; [Djimde, Abdoulaye A.; Doumbo, Ogobara K.] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali; [Zongo, Issaka; Ouedraogo, Jean Bosco] Direct Reg Ouest, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Mangano, Valentina] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] London Sch Hyg & Trop Med, London WC1, England	Wellcome Trust Sanger Institute; Charles Darwin University; Menzies School of Health Research; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Bamako; Sapienza University Rome; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Auburn, S (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, S Cambs, England.	sa3@sanger.ac.uk	Miotto, Olivo/AAE-7124-2019; mangano, valentina/I-2456-2012; Campino, Susana/AAM-2577-2020; Mead, Daniel/AAE-6629-2019; Clark, Taane G./AAM-2570-2020; Auburn, Sarah/N-2266-2013	Miotto, Olivo/0000-0001-8060-6771; Campino, Susana/0000-0003-1403-6138; Mead, Daniel/0000-0001-7717-4330; Clark, Taane G./0000-0001-8985-9265; Mangano, Valentina D/0000-0002-2021-6162; Kwiatkowski, Dominic/0000-0002-5023-0176; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Auburn, Sarah/0000-0002-4638-536X; Maslen, Gareth/0000-0001-7318-3678; Manske, Magnus/0000-0001-5916-0947	Wellcome Trust; Bill and Melinda Gates Foundation; Medical Research Council; Howard Hughes Medical Institution [55005502];  [2004.2.C.f1]; Medical Research Council [G0600718, G19/9] Funding Source: researchfish; MRC [G19/9, G0600718] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institution(Howard Hughes Medical Institute); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The genetic component of this research was funded by the Wellcome Trust, the Bill and Melinda Gates Foundation, and the Medical Research Council. SA, SC, OM, MM, GM, DA, BM, KAA, TGC and DPK were funded by the Wellcome Trust, the Bill and Melinda Gates Foundation, and the Medical Research Council. AAD is supported by a European and Developing Countries Clinical Trial Partnership Senior Fellowship (grant 2004.2.C.f1) and a Howard Hughes Medical Institution International Scholarship (grant 55005502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bereczky S, 2006, T ROY SOC TROP MED H, V100, P248, DOI 10.1016/j.trstmh.2005.03.011; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; COENE J, 1993, MED VET ENTOMOL, V7, P127, DOI 10.1111/j.1365-2915.1993.tb00665.x; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-33; Druilhe P, 1998, J CLIN INVEST, V101, P2008, DOI 10.1172/JCI119890; Engelbrecht F, 2000, ACTA TROP, V74, P63, DOI 10.1016/S0001-706X(99)00044-3; Felger I, 1999, T ROY SOC TROP MED H, V93, pS29, DOI 10.1016/S0035-9203(99)90324-3; FORBES SH, 1995, MOL BIOL EVOL, V12, P1106; FORSYTH KP, 1989, AM J TROP MED HYG, V41, P259, DOI 10.4269/ajtmh.1989.41.259; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Havryliuk T, 2009, MEM I OSWALDO CRUZ, V104, P67, DOI 10.1590/S0074-02762009000100011; Juliano JJ, 2010, P NATL ACAD SCI USA, V107, P20138, DOI 10.1073/pnas.1007068107; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Omumbo JA, 2005, ACTA TROP, V93, P11, DOI 10.1016/j.actatropica.2004.08.010; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Schlotterer C, 1998, CURR BIOL, V8, pR132, DOI 10.1016/S0960-9822(98)70989-3; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; Snounou G, 1998, PARASITOL TODAY, V14, P462, DOI 10.1016/S0169-4758(98)01340-4; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Taylor LH, 1997, P ROY SOC B-BIOL SCI, V264, P927, DOI 10.1098/rspb.1997.0128; VIRIYAKOSOL S, 1995, B WORLD HEALTH ORGAN, V73, P85; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726	38	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32891	10.1371/journal.pone.0032891	http://dx.doi.org/10.1371/journal.pone.0032891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393456	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000303003500111
J	Brucet, S; Boix, D; Nathansen, LW; Quintana, XD; Jensen, E; Balayla, D; Meerhoff, M; Jeppesen, E				Brucet, Sandra; Boix, Dani; Nathansen, Louise W.; Quintana, Xavier D.; Jensen, Elisabeth; Balayla, David; Meerhoff, Mariana; Jeppesen, Erik			Effects of Temperature, Salinity and Fish in Structuring the Macroinvertebrate Community in Shallow Lakes: Implications for Effects of Climate Change	PLOS ONE			English	Article							SPECIES RICHNESS; FEEDING ECOLOGY; AQUATIC INSECTS; DIEL MIGRATION; CHLOROPHYLL-A; ZOOPLANKTON; BRACKISH; BIODIVERSITY; PATTERNS; GRADIENT	Climate warming may lead to changes in the trophic structure and diversity of shallow lakes as a combined effect of increased temperature and salinity and likely increased strength of trophic interactions. We investigated the potential effects of temperature, salinity and fish on the plant-associated macroinvertebrate community by introducing artificial plants in eight comparable shallow brackish lakes located in two climatic regions of contrasting temperature: cold-temperate and Mediterranean. In both regions, lakes covered a salinity gradient from freshwater to oligohaline waters. We undertook day and night-time sampling of macroinvertebrates associated with the artificial plants and fish and free-swimming macroinvertebrate predators within artificial plants and in pelagic areas. Our results showed marked differences in the trophic structure between cold and warm shallow lakes. Plant-associated macroinvertebrates and free-swimming macroinvertebrate predators were more abundant and the communities richer in species in the cold compared to the warm climate, most probably as a result of differences in fish predation pressure. Submerged plants in warm brackish lakes did not seem to counteract the effect of fish predation on macroinvertebrates to the same extent as in temperate freshwater lakes, since small fish were abundant and tended to aggregate within the macrophytes. The richness and abundance of most plant-associated macroinvertebrate taxa decreased with salinity. Despite the lower densities of plant-associated macroinvertebrates in the Mediterranean lakes, periphyton biomass was lower than in cold temperate systems, a fact that was mainly attributed to grazing and disturbance by fish. Our results suggest that, if the current process of warming entails higher chances of shallow lakes becoming warmer and more saline, climatic change may result in a decrease in macroinvertebrate species richness and abundance in shallow lakes.	[Brucet, Sandra; Nathansen, Louise W.; Jensen, Elisabeth; Balayla, David; Meerhoff, Mariana; Jeppesen, Erik] Aarhus Univ, Dept Biosci, Silkeborg, Denmark; [Brucet, Sandra] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Italy; [Boix, Dani; Quintana, Xavier D.] Univ Girona, Fac Ciencies, Inst Aquat Ecol, Girona, Spain; [Boix, Dani; Quintana, Xavier D.] Univ Girona, Fac Ciencies, Dept Environm Sci, Girona, Spain; [Meerhoff, Mariana] Univ Republ, Fac Ciencias, CURE, Dept Ecol & Evoluc, Maldonado, Uruguay; [Jeppesen, Erik] GCRC, Greenland Inst Nat Resources, Nuuk, Greenland; [Jeppesen, Erik] Sinodanish Educ & Res Ctr, Beijing, Peoples R China	Aarhus University; European Commission Joint Research Centre; EC JRC ISPRA Site; Universitat de Girona; Universitat de Girona; Universidad de la Republica, Uruguay; Greenland Institute of Natural Resources	Brucet, S (corresponding author), Aarhus Univ, Dept Biosci, Silkeborg, Denmark.	sandra.brucet-balmana@jrc.ec.europa.eu	Jeppesen, Erik/O-2667-2019; Boix, Dani/L-5190-2014; Quintana, Xavier/L-5083-2014; Jeppesen, Erik/A-4463-2012	Boix, Dani/0000-0001-5468-2236; Quintana, Xavier/0000-0002-4070-1915; Jeppesen, Erik/0000-0002-0542-369X	European Union; Denmark from EU WISER; Denmark from Research Council for Nature and Universe [272-08-0406]; Denmark from Centre for Regional Change in the Earth System (CRES); Spain from Ministerio de Educacion y Ciencia [GL2008-05778/BOS]; Development of Basic Sciences (PEDECIBA); Uruguayan Agency for Research and Innovation (ANII) through the National System of Researchers (SNI) [FCE 2749]; Women in Science LOreal-UNESCO Uruguay; Marie Curie fellowship [MEIF-CT-2006-038366]	European Union(European Commission); Denmark from EU WISER; Denmark from Research Council for Nature and Universe; Denmark from Centre for Regional Change in the Earth System (CRES); Spain from Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); Development of Basic Sciences (PEDECIBA); Uruguayan Agency for Research and Innovation (ANII) through the National System of Researchers (SNI); Women in Science LOreal-UNESCO Uruguay; Marie Curie fellowship(European Commission)	This study is a result of the project REFRESH funded by the European Union under the 7th Framework Programme. Further support was obtained in Denmark from the project EU WISER, The Research Council for Nature and Universe (272-08-0406), and the Centre for Regional Change in the Earth System (CRES), and in Spain from Ministerio de Educacion y Ciencia, Programa de Investigacion Fundamental (GL2008-05778/BOS). M. M. was supported by the Uruguayan Programme for the Development of Basic Sciences (PEDECIBA) and the Uruguayan Agency for Research and Innovation (ANII) through the National System of Researchers (SNI) and project FCE 2749, and the national award for Women in Science LOreal-UNESCO Uruguay. D. B. held a postdoctoral Marie Curie fellowship (MEIF-CT-2006-038366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASER HF, 1995, MAR ECOL PROG SER, V127, P47, DOI 10.3354/meps127047; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; American Public Health Association, 1989, STAND METH EX WAT WA; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; Beklioglu M, 2007, HYDROBIOLOGIA, V584, P317, DOI 10.1007/s10750-007-0577-x; Billard, 1970, ULTRASTRUCTURE COMPA; BLABER SJM, 1976, BIOL J LINN SOC, V8, P267, DOI 10.1111/j.1095-8312.1976.tb00249.x; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Blanco S, 2003, HYDROBIOLOGIA, V506, P473, DOI 10.1023/B:HYDR.0000008583.05327.da; Boix D, 2008, HYDROBIOLOGIA, V597, P53, DOI 10.1007/s10750-007-9221-z; Boix D, 2007, HYDROBIOLOGIA, V584, P347, DOI 10.1007/s10750-007-0579-8; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Brucet S, 2009, ECOGRAPHY, V32, P692, DOI 10.1111/j.1600-0587.2009.05823.x; Burks RL, 2002, FRESHWATER BIOL, V47, P343, DOI 10.1046/j.1365-2427.2002.00824.x; CANFIELD DE, 1984, CAN J FISH AQUAT SCI, V41, P497, DOI 10.1139/f84-059; Cognetti G, 2000, MAR POLLUT BULL, V40, P7, DOI 10.1016/S0025-326X(99)00173-3; Cummins KW, 1996, INTRO AQUATIC INSECT; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Grasshoff K., 1999, METHODS SEAWATER ANA; HART BT, 1991, HYDROBIOLOGIA, V210, P105, DOI 10.1007/BF00014327; Havens KE, 2009, HYDROBIOLOGIA, V628, P165, DOI 10.1007/s10750-009-9754-4; Jensen E, 2010, HYDROBIOLOGIA, V646, P215, DOI 10.1007/s10750-010-0172-4; JEPPESEN E, 1994, HYDROBIOLOGIA, V275, P15, DOI 10.1007/BF00026696; JEPPESEN E, 1997, STRUCTURING ROLE SUB, P369; Jeppesen E, 2007, ECOSYSTEMS, V10, P47, DOI 10.1007/s10021-006-9007-6; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Jones JI, 2003, ECOLOGY, V84, P2155, DOI 10.1890/02-0422; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Kefford BJ, 2003, MAR FRESHWATER RES, V54, P755, DOI 10.1071/MF02081; Marklund O, 2001, FRESHWATER BIOL, V46, P913, DOI 10.1046/j.1365-2427.2001.00726.x; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; Meerhoff M, 2007, GLOBAL CHANGE BIOL, V13, P1888, DOI 10.1111/j.1365-2486.2007.01408.x; Miracle M.R., 2006, Limnetica, V25, P585; Monakov AV, 2003, FEEDING FRESHWATER I; Moss B, 2004, FRESHWATER BIOL, V49, P1633, DOI 10.1111/j.1365-2427.2004.01304.x; MUNOZ I, 1994, HYDROBIOLOGIA, V286, P65, DOI 10.1007/BF00008498; PHILLIPS GL, 1978, AQUAT BOT, V4, P103, DOI 10.1016/0304-3770(78)90012-8; Pinder A.M., 2004, Records of the Western Australian Museum Supplement, V67, P7; Pinder AC, 2001, FRESHWATER BIOL ASS, V60; Piscart C, 2005, HYDROBIOLOGIA, V551, P227, DOI 10.1007/s10750-005-4463-0; PRINCE ED, 1978, FISHERIES, V3, P5; Romo S, 2005, FRESHWATER BIOL, V50, P1706, DOI 10.1111/j.1365-2427.2005.01432.x; Schallenberg M, 2003, MAR ECOL PROG SER, V251, P181, DOI 10.3354/meps251181; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Tachet H., 2000, INVERTEBRES EAU DOUC; Teixeira-de Mello F, 2009, FRESHWATER BIOL, V54, P1202, DOI 10.1111/j.1365-2427.2009.02167.x; UNDERWOOD GJC, 1992, OECOLOGIA, V91, P587, DOI 10.1007/BF00650335; Vizzini S, 2005, ENVIRON BIOL FISH, V72, P259, DOI 10.1007/s10641-004-2586-1; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; WILLIAMS WD, 1990, HYDROBIOLOGIA, V197, P257, DOI 10.1007/BF00026955	53	70	75	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30877	10.1371/journal.pone.0030877	http://dx.doi.org/10.1371/journal.pone.0030877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393354	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500007
J	Li, M; Tian, Y; Zhao, Y; Bu, WJ				Li, Min; Tian, Ying; Zhao, Ying; Bu, Wenjun			Higher Level Phylogeny and the First Divergence Time Estimation of Heteroptera (Insecta: Hemiptera) Based on Multiple Genes	PLOS ONE			English	Article							MOLECULAR EVOLUTION; BAYESIAN-INFERENCE; ABSOLUTE RATES; BUGS INSECTA; DNA; SYSTEMATICS; EXTINCTION; RADIATIONS; NEPOMORPHA; SEQUENCES	Heteroptera, or true bugs, are the largest, morphologically diverse and economically important group of insects with incomplete metamorphosis. However, the phylogenetic relationships within Heteroptera are still in dispute and most of the previous studies were based on morphological characters or with single gene (partial or whole 18S rDNA). Besides, so far, divergence time estimates for Heteroptera totally rely on the fossil record, while no studies have been performed on molecular divergence rates. Here, for the first time, we used maximum parsimony (MP), maximum likelihood (ML) and Bayesian inference (BI) with multiple genes (18S rDNA, 28S rDNA, 16S rDNA and COI) to estimate phylogenetic relationships among the infraorders, and meanwhile, the Penalized Likelihood (r8s) and Bayesian (BEAST) molecular dating methods were employed to estimate divergence time of higher taxa of this suborder. Major results of the present study included: Nepomorpha was placed as the most basal clade in all six trees (MP trees, ML trees and Bayesian trees of nuclear gene data and four-gene combined data, respectively) with full support values. The sister-group relationship of Cimicomorpha and Pentatomomorpha was also strongly supported. Nepomorpha originated in early Triassic and the other six infraorders originated in a very short period of time in middle Triassic. Cimicomorpha and Pentatomomorpha underwent a radiation at family level in Cretaceous, paralleling the proliferation of the flowering plants. Our results indicated that the higher-group radiations within hemimetabolous Heteroptera were simultaneously with those of holometabolous Coleoptera and Diptera which took place in the Triassic. While the aquatic habitat was colonized by Nepomorpha already in the Triassic, the Gerromorpha independently adapted to the semi-aquatic habitat in the Early Jurassic.	[Li, Min; Tian, Ying; Zhao, Ying; Bu, Wenjun] Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China; [Tian, Ying] State Interllectual Property Off Peoples Republ C, Patent Examinat Cooperat Ctr, Beijing, Peoples R China	Nankai University	Li, M (corresponding author), Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China.	wenjunbu@nankai.edu.cn			Natural Science Foundation of China [30725005, 31071959, J0630963]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Natural Science Foundation of China (No. 30725005, No. 31071959 and No. J0630963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar D, 1998, ESTUDIOS MUSEO CIENC, V14, P217; Azar D, 2010, ANN SOC ENTOMOL FR, V46, P193, DOI 10.1080/00379271.2010.10697657; Cassis G, 2010, CLADISTICS, V26, P262, DOI 10.1111/j.1096-0031.2009.00283.x; COBBEN R. H., 1968, Evolutionary trends in Heteroptera. Part I. Eggs, architecture of the shell, gross embryology and eclosion.; Cobben RH, 1978, MEDEDLINGEN LANDBO 2, V78-5, P407; CROZIER RH, 1993, GENETICS, V133, P97; Damgaard Jakob, 2008, Acta Entomologica Musei Nationalis Pragae, V48, P251; Damgaard J, 2008, INSECT SYST EVOL, V39, P431, DOI 10.1163/187631208788784264; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dufour L, 1833, MEM SAVANTS ETRANG A, V4, P123, DOI DOI 10.5962/BHL.TITLE.12418; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Fieber F.X, 1861, EUROPAISCHEN HEMIPTE; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gillott Cedric., 2005, ENTOMOLOGY; Golub V.B., 2008, Paleontologicheskii Zhurnal, V1, P88; Grimaldi David, 2005, pi; Grimaldi David, 1993, American Museum Novitates, V3071, P1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebsgaard MB, 2004, SYST ENTOMOL, V29, P488, DOI 10.1111/j.0307-6970.2004.00254.x; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; JOBB G, 2008, TREEFINDER VERSION; Kaplan AI, 2003, ENCY INSECTS, P369; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Latreille P.A., 1810, CONSIDERATIONS GEN O; LATREILLE PA, 1825, FAMILLES NATURELLES, P1; Lehrmann DJ, 2006, GEOLOGY, V34, P1053, DOI 10.1130/G22827A.1; LESTON D, 1954, NATURE, V174, P91, DOI 10.1038/174091b0; Li HM, 2005, MOL PHYLOGENET EVOL, V37, P313, DOI 10.1016/j.ympev.2005.07.013; Mahner Martin, 1993, Zoologica (Stuttgart), V48, P1; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nel A., 2004, Geologica Acta, V2, P51; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perrichot V, 2005, CRETACEOUS RES, V26, P793, DOI 10.1016/j.cretres.2005.05.003; Popov Y.A., 1991, Geologica et Palaeontologica, V25, P215; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2010, FIGTREE V1 3 1 I EVO; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; RIEGER C, 1976, ZOOMORPHOLOGIE, V83, P109, DOI 10.1007/BF00993483; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schuh R. T., 1995, True bugs of the world (Hemiptera: Heteroptera): classification and natural history.; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; Schuh RT, 1979, COBBEN SYST ZOOL, V28, P653; Shcherbakov D.E., 2002, HIST INSECTS, P152; Shcherbakov DE, 1996, 1996 STUDIES HEMIPTE, P31; STYS P, 1975, ACTA ENTOMOL BOHEMOS, V72, P65; SWEET MH, 1979, ANN ENTOMOL SOC AM, V72, P575, DOI 10.1093/aesa/72.5.575; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Swofford David L., 1996, P407; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner LH, 2004, EARTH-SCI REV, V65, P103, DOI 10.1016/S0012-8252(03)00082-5; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian XX, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.2888.1.5; Tian Y, 2008, MOL PHYLOGENET EVOL, V47, P581, DOI 10.1016/j.ympev.2008.01.034; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Yang Chung-Tu, 2002, Formosan Entomologist, V22, P297; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yao Yunzhi, 2007, Zootaxa, V1442, P37; ZRZAVY J, 1992, ACTA ENTOMOL BOHEMOS, V89, P77; ZRZAVY J, 1990, Acta Universitatis Carolinae-Biologica, V34, P189	75	68	70	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32152	10.1371/journal.pone.0032152	http://dx.doi.org/10.1371/journal.pone.0032152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384163	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500061
J	Stepp, CE; An, Q; Matsuoka, Y				Stepp, Cara E.; An, Qi; Matsuoka, Yoky			Repeated Training with Augmentative Vibrotactile Feedback Increases Object Manipulation Performance	PLOS ONE			English	Article							SENSORY-FEEDBACK; CONTROLLED PROSTHESIS; CYBERNETIC HAND; STIMULATION; DESIGN; SYSTEM; ARM; PERCEPTION; CORTEX	Most users of prosthetic hands must rely on visual feedback alone, which requires visual attention and cognitive resources. Providing haptic feedback of variables relevant to manipulation, such as contact force, may thus improve the usability of prosthetic hands for tasks of daily living. Vibrotactile stimulation was explored as a feedback modality in ten unimpaired participants across eight sessions in a two-week period. Participants used their right index finger to perform a virtual object manipulation task with both visual and augmentative vibrotactile feedback related to force. Through repeated training, participants were able to learn to use the vibrotactile feedback to significantly improve object manipulation. Removal of vibrotactile feedback in session 8 significantly reduced task performance. These results suggest that vibrotactile feedback paired with training may enhance the manipulation ability of prosthetic hand users without the need for more invasive strategies.	[Stepp, Cara E.] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Stepp, Cara E.] Univ Tokyo, Dept Precis Engn, Tokyo, Japan; [An, Qi; Matsuoka, Yoky] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	Boston University; University of Tokyo; University of Washington; University of Washington Seattle	Stepp, CE (corresponding author), Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA.	cstepp@alum.mit.edu	Stepp, Cara/AAQ-6425-2020		National Institute of Child Health and Human Development (NICHD), through the National Center for Medical Rehabilitation Research (NCMRR) [5T32HD007424]; Walter C. and Anita C. Stolov Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007424] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD), through the National Center for Medical Rehabilitation Research (NCMRR); Walter C. and Anita C. Stolov Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant 5T32HD007424 from the National Institute of Child Health and Human Development (NICHD), through the National Center for Medical Rehabilitation Research (NCMRR) and a grant from the Walter C. and Anita C. Stolov Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW PJ, 1981, AM J OCCUP THER, V35, P722, DOI 10.5014/ajot.35.11.722; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P346, DOI 10.1080/17483100701714733; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Carrozza MC, 2006, BIOL CYBERN, V95, P629, DOI 10.1007/s00422-006-0124-2; Castro M C, 1997, IEEE Trans Rehabil Eng, V5, P140, DOI 10.1109/86.593280; Chatterjee A., 2008, J PROSTHETICS ORTHOT, V20, P27, DOI [10.1097/01.JPO.0000311041.61628.be, DOI 10.1097/01.JP0.0000311041.61628.BE]; Cranny A, 2005, MEAS SCI TECHNOL, V16, P931, DOI 10.1088/0957-0233/16/4/005; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Geng B, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-9; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Lanzetta M, 2004, SCAND J PLAST RECONS, V38, P106, DOI 10.1080/02844310310019860; Leung YY, 2005, J NEUROPHYSIOL, V94, P3037, DOI 10.1152/jn.00001.2005; London BM, 2008, IEEE T NEUR SYS REH, V16, P32, DOI 10.1109/TNSRE.2007.907544; MANN RW, 1970, IEEE T MAN MACHINE, VMM11, P110, DOI 10.1109/TMMS.1970.299971; Micera S, 2008, IEEE T NEUR SYS REH, V16, P453, DOI 10.1109/TNSRE.2008.2006207; Miller LA, 2008, ARCH PHYS MED REHAB, V89, P2057, DOI 10.1016/j.apmr.2008.05.016; PATTERSON PE, 1992, J REHABIL RES DEV, V29, P1, DOI 10.1682/JRRD.1992.01.0001; Pylatiuk C, 2006, J PROSTHET ORTHOT, V18, P57, DOI DOI 10.1097/00008526-200604000-00007; Pylatiuk C, 2007, PROSTHET ORTHOT INT, V31, P362, DOI 10.1080/03093640601061265; Riso R R, 1999, Technol Health Care, V7, P401; Schmidl H, 1977, Prosthet Orthot Int, V1, P21; Schultz AE, 2011, PM&R, V3, P55, DOI 10.1016/j.pmrj.2010.06.016; SCOTT RN, 1980, MED BIOL ENG COMPUT, V18, P65, DOI 10.1007/BF02442481; SHANNON GF, 1976, MED BIOL ENG, V14, P289, DOI 10.1007/BF02478123; SHANNON GF, 1979, MED BIOL ENG COMPUT, V17, P73, DOI 10.1007/BF02440956; Stepp C. E., 2010, 32 ANN INT C IEEE EN, P2089; Stepp CE, 2011, IEEE T NEUR SYS REH, V19, P677, DOI 10.1109/TNSRE.2011.2168981; Stepp CE, 2011, P 33 ANN INT C IEEE, P1061; VERRILLO RT, 1992, MUSIC PERCEPT, V9, P281; Zollo L, 2007, IEEE-ASME T MECH, V12, P418, DOI 10.1109/TMECH.2007.901936	32	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32743	10.1371/journal.pone.0032743	http://dx.doi.org/10.1371/journal.pone.0032743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384283	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500109
J	Clements, JA; Mercer, FC; Paterno, GD; Gillespie, LL				Clements, Jaclyn A.; Mercer, F. Corinne; Paterno, Gary D.; Gillespie, Laura L.			Differential Splicing Alters Subcellular Localization of the Alpha but not Beta Isoform of the MIER1 Transcriptional Regulator in Breast Cancer Cells	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; TUMOR-SUPPRESSOR GENE; PROSTATE-CANCER; XENOPUS-LAEVIS; LEPTOMYCIN B; CO-REPRESSOR; SANT DOMAIN; PROTEIN; RECEPTOR; PHOSPHORYLATION	MIER1 was originally identified in a screen for novel fibroblast growth factor activated early response genes. The mier1 gene gives rise to multiple transcripts encoding protein isoforms that differ in their amino (N-) and carboxy (C-) termini. Much of the work to date has focused on the two C-terminal variants, MIER1 alpha and beta, both of which have been shown to function as transcriptional repressors. Our previous work revealed a dramatic shift in MIER1 alpha subcellular localization from nuclear in normal breast tissue to cytoplasmic in invasive breast carcinoma, suggesting that loss of nuclear MIER1 alpha may play a role in breast cancer development. In the present study, we investigated whether alternative splicing to include a cassette exon and produce an N-terminal variant of MIER1 alpha affects its subcellular localization in MCF7 breast carcinoma cells. We demonstrate that this cassette exon, exon 3A, encodes a consensus leucine-rich nuclear export signal (NES). Inclusion of this exon in MIER1 alpha to produce the MIER1-3A alpha isoform altered its subcellular distribution in MCF7 cells from 81% nuclear to 2% nuclear and this change in localization was abrogated by mutation of critical leucines within the NES. Treatment with leptomycin B (LMB), an inhibitor of the nuclear export receptor CRM1, resulted in a significant increase in the percentage of cells with nuclear MIER1-3A alpha, from 4% to 53%, demonstrating that cytoplasmic localization of this isoform was due to CRM1-dependent nuclear export. Inclusion of exon 3A in MIER1 beta to produce the N-terminal variant MIER1-3A beta however had little effect on the nuclear targeting of this isoform. Our results demonstrate that alternative splicing to include exon 3A specifically affects the localization pattern of the alpha isoform.	[Clements, Jaclyn A.; Mercer, F. Corinne; Paterno, Gary D.; Gillespie, Laura L.] Mem Univ Newfoundland, Fac Med, Terry Fox Canc Res Labs, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Clements, JA (corresponding author), Univ Moncton, Ctr Format Med Nouveau Brunswick, Moncton, NB E1A 3E9, Canada.	lgillesp@mun.ca			Canadian Breast Cancer Foundation-Atlantic Chapter; Memorial University of Newfoundland	Canadian Breast Cancer Foundation-Atlantic Chapter; Memorial University of Newfoundland	Funding for this research was provided by the Canadian Breast Cancer Foundation-Atlantic Chapter (http://www.cbcf.org/atlantic/Pages/default.aspx). No grant number was assigned. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JAC was the recipient of a Memorial University of Newfoundland Dean's Fellowship.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Blackmore Tina M, 2008, BMC Res Notes, V1, P68, DOI 10.1186/1756-0500-1-68; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Luchman HA, 1999, MECH DEVELOP, V80, P111; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McCarthy PL, 2008, BRIT J CANCER, V99, P639, DOI 10.1038/sj.bjc.6604518; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Paterno GD, 1997, J BIOL CHEM, V272, P25591, DOI 10.1074/jbc.272.41.25591; Paterno GD, 1998, GENE, V222, P77, DOI 10.1016/S0378-1119(98)00473-9; Paterno GD, 2002, GENE, V295, P79, DOI 10.1016/S0378-1119(02)00823-5; Post JN, 2001, FEBS LETT, V502, P41, DOI 10.1016/S0014-5793(01)02653-9; Rasband W.S., 1997, IMAGE J; Reynolds JN, 1996, MOL BRAIN RES, V35, P11, DOI 10.1016/0169-328X(95)00172-O; Rodriguez E., 2010, PLOS ONE, V5; RYAN PJ, 1994, DEV BIOL, V166, P101, DOI 10.1006/dbio.1994.1299; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Solari F, 1999, DEVELOPMENT, V126, P2483; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Thorne LB, 2005, DNA SEQUENCE, V16, P237, DOI 10.1080/10425170500069783; Wang L, 2008, EMBO REP, V9, P555, DOI 10.1038/embor.2008.67; Williams KL, 2011, J NEUROSCI RES, V89, P1160, DOI 10.1002/jnr.22634; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X	39	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32499	10.1371/journal.pone.0032499	http://dx.doi.org/10.1371/journal.pone.0032499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384264	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000302916800040
J	Reed, TE; Daunt, F; Kiploks, AJ; Burthe, SJ; Granroth-Wilding, HMV; Takahashi, EA; Newell, M; Wanless, S; Cunningham, EJA				Reed, Thomas E.; Daunt, Francis; Kiploks, Adam J.; Burthe, Sarah J.; Granroth-Wilding, Hanna M. V.; Takahashi, Emi A.; Newell, Mark; Wanless, Sarah; Cunningham, Emma J. A.			Impacts of Parasites in Early Life: Contrasting Effects on Juvenile Growth for Different Family Members	PLOS ONE			English	Article							EARLY DEVELOPMENTAL STRESS; BLACK-HEADED GULLS; PASSERINE BIRD; GREAT TITS; HATCHING ASYNCHRONY; BROOD-REDUCTION; EUROPEAN SHAGS; WITHIN-CLUTCH; ZEBRA FINCHES; HOUSE MARTIN	Parasitism experienced early in ontogeny can have a major impact on host growth, development and future fitness, but whether siblings are affected equally by parasitism is poorly understood. In birds, hatching asynchrony induced by hormonal or behavioural mechanisms largely under parental control might predispose young to respond to infection in different ways. Here we show that parasites can have different consequences for offspring depending on their position in the family hierarchy. We experimentally treated European Shag (Phalacrocorax aristoteli) nestlings with the broad-spectrum anti-parasite drug ivermectin and compared their growth rates with nestlings from control broods. Average growth rates measured over the period of linear growth (10 days to 30 days of age) and survival did not differ for nestlings from treated and control broods. However, when considering individuals within broods, parasite treatment reversed the patterns of growth for individual family members: last-hatched nestlings grew significantly slower than their siblings in control nests but grew faster in treated nests. This was at the expense of their earlier-hatched brood-mates, who showed an overall growth rate reduction relative to last-hatched nestlings in treated nests. These results highlight the importance of exploring individual variation in the costs of infection and suggest that parasites could be a key factor modulating within-family dynamics, sibling competition and developmental trajectories from an early age.	[Reed, Thomas E.; Kiploks, Adam J.; Granroth-Wilding, Hanna M. V.; Takahashi, Emi A.; Cunningham, Emma J. A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Reed, Thomas E.; Daunt, Francis; Burthe, Sarah J.; Newell, Mark; Wanless, Sarah] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Reed, Thomas E.] Netherlands Inst Ecol, Wageningen, Netherlands	University of Edinburgh; UK Centre for Ecology & Hydrology (UKCEH); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Reed, TE (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	t.reed@nioo.knaw.nl	Reed, Thomas E/A-5788-2012; Cunningham, Emma/I-9190-2012; Wanless, Sarah/K-2338-2012; Burthe, Sarah J/Q-9505-2016; Daunt, Francis/K-6688-2012; KNAW, NIOO-KNAW/A-4320-2012	Reed, Thomas E/0000-0002-2993-0477; Wanless, Sarah/0000-0002-2788-4606; Burthe, Sarah J/0000-0001-8871-3432; Daunt, Francis/0000-0003-4638-3388; KNAW, NIOO-KNAW/0000-0002-3835-159X	University of Edinburgh; Royal Society; Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council [CEH010021] Funding Source: researchfish	University of Edinburgh; Royal Society(Royal Society of London); Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by a Principle's Studentship to T.E.R. from the University of Edinburgh, a fellowship to E.J.A.C. from the Royal Society and a Vacation Scholarship from the Association for the Study of Animal Behaviour (ASAB) to A.J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abollo E, 2001, J HELMINTHOL, V75, P209; Baayen RH, 2008, R PACKAGE VERSION 09; Badyaev AV, 2006, P NATL ACAD SCI USA, V103, P14406, DOI 10.1073/pnas.0602452103; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Becker PH, 2007, J ORNITHOL, V148, pS377, DOI 10.1007/s10336-007-0157-x; Bischoff LL, 2009, BEHAV ECOL, V20, P265, DOI 10.1093/beheco/arp012; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Christe P, 1998, OIKOS, V83, P175, DOI 10.2307/3546559; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; COOCH EG, 1991, J ANIM ECOL, V60, P483, DOI 10.2307/5293; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Daunt F, 2001, FUNCT ECOL, V15, P211, DOI 10.1046/j.1365-2435.2001.00515.x; Daunt F, 2001, ARDEA, V89, P449; Dawson RD, 2005, J AVIAN BIOL, V36, P127, DOI 10.1111/j.0908-8857.2005.03406.x; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Fargallo JA, 2002, ECOL LETT, V5, P95, DOI 10.1046/j.1461-0248.2002.00290.x; Fitze PS, 2004, ECOLOGY, V85, P2018, DOI 10.1890/03-0138; Forbes S, 2009, OIKOS, V118, P1561, DOI 10.1111/j.1600-0706.2009.17702.x; FUJIOKA M, 1985, ANIM BEHAV, V33, P1228, DOI 10.1016/S0003-3472(85)80183-4; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; GOWATY PA, 1991, CURR ORNITHOL, V8, P141; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lamka J, 1997, VET MED-CZECH, V42, P157; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mainwaring MC, 2010, J EVOLUTION BIOL, V23, P1302, DOI 10.1111/j.1420-9101.2010.01997.x; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Moller Anders Pape, 1997, P105; MOLLER AP, 1994, OECOLOGIA, V98, P263, DOI 10.1007/BF00324213; Moller AP, 1990, POPULATION BIOL PASS, P269; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Muller W, 2004, BEHAV ECOL, V15, P893, DOI 10.1093/beheco/arh091; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; O'Brien EL, 2009, OIKOS, V118, P1743, DOI 10.1111/j.1600-0706.2009.17692.x; Parejo D, 2007, J AVIAN BIOL, V38, P717, DOI 10.1111/j.2007.0908-8857.04081.x; Pastoret P.-P., 1998, HDB VERTEBRATE IMMUN; Potti J, 1996, P ROY SOC B-BIOL SCI, V263, P9, DOI 10.1098/rspb.1996.0002; Raberg L, 2005, OECOLOGIA, V145, P496, DOI 10.1007/s00442-005-0133-1; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ringsby TH, 1998, J AVIAN BIOL, V29, P241, DOI 10.2307/3677106; Ros AFH, 1997, AM NAT, V150, P201, DOI 10.1086/286063; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saino N, 2001, J AVIAN BIOL, V32, P263, DOI 10.1111/j.0908-8857.2001.320309.x; SHARMA RL, 1990, VET PARASITOL, V37, P307, DOI 10.1016/0304-4017(90)90014-3; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SNOW BARBARA, 1960, IBIS, V102, P554, DOI 10.1111/j.1474-919X.1960.tb07132.x; STOKLAND JN, 1988, AUK, V105, P308, DOI 10.2307/4087495; STOUFFER PC, 1991, AUK, V108, P519, DOI 10.2307/4088092; Szep T, 2000, OECOLOGIA, V125, P201, DOI 10.1007/s004420000447; Szep T, 1999, OECOLOGIA, V119, P9, DOI 10.1007/s004420050755; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Velando A, 2000, ARDEA, V88, P127; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4	68	15	16	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32236	10.1371/journal.pone.0032236	http://dx.doi.org/10.1371/journal.pone.0032236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384190	Green Published, gold, Green Accepted			2022-12-25	WOS:000302916800031
J	Alsina, FC; Irala, D; Fontanet, PA; Hita, FJ; Ledda, F; Paratcha, G				Alsina, Fernando C.; Irala, Dolores; Fontanet, Paula A.; Hita, Francisco J.; Ledda, Fernanda; Paratcha, Gustavo			Sprouty4 Is an Endogenous Negative Modulator of TrkA Signaling and Neuronal Differentiation Induced by NGF	PLOS ONE			English	Article							TYROSINE KINASE; ERK ACTIVATION; PROTEIN-KINASE; GROWTH; ANTAGONIST; PATHWAYS; CELLS; TRANSDUCTION; DOWNSTREAM; INHIBITION	The Sprouty (Spry) family of proteins represents endogenous regulators of downstream signaling pathways induced by receptor tyrosine kinases (RTKs). Using real time PCR, we detect a significant increase in the expression of Spry4 mRNA in response to NGF, indicating that Spry4 could modulate intracellular signaling pathways and biological processes induced by NGF and its receptor TrkA. In this work, we demonstrate that overexpression of wild-type Spry4 causes a significant reduction in MAPK and Rac1 activation and neurite outgrowth induced by NGF. At molecular level, our findings indicate that ectopic expression of a mutated form of Spry4 (Y53A), in which a conserved tyrosine residue was replaced, fail to block both TrkA-mediated Erk/MAPK activation and neurite outgrowth induced by NGF, suggesting that an intact tyrosine 53 site is required for the inhibitory effect of Spry4 on NGF signaling. Downregulation of Spry4 using small interference RNA knockdown experiments potentiates PC12 cell differentiation and MAPK activation in response to NGF. Together, these findings establish a new physiological mechanism through which Spry4 regulates neurite outgrowth reducing not only the MAPK pathway but also restricting Rac1 activation in response to NGF.	[Alsina, Fernando C.; Irala, Dolores; Fontanet, Paula A.; Hita, Francisco J.; Ledda, Fernanda; Paratcha, Gustavo] Univ Buenos Aires, Div Mol & Cellular Neurosci, Inst Cellular Biol & Neurosci Prof Dr E De Robert, CONICET,Sch Med, Buenos Aires, DF, Argentina; [Ledda, Fernanda; Paratcha, Gustavo] Karolinska Inst, Dept Neurosci, Lab Mol & Cellular Neurosci, Stockholm, Sweden	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Karolinska Institutet	Alsina, FC (corresponding author), Univ Buenos Aires, Div Mol & Cellular Neurosci, Inst Cellular Biol & Neurosci Prof Dr E De Robert, CONICET,Sch Med, Buenos Aires, DF, Argentina.	gustavo.paratcha@ki.se	Hita, Francisco Javier J./G-7363-2017	Hita, Francisco Javier J./0000-0003-3576-3342; Fontanet, Paula/0000-0002-5324-6077; Paratcha, Gustavo/0000-0002-0804-4433	Argentine Agency for Promotion of Science and Technology [ANPCyT-PICT2007-01034, PICT-PRH2008-00282]; Swedish Medical Research Council [K2007-68X-20483-01-3, 33SX-14773-01A]; Karolinska Institute [2007-FoBi0594]; Argentine Medical Research Council (CONICET); J. S. Guggenheim Memorial Foundation; CONICET; ANPCyT;  [UBACyT-2010-2012-GC (20020090100227)]	Argentine Agency for Promotion of Science and Technology; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); Argentine Medical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); J. S. Guggenheim Memorial Foundation; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); 	Financial support was obtained from the Argentine Agency for Promotion of Science and Technology (ANPCyT-PICT2007-01034 and PICT-PRH2008-00282), Swedish Medical Research Council (K2007-68X-20483-01-3 and 33SX-14773-01A), Karolinska Institute (2007-FoBi0594), UBACyT-2010-2012-GC (20020090100227). GP and FL were supported by an Independent Research Career Position from the Argentine Medical Research Council (CONICET). GP is additionally supported by a J. S. Guggenheim Memorial Foundation Fellowship Award. DI, PF and FH were supported by a fellowship from CONICET and FCA was supported by a fellowship from ANPCyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Baudet C, 2000, DEVELOPMENT, V127, P4335; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Ledda F, 2007, BIOMARK INSIGHTS, V2, P45; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Li X, 2003, BIOCHEM SOC T, V31, P1445; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	39	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32087	10.1371/journal.pone.0032087	http://dx.doi.org/10.1371/journal.pone.0032087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384148	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100051
J	Dasgupta, S; Sirisha, PVS; Neelaveni, K; Anuradha, K; Reddy, BM				Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Neelaveni, Kudugunti; Anuradha, Katragadda; Reddy, B. Mohan			Association of CAPN10 SNPs and Haplotypes with Polycystic Ovary Syndrome among South Indian Women	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; CALPAIN-10; GENE; POLYMORPHISMS; PREVALENCE; VARIANTS; RISK	Polycystic Ovary Syndrome (PCOS) is known to be characterized by metabolic disorder in which hyperinsulinemia and peripheral insulin resistance are central features. Given the physiological overlap between PCOS and type-2 diabetes (T2DM), and calpain 10 gene (CAPN10) being a strong candidate for T2DM, a number of studies have analyzed CAPN10 SNPs among PCOS women yielding contradictory results. Our study is first of its kind to investigate the association pattern of CAPN10 polymorphisms (UCSNP-44, 43, 56, 19 and 63) with PCOS among Indian women. 250 PCOS cases and 299 controls from Southern India were recruited for this study. Allele and genotype frequencies of the SNPs were determined and compared between the cases and controls. Results show significant association of UCSNP-44 genotype CC with PCOS (p = 0.007) with highly significant odds ratio when compared to TC (OR = 2.51, p = 0.003, 95% CI = 1.37-4.61) as well as TT (OR = 1.94, p = 0.016, 95% CI = 1.13-3.34). While the haplotype carrying the SNP-44 and SNP-19 variants (21121) exhibited a 2 fold increase in the risk for PCOS (OR = 2.37, p = 0.03), the haplotype containing SNP-56 and SNP-19 variants (11221) seems to have a protective role against PCOS (OR = 0.20, p = 0.004). Our results support the earlier evidence for a possible role of UCSNP-44 of the CAPN10 gene in the manifestation of PCOS.	[Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Neelaveni, Kudugunti] Osmania Gen Hosp, Dept Endocrinol, Hyderabad, Andhra Pradesh, India; [Anuradha, Katragadda] Anu Test Tube Baby Ctr, Hyderabad, Andhra Pradesh, India	Indian Statistical Institute	Dasgupta, S (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in			Indian Statistical Institute	Indian Statistical Institute	This work was supported by the Indian Statistical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2010, DIABETES VASC DIS RE, V7, P63, DOI 10.1177/1479164109351370; Bodhini D, 2011, METABOLISM, V60, P681, DOI 10.1016/j.metabol.2010.07.001; Cassell PG, 2002, DIABETES, V51, P1622, DOI 10.2337/diabetes.51.5.1622; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Ehrmann DA, 2002, POLYCYSTIC OVARY SYNDROME, P159; Ehrmann DA, 2002, J CLIN ENDOCR METAB, V87, P1669, DOI 10.1210/jc.87.4.1669; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; El Mkadem SA, 2001, DIABETES, V50, P2164, DOI 10.2337/diabetes.50.9.2164; Escobar-Morreale HF, 2002, FERTIL STERIL, V77, P581, DOI 10.1016/S0015-0282(01)03206-X; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Franks S, 2001, HUM REPROD UPDATE, V7, P405, DOI 10.1093/humupd/7.4.405; Gonzalez A, 2003, J CLIN ENDOCR METAB, V88, P5529, DOI 10.1210/jc.2003-030322; Gonzalez A, 2002, J CLIN ENDOCR METAB, V87, P3971, DOI 10.1210/jc.87.8.3971; Haddad L, 2002, J CLIN ENDOCR METAB, V87, P2606, DOI 10.1210/jc.87.6.2606; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Villuendas G, 2003, FERTIL STERIL, V79, P219, DOI 10.1016/S0015-0282(02)04570-3; Vollmert C, 2007, AM J PHYSIOL-ENDOC M, V292, pE836, DOI 10.1152/ajpendo.00584.2005; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285	23	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32192	10.1371/journal.pone.0032192	http://dx.doi.org/10.1371/journal.pone.0032192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384174	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916100058
J	Li, YZ; Chigurupati, S; Holloway, HW; Mughal, M; Tweedie, D; Bruestle, DA; Mattson, MP; Wang, Y; Harvey, BK; Ray, B; Lahiri, DK; Greig, NH				Li, Yazhou; Chigurupati, Srinivasulu; Holloway, Harold W.; Mughal, Mohamed; Tweedie, David; Bruestle, Daniel A.; Mattson, Mark P.; Wang, Yun; Harvey, Brandon K.; Ray, Balmiki; Lahiri, Debomoy K.; Greig, Nigel H.			Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; RECEPTOR EXPRESSION; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; PROLONGS SURVIVAL	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by a progressive loss of lower motor neurons in the spinal cord. The incretin hormone, glucagon-like peptide-1 (GLP-1), facilitates insulin signaling, and the long acting GLP-1 receptor agonist exendin-4 (Ex-4) is currently used as an anti-diabetic drug. GLP-1 receptors are widely expressed in the brain and spinal cord, and our prior studies have shown that Ex-4 is neuroprotective in several neurodegenerative disease rodent models, including stroke, Parkinson's disease and Alzheimer's disease. Here we hypothesized that Ex-4 may provide neuroprotective activity in ALS, and hence characterized Ex-4 actions in both cell culture (NSC-19 neuroblastoma cells) and in vivo (SOD1 G93A mutant mice) models of ALS. Ex-4 proved to be neurotrophic in NSC-19 cells, elevating choline acetyltransferase (ChAT) activity, as well as neuroprotective, protecting cells from hydrogen peroxide-induced oxidative stress and staurosporine-induced apoptosis. Additionally, in both wild-type SOD1 and mutant SOD1 (G37R) stably transfected NSC-19 cell lines, Ex-4 protected against trophic factor withdrawal-induced toxicity. To assess in vivo translation, SOD1 mutant mice were administered vehicle or Ex-4 at 6-weeks of age onwards to end-stage disease via subcutaneous osmotic pump to provide steady-state infusion. ALS mice treated with Ex-4 showed improved glucose tolerance and normalization of behavior, as assessed by running wheel, compared to control ALS mice. Furthermore, Ex-4 treatment attenuated neuronal cell death in the lumbar spinal cord; immunohistochemical analysis demonstrated the rescue of neuronal markers, such as ChAT, associated with motor neurons. Together, our results suggest that GLP-1 receptor agonists warrant further evaluation to assess whether their neuroprotective potential is of therapeutic relevance in ALS.	[Li, Yazhou; Chigurupati, Srinivasulu; Holloway, Harold W.; Mughal, Mohamed; Tweedie, David; Bruestle, Daniel A.; Mattson, Mark P.; Greig, Nigel H.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Wang, Yun; Harvey, Brandon K.] NIDA, Mol Neuropsychiat Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Ray, Balmiki; Lahiri, Debomoy K.] Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Indiana University System; Indiana University Bloomington	Li, YZ (corresponding author), NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	Greign@grc.nia.nih.gov	Harvey, Brandon Keith/AAY-4080-2021; Lahiri, Debomoy/AAZ-3322-2020; Harvey, Brandon K/A-5559-2010; Mattson, Mark P/F-6038-2012	Harvey, Brandon Keith/0000-0002-4036-1383; 	National Institute on Aging and National Institute on Drug Abuse, National Institutes of Health; National Institute on Aging [AG18379, AG18884]; NATIONAL INSTITUTE ON AGING [R01AG018379, ZIAAG000313, ZIAAG000314, R01AG018884, ZIAAG000333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000461, ZIADA000576, ZIADA000443, ZIADA000429] Funding Source: NIH RePORTER	National Institute on Aging and National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Intramural Research Programs of the National Institute on Aging and National Institute on Drug Abuse, National Institutes of Health, and by the National Institute on Aging grants (AG18379 and AG18884) to D. K. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035; Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Appel S H, 2011, Acta Myol, V30, P4; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Banks WA, 2004, J PHARMACOL EXP THER, V309, P469, DOI 10.1124/jpet.103.063222; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruestle DA, 2009, NEUROMOL MED, V11, P58, DOI 10.1007/s12017-009-8064-3; Calara F, 2005, CLIN THER, V27, P210, DOI 10.1016/j.clinthera.2005.02.008; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chowen JA, 1999, NEUROPEPTIDES, V33, P212, DOI 10.1054/npep.1999.0757; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Dalle S, 2011, CURR MOL PHARM; de Aguilar JLG, 2007, J NEUROCHEM, V101, P1153, DOI 10.1111/j.1471-4159.2006.04408.x; DELGADO E, 1995, PEPTIDES, V16, P225, DOI 10.1016/0196-9781(94)00175-8; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dibaj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017910; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fortin JP, 2010, J PHARMACOL EXP THER, V332, P274, DOI 10.1124/jpet.109.160531; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Habib AA, 2011, EXPERT OPIN EMERG DR, V16, P537, DOI 10.1517/14728214.2011.604312; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Holscher C, 2010, VITAM HORM, V84, P331, DOI [10.1016/B978-0-12-381517-0.00013-8, 10.1016/S0083-6729(10)84005-1]; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; HUBBARD RW, 1992, NEUROLOGY, V42, P1532, DOI 10.1212/WNL.42.8.1532; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Kim SJ, 2011, CELL DEATH DIFFER; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Lambrechts D, 2004, TRENDS MOL MED, V10, P275, DOI 10.1016/j.molmed.2004.04.004; Lee JC, 2011, NEUROL RES, V33, P33, DOI 10.1179/016164110X12807570509899; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lim JG, 2010, NEUROSCI LETT, V479, P13, DOI 10.1016/j.neulet.2010.05.017; Liu WJ, 2011, BRIT J PHARMACOL, V164, P1410, DOI 10.1111/j.1476-5381.2011.01272.x; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakagawa A, 2004, AUTON NEUROSCI-BASIC, V110, P36, DOI 10.1016/j.autneu.2003.11.001; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pawlyk AC, 2010, CURR PHARM DESIGN, V16, P2053; Pedersen WA, 1999, EXP NEUROL, V155, P1, DOI 10.1006/exnr.1998.6890; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Ray B, 2009, BRAIN RES, V1297, P160, DOI 10.1016/j.brainres.2009.07.096; REYES ET, 1984, J NEUROL SCI, V63, P317, DOI 10.1016/0022-510X(84)90154-0; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Schiffer D, 2004, AMYOTROPH LATERAL SC, V5, P22, DOI 10.1080/14660820310016822; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Shimizu T, 2011, AMYOTROPH LATERAL SC, V12, P379, DOI 10.3109/17482968.2010.539234; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P1458, DOI 10.1016/j.clinph.2006.04.016; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Wegorzewska I, 2011, NEURODEGENER DIS, V8, P262, DOI 10.1159/000321547; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Xie XY, 2011, MED SCI MONITOR, V17, pBR35, DOI 10.12659/MSM.881383	86	86	91	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32008	10.1371/journal.pone.0032008	http://dx.doi.org/10.1371/journal.pone.0032008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384126	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100044
J	Cedervall, T; Hansson, LA; Lard, M; Frohm, B; Linse, S				Cedervall, Tommy; Hansson, Lars-Anders; Lard, Mercy; Frohm, Birgitta; Linse, Sara			Food Chain Transport of Nanoparticles Affects Behaviour and Fat Metabolism in Fish	PLOS ONE			English	Article							PLASMA-PROTEIN ADSORPTION; SOLID-LIPID-NANOPARTICLES; APOLIPOPROTEIN-A-I; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; FIBRILLATION; INHIBITION; EXPRESSION; PATTERNS; CORONA	Nano-sized (10(-9)-10(-7) m) particles offer many technical and biomedical advances over the bulk material. The use of nanoparticles in cosmetics, detergents, food and other commercial products is rapidly increasing despite little knowledge of their effect on organism metabolism. We show here that commercially manufactured polystyrene nanoparticles, transported through an aquatic food chain from algae, through zooplankton to fish, affect lipid metabolism and behaviour of the top consumer. At least three independent metabolic parameters differed between control and test fish: the weight loss, the triglycerides:cholesterol ratio in blood serum, and the distribution of cholesterol between muscle and liver. Moreover, we demonstrate that nanoparticles bind to apolipoprotein A-I in fish serum in-vitro, thereby restraining them from properly utilising their fat reserves if absorbed through ingestion. In addition to the metabolic effects, we show that consumption of nanoparticle-containing zooplankton affects the feeding behaviour of the fish. The time it took the fish to consume 95% of the food presented to them was more than doubled for nanoparticle-exposed compared to control fish. Since many nano-sized products will, through the sewage system, end up in freshwater and marine habitats, our study provides a potential bioassay for testing new nano-sized material before manufacturing. In conclusion, our study shows that from knowledge of the molecular composition of the protein corona around nanoparticles it is possible to make a testable molecular hypothesis and bioassay of the potential biological risks of a defined nanoparticle at the organism and ecosystem level.	[Cedervall, Tommy; Frohm, Birgitta; Linse, Sara] Lund Univ, Ctr Chem, Dept Biochem & Struct Biol, Lund, Sweden; [Hansson, Lars-Anders; Lard, Mercy] Lund Univ, Dept Biol Aquat Ecol, Lund, Sweden	Lund University; Lund University	Cedervall, T (corresponding author), Lund Univ, Ctr Chem, Dept Biochem & Struct Biol, Lund, Sweden.	Sara.Linse@biochemistry.lu.se	Hansson, Lars-Anders/HCI-2735-2022; Lard, Mercy/C-4193-2011; Cedervall, Tommy/AAT-9766-2021; Lard, Mercy/R-2035-2019; Lard, Mercy/AAV-6577-2021	Lard, Mercy/0000-0001-9243-4735; Cedervall, Tommy/0000-0003-2255-8446; Lard, Mercy/0000-0001-9243-4735; Hansson, Lars-Anders/0000-0002-3035-1317; Linse, Sara/0000-0001-9629-7109	Nano Vaccin Centre (Copenhagen); Crafoord Foundation (Lund); Swedish Government to the Nanometer Structure Consortium (Lund); Swedish Research Council, VR	Nano Vaccin Centre (Copenhagen); Crafoord Foundation (Lund); Swedish Government to the Nanometer Structure Consortium (Lund); Swedish Research Council, VR(Swedish Research Council)	This work was supported by Nano Vaccin Centre (Copenhagen), the Crafoord Foundation (Lund), Swedish Government to the Nanometer Structure Consortium (Lund), and the Swedish Research Council, VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Behrens S, 2011, NANOSCALE, V3, P877, DOI 10.1039/c0nr00634c; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; Cabaleiro-Lago C, 2008, J AM CHEM SOC, V130, P15437, DOI 10.1021/ja8041806; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chang C, 2010, J AUTOIMMUN, V34, pJ234, DOI 10.1016/j.jaut.2009.11.009; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Diederichs JE, 1996, ELECTROPHORESIS, V17, P607, DOI 10.1002/elps.1150170332; Goppert TM, 2005, EUR J PHARM BIOPHARM, V60, P361, DOI 10.1016/j.ejpb.2005.02.006; Goppert TM, 2005, J DRUG TARGET, V13, P179, DOI 10.1080/10611860500071292; Goppert TM, 2003, J DRUG TARGET, V11, P225, DOI 10.1080/10611860310001615956; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Jiang Y, 2010, PLOS ONE, V5; Kashiwada S, 2006, ENVIRON HEALTH PERSP, V114, P1697, DOI 10.1289/ehp.9209; Lard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013516; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Llewellyn L, 1998, BBA-GENE STRUCT EXPR, V1442, P399, DOI 10.1016/S0167-4781(98)00171-7; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Oslakovic C, 2011, NANOMEDICIN IN PRESS; POWELL R, 1991, GENE, V104, P155, DOI 10.1016/0378-1119(91)90245-7; Ramsden CS, 2009, ECOTOXICOLOGY, V18, P939, DOI 10.1007/s10646-009-0357-7; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Smith CJ, 2007, AQUAT TOXICOL, V82, P94, DOI 10.1016/j.aquatox.2007.02.003; Subbiah R, 2010, CURR MED CHEM, V17, P4559, DOI 10.2174/092986710794183024; Thode K, 1997, PHARMACEUT RES, V14, P905, DOI 10.1023/A:1012104017761	31	277	296	14	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32254	10.1371/journal.pone.0032254	http://dx.doi.org/10.1371/journal.pone.0032254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384193	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500089
J	Nino, G; Hu, AH; Grunstein, JS; McDonough, J; Kreiger, PA; Josephson, MB; Choi, JK; Grunstein, MM				Nino, Gustavo; Hu, Aihua; Grunstein, Judith S.; McDonough, Joseph; Kreiger, Portia A.; Josephson, Maureen B.; Choi, John K.; Grunstein, Michael M.			G Protein beta gamma-Subunit Signaling Mediates Airway Hyperresponsiveness and Inflammation in Allergic Asthma	PLOS ONE			English	Article							PHOSDUCIN-LIKE PROTEIN; SMALL-MOLECULE DISRUPTION; SMOOTH-MUSCLE FUNCTION; COUPLED RECEPTOR; ADRENOCEPTOR RESPONSIVENESS; ALTERED RESPONSIVENESS; PHOSPHODIESTERASE 4D5; KINASE PATHWAY; UP-REGULATION; MURINE MODEL	Since the G beta gamma subunit of Gi protein has been importantly implicated in regulating immune and inflammatory responses, this study investigated the potential role and mechanism of action of G beta gamma signaling in regulating the induction of airway hyperresponsiveness (AHR) in a rabbit model of allergic asthma. Relative to non-sensitized animals, OVA-sensitized rabbits challenged with inhaled OVA exhibited AHR, lung inflammation, elevated BAL levels of IL-13, and increased airway phosphodiesterase-4 (PDE4) activity. These proasthmatic responses were suppressed by pretreatment with an inhaled membrane-permeable anti-G beta gamma blocking peptide, similar to the suppressive effect of glucocorticoid pretreatment. Extended mechanistic studies demonstrated that: 1) corresponding proasthmatic changes in contractility exhibited in isolated airway smooth muscle (ASM) sensitized with serum from OVA-sensitized+challenged rabbits or IL-13 were also G beta gamma-dependent and mediated by MAPK-upregulated PDE4 activity; and 2) the latter was attributed to G beta gamma-induced direct stimulation of the nonreceptor tyrosine kinase, c-Src, resulting in downstream activation of ERK1/2 and its consequent transcriptional upregulation of PDE4. Collectively, these data are the first to identify that a mechanism involving G beta gamma-induced direct activation of c-Src, leading to ERK1/2-mediated upregulation of PDE4 activity, plays a decisive role in regulating the induction of AHR and inflammation in a rabbit model of allergic airway disease.	[Nino, Gustavo; Hu, Aihua; Grunstein, Judith S.; McDonough, Joseph; Josephson, Maureen B.; Grunstein, Michael M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Pulm Med,Res Inst, Philadelphia, PA 19104 USA; [Nino, Gustavo] Penn State Univ, Coll Med, Div Pediat Pulm & Sleep Med, Hershey, PA USA; [Kreiger, Portia A.; Choi, John K.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pathol & Lab Med,Res Inst, Philadelphia, PA 19104 USA; [Kreiger, Portia A.] Nemours AI duPont Hosp Children, Dept Pathol, Wilmington, DE USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Nemours Alfred I. duPont Hospital for Children	Nino, G (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Pulm Med,Res Inst, Philadelphia, PA 19104 USA.	grunstein@email.chop.edu	Choi, John Kim/N-7558-2018	Choi, John Kim/0000-0002-2861-0180	National Institutes of Health (NIH) [HL-061038, HL097739]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061038, R01HL097739] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL-061038 and HL097739. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe W, 1998, AM J PHYSIOL-LUNG C, V275, pL990, DOI 10.1152/ajplung.1998.275.5.L990; BAI TR, 1992, AM J RESP CELL MOL, V6, P647, DOI 10.1165/ajrcmb/6.6.647; Barr AJ, 2000, BIOCHEMISTRY-US, V39, P1800, DOI 10.1021/bi992021f; Billington CK, 2008, AM J RESP CELL MOL, V38, P1, DOI 10.1165/rcmb.2007-0171OC; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Chang M, 2000, J BIOL CHEM, V275, P7021, DOI 10.1074/jbc.275.10.7021; Chapman RW, 2007, EUR J PHARMACOL, V571, P215, DOI 10.1016/j.ejphar.2007.05.074; Conway AM, 1999, BIOCHEM J, V337, P171, DOI 10.1042/0264-6021:3370171; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Ferry X, 2001, J IMMUNOL, V167, P4805, DOI 10.4049/jimmunol.167.9.4805; Gerthoffer WT, 2003, RESP PHYSIOL NEUROBI, V137, P237, DOI 10.1016/S1569-9048(03)00150-2; GOLDIE RG, 1986, BRIT J CLIN PHARMACO, V22, P669, DOI 10.1111/j.1365-2125.1986.tb02956.x; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; GRUNSTEIN MM, 1984, J APPL PHYSIOL, V57, P1238, DOI 10.1152/jappl.1984.57.4.1238; Grunstein MM, 2002, AM J PHYSIOL-LUNG C, V282, pL520, DOI 10.1152/ajplung.00343.2001; Hakonarson H, 1998, AM J RESP CRIT CARE, V158, pS115, DOI 10.1164/ajrccm.158.supplement_2.13tac700; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Hakonarson H, 2003, RESP PHYSIOL NEUROBI, V137, P263, DOI 10.1016/S1569-9048(03)00152-6; HAKONARSON H, 1995, AM J PHYSIOL-LUNG C, V269, pL645, DOI 10.1152/ajplung.1995.269.5.L645; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; Keir SD, 2011, J PHARMACOL TOX MET, V64, P187, DOI 10.1016/j.vascn.2011.08.003; Kinyanjui MW, 2008, CAN J PHYSIOL PHARM, V86, P1, DOI [10.1139/Y07-125, 10.1139/y07-125]; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Krymskaya VP, 2007, CURR TOP DEV BIOL, V79, P61, DOI 10.1016/S0070-2153(06)79003-2; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; Lee PJ, 2006, J CLIN INVEST, V116, P163, DOI 10.1172/JCI25711; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; Mizutani N, 2011, IMMUNOL LET IN PRESS; Moynihan B, 2008, AM J PHYSIOL-LUNG C, V295, pL171, DOI 10.1152/ajplung.00457.2007; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Nocker RET, 1999, INT ARCH ALLERGY IMM, V119, P45, DOI 10.1159/000024174; Ohnishi H, 2009, J ALLERGY CLIN IMMUN, V123, P249, DOI 10.1016/j.jaci.2008.10.054; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Schroder S, 2000, N-S ARCH PHARMACOL, V362, P435, DOI 10.1007/s002100000298; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun JG, 2006, LIFE SCI, V79, P2077, DOI 10.1016/j.lfs.2006.07.001; Tang HF, 2005, AM J RESP CRIT CARE, V171, P823, DOI 10.1164/rccm.200406-771OC; Taube C, 2003, J IMMUNOL, V170, P4301, DOI 10.4049/jimmunol.170.8.4301; Thibault C, 1997, J BIOL CHEM, V272, P12253, DOI 10.1074/jbc.272.19.12253; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; Trifilieff A, 2000, AM J PHYSIOL-LUNG C, V279, pL1120, DOI 10.1152/ajplung.2000.279.6.L1120; van Schalkwyk E, 2005, J ALLERGY CLIN IMMUN, V116, P292, DOI 10.1016/j.jaci.2005.04.023; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zschauer AOA, 1999, J APPL PHYSIOL, V86, P1721, DOI 10.1152/jappl.1999.86.5.1721	69	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32078	10.1371/journal.pone.0032078	http://dx.doi.org/10.1371/journal.pone.0032078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384144	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500072
J	Souza, MS; Hansson, LA; Hylander, S; Modenutti, B; Balseiro, E				Sol Souza, Maria; Hansson, Lars-Anders; Hylander, Samuel; Modenutti, Beatriz; Balseiro, Esteban			Rapid Enzymatic Response to Compensate UV Radiation in Copepods	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; ACETYLCHOLINESTERASE ACTIVITY; PHOTOPROTECTIVE COMPOUNDS; OXIDATIVE STRESS; AMINO-ACIDS; ZOOPLANKTON; PIGMENTATION; PREDATION; DAPHNIA; APOPTOSIS	Ultraviolet radiation (UVR) causes physical damage to DNA, carboxylation of proteins and peroxidation of lipids in copepod crustaceans, ubiquitous and abundant secondary producers in most aquatic ecosystems. Copepod adaptations for long duration exposures include changes in behaviour, changes in pigmentation and ultimately changes in morphology. Adaptations to short-term exposures are little studied. Here we show that short-duration exposure to UVR causes the freshwater calanoid copepod, Eudiaptomus gracilis, to rapidly activate production of enzymes that prevent widespread collateral peroxidation (glutathione S-transferase, GST), that regulate apoptosis cell death (Caspase-3, Casp-3), and that facilitate neurotransmissions (cholinesterase-ChE). None of these enzyme systems is alone sufficient, but they act in concert to reduce the stress level of the organism. The interplay among enzymatic responses provides useful information on how organisms respond to environmental stressors acting on short time scales.	[Sol Souza, Maria; Modenutti, Beatriz; Balseiro, Esteban] INIBIOMA CONICET UNComahue, Lab Limnol, San Carlos De Bariloche, Rio Negro, Argentina; [Hansson, Lars-Anders; Hylander, Samuel] Lund Univ, Inst Biol Aquat Ecol, Lund, Sweden	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Lund University	Souza, MS (corresponding author), INIBIOMA CONICET UNComahue, Lab Limnol, San Carlos De Bariloche, Rio Negro, Argentina.	Lars-Anders.Hansson@biol.lu.se	Balseiro, Esteban/Y-2743-2019; Hansson, Lars-Anders/HCI-2735-2022	Balseiro, Esteban/0000-0002-5052-0587; Hansson, Lars-Anders/0000-0002-3035-1317; Hylander, Samuel/0000-0002-3740-5998; Modenutti, Beatriz/0000-0002-8683-5679	CONICET (Argentina); Swedish Research Council (VR) [PICT 2007-01256, PICT 2007-01258]	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Swedish Research Council (VR)(Swedish Research Council)	This work was carried out during a stay at Lund University (Sweden) of MSS supported by CONICET (Argentina). The authors acknowledge the support of the Swedish Research Council (VR) to LAH, PICT 2007-01256 to BM and PICT 2007-01258 to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balseiro E, 2008, LIMNOL OCEANOGR, V53, P2383, DOI 10.4319/lo.2008.53.6.2383; Bancroft BA, 2007, ECOL LETT, V10, P332, DOI 10.1111/j.1461-0248.2007.01022.x; Borgeraas J, 2000, J PLANKTON RES, V22, P1167, DOI 10.1093/plankt/22.6.1167; Borgeraas J, 2002, ARCH HYDROBIOL, V156, P83, DOI 10.1127/0003-9136/2002/0156-0083; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fischer JM, 2006, PHOTOCHEM PHOTOBIOL, V82, P547, DOI 10.1562/2005-08-30-RA-664; Forget J, 2003, AQUAT TOXICOL, V62, P195, DOI 10.1016/S0166-445X(02)00084-X; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; Gabriel W, 2005, AM NAT, V166, P339, DOI 10.1086/432558; Gewies A, 2003, APOREVIEW, V1002, P1; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P38, DOI 10.4319/lo.1979.24.1.0038; Hansson LA, 2000, P ROY SOC B-BIOL SCI, V267, P2327, DOI 10.1098/rspb.2000.1287; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hansson LA, 2009, PHOTOCH PHOTOBIO SCI, V8, P1266, DOI 10.1039/b908825c; Hylander S, 2009, LIMNOL OCEANOGR, V54, P1883, DOI 10.4319/lo.2009.54.6.1883; Hylander S, 2009, LIMNOL OCEANOGR, V54, P483, DOI 10.4319/lo.2009.54.2.0483; Janknegt PJ, 2009, EUR J PHYCOL, V44, P525, DOI 10.1080/09670260902943273; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kessler K, 2008, LIMNOL OCEANOGR, V53, P2374, DOI 10.4319/lo.2008.53.6.2374; Linan-Cabello MA, 2010, REV BIOL TROP, V58, P103; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Lopez-Martinez G, 2008, INSECT BIOCHEM MOLEC, V38, P796, DOI 10.1016/j.ibmb.2008.05.006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacFadyen EJ, 2004, GLOBAL CHANGE BIOL, V10, P408, DOI 10.1111/j.1529-8817.2003.00750.x; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Menze MA, 2010, APOPTOSIS, V15, P293, DOI 10.1007/s10495-009-0443-6; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moeller RE, 2005, LIMNOL OCEANOGR, V50, P427, DOI 10.4319/lo.2005.50.2.0427; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Pigliucci M., 2001, SYN ECO EVO; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Siebeck Otto, 1994, Advances in Limnology, V43, P101; Souza MS, 2010, PHOTOCHEM PHOTOBIOL, V86, P367, DOI 10.1111/j.1751-1097.2009.00675.x; Souza MS, 2010, LIMNOL OCEANOGR, V55, P1024, DOI 10.4319/lo.2010.55.3.1024; Souza MS, 2007, WATER AIR SOIL POLL, V183, P49, DOI 10.1007/s11270-007-9354-8; Tartarotti B, 2004, J PLANKTON RES, V26, P753, DOI 10.1093/plankt/fbh073; Tartarotti B, 2002, ARCH HYDROBIOL, V154, P691; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; West-Eberhard Mary Jane, 2003, pi; Williamson CE, 2010, SCIENCE, V329, P637, DOI 10.1126/science.1191192	48	21	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32046	10.1371/journal.pone.0032046	http://dx.doi.org/10.1371/journal.pone.0032046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384136	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500067
J	Hamdan, AM; Koyanagi, S; Wada, E; Kusunose, N; Murakami, Y; Matsunaga, N; Ohdo, S				Hamdan, Ahmed M.; Koyanagi, Satoru; Wada, Erika; Kusunose, Naoki; Murakami, Yuichi; Matsunaga, Naoya; Ohdo, Shigehiro			Intestinal Expression of Mouse Abcg2/Breast Cancer Resistance Protein (BCRP) Gene Is under Control of Circadian Clock-activating Transcription Factor-4 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LINES; ABCG2; IDENTIFICATION; BCRP/ABCG2; PROMOTERS; ATF4; DBP	ABCG2, encoding breast cancer resistance protein (BCRP), is a member of the ATP-binding cassette transporter family and is often associated with cancer chemotherapeutic resistance. BCRP is also expressed in a variety of normal cells and acts as a xenobiotic efflux transporter. Because intestinal BCRP limits systemic exposure to xenobiotics, alterations in the function and expression of this transporter could account for part of the variation in oral drug absorption. In this study, we show that ATF4, a molecular component of the circadian clock, induces circadian expression of the Abcg2 gene in mouse small intestine. Three types of leader exons (termed exons 1A, 1B, and 1C) are identified in the 5'-untranslated region of mouse Abcg2 transcripts. The exon 1B-containing Abcg2 transcript was the only isoform detected in mouse small intestine, and its mRNA levels oscillated in a circadian time-dependent manner. ATF4 bound time-dependently to the cAMP response element within the exon 1B promoter region of the Abcg2 gene, thereby causing the oscillation of BCRP protein abundance and its efflux pump function. The circadian clock-ATF4 pathway appears to enhance the function of BCRP during a specific time window and to modulate intestinal drug absorption. Our findings suggest a mechanism underlying circadian change in xenobiotic detoxification.	[Hamdan, Ahmed M.; Koyanagi, Satoru; Wada, Erika; Kusunose, Naoki; Murakami, Yuichi; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Ohdo, S (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020; Hamdan, Ahmed M/H-3794-2018	Hamdan, Ahmed M/0000-0003-4930-792X; matsunaga2, naoya2/0000-0001-6226-8473; Koyanagi, Satoru/0000-0003-4849-2377	Japan Society for the Promotion of Science [21390047, 24390149]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research (B) 21390047 (to S. O.) and 24390149 (to S. K.) from the Japan Society for the Promotion of Science.	Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175; Beal S., 1992, CRIT REV BIOMED ENG, V8, P195; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Iwamoto T, 2011, BIOSCI BIOTECH BIOCH, V75, P925, DOI 10.1271/bbb.100887; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Litman T, 2000, J CELL SCI, V113, P2011; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohdo S, 2010, BIOL PHARM BULL, V33, P159, DOI 10.1248/bpb.33.159; Ripperger JA, 2000, GENE DEV, V14, P679; Stearns AT, 2008, J PHARMACOL SCI, V108, P144, DOI 10.1254/jphs.08100SC; Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zaher H, 2006, MOL PHARMACEUT, V3, P55, DOI 10.1021/mp050113v; Zong Y, 2006, J BIOL CHEM, V281, P29625, DOI 10.1074/jbc.M606314200	24	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17224	17231		10.1074/jbc.M111.333377	http://dx.doi.org/10.1074/jbc.M111.333377			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22396548	hybrid, Green Published			2022-12-25	WOS:000306373000022
J	Ermak, G; Sojitra, S; Yin, F; Cadenas, E; Cuervo, AM; Davies, KJA				Ermak, Gennady; Sojitra, Sonal; Yin, Fei; Cadenas, Enrique; Cuervo, Ana Maria; Davies, Kelvin J. A.			Chronic Expression of RCAN1-1L Protein Induces Mitochondrial Autophagy and Metabolic Shift from Oxidative Phosphorylation to Glycolysis in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; SYNDROME CRITICAL REGION-1; ALZHEIMERS-DISEASE; DOWN-SYNDROME; DSCR1 ADAPT78; CALCINEURIN REGULATORS; MONITORING AUTOPHAGY; INHIBITS CALCINEURIN; RAT HEPATOCYTES; STRESS	Expression of the RCAN1 gene can be induced by multiple stresses. RCAN1 proteins (RCAN1s) have both protective and harmful effects and are implicated in common human pathologies. The mechanisms by which RCAN1s function, however, remain poorly understood. We identify RCAN1s as regulators of mitochondrial autophagy (mitophagy) and demonstrate that induction of RCAN1-1L can cause dramatic degradation of mitochondria. The mechanisms of such degradation involve the adenine nucleotide translocator and mitochondrial permeability transition pore opening. We also demonstrate that RCAN1-1L induction can shift cellular bioenergetics from aerobic respiration to glycolysis, yet RCAN1-1L has very little effect on cell division, whereas it has a cumulative negative effect on cell survival. These results shed the light on mechanisms by which RCAN1s can protect or harm cells and by which they may operate in human pathologies. They also suggest that RCAN1s are important players in autophagy and such elusive phenomena as the mitochondrial permeability transition pore.	[Ermak, Gennady; Sojitra, Sonal; Davies, Kelvin J. A.] Univ So Calif, Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; [Ermak, Gennady; Sojitra, Sonal; Davies, Kelvin J. A.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Div Mol & Computat Biol, Los Angeles, CA 90089 USA; [Yin, Fei; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Southern California; University of Southern California; University of Southern California; Yeshiva University; Albert Einstein College of Medicine	Davies, KJA (corresponding author), Univ So Calif, Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Yin, Fei/0000-0002-5996-2410; Davies, Kelvin/0000-0001-7790-3003; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [RO1-ES003598, 3RO1-ES 003598-22S2, R01AG016718]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES003598 (and American Recovery and Reinvestment Act supplement 3RO1-ES 003598-22S2) (to K. J. A. D.) and R01AG016718 (to E. C.).	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2004, FASEB J, V18, P62, DOI 10.1096/fj.03-0451com; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ermak G, 2003, IUBMB LIFE, V55, P29, DOI 10.1080/1521654031000066820; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Romanello V, 2010, CURR HYPERTENS REP, V12, P433, DOI 10.1007/s11906-010-0157-8; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Wang YL, 2002, AM J PHYSIOL-HEART C, V283, pH533, DOI 10.1152/ajpheart.00002.2002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	44	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14088	14098		10.1074/jbc.M111.305342	http://dx.doi.org/10.1074/jbc.M111.305342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389495	Green Published, hybrid			2022-12-25	WOS:000303996300062
J	Jung, S; Sonnichsen, FD; Hung, CW; Tholey, A; Boidin-Wichlacz, C; Haeusgen, W; Gelhaus, C; Desel, C; Podschun, R; Waetzig, V; Tasiemski, A; Leippe, M; Grotzinger, J				Jung, Sascha; Soennichsen, Frank D.; Hung, Chien-Wen; Tholey, Andreas; Boidin-Wichlacz, Celine; Haeusgen, Wiebke; Gelhaus, Christoph; Desel, Christine; Podschun, Rainer; Waetzig, Vicki; Tasiemski, Aurelie; Leippe, Matthias; Groetzinger, Joachim			Macin Family of Antimicrobial Proteins Combines Antimicrobial and Nerve Repair Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDES; SYSTEM; LEECH; ANTIBACTERIAL; CHALLENGE; RESISTANT; DEFENSIN	The tertiary structures of theromacin and neuromacin confirmed the macin protein family as a self-contained family of antimicrobial proteins within the superfamily of scorpion toxinlike proteins. The macins, which also comprise hydramacin-1, are antimicrobially active against Gram-positive and Gram-negative bacteria. Despite high sequence identity, the three proteins showed distinct differences with respect to their biological activity. Neuromacin exhibited a significantly stronger capacity to permeabilize the cytoplasmic membrane of Bacillus megaterium than theromacin and hydramacin-1. Accordingly, it is the only macin that displays pore-forming activity and that was potently active against Staphylococcus aureus. Moreover, neuromacin and hydramacin-1 led to an aggregation of bacterial cells that was not observed with theromacin. Analysis of the molecular surface properties of macins allowed confirmation of the barnacle model as the mechanistic model for the aggregation effect. Besides being antimicrobially active, neuromacin and theromacin, in contrast to hydramacin-1, were able to enhance the repair of leech nerves ex vivo. Notably, all three macins enhanced the viability of murine neuroblastoma cells, extending their functional characteristics. As neuromacin appears to be both a functional and structural chimera of hydramacin-1 and theromacin, the putative structural correlate responsible for the nerve repair capacity in leech was located to a cluster of six amino acid residues using the sequence similarity of surface-exposed regions.	[Jung, Sascha; Desel, Christine; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany; [Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Hung, Chien-Wen; Tholey, Andreas] Univ Kiel, Inst Expt Med, Div Systemat Proteome Res, D-24105 Kiel, Germany; [Boidin-Wichlacz, Celine; Tasiemski, Aurelie] Univ Lille 1, CNRS FRE2933, Lab Neuroimmunol & Neurochim Evolut, F-59655 Villeneuve Dascq, France; [Haeusgen, Wiebke; Waetzig, Vicki] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, D-24105 Kiel, Germany; [Podschun, Rainer] Univ Hosp Schleswig Holstein, Inst Infect Med, D-24105 Kiel, Germany	University of Kiel; University of Kiel; University of Kiel; University of Kiel; Universite de Lille - ISITE; Universite de Lille; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Grotzinger, J (corresponding author), Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	jgroetzinger@biochem.uni-kiel.de	Sönnichsen, Frank D/D-8408-2011; Tholey, Andreas/B-3407-2010; Leippe, Matthias/AAP-1677-2020; Gelhaus, Christoph/D-8050-2011; Tasiemski, Aurelie/S-2537-2016	Sönnichsen, Frank D/0000-0002-4539-3755; Tholey, Andreas/0000-0002-8687-6817; Wichlacz, Celine/0000-0002-0242-868X; Jung, Sascha/0000-0003-4970-6904; Tasiemski, Aurelie/0000-0003-3559-5115	excellence cluster "Inflammation at Interfaces"; Ministere de l'Enseignement de la Recherche et des Technologies; CNRS	excellence cluster "Inflammation at Interfaces"; Ministere de l'Enseignement de la Recherche et des Technologies; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the excellence cluster "Inflammation at Interfaces," the Ministere de l'Enseignement de la Recherche et des Technologies, and the CNRS.	Blanc E, 1998, BIOCHEMISTRY-US, V37, P12412, DOI 10.1021/bi9809371; Boidin-Wichlacz C., 2012, CELL MOL LI IN PRESS; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cook WJ, 2002, PROTEIN SCI, V11, P479, DOI 10.1110/ps.39202; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30; Duan YL, 2005, CELL MOL NEUROBIOL, V25, P441, DOI 10.1007/s10571-005-3152-x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Otero-Gonzalez AJ, 2010, FASEB J, V24, P1320, DOI 10.1096/fj.09-143388; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung S, 2011, ANTIMICROB AGENTS CH, V55, P954, DOI 10.1128/AAC.00872-10; Jung S, 2009, J BIOL CHEM, V284, P1896, DOI 10.1074/jbc.M804713200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; Neonakis IK, 2011, INT J ANTIMICROB AG, V37, P102, DOI 10.1016/j.ijantimicag.2010.10.014; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003; Schaller HC, 1996, INT J DEV BIOL, V40, P339; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Schwab U, 1999, ANTIMICROB AGENTS CH, V43, P1435, DOI 10.1128/AAC.43.6.1435; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; Tasiemski A, 2010, ADV EXP MED BIOL, V708, P80; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zucca M, 2011, MINI-REV MED CHEM, V11, P888, DOI 10.2174/138955711796575498	37	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14246	14258		10.1074/jbc.M111.336495	http://dx.doi.org/10.1074/jbc.M111.336495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396551	Green Published, hybrid			2022-12-25	WOS:000303996300076
J	Follows, GA; Ferreira, R; Janes, ME; Spensberger, D; Cambuli, F; Chaney, AF; Kinston, SJ; Landry, JR; Green, AR; Gottgens, B				Follows, George A.; Ferreira, Rita; Janes, Mary E.; Spensberger, Dominik; Cambuli, Francesco; Chaney, Amy F.; Kinston, Sarah J.; Landry, Josette R.; Green, Anthony R.; Goettgens, Berthold			Mapping and Functional Characterisation of a CTCF-Dependent Insulator Element at the 3 ' Border of the Murine Scl Transcriptional Domain	PLOS ONE			English	Article							STEM-CELL ENHANCER; DNASEI-HYPERSENSITIVE SITES; BETA-GLOBIN DOMAIN; HEMATOPOIETIC PROGENITORS; GENOME BROWSER; GENE; LOCUS; MOUSE; EXPRESSION; TARGETS	The Scl gene encodes a transcription factor essential for haematopoietic development. Scl transcription is regulated by a panel of cis-elements spread over 55 kb with the most distal 3' element being located downstream of the neighbouring gene Map17, which is co-regulated with Scl in haematopoietic cells. The Scl/Map17 domain is flanked upstream by the ubiquitously expressed Sil gene and downstream by a cluster of Cyp genes active in liver, but the mechanisms responsible for delineating the domain boundaries remain unclear. Here we report identification of a DNaseI hypersensitive site at the 3' end of the Scl/Map17 domain and 45 kb downstream of the Scl transcription start site. This element is located at the boundary of active and inactive chromatin, does not function as a classical tissue-specific enhancer, binds CTCF and is both necessary and sufficient for insulator function in haematopoietic cells in vitro. Moreover, in a transgenic reporter assay, tissue-specific expression of the Scl promoter in brain was increased by incorporation of 350 bp flanking fragments from the +45 element. Our data suggests that the +45 region functions as a boundary element that separates the Scl/Map17 and Cyp transcriptional domains, and raise the possibility that this element may be useful for improving tissue-specific expression of transgenic constructs.	[Follows, George A.; Ferreira, Rita; Janes, Mary E.; Spensberger, Dominik; Cambuli, Francesco; Chaney, Amy F.; Kinston, Sarah J.; Landry, Josette R.; Green, Anthony R.; Goettgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England	University of Cambridge	Follows, GA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England.	gf246@cam.ac.uk	Ferreira, Rita/GZL-4970-2022	Green, Anthony/0000-0002-9795-0218; Cambuli, Francesco/0000-0002-8237-7121; Spensberger, Dominik/0000-0002-9798-2949; Gottgens, Berthold/0000-0001-6302-5705; Ferreira, Rita/0000-0001-7440-2246	Wellcome Trust [74608/Z/04/Z]; Leukaemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council; Medical Research Council; Cancer Research United Kingdom; Leukemia and Lymphoma Society; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Leukaemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research United Kingdom(Cancer Research UK); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	Work in Dr. Green's laboratory is funded by grants from the Wellcome Trust (74608/Z/04/Z) and Leukaemia and Lymphoma Research. Work in Gottgens's laboratory is funded by the Biotechnology and Biological Sciences Research Council, Medical Research Council, Leukaemia & Lymphoma Research, Cancer Research United Kingdom and the Leukemia and Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anizy M, 2006, FEBS J, V273, P936, DOI 10.1111/j.1742-4658.2006.05119.x; Arumugam PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006995; Begley CG, 1999, BLOOD, V93, P2760; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bradley CK, 2006, EUR J NEUROSCI, V23, P1677, DOI 10.1111/j.1460-9568.2006.04712.x; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009059; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Follows GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm108; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Gottgens B, 2010, MOL CELL BIOL, V30, P5741, DOI 10.1128/MCB.00870-10; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kang SHL, 2004, GENES CELLS, V9, P1043, DOI 10.1111/j.1365-2443.2004.00788.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Mead PE, 1998, DEVELOPMENT, V125, P2611; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Pfeifer GP, 1999, METHOD ENZYMOL, V304, P548; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Sanchez MJ, 2001, DEVELOPMENT, V128, P4815; Silberstein L, 2005, STEM CELLS, V23, P1378, DOI 10.1634/stemcells.2005-0090; Sinclair AM, 2002, BLOOD, V99, P3931, DOI 10.1182/blood.V99.11.3931; Sinclair AM, 1999, DEV BIOL, V209, P128, DOI 10.1006/dbio.1999.9236; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhao H, 2006, J BIOL CHEM, V281, P30573, DOI 10.1074/jbc.M606803200	39	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31484	10.1371/journal.pone.0031484	http://dx.doi.org/10.1371/journal.pone.0031484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396734	Green Submitted, gold, Green Published			2022-12-25	WOS:000303005000006
J	Coppola, A; Tomasello, L; Pizzolanti, G; Pucci-Minafra, I; Albanese, N; Di Cara, G; Cancemi, P; Pitrone, M; Bommarito, A; Carissimi, E; Zito, G; Criscimanna, A; Galluzzo, A; Giordano, C				Coppola, Antonina; Tomasello, Laura; Pizzolanti, Giuseppe; Pucci-Minafra, Ida; Albanese, Nadia; Di Cara, Gianluca; Cancemi, Patrizia; Pitrone, Maria; Bommarito, Alessandra; Carissimi, Elvira; Zito, Giovanni; Criscimanna, Angela; Galluzzo, Aldo; Giordano, Carla			In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine beta-TC3 Cell Line	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-SECRETION; RAT ISLETS; INDUCED DYSFUNCTION; PROTEIN EXPRESSION; GENE-EXPRESSION; APOPTOSIS; AUTOIMMUNE; SUMO4; STRESS	Type 1 diabetes mellitus (T1DM) is caused by the selective destruction of insulin-producing beta-cells. This process is mediated by cells of the immune system through release of nitric oxide, free radicals and pro-inflammatory cytokines, which induce a complex network of intracellular signalling cascades, eventually affecting the expression of genes involved in beta-cell survival. The aim of our study was to investigate possible mechanisms of resistance to cytokine-induced beta-cell death. To this purpose, we created a cytokine-resistant beta-cell line (beta-TC3R) by chronically treating the beta-TC3 murine insulinoma cell line with IL-1 beta + IFN-gamma. beta-TC3R cells exhibited higher proliferation rate and resistance to cytokine-mediated cell death in comparison to the parental line. Interestingly, they maintained expression of beta-cell specific markers, such as PDX1, NKX6.1, GLUT2 and insulin. The analysis of the secretory function showed that beta-TC3R cells have impaired glucose-induced c-peptide release, which however was only moderately reduced after incubation with KCl and tolbutamide. Gene expression analysis showed that beta-TC3R cells were characterized by downregulation of IL-1 beta and IFN-gamma receptors and upregulation of SOCS3, the classical negative regulator of cytokines signaling. Comparative proteomic analysis showed specific upregulation of 35 proteins, mainly involved in cell death, stress response and folding. Among them, SUMO4, a negative feedback regulator in NF-kB and JAK/STAT signaling pathways, resulted hyper-expressed. Silencing of SUMO4 was able to restore sensitivity to cytokine-induced cell death in beta-TC3R cells, suggesting it may play a key role in acquired cytokine resistance by blocking JAK/STAT and NF-kB lethal signaling. In conclusion, our study represents the first extensive proteomic characterization of a murine cytokine-resistant beta-cell line, which might represent a useful tool for studying the mechanisms involved in resistance to cytokine-mediated beta-cell death. This knowledge may be of potential benefit for patients with T1DM. In particular, SUMO4 could be used as a therapeutical target.	[Coppola, Antonina; Tomasello, Laura; Pizzolanti, Giuseppe; Pitrone, Maria; Bommarito, Alessandra; Carissimi, Elvira; Zito, Giovanni; Criscimanna, Angela; Galluzzo, Aldo; Giordano, Carla] Univ Palermo, Endocrinol Sect, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy; [Albanese, Nadia] Univ Palermo, Dept Phys, Ctr Oncobiol Sperimentale COBS, I-90123 Palermo, Italy; [Cancemi, Patrizia] Univ Palermo, Sect Expt Oncol, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy; [Giordano, Carla] Inst Biomed & Mol Immunol A Monroy CNR IBIM, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Coppola, A (corresponding author), Univ Palermo, Endocrinol Sect, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy.	carla.giordano@unipa.it	Pizzolanti, Giuseppe/K-7097-2016; Coppola, Antonina/AAJ-6763-2020; GIORDANO, Carla/R-4296-2017; Zito, Giovanni/AAC-3639-2022; Tomasello, Laura/AAR-2339-2021; Coppola, Antonina/AAO-8203-2020; Coppola, Antonina/AAE-5901-2021; Albanese, Nadia/AAN-3634-2020; , Zito/O-3836-2019; Pizzolanti, Giuseppe/I-4547-2019	Pizzolanti, Giuseppe/0000-0001-6052-8438; GIORDANO, Carla/0000-0003-1731-9395; Coppola, Antonina/0000-0001-6664-8553; , Zito/0000-0002-0482-6729; CANCEMI, Patrizia/0000-0002-3951-7213; TOMASELLO, Laura/0000-0002-2304-6007				Ahmed M, 2005, DIABETOLOGIA, V48, P477, DOI 10.1007/s00125-004-1661-7; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Cailleau C, 1997, DIABETES, V46, P937, DOI 10.2337/diabetes.46.6.937; Cardozo AK, 2003, J PROTEOME RES, V2, P553, DOI 10.1021/pr034029o; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chen GX, 2001, J BIOL CHEM, V276, P766, DOI 10.1074/jbc.M008330200; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; D'Hertog W, 2007, MOL CELL PROTEOMICS, V6, P2180, DOI 10.1074/mcp.M700085-MCP200; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fernandez C, 2008, J PROTEOME RES, V7, P400, DOI 10.1021/pr070547d; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Jacobsen MLB, 2009, DIABETOLOGIA, V52, P281, DOI 10.1007/s00125-008-1199-1; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kaminitz A, 2007, IMMUNOL CELL BIOL, V85, P582, DOI 10.1038/sj.icb.7100093; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kracklauer Martin P, 2003, Mol Cancer, V2, P39, DOI 10.1186/1476-4598-2-39; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Larsen PM, 2001, DIABETES, V50, P1056, DOI 10.2337/diabetes.50.5.1056; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; NICOLETTI F, 1994, EUR J IMMUNOL, V24, P1843, DOI 10.1002/eji.1830240818; Nicoletti F, 1997, ENDOCRINOLOGY, V138, P281, DOI 10.1210/en.138.1.281; Nielsen K, 2004, DIABETOLOGIA, V47, P62, DOI 10.1007/s00125-003-1277-3; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; Pucci-Minafra I, 2002, PROTEOMICS, V2, P919, DOI 10.1002/1615-9861(200207)2:7<919::AID-PROT919>3.0.CO;2-P; SJOHOLM A, 1991, IMMUNOL LETT, V30, P81, DOI 10.1016/0165-2478(91)90093-P; SOUTHERN C, 1990, BIOCHEM J, V272, P243, DOI 10.1042/bj2720243; Sparre T, 2002, DIABETOLOGIA, V45, P1550, DOI 10.1007/s00125-002-0953-z; Stassi G, 1995, TRANSPLANT P, V27, P3271; Stassi G, 1997, J EXP MED, V186, P1193, DOI 10.1084/jem.186.8.1193; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wang CY, 2008, DIABETES-METAB RES, V24, P93, DOI 10.1002/dmrr.797; Wang CY, 2009, BIOCHEM BIOPH RES CO, V381, P477, DOI 10.1016/j.bbrc.2009.02.060; Watson D, 2009, BRIT J BIOMED SCI, V66, P208, DOI 10.1080/09674845.2009.11730278; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Whittle N, 2011, AMINO ACIDS, V40, P1231, DOI 10.1007/s00726-010-0758-1; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zou YF, 2010, INT J IMMUNOGENET, V37, P345, DOI 10.1111/j.1744-313X.2010.00931.x	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32109	10.1371/journal.pone.0032109	http://dx.doi.org/10.1371/journal.pone.0032109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393382	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500035
J	Hoi, H; Griggio, M				Hoi, Herbert; Griggio, Matteo			Bearded Reedlings Adjust Their Pair-Bond Behaviour in Relation to the Sex and Attractiveness of Unpaired Conspecifics	PLOS ONE			English	Article							MATE CHOICE; FIGHTING MALES; FEMALE; PATERNITY; BIRDS; AUDIENCE; SELECTION; CONFLICT; PREFERENCES; EAVESDROP	An individual's investment in mating or keeping a pair bond intact may be influenced not only by the attractiveness of its current mate, but also by that of other potential mates. In this study, we investigated the effect of relative attractiveness on pair-bond behaviour in bearded reedlings, Panurus biarmicus. We showed that mate attractiveness, in terms of beard length in males and tail length in females, influenced courtship behaviour when the pair was kept isolated. In the presence of a conspecific, contact initiations within a pair increased. This increment was mainly related to the sex of the unpaired conspecific, however, and less to differences in attractiveness between the current partner and the unpaired conspecific. Female contact initiations towards potential extra mates were independent of male attractiveness, whereas male contact behaviour was significantly influenced by female attractiveness. However, females displayed more contact initiations to their current mate when they were less attractive than the unpaired females. Males decreased their overtures towards other females with increasing attractiveness of their current mates. Overall, our results suggested that, when there was a risk of losing their mate, bearded reedlings adjust their pair-bond investment mainly in response to the presence or absence of a competitor, and fine-tune investment to a lesser extent in response to the attractiveness of that potential competitor.	[Hoi, Herbert; Griggio, Matteo] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna	Hoi, H (corresponding author), Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.	matteo.griggio@vetmeduni.ac.at		Griggio, Matteo/0000-0002-3298-2905				Alonzo SH, 1999, BEHAV ECOL, V10, P105, DOI 10.1093/beheco/10.1.105; Altmann J., 1997, FEMINISM EVOLUTIONAR, P320; Andersson Malte, 1994; Aquiloni L, 2008, CURR BIOL, V18, pR462, DOI 10.1016/j.cub.2008.04.006; Balenger S, 2009, BEHAV ECOL SOCIOBIOL, V63, P403, DOI 10.1007/s00265-008-0674-5; Bateson P., 1983, MATE CHOICE; BIBBY CJ, 1983, BRIT BIRDS, V76, P549; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead T.R., 1996, Oxford Ornithology Series, V6, P323; Birkhead TR, 1998, SPERM COMPETITION SE; BOAKE CRB, 1989, EVOL ECOL, V3, P173, DOI 10.1007/BF02270919; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; Eikenaar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023288; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Ens BJ, 1996, PARTNERSHIPS BIRDS S, P345; Gowaty P. A., 1999, P 22 INT ORN C, P2639; Gowaty Patricia Adair, 1996, Oxford Ornithology Series, V6, P21; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griggio M, 2005, BEHAV ECOL, V16, P435, DOI 10.1093/beheco/ari009; Griggio M, 2007, ANIM BEHAV, V74, P779, DOI 10.1016/j.anbehav.2007.01.007; Griggio M, 2011, ANIM BEHAV, V82, P1329, DOI 10.1016/j.anbehav.2011.09.016; Hall ML, 2009, BEHAV ECOL, V20, P222, DOI 10.1093/beheco/arn139; Hoi H, 1997, BEHAV ECOL, V8, P113, DOI 10.1093/beheco/8.2.113; Hoi H, 1997, ANIM BEHAV, V53, P277, DOI 10.1006/anbe.1996.0401; Hoi H, 2008, ETHOLOGY, V114, P1094, DOI 10.1111/j.1439-0310.2008.01566.x; JOHNSEN A, 1995, ETHOLOGY, V101, P200; Kokko H, 2005, BEHAV ECOL, V16, P724, DOI 10.1093/beheco/ari050; Kristin A, 2008, FOLIA ZOOL, V57, P240; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; LIFJELD JT, 1994, J AVIAN BIOL, V25, P244, DOI 10.2307/3677082; Liu M, 2009, ANIM BEHAV, V78, P879, DOI 10.1016/j.anbehav.2009.07.012; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; OLLASON JC, 1978, J ANIM ECOL, V47, P961, DOI 10.2307/3681; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; PETRIE M, 1993, BEHAVIOUR, V127, P265, DOI 10.1163/156853993X00056; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2009, BEHAV ECOL SOCIOBIOL, V63, P381, DOI 10.1007/s00265-008-0672-7; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Romero-Pujante M, 2002, ETHOLOGY, V108, P885, DOI 10.1046/j.1439-0310.2002.00821.x; Simmons, 2006, ESSAYS ANIMAL BEHAV, P221; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; Striedter GF, 2003, ANIM BEHAV, V65, P875, DOI 10.1006/anbe.2003.2135; Toth Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026605; Ung D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022686; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 2000, ANIM BEHAV, V59, P467, DOI 10.1006/anbe.1999.1341	52	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32806	10.1371/journal.pone.0032806	http://dx.doi.org/10.1371/journal.pone.0032806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393449	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500103
J	Kaushik, DK; Gupta, M; Kumawat, KL; Basu, A				Kaushik, Deepak Kumar; Gupta, Malvika; Kumawat, Kanhaiya Lal; Basu, Anirban			NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis	PLOS ONE			English	Article							WEST NILE VIRUS; NALP3 INFLAMMASOME; MICROGLIAL ACTIVATION; OXIDATIVE STRESS; INFLUENZA-VIRUS; HOST RESPONSE; INTERLEUKIN-1-BETA; EXPRESSION; CASPASE-1; IL-1-BETA	Background: Japanese Encephalitis virus (JEV) is a common cause of acute and epidemic viral encephalitis. JEV infection is associated with microglial activation resulting in the production of pro-inflammatory cytokines including Interleukin-1 beta (IL-1 beta) and Interleukin-18 (IL-18). The Pattern Recognition Receptors (PRRs) and the underlying mechanism by which microglia identify the viral particle leading to the production of these cytokines is unknown. Methodology/Principal Findings: For our studies, we have used murine model of JEV infection as well as BV-2 mouse microglia cell line. In this study, we have identified a signalling pathway which leads to the activation of caspase-1 as the key enzyme responsible for the maturation of both IL-1 beta and IL-18 in NACHT, LRR and PYD domains-containing protein-3 (NLRP3) dependent manner. Depletion of NLRP3 results in the reduction of caspase-1 activity and subsequent production of these cytokines. Conclusion/Significance: Our results identify a mechanism mediated by Reactive Oxygen Species (ROS) production and potassium efflux as the two danger signals that link JEV infection to caspase-1 activation resulting in subsequent IL-1 beta and IL-18 maturation.	[Kaushik, Deepak Kumar; Gupta, Malvika; Kumawat, Kanhaiya Lal; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Kaushik, DK (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	deepakkaushiik@gmail.com		Basu, Anirban/0000-0002-5200-2054	Department of Biotechnology; Indian Council of Medical Research, Government of India	Department of Biotechnology; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the core grant from the Department of Biotechnology, to the National Brain Research Centre, Government of India. DKK is the recipient of Senior Research Fellowship from Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009; Das S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017225; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gupta N, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-92; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kaushik DK, 2011, FRONT BIOSCI-LANDMRK, V16, P2187, DOI 10.2741/3847; Krady JK, 2002, GLIA, V40, P11, DOI 10.1002/glia.10101; KUMAR R, 1990, INDIAN J MED RES-A, V91, P321; Levison SW, 2003, DEV NEUROSCI-BASEL, V25, P184, DOI 10.1159/000072267; Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Mishra MK, 2009, NEUROCHEM INT, V54, P464, DOI 10.1016/j.neuint.2009.01.022; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	56	100	106	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32270	10.1371/journal.pone.0032270	http://dx.doi.org/10.1371/journal.pone.0032270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393394	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500047
J	Zhang, XK; Robertson, G; Woo, S; Hoffman, BG; Gottardo, R				Zhang, Xuekui; Robertson, Gordon; Woo, Sangsoon; Hoffman, Brad G.; Gottardo, Raphael			Probabilistic Inference for Nucleosome Positioning with MNase-Based or Sonicated Short-Read Data	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RECOGNITION; METHYLATION; OCCUPANCY; ELEMENTS	We describe a model-based method, PING, for predicting nucleosome positions in MNase-Seq and MNase- or sonicated-ChIP-Seq data. PING compares favorably to NPS and TemplateFilter in scalability, accuracy and robustness to low read density. To demonstrate that PING predictions from widely available sonicated data can have sufficient spatial resolution to be to be useful for biological inference, we use Illumina H3K4me1 ChIP-seq data to detect changes in nucleosome positioning around transcription factor binding sites due to tamoxifen stimulation, to discriminate functional and nonfunctional transcription factor binding sites more effectively than with enrichment profiles, and to confirm that the pioneer transcription factor Foxa2 associates with the accessible major groove of nucleosomal DNA.	[Zhang, Xuekui] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Robertson, Gordon] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Woo, Sangsoon; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Woo, Sangsoon; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hoffman, Brad G.] Sunny Hill Hlth Ctr, Vancouver, BC, Canada; [Hoffman, Brad G.] British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada; [Hoffman, Brad G.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia; British Columbia Cancer Agency; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; University of British Columbia	Zhang, XK (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada.	rgottard@fhcrc.org	Gottardo, Raphael/HCH-3169-2022; Zhang, Xuekui/C-5105-2015	Zhang, Xuekui/0000-0003-4728-2343; Hoffman, Brad/0000-0002-5420-4493; Gottardo, Raphael/0000-0002-3867-0232	National Insititutes of Health [HG005692]; Natural Sciences and Engineering Research Council of Canada; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005692] Funding Source: NIH RePORTER	National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	RG was supported by National Insititutes of Health HG005692. XZ was supported by Natural Sciences and Engineering Research Council of Canada via the Alexander Graham Bell Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Edayathumangalam RS, 2004, P NATL ACAD SCI USA, V101, P6864, DOI 10.1073/pnas.0401743101; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kuan PF, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1454; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lo K, 2007, BIOINFORMATICS, V23, P328, DOI 10.1093/bioinformatics/btl612; Longo A, 2007, BIOCHEMISTRY-US, V46, P2948, DOI 10.1021/bi060969l; Munzel U, 2001, BIOMETRICAL J, V43, P553, DOI 10.1002/1521-4036(200109)43:5<553::AID-BIMJ553>3.0.CO;2-N; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	35	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32095	10.1371/journal.pone.0032095	http://dx.doi.org/10.1371/journal.pone.0032095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393380	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500033
J	Kraning-Rush, CM; Califano, JP; Reinhart-King, CA				Kraning-Rush, Casey M.; Califano, Joseph P.; Reinhart-King, Cynthia A.			Cellular Traction Stresses Increase with Increasing Metastatic Potential	PLOS ONE			English	Article							BREAST-CANCER; TUMOR-CELL; MATRIX STIFFNESS; SUBSTRATE STIFFNESS; EPITHELIAL-CELLS; INVASION; MIGRATION; ADHESION; CONTACT; PROGRAM	Cancer cells exist in a mechanically and chemically heterogeneous microenvironment which undergoes dynamic changes throughout neoplastic progression. During metastasis, cells from a primary tumor acquire characteristics that enable them to escape from the primary tumor and migrate through the heterogeneous stromal environment to establish secondary tumors. Despite being linked to poor prognosis, there are no direct clinical tests available to diagnose the likelihood of metastasis. Moreover, the physical mechanisms employed by metastatic cancer cells to migrate are poorly understood. Because metastasis of most solid tumors requires cells to exert force to reorganize and navigate through dense stroma, we investigated differences in cellular force generation between metastatic and non-metastatic cells. Using traction force microscopy, we found that in human metastatic breast, prostate and lung cancer cell lines, traction stresses were significantly increased compared to non-metastatic counterparts. This trend was recapitulated in the isogenic MCF10AT series of breast cancer cells. Our data also indicate that increased matrix stiffness and collagen density promote increased traction forces, and that metastatic cells generate higher forces than non-metastatic cells across all matrix properties studied. Additionally, we found that cell spreading for these cell lines has a direct relationship with collagen density, but a biphasic relationship with substrate stiffness, indicating that cell area alone does not dictate the magnitude of traction stress generation. Together, these data suggest that cellular contractile force may play an important role in metastasis, and that the physical properties of the stromal environment may regulate cellular force generation. These findings are critical for understanding the physical mechanisms of metastasis and the role of the extracellular microenvironment in metastatic progression.	[Kraning-Rush, Casey M.; Califano, Joseph P.; Reinhart-King, Cynthia A.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Kraning-Rush, CM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cak57@cornell.edu	Reinhart-King, Cynthia A./A-9264-2016	Reinhart-King, Cynthia A./0000-0001-6959-3914	Cornell Center on the Microenvironment and Metastasis from the National Cancer Institute [U54CA143876]; National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	Cornell Center on the Microenvironment and Metastasis from the National Cancer Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Cornell Center on the Microenvironment and Metastasis through Award Number U54CA143876 from the National Cancer Institute to CAR-K and a National Science Foundation Graduate Research Fellowship to CMK-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Darling EM, 2007, BIOPHYS J, V92, P1784, DOI 10.1529/biophysj.106.083097; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Dennis C, 2006, NATURE, V442, P739, DOI 10.1038/442739a; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Duffy MJ, 1996, CLIN CANCER RES, V2, P613; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Indra I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015015; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Kraning-Rush CM, 2012, COMPUTATION IN PRESS; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pickle LW, 2007, CA-CANCER J CLIN, V57, P30, DOI 10.3322/canjclin.57.1.30; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P45, DOI 10.1016/S0076-6879(08)02003-X; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	55	256	256	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32572	10.1371/journal.pone.0032572	http://dx.doi.org/10.1371/journal.pone.0032572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389710	gold, Green Submitted, Green Published			2022-12-25	WOS:000302999600049
J	Manikkam, M; Guerrero-Bosagna, C; Tracey, R; Haque, MM; Skinner, MK				Manikkam, Mohan; Guerrero-Bosagna, Carlos; Tracey, Rebecca; Haque, Md. M.; Skinner, Michael K.			Transgenerational Actions of Environmental Compounds on Reproductive Disease and Identification of Epigenetic Biomarkers of Ancestral Exposures	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; JET FUELS; HEALTH; ONSET; INHIBITION; INDUCTION; PUBERTY; INSECT	Environmental factors during fetal development can induce a permanent epigenetic change in the germ line (sperm) that then transmits epigenetic transgenerational inheritance of adult-onset disease in the absence of any subsequent exposure. The epigenetic transgenerational actions of various environmental compounds and relevant mixtures were investigated with the use of a pesticide mixture (permethrin and insect repellant DEET), a plastic mixture (bisphenol A and phthalates), dioxin (TCDD) and a hydrocarbon mixture (jet fuel, JP8). After transient exposure of F0 gestating female rats during the period of embryonic gonadal sex determination, the subsequent F1-F3 generations were obtained in the absence of any environmental exposure. The effects on the F1, F2 and F3 generations pubertal onset and gonadal function were assessed. The plastics, dioxin and jet fuel were found to promote early-onset female puberty transgenerationally (F3 generation). Spermatogenic cell apoptosis was affected transgenerationally. Ovarian primordial follicle pool size was significantly decreased with all treatments transgenerationally. Differential DNA methylation of the F3 generation sperm promoter epigenome was examined. Differential DNA methylation regions (DMR) were identified in the sperm of all exposure lineage males and found to be consistent within a specific exposure lineage, but different between the exposures. Several genomic features of the DMR, such as low density CpG content, were identified. Exposure-specific epigenetic biomarkers were identified that may allow for the assessment of ancestral environmental exposures associated with adult onset disease.	[Manikkam, Mohan; Guerrero-Bosagna, Carlos; Tracey, Rebecca; Haque, Md. M.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Manikkam, M (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	USA Department of Defense; National Institutes of Health [NIEHS ES012974]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	USA Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support of the USA Department of Defense and National Institutes of Health (NIEHS ES012974). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Cesario SK, 2007, JOGNN-J OBST GYN NEO, V36, P263, DOI 10.1111/J.1552-6909.2007.00145.x; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Das Parikshit C., 2008, Drug Metabolism and Drug Interactions, V23, P237; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Guerrero-Bosagna C, 2011, BIOMARKERS UNPUB; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Heder AF, 2001, BIOCHEM PHARMACOL, V62, P71, DOI 10.1016/S0006-2952(01)00639-6; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Hotchkiss AK, 2007, TOXICOL SCI, V96, P335, DOI 10.1093/toxsci/kfm002; Hunt PA, 2009, BIOL REPROD, V81, P807, DOI 10.1095/biolreprod.109.077008; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kavlock R, 2005, CRIT REV TOXICOL, V35, P721, DOI 10.1080/10408440591007377; Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Olgun S, 2004, TOXICOLOGY, V196, P181, DOI 10.1016/j.tox.2003.09.007; Pimentel D, 2007, HUM ECOL, V35, P653, DOI 10.1007/s10745-007-9128-3; Ritchie GD, 2003, J TOXICOL ENV HEAL B, V6, P357, DOI 10.1080/10937400306473; Rockett JC, 2004, ENVIRON HEALTH PERSP, V112, P105, DOI 10.1289/ehp.6265; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; Torres-Altoro MI, 2011, J NEUROCHEM, V119, P303, DOI 10.1111/j.1471-4159.2011.07428.x; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Watanabe N, 2001, ENVIRON HEALTH PERSP, V109, P111; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Wong SS, 2008, TOXICOLOGY, V254, P106, DOI 10.1016/j.tox.2008.09.018; Zhang WY, 2007, BIOINFORMATICS, V23, P1217, DOI 10.1093/bioinformatics/btm081	49	294	303	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31901	10.1371/journal.pone.0031901	http://dx.doi.org/10.1371/journal.pone.0031901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389676	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600014
J	Poland, JA; Brown, PJ; Sorrells, ME; Jannink, JL				Poland, Jesse A.; Brown, Patrick J.; Sorrells, Mark E.; Jannink, Jean-Luc			Development of High-Density Genetic Maps for Barley and Wheat Using a Novel Two-Enzyme Genotyping-by-Sequencing Approach	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM DISCOVERY; THROUGHPUT SNP DISCOVERY; GENOME-WIDE ASSOCIATION; LINKAGE MAP; SELECTION	Advancements in next-generation sequencing technology have enabled whole genome re-sequencing in many species providing unprecedented discovery and characterization of molecular polymorphisms. There are limitations, however, to next-generation sequencing approaches for species with large complex genomes such as barley and wheat. Genotyping-by-sequencing (GBS) has been developed as a tool for association studies and genomics-assisted breeding in a range of species including those with complex genomes. GBS uses restriction enzymes for targeted complexity reduction followed by multiplex sequencing to produce high-quality polymorphism data at a relatively low per sample cost. Here we present a GBS approach for species that currently lack a reference genome sequence. We developed a novel two-enzyme GBS protocol and genotyped bi-parental barley and wheat populations to develop a genetically anchored reference map of identified SNPs and tags. We were able to map over 34,000 SNPs and 240,000 tags onto the Oregon Wolfe Barley reference map, and 20,000 SNPs and 367,000 tags on the Synthetic W9784xOpata85 (SynOpDH) wheat reference map. To further evaluate GBS in wheat, we also constructed a de novo genetic map using only SNP markers from the GBS data. The GBS approach presented here provides a powerful method of developing high-density markers in species without a sequenced genome while providing valuable tools for anchoring and ordering physical maps and whole-genome shotgun sequence. Development of the sequenced reference genome(s) will in turn increase the utility of GBS data enabling physical mapping of genes and haplotype imputation of missing data. Finally, as a result of low per-sample costs, GBS will have broad application in genomics-assisted plant breeding programs.	[Poland, Jesse A.] ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS 66502 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Brown, Patrick J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Sorrells, Mark E.; Jannink, Jean-Luc] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Jannink, Jean-Luc] ARS, Plant Soil & Nutr Res Unit, USDA, Ithaca, NY USA	United States Department of Agriculture (USDA); Kansas State University; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; United States Department of Agriculture (USDA)	Poland, JA (corresponding author), ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS 66502 USA.	jpoland@ksu.edu		Jannink, Jean-Luc/0000-0003-4849-628X; Poland, Jesse/0000-0002-7856-1399	United States 282 Department of Agriculture - Agricultural Research Service [5430-283 21000-005-00]; USDA NIFA 284 NRI CAP [2009-85606-05701]; Bill and Melinda Gates Foundation; USDA- NIFA NRI CAP [286 2005-05130, 287 2011-68002-30029]	United States 282 Department of Agriculture - Agricultural Research Service; USDA NIFA 284 NRI CAP; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USDA- NIFA NRI CAP	Funding for this research was provided by United States 282 Department of Agriculture - Agricultural Research Service (Appropriation No. 5430-283 21000-005-00), the Barley Coordinated Agriculture Project (BarleyCAP - USDA NIFA 284 NRI CAP grant No. 2009-85606-05701), The Bill and Melinda Gates Foundation, the 285 Wheat Coordinated Agriculture Project (WheatCAP; USDA- NIFA NRI CAP grant No. 286 2005-05130), and the Triticeae Coordinated Agriculture Project (USDA-NIFA, NRI CAP No. 287 2011-68002-30029). The funders had no role in study design, data collection and 288 analysis, decision to publish, or preparation of the manuscript. Mention of trade names is 289 for research purposes only and does not constitute endorsement by the USDA.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Wolfe R. I., 1972, Barley Genetics Newsletter, V2, P170; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Franckowiak J.D, 1991, BARLEY GENET NEWSL, V20, P117; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-475; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	31	1113	1140	5	362	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32253	10.1371/journal.pone.0032253	http://dx.doi.org/10.1371/journal.pone.0032253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389690	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600028
J	Pernas, M; Casado, C; Arcones, C; Llano, A; Sanchez-Merino, V; Mothe, B; Vicario, JL; Grau, E; Ruiz, L; Sanchez, J; Telenti, A; Yuste, E; Brander, C; Lopez-Galindez, C				Pernas, Maria; Casado, Concepcion; Arcones, Carolina; Llano, Anuska; Sanchez-Merino, Victor; Mothe, Beatriz; Vicario, Jose L.; Grau, Eulalia; Ruiz, Lidia; Sanchez, Jorge; Telenti, Amalio; Yuste, Eloisa; Brander, Christian; Lopez-Galindez, Cecilio			Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODY-RESPONSE; T-CELL RESPONSES; LONG-TERM; IN-VIVO; TYPE-1; INFECTION; GENOME; SUPPRESSORS; MECHANISMS	Objective: To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite controller patient. Methodology and Principal Findings: We studied host genetic, virological and immunological factors associated with viral control in a SI long term non progressor elite controller (LTNP-EC). The individual contained both viruses and maintained undetectable viral loads for >20 years and he did not express any of the described host genetic polymorphisms associated with viral control. None of four full-length gp160 recombinants derived from the LTNP-EC replicated in heterologous peripheral blood mononuclear cells. CTL responses after SI were maintained in two samples separated by 9 years and they were higher in breadth and magnitude than responses seen in most of 250 treatment naive patients and also 25 controller subjects. The LTNP-EC showed a neutralization response, against 4 of the 6 viruses analyzed, superior to other ECs. Conclusions: The study demonstrated that a strong and sustained cellular and humoral immune response and low replicating viruses are associated with viral control in the superinfected LTNP-EC.	[Pernas, Maria; Casado, Concepcion; Arcones, Carolina; Lopez-Galindez, Cecilio] Inst Salud Carlos III, Serv Virol Mol, Ctr Nacl Microbiol, Madrid, Spain; [Llano, Anuska; Mothe, Beatriz; Grau, Eulalia; Ruiz, Lidia; Brander, Christian] Hosp Badalona Germans Trias & Pujol, Inst Recerca Sida, Fundacio irsiCaixa HIVACAT, Badalona, Spain; [Sanchez-Merino, Victor; Yuste, Eloisa] Lab Retrovirol & Inmunol IDIBAPS Fac Med, Barcelona, Spain; [Vicario, Jose L.] Ctr Transfus Comunidad Madrid, Madrid, Spain; [Sanchez, Jorge] Asociac Civil IMPACTA Salud & Educ, Lima, Peru; [Telenti, Amalio] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Brander, Christian] ICREA, Barcelona, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Lausanne; ICREA	Pernas, M (corresponding author), Inst Salud Carlos III, Serv Virol Mol, Ctr Nacl Microbiol, Madrid, Spain.	clopez@isciii.es	Pernas, Maria/E-3998-2018; Yuste, Eloisa/R-9493-2019; Telenti, Amalio/AAY-1674-2021; Casado, Concepcion/F-3060-2016; Ruiz, Lidia/ABF-9720-2021; Lopez-Galindez, Cecilio/A-3603-2008	Pernas, Maria/0000-0003-2966-0160; Yuste, Eloisa/0000-0002-9484-9974; Casado, Concepcion/0000-0003-3412-2877; Lopez-Galindez, Cecilio/0000-0002-2324-9584; Grau, Eulalia/0000-0002-2442-9165; Brander, Christian/0000-0002-0548-5778; Mothe, Beatriz/0000-0001-9975-407X; Sanchez-Merino, Victor/0000-0001-9400-427X	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36558/06, 36641/07, 36779/08, 360766/09, 360737/09]; United States National Institute of Health NIH-NIAID [N01-AI-30024]; Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) [173];  [SAF 2007-61036];  [SAF 2010-17226]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030024] Funding Source: NIH RePORTER	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); United States National Institute of Health NIH-NIAID; Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss); ; ; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants SAF 2007-61036 and SAF 2010-17226, by Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) grants 36558/06, 36641/07, 36779/08, 360766/09 and 360737/09, and by the United States National Institute of Health NIH-NIAID contract N01-AI-30024. Support by the Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Altfeld M, 2000, CURR OPIN IMMUNOL, V12, P375, DOI 10.1016/S0952-7915(00)00103-5; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Blankson JN, 2010, DISCOV MED, V9, P261; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Braibant M, 2010, VIROLOGY, V405, P81, DOI 10.1016/j.virol.2010.05.026; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Calugi G, 2006, J VIROL, V80, P11892, DOI 10.1128/JVI.00932-06; Casado C, 2007, J INFECT DIS, V196, P895, DOI 10.1086/520885; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Gasser O, 2007, PLOS MED, V4, P556, DOI 10.1371/journal.pmed.0040096; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KUSUMI K, 1992, J VIROL, V66, P875, DOI 10.1128/JVI.66.2.875-885.1992; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lotti B, 2002, J CLIN IMMUNOL, V22, P253, DOI 10.1023/A:1020066404226; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Mascola Jr, 1999, METH MOLEC MED, V17, P317, DOI 10.1385/0-89603-369-4:317; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Meng ZF, 2008, AIDS RES HUM RETROV, V24, P259, DOI 10.1089/aid.2007.0128; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miura T, 2007, 14 C RETR OPP INF LO; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Olivares I, 1997, AIDS RES HUM RETROV, V13, P979, DOI 10.1089/aid.1997.13.979; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; PERUCHO M, 1980, CELL, V22, P309, DOI 10.1016/0092-8674(80)90178-6; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Rachinger A, 2008, CLIN INFECT DIS, V47, pE86, DOI 10.1086/592978; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Sealy R, 2009, CURR HIV RES, V7, P497, DOI 10.2174/157016209789346255; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; SPIRA AI, 1995, J VIROL, V69, P422, DOI 10.1128/JVI.69.1.422-429.1995; Voronin Y, 2007, J VIROL, V81, P10232, DOI 10.1128/JVI.01035-07; Wang B, 2002, VIROLOGY, V304, P246, DOI 10.1006/viro.2002.1706; Yang OO, 2005, J VIROL, V79, P860, DOI 10.1128/JVI.79.2.860-868.2005	56	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31928	10.1371/journal.pone.0031928	http://dx.doi.org/10.1371/journal.pone.0031928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384103	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800021
J	Pi, RB; Mao, XX; Chao, XJ; Cheng, ZY; Liu, MF; Duan, XL; Ye, MZ; Chen, XH; Mei, ZR; Liu, PQ; Li, WM; Han, YF				Pi, Rongbiao; Mao, Xuexuan; Chao, Xiaojuan; Cheng, Zhiyi; Liu, Mengfei; Duan, Xiaolu; Ye, Mingzhong; Chen, Xiaohong; Mei, Zhengrong; Liu, Peiqing; Li, Wenming; Han, Yifan			Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-beta-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo	PLOS ONE			English	Article							FERULIC ACID; OXIDATIVE STRESS; ACETYLCHOLINESTERASE INHIBITORS; COGNITIVE DEFICITS; FIBRILS; TACRINE; DERIVATIVES; TOXICITY; MICE; IMPAIRMENT	We have previously synthesized a series of hybrid compounds by linking ferulic acid to tacrine as multifunctional agents based on the hypotheses that Alzheimer's disease (AD) generates cholinergic deficiency and oxidative stress. Interestingly, we found that they may have potential pharmacological activities for treating AD. Here we report for the first time that tacrine-6-ferulic acid (T6FA), one of these compounds, can prevent amyloid-beta peptide (A beta)-induced AD-associated pathological changes in vitro and in vivo. Our results showed that T6FA significantly inhibited auto-and acetylcholinesterase (AChE)-induced aggregation of A beta(1-40) in vitro and blocked the cell death induced by A beta(1-40) in PC12 cells. In an AD mouse model by the intracerebroventricular injection of A beta(1-40), T6FA significantly improved the cognitive ability along with increasing choline acetyltransferase and superoxide dismutase activity, decreasing AChE activity and malondialdehyde level. Based on our findings, we conclude that T6FA may be a promising multifunctional drug candidate for AD.	[Pi, Rongbiao; Mao, Xuexuan; Chao, Xiaojuan; Cheng, Zhiyi; Liu, Mengfei; Duan, Xiaolu; Ye, Mingzhong; Mei, Zhengrong; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Xiaohong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wenming; Han, Yifan] Hong Kong Polytech Univ, Inst Modern Chinese Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Li, Wenming] Emory Univ, Sch Med, Dept Pharmacol & Neurol, Atlanta, GA USA	Sun Yat Sen University; Sun Yat Sen University; Hong Kong Polytechnic University; Emory University	Pi, RB (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510275, Guangdong, Peoples R China.	pirb@mail.sysu.edu.cn; bcwmli@pharm.emory.edu; bcyfhan@inet.polyu.edu.hk		Han, Yifan/0000-0002-5833-069X	Fundamental Research Funds for the Central Universities [10ykpy23]; National Natural Science Foundation of China/RGC Hong Kong [30731160617]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China/RGC Hong Kong	This research is supported by in part by Fundamental Research Funds for the Central Universities (No 10ykpy23) and National Natural Science Foundation of China/RGC Hong Kong Joint Research Scheme (No 30731160617) to Dr. Pi. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bartolini M, 2003, BIOCHEM PHARMACOL, V65, P407, DOI 10.1016/S0006-2952(02)01514-9; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Byeon SR, 2007, BIOORG MED CHEM LETT, V17, P4022, DOI 10.1016/j.bmcl.2007.04.079; Castro A, 2006, CURR PHARM DESIGN, V12, P4377, DOI 10.2174/138161206778792985; Chen XH, 2010, J PHARM PHARMACOL, V62, P915, DOI 10.1211/jpp.62.07.0013; Chopra K, 2011, EXPERT OPIN PHARMACO, V12, P335, DOI 10.1517/14656566.2011.520702; Colombres M, 2004, CURR PHARM DESIGN, V10, P3123, DOI 10.2174/1381612043383359; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Fang L, 2008, BIOORG MED CHEM LETT, V18, P2905, DOI 10.1016/j.bmcl.2008.03.073; Fleck C, 2010, ARZNEIMITTELFORSCH, V60, P299, DOI 10.1055/s-0031-1296291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiramatsu M, 2010, BRIT J PHARMACOL, V161, P1899, DOI 10.1111/j.1476-5381.2010.01014.x; Inestrosa NC, 2005, SUB CELL BIOCHEM, V38, P299; Inestrosa Nibaldo C., 2005, Current Alzheimer Research, V2, P301, DOI 10.2174/1567205054367928; Jesudason EP, 2008, MOL CELL BIOCHEM, V311, P145, DOI 10.1007/s11010-008-9705-9; Kane MD, 1999, J NEUROCHEM, V72, P1939, DOI 10.1046/j.1471-4159.1999.0721939.x; Kawabata J, 2002, J AGR FOOD CHEM, V50, P5468, DOI 10.1021/jf020347g; Lahiri DK, 1998, MOL BRAIN RES, V62, P131, DOI 10.1016/S0169-328X(98)00236-8; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Lee KH, 2005, BIOCHEM BIOPH RES CO, V328, P816, DOI 10.1016/j.bbrc.2005.01.030; Lupp A, 2010, ARZNEIMITTEL-FORSCH, V60, P229; Munoz-Ruiz P, 2005, J MED CHEM, V48, P7223, DOI 10.1021/jm0503289; Nitsch RM, 2008, NEUROTHERAPEUTICS, V5, P415, DOI 10.1016/j.nurt.2008.05.013; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pi RYM, 2008, NEW TACRINE FERULIC; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; Srinivasan M, 2005, FUND CLIN PHARMACOL, V19, P491, DOI 10.1111/j.1472-8206.2005.00332.x; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tumiatti V, 2010, CURR MED CHEM, V17, P1825, DOI 10.2174/092986710791111206; Van der Schyf CJ, 2006, J NEUROCHEM, V99, P1033, DOI 10.1111/j.1471-4159.2006.04141.x; Xue LB, 2008, NEUROL RES, V30, P389, DOI 10.1179/174313208X300413; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Ye M, 2009, NOVEL TACRINE FARULI; Ye MZ, 2008, CHINESE PHARMACOL B, V24, P421	42	79	81	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31921	10.1371/journal.pone.0031921	http://dx.doi.org/10.1371/journal.pone.0031921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384101	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100040
J	Singh, AK; Singh, R; Naz, F; Chauhan, SS; Dinda, A; Shukla, AA; Gill, K; Kapoor, V; Dey, S				Singh, Abhay Kumar; Singh, Ratnakar; Naz, Farhat; Chauhan, Shyam Singh; Dinda, Amit; Shukla, Abhay Anand; Gill, Kamaldeep; Kapoor, Vaishali; Dey, Sharmistha			Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12: In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast Cancer	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; CELL-LINE; LIPOXYGENASE INHIBITORS; 12-LIPOXYGENASE; GROWTH; EXPRESSION; CARCINOMA; CYCLOOXYGENASE-2; CHEMOTHERAPY; APOPTOSIS	Human breast cancer cell proliferation involves a complex interaction between growth factors, steroid hormones and peptide hormones. The interaction of growth factors, such as epidermal growth factor (EGF), with their receptors on breast cancer cells can lead to the hydrolysis of phospholipids and release of fatty acid such as arachidonic acid, which can be further metabolized by cyclooxygenase (COX) and lipoxygenase (LOX) pathways to produce prostaglandins. The high concentration of prostaglandins has been associated with chronic inflammatory diseases and several types of human cancers. This is due to the over expression COX, LOX and other inflammatory enzymes. Ten peptides were designed and synthesized by solid phase peptide synthesis and analyzed in vitro for enzyme inhibition. Out of these peptides, YWCS had shown significant inhibitory effects. The dissociation constant (K-D) was determined by surface plasmon resonance (SPR) analysis and was found to be 3.39x10(-8) M and 8.6x10(-8) M for YWCS and baicalein (positive control), respectively. The kinetic constant Ki was 72.45x10(-7) M as determined by kinetic assay. The peptide significantly reduced the cell viability of estrogen positive MCF-7 and estrogen negative MDA-MB-231 cell line with the half maximal concentration (IC50) of 75 mu M and 400 mu M, respectively. The peptide also induced 49.8% and 20.8% apoptosis in breast cancer cells MCF-7 and MDA-MB-231, respectively. The YWCS was also found to be least hemolytic at a concentration of 358 mu M. In vivo studies had shown that the peptide significantly inhibits tumor growth in mice (p<0.017). This peptide can be used as a lead compound and complement for ongoing efforts to develop differentiation therapies for breast cancer.	[Singh, Abhay Kumar; Gill, Kamaldeep; Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Ratnakar; Chauhan, Shyam Singh; Shukla, Abhay Anand] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Naz, Farhat; Dinda, Amit] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Kapoor, Vaishali] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, AK (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	sharmistha_d@hotmail.com	SINGH, ABHAY/P-3494-2019; Kapoor, Vaishali/I-8189-2019; Singh, Ratnakar/K-2848-2018	SINGH, ABHAY/0000-0001-8399-7974; Kapoor, Vaishali/0000-0002-7581-1487; Singh, Ratnakar/0000-0002-3226-3847	Council of Scientific and Industrial Research; Indian council of medical research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian council of medical research(Indian Council of Medical Research (ICMR))	Authors acknowledge Council of Scientific and Industrial Research for financial support for purchasing the consumable items and Indian council of medical research for the fellowship of Abhay kumar Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Hammamieh R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-138; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Ikemoto S, 2004, ANTICANCER RES, V24, P733; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; Kamitani H, 1999, ADV EXP MED BIOL, V469, P593; Koutsilieris M, 1999, MOL MED, V5, P86, DOI 10.1007/BF03402143; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135, DOI 10.1515/zna-1968-1247; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu XH, 1996, CLIN EXP METASTAS, V14, P145, DOI 10.1007/BF00121211; Liu XH, 1996, CANCER LETT, V109, P223, DOI 10.1016/S0304-3835(96)04462-X; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Nakano H, 2000, BIOORGAN MED CHEM, V8, P373, DOI 10.1016/S0968-0896(99)00291-6; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; Nie D, 1998, CANCER RES, V58, P4047; NYLANDER C, 1982, SENSOR ACTUATOR, V3, P79, DOI 10.1016/0250-6874(82)80008-5; OTTO A, 1968, Z PHYS, V216, P398, DOI 10.1007/BF01391532; Singh AK, 2011, BIOCHEM BIOPH RES CO, V414, P304, DOI 10.1016/j.bbrc.2011.09.044; Singh AK, 2011, DNA CELL BIOL, V30, P801, DOI 10.1089/dna.2011.1215; Skrzypczak-Jankun E, 2003, INT J MOL MED, V12, P17; Somvanshi RK, 2008, BBA-PROTEINS PROTEOM, V1784, P1812, DOI 10.1016/j.bbapap.2008.07.004; Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467; Wenzel SE, 1996, ANN PHARMACOTHER, V30, P858, DOI 10.1177/106002809603000725; Whitman S, 2002, J MED CHEM, V45, P2659, DOI 10.1021/jm0201262; Wong BCY, 2001, CARCINOGENESIS, V22, P1349, DOI 10.1093/carcin/22.9.1349; Yoshimura R, 2004, INT J MOL MED, V13, P41	27	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32521	10.1371/journal.pone.0032521	http://dx.doi.org/10.1371/journal.pone.0032521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384268	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100085
J	Woo, JS; Cho, CH; Lee, KJ; Kim, DH; Ma, JJ; Lee, EH				Woo, Jin Seok; Cho, Chung-Hyun; Lee, Keon Jin; Kim, Do Han; Ma, Jianjie; Lee, Eun Hui			Hypertrophy in Skeletal Myotubes Induced by Junctophilin-2 Mutant, Y141H, Involves an Increase in Store-operated Ca2+ Entry via Orai1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CARDIAC-HYPERTROPHY; TRIADIC PROTEINS; PLASMA-MEMBRANE; CALCIUM INFLUX; HEART-FAILURE; MUSCLE FIBERS; STIM1; CARDIOMYOPATHY; CONTRACTION	Junctophilins (JPs) play an important role in the formation of junctional membrane complexes (JMC) in striated muscle by physically linking the transverse-tubule and sarcoplasmic reticulum (SR) membranes. Researchers have found five JP2 mutants in humans with hypertrophic cardiomyopathy. Among these, Y141H and S165F are associated with severely altered Ca2+ signaling in cardiomyocytes. We previously reported that S165F also induced both hypertrophy and altered intracellular Ca2+ signaling in mouse skeletal myotubes. In the present study, we attempted to identify the dominant-negative role(s) of Y141H in primary mouse skeletal myotubes. Consistent with S165F, Y141H led to hypertrophy and altered Ca2+ signaling (a decrease in the gain of excitation-contraction coupling and an increase in the resting level of myoplasmic Ca2+). However, unlike S165F, neither ryanodine receptor 1-mediated Ca2+ release from the SR nor the phosphorylation of the mutated JP2 by protein kinase C was related to the altered Ca2+ signaling by Y141H. Instead, abnormal JMC and increased SOCE via Orai1 were found, suggesting that the hypertrophy caused by Y141H progressed differently from S165F. Therefore JP2 can be linked to skeletal muscle hypertrophy via various Ca2+ signaling pathways, and SOCE could be one of the causes of altered Ca2+ signaling observed in muscle hypertrophy.	[Woo, Jin Seok; Lee, Keon Jin; Lee, Eun Hui] Catholic Univ Korea, Coll Med, Dept Physiol, Seoul 137701, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 110799, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Kim, Do Han] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Ma, Jianjie] UMDNJ Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, EH (corresponding author), Catholic Univ Korea, Coll Med, Dept Physiol, Seoul 137701, South Korea.	EHUI@catholic.ac.kr	Cho, Chung-Hyun/H-7286-2012	Lee, Eun Hui/0000-0003-4555-1730	Ministry of Health & Welfare, Republic of Korea [A090047]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0022731, 2010-0028236]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A090047) (to E. H. L.), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science and Technology Grants 2010-0022731 (to E. H. L.) and 2010-0028236 (to C. H. C.).	Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Garbino A, 2009, PHYSIOL GENOMICS, V37, P175, DOI 10.1152/physiolgenomics.00017.2009; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Lee EH, 2006, MOL CELLS, V21, P315; Lee EH, 2010, PROG BIOPHYS MOL BIO, V103, P35, DOI 10.1016/j.pbiomolbio.2010.05.003; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Woo JS, 2008, BIOCHEM J, V411, P399, DOI [10.1042/BJ20071504, 10.1042/bj20071504]; Woo JS, 2010, BIOCHEM J, V427, P125, DOI 10.1042/BJ20091225; Woo JS, 2009, MOL CELL BIOCHEM, V328, P25, DOI 10.1007/s11010-009-0070-0; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Yamazaki D, 2009, PHARMACOL THERAPEUT, V121, P265, DOI 10.1016/j.pharmthera.2008.11.004; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zucchi R, 1997, PHARMACOL REV, V49, P1	46	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14336	14348		10.1074/jbc.M111.304808	http://dx.doi.org/10.1074/jbc.M111.304808			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22389502	hybrid, Green Published			2022-12-25	WOS:000304003200003
J	Yu, X; Luo, Y; Dinkel, P; Zheng, J; Wei, GH; Margittai, M; Nussinov, R; Ma, BY				Yu, Xiang; Luo, Yin; Dinkel, Paul; Zheng, Jie; Wei, Guanghong; Margittai, Martin; Nussinov, Ruth; Ma, Buyong			Cross-seeding and Conformational Selection between Three- and Four-repeat Human Tau Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; BETA-SHEET; AGGREGATION; BINDING; TRANSMISSION; ISOFORMS; FIBRILS; BRAIN; CORE	In Alzheimer's disease and frontotemporal dementias, the microtubule-associated protein Tau forms intracellular paired helical filaments. The filaments can form not only by the full-length human Tau protein, but also by the three repeated (K19) or four repeated (K18) Tau segments. However, of interest, experimentally, K19 can seed K18, but not vice versa. To obtain insight into the cross-seeding between K18 and K19 aggregates, here, K18 and K19 octamers with repeat 3 (R3) in U-shaped, L-shaped, and long straight line-shaped (SL-shape) conformations are assembled into different structures. The simulation results show that K18-8/K19-8 (K18 and K19 assemblies number 8) with R3 in an L shape and K18-9/K19-9 with R3 in an SL shape are highly populated and present the highest structural similarity among all simulated K18 and K19 octamers, suggesting that similar folding of K18/K19 may serve as structural core for the K18-K19 co-assembled heterogeneous filament. We demonstrate that formation of stable R2 and R3 conformations is the critical step for K18 aggregation, and R3 is critical for K19 fibrillization. The different core units in K18 and K19 may create a cross-seeding barrier for the K18 seed to trigger K19 fibril growth because R2 is not available for K19. Our study provides insights into cross-seeding involving heterogeneous structures. The polymorphic nature of protein aggregation could be magnified in the cross-seeding process. If the seeding conformations lead to too much divergence in the energy landscape, it could impede fibril formation. Such an effect could also contribute to the asymmetric barrier between K18 and K19.	[Yu, Xiang; Luo, Yin; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Luo, Yin; Wei, Guanghong] Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci, Minist Educ, Shanghai 200433, Peoples R China; [Luo, Yin; Wei, Guanghong] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Dinkel, Paul; Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA; [Nussinov, Ruth; Ma, Buyong] NCI, Basic Res Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Dept Human Genet & Mol Med, Sackler Inst Mol Med, Sackler Sch Med, IL-69978 Tel Aviv, Israel	University System of Ohio; University of Akron; Fudan University; Fudan University; University of Denver; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Zheng, J (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	zhengj@uakron.edu; ghwei@fudan.edu.cn; ruthnu@helix.nih.gov	Zheng, Jie/B-5057-2013; Ma, Buyong/F-9491-2011; Margittai, Martin/D-5039-2014; Yu, Xiang/A-9765-2012	Zheng, Jie/0000-0003-1547-3612; Ma, Buyong/0000-0002-7383-719X; Margittai, Martin/0000-0003-1903-5927; Nussinov, Ruth/0000-0002-8115-6415; Yu, Xiang/0000-0002-0486-1110; Wei, Guanghong/0000-0001-5814-3328	National Institutes of Health [R01NS076619]; National Cancer Institute [HHSN261200800001E]; National Cancer Institute Center for Cancer Research, National Science Foundation [CBET-0952624]; National Natural Science Foundation of China [11074047]; Research Fund for the Doctoral Program of Higher Education of China [RFDP-20100071110006]; NATIONAL CANCER INSTITUTE [ZIABC010441, ZIABC010440] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0952624] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center for Cancer Research, National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS076619 (to M. M.). This work was also supported by National Cancer Institute Contract HHSN261200800001E, the intramural research program of the National Cancer Institute Center for Cancer Research, National Science Foundation CAREER Award CBET-0952624 (to J. Z.), a 3M nontenured faculty award (to J. Z.), National Natural Science Foundation of China Grant 11074047 (to G. W.), and Research Fund for the Doctoral Program of Higher Education of China Grant RFDP-20100071110006 (to G. W.).	Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Ma B., 2012, J MOL BIOL IN PRESS; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2006, PHYS BIOL, V3, pP1, DOI 10.1088/1478-3975/3/3/P01	42	55	56	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14950	14959		10.1074/jbc.M112.340794	http://dx.doi.org/10.1074/jbc.M112.340794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393063	Green Published, hybrid			2022-12-25	WOS:000304003200057
J	Hehemann, JH; Smyth, L; Yadav, A; Vocadlo, DJ; Boraston, AB				Hehemann, Jan-Hendrik; Smyth, Leo; Yadav, Anuj; Vocadlo, David J.; Boraston, Alisdair B.			Analysis of Keystone Enzyme in Agar Hydrolysis Provides Insight into the Degradation of a Polysaccharide from Red Seaweeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZOBELLIA-GALACTANIVORANS; REVEALS; PURIFICATION; MECHANISMS; PREDICTION; PORPHYRAN; HYDROLASE; PROTEINS; FAMILY; NOV	Agars are abundant polysaccharides from marine red algae, and their chemical structure consists of alternating D-galactose and 3,6-anhydro-L-galactose residues, the latter of which are presumed to make the polymer recalcitrant to degradation by most terrestrial bacteria. Here we study a family 117 glycoside hydrolase (BpGH117) encoded within a recently discovered locus from the human gut bacterium Bacteroides plebeius. Consistent with this locus being involved in agarocolloid degradation, we show that BpGH117 is an exo-acting 3,6-anhydro-alpha(1,3)-L-galactosidase that removes the 3,6-anhydrogalactose from the non-reducing end of neoagaro-oligosaccharides. A Michaelis complex of BpGH117 with neoagarobiose reveals the distortion of the constrained 3,6-anhydro-L-galactose into a conformation that favors catalysis. Furthermore, this complex, supported by analysis of site-directed mutants, provides evidence for an organization of the active site and positioning of the catalytic residues that are consistent with an inverting mechanism of catalysis and suggests that a histidine residue acts as the general acid. This latter feature differs from the vast majority of glycoside hydrolases, which use a carboxylic acid, highlighting the alternative strategies that enzymes may utilize in catalizing the cleavage of glycosidic bonds.	[Hehemann, Jan-Hendrik; Smyth, Leo; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Yadav, Anuj; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Smyth, Leo/0000-0002-4329-4331; Boraston, Alisdair/0000-0001-6417-0592	Natural Sciences and Engineering Research Council of Canada; European Molecular Biology Organization	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada discovery grant.; Supported by a European Molecular Biology Organization long term fellowship.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DUCKWORTH M, 1970, J CHROMATOGR, V49, P482, DOI 10.1016/S0021-9673(00)93663-X; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; Ha SC, 2011, BIOCHEM BIOPH RES CO, V412, P238, DOI 10.1016/j.bbrc.2011.07.073; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Hitchens AP, 1939, J BACTERIOL, V37, P485, DOI 10.1128/JB.37.5.485-493.1939; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee S, 2009, ACTA CRYSTALLOGR F, V65, P1299, DOI 10.1107/S174430910904603X; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navarro DA, 2005, CARBOHYD RES, V340, P2030, DOI 10.1016/j.carres.2005.05.022; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; POTIN P, 1993, EUR J BIOCHEM, V214, P599, DOI 10.1111/j.1432-1033.1993.tb17959.x; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; REES DA, 1961, BIOCHEM J, V81, P347, DOI 10.1042/bj0810347; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S0108767307043930, 10.1107/S2053229614024218]; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Suzuki H, 2002, J BIOSCI BIOENG, V93, P456, DOI 10.1263/jbb.93.456; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	50	64	66	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13985	13995		10.1074/jbc.M112.345645	http://dx.doi.org/10.1074/jbc.M112.345645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393053	hybrid, Green Published			2022-12-25	WOS:000303996300053
J	Narute, PS; Smithgall, TE				Narute, Purushottam S.; Smithgall, Thomas E.			Nef Alleles from All Major HIV-1 Clades Activate Src-Family Kinases and Enhance HIV-1 Replication in an Inhibitor-Sensitive Manner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HCK TYROSINE KINASE; CD4 DOWN-REGULATION; SH3 DOMAIN; GENETIC SUBTYPES; BINDING SURFACE; TRANSGENIC MICE; C-SRC; PROTEIN; INFECTION	The HIV-1 accessory factor Nef is essential for high-titer viral replication and AIDS progression. Nef function requires interaction with many host cell proteins, including specific members of the Src kinase family. Here we explored whether Src-family kinase activation is a conserved property of Nef alleles from a wide range of primary HIV-1 isolates and their sensitivity to selective pharmacological inhibitors. Representative Nef proteins from the major HIV-1 subtypes A1, A2, B, C, F1, F2, G, H, J and K strongly activated Hck and Lyn as well as c-Src to a lesser extent, demonstrating for the first time that Src-family kinase activation is a highly conserved property of primary M-group HIV-1 Nef isolates. Recently, we identified 4-amino substituted diphenylfuropyrimidines (DFPs) that selectively inhibit Nef-dependent activation of Src-family kinases as well as HIV replication. To determine whether DFP compounds exhibit broad-spectrum Nef-dependent antiretroviral activity against HIV-1, we first constructed chimeric forms of the HIV-1 strain NL4-3 expressing each of the primary Nef alleles. The infectivity and replication of these Nef chimeras was indistinguishable from that of wild-type virus in two distinct cell lines (U87MG astroglial cells and CEM-T4 lymphoblasts). Importantly, the 4-aminopropanol and 4-aminobutanol derivatives of DFP potently inhibited the replication of all chimeric forms of HIV-1 in both U87MG and CEM-T4 cells in a Nef-dependent manner. The antiretroviral effects of these compounds correlated with inhibition of Nef-dependent activation of endogenous Src-family kinases in the HIV-infected cells. Our results demonstrate that the activation of Hck, Lyn and c-Src by Nef is highly conserved among all major clades of HIV-1 and that selective targeting of this pathway uniformly inhibits HIV-1 replication.	[Narute, Purushottam S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Narute, Purushottam S.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narute, PS (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	tsmithga@pitt.edu	Narute, Purushottam/M-5471-2015		National Institutes of Health [AI057083]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI057083 and the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Bell I, 2001, VIROLOGY, V283, P148, DOI 10.1006/viro.2001.0872; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Coleman SH, 2006, J VIROL, V80, P1837, DOI 10.1128/JVI.80.4.1837-1849.2006; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dumitrescu TP, 2012, BMC CHEM BI IN PRESS; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; FREUND J, 1994, EUR J BIOCHEM, V223, P589, DOI 10.1111/j.1432-1033.1994.tb19029.x; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harris M, 1999, CURR BIOL, V9, pR459, DOI 10.1016/S0960-9822(99)80282-6; HARRIS MPG, 1994, J MOL BIOL, V241, P136; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hodge DR, 1998, J BIOL CHEM, V273, P15727, DOI 10.1074/jbc.273.25.15727; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khan M, 2001, J VIROL, V75, P12081, DOI 10.1128/JVI.75.24.12081-12087.2001; Kim MO, 2006, J VIROL, V80, P62, DOI 10.1128/JVI.80.1.62-72.2006; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Komuro I, 2003, J EXP MED, V198, P443, DOI 10.1084/jem.20022018; Kondo M, 2005, J INFECT DIS, V192, P56, DOI 10.1086/430739; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lindwasser OW, 2007, CURR MOL MED, V7, P171; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Los Alamos National Laboratory, LOS AL NAT LAB HIV S; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Mitchell JL, 2007, J MOL BIOL, V366, P1282, DOI 10.1016/j.jmb.2006.12.026; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; TERWILLIGER E, 1986, J VIROL, V60, P754, DOI 10.1128/JVI.60.2.754-760.1986; Trible RP, 2007, J MOL BIOL, V374, P121, DOI 10.1016/j.jmb.2007.09.009; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Walk SF, 2001, J VIROL, V75, P834, DOI 10.1128/JVI.75.2.834-843.2001; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f	65	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32561	10.1371/journal.pone.0032561	http://dx.doi.org/10.1371/journal.pone.0032561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393415	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500067
J	Sharma, G; Tamang, R; Chaudhary, R; Singh, VK; Shah, AM; Anugula, S; Rani, DS; Reddy, AG; Eaaswarkhanth, M; Chaubey, G; Singh, L; Thangaraj, K				Sharma, Gunjan; Tamang, Rakesh; Chaudhary, Ruchira; Singh, Vipin Kumar; Shah, Anish M.; Anugula, Sharath; Rani, Deepa Selvi; Reddy, Alla G.; Eaaswarkhanth, Muthukrishnan; Chaubey, Gyaneshwer; Singh, Lalji; Thangaraj, Kumarasamy			Genetic Affinities of the Central Indian Tribal Populations	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; SOUTH-ASIA; MACROHAPLOGROUP-M; CASTE; DISPERSAL; ADMIXTURE; LINEAGES; HERITAGE	Background: The central Indian state Madhya Pradesh is often called as 'heart of India' and has always been an important region functioning as a trinexus belt for three major language families (Indo-European, Dravidian and Austroasiatic). There are less detailed genetic studies on the populations inhabited in this region. Therefore, this study is an attempt for extensive characterization of genetic ancestries of three tribal populations, namely; Bharia, Bhil and Sahariya, inhabiting this region using haploid and diploid DNA markers. Methodology/Principal Findings: Mitochondrial DNA analysis showed high diversity, including some of the older sublineages of M haplogroup and prominent R lineages in all the three tribes. Y-chromosomal biallelic markers revealed high frequency of Austroasiatic-specific M95-O2a haplogroup in Bharia and Sahariya, M82-H1a in Bhil and M17-R1a in Bhil and Sahariya. The results obtained by haploid as well as diploid genetic markers revealed strong genetic affinity of Bharia (a Dravidian speaking tribe) with the Austroasiatic (Munda) group. The gene flow from Austroasiatic group is further confirmed by their Y-STRs haplotype sharing analysis, where we determined their founder haplotype from the North Munda speaking tribe, while, autosomal analysis was largely in concordant with the haploid DNA results. Conclusions/Significance: Bhil exhibited largely Indo-European specific ancestry, while Sahariya and Bharia showed admixed genetic package of Indo-European and Austroasiatic populations. Hence, in a landscape like India, linguistic label doesn't unequivocally follow the genetic footprints.	[Sharma, Gunjan; Chaudhary, Ruchira] Govt Motilal Vigyan Mahavidyalaya, Dept Zool, Bhopal, India; [Tamang, Rakesh; Singh, Vipin Kumar; Shah, Anish M.; Anugula, Sharath; Rani, Deepa Selvi; Reddy, Alla G.; Eaaswarkhanth, Muthukrishnan; Singh, Lalji; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Chaubey, Gyaneshwer] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Chaubey, Gyaneshwer] Estonian Bioctr, Tartu, Estonia; [Singh, Lalji] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Singh, Lalji] Genome Fdn, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Tartu; Estonian Biocentre; Banaras Hindu University (BHU)	Sharma, G (corresponding author), Govt Motilal Vigyan Mahavidyalaya, Dept Zool, Bhopal, India.	ruchira_2006@yahoo.co.in; thangs@ccmb.res.in	Chaubey, Gyaneshwer/AAC-6409-2019; Muthukrishnan, Eaaswarkhanth/AAA-7106-2022; Anugula, Sharath/AAI-2443-2019; ANUGULA, SHARATH/N-8362-2015; Chaubey, Gyaneshwer/H-2753-2012	Chaubey, Gyaneshwer/0000-0003-2899-3852; Muthukrishnan, Eaaswarkhanth/0000-0001-9631-8555; Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaudhary, Rubina/0000-0002-0486-1022; Thangaraj, Kumarasamy/0000-0002-0075-0106	UK-India Education and Research Initiative [RG-4772]; Indian Council of Medical Research; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology, Government of India; Centre of Excellence of the Estonian Biocentre; UGC [38-76/2009]	UK-India Education and Research Initiative; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Centre of Excellence of the Estonian Biocentre; UGC(University Grants Commission, India)	KT was supported by the UK-India Education and Research Initiative (RG-4772), the Indian Council of Medical Research, and the Council of Scientific and Industrial Research, Government of India. LS was supported by a Bose Fellowship from the Department of Science and Technology, Government of India and Bhatnagar fellowship from the Council of Scientific and Industrial Research, Government of India, and GC was supported by the Centre of Excellence of the Estonian Biocentre. RC was supported by UGC grant 38-76/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chaubey G, 2010, THESIS U TARTUENSIS, P9; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Chaubey G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-227; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Field JS, 2007, J ANTHROPOL ARCHAEOL, V26, P88, DOI 10.1016/j.jaa.2006.06.001; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Patnaik R, 2009, J BIOSCIENCES, V34, P729, DOI 10.1007/s12038-009-0056-9; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shah AM, 2011, AM J HUM GENET, V89, P154, DOI 10.1016/j.ajhg.2011.05.030; Thangaraj K, 2002, J ANDROL, V23, P815; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	27	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32546	10.1371/journal.pone.0032546	http://dx.doi.org/10.1371/journal.pone.0032546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393414	Green Published, gold			2022-12-25	WOS:000303003500066
J	Super, H; Romeo, A				Super, Hans; Romeo, August			Masking of Figure-Ground Texture and Single Targets by Surround Inhibition: A Computational Spiking Model	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CLASSICAL RECEPTIVE-FIELD; VISUAL-CORTEX V1; FEEDFORWARD INHIBITION; METACONTRAST MASKING; TIME-COURSE; FEEDBACK CONNECTIONS; BACKWARD-MASKING; SUPPRESSION; CELLS	A visual stimulus can be made invisible, i.e. masked, by the presentation of a second stimulus. In the sensory cortex, neural responses to a masked stimulus are suppressed, yet how this suppression comes about is still debated. Inhibitory models explain masking by asserting that the mask exerts an inhibitory influence on the responses of a neuron evoked by the target. However, other models argue that the masking interferes with recurrent or reentrant processing. Using computer modeling, we show that surround inhibition evoked by ON and OFF responses to the mask suppresses the responses to a briefly presented stimulus in forward and backward masking paradigms. Our model results resemble several previously described psychophysical and neurophysiological findings in perceptual masking experiments and are in line with earlier theoretical descriptions of masking. We suggest that precise spatiotemporal influence of surround inhibition is relevant for visual detection.	[Super, Hans] Inst Brain Cognit & Behav, Barcelona, Spain; [Super, Hans; Romeo, August] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies, Barcelona, Spain	University of Barcelona; ICREA	Super, H (corresponding author), Inst Brain Cognit & Behav, Barcelona, Spain.	hans.super@icrea.es		Super, Hans/0000-0001-9328-0096	Spanish Ministry of Education and Science (MICINN) [SAF2009-10367, PSI2010-18139]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (SAF2009-10367 & PSI2010-18139) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from the Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; Almeida J, 2008, P NATL ACAD SCI USA, V105, P15214, DOI 10.1073/pnas.0805867105; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bacon-Mace N, 2005, VISION RES, V45, P1459, DOI 10.1016/j.visres.2005.01.004; Bair W, 2003, J NEUROSCI, V23, P7690; Becker MW, 2004, VISION RES, V44, P2537, DOI 10.1016/j.visres.2004.05.007; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Block N, 2005, TRENDS COGN SCI, V9, P46, DOI 10.1016/j.tics.2004.12.006; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; Breitmeyer BG, 2008, VISION RES, V48, P2433, DOI 10.1016/j.visres.2008.08.003; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Carandini M, 2002, J NEUROSCI, V22, P10053; da Silva FHL, 2006, PROG BRAIN RES, V159, P3, DOI 10.1016/S0079-6123(06)59001-6; De Graaf TA, 2011, NEUROIMAGE; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Francis G, 2000, PSYCHOL REV, V107, P768, DOI 10.1037/0033-295X.107.4.768; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Izhikevich E M, 2005, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jackson A, 2002, J PHYSIOL-LONDON, V541, P685, DOI 10.1113/jphysiol.2001.015099; Jehee JFM, 2007, BRAIN RES, V1157, P167, DOI 10.1016/j.brainres.2007.03.090; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lamme V.A.F., 2000, BRAIN MIND, V1, P385, DOI [10.1023/A:1011569019782, DOI 10.1023/A:1011569019782]; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Macknik SL, 2004, NEUROCOMPUTING, V58, P775, DOI 10.1016/j.neucom.2004.01.126; Macknik Stephen L, 2008, Adv Cogn Psychol, V3, P125, DOI 10.2478/v10053-008-0020-5; Macknik SL, 2006, PROG BRAIN RES, V155, P177, DOI 10.1016/S0079-6123(06)55011-3; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P381, DOI 10.1152/jn.1987.57.2.381; Mitra P, 2007, VISUAL NEUROSCI, V24, P709, DOI 10.1017/S0952523807070654; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Saarela TP, 2008, J VISION, V8, DOI 10.1167/8.3.23; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Super H, 2003, NEUROSCI LETT, V344, P75, DOI 10.1016/S0304-3940(03)00360-4; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Super H, 2007, CEREB CORTEX, V17, P1468, DOI 10.1093/cercor/bhl058; Super H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021641; Super H, 2011, J COGNITIVE NEUROSCI, V23, P491, DOI 10.1162/jocn.2010.21512; Super H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010705; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Tse PU, 2005, P NATL ACAD SCI USA, V102, P17178, DOI 10.1073/pnas.0508010102; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Webb BS, 2005, J NEUROPHYSIOL, V94, P1789, DOI 10.1152/jn.00826.2004; Yu C, 2000, NAT NEUROSCI, V3, P724, DOI 10.1038/76687; [章杰兵 ZHANG Jie-bing], 2009, [药学服务与研究, Pharmaceutical Care and Research], V9, P1; Zhu JJ, 1996, BRAIN RES BULL, V41, P281, DOI 10.1016/S0361-9230(96)00201-8	71	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31773	10.1371/journal.pone.0031773	http://dx.doi.org/10.1371/journal.pone.0031773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393370	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500023
J	Kaiser, K; Pollinger, J				Kaiser, Kristine; Pollinger, John			Batrachochytrium dendrobatidis Shows High Genetic Diversity and Ecological Niche Specificity among Haplotypes in the Maya Mountains of Belize	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; EMERGING INFECTIOUS-DISEASE; PATHOGEN; CHYTRIDIOMYCOSIS; POPULATIONS; DECLINE; DISTRIBUTIONS; BIODIVERSITY; EMERGENCE; COMMUNITY	The amphibian pathogen Batrachochytrium dendrobatidis (Bd) has been implicated in amphibian declines around the globe. Although it has been found in most countries in Central America, its presence has never been assessed in Belize. We set out to determine the range, prevalence, and diversity of Bd using quantitative PCR (qPCR) and sequencing of a portion of the 5.8 s and ITS1-2 regions. Swabs were collected from 524 amphibians of at least 26 species in the protected areas of the Maya Mountains of Belize. We sequenced a subset of 72 samples that had tested positive for Bd by qPCR at least once; 30 samples were verified as Bd. Eight unique Bd haplotypes were identified in the Maya Mountains, five of which were previously undescribed. We identified unique ecological niches for the two most broadly distributed haplotypes. Combined with data showing differing virulence shown in different strains in other studies, the 5.8 s - ITS1-2 region diversity found in this study suggests that there may be substantial differences among populations or haplotypes. Future work should focus on whether specific haplotypes for other genomic regions and possibly pathogenicity can be associated with haplotypes at this locus, as well as the integration of molecular tools with other ecological tools to elucidate the ecology and pathogenicity of Bd.	[Kaiser, Kristine; Pollinger, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Kaiser, K (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	kristinekaiser@gmail.com			Critical Ecosystems Partnership Fund; Columbus Zoo and Aquarium	Critical Ecosystems Partnership Fund; Columbus Zoo and Aquarium	This work was funded in part by the Critical Ecosystems Partnership Fund, and the Columbus Zoo and Aquarium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was funded in part by the Columbus Zoo and Aquarium. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bridgewater SGM, 2006, ECON BOT, V60, P265, DOI 10.1663/0013-0001(2006)60[265:CXITGM]2.0.CO;2; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Farrer RA, 2011, P NATL ACAD SCI; Federici S., 2009, HERPETOLOGY NOTES, V1, P33; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Gaertner JP, 2008, DETECTION BATRACHOCH; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Kaiser K, 2011, B ENV CONTAMINATION, P1; Kantzoura V, 2011, INT J PARASITOLOGY; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Mendelson JR, 2004, REV BIOL TROP, V52, P991; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Pauly GB, 2008, J HERPETOL, V42, P668, DOI 10.1670/07-303R1.1; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rodriguez Edmarie Martinez, 2009, Herpetological Review, V40, P48; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Voyles J, 2011, FUNGAL ECOLOGY	35	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32113	10.1371/journal.pone.0032113	http://dx.doi.org/10.1371/journal.pone.0032113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389681	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600019
J	Ruggenenti, P; Gaspari, F; Cannata, A; Carrara, F; Cella, C; Ferrari, S; Stucchi, N; Prandini, S; Ene-Iordache, B; Diadei, O; Perico, N; Ondei, P; Pisani, A; Buongiorno, E; Messa, P; Dugo, M; Remuzzi, G				Ruggenenti, Piero; Gaspari, Flavio; Cannata, Antonio; Carrara, Fabiola; Cella, Claudia; Ferrari, Silvia; Stucchi, Nadia; Prandini, Silvia; Ene-Iordache, Bogdan; Diadei, Olimpia; Perico, Norberto; Ondei, Patrizia; Pisani, Antonio; Buongiorno, Erasmo; Messa, Piergiorgio; Dugo, Mauro; Remuzzi, Giuseppe		GFR-ADPKD Study Grp	Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; POLYCYSTIC KIDNEY-DISEASE; PLASMA-CLEARANCE; RENAL-FUNCTION; PREDICTION EQUATIONS; INULIN CLEARANCE; SERUM CREATININE; IOHEXOL; PROGRESSION; SIROLIMUS	Trials failed to demonstrate protective effects of investigational treatments on glomerular filtration rate (GFR) reduction in Autosomal Dominant Polycystic Kidney Disease (ADPKD). To assess whether above findings were explained by unreliable GFR estimates, in this academic study we compared GFR values centrally measured by iohexol plasma clearance with corresponding values estimated by Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi) and abbreviated Modification of Diet in Renal Disease (aMDRD) formulas in ADPKD patients retrieved from four clinical trials run by a Clinical Research Center and five Nephrology Units in Italy. Measured baseline GFRs and one-year GFR changes averaged 78.6 +/- 26.7 and 8.4 +/- 10.3 mL/min/1.73 m(2) in 111 and 71 ADPKD patients, respectively. CKD-Epi significantly overestimated and aMDRD underestimated baseline GFRs. Less than half estimates deviated by <10% from measured values. One-year estimated GFR changes did not detect measured changes. Both formulas underestimated GFR changes by 50%. Less than 9% of estimates deviated <10% from measured changes. Extent of deviations even exceeded that of measured one-year GFR changes. In ADPKD, prediction formulas unreliably estimate actual GFR values and fail to detect their changes over time. Direct kidney function measurements by appropriate techniques are needed to adequately evaluate treatment effects in clinics and research.	[Ruggenenti, Piero; Gaspari, Flavio; Cannata, Antonio; Carrara, Fabiola; Cella, Claudia; Ferrari, Silvia; Stucchi, Nadia; Prandini, Silvia; Ene-Iordache, Bogdan; Diadei, Olimpia; Perico, Norberto; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24100 Bergamo, Italy; [Ruggenenti, Piero; Ondei, Patrizia; Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, Nephrol Unit, I-24100 Bergamo, Italy; [Pisani, Antonio] Univ Naples Federico II, Azienda Osped, Naples, Italy; [Buongiorno, Erasmo] Presidio Osped V Fazzi, Lecce, Italy; [Messa, Piergiorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Dugo, Mauro] Azienda ULSS 9 Osped S Maria di Ca Foncello, Treviso, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; University of Naples Federico II; IRCCS Ca Granda Ospedale Maggiore Policlinico; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso	Ruggenenti, P (corresponding author), Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Via Gavazzeni 11, I-24100 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Stucchi, Nadia/ABF-5669-2020; Perico, Norberto/ABH-3222-2020; Carrara, Fabiola/ABF-4666-2020; Ene-Iordache, Bogdan/C-6824-2018; Diadei, Olimpia/ABF-4552-2020; Prandini, Silvi/ABG-7735-2020; Ferrari, Silvia/ABF-5648-2020; Remuzzi, Giuseppe/V-9766-2017	Stucchi, Nadia/0000-0002-3739-2373; Perico, Norberto/0000-0002-3147-4327; Carrara, Fabiola/0000-0002-5799-9535; Ene-Iordache, Bogdan/0000-0002-4011-9343; Prandini, Silvi/0000-0001-9337-9512; Ferrari, Silvia/0000-0003-0769-0414; Trillini, Matias/0000-0003-1859-1729; Remuzzi, Giuseppe/0000-0002-6194-3446; PISANI, Antonio/0000-0003-0241-8323; Cella, Claudia/0000-0002-9210-0775				Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Berg UB, 2011, AM J KIDNEY DIS, V57, P55, DOI 10.1053/j.ajkd.2010.07.013; Brandstrom E, 1998, NEPHROL DIAL TRANSPL, V13, P1176, DOI 10.1093/ndt/13.5.1176; BROCHNER.J, 1969, SCAND J CLIN LAB INV, V23, P301, DOI 10.3109/00365516909081695; BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Chudleigh RA, 2007, DIABETES CARE, V30, P300, DOI 10.2337/dc06-1688; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; EFFERSOE H, 1990, INVEST RADIOL, V25, P778, DOI 10.1097/00004424-199007000-00005; Erley CM, 2001, CRIT CARE MED, V29, P1544, DOI 10.1097/00003246-200108000-00008; Fontsere N, 2006, NEPHROL DIAL TRANSPL, V21, P2152, DOI 10.1093/ndt/gfl221; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Gaspari F, 2004, AM J TRANSPLANT, V4, P1826, DOI 10.1111/j.1600-6143.2004.00579.x; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; HEATH DA, 1968, LANCET, V2, P1110; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; Kuypers DRJ, 2004, TRANSPLANTATION, V78, P1204, DOI 10.1097/01.TP.0000137793.23371.42; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Orskov B, 2010, AM J NEPHROL, V31, P53, DOI 10.1159/000256657; Perico N, 2010, NAT REV NEPHROL, V6, P696, DOI 10.1038/nrneph.2010.153; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; PRICE M, 1972, J UROLOGY, V107, P339, DOI 10.1016/S0022-5347(17)61021-8; Qian Q, 2008, J AM SOC NEPHROL, V19, P631, DOI 10.1681/ASN.2007050626; REHLING M, 1984, CLIN SCI, V66, P613, DOI 10.1042/cs0660613; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Ruggenenti P, 2005, NEW ENGL J MED, V352, P834; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Schutzer KM, 2010, EUR J CLIN PHARMACOL, V66, P903, DOI 10.1007/s00228-010-0849-7; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Stengel B, 2003, NEPHROL DIAL TRANSPL, V18, P1824, DOI 10.1093/ndt/gfg233; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009	43	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32533	10.1371/journal.pone.0032533	http://dx.doi.org/10.1371/journal.pone.0032533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22393413	Green Submitted, Green Published, gold			2022-12-25	WOS:000302999600046
J	Aoki, W; Kitahara, N; Miura, N; Morisaka, H; Yamamoto, Y; Kuroda, K; Ueda, M				Aoki, Wataru; Kitahara, Nao; Miura, Natsuko; Morisaka, Hironobu; Yamamoto, Yoshihiro; Kuroda, Kouichi; Ueda, Mitsuyoshi			Candida albicans Possesses Sap7 as a Pepstatin A-Insensitive Secreted Aspartic Protease	PLOS ONE			English	Article							VIRULENCE FACTORS; GENE FAMILY; PROTEINASES; MODEL; DEGRADATION; EXPRESSION; INVASION; INFECTION	Background: Candida albicans, a commensal organism, is a part of the normal flora of healthy individuals. However, once the host immunity is compromised, C. albicans opportunistically causes recurrent superficial or fatal systemic candidiasis. Secreted aspartic proteases (Sap), encoded by 10 types of SAP genes, have been suggested to contribute to various virulence processes. Thus, it is important to elucidate their biochemical properties for better understanding of the molecular mechanisms that how Sap isozymes damage host tissues. Methodology/Principal Findings: The SAP7 gene was cloned from C. albicans SC5314 and heterogeneously produced by Pichia pastoris. Measurement of Sap7 proteolytic activity using the FRETS-25Ala library showed that Sap7 was a pepstatin A-insensitive protease. To understand why Sap7 was insensitive to pepstatin A, alanine substitution mutants of Sap7 were constructed. We found that M242A and T467A mutants had normal proteolytic activity and sensitivity to pepstatin A. M242 and T467 were located in close proximity to the entrance to an active site, and alanine substitution at these positions widened the entrance. Our results suggest that this alteration might allow increased accessibility of pepstatin A to the active site. This inference was supported by the observation that the T467A mutant has stronger proteolytic activity than the wild type. Conclusions/Significance: We found that Sap7 was a pepstatin A-insensitive protease, and that M242 and T467 restricted the accessibility of pepstatin A to the active site. This finding will lead to the development of a novel protease inhibitor beyond pepstatin A. Such a novel inhibitor will be an important research tool as well as pharmaceutical agent for patients suffering from candidiasis.	[Aoki, Wataru; Miura, Natsuko] Japan Soc Promot Sci, Sakyo Ku, Kyoto, Japan; [Aoki, Wataru; Kitahara, Nao; Miura, Natsuko; Morisaka, Hironobu; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Yamamoto, Yoshihiro] Kyoto Municipal Inst Ind Technol & Culture, Ind Technol Ctr, Simogyo Ku, Kyoto, Japan	Japan Society for the Promotion of Science; Kyoto University	Aoki, W (corresponding author), Japan Soc Promot Sci, Sakyo Ku, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp	Kuroda, Kouichi/AAQ-3678-2021; Miura, Natsuko/R-7392-2019; 航, 青木/N-7269-2013	Miura, Natsuko/0000-0002-8722-0406; Kuroda, Kouichi/0000-0002-9249-0486; Aoki, Wataru/0000-0002-3118-9390	Japan Society for the Promotion of Science for Young Scientists [22-101]; Regional Innovation Creation RD Programs [22R5005]; Grants-in-Aid for Scientific Research [10J00101, 09J02920] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Regional Innovation Creation RD Programs; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists (grant 22-101, http://www.jsps.go.jp/j-pd/index.html); and Regional Innovation Creation R&D Programs (grant 22R5005, http://www.meti.go.jp/policy/sme_chiiki/cluster/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743; Colina AR, 1996, INFECT IMMUN, V64, P4514, DOI 10.1128/IAI.64.11.4514-4519.1996; CUTFIELD SM, 1995, STRUCTURE, V3, P1261, DOI 10.1016/S0969-2126(01)00261-1; DeBernardis F, 1997, INFECT IMMUN, V65, P3399, DOI 10.1128/IAI.65.8.3399-3405.1997; EDISON AM, 1988, INFECT IMMUN, V56, P1388, DOI 10.1128/IAI.56.5.1388-1390.1988; Fallon K, 1997, INFECT IMMUN, V65, P551, DOI 10.1128/IAI.65.2.551-556.1997; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Hornbach A, 2009, INFECT IMMUN, V77, P5216, DOI 10.1128/IAI.00723-09; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Hube Bernhard, 1998, Revista Iberoamericana de Micologia, V15, P65; KAMINISHI H, 1995, INFECT IMMUN, V63, P984, DOI 10.1128/IAI.63.3.984-988.1995; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; MARCINISZYN J, 1976, J BIOL CHEM, V251, P7088; Marciniszyn J Jr, 1977, Adv Exp Med Biol, V95, P199; Monod M, 1998, MICROBIOL-UK, V144, P2731, DOI 10.1099/00221287-144-10-2731; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 1999, INFECT IMMUN, V67, P2482, DOI 10.1128/IAI.67.5.2482-2490.1999; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Odds FC, 2008, MICROBIOL-SGM, V154, P3245, DOI 10.1099/mic.0.2008/023671-0; RUCHEL R, 1986, MICROBIOL SCI, V3, P316; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Schaller M, 2001, J MED MICROBIOL, V50, P743, DOI 10.1099/0022-1317-50-8-743; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Sims AH, 2004, FEMS MICROBIOL LETT, V239, P95, DOI 10.1016/j.femsle.2004.08.023; Smolenski G, 1997, MICROBIOL-SGM, V143, P349, DOI 10.1099/00221287-143-2-349; Sobel J D, 1988, Ann N Y Acad Sci, V544, P547, DOI 10.1111/j.1749-6632.1988.tb40450.x; SOBEL JD, 1992, CLIN INFECT DIS, V14, pS148, DOI 10.1093/clinids/14.Supplement_1.S148; Tanskul S, 2003, BIOCHEM BIOPH RES CO, V309, P547, DOI 10.1016/j.bbrc.2003.08.035; Taylor BN, 2005, INFECT IMMUN, V73, P7061, DOI 10.1128/IAI.73.10.7061-7063.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; WHITE TC, 1993, J BACTERIOL, V175, P6126, DOI 10.1128/JB.175.19.6126-6133.1993	46	20	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32513	10.1371/journal.pone.0032513	http://dx.doi.org/10.1371/journal.pone.0032513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384266	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500097
J	Hoogewijs, D; Dewilde, S; Vierstraete, A; Moens, L; Vinogradov, SN				Hoogewijs, David; Dewilde, Sylvia; Vierstraete, Andy; Moens, Luc; Vinogradov, Serge N.			A Phylogenetic Analysis of the Globins in Fungi	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NITRIC-OXIDE DIOXYGENASE; NITROSATIVE STRESS; 2 FLAVOHEMOGLOBINS; GENOME EVOLUTION; PROTEIN FOLD; PSI-BLAST; GENE; HEMOGLOBIN; ACCURACY	Background: All globins belong to one of three families: the F (flavohemoglobin) and S (sensor) families that exhibit the canonical 3/3 alpha-helical fold, and the T (truncated 3/3 fold) globins characterized by a shortened 2/2 alpha-helical fold. All eukaryote 3/3 hemoglobins are related to the bacterial single domain F globins. It is known that Fungi contain flavohemoglobins and single domain S globins. Our aims are to provide a census of fungal globins and to examine their relationships to bacterial globins. Results: Examination of 165 genomes revealed that globins are present in > 90% of Ascomycota and similar to 60% of Basidiomycota genomes. The S globins occur in Blastocladiomycota and Chytridiomycota in addition to the phyla that have FHbs. Unexpectedly, group 1 T globins were found in one Blastocladiomycota and one Chytridiomycota genome. Phylogenetic analyses were carried out on the fungal globins, alone and aligned with representative bacterial globins. The Saccharomycetes and Sordariomycetes with two FHbs form two widely divergent clusters separated by the remaining fungal sequences. One of the Saccharomycete groups represents a new subfamily of FHbs, comprising a previously unknown N-terminal and a FHb missing the C-terminal moiety of its reductase domain. The two Saccharomycete groups also form two clusters in the presence of bacterial FHbs; the surrounding bacterial sequences are dominated by Proteobacteria and Bacilli (Firmicutes). The remaining fungal FHbs cluster with Proteobacteria and Actinobacteria. The Sgbs cluster separately from their bacterial counterparts, except for the intercalation of two Planctomycetes and a Proteobacterium between the Fungi incertae sedis and the Blastocladiomycota and Chytridiomycota. Conclusion: Our results are compatible with a model of globin evolution put forward earlier, which proposed that eukaryote F, S and T globins originated via horizontal gene transfer of their bacterial counterparts to the eukaryote ancestor, resulting from the endosymbiotic events responsible for the origin of mitochondria and chloroplasts.	[Hoogewijs, David] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Hoogewijs, David] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Vierstraete, Andy] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Vinogradov, Serge N.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Antwerp; Ghent University; Wayne State University	Hoogewijs, D (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	david.hoogewijs@access.uzh.ch	Hoogewijs, David/L-5144-2016		Fund for Scientific Research (FWO); European Commission [PIEF-GA-2009-236157]	Fund for Scientific Research (FWO)(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre)	S.D. and L. M. are supported by the Fund for Scientific Research (FWO). D.H. is a recipient of a Marie Curie Intra-European Fellowship from the European Commission (PIEF-GA-2009-236157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Biesebeke RT, 2010, FUNGAL BIOL-UK, V114, P135, DOI 10.1016/j.mycres.2009.08.007; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Cliften PF, 2006, GENETICS, V172, P863, DOI 10.1534/genetics.105.048900; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fitzpatrick DA, 2011, FEMS MICROBIOL  1123; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Goffeau A, 2005, NATURE, V438, P1092, DOI 10.1038/4381092b; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IWAASA H, 1992, J MOL BIOL, V227, P948, DOI 10.1016/0022-2836(92)90236-D; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2010, GENOME BIOL EVOL, V2, P304, DOI 10.1093/gbe/evq022; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; KEILIN D, 1953, NATURE, V172, P390, DOI 10.1038/172390a0; KEILIN D, 1953, NATURE, V172, P393, DOI 10.1038/172393a0; Kirk PM, 2008, DICT FUNGI; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Liti G, 2005, ANNU REV MICROBIOL, V59, P135, DOI 10.1146/annurev.micro.59.030804.121400; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Nardini M, 2007, GENE, V398, P2, DOI 10.1016/j.gene.2007.02.045; OSHINO R, 1973, EUR J BIOCHEM, V39, P581, DOI 10.1111/j.1432-1033.1973.tb03157.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Redecker D, 2006, MYCOLOGIA, V98, P885, DOI 10.3852/mycologia.98.6.885; Richards TA, 2011, CURR BIOL, V21, pR166, DOI 10.1016/j.cub.2011.01.028; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Salto JA, 2008, FEBS LETT, V582, P1840, DOI 10.1016/j.febslet.2008.05.004; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2011, MOL PLANT, V4, P42, DOI 10.1093/mp/ssq040; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Vinogradov SN, 2011, HEMOGLOBIN RECENT DE, P231; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7; Zhou SM, 2011, FUNGAL GENET BIOL, V48, P200, DOI 10.1016/j.fgb.2010.08.011; Zhou SM, 2010, BIOCHEM BIOPH RES CO, V394, P558, DOI 10.1016/j.bbrc.2010.03.018; Zhou SM, 2009, BIOCHEM BIOPH RES CO, V381, P7, DOI 10.1016/j.bbrc.2009.01.112; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	79	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31856	10.1371/journal.pone.0031856	http://dx.doi.org/10.1371/journal.pone.0031856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384087	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000302918500042
J	Liu, YC; Painter, JA; Posey, DL; Cain, KP; Weinberg, MS; Maloney, SA; Ortega, LS; Cetron, MS				Liu, Yecai; Painter, John A.; Posey, Drew L.; Cain, Kevin P.; Weinberg, Michelle S.; Maloney, Susan A.; Ortega, Luis S.; Cetron, Martin S.			Estimating the Impact of Newly Arrived Foreign-Born Persons on Tuberculosis in the United States	PLOS ONE			English	Article							IMMIGRATION STATUS; COUNTRIES; REFUGEES	Background: Among approximately 163.5 million foreign-born persons admitted to the United States annually, only 500,000 immigrants and refugees are required to undergo overseas tuberculosis (TB) screening. It is unclear what extent of the unscreened nonimmigrant visitors contributes to the burden of foreign-born TB in the United States. Methodology/Principal Findings: We defined foreign-born persons within 1 year after arrival in the United States as "newly arrived'', and utilized data from U.S. Department of Homeland Security, U.S. Centers for Disease Control and Prevention, and World Health Organization to estimate the incidence of TB among newly arrived foreign-born persons in the United States. During 2001 through 2008, 11,500 TB incident cases, including 291 multidrug-resistant TB incident cases, were estimated to occur among 20,989,738 person-years for the 1,479,542,654 newly arrived foreign-born persons in the United States. Of the 11,500 estimated TB incident cases, 41.6% (4,783) occurred among immigrants and refugees, 36.6% (4,211) among students/exchange visitors and temporary workers, 13.8% (1,589) among tourists and business travelers, and 7.3% (834) among Canadian and Mexican nonimmigrant visitors without an I-94 form (e.g., arrival-departure record). The top 3 newly arrived foreign-born populations with the largest estimated TB incident cases per 100,000 admissions were immigrants and refugees from high-incidence countries (e.g., 2008 WHO-estimated TB incidence rate of >= 100 cases/100,000 population/year; 235.8 cases/100,000 admissions, 95% confidence interval [CI], 228.3 to 243.3), students/exchange visitors and temporary workers from high-incidence countries (60.9 cases/100,000 admissions, 95% CI, 58.5 to 63.3), and immigrants and refugees from medium-incidence countries (e.g., 2008 WHO-estimated TB incidence rate of 15-99 cases/100,000 population/year; 55.2 cases/100,000 admissions, 95% CI, 51.6 to 58.8). Conclusions/Significance: Newly arrived nonimmigrant visitors contribute substantially to the burden of foreign-born TB in the United States. To achieve the goals of TB elimination, direct investment in global TB control and strategies to target nonimmigrant visitors should be considered.	[Liu, Yecai; Painter, John A.; Posey, Drew L.; Weinberg, Michelle S.; Ortega, Luis S.; Cetron, Martin S.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Cain, Kevin P.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Maloney, Susan A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Int Emerging Infect Program, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Liu, YC (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	yliu@cdc.gov						[Anonymous], WHOHTMTB2008394; [Anonymous], WHOHTMTB20103; Barr M, 2007, NONIMMIGRANT ADMISSI; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Centers for Disease Control and Prevention, 1991, TECHN INSTR PAN PHYS; Coker R, 2006, EUR RESPIR J, V27, P801, DOI 10.1183/09031936.06.00104305; Grieco EM, 2004, ESTIMATES NONIMMIGRA; Grieco EM, 2003, LENGTH VISIT NONIMMI; Grieco EM, 2005, TEMPORARY ADMISSIONS; Hennessey KA, 1998, JAMA-J AM MED ASSOC, V280, P2008, DOI 10.1001/jama.280.23.2008; HOEFER M, 2009, ESTIMATES UNAUTHORIZ; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Menzies D, 2001, AM J RESP CRIT CARE, V164, P914, DOI 10.1164/ajrccm.164.6.2107090b; Monger R, 2008, NONIMMIGRANT ADMISSI; Monger R., 2009, NONIMMIGRANT ADMISSI; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Public Health Agency of Canada, 2007, CAN TUB STAND; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Saraiya M, 2002, AM J PUBLIC HEALTH, V92, P826, DOI 10.2105/AJPH.92.5.826; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; Tan L, 2001, ARCH INTERN MED, V161, P334, DOI 10.1001/archinte.161.3.334; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P333; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, 2008, 2008 TECHN TUB INSTR; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, ONL TUB INF SYST; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, TECHN INSTR TUB SCRE; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, 2007, 2007 TUB TECHN INSTR; U. S. Department of Homeland Security, 2006, TEMP ADM NON US 2006; U. S. Department of Homeland Security Office of Immigration Statistics, 2009, 2009 YB IMM STAT; Weis SE, 2001, AM J RESP CRIT CARE, V164, P953, DOI 10.1164/ajrccm.164.6.2102132; World Health Organization, WHO TB BURDEN ESTIMA; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	35	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32158	10.1371/journal.pone.0032158	http://dx.doi.org/10.1371/journal.pone.0032158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384165	Green Published, gold			2022-12-25	WOS:000302918500062
J	Olesen, J; Larsson, S; Iversen, N; Yousafzai, S; Hellsten, Y; Pilegaard, H				Olesen, Jesper; Larsson, Signe; Iversen, Ninna; Yousafzai, Simi; Hellsten, Ylva; Pilegaard, Henriette			Skeletal Muscle PGC-1 alpha Is Required for Maintaining an Acute LPS-Induced TNF alpha Response	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; INSULIN-RESISTANCE; MOUSE SKELETAL; MITOCHONDRIAL BIOGENESIS; HUMAN ENDOTOXEMIA; GENE-EXPRESSION; KAPPA-B; EXERCISE; INFLAMMATION	Many lifestyle-related diseases are associated with low-grade inflammation and peroxisome proliferator activated receptor gamma coactivator (PGC)-1 alpha has been suggested to be protective against low-grade inflammation. However, whether these anti-inflammatory properties affect acute inflammation is not known. The aim of the present study was therefore to investigate the role of muscle PGC-1 alpha in acute inflammation. Quadriceps muscles were removed from 10-week old whole body PGC-1 alpha knockout (KO), muscle specific PGC-1 alpha KO (MKO) and muscle-specific PGC-1 alpha overexpression mice (TG), 2 hours after an intraperitoneal injection of either 0.8 mu g LPS/g body weight or saline. Basal TNF alpha mRNA content was lower in skeletal muscle of whole body PGC-1 alpha KO mice and in accordance TG mice showed increased TNF alpha mRNA and protein level relative to WT, indicating a possible PGC-1 alpha mediated regulation of TNF alpha. Basal p65 phosphorylation was increased in TG mice possibly explaining the elevated TNF alpha expression in these mice. Systemically, TG mice had reduced basal plasma TNF alpha levels compared with WT suggesting a protective effect against systemic low-grade inflammation in these animals. While TG mice reached similar TNF alpha levels as WT and showed more marked induction in plasma TNF alpha than WT after LPS injection, MKO PGC-1 alpha mice had a reduced plasma TNF alpha and skeletal muscle TNF alpha mRNA response to LPS. In conclusion, the present findings suggest that PGC-1 alpha enhances basal TNF alpha expression in skeletal muscle and indicate that PGC-1 alpha does not exert anti-inflammatory effects during acute inflammation. Lack of skeletal muscle PGC-1 alpha seems however to impair the acute TNF alpha response, which may reflect a phenotype more susceptible to infections as also observed in type 2 diabetes patients.	[Olesen, Jesper; Larsson, Signe; Iversen, Ninna; Yousafzai, Simi; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark; [Olesen, Jesper; Larsson, Signe; Iversen, Ninna; Yousafzai, Simi; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen Muscle Res Ctr, Copenhagen, Denmark; [Hellsten, Ylva] Univ Copenhagen, Dept Sport Sci, Copenhagen Muscle Res Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Olesen, J (corresponding author), Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark.	jolesen@bio.ku.dk	Pilegaard, Henriette/M-2315-2014; Hellsten, Ylva/B-3420-2015	Pilegaard, Henriette/0000-0002-1071-0327; Olesen, Jes/0000-0002-6712-2702; Hellsten, Ylva/0000-0002-2435-9558	Augustinus Foundation, Denmark; Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Augustinus Foundation, Denmark; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	The present study was supported by a grant from the Augustinus Foundation, Denmark. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Andreasen AS, 2010, INTENS CARE MED, V36, P1548, DOI 10.1007/s00134-010-1845-1; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Borge BAS, 2009, AM J PHYSIOL-HEART C, V296, pH735, DOI 10.1152/ajpheart.01309.2008; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Favorite GO, 1942, J CLIN INVEST, V21, P589, DOI 10.1172/JCI101337; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huey KA, 2008, J APPL PHYSIOL, V105, P1830, DOI 10.1152/japplphysiol.90955.2008; Kusuhara K, 2007, BIOL CHEM, V388, P481, DOI 10.1515/BC.2007.052; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	37	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32222	10.1371/journal.pone.0032222	http://dx.doi.org/10.1371/journal.pone.0032222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384185	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500067
J	Pollack, SM; Li, YQ; Blaisdell, MJ; Farrar, EA; Chou, J; Hoch, BL; Loggers, ET; Rodler, E; Eary, JF; Conrad, EU; Jones, RL; Yee, C				Pollack, Seth M.; Li, Yonqing; Blaisdell, Megan J.; Farrar, Erik A.; Chou, Jeffrey; Hoch, Benjamin L.; Loggers, Elizabeth T.; Rodler, Eve; Eary, Janet F.; Conrad, Ernest U., III; Jones, Robin L.; Yee, Cassian			NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; CANCER/TESTIS ANTIGEN; METASTATIC MELANOMA; EXPRESSION; CANCER; INDUCTION; NY-ESO-1; MAGE; 5-AZA-2'-DEOXYCYTIDINE; LYMPHOCYTE	Background: Chondrosarcoma has no proven systemic option in the metastatic setting. The development of a non-cross-resistant strategy, such as cellular immunotherapy using antigen-specific T cells would be highly desirable. NY-ESO-1 and PRAME are members of the Cancer Testis Antigen (CTA) family that have been identified as promising targets for T cell therapy. LAGE-1 is a cancer testis antigen 90% homologous to NY-ESO-1, sharing the 157-165 A* 0201 NY-ESO-1 epitope with its transcript variant, LAGE-1s. A number of CTA's have been induced using 5-Aza-2-Deoxycitabine (5-Aza-dC) in other cancers. We sought to evaluate the feasibility of targeting chondrosarcoma tumors using NY-ESO-1/LAGE-1s and PRAME specific T cells using 5-Aza-dC to induce antigen expression. Methods: We used 11 flash frozen tumors from the University of Washington tumor bank to test for the expression of NY-ESO-1, PRAME, LAGE-1s and LAGE-1L in chondrosarcoma tumors. Using four chondrosarcoma cell lines we tested the expression of these CTA's with and without 5-Aza-dC treatments. Finally, using NY-ESO-1/LAGE-1s and PRAME specific effectors that we generated from sarcoma patients, we evaluated the ability of these T cells to lyse A* 0201 expressing chondrosarcoma cell lines in vitro both with and without 5-Aza-dC treatment. Results: A minority (36%) of chondrosarcoma tumors expressed either NY-ESO-1 or LAGE-1s at >10% of our reference value and none expressed PRAME at that level. However, in all four of the chondrosarcoma cell lines tested, NY-ESO-1 and PRAME expression could be induced following treatment with 5-Aza-dC including in cell lines where expression was absent or barely detectable. Furthermore, NY-ESO-1/LAGE-1s and PRAME specific CD8+ effector T cells were able to specifically recognize and lyse A*0201 expressing chondrosarcoma cell lines following 5-Aza-dC treatment. Conclusion: These data suggest that adoptive immunotherapy in combination with 5-Aza-dC may be a potential strategy to treat unresectable or metastatic chondrosarcoma patients where no proven systemic therapies exist.	[Pollack, Seth M.; Li, Yonqing; Blaisdell, Megan J.; Farrar, Erik A.; Chou, Jeffrey; Loggers, Elizabeth T.; Jones, Robin L.; Yee, Cassian] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Pollack, Seth M.; Chou, Jeffrey; Loggers, Elizabeth T.; Rodler, Eve; Jones, Robin L.; Yee, Cassian] Univ Washington, Dept Oncol, Seattle, WA 98195 USA; [Hoch, Benjamin L.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Loggers, Elizabeth T.] Grp Hlth Res Inst, Seattle, WA USA; [Eary, Janet F.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Conrad, Ernest U., III] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pollack, SM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	spollac@fhcrc.org; cyee@fhcrc.org	Pollack, Seth/ABI-1013-2020; Jones, Robin L/AAO-3738-2020	Jones, Robin L/0000-0003-4173-3844	Bob and Eileen Gilman Family Sarcoma Research Program; Walker Immunotherapy Research Fellowship; Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award; Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research;  [RO1 CA65537-16]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA065537] Funding Source: NIH RePORTER	Bob and Eileen Gilman Family Sarcoma Research Program; Walker Immunotherapy Research Fellowship; Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award; Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Bob and Eileen Gilman Family Sarcoma Research Program as well as the Walker Immunotherapy Research Fellowship and the Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award. Cassian Yee is a recipient of a Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research. The University of Washington Tissue Bank is supported by RO1 CA65537-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; BLOCK JA, 1991, J BONE JOINT SURG AM, V73A, P647, DOI 10.2106/00004623-199173050-00002; BLOCK JA, 1991, CONNECT TISSUE RES, V26, P295, DOI 10.3109/03008209109152446; Block MI, 2001, ANN THORAC SURG, V71, P301; Bluman EM, 2007, J ORTHOP RES, V25, P678, DOI 10.1002/jor.20368; Chou Jeffrey, J IMMUNOTHE IN PRESS; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Dickey ID, 2004, J BONE JOINT SURG AM, V86A, P2412, DOI 10.2106/00004623-200411000-00008; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Figueiredo DLA, 2011, HEAD NECK-J SCI SPEC, V33, P702, DOI 10.1002/hed.21522; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Hiraki A, 2001, BIOCHEM BIOPH RES CO, V286, P786, DOI 10.1006/bbrc.2001.5411; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jager E, 2000, P NATL ACAD SCI USA, V97, P12198, DOI 10.1073/pnas.220413497; James SE, 2010, J IMMUNOL, V184, P4284, DOI 10.4049/jimmunol.0903701; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Li YQ, 2008, BLOOD, V111, P229, DOI 10.1182/blood-2007-05-089375; Lin CZ, 2002, GENE, V285, P269, DOI 10.1016/S0378-1119(02)00395-5; Mitchell AD, 2000, J BONE JOINT SURG BR, V82B, P55, DOI 10.1302/0301-620X.82B1.9020; Murphey MD, 2003, RADIOGRAPHICS, V23, P1245, DOI 10.1148/rg.235035134; Oi S, 2009, J NEURO-ONCOL, V92, P15, DOI 10.1007/s11060-008-9732-0; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Pollack Seth M., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/438940; Quintarelli C, 2008, BLOOD, V112, P1876, DOI 10.1182/blood-2008-04-150045; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2011, J CLIN ONCOL; Roman-Gomez O, 2007, LEUKEMIA RES, V31, P1521, DOI 10.1016/j.leukres.2007.02.016; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Schenk T, 2007, GENE CHROMOSOME CANC, V46, P796, DOI 10.1002/gcc.20465; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Schwab JH, 2009, CANCER IMMUNOL IMMUN, V58, P339, DOI 10.1007/s00262-008-0557-7; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Staals EL, 2006, CANCER-AM CANCER SOC, V106, P2682, DOI 10.1002/cncr.21936; Vaughan HA, 2004, CLIN CANCER RES, V10, P8396, DOI 10.1158/1078-0432.CCR-04-0809; Weiser TS, 2001, ANN THORAC SURG, V71, P295, DOI 10.1016/S0003-4975(00)02421-8; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4	41	44	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32165	10.1371/journal.pone.0032165	http://dx.doi.org/10.1371/journal.pone.0032165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384167	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500063
J	Li, XX; Jiang, SW; Li, X; Mei, J; Zhong, Q; Xu, WG; Li, J; Li, WB; Liu, XQ; Zhang, H; Wang, LX				Li, Xinxu; Jiang, Shiwen; Li, Xue; Mei, Jian; Zhong, Qiu; Xu, Weiguo; Li, Jun; Li, Weibin; Liu, Xiaoqiu; Zhang, Hui; Wang, Lixia			Predictors on Delay of Initial Health-Seeking in New Pulmonary Tuberculosis Cases among Migrants Population in East China	PLOS ONE			English	Article							DIAGNOSIS; PATIENT; ETHIOPIA	Objectives: To determine the length of delay in initial health-seeking in new pulmonary tuberculosis (PTB) cases among migrant population in the eastern part of China, and factors associated with it. Methods: A cross-sectional study was conducted using a structured questionnaire in six counties in Shanghai, Guangdong and Jiangsu from May to October, 2008, to estimate the extent and factors responsible for delayed initial health-seeking of the new PTB cases. The interval between self-reported onset of TB symptoms and date of first attendance at any medical institution was determined. More than the median duration was defined as delayed health-seeking. Results: A total of 323 new migrant PTB patients participated in the study. Only 6.5% had medical insurance. The median and mean durations to initial health-seeking were respectively 10 and 31 days. There was no significant association between socio-demographic factors and delayed initial health-seeking. Average monthly working days >24 (AOR, 1.61; 95% CI, 1.03-2.51), and hemoptysis or bloody sputum (AOR, 0.48; 95% CI, 0.28-0.85) were significantly associated with delayed initial health-seeking. Conclusions: Interventions to improve health seeking behavior among the migrant population in China must focus on strengthening their labor, medical security and health education.	[Li, Xinxu; Jiang, Shiwen; Li, Xue; Li, Jun; Li, Weibin; Liu, Xiaoqiu; Zhang, Hui; Wang, Lixia] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Zhong, Qiu] TB Res Inst Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Xu, Weiguo] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Li, XX (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	jiangsw@chinatb.org						Basnet R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-236; Cambanis A, 2007, TROP MED INT HEALTH, V12, P1309, DOI 10.1111/j.1365-3156.2007.01925.x; Census Office of the State Council of PRC National Bureau of Statistics of PRC, 2001, CENS DAT CHIN 2000; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P222; Chang Ching Thon, 2007, Rural Remote Health, V7, P667; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Department of Disease Control and Department of Medical Administration of Ministry of Health of PRC Chinese Center for Disease Control and Prevention, 2009, GUID IMPL NAT TUB CO; Department of Floating Population Service and Management of National Population and Family Planning Commission of PRC, 2010, REP 2010 CHIN MIGR P; Hu LX, 2007, MODERN PREVENTIVE ME, V34, P96; Huang LQ, 2007, J CHIN ANTITUBERC, V29, P127; Legislative Affairs Office of the State Council of PRC, 2007, LAW PEOPL REP CHIN E; Li B., 2010, POPULATION RES, V34, P6; Li XX, 2010, J IMMIGR MINOR HEALT, V12, P811, DOI 10.1007/s10903-010-9336-6; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-393; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Ministry of Health of PRC, 2011, NAT TUB EP SIT 2010; Mirsaeidi SM, 2007, ARCH IRAN MED, V10, P190; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-196; Phoa LL, 2005, RESPIROLOGY, V10, P196; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Wang WB, 2007, EUR J PUBLIC HEALTH, V17, P419, DOI 10.1093/eurpub/ckm029; World Health Organization, 2010, WHOHTMTB20107; Xi HF, 2008, RES FACTORS AFFECTIN, P1; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	25	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31995	10.1371/journal.pone.0031995	http://dx.doi.org/10.1371/journal.pone.0031995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384123	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500063
J	Mencarelli, C; Bode, GH; Losen, M; Kulharia, M; Molenaar, PC; Veerhuis, R; Steinbusch, HWM; De Baets, MH; Nicolaes, GAF; Martinez-Martinez, P				Mencarelli, Chiara; Bode, Gerard H.; Losen, Mario; Kulharia, Mahesh; Molenaar, Peter C.; Veerhuis, Robert; Steinbusch, Harry W. M.; De Baets, Marc H.; Nicolaes, Gerry A. F.; Martinez-Martinez, Pilar			Goodpasture Antigen-binding Protein/Ceramide Transporter Binds to Human Serum Amyloid P-Component and Is Present in Brain Amyloid Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; GLOMERULAR-BASEMENT-MEMBRANE; MICROSCALE THERMOPHORESIS; NONVESICULAR TRAFFICKING; ALZHEIMERS-DISEASE; HEPARAN-SULFATE; IV COLLAGEN; AGGREGATION; CERAMIDE; PHOSPHORYLATES	Serum amyloid P component (SAP) is a non-fibrillar glycoprotein belonging to the pentraxin family of the innate immune system. SAP is present in plasma, basement membranes, and amyloid deposits. This study demonstrates, for the first time, that the Goodpasture antigen-binding protein (GPBP) binds to human SAP. GPBP is a nonconventional Ser/Thr kinase for basement membrane type IV collagen. Also GPBP is found in plasma and in the extracellular matrix. In the present study, we demonstrate that GPBP specifically binds SAP in its physiological conformations, pentamers and decamers. The START domain in GPBP is important for this interaction. SAP and GPBP form complexes in blood and partly colocalize in amyloid plaques from Alzheimer disease patients. These data suggest the existence of complexes of SAP and GPBP under physiological and pathological conditions. These complexes are important for understanding basement membrane, blood physiology, and plaque formation in Alzheimer disease.	[Mencarelli, Chiara; Bode, Gerard H.; Losen, Mario; Molenaar, Peter C.; Steinbusch, Harry W. M.; De Baets, Marc H.; Martinez-Martinez, Pilar] Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands; [Kulharia, Mahesh; Nicolaes, Gerry A. F.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Dept Clin Chem, Univ Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Dept Psychiat, Univ Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Alzheimer Ctr, Univ Med Ctr, NL-1007 MB Amsterdam, Netherlands; [De Baets, Marc H.] Hasselt Univ, Neuroimmunol Grp, Biomed Res Inst BIOMED, Diepenbeek, Belgium	Maastricht University; Maastricht University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Hasselt University	Martinez-Martinez, P (corresponding author), Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	p.martinez@maastrichtuniversity.nl	Nicolaes, Gerry A.F./A-8421-2016; Steinbusch, Heinrich/L-6950-2017	Nicolaes, Gerry A.F./0000-0002-2482-0412; Martinez Martinez, Pilar/0000-0002-5990-3373; Losen, Mario/0000-0002-9761-0002	Netherlands Organization for Scientific Research [91107006]; Transnationale Universiteit Limburg; Netherlands Organization for Scientific Research; Brain Foundation of the Netherlands	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Transnationale Universiteit Limburg; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Brain Foundation of the Netherlands	This work was supported by Netherlands Organization for Scientific Research Grant 91107006 (to G. A. F. N.) and a grant from the .Transnationale Universiteit Limburg (to G. A. F. N.).; Supported by a Veni fellowship of the Netherlands Organization for Scientific Research and a fellowship of the Brain Foundation of the Netherlands	ALMUTLAQ H, 1993, HISTOCHEM J, V25, P219, DOI 10.1007/BF00163818; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; BALTZ ML, 1982, BIOCHIM BIOPHYS ACTA, V701, P229, DOI 10.1016/0167-4838(82)90118-2; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRISTOW CL, 1986, MOL IMMUNOL, V23, P1045, DOI 10.1016/0161-5890(86)90003-9; Burgess RR, 2000, METHOD ENZYMOL, V328, P141, DOI 10.1016/S0076-6879(00)28396-1; CATHCART ES, 1965, NEW ENGL J MED, V273, P143, DOI 10.1056/NEJM196507152730306; Chan CS, 2008, ADV BIOCHEM ENG BIOT, V110, P195, DOI 10.1007/10_2007_090; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; DEBEER FC, 1981, J EXP MED, V154, P1134, DOI 10.1084/jem.154.4.1134; DYCK RF, 1980, LANCET, V2, P607; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; Familian A, 2001, J IMMUNOL, V167, P647, DOI 10.4049/jimmunol.167.2.647; Familian A, 2007, NEUROSCI LETT, V416, P87, DOI 10.1016/j.neulet.2007.01.052; HAMAZAKI H, 1995, J BIOL CHEM, V270, P10392, DOI 10.1074/jbc.270.18.10392; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Ho JGS, 2005, J BIOL CHEM, V280, P31999, DOI 10.1074/jbc.M504403200; Hohenester E, 1997, J MOL BIOL, V269, P570, DOI 10.1006/jmbi.1997.1075; HUTCHCRAFT CL, 1981, J IMMUNOL, V126, P1217; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; MELVIN T, 1986, AM J PATHOL, V125, P460; Mencarelli C, 2010, J NEUROCHEM, V113, P1369, DOI 10.1111/j.1471-4159.2010.06673.x; Mencarelli C, 2009, J CHEM NEUROANAT, V38, P97, DOI 10.1016/j.jchemneu.2009.06.005; NIELSEN EH, 1994, APMIS, V102, P420, DOI 10.1111/j.1699-0463.1994.tb04893.x; PAINTER RH, 1982, ANN NY ACAD SCI, V389, P199, DOI 10.1111/j.1749-6632.1982.tb22138.x; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; POTEMPA LA, 1985, J BIOL CHEM, V260, P2142; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Saus J. V., 2011, U.S. Patent, Patent No. [US7935492, 7935492]; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; STANTON M. C., 1958, AUSTRALASEAN ANN MED, V7, P132; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Thompson D, 2002, J MOL BIOL, V320, P1081, DOI 10.1016/S0022-2836(02)00514-4; TSENG J, 1986, IMMUNOL INVEST, V15, P749, DOI 10.3109/08820138609036360; Veerhuis R, 2003, ACTA NEUROPATHOL, V105, P135, DOI 10.1007/s00401-002-0624-7; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; YING SC, 1993, J IMMUNOL, V150, P169; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zahedi K, 1996, J BIOL CHEM, V271, P14897, DOI 10.1074/jbc.271.25.14897; Zahedi K, 1997, J BIOL CHEM, V272, P2143; ZHAN SS, 1995, NEURODEGENERATION, V4, P291, DOI 10.1016/1055-8330(95)90018-7	52	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14897	14911		10.1074/jbc.M111.299545	http://dx.doi.org/10.1074/jbc.M111.299545			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396542	hybrid, Green Published			2022-12-25	WOS:000304003200053
J	Takahashi, K; Mitoma, J; Hosono, M; Shiozaki, K; Sato, C; Yamaguchi, K; Kitajima, K; Higashi, H; Nitta, K; Shima, H; Miyagi, T				Takahashi, Kohta; Mitoma, Junya; Hosono, Masahiro; Shiozaki, Kazuhiro; Sato, Chihiro; Yamaguchi, Kazunori; Kitajima, Ken; Higashi, Hideyoshi; Nitta, Kazuo; Shima, Hiroshi; Miyagi, Taeko			Sialidase NEU4 Hydrolyzes Polysialic Acids of Neural Cell Adhesion Molecules and Negatively Regulates Neurite Formation by Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; COLON-CANCER CELLS; GANGLIOSIDE SIALIDASE; EXPRESSION; DIFFERENTIATION; NCAM; PLASTICITY; GROWTH; MICE	Modulation of levels of polysialic acid (polySia), a sialic acid polymer, predominantly associated with the neural cell adhesion molecule (NCAM), influences neural functions, including synaptic plasticity, neurite growth, and cell migration. Biosynthesis of polySia depends on two polysialyltransferases ST8SiaII and ST8SiaIV in vertebrate. However, the enzyme involved in degradation of polySia in its physiological turnover remains uncertain. In the present study, we identified and characterized a murine sialidase NEU4 that catalytically degrades polySia. Murine NEU4, dominantly expressed in the brain, was found to efficiently hydrolyze oligoSia and polySia chains as substrates in sialidase in vitro assays, and also NCAM-Fc chimera as well as endogenous NCAM in tissue homogenates of postnatal mouse brain as assessed by immunoblotting with anti-polySia antibodies. Degradation of polySia by NEU4 was also evident in neuroblastoma Neuro2a cells that were co-transfected with Neu4 and ST8SiaIV genes. Furthermore, in mouse embryonic hippocampal primary neurons, the endogenously expressed NEU4 was found to decrease during the neuronal differentiation. Interestingly, GFP- or FLAG-tagged NEU4 was partially co-localized with polySia in neurites and significantly suppressed their outgrowth, whereas silencing of NEU4 showed the acceleration together with an increase in polySia expression. These results suggest that NEU4 is involved in regulation of neuronal function by polySia degradation in mammals.	[Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Mitoma, Junya; Higashi, Hideyoshi] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycosignal Res, Sendai, Miyagi 9818558, Japan; [Hosono, Masahiro; Nitta, Kazuo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Sendai, Miyagi 9818558, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Marine Biochem Lab, Kagoshima 8900056, Japan; [Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Yamaguchi, Kazunori; Shima, Hiroshi] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Takahashi, Kohta; Shima, Hiroshi] Tohoku Univ, Grad Sch Med, Div Canc Mol Biol, Sendai, Miyagi 9808575, Japan	Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Kagoshima University; Nagoya University; Miyagi Cancer Center; Tohoku University	Miyagi, T (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp	Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Naganawa, Shinji/0000-0002-0214-613X; Shiozaki, Kazuhiro/0000-0002-0523-838X				Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Brocco MA, 2006, FEBS LETT, V580, P4723, DOI 10.1016/j.febslet.2006.07.058; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Fanzani A, 2004, FEBS LETT, V566, P178, DOI 10.1016/j.febslet.2004.03.115; Franceschini I, 2001, GLYCOBIOLOGY, V11, P231, DOI 10.1093/glycob/11.3.231; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Miyagi T., 2007, COMPREHENSIVE GLYCOS, P297; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Schonherr C, 2010, ONCOGENE, V29, P2817, DOI 10.1038/onc.2010.27; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Seyrantepe V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001118; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017	48	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14816	14826		10.1074/jbc.M111.324186	http://dx.doi.org/10.1074/jbc.M111.324186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393058	hybrid, Green Published			2022-12-25	WOS:000304003200046
J	Noh, KT; Son, KH; Jung, ID; Kang, HK; Hwang, SA; Lee, WS; You, JC; Park, YM				Noh, Kyung Tae; Son, Kwang Hee; Jung, In Duk; Kang, Hyun Kyu; Hwang, Sun Ae; Lee, Won Suk; You, Ji Chang; Park, Yeong-Min			Protein Kinase C delta (PKC delta)-Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling Cascade Regulates Glycogen Synthase Kinase-3 (GSK-3) Inhibition-mediated Interleukin-10 (IL-10) Expression in Lipopolysaccharide (LPS)-induced Endotoxemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; UNITED-STATES; SEVERE SEPSIS; NITRIC-OXIDE; INNATE; EPIDEMIOLOGY; DYSFUNCTION; MICE	Glycogen synthase kinase-3 (GSK-3) modulates a wide array of cellular processes, including embryonic development, cell differentiation, survival, and apoptosis. Recently, it was reported that a GSK-3 inhibitor attenuates lipopolysaccharide (LPS)-induced septic shock and regulates the mortality of endotoxemic mice. However, the detailed mechanism of reduced mortality via GSK-3 inhibition is not well defined. Herein, we showed that GSK-3 inhibition induces extracellular signal-regulated kinase 1/2 (ERK1/2) activation under LPS-stressed conditions via protein kinase C delta (PKC delta) activation. Furthermore, PKC delta-induced ERK1/2 activation by the inhibition of GSK-3 provoked the production of interleukin (IL)-10, playing a crucial role in regulating endotoxemia. Using a mitogen-activated protein kinase kinase-1 (MEK-1) and PKC delta inhibitor, we confirmed that GSK-3 inhibition induces PKC delta and subsequent ERK1/2 activation, resulting in increased IL-10 expression under LPS-treated conditions. We verified that septic shock caused by LPS is attenuated by GSK-3 inhibition using a GSK-3 inhibitor. This relieved endotoxemia induced by GSK-3 inhibition was restored in an ERK1/2-dependent manner. Taken together, IL-10 expression produced by GSK-3 inhibition-induced ERK1/2 activation via PKC delta relieved LPS-mediated endotoxemia. This finding suggests that IL-10 hyperexpression resulting from GSK-3 inhibition-induced ERK activation could be a new therapeutic pathway for endotoxemia.	[Noh, Kyung Tae; Son, Kwang Hee; Jung, In Duk; Kang, Hyun Kyu; Park, Yeong-Min] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Yangsan 626870, Gyeongsangnam D, South Korea; [Hwang, Sun Ae; Lee, Won Suk] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan 626870, Gyeongsangnam D, South Korea; [Park, Yeong-Min] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea; [You, Ji Chang] Catholic Univ Korea, Sch Med, Dept Pathol, Natl Res Lab Mol Virol, Seoul 137701, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Catholic University of Korea	Park, YM (corresponding author), Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Yangsan 626870, Gyeongsangnam D, South Korea.	immunpym@pusan.ac.kr			Ministry for Health Welfare and Family Affairs, Republic of Korea [A100462]	Ministry for Health Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Healthcare Technology R&D Project, Ministry for Health Welfare and Family Affairs, Republic of Korea, Grant A100462.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bauer Philippe R., 2002, Pathophysiology, V8, P141, DOI 10.1016/S0928-4680(02)00007-X; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Doughty L, 1998, CHEST, V113, P1625, DOI 10.1378/chest.113.6.1625; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Ginnan R, 2006, AM J PHYSIOL-CELL PH, V290, pC1583, DOI 10.1152/ajpcell.00390.2005; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Noh KT, 2011, EXP CELL RES, V317, P1663, DOI 10.1016/j.yexcr.2011.03.022; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schwartz D, 1997, J CLIN INVEST, V100, P439, DOI 10.1172/JCI119551; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Song GY, 1999, SURGERY, V126, P378, DOI 10.1016/S0039-6060(99)70180-7; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Tschoeke SK, 2008, SCAND J IMMUNOL, V68, P565, DOI 10.1111/j.1365-3083.2008.02176.x; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; WRIGHT CE, 1992, CARDIOVASC RES, V26, P48, DOI 10.1093/cvr/26.1.48; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	38	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14226	14233		10.1074/jbc.M111.308841	http://dx.doi.org/10.1074/jbc.M111.308841			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393041	Green Published, hybrid			2022-12-25	WOS:000303996300074
J	Xu, J; Kang, Y; Liao, WM; Yu, L				Xu, Jun; Kang, Yan; Liao, Wei-ming; Yu, Ling			MiR-194 Regulates Chondrogenic Differentiation of Human Adipose-Derived Stem Cells by Targeting Sox5	PLOS ONE			English	Article							CHONDROCYTE DIFFERENTIATION; CARTILAGE FORMATION; NUCLEAR EXPORT; CANCER-CELLS; N-CADHERIN; EXPRESSION; MICRORNAS; RNAS; OSTEOARTHRITIS; MATURATION	Osteoarthritis, also known as degenerative arthritis or degenerative joint disease, causes pain and disability worldwide. Cartilage regeneration is key to finding a cure for this disease. Adipose-derived stem cells (ASCs) are capable of differentiating into cartilage lineages in vitro and they have shown promise in the field of regenerative medicine. However, the underlying mechanisms remain unclear. In this study, we demonstrated that miR-194 levels gradually decreased during the chondrogenic differentiation of human ASCs (hASCs). After predicting the target of miR-194 using Pictar and Targetscan, we hypothesized that Sox5 is potentially the key link between miR-194 and the chondrogenesis of ASCs. Initially, we demonstrated that Sox5 is a target of miR194 according to luciferase assay analysis. We further demonstrated that the differentiation of ASCs can be controlled by miR-194 through gain or loss of function experiments, and we observed that the down-regulation of miR-194 increases its direct target gene, Sox5, and results in enhanced chondrogenic differentiation of hASCs, whereas up-regulation decreases Sox5 and inhibits chondrogenesis. We also found that miR-194 correlates with Sox5 in osteoarthritis. These findings, taken together, are the first to illustrate the critical role of miR-194 in hASC chondrogenesis, and may provide novel insight beneficial to cell manipulation methods during cartilage regeneration.	[Xu, Jun; Kang, Yan; Liao, Wei-ming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Ling] Wuhan Univ, Renmin Hosp, Dept Orthoped, Wuhan 430072, Hubei, Peoples R China	Sun Yat Sen University; Wuhan University	Xu, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China.	liaoweiming29@163.com			National Natural Science Foundation of China [30872615]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30872615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Chimal-Monroy J, 1999, INT J DEV BIOL, V43, P59; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang B, 2011, BMB REP, V44, P28, DOI 10.5483/BMBRep.2011.44.1.28; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhou PH, 2008, J ORTHOP RES, V26, P1643, DOI 10.1002/jor.20683	36	69	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31861	10.1371/journal.pone.0031861	http://dx.doi.org/10.1371/journal.pone.0031861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396742	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000010
J	Hogstrand, K; Hejll, E; Sander, B; Rozell, B; Larsson, LG; Grandien, A				Hoegstrand, Kari; Hejll, Eduar; Sander, Birgitta; Rozell, Bjoern; Larsson, Lars-Gunnar; Grandien, Alf			Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia	PLOS ONE			English	Article							C-MYC; TRANSGENIC MICE; HEMATOPOIETIC-CELLS; EXPRESSION; TUMORS; DEATH; SUPPRESSOR; FLIP; OVEREXPRESSION; BCL-X(L)	Myc plays an important role in tumor development, including acute myeloid leukemia (AML). However, MYC is also a powerful inducer of apoptosis, which is one of the major failsafe programs to prevent cancer development. To clarify the relative importance of the extrinsic (death receptor-mediated) versus the intrinsic (mitochondrial) pathway of apoptosis in MYC-driven AML, we coexpressed MYC together with anti-apoptotic proteins of relevance for AML; BCL-X-L/BCL-2 (inhibiting the intrinsic pathway) or FLIPL (inhibiting the extrinsic pathway), in hematopoietic stems cells (HSCs). Transplantation of HSCs expressing MYC into syngeneic recipient mice resulted in development of AML and T-cell lymphomas within 7-9 weeks as expected. Importantly, coexpression of MYC together with BCL-X-L/BCL-2 resulted in strongly accelerated kinetics and favored tumor development towards aggressive AML. In contrast, coexpression of MYC and FLIPL did neither accelerate tumorigenesis nor change the ratio of AML versus T-cell lymphoma. However, a change in distribution of immature CD4(+)CD8(+) versus mature CD4(+) T-cell lymphoma was observed in MYC/FLIPL mice, possibly as a result of increased survival of the CD4(+) population, but this did not significantly affect the outcome of the disease. In conclusion, our findings provide direct evidence that BCL-X-L and BCL-2 but not FLIPL acts in synergy with MYC to drive AML development.	[Hoegstrand, Kari; Grandien, Alf] Karolinska Inst, Dept Med, Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden; [Hejll, Eduar; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Sander, Birgitta; Rozell, Bjoern] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Res Ctr, Stockholm, Sweden; [Hoegstrand, Kari; Grandien, Alf] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Sander, Birgitta; Rozell, Bjoern] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hogstrand, K (corresponding author), Karolinska Inst, Dept Med, Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden.	alf.grandien@ki.se	Larsson, Lars-Gunnar/D-9747-2012		Swedish Cancer Society; Swedish Childhood Cancer Society; Swedish Research Council; Stockholm Cancer Society; KI Foundations	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm Cancer Society; KI Foundations	This work was funded by the Swedish Cancer Society (AG, LGL, BS), the Swedish Childhood Cancer Society (LGL, BS), the Swedish Research Council (AG, LGL, BS), the Stockholm Cancer Society (LGL, BS), KI Foundations (AG, LGL, BS), KI support to the Advanced Cancer Therapies (ACT!) consortium (LGL, BS), The County Council of Stockholm (BS), Olle Engkvist's Foundation (LGL), and Ake Olsson's Foundation for Hematology Research (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanullah A, 2002, ONCOGENE, V21, P1600, DOI 10.1038/sj.onc.1205231; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; BONHAM L, 1992, ONCOGENE, V7, P2219; Cameron ER, 2000, CELL DEATH DIFFER, V7, P80, DOI 10.1038/sj.cdd.4400630; Djerbi M, 2007, SCAND J IMMUNOL, V66, P410, DOI 10.1111/j.1365-3083.2007.01957.x; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Dolnikov A, 1998, LEUKEMIA, V12, P542, DOI 10.1038/sj.leu.2400968; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Frankfurt O, 2007, CURR OPIN ONCOL, V19, P635, DOI 10.1097/CCO.0b013e3282f10e55; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Jones L, 2010, J EXP MED, V207, P2581, DOI 10.1084/jem.20091071; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Larramendy ML, 2002, HAEMATOLOGICA, V87, P569; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nieminen AI, 2007, EMBO J, V26, P1055, DOI 10.1038/sj.emboj.7601551; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Nyakeriga AM, 2005, SCAND J IMMUNOL, V61, P545, DOI 10.1111/j.1365-3083.2005.01607.x; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; PREISLER H D, 1987, Blood Reviews, V1, P97, DOI 10.1016/0268-960X(87)90003-8; PREISLER HD, 1987, LEUKEMIA RES, V11, P923, DOI 10.1016/0145-2126(87)90138-X; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Schreiner S, 2001, CANCER RES, V61, P6480; Screpanti V, 2001, J IMMUNOL, V167, P2068, DOI 10.4049/jimmunol.167.4.2068; Smith DP, 2006, BLOOD, V108, P653, DOI 10.1182/blood-2006-01-0172; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Swanson PJ, 2004, J IMMUNOL, V172, P6684, DOI 10.4049/jimmunol.172.11.6684; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Testa U, 2007, HAEMATOL-HEMATOL J, V92, P81, DOI 10.3324/haematol.10279; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; ZORNIG M, 1995, ONCOGENE, V11, P2165; ZORNIG M, 1995, ONCOGENE, V10, P2397	51	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31366	10.1371/journal.pone.0031366	http://dx.doi.org/10.1371/journal.pone.0031366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393362	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500015
J	Myllykoski, M; Raasakka, A; Han, HJ; Kursula, P				Myllykoski, Matti; Raasakka, Arne; Han, Huijong; Kursula, Petri			Myelin 2 ',3 '-Cyclic Nucleotide 3 '-Phosphodiesterase: Active-Site Ligand Binding and Molecular Conformation	PLOS ONE			English	Article							TRANSFER-RNA; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; 2'-5'-RNA LIGASE; MEMBRANE ANCHOR; PROTEIN; PHOSPHODIESTERASE; 3-PHOSPHODIESTERASE; DOMAIN	The 2'3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) is a highly abundant membrane-associated enzyme in the myelin sheath of the vertebrate nervous system. CNPase is a member of the 2H phosphoesterase family and catalyzes the formation of 2'-nucleotide products from 2',3'-cyclic substrates; however, its physiological substrate and function remain unknown. It is likely that CNPase participates in RNA metabolism in the myelinating cell. We solved crystal structures of the phosphodiesterase domain of mouse CNPase, showing the binding mode of nucleotide ligands in the active site. The binding mode of the product 2'-AMP provides a detailed view of the reaction mechanism. Comparisons of CNPase crystal structures highlight flexible loops, which could play roles in substrate recognition; large differences in the active-site vicinity are observed when comparing more distant members of the 2H family. We also studied the full-length CNPase, showing its N-terminal domain is involved in RNA binding and dimerization. Our results provide a detailed picture of the CNPase active site during its catalytic cycle, and suggest a specific function for the previously uncharacterized N-terminal domain.	[Myllykoski, Matti; Raasakka, Arne; Han, Huijong; Kursula, Petri] Univ Oulu, Dept Biochem, Oulu, Finland; [Myllykoski, Matti; Raasakka, Arne; Han, Huijong; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Han, Huijong; Kursula, Petri] German Electron Synchrotron DESY, Ctr Struct Syst Biol, Helmholtz Ctr Infect Res CSSB HZI, Hamburg, Germany; [Kursula, Petri] Univ Hamburg, Dept Chem, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; University of Hamburg	Myllykoski, M (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@oulu.fi	Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012; Raasakka, Arne/AAA-5251-2020	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Raasakka, Arne/0000-0002-9443-9959; Han, Huijong/0000-0002-1197-3014; Myllykoski, Matti/0000-0001-6641-5856	Academy of Finland; Sigrid Juselius Foundation (Finland); Magnus Ehrnrooth Foundation (Finland); Department of Biochemistry, University of Oulu (Finland); Science and Research Foundation of the City of Hamburg (Germany); European Community [226716]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation (Finland); Department of Biochemistry, University of Oulu (Finland); Science and Research Foundation of the City of Hamburg (Germany); European Community(European Commission)	This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation (Finland), the Magnus Ehrnrooth Foundation (Finland), the Department of Biochemistry, University of Oulu (Finland), and the Science and Research Foundation of the City of Hamburg (Germany). The research leading to these results received funding from the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreement #226716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bekesi A, 2011, FEBS J, V278, P295, DOI 10.1111/j.1742-4658.2010.07951.x; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; BRAUN PE, 1991, J NEUROSCI RES, V30, P540, DOI 10.1002/jnr.490300311; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Calvin K, 2008, CELL MOL LIFE SCI, V65, P1176, DOI 10.1007/s00018-008-7393-y; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeAngelis DA, 1996, J NEUROCHEM, V67, P943; deVries H, 1997, J NEUROSCI RES, V47, P479, DOI 10.1002/(SICI)1097-4547(19970301)47:5<479::AID-JNR3>3.0.CO;2-E; DRUMMOND GI, 1962, J BIOL CHEM, V237, P3535; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito C, 2008, BIOCHEMISTRY-US, V47, P308, DOI 10.1021/bi701474t; Gao YG, 2006, ACTA CRYSTALLOGR F, V62, P1196, DOI 10.1107/S1744309106046616; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Gold MG, 2008, J MOL BIOL, V375, P1329, DOI 10.1016/j.jmb.2007.11.037; Gravel M, 2009, J NEUROSCI RES, V87, P1069, DOI 10.1002/jnr.21939; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai A, 2009, RNA, V15, P420, DOI 10.1261/rna.1122109; Kato M, 2003, J MOL BIOL, V329, P903, DOI 10.1016/S0022-2836(03)00448-0; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozlov G, 2003, J BIOL CHEM, V278, P46021, DOI 10.1074/jbc.M305176200; Kozlov G, 2007, FEBS J, V274, P1600, DOI 10.1111/j.1742-4658.2007.05707.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kursula P, 2001, INT J MOL MED, V8, P475; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2010, AMINO ACIDS, V39, P59, DOI 10.1007/s00726-009-0364-2; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MULLER HW, 1982, FEBS LETT, V144, P77, DOI 10.1016/0014-5793(82)80572-3; Muraro PA, 2002, J NEUROIMMUNOL, V130, P233, DOI 10.1016/S0165-5728(02)00229-1; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myllykoski M, 2011, AMINO ACIDS; Myllykoski Matti, 2010, BMC Res Notes, V3, P12, DOI 10.1186/1756-0500-3-12; Sakamoto Y, 2005, J MOL BIOL, V346, P789, DOI 10.1016/j.jmb.2004.12.024; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; Spinelli SL, 1999, J BIOL CHEM, V274, P2637, DOI 10.1074/jbc.274.5.2637; SPRINKLE TJ, 1980, J NEUROCHEM, V34, P880, DOI 10.1111/j.1471-4159.1980.tb09661.x; Stingo S, 2007, CHEM BIOL DRUG DES, V70, P502, DOI 10.1111/j.1747-0285.2007.00592.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walsh MJ, 1998, J CLIN INVEST, V101, P1923, DOI 10.1172/JCI1983	60	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32336	10.1371/journal.pone.0032336	http://dx.doi.org/10.1371/journal.pone.0032336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393399	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500051
J	Trushina, E; Nemutlu, E; Zhang, S; Christensen, T; Camp, J; Mesa, J; Siddiqui, A; Tamura, Y; Sesaki, H; Wengenack, TM; Dzeja, PP; Poduslo, JF				Trushina, Eugenia; Nemutlu, Emirhan; Zhang, Song; Christensen, Trace; Camp, Jon; Mesa, Janny; Siddiqui, Ammar; Tamura, Yasushi; Sesaki, Hiromi; Wengenack, Thomas M.; Dzeja, Petras P.; Poduslo, Joseph F.			Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; FAST AXONAL-TRANSPORT; TRANSGENIC MICE; A-BETA; HIPPOCAMPAL-NEURONS; NEURODEGENERATIVE DISEASES; PRESENILIN-1 MUTATIONS; MUTANT PRESENILIN-1; OXIDATIVE DAMAGE; IN-VIVO	Background: The identification of early mechanisms underlying Alzheimer's Disease (AD) and associated biomarkers could advance development of new therapies and improve monitoring and predicting of AD progression. Mitochondrial dysfunction has been suggested to underlie AD pathophysiology, however, no comprehensive study exists that evaluates the effect of different familial AD (FAD) mutations on mitochondrial function, dynamics, and brain energetics. Methods and Findings: We characterized early mitochondrial dysfunction and metabolomic signatures of energetic stress in three commonly used transgenic mouse models of FAD. Assessment of mitochondrial motility, distribution, dynamics, morphology, and metabolomic profiling revealed the specific effect of each FAD mutation on the development of mitochondrial stress and dysfunction. Inhibition of mitochondrial trafficking was characteristic for embryonic neurons from mice expressing mutant human presenilin 1, PS1(M146L) and the double mutation of human amyloid precursor protein APP(Tg2576) and PS1(M146L) contributing to the increased susceptibility of neurons to excitotoxic cell death. Significant changes in mitochondrial morphology were detected in APP and APP/PS1 mice. All three FAD models demonstrated a loss of the integrity of synaptic mitochondria and energy production. Metabolomic profiling revealed mutation-specific changes in the levels of metabolites reflecting altered energy metabolism and mitochondrial dysfunction in brains of FAD mice. Metabolic biomarkers adequately reflected gender differences similar to that reported for AD patients and correlated well with the biomarkers currently used for diagnosis in humans. Conclusions: Mutation-specific alterations in mitochondrial dynamics, morphology and function in FAD mice occurred prior to the onset of memory and neurological phenotype and before the formation of amyloid deposits. Metabolomic signatures of mitochondrial stress and altered energy metabolism indicated alterations in nucleotide, Krebs cycle, energy transfer, carbohydrate, neurotransmitter, and amino acid metabolic pathways. Mitochondrial dysfunction, therefore, is an underlying event in AD progression, and FAD mouse models provide valuable tools to study early molecular mechanisms implicated in AD.	[Trushina, Eugenia; Mesa, Janny; Siddiqui, Ammar] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut & Neurol, Rochester, MN 55905 USA; [Christensen, Trace] Mayo Clin, Electron Microscopy Core Facil, Rochester, MN USA; [Tamura, Yasushi; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Wengenack, Thomas M.; Poduslo, Joseph F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Wengenack, Thomas M.; Poduslo, Joseph F.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Johns Hopkins University; Mayo Clinic; Mayo Clinic	Trushina, E (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut & Neurol, Rochester, MN 55905 USA.	Trushina.eugenia@mayo.edu	Tamura, Yasushi/H-8270-2017; Camp, Jon J/A-8219-2011; Nemutlu, Emirhan/D-3218-2013; Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/A-9997-2013	Tamura, Yasushi/0000-0002-8462-0607; Nemutlu, Emirhan/0000-0002-7337-6215; 	Alzheimer Drug Discovery Foundation and Institute for the Study of Aging [291204]; American Health Assistance Foundation [A2011084]; Mayo Clinic Alzheimer Disease Research Center; National Institutes of Health [ES20715, GM089853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER	Alzheimer Drug Discovery Foundation and Institute for the Study of Aging; American Health Assistance Foundation(BrightFocus Foundation); Mayo Clinic Alzheimer Disease Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants from Alzheimer Drug Discovery Foundation and Institute for the Study of Aging 291204 (http://www.alzdiscovery.org/), American Health Assistance Foundation A2011084 (http://www.ahaf.org/), Mayo Clinic Alzheimer Disease Research Center (to ET), and National Institutes of Health grants ES20715 (to ET) and GM089853 (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello M, 2008, CYTOTECHNOLOGY, V56, P145, DOI 10.1007/s10616-008-9143-2; AMADORO G, 2009, NEUROBIOL AGING; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Baloyannis Stavros J, 2004, Am J Alzheimers Dis Other Demen, V19, P89, DOI 10.1177/153331750401900205; Barba I, 2008, J CELL MOL MED, V12, P1477, DOI 10.1111/j.1582-4934.2008.00385.x; Barrow PA, 2000, NEUROBIOL DIS, V7, P119, DOI 10.1006/nbdi.1999.0276; Beal MF, 2005, NEUROBIOL AGING, V26, P585, DOI 10.1016/j.neurobiolaging.2004.09.022; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Dragicevic N, 2010, J ALZHEIMERS DIS; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Dzeja PP, 2004, MOL CELL BIOCHEM, V256, P13, DOI 10.1023/B:MCBI.0000009856.23646.38; DZEJA PP, 2007, HDB NEUROCHEMISTRY M, P641; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Hanson DP, 1997, J DIGIT IMAGING, V10, P229, DOI 10.1007/BF03168711; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Nemutly E, 2011, METABOLIC PROFILING; Nimmrich V, 2009, REV NEUROSCIENCE, V20, P1; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Pigino G, 2003, J NEUROSCI, V23, P4499; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Poduslo JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008813; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Pucar D, 2001, J BIOL CHEM, V276, P44812, DOI 10.1074/jbc.M104425200; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; REDDY PH, 2011, CURR ALZHEIMER RES; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570; Santos RX, 2010, J ALZHEIMERS DIS, V20, pS401, DOI 10.3233/JAD-2010-100666; Scholl M, 2011, J ALZHEIMERS DIS; Schon EA, 2010, J ALZHEIMERS DIS, V20, pS281, DOI 10.3233/JAD-2010-100495; SCOTT MD, 1992, J CHROMATOGR-BIOMED, V576, P149, DOI 10.1016/0378-4347(92)80186-T; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Titman CM, 2009, MOL BIOSYST, V5, P1913, DOI 10.1039/b907754e; Trinczek B, 1999, J CELL SCI, V112, P2355; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wang GJ, 2003, J NEUROCHEM, V87, P85, DOI 10.1046/j.1471-4159.2003.01970.x; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wengenack TM, 2000, NEUROSCIENCE, V101, P939, DOI 10.1016/S0306-4522(00)00388-2; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	84	185	190	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32737	10.1371/journal.pone.0032737	http://dx.doi.org/10.1371/journal.pone.0032737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393443	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500096
J	Zhao, LQ; Morgan, TE; Mao, ZS; Lin, SR; Cadenas, E; Finch, CE; Pike, CJ; Mack, WJ; Brinton, RD				Zhao, Liqin; Morgan, Todd E.; Mao, Zisu; Lin, Sharon; Cadenas, Enrique; Finch, Caleb E.; Pike, Christian J.; Mack, Wendy J.; Brinton, Roberta D.			Continuous versus Cyclic Progesterone Exposure Differentially Regulates Hippocampal Gene Expression and Functional Profiles	PLOS ONE			English	Article							HEALTH INITIATIVE MEMORY; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; RANDOMIZED CONTROLLED-TRIAL; MITOCHONDRIAL ATP-SYNTHASE; ALZHEIMERS-DISEASE; POSTMENOPAUSAL WOMEN; GROWTH-FACTOR	This study investigated the impact of chronic exposure to continuous (CoP4) versus cyclic progesterone (CyP4) alone or in combination with 17 beta-estradiol (E2) on gene expression profiles targeting bioenergetics, metabolism and inflammation in the adult female rat hippocampus. High-throughput qRT-PCR analyses revealed that ovarian hormonal depletion induced by ovariectomy (OVX) led to multiple significant gene expression alterations, which were to a great extent reversed by co-administration of E2 and CyP4. In contrast, co-administration of E2 and CoP4 induced a pattern highly resembling OVX. Bioinformatics analyses further revealed clear disparities in functional profiles associated with E2+CoP4 and E2+CyP4. Genes involved in mitochondrial energy (ATP synthase alpha subunit; Atp5a1), redox homeostasis (peroxiredoxin 5; Prdx5), insulin signaling (insulin-like growth factor I; Igf1), and cholesterol trafficking (liver X receptor alpha subtype; Nr1h3), differed in direction of regulation by E2+CoP4 (down-regulation relative to OVX) and E2+CyP4 (up-regulation relative to OVX). In contrast, genes involved in amyloid metabolism (beta-secretase; Bace1) differed only in degree of regulation, as both E2+CoP4 and E2+CyP4 induced down-regulation at different efficacy. E2+CyP4-induced changes could be associated with regulation of progesterone receptor membrane component 1(Pgrmc1). In summary, results from this study provide evidence at the molecular level that differing regimens of hormone therapy (HT) can induce disparate gene expression profiles in brain. From a translational perspective, confirmation of these results in a model of natural menopause, would imply that the common regimen of continuous combined HT may have adverse consequences whereas a cyclic combined regimen, which is more physiological, could be an effective strategy to maintain neurological health and function throughout menopausal aging.	[Zhao, Liqin; Mao, Zisu; Cadenas, Enrique; Brinton, Roberta D.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Morgan, Todd E.; Lin, Sharon; Finch, Caleb E.; Pike, Christian J.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Mack, Wendy J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Brinton, Roberta D.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhao, LQ (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	liqinz@usc.edu; rbrinton@usc.edu	Pike, Christian J/D-4013-2018; Finch, Caleb/AAA-7250-2022	Brinton, Roberta/0000-0001-8450-772X; Pike, Christian/0000-0003-4577-7668	National Institute on Aging [1PO1 AG026572]; NATIONAL INSTITUTE ON AGING [P01AG026572, R01AG034103] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging 1PO1 AG026572 - Progesterone in Brain Aging and Alzheimer's Disease (RDB): Project 1 to EC, Project 2 to CEF, Project 3 to RDB, Project 5 to CJP, Animal Core B to TEM and Analytic Core C to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bali N, 2011, ENDOCRINOLO IN PRESS; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brinton RD, 2003, JAMA-J AM MED ASSOC, V290, P1706, DOI 10.1001/jama.290.13.1706-a; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carroll JC, 2010, ENDOCRINOLOGY, V151, P2713, DOI 10.1210/en.2009-1487; Chesik D, 2010, NEUROSCI LETT, V468, P178, DOI 10.1016/j.neulet.2009.10.051; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Denisov V, 2008, 5761 BIOR EL; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Garcia-Segura LM, 2006, NEUROENDOCRINOLOGY, V84, P275, DOI 10.1159/000097485; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Goulter AB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-34; GUENNOUN R, 1990, DEV BRAIN RES, V55, P151, DOI 10.1016/0165-3806(90)90196-6; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Hampel H, 2009, SCAND J CLIN LAB INV, V69, P8, DOI 10.1080/00365510701864610; Intlekofer KA, 2011, NEUROSCIENCE, V176, P86, DOI 10.1016/j.neuroscience.2010.12.033; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Irwin RW, 2011, ENDOCRINOLOGY, V152, P556, DOI 10.1210/en.2010-1061; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; KOHAMA SG, 1989, BIOL REPROD, V41, P233, DOI 10.1095/biolreprod41.2.233; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Marriott LK, 2007, ENDOCRINE, V32, P317, DOI 10.1007/s12020-008-9038-1; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma S, 2008, NEUROBIOL DIS, V32, P426, DOI 10.1016/j.nbd.2008.08.002; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Smeets A, 2008, ARCH BIOCHEM BIOPHYS, V477, P98, DOI 10.1016/j.abb.2008.04.036; Szabo M, 2000, BIOL REPROD, V62, P95, DOI 10.1095/biolreprod62.1.95; Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Viero C, 2006, CELL CALCIUM, V40, P383, DOI 10.1016/j.ceca.2006.04.007; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yao J, 2011, BRAIN RES, V1379, P2, DOI 10.1016/j.brainres.2010.11.090; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	58	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31267	10.1371/journal.pone.0031267	http://dx.doi.org/10.1371/journal.pone.0031267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393359	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500012
J	Jiu, YM; Jin, CY; Liu, YB; Holmberg, CI; Jantti, J				Jiu, Yaming; Jin, Congyu; Liu, Yanbo; Holmberg, Carina I.; Jantti, Jussi			Exocyst Subunits Exo70 and Exo84 Cooperate with Small GTPases to Regulate Behavior and Endocytic Trafficking in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; POLARIZED EXOCYTOSIS; EPITHELIAL-CELLS; RAL GTPASES; COMPLEX; PROTEIN; EFFECTOR; PATHWAY	The exocyst complex is required for cell polarity regulation and the targeting and tethering of transport vesicles to the plasma membrane. The complex is structurally well conserved, however, the functions of individual subunits and their regulation is poorly understood. Here we characterize the mutant phenotypes for the exocyst complex genes exoc-7 (exo70) and exoc-8 (exo84) in Caenorhabditis elegans. The mutants display pleiotropic behavior defects that resemble those observed in cilia mutants (slow growth, uncoordinated movement, defects in chemo-, mechano- and thermosensation). However, no obvious morphological defects in cilia were observed. A targeted RNAi screen for small GTPases identified eleven genes with enhanced phenotypes when combined with exoc-7, exoc-8 single and exoc-7;exoc-8 double mutants. The screen verified previously identified functional links between the exocyst complex and small GTPases and, in addition, identified several novel potential regulators of exocyst function. The exoc-8 and exoc-7;exoc-8 mutations caused a significant size increase in the rab-10 RNAi-induced endocytic vacuoles in the intestinal epithelial cells. In addition, exoc-8 and exoc-7;exoc-8 mutations resulted in up-regulation of RAB-10 expression and affected the accumulation of endocytic marker proteins in these cells in response to rab-10 RNAi. The findings identify novel, potential regulators for exocyst function and show that exoc-7 and exoc-8 are functionally linked to rab-10 in endosomal trafficking in intestinal epithelial cells in C. elegans.	[Jiu, Yaming; Liu, Yanbo; Jantti, Jussi] Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland; [Jin, Congyu; Holmberg, Carina I.] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Jin, Congyu; Holmberg, Carina I.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Jiu, YM (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland.	jussi.jantti@helsinki.fi		Holmberg-Still, Carina/0000-0001-9645-2009	Academy of Finland [1133552, 1131408, 113485]; Institute of Biotechnology; University of Helsinki; International Human Frontier Science Program Organization; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Institute of Biotechnology; University of Helsinki; International Human Frontier Science Program Organization(Human Frontier Science Program); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Academy of Finland (1133552, JJ; 1131408 and 113485,CIH), Institute of Biotechnology (JJ), University of Helsinki (CIH), International Human Frontier Science Program Organization (CIH) and Sigrid Juselius Foundation (CIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; BOWSER R, 1991, J CELL BIOL, V112, P1117, DOI 10.1083/jcb.112.6.1117; BRENNER S, 1974, GENETICS, V77, P71; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Das A, 2011, TRENDS CELL BIOL, V21, P383, DOI 10.1016/j.tcb.2011.03.006; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Inglis P. N., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.126.2, DOI 10.1895/WORMBOOK.1.126.2]; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jiu YM, 2010, PROTEIN CELL, V1, P75, DOI 10.1007/s13238-010-0003-4; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kang J, 2009, DEVELOPMENT, V136, P2705, DOI 10.1242/dev.035485; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; McGhee J.D., 2007, C ELEGANS INTESTINE, P1; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaux G, 2011, J THROMB HAEMOST, V9, P392, DOI 10.1111/j.1538-7836.2010.04138.x; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Yu Y, 2011, BIOCHEM J, V434, P383, DOI 10.1042/BJ20110027; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	62	13	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32077	10.1371/journal.pone.0032077	http://dx.doi.org/10.1371/journal.pone.0032077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389680	Green Published, gold			2022-12-25	WOS:000302999600018
J	Pulicherla, N; Kota, P; Dokholyan, NV; Asokan, A				Pulicherla, Nagesh; Kota, Pradeep; Dokholyan, Nikolay V.; Asokan, Aravind			Intra- and Inter-Subunit Disulfide Bond Formation Is Nonessential in Adeno-Associated Viral Capsids	PLOS ONE			English	Article							ESCHERICHIA-COLI THIOREDOXIN; SITE CYSTEINE RESIDUES; MUTATIONAL ANALYSIS; GENE-THERAPY; VIRUS; PROTEIN; IONIZATION; REACTIVITY; VECTORS; CONFORMATION	The capsid proteins of adeno-associated viruses (AAV) have five conserved cysteine residues. Structural analysis of AAV serotype 2 reveals that Cys289 and Cys361 are located adjacent to each other within each monomer, while Cys230 and Cys394 are located on opposite edges of each subunit and juxtaposed at the pentamer interface. The Cys482 residue is located at the base of a surface loop within the trimer region. Although plausible based on molecular dynamics simulations, intra- or inter-subunit disulfides have not been observed in structural studies. In the current study, we generated a panel of Cys-to-Ser mutants to interrogate the potential for disulfide bond formation in AAV capsids. The C289S, C361S and C482S mutants were similar to wild type AAV with regard to titer and transduction efficiency. However, AAV capsid protein subunits with C230S or C394S mutations were prone to proteasomal degradation within the host cells. Proteasomal inhibition partially blocked degradation of mutant capsid proteins, but failed to rescue infectious virions. While these results suggest that the Cys230/394 pair is critical, a C394V mutant was found viable, but not the corresponding C230V mutant. Although the exact nature of the structural contribution(s) of Cys230 and Cys394 residues to AAV capsid formation remains to be determined, these results support the notion that disulfide bond formation within the Cys289/361 or Cys230/394 pair appears to be nonessential. These studies represent an important step towards understanding the role of inter-subunit interactions that drive AAV capsid assembly.	[Pulicherla, Nagesh; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Kota, Pradeep; Dokholyan, Nikolay V.; Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Pulicherla, N (corresponding author), Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; Core, Vector/CAF-4832-2022	Dokholyan, Nikolay/0000-0002-8225-4025; 	National Institutes of Health (NIH) [R01HL089221-A1]; ARRA [-S2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grant R01HL089221-A1 and ARRA grant -S2 (awarded to A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright BS, 2011, J VIROL, V85, P8616, DOI 10.1128/JVI.00123-11; Bleker S, 2006, J VIROL, V80, P810, DOI 10.1128/JVI.80.2.810-820.2006; Bleker S, 2005, J VIROL, V79, P2528, DOI 10.1128/JVI.79.4.2528-2540.2005; Bowles D.E., 2006, PARVOVIRUSES, P15; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Chapman MS, 2006, PARVOVIRUSES, P107; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; DiPritmio N, 2008, J VIROL, V82, P5178, DOI 10.1128/JVI.02721-07; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; Li PP, 2005, J VIROL, V79, P3859, DOI 10.1128/JVI.79.6.3859-3864.2005; Li PP, 2000, J VIROL, V74, P11388, DOI 10.1128/JVI.74.23.11388-11393.2000; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; Perez R, 2011, J MOL BIOL, V413, P32, DOI 10.1016/j.jmb.2011.08.020; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Raso SW, 2001, J MOL BIOL, V307, P899, DOI 10.1006/jmbi.2001.4476; Reguera J, 2004, P NATL ACAD SCI USA, V101, P2724, DOI 10.1073/pnas.0307748101; Riolobos L, 2006, J MOL BIOL, V357, P1026, DOI 10.1016/j.jmb.2006.01.019; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32163	10.1371/journal.pone.0032163	http://dx.doi.org/10.1371/journal.pone.0032163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389684	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600022
J	Estrada-Bernal, A; Sanford, SD; Sosa, LJ; Simon, GC; Hansen, KC; Pfenninger, KH				Estrada-Bernal, Adriana; Sanford, Staci D.; Sosa, Lucas J.; Simon, Glenn C.; Hansen, Kirk C.; Pfenninger, Karl H.			Functional Complexity of the Axonal Growth Cone: A Proteomic Analysis	PLOS ONE			English	Article							LARGE GENE LISTS; FETAL-RAT-BRAIN; PROTEIN-SYNTHESIS; MESSENGER-RNA; TRANSLATIONAL REGULATION; LOCAL TRANSLATION; NEURONS; LOCALIZATION; REGENERATION; TRANSPORT	The growth cone, the tip of the emerging neurite, plays a crucial role in establishing the wiring of the developing nervous system. We performed an extensive proteomic analysis of axonal growth cones isolated from the brains of fetal Sprague-Dawley rats. Approximately 2000 proteins were identified at >= 99% confidence level. Using informatics, including functional annotation cluster and KEGG pathway analysis, we found great diversity of proteins involved in axonal pathfinding, cytoskeletal remodeling, vesicular traffic and carbohydrate metabolism, as expected. We also found a large and complex array of proteins involved in translation, protein folding, posttranslational processing, and proteasome/ubiquitination-dependent degradation. Immunofluorescence studies performed on hippocampal neurons in culture confirmed the presence in the axonal growth cone of proteins representative of these processes. These analyses also provide evidence for rough endoplasmic reticulum and reveal a reticular structure equipped with Golgi-like functions in the axonal growth cone. Furthermore, Western blot revealed the growth cone enrichment, relative to fetal brain homogenate, of some of the proteins involved in protein synthesis, folding and catabolism. Our study provides a resource for further research and amplifies the relatively recently developed concept that the axonal growth cone is equipped with proteins capable of performing a highly diverse range of functions.	[Estrada-Bernal, Adriana; Sanford, Staci D.; Sosa, Lucas J.; Simon, Glenn C.; Pfenninger, Karl H.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Estrada-Bernal, Adriana; Sanford, Staci D.; Sosa, Lucas J.; Simon, Glenn C.; Pfenninger, Karl H.] Univ Colorado, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr, Aurora, CO USA; [Hansen, Kirk C.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Estrada-Bernal, A (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	karl.pfenninger@ucdenver.edu		Sosa, Lucas/0000-0002-9153-7537	Molecular Discovery Core of the Colorado Intellectual and Developmental Disabilities Research Center (NIH/NICHD) [P30 HD004024]; National Institutes of Health (NIH) [R01 NS041029, NS061940, P30 CA046934, S1 ORR023015]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD004024] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041029, R01NS061940] Funding Source: NIH RePORTER	Molecular Discovery Core of the Colorado Intellectual and Developmental Disabilities Research Center (NIH/NICHD); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Molecular Discovery Core of the Colorado Intellectual and Developmental Disabilities Research Center (NIH/NICHD grant P30 HD004024), and by National Institutes of Health (NIH) grants R01 NS041029 and NS061940 (awarded to KHP), and by NIH grants P30 CA046934 and S1 ORR023015 (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassell GJ, 1998, J NEUROSCI, V18, P251; Bi J, 2006, P NATL ACAD SCI USA, V103, P19919, DOI 10.1073/pnas.0607394104; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; DUNPHY WG, 1983, J CELL BIOL, V97, P270, DOI 10.1083/jcb.97.1.270; FERREIRA A, 1987, DEV BRAIN RES, V34, P9, DOI 10.1016/0165-3806(87)90191-X; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; JONES SM, 1993, J CELL BIOL, V122, P775, DOI 10.1083/jcb.122.4.775; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Letourneau PC, 1996, PERSPECT DEV NEUROBI, V4, P111; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lohse K, 1996, DEV BRAIN RES, V96, P83, DOI 10.1016/0165-3806(96)00076-4; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; NEGREAMINOU P, 1993, J NEUROCHEM, V60, P1126, DOI 10.1111/j.1471-4159.1993.tb03263.x; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nozumi M, 2009, P NATL ACAD SCI USA, V106, P17211, DOI 10.1073/pnas.0904092106; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Perry RBT, 2009, SEMIN CELL DEV BIOL, V20, P600, DOI 10.1016/j.semcdb.2009.04.014; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; PFENNINGER KH, 1981, J CELL BIOL, V89, P536, DOI 10.1083/jcb.89.3.536; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	56	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31858	10.1371/journal.pone.0031858	http://dx.doi.org/10.1371/journal.pone.0031858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384089	Green Submitted, gold, Green Published			2022-12-25	WOS:000302918500043
J	Yu, TX; Chen, X; Zhang, W; Li, J; Xu, R; Wang, TC; Ai, W; Liu, CM				Yu, Tianxin; Chen, Xi; Zhang, Wen; Li, Juan; Xu, Ren; Wang, Timothy C.; Ai, Walden; Liu, Chunming			Kruppel-like Factor 4 Regulates Intestinal Epithelial Cell Morphology and Polarity	PLOS ONE			English	Article							COLORECTAL-CANCER; BETA-CATENIN; STEM-CELLS; CROSS-TALK; EXPRESSION; WNT; GENE; KRUPPEL-LIKE-FACTOR-4; IDENTIFICATION; COLON	Kruppel-like factor 4 (KLF4) is a zinc finger transcription factor that plays a vital role in regulating cell lineage differentiation during development and maintaining epithelial homeostasis in the intestine. In normal intestine, KLF4 is predominantly expressed in the differentiated epithelial cells. It has been identified as a tumor suppressor in colorectal cancer. KLF4 knockout mice demonstrated a decrease in number of goblet cells in the colon, and conditional ablation of KLF4 from the intestinal epithelium led to altered epithelial homeostasis. However, the role of KLF4 in differentiated intestinal cells and colon cancer cells, as well as the mechanism by which it regulates homeostasis and represses tumorigenesis in the intestine is not well understood. In our study, KLF4 was partially depleted in the differentiated intestinal epithelial cells by a tamoxifen-inducible Cre recombinase. We found a significant increase in the number of goblet cells in the KLF4-deleted small intestine, suggesting that KLF4 is not only required for goblet cell differentiation, but also required for maintaining goblet cell numbers through its function in inhibiting cell proliferation. The number and position of Paneth cells also changed. This is consistent with the KLF4 knockout study using villin-Cre [1]. Through immunohistochemistry (IHC) staining and statistical analysis, we found that a stem cell and/or tuft cell marker, DCAMKL1, and a proliferation marker, Ki67, are affected by KLF4 depletion, while an enteroendocrine cell marker, neurotensin (NT), was not affected. In addition, we found KLF4 depletion altered the morphology and polarity of the intestinal epithelial cells. Using a three-dimensional (3D) intestinal epithelial cyst formation assay, we found that KLF4 is essential for cell polarity and crypt-cyst formation in human colon cancer cells. These findings suggest that, as a tumor suppressor in colorectal cancer, KLF4 affects intestinal epithelial cell morphology by regulating proliferation, differentiation and polarity of the cells.	[Yu, Tianxin; Chen, Xi; Zhang, Wen; Xu, Ren; Liu, Chunming] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA; [Yu, Tianxin] Univ Texas Med Branch, Dept Biol & Mol Biochem, Galveston, TX USA; [Li, Juan; Ai, Walden] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Xu, Ren] Univ Kentucky, Dept Pharmacol & Toxicol, Lexington, KY USA; [Wang, Timothy C.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY USA; [Wang, Timothy C.] Columbia Univ, Irving Canc Ctr, New York, NY USA; [Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Kentucky; Columbia University; Columbia University; University of Kentucky	Yu, TX (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA.	cli229@uky.edu		Wang, Timothy/0000-0001-5730-3019; Xu, Ren/0000-0002-3591-9522	National Institutes of Health [R01 DK071976]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CL was supported by R01 DK071976 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Chen X, 2008, ACTA BIOCH BIOPH SIN, V40, P577, DOI 10.1111/j.1745-7270.2008.00440.x; Chiambaretta F, 2004, MOL VIS, V10, P901; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Fruman DA, 2002, P NATL ACAD SCI USA, V99, P359, DOI 10.1073/pnas.012605099; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2010, DEV BIOL; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Juan Li HZ, 2011, NEOPLASIA UNPUB; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Panigada M, 1999, MECH DEVELOP, V81, P103, DOI 10.1016/S0925-4773(98)00237-8; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pinto D, 2005, BIOL CELL, V97, P185; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 2000, GENE DEV, V14, P1837; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	41	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32492	10.1371/journal.pone.0032492	http://dx.doi.org/10.1371/journal.pone.0032492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384261	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916800039
J	Gomez-Pinilla, F; Ying, Z; Zhuang, YM				Gomez-Pinilla, Fernando; Ying, Zhe; Zhuang, Yumei			Brain and Spinal Cord Interaction: Protective Effects of Exercise Prior to Spinal Cord Injury	PLOS ONE			English	Article							SYNAPTIC-PLASTICITY; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; BDNF; EXPRESSION; PROTEIN; GROWTH; RATS; RECOVERY; NT-3	We have investigated the effects of a spinal cord injury on the brain and spinal cord, and whether exercise provided before the injury could organize a protective reaction across the neuroaxis. Animals were exposed to 21 days of voluntary exercise, followed by a full spinal transection (T7-T9) and sacrificed two days later. Here we show that the effects of spinal cord injury go beyond the spinal cord itself and influence the molecular substrates of synaptic plasticity and learning in the brain. The injury reduced BDNF levels in the hippocampus in conjunction with the activated forms of p-synapsin I, p-CREB and p-CaMK II, while exercise prior to injury prevented these reductions. Similar effects of the injury were observed in the lumbar enlargement region of the spinal cord, where exercise prevented the reductions in BDNF, and p-CREB. Furthermore, the response of the hippocampus to the spinal lesion appeared to be coordinated to that of the spinal cord, as evidenced by corresponding injury-related changes in BDNF levels in the brain and spinal cord. These results provide an indication for the increased vulnerability of brain centers after spinal cord injury. These findings also imply that the level of chronic activity prior to a spinal cord injury could determine the level of sensory-motor and cognitive recovery following the injury. In particular, exercise prior to the injury onset appears to foster protective mechanisms in the brain and spinal cord.	[Gomez-Pinilla, Fernando; Ying, Zhe] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Gomez-Pinilla, Fernando; Zhuang, Yumei] Univ Calif Los Angeles, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu			National Institutes of Health [R01 NS056413]; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health award R01 NS056413 and the Craig H. Neilsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Anderson CJ, 2009, DEV MED CHILD NEUROL, V51, P826, DOI 10.1111/j.1469-8749.2009.03268.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BROCK TO, 1987, J NEUROSCI, V7, P931; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fumagalli F, 2009, NEUROSCIENCE, V159, P936, DOI 10.1016/j.neuroscience.2009.01.030; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2004, J NEUROPHYSIOL, V92, P3423, DOI 10.1152/jn.00432.2004; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Lau BYB, 2011, EXP NEUROL, V228, P283, DOI 10.1016/j.expneurol.2011.02.003; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Seebach BS, 1999, J NEUROPHYSIOL, V81, P2398, DOI 10.1152/jn.1999.81.5.2398; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057	25	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32298	10.1371/journal.pone.0032298	http://dx.doi.org/10.1371/journal.pone.0032298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384207	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500092
J	Ma, LS; Narberhaus, F; Lai, EM				Ma, Lay-Sun; Narberhaus, Franz; Lai, Erh-Min			IcmF Family Protein TssM Exhibits ATPase Activity and Energizes Type VI Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; GRAM-NEGATIVE BACTERIA; II SECRETION; AGROBACTERIUM-TUMEFACIENS; AEROMONAS-HYDROPHILA; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; MEMBRANE-PROTEIN; EXEAB COMPLEX; IV SECRETION	The type VI secretion system (T6SS) with diversified functions is widely distributed in pathogenic Proteobacteria. The IcmF (intracellular multiplication protein F) family protein TssM is a conserved T6SS inner membrane protein. Despite the conservation of its Walker A nucleotide-binding motif, the NTPase activity of TssM and its role in T6SS remain obscure. In this study, we characterized TssM in the plant pathogen Agrobacterium tumefaciens and provided the first biochemical evidence for TssM exhibiting ATPase activity to power the secretion of the T6SS hallmark protein, hemolysin-coregulated protein (Hcp). Amino acid substitutions in the Walker A motif of TssM caused reduced ATP binding and hydrolysis activity. Importantly, we discovered the Walker B motif of TssM and demonstrated that it is critical for ATP hydrolysis activity. Protein-protein interaction studies and protease susceptibility assays indicated that TssM undergoes an ATP binding-induced conformational change and that subsequent ATP hydrolysis is crucial for recruiting Hcp to interact with the periplasmic domain of the TssM-interacting protein TssL (an IcmH/DotU family protein) into a ternary complex and mediating Hcp secretion. Our findings strongly argue that TssM functions as a T6SS energizer to recruit Hcp into the TssM-TssL inner membrane complex prior to Hcp secretion across the outer membrane.	[Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Mol & Biol Agr Sci Program, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 402, Taiwan; [Narberhaus, Franz] Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, D-44780 Bochum, Germany	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University; Ruhr University Bochum	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, 128,Sec 2,Acad Rd, Taipei 11529, Taiwan.	emlai@gate.sinica.edu.tw	Ma, Lay-Sun/ABH-3013-2020; Lai, Erh-Min/ABG-9558-2020	Ma, Lay-Sun/0000-0003-4349-228X; Lai, Erh-Min/0000-0003-3630-8683; Narberhaus, Franz/0000-0002-8552-5310	National Science Council [NSC 98-2311-B-001-002-MY3]; German Academic Exchange Service (DAAD); Taiwan National Science Council (PPP) [0970029248P]	National Science Council(Ministry of Science and Technology, Taiwan); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Taiwan National Science Council (PPP)	This work was supported by National Science Council Grant NSC 98-2311-B-001-002-MY3 and a joint grant from the German Academic Exchange Service (DAAD) and the Taiwan National Science Council (PPP Grant 0970029248P) (to F. N. and E.-M. L.).	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Ast VM, 2002, MOL MICROBIOL, V44, P217, DOI 10.1046/j.1365-2958.2002.02870.x; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162; Bruser T, 2007, APPL MICROBIOL BIOT, V76, P35, DOI 10.1007/s00253-007-0991-z; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; CHANG BY, 1994, J BACTERIOL, V176, P3102, DOI 10.1128/jb.176.11.3102-3110.1994; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hormaeche I, 2002, J BIOL CHEM, V277, P46456, DOI 10.1074/jbc.M207250200; Howard SP, 2006, MOL MICROBIOL, V59, P1062, DOI 10.1111/j.1365-2958.2005.05003.x; Howard SP, 1996, MOL MICROBIOL, V22, P595, DOI 10.1046/j.1365-2958.1996.d01-1713.x; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; KORONAKIS E, 1995, MOL MICROBIOL, V16, P87, DOI 10.1111/j.1365-2958.1995.tb02394.x; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Li G, 2011, J BACTERIOL, V193, P197, DOI 10.1128/JB.00882-10; Liu AC, 2008, J APPL MICROBIOL, V105, P1372, DOI 10.1111/j.1365-2672.2008.03874.x; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Possot OM, 1997, MOL MICROBIOL, V24, P457, DOI 10.1046/j.1365-2958.1997.3451726.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ratelade J, 2009, APPL ENVIRON MICROB, V75, P3803, DOI 10.1128/AEM.00255-09; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; SCHNEIDER E, 1994, J BIOL CHEM, V269, P20456; Schoenhofen IC, 2005, J BACTERIOL, V187, P6370, DOI 10.1128/JB.187.18.6370-6378.2005; Schoenhofen IC, 1998, MOL MICROBIOL, V29, P1237, DOI 10.1046/j.1365-2958.1998.01011.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; SHINKAI A, 1991, J BIOL CHEM, V266, P5827; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	76	58	58	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15610	15621		10.1074/jbc.M111.301630	http://dx.doi.org/10.1074/jbc.M111.301630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393043	Green Published, hybrid			2022-12-25	WOS:000304006300041
J	Ren, KQ; Lu, J; Porollo, A; Du, CY				Ren, Keqin; Lu, Jing; Porollo, Aleksey; Du, Chunying			Tumor-suppressing Function of Caspase-2 Requires Catalytic Site Cys-320 and Site Ser-139 in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; DNA-DAMAGE; MITOTIC CATASTROPHE; GENE-EXPRESSION; CYTOCHROME-C; HEPATOCELLULAR-CARCINOMA; B-CELLS; KAPPA-B; APOPTOSIS; CANCER	The multifunctional caspase-2 protein is involved in apoptosis, NF-kappa B regulation, and tumor suppression in mice. However, the mechanisms of caspase-2 responsible for tumor suppression remain unclear. Here we identified two sites of caspase-2, the catalytic Cys-320 site and the Ser-139 site, to be important for suppression of cellular transformation and tumorigenesis. Using SV40- and K-Ras-transformed caspase-2 KO mouse embryonic fibroblast cells reconstituted with expression of wild-type, catalytic dead (C320A), or Ser-139 (S139A) mutant caspase-2, we demonstrated that similar to caspase-2 deficiency, when Cys-320 and Ser-139 were mutated, caspase-2 lost its ability to inhibit cellular transformation and tumorigenesis. These mutant cells exhibited enhanced cell proliferation, elevated clonogenic activity, accelerated anchorage-independent growth, and transformation and were highly tumorigenic, rapidly producing large tumors in athymic nude mice. Investigation into the underlying mechanism showed that these two residues are needed for caspase-2 to suppress NF-kappa B activity, promote apoptosis, and sustain the G(2)/M checkpoint following DNA damage induction. In addition, tumors in nude mice derived from the two mutant cell lines had higher constitutive NF-kappa B activity and elevated expression of NF-kappa B targets of antiapoptotic proteins Bcl-xL, XIAP, and cIAP2. A reduction in caspase-2 mRNA was associated with multiple types of cancers in patients. Together, these observations suggest the combined functions of caspase-2 in suppressing NF-kappa B activation, promoting apoptosis, and sustaining G(2)/M checkpoint contribute to caspase-2 tumor-suppressing function and that caspase-2 may also impact tumor suppression in humans. These findings provide insight into tumor suppression at the cross-roads of apoptosis, cell cycle checkpoint, and NF-kappa B pathways.	[Du, Chunying] Univ Cincinnati, Med Ctr, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA; [Porollo, Aleksey] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Du, CY (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Dept Canc & Cell Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	ducg@ucmail.uc.edu		Porollo, Alexey/0000-0002-3202-5099	Department of Cancer and Cell Biology, University of Cincinnati College of Medicine	Department of Cancer and Cell Biology, University of Cincinnati College of Medicine	This work was supported by the startup fund of the Department of Cancer and Cell Biology, University of Cincinnati College of Medicine.	Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersen JL, 2009, EMBO J, V28, P3216, DOI 10.1038/emboj.2009.253; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guha M, 2010, ONCOGENE, V29, P1280, DOI 10.1038/onc.2009.428; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kashkar H, 2003, J EXP MED, V198, P341, DOI 10.1084/jem.20021279; Kashkar H, 2006, BLOOD, V108, P3434, DOI 10.1182/blood-2006-05-021675; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Krumschnabel G, 2009, ONCOGENE, V28, P3093, DOI 10.1038/onc.2009.173; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; KUMAR S, 1995, HUM GENET, V95, P641; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lavrik IN, 2006, BLOOD, V108, P559, DOI 10.1182/blood-2005-07-007096; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mendelsohn AR, 2002, P NATL ACAD SCI USA, V99, P6871, DOI 10.1073/pnas.072290599; Narine KAD, 2010, DNA REPAIR, V9, P161, DOI 10.1016/j.dnarep.2009.11.010; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Oliver TG, 2011, MOL CELL, V43, P57, DOI 10.1016/j.molcel.2011.06.012; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Tang J, 2005, CANCER BIOL THER, V4, P645, DOI 10.4161/cbt.4.6.1729; Tinel A, 2011, CELL DEATH DIFFER, V18, P506, DOI 10.1038/cdd.2010.124; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tyagi A, 2006, CARCINOGENESIS, V27, P2269, DOI 10.1093/carcin/bgl098; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Vega MI, 2005, J IMMUNOL, V175, P2174, DOI 10.4049/jimmunol.175.4.2174; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	59	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14792	14802		10.1074/jbc.M112.347625	http://dx.doi.org/10.1074/jbc.M112.347625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396545	Green Published, hybrid			2022-12-25	WOS:000304003200044
J	Hu, D; Zhou, Z; Davidson, NE; Huang, Y; Wan, Y				Hu, Dong; Zhou, Zhuan; Davidson, Nancy E.; Huang, Yi; Wan, Yong			Novel Insight into KLF4 Proteolytic Regulation in Estrogen Receptor Signaling and Breast Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; INDUCED DNA-DAMAGE; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; CANCER CELLS; GROWTH-INHIBITION; PROMOTER ACTIVITY; FACTOR EXPRESSION; DOWN-REGULATION; STEM-CELLS	Kruppel-like factor 4 (KLF4), a zinc finger-containing transcriptional factor, is a pivotal regulator of cellular fate. KLF4 has attracted considerable attention for its opposing effect in carcinogenesis as tumor suppressor (e. g. colorectal cancer) or oncoprotein (e. g. breast cancer), depending on tissue context, with the underlying mechanism remaining largely unknown. Here we report that KLF4 mediates estrogen signaling in breast cancer formation. Accumulation of KLF4 by inhibiting its turnover triggers estrogen-induced transactivation. We identified Von Hippel-Lindau, pVHL, as the protein that governs KLF4 turnover in breast cancer cells and demonstrated that estrogen-induced down-regulation of pVHL facilitates accumulation of KLF4. We provide mechanistic insights into KLF4 steady-state degradation as well as its elevation in the presence of estrogen and show that elevated levels of pVHL or depletion of KLF4 attenuates the estrogen-induced transactivation and cell growth. Finally, immunohistochemical staining revealed reduced concentration of pVHL and accumulation of KLF4 in breast cancer tissues. We thus propose that suppression of pVHL in response to estrogen signaling results in elevation of KLF4, which mediates estrogen-induced mitogenic effect.	[Wan, Yong] Univ Pittsburgh, Inst Canc, Sch Med, Dept Cell Biol,Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Hu, Dong; Zhou, Zhuan; Wan, Yong] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Davidson, Nancy E.; Huang, Yi] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wan, Y (corresponding author), Univ Pittsburgh, Inst Canc, Sch Med, Dept Cell Biol,Hillman Canc Ctr, Suite 2-6C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yow4@pitt.edu	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X	National Institutes of Health [CA115943]; Pittsburgh Woman Cancer Fund; NATIONAL CANCER INSTITUTE [R01CA115943, R01CA154695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Woman Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115943. This work was also supported by the Pittsburgh Woman Cancer Fund.	Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brown RJ, 2006, SEMIN ONCOL, V33, P657, DOI 10.1053/j.seminoncol.2006.08.014; Chen C.J., 2011, PATHOL ONCO IN PRESS; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chu PY, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-58; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Fujita T, 2008, CLIN CANCER RES, V14, P1966, DOI 10.1158/1078-0432.CCR-07-1585; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Gluck S., 2011, BREAST CANC IN PRESS; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hu D, 2011, J BIOL CHEM, V286, P6890, DOI 10.1074/jbc.M110.179952; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Seagroves TN, 2010, AM J PATHOL, V176, P2269, DOI 10.2353/ajpath.2010.090310; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Sourvinos G, 2001, TUMOR BIOL, V22, P131, DOI 10.1159/000050607; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345; Zia MK, 2007, INT J MOL MED, V20, P605	64	25	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13584	13597		10.1074/jbc.M112.343566	http://dx.doi.org/10.1074/jbc.M112.343566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389506	Green Published, hybrid			2022-12-25	WOS:000303996300015
J	Konishi, A; Arakawa, S; Yue, ZY; Shimizu, S				Konishi, Akimitsu; Arakawa, Satoko; Yue, Zhenyu; Shimizu, Shigeomi			Involvement of Beclin 1 in Engulfment of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; CAENORHABDITIS-ELEGANS; EMBRYONIC-DEVELOPMENT; PHAGOSOME MATURATION; DEAD CELLS; CLEARANCE; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; AUTOPHAGY; IDENTIFICATION	Efficient apoptotic cell engulfment is important for both tissue homeostasis and immune response in mammals. In the present study, we report that Beclin 1 (a regulator of autophagy) is required for apoptotic cell engulfment. The engulfment process was largely abolished in Beclin 1 knock-out cells, and Beclin 1 knockdown significantly decreased apoptotic cell internalization in macrophage and fibroblast cell lines. Beclin 1 was recruited to the early phagocytic cup along with the generation of phosphatidylinositol 3-phosphate and Rac1, which regulates actin dynamics in lamellipodia. No lamellipodia were formed in Beclin 1 knock-out cells, and Beclin 1 knockdown completely inhibited the promotion of engulfment by ectopic expression of Rac1. Beclin 1 was co-immunoprecipitated with Rac1. These data indicate that Beclin 1 coordinates actin dynamics and membrane phospholipid synthesis to promote efficient apoptotic cell engulfment.	[Konishi, Akimitsu] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Dept Pathol Cell Biol,Bunkyo Ku, Tokyo 1138510, Japan; [Yue, Zhenyu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurol & Neurosci, New York, NY 10029 USA	Tokyo Medical & Dental University (TMDU); Icahn School of Medicine at Mount Sinai	Konishi, A (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Dept Pathol Cell Biol,Bunkyo Ku, Tokyo 1138510, Japan.	konishi.mtt@mri.tmd.ac.jp; shimizu.pcb@mri.tmd.ac.jp	Arakawa, Satoko/AAM-9638-2020; Konishi, Akimitsu/J-4024-2019	Arakawa, Satoko/0000-0002-4375-1643; Konishi, Akimitsu/0000-0002-3291-0821	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; Takeda Science Foundation; Uehara Memorial Foundation; Sumitomo Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [22570180, 22019011, 23657084, 22770054] Funding Source: KAKEN	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Grant-in-Aid for Scientific Research (S), a Grant-in-Aid for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant for the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation. This work was also supported by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Sumitomo Foundation, and the Naito Foundation.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	29	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13919	13929		10.1074/jbc.M112.348375	http://dx.doi.org/10.1074/jbc.M112.348375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393062	Green Published, hybrid			2022-12-25	WOS:000303996300047
J	Phuan, PW; Ratelade, J; Rossi, A; Tradtrantip, L; Verkman, AS				Phuan, Puay-Wah; Ratelade, Julien; Rossi, Andrea; Tradtrantip, Lukmanee; Verkman, A. S.			Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; WATER CHANNEL; MULTIPLE-SCLEROSIS; 1ST COMPONENT; RAT-BRAIN; BINDING; IGG; ANTIBODIES; CELLS; ACTIVATION	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system in which binding of pathogenic autoantibodies (NMO-IgG) to astrocyte aquaporin-4 (AQP4) causes complement-dependent cytotoxicity (CDC) and inflammation. We previously reported a wide range of binding affinities of NMO-IgGs to AQP4 in separate tetramers versus intramembrane aggregates (orthogonal arrays of particles, OAPs). We report here a second, independent mechanism by which CDC is affected by AQP4 assembly. Utilizing lactate dehydrogenase release and live/dead cell cytotoxicity assays, we found in different cell lines, and with different monoclonal and patient-derived NMO-IgGs, that CDC was greatly (>100-fold) reduced in cells expressing M1-versus M23-AQP4. Studies using a M23-AQP4 mutant containing an OAP-disrupting mutation, and in cells expressing AQP4 in different M1/M23 ratios, indicated that NMO-IgG-dependent CDC requires AQP4OAP assembly. In contrast, antibody-dependent cell-mediated cytotoxicity produced by natural killer cells did not depend on AQP4 OAP assembly. Measurements of C1q binding and complement attack complex (C9neo) supported the conclusion that the greatly enhanced CDC by OAPs is due to efficient, multivalent binding of C1q to clustered NMO-IgG on OAPs. We conclude that AQP4 assembly in OAPs is required for CDC in NMO, establishing a new mechanism of OAP-dependent NMO pathogenesis. Disruption of AQP4 OAPs may greatly reduce NMO-IgG dependent CDC and NMO pathology.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu		Ratelade, Julien/0000-0001-7968-5409; Rossi, Andrea/0000-0001-5863-6448	National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, RC1DK086125, R37DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.) This work was also supported by a grant from the Guthy-Jackson Charitable Foundation.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2011, J NEUROIMMUNOL, V236, P93, DOI 10.1016/j.jneuroim.2011.05.001; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Eggleton P, 1998, TRENDS CELL BIOL, V8, P428, DOI 10.1016/S0962-8924(98)01373-7; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gomez AM, 2010, AUTOIMMUNITY, V43, P353, DOI 10.3109/08916930903555943; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; HUGHESJONES NC, 1977, IMMUNOLOGY, V32, P191; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Jin BJ, 2011, BIOPHYS J, V100, P2936, DOI 10.1016/j.bpj.2011.05.012; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; LANDIS DMD, 1974, J CELL BIOL, V60, P316, DOI 10.1083/jcb.60.1.316; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Miyamoto K, 2009, THER APHER DIAL, V13, P505, DOI 10.1111/j.1744-9987.2009.00780.x; Nielsen S, 1997, J NEUROSCI, V17, P171; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ratelade J, 2011, J BIOL CHEM, V286, P45156, DOI 10.1074/jbc.M111.297275; REID KBM, 1983, BIOCHEM SOC T, V11, P1; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; SCHUMAKER VN, 1976, BIOCHEMISTRY-US, V15, P5175, DOI 10.1021/bi00668a035; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Skerka C, 2010, SEMIN THROMB HEMOST, V36, P625, DOI 10.1055/s-0030-1262884; SLEDGE CR, 1973, J BIOL CHEM, V248, P2818; Tajima M, 2010, J BIOL CHEM, V285, P8163, DOI 10.1074/jbc.M109.093948; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wilde B, 2011, KIDNEY INT, V79, P599, DOI 10.1038/ki.2010.472; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; WOLBURG H, 1995, J BRAIN RES, V36, P239; Yang BX, 1996, J BIOL CHEM, V271, P4577	53	101	115	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13829	13839		10.1074/jbc.M112.344325	http://dx.doi.org/10.1074/jbc.M112.344325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393049	Green Published, hybrid			2022-12-25	WOS:000303996300038
J	Stabler, RA; Dawson, LF; Valiente, E; Cairns, MD; Martin, MJ; Donahue, EH; Riley, TV; Songer, JG; Kuijper, EJ; Dingle, KE; Wren, BW				Stabler, Richard A.; Dawson, Lisa F.; Valiente, Esmeralda; Cairns, Michelle D.; Martin, Melissa J.; Donahue, Elizabeth H.; Riley, Thomas V.; Songer, J. Glenn; Kuijper, Ed J.; Dingle, Kate E.; Wren, Brendan W.			Macro and Micro Diversity of Clostridium difficile Isolates from Diverse Sources and Geographical Locations	PLOS ONE			English	Article							INTERGENIC SPACER REGION; B-POSITIVE STRAINS; PSEUDOMEMBRANOUS COLITIS; PHYLOGENETIC TREES; PCR RIBOTYPES; EMERGENCE; RESISTANT; INFECTION; FOOD; TOXINOTYPES	Clostridium difficile has emerged rapidly as the leading cause of antibiotic-associated diarrheal disease, with the temporal and geographical appearance of dominant PCR ribotypes such as 017, 027 and 078. Despite this continued threat, we have a poor understanding of how or why particular variants emerge and the sources of strains that dominate different human populations. We have undertaken a breadth genotyping study using multilocus sequence typing (MLST) analysis of 385 C. difficile strains from diverse sources by host (human, animal and food), geographical locations (North America, Europe and Australia) and PCR ribotypes. Results identified 18 novel sequence types (STs) and 3 new allele sequences and confirmed the presence of five distinct clonal lineages generally associated with outbreaks of C. difficile infection in humans. Strains of animal and food origin were found of both ST-1 and ST-11 that are frequently associated with human disease. An in depth MLST analysis of the evolutionary distant ST-11/PCR ribotype 078 clonal lineage revealed that ST-11 can be found in alternative but closely related PCR ribotypes and PCR ribotype 078 alleles contain mutations generating novel STs. PCR ribotype 027 and 017 lineages may consist of two divergent subclades. Furthermore evidence of microdiversity was present within the heterogeneous clade 1. This study helps to define the evolutionary origin of dominant C. difficile lineages and demonstrates that C. difficile is continuing to evolve in concert with human activity.	[Stabler, Richard A.; Dawson, Lisa F.; Valiente, Esmeralda; Cairns, Michelle D.; Martin, Melissa J.; Donahue, Elizabeth H.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Cairns, Michelle D.] Royal London Hosp, Div Infect, Hlth Protect Agcy, Publ Hlth Lab London, London E1 1BB, England; [Cairns, Michelle D.] UCL, UCL Ctr Clin Microbiol, London, England; [Riley, Thomas V.] Univ Western Australia, Perth, WA 6009, Australia; [Songer, J. Glenn] Iowa State Univ, Coll Vet Med, Ames, IA USA; [Kuijper, Ed J.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands; [Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept, Clin Sci Lab, Oxford OX3 9DU, England	University of London; London School of Hygiene & Tropical Medicine; Barts Health NHS Trust; Royal London Hospital; Health Protection Agency; Public Health England; University of London; University College London; University of Western Australia; Iowa State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford	Stabler, RA (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	Brendan.Wren@lshtm.ac.uk	Kuijper, ed/AAB-7853-2022; Martin, Melissa/GYV-4162-2022	Kuijper, ed/0000-0001-5726-2405; Martin, Melissa Janet/0000-0002-8772-9392; Stabler, Richard/0000-0002-2402-6630; Dingle, Kate/0000-0002-2303-5957	Wellcome Trust [086418/Z/]; National Institute for Health Research; Marie Curie Intra-European fellowship [PIEF-GA-2009-252207-CDI]; NIHR Biomedical Research Centre, Oxford, United Kingdom; CSO; Engineering and Physical Sciences Research Council [EP/E500412/1] Funding Source: researchfish; Medical Research Council [G0300020] Funding Source: researchfish; National Institute for Health Research [HCS/D10/020] Funding Source: researchfish; MRC [G0300020] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Marie Curie Intra-European fellowship(European Commission); NIHR Biomedical Research Centre, Oxford, United Kingdom(National Institute for Health Research (NIHR)); CSO; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust grant number 086418/Z/. MC is funded by a Doctoral Research Fellowship award from the National Institute for Health Research. EV was supported by a Marie Curie Intra-European fellowship for career development (PIEF-GA-2009-252207-CDI). KD was supported by the NIHR Biomedical Research Centre, Oxford, United Kingdom. This report is independent research arising from a CSO Healthcare Scientist Award supported by the National Institute for Health Research and the CSO. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSaif N, 1996, J MED MICROBIOL, V45, P133, DOI 10.1099/00222615-45-2-133; Bakri MM, 2009, EMERG INFECT DIS, V15, P817, DOI 10.3201/eid1505.081186; BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Burns K, 2010, J HOSP INFECT, V75, P287, DOI 10.1016/j.jhin.2010.03.025; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Drudy D, 2007, INFECT CONT HOSP EP, V28, P932, DOI 10.1086/519181; Elliott B, 2011, J MED MICROBIOL, V60, P1108, DOI 10.1099/jmm.0.031062-0; Elliott B, 2009, ANAEROBE, V15, P249, DOI 10.1016/j.anaerobe.2009.08.006; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Health Protection Agency, 2011, CLOSTR DIFF RIB NETW; Hensgens MP, 2009, EURO SURVEILL, V14; Huang H, 2009, CLIN MICROBIOL INFEC, V15, P1170, DOI 10.1111/j.1469-0691.2009.02992.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Indra A, 2010, J MED MICROBIOL, V59, P1317, DOI 10.1099/jmm.0.020792-0; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Kim H, 2010, KOREAN J LAB MED, V30, P491, DOI 10.3343/kjlm.2010.30.5.491; Knetsch CW, 2011, MICROBIOLOGY; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper EJ, 2001, EUR J CLIN MICROBIOL, V20, P528, DOI 10.1007/s100960100550; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Metcalf DS, 2010, LETT APPL MICROBIOL, V51, P600, DOI 10.1111/j.1472-765X.2010.02933.x; Nyc O, 2011, LANCET, V377, P1407, DOI 10.1016/S0140-6736(11)60575-8; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Solomon K, 2011, J MED MICROBIOL, V60, P1080, DOI 10.1099/jmm.0.029983-0; Songer J. Glenn, 2004, Animal Health Research Reviews, V5, P321, DOI 10.1079/AHR200492; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Tenover FC, 2011, J CLIN MICROBIOL, V49, P1831, DOI 10.1128/JCM.02446-10; Valiente E, 2011, J MED MICROBIOL; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; von Eichel-Streiber C, 1999, FEMS MICROBIOL LETT, V178, P163, DOI 10.1016/S0378-1097(99)00327-4; Weese JS, 2010, CLIN MICROBIOL INFEC, V16, P3, DOI 10.1111/j.1469-0691.2009.03108.x	50	102	103	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e31559	10.1371/journal.pone.0031559	http://dx.doi.org/10.1371/journal.pone.0031559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396735	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000303006500006
J	Carrascal, LM; Santos, T; Telleria, JL				Carrascal, Luis M.; Santos, Tomas; Telleria, Jose L.			Does Day Length Affect Winter Bird Distribution? Testing the Role of an Elusive Variable	PLOS ONE			English	Article							FORAGING ACTIVITY CONTRIBUTES; BLACKBIRDS TURDUS-MERULA; GREAT TIT; PREDATION RISK; FATTENING STRATEGIES; FOREST FRAGMENTATION; TEMPERATURE; ABUNDANCE; FOOD; THERMOREGULATION	Differences in day length may act as a critical factor in bird biology by introducing time constraints in energy acquisition during winter. Thus, differences in day length might operate as a main determinant of bird abundance along latitudinal gradients. This work examines the influence of day length on the abundance of wintering crested tits (Lophophanes cristatus) in 26 localities of Spanish juniper (Juniperus thurifera) dwarf woodlands (average height of 5 m) located along a latitudinal gradient in the Spanish highlands, while controlling for the influence of food availability, minimum night temperature, habitat structure and landscape characteristics. Top regression models in the AIC framework explained 56% of variance in bird numbers. All models incorporated day length as the variable with the highest magnitude effect. Food availability also played an important role, although only the crop of ripe juniper fruits, but not arthropods, positively affected crested tit abundance. Differences in vegetation structure across localities had also a strong positive effect (average tree height and juniper tree density). Geographical variation in night temperature had no influence on crested tit distribution, despite the low winter temperatures reached in these dwarf forests. This paper demonstrates for the first time that winter bird abundance increases with day length after controlling for the effect of other environmental variables. Winter average difference in day length was only 10.5 minutes per day along the 1 degrees 47' latitudinal interval (190 km) included in this study. This amount of time, which reaches 13.5 h accumulated throughout the winter season, appears to be large enough to affect the long-term energy budget of small passerines during winter and to shape the distribution of winter bird abundance under restrictive environmental conditions.	[Carrascal, Luis M.] CSIC, MNCN, Dept Biodiversidad & Biol Evolut, Madrid, Spain; [Santos, Tomas; Telleria, Jose L.] Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Complutense University of Madrid	Carrascal, LM (corresponding author), CSIC, MNCN, Dept Biodiversidad & Biol Evolut, Madrid, Spain.	lmcarrascal@mncn.csic.es	Carrascal, Luis M./B-8381-2008; Carrascal, Luis M./Q-2190-2016; Santos, Tomás/AAA-5412-2019; Tellería, José Luis/K-2944-2013; Tellería, José Luis/AAQ-3702-2020	Carrascal, Luis M./0000-0003-1288-5531; Carrascal, Luis M./0000-0003-1288-5531; Tellería, José Luis/0000-0001-6170-8860; Tellería, José Luis/0000-0001-6170-8860	Spanish Ministry of Educacion y Ciencia [CGL2008-02211/BOS]	Spanish Ministry of Educacion y Ciencia(Spanish Government)	This paper was funded by project CGL2008-02211/BOS of the Spanish Ministry of Educacion y Ciencia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco E., 1997, BOSQUES IBERICOS UNA; Blem C.R., 1990, Current Ornithology, V7, P59; Broggi J, 2004, J ANIM ECOL, V73, P967, DOI 10.1111/j.0021-8790.2004.00872.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calder W.A., 1974, AVIAN BIOL, V4, P259; Carrascal L.M., 1985, Ardeola, V32, P95; CARRASCAL LM, 1987, HOLARCTIC ECOL, V10, P185; Ceballos L., 1979, ARBOLES ARBUSTOS ESP; Cooper R.J., 1990, Studies in Avian Biology, P29; Cooper SJ, 2007, CONDOR, V109, P446, DOI 10.1650/0010-5422(2007)109[446:HPFFAC]2.0.CO;2; Cope DR, 2003, J ZOOL, V260, P65, DOI 10.1017/S0952836903003509; Crampton LH, 2011, OIKOS, V120, P65, DOI 10.1111/j.1600-0706.2010.18624.x; Cresswell W, 2009, P R SOC B, V276, P3553, DOI 10.1098/rspb.2009.1000; Cresswell W, 1998, J ANIM ECOL, V67, P78, DOI 10.1046/j.1365-2656.1998.00174.x; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P372, DOI 10.1111/j.1466-822x.2006.00228.x; FRETWELL S D, 1972, P217; Gibb J., 1954, Ibis, V96, P513, DOI 10.1111/j.1474-919X.1954.tb05476.x; Gosler AG, 2002, J ANIM ECOL, V71, P771, DOI 10.1046/j.1365-2656.2002.00642.x; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; GRUBB TC, 1991, WILSON BULL, V103, P435; Guitian J, 2008, OIKOS, V117, P265, DOI 10.1111/j.2007.0030-1299.16316.x; Herrando S, 2011, CATALAN WINTER BIRD; HERRERA CM, 1987, ECOL MONOGR, V57, P305, DOI 10.2307/2937089; JARVINEN O, 1975, OIKOS, V26, P316, DOI 10.2307/3543502; Krams I, 2010, FUNCT ECOL, V24, P172, DOI 10.1111/j.1365-2435.2009.01628.x; Kwit C, 2004, OECOLOGIA, V139, P30, DOI 10.1007/s00442-003-1470-6; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Llorente R, 2006, ACT 3 C INT SAB EN G; Macleod R, 2005, J ANIM ECOL, V74, P956, DOI 10.1111/j.1365-2656.2005.00993.x; Macleod R, 2005, J ANIM ECOL, V74, P292, DOI 10.1111/j.1365-2656.2005.00923.x; MANZUR MI, 1984, OIKOS, V43, P265, DOI 10.2307/3544142; MCNAMARA JM, 1994, J AVIAN BIOL, V25, P287, DOI 10.2307/3677276; Meehan TD, 2004, ECOL LETT, V7, P532, DOI 10.1111/j.1461-0248.2004.00611.x; NEWTON I, 1980, ARDEA, V68, P11; Newton I., 1998, POPULATION LIMITATIO; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Perrins, 1998, COMPLETE BIRDS W PAL; Polo V, 2007, J ANIM ECOL, V76, P866, DOI 10.1111/j.1365-2656.2007.01270.x; Pravosudov VV, 1997, BEHAV ECOL, V8, P332, DOI 10.1093/beheco/8.3.332; REPASKY RR, 1991, ECOLOGY, V72, P2274, DOI 10.2307/1941577; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Ruiz de la Torre J., 1990, MAPA FORESTAL ESPANA; SANTOS T, 1994, BIOL CONSERV, V70, P129, DOI 10.1016/0006-3207(94)90280-1; Santos T., 1983, P79; Stapanian MA, 1999, WILSON BULL, V111, P550; Telleria J.L., 1999, AVES IBERICAS, VII; TELLERIA JL, 1995, BIOL CONSERV, V71, P61, DOI 10.1016/0006-3207(94)00021-H; Telleria JL, 2008, ECOGRAPHY, V31, P381, DOI 10.1111/j.0906-7590.2008.05283.x; Turcotte Y, 2005, ECOGRAPHY, V28, P129, DOI 10.1111/j.0906-7590.2005.04047.x; WEBSTER MD, 1990, PHYSIOL ZOOL, V63, P777, DOI 10.1086/physzool.63.4.30158176; Yamaura Y, 2005, FOREST ECOL MANAG, V216, P187, DOI 10.1016/j.foreco.2005.05.028	53	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32733	10.1371/journal.pone.0032733	http://dx.doi.org/10.1371/journal.pone.0032733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393442	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500095
J	Chuquimia, OD; Petursdottir, DH; Rahman, MJ; Hartl, K; Singh, M; Fernandez, C				Chuquimia, Olga D.; Petursdottir, Dagbjort H.; Rahman, Muhammad J.; Hartl, Katharina; Singh, Mahavir; Fernandez, Carmen			The Role of Alveolar Epithelial Cells in Initiating and Shaping Pulmonary Immune Responses: Communication between Innate and Adaptive Immune Systems	PLOS ONE			English	Article							MACROPHAGE-INFLAMMATORY PROTEIN-2; MYCOBACTERIUM-TUBERCULOSIS; PRIMARY CULTURE; II CELLS; ANTIGEN; EXPRESSION; KC; MATRIX-METALLOPROTEINASE-9; CHEMOKINES; TOLERANCE	Macrophages and dendritic cells have been recognized as key players in the defense against mycobacterial infection. However, more recently, other cells in the lungs such as alveolar epithelial cells (AEC) have been found to play important roles in the defense and pathogenesis of infection. In the present study we first compared AEC with pulmonary macrophages (PuM) isolated from mice in their ability to internalize and control Bacillus Calmette-Guerin (BCG) growth and their capacity as APCs. AEC were able to internalize and control bacterial growth as well as present antigen to primed T cells. Secondly, we compared both cell types in their capacity to secrete cytokines and chemokines upon stimulation with various molecules including mycobacterial products. Activated PuM and AEC displayed different patterns of secretion. Finally, we analyzed the profile of response of AEC to diverse stimuli. AEC responded to both microbial and internal stimuli exemplified by TLR ligands and IFNs, respectively. The response included synthesis by AEC of several factors, known to have various effects in other cells. Interestingly, TNF could stimulate the production of CCL2/MCP-1. Since MCP-1 plays a role in the recruitment of monocytes and macrophages to sites of infection and macrophages are the main producers of TNF, we speculate that both cell types can stimulate each other. Also, another cell-cell interaction was suggested when IFNs (produced mainly by lymphocytes) were able to induce expression of chemokines (IP-10 and RANTES) by AEC involved in the recruitment of circulating lymphocytes to areas of injury, inflammation, or viral infection. In the current paper we confirm previous data on the capacity of AEC regarding internalization of mycobacteria and their role as APC, and extend the knowledge of AEC as a multifunctional cell type by assessing the secretion of a broad array of factors in response to several different types of stimuli.	[Chuquimia, Olga D.; Petursdottir, Dagbjort H.; Rahman, Muhammad J.; Hartl, Katharina; Fernandez, Carmen] Stockholm Univ, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Singh, Mahavir] Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany	Stockholm University; Lionex Diagnostics & Therapeutics GmbH	Chuquimia, OD (corresponding author), Stockholm Univ, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	olga.flores@imun.su.se			European Commission [HEALTH-F3-2008-200732]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grant FP7 (HEALTH-F3-2008-200732) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Bousquet J., 2007, GLOBAL SURVEILLANCE, P146; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Corbiere V, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-15; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; deMello DE, 2000, IN VITRO CELL DEV-AN, V36, P374; Dobbs LG, 2010, CELL PHYSIOL BIOCHEM, V25, P55, DOI 10.1159/000272063; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; FREVERT CW, 1995, J IMMUNOL, V154, P335; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; HUANG S, 1992, AM J PATHOL, V141, P981; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Li Q, 2003, INFECT IMMUN, V71, P4873, DOI 10.1128/IAI.71.9.4873-4882.2003; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Power CA, 1998, INFECT IMMUN, V66, P5743, DOI 10.1128/IAI.66.12.5743-5750.1998; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Shibata T, 2006, J LEUKOCYTE BIOL, V80, P744, DOI 10.1189/jlb.0106012; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Thorley AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021827; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931	40	60	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32125	10.1371/journal.pone.0032125	http://dx.doi.org/10.1371/journal.pone.0032125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393384	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500037
J	Clark, JS; Soltoff, BD; Powell, AS; Read, QD				Clark, James S.; Soltoff, Benjamin D.; Powell, Amanda S.; Read, Quentin D.			Evidence from Individual Inference for High-Dimensional Coexistence: Long-Term Experiments on Recruitment Response	PLOS ONE			English	Article							CLIMATE-CHANGE VULNERABILITY; CANOPY GAPS; GROWTH-RESPONSES; FOREST RESPONSE; LIGHT GRADIENT; NEW-ENGLAND; TREE; COMPETITION; BIODIVERSITY; PERFORMANCE	Background: For competing species to coexist, individuals must compete more with others of the same species than with those of other species. Ecologists search for tradeoffs in how species might partition the environment. The negative correlations among competing species that would be indicative of tradeoffs are rarely observed. A recent analysis showed that evidence for partitioning the environment is available when responses are disaggregated to the individual scale, in terms of the covariance structure of responses to environmental variation. That study did not relate that variation to the variables to which individuals were responding. To understand how this pattern of variation is related to niche variables, we analyzed responses to canopy gaps, long viewed as a key variable responsible for species coexistence. Methodology/Principal Findings: A longitudinal intervention analysis of individual responses to experimental canopy gaps with 12 yr of pre-treatment and 8 yr post-treatment responses showed that species-level responses are positively correlated - species that grow fast on average in the understory also grow fast on average in response to gap formation. In other words, there is no tradeoff. However, the joint distribution of individual responses to understory and gap showed a negative correlation - species having individuals that respond most to gaps when previously growing slowly also have individuals that respond least to gaps when previously growing rapidly (e.g., Morus rubra), and vice versa (e.g., Quercus prinus). Conclusions/Significance: Because competition occurs at the individual scale, not the species scale, aggregated species-level parameters and correlations hide the species-level differences needed for coexistence. By disaggregating models to the scale at which the interaction occurs we show that individual variation provides insight for species differences.	[Clark, James S.; Soltoff, Benjamin D.; Powell, Amanda S.; Read, Quentin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Clark, James S.] Duke Univ, Dept Biol, Durham, NC USA; [Clark, James S.] Duke Univ, Dept Stat Sci, Durham, NC USA	Duke University; Duke University; Duke University	Clark, JS (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	jimclark@duke.edu			National Science Foundation [DDDAS0540347, SEII0430693, DEB0425465]; Direct For Biological Sciences [0955904, 1137309, 1137364] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [0940671] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was funded by National Science Foundation grants DDDAS0540347, SEII0430693, DEB0425465, and the Coweeta LTER, which supported field work and analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2010, ECOL LETT, V13, P1019, DOI 10.1111/j.1461-0248.2010.01496.x; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Ashton MS, 1996, FOREST ECOL MANAG, V80, P81, DOI 10.1016/0378-1127(95)03636-9; Baltzer JL, 2007, J ECOL, V95, P1208, DOI 10.1111/j.1365-2745.2007.01286.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Beckage B, 2000, CAN J FOREST RES, V30, P1617, DOI 10.1139/cjfr-30-10-1617; BICKEL PJ, 1975, SCIENCE, V187, P398, DOI 10.1126/science.187.4175.398; Chase J.M., 2009, ECOLOGICAL NICHES LI; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1; Clark JS, 2012, PHILOS T R SOC B, V367, P236, DOI 10.1098/rstb.2011.0183; Clark JS, 2011, ECOL LETT, V14, P1273, DOI 10.1111/j.1461-0248.2011.01685.x; Clark JS, 2011, GLOBAL CHANGE BIOL, V17, P1834, DOI 10.1111/j.1365-2486.2010.02380.x; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Cooper-Ellis S, 1999, ECOLOGY, V80, P2683, DOI 10.1890/0012-9658(1999)080[2683:FRTCWR]2.0.CO;2; Dalling JW, 2004, FUNCT ECOL, V18, P725, DOI 10.1111/j.0269-8463.2004.00868.x; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Freedman D. A., 1998, J AM STAT ASSOC, V93, P1518, DOI DOI 10.2307/2670067; Hart JL, 2009, PLANT ECOL, V201, P131, DOI 10.1007/s11258-008-9488-9; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; King G., 1997, SOLUTION ECOLOGICAL; Kinzig AP, 1999, AM NAT, V153, P371, DOI 10.1086/303182; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; LATHAM RE, 1992, ECOLOGY, V73, P2129, DOI 10.2307/1941461; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Palow DT, 2009, PLANT SOIL, V319, P25, DOI 10.1007/s11104-008-9846-3; Pedersen BS, 2004, FOREST ECOL MANAG, V196, P351, DOI 10.1016/j.foreco.2004.03.031; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Portsmuth A, 2007, FUNCT ECOL, V21, P61, DOI 10.1111/j.1365-2435.2006.01208.x; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; SIPE TW, 1995, ECOLOGY, V76, P1587, DOI 10.2307/1938160; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Wakefield J., 2005, BIOSTATISTICS, V1, P1; Wilder CM, 1999, AM MIDL NAT, V142, P201, DOI 10.1674/0003-0031(1999)142[0201:SSDAGI]2.0.CO;2; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114	44	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30050	10.1371/journal.pone.0030050	http://dx.doi.org/10.1371/journal.pone.0030050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393349	Green Published, gold			2022-12-25	WOS:000303003500002
J	Hoekstra, AY; Mekonnen, MM; Chapagain, AK; Mathews, RE; Richter, BD				Hoekstra, Arjen Y.; Mekonnen, Mesfin M.; Chapagain, Ashok K.; Mathews, Ruth E.; Richter, Brian D.			Global Monthly Water Scarcity: Blue Water Footprints versus Blue Water Availability	PLOS ONE			English	Article							RESOURCES; GREEN; MODEL	Freshwater scarcity is a growing concern, placing considerable importance on the accuracy of indicators used to characterize and map water scarcity worldwide. We improve upon past efforts by using estimates of blue water footprints (consumptive use of ground- and surface water flows) rather than water withdrawals, accounting for the flows needed to sustain critical ecological functions and by considering monthly rather than annual values. We analyzed 405 river basins for the period 1996-2005. In 201 basins with 2.67 billion inhabitants there was severe water scarcity during at least one month of the year. The ecological and economic consequences of increasing degrees of water scarcity - as evidenced by the Rio Grande (Rio Bravo), Indus, and Murray-Darling River Basins - can include complete desiccation during dry seasons, decimation of aquatic biodiversity, and substantial economic disruption.	[Hoekstra, Arjen Y.; Mekonnen, Mesfin M.] Univ Twente, Dept Water Engn & Management, NL-7500 AE Enschede, Netherlands; [Hoekstra, Arjen Y.; Mathews, Ruth E.] Water Footprint Network, Enschede, Netherlands; [Chapagain, Ashok K.] World Wide Fund United Kingdom, Godalming, Surrey, England; [Richter, Brian D.] Nature Conservancy, Charlottesville, VA USA	University of Twente; Nature Conservancy	Hoekstra, AY (corresponding author), Univ Twente, Dept Water Engn & Management, POB 217, NL-7500 AE Enschede, Netherlands.	a.y.hoekstra@utwente.nl	Hoekstra, Arjen Y./B-4980-2008; Chapagain, Ashok/AAE-7998-2019; Mekonnen, Mesfin/H-7585-2019	Hoekstra, Arjen Y./0000-0002-4769-5239; Mekonnen, Mesfin/0000-0002-3573-9759				Alcamo J, 2002, AQUAT SCI, V64, P352, DOI 10.1007/PL00012591; [Anonymous], 2005, EC HUM WELL BEING WE; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Comprehensive Assessment of Water Management in Agriculture, 2007, WAT FOOD WAT LIFE CO; CONTRERAS S, 1994, CONSERV BIOL, V8, P379, DOI 10.1046/j.1523-1739.1994.08020379.x; Fader M, 2011, HYDROL EARTH SYST SC, V15, P1641, DOI 10.5194/hess-15-1641-2011; FALKENMARK M, 1989, AMBIO, V18, P112; Falkenmark M, 2003, PHILOS T R SOC B, V358, P2037, DOI 10.1098/rstb.2003.1386; FAO, 2010, AQUASTAT ON LIN DAT; Fekete BM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/1999GB001254; GRDC, 2007, MAJ RIV BAS WORLD; Hanasaki N, 2008, HYDROL EARTH SYST SC, V12, P1027, DOI 10.5194/hess-12-1027-2008; Hanasaki N, 2010, J HYDROL, V384, P232, DOI 10.1016/j.jhydrol.2009.09.028; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE; Hoff H, 2010, J HYDROL, V384, P177, DOI 10.1016/j.jhydrol.2009.06.026; Liu JG, 2010, J HYDROL, V384, P187, DOI 10.1016/j.jhydrol.2009.11.024; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Mekonnen MM, 2010, HYDROL EARTH SYST SC, V14, P1259, DOI 10.5194/hess-14-1259-2010; Mekonnen M. M., 2011, NATL WATER FOOTPRINT; Murray-Darling Basin Authority, 2010, GUID PROP BAS PLAN O; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Perry C, 2007, IRRIG DRAIN, V56, P367, DOI 10.1002/ird.323; Postel S, 2003, RIVERS LIFE MANAGING; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Richter BD, 2012, RIVER RES APPL, V28, P1312, DOI 10.1002/rra.1511; Richter BD, 2010, RIVER RES APPL, V26, P1052, DOI 10.1002/rra.1320; Robinson JRC, 2002, ALTERNATIVE APPROACH; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Rost S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006331; Savenije HHG, 2000, PHYS CHEM EARTH PT B, V25, P199, DOI 10.1016/S1464-1909(00)00004-6; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Shiklomanov IA, WORLD WATER RESOURCE; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Smakhtin V, 2004, WATER INT, V29, P307, DOI 10.1080/02508060408691785; UNDP (United Nations Development Programme), 2006, HUMAN DEV REPORT 200; VOROSMARTY C. J., 2005, MILLENNIUM ECOSYSTEM, V1, P165; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; WADA Y, 2011, WATER RESOUR RES, V47, DOI DOI 10.1029/2010WR009792; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; World Economic Forum, 2011, GLOB RISKS 2011; World Water Assessment Programme, 2009, 3 UN WORLD WAT DEV	42	541	557	23	352	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32688	10.1371/journal.pone.0032688	http://dx.doi.org/10.1371/journal.pone.0032688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393438	Green Published, gold			2022-12-25	WOS:000303003500091
J	Kawabe, T				Kawabe, Takahiro			Postdictive Modulation of Visual Orientation	PLOS ONE			English	Article							INDUCED POSITION SHIFT; OBJECT SUBSTITUTION; APPARENT MOTION; TARGET; MASKING; EXTRAPOLATION; PSYCHOPHYSICS; AWARENESS; COLOR; METACONTRAST	The present study investigated how visual orientation is modulated by subsequent orientation inputs. Observers were presented a near-vertical Gabor patch as a target, followed by a left- or right-tilted second Gabor patch as a distracter in the spatial vicinity of the target. The task of the observers was to judge whether the target was right-or left-tilted (Experiment 1) or whether the target was vertical or not (Supplementary experiment). The judgment was biased toward the orientation of the distracter (the postdictive modulation of visual orientation). The judgment bias peaked when the target and distracter were temporally separated by 100 ms, indicating a specific temporal mechanism for this phenomenon. However, when the visibility of the distracter was reduced via backward masking, the judgment bias disappeared. On the other hand, the low-visibility distracter could still cause a simultaneous orientation contrast, indicating that the distracter orientation is still processed in the visual system (Experiment 2). Our results suggest that the postdictive modulation of visual orientation stems from spatiotemporal integration of visual orientation on the basis of a slow feature matching process.	NTT Commun Sci Labs, Human & Informat Sci Lab, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Kawabe, T (corresponding author), NTT Commun Sci Labs, Human & Informat Sci Lab, Atsugi, Kanagawa, Japan.	kawabe.takahiro@lab.ntt.co.jp			Japan Society for the Promotion of Science [23730707]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) 23730707 to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DH, 2007, VISION RES, V47, P2403, DOI 10.1016/j.visres.2007.04.025; Boehler CN, 2008, P NATL ACAD SCI USA, V105, P8742, DOI 10.1073/pnas.0801999105; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; BURR DC, 1984, PERCEPTION, V13, P183, DOI 10.1068/p130183; BURR DC, 1986, PROC R SOC SER B-BIO, V227, P249, DOI 10.1098/rspb.1986.0022; Carlson TA, 2007, PSYCHOL SCI, V18, P298, DOI 10.1111/j.1467-9280.2007.01892.x; Chung STL, 2007, VISION RES, V47, P231, DOI 10.1016/j.visres.2006.10.008; Clifford CWG, 2005, CURR BIOL, V15, P574, DOI 10.1016/j.cub.2005.01.055; Corbett JE, 2009, VISION RES, V49, P28, DOI 10.1016/j.visres.2008.09.020; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Enns JT, 2002, PSYCHON B REV, V9, P489, DOI 10.3758/BF03196304; Enns JT, 2004, VISION RES, V44, P1321, DOI 10.1016/j.visres.2003.10.024; Enns JT, 1997, PSYCHOL SCI, V8, P135, DOI 10.1111/j.1467-9280.1997.tb00696.x; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Hirose N, 2007, J EXP PSYCHOL HUMAN, V33, P1495, DOI 10.1037/0096-1523.33.6.1495; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; Kahan TA, 2010, J EXP PSYCHOL HUMAN, V36, P88, DOI 10.1037/a0016466; Kanai R, 2006, CURR BIOL, V16, P2332, DOI 10.1016/j.cub.2006.10.001; Kawabe T, 2011, ATTEN PERCEPT PSYCHO, V73, P1522, DOI 10.3758/s13414-011-0128-4; Kawachi Y, 2011, I-PERCEPTION, V2, P428, DOI 10.1068/i0399; Kerzel D, 2003, COGNITION, V88, P109, DOI 10.1016/S0010-0277(03)00018-0; Kolers P. A., 1984, Computer Graphics, V18, P12, DOI 10.1145/988525.988527; KOLERS PA, 1971, J EXP PSYCHOL, V87, P99, DOI 10.1037/h0030156; KOLERS PA, 1976, VISION RES, V16, P329, DOI 10.1016/0042-6989(76)90192-9; KOLERS PA, 1975, SCIENCE, V187, P757, DOI 10.1126/science.1114322; Lamme VAF, 2010, COGN NEUROSCI-UK, V1, P204, DOI 10.1080/17588921003731586; Lleras A, 2003, J EXP PSYCHOL HUMAN, V29, P106, DOI 10.1037/0096-1523.29.1.106; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Moore CM, 2007, VISION RES, V47, P1624, DOI 10.1016/j.visres.2007.01.030; Moore CM, 2004, PSYCHOL SCI, V15, P866, DOI 10.1111/j.0956-7976.2004.00768.x; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nishida S, 2007, CURR BIOL, V17, P366, DOI 10.1016/j.cub.2006.12.041; Ogmen H, 2006, VISION RES, V46, P4726, DOI 10.1016/j.visres.2006.09.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Prins N, 2008, PERCEPTION, V37, P1022, DOI 10.1068/p5945; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; ROBINSON DN, 1966, SCIENCE, V154, P157, DOI 10.1126/science.154.3745.157; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; TENKINK E, 1981, PERCEPT PSYCHOPHYS, V30, P129, DOI 10.3758/BF03204470; Watanabe K, 2005, VISION RES, V45, P2580, DOI 10.1016/j.visres.2005.03.001	49	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32608	10.1371/journal.pone.0032608	http://dx.doi.org/10.1371/journal.pone.0032608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393421	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500073
J	Kimura-Kuroda, J; Komuta, Y; Kuroda, Y; Hayashi, M; Kawano, H				Kimura-Kuroda, Junko; Komuta, Yukari; Kuroda, Yoichiro; Hayashi, Masaharu; Kawano, Hitoshi			Nicotine-Like Effects of the Neonicotinoid Insecticides Acetamiprid and Imidacloprid on Cerebellar Neurons from Neonatal Rats	PLOS ONE			English	Article							ADOLESCENT FEMALE RATS; ACETYLCHOLINE-RECEPTOR; GRANULE CELLS; MESSENGER-RNA; IN-UTERO; ELECTRONEGATIVE PHARMACOPHORE; INTESTINAL-ABSORPTION; MATERNAL SMOKING; DIVERSE ACTIONS; NERVOUS-SYSTEM	Background: Acetamiprid (ACE) and imidacloprid (IMI) belong to a new, widely used class of pesticide, the neonicotinoids. With similar chemical structures to nicotine, neonicotinoids also share agonist activity at nicotinic acetylcholine receptors (nAChRs). Although their toxicities against insects are well established, their precise effects on mammalian nAChRs remain to be elucidated. Because of the importance of nAChRs for mammalian brain function, especially brain development, detailed investigation of the neonicotinoids is needed to protect the health of human children. We aimed to determine the effects of neonicotinoids on the nAChRs of developing mammalian neurons and compare their effects with nicotine, a neurotoxin of brain development. Methodology/Principal Findings: Primary cultures of cerebellar neurons from neonatal rats allow for examinations of the developmental neurotoxicity of chemicals because the various stages of neurodevelopment-including proliferation, migration, differentiation, and morphological and functional maturation-can be observed in vitro. Using these cultures, an excitatory Ca2+-influx assay was employed as an indicator of neural physiological activity. Significant excitatory Ca2+ influxes were evoked by ACE, IMI, and nicotine at concentrations greater than 1 mu M in small neurons in cerebellar cultures that expressed the mRNA of the alpha 3, alpha 4, and alpha 7 nAChR subunits. The firing patterns, proportion of excited neurons, and peak excitatory Ca2+ influxes induced by ACE and IMI showed differences from those induced by nicotine. However, ACE and IMI had greater effects on mammalian neurons than those previously reported in binding assay studies. Furthermore, the effects of the neonicotinoids were significantly inhibited by the nAChR antagonists mecamylamine, alpha-bungarotoxin, and dihydro-beta-erythroidine. Conclusions/Significance: This study is the first to show that ACE, IMI, and nicotine exert similar excitatory effects on mammalian nAChRs at concentrations greater than 1 mu M. Therefore, the neonicotinoids may adversely affect human health, especially the developing brain.	[Kimura-Kuroda, Junko; Komuta, Yukari; Kuroda, Yoichiro; Hayashi, Masaharu; Kawano, Hitoshi] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya City, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science	Kimura-Kuroda, J (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya City, Tokyo, Japan.	kuroda-jk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21510075]; Grants-in-Aid for Scientific Research [23500422] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21510075). http://www.jsps.go.jp/english/e-grants/grants.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P119, DOI 10.1080/15287390701613140; Agulhon C, 1998, MOL BRAIN RES, V58, P123, DOI 10.1016/S0169-328X(98)00113-2; Bal R, 2010, NEUROTOXICOLOGY, V31, P113, DOI 10.1016/j.neuro.2009.10.004; Brunet JL, 2008, J ENVIRON SCI HEAL B, V43, P261, DOI 10.1080/03601230701771446; Brunet JL, 2004, TOXICOL APPL PHARM, V194, P1, DOI 10.1016/j.taap.2003.08.018; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; DIDIER M, 1995, MOL BRAIN RES, V30, P17, DOI 10.1016/0169-328X(94)00266-H; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Eugenin J, 2008, J NEUROSCI, V28, P13907, DOI 10.1523/JNEUROSCI.4441-08.2008; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Hogberg HT, 2010, TOXICOL SCI, V113, P95, DOI 10.1093/toxsci/kfp175; Huang LZ, 2007, NEUROSCIENCE, V146, P1854, DOI 10.1016/j.neuroscience.2007.03.008; Kawa K, 2002, J PHYSIOL-LONDON, V538, P87, DOI 10.1113/jphysiol.2001.012885; Kimura-Kuroda J, 2002, DEV BRAIN RES, V137, P55, DOI 10.1016/S0165-3806(02)00408-X; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Li P, 2011, J NEUROSCI RES, V89, P1295, DOI 10.1002/jnr.22644; de Oliveira IM, 2010, TOXICOL LETT, V192, P294, DOI 10.1016/j.toxlet.2009.11.005; Mao C, 2007, BRAZ J MED BIOL RES, V40, P735, DOI 10.1590/S0100-879X2007000500019; Mao CP, 2008, BRAIN RES, V1189, P43, DOI 10.1016/j.brainres.2007.10.089; Marchi M, 1999, NEUROCHEM INT, V34, P319, DOI 10.1016/S0197-0186(99)00015-7; Masgrau R, 2000, J NEUROCHEM, V74, P818, DOI 10.1046/j.1471-4159.2000.740818.x; Matsuda K, 2005, BIOSCI BIOTECH BIOCH, V69, P1442, DOI 10.1271/bbb.69.1442; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Matsuda K, 2009, MOL PHARMACOL, V76, P1, DOI 10.1124/mol.109.055186; Moccia F, 2004, AM J PHYSIOL-HEART C, V286, pH486, DOI 10.1152/ajpheart.00620.2003; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Nagata I, 2006, J COMP NEUROL, V499, P274, DOI 10.1002/cne.21102; Nagata K, 1998, J PHARMACOL EXP THER, V285, P731; Neuman RJ, 2007, BIOL PSYCHIAT, V61, P1320, DOI 10.1016/j.biopsych.2006.08.049; Oikawa H, 2005, J NEUROSCI RES, V79, P535, DOI 10.1002/jnr.20398; POCOCK JM, 1995, NEUROSCIENCE, V67, P595, DOI 10.1016/0306-4522(95)00061-M; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rodrigues KJA, 2010, ECOTOX ENVIRON SAFE, V73, P101, DOI 10.1016/j.ecoenv.2009.04.021; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Sampaio LFS, 2005, BRAZ J MED BIOL RES, V38, P603, DOI 10.1590/S0100-879X2005000400015; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Slikker W, 2005, CRIT REV TOXICOL, V35, P703, DOI 10.1080/10408440591007421; Takeda Yasuo, 2001, Keio Journal of Medicine, V50, P240; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 1999, BRIT J PHARMACOL, V127, P115, DOI 10.1038/sj.bjp.0702526; Tomizawa M, 2003, BIOCHEMISTRY-US, V42, P7819, DOI 10.1021/bi0300130; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Ward C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-81; Wei JX, 2011, INT J NEUROPSYCHOPH, V14, P91, DOI 10.1017/S1461145710000416; Winzer-Serhan UH, 2008, FRONT BIOSCI-LANDMRK, V13, P636, DOI 10.2741/2708; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645; Zhang X, 1998, INT J DEV NEUROSCI, V16, P507, DOI 10.1016/S0736-5748(98)00044-6	52	157	168	7	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32432	10.1371/journal.pone.0032432	http://dx.doi.org/10.1371/journal.pone.0032432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393406	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500059
J	McColl, G; James, SA; Mayo, S; Howard, DL; Ryan, CG; Kirkham, R; Moorhead, GF; Paterson, D; de Jonge, MD; Bush, AI				McColl, Gawain; James, Simon A.; Mayo, Sheridan; Howard, Daryl L.; Ryan, Christopher G.; Kirkham, Robin; Moorhead, Gareth F.; Paterson, David; de Jonge, Martin D.; Bush, Ashley I.			Caenorhabditis elegans Maintains Highly Compartmentalized Cellular Distribution of Metals and Steep Concentration Gradients of Manganese	PLOS ONE			English	Article							RAY-FLUORESCENCE MICROSCOPY; METHIONINE AMINOPEPTIDASE; NEURONS; FE(II)	Bioinorganic chemistry is critical to cellular function. Homeostasis of manganese (Mn), for example, is essential for life. A lack of methods for direct in situ visualization of Mn and other biological metals within intact multicellular eukaryotes limits our understanding of management of these metals. We provide the first quantitative subcellular visualization of endogenous Mn concentrations (spanning two orders of magnitude) associated with individual cells of the nematode, Caenorhabditis elegans.	[McColl, Gawain; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [McColl, Gawain] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [James, Simon A.; Mayo, Sheridan; Ryan, Christopher G.; Kirkham, Robin; Moorhead, Gareth F.] Commonwealth Sci & Ind Res Org, Clayton, Vic, Australia; [Howard, Daryl L.; Paterson, David; de Jonge, Martin D.] Australian Synchrotron, Clayton, Vic, Australia; [Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne	McColl, G (corresponding author), Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia.	martin.dejonge@synchrotron.org.au; abush@mhri.edu.au	James, Simon/J-5320-2012; Mayo, Sheridan C/A-4952-2010; Bush, Ashley I/A-1186-2007; Ryan, Chris G/A-6032-2011; Mayo, Sheridan/AAY-6911-2020; James, Simon/ABA-8646-2020; de Jonge, Martin D/C-3400-2011; Kirkham, Robin/C-9786-2010; Moorhead, Gareth F/B-6634-2009; Bush, Ashley/Y-2457-2019; McColl, Gawain/Y-8959-2018; Howard, Daryl/E-9107-2013	James, Simon/0000-0001-9369-3288; Mayo, Sheridan C/0000-0002-7333-5472; Bush, Ashley I/0000-0001-8259-9069; Ryan, Chris G/0000-0003-2891-3912; Mayo, Sheridan/0000-0002-7333-5472; de Jonge, Martin D/0000-0001-7731-6175; Kirkham, Robin/0000-0003-1012-3496; Moorhead, Gareth F/0000-0002-9299-9549; Bush, Ashley/0000-0001-8259-9069; McColl, Gawain/0000-0002-6347-6722; Howard, Daryl/0000-0001-6071-2382	Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds from the Australian Research Council and the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Au C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007792; Bandyopadhyay J, 2009, BIOCHEM BIOPH RES CO, V390, P136, DOI 10.1016/j.bbrc.2009.09.082; BRENNER S, 1974, GENETICS, V77, P71; Chai SC, 2008, J BIOL CHEM, V283, P26879, DOI 10.1074/jbc.M804345200; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; de Jonge MD, 2010, CURR OPIN STRUC BIOL, V20, P606, DOI 10.1016/j.sbi.2010.09.002; de Jonge MD, 2010, P NATL ACAD SCI USA, V107, P15676, DOI 10.1073/pnas.1001469107; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; James SA, 2011, ANAL BIOANAL CHEM, V401, P853, DOI 10.1007/s00216-011-4978-3; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Leopoldini M, 2007, J AM CHEM SOC, V129, P7776, DOI 10.1021/ja068168t; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Ryan CG, 2010, AIP CONF PROC, V1221, P9, DOI 10.1063/1.3399266; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; Sanz-Medel A, 2008, ANAL BIOANAL CHEM, V390, P3, DOI 10.1007/s00216-007-1615-2; Teramoto T, 2006, CELL CALCIUM, V40, P319, DOI 10.1016/j.ceca.2006.04.009; Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Xiao J, 2009, J ENVIRON SCI-CHINA, V21, P842, DOI 10.1016/S1001-0742(08)62350-5; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746	27	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32685	10.1371/journal.pone.0032685	http://dx.doi.org/10.1371/journal.pone.0032685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393436	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500089
J	Pillet, L; Fontaine, D; Pawlowski, J				Pillet, Loic; Fontaine, Delia; Pawlowski, Jan			Intra-Genomic Ribosomal RNA Polymorphism and Morphological Variation in Elphidium macellum Suggests Inter-Specific Hybridization in Foraminifera	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SECONDARY STRUCTURE; SMALL-SUBUNIT; SEQUENCE HETEROGENEITY; CONCERTED EVOLUTION; RDNA; GENE; DNA; ITS1; IDENTIFICATION	Elphidium macellum is a benthic foraminifer commonly found in the Patagonian fjords. To test whether its highly variable morphotypes are ecophenotypes or different genotypes, we analysed 70 sequences of the SSU rRNA gene from 25 specimens. Unexpectedly, we identified 11 distinct ribotypes, with up to 5 ribotypes co-occurring within the same specimen. The ribotypes differ by varying blocks of sequence located at the end of stem-loop motifs in the three expansion segments specific to foraminifera. These changes, distinct from typical SNPs and indels, directly affect the structure of the expansion segments. Their mosaic distribution suggests that ribotypes originated by recombination of two or more clusters of ribosomal genes. We propose that this expansion segment polymorphism (ESP) could originate from hybridization of morphologically different populations of Patagonian Elphidium. We speculate that the complex geological history of Patagonia enhanced divergence of coastal foraminiferal species and contributed to increasing genetic and morphological variation.	[Pillet, Loic; Fontaine, Delia; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva	Pillet, L (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	loic.pillet@unige.ch	Pawlowski, Jan/AAO-3306-2021	Pawlowski, Jan/0000-0003-2421-388X	Swiss National Science Foundation [31003A_125372]; Ernest Boninchi Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernest Boninchi Foundation	This work was supported by the Swiss National Science Foundation (www.snf.ch) grant 31003A_125372 (JP) and a grant from the Ernest Boninchi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani AD, 1993, U NEW S WALES CTR MA, V5, P1; Alverson AJ, 2005, J PHYCOL, V41, P1248, DOI 10.1111/j.1529-8817.2005.00136.x; Arnold M.L., 1997, NATURAL HYBRIDIZATIO, P215; Bass D, 2009, PROTIST, V160, P483, DOI 10.1016/j.protis.2009.01.004; BOLTOVSKOY E, 1980, Journal of Foraminiferal Research, V10, P163; BOLTOVSKOY E, 1991, J PALEONTOL, V65, P175, DOI 10.1017/S0022336000020394; Bowser Samuel S., 2008, P78; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; BUZAS MA, 1985, J PALEONTOL, V59, P1075; BYRNE M, 1994, EVOLUTION, V48, P564, DOI 10.1111/j.1558-5646.1994.tb01344.x; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; Casteleyn G, 2009, PROTIST, V160, P343, DOI 10.1016/j.protis.2008.11.002; CHAN YL, 1983, NUCLEIC ACIDS RES, V11, P7819, DOI 10.1093/nar/11.22.7819; Clapperton C. M., 1993, QUATERNARY GEOLOGY G, P779; CLARK CG, 1984, NUCLEIC ACIDS RES, V12, P6197, DOI 10.1093/nar/12.15.6197; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Coyer JA, 2001, J PHYCOL, V37, P574, DOI 10.1046/j.1529-8817.2001.037001574.x; D'Alelio D, 2009, PROTIST, V160, P9, DOI 10.1016/j.protis.2008.07.001; d'Orbigny AD, 1839, VOYAGE AM MERIDIONAL, P86; Edvardsen B, 2003, J PHYCOL, V39, P395, DOI 10.1046/j.1529-8817.2003.01252.x; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fama P, 2000, EUR J PHYCOL, V35, P349, DOI 10.1080/09670260010001735951; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenton B, 1998, GENOME, V41, P337, DOI 10.1139/gen-41-3-337; Fiore-Donno AM, 2010, J EUKARYOT MICROBIOL, V57, P189, DOI 10.1111/j.1550-7408.2009.00466.x; Franceschini G, 2005, S AFR J GEOL, V108, P285, DOI 10.2113/108.2.285; Galloway J. J, 1933, MANUAL FORAMINIFERA, P483; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; GORSKI JL, 1987, J MOL EVOL, V24, P236, DOI 10.1007/BF02111237; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HANCOCK JM, 1990, NUCLEIC ACIDS RES, V18, P5949, DOI 10.1093/nar/18.20.5949; Harper FM, 2007, INVERTEBR BIOL, V126, P373, DOI 10.1111/j.1744-7410.2007.00107.x; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Hart MC, 2007, HARMFUL ALGAE, V6, P271, DOI 10.1016/j.hal.2006.10.001; Hartmann S, 2001, J MOL EVOL, V53, P124, DOI 10.1007/s002390010200; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Haynes J.R., 1992, Journal of Micropalaeontology, V11, P59; HAYWARD BW, 1994, MICROPALEONTOLOGY, V40, P185, DOI 10.2307/1485816; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hollis C. J, 1997, I GEOLOGICAL NUCL SC, V16, P170; Holzmann M, 1996, J MOL EVOL, V43, P145, DOI 10.1007/BF02337359; Holzmann M, 2001, MAR MICROPALEONTOL, V43, P57, DOI 10.1016/S0377-8398(01)00021-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeeps MW, 1942, J MAR BIOL ASSOC UK, V25, P612; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kita Y, 2000, PLANT SYST EVOL, V225, P1, DOI 10.1007/BF00985455; Lee J. J., 1991, BIOL FORAMINIFERA, P285; LEFFERS H, 1993, NUCLEIC ACIDS RES, V21, P1449, DOI 10.1093/nar/21.6.1449; Lena H., 1966, Ameghiniana, V4, P311; Lister JJ., 1896, PHILOSOPH TRANSACT R, V186, P401; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Malumian N, 2005, AMEGHINIANA, V42, P363; Malumián N., 2006, Rev. Asoc. Geol. Argent., V61, P139; Malumian N, 2011, BIOL J LINN SOC, V103, P269, DOI 10.1111/j.1095-8312.2011.01649.x; MASHKOVA TD, 1981, NUCLEIC ACIDS RES, V9, P2141, DOI 10.1093/nar/9.9.2141; McTaggart SJ, 2005, MOL BIOL EVOL, V22, P1309, DOI 10.1093/molbev/msi119; MILLER AAL, 1982, J FORAMIN RES, V12, P116, DOI 10.2113/gsjfr.12.2.116; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Nanez C., 1990, REV ASOC GEOL ARGENT, V43, P493; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nylander JAA, 2004, MRAIC PL 1 4 3 PROGR; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; PETERSON RC, 1980, CELL, V20, P131, DOI 10.1016/0092-8674(80)90241-X; Pillet L, 2011, PROTIST, V162, P394, DOI 10.1016/j.protis.2010.10.001; Poag CW, 1978, GULF COAST ASS GEOLO, V28, P395; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; Ruggiero MV, 2004, J MOL EVOL, V58, P115, DOI 10.1007/s00239-003-2536-0; SCHNITKER D, 1974, Journal of Foraminiferal Research, V4, P217; Schweizer M, 2008, MAR MICROPALEONTOL, V66, P233, DOI 10.1016/j.marmicro.2007.10.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; WEGNEZ M, 1972, FEBS LETT, V25, P13, DOI 10.1016/0014-5793(72)80443-5; WILKINSON IP, 1979, J PALEONTOL, V53, P628; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017	82	60	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32373	10.1371/journal.pone.0032373	http://dx.doi.org/10.1371/journal.pone.0032373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393402	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500055
J	Cai, Y; Wang, JH; Ren, CX; Ittmann, M				Cai, Yi; Wang, Jianghua; Ren, Chengxi; Ittmann, Michael			Frequent Heterogeneous Missense Mutations of GGAP2 in Prostate Cancer: Implications for Tumor Biology, Clonality and Mutation Analysis	PLOS ONE			English	Article							PROGRESSION; PATHWAYS; AKT; P53; ADENOCARCINOMAS; INVASION; GTPASE; GROWTH; GENES	Prostate cancer is the most common visceral malignancy in Western men and a major cause of cancer deaths. Increased activation of the AKT and NFkB pathways have been identified as critical steps in prostate cancer initiation and progression. GGAP2 (GTP-binding and GTPase activating protein 2) is a multidomain protein that contains an N-terminal Ras homology domain (GTPase), followed by a PH domain, a C-terminal GAP domain and an ankyrin repeat domain. GGAP2 can directly activate signaling via both the AKT and NFkB pathways and acts as a node of crosstalk between these pathways. Increased GGAP2 expression is present in three quarters of prostate cancers. Mutations of GGAP2 have been reported in cell lines from other malignancies. We therefore analyzed 84 prostate cancer tissues and 43 benign prostate tissues for somatic mutations in GGAP2 by direct sequencing of individual clones derived from the GAP and GTPase domains of normal and tumor tissue. Overall, half of cancers contained mutant GAP domain clones and in 20% of cancers, 30% or more of clones were mutant in the GAP domain. Surprisingly, the mutations were heterogeneous and nonclonal, with multiple different mutations being present in many tumors. Similar findings were observed in the analysis of the GTPase domain. Mutant GGAP2 proteins had significantly higher transcriptional activity using AP-1 responsive reporter constructs when compared to wild-type protein. Furthermore, the presence of these mutations was associated with aggressive clinical behavior. The presence of high frequency nonclonal mutations of a single gene is novel and represents a new mode of genetic alteration that can promote tumor progression. Analysis of mutations in cancer has been used to predict outcome and guide therapeutic target identification but such analysis has focused on clonal mutations. Our studies indicate that in some cases high frequency nonclonal mutations may need to be assessed as well.	[Cai, Yi; Wang, Jianghua; Ren, Chengxi; Ittmann, Michael] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Cai, Yi; Wang, Jianghua; Ren, Chengxi; Ittmann, Michael] Michael E DeBakey Dept Vet Affairs, Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Cai, Y (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mittmann@bcm.tmc.edu			Department of Defense [W81XWH-07-1-0023, W81 WH-07-01-0220]; National Cancer Institute [P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for MI was made possible via Department of Defense Prostate Cancer Research program (W81XWH-07-1-0023; http://cdmrp.army.mil), the National Cancer Institute to the Dan L. Duncan Cancer Center (P30CA125123; www.nih.gov) and by the use of the facilities of the Michael E. DeBakey Department of Veterans Affairs Medical Center (www.houston.va.gov). Support for YC was made possible via Department of Defense Prostate Cancer Research program (W81 WH-07-01-0220; http://cdmrp.army.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Cai Y, 2009, CANCER RES, V69, P819, DOI 10.1158/0008-5472.CAN-08-2537; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Hu YX, 2005, P NATL ACAD SCI USA, V102, P16853, DOI 10.1073/pnas.0507365102; ITTMANN M, 1994, AM J PATHOL, V145, P287; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Ren ZP, 2007, J NEUROPATH EXP NEUR, V66, P944, DOI 10.1097/nen.0b013e318156bc05; Stapleton AMF, 1997, CLIN CANCER RES, V3, P1389; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wang SI, 1998, CLIN CANCER RES, V4, P811; WHEELER TM, 1994, PROSTATE, V25, P274, DOI 10.1002/pros.2990250507; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32708	10.1371/journal.pone.0032708	http://dx.doi.org/10.1371/journal.pone.0032708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389719	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600058
J	Ifeadi, V; Garnett-Benson, C				Ifeadi, Victoria; Garnett-Benson, Charlie			Sub-Lethal Irradiation of Human Colorectal Tumor Cells Imparts Enhanced and Sustained Susceptibility to Multiple Death Receptor Signaling Pathways	PLOS ONE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; RADIATION-THERAPY; IONIZING-RADIATION; INDUCED APOPTOSIS; NECROSIS-FACTOR; CANCER-CELLS; COMBINING RADIOTHERAPY; COLON-CARCINOMA; TNF SUPERFAMILY; CD95 EXPRESSION	Background: Death receptors (DR) of the TNF family function as anti-tumor immune effector molecules. Tumor cells, however, often exhibit DR-signaling resistance. Previous studies indicate that radiation can modify gene expression within tumor cells and increase tumor cell sensitivity to immune attack. The aim of this study is to investigate the synergistic effect of sub-lethal doses of ionizing radiation in sensitizing colorectal carcinoma cells to death receptor-mediated apoptosis. Methodology/Principal Findings: The ability of radiation to modulate the expression of multiple death receptors (Fas/CD95, TRAILR1/DR4, TRAILR2/DR5, TNF-R1 and LT beta R) was examined in colorectal tumor cells. The functional significance of sub-lethal doses of radiation in enhancing tumor cell susceptibility to DR-induced apoptosis was determined by in vitro functional sensitivity assays. The longevity of these changes and the underlying molecular mechanism of irradiation in sensitizing diverse colorectal carcinoma cells to death receptor-mediated apoptosis were also examined. We found that radiation increased surface expression of Fas, DR4 and DR5 but not LT beta R or TNF-R1 in these cells. Increased expression of DRs was observed 2 days post-irradiation and remained elevated 7-days post irradiation. Sub-lethal tumor cell irradiation alone exhibited minimal cell death, but effectively sensitized three of three colorectal carcinoma cells to both TRAIL and Fas-induced apoptosis, but not LT beta R-induced death. Furthermore, radiation-enhanced Fas and TRAIL-induced cell death lasted as long as 5-days post-irradiation. Specific analysis of intracellular sensitizers to apoptosis indicated that while radiation did reduce Bcl-X-L and c-FLIP protein expression, this reduction did not correlate with the radiation-enhanced sensitivity to Fas and/or TRAIL mediated apoptosis among the three cell types. Conclusions/Significance: Irradiation of tumor cells can overcome Fas and TRAIL resistance that is long lasting. Overall, results of these investigations suggest that non-lethal doses of radiation can be used to make human tumors more amenable to attack by anti-tumor effector molecules and cells.	[Ifeadi, Victoria; Garnett-Benson, Charlie] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Ifeadi, V (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	cgarnettbenson@gsu.edu		Garnett-Benson, Charlie/0000-0002-0238-3303	Georgia State University Office of University Research Services Administration; Georgia State University, Department of Biology	Georgia State University Office of University Research Services Administration; Georgia State University, Department of Biology	This research was supported by an Internal Research Initiation Grant (RIG) from Georgia State University Office of University Research Services & Administration. This research was supported by laboratory start-up funds from Georgia State University, Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal S, 2000, GENES IMMUN, V1, P271, DOI 10.1038/sj.gene.6363674; Andersen MH, 2005, NAT REV DRUG DISCOV, V4, P399, DOI 10.1038/nrd1717; Antonia S, 2004, CURR OPIN IMMUNOL, V16, P130, DOI 10.1016/j.coi.2004.01.012; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chakraborty M, 2003, J IMMUNOL, V170, P6338, DOI 10.4049/jimmunol.170.12.6338; Chakraborty M, 2008, CLIN CANCER RES, V14, P4241, DOI 10.1158/1078-0432.CCR-08-0335; Chen MC, 2003, J BIOL CHEM, V278, P16073, DOI 10.1074/jbc.M208661200; Chi KW, 2005, J IMMUNOTHER, V28, P129, DOI 10.1097/01.cji.0000154248.74383.5e; Decker RH, 2008, SEMIN THORAC CARDIOV, V20, P184, DOI 10.1053/j.semtcvs.2008.09.004; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Ferrara TA, 2009, CURR OPIN MOL THER, V11, P37; Formenti SC, 2008, J CLIN ONCOL, V26, P1562, DOI 10.1200/JCO.2007.15.5499; Friedman EJ, 2002, CURR PHARM DESIGN, V8, P1765, DOI 10.2174/1381612023394089; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gelbard A, 2006, CLIN CANCER RES, V12, P1897, DOI 10.1158/1078-0432.CCR-05-1761; Gulley JL, 2005, CLIN CANCER RES, V11, P3353, DOI 10.1158/1078-0432.CCR-04-2062; Guyot F, 2005, ANN ONCOL, V16, P756, DOI 10.1093/annonc/mdi151; Hamasu T, 2005, J RADIAT RES, V46, P103, DOI 10.1269/jrr.46.103; Hodge JW, 2008, ONCOLOGY-NY, V22, P1064; Hoos A, 2010, SEMIN ONCOL, V37, P533, DOI 10.1053/j.seminoncol.2010.09.015; Houghton JA, 1997, P NATL ACAD SCI USA, V94, P8144, DOI 10.1073/pnas.94.15.8144; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kataoka T, 1998, J IMMUNOL, V161, P3936; Kimura K, 2000, J BIOL CHEM, V275, P8610, DOI 10.1074/jbc.275.12.8610; Kopetz S, 2009, CLIN CANCER RES, V15, P7451, DOI 10.1158/1078-0432.CCR-09-2523; Kufe D, 2003, CANCER BIOL THER, V2, P326, DOI 10.4161/cbt.2.4.495; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lechleider RJ, 2008, CLIN CANCER RES, V14, P5284, DOI 10.1158/1078-0432.CCR-07-5162; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Lugade AA, 2008, J IMMUNOL, V180, P3132, DOI 10.4049/jimmunol.180.5.3132; Lukashev M, 2006, CANCER RES, V66, P9617, DOI 10.1158/0008-5472.CAN-06-0217; Marini P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-5; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Nesslinger NJ, 2007, CLIN CANCER RES, V13, P1493, DOI 10.1158/1078-0432.CCR-06-1772; Niyazi M, 2009, ONCOL REP, V21, P1455, DOI 10.3892/or_00000374; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ravi R, 2002, CANCER RES, V62, P4180; Rigberg DA, 1999, J SURG ONCOL, V71, P91, DOI 10.1002/(SICI)1096-9098(199906)71:2<91::AID-JSO6>3.0.CO;2-7; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shankar S, 2004, PROSTATE, V61, P35, DOI 10.1002/pros.20069; Sharp HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4900, DOI 10.2741/2436; Sheard MA, 1999, BRIT J CANCER, V80, P1689, DOI 10.1038/sj.bjc.6690585; Sheard MA, 2003, CANCER RES, V63, P7176; Sheard MA, 1997, INT J CANCER, V73, P757, DOI 10.1002/(SICI)1097-0215(19971127)73:5<757::AID-IJC24>3.0.CO;2-1; Shibue T, 2006, EMBO J, V25, P4952, DOI 10.1038/sj.emboj.7601359; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Takamizawa S, 2000, J PEDIATR SURG, V35, P390, DOI 10.1016/S0022-3468(00)90047-2; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Verbrugge I, 2009, CLIN CANCER RES, V15, P2031, DOI 10.1158/1078-0432.CCR-08-2125; Vergati M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/596432; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Whelan M, 2003, DRUG DISCOV TODAY, V8, P253, DOI 10.1016/S1359-6446(03)02633-3; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang D, 2007, CLIN CANCER RES, V13, P5202, DOI 10.1158/1078-0432.CCR-07-1161	76	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31762	10.1371/journal.pone.0031762	http://dx.doi.org/10.1371/journal.pone.0031762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389673	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600010
J	Kagawa, K; Nakano, A; Miki, H; Oda, A; Amou, H; Takeuchi, K; Nakamura, S; Harada, T; Fujii, S; Yata, K; Ozaki, S; Matsumoto, T; Abe, M				Kagawa, Kumiko; Nakano, Ayako; Miki, Hirokazu; Oda, Asuka; Amou, Hiroe; Takeuchi, Kyoko; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Yata, Kenichiro; Ozaki, Shuji; Matsumoto, Toshio; Abe, Masahiro			Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; MULTIPLE-MYELOMA; BONE-MARROW; DEATH RECEPTORS; UP-REGULATION; C-FLIP; APOPTOSIS; GROWTH; METALLOPROTEINASES	Background: TNF-related apoptosis-inducing ligand/Apo2 ligand (TRAIL/Apo2L) selectively induces apoptosis in various cancer cells including myeloma (MM) cells. However, the susceptibility of MM cells to TRAIL is largely low in most of MM cells by yet largely unknown mechanisms. Because TNF-alpha converting enzyme (TACE) can cleave some TNF receptor family members, in the present study we explored the roles of proteolytic modulation by TACE in TRAIL receptor expression and TRAIL-mediated cytotoxicity in MM cells. Methodology/Principal Findings: MM cells preferentially expressed death receptor 4 (DR4) but not DR5 on their surface along with TACE. Conditioned media from RPMI8226 and U266 cells contained a soluble form of DR4. The DR4 levels in these conditioned media were reduced by TACE inhibition by the TACE inhibitor TAPI-0 as well as TACE siRNA. Conversely, the TACE inhibition restored surface levels of DR4 but not DR5 in these cells without affecting DR4 mRNA levels. The TACE inhibition was able to restore cell surface DR4 expression in MM cells even in the presence of bone marrow stromal cells or osteoclasts, and enhanced the cytotoxic effects of recombinant TRAIL and an agonistic antibody against DR4 on MM cells. Conclusions/Significance: These results demonstrate that MM cells post-translationally down-modulate the cell surface expression of DR4 through ectodomain shedding by endogenous TACE, and that TACE inhibition is able to restore cell surface DR4 levels and the susceptibility of MM cells to TRAIL or an agonistic antibody against DR4. Thus, TACE may protect MM cells from TRAIL-mediated death through down-modulation of cell-surface DR4. It can be envisaged that TACE inhibition augments clinical efficacy of TRAIL-based immunotherapy against MM, which eventually becomes resistant to the present therapeutic modalities.	[Kagawa, Kumiko; Nakano, Ayako; Miki, Hirokazu; Oda, Asuka; Amou, Hiroe; Takeuchi, Kyoko; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Yata, Kenichiro; Matsumoto, Toshio; Abe, Masahiro] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Ozaki, Shuji] Tokushima Prefectural Cent Hosp, Div Internal Med, Tokushima, Japan	Tokushima University	Kagawa, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan.	masabe@clin.med.tokushima-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund; Japan Leukemia Research Fund	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF))	This work was supported in part by Grants-in-aid for Scientific Research (A) to T.M. and (C) to M.A., a Grant-in-aid for Cancer Research to M.A. from the Ministry of Health, Labor and Welfare of Japan, National Cancer Center Research and Development Fund to M.A., and Japan Leukemia Research Fund to M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Benoit V, 2004, CANCER RES, V64, P2684, DOI 10.1158/0008-5472.CAN-03-2914; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buchsbaum Donald J, 2007, Future Oncol, V3, P405, DOI 10.2217/14796694.3.4.405; David E, 2008, CLIN CANCER RES, V14, P5090, DOI 10.1158/1078-0432.CCR-08-0016; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hiasa M, 2009, BLOOD, V114, P4517, DOI 10.1182/blood-2009-04-215020; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kitazoe K, 2009, INT J HEMATOL, V89, P45, DOI 10.1007/s12185-008-0226-9; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mizrahi K, 2010, LEUKEMIA, V24, P1325, DOI 10.1038/leu.2010.97; Moretto P, 2009, EXPERT OPIN INV DRUG, V18, P311, DOI [10.1517/13543780902752463, 10.1517/13543780902752463 ]; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Pratt G, 2007, BRIT J HAEMATOL, V138, P563, DOI 10.1111/j.1365-2141.2007.06705.x; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Romagnoli M, 2007, CLIN CANCER RES, V13, P6010, DOI 10.1158/1078-0432.CCR-07-0140; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6; Shipman CM, 2003, CANCER RES, V63, P912; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Zdzisinska B, 2008, ARCH IMMUNOL THER EX, V56, P207, DOI 10.1007/s00005-008-0022-5	29	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31594	10.1371/journal.pone.0031594	http://dx.doi.org/10.1371/journal.pone.0031594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389670	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600007
J	Ng, KTP; Guo, DY; Cheng, Q; Geng, W; Ling, CC; Li, CX; Liu, XB; Ma, YY; Lo, CM; Poon, RTP; Fan, ST; Man, K				Ng, Kevin T. P.; Guo, Dong Yong; Cheng, Qiao; Geng, Wei; Ling, Chang Chun; Li, Chang Xian; Liu, Xiao Bing; Ma, Yuen Yuen; Lo, Chung Mau; Poon, Ronnie T. P.; Fan, Sheung Tat; Man, Kwan			A Garlic Derivative, S-allylcysteine (SAC), Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CANCER-CELLS; ORGANOSULFUR COMPOUNDS; TARGETED THERAPY; E-CADHERIN; EXPRESSION; INHIBITION; PREVENTION; INVASION; GROWTH	Background: Hepatocellular carcinoma (HCC) is highly malignant and metastatic. Currently, there is no effective chemotherapy for patients with advanced HCC leading to an urgent need to seek for novel therapeutic options. We aimed to investigate the effect of a garlic derivative, S-allylcysteine (SAC), on the proliferation and metastasis of HCC. Methodology/Principal Findings: A series of in vitro experiments including MTT, colony-forming, wound-healing, invasion, apoptosis and cell cycle assays were performed to examine the anti-proliferative and anti-metastatic effects of SAC on a metastatic HCC cell line MHCC97L. The therapeutic values of SAC single and combined with cisplatin treatments were examined in an in vivo orthotopic xenograft liver tumor model. The result showed that the proliferation rate and colony-forming abilities of MHCC97L cells were suppressed by SAC together with significant suppression of the expressions of proliferation markers, Ki-67 and proliferating cell nuclear antigen (PCNA). Moreover, SAC hindered the migration and invasion of MHCC97L cells corresponding with up-regulation of E-cadherin and down-regulation of VEGF. Furthermore, SAC significantly induced apoptosis and necrosis of MHCC97L cells through suppressing Bcl-xL and Bcl-2 as well as activating caspase-3 and caspase-9. In addition, SAC could significantly induce the S phase arrest of MHCC97L cells together with down-regulation of cdc25c, cdc2 and cyclin B1. In vivo xenograft liver tumor model demonstrated that SAC single or combined with cisplatin treatment inhibited the progression and metastasis of HCC tumor. Conclusions/Significance: Our data demonstrate the anti-proliferative and anti-metastatic effects of SAC on HCC cells and suggest that SAC may be a potential therapeutic agent for the treatment of HCC patients.	[Ng, Kevin T. P.; Guo, Dong Yong; Cheng, Qiao; Geng, Wei; Ling, Chang Chun; Li, Chang Xian; Liu, Xiao Bing; Ma, Yuen Yuen; Lo, Chung Mau; Poon, Ronnie T. P.; Fan, Sheung Tat; Man, Kwan] Univ Hong Kong, Dept Surg, LKS Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Guo, Dong Yong] Tianjin Med Univ, Canc Hosp, Inst Canc, Dept Anesthesiol, Tianjin, Peoples R China	University of Hong Kong; Tianjin Medical University	Ng, KTP (corresponding author), Univ Hong Kong, Dept Surg, LKS Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	kwanman@hku.hk	NG, Kevin Tak-Pan/J-1510-2018; Ng, Tak Pan/C-4698-2009	NG, Kevin Tak-Pan/0000-0001-9822-1335; 	Small Project Funding; University of Hong Kong	Small Project Funding; University of Hong Kong(University of Hong Kong)	This study was supported by the Small Project Funding and Seed Funding from the University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Cho SB, 2008, PATHOL INT, V58, P635, DOI 10.1111/j.1440-1827.2008.02282.x; Chu QJ, 2007, BJU INT, V99, P925, DOI 10.1111/j.1464-410X.2006.06639.x; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Fransvea E, 2008, HEPATOLOGY; Gapter LA, 2008, BIOCHEM BIOPH RES CO, V367, P446, DOI 10.1016/j.bbrc.2007.12.175; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman-Antosiewicz A, 2004, MUTAT RES-FUND MOL M, V555, P121, DOI 10.1016/j.mrfmmm.2004.04.016; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Knowles LM, 2000, CARCINOGENESIS, V21, P1129, DOI 10.1093/carcin/21.6.1129; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Murphy D, 2001, HEPATOLOGY, V33, P346, DOI 10.1053/jhep.2001.21749; Ng KTP, 2010, INT J CANCER, V127, P859, DOI 10.1002/ijc.25105; Ng KT, 2011, EUR J CANC; Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z; Powolny AA, 2008, CANCER LETT, V269, P305, DOI 10.1016/j.canlet.2008.05.027; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Shirin H, 2001, CANCER RES, V61, P725; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stroescu C, 2008, J GASTROINTEST LIVER, V17, P411; Sundaresan S, 2008, MOL CELL BIOCHEM, V310, P209, DOI 10.1007/s11010-007-9682-4; Tanaka S, 2006, J NUTR, V136, p821S, DOI 10.1093/jn/136.3.821S; Tang F. Y., 2010, J AGR FOOD CHEM; Tang FY, 2009, J NUTR BIOCHEM, V20, P1013, DOI 10.1016/j.jnutbio.2008.09.007; Thomson M, 2003, CURR CANCER DRUG TAR, V3, P67, DOI 10.2174/1568009033333736; WELCH C, 1992, CANCER LETT, V63, P211, DOI 10.1016/0304-3835(92)90263-U; Wysocki PJ, 2010, EXPERT OPIN INV DRUG, V19, P265, DOI 10.1517/13543780903514110; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yau T, 2009, LIVER INT, V29, P10, DOI 10.1111/j.1478-3231.2008.01916.x; Zhu AX, 2011, NAT REV CLIN ONCOL	33	55	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31655	10.1371/journal.pone.0031655	http://dx.doi.org/10.1371/journal.pone.0031655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389672	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600009
J	Puget, S; Philippe, C; Bax, DA; Job, B; Varlet, P; Junier, MP; Andreiuolo, F; Carvalho, D; Reis, R; Guerrini-Rousseau, L; Roujeau, T; Dessen, P; Richon, C; Lazar, V; Le Teuff, G; Sainte-Rose, C; Geoerger, B; Vassal, G; Jones, C; Grill, J				Puget, Stephanie; Philippe, Cathy; Bax, Dorine A.; Job, Bastien; Varlet, Pascale; Junier, Marie-Pierre; Andreiuolo, Felipe; Carvalho, Dina; Reis, Ricardo; Guerrini-Rousseau, Lea; Roujeau, Thomas; Dessen, Philippe; Richon, Catherine; Lazar, Vladimir; Le Teuff, Gwenael; Sainte-Rose, Christian; Geoerger, Birgit; Vassal, Gilles; Jones, Chris; Grill, Jacques			Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas	PLOS ONE			English	Article							BRAIN-STEM GLIOMAS; RECURRENT MALIGNANT GLIOMAS; COPY NUMBER ABERRATIONS; GROWTH-FACTOR; STEREOTACTIC BIOPSY; IMATINIB MESYLATE; TUMOR CONSORTIUM; EXPRESSION; CELLS; CHILDREN	Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To address the paucity of understanding of DIPGs, we have carried out integrated molecular profiling of a large series of samples obtained with stereotactic biopsy at diagnosis. While chromosomal imbalances did not distinguish DIPG and supratentorial tumors on CGHarrays, gene expression profiling revealed clear differences between them, with brainstem gliomas resembling midline/thalamic tumours, indicating a closely-related origin. Two distinct subgroups of DIPG were identified. The first subgroup displayed mesenchymal and pro-angiogenic characteristics, with stem cell markers enrichment consistent with the possibility to grow tumor stem cells from these biopsies. The other subgroup displayed oligodendroglial features, and appeared largely driven by PDGFRA, in particular through amplification and/or novel missense mutations in the extracellular domain. Patients in this later group had a significantly worse outcome with an hazard ratio for early deaths, ie before 10 months, 8 fold greater that the ones in the other subgroup (p = 0.041, Cox regression model). The worse outcome of patients with the oligodendroglial type of tumors was confirmed on a series of 55 paraffin-embedded biopsy samples at diagnosis (median OS of 7.73 versus 12.37 months, p = 0.045, log-rank test). Two distinct transcriptional subclasses of DIPG with specific genomic alterations can be defined at diagnosis by oligodendroglial differentiation or mesenchymal transition, respectively. Classifying these tumors by signal transduction pathway activation and by mutation in pathway member genes may be particularily valuable for the development of targeted therapies.	[Puget, Stephanie; Roujeau, Thomas; Sainte-Rose, Christian] Univ Paris 05, Necker Sick Children Hosp, Dept Neurosurg, Paris, France; [Puget, Stephanie; Philippe, Cathy; Andreiuolo, Felipe; Guerrini-Rousseau, Lea; Geoerger, Birgit; Vassal, Gilles; Grill, Jacques] Univ Paris 11, Gustave Roussy Canc Inst, Ctr Natl Rech Sci Vectorol & Anticanc Therapeut, UMR 8203, Villejuif, France; [Bax, Dorine A.; Carvalho, Dina; Jones, Chris] Royal Marsden Hosp, Inst Canc Res, Sect Pediat Oncol, Sutton, Surrey, England; [Job, Bastien; Dessen, Philippe] Univ Paris 11, Integrated Res Canc Inst Villejuif, CNRS, Villejuif, France; [Varlet, Pascale; Junier, Marie-Pierre] Univ Paris 05, St Anne Hosp, Dept Neuropathol, Paris, France; [Varlet, Pascale; Junier, Marie-Pierre] Univ Paris 05, St Anne Hosp, INSERM, Team Glial Plast,UMR 894, Paris, France; [Carvalho, Dina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Carvalho, Dina; Reis, Ricardo] Univ Minho, Life & Hlth Sci Res Inst, Braga, Portugal; [Richon, Catherine; Lazar, Vladimir] Univ Paris 11, Gustave Roussy Canc Inst, Funct Genom Unit, Villejuif, France; [Le Teuff, Gwenael] Univ Paris 11, Gustave Roussy Canc Inst, Dept Biostat & Epidemiol, Villejuif, France; [Geoerger, Birgit; Grill, Jacques] Univ Paris 11, Gustave Roussy Canc Inst, Dept Pediat & Adolescent Oncol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Coimbra; Universidade do Minho; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Puget, S (corresponding author), Univ Paris 05, Necker Sick Children Hosp, Dept Neurosurg, Paris, France.	grill@igr.fr	Lazar, Vladimir/AAV-2087-2020; Jones, Chris/ABE-6059-2021; Lazar, Vladimir/AAQ-2086-2020; PHILIPPE, Cathy/GRY-4381-2022	Jones, Chris/0000-0001-8118-2296; PHILIPPE, Cathy/0000-0002-3262-4390; VARLET, pascale/0000-0002-8164-1517; RICHON, Catherine/0000-0002-3556-3941; Andreiuolo, Felipe/0000-0002-2568-6155; Carvalho, Diana/0000-0001-6881-6151	Canceropole Ile de France - Institut National de Cancer (INCa); LEM-Recherche (Les Entreprises du Medicament); association "L'Etoile de Martin''; Association pour la Recherche en Neurochirurgie Pediatrique (ARNP)	Canceropole Ile de France - Institut National de Cancer (INCa); LEM-Recherche (Les Entreprises du Medicament); association "L'Etoile de Martin''; Association pour la Recherche en Neurochirurgie Pediatrique (ARNP)	The sponsors of the study were the Canceropole Ile de France - Institut National de Cancer (INCa), the LEM-Recherche (Les Entreprises du Medicament), the association "L'Etoile de Martin'' and the Association pour la Recherche en Neurochirurgie Pediatrique (ARNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026; Andreiuolo F, 2010, NEURO-ONCOLOGY, V12, P1126, DOI 10.1093/neuonc/noq074; Appolloni I, 2009, INT J CANCER, V124, P2251, DOI 10.1002/ijc.24206; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrow J, 2011, NEURO-ONCOLOGY, V13, P212, DOI 10.1093/neuonc/noq158; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bax DA, 2009, CLIN CANCER RES, V15, P5753, DOI 10.1158/1078-0432.CCR-08-3210; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Broniscer A, 2010, CANCER-AM CANCER SOC, V116, P4632, DOI 10.1002/cncr.25405; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Ducray F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-234; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garcia JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-454; Geoerger B, 2011, NEURO-ONCOLOGY, V13, P109, DOI 10.1093/neuonc/noq141; Geoerger B, 2009, EUR J CANCER, V45, P2342, DOI 10.1016/j.ejca.2009.03.007; Gilbertson RJ, 2007, CANCER RES, V67, P5579, DOI 10.1158/0008-5472.CAN-07-0760; Gilbertson RJ, 2003, CLIN CANCER RES, V9, P3620; Guillemot Vincent, 2008, International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies (BIOTECHNO 2008), P164, DOI 10.1109/BIOTECHNO.2008.17; Hargrave D, 2008, BRIT J NEUROSURG, V22, P624, DOI 10.1080/02688690802484405; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Herrington B, 2009, PEDIATR BLOOD CANCER, V53, P312, DOI 10.1002/pbc.21950; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; Holdhoff M, 2010, J NEURO-ONCOL, V97, P241, DOI 10.1007/s11060-009-0008-0; Jalali R, 2010, INT J RADIAT ONCOL, V77, P113, DOI 10.1016/j.ijrobp.2009.04.031; Kast RE, 2010, TRANSL ONCOL, V3, P13, DOI 10.1593/tlo.09280; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Lin Kimberly, 2010, Genes Cancer, V1, P409; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; LOUIS DN, 1993, J NEUROPATH EXP NEUR, V52, P507, DOI 10.1097/00005072-199309000-00009; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Masui K, 2010, GLIA, V58, P1050, DOI 10.1002/glia.20986; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Negri T, 2009, J PATHOL, V217, P103, DOI 10.1002/path.2450; Okada H, 2008, J NEURO-ONCOL, V88, P245, DOI 10.1007/s11060-008-9566-9; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Palm T, 2009, CANCER-AM CANCER SOC, V115, P3955, DOI 10.1002/cncr.24476; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Paulsson J, 2011, INT J CANCER, V128, P1981, DOI 10.1002/ijc.25528; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pincus DW, 2006, J NEUROSURG, V104, P108, DOI 10.3171/ped.2006.104.2.108; Pollack IF, 2007, NEURO-ONCOLOGY, V9, P145, DOI 10.1215/15228517-2006-031; Pollack IF, 2011, CHILD NERV SYST, V27, P87, DOI 10.1007/s00381-010-1264-1; Pozniak CD, 2010, P NATL ACAD SCI USA, V107, P21795, DOI 10.1073/pnas.1016485107; Puget S, 2007, J NEUROSURG, V106, P354, DOI 10.3171/ped.2007.106.5.354; Qaddoumi I, 2009, CANCER, V115, P5761, DOI 10.1002/cncr.24663; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; Roujeau T, 2007, J NEUROSURG, V107, P1, DOI 10.3171/PED-07/07/001; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Russell JS, 2003, CANCER RES, V63, P7377; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schumacher M, 2007, J NEUROSURG, V106, P111, DOI 10.3171/ped.2007.106.2.111; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takada N, 2010, GLIA, V58, P996, DOI 10.1002/glia.20981; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thirant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016375; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	79	168	171	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30313	10.1371/journal.pone.0030313	http://dx.doi.org/10.1371/journal.pone.0030313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389665	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600002
J	Kumari, M; Sachar, S; Saxena, RK				Kumari, Mandavi; Sachar, Sumedha; Saxena, Rajiv K.			Loss of Proliferation and Antigen Presentation Activity following Internalization of Polydispersed Carbon Nanotubes by Primary Lung Epithelial Cells	PLOS ONE			English	Article							PULMONARY TOXICITY; BLACK PARTICLES	Interactions between poly-dispersed acid functionalized single walled carbon nanotubes (AF-SWCNTs) and primary lung epithelial (PLE) cells were studied. Peritoneal macrophages (PMs, known phagocytic cells) were used as positive controls in this study. Recovery of live cells from cultures of PLE cells and PMs was significantly reduced in the presence of AF-SWCNTs, in a time and dose dependent manner. Both PLE cells as well as PMs could take up fluorescence tagged AF-SWCNTs in a time dependent manner and this uptake was significantly blocked by cytochalasin D, an agent that blocks the activity of acto-myosin fibers and therefore the phagocytic activity of cells. Confocal microscopic studies confirmed that AF-SWCNTs were internalized by both PLE cells and PMs. Intra-trachially instilled AF-SWCNTs could also be taken up by lung epithelial cells as well as alveolar macrophages. Freshly isolated PLE cells had significant cell division activity and cell cycling studies indicated that treatment with AF-SWCNTs resulted in a marked reduction in S-phase of the cell cycle. In a previously standardized system to study BCG antigen presentation by PLE cells and PMs to sensitized T helper cells, AF-SWCNTs could significantly lower the antigen presentation ability of both cell types. These results show that mouse primary lung epithelial cells can efficiently internalize AF-SWCNTs and the uptake of nanotubes interfered with biological functions of PLE cells including their ability to present BCG antigens to sensitized T helper cells.	[Kumari, Mandavi; Sachar, Sumedha; Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Saxena, Rajiv K.] S Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi	Kumari, M (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rajivksaxena@hotmail.com			Department of Science and Technology, Government of India [SR/NM/NS-50/2008]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was supported bt a grant (SR/NM/NS-50/2008) from the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bianco A, 2003, ADV MATER, V15, P1765, DOI 10.1002/adma.200301646; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Kam NWS, 2006, PHYS STATUS SOLIDI B, V243, P3561, DOI 10.1002/pssb.200669226; Kumari M, 2011, INFECT IMMUN, V79, P3159, DOI 10.1128/IAI.05406-11; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Mercer RR, 2008, AM J PHYSIOL-LUNG C, V294, pL87, DOI 10.1152/ajplung.00186.2007; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Saxena RK, 2007, NANOTOXICOLOGY, V1, P291, DOI 10.1080/17435390701803110; Saxena RK, 2008, BIOTECHNIQUES, V44, P799, DOI 10.2144/000112754; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2008, AM J RESP CELL MOL, V38, P579, DOI 10.1165/rcmb.2007-0255OC; Tong HY, 2009, TOXICOL APPL PHARM, V239, P224, DOI 10.1016/j.taap.2009.05.019; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228	18	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31890	10.1371/journal.pone.0031890	http://dx.doi.org/10.1371/journal.pone.0031890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384094	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500044
J	Berentzen, TL; Angquist, L; Kotronen, A; Borra, R; Yki-Jarvinen, H; Iozzo, P; Parkkola, R; Nuutila, P; Ross, R; Allison, DB; Heymsfield, SB; Overvad, K; Sorensen, TIA; Jakobsen, MU				Berentzen, Tina Landsvig; Angquist, Lars; Kotronen, Anna; Borra, Ronald; Yki-Jarvinen, Hannele; Iozzo, Patricia; Parkkola, Riitta; Nuutila, Pirjo; Ross, Robert; Allison, David B.; Heymsfield, Steven B.; Overvad, Kim; Sorensen, Thorkild I. A.; Jakobsen, Marianne Uhre			Waist Circumference Adjusted for Body Mass Index and Intra-Abdominal Fat Mass	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; LIVER FAT; WEIGHT-LOSS; OBESITY; EXERCISE; PREDICTION; MEN	Background: The association between waist circumference (WC) and mortality is particularly strong and direct when adjusted for body mass index (BMI). One conceivable explanation for this association is that WC adjusted for BMI is a better predictor of the presumably most harmful intra-abdominal fat mass (IAFM) than WC alone. We studied the prediction of abdominal subcutaneous fat mass (ASFM) and IAFM by WC alone and by addition of BMI as an explanatory factor. Methodology/Principal Findings: WC, BMI and magnetic resonance imaging data from 742 men and women who participated in clinical studies in Canada and Finland were pooled. Total adjusted squared multiple correlation coefficients (R-2) of ASFM and IAFM were calculated from multiple linear regression models with WC and BMI as explanatory variables. Mean BMI and WC of the participants in the pooled sample were 30 kg/m(2) and 102 cm, respectively. WC explained 29% of the variance in ASFM and 51% of the variance in IAFM. Addition of BMI to WC added 28% to the variance explained in ASFM, but only 1% to the variance explained in IAFM. Results in subgroups stratified by study center, sex, age, obesity level and type 2 diabetes status were not systematically different. Conclusion/Significance: The prediction of IAFM by WC is not improved by addition of BMI.	[Berentzen, Tina Landsvig; Angquist, Lars; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Kotronen, Anna; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Div Diabet, Helsinki, Finland; [Kotronen, Anna] Minerva Med Res Inst, Helsinki, Finland; [Borra, Ronald; Iozzo, Patricia; Parkkola, Riitta; Nuutila, Pirjo] Univ Turku, Turku PET Ctr, Turku, Finland; [Borra, Ronald; Parkkola, Riitta] Univ Turku, Dept Radiol, Turku, Finland; [Borra, Ronald; Parkkola, Riitta] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland; [Iozzo, Patricia] CNR, Inst Clin Physiol, Pisa, Italy; [Nuutila, Pirjo] Univ Turku, Dept Med, Turku, Finland; [Nuutila, Pirjo] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Ross, Robert] Queens Univ, Dept Med, Sch Kinesiol & Hlth Studies, Div Endocrinol & Metab, Kingston, ON K7L 3N6, Canada; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark	University of Copenhagen; University of Helsinki; University of Turku; University of Turku; University of Turku; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Turku; University of Turku; Queens University - Canada; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Berentzen, TL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	tb@ipm.regionh.dk	Iozzo, P/O-2893-2015; Jakobsen, Marianne Uhre/I-8550-2018; Parkkola, Riitta/AAZ-1341-2020; Heymsfield, Steven B/N-1968-2017; Nuutila, Pirjo/J-2087-2012	Iozzo, P/0000-0001-6443-7074; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Heymsfield, Steven B/0000-0003-1127-9425; Overvad, Kim/0000-0001-6429-7921; Borra, Ronald/0000-0001-8072-1243; Nuutila, Pirjo/0000-0001-9597-338X; Allison, David/0000-0003-3566-9399; Angquist, Lars/0000-0002-9516-4424	European Union [LSHM-CT-2005-018734, Health-F2-2009-241762]; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research [2101-06-0005]	European Union(European Commission); Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was funded by and carried out as a part of two related projects supported by the European Union: Hepadip (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome) under the 6th Framework Program (contract LSHM-CT-2005-018734) and Flip (fatty liver inhibition of progression) under the Seventh Framework Programme (FP7/2007-2013, grant agreement no Health-F2-2009-241762. This work was also supported by the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; Arner P, 1998, LANCET, V351, P1301, DOI 10.1016/S0140-6736(05)79052-8; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; Borra R, 2008, METABOLISM, V57, P1445, DOI 10.1016/j.metabol.2008.05.015; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Bucci M, 2012, CARDIOVASC THER, V30, P333, DOI 10.1111/j.1755-5922.2011.00275.x; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Heitmann BL, 2010, OBES REV; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lautamaki R, 2006, AM J PHYSIOL-ENDOC M, V291, pE282, DOI 10.1152/ajpendo.00604.2005; Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Ross R, 1996, J APPL PHYSIOL, V81, P2445, DOI 10.1152/jappl.1996.81.6.2445; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Viljanen APM, 2009, J CLIN ENDOCR METAB, V94, P50, DOI 10.1210/jc.2008-1689; Virtanen KA, 2003, DIABETES, V52, P283, DOI 10.2337/diabetes.52.2.283; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	30	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32213	10.1371/journal.pone.0032213	http://dx.doi.org/10.1371/journal.pone.0032213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384179	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800028
J	Santi-Rocca, J; Smith, S; Weber, C; Pineda, E; Hon, CC; Saavedra, E; Olivos-Garcia, A; Rousseau, S; Dillies, MA; Coppee, JY; Guillen, N				Santi-Rocca, Julien; Smith, Sherri; Weber, Christian; Pineda, Erika; Hon, Chung-Chau; Saavedra, Emma; Olivos-Garcia, Alfonso; Rousseau, Sandrine; Dillies, Marie-Agnes; Coppee, Jean-Yves; Guillen, Nancy			Endoplasmic Reticulum Stress-Sensing Mechanism Is Activated in Entamoeba histolytica upon Treatment with Nitric Oxide	PLOS ONE			English	Article							CYSTEINE; INFLAMMATION; GLYCOLYSIS; METABOLISM; EXPRESSION; TRANSPORT; VIRULENCE; SURVIVAL; GENES	The Endoplasmic Reticulum stores calcium and is a site of protein synthesis and modification. Changes in ER homeostasis lead to stress responses with an activation of the unfolded protein response (UPR). The Entamoeba histolytica endomembrane system is simple compared to those of higher eukaryotes, as a canonical ER is not observed. During amoebiasis, an infection of the human intestine and liver by E. histolytica, nitric oxide (NO) triggers an apoptotic-like event preceded by an impairment of energy production and a loss of important parasite pathogenic features. We address the question of how this ancient eukaryote responds to stress induced by immune components (i.e. NO) and whether stress leads to ER changes and subsequently to an UPR. Gene expression analysis suggested that NO triggers stress responses marked by (i) dramatic up-regulation of hsp genes although a bona fide UPR is absent; (ii) induction of DNA repair and redox gene expression and iii) up-regulation of glycolysis-related gene expression. Enzymology approaches demonstrate that NO directly inhibits glycolysis and enhance cysteine synthase activity. Using live imaging and confocal microscopy we found that NO dramatically provokes extensive ER fragmentation. ER fission in E. histolytica appears as a protective response against stress, as it has been recently proposed for neuron self-defense during neurologic disorders. Chronic ER stress is also involved in metabolic diseases including diabetes, where NO production reduces ER calcium levels and activates cell death. Our data highlighted unique cellular responses of interest to understand the mechanisms of parasite death during amoebiasis.	[Santi-Rocca, Julien; Smith, Sherri; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Santi-Rocca, Julien; Smith, Sherri; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy] INSERM, U786, Paris, France; [Pineda, Erika; Saavedra, Emma] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico; [Olivos-Garcia, Alfonso] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Rousseau, Sandrine] Inst Pasteur, Bioinformat Grp Genom Anal, Genomes & Genet Dept, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institute of Cardiology - Mexico; Universidad Nacional Autonoma de Mexico; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Santi-Rocca, J (corresponding author), Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France.	nguillen@pasteur.fr	Santi-Rocca, Julien/AAD-2448-2020; Saavedra, Emma/ABB-8989-2020; Weber, Christian/AAW-2153-2020	Santi-Rocca, Julien/0000-0002-9791-3521; Weber, Christian/0000-0003-4610-8714; Saavedra, Emma/0000-0001-8661-9813; Hon, Chung-Chau/0000-0002-3741-7577; Pineda, Erika/0000-0003-2386-1586; Moreira, Sandrine/0000-0002-4580-3566	Pasteur-Weizmann Research Council; French National Research Agency (Intestinalamibe); CONACyT, Mexico [83084]; "Ministere delegue a l'Enseignement Superieur et a la Recherche"; "Regime Social des Independants"; "Fondation pour la Recherche Medicale" in France; Pasteur Foundation; Institut Pasteur	Pasteur-Weizmann Research Council; French National Research Agency (Intestinalamibe)(French National Research Agency (ANR)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Ministere delegue a l'Enseignement Superieur et a la Recherche"; "Regime Social des Independants"; "Fondation pour la Recherche Medicale" in France(Institut National du Cancer (INCA) France); Pasteur Foundation; Institut Pasteur(European Commission)	This work is supported by grants to NG from the Pasteur-Weizmann Research Council, the French National Research Agency (Intestinalamibe) and from grant 83084 CONACyT, Mexico, to ES. JSR received a PhD fellowship from the "Ministere delegue a l'Enseignement Superieur et a la Recherche", the "Regime Social des Independants" and the "Fondation pour la Recherche Medicale" in France. SS is supported by a fellowship of the Pasteur Foundation and CCH from the Roux Fellowship of the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Benjamini Y, 2001, ANN STAT, V29, P1165; Blazquez S, 2007, INT J PARASITOL, V37, P425, DOI 10.1016/j.ijpara.2006.10.008; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DIAMOND LS, 1961, SCIENCE, V134, P336, DOI 10.1126/science.134.3475.336; Fonseca SG, 2011, TRENDS ENDOCRINOL ME; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Girard-Misguich F, 2008, MOL BIOCHEM PARASIT, V157, P236, DOI 10.1016/j.molbiopara.2007.10.014; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gosline SJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019118; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hostetter DR, 2007, J BIOL CHEM, V282, P27865, DOI 10.1074/jbc.M704312200; Isakov E, 2008, MOL BIOCHEM PARASIT, V158, P82, DOI 10.1016/j.molbiopara.2007.11.014; Kucharz K, 2011, J NEUROSCI RES, V89, P1150, DOI 10.1002/jnr.22646; Lee JY, 2007, INT J ONCOL, V31, P685; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Nepusz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-120; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Olivos-Garcia A, 2004, EXP MOL PATHOL, V77, P66, DOI 10.1016/j.yexmp.2003.09.003; Pineda E, 2010, FEBS J, V277, P3382, DOI 10.1111/j.1742-4658.2010.07743.x; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Saavedra E, 2007, FEBS J, V274, P4922, DOI 10.1111/j.1742-4658.2007.06012.x; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Teixeira JE, 2008, EUKARYOT CELL, V7, P1222, DOI 10.1128/EC.00007-08; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Vicente JB, 2008, CELL MICROBIOL; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Weber C, 2009, MOL BIOCHEM PARASIT, V164, P165, DOI 10.1016/j.molbiopara.2008.12.005	41	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31777	10.1371/journal.pone.0031777	http://dx.doi.org/10.1371/journal.pone.0031777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384074	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800019
J	Yan, JH; Zhou, S; Li, YP				Yan, Jianhua; Zhou, Sheng; Li, Yongping			Benign Orbital Tumors with Bone Destruction in Children	PLOS ONE			English	Article							SOLITARY FIBROUS TUMOR; OF-THE-LITERATURE; INTRAOSSEOUS HEMANGIOMA; CAVERNOUS HEMANGIOMA; LEIOMYOMA; HEMANGIOPERICYTOMA; RESORPTION; EROSION	Purpose: To present rare benign orbital tumors with bone destruction in children who could not be diagnosed presurgically and may simulate malignant ones. Methods: A retrospective review of cases. Clinical, operative and pathological records in all children with a diagnosis of benign orbital tumors who showed remarkable bone destruction at a tertiary Ophthalmic Center in China between Jan 1, 2000 and Dec 31, 2009 were reviewed. All patients had definitive histopathologic diagnosis. Results: Eight patients with benign orbital tumors showed obvious bone destruction, including six cases of eosinophilic granuloma, one case of leiomyoma and one case of primary orbital intraosseous hemangioma. Among them, three patients were females and five patients were males. Tumors were unilateral in all cases, with both the right and left side affected equally. Age ranged from 3 to 7 years (mean 4.1 years). Symptom duration ranged from 1 to 5 weeks (mean 4.8 weeks). Eyelid swelling and palpable mass were the most common complaint. There was no evidence for multifocal involvement in cases with eosinophilic granuloma. Among six patients with eosinophilic granuloma, two were treated with low dose radiation (10 Gy), three received systemic corticosteroid and one was periodically observed only after incisional biopsy or subtotal curettage. There was no postoperative therapeutic intervention in the two patients with leiomyoma and intraosseous hemangioma. All eight patients regained normal vision without local recurrence after a mean follow-up time of 32.8 months. Conclusion: Benign orbital tumors such as isolated eosinophilic granuloma, leiomyoma and primary orbital intraosseous hemangioma may show remarkable bone destruction.	[Yan, Jianhua; Zhou, Sheng; Li, Yongping] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yan, JH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	Yan2011@tom.com		yan, jian hua/0000-0001-7564-8491				Arat YO, 2005, OPHTHAL PLAST RECONS, V21, P16, DOI 10.1097/01.IOP.0000150426.79781.54; Ben Simon GJ, 2005, OPHTHALMOLOGY, V112, P2196, DOI 10.1016/j.ophtha.2005.09.013; Bernardini FP, 2003, OPHTHALMOLOGY, V110, P1442, DOI 10.1016/S0161-6420(03)00459-7; Bidar M, 2007, OPHTHAL PLAST RECONS, V23, P87, DOI 10.1097/IOP.0b013e3180333a85; Billings SD, 2001, AM J SURG PATHOL, V25, P1134, DOI 10.1097/00000478-200109000-00003; BOCKMAN RS, 1981, J EXP MED, V154, P529, DOI 10.1084/jem.154.2.529; Calsina M, 2011, ORBIT, V30, P180, DOI 10.3109/01676830.2011.574773; Chung EM, 2008, RADIOGRAPHICS, V28, P1193, DOI 10.1148/rg.284085013; Colombo F, 2001, AM J OPHTHALMOL, V131, P151, DOI 10.1016/S0002-9394(00)00649-8; Furusato E, 2011, HUM PATHOL, V42, P120, DOI 10.1016/j.humpath.2010.05.021; Gengler C, 2006, HISTOPATHOLOGY, V48, P63, DOI 10.1111/j.1365-2559.2005.02290.x; GLOWACKI KA, 1995, J HAND SURG-AM, V20A, P1011, DOI 10.1016/S0363-5023(05)80151-0; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; Gunduz K, 2007, J AAPOS, V11, P506, DOI 10.1016/j.jaapos.2007.03.016; Gunduz K, 2004, SURV OPHTHALMOL, V49, P237, DOI 10.1016/j.survophthal.2003.12.010; Harris Gerald J, 2003, Trans Am Ophthalmol Soc, V101, P93; Harris GJ, 2003, T AM OPHTHAL SOC, V101, P103; Hayashi Y, 2009, CLIN NEUROL NEUROSUR, V111, P34, DOI 10.1016/j.clineuro.2008.07.010; Lin IC, 2005, OPHTHAL PLAST RECONS, V21, P451, DOI 10.1097/01.iop.0000185089.78226.15; LYON DB, 1992, OPHTHALMOLOGY, V99, P1773; Madge SN, 2009, OPHTHAL PLAST RECONS, V25, P37, DOI 10.1097/IOP.0b013e318192a27e; MARUSIC A, 1991, ENDOCRINOLOGY, V129, P2699, DOI 10.1210/endo-129-5-2699; Merani R, 2005, CLIN EXP OPHTHALMOL, V33, P408, DOI 10.1111/j.1442-9071.2005.01034.x; Mynatt CJ, 2011, HEAD NECK PATHOL, V5, P205, DOI 10.1007/s12105-011-0260-4; Rodrigues EB, 2006, OPHTHAL PLAST RECONS, V22, P292, DOI 10.1097/01.iop.0000226900.79557.cf; Rootman Jack, 2003, Orbit, V22, P103, DOI 10.1076/orbi.22.2.103.14311; Sweet C, 1997, AM J NEURORADIOL, V18, P379; Vosoghi H, 2009, OPHTHAL PLAST RECONS, V25, P430, DOI 10.1097/IOP.0b013e3181b80cad; Yan JH, 2006, GRAEF ARCH CLIN EXP, V244, P1534, DOI 10.1007/s00417-005-0188-z; Yates BJ, 2001, FOOT ANKLE INT, V22, P670, DOI 10.1177/107110070102200810	30	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32111	10.1371/journal.pone.0032111	http://dx.doi.org/10.1371/journal.pone.0032111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384155	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916800025
J	Dainat, B; Evans, JD; Chen, YP; Gauthier, L; Neumann, P				Dainat, Benjamin; Evans, Jay D.; Chen, Yan Ping; Gauthier, Laurent; Neumann, Peter			Predictive Markers of Honey Bee Colony Collapse	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA L.; VARROA-DESTRUCTOR; PARALYSIS VIRUS; NOSEMA-CERANAE; WINTER LOSSES; INNATE IMMUNE; TRANSMISSION; KASHMIR; INFECTIONS	Across the Northern hemisphere, managed honey bee colonies, Apis mellifera, are currently affected by abrupt depopulation during winter and many factors are suspected to be involved, either alone or in combination. Parasites and pathogens are considered as principal actors, in particular the ectoparasitic mite Varroa destructor, associated viruses and the microsporidian Nosema ceranae. Here we used long term monitoring of colonies and screening for eleven disease agents and genes involved in bee immunity and physiology to identify predictive markers of honeybee colony losses during winter. The data show that DWV, Nosema ceranae, Varroa destructor and Vitellogenin can be predictive markers for winter colony losses, but their predictive power strongly depends on the season. In particular, the data support that V. destructor is a key player for losses, arguably in line with its specific impact on the health of individual bees and colonies.	[Dainat, Benjamin; Gauthier, Laurent; Neumann, Peter] Swiss Bee Res Ctr, Agroscope Liebefeld Posieux Res Stn ALP, Bern, Switzerland; [Evans, Jay D.; Chen, Yan Ping] ARS, Bee Res Lab, USDA, Beltsville, MD USA; [Neumann, Peter] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Swiss Federal Research Station Agroscope; United States Department of Agriculture (USDA); Rhodes University	Dainat, B (corresponding author), Swiss Bee Res Ctr, Agroscope Liebefeld Posieux Res Stn ALP, Bern, Switzerland.	benjamin.dainat@alp.admin.ch	Neumann, Peter/C-9964-2015; Evans, Jay D/C-8408-2012; Dainat, Benjamin/AFN-8922-2022	Neumann, Peter/0000-0001-5163-5215; Evans, Jay D/0000-0002-0036-4651; Dainat, Benjamin/0000-0002-1740-7136	Swiss Federal Veterinary Office	Swiss Federal Veterinary Office	This work was supported by a grant of the Swiss Federal Veterinary Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, TRENDS ECOL IN PRESS, V27; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; ANDERSON DL, 1988, J GEN VIROL, V69, P1617, DOI 10.1099/0022-1317-69-7-1617; BAILEY L, 1963, VIROLOGY, V21, P390, DOI 10.1016/0042-6822(63)90200-9; Ball B.V., 1988, P457; BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chauzat MP, 2010, J APICULT RES, V49, P40, DOI 10.3896/IBRA.1.49.1.06; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Dainat B, 2012, ENV MICROBIOL REP, V4, P123, DOI 10.1111/j.1758-2229.2011.00312.x; DALL DJ, 1985, ANN APPL BIOL, V106, P461, DOI 10.1111/j.1744-7348.1985.tb03136.x; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Fievet J, VIROLOGY J, V3, P1; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goodwin RM, 2006, J APICULT RES, V45, P155, DOI 10.1080/00218839.2006.11101335; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, ENV MICROBIOL, V10, P2659; Higes M, 2010, ENV MICROBIOL REP, V2, P745, DOI 10.1111/j.1758-2229.2010.00170.x; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Highfield AC, APPL ENV MICROBIOL, V75, P7212; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; IMDORF A, 2003, APIACTA, V38, P258; Imdorf A, 1998, BEE BIZ, V7, P37; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; MERZ R, 1979, REV SUISSE ZOOL, V86, P663, DOI 10.5962/bhl.part.82329; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ribiere M., 2008, VIROLOGY HONEY BEE, P15, DOI DOI 10.1016/J.JVIROMET.2019.04.020; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Schafer MO, 2010, J ECON ENTOMOL, V103, P10, DOI 10.1603/EC09233; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, APPL ENV MICROBIOL, V70, P7185; Santillan-Galicia MT, 2010, J APICULT RES, V49, P141, DOI 10.3896/IBRA.1.49.2.01; TRENCZEK T, 1988, INSECT BIOCHEM, V18, P299, DOI 10.1016/0020-1790(88)90095-9; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	72	240	248	4	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32151	10.1371/journal.pone.0032151	http://dx.doi.org/10.1371/journal.pone.0032151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384162	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100055
J	Falcone, R; Brunamonti, E; Ferraina, S; Genovesio, A				Falcone, Rossella; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo			Monkeys Monitor Human Goals in a Nonmatch-to-Goal Interactive Task	PLOS ONE			English	Article							RHESUS-MONKEYS; CAPUCHIN MONKEYS; CEBUS-APELLA; COGNITIVE IMITATION; PREFRONTAL CORTEX; MACACA-MULATTA; GAZE; RESPONSES; NEURONS	We designed a new task, called nonmatch-to-goal, to study the ability of macaque monkeys to interact with humans in a rule-guided paradigm. In this task the monkeys were required to choose one of two targets, from a list of three. For each choice, they were required to switch from their choice on the previous trial to a different one. In a subset of trials the monkeys observed a human partner performing the task. When the human concluded his turn, the monkeys were required to switch to a new goal discarding the human's previous goal. We found that monkeys were very skillful in monitoring goals, not only of their own choice by also those of their human partner. They showed also a surprising ability to coordinate their actions, taking turns with the human partner, starting and stopping their own turn following the decision of the human partner in the task.	[Falcone, Rossella; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	Sapienza University Rome	Falcone, R (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	aldo.genovesio@uniroma1.it	ferraina, stefano/M-5230-2018	ferraina, stefano/0000-0001-6100-2438; FALCONE, ROSSELLA/0000-0001-5068-2984; Brunamonti, Emiliano/0000-0002-5119-6950; Genovesio, Aldo/0000-0003-2521-143X	'Sapienza' University of Rome; Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie [P288/09]	'Sapienza' University of Rome; Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie	This work was supported by the 'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie (Protocol number: P288/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Anderson JR, 1996, BEHAV PROCESS, V37, P47, DOI 10.1016/0376-6357(95)00074-7; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; Custance D, 1999, J COMP PSYCHOL, V113, P13, DOI 10.1037/0735-7036.113.1.13; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fredman T, 2008, ANIM COGN, V11, P295, DOI 10.1007/s10071-007-0117-0; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2011, PERSPECT PSYCHOL SCI, V6, P369, DOI 10.1177/1745691611413392; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A, NEUROSCIENCE RULE GU, P81; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Hauser MD, 2007, P ROY SOC B-BIOL SCI, V274, P1913, DOI 10.1098/rspb.2007.0586; Hauser MD, 2011, P ROY SOC B-BIOL SCI, V278, P158, DOI 10.1098/rspb.2010.1441; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; MYERS WA, 1970, J EXP ANAL BEHAV, V14, P225, DOI 10.1901/jeab.1970.14-225; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Sebastian C, 2008, TRENDS COGN SCI, V12, P441, DOI 10.1016/j.tics.2008.07.008; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Subiaul F, 2007, ANIM COGN, V10, P369, DOI 10.1007/s10071-006-0070-3; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; VISALBERGHI E, 1989, PRIMATES, V30, P511, DOI 10.1007/BF02380877; VISALBERGHI E, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P138; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32209	10.1371/journal.pone.0032209	http://dx.doi.org/10.1371/journal.pone.0032209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384177	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100059
J	Choi, SH; Wiesner, P; Almazan, F; Kim, J; Miller, YI				Choi, Soo-Ho; Wiesner, Philipp; Almazan, Felicidad; Kim, Jungsu; Miller, Yury I.			Spleen Tyrosine Kinase Regulates AP-1 Dependent Transcriptional Response to Minimally Oxidized LDL	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTORS; KAPPA-B; MACROPHAGES; SYK; ACTIVATION; ATHEROSCLEROSIS; PHOSPHORYLATION; ACCUMULATION; OXIDATION	Oxidative modification of low-density lipoprotein (LDL) turns it into an endogenous ligand recognized by pattern-recognition receptors. We have demonstrated that minimally oxidized LDL (mmLDL) binds to CD14 and mediates TLR4/MD-2-dependent responses in macrophages, many of which are MyD88-independent. We have also demonstrated that the mmLDL activation leads to recruitment of spleen tyrosine kinase (Syk) to TLR4 and TLR4 and Syk phosphorylation. In this study, we produced a macrophage-specific Syk knockout mouse and used primary Syk(-/-) macrophages in our studies. We demonstrated that Syk mediated phosphorylation of ERK1/2 and JNK, which in turn phosphorylated c-Fos and c-Jun, respectively, as assessed by an in vitro kinase assay. c-Jun phosphorylation was also mediated by IKK epsilon. c-Jun and c-Fos bound to consensus DNA sites and thereby completed an AP-1 transcriptional complex and induced expression of CXCL2 and IL-6. These results suggest that Syk plays a key role in TLR4-mediated macrophage responses to host-generated ligands, like mmLDL, with subsequent activation of an AP-1 transcription program.	[Choi, Soo-Ho; Wiesner, Philipp; Almazan, Felicidad; Kim, Jungsu; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Choi, SH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	yumiller@ucsd.edu			National Institutes of Health [HL081862, HL088093]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL081862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants HL081862 and HL088093 as well as a grant from the Leducq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Harkewicz R, 2008, J BIOL CHEM, V283, P10241, DOI 10.1074/jbc.M709006200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hilgendorf I, 2011, ARTERIOSCL THROM VAS, V31, P1991, DOI 10.1161/ATVBAHA.111.230847; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2005, FUTUR CARDIOL, V1, P785, DOI 10.2217/14796678.1.6.785; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miller YI, 2009, TRENDS CARDIOVAS MED, V19, P227, DOI 10.1016/j.tcm.2010.02.001; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Sweeney SE, 2005, J IMMUNOL, V174, P6424, DOI 10.4049/jimmunol.174.10.6424; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Ulanova M, 2007, J ENDOTOXIN RES, V13, P117, DOI 10.1177/0968051907079125; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32378	10.1371/journal.pone.0032378	http://dx.doi.org/10.1371/journal.pone.0032378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384232	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500097
J	van der Veen, DR; Shao, JP; Chapman, S; Leevy, WM; Duffield, GE				van der Veen, Daan R.; Shao, Jinping; Chapman, Sarah; Leevy, W. Matthew; Duffield, Giles E.			A 24-Hour Temporal Profile of In Vivo Brain and Heart PET Imaging Reveals a Nocturnal Peak in Brain F-18-Fluorodeoxyglucose Uptake	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; OLFACTORY-BULB; F-18-FDG PET; MOUSE-BRAIN; CLOCK GENES; ACCUMULATION; METABOLISM; EXPRESSION	Using positron emission tomography, we measured in vivo uptake of F-18-fluorodeoxyglucose (FDG) in the brain and heart of C57Bl/6 mice at intervals across a 24-hour light-dark cycle. Our data describe a significant, high amplitude rhythm in FDG uptake throughout the whole brain, peaking at the mid-dark phase of the light-dark cycle, which is the active phase for nocturnal mice. Under these conditions, heart FDG uptake did not vary with time of day, but did show biological variation throughout the 24-hour period for measurements within the same mice. FDG uptake was scanned at different times of day within an individual mouse, and also compared to different times of day between individuals, showing both biological and technical reproducibility of the 24-hour pattern in FDG uptake. Regional analysis of brain FDG uptake revealed especially high amplitude rhythms in the olfactory bulb and cortex, while low amplitude rhythms were observed in the amygdala, brain stem and hypothalamus. Low amplitude 24-hour rhythms in regional FDG uptake may be due to multiple rhythms with different phases in a single brain structure, quenching some of the amplitude. Our data show that the whole brain exhibits significant, high amplitude daily variation in glucose uptake in living mice. Reports applying the 2-deoxy-D[C-14]-glucose method for the quantitative determination of the rates of local cerebral glucose utilization indicate only a small number of brain regions exhibiting a day versus night variation in glucose utilization. In contrast, our data show 24-hour patterns in glucose uptake in most of the brain regions examined, including several regions that do not show a difference in glucose utilization. Our data also emphasizes a methodological requirement of controlling for the time of day of scanning FDG uptake in the brain in both clinical and pre-clinical settings, and suggests waveform normalization of FDG measurements at different times of the day.	[van der Veen, Daan R.; Shao, Jinping; Duffield, Giles E.] Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA; [Shao, Jinping] Nankai Univ, Sch Med, Dept Physiol, Tianjin 300071, Peoples R China; [Chapman, Sarah; Leevy, W. Matthew] Univ Notre Dame, Notre Dame Integrated Imaging Facil, Notre Dame, IN 46556 USA; [Leevy, W. Matthew] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; Nankai University; University of Notre Dame; University of Notre Dame	van der Veen, DR (corresponding author), Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	van der Veen, Daan R/T-1013-2017	van der Veen, Daan R/0000-0001-8037-1407	American Heart Association [10SDG4030011]; National Institute of General Medical Sciences [R01-GM087508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to GED from the American Heart Association (10SDG4030011) and the National Institute of General Medical Sciences (R01-GM087508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Aeschbach D, 1997, NEUROSCI LETT, V239, P121, DOI 10.1016/S0304-3940(97)00904-X; Amir S, 1999, NEUROSCIENCE, V92, P1165, DOI 10.1016/S0306-4522(99)00222-5; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Basu S, 2008, J NUCL MED, V49, p17N; Best JD, 1999, J NEUROSCI, V19, P828; Beyer T, 2000, J NUCL MED, V41, P1369; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cantwell EL, 2002, BRAIN RES BULL, V57, P603, DOI 10.1016/S0361-9230(01)00753-5; CASSONE VM, 1988, BRAIN RES, V459, P178, DOI 10.1016/0006-8993(88)90301-0; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; CRANE PD, 1980, J NEUROCHEM, V34, P1700, DOI 10.1111/j.1471-4159.1980.tb11263.x; Davidson AJ, 2005, CLIN EXP HYPERTENS, V27, P307, DOI 10.1081/CEH-200048933; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Fueger BJ, 2006, J NUCL MED, V47, P999; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; GROPLER RJ, 1990, J NUCL MED, V31, P1749; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; Hjelstuen OK, 2011, EUR J PHARM BIOPHARM, V78, P307, DOI 10.1016/j.ejpb.2011.01.002; JAY TM, 1985, BRAIN RES, V342, P297, DOI 10.1016/0006-8993(85)91129-1; Kalsbeek A, 2011, FEBS LETT, V585, P1412, DOI 10.1016/j.febslet.2011.03.021; Karaganis SP, 2009, GEN COMP ENDOCR, V161, P179, DOI 10.1016/j.ygcen.2008.12.015; Kim C, 2011, NUCL MED MOLEC IMAG, V45, P169, DOI 10.1007/s13139-011-0087-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KNUUTI MJ, 1992, J NUCL MED, V33, P1255; Kreissl M. C., 2011, EUROPEAN J NUCL MED, V1, P1; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Nanni C, 2007, NUCL MED COMMUN, V28, P547, DOI 10.1097/MNM.0b013e3281fbd42b; PAULY JE, 1967, AM J ANAT, V120, P627, DOI 10.1002/aja.1001200312; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; RIVKEES SA, 1988, J NEUROSCI, V8, P4269; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; ROOM P, 1989, BRAIN RES, V505, P321, DOI 10.1016/0006-8993(89)91460-1; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Schnockel U, 2010, EUR J PHARM BIOPHARM, V74, P50, DOI 10.1016/j.ejpb.2009.05.012; SCHWARTZ WJ, 1983, BRAIN RES, V274, P184, DOI 10.1016/0006-8993(83)90538-3; Schwartz WJ, 1991, SUPRACHIASMATIC NUCL, P144; Shimoji K, 2004, J NUCL MED, V45, P665; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Taegtmeyer H, 2010, J NUCL MED, V51, p80S, DOI 10.2967/jnumed.109.068205; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741	56	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31792	10.1371/journal.pone.0031792	http://dx.doi.org/10.1371/journal.pone.0031792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384076	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500042
J	Tang, YJ; LeMaster, DM; Nauwelaers, G; Gu, D; Langouet, S; Turesky, RJ				Tang, Yijin; LeMaster, David M.; Nauwelaers, Gwendoline; Gu, Dan; Langouet, Sophie; Turesky, Robert J.			UDP-Glucuronosyltransferase-mediated Metabolic Activation of the Tobacco Carcinogen 2-Amino-9H-pyrido[2,3-b]indole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROCYCLIC AROMATIC-AMINES; CIGARETTE-SMOKE CONDENSATE; DNA ADDUCT FORMATION; A-ALPHA-C; MASS-SPECTROMETRY; IN-VITRO; EPIDEMIOLOGIC EVIDENCE; COLORECTAL-CANCER; N-GLUCURONIDATION; LIVER-MICROSOMES	2-Amino-9H-pyrido[2,3-b]indole (A alpha C) is a carcinogenic heterocyclic aromatic amine (HAA) that arises in tobacco smoke. UDP-glucuronosyltransferases (UGTs) are important enzymes that detoxicate many procarcinogens, including HAAs. UGTs compete with P450 enzymes, which bioactivate HAAs by N-hydroxylation of the exocyclic amine group; the resultantN-hydroxy-HAA metabolites form covalent adducts with DNA. We have characterized the UGT-catalyzed metabolic products of A alpha C and the genotoxic metabolite 2-hydroxyamino-9Hpyrido[2,3-b] indole (HONH-A alpha C) formed with human liver microsomes, recombinant human UGT isoforms, and human hepatocytes. The structures of the metabolites were elucidated by H-1 NMR and mass spectrometry. A alpha C and HONH-A alpha C underwent glucuronidation by UGTs to form, respectively, N-2-(beta-D-glucosiduronyl)- 2-amino-9H-pyrido[2,3-b] indole (A alpha C-N-2-Gl) and N-2-(beta-D-glucosidurony1)-2-hydroxyamino-9H-pyrido[2,3-b] indole (A alpha C-HON2-Gl). HONH-A alpha C also underwent glucuronidation to form a novel O-linked glucuronide conjugate, O(beta-D-glucosiduronyl)-2-hydroxyamino-9H-pyrido[2,3-b] indole (A alpha C-HN2-O-Gl). A alpha C-HN2-O-Glisabiologicallyreactivemetabolite and binds to calf thymus DNA (pH 5.0 or 7.0) to form the N-(deoxyguanosin-8-yl)-A alpha C adduct at 20-50-fold higher levels than the adduct levels formed with HONH-A alpha C. Major UGT isoforms were examined for their capacity to metabolize A alpha C and HONH-A alpha C. UGT1A4was the most catalytically efficient enzyme (V-max/K-m) at forming A alpha C-N-2-Gl (0.67 mu l.min(-1).mg of protein(-1)), and UGT1A9 was most catalytically efficient at forming A alpha C-HN-O-Gl (77.1 mu l.min(-1) mg of protein(-1)), whereasUGT1A1was most efficient at forming A alpha C-HON2-Gl (5.0 mu l.min(-1).mg of protein (-1)). Human hepatocytes produced A alpha C-N-2-Gl and A alpha C-(HNO)-O-2- Gl in abundant quantities, but A alpha C-HON2-Gl was a minor product. Thus, UGTs, usually important enzymes in the detoxication of many procarcinogens, serve as a mechanism of bioactivation of HONH-A alpha C.	[Tang, Yijin; Gu, Dan; Turesky, Robert J.] New York State Dept Hlth, Div Environm Hlth Sci, Wadsworth Ctr, Albany, NY 12201 USA; [LeMaster, David M.] New York State Dept Hlth, Div Translat Med, Wadsworth Ctr, Albany, NY 12201 USA; [Nauwelaers, Gwendoline; Langouet, Sophie] Univ Rennes 1, INSERM, U1085, IRSET,Federat Rech BioSit Rennes UMS 3480, F-35043 Rennes, France; [Nauwelaers, Gwendoline] La Haute Marche, ANSES, Fougeres Lab, Contaminant Toxicol Unit, F-35302 Fougeres, France	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; Wadsworth Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres	Turesky, RJ (corresponding author), New York State Dept Hlth, Div Environm Hlth Sci, Wadsworth Ctr, Albany, NY 12201 USA.	Rturesky@wadsworth.org	Langouet, Sophie A/I-2776-2015	Langouet, Sophie/0000-0002-0016-5425	National Institutes of Health [R01 CA122320, R01 CA134700]; INSERM, la Ligue contre le Cance; region Bretagne; Anses; College Doctoral International of the Universite Europeenne de Bretagne; NATIONAL CANCER INSTITUTE [R01CA134700, R01CA122320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM, la Ligue contre le Cance; region Bretagne(Region Bretagne); Anses; College Doctoral International of the Universite Europeenne de Bretagne; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA122320 and R01 CA134700 (to R. J. T.). This work was also supported by INSERM, la Ligue contre le Cancer, the region Bretagne and Anses for financial aid (to G. N. and S. L.), and the College Doctoral International of the Universite Europeenne de Bretagne for a travel fellowship (to G. N.).	[Anonymous], 2004, IARC MON EV CARC RIS, P1005; Bessette EE, 2010, CHEM RES TOXICOL, V23, P1234, DOI 10.1021/tx100098f; Bessette EE, 2009, ANAL CHEM, V81, P809, DOI 10.1021/ac802096p; Clement B, 2001, CHEM RES TOXICOL, V14, P319, DOI 10.1021/tx000105f; CRAMER JW, 1960, J BIOL CHEM, V235, P885; FENG PCC, 1983, DRUG METAB DISPOS, V11, P103; Frederiksen H, 2005, MOL NUTR FOOD RES, V49, P263, DOI 10.1002/mnfr.200400061; Frederiksen H, 2004, FOOD CHEM TOXICOL, V42, P879, DOI 10.1016/j.fct.2004.01.011; Frederiksen H, 2003, PHARMACOL TOXICOL, V92, P246, DOI 10.1034/j.1600-0773.2003.920508.x; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Glatt H, 2006, WOODHEAD PUBL FOOD S, P358, DOI 10.1533/9781845692018.2.358; Goodenough AK, 2007, CHEM RES TOXICOL, V20, P263, DOI 10.1021/tx0601713; Gu D, 2012, CARCINOGENESIS, V33, P124, DOI 10.1093/carcin/bgr252; Irving C. C., 1981, NATL CANCER I MONOGR, V58, P109; Irving C. C., 1973, METAB CONJUGATION, P53; Kadlubar F. F., 1985, POLYCYCLIC HYDROCARB, P341; KADLUBAR FF, 1977, CANCER RES, V37, P805; KATO R, 1986, CRIT REV TOXICOL, V16, P307, DOI 10.3109/10408448609037466; King RS, 2000, CARCINOGENESIS, V21, P1347, DOI 10.1093/carcin/21.7.1347; KRIEK E, 1992, J CANCER RES CLIN, V118, P481, DOI 10.1007/BF01225261; Lawley P. D., 1984, ACS MONOGR SER, V1, P324; Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; Luchtenborg M, 2007, CANCER EPIDEM BIOMAR, V16, P1341, DOI 10.1158/1055-9965.EPI-06-0519; Luukkanen L, 2005, DRUG METAB DISPOS, V33, P1017, DOI 10.1124/dmd.105.004093; Malfatti MA, 2004, CHEM RES TOXICOL, V17, P1137, DOI 10.1021/tx049898m; MILLER EC, 1978, CANCER RES, V38, P1479; MULDER GJ, 1977, BIOCHEM PHARMACOL, V26, P189, DOI 10.1016/0006-2952(77)90301-X; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Nauwelaers G, 2011, CHEM RES TOXICOL, V24, P913, DOI 10.1021/tx200091y; Nowell SA, 1999, CARCINOGENESIS, V20, P1107, DOI 10.1093/carcin/20.6.1107; Okonogi H, 1997, CANCER LETT, V111, P105, DOI 10.1016/S0304-3835(96)04505-3; Raza H, 1996, DRUG METAB DISPOS, V24, P395; Schaber G, 2001, DRUG METAB DISPOS, V29, P923; SHIMADA T, 1991, CANCER RES, V51, P5284; Smith CJ, 2004, J CHROMATOGR A, V1046, P211, DOI 10.1016/j.chroma.2004.06.082; SNYDERWINE EG, 1992, CHEM RES TOXICOL, V5, P843, DOI 10.1021/tx00030a018; STRAUB K, 1988, DRUG METAB DISPOS, V16, P359; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; TURESKY RJ, 1991, CARCINOGENESIS, V12, P1839, DOI 10.1093/carcin/12.10.1839; TURESKY RJ, 1990, CHEM RES TOXICOL, V3, P524, DOI 10.1021/tx00018a006; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; TURGEON J, 1992, DRUG METAB DISPOS, V20, P762; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; YOSHIDA D, 1980, CANCER LETT, V10, P141, DOI 10.1016/0304-3835(80)90037-3; YOSHIDA D, 1978, BIOCHEM BIOPH RES CO, V83, P915, DOI 10.1016/0006-291X(78)91482-1; Yuan ZX, 2007, CHEM RES TOXICOL, V20, P497, DOI 10.1021/tx600303d; Zenser TV, 2002, MUTAT RES-FUND MOL M, V506, P29, DOI 10.1016/S0027-5107(02)00149-5; Zenser TV, 1999, DRUG METAB DISPOS, V27, P1064; Zhang XB, 1996, CARCINOGENESIS, V17, P2259, DOI 10.1093/carcin/17.10.2259	51	17	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14960	14972		10.1074/jbc.M111.320093	http://dx.doi.org/10.1074/jbc.M111.320093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393056	Green Published, hybrid			2022-12-25	WOS:000304003200058
J	Navarrete, P; Magne, F; Araneda, C; Fuentes, P; Barros, L; Opazo, R; Espejo, R; Romero, J				Navarrete, Paola; Magne, Fabien; Araneda, Cristian; Fuentes, Pamela; Barros, Luis; Opazo, Rafael; Espejo, Romilio; Romero, Jaime			PCR-TTGE Analysis of 16S rRNA from Rainbow Trout (Oncorhynchus mykiss) Gut Microbiota Reveals Host-Specific Communities of Active Bacteria	PLOS ONE			English	Article							ATLANTIC SALMON; SOYBEAN-MEAL; INTESTINAL MICROBIOTA; PHYLOGENETIC ANALYSIS; MOLECULAR ANALYSIS; FISH-MEAL; ZEBRAFISH; DIVERSITY; MUCOSA; REPLACEMENT	This study assessed the relative contributions of host genetics and diet in shaping the gut microbiota of rainbow trout. Full sibling fish from four unrelated families, each consisting of individuals derived from the mating of one male and one female belonging to a breeding program, were fed diets containing either vegetable proteins or vegetable oils for two months in comparison to a control diet consisting of only fish protein and fish oil. Two parallel approaches were applied on the same samples: transcriptionally active bacterial populations were examined based on RNA analysis and were compared with bacterial populations obtained from DNA analysis. Comparison of temporal temperature gradient gel electrophoresis (TTGE) profiles from DNA and RNA showed important differences, indicating that active bacterial populations were better described by RNA analysis. Results showed that some bacterial groups were significantly (P<0.05) associated with specific families, indicating that microbiota composition may be influenced by the host. In addition, the effect of diet on microbiota composition was dependent on the trout family.	[Navarrete, Paola; Fuentes, Pamela; Barros, Luis; Opazo, Rafael; Espejo, Romilio; Romero, Jaime] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Region Metropol, Chile; [Magne, Fabien] Conservatoire Natl Arts & Metiers, Biol Lab, Paris, Ile De France, France; [Araneda, Cristian] Univ Chile, Fac Ciencias Agron, Santiago, Region Metropol, Chile	Universidad de Chile; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universidad de Chile	Navarrete, P (corresponding author), Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Region Metropol, Chile.	pnavarre@inta.cl	navarrete, paola/B-5371-2014; Magne, Fabien/F-1393-2014; Espejo, Romilio T/J-3183-2015; Romero, Jaime/I-2816-2013; Araneda, Cristian M/H-4036-2013	navarrete, paola/0000-0003-0692-2324; Magne, Fabien/0000-0002-8210-4561; Espejo, Romilio T/0000-0003-0495-4576; Romero, Jaime/0000-0001-9614-2393; Araneda, Cristian M/0000-0002-9986-5340	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [3100075, 1110253]; INNOVA [07CN13PBT-41]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INNOVA	This study was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT N<SUP>o</SUP>3100075, N<SUP>o</SUP>1110253) and INNOVA 07CN13PBT-41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Clayton D, 2007, HDB STAT GENETICS, P1216; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Heikkinen J, 2006, AQUACULTURE, V261, P259, DOI 10.1016/j.aquaculture.2006.07.012; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Huber I, 2004, J APPL MICROBIOL, V96, P117, DOI 10.1046/j.1365-2672.2003.02109.x; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Merrifield DL, 2009, AQUAC RES, V40, P1064, DOI 10.1111/j.1365-2109.2009.02200.x; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; Navarrete P, 2010, AQUAC RES, V41, pe667, DOI 10.1111/j.1365-2109.2010.02590.x; Navarrete P, 2010, FEMS MICROBIOL ECOL, V71, P148, DOI 10.1111/j.1574-6941.2009.00769.x; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ringo E, 1998, J APPL MICROBIOL, V85, P855, DOI 10.1046/j.1365-2672.1998.00595.x; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Romero J, 2001, J SHELLFISH RES, V20, P1235; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Sales J, 2009, BRIT J NUTR, V102, P1709, DOI 10.1017/S0007114509991279; Sharifuzzaman SM, 2010, FISH SHELLFISH IMMUN, V29, P212, DOI 10.1016/j.fsi.2010.03.008; Smith VJ, 2010, MAR DRUGS, V8, P1213, DOI 10.3390/md8041213; Smriga S, 2010, FEMS MICROBIOL ECOL, V73, P31, DOI 10.1111/j.1574-6941.2010.00879.x; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Uran PA, 2009, J FISH DIS, V32, P733, DOI 10.1111/j.1365-2761.2009.01049.x; vandePeer Y, 1997, COMPUT APPL BIOSCI, V13, P227; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Zar JH, 1974, BIOSTATISTICAL ANAL; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	45	110	120	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31335	10.1371/journal.pone.0031335	http://dx.doi.org/10.1371/journal.pone.0031335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393360	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500013
J	Seelke, AMH; Dooley, JC; Krubitzer, LA				Seelke, Adele M. H.; Dooley, James C.; Krubitzer, Leah A.			The Emergence of Somatotopic Maps of the Body in S1 in Rats: The Correspondence Between Functional and Anatomical Organization	PLOS ONE			English	Article							BARREL-FIELD CORTEX; PRIMARY SOMATOSENSORY CORTEX; 2/3 PYRAMIDAL NEURONS; CEREBRAL-CORTEX; POSTNATAL-DEVELOPMENT; CRITICAL PERIOD; NEONATAL-RAT; IN-VIVO; THALAMOCORTICAL SYNAPSES; SYNAPTIC PLASTICITY	Most of what we know about cortical map development and plasticity comes from studies in mice and rats, and for the somatosensory cortex, almost exclusively from the whisker-dominated posteromedial barrel fields. Whiskers are the main effector organs of mice and rats, and their representation in cortex and subcortical pathways is a highly derived feature of murine rodents. This specialized anatomical organization may therefore not be representative of somatosensory cortex in general, especially for species that utilize other body parts as their main effector organs, like the hands of primates. For these reasons, we examined the emergence of whole body maps in developing rats using electrophysiological recording techniques. In P5, P10, P15, P20 and adult rats, multiple recordings were made in the medial portion of S1 in each animal. Subsequently, these functional maps were related to anatomical parcellations of S1 based on a variety of histological stains. We found that at early postnatal ages (P5) medial S1 was composed almost exclusively of the representation of the vibrissae. At P10, other body part representations including the hindlimb and forelimb were present, although these were not topographically organized. By P15, a clear topographic organization began to emerge coincident with a reduction in receptive field size. By P20, body maps were adult-like. This study is the first to describe how topography of the body develops in S1 in any mammal. It indicates that anatomical parcellations and functional maps are initially incongruent but become tightly coupled by P15. Finally, because anatomical and functional specificity of developing barrel cortex appears much earlier in postnatal life than the rest of the body, the entire primary somatosensory cortex should be considered when studying general topographic map formation in development.	[Seelke, Adele M. H.; Dooley, James C.; Krubitzer, Leah A.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Krubitzer, Leah A.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Seelke, AMH (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	lakrubitzer@ucdavis.edu		Dooley, James/0000-0002-9868-9840; Seelke, Adele/0000-0002-2867-0335	National Institutes of Health [5R21NS071225-02, 1F32NS064792-01A2, 5T32EY015387- 05, T32DC8072]; NATIONAL EYE INSTITUTE [T32EY015387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071225, F32NS064792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC008072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by a grant to Leah Krubitzer (5R21NS071225-02), a grant to Adele Seelke (1F32NS064792-01A2), and by training grants (5T32EY015387- 05 and T32DC8072), all grants were from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JR., 2005, BEHAV LABORATOTY RAT, P266; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENNETTCLARKE CA, 1991, NEUROSCIENCE, V43, P163, DOI 10.1016/0306-4522(91)90425-N; BERRY M, 1965, J ANAT, V99, P691; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BOLLES RC, 1964, ANIM BEHAV, V12, P427, DOI 10.1016/0003-3472(64)90062-4; Campi KL, 2011, BRAIN BEHAV EVOLUT, V77, P116, DOI 10.1159/000324862; Campi KL, 2010, J COMP NEUROL, V518, P4491, DOI 10.1002/cne.22466; CATALANO SM, 1991, P NATL ACAD SCI USA, V88, P2999, DOI 10.1073/pnas.88.8.2999; Catania KC, 2000, BRAIN BEHAV EVOLUT, V55, P311, DOI 10.1159/000006666; Catania KC, 2006, CURR OPIN NEUROBIOL, V16, P467, DOI 10.1016/j.conb.2006.06.010; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Cooke DF, 2011, FUNCTIONAL ORG CORTE; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; De Felipe J, 1997, CEREBRAL CORTEX, P7; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; EAYRS JT, 1959, J ANAT, V93, P385; Erzurumlu R, 2008, SENSES COMPREHENSIVE, P171; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gallyas F, 1979, Neurol Res, V1, P203; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Jain N, 2003, J NEUROSCI, V23, P10321; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Jones L, 2002, DEVELOPMENT, V129, P5041; Karlen SJ, 2006, J COMP NEUROL, V499, P990, DOI 10.1002/cne.21156; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; KILLACKEY HP, 1994, J NEUROSCI, V14, P1496, DOI 10.1523/JNEUROSCI.14-03-01496.1994; Krubitzer L, 2011, ALL RODENTS ARE NOT; LAND PW, 1985, J COMP NEUROL, V238, P225, DOI 10.1002/cne.902380209; Larsen DD, 2008, BRAIN RES BULL, V75, P391, DOI 10.1016/j.brainresbull.2007.10.041; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li H, 2011, ANN NY ACAD SCI, V1225, P119, DOI 10.1111/j.1749-6632.2011.06024.x; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Maravall M, 2004, CEREB CORTEX, V14, P655, DOI 10.1093/cercor/bhh026; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; MCCANDLISH C, 1989, EXP BRAIN RES, V77, P425, DOI 10.1007/BF00275001; MCCANDLISH CA, 1993, EXP BRAIN RES, V92, P369; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MILLER MW, 1988, CEREB CORTEX, V7, P133; Molnar Z, 1998, J NEUROSCI, V18, P5723; MUNGER BL, 1986, J COMP NEUROL, V252, P404, DOI 10.1002/cne.902520309; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ohsaki K, 2002, DEV BRAIN RES, V137, P159, DOI 10.1016/S0165-3806(02)00462-5; OLEARY DDM, 1981, DEV BRAIN RES, V1, P607, DOI 10.1016/0165-3806(81)90012-2; Pallas SL, 2001, TRENDS NEUROSCI, V24, P417, DOI 10.1016/S0166-2236(00)01853-1; PARNAVELAS JG, 1980, BRAIN RES, V193, P373, DOI 10.1016/0006-8993(80)90171-7; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; RICE FL, 1985, J COMP NEUROL, V236, P477, DOI 10.1002/cne.902360405; RICE FL, 1985, J COMP NEUROL, V236, P496, DOI 10.1002/cne.902360406; RICHMOND G, 1980, BEHAVIOUR, V75, P82, DOI 10.1163/156853980X00573; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Seelke AMH, 2008, SLEEP, V31, P691, DOI 10.1093/sleep/31.5.691; Seelke AMH, 2010, BRAIN RES, V1324, P34, DOI 10.1016/j.brainres.2010.01.088; Shoykhet M, 2008, J NEUROPHYSIOL, V99, P356, DOI 10.1152/jn.01063.2007; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; SUR M, 1990, TRENDS NEUROSCI, V13, P227, DOI 10.1016/0166-2236(90)90165-7; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uziel D, 2006, ANAT REC PART A, V288A, P135, DOI 10.1002/ar.a.20286; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANDERLOOS H, 1978, NEUROSCI LETT, V7, P23, DOI 10.1016/0304-3940(78)90107-6; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Vercelli A, 1999, EXP NEUROL, V156, P294, DOI 10.1006/exnr.1999.7025; WALLACE JA, 1982, BRAIN RES BULL, V9, P117, DOI 10.1016/0361-9230(82)90127-7; WATERS RS, 1995, EXP BRAIN RES, V103, P183; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WELKER E, 1986, J NEUROSCI, V6, P3355; WELLER WL, 1972, BRAIN RES, V43, P11; WHISHAW IQ, 1992, BEHAV BRAIN RES, V48, P113, DOI 10.1016/S0166-4328(05)80147-0; WHISHAW IQ, 1994, BEHAV BRAIN RES, V60, P15, DOI 10.1016/0166-4328(94)90058-2; Whishaw IQ, 1996, BEHAV BRAIN RES, V77, P135, DOI 10.1016/0166-4328(95)00209-X; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; WONGRILEY MTT, 1984, J COMP NEUROL, V222, P18, DOI 10.1002/cne.902220103; Woolsey T.A., 1990, P461; WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	102	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32322	10.1371/journal.pone.0032322	http://dx.doi.org/10.1371/journal.pone.0032322			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393398	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500050
J	Starr, LM; Fruci, M; Poole, K				Starr, Lisa M.; Fruci, Michael; Poole, Keith			Pentachlorophenol Induction of the Pseudomonas aeruginosa mexAB-oprM Efflux Operon: Involvement of Repressors NalC and MexR and the Antirepressor ArmR	PLOS ONE			English	Article							CLINICAL STRAINS; ANTIBIOTIC INDUCIBILITY; MULTIDRUG-RESISTANCE; FRENCH MULTICENTER; CRYSTAL-STRUCTURE; CROSS-RESISTANCE; GENE-EXPRESSION; ACTIVE EFFLUX; SYSTEM; PUMPS	Pentachlorophenol (PCP) induced expression of the NalC repressor-regulated PA3720-armR operon and the MexR repressor-controlled mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa. PCP's induction of PA3720-armR resulted from its direct modulation of NalC, the repressor's binding to PA3720-armR promoter-containing DNA as seen in electromobility shift assays (EMSAs) being obviated in the presence of this agent. The NalC binding site was localized to an inverted repeat (IR) sequence upstream of PA3720-armR and overlapping a promoter region whose transcription start site was mapped. While modulation of MexR by the ArmR anti-repressor explains the upregulation of mexAB-oprM in nalC mutants hyperexpressing PA3720-armR, the induction of mexAB-oprM expression by PCP is not wholly explainable by PCP induction of PA3720-armR and subsequent ArmR modulation of MexR, inasmuch as armR deletion mutants still showed PCP-inducible mexAB-oprM expression. PCP failed, however, to induce mexAB-oprM in a mexR deletion strain, indicating that MexR was required for this, although PCP did not modulate MexR binding to mexAB-oprM promoter-containing DNA in vitro. One possibility is that MexR responds to PCP-generated in vivo effector molecules in controlling mexAB-oprM expression in response to PCP. PCP is an unlikely effector and substrate for NalC and MexAB-OprM - its impact on NalC binding to the PA3720-armR promoter DNA occurred only at high mu M levels - suggesting that it mimics an intended phenolic effector/substrate(s). In this regard, plants are an abundant source of phenolic antimicrobial compounds and, so, MexAB-OprM may function to protect P. aeruginosa from plant antimicrobials that it encounters in nature.	[Starr, Lisa M.; Fruci, Michael; Poole, Keith] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Starr, LM (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	poolek@queensu.ca		Starr, Lisa/0000-0002-4112-9869	Canadian Institutes of Health Research [10274]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research, Grant number 10274 (http://www.cihr-irsc.gc.ca) and Cystic Fibrosis Canada (http://www.cysticfibrosis.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Boutoille D, 2004, FEMS MICROBIOL LETT, V230, P143, DOI 10.1016/S0378-1097(03)00882-6; Cao L, 2004, MOL MICROBIOL, V53, P1423, DOI 10.1111/j.1365-2958.2004.04210.x; Cavallo JD, 2007, J ANTIMICROB CHEMOTH, V59, P1021, DOI 10.1093/jac/dkm076; Cavallo JD, 2002, J ANTIMICROB CHEMOTH, V50, P1039, DOI 10.1093/jac/dkf186; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Daigle DM, 2007, J BACTERIOL, V189, P5441, DOI 10.1128/JB.00543-07; Dupont P, 2005, J ANTIMICROB CHEMOTH, V55, P518, DOI 10.1093/jac/dki030; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Fraud S, 2011, ANTIMICROB AGENTS CH, V55, P1068, DOI 10.1128/AAC.01495-10; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Ghosh S, 2011, MOL MICROBIOL, V79, P1547, DOI 10.1111/j.1365-2958.2011.07544.x; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hocquet D, 2007, ANTIMICROB AGENTS CH, V51, P1582, DOI 10.1128/AAC.01334-06; Jalal S, 2000, ANTIMICROB AGENTS CH, V44, P710, DOI 10.1128/AAC.44.3.710-712.2000; Jalal S, 1998, MICROB DRUG RESIST, V4, P257, DOI 10.1089/mdr.1998.4.257; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jo JTH, 2003, ANTIMICROB AGENTS CH, V47, P1101, DOI 10.1128/AAC.47.3.1101-1111.2003; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Lanoue A, 2010, PLANT SIGNAL BEHAV, V5, P1037, DOI [10.4161/psb.5.8.12337, 10.1111/j.1469-8137.2009.03066.x]; Li XZ, 1999, CAN J MICROBIOL, V45, P18, DOI 10.1139/cjm-45-1-18; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Masoko P, 2010, AFR J TRADIT COMPLEM, V7, P138; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Mclamore ES, 2010, ENVIRON SCI TECHNOL, V44, P7050, DOI 10.1021/es1012356; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Morita Y, 2006, J BACTERIOL, V188, P8649, DOI 10.1128/JB.01342-06; Morita Y, 2009, J BACTERIOL, V191, P4966, DOI 10.1128/JB.00073-09; Muller JF, 2007, APPL ENVIRON MICROB, V73, P4550, DOI 10.1128/AEM.00169-07; Park YJ, 2011, J FOOD SCI, V76, pM101, DOI 10.1111/j.1750-3841.2010.01974.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Pournaras S, 2005, J ANTIMICROB CHEMOTH, V56, P761, DOI 10.1093/jac/dki296; Saito K, 1999, FEMS MICROBIOL LETT, V179, P67, DOI 10.1016/S0378-1097(99)00394-8; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez P, 2002, FEMS MICROBIOL LETT, V207, P63, DOI 10.1016/S0378-1097(01)00562-6; Schweizer HP, 1998, ANTIMICROB AGENTS CH, V42, P394; Sheu DS, 2000, MICROBIOL-UK, V146, P2019, DOI 10.1099/00221287-146-8-2019; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; Srikumar R, 1998, ANTIMICROB AGENTS CH, V42, P65, DOI 10.1128/AAC.42.1.65; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; Srikumar R, 1999, CLIN MICROBIOL INFEC, V5, p5S58; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Wang J, 2010, INT J ANTIMICROB AG, V35, P486, DOI 10.1016/j.ijantimicag.2009.12.014; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Zhao JL, 2011, MOLECULES, V16, P2259, DOI 10.3390/molecules16032259; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	64	20	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32684	10.1371/journal.pone.0032684	http://dx.doi.org/10.1371/journal.pone.0032684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393435	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500088
J	Derraik, JGB; Reed, PW; Jefferies, C; Cutfield, SW; Hofman, PL; Cutfield, WS				Derraik, Jose G. B.; Reed, Peter W.; Jefferies, Craig; Cutfield, Samuel W.; Hofman, Paul L.; Cutfield, Wayne S.			Increasing Incidence and Age at Diagnosis among Children with Type 1 Diabetes Mellitus over a 20-Year Period in Auckland (New Zealand)	PLOS ONE			English	Article							ACCELERATOR HYPOTHESIS; INCIDENCE TRENDS; YOUNGER AGE; BODY-MASS; CHILDHOOD; WEIGHT; WORLDWIDE; COHORT; ONSET; BORN	Background: We aimed to evaluate the incidence of type 1 diabetes mellitus in children <15 years of age (yr) in the Auckland region (New Zealand) over 20 years (1990-2009). Methods: We performed a retrospective review of all patients <15 yr diagnosed with type 1 diabetes, from an unselected complete regional cohort. Results: There were 884 new cases of type 1 diabetes, and age at diagnosis rose from 7.6 yr in 1990/1 to 8.9 yr in 2008/9 (r(2) = 0.31, p = 0.009). There was a progressive increase in type 1 diabetes incidence among children <15 yr (p<0.0001), reaching 22.5 per 100,000 in 2009. However, the rise in incidence did not occur evenly among age groups, being 2.5-fold higher in older children (10-14 yr) than in the youngest group (0-4 yr). The incidence of new cases of type 1 diabetes was highest in New Zealand Europeans throughout the study period in all age groups (p<0.0001), but the rate of increase was similar in New Zealand Europeans and Non-Europeans. Type 1 diabetes incidence and average annual increase were similar in both sexes. There was no change in BMI SDS shortly after diagnosis, and no association between BMI SDS and age at diagnosis. Conclusions: There has been a steady increase in type 1 diabetes incidence among children <15 yr in Auckland over 20 years. Contrary to other studies, age at diagnosis has increased and the greatest rise in incidence occurred in children 10-14 yr. There was little change in BMI SDS in this population, providing no support for the 'accelerator hypothesis'.	[Derraik, Jose G. B.; Jefferies, Craig; Cutfield, Samuel W.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Reed, Peter W.; Jefferies, Craig] Auckland Dist Hlth Board, Auckland, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; Auckland District Health Board; University of Auckland	Derraik, JGB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008; Jefferies, craig/ABA-1921-2021	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Jefferies, Craig/0000-0002-0541-6094				Australian Institute of Health and Welfare, 2010, INC TYPE 1 DIAB AUST; Banin Patrizia, 2010, Acta Biomed, V81, P35; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; Cadario F, 2004, J ENDOCRINOL INVEST, V27, P913, DOI 10.1007/BF03347532; Campbell-Stokes PL, 2005, DIABETOLOGIA, V48, P643, DOI 10.1007/s00125-005-1697-3; Delli AJ, 2010, PEDIATR DIABETES, V11, P513, DOI 10.1111/j.1399-5448.2010.00637.x; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; ELLIOTT RB, 1985, NEW ZEAL MED J, V98, P922; ELLIOTT RB, 1992, PEDIAT AD E, V21, P66; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gale EAM, 2007, DIABETOLOGIA, V50, P1571, DOI 10.1007/s00125-007-0726-9; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Knerr I, 2005, DIABETOLOGIA, V48, P2501, DOI 10.1007/s00125-005-0033-2; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; SCOTT RS, 1992, DIABETES CARE, V15, P895, DOI 10.2337/diacare.15.7.895; Sella T, 2011, DIABETIC MED, V28, P48, DOI 10.1111/j.1464-5491.2010.03174.x; Statistics New Zealand, 2010, 2006 CENS POP DWELLI; Wilkin TJ, 2006, DIABETES CARE, V29, P1462, DOI 10.2337/dc06-0345; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; Wu Denise, 2005, N Z Med J, V118, pU1557	25	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32640	10.1371/journal.pone.0032640	http://dx.doi.org/10.1371/journal.pone.0032640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389717	Green Submitted, Green Published, gold			2022-12-25	WOS:000302999600056
J	Karasov, WH; Caviedes-Vidal, E; Bakken, BH; Izhaki, I; Samuni-Blank, M; Arad, Z				Karasov, William H.; Caviedes-Vidal, Enrique; Bakken, Bradley Hartman; Izhaki, Ido; Samuni-Blank, Michal; Arad, Zeev			Capacity for Absorption of Water-Soluble Secondary Metabolites Greater in Birds than in Rodents	PLOS ONE			English	Article							INTESTINAL PASSIVE ABSORPTION; VERTEBRATE-DISPERSED FRUITS; TRANSEPITHELIAL TRANSPORT; IN-VITRO; PHYSIOLOGICAL REGULATION; PARACELLULAR ABSORPTION; GLOMERULAR-FILTRATION; EPITHELIAL-CELLS; CHLOROGENIC ACID; MOLECULAR-BASIS	Plant secondary metabolites (SMs) are pervasive in animal foods and potentially influence feeding behavior, interspecies interactions, and the distribution and abundance of animals. Some of the major classes of naturally occurring SMs in plants include many water-soluble compounds in the molecular size range that could cross the intestinal epithelium via the paracellular space by diffusion or solvent drag. There are differences among species in paracellular permeability. Using Middle Eastern rodent and avian consumers of fruits containing SMs, we tested the hypothesis that avian species would have significantly higher paracellular permeability than rodent species. Permeability in intact animals was assessed using standard pharmacological methodology to measure absorption of two radiolabeled, inert, neutral water-soluble probes that do not interact with intestinal nutrient transporters, L-arabinose (M-r = 150.1 Da) and lactulose (M-r = 342.3 Da). We also measured absorption of labeled 3-O-methyl-D-glucose (3OMD-glucose; M-r = 194.2 Da), which is a nonmetabolized analogue of D-glucose that is passively absorbed through the paracellular space but also transported across the enterocyte membranes. Most glucose was absorbed by all species, but arabinose fractional absorption (f) was nearly three times higher in birds (1.03 +/- 0.17, n = 15 in two species) compared to rodents (0.37 +/- 0.06, n = 10 in two species) (P < 0.001). Surprisingly, the apparent rates of absorption in birds of arabinose exceeded those of 3OMD-glucose. Our findings are in agreement with previous work showing that the paracellular pathway is more prominent in birds relative to nonflying mammals, and suggests that birds may be challenged by greater absorption of water-soluble, dietary SMs. The increased expression of the paracellular pathway in birds hints at a tradeoff: the free energy birds gain by absorbing water-soluble nutrients passively may be offset by the metabolic demands placed on them to eliminate concomitantly absorbed SMs.	[Karasov, William H.; Bakken, Bradley Hartman] Univ Wisconsin, Dept Forest & Wildlife Ecol, Russell Labs, Madison, WI 53706 USA; [Caviedes-Vidal, Enrique] Univ Nacl San Luis, Dept Bioquim & Ciencias Biol, San Luis, Argentina; [Caviedes-Vidal, Enrique] Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol San Luis, Chacabuco, San Luis, Argentina; [Izhaki, Ido] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Samuni-Blank, Michal; Arad, Zeev] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	University of Wisconsin System; University of Wisconsin Madison; Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Haifa; Technion Israel Institute of Technology	Karasov, WH (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Russell Labs, Madison, WI 53706 USA.	wkarasov@wisc.edu	Izhaki, Ido/I-9712-2019; Izhaki, Ido/D-5586-2011; Caviedes-Vidal, Enrique/J-9204-2013	Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683; Caviedes-Vidal, Enrique/0000-0003-4526-4969	United States-Israel Binational Science Foundation [2006043, 2008124T]; Israel Science Foundation [189/08]; United States National Science Foundation [IOS-1025886]; Division Of Integrative Organismal Systems [1025886] Funding Source: National Science Foundation	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); United States National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the United States-Israel Binational Science Foundation (#2006043 and #2008124T) to BHB, Israel Science Foundation (#189/08) to II, and United States National Science Foundation (#IOS-1025886) to WHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altestein O, 2005, FLESHY FRUITED PLANT; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; Bakken BH, 2004, J EXP BIOL, V207, P4383, DOI 10.1242/jeb.01238; Barbehenn RV, 1998, ARCH INSECT BIOCHEM, V39, P109, DOI 10.1002/(SICI)1520-6327(1998)39:3&lt;109::AID-ARCH3&gt;3.0.CO;2-B; BIJLSMA PB, 1995, GASTROENTEROLOGY, V108, P687, DOI 10.1016/0016-5085(95)90440-9; Brody T., 1999, NUTR BIOCH, V2nd ed., P1; Cai KH, 2006, BIOCHEM PHARMACOL, V72, P974, DOI 10.1016/j.bcp.2006.06.026; Cai KH, 2006, BIOCHEM PHARMACOL, V71, P1570, DOI 10.1016/j.bcp.2006.02.013; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Chang MH, 2004, ZOOLOGY, V107, P121, DOI 10.1016/j.zool.2004.03.001; Chang MH, 2004, J EXP BIOL, V207, P3109, DOI 10.1242/jeb.01154; CHANG RLS, 1975, BIOPHYS J, V15, P861, DOI 10.1016/S0006-3495(75)85862-0; Chediack JG, 2006, J COMP PHYSIOL B, V176, P303, DOI 10.1007/s00360-005-0052-9; Chediack JG, 2003, J COMP PHYSIOL B, V173, P187, DOI 10.1007/s00360-002-0314-8; Chediack JG, 2001, AM ZOOL, V41, P1410; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2000, REV CHIL HIST NAT, V73, P421; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; FINE KD, 1993, GASTROENTEROLOGY, V105, P1117, DOI 10.1016/0016-5085(93)90957-E; Foley WJ, 2005, CURR OPIN PLANT BIOL, V8, P430, DOI 10.1016/j.pbi.2005.05.009; GIBALDI M, 1982, PHARMACOKINETICS, P1; Gilbert ER, 2007, POULTRY SCI, V86, P1739, DOI 10.1093/ps/86.8.1739; HAMILTON I, 1987, CLIN SCI, V73, P189, DOI 10.1042/cs0730189; Harborne JB, 1993, INTRO ECOLOGICAL BIO, P1; He YL, 1998, J PHARM SCI, V87, P626, DOI 10.1021/js970120d; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Janzen D. H., 1975, ECOLOGY PLANTS TROPI; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Karasov WH, 2011, AM J PHYSL IN PRESS; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kavimandan NJ, 2008, INT J PHARMACEUT, V354, P143, DOI 10.1016/j.ijpharm.2007.12.014; Konishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P583, DOI 10.1271/bbb.69.583; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c; Konishi Y, 2003, J AGR FOOD CHEM, V51, P7296, DOI 10.1021/jf034894t; Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2317, DOI 10.1271/bbb.67.2317; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714; Lane JS, 1999, AM J PHYSIOL-GASTR L, V276, pG789, DOI 10.1152/ajpgi.1999.276.3.G789; Lavin SR, 2007, J EXP BIOL, V210, P2754, DOI 10.1242/jeb.006114; LEAHY DE, 1994, J PHARMACOKINET BIOP, V22, P411, DOI 10.1007/BF02353863; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Li H, 2008, ANIM GENET, V39, P407, DOI 10.1111/j.1365-2052.2008.01744.x; LOBLEY RW, 1990, CLIN SCI, V79, P175, DOI 10.1042/cs0790175; Lohner K, 2007, MOL NUTR FOOD RES, V51, P293, DOI 10.1002/mnfr.200600225; LOO JCK, 1968, J PHARM SCI, V57, P918, DOI 10.1002/jps.2600570602; MA TY, 1993, J LAB CLIN MED, V122, P590; McWhorter TJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P376, DOI 10.1086/597524; McWhorter TJ, 2009, BIOL REV, V84, P533, DOI 10.1111/j.1469-185X.2009.00086.x; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Mott CR, 2008, POULTRY SCI, V87, P2215, DOI 10.3382/ps.2008-00101; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Nielsen HM, 2002, EUR J PHARM SCI, V16, P151, DOI 10.1016/S0928-0987(02)00083-0; PAPPENHEIMER JR, 1990, AM J PHYSIOL, V259, pG290, DOI 10.1152/ajpgi.1990.259.2.G290; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Ritschel WA, 1999, HDB BASIC PHARMACOKI, P1; Riviere JE, 1999, COMP PHARMACOKINETIC; SADOWSKI DC, 1993, CAN J PHYSIOL PHARM, V71, P835, DOI 10.1139/y93-125; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Skopec MM, 2010, J CHEM ECOL, V36, P236, DOI 10.1007/s10886-010-9747-9; SMULDERS AP, 1971, J MEMBRANE BIOL, V5, P297, DOI 10.1007/BF01957348; Sokal RR.RohlfFJ, 1981, BIOMETRY, P1; Sorensen JS, 2006, J CHEM ECOL, V32, P1181, DOI 10.1007/s10886-006-9079-y; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Struempf HM, 1999, AUK, V116, P749, DOI 10.2307/4089335; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tian XJ, 2009, INT J PHARMACEUT, V367, P58, DOI 10.1016/j.ijpharm.2008.09.023; TURNER JR, 1995, GASTROENTEROLOGY, V109, P1391, DOI 10.1016/0016-5085(95)90605-3; UHING MR, 1995, J CLIN INVEST, V95, P2799, DOI 10.1172/JCI117984; WELLING PG, 1986, PHARMACOKINETICS PRO; YOKOTA SD, 1985, RENAL PHYSIOL BIOCH, V8, P193	73	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32417	10.1371/journal.pone.0032417	http://dx.doi.org/10.1371/journal.pone.0032417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389702	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600040
J	Pasquo, A; Consalvi, V; Knapp, S; Alfano, I; Ardini, M; Stefanini, S; Chiaraluce, R				Pasquo, Alessandra; Consalvi, Valerio; Knapp, Stefan; Alfano, Ivan; Ardini, Matteo; Stefanini, Simonetta; Chiaraluce, Roberta			Structural Stability of Human Protein Tyrosine Phosphatase rho Catalytic Domain: Effect of Point Mutations	PLOS ONE			English	Article							SOMATIC MUTATIONS; RECEPTOR-T; CANCER; IDENTIFICATION; DISEASE; SUBSTRATE; CATALOG; GENOME; GENES; SNPS	Protein tyrosine phosphatase rho (PTP rho) belongs to the classical receptor type IIB family of protein tyrosine phosphatase, the most frequently mutated tyrosine phosphatase in human cancer. There are evidences to suggest that PTP rho may act as a tumor suppressor gene and dysregulation of Tyr phosphorylation can be observed in diverse diseases, such as diabetes, immune deficiencies and cancer. PTP rho variants in the catalytic domain have been identified in cancer tissues. These natural variants are nonsynonymous single nucleotide polymorphisms, variations of a single nucleotide occurring in the coding region and leading to amino acid substitutions. In this study we investigated the effect of amino acid substitution on the structural stability and on the activity of the membrane-proximal catalytic domain of PTP rho. We expressed and purified as soluble recombinant proteins some of the mutants of the membrane-proximal catalytic domain of PTP rho identified in colorectal cancer and in the single nucleotide polymorphisms database. The mutants show a decreased thermal and thermodynamic stability and decreased activation energy relative to phosphatase activity, when compared to wild-type. All the variants show three-state equilibrium unfolding transitions similar to that of the wild-type, with the accumulation of a folding intermediate populated at similar to 4.0 M urea.	[Pasquo, Alessandra] UT BIORAD FARM CR Casaccia ENEA, Rome, Italy; [Consalvi, Valerio; Ardini, Matteo; Stefanini, Simonetta; Chiaraluce, Roberta] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Knapp, Stefan; Alfano, Ivan] Univ Oxford, Struct Genom Consortium, Oxford, England	Italian National Agency New Technical Energy & Sustainable Economics Development; Sapienza University Rome; University of Oxford	Pasquo, A (corresponding author), UT BIORAD FARM CR Casaccia ENEA, Rome, Italy.	roberta.chiaraluce@uniroma1.it	Ardini, Matteo/V-1884-2018; Knapp, Stefan/AAG-2347-2019; consalvi, valerio/F-1918-2011	Ardini, Matteo/0000-0002-9044-3352; Knapp, Stefan/0000-0001-5995-6494; 	Department of Biochemical Sciences; Uniroma1	Department of Biochemical Sciences; Uniroma1	Department of Biochemical Sciences; Uniroma1, www.uniroma1.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Burgoyne AM, 2009, CANCER RES, V69, P6960, DOI 10.1158/0008-5472.CAN-09-0863; Cheng TMK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000135; Craig SEL, 2011, CANCER RES, V71, P303, DOI 10.1158/0008-5472.CAN-10-2301; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Ervin J, 2002, BIOPHYS J, V83, P473, DOI 10.1016/S0006-3495(02)75183-7; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scott A, 2011, BIOSCIENCE REP, V31, P303, DOI 10.1042/BSR20100134; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	34	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32555	10.1371/journal.pone.0032555	http://dx.doi.org/10.1371/journal.pone.0032555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389709	Green Submitted, Green Published, gold			2022-12-25	WOS:000302999600048
J	Saffarzadeh, M; Juenemann, C; Queisser, MA; Lochnit, G; Barreto, G; Galuska, SP; Lohmeyer, J; Preissner, KT				Saffarzadeh, Mona; Juenemann, Christiane; Queisser, Markus A.; Lochnit, Guenter; Barreto, Guillermo; Galuska, Sebastian P.; Lohmeyer, Juergen; Preissner, Klaus T.			Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECOMBINANT HUMAN DNASE; CYSTIC-FIBROSIS; NETTING NEUTROPHILS; MEDICAL PROGRESS; MYELOPEROXIDASE; LIPOPOLYSACCHARIDE; ENDOTOXIN	Neutrophils play an important role in innate immunity by defending the host organism against invading microorganisms. Antimicrobial activity of neutrophils is mediated by release of antimicrobial peptides, phagocytosis as well as formation of neutrophil extracellular traps (NET). These structures are composed of DNA, histones and granular proteins such as neutrophil elastase and myeloperoxidase. This study focused on the influence of NET on the host cell functions, particularly on human alveolar epithelial cells as the major cells responsible for gas exchange in the lung. Upon direct interaction with epithelial and endothelial cells, NET induced cytotoxic effects in a dose-dependent manner, and digestion of DNA in NET did not change NET-mediated cytotoxicity. Pre-incubation of NET with antibodies against histones, with polysialic acid or with myeloperoxidase inhibitor but not with elastase inhibitor reduced NET-mediated cytotoxicity, suggesting that histones and myeloperoxidase are responsible for NET-mediated cytotoxicity. Although activated protein C (APC) did decrease the histone-induced cytotoxicity in a purified system, it did not change NET-induced cytotoxicity, indicating that histone-dependent cytotoxicity of NET is protected against APC degradation. Moreover, in LPS-induced acute lung injury mouse model, NET formation was documented in the lung tissue as well as in the bronchoalveolar lavage fluid. These data reveal the important role of protein components in NET, particularly histones, which may lead to host cell cytotoxicity and may be involved in lung tissue destruction.	[Saffarzadeh, Mona; Juenemann, Christiane; Queisser, Markus A.; Lochnit, Guenter; Galuska, Sebastian P.; Preissner, Klaus T.] Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany; [Queisser, Markus A.] Northwestern Univ, Chicago, IL 60611 USA; [Barreto, Guillermo] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Lohmeyer, Juergen] Univ Giessen, Dept Internal Med 2, Giessen, Germany	Justus Liebig University Giessen; Northwestern University; Max Planck Society; Justus Liebig University Giessen	Saffarzadeh, M (corresponding author), Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany.	klaus.t.preissner@biochemie.med.uni-giessen.de	Barreto, Guillermo/U-5718-2017	Barreto, Guillermo/0000-0002-7777-4712	Bundesministerium fur Bildung und Forschung (Berlin, Germany); Clinical Research Group "Pneumonia" [01-KI-1004]; "Excellence Cluster Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany)	Bundesministerium fur Bildung und Forschung (Berlin, Germany)(Federal Ministry of Education & Research (BMBF)); Clinical Research Group "Pneumonia"; "Excellence Cluster Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany)	This work was supported in part by the Bundesministerium fur Bildung und Forschung (Berlin, Germany), Clinical Research Group "Pneumonia" (01-KI-1004), and the "Excellence Cluster Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BOTHA AJ, 1995, J TRAUMA, V39, P411; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cabanski M, 2009, AM J PHYSIOL-LUNG C, V297, pL608, DOI 10.1152/ajplung.90433.2008; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; FUJISHIMA S, 1995, INTENS CARE MED, V21, P277, DOI 10.1007/BF01701489; Gong Q, 2008, INT IMMUNOPHARMACOL, V8, P792, DOI 10.1016/j.intimp.2008.01.026; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta A, 2006, ANN NY ACAD SCI, V1075, P118, DOI 10.1196/annals.1368.015; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Haegens A, 2008, EUR RESPIR J, V31, P252, DOI 10.1183/09031936.00029307; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/ajrccm.165.8.2104090; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; Kanthack A. A., 1894, J PHYSL, V17, P80; KANTHACK AA, 1894, J PHYSL, V17, P81; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee JS, 2005, AM J PHYSIOL-LUNG C, V289, pL731, DOI 10.1152/ajplung.00196.2005; Lim MB, 2011, J LEUKOC BIOL; Liu M, 1997, INTENS CARE MED, V23, P718, DOI 10.1007/s001340050400; Liu MY, 2005, AM J RESP CRIT CARE, V171, P298, DOI 10.1164/rccm.2412002; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Manzenreiter R, 2011, J CYST FIBROS; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Medina E, 2009, J INNATE IMMUN, V1, P176, DOI 10.1159/000203699; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Myzak MC, 2002, REDOX REP, V7, P47, DOI 10.1179/135100002125000181; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Perl M, 2008, MOL MED, V14, P465, DOI 10.2119/2008-00011.Perl; RAPTIS L, 1980, J CLIN INVEST, V66, P1391, DOI 10.1172/JCI109992; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Rotta AT, 1998, CRIT CARE MED, V26, P1707, DOI 10.1097/00003246-199810000-00026; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Steinmuller M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-30; Szarka RJ, 1997, J IMMUNOL METHODS, V202, P49, DOI 10.1016/S0022-1759(96)00236-0; Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC; Thulke S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-77; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	73	764	813	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32366	10.1371/journal.pone.0032366	http://dx.doi.org/10.1371/journal.pone.0032366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389696	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600034
J	Edwards, DRV; Tacconelli, A; Wejse, C; Hill, PC; Morris, GAJ; Edwards, TL; Gilbert, JR; Myers, JL; Park, YS; Stryjewski, ME; Abbate, E; Estevan, R; Rabna, P; Novelli, G; Hamilton, CD; Adegbola, R; Ostergaard, L; Williams, SM; Scott, WK; Sirugo, G				Edwards, Digna R. Velez; Tacconelli, Alessandra; Wejse, Christian; Hill, Philip C.; Morris, Gerard A. J.; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Park, Yo Son; Stryjewski, Martin E.; Abbate, Eduardo; Estevan, Rosa; Rabna, Paulo; Novelli, Giuseppe; Hamilton, Carol D.; Adegbola, Richard; Ostergaard, Lars; Williams, Scott M.; Scott, William K.; Sirugo, Giorgio			MCP1 SNPs and Pulmonary Tuberculosis in Cohorts from West Africa, the USA and Argentina: Lack of Association or Epistasis with IL12B Polymorphisms	PLOS ONE			English	Article							HUMAN GENETIC SUSCEPTIBILITY; MYCOBACTERIUM-TUBERCULOSIS; PROMOTER POLYMORPHISM; RISK-FACTORS; GENOTYPE; PROTECTION	The monocyte chemotactic protein-1 (MCP-1) is a chemokine that plays an important role in the recruitment of monocytes to M. tuberculosis infection sites, and previous studies have reported that genetic variants in MCP1 are associated with differential susceptibility to pulmonary tuberculosis (PTB). We examined eight MCP1 single nucleotide polymorphisms (SNPs) in a multi-ethnic, case-control design that included: 321 cases and 346 controls from Guinea-Bissau, 258 cases and 271 controls from The Gambia, 295 cases and 179 controls from the U. S. (African-Americans), and an additional set of 237 cases and 144 controls of European ancestry from the U. S. and Argentina. Two locus interactions were also examined for polymorphisms in MCP1 and interleukin 12B (IL12B), another gene implicated in PTB risk. Examination of previously associated MCP1 SNPs rs1024611 (-2581A/G), rs2857656 (-362G/C) and rs4586 (+900C/T) did not show evidence for association. One interaction between rs2857656 and IL12B SNP rs2288831 was observed among Africans but the effect was in the opposite direction in Guineans (OR = 1.90, p = 0.001) and Gambians (OR = 0.64, p = 0.024). Our data indicate that the effect of genetic variation within MCP1 is not clear cut and additional studies will be needed to elucidate its role in TB susceptibility.	[Edwards, Digna R. Velez; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Park, Yo Son; Scott, William K.] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33152 USA; [Edwards, Digna R. Velez; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Park, Yo Son; Scott, William K.] Univ Miami, Miami Inst Human Genom, Miami, FL USA; [Edwards, Digna R. Velez; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, Nashville, TN USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Tacconelli, Alessandra; Novelli, Giuseppe; Sirugo, Giorgio] Osped San Pietro FBF, Ctr Ric Sci, Ctr Genet, Rome, Italy; [Wejse, Christian; Rabna, Paulo] Danish Epidemiol Sci Ctr, Bandim Hlth Project, Bissau, Guinea Bissau; [Wejse, Christian; Rabna, Paulo] Statens Serum Inst, Bissau, Guinea Bissau; [Wejse, Christian; Ostergaard, Lars] Aarhus Univ, Dept Infect Dis, Skejby, Denmark; [Wejse, Christian] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, Skejby, Denmark; [Hill, Philip C.; Morris, Gerard A. J.; Adegbola, Richard; Sirugo, Giorgio] MRC Labs, Fajara, Gambia; [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Edwards, Todd L.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Stryjewski, Martin E.] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Dept Med, Div Infect Dis, Buenos Aires, DF, Argentina; [Abbate, Eduardo; Estevan, Rosa] Hosp FJ Muniz, Dept Med, Buenos Aires, DF, Argentina; [Novelli, Giuseppe] Univ Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Rome, Italy; [Hamilton, Carol D.] Family Hlth Int 360, Res Triangle Pk, NC USA; [Hamilton, Carol D.] Duke Univ, Med Ctr, Durham, NC USA; [Adegbola, Richard] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Miami; University of Miami; Vanderbilt University; Vanderbilt University; Vanderbilt University; Aarhus University; Statens Serum Institut; Aarhus University; Aarhus University; MRC Laboratory Molecular Biology; University of Otago; Vanderbilt University; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Buenos Aires; University of Rome Tor Vergata; Duke University; Bill & Melinda Gates Foundation	Edwards, DRV (corresponding author), Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33152 USA.	BScott@med.miami.edu; sirugo.giorgio@fbfrm.it	Williams, Scott/B-9491-2012; Williams, Scott/Q-4812-2019; Velez Edwards, Digna/C-1090-2012; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013; Wejse, Christian/C-8468-2014; Sirugo, Giorgio/N-9056-2019; Ostergaard, Lars/AAA-3020-2020; Sirugo, Giorgio/L-1628-2016; Novelli, Giuseppe/GQB-3329-2022	Williams, Scott/0000-0002-4835-9544; Novelli, Giuseppe/0000-0002-7781-602X; Wejse, Christian/0000-0002-2534-2942; Ostergaard, Lars/0000-0003-2459-0511; Novelli, Giuseppe/0000-0002-7781-602X; , YoSon/0000-0002-0465-4744; Scott, William/0000-0001-9336-6404; Stryjewski, Martin/0000-0002-4986-6564; Ostergaard, Lars/0000-0002-7619-605X	Medical Research Council UK (MRC) [G0000690]; MRC (UK) The Gambia Unit; Danish Medical Research Council; Danish Society of Respiratory Medicine; Danish Council of Development Research; United States National Institutes of Health [R01 HL68534]; MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068534] Funding Source: NIH RePORTER	Medical Research Council UK (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC (UK) The Gambia Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Society of Respiratory Medicine; Danish Council of Development Research; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Medical Research Council UK (MRC) award G0000690 to GS; MRC (UK) The Gambia Unit core-funding to PCH and RA; grants from the Danish Medical Research Council, the Danish Society of Respiratory Medicine, the Danish Council of Development Research to CW and LO, and by the United States National Institutes of Health grant R01 HL68534 to WKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Arji N, 2012, J INFECT DEV COUNTR, V6, P73; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Feng WX, 2011, INT J TUBERC LUNG DI; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganachari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008881; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Intemann CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-34; Jensen LE, 2006, AM J MED GENET A, V140A, P1114, DOI 10.1002/ajmg.a.31212; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Modi WS, 2003, AIDS, V17, P2357, DOI 10.1097/00002030-200311070-00011; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Sirugo G, 2004, NAT GENET, V36, P785, DOI 10.1038/ng0804-785; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Stein CM, 2011, MAMM GENOME, V22, P91, DOI 10.1007/s00335-010-9301-7; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; World Health Organization, 2010, GLOB TUB CONTR	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32275	10.1371/journal.pone.0032275	http://dx.doi.org/10.1371/journal.pone.0032275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384203	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500072
J	Ghodrati, M; Khaligh-Razavi, SM; Ebrahimpour, R; Rajaei, K; Pooyan, M				Ghodrati, Masoud; Khaligh-Razavi, Seyed-Mahdi; Ebrahimpour, Reza; Rajaei, Karim; Pooyan, Mohammad			How Can Selection of Biologically Inspired Features Improve the Performance of a Robust Object Recognition Model?	PLOS ONE			English	Article							RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; CORTEX; NEOCOGNITRON; ALGORITHMS; BRAIN	Humans can effectively and swiftly recognize objects in complex natural scenes. This outstanding ability has motivated many computational object recognition models. Most of these models try to emulate the behavior of this remarkable system. The human visual system hierarchically recognizes objects in several processing stages. Along these stages a set of features with increasing complexity is extracted by different parts of visual system. Elementary features like bars and edges are processed in earlier levels of visual pathway and as far as one goes upper in this pathway more complex features will be spotted. It is an important interrogation in the field of visual processing to see which features of an object are selected and represented by the visual cortex. To address this issue, we extended a hierarchical model, which is motivated by biology, for different object recognition tasks. In this model, a set of object parts, named patches, extracted in the intermediate stages. These object parts are used for training procedure in the model and have an important role in object recognition. These patches are selected indiscriminately from different positions of an image and this can lead to the extraction of nondiscriminating patches which eventually may reduce the performance. In the proposed model we used an evolutionary algorithm approach to select a set of informative patches. Our reported results indicate that these patches are more informative than usual random patches. We demonstrate the strength of the proposed model on a range of object recognition tasks. The proposed model outperforms the original model in diverse object recognition tasks. It can be seen from the experiments that selected features are generally particular parts of target images. Our results suggest that selected features which are parts of target objects provide an efficient set for robust object recognition.	[Ghodrati, Masoud; Pooyan, Mohammad] Shahed Univ, Dept Biomed Engn, Fac Engn, Tehran, Iran; [Ghodrati, Masoud; Ebrahimpour, Reza] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi; Ebrahimpour, Reza] Shahid Rajaee Teacher Training Univ, Brain & Intelligent Syst Res Lab BISLab, Dept Elect & Comp Engn, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi] Univ Tehran, Dept Math Stat & Comp Sci, Tehran, Iran; [Rajaei, Karim] Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran	Shahed University; Shahid Rajaee Teacher Training University (SRTTU); University of Tehran; Amirkabir University of Technology	Ghodrati, M (corresponding author), Shahed Univ, Dept Biomed Engn, Fac Engn, Tehran, Iran.	Masoud.ghodrati@ipm.ir	Ebrahimpour, Reza/AAH-8531-2019; Ebrahimpour, Reza/A-9721-2009	Ebrahimpour, Reza/0000-0002-7013-8078; Ghodrati, Masoud/0000-0002-4006-2578; Khaligh-Razavi, Seyed-Mahdi/0000-0002-5700-1704	MRC [MC_U105597120] Funding Source: UKRI; Medical Research Council [MC_U105597120] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Berg AC, 2001, PROC CVPR IEEE, P607; Fergus R, 2003, PROC CVPR IEEE, P264; Fukushima K, 2003, NEUROCOMPUTING, V51, P161, DOI 10.1016/S0925-2312(02)00614-8; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; He XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020002; Holland JH., 1975, Q REV BIOL; Huang Y, 2011, IEEE T SYSTEMS MAN B; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Krupka E, 2008, J MACH LEARN RES, V9, P2349; Lazebnik S., 2009, OBJECT CATEGORIZATIO; Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Meyers E, 2008, INT J COMPUT VISION, V76, P93, DOI 10.1007/s11263-007-0058-8; Ming-Yeong Teo, 1997, Neural Network World, V7, P293; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Opelt A, 2006, IEEE T PATTERN ANAL, V28, P416, DOI 10.1109/TPAMI.2006.54; Pan Z, 1999, EV COMP 1999 CEC 99, V3; Pinto  N., 2011, IEEE WORKSH APPL COM, P463, DOI [10.1109/WACV.2011.5711540, DOI 10.1109/WACV.2011.5711540]; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; Ponce J, 2006, DATASET ISSUES OBJEC, P29; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rolls ET, 2000, PROG NEUROBIOL, V61, P557, DOI 10.1016/S0301-0082(99)00066-0; Rowe JE, 2010, EVOL COMPUT, V18, P635, DOI 10.1162/EVCO_a_00007; Rudolph G, 1996, IEEE C EVOL COMPUTAT, P50, DOI 10.1109/ICEC.1996.542332; Salcedo-Sanz S, 2002, ARTIFICIAL NEURAL NE, V2002, P144; Schneider G, 2005, IEEE T SYST MAN CY B, V35, P426, DOI 10.1109/TSMCB.2005.846649; Serre T., 2005, ARTIF INTELL, P1; Serre T, 2002, BIOL MOTIVATED COMPU, P209; Serre T, 2007, PROG BRAIN RES, V165, P33, DOI 10.1016/S0079-6123(06)65004-8; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shi D, 1999, Int J Neural Syst, V9, P497, DOI 10.1142/S012906579900054X; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Sivanandam S. N., 2007, INTRO GENETIC ALGORI, V1st; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Varma M, 2007, IEEE I CONF COMP VIS, P369; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Weber M, 2000, LECT NOTES COMPUT SC, V1842, P18; Weber M, 2000, THESIS CALTECH PASAD; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091; Zhang H., 2006, 2006 IEEE COMP SOC C, V2, P2126, DOI [DOI 10.1109/CVPR.2006.301, 10.1109/CVPR.2006.301]	51	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32357	10.1371/journal.pone.0032357	http://dx.doi.org/10.1371/journal.pone.0032357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384229	gold, Green Published			2022-12-25	WOS:000302918500081
J	Jiang, WH; Ghosh, D				Jiang, Wenhua; Ghosh, Debashis			Motion and Flexibility in Human Cytochrome P450 Aromatase	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; PROTEIN FLEXIBILITY; LIPID-COMPOSITION; CONFORMATIONAL-CHANGE; MOLECULAR-DYNAMICS; ANALYSIS SUGGESTS; SINGLE-PARAMETER; MECHANISM; MACROMOLECULES; ELECTROSTATICS	The crystal structures of human placental aromatase in complex with the substrate androstenedione and exemestane have revealed an androgen-specific active site and the structural basis for higher order organization. However, X-ray structures do not provide accounts of movements due to short-range fluctuations, ligand binding and protein-protein association. In this work, we conduct normal mode analysis (NMA) revealing the intrinsic fluctuations of aromatase, deduce the internal modes in membrane-free and membrane-integrated monomers as well as the intermolecular modes in oligomers, and propose a quaternary organization for the endoplasmic reticulum (ER) membrane integration. Dynamics of the crystallographic oligomers from NMA is found to be in agreement with the isotropic thermal factors from the X-ray analysis. Calculations of the root mean square fluctuations of the C-alpha atoms from their equilibrium positions confirm that the rigid-core structure of aromatase is intrinsic regardless of the changes in steroid binding interactions, and that aromatase self-association does not deteriorate the rigidity of the catalytic cleft. Furthermore, NMA on membrane-integrated aromatase shows that the internal modes in all likelihood contribute to breathing of the active site access channel. The collective intermolecular hinge bending and twisting modes provide the flexibility in the quaternary association necessary for membrane integration of the aromatase oligomers. Taken together, fluctuations of the active site, the access channel, and the heme-proximal cavity, and a dynamic quaternary organization could all be essential components of the functional aromatase in its role as an ER membrane-embedded steroidogenic enzyme.	[Jiang, Wenhua; Ghosh, Debashis] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Jiang, WH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY USA.	ghoshd@upstate.edu			National Institutes of Health [GM086893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant GM086893. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN DJ, 1989, PLANT PHYSIOL, V90, P955, DOI 10.1104/pp.90.3.955; Catalano S, 2009, MOL ENDOCRINOL, V23, P1634, DOI 10.1210/me.2009-0039; DAVISON SC, 1974, BIOCHEMISTRY-US, V140, P461, DOI 10.1042/bj1400461; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobbins SE, 2008, P NATL ACAD SCI USA, V105, P10390, DOI 10.1073/pnas.0802496105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogolari F, 2002, J MOL RECOGNIT, V15, P377, DOI 10.1002/jmr.577; Forman-Kay JD, 1999, NAT STRUCT BIOL, V6, P1086, DOI 10.1038/70008; Ghosh D, 2011, STEROIDS, V76, P753, DOI 10.1016/j.steroids.2011.02.030; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Hong YY, 2010, J STEROID BIOCHEM, V118, P203, DOI 10.1016/j.jsbmb.2009.11.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kovacs JA, 2004, PROTEINS, V56, P661, DOI 10.1002/prot.20151; Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502; Ma JP, 2004, CURR PROTEIN PEPT SC, V5, P119, DOI 10.2174/1389203043486892; Phan G, 2010, STRUCTURE, V18, P507, DOI 10.1016/j.str.2010.01.018; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Shattuck T W., 2009, MOL OPERATING ENV; Soheilifard R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026008; STEINBERG IZ, 1963, J BIOL CHEM, V238, P172; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tama F, 2000, PROTEINS, V41, P1; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Van Wynsberghe A, 2004, BIOCHEMISTRY-US, V43, P13083, DOI 10.1021/bi049738+; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	36	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32565	10.1371/journal.pone.0032565	http://dx.doi.org/10.1371/journal.pone.0032565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384274	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500101
J	Koren, L; Ng, ESM; Soma, KK; Wynne-Edwards, KE				Koren, Lee; Ng, Ella S. M.; Soma, Kiran K.; Wynne-Edwards, Katherine E.			Sample Preparation and Liquid Chromatography-Tandem Mass Spectrometry for Multiple Steroids in Mammalian and Avian Circulation	PLOS ONE			English	Article							TESTOSTERONE; IMMUNOASSAY; CORTICOSTERONE; INTERFERENCE; EXTRACTION; ESTROGENS; SONGBIRD; CORTISOL; PLASMA; BRAIN	Blood samples from wild mammals and birds are often limited in volume, allowing researchers to quantify only one or two steroids from a single sample by immunoassays. In addition, wildlife serum or plasma samples are often lipemic, necessitating stringent sample preparation. Here, we validated sample preparation for simultaneous liquid chromatography -tandem mass spectrometry (LC-MS/MS) quantitation of cortisol, corticosterone, 11-deoxycortisol, dehydroepiandrosterone (DHEA), 17b-estradiol, progesterone, 17 alpha-hydroxyprogesterone and testosterone from diverse mammalian (7 species) and avian (5 species) samples. Using 100 mL of serum or plasma, we quantified (signal-to-noise (S/N) ratio >= 10) 4-7 steroids depending on the species and sample, without derivatization. Steroids were extracted from serum or plasma using automated solid-phase extraction where samples were loaded onto C18 columns, washed with water and hexane, and then eluted with ethyl acetate. Quantitation by LC-MS/MS was done in positive ion, multiple reaction-monitoring (MRM) mode with an atmospheric pressure chemical ionization (APCI) source and heated nebulizer (500 degrees C). Deuterated steroids served as internal standards and run time was 15 minutes. Extraction recoveries were 87-101% for the 8 analytes, and all intra-and inter-run CVs were <= 8.25%. This quantitation method yields good recoveries with variable lipid-content samples, avoids antibody cross-reactivity issues, and delivers results for multiple steroids. Thus, this method can enrich datasets by providing simultaneous quantitation of multiple steroids, and allow researchers to reimagine the hypotheses that could be tested with their volume-limited, lipemic, wildlife samples.	[Koren, Lee; Ng, Ella S. M.; Wynne-Edwards, Katherine E.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Koren, Lee; Ng, Ella S. M.; Wynne-Edwards, Katherine E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of Calgary; University of Calgary; University of British Columbia	Koren, L (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada.	k.wynne-edwards@ucalgary.ca	Wynne-Edwards, Katherine/P-2326-2019; Wynne-Edwards, Katherine/D-9036-2012; Soma, Kiran K/B-9772-2012	Wynne-Edwards, Katherine/0000-0002-2944-4516; Soma, Kiran K/0000-0003-2169-8092	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Alberta Education and Technology; Faculty of Veterinary Medicine at the University of Calgary (KEWE); CIHR; University of Calgary Faculty of Veterinary Medicine (LK/KEWE)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Education and Technology; Faculty of Veterinary Medicine at the University of Calgary (KEWE); CIHR(Canadian Institutes of Health Research (CIHR)); University of Calgary Faculty of Veterinary Medicine (LK/KEWE)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, Alberta Education and Technology, and the Faculty of Veterinary Medicine at the University of Calgary (KEWE). In addition, support was provided by CIHR (KKS) plus a postdoctoral award from the University of Calgary Faculty of Veterinary Medicine (LK/KEWE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasco M, 2009, J CHROMATOGR B, V877, P1509, DOI 10.1016/j.jchromb.2009.03.028; Bock JL, 2000, AM J CLIN PATHOL, V113, P628, DOI 10.1309/DUDM-3Y6L-3R1L-QP15; Ceglarek U, 2010, J STEROID BIOCHEM, V121, P479, DOI 10.1016/j.jsbmb.2010.07.002; Charlier TD, 2010, GEN COMP ENDOCR, V167, P18, DOI 10.1016/j.ygcen.2010.02.002; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; Guo TD, 2004, ARCH PATHOL LAB MED, V128, P469; Guo TD, 2008, CLIN BIOCHEM, V41, P736, DOI 10.1016/j.clinbiochem.2008.02.009; Guo TD, 2006, CLIN CHIM ACTA, V372, P76, DOI 10.1016/j.cca.2006.03.034; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Ismail AAA, 2002, ANN CLIN BIOCHEM, V39, P366, DOI 10.1258/000456302760042128; Lee C, 1998, CLIN BIOCHEM, V31, P229, DOI 10.1016/S0009-9120(98)00025-3; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Newman AEM, 2008, ENDOCRINOLOGY, V149, P2537, DOI 10.1210/en.2007-1363; Penning TM, 2010, J STEROID BIOCHEM, V121, P546, DOI 10.1016/j.jsbmb.2010.01.005; Rossi C, 2010, CLIN CHIM ACTA, V411, P222, DOI 10.1016/j.cca.2009.11.007; Schmidt G, 2002, FOOD CHEM, V76, P83, DOI 10.1016/S0308-8146(01)00237-0; Schmidt KL, 2010, BRAIN BEHAV IMMUN, V24, P908, DOI 10.1016/j.bbi.2010.02.008; Shackleton C, 2010, J STEROID BIOCHEM, V121, P481, DOI 10.1016/j.jsbmb.2010.02.017; Soldin SJ, 2009, CLIN CHEM, V55, P1061, DOI 10.1373/clinchem.2007.100008; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stanczyk FZ, 2003, STEROIDS, V68, P1173, DOI 10.1016/j.steroids.2003.08.012; Taves MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015727; Taves MD, 2011, FRONTIERS ENDOCRINOL, V2; WINGFIELD JC, 1994, ANIM BEHAV, V47, P77, DOI 10.1006/anbe.1994.1009	24	51	51	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32496	10.1371/journal.pone.0032496	http://dx.doi.org/10.1371/journal.pone.0032496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384262	gold, Green Published			2022-12-25	WOS:000302918500096
J	Lifjeld, JT; Laskemoen, T; Kleven, O; Pedersen, ATM; Lampe, HM; Rudolfsen, G; Schmoll, T; Slagsvold, T				Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund; Pedersen, A. Tiril M.; Lampe, Helene M.; Rudolfsen, Geir; Schmoll, Tim; Slagsvold, Tore			No Evidence for Pre-Copulatory Sexual Selection on Sperm Length in a Passerine Bird	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; PIED FLYCATCHERS; FICEDULA-HYPOLEUCA; COMPETITION; MALES; MATE; HYPOTHESIS; MORPHOLOGY; FERTILITY; EVOLUTION	There is growing evidence that post-copulatory sexual selection, mediated by sperm competition, influences the evolution of sperm phenotypes. Evidence for pre-copulatory sexual selection effects on sperm traits, on the other hand, is rather scarce. A recent paper on the pied flycatcher, Ficedula hypoleuca, reported phenotypic associations between sperm length and two sexually selected male traits, i.e. plumage colour and arrival date, thus invoking pre-copulatory sexual selection for longer sperm. We were unable to replicate these associations with a larger data set from the same and two additional study populations; sperm length was not significantly related to either male plumage colour or arrival date. Furthermore, there was no significant difference in sperm length between populations despite marked differences in male plumage colour. We also found some evidence against the previously held assumption of longer sperm being qualitatively superior; longer sperm swam at the same speed as shorter sperm, but were less able to maintain speed over time. We argue that both empirical evidence and theoretical considerations suggest that the evolution of sperm morphology is not primarily associated with pre-copulatory sexual selection on male secondary sexual traits in this or other passerine bird species. The relatively large between-male variation in sperm length in this species is probably due to relaxed post-copulatory sexual selection.	[Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund] Univ Oslo, Nat Hist Museum, NCB, Oslo, Norway; [Pedersen, A. Tiril M.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Lampe, Helene M.; Slagsvold, Tore] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Rudolfsen, Geir] Norwegian Radiat Protect Author, Dept Environm Radioact, Tromso, Norway; [Schmoll, Tim] Univ Bielefeld, D-33615 Bielefeld, Germany	University of Oslo; Norwegian University of Life Sciences; University of Oslo; University of Bielefeld	Lifjeld, JT (corresponding author), Univ Oslo, Nat Hist Museum, NCB, Oslo, Norway.	j.t.lifjeld@nhm.uio.no	Kleven, Oddmund/A-6116-2009; Rudolfsen, Geir/ABD-7777-2020; Lifjeld, Jan T/B-1978-2008	Kleven, Oddmund/0000-0003-0267-6795; Lifjeld, Jan T/0000-0002-9172-9985; Rudolfsen, Geir/0000-0001-7984-8458	Research Council of Norway [170853/V40, 196554/V40]	Research Council of Norway(Research Council of Norway)	The work was funded by two grants (170853/V40 and 196554/V40) from the Research Council of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, SPERM COMPETITION SE; Birkhead TR, SPERM BIOL EVOLUTION; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Calhim S, 2009, BIOL LETTERS, V5, P58, DOI 10.1098/rsbl.2008.0544; Chek AA, 1996, ETHOLOGY, V102, P134; Drost R, 1936, VOGELZUG, V6, P179; Ellegren H, 1995, MOL ECOL, V4, P739, DOI 10.1111/j.1365-294X.1995.tb00274.x; Gelman A., 2007, DATA ANAL USING REGR; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2007, REPRODUCTION, V134, P19, DOI 10.1530/REP-07-0143; Helfenstein F, 2010, BEHAV ECOL SOCIOBIOL, V64, P557, DOI 10.1007/s00265-009-0871-x; KELLER L, 1995, ADV STUD BEHAV, V24, P291, DOI 10.1016/S0065-3454(08)60397-6; Kelly CD, 2006, Q REV BIOL, V81, P221, DOI 10.1086/506236; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lehtonen PK, 2009, ANIM BEHAV, V77, P1103, DOI 10.1016/j.anbehav.2009.01.014; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; Lifjeld JT, 1997, AUK, V114, P112, DOI 10.2307/4089072; LIFJELD JT, 1991, BEHAV ECOL SOCIOBIOL, V29, P95, DOI 10.1007/BF00166483; Lifjeld JT, 1997, ANIM BEHAV, V53, P1225, DOI 10.1006/anbe.1996.0430; Lubjuhn T, 2000, BEHAV ECOL SOCIOBIOL, V48, P12, DOI 10.1007/s002650000208; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; RATTI O, 1995, BEHAV ECOL SOCIOBIOL, V37, P419, DOI 10.1007/BF00170590; ROSKAFT E, 1992, J ZOOL, V228, P521, DOI 10.1111/j.1469-7998.1992.tb04452.x; SAETRE GP, 1995, J ANIM ECOL, V64, P21, DOI 10.2307/5824; Saetre GP, 1997, NATURE, V387, P589; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; SLAGSVOLD T, 1986, ORNIS SCAND, V17, P210, DOI 10.2307/3676829; Slagsvold T, 2001, BEHAV ECOL, V12, P412, DOI 10.1093/beheco/12.4.412; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011	38	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32611	10.1371/journal.pone.0032611	http://dx.doi.org/10.1371/journal.pone.0032611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384277	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000302918500104
J	Monaco, S; Fiorini, M; Farinazzo, A; Ferrari, S; Gelati, M; Piccardo, P; Zanusso, G; Ghetti, B				Monaco, Salvatore; Fiorini, Michele; Farinazzo, Alessia; Ferrari, Sergio; Gelati, Matteo; Piccardo, Pedro; Zanusso, Gianluigi; Ghetti, Bernardino			Allelic Origin of Protease-Sensitive and Protease-Resistant Prion Protein Isoforms in Gerstmann-Straussler-Scheinker Disease with the P102L Mutation	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; SYNTHETIC PEPTIDE; TRUNCATED FORMS; WILD-TYPE; PRP; NEURODEGENERATION; IDENTIFICATION; VARIABILITY; FRAGMENTS; FAMILY	Gerstmann-Straussler-Scheinker (GSS) disease is a dominantly inherited prion disease associated with point mutations in the Prion Protein gene. The most frequent mutation associated with GSS involves a proline-to-leucine substitution at residue 102 of the prion protein, and is characterized by marked variability at clinical, pathological and molecular levels. Previous investigations of GSS P102L have shown that disease-associated pathological prion protein, or PrPSc, consists of two main conformers, which under exogenous proteolysis generates a core fragment of 21 kDa and an internal fragment of 8 kDa. Both conformers are detected in subjects with spongiform degeneration, whereas only the 8 kDa fragment is recovered in cases lacking spongiosis. Several studies have reported an exclusive derivation of protease-resistant PrPSc isoforms from the mutated allele; however, more recently, the propagation of protease-resistant wild-type PrPSc has been described. Here we analyze the molecular and pathological phenotype of six GSS P102L cases characterized by the presence of 21 and 8 kDa PrP fragments and two subjects with only the 8 kDa PrP fragment. Using sensitive protein separation techniques and Western blots with antibodies differentially recognizing wild-type and mutant PrP we observed a range of PrPSc allelic conformers, either resistant or sensitive to protease treatment in all investigated subjects. Additionally, tissue deposition of protease-sensitive wild-type PrPSc molecules was seen by conventional PrP immunohistochemistry and paraffin-embedded tissue blot. Our findings enlarge the spectrum of conformational allelic PrPSc quasispecies propagating in GSS P102L thus providing a molecular support to the spectrum of disease phenotypes, and, in addition, impact the diagnostic role of PrP immunohistochemistry in prion diseases.	[Monaco, Salvatore; Fiorini, Michele; Farinazzo, Alessia; Ferrari, Sergio; Gelati, Matteo; Zanusso, Gianluigi] Univ Verona, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37100 Verona, Italy; [Piccardo, Pedro] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Piccardo, Pedro; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA	University of Verona; US Food & Drug Administration (FDA); Indiana University System; Indiana University Bloomington	Monaco, S (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37100 Verona, Italy.	salvatore.monaco@univr.it	Gelati, Matteo/AAR-1692-2020; Monaco, Salvatore/K-4659-2018; Zanusso, Gianluigi/K-2823-2018; Ferrari, Sergio/AAE-5649-2019	Monaco, Salvatore/0000-0003-3191-8597; Zanusso, Gianluigi/0000-0001-5199-6264; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716	National Institute of Neurological Disease and Stroke (NINDS), National Institutes of Health [R01 NS029822]; National Institute on Aging (NIA), National Institutes of Health [P30 AG010133]; Fondazione Cariverona; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: researchfish; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke (NINDS), National Institutes of Health; National Institute on Aging (NIA), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fondazione Cariverona(Fondazione Cariverona); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants R01 NS029822 to BG from National Institute of Neurological Disease and Stroke (NINDS), P30 AG010133 from National Institute on Aging (NIA) to BG (both Institutes are part of the National Institutes of Health) and by the grant "Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbanti P, 1996, NEUROLOGY, V47, P734, DOI 10.1212/WNL.47.3.734; Bergstrom AL, 2009, CLIN NEUROPATHOL, V28, P321, DOI 10.2379/NPX07098; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Colucci M, 2006, J NEUROPATH EXP NEUR, V65, P642, DOI 10.1097/01.jnen.0000228198.81797.4d; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; HAINFELLNER JA, 1995, BRAIN PATHOL, V5, P201, DOI 10.1111/j.1750-3639.1995.tb00596.x; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1992, BIOCHEMISTRY-US, V31, P12277, DOI 10.1021/bi00164a001; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Webb TEF, 2008, BRAIN, V131, P2632, DOI 10.1093/brain/awn202; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; ZANUSSO G, 2005, DRUG DISCOV TODAY, V2, P511; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	33	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32382	10.1371/journal.pone.0032382	http://dx.doi.org/10.1371/journal.pone.0032382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384235	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100076
J	Guo, W; Zou, LF; Li, YR; Cui, YP; Ji, ZY; Cai, LL; Zou, HS; Hutchins, WC; Yang, CH; Chen, GY				Guo, Wei; Zou, Li-fang; Li, Yu-rong; Cui, Yi-ping; Ji, Zhi-yuan; Cai, Lu-lu; Zou, Hua-song; Hutchins, William C.; Yang, Ching-hong; Chen, Gong-you			Fructose-Bisphophate Aldolase Exhibits Functional Roles between Carbon Metabolism and the hrp System in Rice Pathogen Xanthomonas oryzae pv. oryzicola	PLOS ONE			English	Article							ACTING REGULATORY ELEMENT; HYPERSENSITIVE-RESPONSE; TRANSCRIPTIONAL INDUCTION; BACTERIAL PATHOGENS; GENOME SEQUENCE; GENE HRPG; CAMPESTRIS; PLANT; EXPRESSION; VESICATORIA	Fructose-bisphophate aldolase (FbaB), is an enzyme in glycolysis and gluconeogenesis in living organisms. The mutagenesis in a unique fbaB gene of Xanthomonas oryzae pv. oryzicola, the causal agent of rice bacterial leaf streak, led the pathogen not only unable to use pyruvate and malate for growth and delayed its growth when fructose was used as the sole carbon source, but also reduced extracellular polysaccharide (EPS) production and impaired bacterial virulence and growth in rice. Intriguingly, the fbaB promoter contains an imperfect PIP-box (plant-inducible promoter) (TTCGT-N-9-TTCGT). The expression of fbaB was negatively regulated by a key hrp regulatory HrpG and HrpX cascade. Base substitution in the PIP-box altered the regulation of fbaB with the cascade. Furthermore, the expression of fbaB in X. oryzae pv. oryzicola RS105 strain was inducible in planta rather than in a nutrient-rich medium. Except other hrp-hrc-hpa genes, the expression of hrpG and hrpX was repressed and the transcripts of hrcC, hrpE and hpa3 were enhanced when fbaB was deleted. The mutation in hrcC, hrpE or hpa3 reduced the ability of the pathogen to acquire pyruvate and malate. In addition, bacterial virulence and growth in planta and EPS production in R Delta fbaB mutant were completely restored to the wild-type level by the presence of fbaB in trans. This is the first report to demonstrate that carbohydrates, assimilated by X. oryzae pv. oryzicola, play critical roles in coordinating hrp gene expression through a yet unknown regulator.	[Zou, Li-fang; Li, Yu-rong; Ji, Zhi-yuan; Cai, Lu-lu; Zou, Hua-song; Chen, Gong-you] Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban South, Shanghai 200030, Peoples R China; [Guo, Wei; Cui, Yi-ping; Chen, Gong-you] Nanjing Agr Univ, Coll Plant Protect, Minist Educ China, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Peoples R China; [Hutchins, William C.; Yang, Ching-hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University; Ministry of Education, China; Nanjing Agricultural University; University of Wisconsin System; University of Wisconsin Milwaukee	Guo, W (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban South, Shanghai 200030, Peoples R China.	chyang@uwm.edu; gyouchen@sjtu.edu.cn	Zou, Huasong/GLN-3569-2022; CHEN, Gongyou/AAA-9694-2019; Cai, Lulu/AAN-1269-2021	CHEN, Gongyou/0000-0003-1979-2880; Cai, Lulu/0000-0002-4830-4105; Zou, Huasong/0000-0001-5758-1975	State Key Basic Research and Development Project of China [2011CB16141]; National Natural Science Foundation of China [31071656, 31000071]; Foundation of Ministry of Education of China [20100073110045]	State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by the State Key Basic Research and Development Project of China (2011CB16141), the National Natural Science Foundation of China (31071656 to Dr. Chen and 31000071 to Zou) and the Ph.D. Programs Foundation of Ministry of Education of China (20100073110045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; ANKENBAUER RG, 1990, J BACTERIOL, V172, P6442, DOI 10.1128/jb.172.11.6442-6446.1990; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Buttner D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002; Cunnac S, 2004, J BACTERIOL, V186, P2309, DOI 10.1128/JB.186.8.2309-2318.2004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Furutani A, 2004, J BACTERIOL, V186, P1374, DOI 10.1128/JB.186.5.1374-1380.2004; Guo Xiaoxia, 2010, Wei Sheng Wu Xue Bao, V50, P1155; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; HOCHSTER RM, 1958, CAN J BIOCHEM PHYS, V36, P669; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Islam MR, 2009, J GEN PLANT PATHOL, V75, P66, DOI 10.1007/s10327-008-0124-2; Jiang Jia, 2009, Wei Sheng Wu Xue Bao, V49, P1018; Kim SY, 2010, BIOTECHNOL LETT, V32, P527, DOI 10.1007/s10529-009-0193-0; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Letisse F, 2002, J BIOTECHNOL, V99, P307, DOI 10.1016/S0168-1656(02)00221-3; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Lu GT, 2009, MICROBIOL-SGM, V155, P1602, DOI 10.1099/mic.0.023762-0; Mellgren EM, 2009, J BACTERIOL, V191, P3132, DOI 10.1128/JB.01570-08; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Oku Takashi, 2004, Journal of General Plant Pathology, V70, P159, DOI 10.1007/s10327-004-0106-y; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; SCHULTE R, 1992, J BACTERIOL, V174, P815, DOI 10.1128/jb.174.3.815-823.1992; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Sugio A, 2005, MOL PLANT MICROBE IN, V18, P546, DOI 10.1094/MPMI-18-0546; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Tamir-Ariel D, 2011, MOL PLANT PATHOL, V12, P57, DOI 10.1111/j.1364-3703.2010.00652.x; Tang DJ, 2005, J BACTERIOL, V187, P6231, DOI 10.1128/JB.187.17.6231-6237.2005; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Tsuge S, 2006, J BACTERIOL, V188, P4158, DOI 10.1128/JB.00006-06; Tung SY, 1999, APPL ENVIRON MICROB, V65, P5564; Turner PE, 2004, GENETICS, V167, P9, DOI 10.1534/genetics.167.1.9; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang LF, 2008, MOL PLANT MICROBE IN, V21, P555, DOI 10.1094/MPMI-21-5-0555; Wang YinPeng, 2009, Acta Phytopathologica Sinica, V39, P392; Watt TF, 2009, J BIOTECHNOL, V140, P59, DOI 10.1016/j.jbiotec.2008.12.003; Weber E, 2005, J BACTERIOL, V187, P6175, DOI 10.1128/JB.187.17.6175-6186.2005; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; WINANS SC, 1990, J BACTERIOL, V172, P2433, DOI 10.1128/jb.172.5.2433-2438.1990; Xiao You-lun, 2007, Weishengwu Xuebao, V47, P396; Yang WF, 2007, CURR MICROBIOL, V54, P307, DOI 10.1007/s00284-006-0485-8; Yoshimochi T, 2009, J BACTERIOL, V191, P3424, DOI 10.1128/JB.01113-08; ZAGALLO AC, 1967, J BACTERIOL, V93, P970, DOI 10.1128/JB.93.3.970-975.1967; Zhang SS, 2008, RES MICROBIOL, V159, P569, DOI 10.1016/j.resmic.2008.06.010; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06	65	17	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31855	10.1371/journal.pone.0031855	http://dx.doi.org/10.1371/journal.pone.0031855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384086	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500048
J	Riaz, A; Zeller, KS; Johansson, S				Riaz, Anjum; Zeller, Kathrin Stephanie; Johansson, Staffan			Receptor-Specific Mechanisms Regulate Phosphorylation of AKT at Ser473: Role of RICTOR in beta 1 Integrin-Mediated Cell Survival	PLOS ONE			English	Article							PROTEIN-KINASE-B/AKT; LINKED KINASE; HYDROPHOBIC MOTIF; CANCER-CELLS; SUBSTRATE-SPECIFICITY; P21-ACTIVATED KINASE; SIGNALING PATHWAYS; MTOR COMPLEX; MICE REVEALS; ACTIVATION	A tight control over AKT/PKB activation is essential for cells, and they realise this in part by regulating the phosphorylation of Ser473 in the "hydrophobic motif" of the AKT carboxy-terminal region. The RICTOR-mTOR complex (TORC2) is a major kinase for AKT Ser473 phosphorylation after stimulation by several growth factors, in a reaction proposed to require p21-activated kinase (PAK) as a scaffold. However, other kinases may catalyse this reaction in stimuli-specific manners. Here we characterised the requirement of RICTOR, ILK, and PAK for AKT Ser473 phosphorylation downstream of selected family members of integrins, G protein-coupled receptors, and tyrosine-kinase receptors and analysed the importance of this phosphorylation site for adhesion-mediated survival. siRNA-mediated knockdown in HeLa and MCF7 cells showed that RICTOR-mTOR was required for phosphorylation of AKT Ser473, and for efficient phosphorylation of the downstream AKT targets FOXO1 Thr24 and BAD Ser136, in response to beta 1 integrin-stimulation. ILK and PAK1/2 were dispensable for these reactions. RICTOR knockdown increased the number of apoptotic MCF7 cells on beta 1 integrin ligands up to 2-fold after 24 h in serum-free conditions. beta 1 integrin-stimulation induced phosphorylation of both AKT1 and AKT2 but markedly preferred AKT2. RICTOR-mTOR was required also for LPA-induced AKT Ser473 phosphorylation in MCF7 cells, but, interestingly, not in HeLa cells. PAK was needed for the AKT Ser473 phosphorylation in response to LPA and PDGF, but not to EGF. These results demonstrate that different receptors utilise different enzyme complexes to phosphorylate AKT at Ser473, and that AKT Ser473 phosphorylation significantly contributes to beta 1 integrin-mediated anchorage-dependent survival of cells.	[Riaz, Anjum; Zeller, Kathrin Stephanie; Johansson, Staffan] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Riaz, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	staffan.johansson@imbim.uu.se			Swedish Research Council [7147]; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation; Higher Education Commission, Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Economic support was obtained from the Swedish Research Council (Grant No. 7147), Swedish Cancer Foundation, and Swedish Childhood Cancer Foundation. Anjum Riaz was supported by a scholarship from the Higher Education Commission, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dibble CC, 2009, CANCER CELL, V16, P178, DOI 10.1016/j.ccr.2009.08.011; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Farias E, 2005, BIOCHEM BIOPH RES CO, V329, P305, DOI 10.1016/j.bbrc.2005.01.125; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Liao Y, 2010, AM J TRANSL RES, V2, P19; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Park J, 2009, J BIOL CHEM, V284, P6169, DOI 10.1074/jbc.C800210200; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Santi SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014614; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Vachon P. H., 2011, J SIGNAL TRANSDUCT, V2011; Velling T, 2008, EXP CELL RES, V314, P309, DOI 10.1016/j.yexcr.2007.08.018; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	59	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32081	10.1371/journal.pone.0032081	http://dx.doi.org/10.1371/journal.pone.0032081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384145	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500073
J	Shchors, K; Nozawa, H; Xu, J; Rostker, F; Swigart-Brown, L; Evan, G; Hanahan, D				Shchors, K.; Nozawa, H.; Xu, J.; Rostker, F.; Swigart-Brown, L.; Evan, G.; Hanahan, D.			Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis	ONCOGENE			English	Article						tumor; metalloproteinase; invasion; cathepsin; Myc; interleukin-1 beta	MATRIX-METALLOPROTEINASE INHIBITORS; LYSOSOMAL CYSTEINE PROTEASES; CAPILLARY ENDOTHELIAL-CELLS; MARROW-DERIVED CELLS; CATHEPSIN-B; ANGIOGENIC SWITCH; PHASE-III; MULTISTAGE TUMORIGENESIS; MALIGNANT PROGRESSION; EXTRACELLULAR-MATRIX	Despite their apparent success in pre-clinical trials, metalloproteinase (MMP) inhibitors proved to be inefficacious in clinical settings. In an effort to understand the underlying causes of this unanticipated outcome, we modeled the consequences of long-term MMP inhibition by removing one of the major players in tumorigenesis, MMP9, in two complimentary mouse models of pancreatic neuroendocrine carcinogenesis: Myc;BclXI and RIP1-Tag2. By employing gel zymography and a fluoregenic solution assay, we first established that MMP9 is expressed and activated in Myc;BclXI tumors in an interleukin-1 beta-dependent manner. The genetic deletion of MMP9 in Myc;BclXI mice impairs tumor angiogenesis and growth analogous to its absence in the RIP1-Tag2 model. Notably, tumors that developed in the context of MMP9-deficient backgrounds in both models were markedly more invasive than their typical wild-type counterparts, and expressed elevated levels of pro-invasive cysteine cathepsin B. The increased invasion of MMP9-deficient tumors was associated with a switch in the spectrum of inflammatory cells at the tumor margins, involving homing of previously undetected, cathepsin-B expressing CD11b;Gr1-positive cells to the invasive fronts. Thus, plasticity in the tumor inflammatory compartment is partially responsible for changes in the expression pattern of tumor-associated proteases, and may contribute to the compensatory effects observed on MMP inhibition, hence accounting for the heightened tumor progression described in late stage clinical trials. Oncogene (2013) 32, 502-513; doi:10.1038/onc.2012.60; published online 5 March 2012	[Shchors, K.; Hanahan, D.] Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [Shchors, K.; Xu, J.; Rostker, F.; Swigart-Brown, L.; Evan, G.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Nozawa, H.; Hanahan, D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shchors, K (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res, SV2818,Stn 19, CH-1015 Lausanne, Switzerland.	ksenya.shchors@epfl.ch			NCI; EPLF [F32-CA106039]; Cancer Research UK [12077] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F32CA106039] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EPLF; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NCI and by core support from EPLF to DH. KS is a recipient of F32-CA106039. We are extremely grateful to Dr Zena Werb (UCSF) providing the MMP9-deficient animal model. Special thanks to Drs Johanna Joyce and Vasilena Gocheva (MSKCC) for providing cathepsin activity probe, antibodies and experimental protocols. We are grateful to Dr Elizabeth Allen and Dr Masahiro Inoue for providing Sutent-treated RT2 samples and RT2;RipCre;VEGFA FL/FL samples, respectively. We are grateful to Drs Lisa Coussens, Luisa Iruela-Arrispe (UCLA), Enrico Giraudo (U of Torino) for helpful discussions and advice. We are grateful to Mr Jeffrey A Kasten (EPFL) for critical reading of the paper. Authors also would like to acknowledge the Bioimaging and Optics platform (PT-BIOP) and the Histology Core Facility at EPFL for their services.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Batist G, 2002, ANN ONCOL, V13, P1259, DOI 10.1093/annonc/mdf195; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bissett D, 2005, J CLIN ONCOL, V23, P842, DOI 10.1200/JCO.2005.03.170; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Chun MGH, 2010, P NATL ACAD SCI USA, V107, P17268, DOI 10.1073/pnas.1012705107; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Creemers LB, 1998, MATRIX BIOL, V16, P575, DOI 10.1016/S0945-053X(98)90068-3; Czyzewska J, 2008, FOLIA HISTOCHEM CYTO, V46, P57, DOI 10.2478/v10042-008-0007-6; DALETFUMERON V, 1993, FEBS LETT, V332, P251, DOI 10.1016/0014-5793(93)80643-9; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HERRON GS, 1986, J BIOL CHEM, V261, P2810; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; HIMELSTEIN BP, 1994, INVAS METAST, V14, P246; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Kirschke H, 1997, J CANCER RES CLIN, V123, P402, DOI 10.1007/s004320050078; Kruger A, 2001, CANCER RES, V61, P1272; LAH TT, 1989, CLIN EXP METASTAS, V7, P461, DOI 10.1007/BF01753666; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Lee HT, 2004, J BIOL CHEM, V279, P32325, DOI 10.1074/jbc.M405208200; Levicar N, 2003, ACTA NEUROCHIR, V145, P825, DOI 10.1007/s00701-003-0097-z; Levin VA, 2006, J NEURO-ONCOL, V78, P295, DOI 10.1007/s11060-005-9098-5; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Lockwood CJ, 2006, AM J PATHOL, V168, P445, DOI 10.2353/ajpath.2006.050082; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; McCawley LJ, 2008, AM J PATHOL, V173, P1528, DOI 10.2353/ajpath.2008.080132; MELCHIORI A, 1992, CANCER RES, V52, P2353; Moore MJ, 2003, J CLIN ONCOL, V21, P3296, DOI 10.1200/JCO.2003.02.098; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Raymond L, 2006, J CELL PHYSIOL, V207, P683, DOI 10.1002/jcp.20608; Sekhon HS, 2008, LUNG CANCER, V60, P347, DOI 10.1016/j.lungcan.2007.10.028; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sillanpaa S, 2007, GYNECOL ONCOL, V104, P296, DOI 10.1016/j.ygyno.2006.09.004; Sounni NE, 2010, DIS MODEL MECH, V3, P317, DOI 10.1242/dmm.003863; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Turk V, 2002, ADV ENZYME REGUL, V42, P285, DOI 10.1016/S0065-2571(01)00034-6; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	71	41	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2013	32	4					502	513		10.1038/onc.2012.60	http://dx.doi.org/10.1038/onc.2012.60			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22391572	Green Published			2022-12-25	WOS:000315551300011
J	Lee, DM; Lee, HW; Hong, ST; Choi, BI; Kim, HW; Han, SB; Kim, IH; Bae, JY; Bae, YC; Rhyu, IJ; Sun, W; Kim, H				Lee, Dongmin; Lee, Hyun Woo; Hong, Soontaek; Choi, Byung-Il; Kim, Hyun-Wook; Han, Seung Baek; Kim, Il Hwan; Bae, Jin Young; Bae, Yong Chul; Rhyu, Im Joo; Sun, Woong; Kim, Hyun			Inositol 1,4,5-Trisphosphate 3-Kinase A Is a Novel Microtubule-associated Protein PKA-DEPENDENT PHOSPHOREGULATION OF MICROTUBULE BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR ACTIVATION; TAU-PROTEIN; F-ACTIN; KINASE; PHOSPHORYLATION; EXPRESSION; DOUBLECORTIN; ISOFORMS; PURIFICATION	Inositol 1,4,5-trisphosphate 3-kinase A (IP3K-A) is a brain specific and F-actin-binding protein. We recently demonstrated that IP3K-A modulates a structural reorganization of dendritic spines through F-actin remodeling, which is required for synaptic plasticity and memory formation in brain. However, detailed functions of IP3K-A and its regulatory mechanisms involved in the neuronal cytoskeletal dynamics still remain unknown. In the present study, we identified tubulin as a candidate of IP3K-A-binding protein through proteomic screening. By various in vitro and in vivo approaches, we demonstrated that IP3K-A was a novel microtubule-associated protein (MAP), and the N terminus of IP3K-A was a critical region for direct binding to tubulin in dendritic shaft of hippocampal neurons. Moreover, PKA phosphorylated Ser-119 within IP3K-A, leading to a significant reduction of microtubule binding affinity. These results suggest that PKA-dependent phosphorylation and microtubule binding of IP3K-A are involved in its regulatory mechanism for activity-dependent neuronal events such as local calcium signaling and its synaptic targeting.	[Rhyu, Im Joo; Sun, Woong; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Il Hwan] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Bae, Jin Young; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, Taegu, South Korea	Korea University; Korea University Medicine (KU Medicine); Duke University; Kyungpook National University	Kim, H (corresponding author), Korea Univ, Coll Med, Dept Anat, Brain Korea 21, Seoul 136705, South Korea.	kimhyun@korea.ac.kr		Lee, Dongmin/0000-0003-2039-6586; Han, Seung Baek/0000-0002-9798-0679; Kim, Hyun/0000-0002-7210-5798; sun, woong/0000-0003-1792-4894; Rhyu, Im Joo/0000-0002-5558-6278	Korea Science and Engineering Foundation (KOSEF) [2011-0019229, 2011-0019227, 2010K000830]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) Grant 2011-0019229 (to H. W. L.), 2011-0019227 (to H. K.), and 2010K000830 (to H. K.).	Bae YC, 2002, J COMP NEUROL, V442, P308, DOI 10.1002/cne.10092; Baratta MV, 2002, J NEUROPHYSIOL, V88, P3078, DOI 10.1152/jn.00398.2002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; COFFEY RL, 1995, J BIOL CHEM, V270, P1035, DOI 10.1074/jbc.270.3.1035; Communi D, 1997, EMBO J, V16, P1943, DOI 10.1093/emboj/16.8.1943; FADOOL DA, 1994, P NATL ACAD SCI USA, V91, P9471, DOI 10.1073/pnas.91.20.9471; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FULLER GM, 1976, J SUPRAMOL STR CELL, V5, P497, DOI 10.1002/jss.400050407; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; He LS, 2011, CELL MOL LIFE SCI, V68, P1633, DOI 10.1007/s00018-010-0562-9; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Hughes JR, 2008, PLOS BIOL, V6, P785, DOI 10.1371/journal.pbio.0060098; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; LEE SY, 1990, J BIOL CHEM, V265, P9434; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Paik SK, 2007, J COMP NEUROL, V503, P779, DOI 10.1002/cne.21423; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schell MJ, 2010, CELL MOL LIFE SCI, V67, P1755, DOI 10.1007/s00018-009-0238-5; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; SCHLIWA M, 1976, J CELL BIOL, V70, P527, DOI 10.1083/jcb.70.3.527; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SIM SS, 1990, J BIOL CHEM, V265, P10367; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Windhorst S, 2008, BIOCHEM J, V414, P407, DOI 10.1042/BJ20080630; Windhorst S, 2012, CELL SIGNAL, V24, P750, DOI 10.1016/j.cellsig.2011.11.010; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	50	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15981	15995		10.1074/jbc.M112.344101	http://dx.doi.org/10.1074/jbc.M112.344101			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22389500	Green Published, hybrid			2022-12-25	WOS:000304006300076
J	Yien, YY; Bieker, JJ				Yien, Yvette Y.; Bieker, James J.			Functional Interactions between Erythroid Kruppel-like Factor (EKLF/KLF1) and Protein Phosphatase PPM1B/PP2C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EKLF-DEFICIENT MICE; BETA-GLOBIN LOCUS; P-TEFB; TRANSCRIPTION-ELONGATION; ACTIVATION DOMAIN; GAMMA-GLOBIN; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; CHIP-SEQ; IN-VIVO	Erythroid Kruppel-like factor (EKLF; KLF1) is an erythroid-specific transcription factor required for the transcription of genes that regulate erythropoiesis. In this paper, we describe the identification of a novel EKLF interactor, Ppm1b, a serine-threonine protein phosphatase that has been implicated in the attenuation of NF kappa B signaling and the regulation of Cdk9 phosphorylation status. We show that Ppm1b interacts with EKLF via its PEST1 sequence. However, its genetic regulatory role is complex. Using a promoter-reporter assay in an erythroid cell line, we show that Ppm1b superactivates EKLF at the beta-globin and BKLF promoters, dependent on intact Ppm1b phosphatase activity. Conversely, depletion of Ppm1b in CD34(+) cells leads to a higher level of endogenous beta-globin gene activation after differentiation. We also observe that Ppm1b likely has an indirect role in regulating EKLF turnover via its zinc finger domain. Together, these studies show that Ppm1b plays a multilayered role in regulating the availability and optimal activity of the EKLF protein in erythroid cells.	[Yien, Yvette Y.; Bieker, James J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Bieker, JJ (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Box 1020,1 Gustave L Levy Pl, New York, NY 10029 USA.	james.bieker@mssm.edu			National Institutes of Health from USPHS [DK46865]; NYSTEM [C026435]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046865] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NYSTEM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46865 from USPHS. This work was also supported by NYSTEM Contract C026435 (to J. J. B.).	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Blau CA, 2005, J BIOL CHEM, V280, P36642, DOI 10.1074/jbc.M504402200; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Chen J, 2010, P NATL ACAD SCI USA, V107, P16846, DOI 10.1073/pnas.0912896107; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drexler HG, 2004, LEUKEMIA RES, V28, P1243, DOI 10.1016/j.leukres.2004.03.022; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Lohmann F, 2008, DEVELOPMENT, V135, P2071, DOI 10.1242/dev.018200; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Nilson DG, 2006, EXP HEMATOL, V34, P705, DOI 10.1016/j.exphem.2006.02.018; Ouyang L, 1998, J BIOL CHEM, V273, P23019, DOI 10.1074/jbc.273.36.23019; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Park JH, 2011, J BIOL CHEM, V286, P10911, DOI 10.1074/jbc.C110.210211; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Quadrini KJ, 2006, FEBS LETT, V580, P2285, DOI 10.1016/j.febslet.2006.03.039; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SHOJI W, 1994, J BIOL CHEM, V269, P5078; Shyu YC, 2007, MOL CELL BIOL, V27, P2309, DOI 10.1128/MCB.01875-06; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Siatecka M, 2010, MOL CELL BIOL, V30, P2811, DOI 10.1128/MCB.01016-09; Song SH, 2010, BLOOD, V116, P2356, DOI 10.1182/blood-2010-03-272252; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Tallack MR, 2007, J MOL BIOL, V369, P313, DOI 10.1016/j.jmb.2007.02.109; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tallack MR, 2009, J BIOL CHEM, V284, P20966, DOI 10.1074/jbc.M109.006346; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Wu MH, 2001, BONE MARROW TRANSPL, V27, P1201, DOI 10.1038/sj.bmt.1703054; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	55	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15193	15204		10.1074/jbc.M112.350496	http://dx.doi.org/10.1074/jbc.M112.350496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393050	Green Published, hybrid			2022-12-25	WOS:000304006300004
J	Yan, XH; Zhang, JY; Sun, QY; Tuazon, PT; Wu, XP; Traugh, JA; Chen, YG				Yan, Xiaohua; Zhang, Junyu; Sun, Qinyu; Tuazon, Polygena T.; Wu, Xiaoping; Traugh, Jolinda A.; Chen, Ye-Guang			p21-activated Kinase 2 (PAK2) Inhibits TGF-beta Signaling in Madin-Darby Canine Kidney (MDCK) Epithelial Cells by Interfering with the Receptor-Smad Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; CROSS-TALK; ACTIVATION; TRANSDUCTION; SPECIFICITY; APOPTOSIS; PATHWAYS; PROTEINS; PHOSPHORYLATION; RECOGNITION	TGF-beta (transforming growth factor beta) plays a variety of cellular functions mainly through the Smad pathway. Phosphorylation of the carboxyl SXS motif in R-Smads (Smad2 and Smad3) by the type I receptor T beta RI is a key step for their activation. It has been reported that the serine/threonine kinase PAK2 (p21-activated kinase 2) can mediate TGF-beta signaling in mesenchymal cells. Here, we report that PAK2 restricts TGF-beta-induced Smad2/3 activation and transcriptional responsiveness in MDCK epithelial cells. Mechanistically, PAK2 associates with Smad2 and Smad3 in a kinase activity-dependent manner and blocks their activation. PAK2 phosphorylates Smad2 at Ser-417, which is adjacent to the L3 loop that contributes to the T beta RI-R-Smad association. Consistently, substitution of Ser-417 with glutamic acid attenuates the interaction of Smad2 with T beta RI. Together, our results indicate that PAK2 negatively modulate TGF-beta signaling by attenuating the receptor-Smad interaction and thus Smad activation.	[Yan, Xiaohua; Zhang, Junyu; Sun, Qinyu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Tuazon, Polygena T.; Traugh, Jolinda A.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Wu, Xiaoping] Nanchang Univ, Dept Biotechnol, Nanchang 330031, Peoples R China	Tsinghua University; University of California System; University of California Riverside; Nanchang University	Yan, XH (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	yanxiaohua@tsinghua.org.cn; ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771; Sun, Qinyu/0000-0003-4377-6864	China Postdoctoral Science Foundation; National Natural Science Foundation of China (NSFC) [31171340]; NSFC [30930050, 30921004]; 973 Program [2010CB833706, 2011CB943803]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by the China Postdoctoral Science Foundation and the National Natural Science Foundation of China (NSFC, 31171340) (to X. Y.), NSFC (30930050, 30921004), and the 973 Program (2010CB833706, 2011CB943803) (to Y. G. C.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Hong M, 2011, J BIOL CHEM, V286, P17841, DOI 10.1074/jbc.M111.233676; Hsu Y. H., 2011, J VIS EXP, V57, pe3602; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2000, GENE DEV, V14, P627; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Pacheco A, 2010, INT J BIOCHEM CELL B, V42, P13, DOI 10.1016/j.biocel.2009.09.006; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	46	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13705	13712		10.1074/jbc.M112.346221	http://dx.doi.org/10.1074/jbc.M112.346221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393057	Green Published, hybrid			2022-12-25	WOS:000303996300026
J	Aldrich, C; Magini, A; Emiliani, C; Dottorini, T; Bistoni, F; Crisanti, A; Spaccapelo, R				Aldrich, Cassandra; Magini, Alessandro; Emiliani, Carla; Dottorini, Tania; Bistoni, Francesco; Crisanti, Andrea; Spaccapelo, Roberta			Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SALIVARY-GLANDS; FALCIPARUM SPOROZOITES; ANOPHELES-STEPHENSI; MALARIA PARASITE; MONOCLONAL-ANTIBODIES; PROTECTIVE ANTIBODIES; CELL INVASION; AEDES-AEGYPTI; II-PLUS	The circumsporozoite protein (CSP) plays a key role in malaria sporozoite infection of both mosquito salivary glands and the vertebrate host. The conserved Regions I and II have been well studied but little is known about the immunogenic central repeat region and the N-terminal region of the protein. Rodent malaria Plasmodium berghei parasites, in which the endogenous CS gene has been replaced with the avian Plasmodium gallinaceum CS (PgCS) sequence, develop normally in the A. stephensi mosquito midgut but the sporozoites are not infectious. We therefore generated P. berghei transgenic parasites carrying the PgCS gene, in which the repeat region was replaced with the homologous region of P. berghei CS (PbCS). A further line, in which both the N-terminal region and repeat region were replaced with the homologous regions of PbCS, was also generated. Introduction of the PbCS repeat region alone, into the PgCS gene, did not rescue sporozoite species-specific infectivity. However, the introduction of both the PbCS repeat region and the N-terminal region into the PgCS gene completely rescued infectivity, in both the mosquito vector and the mammalian host. Immunofluorescence experiments and western blot analysis revealed correct localization and proteolytic processing of CSP in the chimeric parasites. The results demonstrate, in vivo, that the repeat region of P. berghei CSP, alone, is unable to mediate sporozoite infectivity in either the mosquito or the mammalian host, but suggest an important role for the N-terminal region in sporozoite host cell invasion.	[Aldrich, Cassandra; Magini, Alessandro; Emiliani, Carla; Dottorini, Tania; Bistoni, Francesco; Crisanti, Andrea; Spaccapelo, Roberta] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Aldrich, Cassandra] Univ Oxford, Keble Coll, Oxford, England; [Aldrich, Cassandra; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	University of Perugia; University of Oxford; Imperial College London	Aldrich, C (corresponding author), Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy.	roberta.spaccapelo@unipg.it	Magini, Alessandro/P-1201-2019; Emiliani, Carla/G-3738-2010; Magini, Alessandro/L-9175-2015	Emiliani, Carla/0000-0002-6368-1515; Magini, Alessandro/0000-0002-2750-6226; Crisanti, Andrea/0000-0002-2406-4426; Dottorini, Tania/0000-0001-7733-906X; Spaccapelo, Roberta/0000-0003-2100-6172	Italian Ministry of Research [2005065913]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Ministry of Research PRIN (Research Programmes of National Interest) n. 2005065913. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; BALLOU WR, 1987, LANCET, V1, P1277; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; BOULANGER N, 1995, PARASITOL RES, V81, P58, DOI 10.1007/BF00932418; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; CERAMI C, 1994, J EXP MED, V179, P695, DOI 10.1084/jem.179.2.695; Cerede O, 2002, EMBO J, V21, P2526, DOI 10.1093/emboj/21.11.2526; COCHRANE AH, 1982, P NATL ACAD SCI-BIOL, V79, P5651, DOI 10.1073/pnas.79.18.5651; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; GODSON GN, 1983, NATURE, V305, P29, DOI 10.1038/305029a0; Gonzalez-Ceron L, 1998, EXP PARASITOL, V90, P203, DOI 10.1006/expr.1998.4334; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; NAGASAWA H, 1987, INFECT IMMUN, V55, P2928, DOI 10.1128/IAI.55.12.2928-2932.1987; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; POSTHUMA G, 1988, EUR J CELL BIOL, V46, P18; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Rathore D, 2000, MOL BIOCHEM PARASIT, V108, P253, DOI 10.1016/S0166-6851(00)00214-0; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rathore D, 2001, BIOCHEMISTRY-US, V40, P11518, DOI 10.1021/bi0105476; Robson KJH, 1997, MOL BIOCHEM PARASIT, V84, P1, DOI 10.1016/S0166-6851(96)02774-0; SANTORO F, 1983, J BIOL CHEM, V258, P3341; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; SIMONETTI AB, 1993, J EUKARYOT MICROBIOL, V40, P569, DOI 10.1111/j.1550-7408.1993.tb06109.x; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; Spaccapelo R, 1997, LANCET, V350, P335, DOI 10.1016/S0140-6736(97)24031-6; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Tewari R, 2005, CELL MICROBIOL, V7, P699, DOI 10.1111/j.1462-5822.2005.00503.x; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; WARBURG A, 1992, EXP PARASITOL, V75, P303, DOI 10.1016/0014-4894(92)90215-V; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Ying P, 1997, EXP PARASITOL, V85, P168, DOI 10.1006/expr.1996.4134; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	49	31	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32524	10.1371/journal.pone.0032524	http://dx.doi.org/10.1371/journal.pone.0032524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393411	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500064
J	Chi, JW; Li, L; Liu, MJ; Tan, JQ; Tang, CY; Pan, Q; Wang, DL; Zhang, ZH				Chi, Jingwei; Li, Li; Liu, Mujun; Tan, Jieqiong; Tang, Chengyuan; Pan, Qian; Wang, Danling; Zhang, Zhuohua			Pathogenic Connexin-31 Forms Constitutively Active Hemichannels to Promote Necrotic Cell Death	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; ICHTHYOSIS-DEAFNESS SYNDROME; TUMOR-NECROSIS-FACTOR; ERYTHROKERATODERMIA VARIABILIS; OXIDATIVE STRESS; SKIN-DISEASE; HELA-CELLS; ER STRESS; MUTATIONS; CALCIUM	Mutations in Connexin-31 (Cx31) are associated with multiple human diseases including erythrokeratodermia variabilis (EKV). The molecular action of Cx31 pathogenic mutants remains largely elusive. We report here that expression of EKV pathogenic mutant Cx31R42P induces cell death with necrotic characteristics. Inhibition of hemichannel activity by a connexin hemichannel inhibitor or high extracellular calcium suppresses Cx31R42P-induced cell death. Expression of Cx31R42P induces ER stress resulting in reactive oxygen species (ROS) production, in turn, to regulate gating of Cx31R42P hemichannels and Cx31R42P induced cell death. Moreover, Cx31R42P hemichannels play an important role in mediating ATP release from the cell. In contrast, no hemichannel activity was detected with cells expressing wildtype Cx31. Together, the results suggest that Cx31R42P forms constitutively active hemichannels to promote necrotic cell death. The Cx31R42P active hemichannels are likely resulted by an ER stress mediated ROS overproduction. The study identifies a mechanism of EKV pathogenesis induced by a Cx31 mutant and provides a new avenue for potential treatment strategy of the disease.	[Chi, Jingwei; Li, Li; Tan, Jieqiong; Tang, Chengyuan; Pan, Qian; Wang, Danling; Zhang, Zhuohua] Cent S Univ, State Key Lab Med Genet, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Liu, Mujun] Cent S Univ, Sch Biol Sci & Technol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chi, JW (corresponding author), Cent S Univ, State Key Lab Med Genet, Xiangya Med Sch, Changsha, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn			Natural Science Foundation of China [30730052, 30971469, 30600334, 30900801]; Ministry of Sciences and Technology of China [2011CB510002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) (30730052 to Z.Z., 30971469 to D.W., 30600334 to Q.P. and 30900801 to M.L.) and a grant from Ministry of Sciences and Technology of China (http://www.most.cn/eng/) (2011CB510002 to Z.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CK, 2002, P NATL ACAD SCI USA, V99, P3980, DOI 10.1073/pnas.261713499; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Di WL, 2002, HUM MOL GENET, V11, P2005, DOI 10.1093/hmg/11.17.2005; Diestel S, 2002, BIOCHEM BIOPH RES CO, V296, P721, DOI 10.1016/S0006-291X(02)00929-4; Essenfelder GM, 2004, HUM MOL GENET, V13, P1703, DOI 10.1093/hmg/ddh191; Fuchs-Telem D, 2011, CLIN EXP DERMATOL, V36, P406, DOI 10.1111/j.1365-2230.2010.03986.x; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; He LQ, 2005, ACTA BIOCH BIOPH SIN, V37, P547, DOI 10.1111/j.1745-7270.2005.00080.x; Hunzeker Christopher M, 2008, Dermatol Online J, V14, P13; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lopez-Bigas N, 2001, HUM MOL GENET, V10, P947, DOI 10.1093/hmg/10.9.947; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Montgomery JR, 2004, J AM ACAD DERMATOL, V51, P377, DOI 10.1016/j.jaad.2003.12.042; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; Rajagopalan B, 1999, CLIN EXP DERMATOL, V24, P173; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Richard G, 2003, J INVEST DERMATOL, V120, P601, DOI 10.1046/j.1523-1747.2003.12080.x; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wilgoss A, 1999, J INVEST DERMATOL, V113, P1119, DOI 10.1046/j.1523-1747.1999.00792.x; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Xia K, 2010, PROTEIN CELL, V1, P935, DOI 10.1007/s13238-010-0118-7; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	42	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32531	10.1371/journal.pone.0032531	http://dx.doi.org/10.1371/journal.pone.0032531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393412	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500065
J	Li, CG; Chu, N; Wang, BB; Wang, J; Luan, J; Han, L; Meng, DM; Wang, YL; Suo, PS; Cheng, LF; Ma, X; Miao, ZM; Liu, SG				Li, Changgui; Chu, Nan; Wang, Binbin; Wang, Jing; Luan, Jian; Han, Lin; Meng, Dongmei; Wang, Yunlong; Suo, Peisu; Cheng, Longfei; Ma, Xu; Miao, Zhimin; Liu, Shiguo			Polymorphisms in the Presumptive Promoter Region of the SLC2A9 Gene Are Associated with Gout in a Chinese Male Population	PLOS ONE			English	Article							URIC-ACID LEVELS; HUMAN ARTICULAR CHONDROCYTES; GENOME-WIDE ASSOCIATION; COMMON POLYMORPHISMS; SERUM URATE; GLUT9; HYPERURICEMIA; SUSCEPTIBILITY; PREVALENCE; DISEASE	Background: Glucose transporter 9 (GLUT9) is a high-capacity/low-affinity urate transporter. To date, several recent genome-wide association studies (GWAS) and follow-up studies have identified genetic variants of SLC2A9 associated with urate concentrations and susceptibility to gout. We therefore investigated associations between gout and polymorphisms and haplotypes in the presumptive promoter region of GLUT9 in Chinese males. Methodology/Principal Findings: The approximately 2000 bp presumptive promoter region upstream of the start site of exon 1 of GLUT9 was sequenced and subjected to genetic analysis. A genotype-phenotype correlation was performed and polymorphisms-induced changes in transcription factor binding sites were predicted. Of 21 SNPs identified in GLUT9, five had not been previously reported. Two of the SNPs (rs13124007 and rs6850166) were associated with susceptibility to gout (p = 0.009 and p = 0.042, respectively). The C allele of rs13124007 appeared to be the risk allele for predisposition to gout (p = 0.006, OR 1.709 [95% CI 1.162-2.514]). For rs6850166, an increased risk of gout was associated with the A allele (p = 0.029, OR 1.645 [95% CI 1.050-2.577]). After Bonferroni correction, there was statistically difference in rs13124007 allele frequencies between gout cases and controls (P = 0.042). Haplotype analyses showed that haplotype GG was a protective haplotype (p = 0.0053) and haplotype CA was associated with increased risk of gout (p = 0.0326). Genotype-phenotype analysis among gout patients revealed an association of rs13124007 with serum triglycerides levels (P = 0.001). The C to G substitution in polymorphism rs13124007 resulted in a loss of a binding site for transcription factor interferon regulatory factor 1 (IRF-1). Conclusions/Significance: Polymorphisms rs13124007 and rs6850166 are associated with susceptibility to gout in Chinese males.	[Li, Changgui; Chu, Nan; Han, Lin; Meng, Dongmei; Wang, Yunlong; Miao, Zhimin; Liu, Shiguo] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China; [Wang, Binbin; Wang, Jing; Suo, Peisu; Cheng, Longfei; Ma, Xu] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Wang, Binbin; Wang, Jing; Suo, Peisu; Cheng, Longfei; Ma, Xu] Natl Res Inst Family Planning, Beijing, Peoples R China; [Luan, Jian] Qingdao Municipal Hosp, Qingdao, Peoples R China; [Ma, Xu] WHO, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Qingdao Municipal Hospital; World Health Organization	Li, CG (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China.	lichanggui@medmail.com.cn; liushiguo2002@126.com		Wang, Binbin/0000-0002-1597-5930	National Basic Research Program of China [2010CB534902]; National Science Foundation of China (NSFC) [30570890, 30871192]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 2010CB534902) and National Science Foundation of China (NSFC: 30570890 and 30871192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Cummings N, 2010, EUR J HUM GENET, V18, P1243, DOI 10.1038/ejhg.2010.97; Dalbeth N, 2009, RHEUMATOLOGY, V48, P222, DOI 10.1093/rheumatology/ken460; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Doege H, 2000, BIOCHEM J, V350, P771, DOI 10.1042/0264-6021:3500771; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Hollis-Moffatt JE, 2009, ARTHRITIS RHEUM-US, V60, P3485, DOI 10.1002/art.24938; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; McArdle PF, 2008, ARTHRITIS RHEUM-US, V58, P2874, DOI 10.1002/art.23752; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Mobasheri A, 2002, CELL BIOL INT, V26, P297, DOI 10.1006/cbir.2001.0850; Polasek O, 2010, CROAT MED J, V51, P48, DOI 10.3325/cmj.2010.51.48; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Schumacher HR, 2005, J RHEUMATOL, V32, P2368; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Terkeltaub R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1909; Tu HP, 2010, ANN RHEUM DIS, V69, P887, DOI 10.1136/ard.2009.113357; Urano W, 2010, ANN RHEUM DIS, V69, P932, DOI 10.1136/ard.2009.111096; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	38	12	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e24561	10.1371/journal.pone.0024561	http://dx.doi.org/10.1371/journal.pone.0024561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393348	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500001
J	Wang, HC; Peng, V; Zhao, Y; Sun, XH				Wang, Hong-Cheng; Peng, Vincent; Zhao, Ying; Sun, Xiao-Hong			Enhanced Notch Activation Is Advantageous but Not Essential for T Cell Lymphomagenesis in Id1 Transgenic Mice	PLOS ONE			English	Article							FBXW7 MUTATIONS; PRE-TCR; LEUKEMIA; TAL1; TRANSCRIPTION; INHIBITION; APOPTOSIS; GENE; ABNORMALITIES; MECHANISMS	T cell lymphoblastic leukemia (T-ALL) is known to be associated with chromosomal abnormalities that lead to aberrant expression of a number of transcription factors such as TAL1, which dimerizes with basic helix-loop-helix (bHLH) E proteins and inhibits their function. Activated Notch receptors also efficiently induce T cell leukemogenesis in mouse models. Interestingly, gain-of-function mutations or cryptic transcription initiation of the Notch1 gene have been frequently found in both human and mouse T-ALL. However, the correlations between these alterations and overall Notch activities or leukemogenesis have not been thoroughly evaluated. Therefore, we made use of our collection of T cell lymphomas developed in transgenic mice expressing Id1, which like TAL1, inhibits E protein function. By comparing expression levels of Notch target genes in Id1-expressing tumors to those in tumors induced by a constitutively active form of Notch1, N1C, we were able to assess the overall activities of Notch pathways and conclude that the majority of Id1-expressing tumors had elevated Notch function to a varying degree. However, 26% of the Id1-expressing tumors had no evidence of enhanced Notch activation, but that did not delay the onset of tumorigenesis. Furthermore, we examined the genetic or epigenetic alterations thought to contribute to ligand-independent activation or protein stabilization of Notch1 and found that some of the Id1-expressing tumors acquired these changes, but they are not uniformly associated with elevated Notch activities in Id1 tumor samples. In contrast, N1C-expressing tumors do not harbor any PEST domain mutations nor exhibit intragenic transcription initiation. Taken together, it appears that Notch activation provides Id1-expressing tumor cells with selective advantages in growth and survival. However, this may not be absolutely essential for lymphomagenesis in Id1 transgenic mice and additional factors could also cooperate with Id1 to induce T cell lymphoma. Therefore, a broad approach is necessary in designing T-ALL therapy.	[Wang, Hong-Cheng; Zhao, Ying; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Peng, Vincent] Oklahoma Sch Sci & Math, Oklahoma City, OK USA	Oklahoma Medical Research Foundation	Wang, HC (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.ouhsc.edu		Peng, Vincent/0000-0002-0301-2985	National Institutes of Health [AI56129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health to Dr. Sun. (AI56129). Dr. Sun holds the Lew and Myra Ward Chair in Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Clappier E, 2010, LEUKEMIA, V24, P2023, DOI 10.1038/leu.2010.205; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dudley DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006678; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; Gedman AL, 2009, LEUKEMIA, V23, P1417, DOI 10.1038/leu.2009.64; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; Jeannet R, 2010, BLOOD, V116, P5443, DOI 10.1182/blood-2010-05-286658; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kim DS, 2002, IMMUNITY, V16, P9, DOI 10.1016/S1074-7613(02)00264-9; Kox C, 2010, LEUKEMIA, V24, P2005, DOI 10.1038/leu.2010.203; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; O'Neil J, 2003, BLOOD; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Qi ZB, 2004, MOL CELL BIOL, V24, P7313, DOI 10.1128/MCB.24.17.7313-7323.2004; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Reschly EJ, 2006, BLOOD, V107, P4115, DOI 10.1182/blood-2005-09-3551; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tatarek J, 2011, BLOOD, V118, P1579, DOI 10.1182/blood-2010-08-300343; Tiyanont K, 2011, STRUCTURE, V19, P546, DOI 10.1016/j.str.2011.01.016; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang HC, 2009, MOL CELL BIOL, V29, P4640, DOI 10.1128/MCB.00119-09; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yang YZ, 2006, J BIOL CHEM, V281, P34989, DOI 10.1074/jbc.M608078200; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zuurbier L, 2010, LEUKEMIA, V24, P2014, DOI 10.1038/leu.2010.204	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32944	10.1371/journal.pone.0032944	http://dx.doi.org/10.1371/journal.pone.0032944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393458	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500113
J	Lapchak, PH; Ioannou, A; Kannan, L; Rani, P; Lucca, JJD; Tsokos, GC				Lapchak, Peter H.; Ioannou, Antonis; Kannan, Lakshmi; Rani, Poonam; Lucca, Jurandir J. Dalle; Tsokos, George C.			Platelet-Associated CD40/CD154 Mediates Remote Tissue Damage after Mesenteric Ischemia/Reperfusion Injury	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTIGEN-INDUCED ARTHRITIS; ISCHEMIC-STROKE; P-SELECTIN; REPERFUSION INJURY; ENDOTHELIAL-CELLS; COMPLEMENT; LINK; ACTIVATION; MICE	Several innate and adaptive immune cell types participate in ischemia/reperfusion induced tissue injury. Amongst them, platelets have received little attention as contributors in the process of tissue damage after ischemia reperfusion (I/R) injury. It is currently unknown whether platelets participate through the immunologically important molecules including, CD40 and when activated, CD154 (CD40L), in the pathogenesis of I/R injury. We hypothesized that constitutive expression of CD40 and activation-induced expression of CD154 on platelets mediate local mesenteric and remote lung tissue damage after I/R injury. Wild type (WT; C57BL/6J), CD40 and CD154 deficient mice underwent mesenteric ischemia for 30 minutes followed by reperfusion for 3 hours. WT mice subjected to mesenteric I/R injury displayed both local intestinal and remote lung damage. In contrast, there was significantly less intestinal damage and no remote lung injury in CD40 and CD154 deficient mice when compared to WT mice. Platelet-depleted WT mice transfused with platelets from CD40 or CD154 deficient mice failed to reconstitute remote lung damage. In contrast, when CD40 or CD154 deficient mice were transfused with WT platelets lung tissue damage was re-established. Together, these findings suggest that multiple mechanisms are involved in local and remote tissue injury and also identify platelet-expressed CD40 and/or CD154 as mediators of remote tissue damage.	[Lapchak, Peter H.; Ioannou, Antonis; Kannan, Lakshmi; Rani, Poonam; Tsokos, George C.] Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol, Boston, MA 02215 USA; [Lapchak, Peter H.; Ioannou, Antonis; Kannan, Lakshmi; Rani, Poonam; Tsokos, George C.] Harvard Univ, Sch Med, Boston, MA USA; [Lucca, Jurandir J. Dalle] USA, Inst Surg Res, San Antonio, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lapchak, PH (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol, Boston, MA 02215 USA.	aioannou@bicmc.harvard.edu; gtsokos@bidmc.harvard.edu	Lapchak, Peter H./B-3559-2009; tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Lapchak, Peter/0000-0001-8597-088X; Ioannou, Antonis/0000-0003-0064-5004	Medical Research and Material Command of the Department of the Army [W81XWH-09-1-0530, W81XWH-09-1-0536]	Medical Research and Material Command of the Department of the Army	The research presented herein was supported by grant numbers W81XWH-09-1-0530 and W81XWH-09-1-0536 from Medical Research and Material Command of the Department of the Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2006, J GASTROENTEROL, V41, P47, DOI 10.1007/s00535-005-1721-x; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Baldwin WM, 2010, CURR OPIN ORGAN TRAN; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Chen J, 2009, J AUTOIMMUN, V32, P195, DOI 10.1016/j.jaut.2009.02.021; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Collins CE, 1997, ALIMENT PHARM THER, V11, P237, DOI 10.1046/j.1365-2036.1997.153328000.x; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Dole VS, 2007, THROMB HAEMOSTASIS, V98, P806, DOI 10.1160/TH07-03-0207; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Fleming SD, 2003, CLIN IMMUNOL, V106, P55, DOI 10.1016/S1521-6616(02)00021-9; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; HERD CM, 1994, EUR RESPIR J, V7, P1145; Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001; Irving PM, 2008, EUR J GASTROEN HEPAT, V20, P283, DOI 10.1097/MEG.0b013e3282f246c2; Irving PM, 2004, INFLAMM BOWEL DIS, V10, P361, DOI 10.1097/00054725-200407000-00007; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Lapchak PH, 2012, AM J PHYSL IN PRESS; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Marquardt L, 2009, CEREBROVASC DIS, V28, P276, DOI 10.1159/000228710; Matthijsen RA, 2007, AM J PATHOL, V171, P1743, DOI 10.2353/ajpath.2007.070184; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Mehta N, 2008, STROKE, V39, P3236, DOI 10.1161/STROKEAHA.108.514687; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.009; Prodan CI, 2008, INT J STROKE, V3, P249, DOI 10.1111/j.1747-4949.2008.00223.x; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Ramesh N, 1998, SPRINGER SEMIN IMMUN, V19, P383, DOI 10.1007/BF00792598; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Schmitt-Sody M, 2007, SCAND J RHEUMATOL, V36, P311, DOI 10.1080/03009740701218741; Schmitt-Sody M, 2007, PLATELETS, V18, P365, DOI 10.1080/09537100701191315; Seizer P, 2008, CURR MED CHEM, V15, P1976, DOI 10.2174/092986708785132852; Slotta JE, 2009, PLATELETS, V20, P505, DOI 10.3109/09537100903215417; Wang F, 2007, CLIN RHEUMATOL, V26, P768, DOI 10.1007/s10067-007-0550-0; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Williams KT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000159; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011	46	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32260	10.1371/journal.pone.0032260	http://dx.doi.org/10.1371/journal.pone.0032260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384195	Green Submitted, gold, Green Published			2022-12-25	WOS:000302918500069
J	Zheng, LN; Zhou, X; Zhang, HD; Ji, XF; Li, L; Huang, L; Bai, LQ; Zhang, HJ				Zheng, Lina; Zhou, Xiang; Zhang, Huaidong; Ji, Xiaofeng; Li, Lei; Huang, Lin; Bai, Linquan; Zhang, Houjin			Structural and Functional Analysis of Validoxylamine A 7 '-phosphate Synthase ValL Involved in Validamycin A Biosynthesis	PLOS ONE			English	Article							GENE-CLUSTER; STREPTOMYCES; GLUCOSYLTRANSFERASE; INHIBITOR; PROTEIN	Validamycin A (Val-A) is an effective antifungal agent widely used in Asian countries as crop protectant. Validoxylamine A, the core structure and intermediate of Val-A, consists of two C7-cyclitol units connected by a rare C-N bond. In the Val-A biosynthetic gene cluster in Streptomyces hygroscopicus 5008, the ORF valL was initially annotated as a validoxylamine A 7'-phosphate(V7P) synthase, whose encoded 497-aa protein shows high similarity with trehalose 6-phosphate(T6P) synthase. Gene inactivation of valL abolished both validoxylamine A and validamycin A productivity, and complementation with a cloned valL recovered 10% production of the wild-type in the mutant, indicating the involvement of ValL in validoxylamine A biosynthesis. Also we determined the structures of ValL and ValL/trehalose complex. The structural data indicates that ValL adopts the typical fold of GT-B protein family, featuring two Rossmann-fold domains and an active site at domain junction. The residues in the active site are arranged in a manner homologous to that of Escherichia coli (E. coli) T6P synthase OtsA. However, a significant discrepancy is found in the active-site loop region. Also noticeable structural variance is found around the active site entrance in the apo ValL structure while the region takes an ordered configuration upon binding of product analog trehalose. Furthermore, the modeling of V7P in the active site of ValL suggests that ValL might have a similar SNi-like mechanism as OtsA.	[Zheng, Lina; Zhang, Huaidong; Huang, Lin; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zhou, Xiang; Li, Lei; Bai, Linquan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhou, Xiang; Li, Lei; Bai, Linquan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Ji, Xiaofeng] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Shandong, Peoples R China	Huazhong University of Science & Technology; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Zhang, HJ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China.	bailq@sjtu.edu.cn; hjzhang@mail.hust.edu.cn	BAI, Linquan/AAI-9833-2020	Zhang, Huaidong/0000-0001-6572-4737	National Natural Science Foundation of China [31000326, 31070070]; Ministry of Science Technology [2009CB118901]; Ministry of Education [20100142120002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology; Ministry of Education	This research was financially supported by National Natural Science Foundation of China (No. 31000326 and 31070070), the 973 Program from Ministry of Science & Technology (No. 2009CB118901), and the Ph.D. Training Fund of the Ministry of Education (No. 20100142120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asamizu S, 2011, J AM CHEM SOC, V133, P12124, DOI 10.1021/ja203574u; ASANO N, 1987, J ANTIBIOT, V40, P526, DOI 10.7164/antibiotics.40.526; Bai L, 2006, CHEM BIOL, V13, P387, DOI 10.1016/j.chembiol.2006.02.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong HJ, 2001, J AM CHEM SOC, V123, P2733, DOI 10.1021/ja003643n; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Iwasa T., 1970, J ANTIBIOT, V23, P595, DOI DOI 10.7164/ANTIBIOTICS.23.595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawamura N, 1996, J ANTIBIOT, V49, P651, DOI 10.7164/antibiotics.49.651; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Mahmud T, 2003, NAT PROD REP, V20, P137, DOI 10.1039/b205561a; Mahmud T, 2009, CURR OPIN CHEM BIOL, V13, P161, DOI 10.1016/j.cbpa.2009.02.030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minagawa K, 2007, CHEMBIOCHEM, V8, P632, DOI 10.1002/cbic.200600528; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Singh D, 2006, GENE, V376, P13, DOI 10.1016/j.gene.2005.12.035; SMOKVINA T, 1990, GENE, V94, P53, DOI 10.1016/0378-1119(90)90467-6; SUAMI T, 1980, J ANTIBIOT, V33, P98, DOI 10.7164/antibiotics.33.98; Sun YH, 2009, APPL MICROBIOL BIOT, V82, P303, DOI 10.1007/s00253-008-1793-7; Wehmeier UF, 2004, APPL MICROBIOL BIOT, V63, P613, DOI 10.1007/s00253-003-1477-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu H, 2009, CHEM BIOL, V16, P567, DOI 10.1016/j.chembiol.2009.04.006; YOKOSE K, 1983, J ANTIBIOT, V36, P1166, DOI 10.7164/antibiotics.36.1166; Yu Y, 2005, APPL ENVIRON MICROB, V71, P5066, DOI 10.1128/AEM.71.9.5066-5076.2005	35	8	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32033	10.1371/journal.pone.0032033	http://dx.doi.org/10.1371/journal.pone.0032033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384130	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500055
J	Henkel, CV; Burgerhout, E; de Wijze, DL; Dirks, RP; Minegishi, Y; Jansen, HJ; Spaink, HP; Dufour, S; Weltzien, FA; Tsukamoto, K; van den Thillart, GEEJM				Henkel, Christiaan V.; Burgerhout, Erik; de Wijze, Danielle L.; Dirks, Ron P.; Minegishi, Yuki; Jansen, Hans J.; Spaink, Herman P.; Dufour, Sylvie; Weltzien, Finn-Arne; Tsukamoto, Katsumi; van den Thillart, Guido E. E. J. M.			Primitive Duplicate Hox Clusters in the European Eel's Genome	PLOS ONE			English	Article							ANGUILLA-JAPONICA; EVOLUTION; GENE; ORIGIN; BODY; TRANSCRIPTION; PHYSIOLOGY	The enigmatic life cycle and elongated body of the European eel (Anguilla anguilla L., 1758) have long motivated scientific enquiry. Recently, eel research has gained in urgency, as the population has dwindled to the point of critical endangerment. We have assembled a draft genome in order to facilitate advances in all provinces of eel biology. Here, we use the genome to investigate the eel's complement of the Hox developmental transcription factors. We show that unlike any other teleost fish, the eel retains fully populated, duplicate Hox clusters, which originated at the teleost-specific genome duplication. Using mRNA-sequencing and in situ hybridizations, we demonstrate that all copies are expressed in early embryos. Theories of vertebrate evolution predict that the retention of functional, duplicate Hox genes can give rise to additional developmental complexity, which is not immediately apparent in the adult. However, the key morphological innovation elsewhere in the eel's life history coincides with the evolutionary origin of its Hox repertoire.	[Henkel, Christiaan V.; Burgerhout, Erik; Dirks, Ron P.; Jansen, Hans J.] ZF Screens BV, Leiden, Netherlands; [de Wijze, Danielle L.; Minegishi, Yuki; Spaink, Herman P.; van den Thillart, Guido E. E. J. M.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Dufour, Sylvie] Museum Natl Hist Nat, UMR BOREA, CNRS 7208, F-75231 Paris, France; [Weltzien, Finn-Arne] Norwegian Sch Vet Sci, Oslo, Norway; [Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Norwegian University of Life Sciences; University of Tokyo	Henkel, CV (corresponding author), ZF Screens BV, Leiden, Netherlands.	henkel@zfscreens.com	Spaink, Herman P./S-3586-2017; Burgerhout, Erik/AAI-4527-2020	Spaink, Herman P./0000-0003-4128-9501; Henkel, Christiaan/0000-0001-9838-8215; Jansen, Hans/0000-0002-8563-4146; weltzien, finn-arne/0000-0002-5111-1558	Norwegian School of Veterinary Science; Research Council of Norway [184851]; Centre National de la Recherche Scientifique; L'Agence Nationale de la Recherche [08-BLAN-0173]; ZF-screens B.V., Leiden University; University of Tokyo	Norwegian School of Veterinary Science; Research Council of Norway(Research Council of Norway); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); L'Agence Nationale de la Recherche(French National Research Agency (ANR)); ZF-screens B.V., Leiden University; University of Tokyo	This work was supported by the Norwegian School of Veterinary Science and the Research Council of Norway (184851), by Centre National de la Recherche Scientifique and L'Agence Nationale de la Recherche (08-BLAN-0173), and by private resources from ZF-screens B.V., Leiden University and The University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; AVISE JC, 1990, EVOLUTION, V44, P1254, DOI [10.2307/2409286, 10.1111/j.1558-5646.1990.tb05229.x]; Bishop RE, 1999, J EXP BIOL, V202, P2485; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Burgerhout E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-16; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Cunningham JT, 1897, NATURE, V55, P467; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Freyhof J, 2010, ANGUILLA ANGUILLA IU; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; Guo BC, 2010, J EXP ZOOL PART B, V314B, P135, DOI 10.1002/jez.b.21318; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Hiroi J, 2004, DEV GENES EVOL, V214, P176, DOI 10.1007/s00427-004-0397-1; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Matschiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018911; Mehta RS, 2010, INTEGR COMP BIOL, V50, P1091, DOI 10.1093/icb/icq075; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; Nelson JS, 1984, FISHES WORLD; Oliveira K, 2010, CAN J ZOOL, V88, P1121, DOI 10.1139/Z10-081; Otake T, 2003, EEL BIOLOGY, P61; Pfeiler E, 1999, COMP BIOCHEM PHYS A, V123, P113, DOI 10.1016/S1095-6433(99)00028-8; Raff RA, 2008, PHILOS T R SOC B, V363, P1473, DOI 10.1098/rstb.2007.2237; Raincrow JD, 2011, J EXP ZOOL PART B, V316B, P451, DOI 10.1002/jez.b.21420; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tesch F-W., 2003, EEL; Van den Thillart G, SPAWNING MIGRATION E; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400	54	107	108	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32231	10.1371/journal.pone.0032231	http://dx.doi.org/10.1371/journal.pone.0032231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384188	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916800030
J	Huang, RB; Eniola-Adefeso, O				Huang, Ryan B.; Eniola-Adefeso, Omolola			Shear Stress Modulation of IL-1 beta-Induced E-Selectin Expression in Human Endothelial Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; IN-VITRO; INFLAMMATION; INTERLEUKIN-1; FLOW; DYSFUNCTION; REPERFUSION; RESPONSES; ISCHEMIA	Background: Endothelial cells (ECs) are continuously exposed to hemodynamic forces imparted by blood flow. While it is known that endothelial behavior can be influenced by cytokine activation or fluid shear, the combined effects of these two independent agonists have yet to be fully elucidated. Methodology: We investigated EC response to long-term inflammatory cues under physiologically relevant shear conditions via E-selectin expression where monolayers of human umbilical vein ECs were simultaneously exposed to laminar fluid shear and interleukin-1 beta (shear-cytokine activation) in a parallel plate flow chamber. Results and Conclusion: Naive ECs exposed to shear-cytokine activation display significantly higher E-selectin expression for up to 24 hr relative to ECs activated in static (static-cytokine). Peak E-selectin expression occurred after 8-12 hr of continuous shear-cytokine activation contrary to the commonly observed 4-6 hr peak expression in ECs exposed to static-cytokine activation. Cells with some history of high shear conditioning exhibited either high or muted E-selectin expression depending on the durations of the shear pre-conditioning and the ensuing shear-cytokine activation. Overall, the presented data suggest that a high laminar shear enhances acute EC response to interleukin-1 beta in naive or shear-conditioned ECs as may be found in the pathological setting of ischemia/reperfusion injury while conferring rapid E-selectin downregulation to protect against chronic inflammation.	[Huang, Ryan B.; Eniola-Adefeso, Omolola] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Huang, RB (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	lolaa@umich.edu		Eniola-Adefeso, Omolola/0000-0002-8728-6608	American Heart Association [0735043N]; University of Michigan COPE	American Heart Association(American Heart Association); University of Michigan COPE	This work was supported by a grant from the American Heart Association (0735043N) to OEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This article was made available as Open Access with the support of the University of Michigan COPE Fund, http://lib.umich.edu/cope.	Aird WC, 2008, PHARMACOL REP, V60, P139; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Burns AR, 2000, J CELL SCI, V113, P45; CARDEN DL, 1990, CIRC RES, V66, P1436, DOI 10.1161/01.RES.66.5.1436; Charoenphol P, 2011, ATHEROSCLEROSIS, V217, P364, DOI 10.1016/j.atherosclerosis.2011.04.016; Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Cicha I, 2009, ATHEROSCLEROSIS, V207, P93, DOI 10.1016/j.atherosclerosis.2009.04.034; Conway DE, 2010, AM J PHYSIOL-HEART C, V298, pH367, DOI 10.1152/ajpheart.00565.2009; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davies PF, 2001, ANN NY ACAD SCI, V947, P7; Davies PF, 2001, ANN NY ACAD SCI, P947; DEPAOLA N, 1992, ARTERIOSCLER THROMB, V12, P1254, DOI 10.1161/01.ATV.12.11.1254; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eniola-Adefeso O, 2009, ANN BIOMED ENG, V37, P737, DOI 10.1007/s10439-009-9647-8; Erdman SE, 2010, INT J CANCER, V127, P768, DOI 10.1002/ijc.25430; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Griffin WST, 2002, J LEUKOCYTE BIOL, V72, P233; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Haring HP, 1996, STROKE, V27, P1386, DOI 10.1161/01.STR.27.8.1386; Henninger DD, 1997, J IMMUNOL, V158, P1825; Imberti B, 2002, ENDOTHELIUM-NEW YORK, V9, P11, DOI 10.1080/10623320210714; INAUEN W, 1990, FREE RADICAL BIO MED, V9, P219, DOI 10.1016/0891-5849(90)90031-D; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; JANG IK, 1993, EUR HEART J, V14, P2; Ji JY, 2008, ANN BIOMED ENG, V36, P586, DOI 10.1007/s10439-008-9465-4; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Kluger MS, 1997, J IMMUNOL, V158, P887; Kraiss LW, 2003, J VASC SURG, V37, P161, DOI 10.1067/mva.2003.67; KUIJPERS TW, 1994, J IMMUNOL, V152, P5060; LANGILLE BL, 1991, ARTERIOSCLER THROMB, V11, P1814, DOI 10.1161/01.ATV.11.6.1814; Lei YP, 2008, J NUTR, V138, P996, DOI 10.1093/jn/138.6.996; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Maedler K, 2011, HANDB EXP PHARMACOL, V203, P257, DOI 10.1007/978-3-642-17214-4_11; Malek AM, 1996, J CELL SCI, V109, P713; Matharu NM, 2008, J CELL PHYSIOL, V216, P732, DOI 10.1002/jcp.21457; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; PAREKH RB, 1994, TRENDS BIOTECHNOL, V12, P339, DOI 10.1016/0167-7799(94)90034-5; PARKS DA, 1986, AM J PHYSIOL, V250, pG749, DOI 10.1152/ajpgi.1986.250.6.G749; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; POBER JS, 1986, J IMMUNOL, V136, P1680; Pries A. R., 2006, V176, P1; REMUZZI A, 1984, BIORHEOLOGY, V21, P617; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001217; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Shimokawa H, 1999, J MOL CELL CARDIOL, V31, P23, DOI 10.1006/jmcc.1998.0841; Thorin E, 1998, PHARMACOL THERAPEUT, V78, P155, DOI 10.1016/S0163-7258(98)00005-9; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Yamawaki H, 2003, CIRCULATION, V108, P1619, DOI 10.1161/01.CIR.0000089373.49941.C4; Yee A, 2006, ANN BIOMED ENG, V34, P593, DOI 10.1007/s10439-006-9078-8; Zhang RL, 1996, J CEREBR BLOOD F MET, V16, P1126, DOI 10.1097/00004647-199611000-00006	65	39	40	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31874	10.1371/journal.pone.0031874	http://dx.doi.org/10.1371/journal.pone.0031874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384091	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916800020
J	Ardeshirpour, Y; Chernomordik, V; Zielinski, R; Capala, J; Griffiths, G; Vasalatiy, O; Smirnov, AV; Knutson, JR; Lyakhov, I; Achilefu, S; Gandjbakhche, A; Hassan, M				Ardeshirpour, Yasaman; Chernomordik, Victor; Zielinski, Rafal; Capala, Jacek; Griffiths, Gary; Vasalatiy, Olga; Smirnov, Aleksandr V.; Knutson, Jay R.; Lyakhov, Ilya; Achilefu, Samuel; Gandjbakhche, Amir; Hassan, Moinuddin			In Vivo Fluorescence Lifetime Imaging Monitors Binding of Specific Probes to Cancer Biomarkers	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; AGENTS	One of the most important factors in choosing a treatment strategy for cancer is characterization of biomarkers in cancer cells. Particularly, recent advances in Monoclonal Antibodies (MAB) as primary-specific drugs targeting tumor receptors show that their efficacy depends strongly on characterization of tumor biomarkers. Assessment of their status in individual patients would facilitate selection of an optimal treatment strategy, and the continuous monitoring of those biomarkers and their binding process to the therapy would provide a means for early evaluation of the efficacy of therapeutic intervention. In this study we have demonstrated for the first time in live animals that the fluorescence lifetime can be used to detect the binding of targeted optical probes to the extracellular receptors on tumor cells in vivo. The rationale was that fluorescence lifetime of a specific probe is sensitive to local environment and/or affinity to other molecules. We attached Near-InfraRed (NIR) fluorescent probes to Human Epidermal Growth Factor 2 (HER2/neu)-specific Affibody molecules and used our time-resolved optical system to compare the fluorescence lifetime of the optical probes that were bound and unbound to tumor cells in live mice. Our results show that the fluorescence lifetime changes in our model system delineate HER2 receptor bound from the unbound probe in vivo. Thus, this method is useful as a specific marker of the receptor binding process, which can open a new paradigm in the "image and treat" concept, especially for early evaluation of the efficacy of the therapy.	[Ardeshirpour, Yasaman; Chernomordik, Victor; Gandjbakhche, Amir; Hassan, Moinuddin] NICHHD, NIH, Bethesda, MD 20892 USA; [Zielinski, Rafal; Capala, Jacek; Lyakhov, Ilya] NCI, NIH, Bethesda, MD 20892 USA; [Zielinski, Rafal] John Paul II Catholic Univ Lublin, Dept Mol Biol, Lublin, Poland; [Griffiths, Gary; Vasalatiy, Olga] NIH, Imaging Probe Dev Ctr, Rockville, MD USA; [Smirnov, Aleksandr V.; Knutson, Jay R.] NHLBI, NIH, Bethesda, MD 20892 USA; [Achilefu, Samuel] Washington Univ, Dept Radiol, St Louis, MO USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Lublin; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL)	Ardeshirpour, Y (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	amir@helix.nih.gov	Capala, Jacek/S-3553-2019; Achilefu, Samuel/AAC-2401-2019	Achilefu, Samuel/0000-0002-3133-6717	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute, Imaging Probe Development Center, National Heart, Lung and Blood Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000261] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006065, ZIAHL006067, ZICHL005090, ZIAHL001452] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, Imaging Probe Development Center, National Heart, Lung and Blood Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and by the National Cancer Institute, Imaging Probe Development Center, National Heart, Lung and Blood Institute, National Institutes of Health. As YA, RF, VC, JC, GG, OV, AS, JK, IL, AG and MH are employees of the National Institutes of Health; this funder played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers W, 2007, MOL IMAGING, V6, P237, DOI 10.2310/7290.2007.00020; Alford R, 2010, CONTRAST MEDIA MOL I, V5, P1, DOI 10.1002/cmmi.360; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Amiot CL, 2008, SENSORS-BASEL, V8, P3082, DOI 10.3390/s8053082; [Anonymous], 1999, PRINCIPLES FLUORESCE; [Anonymous], R PROJECT STAT COMPU; Ardeshirpour Y, 2011, TECHNOL CANCER RES T, V10, P549, DOI 10.1177/153303461101000605; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; Bremer C, 2003, EUR RADIOL, V13, P231, DOI 10.1007/s00330-002-1610-0; Cheng Z, 2010, J BIOMEDICAL OPTICS, V15; Chernomordik V, 2010, MOL IMAGING, V9, P192, DOI 10.2310/7290.2010.00018; Christian NA, 2009, MOL IMAGING BIOL, V11, P167, DOI 10.1007/s11307-008-0184-x; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gannot I, 2004, LASER SURG MED, V35, P342, DOI 10.1002/lsm.20101; Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102; Goldshaid L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2579; Gurfinkel M, 2003, DIS MARKERS, V19, P107; Hall D, 2004, OPT LETT, V29, P2258, DOI 10.1364/OL.29.002258; Hassan M, 2007, MOL IMAGING, V6, P229, DOI 10.2310/7290.2007.00019; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lee SB, 2008, CLIN CANCER RES, V14, P3840, DOI 10.1158/1078-0432.CCR-07-4076; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lyakhov I, 2010, CHEMBIOCHEM, V11, P345, DOI 10.1002/cbic.200900532; Mathejczyk JE, 2011, MOL IMAGING; Nutt R, 2007, CLIN PHARMACOL THER, V81, P792, DOI 10.1038/sj.clpt.6100213; OLeary MA, 1996, OPT LETT, V21, P158, DOI 10.1364/OL.21.000158; Paithankar DY, 1997, APPL OPTICS, V36, P2260, DOI 10.1364/AO.36.002260; Pogue BW, 2010, J BIOMEDICAL OPTICS, V15; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smirnov A, 2009, 3 DIMENSIONAL MULTID, V7184, p71841D1; Szmacinski H., 1994, TOPICS FLUORESCENCE; VAUPEL P, 1989, CANCER RES, V49, P6449; Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; ZIMMERMAN HE, 1982, P NATL ACAD SCI USA, V79, P2128, DOI 10.1073/pnas.79.6.2128	40	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31881	10.1371/journal.pone.0031881	http://dx.doi.org/10.1371/journal.pone.0031881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384092	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100037
J	Demidova-Rice, TN; Wolf, L; Deckenback, J; Hamblin, MR; Herman, IM				Demidova-Rice, Tatiana N.; Wolf, Lindsey; Deckenback, Jeffry; Hamblin, Michael R.; Herman, Ira M.			Human Platelet-Rich Plasma- and Extracellular Matrix-Derived Peptides Promote Impaired Cutaneous Wound Healing In Vivo	PLOS ONE			English	Article							GROWTH-FACTORS; CELLS; MICE; ANGIOGENESIS; CYTOKINES; INJURY; VITRO	Previous work in our laboratory has described several pro-angiogenic short peptides derived from endothelial extracellular matrices degraded by bacterial collagenase. Here we tested whether these peptides could stimulate wound healing in vivo. Our experiments demonstrated that a peptide created as combination of fragments of tenascin X and fibrillin 1 (comb1) applied into cranial dermal wounds created in mice treated with cyclophosphamide to impair wound healing, can improve the rate of wound closure. Furthermore, we identify and characterize a novel peptide (UN3) created and modified from two naturally-occurring peptides, which are present in human platelet-rich plasma. In vitro testing of UN3 demonstrates that it causes a 50% increase in endothelial proliferation, 250% increase in angiogenic response and a tripling of epithelial cell migration in response to injury. Results of in vivo experiments where comb1 and UN3 peptides were added together to cranial wounds in cyclophosphamide-treated mice leads to improvement of wound vascularization as shown by an increase of the number of blood vessels present in the wound beds. Application of the peptides markedly promotes cellular responses to injury and essentially restores wound healing dynamics to those of normal, acute wounds in the absence of cyclophosphamide impairment. Our current work is aimed at understanding the mechanisms underlying the stimulatory effects of these peptides as well as identification of the cellular receptors mediating these effects.	[Demidova-Rice, Tatiana N.; Wolf, Lindsey; Deckenback, Jeffry; Herman, Ira M.] Tufts Univ, Sch Med, Ctr Innovat Wound Healing Res, Grad Program Cellular & Mol Physiol,Sackler Sch G, Boston, MA 02111 USA; [Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Demidova-Rice, TN (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.	ira.herman@tufts.edu	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022	Hamblin, Michael R/0000-0001-6431-4605; 	National Institutes of Heatlh [EY15125, EY19533]; Wound Care Partners, LLC; NATIONAL EYE INSTITUTE [K08EY019533, R01EY015125] Funding Source: NIH RePORTER	National Institutes of Heatlh; Wound Care Partners, LLC; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Heatlh EY15125, EY19533, and Wound Care Partners, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Borzini P, 2005, CURR OPIN HEMATOL, V12, P473, DOI 10.1097/01.moh.0000177831.70657.e8; Burkatovskaya M, 2008, WOUND REPAIR REGEN, V16, P425, DOI 10.1111/j.1524-475X.2008.00382.x; Chung TY, 2010, PHOTOMED LASER SURG, V28, P251, DOI 10.1089/pho.2009.2493; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; Demidova-Rice TN, 2011, WOUND REPAIR REGEN, V19, P59, DOI 10.1111/j.1524-475X.2010.00642.x; Durham JT, 2009, MICROVASC RES, V77, P281, DOI 10.1016/j.mvr.2008.12.003; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; HAWRYLOWICZ CM, 1991, J EXP MED, V174, P785, DOI 10.1084/jem.174.4.785; HEALY AM, 1992, EXP EYE RES, V55, P663, DOI 10.1016/0014-4835(92)90171-N; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Hostetler SG, 2006, WOUNDS, V18, P340; Imegwu Obi, 1997, Wound Repair and Regeneration, V5, P364, DOI 10.1046/j.1460-9568.1997.50411.x; Liu L, 2006, INVEST OPHTH VIS SCI, V47, P2438, DOI 10.1167/iovs.05-0876; Malinda KM, 2008, INT J BIOCHEM CELL B, V40, P2771, DOI 10.1016/j.biocel.2008.05.025; Nurden AT, 2011, THROMB HAEMOST S1; O'Connor R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/107859; Reid RR, 2004, J AM COLL SURGEONS, V199, P578, DOI 10.1016/j.jamcollsurg.2004.05.262; Rhee JS, 2004, THROMB HAEMOSTASIS, V92, P394, DOI 10.1160/TH03-04-0213; Roedersheimer M, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-4; Sharma A, 2006, J INVEST DERMATOL, V126, P2323, DOI 10.1038/sj.jid.5700428; Shuster CB, 1996, CELL MOTIL CYTOSKEL, V35, P175; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Ye J, 2008, GRAEF ARCH CLIN EXP, V246, P217, DOI 10.1007/s00417-007-0716-0	25	51	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32146	10.1371/journal.pone.0032146	http://dx.doi.org/10.1371/journal.pone.0032146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384158	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100054
J	Endo, Y; Zhang, MJ; Yamaji, S; Cang, Y				Endo, Yoko; Zhang, Mingjun; Yamaji, Sachie; Cang, Yong			Genetic Abolishment of Hepatocyte Proliferation Activates Hepatic Stem Cells	PLOS ONE			English	Article							LIVER-REGENERATION; PROGENITOR CELLS; MOUSE-LIVER; OVAL CELLS; SURFACE-MARKERS; DNA-DAMAGE; RAT-LIVER; DEGRADATION; EXPRESSION; DIFFERENTIATION	Quiescent hepatic stem cells (HSCs) can be activated when hepatocyte proliferation is compromised. Chemical injury rodent models have been widely used to study the localization, biomarkers, and signaling pathways in HSCs, but these models usually exhibit severe promiscuous toxicity and fail to distinguish damaged and non-damaged cells. Our goal is to establish new animal models to overcome these limitations, thereby providing new insights into HSC biology and application. We generated mutant mice with constitutive or inducible deletion of Damaged DNA Binding protein 1 (DDB1), an E3 ubiquitin ligase, in hepatocytes. We characterized the molecular mechanism underlying the compensatory activation and the properties of oval cells (OCs) by methods of mouse genetics, immuno-staining, cell transplantation and gene expression profiling. We show that deletion of DDB1 abolishes self-renewal capacity of mouse hepatocytes in vivo, leading to compensatory activation and proliferation of DDB1-expressing OCs. Partially restoring proliferation of DDB1-deficient hepatocytes by ablation of p21, a substrate of DDB1 E3 ligase, alleviates OC proliferation. Purified OCs express both hepatocyte and cholangiocyte markers, form colonies in vitro, and differentiate to hepatocytes after transplantation. Importantly, the DDB1 mutant mice exhibit very minor liver damage, compared to a chemical injury model. Microarray analysis reveals several previously unrecognized markers, including Reelin, enriched in oval cells. Here we report a genetic model in which irreversible inhibition of hepatocyte duplication results in HSC-driven liver regeneration. The DDB1 mutant mice can be broadly applied to studies of HSC differentiation, HSC niche and HSCs as origin of liver cancer.	[Endo, Yoko; Zhang, Mingjun; Yamaji, Sachie; Cang, Yong] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA; [Cang, Yong] Zhejiang Univ, Inst Life Sci, Hangzhou 310027, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; Zhejiang University	Endo, Y (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA.	ycang@sanfordburnham.org		Cang, Yong/0000-0002-1148-7008; Zhang, Mingjun/0000-0002-0641-1877	Japan Society for the Promotion of Science for Young Scientists; V Foundation for Cancer Research	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); V Foundation for Cancer Research	This work was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (Y.E.) and V Foundation for Cancer Research (Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; ENGELHARDT NV, 1993, DIFFERENTIATION, V55, P19, DOI 10.1111/j.1432-0436.1993.tb00029.x; FACTOR VM, 1993, EXP TOXICOL PATHOL, V45, P239, DOI 10.1016/S0940-2993(11)80399-4; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fonia O, 1996, HEPATOLOGY, V24, P697, DOI 10.1053/jhep.1996.v24.pm0008781345; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Jackson S, 2009, TRENDS BIOCH SCI; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kobold D, 2002, J HEPATOL, V36, P607, DOI 10.1016/S0168-8278(02)00050-8; Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696; LAISHES BA, 1981, CANCER RES, V41, P1731; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Preisegger KH, 1999, LAB INVEST, V79, P103; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Van den Heuvel MC, 2001, HEPATOLOGY, V33, P1387, DOI 10.1053/jhep.2001.24453; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	43	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31846	10.1371/journal.pone.0031846	http://dx.doi.org/10.1371/journal.pone.0031846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384083	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100035
J	Kiss, J; Nagy, B; Olasz, F				Kiss, Janos; Nagy, Bela; Olasz, Ferenc			Stability, Entrapment and Variant Formation of Salmonella Genomic Island 1	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; ENTERICA SEROVAR KENTUCKY; TYPHIMURIUM DT104; GENE-CLUSTER; SGI1; REGION; SEQUENCE; SALMONELLA-GENOMIC-ISLAND-1; AGONA; RECOMBINATION	Background: The Salmonella genomic island 1 (SGI1) is a 42.4 kb integrative mobilizable element containing several antibiotic resistance determinants embedded in a complex integron segment In104. The numerous SGI1 variants identified so far, differ mainly in this segment and the explanations of their emergence were mostly based on comparative structure analyses. Here we provide experimental studies on the stability, entrapment and variant formation of this peculiar gene cluster originally found in S. Typhimurium. Methodology/Principal Findings: Segregation and conjugation tests and various molecular techniques were used to detect the emerging SGI1 variants in Salmonella populations of 17 Salmonella enterica serovar Typhimurium DT104 isolates from Hungary. The SGI1s in these isolates proved to be fully competent in excision, conjugal transfer by the IncA/C helper plasmid R55, and integration into the E. coli chromosome. A trap vector has been constructed and successfully applied to capture the island on a plasmid. Monitoring of segregation of SGI1 indicated high stability of the island. SGI1-free segregants did not accumulate during long-term propagation, but several SGI1 variants could be obtained. Most of them appeared to be identical to SGI1-B and SGI1-C, but two new variants caused by deletions via a short-homology-dependent recombination process have also been detected. We have also noticed that the presence of the conjugation helper plasmid increased the formation of these deletion variants considerably. Conclusions/Significance: Despite that excision of SGI1 from the chromosome was proven in SGI1(+) Salmonella populations, its complete loss could not be observed. On the other hand, we demonstrated that several variants, among them two newly identified ones, arose with detectable frequencies in these populations in a short timescale and their formation was promoted by the helper plasmid. This reflects that IncA/C helper plasmids are not only involved in the horizontal spreading of SGI1, but may also contribute to its evolution.	[Kiss, Janos; Olasz, Ferenc] Agr Biotechnol Ctr, H-2101 Godollo, Hungary; [Nagy, Bela] Hungarian Acad Sci, Vet Med Res Inst, H-1581 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Kiss, J (corresponding author), Agr Biotechnol Ctr, H-2101 Godollo, Hungary.	kissj@abc.hu		Kiss, Janos/0000-0002-0506-5474	EU [MedVetNet FP6-506122, WP21, CRAB LSH-2004-2.1.2-4]; Stipendium Bolyai of the Hungarian Academy of Sciences [BO/00326/09]	EU(European Commission); Stipendium Bolyai of the Hungarian Academy of Sciences	This work was supported by the EU FP6 program (MedVetNet FP6-506122, WP21 and CRAB LSH-2004-2.1.2-4). JK was also supported by the Stipendium Bolyai of the Hungarian Academy of Sciences (BO/00326/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2007, J ANTIMICROB CHEMOTH, V59, P184, DOI 10.1093/jac/dkl471; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Cloeckaert A, 2006, ANTIMICROB AGENTS CH, V50, P3944, DOI 10.1128/AAC.00697-06; DALENCON E, 1994, EMBO J, V13, P2725, DOI 10.1002/j.1460-2075.1994.tb06563.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Djordjevic SP, 2009, ANTIMICROB AGENTS CH, V53, P2319, DOI 10.1128/AAC.01532-08; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P2510, DOI 10.1128/AAC.48.7.2510-2517.2004; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P3806, DOI 10.1128/AAC.48.10.3806-3812.2004; Doublet B, 2008, ANTIMICROB AGENTS CH, V52, P3745, DOI 10.1128/AAC.00525-08; Doublet B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002060; Fekete PZ, 2008, ACTA VET HUNG, V56, P5, DOI 10.1556/AVet.56.2008.1.2; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GIBSON T, 1984, THESIS U CAMBRIDGE U; Golding GR, 2007, MICROBES INFECT, V9, P21, DOI 10.1016/j.micinf.2006.10.004; GONZYTREBOUL G, 1992, J MOL BIOL, V224, P967, DOI 10.1016/0022-2836(92)90463-T; Imre A, 2011, FEMS MICROBIOL LETT, V317, P52, DOI 10.1111/j.1574-6968.2011.02210.x; Kiss J, 1999, MOL MICROBIOL, V34, P37, DOI 10.1046/j.1365-2958.1999.01567.x; Levings RS, 2008, ANTIMICROB AGENTS CH, V52, P2529, DOI 10.1128/AAC.00189-08; Levings RS, 2007, ANTIMICROB AGENTS CH, V51, P317, DOI 10.1128/AAC.01229-06; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Lovett ST, 2002, GENETICS, V160, P851; Mather AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027220; Middendorf B, 2004, J BACTERIOL, V186, P3086, DOI 10.1128/JB.186.10.3086-3096.2004; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Partridge SR, 2003, ANTIMICROB AGENTS CH, V47, P342, DOI 10.1128/AAC.47.1.342-349.2003; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Quiroz TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026031; Sambrook J., 2002, MOL CLONING LAB MANU; Siebor E, 2011, J ANTIMICROB CHEMOTH, V66, P2513, DOI 10.1093/jac/dkr335; Szabo M, 1999, PLASMID, V42, P192, DOI 10.1006/plas.1999.1425; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Vo ATT, 2007, J ANTIMICROB CHEMOTH, V59, P594, DOI 10.1093/jac/dkl531; Weill FX, 2005, ANTIMICROB AGENTS CH, V49, P2793, DOI 10.1128/AAC.49.7.2793-2801.2005; WESTONHAFER K, 1991, GENETICS, V127, P649; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786	42	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32497	10.1371/journal.pone.0032497	http://dx.doi.org/10.1371/journal.pone.0032497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384263	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100084
J	Ledford, JG; Mukherjee, S; Kislan, MM; Nugent, JL; Hollingsworth, JW; Wright, JR				Ledford, Julie G.; Mukherjee, Sambuddho; Kislan, Michele M.; Nugent, Julia L.; Hollingsworth, John W.; Wright, Jo Rae			Surfactant Protein-A Suppresses Eosinophil-Mediated Killing of Mycoplasma pneumoniae in Allergic Lungs	PLOS ONE			English	Article							B GENETIC-VARIANTS; RESPIRATORY-DISTRESS-SYNDROME; CHRONIC ASTHMA; INFLAMMATION; INFECTION; MICE; DEGRANULATION; PEROXIDASE; EXPRESSION; CHILDREN	Surfactant protein-A (SP-A) has well-established functions in reducing bacterial and viral infections but its role in chronic lung diseases such as asthma is unclear. Mycoplasma pneumoniae (Mp) frequently colonizes the airways of chronic asthmatics and is thought to contribute to exacerbations of asthma. Our lab has previously reported that during Mp infection of non-allergic airways, SP-A aides in maintaining airway homeostasis by inhibiting an overzealous TNF-alpha mediated response and, in allergic mice, SP-A regulates eosinophilic infiltration and inflammation of the airway. In the current study, we used an in vivo model with wild type (WT) and SP-A(-/-) allergic mice challenged with the model antigen ovalbumin (Ova) that were concurrently infected with Mp (Ova+Mp) to test the hypothesis that SP-A ameliorates Mp-induced stimulation of eosinophils. Thus, SP-A could protect allergic airways from injury due to release of eosinophil inflammatory products. SP-A deficient mice exhibit significant increases in inflammatory cells, mucus production and lung damage during concurrent allergic airway disease and infection (Ova+Mp) as compared to the WT mice of the same treatment group. In contrast, SP-A deficient mice have significantly decreased Mp burden compared to WT mice. The eosinophil specific factor, eosinophil peroxidase (EPO), which has been implicated in pathogen killing and also in epithelial dysfunction due to oxidative damage of resident lung proteins, is enhanced in samples from allergic/infected SP-A(-/-) mice as compared to WT mice. In vitro experiments using purified eosinophils and human SP-A suggest that SP-A limits the release of EPO from Mp-stimulated eosinophils thereby reducing their killing capacity. These findings are the first to demonstrate that although SP-A interferes with eosinophil-mediated biologic clearance of Mp by mediating the interaction of Mp with eosinophils, SP-A simultaneously benefits the airway by limiting inflammation and damage.	[Ledford, Julie G.; Mukherjee, Sambuddho; Kislan, Michele M.; Nugent, Julia L.; Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Ledford, Julie G.; Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Pulm Allergy & Crit Care Med, Durham, NC USA; [Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Duke University; Duke University	Ledford, JG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	j.ledford@cellbio.duke.edu			NIH [P01-AI81672, ES016126]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091642, K99HL111151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grant to Jo Rae Wright, P01-AI81672, and ES016126 to John Hollingsworth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Allergy A and Immunology (1996- 2011) Asthma Stastics, 1996, ASTHM STAST; Biscardi S, 2004, CLIN INFECT DIS, V38, P1341, DOI 10.1086/392498; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Chu HW, 2003, CHEST, V123, p390S, DOI 10.1378/chest.123.3_suppl.390S; Chu HW, 2003, INFECT IMMUN, V71, P1520, DOI 10.1128/IAI.71.3.1520-1526.2003; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Erpenbeck VJ, 2009, N-S ARCH PHARMACOL, V379, P217, DOI 10.1007/s00210-008-0354-z; Erpenbeck VJ, 2006, ALLERGY, V61, P598, DOI 10.1111/j.1398-9995.2006.01062.x; Floros J, 2001, BIOL NEONATE, V80, P22, DOI 10.1159/000047173; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Kraft M, 2006, J ALLERGY CLIN IMMUN, V117, P1197, DOI 10.1016/j.jaci.2006.03.001; Ledford JG, 2010, J IMMUNOL, V185, P3884, DOI 10.4049/jimmunol.1000387; Ledford JG, 2010, INNATE IMMUN-LONDON, V16, P183, DOI 10.1177/1753425910368446; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Lee NA, 1997, J IMMUNOL, V158, P1332; Malherbe DC, 2005, AM J PHYSIOL-LUNG C, V289, pL856, DOI 10.1152/ajplung.00009.2005; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Marttila R, 2003, AM J RESP CRIT CARE, V168, P1216, DOI 10.1164/rccm.200304-524OC; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; Ou Chun-Yen, 2008, Acta Paediatrica Taiwanica, V49, P14; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Pastva AM, 2011, J IMMUNOL, V186, P2842, DOI 10.4049/jimmunol.0904190; Pegorier S, 2006, J IMMUNOL, V177, P4861, DOI 10.4049/jimmunol.177.7.4861; Pelaia G, 2006, RESP MED, V100, P775, DOI 10.1016/j.rmed.2005.08.025; Persson T, 2001, INFECT IMMUN, V69, P3591, DOI 10.1128/IAI.69.6.3591-3596.2001; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; Prevention CfDCa (2009-2010) Asthma, 2009, ASTHM; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Schagat TL, 2003, AM J PHYSIOL-LUNG C, V284, pL140, DOI 10.1152/ajplung.00125.2002; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Schmiedl A, 2009, INT ARCH ALLERGY IMM, V148, P118, DOI 10.1159/000155742; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Thomas NJ, 2009, PEDIATR RES, V66, P70, DOI 10.1203/PDR.0b013e3181a1d768; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Verjan Garcia N, 2011, J IMMUNOL; von Bredow C, 2006, CLIN EXP ALLERGY, V36, P1566, DOI 10.1111/j.1365-2222.2006.02598.x; Wang Y, 2011, AM J PHYSL LUNG CELL	46	25	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32436	10.1371/journal.pone.0032436	http://dx.doi.org/10.1371/journal.pone.0032436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384248	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100080
J	Trowbridge, AM; Asensio, D; Eller, ASD; Way, DA; Wilkinson, MJ; Schnitzler, JP; Jackson, RB; Monson, RK				Trowbridge, Amy M.; Asensio, Dolores; Eller, Allyson S. D.; Way, Danielle A.; Wilkinson, Michael J.; Schnitzler, Joerg-Peter; Jackson, Robert B.; Monson, Russell K.			Contribution of Various Carbon Sources Toward Isoprene Biosynthesis in Poplar Leaves Mediated by Altered Atmospheric CO2 Concentrations	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; EMISSION RATE; PHOSPHATE TRANSLOCATORS; INTACT LEAVES; ASPEN LEAVES; PTR-MS; (CO2)-C-13; PLANTS; METABOLISM; PATHWAY	Biogenically released isoprene plays important roles in both tropospheric photochemistry and plant metabolism. We performed a (CO2)-C-13-labeling study using proton-transfer-reaction mass spectrometry (PTR-MS) to examine the kinetics of recently assimilated photosynthate into isoprene emitted from poplar (Populus x canescens) trees grown and measured at different atmospheric CO2 concentrations. This is the first study to explicitly consider the effects of altered atmospheric CO2 concentration on carbon partitioning to isoprene biosynthesis. We studied changes in the proportion of labeled carbon as a function of time in two mass fragments, M41(+), which represents, in part, substrate derived from pyruvate, and M69(+), which represents the whole unlabeled isoprene molecule. We observed a trend of slower C-13 incorporation into isoprene carbon derived from pyruvate, consistent with the previously hypothesized origin of chloroplastic pyruvate from cytosolic phosphenolpyruvate (PEP). Trees grown under sub-ambient CO2 (190 ppmv) had rates of isoprene emission and rates of labeling of M41(+) and M69(+) that were nearly twice those observed in trees grown under elevated CO2 (590 ppmv). However, they also demonstrated the lowest proportion of completely labeled isoprene molecules. These results suggest that under reduced atmospheric CO2 availability, more carbon from stored/older carbon sources is involved in isoprene biosynthesis, and this carbon most likely enters the isoprene biosynthesis pathway through the pyruvate substrate. We offer direct evidence that extra-chloroplastic rather than chloroplastic carbon sources are mobilized to increase the availability of pyruvate required to up-regulate the isoprene biosynthesis pathway when trees are grown under sub-ambient CO2.	[Trowbridge, Amy M.; Asensio, Dolores; Eller, Allyson S. D.; Wilkinson, Michael J.; Monson, Russell K.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Eller, Allyson S. D.; Monson, Russell K.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Schnitzler, Joerg-Peter] Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat, Neuherberg, Germany; [Jackson, Robert B.] Duke Univ, Dept Biol, Nicholas Sch Environm, Durham, NC USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Duke University	Trowbridge, AM (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	amy.m.trowbridge@gmail.com	Asensio, Dolores/I-3383-2016; Schnitzler, Joerg-Peter/C-5268-2011; Way, Danielle/AAY-6395-2021; Way, Danielle A/N-1867-2014; Eller, Allyson/I-7021-2012	Asensio, Dolores/0000-0002-7622-1200; Schnitzler, Joerg-Peter/0000-0002-9825-867X; Way, Danielle/0000-0003-4801-5319; Way, Danielle A/0000-0003-4801-5319; Eller, Allyson/0000-0003-3125-5658; Trowbridge, Amy/0000-0001-8993-2530; Jackson, Robert/0000-0001-8846-7147	Human Frotiers in Science Program in Strasbourg, France; U.S. Department of Energy [ER64242]	Human Frotiers in Science Program in Strasbourg, France; U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Human Frotiers in Science Program in Strasbourg, France http://www.hfsp.org/, and the U.S. Department of Energy (Program in Ecosystem Research #ER64242) http://per.ornl.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnke K, 2007, PLANT J, V51, P485, DOI 10.1111/j.1365-313X.2007.03157.x; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Cegelski L, 2006, J MAGN RESON, V178, P1, DOI 10.1016/j.jmr.2005.10.010; DELWICHE CF, 1993, PLANT CELL ENVIRON, V16, P587, DOI 10.1111/j.1365-3040.1993.tb00907.x; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Fischer K, 1997, PLANT CELL, V9, P453, DOI 10.1105/tpc.9.3.453; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Funk JL, 2004, PLANT CELL ENVIRON, V27, P747, DOI 10.1111/j.1365-3040.2004.01177.x; Ghirardo A, 2010, PLANT CELL ENVIRON, V33, P781, DOI 10.1111/j.1365-3040.2009.02104.x; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Guenther A., 2006, ATMOS CHEM PHYS, V6, P3181, DOI [10.5194/acp-6-3181-2006, DOI 10.5194/ACP-6-3181-2006, DOI 10.5194/ACPD-6-107-2006]; Guenther A.B., 1993, J GEOPHYS RES, V98, P609, DOI DOI 10.1029/93JD00527; GUENTHER AB, 1991, J GEOPHYS RES-ATMOS, V96, P10799, DOI 10.1029/91JD00960; Harley PC, 1999, OECOLOGIA, V118, P109, DOI 10.1007/s004420050709; Hasunuma T, 2010, J EXP BOT, V61, P1041, DOI 10.1093/jxb/erp374; Heald CL, 2009, GLOBAL CHANGE BIOL, V15, P1127, DOI 10.1111/j.1365-2486.2008.01802.x; Karl T, 2002, PLANTA, V215, P894, DOI 10.1007/s00425-002-0825-2; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; Logan BA, 2000, TRENDS PLANT SCI, V5, P477, DOI 10.1016/S1360-1385(00)01765-9; LORETO F, 1990, PLANTA, V182, P523, DOI 10.1007/BF02341027; Loreto F, 1996, PLANT PHYSIOL, V110, P1317, DOI 10.1104/pp.110.4.1317; Loreto F, 2007, PLANT CELL ENVIRON, V30, P662, DOI 10.1111/j.1365-3040.2007.01648.x; MONSON RK, 1989, PLANT PHYSIOL, V90, P267, DOI 10.1104/pp.90.1.267; Monson RK, 2007, PHILOS T R SOC A, V365, P1677, DOI 10.1098/rsta.2007.2038; Possell M, 2011, GLOBAL CHANGE BIOL, V17, P1595, DOI 10.1111/j.1365-2486.2010.02306.x; Rasulov B, 2009, PLANT PHYSIOL, V151, P448, DOI 10.1104/pp.109.141978; Rasulov B, 2009, PLANT PHYSIOL, V149, P1609, DOI 10.1104/pp.108.133512; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; Rosenstiel TN, 2003, NATURE, V421, P256, DOI 10.1038/nature01312; Sanadze GA, 1964, PHOTOSYNTH RES, V2, P701; Schnitzler JP, 2004, PLANT PHYSIOL, V135, P152, DOI 10.1104/pp.103.037374; Scholefield PA, 2004, PLANT CELL ENVIRON, V27, P393, DOI 10.1111/j.1365-3040.2003.01155.x; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Wilkinson MJ, 2009, GLOBAL CHANGE BIOL, V15, P1189, DOI 10.1111/j.1365-2486.2008.01803.x	38	35	38	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32387	10.1371/journal.pone.0032387	http://dx.doi.org/10.1371/journal.pone.0032387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384238	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100077
J	Magee, DA; Taraktsoglou, M; Killick, KE; Nalpas, NC; Browne, JA; Park, SDE; Conlon, KM; Lynn, DJ; Hokamp, K; Gordon, SV; Gormley, E; MacHugh, DE				Magee, David A.; Taraktsoglou, Maria; Killick, Kate E.; Nalpas, Nicolas C.; Browne, John A.; Park, Stephen D. E.; Conlon, Kevin M.; Lynn, David J.; Hokamp, Karsten; Gordon, Stephen V.; Gormley, Eamonn; MacHugh, David E.			Global Gene Expression and Systems Biology Analysis of Bovine Monocyte-Derived Macrophages in Response to In Vitro Challenge with Mycobacterium bovis	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; INTERFERON-GAMMA; 19-KDA LIPOPROTEIN; ADAPTIVE IMMUNITY; IFN-GAMMA; TUBERCULOSIS; INHIBITION; INFECTION; MECHANISM	Background: Mycobacterium bovis, the causative agent of bovine tuberculosis, is a major cause of mortality in global cattle populations. Macrophages are among the first cell types to encounter M. bovis following exposure and the response elicited by these cells is pivotal in determining the outcome of infection. Here, a functional genomics approach was undertaken to investigate global gene expression profiles in bovine monocyte-derived macrophages (MDM) purified from seven age-matched non-related females, in response to in vitro challenge with M. bovis (multiplicity of infection 2:1). Total cellular RNA was extracted from non-challenged control and M. bovis-challenged MDM for all animals at intervals of 2 hours, 6 hours and 24 hours post-challenge and prepared for global gene expression analysis using the Affymetrix (R) GeneChip (R) Bovine Genome Array. Results: Comparison of M. bovis-challenged MDM gene expression profiles with those from the non-challenged MDM controls at each time point identified 3,064 differentially expressed genes 2 hours post-challenge, with 4,451 and 5,267 differentially expressed genes detected at the 6 hour and 24 hour time points, respectively (adjusted P-value threshold <= 0.05). Notably, the number of downregulated genes exceeded the number of upregulated genes in the M. bovis-challenged MDM across all time points; however, the fold-change in expression for the upregulated genes was markedly higher than that for the downregulated genes. Systems analysis revealed enrichment for genes involved in: (1) the inflammatory response; (2) cell signalling pathways, including Toll-like receptors and intracellular pathogen recognition receptors; and (3) apoptosis. Conclusions: The increased number of downregulated genes is consistent with previous studies showing that M. bovis infection is associated with the repression of host gene expression. The results also support roles for MyD88-independent signalling and intracellular PRRs in mediating the host response to M. bovis.	[Magee, David A.; Taraktsoglou, Maria; Killick, Kate E.; Nalpas, Nicolas C.; Browne, John A.; Park, Stephen D. E.; Gordon, Stephen V.; MacHugh, David E.] Univ Coll Dublin, UCD Sch Agr & Food Sci, Anim Genom Lab, Dublin 2, Ireland; [Gormley, Eamonn] Univ Coll Dublin, UCD Sch Vet Med, TB Diagnost & Immunol Res Ctr, Dublin 2, Ireland; [Lynn, David J.] TEAGASC, Anim Biosci Ctr, Dunsany, Meath, Ireland; [Hokamp, Karsten] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Gordon, Stephen V.; MacHugh, David E.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin; Teagasc; Trinity College Dublin; University College Dublin	Magee, DA (corresponding author), Univ Coll Dublin, UCD Sch Agr & Food Sci, Anim Genom Lab, Dublin 2, Ireland.	david.machugh@ucd.ie	Conlon, Kevin M/G-2533-2013; Gormley, Eamonn/AAU-6678-2020	Conlon, Kevin M/0000-0002-4365-3955; Gormley, Eamonn/0000-0003-3900-0393; Browne, John/0000-0002-7698-9834; Nalpas, Nicolas/0000-0002-7255-6214; Gordon, Stephen/0000-0002-4833-5542; Lynn, David/0000-0003-4664-1404; MacHugh, David/0000-0002-8112-4704; Hokamp, Karsten/0000-0001-7464-2370	Science Foundation Ireland [SFI/01/F.1/B028, SFI/08/IN.1/B2038]; Department of Agriculture, Fisheries and Food [RSF 06 405]; European Union [KBBE-211602-MACROSYS]; Irish Research Council for Science, Engineering and Technology (IRCSET); Bioinformatics and Systems Biology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture, Fisheries and Food; European Union(European Commission); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Bioinformatics and Systems Biology	This work was funded by the following sources: Science Foundation Ireland (www.sfi.ie) Investigator grants (Nos: SFI/01/F.1/B028 and SFI/08/IN.1/B2038); Department of Agriculture, Fisheries and Food (www.agriculture.ie) Research Stimulus Grant (No: RSF 06 405); European Union Framework 7 (http://cordis.europa.eu/fp7) Project Grant (No: KBBE-211602-MACROSYS); Irish Research Council for Science, Engineering and Technology (IRCSET) funded Bioinformatics and Systems Biology PhD Programme (http://bioinfo-casl.ucd.ie/PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron A, 1997, J IMMUNOL, V159, P3034; Bezuidenhout J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004228; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Cheallaigh CN, 2011, CLIN EXP IMMUNOL, V164, P291, DOI 10.1111/j.1365-2249.2011.04381.x; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dasgupta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012225; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Denis M, 2007, TUBERCULOSIS, V87, P53, DOI 10.1016/j.tube.2006.03.005; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dhiman R, 2011, J IMMUNOL, V186, P1638, DOI 10.4049/jimmunol.1003146; Ding AH, 2005, IMMUNOLOGY, V116, P381, DOI 10.1111/j.1365-2567.2005.02238.x; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haddad JJ, 2003, CELL SIGNAL, V15, P255, DOI 10.1016/S0898-6568(02)00075-X; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JACOBSEN CN, 1993, VET IMMUNOL IMMUNOP, V39, P461, DOI 10.1016/0165-2427(93)90075-F; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kabara E, 2010, BRIEF FUNCT GENOMICS, V9, P220, DOI 10.1093/bfgp/elq009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly DM, 2008, INFECT IMMUN, V76, P351, DOI 10.1128/IAI.00614-07; Killick KE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-611; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lukey PT, 2001, MYCOBACTERIUM TUBERC, P403; MASAKI S, 1990, MICROBIOL IMMUNOL, V34, P653, DOI 10.1111/j.1348-0421.1990.tb01041.x; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Netea MG, 2004, TRENDS MICROBIOL, V12, P484, DOI 10.1016/j.tim.2004.09.004; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Pollock JM, 2005, VET IMMUNOL IMMUNOP, V108, P37, DOI 10.1016/j.vetimm.2005.08.012; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rivero-Lezcano OM, 2010, CLIN EXP IMMUNOL, V162, P289, DOI 10.1111/j.1365-2249.2010.04168.x; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAFRAN M, 2010, GENECARDS VERSION 3, pAQ20; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; SATTLER TH, 1948, J BACTERIOL, V56, P235, DOI 10.1128/JB.56.2.235-243.1948; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Taraktsoglou M, 2011, VET IMMUNOL IMMUNOP, V140, P130, DOI 10.1016/j.vetimm.2010.12.002; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; VanHeyningen TK, 1997, J IMMUNOL, V158, P330; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang Y, 2011, FEMS MICROBIOL LETT, V321, P30, DOI 10.1111/j.1574-6968.2011.02304.x; Waters W Ray, 2011, Clin Dev Immunol, V2011, P768542, DOI 10.1155/2011/768542; Weiss DJ, 2008, VET PATHOL, V45, P829, DOI 10.1354/vp.45-6-829; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302; Widdison S, 2006, CLIN EXP IMMUNOL, V144, P281, DOI 10.1111/j.1365-2249.2006.03053.x; Widdison S, 2007, VET IMMUNOL IMMUNOP, V117, P302, DOI 10.1016/j.vetimm.2007.01.016; Widdison S, 2011, DEV COMP IMMUNOL, V35, P580, DOI 10.1016/j.dci.2011.01.001; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225	90	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32034	10.1371/journal.pone.0032034	http://dx.doi.org/10.1371/journal.pone.0032034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384131	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500066
J	Nielsen, N; Odum, N; Urso, B; Lanier, LL; Spee, P				Nielsen, Natasja; Odum, Niels; Urso, Birgitte; Lanier, Lewis L.; Spee, Pieter			Cytotoxicity of CD56(bright) NK Cells towards Autologous Activated CD4(+) T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; LIGAND EXPRESSION; IN-VIVO; DEPENDENT ACTIVATION; MULTIPLE-SCLEROSIS; ARTHRITIS PATIENTS; PERIPHERAL-BLOOD; RAPID INDUCTION; CUTTING EDGE	In mouse models of chronic inflammatory diseases, Natural Killer (NK) cells can play an immunoregulatory role by eliminating chronically activated leukocytes. Indirect evidence suggests that NK cells may also be immunoregulatory in humans. Two subsets of human NK cells can be phenotypically distinguished as CD16(+)CD56(dim) and CD16(dim/-)D56(bright). An expansion in the CD56(bright) NK cell subset has been associated with clinical responses to therapy in various autoimmune diseases, suggesting an immunoregulatory role for this subset in vivo. Here we compared the regulation of activated human CD4(+) T cells by CD56(dim) and CD56(bright) autologous NK cells in vitro. Both subsets efficiently killed activated, but not resting, CD4(+) T cells. The activating receptor NKG2D, as well as the integrin LFA-1 and the TRAIL pathway, played important roles in this process. Degranulation by NK cells towards activated CD4(+) T cells was enhanced by IL-2, IL-15, IL-12+IL-18 and IFN-alpha. Interestingly, IL-7 and IL-21 stimulated degranulation by CD56(bright) NK cells but not by CD56(dim) NK cells. NK cell killing of activated CD4(+) T cells was suppressed by HLA-E on CD4(+) T cells, as blocking the interaction between HLA-E and the inhibitory CD94/NKG2A NK cell receptor enhanced NK cell degranulation. This study provides new insight into CD56(dim) and CD56(bright) NK cell-mediated elimination of activated autologous CD4(+) T cells, which potentially may provide an opportunity for therapeutic treatment of chronic inflammation.	[Nielsen, Natasja; Spee, Pieter] Novo Nordisk AS, Translat Immunol, Malov, Denmark; [Urso, Birgitte] Novo Nordisk AS, Inflammat Biol, Monocyte Biol, Malov, Denmark; [Odum, Niels] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Nielsen, Natasja; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Nielsen, Natasja; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	Novo Nordisk; Novo Nordisk; University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nielsen, N (corresponding author), Novo Nordisk AS, Translat Immunol, Malov, Denmark.	spee@novonordisk.com	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation; National Institutes of Health [AI066897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897] Funding Source: NIH RePORTER	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Novo Nordisk A/S, the Danish Agency for Science, Technology and Innovation (http://en.fi.dk/research/industrial-phd-programme), and the National Institutes of Health (grant AI066897). LLL is an American Cancer Society Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2009, J IMMUNOL, V183, P897, DOI 10.4049/jimmunol.0803014; Ardolino M, 2011, BLOOD, V117, P4778, DOI 10.1182/blood-2010-08-300954; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; Brooks CR, 2006, J IMMUNOL, V176, P1141, DOI 10.4049/jimmunol.176.2.1141; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DADMARZ R, 1994, LYMPHOKINE CYTOK RES, V13, P349; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; Dalbeth Nicola, 2007, V136, P149; de Matos CT, 2007, IMMUNOLOGY, V122, P291, DOI 10.1111/j.1365-2567.2007.02638.x; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Eagle Robert A., 2009, Current Immunology Reviews, V5, P22; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; ELLIS TM, 1989, J IMMUNOL, V142, P2949; Fehniger TA, 2000, J CLIN INVEST, V106, P117, DOI 10.1172/JCI6218; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fort MM, 1998, J IMMUNOL, V161, P3256; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Helander TS, 1998, CURR TOP MICROBIOL, V230, P89; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Kastrukoff LF, 1998, J NEUROIMMUNOL, V86, P123, DOI 10.1016/S0165-5728(98)00014-9; Kastrukoff LF, 2003, J NEUROIMMUNOL, V145, P103, DOI 10.1016/j.jneuroim.2003.10.001; Katchar K, 2005, EUR RESPIR J, V26, P77, DOI 10.1183/09031936.05.00030805; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1986, J IMMUNOL, V136, P4480; Leavenworth JW, 2011, P NATL ACAD SCI USA, V108, P14584, DOI 10.1073/pnas.1112188108; Leavenworth JW, 2010, P NATL ACAD SCI USA, V107, P2562, DOI 10.1073/pnas.0914732107; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Molinero LL, 2006, HUM IMMUNOL, V67, P170, DOI 10.1016/j.humimm.2006.02.010; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Lunemann A, 2008, J IMMUNOL, V181, P6170, DOI 10.4049/jimmunol.181.9.6170; Magri G, 2011, BLOOD, V117, P848, DOI 10.1182/blood-2010-08-301374; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Mittendorf EA, 2005, BREAST CANCER RES TR, V92, P85, DOI 10.1007/s10549-005-0988-1; Mottonen M, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar589; NAGLER A, 1989, J IMMUNOL, V143, P3183; Nilsson N, 1999, CLIN EXP IMMUNOL, V117, P63; Niu XY, 2010, HUM IMMUNOL, V71, P334, DOI 10.1016/j.humimm.2010.01.010; Ottaviani C, 2006, EUR J IMMUNOL, V36, P118, DOI 10.1002/eji.200535243; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Roy S, 2008, J IMMUNOL, V180, P1729, DOI 10.4049/jimmunol.180.3.1729; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Schierloh P, 2005, J IMMUNOL, V175, P6852, DOI 10.4049/jimmunol.175.10.6852; Schulz U, 2010, SCAND J IMMUNOL, V72, P319, DOI 10.1111/j.1365-3083.2010.02435.x; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Takao S, 2010, J IMMUNOL, V185, P6031, DOI 10.4049/jimmunol.1000176; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; van Roon JAG, 2005, ARTHRITIS RHEUM, V52, P1700, DOI 10.1002/art.21045; Vandenbark AA, 2009, J NEUROIMMUNOL, V215, P125, DOI 10.1016/j.jneuroim.2009.08.007; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wilson JL, 1999, J IMMUNOL, V163, P6365; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	70	107	113	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31959	10.1371/journal.pone.0031959	http://dx.doi.org/10.1371/journal.pone.0031959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384114	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500059
J	Williams, SM; Nast, A; Coleman, MJ				Williams, Shayna M.; Nast, Alexis; Coleman, Melissa J.			Characterization of Synaptically Connected Nuclei in a Potential Sensorimotor Feedback Pathway in the Zebra Finch Song System	PLOS ONE			English	Article							WHITE-CROWNED SPARROW; VOCAL CONTROL NUCLEUS; AUDITORY RESPONSES; PARALLEL PATHWAYS; AUTOGENOUS SONG; BASAL GANGLIA; MOTOR PATHWAY; FOREBRAIN; NEURONS; SONGBIRDS	Birdsong is a learned behavior that is controlled by a group of identified nuclei, known collectively as the song system. The cortical nucleus HVC (used as a proper name) is a focal point of many investigations as it is necessary for song production, song learning, and receives selective auditory information. HVC receives input from several sources including the cortical area MMAN (medial magnocellular nucleus of the nidopallium). The MMAN to HVC connection is particularly interesting as it provides potential sensorimotor feedback to HVC. To begin to understand the role of this connection, we investigated the physiological relation between MMAN and HVC activity with simultaneous multiunit extracellular recordings from these two nuclei in urethane anesthetized zebra finches. As previously reported, we found similar timing in spontaneous bursts of activity in MMAN and HVC. Like HVC, MMAN responds to auditory playback of the bird's own song (BOS), but had little response to reversed BOS or conspecific song. Stimulation of MMAN resulted in evoked activity in HVC, indicating functional excitation from MMAN to HVC. However, inactivation of MMAN resulted in no consistent change in auditory responses in HVC. Taken together, these results indicate that MMAN provides functional excitatory input to HVC but does not provide significant auditory input to HVC in anesthetized animals. We hypothesize that MMAN may play a role in motor reinforcement or coordination, or may provide modulatory input to the song system about the internal state of the animal as it receives input from the hypothalamus.	[Nast, Alexis; Coleman, Melissa J.] Scripps Coll, Claremont, CA 91711 USA; [Coleman, Melissa J.] Pitzer Coll, Claremont McKenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Scripps College; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College	Williams, SM (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Neuroendocrinol Lab, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	mcoleman@kecksci.claremont.edu		Williams-Burris, Shayna/0000-0002-9644-0136	institutional start-up funds; Rose Hills Foundation	institutional start-up funds; Rose Hills Foundation	This work was supported by institutional start-up funds (MJC) and by the Rose Hills Foundation (SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Bottjer SW, 2010, NAT NEUROSCI, V13, P153, DOI 10.1038/nn.2472; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Coleman MJ, 2007, J NEUROSCI, V27, P10024, DOI 10.1523/JNEUROSCI.2215-07.2007; Coleman MJ, 2005, J NEUROBIOL, V63, P70, DOI 10.1002/neu.20122; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Coleman MJ, 2008, 2008 NEUR M PLANN WA, V15; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Foster EF, 2001, J NEUROBIOL, V46, P142, DOI 10.1002/1097-4695(20010205)46:2<142::AID-NEU60>3.0.CO;2-R; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Green D.M., 1966, SIGNAL DETECTION THE, V11, P455; Green DM, 1966, SIGNAL DETECTION THE; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamaguchi K, 2010, 2010 NEUR M PLANN SA; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Seki Y, 2008, NEUROREPORT, V19, P679, DOI 10.1097/WNR.0b013e3282fb7dae; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; Solis MM, 1997, J NEUROSCI, V17, P6447; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Thode C, 2008, NEUROSCIENCE, V157, P143, DOI 10.1016/j.neuroscience.2008.08.057; Vates GE, 1997, J COMP NEUROL, V380, P275; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Vu E, 2001, 2001 NEUR M PLANN SA; VU ET, 1994, J NEUROSCI, V14, P6924; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Williams SM, 2008, 2008 NEUR M PLANN WA, V14; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32178	10.1371/journal.pone.0032178	http://dx.doi.org/10.1371/journal.pone.0032178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384172	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500083
J	Yang, H; Liu, Y; Bai, F; Zhang, JY; Ma, SH; Liu, J; Xu, ZD; Zhu, HG; Ling, ZQ; Ye, D; Guan, KL; Xiong, Y				Yang, H.; Liu, Y.; Bai, F.; Zhang, J-Y; Ma, S-H; Liu, J.; Xu, Z-D; Zhu, H-G; Ling, Z-Q; Ye, D.; Guan, K-L; Xiong, Y.			Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation	ONCOGENE			English	Article						TET; 5-hydroxymethylation; DNA methylation; cancer biomarker	MAFFUCCI SYNDROME; IDH2 MUTATIONS; OLLIER DISEASE; MAMMALIAN DNA; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE; CONVERSION; PROTEINS; CANCERS	The TET (ten eleven translocation) family of alpha-ketoglutarate (alpha-KG)-dependent dioxygenases catalyzes the sequential oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formyleytosine and 5-carboxylcytosine, leading to eventual DNA demethylation. The TET2 gene is a bona fide tumor suppressor frequently mutated in leukemia, and TET enzyme activity is inhibited in IDH1/2-mutated tumors by the oncometabolite 2-hydroxyglutarate, an antagonist of alpha-KG, linking 5mC oxidation to cancer development. We report here that the levels of 5hmC are dramatically reduced in human breast, liver, lung, pancreatic and prostate cancers when compared with the matched surrounding normal tissues. Associated with the 5hmC decrease is the substantial reduction of the expression of all three TET genes, revealing a possible mechanism for the reduced 5hmC in cancer cells. The decrease of 5hmC was also observed during tumor development in different genetically engineered mouse models. Together, our results identify 5hmC as a biomarker whose decrease is broadly and tightly associated with tumor development. Oncogene (2013) 32, 663-669; doi:10.1038/onc.2012.67;published online 5 March 2012	[Yang, H.; Zhang, J-Y; Ma, S-H; Ye, D.; Guan, K-L; Xiong, Y.] Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yang, H.; Ma, S-H; Xiong, Y.] Fudan Univ, Coll Life Sci, Shanghai 200433, Peoples R China; [Liu, Y.; Liu, J.; Xu, Z-D; Zhu, H-G] Fudan Univ, Dept Pathol, Shanghai 200433, Peoples R China; [Liu, Y.; Liu, J.; Xu, Z-D; Zhu, H-G; Guan, K-L] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Bai, F.; Xiong, Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ling, Z-Q] Zhejiang Prov Canc Hosp, Zhejiang Canc Res Inst, Zhejiang Canc, Hangzhou, Zhejiang, Peoples R China; [Guan, K-L] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; Zhejiang Cancer Hospital; University of California System; University of California San Diego	Ye, D (corresponding author), Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai 200433, Peoples R China.	yedan@fudan.edu.cn; kuguan@ucsd.edu; yxiong@email.unc.edu	Guan, Kun-Liang/ADK-7088-2022; Yang, Hui/AAM-4564-2021; Yang, Hui/ABG-0952-2022	Yang, Hui/0000-0002-2865-5311	MOST [2009CB918401, 2011CB910600]; NSFC [30600112, 30871255, 31071192]; 985 Program; Shanghai key project [09JC1402300]; Shanghai Leading Academic Discipline Project [B110]; NIH; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA163834] Funding Source: NIH RePORTER	MOST; NSFC(National Natural Science Foundation of China (NSFC)); 985 Program; Shanghai key project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Fudan MCB laboratory for discussions and support throughout this study, and Eric Oermann for reading the manuscript. This work was supported by MOST 973 (No. 2009CB918401, No. 2011CB910600), NSFC (Grant No. 30600112, 30871255, 31071192). This work was also supported by the 985 Program, Shanghai key project (Grant No. 09JC1402300), the Shanghai Leading Academic Discipline Project (project number B110), and NIH grants (to YX and KLG).	Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Haffner MC, 2011, ONCOTARGET, V2, P627; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mullighan CG, 2009, NAT GENET, V41, P766, DOI 10.1038/ng0709-766; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	22	422	437	2	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 31	2013	32	5					663	669		10.1038/onc.2012.67	http://dx.doi.org/10.1038/onc.2012.67			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22391558	Green Published, Green Accepted			2022-12-25	WOS:000316164700013
J	Zizza, P; Iurisci, C; Bonazzi, M; Cossart, P; Leslie, CC; Corda, D; Mariggio, S				Zizza, Pasquale; Iurisci, Cristiano; Bonazzi, Matteo; Cossart, Pascale; Leslie, Christina C.; Corda, Daniela; Mariggio, Stefania			Phospholipase A(2)IV alpha Regulates Phagocytosis Independent of Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE-A(2)ALPHA; LISTERIA-MONOCYTOGENES; PERITONEAL-MACROPHAGES; BINDING DOMAIN; CELL-GROWTH; A(2); TRANSLOCATION; PHAGOSOMES; RECEPTORS; A(2)ALPHA	Group IV alpha phospholipase A(2) (PLA(2)IV alpha) is a lipolytic enzyme that catalyzes the hydrolysis of membrane phospholipids to generate precursors of potent inflammatory lipid mediators. Here, the role of PLA(2)IV alpha in Fc receptor (FcR)-mediated phagocytosis was investigated, demonstrating that PLA(2)IV alpha is selectively activated upon FcR-mediated phagocytosis in macrophages and that it rapidly translocates to the site of the nascent phagosome. Moreover, pharmacological inhibition of PLA(2)IV alpha by pyrrophenone reduces particle internalization by up to 50%. In parallel, fibroblasts from PLA(2)IV alpha knock-out mice overexpressing Fc gamma RIIA and able to internalize IgG-opsonized beads show 50% lower phagocytosis, compared with wild-type cells, and transfection of PLA(2)IV alpha fully recovers this impaired function. Interestingly, transfection of the catalytically inactive deleted PLA(2)IV alpha mutant (PLA(2)IV alpha(1-525)) and point mutant (PLA(2)IV alpha-S228C) also promotes recovery of this impaired function. Finally, transfection of the PLA(2)IV alpha C2 domain (which is directly involved in PLA(2)IV alpha membrane binding), but not of PLA(2)IV alpha-D43N (which cannot bind to membranes), rescues FcR-mediated phagocytosis. These data unveil a new mechanism of action for PLA(2)IV alpha, which demonstrates that the membrane binding, and not the enzymatic activity, is required for PLA(2)IV alpha modulation of FcR-mediated phagocytosis.	[Zizza, Pasquale; Corda, Daniela; Mariggio, Stefania] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Zizza, Pasquale; Iurisci, Cristiano; Corda, Daniela; Mariggio, Stefania] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Bonazzi, Matteo; Cossart, Pascale] Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules, F-75724 Paris, France; [Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Jewish Health	Corda, D (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	d.corda@ibp.cnr.it; s.mariggio@ibp.cnr.it	Mariggio', Stefania/H-5467-2015; Zizza, Pasquale/K-3292-2018; Bonazzi, Matteo/AAT-2653-2020; Bonazzi, Matteo/G-1623-2011; Corda, Daniela/K-6385-2016	Mariggio', Stefania/0000-0002-6397-3016; Zizza, Pasquale/0000-0001-7281-6090; Bonazzi, Matteo/0000-0001-5499-8759; Bonazzi, Matteo/0000-0001-5499-8759; Corda, Daniela/0000-0002-3614-751X	National Institutes of Health [HL34303, HL61378]; Italian Association for Cancer Research (Milan, Italy) [IG10341, GGP030295]; European Community [202272 HEALTH-2007-2.1.1-6 (LipidomicNet)]; Italian Ministry of Economy and Finance; Italian Foundation for Cancer Research (Milan, Italy); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061378, P01HL034303] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Italian Ministry of Economy and Finance; Italian Foundation for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondazione Telethon(Fondazione Telethon)	This work was supported, in whole or in part, by National Institutes of Health Grants HL34303 and HL61378 (to C. C. L.). This work was also supported by Italian Association for Cancer Research Grant IG10341 (Milan, Italy) (to D. C.), Telethon Italia Grant GGP030295, MIUR (Italy), the European Community Seventh Framework Programme FP7/2007-2013, Grants 202272 HEALTH-2007-2.1.1-6 (LipidomicNet) (to D. C.), and the Italian Ministry of Economy and Finance to the National Research Council (FaReBio di Qualita) (to D. C.).; Recipient of an Italian Foundation for Cancer Research Fellowship (Milan, Italy).	Absolom D R, 1986, Methods Enzymol, V132, P95; ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ADEREM AA, 1985, J EXP MED, V161, P617, DOI 10.1084/jem.161.3.617; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Casas J, 2010, J LIPID RES, V51, P388, DOI 10.1194/jlr.M001461; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; DIGIROLAMO M, 1991, ACTA ENDOCRINOL-COP, V125, P192, DOI 10.1530/acta.0.1250192; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Huang Z, 1996, BIOCHEMISTRY-US, V35, P3712, DOI 10.1021/bi952541k; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; Judson BL, 2009, BIOCHEM BIOPH RES CO, V389, P473, DOI 10.1016/j.bbrc.2009.08.173; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; May RC, 2001, J CELL SCI, V114, P1061; Mosiman VL, 1997, CYTOMETRY, V30, P151; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Noor S, 2008, J BIOL CHEM, V283, P4744, DOI 10.1074/jbc.M709956200; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stewart C C, 1986, Methods Enzymol, V132, P183; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; TUIJNMAN WB, 1992, BLOOD, V79, P1651; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Uozumi N, 2002, PROSTAG OTH LIPID M, V68-9, P59, DOI 10.1016/S0090-6980(02)00021-7; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622	59	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16849	16859		10.1074/jbc.M111.309419	http://dx.doi.org/10.1074/jbc.M111.309419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22393044	Green Published, hybrid			2022-12-25	WOS:000304030900071
J	Han, XB; Li, X; Yue, SC; Anandaiah, A; Hashem, F; Reinach, PS; Koziel, H; Tachado, SD				Han, Xinbing; Li, Xin; Yue, Simon C.; Anandaiah, Asha; Hashem, Falah; Reinach, Peter S.; Koziel, Henry; Tachado, Souvenir D.			Epigenetic Regulation of Tumor Necrosis Factor alpha (TNF alpha) Release in Human Macrophages by HIV-1 Single-stranded RNA (ssRNA) Is Dependent on TLR8 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; HISTONE H3; ALVEOLAR MACROPHAGES; ACETYLATION; ACTIVATION; RECOGNITION; TRANSCRIPTION; METHYLATION; EXPRESSION; INFECTION	Human macrophages at mucosal sites are essential targets for acute HIV infection. During the chronic phase of infection, they are persistent reservoirs for the AIDS virus. HIV virions gain entry into macrophages following ligation of surface CD4-CCR5 co-receptors, which leads to the release of two copies of HIV ssRNA. These events lead to reverse transcription and viral replication initiation. Toll-like receptors TLR7 and TLR8 recognize specific intracellular viral ssRNA sequences, but in human alveolar macrophages, their individual roles in TLR-mediated HIV ssRNA recognition are unclear. In the current study, HIV-1 ssRNA induced TNF alpha release in a dose-dependent manner in adherent human macrophages expressing both intracellular TLR7 and TLR8. This response was reduced by inhibiting either endocytosis (50 mu M dynasore) or endosomal acidification (1 mu g/ml chloroquine). Either MYD88 or TLR8 gene knockdown with relevant siRNA reduced HIV-1 ssRNA-mediated TNF alpha release, but silencing TLR7 had no effect on this response. Furthermore, HIV-1 ssRNA induced histone 4 acetylation at the TNF alpha promoter as well as trimethylation of histone 3 at lysine 4, whereas TLR8 gene knockdown reduced these effects. Taken together in human macrophages, TLR8 binds and internalizes HIV ssRNA, leading to endosomal acidification, chromatin remodeling, and increases in TNF alpha release. Drugs targeting macrophage TLR8-linked signaling pathways may modulate the innate immune response to acute HIV infection by reducing viral replication.	[Han, Xinbing; Li, Xin; Yue, Simon C.; Anandaiah, Asha; Hashem, Falah; Koziel, Henry; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA; [Han, Xinbing; Li, Xin; Yue, Simon C.; Anandaiah, Asha; Hashem, Falah; Koziel, Henry; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Reinach, Peter S.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; State University of New York (SUNY) System; SUNY Optometry	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, 330 Brookline Ave,Dana Bldg,Rm 652, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu	Reinach, Peter/AAI-3582-2021	Tachado, Souvenir/0000-0002-8368-6102	National Institutes of Health [R01-HL092811, R01-HL063655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811, R01HL063655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL092811 (to S. D. T.) and R01-HL063655 (to H. K.). A preliminary account of this study was presented in part at the American Thoracic Society International Meeting, May 13-18, 2011, Denver, CO.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chang JJ, 2012, AIDS, V26, P533, DOI 10.1097/QAD.0b013e32834f3167; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lee JY, 2003, J LEUKOCYTE BIOL, V73, P862, DOI 10.1189/jlb.1202618; Leng J, 2009, PARASITE IMMUNOL, V31, P717, DOI 10.1111/j.1365-3024.2009.01122.x; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li X, 2011, J IMMUNOL, V187, P6052, DOI 10.4049/jimmunol.1101532; Lyn-Kew K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011145; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Muegge K, 2002, NAT IMMUNOL, V3, P16, DOI 10.1038/ni0102-16; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Park IW, 1999, AM J RESP CELL MOL, V20, P864, DOI 10.1165/ajrcmb.20.5.3547; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Saruta M, 2009, EUR J IMMUNOL, V39, P2195, DOI 10.1002/eji.200939216; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tsaprouni LG, 2007, CLIN EXP IMMUNOL, V150, P151, DOI 10.1111/j.1365-2249.2007.03484.x	39	39	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13778	13786		10.1074/jbc.M112.342683	http://dx.doi.org/10.1074/jbc.M112.342683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393042	Green Published, hybrid			2022-12-25	WOS:000303996300033
J	Oliver, KM; Lenihan, CR; Bruning, U; Cheong, A; Laffey, JG; McLoughlin, P; Taylor, CT; Cummins, EP				Oliver, Kathryn M.; Lenihan, Colin R.; Bruning, Ulrike; Cheong, Alex; Laffey, John G.; McLoughlin, Paul; Taylor, Cormac T.; Cummins, Eoin P.			Hypercapnia Induces Cleavage and Nuclear Localization of RelB Protein, Giving Insight into CO2 Sensing and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; NITRIC-OXIDE; ACIDOSIS; INFLAMMATION; CELLS; PH; DEGRADATION; VENTILATION	Carbon dioxide (CO2) is increasingly being appreciated as an intracellular signaling molecule that affects inflammatory and immune responses. Elevated arterial CO2 (hypercapnia) is encountered in a range of clinical conditions, including chronic obstructive pulmonary disease, and as a consequence of therapeutic ventilation in acute respiratory distress syndrome. In patients suffering from this syndrome, therapeutic hypoventilation strategy designed to reduce mechanical damage to the lungs is accompanied by systemic hypercapnia and associated acidosis, which are associated with improved patient outcome. However, the molecular mechanisms underlying the beneficial effects of hypercapnia and the relative contribution of elevated CO2 or associated acidosis to this response remain poorly understood. Recently, a role for the noncanonical NF-kappa B pathway has been postulated to be important in signaling the cellular transcriptional response to CO2. In this study, we demonstrate that in cells exposed to elevated CO2, the NF-kappa B family member RelB was cleaved to a lower molecular weight form and translocated to the nucleus in both mouse embryonic fibroblasts and human pulmonary epithelial cells (A549). Furthermore, elevated nuclear RelB was observed in vivo and correlated with hypercapnia-induced protection against LPS-induced lung injury. Hypercapnia-induced RelB processing was sensitive to proteasomal inhibition by MG-132 but was independent of the activity of glycogen synthase kinase 3 beta or MALT-1, both of which have been previously shown to mediate RelB processing. Taken together, these data demonstrate that RelB is a CO2-sensitive NF-kappa B family member that may contribute to the beneficial effects of hypercapnia in inflammatory diseases of the lung.	[Oliver, Kathryn M.; Lenihan, Colin R.; Bruning, Ulrike; Cheong, Alex; McLoughlin, Paul; Taylor, Cormac T.; Cummins, Eoin P.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Cheong, Alex; Taylor, Cormac T.] Natl Univ Ireland Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Laffey, John G.] Natl Univ Ireland, Sch Med, Galway, Ireland	University College Dublin; University College Dublin; Ollscoil na Gaillimhe-University of Galway	Taylor, CT (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.	cormac.taylor@ucd.ie	Cheong, Alex/E-5049-2011; Cummins, Eoin/S-7554-2019	Cheong, Alex/0000-0003-2482-9078; Cummins, Eoin/0000-0002-9346-8299; McLoughlin, Paul/0000-0001-6200-016X; Taylor, Cormac/0000-0002-0946-1247; Laffey, John/0000-0002-1246-9573	Science Foundation of Ireland; Health Research Board of Ireland; Science Foundation Ireland Centres for Science Engineering and Technology	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board of Ireland; Science Foundation Ireland Centres for Science Engineering and Technology(Science Foundation Ireland)	This work was supported by a Science Foundation of Ireland grant (to C. T. T.), by a Health Research Board of Ireland clinical training fellowship (to J. G. L.), and by a Science Foundation Ireland Centres for Science Engineering and Technology grant (to Systems Biology Ireland).	Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Crummy F, 2007, RESP MED, V101, P53, DOI 10.1016/j.rmed.2006.04.013; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Curley G, 2010, CRIT CARE, V14, DOI 10.1186/cc8926; Curley G, 2010, ANESTHESIOLOGY, V112, P462, DOI 10.1097/ALN.0b013e3181ca361f; De Smet HR, 2007, J CRIT CARE, V22, P305, DOI 10.1016/j.jcrc.2006.12.002; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Heming TA, 2001, CLIN SCI, V101, P267, DOI 10.1042/CS20010139; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KNOWLES RG, 1992, TRENDS BIOCHEM SCI, V17, P399, DOI 10.1016/0968-0004(92)90008-W; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; LERNBECHER T, 1993, NATURE, V365, P767, DOI 10.1038/365767a0; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; O'Toole D, 2005, J CELL BIOCHEM, V96, P589, DOI 10.1002/jcb.20539; Peltekova V, 2010, INTENS CARE MED, V36, P869, DOI 10.1007/s00134-010-1787-7; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Shi Q, 2000, J INTERF CYTOK RES, V20, P1023, DOI 10.1089/10799900050198471; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; WEIH F, 1994, ONCOGENE, V9, P3289; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007	33	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14004	14011		10.1074/jbc.M112.347971	http://dx.doi.org/10.1074/jbc.M112.347971			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396550	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000303996300055
J	Talekar, A; Pessi, A; Glickman, F; Sengupta, U; Briese, T; Whitt, MA; Mathieu, C; Horvat, B; Moscona, A; Porotto, M				Talekar, Aparna; Pessi, Antonello; Glickman, Fraser; Sengupta, Uttara; Briese, Thomas; Whitt, Michael A.; Mathieu, Cyrille; Horvat, Branka; Moscona, Anne; Porotto, Matteo			Rapid Screening for Entry Inhibitors of Highly Pathogenic Viruses under Low-Level Biocontainment	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; NIPAH-VIRUS; HENDRA-VIRUS; PROTECTIVE EFFICACY; HAMSTER MODEL; INFECTION; VACCINE; IDENTIFICATION; IMMUNIZATION; BANGLADESH	Emerging viruses including Nipah, Hendra, Lujo, and Junin viruses have enormous potential to spread rapidly. Nipah virus, after emerging as a zoonosis, has also evolved the capacity for human-to-human transmission. Most of the diseases caused by these pathogens are untreatable and require high biocontainment conditions. Universal methods for rapidly identifying and screening candidate antivirals are urgently needed. We have developed a modular antiviral platform strategy that relies on simple bioinformatic and genetic information about each pathogen. Central to this platform is the use of envelope glycoprotein cDNAs to establish multi-cycle replication systems under BSL2 conditions for viral pathogens that normally require BSL3 and BSL4 facilities. We generated monoclonal antibodies against Nipah G by cDNA immunization in rats, and we showed that these antibodies neutralize both Nipah and Hendra live viruses. We then used these effective Henipavirus inhibitors to validate our screening strategy. Our proposed strategy should contribute to the response capability for emerging infectious diseases, providing a way to initiate antiviral development immediately upon identifying novel viruses.	[Talekar, Aparna; Sengupta, Uttara; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Talekar, Aparna; Sengupta, Uttara; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Microbiol, New York, NY 10021 USA; [Talekar, Aparna; Sengupta, Uttara; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Immunol, New York, NY 10021 USA; [Pessi, Antonello] PeptiPharma, Pomezia, Italy; [Glickman, Fraser] Rockefeller Univ, High Throughput Screening Resource Ctr, New York, NY 10021 USA; [Briese, Thomas] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA; [Whitt, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Horvat, Branka] Univ Lyon 1, BioSci Lyon Gerland Lyon Sud IFR128, F-69365 Lyon, France; [Mathieu, Cyrille; Horvat, Branka] Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France	Cornell University; Cornell University; Cornell University; Rockefeller University; Columbia University; University of Tennessee System; University of Tennessee Health Science Center; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Talekar, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA.	map2028@med.cornell.edu	Mathieu, Cyrille/A-1976-2015; Glickman, Joseph/H-3021-2013; Horvat, Branka/M-3504-2014; Mathieu, Cyrille/ABF-5074-2020; SenGupta, Uttara/ABF-7984-2021	Mathieu, Cyrille/0000-0002-6682-2029; Glickman, Joseph/0000-0002-6706-4039; Horvat, Branka/0000-0003-0578-7765; POROTTO, Matteo/0000-0003-3866-9220	Public Health Service from the National Institutes of Health (NIAID) [AI076335]; NIH (NIAID) Northeast Center of Excellence for Bio-defense and Emerging Infectious Disease Research [U54AI057158]; INSERM; Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076335, U54AI057158, R56AI076335] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health (NIAID); NIH (NIAID) Northeast Center of Excellence for Bio-defense and Emerging Infectious Disease Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI076335 from the National Institutes of Health (NIAID) to Dr. Moscona, NIH (NIAID) Northeast Center of Excellence for Bio-defense and Emerging Infectious Disease Research U54AI057158 grants to Dr. Moscona, Dr. Porotto and Dr. Briese (PI of Center of Excellence grant: Dr. Lipkin) and grants from INSERM and Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME) to Dr. Horvat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljofan M, 2008, J VIROL METHODS, V149, P12, DOI 10.1016/j.jviromet.2008.01.016; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Chen H, 2011, CLIN VACCINE IMMUNOL; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Drosten C, 2003, TRENDS MOL MED, V9, P325, DOI 10.1016/S1471-4914(03)00133-3; Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Guillaume V, 2006, J VIROL, V80, P1972, DOI 10.1128/JVI.80.4.1972-1978.2006; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Lagerqvist N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-6; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; Marzi A, 2011, J INFECT DIS, V204, pS1066, DOI 10.1093/infdis/jir348; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2007, J VIROL, V81, P10804, DOI 10.1128/JVI.00999-07; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Rahman MA, 2011, VECTOR BORNE ZOONOTI; Sejvar JJ, 2007, ANN NEUROL, V62, P235, DOI 10.1002/ana.21178; Talekar A, 2011, J VIROL, V85, P8422, DOI 10.1128/JVI.00452-11; Wang XJ, 2006, ANN NY ACAD SCI, V1081, P243, DOI 10.1196/annals.1373.029; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; Wong KT, 2010, ACTA NEUROPATHOL, V120, P317, DOI 10.1007/s00401-010-0720-z; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng LY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-17; Zhu ZY, 2006, J VIROL, V80, P891, DOI 10.1128/JVI.80.2.891-899.2006	39	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e30538	10.1371/journal.pone.0030538	http://dx.doi.org/10.1371/journal.pone.0030538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396728	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500003
J	Shen, CJ; Cheng, WTK; Wu, SC; Chen, HL; Tsai, TC; Yang, SH; Chen, CM				Shen, Chih-Jie; Cheng, Winston T. K.; Wu, Shinn-Chih; Chen, Hsiao-Ling; Tsai, Tung-Chou; Yang, Shang-Hsun; Chen, Chuan-Mu			Differential Differences in Methylation Status of Putative Imprinted Genes among Cloned Swine Genomes	PLOS ONE			English	Article							BECKWITH-WIEDEMANN SYNDROME; CELL NUCLEAR TRANSFER; FACTOR-II GENE; DNA METHYLATION; MAMMALIAN DEVELOPMENT; DONOR GENOME; SHEEP EMBRYO; MOUSE EMBRYO; MICE; GROWTH	DNA methylation is a major epigenetic modification in the mammalian genome that regulates crucial aspects of gene function. Mammalian cloning by somatic cell nuclear transfer (SCNT) often results in gestational or neonatal failure with only a small proportion of manipulated embryos producing live births. Many of the embryos that survive to term later succumb to a variety of abnormalities that are likely due to inappropriate epigenetic reprogramming. Aberrant methylation patterns of imprinted genes in cloned cattle and mice have been elucidated, but few reports have analyzed the cloned pig genome. Four surviving cloned sows that were created by ear fibroblast nuclear transfer, each with a different life span and multiple organ defects, such as heart defects and bone growth delay, were used as epigenetic study materials. First, we identified four putative differential methylation regions (DMR) of imprinted genes in the wild-type pig genome, including two maternally imprinted loci (INS and IGF2) and two paternally imprinted loci (H19 and IGF2R). Aberrant DNA methylation, either hypermethylation or hypomethylation, commonly appeared in H19 (45% of imprinted loci hypermethylated vs. 30% hypomethylated), IGF2 (40% vs. 0%), INS (50% vs. 5%), and IGF2R (15% vs. 45%) in multiple tissues from these four cloned sows compared with wild-type pigs. Our data suggest that aberrant epigenetic modifications occur frequently in the genome of cloned swine. Even with successful production of cloned swine that avoid prenatal or postnatal death, the perturbation of methylation in imprinted genes still exists, which may be one of reason for their adult pathologies and short life. Understanding the aberrant pattern of gene imprinting would permit improvements in future cloning techniques.	[Shen, Chih-Jie; Tsai, Tung-Chou; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Shen, Chih-Jie; Tsai, Tung-Chou; Chen, Chuan-Mu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Cheng, Winston T. K.; Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Cheng, Winston T. K.] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan; [Chen, Hsiao-Ling] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Yang, Shang-Hsun] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan	National Chung Hsing University; National Chung Hsing University; National Taiwan University; Tunghai University; Da Yeh University; National Cheng Kung University	Shen, CJ (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	chchen1@dragon.nchu.edu.tw	Chen, Chuan-Mu/K-7049-2013; Yang, Shang-Hsun/AAV-3763-2020	Chen, Chuan-Mu/0000-0003-2461-9150; SHEN, CHIH-JIE/0000-0001-7392-056X; Yang, Shang-Hsun/0000-0002-1601-3653; Wu, Shinn-Chih/0000-0001-8881-1550	National Science Council [NSC-96-2313-B-005-012, NSC-100-2313-B-005-028-MY3]; Ministry of Education, Taiwan, Republic of China under ATU	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China under ATU	This research was supported by grants NSC-96-2313-B-005-012 and NSC-100-2313-B-005-028-MY3 from the National Science Council and by the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Chen CM, 2003, AM J PATHOL, V163, P37, DOI 10.1016/S0002-9440(10)63628-0; Chen HL, 2008, VACCINE, V26, P891, DOI 10.1016/j.vaccine.2007.12.013; Chen HL, 2006, EMBO J, V25, P5329, DOI 10.1038/sj.emboj.7601399; Chen T, 2006, MOL REPROD DEV, V73, P313, DOI 10.1002/mrd.20421; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Deltour L, 2004, GENE EXPR PATTERNS, V5, P297, DOI 10.1016/j.modgep.2004.04.013; Enklaar Thorsten, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000020; Estecio MRH, 2006, ONCOGENE, V25, P5018, DOI 10.1038/sj.onc.1209509; Eyestone WH, 1999, J REPROD FERTIL, P489; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Horsthemke B, 2010, AM J MED GENET C, V154C, P321, DOI 10.1002/ajmg.c.30269; Hurst LD, 1997, TRENDS GENET, V13, P436, DOI 10.1016/S0168-9525(97)01273-0; Inoue Kimiko, 2002, Science (Washington D C), V295, P297, DOI 10.1126/science.295.5553.297; Kaneko-Ishino T, 2003, J BIOCHEM, V133, P699, DOI 10.1093/jb/mvg090; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kang YK, 2001, J BIOL CHEM, V276, P39980, DOI 10.1074/jbc.M106516200; LATHAM KE, 1994, DEVELOPMENT, V120, P3419; Lee DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012630; Lee JW, 2003, BIOL REPROD, V69, P995, DOI 10.1095/biolreprod.103.015917; Li C, 2008, ANIM BIOTECHNOL, V19, P22, DOI 10.1080/10495390701758563; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li Q, 1999, CLIN CANCER RES, V5, P1077; Lirussi F, 2007, AM J MED GENET A, V143A, P2796, DOI 10.1002/ajmg.a.31768; Lucifero D, 2004, HUM REPROD UPDATE, V10, P3, DOI 10.1093/humupd/dmh002; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Park MR, 2005, PROTEOMICS, V5, P1928, DOI 10.1002/pmic.200401079; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Polejaeva IA, 2001, J REP FER S, P293; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhind SM, 2003, NAT BIOTECHNOL, V21, P744, DOI 10.1038/nbt0703-744; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shi W, 2003, DIFFERENTIATION, V71, P91, DOI 10.1046/j.1432-0436.2003.710201.x; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tsai TC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-88; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Wei YC, 2010, CELL REPROGRAM, V12, P213, DOI 10.1089/cell.2009.0090; WILLISON K, 1991, TRENDS GENET, V7, P107, DOI 10.1016/0168-9525(91)90441-R; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu SC, 2007, J AGR FOOD CHEM, V55, P4670, DOI 10.1021/jf063759o; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yan PS, 2001, CANCER RES, V61, P8375; Yen CC, 2009, J INFECT DIS, V199, P590, DOI 10.1086/596212; Young LE, 2000, THERIOGENOLOGY, V53, P627, DOI 10.1016/S0093-691X(99)00263-0; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	62	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32812	10.1371/journal.pone.0032812	http://dx.doi.org/10.1371/journal.pone.0032812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393450	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500105
J	van der Peet, P; Ralton, JE; McConville, MJ; Williams, SJ				van der Peet, Phillip; Ralton, Julie E.; McConville, Malcolm J.; Williams, Spencer J.			Discovery of Inhibitors of Leishmania beta-1,2-Mannosyltransferases Using a Click-Chemistry-Derived Guanosine Monophosphate Library	PLOS ONE			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHETIC-PATHWAY; CHEMICAL SYNTHESIS; GLYCOSYLTRANSFERASE; MEXICANA; VIRULENCE; ANALOGS; DEOXYOLIGONUCLEOTIDES; GLYCOSYLATION; ACTIVATION; INSIGHT	Leishmania spp. are a medically important group of protozoan parasites that synthesize a novel intracellular carbohydrate reserve polymer termed mannogen. Mannogen is a soluble homopolymer of beta-1,2-linked mannose residues that accumulates in the major pathogenic stages in the sandfly vector and mammalian host. While several steps in mannogen biosynthesis have been defined, none of the enzymes have been isolated or characterized. We report the development of a simple assay for the GDP-mannose-dependent beta-1,2-mannosyltransferases involved in mannogen synthesis. This assay utilizes octyl alpha-D-mannopyranoside to prime the formation of short mannogen oligomers up to 5 mannose residues. This assay was used to screen a focussed library of 44 GMP-triazole adducts for inhibitors. Several compounds provided effective inhibition of mannogen beta-1,2-mannosyltransferases in a cell-free membrane preparation. This assay and inhibitor compounds will be useful for dissecting the role of different mannosyltransferases in regulating de novo biosynthesis and elongation reactions in mannogen metabolism.	[van der Peet, Phillip; Williams, Spencer J.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Ralton, Julie E.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	van der Peet, P (corresponding author), Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	malcolmm@unimelb.edu.au; sjwill@unimelb.edu.au	Williams, Spencer/C-3545-2009	Williams, Spencer/0000-0001-6341-4364	Australian Research Council; Australian National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the Australian Research Council and the Australian National Health and Medical Research Council for financial support. MJM is a National Health and Medical Research Council Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONE AD, 1984, NUCLEIC ACIDS RES, V12, P4051, DOI 10.1093/nar/12.10.4051; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Botte CY, 2011, NAT CHEM BIOL, V7, P834, DOI 10.1038/nchembio.658; CARUTHERS MH, 1987, METHOD ENZYMOL, V154, P287; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Compain P, 2003, CURR TOP MED CHEM, V3, P541, DOI 10.2174/1568026033452474; Crossman A, 2002, CARBOHYD RES, V337, P2049, DOI 10.1016/S0008-6215(02)00187-8; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Dinev Z, 2007, ORG BIOMOL CHEM, V5, P952, DOI 10.1039/b616450a; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Fiammengo R, 2005, J AM CHEM SOC, V127, P9271, DOI 10.1021/ja051179m; Funk VA, 1997, MOL BIOCHEM PARASIT, V84, P33, DOI 10.1016/S0166-6851(96)02780-6; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; GRYAZNOV SM, 1991, J AM CHEM SOC, V113, P5876, DOI 10.1021/ja00015a059; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Hayashi T, 1997, BIOORGAN MED CHEM, V5, P497, DOI 10.1016/S0968-0896(96)00263-5; Hilley JD, 2000, MOL BIOL CELL, V11, P1183, DOI 10.1091/mbc.11.4.1183; Hosoguchi K, 2010, J MED CHEM, V53, P5607, DOI 10.1021/jm100612r; Ilg T, 2001, J BIOL CHEM, V276, P4988, DOI 10.1074/jbc.M008030200; Izumi M, 2009, CURR TOP MED CHEM, V9, P87, DOI 10.2174/156802609787354351; KIERZEK R, 1986, NUCLEIC ACIDS RES, V14, P4751, DOI 10.1093/nar/14.12.4751; Kraszewski A, 1987, Nucleic Acids Symp Ser, P177; Lee KY, 2002, J BIOL CHEM, V277, P49341, DOI 10.1074/jbc.M209618200; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; LOWARY TL, 1994, CARBOHYD RES, V251, P33, DOI 10.1016/0008-6215(94)84275-2; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; NIELSEN J, 1986, NUCLEIC ACIDS RES, V14, P7391, DOI 10.1093/nar/14.18.7391; Ohkubo A, 2004, J AM CHEM SOC, V126, P10884, DOI 10.1021/ja048125h; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; Smith TK, 2000, BIOCHEMISTRY-US, V39, P11801, DOI 10.1021/bi000854w; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Urbaniak MD, 2008, ACS CHEM BIOL, V3, P625, DOI 10.1021/cb800143w; van der Peet P, 2006, CHEMBIOCHEM, V7, P1384, DOI 10.1002/cbic.200600159; Walker-Nasir E, 2007, CURR ORG CHEM, V11, P591, DOI 10.2174/138527207780598837; Watt JA, 2005, ORG BIOMOL CHEM, V3, P1982, DOI 10.1039/b503919c; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Zhu XF, 2000, J CHEM SOC PERK T 1, P2305, DOI 10.1039/b003562i	49	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32642	10.1371/journal.pone.0032642	http://dx.doi.org/10.1371/journal.pone.0032642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393429	Green Published, gold			2022-12-25	WOS:000303003500081
J	Heenan, CB; Seymour, RS				Heenan, Caragh B.; Seymour, Roger S.			The Effect of Wind on the Rate of Heat Loss from Avian Cup-Shaped Nests	PLOS ONE			English	Article							NESTLING CACTUS WRENS; SITE SELECTION; METABOLIC-RATE; TEMPERATURE REGULATION; RELATIVE IMPORTANCE; MICROCLIMATE; INCUBATION; ORIENTATION; SPARROW; DESIGN	Forced convection can significantly influence the heat loss from birds and their offspring but effects may be reduced by using sheltered micro-sites such as cavities or constructing nests. The structural and thermal properties of the nests of two species, the spiny-cheeked honeyeater (Acanthagenys rufogularis) and yellow-throated miner (Manorina flavigula), were measured in relation to three wind speeds. Nest dimensions differ between the two species, despite the similar body mass of the incubating adults, however nest conductance is comparable. As wind speed increases, so does the rate of heat loss from the nests of both species, and further still during incubation recesses. The significance of forced convection through the nest is a near-doubling in heat production required by the parent, even when incubating at relatively low wind speeds. This provides confirmation that selecting a sheltered nest site is important for avian reproductive success.	[Heenan, Caragh B.; Seymour, Roger S.] Univ Adelaide, Dept Ecol Evolut & Landscape Sci, Adelaide, SA, Australia	University of Adelaide	Heenan, CB (corresponding author), Univ Adelaide, Dept Ecol Evolut & Landscape Sci, Adelaide, SA, Australia.	caragh.heenan@adelaide.edu.au	Heenan, Caragh/C-8566-2013	Heenan, Caragh/0000-0002-5368-7606	University of Adelaide	University of Adelaide	The work was funded by the University of Adelaide postgraduate research student support scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby M, 2002, ENCY WEATHER CLIMATE; Ar A, 2002, OX ORN SER, V13, P143; AUSTIN GT, 1976, AUK, V93, P245; AUSTIN GT, 1974, CONDOR, V76, P216, DOI 10.2307/1366737; BAKKEN GS, 1990, AUK, V107, P587; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; BIEBACH H, 1986, PHYSIOL ZOOL, V59, P69, DOI 10.1086/physzool.59.1.30156092; Bradshaw P., 1964, PROG AEROSP SCI, V5, P1, DOI DOI 10.1016/0376-0421(64)90003-X; BUTTEMER WA, 1986, PHYSIOL ZOOL, V59, P131, DOI 10.1086/physzool.59.2.30156027; BUTTEMER WA, 1985, OECOLOGIA, V68, P126, DOI 10.1007/BF00379484; Cahill JRA, 2008, WILSON J ORNITHOL, V120, P545, DOI 10.1676/07-066.1; CALDER W A, 1973, Ecology (Washington D C), V54, P127, DOI 10.2307/1934381; Calder W.A., 1974, AVIAN BIOL, V4, P259; Carey C, 2002, OX ORN SER, V13, P238; CONNER RN, 1975, AUK, V92, P371, DOI 10.2307/4084566; Cooper SJ, 1999, CONDOR, V101, P863, DOI 10.2307/1370077; D'Alba L, 2009, J THERM BIOL, V34, P93, DOI 10.1016/j.jtherbio.2008.11.005; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Eikenaar C, 2003, J AVIAN BIOL, V34, P419, DOI 10.1111/j.0908-8857.2003.03147.x; GOLDSTEIN DL, 1983, PHYSIOL ZOOL, V56, P485, DOI 10.1086/physzool.56.4.30155871; HADLEY N F, 1969, Arctic and Alpine Research, V1, P121, DOI 10.2307/1550018; HAGGERTY TM, 1995, SOUTHWEST NAT, V40, P62; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Heenan C. B., EFFECT WATER S UNPUB; Heenan CB, 2011, P ROY SOC B-BIOL SCI, V278, P2924, DOI 10.1098/rspb.2010.2798; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; INOUYE RS, 1981, CONDOR, V83, P88, DOI 10.2307/1367613; KERN MD, 1984, CONDOR, V86, P455, DOI 10.2307/1366826; KERN MD, 1993, J FIELD ORNITHOL, V64, P367; Kim SY, 2005, J ORNITHOL, V146, P176, DOI 10.1007/s10336-005-0077-6; Kristjansson TO, 2011, POLAR BIOL, V34, P985, DOI 10.1007/s00300-010-0956-z; Long AM, 2009, CONDOR, V111, P395, DOI 10.1525/cond.2009.080076; Lundy H., 1969, FERTILITY HATCHABILI, P143; Marchant S., 1990, P1; MAYER L, 1982, INT J BIOMETEOROL, V26, P231, DOI 10.1007/BF02184939; MEHTA RD, 1979, AERONAUT J, V83, P443; MITCHELL JW, 1976, BIOPHYS J, V16, P561, DOI 10.1016/S0006-3495(76)85711-6; MITCHELL MA, 1985, BRIT POULTRY SCI, V26, P413, DOI 10.1080/00071668508416830; MOLLER AP, 1991, ORNIS SCAND, V22, P396, DOI 10.2307/3676514; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; ORR Y, 1970, CONDOR, V72, P476, DOI 10.2307/1366401; Palmgren M., 1939, Ornis Fennica Helsingfors, V16, P1; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Pinowski J, 2006, J THERM BIOL, V31, P573, DOI 10.1016/j.jtherbio.2006.05.007; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Reid JM, 2002, OX ORN SER, V13, P314; RELLER AW, 1972, AM MIDL NAT, V88, P270, DOI 10.2307/2424354; RICKLEFS RE, 1969, CONDOR, V71, P32, DOI 10.2307/1366045; RICKLEFS RE, 1968, CONDOR, V70, P121, DOI 10.2307/1365955; Southwick E.E., 1975, Ecological Stud, V12, P417; Tieleman BI, 2008, CONDOR, V110, P116, DOI 10.1525/cond.2008.110.1.116; TRACY CR, 1972, BIOSCIENCE, V22, P656, DOI 10.2307/1296267; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Wachob DG, 1996, J FIELD ORNITHOL, V67, P525; Walsberg G.E., 1985, P389; WALSBERG GE, 1986, AUK, V103, P1; WEBB DR, 1983, PHYSIOL ZOOL, V56, P493, DOI 10.1086/physzool.56.4.30155872; WEBB DR, 1983, J THERM BIOL, V8, P301, DOI 10.1016/0306-4565(83)90013-X; WEBB DR, 1993, J THERM BIOL, V18, P117, DOI 10.1016/0306-4565(93)90024-N; WEBSTER MD, 1988, PHYSIOL ZOOL, V61, P543, DOI 10.1086/physzool.61.6.30156163; WITH KA, 1993, CONDOR, V95, P401, DOI 10.2307/1369363; Wolf BO, 1996, ECOLOGY, V77, P2228, DOI 10.2307/2265716	63	32	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32252	10.1371/journal.pone.0032252	http://dx.doi.org/10.1371/journal.pone.0032252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389689	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600027
J	Li, S; Hao, BX; Lu, YY; Yu, PL; Lee, HC; Yue, JB				Li, Sen; Hao, Baixia; Lu, Yingying; Yu, Peilin; Lee, Hon-Cheung; Yue, Jianbo			Intracellular Alkalinization Induces Cytosolic Ca2+ Increases by Inhibiting Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA)	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PANCREATIC ACINAR-CELLS; CALCIUM-PUMP; SARCOPLASMIC-RETICULUM; NA+/H+ EXCHANGER; EXTRACELLULAR PH; LEAK CHANNELS; FERTILIZATION; STORES; ENTRY	Intracellular pH (pHi) and Ca2+ regulate essentially all aspects of cellular activities. Their inter-relationship has not been mechanistically explored. In this study, we used bases and acetic acid to manipulate the pHi. We found that transient pHi rise induced by both organic and inorganic bases, but not acidification induced by acid, produced elevation of cytosolic Ca2+. The sources of the Ca2+ increase are from the endoplasmic reticulum (ER) Ca2+ pools as well as from Ca2+ influx. The store-mobilization component of the Ca2+ increase induced by the pHi rise was not sensitive to antagonists for either IP3-receptors or ryanodine receptors, but was due to inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to depletion of the ER Ca2+ store. We further showed that the physiological consequence of depletion of the ER Ca2+ store by pHi rise is the activation of store-operated channels (SOCs) of Orai1 and Stim1, leading to increased Ca2+ influx. Taken together, our results indicate that intracellular alkalinization inhibits SERCA activity, similar to thapsigargin, thereby resulting in Ca2+ leak from ER pools followed by Ca2+ influx via SOCs.	[Li, Sen; Hao, Baixia; Lu, Yingying; Yu, Peilin; Lee, Hon-Cheung; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, S (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	Hao, Helen Baixia/0000-0002-5648-3705; Li, Sen/0000-0003-4496-5050; Lu, Yingying/0000-0002-5423-9522; Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC from Hong Kong [N_HKU 737/09]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC from Hong Kong; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants (HKU 784710M, HKU 782709M, HKU 785911M), a National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong (N_HKU 737/09), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (Dr. Yue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso A, 2000, BRIT J PHARMACOL, V130, P1809, DOI 10.1038/sj.bjp.0703490; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; Austin C, 1996, BIOCHEM BIOPH RES CO, V222, P537, DOI 10.1006/bbrc.1996.0779; Cabado AG, 2000, CELL SIGNAL, V12, P573, DOI 10.1016/S0898-6568(00)00101-7; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; COHEN PG, 1984, MED HYPOTHESES, V15, P135, DOI 10.1016/0306-9877(84)90118-X; Crepin A, 2007, BIOCHEM J, V401, P49, DOI 10.1042/BJ20060870; DANTHULURI NR, 1990, J BIOL CHEM, V265, P19071; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Epel D., 1978, Current Topics in Developmental Biology, V12, P185, DOI 10.1016/S0070-2153(08)60597-9; Epel D, 1978, Birth Defects Orig Artic Ser, V14, P377; Fujita F, 2008, J CLIN INVESTIGATION; Heppner TJ, 2002, AM J PHYSIOL-HEART C, V283, pH2169, DOI 10.1152/ajpheart.00603.2002; Jadot M, 2001, EUR J BIOCHEM, V268, P1392, DOI 10.1046/j.1432-1327.2001.02006.x; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kargacin GJ, 2005, PFLUG ARCH EUR J PHY, V449, P356, DOI 10.1007/s00424-004-1345-7; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; KLOCKNER U, 1994, J GEN PHYSIOL, V103, P647, DOI 10.1085/jgp.103.4.647; Lajas AI, 2001, CELL SIGNAL, V13, P451, DOI 10.1016/S0898-6568(01)00161-9; Lang S, 2011, CHANNELS, V5, P228, DOI 10.4161/chan.5.3.15314; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Leffler CW, 1999, AM J PHYSIOL-HEART C, V277, pH1878, DOI 10.1152/ajpheart.1999.277.5.H1878; LYALL V, 1994, AM J PHYSIOL, V266, pF685, DOI 10.1152/ajprenal.1994.266.5.F685; Marumo M, 2001, THROMB RES, V104, P353, DOI 10.1016/S0049-3848(01)00374-7; Mogyoros I, 1997, BRAIN, V120, P317, DOI 10.1093/brain/120.2.317; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nitschke R, 1996, PFLUG ARCH EUR J PHY, V433, P98, DOI 10.1007/s004240050254; NUCCITELLI R, 1981, P NATL ACAD SCI-BIOL, V78, P4421, DOI 10.1073/pnas.78.7.4421; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Poteser M, 2003, CIRC RES, V92, P888, DOI 10.1161/01.RES.0000069216.80612.66; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Speake T, 1998, J PHYSIOL-LONDON, V506, P415, DOI 10.1111/j.1469-7793.1998.415bw.x; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srinivas SP, 2002, INVEST OPHTH VIS SCI, V43, P2341; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Tengholm A, 2000, CELL CALCIUM, V27, P43, DOI 10.1054/ceca.1999.0087; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; TSUKIOKA M, 1994, J PHYSIOL-LONDON, V475, P369, DOI 10.1113/jphysiol.1994.sp020078; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wakabayashi I, 2006, J VASC RES, V43, P238, DOI 10.1159/000091235; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767	52	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31905	10.1371/journal.pone.0031905	http://dx.doi.org/10.1371/journal.pone.0031905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384096	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500045
J	Sainz, J; Lupianez, CB; Segura-Catena, J; Vazquez, L; Rios, R; Oyonarte, S; Hemminki, K; Forsti, A; Jurado, M				Sainz, Juan; Belen Lupianez, Carmen; Segura-Catena, Juana; Vazquez, Lourdes; Rios, Rafael; Oyonarte, Salvador; Hemminki, Kari; Forsti, Asta; Jurado, Manuel			Dectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BETA-GLUCAN RECEPTOR; MULTIFACTOR DIMENSIONALITY REDUCTION; VIRUS TYPE-1 INFECTION; GENE-GENE INTERACTIONS; PROMOTER POLYMORPHISM; DENDRITIC CELLS; FUMIGATUS CONIDIA; IMMUNE-RESPONSES; MCP-1 EXPRESSION	The recognition of pathogen-derived structures by C-type lectins and the chemotactic activity mediated by the CCL2/CCR2 axis are critical steps in determining the host immune response to fungi. The present study was designed to investigate whether the presence of single nucleotide polymorphisms (SNPs) within DC-SIGN, Dectin-1, Dectin-2, CCL2 and CCR2 genes influence the risk of developing Invasive Pulmonary Aspergillosis (IPA). Twenty-seven SNPs were selected using a hybrid functional/tagging approach and genotyped in 182 haematological patients, fifty-seven of them diagnosed with proven or probable IPA according to the 2008 EORTC/MSG criteria. Association analysis revealed that carriers of the Dectin-1(rs3901533) (T/T) and Dectin-1(rs7309123) (G/G) genotypes and DC-SIGN(rs4804800) (G), DC-SIGN(rs11465384) T, DC-SIGN(7248637 A) and DC-SIGN(7252229) (C) alleles had a significantly increased risk of IPA infection (OR = 5.59 95% CI 1.37-22.77; OR = 4.91 95% CI 1.52-15.89; OR = 2.75 95% CI 1.27-5.95; OR = 2.70 95% CI 1.24-5.90; OR = 2.39 95% CI 1.09-5.22 and OR = 2.05 95% CI 1.00-4.22, respectively). There was also a significantly increased frequency of galactomannan positivity among patients carrying the Dectin-1(rs3901533_T) allele and Dectin-1(rs7309123_G/G) genotype. In addition, healthy individuals with this latter genotype showed a significantly decreased level of Dectin-1 mRNA expression compared to C-allele carriers, suggesting a role of the Dectin-1(rs7309123) polymorphism in determining the levels of Dectin-1 and, consequently, the level of susceptibility to IPA infection. SNP-SNP interaction (epistasis) analysis revealed significant interactions models including SNPs in Dectin-1, Dectin-2, CCL2 and CCR2 genes, with synergistic genetic effects. Although these results need to be further validated in larger cohorts, they suggest that Dectin-1, DC-SIGN, Dectin-2, CCL2 and CCR2 genetic variants influence the risk of IPA infection and might be useful in developing a risk-adapted prophylaxis.	[Sainz, Juan; Belen Lupianez, Carmen; Segura-Catena, Juana; Rios, Rafael; Jurado, Manuel] Genyo Pfizer Univ Granada Andalusian Govt Ctr Gen, Genom Oncol Area, Granada, Spain; [Sainz, Juan; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Mol Genet Epidemiol Dept, D-6900 Heidelberg, Germany; [Sainz, Juan; Belen Lupianez, Carmen; Segura-Catena, Juana; Rios, Rafael; Jurado, Manuel] Univ Hosp Virgen de las Nieves, Dept Haematol, Granada, Spain; [Vazquez, Lourdes] Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain; [Oyonarte, Salvador] Blood Transfus Reg Ctr, Granada, Spain; [Oyonarte, Salvador] Sectorial Tissue Bank, Granada, Spain; [Hemminki, Kari; Forsti, Asta] Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Pfizer; University of Granada; Helmholtz Association; German Cancer Research Center (DKFZ); Hospital Universitario Virgen de las Nieves; University of Salamanca	Sainz, J (corresponding author), Genyo Pfizer Univ Granada Andalusian Govt Ctr Gen, Genom Oncol Area, Granada, Spain.	juan.sainz@genyo.es	Rios-Tamayo, Rafael/AAA-3204-2019; Segura-Catena, Juana/G-1242-2016; Juan, Sainz/Y-6473-2019; VAZQUEZ, LOURDES/A-2839-2019	Segura-Catena, Juana/0000-0002-1190-0368; Juan, Sainz/0000-0002-9355-2423; Oyonarte, Salvador/0000-0002-5888-430X; VAZQUEZ, LOURDES/0000-0001-8191-0046	Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain) [P08-CVI-4116]; Fondo de Investigaciones Sanitarias (Madrid, Spain) [PI081051]	Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain); Fondo de Investigaciones Sanitarias (Madrid, Spain)	This study was supported by grants P08-CVI-4116 from Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain) and PI081051 from Fondo de Investigaciones Sanitarias (Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Asakura Y, 2009, NEW ENGL J MED, P360; Asakura Y, 2009, NEW ENGL J MED, V360, P635; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; Chan KYK, 2010, HUM IMMUNOL, V71, P702, DOI 10.1016/j.humimm.2010.03.006; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; de Boer MGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018403; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; den Dunnen J, 2009, CANCER IMMUNOL IMMUN, V58, P1149, DOI 10.1007/s00262-008-0615-1; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganachari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008881; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Kashima S, 2009, J GEN VIROL, V90, P927, DOI 10.1099/vir.0.008367-0; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Maertens J, 2002, J INFECT DIS, V186, P1297, DOI 10.1086/343804; Maertens J, 2004, BRIT J HAEMATOL, V126, P852, DOI 10.1111/j.1365-2141.2004.05140.x; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Mezger M, 2008, BLOOD, V111, P534, DOI 10.1182/blood-2007-05-090928; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Ok M, 2011, INT J MED MICROBIOL, V301, P445, DOI 10.1016/j.ijmm.2011.04.013; Park BL, 2006, EXP MOL MED, V38, P694, DOI 10.1038/emm.2006.82; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Ryan EJ, 2010, HUM IMMUNOL, V71, P829, DOI 10.1016/j.humimm.2010.05.007; Saijo S, 2011, INT IMMUNOL; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Sainz J, 2010, Methods Find Exp Clin Pharmacol, V32 Suppl A, P9; Sainz J, 2010, INT J IMMUNOPATH PH, V23, P423, DOI 10.1177/039463201002300205; Sainz J, 2007, HUM IMMUNOL, V68, P41, DOI 10.1016/j.humimm.2006.10.011; Sainz J, 2007, IMMUNOL LETT, V109, P76, DOI 10.1016/j.imlet.2007.01.005; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Seo KW, 2005, BONE MARROW TRANSPL, V36, P1089, DOI 10.1038/sj.bmt.1705181; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Vannberg FO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001388; Werner JL, 2011, INFECT IMMUN; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zaas AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000101	64	101	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32273	10.1371/journal.pone.0032273	http://dx.doi.org/10.1371/journal.pone.0032273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384201	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500071
J	Baselga, A; Gomez-Rodriguez, C; Lobo, JM				Baselga, Andres; Gomez-Rodriguez, Carola; Lobo, Jorge M.			Historical Legacies in World Amphibian Diversity Revealed by the Turnover and Nestedness Components of Beta Diversity	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; LATITUDINAL GRADIENTS; NICHE CONSERVATISM; CLIMATE-CHANGE; SCALE; EVOLUTIONARY; ENERGY; WATER; ENDEMISM	Historic processes are expected to influence present diversity patterns in combination with contemporary environmental factors. We hypothesise that the joint use of beta diversity partitioning methods and a threshold-based approach may help reveal the effect of large-scale historic processes on present biodiversity. We partitioned intra-regional beta diversity into its turnover (differences in composition caused by species replacements) and nestedness-resultant (differences in species composition caused by species losses) components. We used piecewise regressions to show that, for amphibian beta diversity, two different world regions can be distinguished. Below parallel 37, beta diversity is dominated by turnover, while above parallel 37, beta diversity is dominated by nestedness. Notably, these regions are revealed when the piecewise regression method is applied to the relationship between latitude and the difference between the Last Glacial Maximum (LGM) and the present temperature but not when present energy-water factors are analysed. When this threshold effect of historic climatic change is partialled out, current energy-water variables become more relevant to the nestedness-resultant dissimilarity patterns, while mountainous areas are associated with higher spatial turnover. This result suggests that nested patterns are caused by species losses that are determined by physiological constraints, whereas turnover is associated with speciation and/or Pleistocene refugia. Thus, the new threshold-based view may help reveal the role of historic factors in shaping present amphibian beta diversity patterns.	[Baselga, Andres; Gomez-Rodriguez, Carola] Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela, Spain; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Baselga, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela, Spain.	andres.baselga@usc.es	Lobo, Jorge M/E-2309-2013; Gómez-Rodríguez, Carola/B-6823-2016; Baselga, Andres/A-6740-2008	Lobo, Jorge M/0000-0002-3152-4769; Gómez-Rodríguez, Carola/0000-0002-2019-7176; Baselga, Andres/0000-0001-7914-7109	Spanish Ministry of Science and Innovation [CGL2009-10111]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	AB is funded by the Spanish Ministry of Science and Innovation (grant CGL2009-10111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Baselga A, 2012, GLOBAL ECOL IN PRESS; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Clark Labs, 2000, GLOB CHANG DAT ARCH, V3; Crawley MJ., 2007, R BOOK; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Dutilleul P, 1993, BIOMETRICS, V6, P46; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Ehlers J, 2004, EXTENT CHRONOLOGY GL, V2; Ehlers J, 2004, EXTENT CHRONOLOGY GL, V3; Ehlers J, 2004, EXTENT CHRONOLOGY GL, V1; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, ECOL ENTOMOL, V28, P678, DOI 10.1111/j.1365-2311.2003.00551.x; Hawkins BA, 2003, GLOBAL ECOL BIOGEOGR, V12, P475, DOI 10.1046/j.1466-822X.2003.00060.x; Hawkins BA, 2010, J BIOGEOGR, V37, P647, DOI 10.1111/j.1365-2699.2009.02250.x; Heaney LR, 2005, J BIOGEOGR, V32, P229, DOI 10.1111/j.1365-2699.2004.01120.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; IUCN, 2014, IUCN RED LIST THREAT; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Kerr JT, 1999, ECOSCIENCE, V6, P329, DOI 10.1080/11956860.1999.11682546; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Latham Roger Earl, 1993, P294; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.0906-7590.2007.04873.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2010, ECOL RES, V25, P629, DOI 10.1007/s11284-010-0695-1; R Development Core Team, 2009, R FDN STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 1999, OIKOS, V86, P369, DOI 10.2307/3546454; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; Sastre P, 2009, J BIOGEOGR, V36, P568, DOI 10.1111/j.1365-2699.2008.02070.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Tello JS, 2012, GLOBAL ECOL BIOGEOGR, V21, P212, DOI 10.1111/j.1466-8238.2011.00661.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Wiens JJ, 2007, AM NAT, V170, pS86, DOI 10.1086/519396; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Zobel M, 2011, GLOBAL ECOL BIOGEOGR, V20, P251, DOI 10.1111/j.1466-8238.2010.00593.x	63	106	108	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32341	10.1371/journal.pone.0032341	http://dx.doi.org/10.1371/journal.pone.0032341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384222	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100070
J	Delaney, JT; Jeff, JM; Brown, NJ; Pretorius, M; Okafor, HE; Darbar, D; Roden, DM; Crawford, DC				Delaney, Jessica T.; Jeff, Janina M.; Brown, Nancy J.; Pretorius, Mias; Okafor, Henry E.; Darbar, Dawood; Roden, Dan M.; Crawford, Dana C.			Characterization of Genome-Wide Association-Identified Variants for Atrial Fibrillation in African Americans	PLOS ONE			English	Article							SAMPLE-SIZE REQUIREMENTS; BREAST-CANCER RISK; ATHEROSCLEROSIS RISK; EUROPEAN ANCESTRY; GENETIC ANCESTRY; UNITED-STATES; POPULATION; PREVALENCE; SUSCEPTIBILITY; DISEASE	Background: Despite a greater burden of risk factors, atrial fibrillation (AF) is less common among African Americans than European-descent populations. Genome-wide association studies (GWAS) for AF in European-descent populations have identified three predominant genomic regions associated with increased risk (1q21, 4q25, and 16q22). The contribution of these loci to AF risk in African American is unknown. Methodology/Principal Findings: We studied 73 African Americans with AF from the Vanderbilt-Meharry AF registry and 71 African American controls, with no history of AF including after cardiac surgery. Tests of association were performed for 148 SNPs across the three regions associated with AF, and 22 SNPs were significantly associated with AF (P<0.05). The SNPs with the strongest associations in African Americans were both different from the index SNPs identified in European-descent populations and independent from the index European-descent population SNPs (r(2)<0.40 in HapMap CEU): 1q21 rs4845396 (odds ratio [OR] 0.30, 95% confidence interval [CI] 0.13-0.67, P = 0.003), 4q25 rs4631108 (OR 3.43, 95% CI 1.59-7.42, P = 0.002), and 16q22 rs16971547 (OR 8.1, 95% CI 1.46-45.4, P = 0.016). Estimates of European ancestry were similar among cases (23.6%) and controls (23.8%). Accordingly, the probability of having two copies of the European derived chromosomes at each region did not differ between cases and controls. Conclusions/Significance: Variable European admixture at known AF loci does not explain decreased AF susceptibility in African Americans. These data support the role of 1q21, 4q25, and 16q22 variants in AF risk for African Americans, although the index SNPs differ from those identified in European-descent populations.	[Delaney, Jessica T.; Brown, Nancy J.; Darbar, Dawood; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Jeff, Janina M.; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Jeff, Janina M.; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Brown, Nancy J.; Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Pretorius, Mias] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN USA; [Okafor, Henry E.] Meharry Med Coll, Dept Med, Nashville, TN 37208 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Meharry Medical College	Delaney, JT (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA.	dana.crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/C-1054-2012; Crawford, Dana/O-5578-2019; Roden, Dan/ABD-5412-2021; Darbar, Dawood/C-9079-2015	Crawford, Dana/0000-0002-6437-6248; Darbar, Dawood/0000-0002-4103-5977; Pretorius, Mias/0000-0002-8777-3940	National Institutes of Health Pharmacogenetics Research Network [U01 HL65962, U01 HL92217]; NIH [GM007569, R01 HL092217]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092217, U01HL065962, U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, T32GM080178, T32GM007569] Funding Source: NIH RePORTER	National Institutes of Health Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health Pharmacogenetics Research Network (U01 HL65962 and U01 HL92217), NIH training grant (GM007569), NIH grant R01 HL092217, and an American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Bock CH, 2009, HUM GENET, V126, P637, DOI 10.1007/s00439-009-0712-z; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng CY, 2010, OBESITY, V18, P563, DOI 10.1038/oby.2009.282; Cheng CY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000490; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Darbar D, 2007, HEART RHYTHM, V4, P743, DOI 10.1016/j.hrthm.2007.02.006; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fejerman L, 2009, CANCER EPIDEM BIOMAR, V18, P3110, DOI 10.1158/1055-9965.EPI-09-0464; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Hughes LB, 2008, ARTHRITIS RHEUM-US, V58, P349, DOI 10.1002/art.23166; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Keebler ME, 2010, CIRC-CARDIOVASC GENE, V3, P358, DOI 10.1161/CIRCGENETICS.109.914267; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; LaRosa JC, 2005, AM J MED, V118, P1314, DOI 10.1016/j.amjmed.2005.04.041; Li C, 2011, HUM GENET, V129, P239, DOI 10.1007/s00439-010-0912-6; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; Milan DJ, 2010, HEART RHYTHM, V7, P1141, DOI 10.1016/j.hrthm.2010.04.021; Motsinger Alison A, 2006, Pac Symp Biocomput, P584, DOI 10.1142/9789812701626_0054; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Postma AV, 2011, CARDIOVASC RES, V91, P243, DOI 10.1093/cvr/cvr134; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Ruiz-Narvaez EA, 2010, HUM GENET, V127, P629, DOI 10.1007/s00439-010-0803-x; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Rybicki BA, 2002, HUM HERED, V53, P187, DOI 10.1159/000066193; Tsai CT, 2008, HEART RHYTHM, V5, P1285, DOI 10.1016/j.hrthm.2008.05.012; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	50	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32338	10.1371/journal.pone.0032338	http://dx.doi.org/10.1371/journal.pone.0032338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384221	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100069
J	Paraschiv-Ionescu, A; Perruchoud, C; Buchser, E; Aminian, K				Paraschiv-Ionescu, Anisoara; Perruchoud, Christophe; Buchser, Eric; Aminian, Kamiar			Barcoding Human Physical Activity to Assess Chronic Pain Conditions	PLOS ONE			English	Article							LOW-BACK-PAIN; SPINAL-CORD STIMULATION; DWELLING OLDER-ADULTS; FRACTAL DYNAMICS; AMBULATORY SYSTEM; ACTIVITY PATTERNS; DISEASE; GAIT; COMPLEXITY; MOVEMENT	Background: Modern theories define chronic pain as a multidimensional experience - the result of complex interplay between physiological and psychological factors with significant impact on patients' physical, emotional and social functioning. The development of reliable assessment tools capable of capturing the multidimensional impact of chronic pain has challenged the medical community for decades. A number of validated tools are currently used in clinical practice however they all rely on self-reporting and are therefore inherently subjective. In this study we show that a comprehensive analysis of physical activity (PA) under real life conditions may capture behavioral aspects that may reflect physical and emotional functioning. Methodology: PA was monitored during five consecutive days in 60 chronic pain patients and 15 pain-free healthy subjects. To analyze the various aspects of pain-related activity behaviors we defined the concept of PA 'barcoding'. The main idea was to combine different features of PA (type, intensity, duration) to define various PA states. The temporal sequence of different states was visualized as a 'barcode' which indicated that significant information about daily activity can be contained in the amount and variety of PA states, and in the temporal structure of sequence. This information was quantified using complementary measures such as structural complexity metrics (information and sample entropy, Lempel-Ziv complexity), time spent in PA states, and two composite scores, which integrate all measures. The reliability of these measures to characterize chronic pain conditions was assessed by comparing groups of subjects with clinically different pain intensity. Conclusion: The defined measures of PA showed good discriminative features. The results suggest that significant information about pain-related functional limitations is captured by the structural complexity of PA barcodes, which decreases when the intensity of pain increases. We conclude that a comprehensive analysis of daily-life PA can provide an objective appraisal of the intensity of pain.	[Paraschiv-Ionescu, Anisoara; Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Lausanne, Switzerland; [Perruchoud, Christophe; Buchser, Eric] Hosp Morges, EHC, Anesthesia & Pain Management Dept, Morges, Switzerland; [Perruchoud, Christophe; Buchser, Eric] Univ Hosp Ctr, Dept Anesthesiol, Lausanne, Switzerland; [Perruchoud, Christophe; Buchser, Eric] Univ Lausanne, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Paraschiv-Ionescu, A (corresponding author), Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Lausanne, Switzerland.	anisoara.ionescu@epfl.ch	Aminian, Kamiar/H-4568-2011	Aminian, Kamiar/0000-0002-6582-5375	Swiss Innovation Promotion Agency (CTI) [6579.2MTS-LS]	Swiss Innovation Promotion Agency (CTI)	This study was supported by the Swiss Innovation Promotion Agency (CTI) under grant number 6579.2MTS-LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjoro K, 2008, CLIN GERIATR MED, V24, P237, DOI 10.1016/j.cger.2007.12.001; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Buchser E, 2005, NEUROMODULATION, V8, P40, DOI 10.1111/j.1094-7159.2005.05219.x; Bussmann JBJ, 1998, PAIN, V74, P153, DOI 10.1016/S0304-3959(97)00161-9; Cavanaugh JT, 2010, J GERONTOL A-BIOL, V65, P197, DOI 10.1093/gerona/glp144; Chou SW, 2003, AM J PHYS MED REHAB, V82, P42, DOI 10.1097/01.PHM.0000043769.93584.4D; Cohen J, 1987, STAT POWER ANAL BEHA; Cote JN, 2010, CLIN J PAIN, V26, P754, DOI 10.1097/AJP.0b013e3181e0174f; Cover Thomas M., 2001, FRONTMATTER INDEX EL, pi; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Cysarz D, 2000, AM J PHYSIOL-HEART C, V278, pH2163, DOI 10.1152/ajpheart.2000.278.6.H2163; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; Duhn Lenora J, 2004, Adv Neonatal Care, V4, P126, DOI 10.1016/j.adnc.2004.04.005; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Griffin DW, PHYSIOTHERAPY IN PRE; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hodges PW, 2011, J ELECTROMYOGR KINES, V21, P220, DOI 10.1016/j.jelekin.2011.01.002; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Jamison RN, 2006, J PAIN, V7, P192, DOI 10.1016/j.jpain.2005.10.006; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; KASPAR F, 1987, PHYS REV A, V36, P842, DOI 10.1103/PhysRevA.36.842; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; LIPSITZ LA, 2004, SCI AGING KNOWLEDGE, pPE16; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Nagarajan R, 2002, IEEE T BIO-MED ENG, V49, P1371, DOI 10.1109/TBME.2002.804582; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Nang EEK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-644; Ohashi K, 2004, METHOD INFORM MED, V43, P26; Paraschiv-Ionescu A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021913; Paraschiv-Ionescu A, 2004, GAIT POSTURE, V20, P113, DOI 10.1016/j.gaitpost.2003.07.005; Park CH, 2008, PATTERN RECOGN, V41, P1083, DOI 10.1016/j.patcog.2007.07.022; Rapp PE, 2007, COGN NEURODYNAMICS, V1, P287, DOI 10.1007/s11571-007-9027-8; Rapp PE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016209; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ryan CG, 2009, AUST J PHYSIOTHER, V55, P53, DOI 10.1016/S0004-9514(09)70061-3; Schenkman ML, 2001, PHYS THER, V81, P1400, DOI 10.1093/ptj/81.8.1400; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stolee P, 2005, J AM GERIATR SOC, V53, P319, DOI 10.1111/j.1532-5415.2005.53121.x; Sullivan MJL, 2008, CLIN J PAIN, V24, P281, DOI 10.1097/AJP.0b013e318164bb15; van Weering MGH, 2009, EUR J PAIN, V13, P649, DOI 10.1016/j.ejpain.2008.07.005; Verbunt JA, 2001, ARCH PHYS MED REHAB, V82, P726, DOI 10.1053/apmr.2001.23182; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WYNER AD, 1989, IEEE T INFORM THEORY, V35, P1250, DOI 10.1109/18.45281; Yang CC, 2009, TELEMED J E-HEALTH, V15, P62, DOI 10.1089/tmj.2008.0060; Younger J, 2009, CURR PAIN HEADACHE R, V13, P39, DOI 10.1007/s11916-009-0009-x; ZIV J, 1978, IEEE T INFORM THEORY, V24, P530, DOI 10.1109/TIT.1978.1055934	58	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32239	10.1371/journal.pone.0032239	http://dx.doi.org/10.1371/journal.pone.0032239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384191	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100061
J	Rattanama, P; Thompson, JR; Kongkerd, N; Srinitiwarawong, K; Vuddhakul, V; Mekalanos, JJ				Rattanama, Pimonsri; Thompson, Janelle R.; Kongkerd, Natthawan; Srinitiwarawong, Kanchana; Vuddhakul, Varaporn; Mekalanos, John J.			Sigma E Regulators Control Hemolytic Activity and Virulence in a Shrimp Pathogenic Vibrio harveyi	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; PENAEUS-MONODON; GENE-EXPRESSION; SUICIDE VECTOR; CHOLERAE; RPOE; PHOSPHOLIPASE; CONSTRUCTION; CLONING	Members of the genus Vibrio are important marine and aquaculture pathogens. Hemolytic activity has been identified as a virulence factor in many pathogenic vibrios including V. cholerae, V. parahaemolyticus, V. alginolyticus, V. harveyi and V. vulnificus. We have used transposon mutagenesis to identify genes involved in the hemolytic activity of shrimp-pathogenic V. harveyi strain PSU3316. Out of 1,764 mutants screened, five mutants showed reduced hemolytic activity on sheep blood agar and exhibited virulence attenuation in shrimp (Litopenaeus vannamei). Mutants were identified by comparing transposon junction sequences to a draft of assembly of the PSU3316 genome. Surprisingly none of the disrupted open reading frames or gene neighborhoods contained genes annotated as hemolysins. The gene encoding RseB, a negative regulator of the sigma factor (sigma(E)), was interrupted in 2 out of 5 transposon mutants, in addition, the transcription factor CytR, a threonine synthetase, and an efflux-associated cytoplasmic protein were also identified. Knockout mutations introduced into the rpoE operon at the rseB gene exhibited low hemolytic activity in sheep blood agar, and were 3- to 7-fold attenuated for colonization in shrimp. Comparison of whole cell extracted proteins in the rseB mutant (PSU4030) to the wild-type by 2-D gel electrophoresis revealed 6 differentially expressed proteins, including two down-regulated porins (OmpC-like and OmpN) and an upregulated protease (DegQ) which have been associated with sigma(E) in other organisms. Our study is the first report linking hemolytic activity to the sigma(E) regulators in pathogenic Vibrio species and suggests expression of this virulence-linked phenotype is governed by multiple regulatory pathways within the V. harveyi.	[Rattanama, Pimonsri; Kongkerd, Natthawan; Srinitiwarawong, Kanchana; Vuddhakul, Varaporn] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Songkhla, Thailand; [Rattanama, Pimonsri] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Songkhla, Thailand; [Thompson, Janelle R.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Prince of Songkla University; Prince of Songkla University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rattanama, P (corresponding author), Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Songkhla, Thailand.	john_mekalanos@hms.harvard.edu	Thompson, Janelle/AAJ-8225-2020	Thompson, Janelle/0000-0003-0445-3720; Mittraparp-arthorn, Pimonsri/0000-0003-2474-5229	Thailand Research Fund through the Royal Golden Jubilee Ph.D. program [HD/0153/2547]; Harvard University; Massachusetts Institute of Technology	Thailand Research Fund through the Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); Harvard University; Massachusetts Institute of Technology	Thailand Research Fund provided financial support through the Royal Golden Jubilee Ph.D. program (Grant No. HD/0153/2547) and financial support also came from Harvard University and the Massachusetts Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 1998, J FISH DIS, V21, P313, DOI 10.1046/j.1365-2761.1998.00101.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; Brown RN, 2009, INFECT IMMUN, V77, P3768, DOI 10.1128/IAI.00205-09; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; CHI E, 1995, MOL MICROBIOL, V17, P713, DOI 10.1111/j.1365-2958.1995.mmi_17040713.x; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Fiore AE, 1997, INFECT IMMUN, V65, P3112, DOI 10.1128/IAI.65.8.3112-3117.1997; Gorham HC, 1996, MOL MICROBIOL, V19, P171, DOI 10.1046/j.1365-2958.1996.360888.x; Hannan TJ, 2008, MOL MICROBIOL, V67, P116, DOI 10.1111/j.1365-2958.2007.06025.x; Harris LJ, 1997, AUSTASIA AQUACULT, V11, P59; Hiratsu, 1995, J BACTERIOL, V177, P2918; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Kabir MS, 2005, MICROBIOL-SGM, V151, P2721, DOI 10.1099/mic.0.28004-0; Kang JH, 1998, BBA-LIPID LIPID MET, V1394, P85, DOI 10.1016/S0005-2760(98)00100-3; Kautsky N, 2000, AQUACULTURE, V191, P145, DOI 10.1016/S0044-8486(00)00424-5; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Leano EM, 1998, AQUACULTURE, V164, P367, DOI 10.1016/S0044-8486(98)00201-4; Liu PC, 1996, LETT APPL MICROBIOL, V22, P413, DOI 10.1111/j.1472-765X.1996.tb01192.x; Liu PC, 1996, CURR MICROBIOL, V33, P129, DOI 10.1007/s002849900087; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; Moreno MLG, 1998, J APPL MICROBIOL, V84, P747, DOI 10.1046/j.1365-2672.1998.00404.x; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; PIZZUTTO M, 1995, DIS AQUAT ORGAN, V21, P61, DOI 10.3354/dao021061; Rattanama P, 2009, DIS AQUAT ORGAN, V86, P113, DOI 10.3354/dao02119; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; SHINODA S, 1991, J GEN MICROBIOL, V137, P2705, DOI 10.1099/00221287-137-12-2705; Sun BG, 2007, J BACTERIOL, V189, P2575, DOI 10.1128/JB.01650-06; Thaithongnum S, 2006, AQUACULTURE, V261, P1, DOI 10.1016/j.aquaculture.2006.07.001; Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08; Zhang XH, 2001, APPL ENVIRON MICROB, V67, P3161, DOI 10.1128/AEM.67.7.3161-3167.2001	42	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32523	10.1371/journal.pone.0032523	http://dx.doi.org/10.1371/journal.pone.0032523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384269	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100086
J	Vasudev, M; Cheung, DS; Pincsak, H; Li, SH; Yan, K; Simpson, P; Dasu, T; Grayson, MH				Vasudev, Monica; Cheung, Dorothy S.; Pincsak, Hannah; Li, Shun-Hwa; Yan, Ke; Simpson, Pippa; Dasu, Trivikram; Grayson, Mitchell H.			Expression of High-Affinity IgE Receptor on Human Peripheral Blood Dendritic Cells in Children	PLOS ONE			English	Article							FC-EPSILON-RI; ASTHMA; DIFFERENTIATION; BRONCHIOLITIS; POPULATIONS; INFECTION; ALLERGY	Background: In a mouse model of viral induced atopic disease, expression of FceRI on dendritic cells is critical. While adult human conventional (cDC) and plasmacytoid (pDC) dendritic cells have been shown to express FceRI, it is not known if this receptor is expressed in childhood and how its expression is governed by IgE. Methods: Following informed consent of subjects (n = 27, aged 12-188 months), peripheral blood was stained for surface expression of CD19, ILT7, CD1c, IgE, FceRI and analyzed by flow cytometry (cDC: CD19(-) ILT7(-) CD1c(+); pDC: CD19(-) ILT7(+) CD1c(-)). Total and specific serum IgE levels to food and inhalant allergens were determined by ImmunoCAP, and the relationship between FceRI expression on dendritic cells and sensitization, free IgE, cell bound IgE, and age was determined. Results: Independent of sensitization status, FceRI expression was noted on cDC and pDC as early as 12 months of age. Serum IgE level correlated with expression of FceRI on cDC, but not pDC. Based on the concentration of IgE, a complex relationship was found between surface bound IgE and expression of FceRI on cDC. pDC exhibited a linear relationship of FceRI expression and bound IgE that was consistent through all IgE concentrations. Conclusions: In children, FceRI expression on cDC and pDC is modulated differently by serum and cell bound IgE. IgE governance of FceRI expression on cDC depends upon a complex relationship. Further studies are needed to determine the functional roles of FceRI on cDC and pDC.	[Vasudev, Monica; Cheung, Dorothy S.; Pincsak, Hannah; Li, Shun-Hwa; Yan, Ke; Simpson, Pippa; Dasu, Trivikram; Grayson, Mitchell H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Vasudev, M (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wheeze@allergist.com	Grayson, Mitchell H/A-3693-2008; simpson, pippa/AAI-8172-2020; Grayson, Mitchell/AAX-3674-2020	Grayson, Mitchell H/0000-0002-4673-2122; simpson, pippa/0000-0003-1458-3748; Grayson, Mitchell/0000-0002-4673-2122	Genentech; National Institutes of Health [HL087778]; Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087778] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by Genentech (www.gene.com), National Institutes of Health grant HL087778 (www.nih.gov), and the Children's Research Institute of the Children's Hospital of Wisconsin (www.chw.org/display/PPF/DocID/30477/router.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chen Xiuxu, 2011, Open Immunol J, V4, P22; Cheung DS, 2010, ANN ALLERG ASTHMA IM, V105, P437, DOI 10.1016/j.anai.2010.09.010; Cheung DS, 2010, J IMMUNOL, V185, P4983, DOI 10.4049/jimmunol.1002456; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Escobar GJ, 2010, ARCH PEDIAT ADOL MED, V164, P915, DOI 10.1001/archpediatrics.2010.177; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; JURGENS M, 1995, J IMMUNOL, V155, P5184; Khan SH, 2010, J ALLERGY CLIN IMMUN, V125, P265, DOI 10.1016/j.jaci.2009.09.038; Kirsche H, 2010, ALLERGY, V65, P24, DOI 10.1111/j.1398-9995.2009.02174.x; Lundberg K, 2010, HUM IMMUNOL, V71, P931, DOI 10.1016/j.humimm.2010.07.008; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Saini S, 1997, J ALLERGY CLIN IMMUN, V99, P417; Schroeder JT, 2010, J ALLERGY CLIN IMMUN, V125, P896, DOI 10.1016/j.jaci.2009.10.021; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Silver E, 2009, PEDIAT ALLERG IMM-UK, V20, P471, DOI 10.1111/j.1399-3038.2008.00818.x; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; THOMPSON HL, 1990, J CLIN INVEST, V85, P1227, DOI 10.1172/JCI114557	26	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32556	10.1371/journal.pone.0032556	http://dx.doi.org/10.1371/journal.pone.0032556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384272	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100087
J	Trepel, M; Martens, V; Doll, C; Rahlff, J; Gosch, B; Loges, S; Binder, M				Trepel, Martin; Martens, Victoria; Doll, Christian; Rahlff, Janina; Goesch, Barbara; Loges, Sonja; Binder, Mascha			Phenotypic Detection of Clonotypic B Cells in Multiple Myeloma by Specific Immunoglobulin Ligands Reveals their Rarity in Multiple Myeloma	PLOS ONE			English	Article							CIRCULATING CLONAL LYMPHOCYTES; HIGH-DOSE THERAPY; PERIPHERAL-BLOOD; BONE-MARROW; PLASMA-CELLS; MONOCLONAL GAMMOPATHY; ADENOASSOCIATED VIRUS; PEPTIDE LIBRARIES; RAS MUTATIONS; PHAGE DISPLAY	In multiple myeloma, circulating "clonotypic" B cells, that express the immunoglobulin rearrangement of the malignant plasma cell clone, can be indirectly detected by PCR. Their role as potential "feeder" cells for the malignant plasma cell pool remains controversial. Here we established for the first time an approach that allows direct tracking of such clonotypic cells by labeling with patient-specific immunoglobulin ligands in 15 patients with myeloma. Fifty percent of patients showed evidence of clonotypic B cells in blood or bone marrow by PCR. Epitope-mimicking peptides from random libraries were selected on each patient's individual immunoglobulin and used as ligands to trace cells expressing the idiotypic immunoglobulin on their surface. We established a flow cytometry and immunofluorescence protocol to track clonotypic B cells and validated it in two independent monoclonal B cell systems. Using this method, we found clonotypic B cells in only one out of 15 myeloma patients. In view of the assay's validated sensitivity level of 10(-3), this surprising data suggests that the abundance of such cells has been vastly overestimated in the past and that they apparently represent a very rare population in myeloma. Our novel tracing approach may open perspectives to isolate and analyze clonotypic B cells and determine their role in myeloma pathobiology.	[Trepel, Martin; Martens, Victoria; Rahlff, Janina; Goesch, Barbara; Loges, Sonja; Binder, Mascha] Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Univ Med Ctr Hamburg Eppendorf, Dept Oncol & Hematol,BMT Sect Pneumol, Hamburg, Germany; [Doll, Christian] Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Trepel, M (corresponding author), Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Univ Med Ctr Hamburg Eppendorf, Dept Oncol & Hematol,BMT Sect Pneumol, Hamburg, Germany.	m.trepel@uke.de; m.binder@uke.de	Loges, Sonja/ABE-9868-2021; Rahlff, Janina/H-9952-2019	Loges, Sonja/0000-0002-7650-8527; Rahlff, Janina/0000-0002-2132-2709; Doll, Christian/0000-0002-0439-759X; Binder, Mascha/0000-0003-0663-3004	Wilhelm Sander-Stiftung [2009.035.1]; Hamburger Krebsgesellschaft; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft [TR448/6-1]	Wilhelm Sander-Stiftung; Hamburger Krebsgesellschaft; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Wilhelm Sander-Stiftung (grant # 2009.035.1 to MB and MT), the Hamburger Krebsgesellschaft (scholarship to MB), the Deutsche Krebshilfe (Max-Eder group leader program to SL) and the Deutsche Forschungsgemeinschaft (grant # TR448/6-1 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkus MHC, 2001, LEUKEMIA, V15, P1127, DOI 10.1038/sj.leu.2402164; Basak GW, 2010, BIOL BLOOD MARROW TR, V16, P587, DOI 10.1016/j.bbmt.2009.10.024; BERENSON JR, 1990, BLOOD, V75, P2107; BERGSAGEL PL, 1995, BLOOD, V85, P436, DOI 10.1182/blood.V85.2.436.bloodjournal852436; Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Billadeau D, 1996, BLOOD, V88, P289; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; Binder M, 2007, CANCER RES, V67, P3518, DOI 10.1158/0008-5472.CAN-06-3919; Binder M, 2006, BLOOD, V108, P1975, DOI 10.1182/blood-2006-04-014639; Brennan SK, 2009, J MOL MED, V87, P1079, DOI 10.1007/s00109-009-0531-7; BROWN R, 1995, BRIT J HAEMATOL, V90, P113, DOI 10.1111/j.1365-2141.1995.tb03388.x; Chen BZJ, 1996, BLOOD, V87, P1972, DOI 10.1182/blood.V87.5.1972.bloodjournal8751972; CORRADINI P, 1993, LEUKEMIA, V7, P1879; CORRADINI P, 1993, J EXP MED, V178, P1091, DOI 10.1084/jem.178.3.1091; Ghosh N, 2009, CANCER LETT, V277, P1, DOI 10.1016/j.canlet.2008.08.005; Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Jager S, 2007, LEUKEMIA, V21, P411, DOI 10.1038/sj.leu.2404548; Joshua DE, 1996, BLOOD, V88, P1125; Kiel K, 1999, BONE MARROW TRANSPL, V23, P1019, DOI 10.1038/sj.bmt.1701767; KIYOTAKI M, 1987, J IMMUNOL, V138, P4150; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; McSweeney PA, 1996, BLOOD, V88, P622, DOI 10.1182/blood.V88.2.622.bloodjournal882622; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Pfeifer S, 2011, LEUKEMIA, V25, P1213, DOI 10.1038/leu.2011.70; Pilarski LM, 2000, CLIN CANCER RES, V6, P585; Pilarski LM, 2002, EXP HEMATOL, V30, P221, DOI 10.1016/S0301-472X(01)00788-3; Pilarski LM, 1999, LEUKEMIA LYMPHOMA, V32, P199, DOI 10.3109/10428199909167381; Pilarski LM, 1996, LEUKEMIA LYMPHOMA, V22, P375, DOI 10.3109/10428199609054775; Pilarski LM, 2000, BLOOD, V95, P1056, DOI 10.1182/blood.V95.3.1056.003k26_1056_1065; Rasmussen T, 2000, BLOOD, V96, P4357; Rasmussen T, 2005, BLOOD, V105, P317, DOI 10.1182/blood-2004-03-0833; Rasmussen T, 2010, HAEMATOL-HEMATOL J, V95, P1730, DOI 10.3324/haematol.2010.024778; Rottenburger C, 1999, BRIT J HAEMATOL, V106, P545, DOI 10.1046/j.1365-2141.1999.01548.x; Santonocito AM, 2004, LEUKEMIA RES, V28, P469, DOI 10.1016/j.leukres.2003.09.015; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Taylor BJ, 2002, CLIN CANCER RES, V8, P502; Taylor BJ, 2008, BLOOD, V112, P1894, DOI 10.1182/blood-2008-01-129221; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Trepel M, 2001, CANCER RES, V61, P8110; Turesson I, 2010, J CLIN ONCOL, V28, P830, DOI 10.1200/JCO.2009.25.4177; Wehr C, 2011, INT J CANC; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zojer N, 2002, BRIT J HAEMATOL, V117, P852, DOI 10.1046/j.1365-2141.2002.03529.x	51	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31998	10.1371/journal.pone.0031998	http://dx.doi.org/10.1371/journal.pone.0031998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384124	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500064
J	Li, X; Stevens, PD; Yang, H; Gulhati, P; Wang, W; Evers, BM; Gao, T				Li, X.; Stevens, P. D.; Yang, H.; Gulhati, P.; Wang, W.; Evers, B. M.; Gao, T.			The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer	ONCOGENE			English	Article						PHLPP; USP46; Akt; deubiquitination; tumor suppressor	PROTEIN-KINASE-C; E3 LIGASE; PHOSPHATASE; GLIOBLASTOMA; ACTIVATION; STABILITY; APOPTOSIS; FEEDBACK; PTEN	PH domain leucine-rich-repeats protein phosphatase (PHLPP) is a family of Ser/Thr protein phosphatases that serve as tumor suppressors by negatively regulating Akt. Our recent studies have demonstrated that the ubiquitin proteasome pathway has an important role in the downregulation of PHLPP in colorectal cancer. In this study, we show that the deubiquitinase USP46 stabilizes the expression of both PHLPP isoforms by reducing the rate of PHLPP degradation. USP46 binds to PHLPP and directly removes the polyubiquitin chains from PHLPP in vitro and in cells. Increased USP46 expression correlates with decreased ubiquitination and upregulation of PHLPP proteins in colon cancer cells, whereas knockdown of USP46 has the opposite effect. Functionally, USP46-mediated stabilization of PHLPP and the subsequent inhibition of Akt result in a decrease in cell proliferation and tumorigenesis of colon cancer cells in vivo. Moreover, reduced USP46 protein level is found associated with poor PHLPP expression in colorectal cancer patient specimens. Taken together, these results indentify a tumor suppressor role of USP46 in promoting PHLPP expression and inhibiting Akt signaling in colon cancer. Oncogene (2013) 32, 471-478; doi:10.1038/onc.2012.66; published online 5 March 2012	[Li, X.; Stevens, P. D.; Gulhati, P.; Wang, W.; Evers, B. M.; Gao, T.] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Yang, H.] Taizhou Hosp, Dept Oncol, Taizhou, Peoples R China; [Gulhati, P.; Evers, B. M.] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Gulhati, P.] Univ Texas Med Branch, MD PhD Program, Galveston, TX 77555 USA; [Gao, T.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Kentucky	Gao, T (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			NIH [R01CA133429]; American Cancer Society [RSG0822001TBE, P20CA1530343, R01DK48498]; NATIONAL CANCER INSTITUTE [P20CA150343, R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Wade Harper (Harvard Medical School) for providing USP46, USP7 and USP16 expression plasmids, and Dr Hui-Kuan Lin (University of Texas MD Anderson Cancer Center) for providing His-tagged ubiquitin construct. The Biostatistic Core at the Markey Cancer Center (University of Kentucky) provided assistant with the statistical analysis in our study. This work was supported by NIH R01CA133429 (TG), American Cancer Society RSG0822001TBE (TG), P20CA1530343 (UK GI SPORE) and R01DK48498 (BME).	Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; REINER A, 1990, CANCER RES, V50, P7057; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shimizu K, 2010, MOL BIOSYST, V6, P38, DOI 10.1039/b911410f; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	24	73	75	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2013	32	4					471	478		10.1038/onc.2012.66	http://dx.doi.org/10.1038/onc.2012.66			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22391563	Green Accepted			2022-12-25	WOS:000315551300008
J	Lam, YMP; McBride, KL; Amin, J; Cordery, DV; Kelleher, AD; Cooper, DA; Koelsch, KK				Lam, Yu Ming Paul; McBride, Kristin L.; Amin, Janaki; Cordery, Damien V.; Kelleher, Anthony D.; Cooper, David A.; Koelsch, Kersten K.			Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INTEGRASE INHIBITOR; TISSUE RESERVOIRS; LYMPHOID-TISSUE; INTENSIFICATION; REPLICATION; VIREMIA; GUT; ACTIVATION; RESISTANCE	Background: Current HIV-1 antiretroviral therapy (ART) greatly reduces virus replication but does not significantly affect the viral reservoir. Raltegravir, a recently introduced integrase inhibitor, could, at least theoretically, reduce residual viremia in patients on ART and affect the viral reservoir size. The aim of this study was to assess whether switching therapy in treatment-experienced patients that were virally suppressed to a raltegravir-containing regimen reduces the size of the viral reservoir, and if such treatment leads to a change in levels of HIV 2-LTR circles in this patient group. Methods: 14 ART experienced individuals with a suppressed viral load (<50 HIV-1 RNA copies/mL plasma) at baseline (for at least 2 months) were switched to a raltegravir-containing regimen. Blood samples were taken at baseline and at >= 2 timepoints up to 48 +/- 6 weeks. Levels of total HIV-1 DNA and 2-LTR circles in peripheral blood mononuclear cells (PBMCs) were measured using real-time PCR assays. Results: There was no significant change in HIV-1 total DNA levels over the study duration (p = 0.808), median slope 0.24 (conservative nonparametric 95% CI: -11.78, 26.23). Low levels of 2-LTR circles were detected in 2 patients. One had 16 copies/10(6) PBMCs at baseline and the other had 34 copies/10(6) PBMCs at week 51. Conclusions: The switch to a raltegravir containing regimen was not associated with a significant change in HIV-1 total DNA levels in this cohort. There were no observed changes in the levels of HIV-1 2-LTR circles associated with raltegravir treatment initiation.	[Lam, Yu Ming Paul; McBride, Kristin L.; Amin, Janaki; Cordery, Damien V.; Kelleher, Anthony D.; Cooper, David A.; Koelsch, Kersten K.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Lam, Yu Ming Paul; McBride, Kristin L.; Amin, Janaki; Cordery, Damien V.; Kelleher, Anthony D.; Cooper, David A.; Koelsch, Kersten K.] St Vincents Hosp Sydney, Ctr Appl Med Res, Darlinghurst, NSW, Australia	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney	Lam, YMP (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	paulymlam@gmail.com		Amin, Janaki/0000-0003-2161-9366	National Health and Medical Research Council [510448]; Merck; Merck Sharp Dohme	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Merck(Merck & Company); Merck Sharp Dohme(Merck & Company)	This study was funded through a National Health and Medical Research Council grant (#510448), http://www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ADK has received travel support from Merck and Merck Sharp & Dohme and honorarium from Viiv. KKK has received honoraria from Bristol-Myers Squibb. DAC has received consultancy, honoraria and grant support from Merck. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cordery DV, 2010, ANTIVIR THER, V15, P1035, DOI 10.3851/IMP1647; Delaugerre C, 2010, AIDS, V24, P2391, DOI 10.1097/QAD.0b013e32833d214c; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Goffinet C, 2009, J VIROL, V83, P7706, DOI 10.1128/JVI.00683-09; Grant PM, 2009, J CLIN VIROL, V46, P305, DOI 10.1016/j.jcv.2009.09.025; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Koelsch KK, 2011, AIDS IN PRESS; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Ruiz L, 1999, AIDS, V13, pF1, DOI 10.1097/00002030-199901140-00001; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zhu WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021081	33	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31990	10.1371/journal.pone.0031990	http://dx.doi.org/10.1371/journal.pone.0031990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396745	Green Submitted, gold, Green Published			2022-12-25	WOS:000303005000012
J	Cegan, R; Vyskot, B; Kejnovsky, E; Kubat, Z; Blavet, H; Safar, J; Dolezel, J; Blavet, N; Hobza, R				Cegan, Radim; Vyskot, Boris; Kejnovsky, Eduard; Kubat, Zdenek; Blavet, Hana; Safar, Jan; Dolezel, Jaroslav; Blavet, Nicolas; Hobza, Roman			Genomic Diversity in Two Related Plant Species with and without Sex Chromosomes - Silene latifolia and S. vulgaris	PLOS ONE			English	Article							Y-CHROMOSOME; DNA-SEQUENCES; TRANSPOSABLE ELEMENTS; REPETITIVE DNA; SIZE; EVOLUTION; GENE; ACCUMULATION; RETROTRANSPOSONS; AMPLIFICATION	Background: Genome size evolution is a complex process influenced by polyploidization, satellite DNA accumulation, and expansion of retroelements. How this process could be affected by different reproductive strategies is still poorly understood. Methodology/Principal Findings: We analyzed differences in the number and distribution of major repetitive DNA elements in two closely related species, Silene latifolia and S. vulgaris. Both species are diploid and possess the same chromosome number (2n = 24), but differ in their genome size and mode of reproduction. The dioecious S. latifolia (1C = 2.70 pg DNA) possesses sex chromosomes and its genome is 2.5 x larger than that of the gynodioecious S. vulgaris (1C = 1.13 pg DNA), which does not possess sex chromosomes. We discovered that the genome of S. latifolia is larger mainly due to the expansion of Ogre retrotransposons. Surprisingly, the centromeric STAR-C and TR1 tandem repeats were found to be more abundant in S. vulgaris, the species with the smaller genome. We further examined the distribution of major repetitive sequences in related species in the Caryophyllaceae family. The results of FISH (fluorescence in situ hybridization) on mitotic chromosomes with the Retand element indicate that large rearrangements occurred during the evolution of the Caryophyllaceae family. Conclusions/Significance: Our data demonstrate that the evolution of genome size in the genus Silene is accompanied by the expansion of different repetitive elements with specific patterns in the dioecious species possessing the sex chromosomes.	[Cegan, Radim; Vyskot, Boris; Kejnovsky, Eduard; Kubat, Zdenek; Blavet, Hana; Hobza, Roman] Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, CS-61265 Brno, Czech Republic; [Cegan, Radim] Mendel Univ Brno, Fac Agron, Dept Plant Biol, Brno, Czech Republic; [Safar, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol Agr Res, Olomouc, Czech Republic; [Blavet, Nicolas] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Mendel University in Brno; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich	Cegan, R (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic.	hobza@ibp.cz	Kejnovsky, Eduard/D-8878-2012; Vyskot, Boris/H-1962-2014; Hobza, Roman/I-4297-2014; Safar, Jan/G-1038-2014; Dolezel, Jaroslav/B-7716-2008; Blavet, Nicolas/S-5594-2019; Kubát, Zdeněk/D-9221-2012; Blavet, Hana/G-1988-2014; Blavet, Nicolas/F-8148-2014; Hobza, Roman/G-3119-2014; Čegan, Radim/H-1892-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Blavet, Nicolas/0000-0003-2199-9119; Kubát, Zdeněk/0000-0001-8278-9495; Blavet, Nicolas/0000-0003-2199-9119; Čegan, Radim/0000-0002-6789-6564; Hobza, Roman/0000-0003-3062-2962	Internal Grant Agency at Mendel University, Faculty of Agronomy, Brno, Czech Republic [DP7/2009]; Grant Agency of AS CR [KJB600040901]; Czech Science Foundation [P501/10/P483, P501/10/0102, 204/09/H002, P305/10/0930, 522/09/0083]; Academy of Sciences of the Czech Republic [AV0Z50040507, AV0Z50040702]	Internal Grant Agency at Mendel University, Faculty of Agronomy, Brno, Czech Republic; Grant Agency of AS CR(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The work was supported by the Internal Grant Agency at Mendel University, Faculty of Agronomy, Brno, Czech Republic (grant no. DP7/2009), the Grant Agency of AS CR (KJB600040901), Czech Science Foundation (grant nos. P501/10/P483, P501/10/0102, 204/09/H002, P305/10/0930 and 522/09/0083) and the Academy of Sciences of the Czech Republic (grant nos. AV0Z50040507 and AV0Z50040702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bergero R, 2008, GENETICS, V178, P1085, DOI 10.1534/genetics.107.081745; Bouzidi MF, 2006, THEOR APPL GENET, V113, P81, DOI 10.1007/s00122-006-0274-6; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Buzek J, 1997, CHROMOSOME RES, V5, P57, DOI 10.1023/A:1011693603279; Cegan R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-180; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cohen S, 2009, CYTOGENET GENOME RES, V124, P327, DOI 10.1159/000218136; Dong H, 2011, ACTA BIOCH BIOPH SIN, V43, P496, DOI 10.1093/abbs/gmr030; Drummond AJ, 2010, GENEIOUS V5 3; Duret L, 1996, COMPUT APPL BIOSCI, V12, P507; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; FIGUEIRA A, 1992, J AM SOC HORTIC SCI, V117, P673, DOI 10.21273/JASHS.117.4.673; Filatov DA, 2009, GENETICS, V181, P811, DOI 10.1534/genetics.108.099267; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heslop-Harrison JS, 2003, CHROMOSOME RES, V11, P241, DOI 10.1023/A:1022998709969; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kazama Y, 2003, J PLANT RES, V116, P317, DOI 10.1007/s10265-003-0106-6; Kazama Y, 2006, GENOME, V49, P520, DOI 10.1139/G05-130; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Kejnovsky E, 2006, MOL GENET GENOMICS, V276, P254, DOI 10.1007/s00438-006-0140-x; Kejnovsky E, 2009, TRENDS ECOL EVOL, V24, P572, DOI 10.1016/j.tree.2009.04.010; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; Lengerova M, 2004, THEOR APPL GENET, V108, P1193, DOI 10.1007/s00122-003-1568-6; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Matsunaga S, 2002, GENOME, V45, P745, DOI 10.1139/G02-026; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Obara M, 2002, GENES GENET SYST, V77, P393, DOI 10.1266/ggs.77.393; Pellicer J, 2010, BOT J LINN SOC, V164, P10, DOI 10.1111/j.1095-8339.2010.01072.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petrov Dmitri, 2006, P144; Pritham EJ, 2003, GENETICS, V165, P799; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Siroky J, 2001, CHROMOSOME RES, V9, P387, DOI 10.1023/A:1016783501674; Siroky J, 1999, ANN BOT-LONDON, V84, P633, DOI 10.1006/anbo.1999.0958; Smit A, 1996, REPEATMASKER OPEN 30; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Taylor DR, 2001, GENETICS, V158, P833; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286	62	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31898	10.1371/journal.pone.0031898	http://dx.doi.org/10.1371/journal.pone.0031898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393373	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500026
J	Harney, AS; Meade, TJ; LaBonne, C				Harney, Allison S.; Meade, Thomas J.; LaBonne, Carole			Targeted Inactivation of Snail Family EMT Regulatory Factors by a Co(III)-Ebox Conjugate	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REPRESSES E-CADHERIN; HUMAN ALPHA-THROMBIN; NEURAL CREST; TRANSCRIPTION FACTOR; SLUG; XENOPUS; CELLS; METASTASIS; INHIBITION	Snail family proteins are core EMT (epithelial-mesenchymal transition) regulatory factors that play essential roles in both development and disease processes and have been associated with metastasis in carcinomas. Snail factors are required for the formation of neural crest stem cells in most vertebrate embryos, as well as for the migratory invasive behavior of these cells. Snail factors have recently been linked to the formation of cancer stem cells, and expression of Snail proteins may be associated with tumor recurrence and resistance to chemotherapy and radiotherapy. We report that Co(III)-Ebox is a potent inhibitor of Snail-mediated transcriptional repression in breast cancer cells and in the neural crest of Xenopus. We further show that the activity of Co(III)-Ebox can be modulated by temperature, increasing the utility of this conjugate as a Snail inhibitor in model organisms. We exploit this feature to further delineate the requirements for Snail function during neural crest development, showing that in addition to the roles that Snail factors play in neural crest precursor formation and neural crest EMT/migration, inhibition of Snail function after the onset of neural crest migration leads to a loss of neural crest derived melanocytes. Co(III)-Ebox-mediated inhibition therefore provides a powerful tool for analysing the function of these core EMT factors with unparalleled temporal resolution. Moreover, the potency of Co(III)-Ebox as a Snail inhibitor in breast cancer cells suggests its potential as a therapeutic inhibitor of tumor progression and metastasis.	[Harney, Allison S.; Meade, Thomas J.; LaBonne, Carole] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Harney, Allison S.; Meade, Thomas J.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Harney, Allison S.; Meade, Thomas J.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Harney, Allison S.; Meade, Thomas J.] Northwestern Univ, Dept Radiol, Evanston, IL USA; [Meade, Thomas J.; LaBonne, Carole] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Harney, AS (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	clabonne@northwestern.edu			NIH [R01CA114058, U54CA151880]; Rosenberg Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA114058, U54CA151880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosenberg Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01CA114058 (CL) and U54CA151880 (TJM), and the Rosenberg Cancer Foundation. A. S. H. is a fellow of the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Asbell PA, 1998, CORNEA, V17, P550; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Baygi ME, 2010, TUMOR BIOL, V31, P297, DOI 10.1007/s13277-010-0037-5; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chandler HL, 2007, EXP EYE RES, V84, P400, DOI 10.1016/j.exer.2006.10.010; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Epstein Seth P, 2006, BMC Ophthalmol, V6, P22, DOI 10.1186/1471-2415-6-22; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Geradts J, 2011, HUMAN PATHO IN PRESS; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Harney AS, 2009, P NATL ACAD SCI USA, V106, P13667, DOI 10.1073/pnas.0906423106; Hemavathy K, 2004, DEV BIOL, V269, P411, DOI 10.1016/j.ydbio.2004.01.029; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Kuphal S, 2005, MELANOMA RES, V15, P305, DOI 10.1097/00008390-200508000-00012; LaBonne C, 1998, J NEUROBIOL, V36, P175, DOI 10.1002/(SICI)1097-4695(199808)36:2<175::AID-NEU6>3.0.CO;2-Z; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Louie AY, 1998, P NATL ACAD SCI USA, V95, P6663, DOI 10.1073/pnas.95.12.6663; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Schwartz JA, 2001, J VIROL, V75, P4117, DOI 10.1128/JVI.75.9.4117-4128.2001; Takeuchi T, 1998, J AM CHEM SOC, V120, P8555, DOI 10.1021/ja981191x; Takeuchi T, 1999, BIOORGAN MED CHEM, V7, P815, DOI 10.1016/S0968-0896(98)00272-7; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P173, DOI 10.1016/S1357-2725(03)00243-7; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480	50	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32318	10.1371/journal.pone.0032318	http://dx.doi.org/10.1371/journal.pone.0032318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393397	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500049
J	Zaremba-Czogalla, M; Piekarowicz, K; Wachowicz, K; Koziol, K; Dubinska-Magiera, M; Rzepecki, R				Zaremba-Czogalla, Magdalena; Piekarowicz, Katarzyna; Wachowicz, Katarzyna; Koziol, Katarzyna; Dubinska-Magiera, Magda; Rzepecki, Ryszard			The Different Function of Single Phosphorylation Sites of Drosophila melanogaster Lamin Dm and Lamin C	PLOS ONE			English	Article							PROTEIN-KINASE-C; MATRIX ATTACHMENT REGIONS; NUCLEAR-ENVELOPE BREAKDOWN; IN-VITRO; INTERMEDIATE-FILAMENTS; TAIL DOMAIN; ROD DOMAIN; BINDING; IDENTIFICATION; CHROMATIN	Lamins' functions are regulated by phosphorylation at specific sites but our understanding of the role of such modifications is practically limited to the function of cdc 2 (cdk1) kinase sites in depolymerization of the nuclear lamina during mitosis. In our study we used Drosophila lamin Dm (B-type) to examine the function of particular phosphorylation sites using pseudophosphorylated mutants mimicking single phosphorylation at experimentally confirmed in vivo phosphosites ((SE)-E-25, (SE)-E-45, (TE)-E-435, (SE)-E-595). We also analyzed lamin C (A-type) and its mutant (SE)-E-37 representing the N-terminal cdc2 (mitotic) site as well as lamin Dm (RH)-H-64 mutant as a control, non-polymerizing lamin. In the polymerization assay we could observe different effects of N-terminal cdc2 site pseudophosphorylation on A-and B-type lamins: lamin Dm (SE)-E-45 mutant was insoluble, in contrast to lamin C (SE)-E-37. Lamin Dm (TE)-E-435 (C-terminal cdc2 site) and (RH)-H-64 were soluble in vitro. We also confirmed that none of the single phosphorylation site modifications affected the chromatin binding of lamin Dm, in contrast to the lamin C N-terminal cdc2 site. In vivo, all lamin Dm mutants were incorporated efficiently into the nuclear lamina in transfected Drosophila S2 and HeLa cells, although significant amounts of (SE)-E-45 and (TE)-E-435 were also located in cytoplasm. When farnesylation incompetent mutants were expressed in HeLa cells, lamin Dm (TE)-E-435 was cytoplasmic and showed higher mobility in FRAP assay.	[Zaremba-Czogalla, Magdalena; Piekarowicz, Katarzyna; Wachowicz, Katarzyna; Koziol, Katarzyna; Dubinska-Magiera, Magda; Rzepecki, Ryszard] Univ Wroclaw, Fac Biotechnol, Lab Nucl Prot, PL-50138 Wroclaw, Poland	University of Wroclaw	Zaremba-Czogalla, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Lab Nucl Prot, PL-50138 Wroclaw, Poland.	rzepecki@ibmb.uni.wroc.pl	Rzepecki, Ryszard/AAF-1809-2020; Dubińska-Magiera, Magda/O-4120-2016	Rzepecki, Ryszard/0000-0002-2582-3965; Dubińska-Magiera, Magda/0000-0003-2725-3924; Piekarowicz, Katarzyna/0000-0002-9716-2393	Polish Science Foundation (KBN) [3P04C 01725]; Wroclaw Research Centre EIT+ [POIG.01.01.02-02-003/08]; European Regional Development Fund (Operational Programme Innovative Economy) [1.1.2]	Polish Science Foundation (KBN)(Foundation for Polish SciencePolish State Committee for Scientific Research); Wroclaw Research Centre EIT+; European Regional Development Fund (Operational Programme Innovative Economy)(European Commission)	This work has been supported by Polish Science Foundation (KBN) grant No. 3P04C 01725, and partially by Wroclaw Research Centre EIT+ under the project "Biotechnologies and advanced medical technologies'' BioMed (POIG.01.01.02-02-003/08), financed by the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; AsheryPadan R, 1997, MOL CELL BIOL, V17, P4114, DOI 10.1128/MCB.17.7.4114; Ballester M, 2011, J VIROL, V85, P8263, DOI 10.1128/JVI.00704-11; Baricheva EA, 1996, GENE, V171, P171, DOI 10.1016/0378-1119(96)00002-9; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Broers JLV, 1999, J CELL SCI, V112, P3463; Broers JLV, 2004, EXPTL BIOL REV, P177; Cenni V, 2008, J PROTEOME RES, V7, P4727, DOI 10.1021/pr800262g; Chang KH, 2011, MOL BIOL CELL, V22, P1452, DOI 10.1091/mbc.E10-07-0654; Chiarini A, 2002, J BIOL CHEM, V277, P18827, DOI 10.1074/jbc.M111921200; Chmielewska M, 2011, CELL TISSUE RES, V344, P97, DOI 10.1007/s00441-011-1129-2; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Dechat T, 2010, COLD SPRING HARB PER, V2; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; EGGERT M, 1993, EUR J BIOCHEM, V213, P659, DOI 10.1111/j.1432-1033.1993.tb17806.x; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; GLASS JR, 1990, J CELL BIOL, V111, P1047, DOI 10.1083/jcb.111.3.1047; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; GOSS VL, 1994, J BIOL CHEM, V269, P19074; HAAS M, 1993, EUR J CELL BIOL, V62, P237; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Herrmann H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-16; HOCEVAR BA, 1993, J BIOL CHEM, V268, P7545; HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V; Katsani KR, 2008, MOL BIOL CELL, V19, P3652, DOI 10.1091/mbc.E07-11-1162; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Kuga T, 2010, EXP CELL RES, V316, P2301, DOI 10.1016/j.yexcr.2010.05.017; Kuntziger T, 2006, BIOCHEMISTRY-US, V45, P5868, DOI 10.1021/bi060066s; LAMB NJC, 1991, EMBO J, V10, P1523, DOI 10.1002/j.1460-2075.1991.tb07672.x; LEUKEL M, 1995, EUR J CELL BIOL, V68, P133; LIN L, 1990, J BIOL CHEM, V265, P12596; LUDERUS MEE, 1994, MOL CELL BIOL, V14, P6297, DOI 10.1128/MCB.14.9.6297; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; MAISON C, 1995, EMBO J, V14, P3311, DOI 10.1002/j.1460-2075.1995.tb07338.x; Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; PETER M, 1992, EUR J BIOCHEM, V205, P287, DOI 10.1111/j.1432-1033.1992.tb16779.x; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; RIEMER D, 1995, J CELL SCI, V108, P3189; Rzepecki R, 1998, J CELL SCI, V111, P121; Rzepecki R, 2002, CELL MOL BIOL LETT, V7, P1019; Rzepecki R, 2002, CELL MOL BIOL LETT, V7, P859; Rzepecki R, 2000, J CELL SCI, V113, P1635; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Salpingidou G, 2008, J CELL SCI, V121, P706, DOI 10.1242/jcs.019968; Sasse B, 1997, EUR J BIOCHEM, V250, P30, DOI 10.1111/j.1432-1033.1997.t01-1-00030.x; Sasse B, 1998, J STRUCT BIOL, V123, P56, DOI 10.1006/jsbi.1998.4006; Schneider U, 1999, BIOCHEMISTRY-US, V38, P4620, DOI 10.1021/bi9827060; Shimizu T, 1998, J BIOL CHEM, V273, P8669, DOI 10.1074/jbc.273.15.8669; SHOEMAN RL, 1990, J BIOL CHEM, V265, P9055; SMITH DE, 1987, J CELL BIOL, V105, P771, DOI 10.1083/jcb.105.2.771; Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g; Stuurman N, 1996, J STRUCT BIOL, V117, P1, DOI 10.1006/jsbi.1996.0064; STUURMAN N, 1995, J CELL SCI, V108, P3137; Stuurman N, 1997, FEBS LETT, V401, P171, DOI 10.1016/S0014-5793(96)01464-0; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Yamaguchi A, 2006, EUR J CELL BIOL, V85, P501, DOI 10.1016/j.ejcb.2006.02.002; YUAN J, 1991, J BIOL CHEM, V266, P9211; Zaremba-Czogalla M, 2011, NUCLEUS-PHILA, V2, P478, DOI 10.4161/nucl.2.5.17864; Zaremba-Czogalla M, 2011, CELL MOL BIOL LETT, V16, P114, DOI 10.2478/s11658-010-0038-9; Zhao K, 1996, FEBS LETT, V380, P161, DOI 10.1016/0014-5793(96)00034-8	72	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32649	10.1371/journal.pone.0032649	http://dx.doi.org/10.1371/journal.pone.0032649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393432	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500084
J	Li, CL; Jiang, ZG; Li, LL; Li, ZQ; Fang, HX; Li, CW; Beauchamp, G				Li, Chunlin; Jiang, Zhigang; Li, Linlin; Li, Zhongqiu; Fang, Hongxia; Li, Chunwang; Beauchamp, Guy			Effects of Reproductive Status, Social Rank, Sex and Group Size on Vigilance Patterns in Przewalski's Gazelle	PLOS ONE			English	Article							PREDATION RISK; BIGHORN SHEEP; PROCAPRA-PRZEWALSKII; HUMAN DISTURBANCE; DIURNAL ACTIVITY; NATIONAL-PARK; TIME BUDGET; ELK; BEHAVIOR; RUT	Background: Quantifying vigilance and exploring the underlying mechanisms has been the subject of numerous studies. Less attention has focused on the complex interplay between contributing factors such as reproductive status, social rank, sex and group size. Reproductive status and social rank are of particular interest due to their association with mating behavior. Mating activities in rutting season may interfere with typical patterns of vigilance and possibly interact with social rank. In addition, balancing the tradeoff between vigilance and life maintenance may represent a challenge for gregarious ungulate species rutting under harsh winter conditions. We studied vigilance patterns in the endangered Przewalski's gazelle (Procapra przewalskii) during both the rutting and non-rutting seasons to examine these issues. Methodology/Principal Findings: Field observations were carried out with focal sampling during rutting and non-rutting season in 2008-2009. Results indicated a complex interplay between reproductive status, social rank, sex and group size in determining vigilance in this species. Vigilance decreased with group size in female but not in male gazelles. Males scanned more frequently and thus spent more time vigilant than females. Compared to non-rutting season, gazelles increased time spent scanning at the expense of bedding in rutting season. During the rutting season, territorial males spent a large proportion of time on rutting activities and were less vigilant than non-territorial males. Although territorial males may share collective risk detection with harem females, we suggest that they are probably more vulnerable to predation because they seemed reluctant to leave rut stands under threats. Conclusions/Significance: Vigilance behavior in Przewalski's gazelle was significantly affected by reproductive status, social rank, sex, group size and their complex interactions. These findings shed light on the mechanisms underlying vigilance patterns and the tradeoff between vigilance and other crucial activities.	[Li, Chunlin; Jiang, Zhigang; Li, Linlin; Fang, Hongxia; Li, Chunwang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Li, Chunlin; Jiang, Zhigang; Li, Linlin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Li, Zhongqiu] Nanjing Univ, Coll Life Sci, Nanjing 210008, Peoples R China; [Beauchamp, Guy] Univ Montreal, Fac Vet Med, Quebec City, PQ, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; Universite de Montreal	Li, CL (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014; Li, Zhong-qiu/A-1748-2011	Jiang, Zhigang/0000-0003-2154-8588; Li, Zhong-qiu/0000-0003-2004-293X	Ministry of Science and Technology, China [2008BAC39B04]; Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Sciences Foundation of China [31070469]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Science and Technology Supporting Project, Ministry of Science and Technology, China (Monitoring of Important Biological Species and Demonstration of Key Conservation Technology Application in China, 2008BAC39B04, http://program.most.gov.cn/), Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4, http://www.bio.cas.cn/xmyj/yzscxzdxm/) and National Natural Sciences Foundation of China (Population patterns and structure of Przewalski's gazelle in anthropogenic landscape, No. 31070469, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage KB, 1996, ETHOL ECOL EVOL, V8, P67, DOI 10.1080/08927014.1996.9522936; BALMFORD A, 1992, ANIM BEHAV, V44, P117, DOI 10.1016/S0003-3472(05)80761-4; Bateson P., 1983, MATE CHOICE; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Beauchamp G, 2003, BEHAV PROCESS, V63, P111, DOI 10.1016/S0376-6357(03)00002-0; Beauchamp G, 2003, AM NAT, V161, P672, DOI 10.1086/368225; Beauchamp G, 1997, CAN J ZOOL, V75, P1526, DOI 10.1139/z97-776; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Caro T., 2005, ANTIPREDATOR DEFENSE; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1993, ANIM BEHAV, V46, P1121, DOI 10.1006/anbe.1993.1302; Fairbanks B, 2007, ANIM BEHAV, V73, P115, DOI 10.1016/j.anbehav.2006.07.002; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Guillemain M, 2003, BEHAV ECOL, V14, P724, DOI 10.1093/beheco/arg060; Gutzwiller KJ, 1998, CONDOR, V100, P519, DOI 10.2307/1369718; ILLIUS AW, 1994, ANIM BEHAV, V47, P481, DOI 10.1006/anbe.1994.1067; Inger R, 2006, ANIM BEHAV, V71, P1335, DOI 10.1016/j.anbehav.2005.08.015; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; JACOBSEN OW, 1994, ANIM BEHAV, V47, P488, DOI 10.1006/anbe.1994.1069; Jiang Z.G., 2004, CHINAS PRZEWALSKIS G; Jiang Zhi-Gang, 2004, Acta Zoologica Sinica, V50, P706; Jiang Zhi-Gang, 2003, Chinese Journal of Zoology, V38, P129; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lei RH, 2001, J ZOOL, V255, P175, DOI 10.1017/S0952836901001248; Leslie David M. Jr., 2010, Mammalian Species, P124, DOI 10.1644/860.1; Li C, 2010, CURRENT STA IN PRESS; Li C, 2007, ZOO BIOL, V26, P461, DOI 10.1002/zoo.20132; Li CW, 2009, WILDLIFE RES, V36, P379, DOI 10.1071/WR08117; Li CW, 2001, HORM BEHAV, V40, P518, DOI 10.1006/hbeh.2001.1711; Li Z, 2008, THESIS I ZOOLOGY CHI; Li Z, 2009, J ZOOL LOND; Li ZQ, 2010, J MAMMAL, V91, P674, DOI 10.1644/09-MAMM-A-203.1; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu Bing-wan, 2009, Zoological Research, V30, P694, DOI 10.3724/SP.J.1141.2009.06694; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Marino A, 2008, ETHOLOGY, V114, P413, DOI 10.1111/j.1439-0310.2008.01485_1.x; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McElligott AG, 2003, EVOL ECOL RES, V5, P1239; Mooring MS, 2006, ANIM BEHAV, V72, P737, DOI 10.1016/j.anbehav.2006.02.006; Mooring MS, 2004, HORM BEHAV, V46, P392, DOI 10.1016/j.yhbeh.2004.03.008; Pelletier F, 2009, ETHOLOGY, V115, P141, DOI 10.1111/j.1439-0310.2008.01589.x; Pepin D, 2001, APPL ANIM BEHAV SCI, V74, P233, DOI 10.1016/S0168-1591(01)00172-1; REALE D, 1996, CAN J ZOOL, V74, P1812; Reboreda JC, 1997, ETHOLOGY, V103, P198; Richard E, 2008, BEHAV PROCESS, V79, P28, DOI 10.1016/j.beproc.2008.04.008; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Rieucau G, 2009, BEHAV ECOL, V20, P421, DOI 10.1093/beheco/arn144; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Shih Hsi-Te, 2000, Acta Zoologica Taiwanica, V11, P47; Shorrocks B, 2005, AFR J ECOL, V43, P91, DOI 10.1111/j.1365-2028.2005.00541.x; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Sundaresan SR, 2007, BEHAV ECOL, V18, P860, DOI 10.1093/beheco/arm055; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Tchabovsky AV, 2001, J ETHOL, V19, P105, DOI 10.1007/s101640170006; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Willisch CS, 2007, ETHOLOGY, V113, P97, DOI 10.1111/j.1439-0310.2006.01301.x; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Wolff JO, 1998, OIKOS, V83, P529, DOI 10.2307/3546680; Yang Ji, 2011, PLoS One, V6, pe20144, DOI 10.1371/journal.pone.0020144; Yoccoz NG, 2002, P ROY SOC B-BIOL SCI, V269, P1523, DOI 10.1098/rspb.2002.2047; You Zhang-Qiang, 2005, Acta Zoologica Sinica, V51, P187; You ZQ, 2011, CURR ZOOL, V57, P701, DOI 10.1093/czoolo/57.6.701; Li ZQ, 2008, BEHAV PROCESS, V78, P25, DOI 10.1016/j.beproc.2007.11.011; [No title captured]	72	42	49	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32607	10.1371/journal.pone.0032607	http://dx.doi.org/10.1371/journal.pone.0032607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389714	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600053
J	Mavhu, W; Hatzold, K; Laver, SM; Sherman, J; Tengende, BR; Mangenah, C; Langhaug, LF; Hart, G; Cowan, FM				Mavhu, Webster; Hatzold, Karin; Laver, Susan M.; Sherman, Judith; Tengende, Brenda R.; Mangenah, Collin; Langhaug, Lisa F.; Hart, Graham; Cowan, Frances M.			Acceptability of Early Infant Male Circumcision as an HIV Prevention Intervention in Zimbabwe: A Qualitative Perspective	PLOS ONE			English	Article							INFECTION; HARARE; MEN	Background: Early infant male circumcision (EIMC) is simpler, safer and more cost-effective than adult circumcision. In sub-Saharan Africa, there are concerns about acceptability of EIMC which could affect uptake. In 2009 a quantitative survey of 2,746 rural Zimbabweans (aged 18-44) indicated that 60% of women and 58% of men would be willing to have their newborn son circumcised. Willingness was associated with knowledge of HIV and male circumcision. This qualitative study was conducted to better understand this issue. Methods: In 2010, 24 group discussions were held across Zimbabwe with participants from seven ethnic groups. Additionally, key informant interviews were held with private paediatricians who offer EIMC (n = 2) plus one traditional leader. Discussions were audio-recorded, transcribed, translated into English (where necessary), coded using NVivo 8 and analysed using grounded theory principles. Results: Knowledge of the procedure was poor. Despite this, acceptability of EIMC was high among parents from most ethnic groups. Discussions suggested that fathers would make the ultimate decision regarding EIMC although mothers and extended family can have (often covert) influence. Participants' concerns centred on: safety, motive behind free service provision plus handling and disposal of the discarded foreskin. Older men from the dominant traditionally circumcising population strongly opposed EIMC, arguing that it separates circumcision from adolescent initiation, as well as allowing women (mothers) to nurse the wound, considered taboo. Conclusions: EIMC is likely to be an acceptable HIV prevention intervention for most populations in Zimbabwe, if barriers to uptake are appropriately addressed and fathers are specifically targeted by the programme.	[Mavhu, Webster; Tengende, Brenda R.; Mangenah, Collin; Cowan, Frances M.] Univ Zimbabwe, Zimbabwe AIDS Prevent Project, Dept Community Med, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Laver, Susan M.] UNICEF, CCORE, Harare, Zimbabwe; [Mavhu, Webster; Langhaug, Lisa F.; Hart, Graham; Cowan, Frances M.] UCL, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England	University of Zimbabwe; University of London; University College London	Mavhu, W (corresponding author), Univ Zimbabwe, Zimbabwe AIDS Prevent Project, Dept Community Med, Harare, Zimbabwe.	wmavhu@gmail.com		Hart, Graham/0000-0001-9676-6577; Langhaug, Lisa/0000-0002-9131-8158; Cowan, Frances/0000-0003-3087-4422; Mavhu, Webster/0000-0003-1881-4398	PSI-Zimbabwe; SIDA-Zimbabwe; UKaid-Zimbabwe; UNICEF-Zimbabwe	PSI-Zimbabwe; SIDA-Zimbabwe; UKaid-Zimbabwe; UNICEF-Zimbabwe	This study was funded through several funders including PSI-Zimbabwe, SIDA-Zimbabwe, UKaid-Zimbabwe and UNICEF-Zimbabwe (no grant numbers used). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey R. C., 2010, 18 INT AIDS C VIENN; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bassett MT, 1996, J ACQ IMMUN DEF SYND, V13, P287, DOI 10.1097/00042560-199611010-00012; Binagwaho A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000211; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; El Bcheraoui C, 2010, 18 INT AIDS C VIENN; Fritz K, 2011, AIDS BEHAV, V15, P1732, DOI 10.1007/s10461-011-9922-1; Glaser B, 1978, DISCOV GROUNDED THEO; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kalichman SC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000219; Kong X, 2011, 18 C RETR OPP INF M; Lukobo MD, 2007, AIDS CARE, V19, P471, DOI 10.1080/09540120601163250; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; Manji KP, 2000, ANN TROP PAEDIATR, V20, P101, DOI 10.1080/02724936.2000.11748116; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; Mavhu W, 2010, TROP MED INT HEALTH, V15, P574, DOI 10.1111/j.1365-3156.2010.02493.x; Mavundla TR, 2009, J TRANSCULT NURS, V20, P395, DOI 10.1177/1043659609340801; Ministry of Health, 2010, STRAT SAF MED MAL CI; Ngalande RC, 2006, AIDS BEHAV, V10, P377, DOI 10.1007/s10461-006-9076-8; Plank RM, 2010, AIDS BEHAV, V14, P1198, DOI 10.1007/s10461-009-9632-0; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; UNICEF, 2011, MED MAL CIRC E SO AF MED MAL CIRC E SO AF; Waters E, 2011, AIDS CARE       0628; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WISWELL TE, 1989, PEDIATRICS, V83, P1011; World Health Organization, 2007, NEW DAT MAL CIRC HIV	29	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32475	10.1371/journal.pone.0032475	http://dx.doi.org/10.1371/journal.pone.0032475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384258	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500094
J	Stoffberg, S; Schoeman, MC; Matthee, CA				Stoffberg, Samantha; Schoeman, M. Corrie; Matthee, Conrad A.			Correlated Genetic and Ecological Diversification in a Widespread Southern African Horseshoe Bat	PLOS ONE			English	Article							ECHOLOCATION CALL FREQUENCIES; SPECIES IDENTIFICATION; CLIMATE-CHANGE; EVOLUTION; CHIROPTERA; MORPHOLOGY; SPECIATION; DISTRIBUTIONS; PLEISTOCENE; ECOREGIONS	The analysis of molecular data within a historical biogeographical framework, coupled with ecological characteristics can provide insight into the processes driving diversification. Here we assess the genetic and ecological diversity within a widespread horseshoe bat Rhinolophus clivosus sensu lato with specific emphasis on the southern African representatives which, although not currently recognized, were previously described as a separate species R. geoffroyi comprising four subspecies. Sequence divergence estimates of the mtDNA control region show that the southern African representatives of R. clivosus s.l. are as distinct from samples further north in Africa than they are from R. ferrumequinum, the sister-species to R. clivosus. Within South Africa, five genetically supported geographic groups exist and these groups are corroborated by echolocation and wing morphology data. The groups loosely correspond to the distributions of the previously defined subspecies and Maxent modelling shows a strong correlation between the detected groups and ecoregions. Based on molecular clock calibrations, it is evident that climatic cycling and related vegetation changes during the Quaternary may have facilitated diversification both genetically and ecologically.	[Stoffberg, Samantha; Matthee, Conrad A.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa; [Schoeman, M. Corrie] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	Stellenbosch University; University of Kwazulu Natal	Stoffberg, S (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa.	samanthastoffberg@gmail.com	Matthee, Conrad A./B-1620-2012; Schoeman, Corrie/G-2616-2010	Matthee, Conrad A./0000-0002-6836-069X; Schoeman, Corrie/0000-0003-3736-0264	University of KwaZulu-Natal; National Research Foundation (NRF); Claude Leon Foundation	University of KwaZulu-Natal; National Research Foundation (NRF); Claude Leon Foundation	This research was supported by grants from the University of KwaZulu-Natal to MCS and the National Research Foundation (NRF) to CAM, and Claude Leon Foundation Postdoctoral Fellowships to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2005, TRENDS ECOL EVOL, V20, P278, DOI 10.1016/j.tree.2005.04.001; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Anthony E.L.P., 1988, P47; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Branch WR, 1998, FIELD GUIDE SNAKES O; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Carruthers V., 2001, FROGS FROGGING SO AF; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021460; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cotterill FPD, 2002, J ZOOL, V256, P165, DOI 10.1017/S0952836902000201; Cowling R. M., 1997, VEGETATION SO AFRICA, P615; Csorba G., 2003, HORSESHOE BATS WORLD; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Francis CM, 2007, ACTA CHIROPTEROL, V9, P1, DOI 10.3161/1733-5329(2007)9[1:ANSOKC]2.0.CO;2; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Goodman SM, 2011, ZOOTAXA, P1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2003, BAT ECOLOGY, P301; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kruskop SV, 2008, RUSSIAN J THERIOL, V7, P71; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Matthee C. A., 1997, Journal of Mammalian Evolution, V4, P53, DOI 10.1023/A:1027331727034; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Miller JM, 2011, CONSERV GENET, V12, P423, DOI 10.1007/s10592-010-0149-x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Monadjem A., 2010, BATS SO CENTRAL AFRI, P596; Mugo DN, 1995, S AFR J ZOOL, V30, P115; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Partridge TC, 1999, QUATERN INT, V57-8, P207, DOI 10.1016/S1040-6182(98)00061-5; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambau RV, 2003, MOL PHYLOGENET EVOL, V28, P564, DOI 10.1016/S1055-7903(03)00058-7; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Roberts A., 1951, MAMMALS S AFRICA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Shi LM, 2009, ACTA THERIOL, V54, P371, DOI 10.4098/j.at.0001-7051.099.2008; SMITHERS RHN, 1983, MAMMALS SO AFRICAN S, P736; Stoffberg S, 2004, CAN J ZOOL, V82, P1854, DOI 10.1139/Z04-172; Stoffberg S, 2007, THESIS U CAPE TOWN S; Stoffberg S, 2010, MOL PHYLOGENET EVOL, V54, P1, DOI 10.1016/j.ympev.2009.09.021; Swart BL, 2009, J BIOGEOGR, V36, P78, DOI 10.1111/j.1365-2699.2008.01988.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Tolley KA, 2009, MOL PHYLOGENET EVOL, V51, P120, DOI 10.1016/j.ympev.2008.11.017; TRAPPE M, 1982, NATURWISSENSCHAFTEN, V69, P193, DOI 10.1007/BF00364902; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; WOLOSZYN B W, 1987, Acta Palaeontologica Polonica, V32, P207	88	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31946	10.1371/journal.pone.0031946	http://dx.doi.org/10.1371/journal.pone.0031946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384108	Green Published, gold			2022-12-25	WOS:000302918500049
J	Valles, SM; Oi, DH; Yu, FH; Tan, XX; Buss, EA				Valles, Steven M.; Oi, David H.; Yu, Fahong; Tan, Xin-Xing; Buss, Eileen A.			Metatranscriptomics and Pyrosequencing Facilitate Discovery of Potential Viral Natural Enemies of the Invasive Caribbean Crazy Ant, Nylanderia pubens	PLOS ONE			English	Article							IMPORTED FIRE ANT; STRAND RNA VIRUS; SOLENOPSIS-INVICTA; GENOME SEQUENCE; DRAFT GENOME; HYMENOPTERA; FORMICIDAE; EVOLUTION; PATHOGENS; TAXONOMY	Background: Nylanderia pubens (Forel) is an invasive ant species that in recent years has developed into a serious nuisance problem in the Caribbean and United States. A rapidly expanding range, explosive localized population growth, and control difficulties have elevated this ant to pest status. Professional entomologists and the pest control industry in the United States are urgently trying to understand its biology and develop effective control methods. Currently, no known biological-based control agents are available for use in controlling N. pubens. Methodology and Principal Findings: Metagenomics and pyrosequencing techniques were employed to examine the transcriptome of field-collected N. pubens colonies in an effort to identify virus infections with potential to serve as control agents against this pest ant. Pyrosequencing (454-platform) of a non-normalized N. pubens expression library generated 1,306,177 raw sequence reads comprising 450 Mbp. Assembly resulted in generation of 59,017 non-redundant sequences, including 27,348 contigs and 31,669 singlets. BLAST analysis of these non-redundant sequences identified 51 of potential viral origin. Additional analyses winnowed this list of potential viruses to three that appear to replicate in N. pubens. Conclusions: Pyrosequencing the transcriptome of field-collected samples of N. pubens has identified at least three sequences that are likely of viral origin and, in which, N. pubens serves as host. In addition, the N. pubens transcriptome provides a genetic resource for the scientific community which is especially important at this early stage of developing a knowledgebase for this new pest.	[Valles, Steven M.; Oi, David H.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Yu, Fahong] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Tan, Xin-Xing] SeqWright, Houston, TX USA; [Buss, Eileen A.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Valles, SM (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA.	steven.valles@ars.usda.gov			USDA-NIFA [2010-34135-21096]	USDA-NIFA(United States Department of Agriculture (USDA))	This research was funded by the USDA-NIFA Tropical and Subtropical Agricultural Research Award # 2010-34135-21096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Calibeo D., 2011, INTEGRATED PEST MANA; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Drees BM, 2009, CURRENT STATUS INVAS, P129; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Farmerie WG, 2005, DATA KNOWL ENG, V53, P75, DOI 10.1016/j.datak.2004.06.014; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Fuxa JR, 1987, EPIZOOTIOLOGY INSECT, P555; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hartley CJ, 2005, J VIROL, V79, P13385, DOI 10.1128/JVI.79.21.13385-13398.2005; Hashimoto Y, 2008, J INVERTEBR PATHOL, V98, P243, DOI 10.1016/j.jip.2008.02.002; Hunnicutt LE, 2006, VIROLOGY, V350, P67, DOI 10.1016/j.virol.2006.02.034; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; JOUVENAZ DP, 1977, FLA ENTOMOL, V60, P275, DOI 10.2307/3493922; JOUVENAZ DP, 1983, FLA ENTOMOL, V66, P111, DOI 10.2307/3494557; JOUVENAZ DP, 1990, APPL MYRMECOLOGY WOR, P623; Kaya, 1993, INSECT PATHOLOGY; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; MacGown J., 2010, Midsouth Entomologist, V3, P44; Meyers J., 2008, IDENTIFICATION DISTR; Oi David H., 2009, V6, P237; Oi DH, 2003, ENVIRON ENTOMOL, V32, P1171, DOI 10.1603/0046-225X-32.5.1171; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; TRAGER JC, 1984, SOCIOBIOLOGY, V9, P51; Valles S. M., 2012, Psyche: A Journal of Entomology, V2012, P821591, DOI 10.1155/2012/821591; Valles SM, 2004, VIROLOGY, V328, P151, DOI 10.1016/j.virol.2004.07.016; Valles SM, 2008, J INVERTEBR PATHOL, V99, P74, DOI 10.1016/j.jip.2008.01.004; Valles SM, 2007, VIROLOGY, V365, P457, DOI 10.1016/j.virol.2007.03.043; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; van Regenmortel M. H. V., 2000, VIRUS TAXONOMY CLASS; WARNER J, 2010, CARIBBEAN CRAZY ANT; Webb BA, 1998, VIRUSES, P105; Wetterer JK, 2008, FLA ENTOMOL, V91, P423, DOI 10.1653/0015-4040(2008)91[423:PEOTHC]2.0.CO;2; Wojcik D.P., 1987, P627; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	43	33	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31828	10.1371/journal.pone.0031828	http://dx.doi.org/10.1371/journal.pone.0031828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384082	Green Published, gold			2022-12-25	WOS:000302918500040
J	Hauser, A; Sewangi, J; Mbezi, P; Dugange, F; Lau, I; Ziske, J; Theuring, S; Kuecherer, C; Harms, G; Kunz, A				Hauser, Andrea; Sewangi, Julius; Mbezi, Paulina; Dugange, Festo; Lau, Inga; Ziske, Judith; Theuring, Stefanie; Kuecherer, Claudia; Harms, Gundel; Kunz, Andrea			Emergence of Minor Drug-Resistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; LONG-TERM PERSISTENCE; VIROLOGICAL FAILURE; ZIDOVUDINE RESISTANCE; TREATMENT-NAIVE; PREGNANT-WOMEN; VIRAL LOAD; THERAPY	Background: WHO-guidelines for prevention of mother-to-child transmission of HIV-1 in resource-limited settings recommend complex maternal antiretroviral prophylaxis comprising antenatal zidovudine (AZT), nevirapine single-dose (NVP-SD) at labor onset and AZT/lamivudine (3TC) during labor and one week postpartum. Data on resistance development selected by this regimen is not available. We therefore analyzed the emergence of minor drug-resistant HIV-1 variants in Tanzanian women following complex prophylaxis. Method: 1395 pregnant women were tested for HIV-1 at Kyela District Hospital, Tanzania. 87/202 HIV-positive women started complex prophylaxis. Blood samples were collected before start of prophylaxis, at birth and 1-2, 4-6 and 12-16 weeks postpartum. Allele-specific real-time PCR assays specific for HIV-1 subtypes A, C and D were developed and applied on samples of mothers and their vertically infected infants to quantify key resistance mutations of AZT (K70R/T215Y/T215F), NVP (K103N/Y181C) and 3TC (M184V) at detection limits of <1%. Results: 50/87 HIV-infected women having started complex prophylaxis were eligible for the study. All women took AZT with a median duration of 53 days (IQR 39-64); all women ingested NVP-SD, 86% took 3TC. HIV-1 resistance mutations were detected in 20/50 (40%) women, of which 70% displayed minority species. Variants with AZT-resistance mutations were found in 11/50 (22%), NVP-resistant variants in 9/50 (18%) and 3TC-resistant variants in 4/50 women (8%). Three women harbored resistant HIV-1 against more than one drug. 49/50 infants, including the seven vertically HIV-infected were breastfed, 3/7 infants exhibited drug-resistant virus. Conclusion: Complex prophylaxis resulted in lower levels of NVP-selected resistance as compared to NVP-SD, but AZT-resistant HIV-1 emerged in a substantial proportion of women. Starting AZT in pregnancy week 14 instead of 28 as recommended by the current WHO-guidelines may further increase the frequency of AZT-resistance mutations. Given its impact on HIV-transmission rate and drug-resistance development, HAART for all HIV-positive pregnant women should be considered.	[Hauser, Andrea; Lau, Inga; Ziske, Judith; Theuring, Stefanie; Harms, Gundel; Kunz, Andrea] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Hauser, Andrea; Kuecherer, Claudia] Robert Koch Inst, Ctr HIV & Retrovirol, Berlin, Germany; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya Reg, Dar Es Salaam, Tanzania; [Mbezi, Paulina] Minist Hlth & Social Welf, PMTCT Serv Mbeya Reg, Dar Es Salaam, Tanzania; [Dugange, Festo] Kyela Dist Hosp, Minist Hlth & Social Welf, Dar Es Salaam, Tanzania	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hauser, A (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	andrea.hauser@charite.de			German Ministry for Economic Cooperation and Development [01.2029.5]; H.W. & J. Hector Stiftung, Germany	German Ministry for Economic Cooperation and Development; H.W. & J. Hector Stiftung, Germany	The work was supported by the German Ministry for Economic Cooperation and Development through project 01.2029.5 (Prevention of Mother-to Child Transmission of HIV) and by a grant of the H.W. & J. Hector Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1992, J VIROL, V66, P5627, DOI 10.1128/JVI.66.9.5627-5630.1992; [Anonymous], HIV DRUG RESISTANCE; [Anonymous], BIOEDIT VERSION 7 0; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Arroyo MA, 2005, AIDS, V19, P1517, DOI 10.1097/01.aids.0000183515.14642.76; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P1525, DOI 10.1128/AAC.37.7.1525; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Clarke JR, 1999, J MED VIROL, V59, P364, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;364::AID-JMV17&gt;3.0.CO;2-V; Coffie PA, 2008, CLIN INFECT DIS, V46, P611, DOI 10.1086/526780; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dykes C, 2004, J INFECT DIS, V189, P1091, DOI 10.1086/382033; Eastman PS, 1998, J INFECT DIS, V177, P557, DOI 10.1086/514228; Ekpini RA, 2002, AIDS, V16, P625, DOI 10.1097/00002030-200203080-00015; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V40, P24, DOI 10.1097/01.qai.0000174656.71276.d6; Farr SL, 2010, JAIDS-J ACQ IMM DEF, V54, P515, DOI 10.1097/QAI.0b013e3181e3a70e; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Frank M, 2011, ANTIMICROB AGENTS CH, V55, P5529, DOI 10.1128/AAC.00741-11; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hauser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020357; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Katzenstein TL, 2008, HIV MED, V9, P445, DOI 10.1111/j.1468-1293.2008.00593.x; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kunz A, 2009, J ANTIMICROB CHEMOTH, V63, P170, DOI 10.1093/jac/dkn441; LAND S, 1992, J INFECT DIS, V166, P1139, DOI 10.1093/infdis/166.5.1139; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; NIELSEN C, 1992, ANTIVIR RES, V18, P303, DOI 10.1016/0166-3542(92)90063-B; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Phillips AN, 2007, AIDS, V21, P1717; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; RICHMAN DD, 1990, J ACQ IMMUN DEF SYND, V3, P743; Roquebert B, 2006, AIDS, V20, P287, DOI 10.1097/01.aids.0000202650.03279.69; Ross LL, 2010, J ANTIMICROB CHEMOTH, V65, P307, DOI 10.1093/jac/dkp419; Rowley CF, 2008, J VIROL METHODS, V149, P69, DOI 10.1016/j.jviromet.2008.01.005; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; SCHENKER S, 1990, AM J MED SCI, V299, P16, DOI 10.1097/00000441-199001000-00005; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; SMITH MS, 1994, LEUKEMIA, V8, pS179; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; The United Republic of Tanzania Ministry of Health and Social Welfare, 2007, PREV MOTH TO CHILD T; Welles SL, 2000, AIDS, V14, P263, DOI 10.1097/00002030-200002180-00008; WHO, 2006, ANT DRUGS TREAT PREG	70	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32055	10.1371/journal.pone.0032055	http://dx.doi.org/10.1371/journal.pone.0032055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384138	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100049
J	Schulte, DM; Muller, N; Neumann, K; Oberhauser, F; Faust, M; Gudelhofer, H; Brandt, B; Krone, W; Laudes, M				Schulte, Dominik M.; Mueller, Nike; Neumann, Katrin; Oberhaeuser, Frank; Faust, Michael; Guedelhoefer, Heike; Brandt, Burkhard; Krone, Wilhelm; Laudes, Matthias			Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INSULIN-RESISTANCE; ADIPOGENESIS; ANTAGONIST; PREADIPOCYTES; MACROPHAGES; MECHANISMS; RECEPTORS; WNT-5A; GENE	Background: Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. Methodology: 23 obese human subjects (BMI 44.1 +/- 1.1 kg/m(2)) and 12 age-and sex-matched lean controls (BMI 22.3 +/- 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Principal Findings: Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 +/- 4.0 to 112.3 +/- 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Conclusions/Significance: Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.	[Schulte, Dominik M.; Mueller, Nike; Neumann, Katrin; Laudes, Matthias] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Oberhaeuser, Frank; Faust, Michael; Guedelhoefer, Heike; Krone, Wilhelm] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany; [Brandt, Burkhard] Univ Kiel, Inst Clin Chem, Kiel, Germany	University of Kiel; University of Cologne; University of Kiel	Schulte, DM (corresponding author), Univ Kiel, Dept Internal Med 1, Kiel, Germany.	matthias.laudes@uk-sh.de	Laudes, Matthias/C-8885-2011; Biguzzi, Felipe A/E-4724-2015; Schulte, Dominik M/G-8653-2013	Schulte, Dominik M/0000-0002-4622-6051				Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Rosenvinge A, 2007, SCAND J RHEUMATOL, V36, P91, DOI 10.1080/03009740601179605; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Schultz O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014328; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wang Chao-Ping, 2007, Rev Diabet Stud, V4, P77, DOI 10.1900/RDS.2007.4.77; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao L, 2011, AM J PHYSIOL-ENDOC M, V301, pE587, DOI 10.1152/ajpendo.00709.2010	27	101	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32437	10.1371/journal.pone.0032437	http://dx.doi.org/10.1371/journal.pone.0032437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384249	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100081
J	Amoureux, MC; Nicolas, S; Rougon, G				Amoureux, Marie-Claude; Nicolas, Stephane; Rougon, Genevieve			NCAM180 Regulates Ric8A Membrane Localization and Potentiates beta-Adrenergic Response	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; HETEROTRIMERIC G-PROTEINS; NULL MUTANT MICE; IMMUNOGLOBULIN SUPERFAMILY; LIPID RAFTS; RIC-8 SYNEMBRYN; PLASMA-MEMBRANE; POLYSIALIC ACID; DENTATE GYRUS; GS-ALPHA	Cooperation between receptors allows integrated intracellular signaling leading to appropriate physiological responses. The Neural Cell Adhesion Molecule (NCAM) has three main isoforms of 120, 140 and 180 kDa, with adhesive and signaling properties, but their respective functions remains to be fully identified. Here we show that the human NCAM180 intracellular domain is a novel interactor of the human guanosine exchange factor (GEF) Ric8A using the yeast two hybrid system and immunoprecipitation. Furthermore, NCAM, Ric8A and G(alpha s) form a tripartite complex. Colocalization experiments by confocal microscopy revealed that human NCAM180 specifically induces the recruitment of Ric8A to the membrane. In addition, using an in vitro recombinant system, and in vivo by comparing NCAM knock-out mouse brain to NCAM heterozygous and wild type brains, we show that NCAM expression dose dependently regulates Ric8A redistribution in detergent resistent membrane microdomains (DRM). Previous studies have demonstrated essential roles for Ric8 in G(alpha) protein activity at G protein coupled receptors (GPCR), during neurotransmitter release and for asymmetric cell division. We observed that inhibition of Ric8A by siRNA or its overexpression, decreases or increases respectively, cAMP production following beta-adrenergic receptor stimulation. Furthermore, in human HEK293T recombinant cells, NCAM180 potentiates the G(alpha s) coupled beta-adrenergic receptor response, in a Ric8A dependent manner, whereas NCAM120 or NCAM140 do not. Finally, in mouse hippocampal neurons expressing endogenously NCAM, NCAM is required for the agonist isoproterenol to induce cAMP production, and this requirement depends on Ric8A. These data illustrate a functional crosstalk between a GPCR and an IgCAM in the nervous system.	[Amoureux, Marie-Claude; Nicolas, Stephane; Rougon, Genevieve] Aix Marseille Univ, CNRS 6216, Inst Biol Dev Marseille Luminy, Marseille, France; [Amoureux, Marie-Claude] Eurobio Abcys, Les Ulis, France	UDICE-French Research Universities; Aix-Marseille Universite	Amoureux, MC (corresponding author), Aix Marseille Univ, CNRS 6216, Inst Biol Dev Marseille Luminy, Marseille, France.	Marie-Claude.Amoureux@ibdml.univmed.fr	ROUGON, Genevieve/G-2578-2013	ROUGON, Genevieve/0000-0003-1316-8200	Canceropole PACA; Federation de Recherche sur le Cerveau (FRC); CNRS	Canceropole PACA(Region Grand-Est); Federation de Recherche sur le Cerveau (FRC); CNRS(Centre National de la Recherche Scientifique (CNRS))	The Canceropole PACA (www.canceropole-paca.fr), Federation de Recherche sur le Cerveau (FRC-www.frc.asso.fr) and institutional grants from CNRS (www.cnrs.fr) provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Brock JA, 1997, BRIT J PHARMACOL, V120, P769, DOI 10.1038/sj.bjp.0700959; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; HIRN M, 1981, BRAIN RES, V214, P433, DOI 10.1016/0006-8993(81)91208-7; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Ma L, 2003, J NEUROSCI, V23, P3164; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marino P, 2009, EXP NEUROL, V219, P163, DOI 10.1016/j.expneurol.2009.05.009; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; MURRAY BA, 1986, J CELL BIOL, V103, P1431, DOI 10.1083/jcb.103.4.1431; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Revest JM, 1999, EUR J NEUROSCI, V11, P1134, DOI 10.1046/j.1460-9568.1999.00521.x; Romo X, 2008, J CELL PHYSIOL, V214, P673, DOI 10.1002/jcp.21257; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Touzet O, 2010, AIDS, V24, P1437, DOI 10.1097/QAD.0b013e32833a6114; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10	39	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32216	10.1371/journal.pone.0032216	http://dx.doi.org/10.1371/journal.pone.0032216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384181	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500086
J	Brusegan, C; Pistocchi, A; Frassine, A; Della Noce, I; Schepis, F; Cotelli, F				Brusegan, Chiara; Pistocchi, Anna; Frassine, Andrea; Della Noce, Isabella; Schepis, Filippo; Cotelli, Franco			ccdc80-l1 Is Involved in Axon Pathfinding of Zebrafish Motoneurons	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; IDENTIFIED MOTONEURONS; HEDGEHOG ACTIVITY; SKELETAL-MUSCLE; SONIC-HEDGEHOG; CELL-MIGRATION; MOTOR AXONS; IN-VIVO; NO TAIL; EXPRESSION	Axon pathfinding is a subfield of neural development by which neurons send out axons to reach the correct targets. In particular, motoneurons extend their axons toward skeletal muscles, leading to spontaneous motor activity. In this study, we identified the zebrafish Ccdc80 and Ccdc80-like1 (Ccdc80-l1) proteins in silico on the basis of their high aminoacidic sequence identity with the human CCDC80 (Coiled-Coil Domain Containing 80). We focused on ccdc80-l1 gene that is expressed in nervous and non-nervous tissues, in particular in territories correlated with axonal migration, such as adaxial cells and muscle pioneers. Loss of ccdc80-l1 in zebrafish embryos induced motility issues, although somitogenesis and myogenesis were not impaired. Our results strongly suggest that ccdc80-l1 is involved in axon guidance of primary and secondary motoneurons populations, but not in their proper formation. ccdc80-l1 has a differential role as regards the development of ventral and dorsal motoneurons, and this is consistent with the asymmetric distribution of the transcript. The axonal migration defects observed in ccdc80-l1 loss-of-function embryos are similar to the phenotype of several mutants with altered Hedgehog activity. Indeed, we reported that ccdc80-l1 expression is positively regulated by the Hedgehog pathway in adaxial cells and muscle pioneers. These findings strongly indicate ccdc80-l1 as a down-stream effector of the Hedgehog pathway.	[Brusegan, Chiara; Pistocchi, Anna; Frassine, Andrea; Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Pistocchi, Anna] Ist Sci San Raffaele, DiBiT, Dipartimento Med Rigenerativa, Milan, Italy; [Della Noce, Isabella; Schepis, Filippo] Univ Modena & Reggio Emilia, Dipartimento Med, Modena, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia	Brusegan, C (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	anna.pistocchi@guest.unimi.it; filippo.schepis@unimore.it; franco.cotelli@unimi.it	Pistocchi, Anna/A-6228-2014; Schepis, Filippo/H-9417-2014	Pistocchi, Anna/0000-0001-9467-2542; Schepis, Filippo/0000-0001-6549-5102				Aoki K, 2002, BIOCHEM BIOPH RES CO, V290, P1282, DOI 10.1006/bbrc.2002.6337; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Beattie CE, 1997, DEV BIOL, V187, P171, DOI 10.1006/dbio.1997.8604; Beattie CE, 2000, BRAIN RES BULL, V53, P489, DOI 10.1016/S0361-9230(00)00382-8; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen WB, 2001, DEVELOPMENT, V128, P2385; de Castro F, 2003, NEWS PHYSIOL SCI, V18, P130, DOI 10.1152/nips.01414.2002; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Eisen JS, 1999, TRENDS NEUROSCI, V22, P321, DOI 10.1016/S0166-2236(98)01370-8; EISEN JS, 1991, DEVELOPMENT, P141; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; Ferragud J, 2011, FEBS LETT, V585, P3041, DOI 10.1016/j.febslet.2011.08.025; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Haffter P, 1996, INT J DEV BIOL, V40, P221; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; HATTA K, 1991, DEVELOPMENT, V112, P821; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lewis KE, 2001, DEVELOPMENT, V128, P3485; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; McKerracher L, 1996, MOL NEUROBIOL, V12, P95, DOI 10.1007/BF02740648; Melancon E, 1997, J NEUROSCI, V17, P7796; Melby AE, 1996, DEVELOPMENT, V122, P2225; Menelaou E, 2008, EUR J NEUROSCI, V28, P1080, DOI 10.1111/j.1460-9568.2008.06418.x; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; PIKE SH, 1992, DEVELOPMENT, V114, P825; Rescan PY, 2001, COMP BIOCHEM PHYS B, V130, P1, DOI 10.1016/S1096-4959(01)00412-2; Roos M, 1999, MECH DEVELOP, V87, P103, DOI 10.1016/S0925-4773(99)00153-7; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schnapp E, 2009, J CELL SCI, V122, P481, DOI 10.1242/jcs.038356; Stickney HL, 2000, DEV DYNAM, V219, P287; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Visconti R, 2003, ONCOGENE, V22, P1087, DOI 10.1038/sj.onc.1206194; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., ZEBRAFISH BOOK GUIDE; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Zeller J, 1999, DEVELOPMENT, V126, P3461	57	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31851	10.1371/journal.pone.0031851	http://dx.doi.org/10.1371/journal.pone.0031851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384085	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500047
J	Chen, TH; Chang, CH; Lin, CY; Jenq, CC; Chang, MY; Tian, YC; Hung, CC; Fang, JT; Yang, CW; Wen, MS; Lin, FC; Chen, YC				Chen, Tien-Hsing; Chang, Chih-Hsiang; Lin, Chan-Yu; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Wen, Ming-Shien; Lin, Fun-Chung; Chen, Yung-Chang			Acute Kidney Injury Biomarkers for Patients in a Coronary Care Unit: A Prospective Cohort Study	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; SERUM CYSTATIN-C; INTERLEUKIN-18; MARKER; IL-18; RISK; CREATININE; PROGNOSIS; DIAGNOSIS	Background: Renal dysfunction is an established predictor of all-cause mortality in intensive care units. This study analyzed the outcomes of coronary care unit (CCU) patients and evaluated several biomarkers of acute kidney injury (AKI), including neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18) and cystatin C (CysC) on the first day of CCU admission. Methodology/Principal Findings: Serum and urinary samples collected from 150 patients in the coronary care unit of a tertiary care university hospital between September 2009 and August 2010 were tested for NGAL, IL-18 and CysC. Prospective demographic, clinical and laboratory data were evaluated as predictors of survival in this patient group. The most common cause of CCU admission was acute myocardial infarction (80%). According to Acute Kidney Injury Network criteria, 28.7% (43/150) of CCU patients had AKI of varying severity. Cumulative survival rates at 6-month follow-up following hospital discharge differed significantly (p<0.05) between patients with AKI versus those without AKI. For predicting AKI, serum CysC displayed an excellent areas under the receiver operating characteristic curve (AUROC) (0.895 +/- 0.031, p<0.001). The overall 180-day survival rate was 88.7% (133/150). Multiple Cox logistic regression hazard analysis revealed that urinary NGAL, serum IL-18, Acute Physiology, Age and Chronic Health Evaluation II (APACHE II) and sodium on CCU admission day one were independent risk factors for 6-month mortality. In terms of 6-month mortality, urinary NGAL had the best discriminatory power, the best Youden index, and the highest overall correctness of prediction. Conclusions: Our data showed that serum CysC has the best discriminative power for predicting AKI in CCU patients. However, urinary NGAL and serum IL-18 are associated with short-term mortality in these critically ill patients.	[Chen, Tien-Hsing; Wen, Ming-Shien; Lin, Fun-Chung] Chang Gung Mem Hosp, Sect Cardiol 2, Taipei 10591, Taiwan; [Chang, Chih-Hsiang; Lin, Chan-Yu; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan; [Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Wen, Ming-Shien; Lin, Fun-Chung; Chen, Yung-Chang] Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chen, TH (corresponding author), Chang Gung Mem Hosp, Sect Cardiol 2, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	cyc2356@adm.cgmh.org.tw	Chang, Jason Chih-Hsiang/P-8662-2017; Chang, Ming-Yang/AGH-5397-2022	Chang, Jason Chih-Hsiang/0000-0002-7342-335X; Chang, Ming-Yang/0000-0001-8899-0376	National Science Council of Taiwan (NSC) [99-2314-B-182A-009-MY3]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 99-2314-B-182A-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cadnapaphornchai MA, 2001, CARDIOLOGY, V96, P122, DOI 10.1159/000047396; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Chen YC, 2011, ANN THORAC SURG, V91, P137, DOI 10.1016/j.athoracsur.2010.08.063; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Heise D, 2011, EUR J CARDIO-THORAC, V39, P38, DOI 10.1016/j.ejcts.2010.05.044; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Herget-Rosenthal S, 2007, CLIN BIOCHEM, V40, P153, DOI 10.1016/j.clinbiochem.2006.10.014; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hoste EAJ, 2010, NEPHROL DIAL TRANSPL, V25, P747, DOI 10.1093/ndt/gfp389; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Krawczeski CD, 2010, CLIN J AM SOC NEPHRO, V5, P1552, DOI 10.2215/CJN.02040310; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Li SX, 2003, BRAIN RES, V992, P76, DOI 10.1016/j.brainres.2003.08.033; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2000, J AM COLL CARDIOL, V36, P679, DOI 10.1016/S0735-1097(00)00774-9; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Perianayagam MC, 2009, AM J KIDNEY DIS, V54, P1025, DOI 10.1053/j.ajkd.2009.05.022; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Thompson SR, 2007, CLIN CHEM, V53, P2078, DOI 10.1373/clinchem.2007.092692; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; TOMLANOVICH S, 1986, AM J KIDNEY DIS, V8, P332, DOI 10.1016/S0272-6386(86)80107-X; Westhuyzen J, 2006, ANN CLIN LAB SCI, V36, P387; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	39	45	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32328	10.1371/journal.pone.0032328	http://dx.doi.org/10.1371/journal.pone.0032328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384218	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500095
J	Ma, Q; Zhang, WW; Zhang, L; Qiao, B; Pan, CS; Yi, H; Wang, LL; Yuan, YJ				Ma, Qian; Zhang, Weiwen; Zhang, Lu; Qiao, Bin; Pan, Chensong; Yi, Hong; Wang, Lili; Yuan, Ying-jin			Proteomic Analysis of Ketogulonicigenium vulgare under Glutathione Reveals High Demand for Thiamin Transport and Antioxidant Protection	PLOS ONE			English	Article							INTRACYTOPLASMIC MEMBRANE FORMATION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; COG DATABASE; PROTEIN; CELL; PYROPHOSPHATE; OXIDATION	Ketogulonicigenium vulgare, though grows poorly when mono-cultured, has been widely used in the industrial production of the precursor of vitamin C with the coculture of Bacillus megaterium. Various efforts have been made to clarify the synergic pattern of this artificial microbial community and to improve the growth and production ability of K. vulgare, but there is still no sound explanation. In previous research, we found that the addition of reduced glutathione into K. vulgare monoculture could significantly improve its growth and productivity. By performing SEM and TEM, we observed that after adding GSH into K. vulgare monoculture, cells became about 4-6 folds elongated, and formed intracytoplasmic membranes (ICM). To explore the molecular mechanism and provide insights into the investigation of the synergic pattern of the coculture system, we conducted a comparative iTRAQ-2-D-LC-MS/MS-based proteomic analysis of K. vulgare grown under reduced glutathione. Principal component analysis of proteomic data showed that after the addition of glutathione, proteins for thiamin/thiamin pyrophosphate (TPP) transport, glutathione transport and the maintenance of membrane integrity, together with several membrane-bound dehydrogenases had significant up-regulation. Besides, several proteins participating in the pentose phosphate pathway and tricarboxylic acid cycle were also up-regulated. Additionally, proteins combating intracellular reactive oxygen species were also up-regulated, which similarly occurred in K. vulgare when the cocultured B. megaterium cells lysed from our former research results. This study reveals the demand for transmembrane transport of substrates, especially thiamin, and the demand for antioxidant protection of K. vulgare.	[Ma, Qian; Zhang, Weiwen; Zhang, Lu; Qiao, Bin; Yuan, Ying-jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Ma, Qian; Zhang, Weiwen; Zhang, Lu; Qiao, Bin; Yuan, Ying-jin] Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Pan, Chensong] Bruker Daltonics Inc, Beijing Off, Beijing, Peoples R China; [Yi, Hong; Wang, Lili] Hebei Univ Sci & Technol, Coll Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Tianjin University; Tianjin University; Nokia Corporation; Pfizer; Hebei University of Science & Technology	Ma, Q (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	wang, lili/HDL-7210-2022	Zhang, Weiwen/0000-0001-8305-5653	National Basic Research Program of China ("973'' Program) [2011CBA00802]; National Natural Science Foundation of China [20736006, 21020102040]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support from the National Basic Research Program of China ("973'' Program: 2011CBA00802), and the National Natural Science Foundation of China (Key Program: 20736006, Major International Joint Research Project: 21020102040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUDRANT J, 1990, ENZYME MICROB TECH, V12, P322, DOI 10.1016/0141-0229(90)90159-N; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Cheng JS, 2009, APPL MICROBIOL BIOT, V83, P909, DOI 10.1007/s00253-009-2037-1; CLAUS GW, 1975, J BACTERIOL, V123, P1169, DOI 10.1128/JB.123.3.1169-1183.1975; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; EATON MW, 1974, BIOCHEM J, V144, P327, DOI 10.1042/bj1440327; Fu SL, 2007, APPL MICROBIOL BIOT, V75, P1127, DOI 10.1007/s00253-007-0930-z; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hancock Robert D, 2009, Recent Pat Food Nutr Agric, V1, P39; HEEFNER DL, 1976, J BACTERIOL, V125, P1163, DOI 10.1128/JB.125.3.1163-1171.1976; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Leduc S, 2004, APPL MICROBIOL BIOT, V65, P163, DOI 10.1007/s00253-004-1562-1; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Li ZJ, 2010, ADV BIOCHEM ENG BIOT, V122, P1, DOI 10.1007/10_2010_76; Lin FM, 2009, PROTEOMICS, V9, P5471, DOI 10.1002/pmic.200900100; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; MCCANDLESS DW, 1982, ANN NY ACAD SCI, V378, P355, DOI 10.1111/j.1749-6632.1982.tb31210.x; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miyazaki T, 2006, APPL ENVIRON MICROB, V72, P1487, DOI 10.1128/AEM.72.2.1487-1495.2006; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; RIDGWAY HF, 1981, APPL ENVIRON MICROB, V41, P274, DOI 10.1128/AEM.41.1.274-287.1981; RINDI G, 1966, J NUTR, V89, P197, DOI 10.1093/jn/89.2.197; SAUBERLICH HE, 1994, ANNU REV NUTR, V14, P371, DOI 10.1146/annurev.nu.14.070194.002103; Smirnova GV, 2000, FREE RADICAL BIO MED, V28, P1009, DOI 10.1016/S0891-5849(99)00256-7; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Szent-Gyorgyi A, 1928, BIOCHEM J, V22, P1387, DOI 10.1042/bj0221387; Takagi Y, 2010, APPL MICROBIOL BIOT, V86, P469, DOI 10.1007/s00253-009-2312-1; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993; Urbance JW, 2001, INT J SYST EVOL MICR, V51, P1059, DOI 10.1099/00207713-51-3-1059; Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946; WHITE SA, 1982, J BACTERIOL, V150, P934, DOI 10.1128/JB.150.2.934-943.1982; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yin GL, 1990, United States Patent, Patent No. 4935359; Yuan YJ, 2009, China Patent, Patent No. [CN200910069697.7, 2009100696977]; Zangen A, 1997, BIOCHEM PHARMACOL, V54, P575, DOI 10.1016/S0006-2952(97)00178-0; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhang WC, 2003, China Patent, Patent No. [CN03102060.7, 031020607]; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11	48	28	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32156	10.1371/journal.pone.0032156	http://dx.doi.org/10.1371/journal.pone.0032156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384164	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500078
J	Banfi, A; von Degenfeld, G; Gianni-Barrera, R; Reginato, S; Merchant, MJ; McDonald, DM; Blau, HM				Banfi, Andrea; von Degenfeld, Georges; Gianni-Barrera, Roberto; Reginato, Silvia; Merchant, Milton J.; McDonald, Donald M.; Blau, Helen M.			Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB	FASEB JOURNAL			English	Article						ischemia; gene therapy; adenoviral vectors	FUNCTIONAL VESSEL GROWTH; GENE-THERAPY; PERICYTE COVERAGE; FLOW-CYTOMETRY; BLOOD-FLOW; PURIFICATION; VASCULATURE; RECRUITMENT; COMBINATION; DETERMINES	Therapeutic angiogenesis by delivery of vascular growth factors is an attractive strategy for treating debilitating occlusive vascular diseases, yet clinical trials have thus far failed to show efficacy. As a result, limb amputation remains a common outcome for muscle ischemia due to severe atherosclerotic disease, with an overall incidence of 100 per million people in the United States per year. A challenge has been that the angiogenic master regulator vascular endothelial growth factor (VEGF) induces dysfunctional vessels, if expressed outside of a narrow dosage window. We tested the hypothesis that codelivery of platelet-derived growth factor-BB (PDGF-BB), which recruits pericytes, could induce normal angiogenesis in skeletal muscle irrespective of VEGF levels. Coexpression of VEGF and PDGF-BB encoded by separate vectors in different cells or in the same cells only partially corrected aberrant angiogenesis. In marked contrast, coexpression of both factors in every cell at a fixed relative level via a single bicistronic vector led to robust, uniformly normal angiogenesis, even when VEGF expression was high and heterogeneous. Notably, in an ischemic hindlimb model, single-vector expression led to efficient growth of collateral arteries, revascularization, increased blood flow, and reduced tissue damage. Furthermore, these results were confirmed in a clinically applicable gene therapy approach by adenoviral-mediated delivery of the bicistronic vector. We conclude that coordinated expression of VEGF and PDGF-BB via a single vector constitutes a novel strategy for harnessing the potency of VEGF to induce safe and efficacious angiogenesis.-Banfi, A., von Degenfeld, G., Gianni-Barrera, R., Reginato, S., Merchant, M. J., McDonald, D. M., Blau, H. M. Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB. FASEB J. 26, 2486-2497 (2012). www.fasebj.org	[Blau, Helen M.] Stanford Univ, Baxter Lab Stem Cell Biol, Inst Regenerat Med & Stem Cell Biol, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA; [Banfi, Andrea; Gianni-Barrera, Roberto; Reginato, Silvia] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Banfi, Andrea; Gianni-Barrera, Roberto; Reginato, Silvia] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland; [McDonald, Donald M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [McDonald, Donald M.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [McDonald, Donald M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Stanford University; University of Basel; University of Basel; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Blau, HM (corresponding author), Stanford Univ, Baxter Lab Stem Cell Biol, Inst Regenerat Med & Stem Cell Biol, Dept Microbiol & Immunol,Sch Med, CCSR 4216,269 Campus Dr, Stanford, CA 94305 USA.	abanfi@uhbs.ch; hblau@stanford.edu	Gianni-Barrera, Roberto/ACU-4280-2022; Banfi, Andrea/B-8720-2008	Gianni-Barrera, Roberto/0000-0001-6303-4513; Banfi, Andrea/0000-0001-5737-8811	American Heart Association [043031]; Swiss National Science Foundation [310030-127426]; EU [CP-IP 214402]; Deutsche-Forschungsgemeinschaft [DE 740/1-1]; U.S. National Institutes of Health (NIH) [HL-24136, HL-59157, CA-082923]; NIH [AG-009521, HL-065572, AG-020961, AG-024987]; Baxter Foundation; NATIONAL CANCER INSTITUTE [R01CA082923] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, P01HL024136, R01HL059157, R01HL065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG009521, R01AG024987, R01AG020961] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Deutsche-Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank N. Di Maggio (Basel University Hospital, Basel, Switzerland) for critical comments on the manuscript, P. Lindblom (Karolinska Institute, Stockholm, Sweden) for the hPDGFb cDNA, and L. T. Williams (University of California, San Francisco, CA, USA) for the sPDGFR-beta cDNA. This work was supported by an American Heart Association Scientist Development grant (043031), a Swiss National Science Foundation grant (310030-127426), and the EU FP7 grant ANGIOSCAFF (CP-IP 214402) to A. B.; by a Deutsche-Forschungsgemeinschaft grant (DE 740/1-1) to G. V. D.; by U.S. National Institutes of Health (NIH) grants HL-24136, HL-59157 and CA-082923 to D. M. M.; and by NIH grants AG-009521, HL-065572, AG-020961, and AG-024987 and support from the Baxter Foundation to H. M. B. The authors declare no conflicts of interest.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Bamberg F, 2012, INVEST RADIOL, V47, P71, DOI 10.1097/RLI.0b013e31823fd42b; Banfi Andrea, 2005, Curr Atheroscler Rep, V7, P227, DOI 10.1007/s11883-005-0011-7; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; DUAN DSR, 1991, J BIOL CHEM, V266, P413; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Gueret V, 2002, CYTOTECHNOLOGY, V38, P87, DOI 10.1023/A:1021106116887; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Karvinen H, 2010, CURR OPIN PHARMACOL, V10, P208, DOI 10.1016/j.coph.2010.01.004; Korpisalo P, 2008, CIRC RES, V103, P1092, DOI 10.1161/CIRCRESAHA.108.182287; Korpisalo P, 2010, INTEGR BIOL-UK, V2, P102, DOI 10.1039/b921869f; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Misteli H, 2010, STEM CELLS, V28, P611, DOI 10.1002/stem.291; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rissanen TT, 2005, CIRCULATION, V112, P3937, DOI 10.1161/CIRCULATIONAHA.105.543124; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje; Yla-Herttuala S, 2004, TRENDS CARDIOVAS MED, V14, P295, DOI 10.1016/j.tcm.2004.09.001; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053	32	67	71	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2486	2497		10.1096/fj.11-197400	http://dx.doi.org/10.1096/fj.11-197400			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22391130	Green Published			2022-12-25	WOS:000305017200025
J	Tzenaki, N; Andreou, M; Stratigi, K; Vergetaki, A; Makrigiannakis, A; Vanhaesebroeck, B; Papakonstanti, EA				Tzenaki, Niki; Andreou, Margarita; Stratigi, Kalliopi; Vergetaki, Aikaterini; Makrigiannakis, Antonis; Vanhaesebroeck, Bart; Papakonstanti, Evangelia A.			High levels of p110 delta PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110 delta inhibitors through PTEN activation	FASEB JOURNAL			English	Article						breast; prostate	GENETIC ALTERATIONS; PATHWAY; PIK3CA; CANCER; MUTATIONS; SUBUNIT; PHOSPHORYLATION; TRANSFORMATION; STABILITY; ONCOGENE	Class IA PI3K isoforms have divergent, nonredundant cell biological roles. In untransformed cells and tissues, p110 alpha and p110 beta are ubiquitously expressed, whereas p110 delta expression is highly enriched in leukocytes. High levels of p110 delta expression have been documented in some solid tumor cell lines, but the functional role is unknown. This study aimed to elucidate the link between elevated expression of p110 delta PI3K and cancer. We report that in breast and prostate cancer cells that contain leukocyte levels of p110 delta, p110 delta activity dampens the activity of the PTEN tumor suppressor. Indeed, inactivation of p110 delta in these cells led to PTEN activation, suppression of Akt phosphorylation, and inhibition of cell proliferation, with inhibition of PTEN activity being able to counterbalance p110 delta inactivation. Likewise, forced overexpression of p110 delta in cells with low p110 delta expression reduced PTEN activity, resulting in increased Akt phosphorylation. Our data indicate that the oncogenic potential of p110 delta PI3K overexpression might at least partially act through PTEN inactivation, and that p110 delta-selective PI3K inhibitors can have a dual antitumor mechanism, namely by directly inhibiting p110 delta signaling and by a broader inhibition of class I PI3K activity through PTEN activation. These data may have important implications in the intervention of breast cancer.-Tzenaki, N., Andreou, M., Stratigi, K., Vergetaki, A., Makrigiannakis, A., Vanhaesebroeck, B., Papakonstanti, E. A. High levels of p110 delta PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110 delta inhibitors through PTEN activation. FASEB J. 26, 2498-2508 (2012). www.fasebj.org	[Tzenaki, Niki; Andreou, Margarita; Stratigi, Kalliopi; Papakonstanti, Evangelia A.] Univ Crete, Dept Biochem, Sch Med, GR-71110 Iraklion, Greece; [Vergetaki, Aikaterini; Makrigiannakis, Antonis] Univ Crete, Dept Obstet & Gynecol, Sch Med, GR-71110 Iraklion, Greece; [Vanhaesebroeck, Bart] Univ London, Ctr Cell Signalling, Barts Canc Inst, London, England	University of Crete; University of Crete; University of London; Queen Mary University London	Papakonstanti, EA (corresponding author), Univ Crete, Dept Biochem, Sch Med, GR-71110 Iraklion, Greece.	epapak@med.uoc.gr		Makrigiannakis, Antonis/0000-0002-8475-1500; Papakonstanti, Evangelia/0000-0002-7119-6026	Research Committee of University of Crete [KA 2564, KA 2999, KA 3506, KA 3001]; Cancer Research UK [C23338/A10200]; European Reintegration grant [MERG-CT-2006-044916]	Research Committee of University of Crete; Cancer Research UK(Cancer Research UK); European Reintegration grant	The authors thank Christian Rommel, Thomas Ruckle, and Montserrat Camps (Merck, Geneva, Switzerland) as well as Kevan Shokat (University of California, San Francisco, CA, USA) for pharmacological agents. The authors are also grateful to Jozsef Konya (University of Debrecen, Debrecen, Hungary) for cervical cancer cell lines, Ines Koch (Charite University Hospital, Berlin, Germany) for ovarian cancer cell lines, Antonio Bilancio and Ciro Abbondanza (II Universita' di Napoli, Naples, Italy) for the ZR-75 cell line, El-Nasir Lalani and Hanna Romanska (University of Birmingham, Birmingham, UK) for prostate cancer cell lines, Nicholas Pavlidis (Medical School, University of Ioannina, Ioannina, Greece) for the human cancer tissues, Tim Fenton (Ludwig Institute for Cancer Research, University of California, San Diego, CA, USA) for pBabe-puro p110 delta construct and Gemma Nock (Centre for Cell Signaling, Barts Cancer Institute, Queen Mary, University of London) for transfection experiments. N.T. is supported by the Research Committee of the University of Crete (KA 2999). This work was supported by the European Reintegration grant (MERG-CT-2006-044916) awarded to E. A. P. and by the Research Committee of the University of Crete (KA 2564, KA 2999, KA 3506, and KA 3001). Part of this work was supported by Cancer Research UK (C23338/A10200).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benistant C, 2000, ONCOGENE, V19, P5083, DOI 10.1038/sj.onc.1203871; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; DUFF RG, 1969, VIROLOGY, V39, P18, DOI 10.1016/0042-6822(69)90344-4; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Jiang XN, 2010, J BIOL CHEM, V285, P14980, DOI 10.1074/jbc.M109.085696; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Kok K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005145; Koul D, 2002, ONCOGENE, V21, P2357, DOI 10.1038/sj/onc/1205296; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sawyer C, 2003, CANCER RES, V63, P1667; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Whitehead MA, 2012, BIOCHEM J, V443, P857, DOI 10.1042/BJ20112214; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026	40	33	34	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2498	2508		10.1096/fj.11-198192	http://dx.doi.org/10.1096/fj.11-198192			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22391131				2022-12-25	WOS:000305017200026
J	Santhekadur, PK; Das, SK; Gredler, R; Chen, D; Srivastava, J; Robertson, C; Baldwin, AS; Fisher, PB; Sarkar, D				Santhekadur, Prasanna Kumar; Das, Swadesh K.; Gredler, Rachel; Chen, Dong; Srivastava, Jyoti; Robertson, Chadia; Baldwin, Albert S., Jr.; Fisher, Paul B.; Sarkar, Devanand			Multifunction Protein Staphylococcal Nuclease Domain Containing 1 (SND1) Promotes Tumor Angiogenesis in Human Hepatocellular Carcinoma through Novel Pathway That Involves Nuclear Factor kappa B and miR-221	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE INTRAEPITHELIAL NEOPLASIA; CANCER PROGRESSION; P100; EXPRESSION; COACTIVATOR; METASTASIS; ACTIVATION; COMPONENT; TUDOR; AKT	Staphylococcal nuclease domain-containing 1 (SND1) is a multifunctional protein that is overexpressed in multiple cancers, including hepatocellular carcinoma (HCC). Stable overexpression of SND1 in Hep3B cells expressing a low level of SND1 augments, whereas stable knockdown of SND1 in QGY-7703 cells expressing a high level of SND1 inhibits establishment of xenografts in nude mice, indicating that SND1 promotes an aggressive tumorigenic phenotype. In this study we analyzed the role of SND1 in regulating tumor angiogenesis, a hallmark of cancer. Conditioned medium from Hep3B-SND1 cells stably overexpressing SND1 augmented, whereas that from QGY-SND1si cells stably overexpressing SND1 siRNA significantly inhibited angiogenesis, as analyzed by a chicken chorioallantoic membrane assay and a human umbilical vein endothelial cell differentiation assay. We unraveled a linear pathway in which SND1-induced activation of NF-kappa B resulted in induction of miR-221 and subsequent induction of angiogenic factors Angiogenin and CXCL16. Inhibition of either of these components resulted in significant inhibition of SND1-induced angiogenesis, thus highlighting the importance of this molecular cascade in regulating SND1 function. Because SND1 regulates NF-kappa B and miR-221, two important determinants of HCC controlling the aggressive phenotype, SND1 inhibition might be an effective strategy to counteract this fatal malady.	[Santhekadur, Prasanna Kumar; Das, Swadesh K.; Gredler, Rachel; Srivastava, Jyoti; Robertson, Chadia; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA; [Chen, Dong] Virginia Commonwealth Univ, Dept Pathol, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Inst Mol Med, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Baldwin, Albert S., Jr.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, 1220 E Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Srivastava, Jyoti/AAD-7610-2022; chen, dong/A-6889-2012; SRIVASTAVA, JYOTI/J-6065-2014; Santhekadur, Prasanna/O-7006-2019	chen, dong/0000-0001-6661-9410; SRIVASTAVA, JYOTI/0000-0002-5727-741X; Santhekadur, Prasanna/0000-0003-3338-375X	Dana Foundation; James S. McDonnell Foundation; Massey Cancer Center; National Cancer Institute [R01 CA138540, R01 CA134721]; NATIONAL CANCER INSTITUTE [R01CA138540, R01CA134721] Funding Source: NIH RePORTER	Dana Foundation; James S. McDonnell Foundation; Massey Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Dana Foundation, the James S. McDonnell Foundation, a Massey Cancer Center pilot project grant, and National Cancer Institute Grants R01 CA138540 (to D. S.) and R01 CA134721 (to P. B. F.).	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chandrasekar B, 2004, J BIOL CHEM, V279, P3188, DOI 10.1074/jbc.M311660200; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hartmann A, 1999, CANCER RES, V59, P1578; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li SP, 2012, J CELL PHYSIOL, V227, P1639, DOI 10.1002/jcp.22881; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Pang R, 2006, CANCER LETT, V242, P151, DOI 10.1016/j.canlet.2006.01.008; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Paukku K, 2008, NUCLEIC ACIDS RES, V36, P4474, DOI 10.1093/nar/gkn411; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Shimoyama S, 1999, CLIN CANCER RES, V5, P1125; Shimoyama S, 1996, CANCER RES, V56, P2703; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; TONG X, 1995, MOL CELL BIOL, V15, P4735; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	38	104	108	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13952	13958		10.1074/jbc.M111.321646	http://dx.doi.org/10.1074/jbc.M111.321646			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396537	hybrid, Green Published			2022-12-25	WOS:000303996300050
J	Ghosh, P; Hsu, CY; Alyamani, EJ; Shehata, MM; Al-Dubaib, MA; Al-Naeem, A; Hashad, M; Mahmoud, OM; Alharbi, KBJ; Al-Busadah, K; Al-Swailem, AM; Talaat, AM				Ghosh, Pallab; Hsu, Chungyi; Alyamani, Essam J.; Shehata, Maher M.; Al-Dubaib, Musaad A.; Al-Naeem, Abdulmohsen; Hashad, Mahmoud; Mahmoud, Osama M.; Alharbi, Khalid B. J.; Al-Busadah, Khalid; Al-Swailem, Abdulaziz M.; Talaat, Adel M.			Genome-Wide Analysis of the Emerging Infection with Mycobacterium avium Subspecies paratuberculosis in the Arabian Camels (Camelus dromedarius)	PLOS ONE			English	Article							JOHNES-DISEASE; SEQUENCE; POLYMORPHISMS; PATHOLOGY; INSERTION; IDENTIFICATION; RESTRICTION; CULTURE; EPITOPE; CLONES	Mycobacterium avium subspecies paratuberculosis (M. ap) is the causative agent of paratuberculosis or Johne's disease (JD) in herbivores with potential involvement in cases of Crohn's disease in humans. JD is spread worldwide and is economically important for both beef and dairy industries. Generally, pathogenic ovine strains (M. ap-S) are mainly found in sheep while bovine strains (M. ap-C) infect other ruminants (e.g. cattle, goat, deer), as well as sheep. In an effort to characterize this emerging infection in dromedary/Arabian camels, we successfully cultured M. ap from several samples collected from infected camels suffering from chronic, intermittent diarrhea suggestive of JD. Gene-based typing of isolates indicated that all isolates belong to sheep lineage of strains of M. ap (M. ap-S), suggesting a putative transmission from infected sheep herds. Screening sheep and goat herds associated with camels identified the circulation of this type in sheep but not goats. The current genome-wide analysis recognizes these camel isolates as a sub-lineage of the sheep strain with a significant number of single nucleotide polymorphisms (SNPs) between sheep and camel isolates (similar to 1000 SNPs). Such polymorphism could represent geographical differences among isolates or host adaptation of M. ap during camel infection. To our knowledge, this is the first attempt to examine the genomic basis of this emerging infection in camels with implications on the evolution of this important pathogen. The sequenced genomes of M. ap isolates from camels will further assist our efforts to understand JD pathogenesis and the dynamic of disease transmission across animal species.	[Ghosh, Pallab; Hsu, Chungyi; Talaat, Adel M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Alyamani, Essam J.; Shehata, Maher M.; Al-Swailem, Abdulaziz M.] King Abdulaziz City Sci & Technol, Natl Biotechnol Ctr, Riyadh, Saudi Arabia; [Al-Dubaib, Musaad A.; Hashad, Mahmoud; Mahmoud, Osama M.; Alharbi, Khalid B. J.] Qassim Univ, Coll Agr & Vet Med, Qasim, Saudi Arabia; [Al-Naeem, Abdulmohsen; Al-Busadah, Khalid] King Faisal Univ, Coll Vet Med & Anim Resources, Al Hasa, Saudi Arabia; [Talaat, Adel M.] Univ Wisconsin, Lab Bacterial Genom, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; King Abdulaziz City for Science & Technology; Qassim University; King Faisal University; University of Wisconsin System; University of Wisconsin Madison	Ghosh, P (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	alswailem@kacst.edu.sa; atalaat@wisc.edu	Ghosh, Pallab/I-6140-2018; Alharbi, Khalid Khalaf/GYV-3906-2022	Ghosh, Pallab/0000-0002-1346-407X; Alharbi, Khalid Khalaf/0000-0001-8355-5033; Alharbi, Khaled/0000-0003-4083-8644; Al-Swailem, Abdulaziz/0000-0002-9484-5973	King Abdulaziz City of Science and Technology (KACST), Saudi Arabia; United States Department of Agriculture (USDA) [NRI 2007-35204-18400]; U.S.-Egypt Joint Board on Scientific and Technological Cooperation [1937]	King Abdulaziz City of Science and Technology (KACST), Saudi Arabia; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); U.S.-Egypt Joint Board on Scientific and Technological Cooperation(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund)	This work was supported by funds from King Abdulaziz City of Science and Technology (KACST), Saudi Arabia, NRI 2007-35204-18400 from the United States Department of Agriculture (USDA) and U.S.-Egypt Joint Board on Scientific and Technological Cooperation, grant # 1937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hizab FA, 2010, J CAMEL PRACT RES, V17, P31; Alexander DC, 2009, J BACTERIOL, V191, P1018, DOI 10.1128/JB.01340-08; Alharbi KB, 2012, TROP ANIM HEALTH PRO, V44, P173, DOI 10.1007/s11250-011-9905-2; Alhebabi A. M., 2010, Open Veterinary Science Journal, V4, P41, DOI 10.2174/1874318801004010041; Almubarak AI, 2007, J ANIM VET ADV, V6, P33; Amand W. B., 1974, American Association of Zoo Veterinarians. Annual proceedings, 1974., P150; [Anonymous], 2003, CODE PRACTICE CAMELS; Bannantine JP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00163; Bannantine JP, 2011, CLIN VACCINE IMMUNOL, V18, P105, DOI 10.1128/CVI.00297-10; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Bush RD, 2006, AUST VET J, V84, P246, DOI 10.1111/j.1751-0813.2006.00001.x; Castellanos E, 2007, J CLIN MICROBIOL, V45, P3439, DOI 10.1128/JCM.01411-07; Castellanos E, 2009, APPL ENVIRON MICROB, V75, P676, DOI 10.1128/AEM.01683-08; CHIODINI RJ, 1984, CORNELL VET, V74, P218; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Clarke CJ, 1996, J COMP PATHOL, V114, P419, DOI 10.1016/S0021-9975(96)80017-X; COLLINS MT, 1991, J AM VET MED ASSOC, V199, P1724; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Juan L, 2006, APPL ENVIRON MICROB, V72, P5927, DOI 10.1128/AEM.00451-06; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; Harboe M, 2004, SCAND J IMMUNOL, V59, P190, DOI 10.1111/j.0300-9475.2004.01383.x; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Losinger WC, 2005, J DAIRY RES, V72, P425, DOI 10.1017/S0022029905001007; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; National Animal Health Monitoring System, 2008, JOHN DIS US DAIR 199; NEI M, 1986, MOL BIOL EVOL, V3, P418; PALING RW, 1988, J WILDLIFE DIS, V24, P308, DOI 10.7589/0090-3558-24.2.308; Pasricha R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-41; Ramadan R.O., 1994, SURG RADIOLOGY DROME, V1; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; SAXEGAARD F, 1990, J COMP PATHOL, V102, P149, DOI 10.1016/S0021-9975(08)80120-X; Semret M, 2005, J CLIN MICROBIOL, V43, P3704, DOI 10.1128/JCM.43.8.3704-3712.2005; Sivakumar P, 2006, VET PATHOL, V43, P455, DOI 10.1354/vp.43-4-455; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Smole SC, 2002, J CLIN MICROBIOL, V40, P3374, DOI 10.1128/JCM.40.9.3374-3380.2002; Stevenson K, 2002, J CLIN MICROBIOL, V40, P1798, DOI 10.1128/JCM.40.5.1798-1804.2002; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; Talaat AM, 1997, VET MICROBIOL, V58, P229, DOI 10.1016/S0378-1135(97)00120-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR AW, 1953, J COMP PATHOL THERAP, V63, P368, DOI 10.1016/S0368-1742(53)80038-X; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Whittington R, 1998, MOL CELL PROBE, V12, P349, DOI 10.1006/mcpr.1998.0194; Whittington RJ, 1999, J CLIN MICROBIOL, V37, P1077, DOI 10.1128/JCM.37.4.1077-1083.1999; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x; Wu CW, 2007, J BACTERIOL, V189, P7877, DOI 10.1128/JB.00780-07; Wu CW, 2007, INFECT IMMUN, V75, P2110, DOI 10.1128/IAI.01739-06; Wu CW, 2006, J BACTERIOL, V188, P711, DOI 10.1128/JB.188.2.711-723.2006; Wynne JW, 2010, J BACTERIOL, V192, P6319, DOI 10.1128/JB.00972-10	50	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31947	10.1371/journal.pone.0031947	http://dx.doi.org/10.1371/journal.pone.0031947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393374	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500027
J	Katz, AM; Amankulor, NM; Pitter, K; Helmy, K; Squatrito, M; Holland, EC				Katz, Amanda M.; Amankulor, Nduka M.; Pitter, Ken; Helmy, Karim; Squatrito, Massimo; Holland, Eric C.			Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; MOLECULE TENASCIN-C; VASCULAR NICHE; ANTIGEN PRESENTATION; SUBVENTRICULAR ZONE; REACTIVE GLIOSIS; PRECURSOR CELLS; GLIOBLASTOMA	Background: The tumor microenvironment contains normal, non-neoplastic cells that may contribute to tumor growth and maintenance. Within PDGF-driven murine gliomas, tumor-associated astrocytes (TAAs) are a large component of the tumor microenvironment. The function of non-neoplastic astrocytes in the glioma microenvironment has not been fully elucidated; moreover, the differences between these astrocytes and normal astrocytes are unknown. We therefore sought to identify genes and pathways that are increased in TAAs relative to normal astrocytes and also to determine whether expression of these genes correlates with glioma behavior. Methodology/Principal Findings: We compared the gene expression profiles of TAAs to normal astrocytes and found the Antigen Presentation Pathway to be significantly increased in TAAs. We then identified a gene signature for glioblastoma (GBM) TAAs and validated the expression of some of those genes within the tumor. We also show that TAAs are derived from the non-tumor, stromal environment, in contrast to the Olig2+ tumor cells that constitute the neoplastic elements in our model. Finally, we validate this GBM TAA signature in patients and show that a TAA-derived gene signature predicts survival specifically in the human proneural subtype of glioma. Conclusions/Significance: Our data identifies unique gene expression patterns between populations of TAAs and suggests potential roles for stromal astrocytes within the glioma microenvironment. We show that certain stromal astrocytes in the tumor microenvironment express a GBM-specific gene signature and that the majority of these stromal astrocyte genes can predict survival in the human disease.	[Katz, Amanda M.; Pitter, Ken] Cornell Univ, Biochem Cell & Mol Biol Program, Weill Med Coll, New York, NY 10021 USA; [Katz, Amanda M.; Amankulor, Nduka M.; Pitter, Ken; Helmy, Karim; Squatrito, Massimo; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Katz, Amanda M.; Amankulor, Nduka M.; Pitter, Ken; Helmy, Karim; Squatrito, Massimo; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Amankulor, Nduka M.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Amankulor, Nduka M.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Amankulor, Nduka M.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Katz, AM (corresponding author), Cornell Univ, Biochem Cell & Mol Biol Program, Weill Med Coll, New York, NY 10021 USA.	hollande@mskcc.org	Squatrito, Massimo/F-4149-2016; Amankulor, Nduka/CAJ-3564-2022	Squatrito, Massimo/0000-0002-4593-3790; Pitter, Kenneth/0000-0002-9450-313X	National Institutes of Health (NIH) [U54 CA163167, U01 CA141502, U54 CA143798, RO1 CA100688]; NATIONAL CANCER INSTITUTE [R01CA100688, U01CA141502, U54CA143798, U54CA163167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants U54 CA163167, U01 CA141502, U54 CA143798, and RO1 CA100688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Barker Alison J, 2008, Commun Integr Biol, V1, P207; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; FIERZ W, 1985, J IMMUNOL, V134, P3785; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kazanis I, 2007, J NEUROSCI, V27, P13991, DOI 10.1523/JNEUROSCI.3279-07.2007; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McCarthy BJ, 2005, NEURO-ONCOLOGY, V7, P196, DOI 10.1215/S115285170400050X; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Preusser M, 2007, HISTOPATHOLOGY, V50, P365, DOI 10.1111/j.1365-2559.2007.02614.x; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Shrikant P, 1996, J IMMUNOL, V157, P1819; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; YONG VW, 1991, J NEUROPATH EXP NEUR, V50, P16, DOI 10.1097/00005072-199101000-00002; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	50	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32453	10.1371/journal.pone.0032453	http://dx.doi.org/10.1371/journal.pone.0032453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393407	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500060
J	Mannocci, L; Dabin, W; Augeraud-Veron, E; Dupuy, JF; Barbraud, C; Ridoux, V				Mannocci, Laura; Dabin, Willy; Augeraud-Veron, Emmanuelle; Dupuy, Jean-Francois; Barbraud, Christophe; Ridoux, Vincent			Assessing the Impact of Bycatch on Dolphin Populations: The Case of the Common Dolphin in the Eastern North Atlantic	PLOS ONE			English	Article							DELPHINUS-DELPHIS; VIABILITY ANALYSIS; MORTALITY; MODEL; CONSERVATION; UNCERTAINTY; ELASTICITY; PARAMETERS; CETACEANS; FISHERIES	Fisheries interactions have been implicated in the decline of many marine vertebrates worldwide. In the eastern North Atlantic, at least 1000 common dolphins (Delphinus delphis) are bycaught each year, particularly in pelagic pair-trawls. We have assessed the resulting impact of bycatch on this population using a demographic modeling approach. We relied on a sample of females stranded along the French Atlantic and western Channel coasts. Strandings represent an extensive source of demographic information to monitor our study population. Necropsy analysis provided an estimate of individual age and reproductive state. Then we estimated effective survivorship (including natural and human-induced mortality), age at first reproduction and pregnancy rates. Reproductive parameters were consistent with literature, but effective survivorship was unexpectedly low. Demographic parameters were then used as inputs in two models. A constant parameter matrix proposed an effective growth rate of -5.5 +/- 0.5%, corresponding to the current situation (including bycatch mortality). Subsequently, deterministic projections suggested that the population would be reduced to 20% of its current size in 30 years and would be extinct in 100 years. The demographic invariant model suggested a maximum growth rate of +4.5 +/- 0.09%, corresponding to the optimal demographic situation. Then, a risk analysis incorporating Potential Biological Removal (PBR), based on two plausible scenarii for stock structure suggested that bycatch level was unsustainable for the neritic population of the Bay of Biscay under a two-stock scenario. In depth assessment of stock structure and improved observer programs to provide scientifically robust bycatch estimates are needed. Effective conservation measures would be reducing bycatch to less than 50% of the current level in the neritic stock to reach PBR. Our approach provided indicators of the status and trajectory of the common dolphin population in the eastern North Atlantic and therefore proved to be a valuable tool for management, applicable to other dolphin populations.	[Mannocci, Laura; Ridoux, Vincent] Univ La Rochelle, CNRS, UMR 7266, La Rochelle, France; [Dabin, Willy; Barbraud, Christophe; Ridoux, Vincent] Univ La Rochelle, CNRS, Observ Pelagis, UMS 3462, La Rochelle, France; [Barbraud, Christophe] CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS)	Mannocci, L (corresponding author), Univ La Rochelle, CNRS, UMR 7266, La Rochelle, France.	laura.mannocci@univ-lr.fr	Barbraud, Christophe/A-5870-2012	Barbraud, Christophe/0000-0003-0146-212X; Ridoux, Vincent/0000-0002-9779-9319; Augeraud-Veron, Emmanuelle/0000-0002-7297-2867	French Ministry in charge of the Environment and University of La Rochelle	French Ministry in charge of the Environment and University of La Rochelle	Funding was provided by the French Ministry in charge of the Environment and University of La Rochelle, completed by the EU projects PETRACET and PROCET. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J CETACEAN RES MA S2, V11, P306; [Anonymous], REP DEFRA DOLPH BYCA; [Anonymous], SCI REPORTS WHALES R; Barbraud C, 2008, J APPL ECOL, V45, P1460, DOI 10.1111/j.1365-2664.2008.01537.x; Barlow J., 1995, NMFSOPR6 NOAA US DEP; BERTA A., 1999, MARINE MAMMALS EVOLU; Burkhart SM, 2003, NEW ZEAL J MAR FRESH, V37, P553, DOI 10.1080/00288330.2003.9517189; Byrd G. Vernon, 2009, Marine Ornithology, V37, P197; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell W, 1998, ECOL APPL, V8, P1226, DOI 10.2307/2640975; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Caurant F, 2009, USE ECOLOGICAL TRACE; Collet A., 1981, Aquatic Mammals, V8, P69; Cooke JG, 1999, ICES J MAR SCI, V56, P797, DOI 10.1006/jmsc.1999.0552; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; Dabin W, 2008, MAR BIOL, V156, P127, DOI 10.1007/s00227-008-1070-4; Dans SL, 2003, ECOL APPL, V13, P754, DOI 10.1890/1051-0761(2003)013[0754:ICODIT]2.0.CO;2; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; DEMASTER DP, 1984, REPORTS INT WHALING, V6, P175, DOI DOI 10.1139/Z81-015; Dennis JE, 1987, NUMERICAL METHODS UN; Dillingham PW, 2008, BIOL CONSERV, V141, P1783, DOI 10.1016/j.biocon.2008.04.022; DUGUY R, 1988, OCEANOL ACTA, V11, P227; Efron B., 1994, INTRO BOOTSTRAP; Fernandez-Contreras MM, 2010, ICES J MAR SCI, V67, P1732, DOI 10.1093/icesjms/fsq077; GINZBURG LR, 1990, CONSERV BIOL, V4, P63, DOI 10.1111/j.1523-1739.1990.tb00268.x; Gurevich V., 1980, INT WHALING COMM SPE, V3, P165; Hammond P., 2009, CETACEAN OFFSHORE DI, P43; Hammond P.S., 2006, SMALL CETACEANS EURO; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; ICES SGBYC Report 2010, ICES SGBYC REP 2010; ICES WGMME Report 2009, ICES WGMME REP 2009; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kuiken T, 1991, ECS NEWSLETTER, V17; Kuiken T, 1994, ECS NEWSLETTER, V26; Lahaye V, 2005, MAR ECOL PROG SER, V305, P275, DOI 10.3354/meps305275; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Marmontel M, 1997, CONSERV BIOL, V11, P467, DOI 10.1046/j.1523-1739.1997.96019.x; Mead J.G., 1990, P165; Mirimin L, 2009, MAR BIOL, V156, P1087, DOI 10.1007/s00227-009-1147-8; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Morizur Y, 2009, ANAL SERIES TEMPOREL; Murphy S., 2009, ASCOBANS HELCOM SMAL, P111; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Northridge S., 2007, 2 SEA MAMM RES UN; Northridge S., 2011, OVERVIEW STATE BYCAT; Northridge S, 2006, PETRACET FINAL REPOR, P29; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; PERRIN WF, 1984, REPROD WHALES DOLPHI; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; Silva MA, OPULATION BIOL BOTTL; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Slooten E, 2000, CONSERV BIOL, V14, P1264, DOI 10.1046/j.1523-1739.2000.00099-411.x; Slooten E., 2008, Open Conservation Biology Journal, V2, P37, DOI 10.2174/1874839200802010037; SLOOTEN E, 1991, CAN J ZOOL, V69, P1701, DOI 10.1139/z91-235; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Taylor BL, 2000, CONSERV BIOL, V14, P1243, DOI 10.1046/j.1523-1739.2000.99409.x; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Wade PR, 1994, ABUNDANCE POPULATION; Westgate AJ, 2007, MAR BIOL, V150, P1011, DOI 10.1007/s00227-006-0394-1; Winship A, 2009, MANAGEMENT FRAMEWORK	64	44	44	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32615	10.1371/journal.pone.0032615	http://dx.doi.org/10.1371/journal.pone.0032615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393423	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500075
J	Tobaly-Tapiero, J; Zamborlini, A; Bittoun, P; Saib, A				Tobaly-Tapiero, Joelle; Zamborlini, Alessia; Bittoun, Patricia; Saib, Ali			Investigating the Intercellular Spreading Properties of the Foamy Virus Gag Protein	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; HUMAN IMMUNODEFICIENCY VIRUS; VP22-GFP FUSION PROTEINS; STRUCTURAL PROTEIN; NUCLEAR-LOCALIZATION; TRANSDUCTION; TRAFFICKING; CHROMATIN; DELIVERY; DOMAINS	Small regions called protein transduction domains (PTDs), identified in cellular and viral proteins, have been reported to efficiently cross biological membranes. Here we show that the structural Gag protein of the prototypic foamy virus (PFV) is apparently able to move from cell to cell and to transport the green fluorescent protein (GFP) from few transfected cells to the nuclei of the entire monolayer. Deletion studies showed that this property lies within the second glycine/arginine (GRII) box in the C-terminus of the protein. We also found that uptake and nuclear accumulation of Gag GRII expressed as GFP-fusion protein in recipient cells was observed only following methanol fixation, but never in living cells or when cells were fixed with glutaraldehyde or treated with trichloroacetic acid prior to methanol fixation. Absence of intercellular spreading in vivo was further confirmed using a sensitive luciferase activity assay based on transactivation of the PFV long terminal repeats. Thus, we conclude that intercellular spreading of PFV Gag represents an artificial diffusion event occurring during cell fixation, followed by nuclear retention mediated by the chromatin-binding sequence within the Gag GRII box. In light of these results, we advise caution before defining a peptide as PTD on the basis of intercellular spreading observed by fluorescence microscopy.	[Tobaly-Tapiero, Joelle; Zamborlini, Alessia; Bittoun, Patricia; Saib, Ali] Univ Paris 07, CNRS, INSERM, U944,Inst Univ Hematol,UMR7212, Paris, France; [Zamborlini, Alessia; Saib, Ali] Conservatoire Natl Arts & Metiers, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Tobaly-Tapiero, J (corresponding author), Univ Paris 07, CNRS, INSERM, U944,Inst Univ Hematol,UMR7212, Paris, France.	ali.saib@cnam.fr	Zamborlini, Alessia/ABE-2256-2021	Zamborlini, Alessia/0000-0002-8902-1996; Tobaly-Tapiero, Joelle/0000-0001-6318-8627	Association de recherche contre le Cancer (ARC) [5981]; Agence Nationale de Recherches sur le side et les hepatites virales (ANRS); Sidaction	Association de recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de Recherches sur le side et les hepatites virales (ANRS); Sidaction	This work was supported by Association de recherche contre le Cancer (ARC) (#5981), Agence Nationale de Recherches sur le side et les hepatites virales (ANRS) and Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewis N, 2000, J VIROL, V74, P1051, DOI 10.1128/JVI.74.2.1051-1056.2000; Delelis O, 2004, CURR OPIN MICROBIOL, V7, P400, DOI 10.1016/j.mib.2004.06.009; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Duchardt F, 2009, J BIOL CHEM, V284, P36099, DOI 10.1074/jbc.M109.036426; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Elliott G, 2000, J VIROL, V74, P2131, DOI 10.1128/JVI.74.5.2131-2141.2000; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Elliott G, 1999, GENE THER, V6, P149, DOI 10.1038/sj.gt.3300850; Fang B, 1998, GENE THER, V5, P1420, DOI 10.1038/sj.gt.3300741; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Ingvarsdottir K, 2010, BBA-GENE REGUL MECH, V1799, P200, DOI 10.1016/j.bbagrm.2009.08.002; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Kiernan JA, 2000, FORMALDEHYDE FORMALI, P8; Lecellier CH, 2002, J VIROL, V76, P7220, DOI 10.1128/JVI.76.14.7220-7227.2002; Lopez MR, 2008, VIRUS RES, V136, P175, DOI 10.1016/j.virusres.2008.05.010; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; MELAN MA, 1992, J CELL SCI, V101, P731; Mullers E, 2011, J VIROL, V85, P9276, DOI 10.1128/JVI.00663-11; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Saib A, 1997, J VIROL, V71, P1155; SCHLIEPHAKE AW, 1994, J VIROL, V68, P4946, DOI 10.1128/JVI.68.8.4946-4954.1994; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Tobaly-Tapiero J, 2001, J VIROL, V75, P4367, DOI 10.1128/JVI.75.9.4367-4375.2001; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Yu SF, 1996, J VIROL, V70, P8255, DOI 10.1128/JVI.70.12.8255-8262.1996; Yu SYF, 2006, TRAFFIC, V7, P966, DOI 10.1111/j.1600-0854.2006.00448.x	36	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31108	10.1371/journal.pone.0031108	http://dx.doi.org/10.1371/journal.pone.0031108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393357	gold, Green Submitted, Green Published			2022-12-25	WOS:000303003500010
J	Duerschmied, D; Ahrens, I; Mauler, M; Brandt, C; Weidner, S; Bode, C; Moser, M				Duerschmied, Daniel; Ahrens, Ingo; Mauler, Maximilian; Brandt, Christoph; Weidner, Stefanie; Bode, Christoph; Moser, Martin			Serotonin Antagonism Improves Platelet Inhibition in Clopidogrel Low-Responders after Coronary Stent Placement: An In Vitro Pilot Study	PLOS ONE			English	Article							CYCLIC FLOW VARIATIONS; LIGHT TRANSMISSION AGGREGOMETRY; RECEPTOR ANTAGONIST; REUPTAKE INHIBITOR; BLOOD-FLOW; AGGREGATION; ACTIVATION; SARPOGRELATE; THROMBOXANE-A2; MECHANISMS	Increased residual platelet reactivity remains a burden for coronary artery disease (CAD) patients who received a coronary stent and do not respond sufficiently to treatment with acetylsalicylic acid and clopidogrel. We hypothesized that serotonin antagonism reduces high on-treatment platelet reactivity. Whole blood impedance aggregometry was performed with arachidonic acid (AA, 0.5 mM) and adenosine diphosphate (ADP, 6.5 mu M) in addition to different concentrations of serotonin (1-100 mu M) in whole blood from 42 CAD patients after coronary stent placement and 10 healthy subjects. Serotonin increased aggregation dose-dependently in CAD patients who responded to clopidogrel treatment: After activation with ADP, aggregation increased from 33.7 +/- 1.3% to 40.9 +/- 2.0% in the presence of 50 mu M serotonin (p<0.05) and to 48.2 +/- 2.0% with 100 mu M serotonin (p<0.001). The platelet serotonin receptor antagonist ketanserin decreased ADP-induced aggregation significantly in clopidogrel low-responders (from 59.9 +/- 3.1% to 37.4 +/- 3.5, p<0.01), but not in clopidogrel responders. These results were confirmed with light transmission aggregometry in platelet-rich plasma in a subset of patients. Serotonin hence increased residual platelet reactivity in patients who respond to clopidogrel after coronary stent placement. In clopidogrel low-responders, serotonin receptor antagonism improved platelet inhibition, almost reaching responder levels. This may justify further investigation of triple antiplatelet therapy with anti-serotonergic agents.	[Duerschmied, Daniel; Ahrens, Ingo; Mauler, Maximilian; Brandt, Christoph; Weidner, Stefanie; Bode, Christoph; Moser, Martin] Univ Med Ctr Freiburg, Dept Cardiol & Angiol, Freiburg, Germany	University of Freiburg	Duerschmied, D (corresponding author), Univ Med Ctr Freiburg, Dept Cardiol & Angiol, Freiburg, Germany.	daniel.duerschmied@uniklinik-freiburg.de	Duerschmied, D./K-8182-2015; Duerschmied, D./AAB-5139-2021	Duerschmied, D./0000-0001-5249-4012; Duerschmied, D./0000-0001-5249-4012	University Medical Center of Freiburg	University Medical Center of Freiburg	This pilot study was investigator initiated and financed by the University Medical Center of Freiburg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2009, J PHARMACOL EXP THER, V331, P96, DOI 10.1124/jpet.109.153189; Ahrens I, 2009, CURR OPIN INVEST DR, V10, P902; Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; ASHTON JH, 1986, CIRCULATION, V73, P572, DOI 10.1161/01.CIR.73.3.572; ASHTON JH, 1987, CIRCULATION, V76, P952, DOI 10.1161/01.CIR.76.4.952; ASHTON JH, 1989, J AM COLL CARDIOL, V13, P755, DOI 10.1016/0735-1097(89)90622-0; BENEDICT CR, 1986, CIRC RES, V58, P58, DOI 10.1161/01.RES.58.1.58; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; BUSH LR, 1984, CIRC RES, V55, P642, DOI 10.1161/01.RES.55.5.642; Cattaneo M, 2009, SEMIN THROMB HEMOST, V35, P158, DOI 10.1055/s-0029-1220324; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Duerschmied D, 2009, HAMOSTASEOLOGIE, V29, P356; Duerschmied D, 2009, J THROMB HAEMOST, V7, P1163, DOI 10.1111/j.1538-7836.2009.03476.x; Duerschmied D, 2010, EXPERT REV CARDIOVAS, V8, P1215, DOI [10.1586/erc.10.104, 10.1586/ERC.10.104]; Francischetti IMB, 2000, J BIOL CHEM, V275, P12639, DOI 10.1074/jbc.275.17.12639; Fujita M, 2003, AM HEART J, V145, DOI 10.1067/mhj.2003.176; Galan AM, 2009, THROMB HAEMOSTASIS, V102, P511, DOI 10.1160/TH08-12-0810; Gilles M, 2005, PSYCHOSOM MED, V67, P748, DOI 10.1097/01.psy.0000174994.91245.34; GOLINO P, 1994, NEW ENGL J MED, V330, P523, DOI 10.1056/NEJM199402243300802; GOLINO P, 1989, CIRCULATION, V79, P154, DOI 10.1161/01.CIR.79.1.154; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; GOLINO P, 1988, CIRCULATION, V77, P678, DOI 10.1161/01.CIR.77.3.678; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hamm CW, 2011, EUR HEART J; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; HOLDRINET A, 1969, SCAND J HAEMATOL, V6, P354; Horibe E, 2004, CIRC J, V68, P68, DOI 10.1253/circj.68.68; Kokubu N, 2006, CIRC J, V70, P1451, DOI 10.1253/circj.70.1451; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Levine GN, 2016, CIRCULATION; Lopez-Vilchez I, 2009, CARDIOVASC RES, V84, P309, DOI 10.1093/cvr/cvp205; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Shimizu Y, 2002, J AM COLL CARDIOL, V40, P1347, DOI 10.1016/S0735-1097(02)02158-7; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Siller-Matula JM, 2010, J THROMB HAEMOST, V8, P351, DOI 10.1111/j.1538-7836.2009.03699.x; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Tseng YL, 2010, THROMB RES, V126, P517, DOI 10.1016/j.thromres.2010.09.017; VERSTRAETE M, 1989, BRIT MED J, V298, P424; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324	48	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32656	10.1371/journal.pone.0032656	http://dx.doi.org/10.1371/journal.pone.0032656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384279	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500106
J	Zhang, RK; Fang, H; Chen, YX; Shen, J; Lu, HD; Zeng, C; Ren, JH; Zeng, H; Li, ZF; Chen, SM; Cai, DZ; Zhao, Q				Zhang, RongKai; Fang, Hang; Chen, YuXian; Shen, Jun; Lu, HuaDing; Zeng, Chun; Ren, JianHua; Zeng, Hua; Li, Zhifu; Chen, ShaoMing; Cai, DaoZhang; Zhao, Qing			Gene Expression Analyses of Subchondral Bone in Early Experimental Osteoarthritis by Microarray	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; C-C CHEMOKINES; MATRIX METALLOPROTEINASES; RHEUMATOID-ARTHRITIS; INDIAN HEDGEHOG; INFLAMMATORY ARTHRITIS; CARTILAGE DEGENERATION; ARTICULAR-CARTILAGE; CONDYLAR CARTILAGE; HUMAN CHONDROCYTES	Osteoarthritis (OA) is a degenerative joint disease that affects both cartilage and bone. A better understanding of the early molecular changes in subchondral bone may help elucidate the pathogenesis of OA. We used microarray technology to investigate the time course of molecular changes in the subchondral bone in the early stages of experimental osteoarthritis in a rat model. We identified 2,234 differentially expressed (DE) genes at 1 week, 1,944 at 2 weeks and 1,517 at 4 weeks post-surgery. Further analyses of the dysregulated genes indicated that the events underlying subchondral bone remodeling occurred sequentially and in a time-dependent manner at the gene expression level. Some of the identified dysregulated genes that were identified have suspected roles in bone development or remodeling; these genes include Alp, Igf1, Tgf beta 1, Postn, Mmp3, Tnfsf11, Acp5, Bmp5, Aspn and Ihh. The differences in the expression of these genes were confirmed by real-time PCR, and the results indicated that our microarray data accurately reflected gene expression patterns characteristic of early OA. To validate the results of our microarray analysis at the protein level, immunohistochemistry staining was used to investigate the expression of Mmp3 and Aspn protein in tissue sections. These analyses indicate that Mmp3 protein expression completely matched the results of both the microarray and real-time PCR analyses; however, Aspn protein expression was not observed to differ at any time. In summary, our study demonstrated a simple method of separation of subchondral bone sample from the knee joint of rat, which can effectively avoid bone RNA degradation. These findings also revealed the gene expression profiles of subchondral bone in the rat OA model at multiple time points post-surgery and identified important DE genes with known or suspected roles in bone development or remodeling. These genes may be novel diagnostic markers or therapeutic targets for OA.	[Zhang, RongKai; Fang, Hang; Chen, YuXian; Shen, Jun; Lu, HuaDing; Zeng, Chun; Ren, JianHua; Zeng, Hua; Li, Zhifu; Cai, DaoZhang] Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 3, Guangzhou, Peoples R China; [Zhang, RongKai; Chen, ShaoMing; Zhao, Qing] Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 5, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, RK (corresponding author), Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 3, Guangzhou, Peoples R China.	caidaozhang@gmail.com			Chinese National Natural Science Foundation [2008AA02Z437]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the 863 Scientific Research of the Chinese National Natural Science Foundation (2008AA02Z437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2009, OSTEOARTHR CARTILAGE, V17, P1049, DOI 10.1016/j.joca.2009.02.008; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Bailey AJ, 2002, INT J BIOCHEM CELL B, V34, P176, DOI 10.1016/S1357-2725(01)00107-8; Bailey AJ, 1997, GERONTOLOGY, V43, P296; BLAVIER L, 1995, J CELL SCI, V108, P3649; Bogoch ER, 1998, CAN J SURG, V41, P264; Bord S, 1997, J ANAT, V191, P39, DOI 10.1046/j.1469-7580.1997.19110039.x; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018; Brandt KD, 2002, BIORHEOLOGY, V39, P221; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Couchourel D, 2009, ARTHRITIS RHEUM-US, V60, P1438, DOI 10.1002/art.24489; de Andres MC, 2011, BIOCHEM BIOPH RES CO, V407, P54, DOI 10.1016/j.bbrc.2011.02.101; Dew G, 2000, CELL TISSUE RES, V299, P385, DOI 10.1007/s004419900166; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014; Endres M, 2010, OSTEOARTHR CARTILAGE, V18, P1458, DOI 10.1016/j.joca.2010.08.003; Felson DT, 2004, ARTHRITIS RHEUM-US, V50, P341, DOI 10.1002/art.20051; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Gillan L, 2002, CANCER RES, V62, P5358; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hanada T, CYTOKINE GROWTH FACT, V13, P413, DOI 16/S1359-6101(02)00026-6; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; HILL PA, 1994, J CELL SCI, V107, P3055; Hopwood B, 2005, BONE, V36, P635, DOI 10.1016/j.bone.2005.02.003; Hopwood B, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2301; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Karam MC, 2011, J NEUROIMMUNOL, V234, P49, DOI 10.1016/j.jneuroim.2011.02.003; KING JA, 1994, DEV BIOL, V166, P112, DOI 10.1006/dbio.1994.1300; Klatt AR, 2009, J ORTHOP RES, V27, P65, DOI 10.1002/jor.20716; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lande R, 2004, J IMMUNOL, V173, P2815, DOI 10.4049/jimmunol.173.4.2815; Li XL, 2006, ANN NY ACAD SCI, V1068, P26, DOI 10.1196/annals.1346.006; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Lisignoli G, 2006, J CELL PHYSIOL, V206, P78, DOI 10.1002/jcp.20435; Lisignoli G, 2002, CYTOKINE, V20, P231, DOI 10.1006/cyto.2002.2006; Lisignoli G, 1999, CLIN EXP IMMUNOL, V116, P371; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Lohmander LS, 2000, ARTHRITIS RES, V2, P95, DOI 10.1186/ar74; Ma DD, 2011, J BIOL CHEM, V286, P4302, DOI 10.1074/jbc.M110.140202; Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; Mailhot G, 2008, J CELL PHYSIOL, V214, P56, DOI 10.1002/jcp.21164; Malemud CJ, 2010, DRUG AGING, V27, P95, DOI 10.2165/11319950-000000000-00000; Manacu CA, 2005, ARTHRITIS RES THER, V7, pR324, DOI 10.1186/ar1489; Mansell JP, 1998, J CLIN INVEST, V101, P1596, DOI 10.1172/JCI867; Matyas JR, 1997, OSTEOARTHR CARTILAGE, V5, P99, DOI 10.1016/S1063-4584(97)80003-9; MEIKLE MC, 1992, J CELL SCI, V103, P1093; Ng TCS, 2006, FRONT BIOSCI-LANDMRK, V11, P943; Pastoureau PC, 1999, OSTEOARTHR CARTILAGE, V7, P466, DOI 10.1053/joca.1999.0241; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Lamas JR, 2010, ANN RHEUM DIS, V69, P1880, DOI 10.1136/ard.2009.122564; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sakao K, 2009, J BONE MINER METAB, V27, P412, DOI 10.1007/s00774-009-0058-6; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Sanchez C, 2008, ARTHRITIS RHEUM-US, V58, P442, DOI 10.1002/art.23159; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Sabate E, 2009, OSTEOARTHR CARTILAGE, V17, P1106, DOI 10.1016/j.joca.2009.01.010; Shibakawa A, 2005, OSTEOARTHR CARTILAGE, V13, P679, DOI 10.1016/j.joca.2005.04.010; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; So JS, 2011, LIFE SCI, V88, P358, DOI 10.1016/j.lfs.2010.12.013; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tang GH, 2004, J DENT RES, V83, P434, DOI 10.1177/154405910408300516; Urist MR, 2002, CLIN ORTHOP RELAT R, P5; Vergunst CE, 2005, SCAND J RHEUMATOL, V34, P415, DOI 10.1080/03009740500439159; Westacott CI, 1997, ARTHRITIS RHEUM, V40, P1282, DOI 10.1002/art.1780400713; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200; Yuan GH, 2001, ARTHRITIS RHEUM-US, V44, P1056, DOI 10.1002/1529-0131(200105)44:5<1056::AID-ANR186>3.0.CO;2-U	79	38	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32356	10.1371/journal.pone.0032356	http://dx.doi.org/10.1371/journal.pone.0032356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384228	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500080
J	Acerbi, I; Luque, T; Gimenez, A; Puig, M; Reguart, N; Farre, R; Navajas, D; Alcaraz, J				Acerbi, Irene; Luque, Tomas; Gimenez, Alicia; Puig, Marta; Reguart, Noemi; Farre, Ramon; Navajas, Daniel; Alcaraz, Jordi			Integrin-Specific Mechanoresponses to Compression and Extension Probed by Cylindrical Flat-Ended AFM Tips in Lung Cells	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ADHESION; CONTRACTION; STIFFNESS; RIGIDITY; TENSION; ACTIN	Cells from lung and other tissues are subjected to forces of opposing directions that are largely transmitted through integrin-mediated adhesions. How cells respond to force bidirectionality remains ill defined. To address this question, we nanofabricated flat-ended cylindrical Atomic Force Microscopy (AFM) tips with similar to 1 mu m(2) cross-section area. Tips were uncoated or coated with either integrin-specific (RGD) or non-specific (RGE/BSA) molecules, brought into contact with lung epithelial cells or fibroblasts for 30 s to form focal adhesion precursors, and used to probe cell resistance to deformation in compression and extension. We found that cell resistance to compression was globally higher than to extension regardless of the tip coating. In contrast, both tip-cell adhesion strength and resistance to compression and extension were the highest when probed at integrin-specific adhesions. These integrin-specific mechanoresponses required an intact actin cytoskeleton, and were dependent on tyrosine phosphatases and Ca2+ signaling. Cell asymmetric mechanoresponse to compression and extension remained after 5 minutes of tip-cell adhesion, revealing that asymmetric resistance to force directionality is an intrinsic property of lung cells, as in most soft tissues. Our findings provide new insights on how lung cells probe the mechanochemical properties of the microenvironment, an important process for migration, repair and tissue homeostasis.	[Acerbi, Irene; Luque, Tomas; Gimenez, Alicia; Puig, Marta; Farre, Ramon; Navajas, Daniel; Alcaraz, Jordi] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Acerbi, Irene] Politecn Milan, Dipartimento Bioingn, Lab Tecnol Biomed, I-20133 Milan, Italy; [Acerbi, Irene; Luque, Tomas; Navajas, Daniel] Inst Bioengn Catalunya IBEC, Barcelona, Spain; [Puig, Marta; Farre, Ramon] IDIBAPS, Barcelona, Spain; [Reguart, Noemi; Farre, Ramon; Navajas, Daniel; Alcaraz, Jordi] CIBER Enfermedades Resp CIBERES, Bunyola, Spain	University of Barcelona; Polytechnic University of Milan; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Acerbi, I (corresponding author), Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain.	jalcaraz@ub.edu	Alcaraz, Jordi/AAE-3632-2020; Alcaraz, Jordi/F-5513-2016; Acerbi, Irene/AAA-3120-2019; Farre, Ramon/L-2664-2017; Navajas, Daniel/E-4233-2010	Alcaraz, Jordi/0000-0001-7898-1599; Alcaraz, Jordi/0000-0001-7898-1599; Farre, Ramon/0000-0002-9084-7824; Navajas, Daniel/0000-0001-7150-9363	Ministerio de Ciencia e Innovacion [SAF2009-13243, SAF2008-02991]; Ministerio de Sanidad y Politica Social [PI081908, PS09/01377]; Asociacion Espanola Contra el Cancer; Fundacio Privada Cellex; UBB	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Politica Social(Spanish Government); Asociacion Espanola Contra el Cancer; Fundacio Privada Cellex(Foundation CELLEX); UBB	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2009-13243 to JA, SAF2008-02991 to RF www.micinn.es), Ministerio de Sanidad y Politica Social (PI081908 to DN, PS09/01377 to NR www.msps.es), Asociacion Espanola Contra el Cancer (to NR and JA www.aecc.es), and pre-doctoral fellowships from the Ministerio de Ciencia e Innovacion (to IA, TL and AG), and from the Fundacio Privada Cellex (to MP). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank F Rico (Inst. Curie) for critical reading of the manuscript, X Trepat (IBEC) and X Gasull (UB) for helpful discussions, R Nieto and MA Rodriguez (Unitat de Biofisica i Bioenginyeria -UBB-, UB), and MJ Lopez (Plataforma de Nanotec., UB) for technical assistance, and other members of the UBB for support.	Alberts B, 2002, MOL BIOL CELL; Alcaraz J, 2004, J MAMMARY GLAND BIOL, V9, P361, DOI 10.1007/s10911-004-1406-8; Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Alcaraz J, 2002, LANGMUIR, V18, P716, DOI 10.1021/la0110850; Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Curran-Everett D, 2009, ADV PHYSIOL EDUC, V33, P81, DOI 10.1152/advan.90218.2008; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Deng LH, 2005, J APPL PHYSIOL, V99, P634, DOI 10.1152/japplphysiol.00025.2005; DEPASQUALE JA, 1987, J CELL BIOL, V105, P2803, DOI 10.1083/jcb.105.6.2803; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fung Y.C., 1993, BIOMECHANICS MECH PR; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Glogauer M, 1997, J CELL SCI, V110, P11; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kendall K, 1971, J PHYS D, V4, P10; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lystvet SM, 2011, NANOSCALE, V3, P1788, DOI 10.1039/c0nr00948b; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Mio T, 2001, AM J PHYSIOL-LUNG C, V281, pL164, DOI 10.1152/ajplung.2001.281.1.L164; Nakano N, 2006, J BIOCHEM, V139, P821, DOI 10.1093/jb/mvj092; NAVAJAS D, 1995, J APPL PHYSIOL, V79, P348, DOI 10.1152/jappl.1995.79.1.348; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rico F, 2007, J MOL RECOGNIT, V20, P459, DOI 10.1002/jmr.829; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Scallan J., 2010, FLUID EXCHANGE REGUL; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388	50	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32261	10.1371/journal.pone.0032261	http://dx.doi.org/10.1371/journal.pone.0032261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384196	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100063
J	Montagne, M; Beaudoin, N; Fortin, D; Lavoie, CL; Klinck, R; Lavigne, P				Montagne, Martin; Beaudoin, Nicolas; Fortin, David; Lavoie, Christine L.; Klinck, Roscoe; Lavigne, Pierre			The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities	PLOS ONE			English	Article							DNA-BINDING; PROTEIN; GENE; EXPRESSION; REPRESSION; MIZ-1; COMPLEX; ZIPPER	The inhibition of the functions of c-Myc (endogenous and oncogenic) was recently shown to provide a spectacular therapeutic index in cancer mouse models, with complete tumor regression and minimal side-effects in normal tissues. This was achieved by the systemic and conditional expression of omomyc, the cDNA of a designed mutant of the b-HLH-LZ of c-Myc named Omomyc. The overall mode of action of Omomyc consists in the sequestration of Max and the concomitant competition of the Omomyc/Max complex with the endogenous c-Myc/Max heterodimer. This leads to the inhibition of the transactivation of Myc target genes involved in proliferation and metabolism. While this body of work has provided extraordinary insights to guide the future development of new cancer therapies that target c-Myc, Omomyc itself is not a therapeutic agent. In this context, we sought to exploit the use of a b-HLH-LZ to inhibit c-Myc in a cancer cell line in a more direct fashion. We demonstrate that the b-HLH-LZ domain of Max (Max*) behaves as a bona fide protein transduction domain (PTD) that can efficiently transduce across cellular membrane via through endocytosis and translocate to the nucleus. In addition, we show that the treatment of HeLa cells with Max* leads to a reduction of metabolism and proliferation rate. Accordingly, we observe a decrease of the population of HeLa cells in S phase, an accumulation in G1/G0 and the induction of apoptosis. In agreement with these phenotypic changes, we show by q-RT-PCR that the treatment of HeLa cells with Max* leads to the activation of the transcription c-Myc repressed genes as well as the repression of the expression of c-Myc activated genes. In addition to the novel discovery that the Max b-HLH-LZ is a PTD, our findings open up new avenues and strategies for the direct inhibition of c-Myc with b-HLH-LZ analogs.	[Montagne, Martin; Lavoie, Christine L.; Lavigne, Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Pharmacol, Quebec City, PQ, Canada; [Beaudoin, Nicolas; Fortin, David] Univ Sherbrooke, Fac Med & Sci Sante, Dept Chirurg, Quebec City, PQ, Canada; [Klinck, Roscoe] Univ Sherbrooke, Dept Microbiol & Infectiol, Quebec City, PQ, Canada; [Klinck, Roscoe] Univ Sherbrooke, Lab Genom Fonct, Quebec City, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Montagne, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Pharmacol, Quebec City, PQ, Canada.	Pierre.Lavigne@USherbrooke.ca			Canadian Cancer Society Research Institute [20208]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by a grant from the Canadian Cancer Society Research Institute (Grant #20208). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jean-Francois N, 2003, J MOL BIOL, V326, P1577, DOI 10.1016/S0022-2836(03)00029-9; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; LINDEMAN GJ, 1995, ONCOGENE, V10, P1013; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yap CS, 2011, CELL CYCLE, V10, P2184, DOI 10.4161/cc.10.13.16249; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	37	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32172	10.1371/journal.pone.0032172	http://dx.doi.org/10.1371/journal.pone.0032172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384171	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500082
J	Ono, K; Li, L; Takamura, Y; Yoshiike, Y; Zhu, LJ; Han, F; Mao, X; Ikeda, T; Takasaki, J; Nishijo, H; Takashima, A; Teplow, DB; Zagorski, MG; Yamada, M				Ono, Kenjiro; Li, Lei; Takamura, Yusaku; Yoshiike, Yuji; Zhu, Lijun; Han, Fang; Mao, Xian; Ikeda, Tokuhei; Takasaki, Jun-ichi; Nishijo, Hisao; Takashima, Akihiko; Teplow, David B.; Zagorski, Michael G.; Yamada, Masahito			Phenolic Compounds Prevent Amyloid beta-Protein Oligomerization and Synaptic Dysfunction by Site-specific Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATURATION-TRANSFER DIFFERENCE; FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ALPHA-SYNUCLEIN; CROSS-LINKING; MTT REDUCTION; POLYPHENOLS; NMR; AGGREGATION	Cerebral deposition of amyloid beta protein (A beta) is an invariant feature of Alzheimer disease (AD), and epidemiological evidence suggests that moderate consumption of foods enriched with phenolic compounds reduce the incidence of AD. We reported previously that the phenolic compounds myricetin (Myr) and rosmarinic acid (RA) inhibited A beta aggregation in vitro and in vivo. To elucidate a mechanistic basis for these results, we analyzed the effects of five phenolic compounds in the A beta aggregation process and in oligomer-induced synaptic toxicities. We now report that the phenolic compounds blocked A beta oligomerization, and Myr promoted significant NMR chemical shift changes of monomeric A beta. Both Myr and RA reduced cellular toxicity and synaptic dysfunction of the A beta oligomers. These results suggest that Myr and RA may play key roles in blocking the toxicity and early assembly processes associated with A beta through different binding.	[Li, Lei; Zhu, Lijun; Han, Fang; Mao, Xian; Zagorski, Michael G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Ono, Kenjiro; Ikeda, Tokuhei; Takasaki, Jun-ichi; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol & Aging, Kanazawa, Ishikawa 9208640, Japan; [Takamura, Yusaku; Nishijo, Hisao] Toyama Univ, Toyama 9300194, Japan; [Yoshiike, Yuji; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	Case Western Reserve University; Kanazawa University; University of Toyama; RIKEN; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zagorski, MG (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.	michael.zagorski@case.edu; m-yamada@med.kanazawa-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [22240051, 20390242]; Knowledge Cluster Initiative (High Tech Sensing and Knowledge Handling Technology (Brain Technology)) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare (Japan); Novartis Foundation for Gerontological Research; Alumni Association of Showa University School of Medicine; Japan Society for the Promotion of Science; National Institutes of Health [AG027818, AG027853]; Jim Easton Consortium for Alzheimer Drug Discovery and Biomarkers at UCLA; Grants-in-Aid for Scientific Research [22790815, 22240051] Funding Source: KAKEN; NATIONAL INSTITUTE ON AGING [P01AG027818, R01AG027853] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative (High Tech Sensing and Knowledge Handling Technology (Brain Technology)) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare (Japan)(Ministry of Health, Labour and Welfare, Japan); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Alumni Association of Showa University School of Medicine; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim Easton Consortium for Alzheimer Drug Discovery and Biomarkers at UCLA; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grants-in-aid for Young Scientists (B) (to K. O.), Scientific Research (A) (22240051) (to H. N.), Scientific Research (B) (20390242) (to M. Y.), and Knowledge Cluster Initiative (High Tech Sensing and Knowledge Handling Technology (Brain Technology)) (to M. Y.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, a grant to the Amyloidosis Research Committee from the Ministry of Health, Labor, and Welfare (Japan) (to K. O. and M. Y.), Novartis Foundation for Gerontological Research (to K. O.), Alumni Association of Showa University School of Medicine (to K. O.), Japan Society for the Promotion of Science Asian Core Program (to H. N.), and National Institutes of Health Grants AG027818 (to D. B. T.) and AG027853 (to M. G. Z.), and the Jim Easton Consortium for Alzheimer Drug Discovery and Biomarkers at UCLA (to D. B. T.).	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Flamini R, 2003, MASS SPECTROM REV, V22, P218, DOI 10.1002/mas.10052; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Huang H, 2008, J PHYS CHEM B, V112, P5795, DOI 10.1021/jp7118718; Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Narayanan S, 2005, BIOCHEMISTRY-US, V44, P1444, DOI 10.1021/bi048264b; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Rojas A, 2010, J MOL BIOL, V404, P537, DOI 10.1016/j.jmb.2010.09.057; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shimmyo Y, 2008, BBA-GEN SUBJECTS, V1780, P819, DOI 10.1016/j.bbagen.2008.01.017; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soeda Y, 2010, MOL ENDOCRINOL, V24, P1965, DOI 10.1210/me.2010-0163; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	53	168	170	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14631	14643		10.1074/jbc.M111.325456	http://dx.doi.org/10.1074/jbc.M111.325456			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393064	hybrid, Green Published			2022-12-25	WOS:000304003200030
J	Scott, H; Howarth, J; Lee, YB; Wong, LF; Bantounas, I; Phylactou, L; Verkade, P; Uney, JB				Scott, Helen; Howarth, Joanna; Lee, Youn Bok; Wong, Liang-Fong; Bantounas, Ioannis; Phylactou, Leonidas; Verkade, Paul; Uney, James. B.			MiR-3120 Is a Mirror MicroRNA That Targets Heat Shock Cognate Protein 70 and Auxilin Messenger RNAs and Regulates Clathrin Vesicle Uncoating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN ISOFORMS; IDENTIFICATION; TRANSCRIPTION; FEEDBACK; ATPASE; HSC70; BRAIN	We show that a single gene locus gives rise to two fully processed and functional miRNAs, i.e. that due to imperfect base pairing, two distinct microRNAs (miRNAs) can be produced from the fully complementary DNA strands. The antisense strand encodes miR-214, which is transcribed by its own promoter, whereas a novel miRNA, miR-3120, is co-expressed with its host gene mRNA. We also found that miR-3120 regulates important aspects of cellular function that are similar to that of its host gene, dynamin-3. miR-3120 was found to be located in neuronal cell bodies and to target Hsc70 and auxilin, and its lentivirus-mediated expression inhibited the uncoating of clathrin-coated vesicles. Finally, mirror miRNAs are likely to represent a new group of miRNAs with complex roles in coordinating gene expression.	[Scott, Helen; Howarth, Joanna; Wong, Liang-Fong; Uney, James. B.] Univ Bristol, Henry Wellcome Labs Integrated Neurosci & Endocri, Bristol BS1 3NY, Avon, England; [Lee, Youn Bok] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, MRC, London SE5 8AF, England; [Bantounas, Ioannis] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Phylactou, Leonidas] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, CY-1683 Nicosia, Cyprus; [Verkade, Paul] Univ Bristol, Wolfson Bioimaging Facil, Sch Biochem, Bristol BS8 1TD, Avon, England; [Verkade, Paul] Univ Bristol, Wolfson Bioimaging Facil, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol; University of London; King's College London; University of Manchester; University of Bristol; University of Bristol	Uney, JB (corresponding author), Univ Bristol, Henry Wellcome Labs Integrated Neurosci & Endocri, Dorothy Hodgkin Bldg,Whitson St, Bristol BS1 3NY, Avon, England.	james.uney@bristol.ac.uk	Scott, Helen L/A-6307-2009; Verkade, Paul/N-7240-2014; Howarth, Joanna/AHC-1794-2022	Scott, Helen L/0000-0003-2656-4034; Verkade, Paul/0000-0002-2497-1026; Bantounas, Ioannis/0000-0001-7899-1068; Lee, Younbok/0000-0002-0479-9361	Wellcome Trust; Medical Research Council (NET); Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [MC_G0901331, G0700986] Funding Source: researchfish; MRC [MC_G0901331, G0700986] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (NET)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, Medical Research Council (NET), and Biotechnology and Biological Sciences Research Council (BBSRC).	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Girard M, 2005, MOL CELL PROTEOMICS, V4, P1145, DOI 10.1074/mcp.M500043-MCP200; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; PARTON RG, 1995, J HISTOCHEM CYTOCHEM, V43, P731, DOI 10.1177/43.7.7608529; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107; Zhao MJ, 2002, J BIOL CHEM, V277, P44539, DOI 10.1074/jbc.M208408200	30	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14726	14733		10.1074/jbc.M111.326041	http://dx.doi.org/10.1074/jbc.M111.326041			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393045	hybrid, Green Published			2022-12-25	WOS:000304003200038
J	Seo, JM; Park, S; Kim, JH				Seo, Ji-Min; Park, Sooyoung; Kim, Jae-Hong			Leukotriene B-4 Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER; CONSTITUTIVE ACTIVATION; GENE-EXPRESSION; OXIDASE; PATHWAY; STAT3; PROLIFERATION; INHIBITION; APOPTOSIS; INVASION	Ovarian cancer is the most lethal gynecologic malignancy in women. Despite the fact that the metastatic spread is associated with the majority of deaths from ovarian cancer, the molecular mechanisms regulating the invasive and metastatic phenotypes of ovarian cancer are poorly understood. In this study, we demonstrated that BLT2, a low affinity leukotriene B-4 receptor, is highly expressed in OVCAR-3 and SKOV-3 human ovarian cancer cells, and that this receptor plays a key role in the invasiveness and metastasis of these cells through activation of STAT3 and consequent up-regulation of matrix metalloproteinase 2 (MMP2). In addition, our results suggest that activation of NAD(P) H oxidase-4 (NOX4) and subsequent reactive oxygen species (ROS) generation lie downstream of BLT2, mediating the stimulation of STAT3-MMP2 cascade in this process. For example, knockdown of BLT2 or NOX4 using each specific siRNA suppressed STAT3 stimulation and MMP2 expression. Similarly, inhibition of STAT3 suppressed the expression of MMP2, thus leading to attenuated invasiveness of these ovarian cancer cells. Finally, the metastasis ofSKOV-3 cells in nude mice was markedly suppressed by pharmacological inhibition of BLT2. Together, our results implicate a BLT2-NOX4-ROS-STAT3-MMP2 cascade in the invasiveness and metastasis of ovarian cancer cells.	[Seo, Ji-Min; Park, Sooyoung; Kim, Jae-Hong] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	General Researcher Support Project Grant [2011-0004241]; National Research Foundation; Korean government Ministry of Education and Science Technology [2011-0027753]; Ministry of Health Welfare [A101032]	General Researcher Support Project Grant; National Research Foundation; Korean government Ministry of Education and Science Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health Welfare	This work was supported by General Researcher Support Project Grant 2011-0004241 and the Bio & Medical Technology Development Program of the National Research Foundation funded by Korean government Ministry of Education and Science Technology Grant 2011-0027753. This work was also supported by Grant A101032 from the Korea Healthcare Technology R & D Project, Ministry of Health & Welfare.	Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Davidson B, 2003, CLIN CANCER RES, V9, P1412; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Guo AM, 2011, CANCER CHEMOTH PHARM, V68, P1273, DOI 10.1007/s00280-011-1595-y; Hao M, 2009, J OBSTET GYNAECOL RE, V35, P918, DOI 10.1111/j.1447-0756.2009.01045.x; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ju KD, 2011, INFLAMM RES, V60, P791, DOI 10.1007/s00011-011-0335-4; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim EY, 2010, ONCOGENE, V29, P1167, DOI 10.1038/onc.2009.412; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kusaba T, 2006, ONCOL REP, V15, P1445; Landen CN, 2007, CANCER RES, V67, P10389, DOI 10.1158/0008-5472.CAN-07-0858; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Masuda M, 2002, CANCER RES, V62, P3351; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Perigny M, 2008, AM J CLIN PATHOL, V129, P226, DOI 10.1309/49LA9XCBGWJ8F2KM; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Rosen DG, 2006, CANCER-AM CANCER SOC, V107, P2730, DOI 10.1002/cncr.22293; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; Seo JM, 2011, EXP MOL MED, V43, P129, DOI 10.3858/emm.2011.43.3.014; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Thornber K, 2009, ONCOGENE, V28, P2690, DOI 10.1038/onc.2009.125; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001	49	74	76	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13840	13849		10.1074/jbc.M111.317131	http://dx.doi.org/10.1074/jbc.M111.317131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396544	hybrid, Green Published			2022-12-25	WOS:000303996300039
J	Zhang, SZ; Widemann, E; Bernard, G; Lesot, A; Pinot, F; Pedrini, N; Keyhani, NO				Zhang, Shizhu; Widemann, Emilie; Bernard, Grausem; Lesot, Agnes; Pinot, Franck; Pedrini, Nicolas; Keyhani, Nemat O.			CYP52X1, Representing New Cytochrome P450 Subfamily, Displays Fatty Acid Hydroxylase Activity and Contributes to Virulence and Growth on Insect Cuticular Substrates in Entomopathogenic Fungus Beauveria bassiana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPICUTICULAR HYDROCARBONS; METARHIZIUM-ANISOPLIAE; EXPRESSION ANALYSIS; CORDYCEPS BASSIANA; GERMINATION; SURFACE; DEGRADATION; CUTICLE; ALKANE; YEAST	Infection of insects by the entomopathogenic fungus Beauveria bassiana proceeds via attachment and penetration of the host cuticle. The outermost epicuticular layer or waxy layer of the insect represents a structure rich in lipids including abundant amounts of hydrocarbons and fatty acids. A member of a novel cytochrome P450 subfamily, CYP52X1, implicated in fatty acid assimilation by B. bassiana was characterized. B. bassiana targeted gene knockouts lacking Bbcyp52x1 displayed reduced virulence when topically applied to Galleria mellonella, but no reduction in virulence was noted when the insect cuticle was bypassed using an intrahemoceol injection assay. No significant growth defects were noted in the mutant as compared with the wild-type parent on any lipids substrates tested including alkanes and fatty acids. Insect epicuticle germination assays, however, showed reduced germination of Delta Bbcyp52x1 conidia on grasshopper wings as compared with the wild-type parent. Complementation of the gene-knock with the full-length gene restored virulence and insect epicuticle germination to wild-type levels. Heterologous expression of CYP52X1 in yeast was used to characterize the substrate specificity of the enzyme. CYP52X1 displayed the highest activity against midrange fatty acids (C12:0 and C14:0) and epoxy stearic acid, 4-8-fold lower activity against C16:0, C18:1, and C18:2, and little to no activity against C9:0 and C18:0. Analyses of the products of the C12:0 and C18:1 reactions confirmed NADPH-dependent regioselective addition of a terminal hydroxyl to the substrates (omega-hydroxylase). These data implicate CYP52X1 as contributing to the penetration of the host cuticle via facilitating the assimilation of insect epicuticle lipids.	[Zhang, Shizhu; Keyhani, Nemat O.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Zhang, Shizhu] Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Microbiol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China; [Widemann, Emilie; Bernard, Grausem; Lesot, Agnes; Pinot, Franck] Univ Strasbourg, Inst Biol Mol Plantes, CNRS, Dept Reseaux Metab,UPR 2357, F-67083 Strasbourg, France; [Pedrini, Nicolas] UNLP, Fac Ciencias Med, Inst Invest Bioquim La Plata, RA-1900 La Plata, Argentina	State University System of Florida; University of Florida; Nanjing Normal University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National University of La Plata	Keyhani, NO (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Bldg 981,Museum Rd, Gainesville, FL 32611 USA.	keyhani@ufl.edu	Pedrini, Nicolas/G-4967-2013; Keyhani, Nemat O/I-8150-2013; Pedrini, Nicolas/Q-6386-2019; zhang, shizhu/HDO-3599-2022; Widemann, Emilie/AAH-3825-2020	Pedrini, Nicolas/0000-0002-5383-8611; zhang, shizhu/0000-0002-0283-3714; Widemann, Emilie/0000-0002-6732-5497	USDA; NSF [2010-34135-21095, IOS-1121392]	USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	This work was support in part by USDA and NSF grants (2010-34135-21095 and IOS-1121392) to NOK.; We thank Drs. Almudena Urquiza-Ortiz and Engin Kilic for assistance with several experiments. E. W. is grateful to the French Ministry of Research for supporting her Ph.D. thesis.	BOUCIAS DG, 1988, APPL ENVIRON MICROB, V54, P1795, DOI 10.1128/AEM.54.7.1795-1805.1988; BOUCIAS DG, 1984, J INVERTEBR PATHOL, V43, P288, DOI 10.1016/0022-2011(84)90153-8; Cho EM, 2007, MICROBIOL-SGM, V153, P3438, DOI 10.1099/mic.0.2007/008532-0; Crespo R, 2008, MICROBIOL RES, V163, P148, DOI 10.1016/j.micres.2006.03.013; Crespo R, 2000, MYCOLOGIA, V92, P528, DOI 10.2307/3761512; Crespo R, 2002, BIOCONTROL, V47, P685, DOI 10.1023/A:1020545613148; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; EGLINTON G, 1968, ORG MASS SPECTROM, V1, P593, DOI 10.1002/oms.1210010413; Fan YH, 2012, NAT BIOTECHNOL, V30, P35, DOI 10.1038/nbt.2080; Fan YH, 2011, J INVERTEBR PATHOL, V106, P274, DOI 10.1016/j.jip.2010.11.003; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Gartner CA, 2001, PROTEIN EXPRES PURIF, V22, P443, DOI 10.1006/prep.2001.1464; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Jarrold SL, 2007, MYCOL RES, V111, P240, DOI 10.1016/j.mycres.2006.10.007; KERWIN JL, 1984, CAN J MICROBIOL, V30, P158, DOI 10.1139/m84-025; Kirkland BH, 2004, BIOL CONTROL, V31, P414, DOI 10.1016/j.biocontrol.2004.07.007; Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705; KOLATTUKUDY PE, 1995, P NATL ACAD SCI USA, V92, P4080, DOI 10.1073/pnas.92.10.4080; LATGE JP, 1987, J GEN MICROBIOL, V133, P1987; LAU SMC, 1993, BIOCHEMISTRY-US, V32, P1945, DOI 10.1021/bi00059a010; LEBEAULT JM, 1971, LIPIDS, V6, P444, DOI 10.1007/BF02531226; LECUONA R, 1991, J INVERTEBR PATHOL, V58, P10, DOI 10.1016/0022-2011(91)90156-K; Lida T, 2000, YEAST, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; LINDLEY ND, 1995, CAN J BOT, V73, pS1034, DOI 10.1139/b95-354; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Lord JC, 2004, MYCOPATHOLOGIA, V158, P211, DOI 10.1023/B:MYCO.0000041837.29478.78; Metzenberg R.L., 2000, FUNGAL GENET REP, V47, P13, DOI [10.4148/1941-4765.1209, DOI 10.4148/1941-4765.1209]; Napolitano R, 1997, ARCH BIOCHEM BIOPHYS, V344, P208, DOI 10.1006/abbi.1997.0163; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Pedrini N, 2006, MYCOLOGIA, V98, P528, DOI 10.3852/mycologia.98.4.528; Pedrini N, 2010, MICROBIOL-SGM, V156, P2549, DOI 10.1099/mic.0.039735-0; Pedrini N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000434; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; SAITO T, 1983, APPL ENTOMOL ZOOL, V18, P225, DOI 10.1303/aez.18.225; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x; Zhang SZ, 2010, APPL MICROBIOL BIOT, V87, P1151, DOI 10.1007/s00253-010-2636-x	44	70	73	5	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13477	13486		10.1074/jbc.M111.338947	http://dx.doi.org/10.1074/jbc.M111.338947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22393051	Green Published, hybrid			2022-12-25	WOS:000302903700081
J	Fieuw, A; De Wilde, B; Speleman, F; Vandesompele, J; De Preter, K				Fieuw, Annelies; De Wilde, Bram; Speleman, Frank; Vandesompele, Jo; De Preter, Katleen			Cancer Gene Prioritization for Targeted Resequencing Using FitSNP Scores	PLOS ONE			English	Article							COLORECTAL CANCERS; GENOMIC LANDSCAPES; HUMAN BREAST; GLIOBLASTOMA; CARCINOMA	Background: Although the throughput of next generation sequencing is increasing and at the same time the cost is substantially reduced, for the majority of laboratories whole genome sequencing of large cohorts of cancer samples is still not feasible. In addition, the low number of genomes that are being sequenced is often problematic for the downstream interpretation of the significance of the variants. Targeted resequencing can partially circumvent this problem; by focusing on a limited number of candidate cancer genes to sequence, more samples can be included in the screening, hence resulting in substantial improvement of the statistical power. In this study, a successful strategy for prioritizing candidate genes for targeted resequencing of cancer genomes is presented. Results: Four prioritization strategies were evaluated on six different cancer types: genes were ranked using these strategies, and the positive predictive value (PPV) or mutation rate within the top-ranked genes was compared to the baseline mutation rate in each tumor type. Successful strategies generate gene lists in which the top is enriched for known mutated genes, as evidenced by an increase in PPV. A clear example of such an improvement is seen in colon cancer, where the PPV is increased by 2.3 fold compared to the baseline level when 100 top fitSNP genes are sequenced. Conclusions: A gene prioritization strategy based on the fitSNP scores appears to be most successful in identifying mutated cancer genes across different tumor entities, with variance of gene expression levels as a good second best.	[Fieuw, Annelies; De Wilde, Bram; Speleman, Frank; Vandesompele, Jo; De Preter, Katleen] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium	Ghent University; Ghent University Hospital	Fieuw, A (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.	katleen.depreter@ugent.be	speleman, frank/AAR-5184-2020; De Preter, Katleen/I-7135-2013; Vandesompele, Jo/W-3411-2018	speleman, frank/0000-0002-6628-8559; De Preter, Katleen/0000-0002-7726-5096; Vandesompele, Jo/0000-0001-6274-0184; De Wilde, Bram/0000-0003-0213-1322	Research Foundation - Flanders; Fund for Scientific Research [G.0198.08]; Federal Government Institution [NKP_29_014]; Concerted Research Actions [01G01910]; Ghent University; Hercules Foundation; Flemish Government - Department of Economy, Science and Innovation	Research Foundation - Flanders(FWO); Fund for Scientific Research; Federal Government Institution; Concerted Research Actions; Ghent University(Ghent University); Hercules Foundation; Flemish Government - Department of Economy, Science and Innovation	Dr. Fieuw and Dr. De Wilde are predoctoral fellows supported by a fellowship of the Research Foundation - Flanders (http://www.fwo.be/). Dr. De Preter is a postdoctoral fellow of the Research Foundation - Flanders. This study was supported by the Fund for Scientific Research (grant number G.0198.08), Federal Government Institution (grant number NKP_29_014) and Concerted Research Actions (grant number 01G01910). This work was carried out in part using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation and the Flemish Government - Department of Economy, Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleeker FE, 2009, HUM MUTAT, V30, pE451, DOI 10.1002/humu.20927; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Fu CT, 2010, BLOOD, V115, P4715, DOI 10.1182/blood-2009-11-255778; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Wagle N, 2011, J CLIN ONCOLOGY OFFI; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	17	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31333	10.1371/journal.pone.0031333	http://dx.doi.org/10.1371/journal.pone.0031333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396732	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000005
J	Hama, Y; Chano, T; Inui, T; Matsumoto, K; Okabe, H				Hama, Yusuke; Chano, Tokuhiro; Inui, Takuma; Matsumoto, Kyoichi; Okabe, Hidetoshi			Preparation of Mouse Monoclonal Antibody for RB1CC1 and Its Clinical Application	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; FIP200; COMPLEX; IDENTIFICATION; EXPRESSION; PROTEIN; KINASE	RB1-inducible coiled-coil 1 (RB1CC1; also known as FIP200) plays important roles in several biological pathways such as cell proliferation and autophagy. Evaluation of RB1CC1 expression can provide useful clinical information on various cancers and neurodegenerative diseases. In order to realize the clinical applications, it is necessary to establish a stable supply of antibody and reproducible procedures for the laboratory examinations. In the present study, we have generated mouse monoclonal antibodies for RB1CC1, and four kinds of antibodies (N1-8, N1-216, N3-2, and N3-42) were found to be optimal for clinical applications such as ELISA and immunoblots and work as well as the pre-existing polyclonal antibodies. N1-8 monoclonal antibody provided the best recognition of RB1CC1 in the clinico-pathological examination of formalin-fixed paraffin-embedded tissues. These monoclonal antibodies will help to generate new opportunities in scientific examinations in biology and clinical medicine.	[Hama, Yusuke; Chano, Tokuhiro; Inui, Takuma; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Shiga, Japan; [Matsumoto, Kyoichi] Mikuri Immunol Lab, Osaka, Japan	Shiga University of Medical Science	Hama, Y (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Shiga, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japanese Society of Laboratory Medicine Fund for the Promotion of Science	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society of Laboratory Medicine Fund for the Promotion of Science	The study was supported by KAKENHI (Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the Japanese Society of Laboratory Medicine Fund for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Chano T, 2006, INT J MOL MED, V18, P425; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015737; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Kontani K, 2003, INT J MOL MED, V12, P767; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Morselli E, 2011, CELL CYCLE, V10, P2763, DOI 10.4161/cc.10.16.16868; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Tameno H, 2011, HEAD NECK; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32052	10.1371/journal.pone.0032052	http://dx.doi.org/10.1371/journal.pone.0032052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396748	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000014
J	Shohat, M; Ben-Meir, D; Lavi, S				Shohat, Meytal; Ben-Meir, Daniella; Lavi, Sara			Protein Phosphatase Magnesium Dependent 1A (PPM1A) Plays a Role in the Differentiation and Survival Processes of Nerve Cells	PLOS ONE			English	Article							AKT/PROTEIN KINASE-B; PC12 CELLS; NEURONAL DIFFERENTIATION; CYCLE PROGRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MAMMALIAN-CELLS; GROWTH ARREST; 2C; APOPTOSIS	The serine/threonine phosphatase type 2C (PPM1A) has a broad range of substrates, and its role in regulating stress response is well established. We have investigated the involvement of PPM1A in the survival and differentiation processes of PC6-3 cells, a subclone of the PC12 cell line. This cell line can differentiate into neuron like cells upon exposure to nerve growth factor (NGF). Overexpression of PPM1A in naive PC6-3 cells caused cell cycle arrest at the G2/M phase followed by apoptosis. Interestingly, PPM1A overexpression did not affect fully differentiated cells. Using PPM1A overexpressing cells and PPM1A knockdown cells, we show that this phosphatase affects NGF signaling in PC6-3 cells and is engaged in neurite outgrowth. In addition, the ablation of PPM1A interferes with NGF-induced growth arrest during differentiation of PC6-3 cells.	[Shohat, Meytal; Ben-Meir, Daniella; Lavi, Sara] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Shohat, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	saralav@tauex.tau.ac.il			David Kane Foundation; Ela Kodesz Institute for Research on Cancer Development and Prevention; Ministry of Science and Technology, Israel; DKFZ (Deutsches Krebsforschungs Zentrum); Ministry of Health; Israel Cancer Association	David Kane Foundation; Ela Kodesz Institute for Research on Cancer Development and Prevention; Ministry of Science and Technology, Israel(Ministry of Science, Technology and Space (MOST), Israel); DKFZ (Deutsches Krebsforschungs Zentrum); Ministry of Health; Israel Cancer Association	This work was supported by research grants from the David Kane Foundation, the Ela Kodesz Institute for Research on Cancer Development and Prevention, the Ministry of Science and Technology, Israel and the DKFZ (Deutsches Krebsforschungs Zentrum), the Ministry of Health and Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1992, MOL BRAIN RES, V13, P283, DOI 10.1016/0169-328X(92)90211-S; Bang OS, 2001, J CELL SCI, V114, P81; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Eaton MJ, 2004, MOL CELL ENDOCRINOL, V228, P39, DOI 10.1016/j.mce.2003.02.001; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Guthridge MA, 1997, MOL CELL BIOL, V17, P5485, DOI 10.1128/MCB.17.9.5485; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; Klumpp S, 2002, NEUROCHEM INT, V41, P251, DOI 10.1016/S0197-0186(02)00020-7; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lammers T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-65; Lee SR, 2005, J CELL PHYSIOL, V205, P270, DOI 10.1002/jcp.20395; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Marino S, 2002, DEVELOPMENT, V129, P3513; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; MCGOWAN CH, 1988, METHOD ENZYMOL, V159, P416; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Ofek P, 2003, METHOD ENZYMOL, V366, P338; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Seroussi E, 2001, J MOL BIOL, V312, P439, DOI 10.1006/jmbi.2001.4967; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stern A, 2007, J MOL EVOL, V64, P61, DOI 10.1007/s00239-006-0033-y; Strack S, 2002, J BIOL CHEM, V277, P41525, DOI 10.1074/jbc.M203767200; Szeberenyi J., 1996, Neurobiology (Budapest), V4, P1; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tong Y, 1998, J BIOL CHEM, V273, P35282, DOI 10.1074/jbc.273.52.35282; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Xiao JN, 2003, J NEUROCHEM, V86, P1516, DOI 10.1046/j.1471-4159.2003.01961.x; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200	46	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32438	10.1371/journal.pone.0032438	http://dx.doi.org/10.1371/journal.pone.0032438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384250	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500089
J	Borkosky, SS; Whitley, C; Kopp-Schneider, A; zur Hausen, H; de Villiers, EM				Borkosky, Silvia S.; Whitley, Corinna; Kopp-Schneider, Annette; zur Hausen, Harald; de Villiers, Ethel-Michele			Epstein-Barr Virus Stimulates Torque Teno Virus Replication: A Possible Relationship to Multiple Sclerosis	PLOS ONE			English	Article							HERPES-SIMPLEX VIRUS; VARICELLA-ZOSTER-VIRUS; TT-VIRUS; MOLECULAR MIMICRY; CEREBROSPINAL-FLUID; CELL-LINE; JC VIRUS; INTRAGENOMIC REARRANGEMENT; ENDOGENOUS RETROVIRUS; HUMAN HERPESVIRUS-6	Viral infections have been implicated in the pathogenesis of multiple sclerosis. Epstein-Barr virus (EBV) has frequently been investigated as a possible candidate and torque teno virus (TTV) has also been discussed in this context. Nevertheless, mechanistic aspects remain unresolved. We report viral replication, as measured by genome amplification, as well as quantitative PCR of two TTV-HD14 isolates isolated from multiple sclerosis brain in a series of EBV-positive and -negative lymphoblastoid and Burkitt's lymphoma cell lines. Our results demonstrate the replication of both transfected TTV genomes up to day 21 post transfection in all the evaluated cell lines. Quantitative amplification indicates statistically significant enhanced TTV replication in the EBV-positive cell lines, including the EBV-converted BJAB line, in comparison to the EBV-negative Burkitt's lymphoma cell line BJAB. This suggests a helper effect of EBV infections in the replication of TTV. The present study provides information on a possible interaction of EBV and TTV in the etiology and progression of multiple sclerosis.	[Borkosky, Silvia S.; Whitley, Corinna; zur Hausen, Harald; de Villiers, Ethel-Michele] Deutsch Krebsforschungszentrum DKFZ, Div Characterizat Tumorviruses, Heidelberg, Germany; [Kopp-Schneider, Annette] Deutsch Krebsforschungszentrum, Div Biostat, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Borkosky, SS (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Characterizat Tumorviruses, Heidelberg, Germany.	e.devilliers@dkfz.de		Kopp-Schneider, Annette/0000-0002-1810-0267	Oryx, Munchen	Oryx, Munchen	Partial funding by Oryx, Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarez-Lafuente R, 2007, MULT SCLER J, V13, P590, DOI 10.1177/1352458506073116; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Banwell B, 2011, LANCET NEUROL, V10, P436, DOI 10.1016/S1474-4422(11)70045-X; Bernasconi M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-43; Biagini P, 2010, VIROLOGIE, V14, P3, DOI 10.1684/vir.2010.0279; Blazsek A, 2008, EXP DERMATOL, V17, P446, DOI 10.1111/j.1600-0625.2007.00663.x; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Brudek T, 2007, J NEUROIMMUNOL, V187, P147, DOI 10.1016/j.jneuroim.2007.04.003; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Canaan A, 2009, P NATL ACAD SCI USA, V106, P22421, DOI 10.1073/pnas.0911676106; Cassiani-Ingoni R, 2005, GLIA, V52, P252, DOI 10.1002/glia.20219; Castellazzi M, 2010, MULT SCLER J, V16, P883, DOI 10.1177/1352458510368051; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Chitnis T, 2011, NEUROL CLIN, V29, P481, DOI 10.1016/j.ncl.2011.01.004; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Clark Duncan, 2004, Herpes, V11 Suppl 2, p112A; Comabella M, 2010, MULT SCLER, V16, P355, DOI 10.1177/1352458509357066; Croxford JL, 2005, J VIROL, V79, P8581, DOI 10.1128/JVI.79.13.8581-8590.2005; d'Herouel AF, 2010, VIROLOGY, V405, P524, DOI 10.1016/j.virol.2010.06.040; de Villiers EM, 2009, CURR TOP MICROBIOL, V331, P91; de Villiers EM, 2007, INT J CANCER, V121, P2109, DOI 10.1002/ijc.22931; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Delbue S, 2007, J NEUROVIROL, V13, P73, DOI 10.1080/13550280601094563; Feederle R, 2009, J VIROL, V83, P4952, DOI 10.1128/JVI.00170-09; Figueiredo CP, 2007, LEUKEMIA LYMPHOMA, V48, P731, DOI 10.1080/10428190701203954; FRESEN KO, 1976, INT J CANCER, V17, P161, DOI 10.1002/ijc.2910170203; FRESEN KO, 1978, INT J CANCER, V22, P378, DOI 10.1002/ijc.2910220403; Garbuglia AR, 2003, INT J IMMUNOPATH PH, V16, P109, DOI 10.1177/039463200301600204; GEORGFRIES B, 1984, VIROLOGY, V134, P64, DOI 10.1016/0042-6822(84)90272-1; Gergely P, 2006, AUTOIMMUN REV, V6, P5, DOI 10.1016/j.autrev.2006.03.002; Germi R, 2004, CLIN CHEM, V50, P1814, DOI 10.1373/clinchem.2004.034363; Granieri E, 2001, NEUROL SCI, V22, P179, DOI 10.1007/s100720170021; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; HEILBRONN R, 1989, J VIROL, V63, P3683, DOI 10.1128/JVI.63.9.3683-3692.1989; HEILBRONN R, 1993, P NATL ACAD SCI USA, V90, P11406, DOI 10.1073/pnas.90.23.11406; Hinuma Y, 1967, J Virol, V1, P1045; Hosking MP, 2010, CRIT REV IMMUNOL, V30, P119, DOI 10.1615/CritRevImmunol.v30.i2.20; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Kakkola L, 2007, FEBS J, V274, P4719, DOI 10.1111/j.1742-4658.2007.06020.x; Kanda Y, 1999, BLOOD, V93, P2485, DOI 10.1182/blood.V93.8.2485.408k06_2485_2490; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Kuusisto H, 2008, MULT SCLER J, V14, P54, DOI 10.1177/1352458507080063; LAUER K, 1994, J CLIN EPIDEMIOL, V47, P43, DOI 10.1016/0895-4356(94)90032-9; LEINBACH SS, 1979, J VIROL, V30, P248, DOI 10.1128/JVI.30.1.248-254.1979; Leppik L, 2007, J VIROL, V81, P9346, DOI 10.1128/JVI.00781-07; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Libbey JE, 2007, INT REV NEUROBIOL, V79, P127, DOI 10.1016/S0074-7742(07)79006-2; Libbey JE, 2010, RESULTS PROBL CELL D, V51, P21, DOI 10.1007/400_2008_12; Lunemann JD, 2008, NEUROLOGY, V71, P1033, DOI 10.1212/01.wnl.0000326576.91097.87; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Lunemann JD, 2006, BRAIN, V129, P1493, DOI 10.1093/brain/awl067; Maggi F, 2007, RHEUMATOLOGY, V46, P885, DOI 10.1093/rheumatology/kem032; Maggi F, 2001, J MED VIROL, V64, P190, DOI 10.1002/jmv.1035; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mancuso R, 2007, J MED VIROL, V79, P192, DOI 10.1002/jmv.20777; McLaughlin KA, 2009, J IMMUNOL, V183, P4067, DOI 10.4049/jimmunol.0801888; Mechelli R, 2011, MULT SCLER J, V17, P1290, DOI 10.1177/1352458511410515; MENEZES J, 1975, BIOMEDICINE, V22, P276; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2000, J VIROL, V74, P10236, DOI 10.1128/JVI.74.21.10236-10239.2000; Okamoto H, 2000, BIOCHEM BIOPH RES CO, V270, P657, DOI 10.1006/bbrc.2000.2481; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 1999, J MED VIROL, V57, P252, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;252::AID-JMV7&gt;3.0.CO;2-Q; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d; Ponsonby AL, 2005, LANCET NEUROL, V4, P793, DOI 10.1016/S1474-4422(05)70233-7; Sargsyan SA, 2010, NEUROLOGY, V74, P1127, DOI 10.1212/WNL.0b013e3181d865a1; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHLEHOFER JR, 1986, VIROLOGY, V152, P110, DOI 10.1016/0042-6822(86)90376-4; SCHLEHOFER JR, 1983, INT J CANCER, V32, P99, DOI 10.1002/ijc.2910320116; Sips GJ, 2007, REV MED VIROL, V17, P223, DOI 10.1002/rmv.526; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Sospedra M, 2006, AUTOIMMUNITY, V39, P3, DOI 10.1080/08916930500484922; Sospedra Mireia, 2005, PLoS Pathog, V1, pe41; Sotelo J, 2007, J NEUROL, V254, P493, DOI 10.1007/s00415-006-0402-x; Sugawara Y, 1999, EMBO J, V18, P5755, DOI 10.1093/emboj/18.20.5755; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thomas T, 2008, SEMIN NEUROL, V28, P69, DOI 10.1055/s-2007-1019129; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Torkildsen O, 2008, EUR J NEUROL, V15, P106, DOI 10.1111/j.1468-1331.2007.02009.x; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Waubant E, 2011, NEUROLOGY, V76, P1989, DOI 10.1212/WNL.0b013e31821e552a; Weller B, 2008, VIROLOGY, V381, P36, DOI 10.1016/j.virol.2008.08.017; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; zur Hausen H, 1987, ACCOMPLISHMENTS ONCO, P126; zur Hausen H, 2009, INT J CANCER, V125, P1764, DOI 10.1002/ijc.24365	101	28	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32160	10.1371/journal.pone.0032160	http://dx.doi.org/10.1371/journal.pone.0032160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384166	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500079
J	de Souza, TA; Soprano, AS; de Lira, NPV; Quaresma, AJC; Pauletti, BA; Leme, AFP; Benedetti, CE				de Souza, Tiago Antonio; Soprano, Adriana Santos; Vieira de Lira, Nayara Patricia; Christino Quaresma, Alexandre Jose; Pauletti, Bianca Alves; Paes Leme, Adriana Franco; Benedetti, Celso Eduardo			The TAL Effector PthA4 Interacts with Nuclear Factors Involved in RNA-Dependent Processes Including a HMG Protein That Selectively Binds Poly(U) RNA	PLOS ONE			English	Article							MESSENGER-RNA; XANTHOMONAS-CITRI; TRANSCRIPTION FACTOR; DNA-BINDING; PATHOGENICITY GENE; RECOGNITION; COMPLEX; MECHANISM; SPECIFICITY; AVIRULENCE	Plant pathogenic bacteria utilize an array of effector proteins to cause disease. Among them, transcriptional activator-like (TAL) effectors are unusual in the sense that they modulate transcription in the host. Although target genes and DNA specificity of TAL effectors have been elucidated, how TAL proteins control host transcription is poorly understood. Previously, we showed that the Xanthomonas citri TAL effectors, PthAs 2 and 3, preferentially targeted a citrus protein complex associated with transcription control and DNA repair. To extend our knowledge on the mode of action of PthAs, we have identified new protein targets of the PthA4 variant, required to elicit canker on citrus. Here we show that all the PthA4-interacting proteins are DNA and/or RNA-binding factors implicated in chromatin remodeling and repair, gene regulation and mRNA stabilization/modification. The majority of these proteins, including a structural maintenance of chromosomes protein (CsSMC), a translin-associated factor X (CsTRAX), a VirE2-interacting protein (CsVIP2), a high mobility group (CsHMG) and two poly(A)-binding proteins (CsPABP1 and 2), interacted with each other, suggesting that they assemble into a multiprotein complex. CsHMG was shown to bind DNA and to interact with the invariable leucine-rich repeat region of PthAs. Surprisingly, both CsHMG and PthA4 interacted with PABP1 and 2 and showed selective binding to poly(U) RNA, a property that is novel among HMGs and TAL effectors. Given that homologs of CsHMG, CsPABP1, CsPABP2, CsSMC and CsTRAX in other organisms assemble into protein complexes to regulate mRNA stability and translation, we suggest a novel role of TAL effectors in mRNA processing and translational control.	[de Souza, Tiago Antonio; Soprano, Adriana Santos; Vieira de Lira, Nayara Patricia; Christino Quaresma, Alexandre Jose; Pauletti, Bianca Alves; Paes Leme, Adriana Franco; Benedetti, Celso Eduardo] CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil		de Souza, TA (corresponding author), CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil.	celso.benedetti@lnbio.org.br	Leme, Adriana F Paes/C-9679-2012; Quaresma, Alexandre Jose Christino/E-4229-2010; de Souza, Tiago Antonio/C-1039-2012; Citros, Inct/I-2442-2013	Leme, Adriana F Paes/0000-0001-7959-147X; de Souza, Tiago Antonio/0000-0001-6283-4359; Christino Quaresma, Alexandre Jose/0000-0002-1810-0400; Santos Soprano, Adriana/0000-0001-7117-927X; Benedetti, Celso/0000-0002-4602-0256	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [2010/00634-1, 470410/2008-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br), grant numbers 2010/00634-1 and 470410/2008-6, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saadi A, 2007, MOL PLANT MICROBE IN, V20, P934, DOI 10.1094/MPMI-20-8-0934; Anand A, 2007, PLANT CELL, V19, P1695, DOI 10.1105/tpc.106.042903; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Bell AJ, 2008, BIOCHEM BIOPH RES CO, V377, P262, DOI 10.1016/j.bbrc.2008.09.131; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Chen ES, 2004, P NATL ACAD SCI USA, V101, P8078, DOI 10.1073/pnas.0307976101; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Cunha JL, 2011, BRAZ J MED BIOL RES, V44, P361, DOI 10.1590/S0100-879X2011007500017; Das D, 2001, J BIOL CHEM, V276, P32597, DOI 10.1074/jbc.M011792200; Dasgupta A, 2003, BBA-GENE STRUCT EXPR, V1627, P101, DOI 10.1016/S0167-4781(03)00080-0; Deng Dong, 2012, Science, V335, P720, DOI 10.1126/science.1215670; Dias SMG, 2010, NUCLEUS-PHILA, V1, P139, DOI 10.4161/nucl.1.2.10919; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Erdemir T, 2002, MOL MICROBIOL, V46, P947, DOI 10.1046/j.1365-2958.2002.03224.x; Erdemir T, 2002, J CELL SCI, V115, P207; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Grasser KD, 2007, BBA-GENE STRUCT EXPR, V1769, P346, DOI 10.1016/j.bbaexp.2006.12.004; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Launholt D, 2006, PLANT CELL, V18, P2904, DOI 10.1105/tpc.106.047274; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Lildballe DL, 2008, J MOL BIOL, V384, P9, DOI 10.1016/j.jmb.2008.09.014; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Miyoshi K, 2003, PLANT J, V36, P532, DOI 10.1046/j.1365-313X.2003.01897.x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Ogram SA, 2010, VIROLOGY, V397, P14, DOI 10.1016/j.virol.2009.11.006; Pedersen DS, 2010, PLANT PHYSIOL, V154, P1831, DOI 10.1104/pp.110.163055; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yanagisawa S, 1997, EUR J BIOCHEM, V250, P403, DOI 10.1111/j.1432-1033.1997.0403a.x; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yuan T, 2011, MOL PLANT, V4, P300, DOI 10.1093/mp/ssq076	64	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32305	10.1371/journal.pone.0032305	http://dx.doi.org/10.1371/journal.pone.0032305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384209	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500093
J	Chuang, CY; Lin, KI; Hsiao, M; Stone, L; Chen, HF; Huang, YH; Lin, SP; Ho, HN; Kuo, HC				Chuang, Ching-Yu; Lin, Kuo-I; Hsiao, Michael; Stone, Lee; Chen, Hsin-Fu; Huang, Yen-Hua; Lin, Shau-Ping; Ho, Hong-Nerng; Kuo, Hung-Chih			Meiotic Competent Human Germ Cell-like Cells Derived from Human Embryonic Stem Cells Induced by BMP4/WNT3A Signaling and OCT4/EpCAM (Epithelial Cell Adhesion Molecule) Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FETAL OVARY; EP-CAM; EXPRESSION; MOUSE; DERIVATION; DIFFERENTIATION; MICE; SPECIFICATION; GENERATION; MIGRATION	The establishment of an effective germ cell selection/enrichment platform from in vitro differentiating human embryonic stem cells (hESCs) is crucial for studying the molecular and signaling processes governing human germ cell specification and development. In this study, we developed a germ cell-enriching system that enables us to identify signaling factors involved in germ cell-fate induction from differentiating hESCs in vitro. First, we demonstrated that selection through an OCT4-EGFP reporter system can successfully increase the percentage of meiotic-competent, germ cell-like cells from spontaneously differentiating hESCs. Furthermore, we showed that the pluripotency associated surface marker, epithelial cell adhesion molecule (EpCAM), is also expressed in human fetal gonads and can be used as an effective selection marker for germ cell enrichment from differentiating hESCs. Combining OCT4 and EpCAM selection can further enrich the meiotic-competent germ cell-like cell population. Also, with the percentage of OCT4(+)/EpCAM(+) cells as readout, we demonstrated the synergistic effect of BMP4/pSMAD1/5/8 and WNT3A/beta-CATENIN in promoting hESCs toward the germline fate. Combining BMP4/WNT3A induction and OCT4/EpCAM selection can significantly increase the putative germ cell population with meiotic competency. Co-transplantation of these cells with dissociated mouse neonatal ovary cells into SCID mice resulted in a homogenous germ cell cluster formation in vivo. The stepwise platform established in this study provides a useful tool to elucidate the molecular mechanisms of human germ cell development, which has implications not only for human fertility research but regenerative medicine in general.	[Chuang, Ching-Yu; Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 106, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med, Grad Inst Clin Genom, Taipei 106, Taiwan; [Chuang, Ching-Yu; Lin, Kuo-I; Hsiao, Michael; Kuo, Hung-Chih] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Stone, Lee; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lin, Shau-Ping] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Taipei 100, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Dept Biochem, Grad Inst Med Sci, Sch Med, Taipei 110, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Lin, SP (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 106, Taiwan.	shaupinglin@ntu.edu.tw; kuohuch@gate.sinica.edu.tw	Kuo, Hung-Chih/H-7810-2014; NTU, Ref07/AAX-7890-2021; Hsiao, Michael/U-6238-2019	Kuo, Hung-Chih/0000-0003-1336-1203; Hsiao, Michael/0000-0001-8529-9213; Lin, Shau-Ping/0000-0003-3423-991X; CHEN, HSIN-FU/0000-0002-7748-4440	National Science Council, Taiwan [99-3111-B-001-001, 99-3111-B-002-009, 99-3111-B-002-008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by an intramural grant from Academia Sinica and Stem Cell Priority Grants 99-3111-B-001-001 and 99-3111-B-002-009 (to H. C. K.), and 99-3111-B-002-008 (to S. P. L.) from National Science Council, Taiwan.	Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; BESMER P, 1993, DEVELOPMENT, P125; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Chen HF, 2007, HUM REPROD, V22, P567, DOI 10.1093/humrep/del412; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; de Boer CJ, 1999, J PATHOL, V188, P201, DOI 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; KLEIN CE, 1987, J INVEST DERMATOL, V89, P500, DOI 10.1111/1523-1747.ep12460996; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Nicholas CR, 2009, ENDOCR REV, V30, P264, DOI 10.1210/er.2008-0034; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Psathaki OE, 2011, STEM CELLS DEV, V20, P2205, DOI 10.1089/scd.2010.0575; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	40	39	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14389	14401		10.1074/jbc.M111.338434	http://dx.doi.org/10.1074/jbc.M111.338434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396540	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000304003200007
J	Snelders, E; Camps, SMT; Karawajczyk, A; Schaftenaar, G; Kema, GHJ; van der Lee, HA; Klaassen, CH; Melchers, WJG; Verweij, PE				Snelders, Eveline; Camps, Simone M. T.; Karawajczyk, Anna; Schaftenaar, Gijs; Kema, Gert H. J.; van der Lee, Henrich A.; Klaassen, Corne H.; Melchers, Willem J. G.; Verweij, Paul E.			Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus	PLOS ONE			English	Article							INCREMENTAL CONSTRUCTION ALGORITHM; AZOLE RESISTANCE; HEMATOLOGICAL MALIGNANCIES; LOW-PREVALENCE; FRENCH COHORT; CYP51; POSACONAZOLE; VORICONAZOLE; MECHANISM; EVOLUTION	Background: Azoles play an important role in the management of Aspergillus diseases. Azole resistance is an emerging global problem in Aspergillus fumigatus, and may develop through patient therapy. In addition, an environmental route of resistance development has been suggested through exposure to 14 alpha-demethylase inhibitors (DMIs). The main resistance mechanism associated with this putative fungicide-driven route is a combination of alterations in the Cyp51A-gene (TR34/L98H). We investigated if TR34/L98H could have developed through exposure to DMIs. Methods and Findings: Thirty-one compounds that have been authorized for use as fungicides, herbicides, herbicide safeners and plant growth regulators in the Netherlands between 1970 and 2005, were investigated for cross-resistance to medical triazoles. Furthermore, CYP51-protein homology modeling and molecule alignment studies were performed to identify similarity in molecule structure and docking modes. Five triazole DMIs, propiconazole, bromuconazole, tebuconazole, epoxiconazole and difenoconazole, showed very similar molecule structures to the medical triazoles and adopted similar poses while docking the protein. These DMIs also showed the greatest cross-resistance and, importantly, were authorized for use between 1990 and 1996, directly preceding the recovery of the first clinical TR34/L98H isolate in 1998. Through microsatellite genotyping of TR34/L98H isolates we were able to calculate that the first isolate would have arisen in 1997, confirming the results of the abovementioned experiments. Finally, we performed induction experiments to investigate if TR34/L98H could be induced under laboratory conditions. One isolate evolved from two copies of the tandem repeat to three, indicating that fungicide pressure can indeed result in these genomic changes. Conclusions: Our findings support a fungicide-driven route of TR34/L98H development in A. fumigatus. Similar molecule structure characteristics of five triazole DMIs and the three medical triazoles appear the underlying mechanism of cross resistance development. Our findings have major implications for the assessment of health risks associated with the use of triazole DMIs.	[Snelders, Eveline; Camps, Simone M. T.; van der Lee, Henrich A.; Melchers, Willem J. G.; Verweij, Paul E.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Karawajczyk, Anna; Schaftenaar, Gijs] Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Snelders, Eveline; Camps, Simone M. T.; van der Lee, Henrich A.; Melchers, Willem J. G.; Verweij, Paul E.] Radboud Univ Nijmegen, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Klaassen, Corne H.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Kema, Gert H. J.] Wageningen Univ, Plant Res Int, Wageningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Wageningen University & Research	Snelders, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	p.verweij@mmb.umcn.nl	Snelders, Eveline/HHS-5284-2022; Melchers, Willem/C-8819-2015; Schaftenaar, Gijs/Q-8665-2018; Verweij, P.E./H-8108-2014	Melchers, Willem/0000-0002-5446-2230; Verweij, P.E./0000-0002-8600-9860; Kema, Gerrit HJ/0000-0002-2732-6911; Snelders, Eveline/0000-0002-7868-7928	Netherlands Organization for Health Research and Development [125010006]; Dutch Ministry of Economic Affairs, Agriculture, and Innovation [3201944]; Pfizer; Merck; Gilead Sciences; Cephalon; Astellas; Basilea	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Ministry of Economic Affairs, Agriculture, and Innovation; Pfizer(Pfizer); Merck(Merck & Company); Gilead Sciences(Gilead Sciences); Cephalon; Astellas(Astellas Pharmaceuticals); Basilea	This work was supported by research grants from the Netherlands Organization for Health Research and Development [125010006] and from the Dutch Ministry of Economic Affairs, Agriculture, and Innovation [3201944]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research grants from Pfizer, Merck, Gilead Sciences, Cephalon, Astellas, and Basilea. These research grants were not awarded for the research described in this manuscript. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alanio A, 2011, J ANTIMICROB CHEMOTH, V66, P371, DOI 10.1093/jac/dkq450; Brunner PC, 2008, MOL PLANT PATHOL, V9, P305, DOI 10.1111/J.1364-3703.2007.00464.X; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Enserink M, 2009, SCIENCE, V326, P1173, DOI 10.1126/science.326.5957.1173; Fraczek MG, 2011, ANTIMICROB AGENTS CH, V55, P2483, DOI 10.1128/AAC.01651-10; Hodiamont CJ, 2009, MED MYCOL, V47, P217, DOI 10.1080/13693780802545600; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Kuipers S, 2011, ANTIMICROB AGENTS CH, V55, P3564, DOI 10.1128/AAC.01544-10; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Mavridou E, 2010, ANTIMICROB AGENTS CH, V54, P4758, DOI 10.1128/AAC.00606-10; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; National Committee for Clinical Laboratory Standard, 2002, M38A NAT COMM CLIN L; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rosnow RL, 1996, PSYCHOL METHODS, V1, P331, DOI 10.1037/1082-989X.1.4.331; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; Verweij PE, 2011, J ANTIMICROB CHEMOTH, V66, P954, DOI 10.1093/jac/dkr008; Verweij P. E., 2010, 50 INT C ANT AG CHEM; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8	28	262	268	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31801	10.1371/journal.pone.0031801	http://dx.doi.org/10.1371/journal.pone.0031801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396740	Green Submitted, gold, Green Published			2022-12-25	WOS:000303005000009
J	Dehmer, M; Grabner, M; Varmuza, K				Dehmer, Matthias; Grabner, Martin; Varmuza, Kurt			Information Indices with High Discriminative Power for Graphs	PLOS ONE			English	Article							COMPLEX NETWORKS; ENTROPY; BOUNDS	In this paper, we evaluate the uniqueness of several information-theoretic measures for graphs based on so-called information functionals and compare the results with other information indices and non-information-theoretic measures such as the well-known Balaban J index. We show that, by employing an information functional based on degree-degree associations, the resulting information index outperforms the Balaban J index tremendously. These results have been obtained by using nearly 12 million exhaustively generated, non-isomorphic and unweighted graphs. Also, we obtain deeper insights on these and other topological descriptors when exploring their uniqueness by using exhaustively generated sets of alkane trees representing connected and acyclic graphs in which the degree of a vertex is at most four.	[Dehmer, Matthias; Grabner, Martin] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Varmuza, Kurt] Univ Vienna, Inst Chem Engn, Lab Chemometr, Vienna, Austria	University of Vienna	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at			Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer, Martin Grabner and Kurt Varmuza thank the Austrian Science Funds for supporting this work (project P22029-N13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; Bertz S. H., 1981, J AM CHEM SOC, V103, P3241; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dehmer M, 2011, QUANTUM FRONTIERS AT, P479; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2008, SYMMETRY, V19, P269; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Dehmer MM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-18; Devillers J, 1999, TOPOLOGICAL INDICES; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Diudea MV, 2011, COMPLEXITY, V16, P32, DOI 10.1002/cplx.20363; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; Harary F., 1969, GRAPH THEORY; Hu CY, 1996, J CHEM INF COMP SCI, V36, P82, DOI 10.1021/ci9501150; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Konstantinova EV, 2003, INDIAN J CHEM A, V42, P1227; Konstantinova EV, 1990, VYCHISL SISTEMY, V136, P38; Li X., 2006, MATH CHEM MONOGRAPHS; McKay BD, 1998, J ALGORITHM, V26, P306, DOI 10.1006/jagm.1997.0898; Mehler A, 2010, ENTROPY-SWITZ, V12, P1440, DOI 10.3390/e12061440; Molgen isomer generator software, 2000, MOLG IS GEN SOFTW; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Mueller LAJ, 2011, BIOINFORMATICS, V27, P140, DOI 10.1093/bioinformatics/btq606; R software a language and environment for statistical computing, 2011, R SOFTW LANG ENV STA; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; RAYCHAUDHURY C, 1984, J COMPUT CHEM, V5, P581, DOI 10.1002/jcc.540050612; Shannon C., 1964, MATH THEORY COMMUNIC; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Todeschini R., 2002, HDB MOL DESCRIPTORS; Trinajstic N., 2018, CHEM GRAPH THEORY; Vukicevic D, 2005, INTERNET ELECT J MOL, V4, P491; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Zhou B, 2008, CROAT CHEM ACTA, V81, P319	45	55	55	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31214	10.1371/journal.pone.0031214	http://dx.doi.org/10.1371/journal.pone.0031214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393358	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500011
J	Jonckheere, N; Skrypek, N; Merlin, J; Dessein, AF; Dumont, P; Leteurtre, E; Harris, A; Desseyn, JL; Susini, C; Frenois, F; Van Seuningen, I				Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Dumont, Patrick; Leteurtre, Emmanuelle; Harris, Ann; Desseyn, Jean-Luc; Susini, Christiane; Frenois, Frederic; Van Seuningen, Isabelle			The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways	PLOS ONE			English	Article							CHROMOSOMAL LOCALIZATION; TUMOR MICROENVIRONMENT; COLON-CANCER; BILE-ACIDS; GENE MUC4; TGF-BETA; PROGRESSION; EXPRESSION; PROMOTER; SURVIVAL	The mucin MUC4 and its membrane partner the ErbB2 oncogenic receptor are potential interacting partners in human pancreatic tumour development. However, the way they function is still largely unknown. In this work, we aimed to identify the cellular mechanisms and the intracellular signalling pathways under the control of both ErbB2 and MUC4 in a human pancreatic adenocarcinomatous cell line. Using co-immunoprecipitation and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 via the EGF domains of MUC4. Stable cell clones were generated in which either MUC4 or ErbB2 were knocked down (KD) by a shRNA approach. Biological properties of these cells were then studied in vitro and in vivo. Our results show that ErbB2-KD cells are more apoptotic and less proliferative (decreased cyclin D1 and increased p27kip1 expression) while migration and invasive properties were not altered. MUC4-KD clones were less proliferative with decreased cyclin D1 expression, G1 cell cycle arrest and altered ErbB2/ErbB3 expression. Their migration properties were reduced whereas invasive properties were increased. Importantly, inhibition of ErbB2 and MUC4 expression did not impair the same signalling pathways (inhibition of MUC4 expression affected the JNK pathway whereas that of ErbB2 altered the MAPK pathway). Finally, ErbB2-KD and MUC4-KD cells showed impaired tumour growth in vivo. Our results show that ErbB2 and MUC4, which interact physically, activate different intracellular signalling pathways to regulate biological properties of CAPAN-2 pancreatic cancer cells.	[Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Leteurtre, Emmanuelle; Frenois, Frederic; Van Seuningen, Isabelle] INSERM, UMR837, Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, F-59045 Lille, France; [Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Leteurtre, Emmanuelle; Desseyn, Jean-Luc; Frenois, Frederic; Van Seuningen, Isabelle] Univ Lille Nord France, Lille, France; [Dumont, Patrick] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, Inst Biol Lille,UMR8161, F-59019 Lille, France; [Leteurtre, Emmanuelle] Ctr Hosp Reg & Univ Lille, Ctr Biol Pathol, F-59037 Lille, France; [Harris, Ann] Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Harris, Ann] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Desseyn, Jean-Luc] INSERM, U995, F-59045 Lille, France; [Susini, Christiane] Fac Med Toulouse, INSERM, U858, Inst Med Mol Rangueil, F-31073 Toulouse, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Northwestern University; Northwestern University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jonckheere, N (corresponding author), INSERM, UMR837, Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, F-59045 Lille, France.	nicolas.jonckheere@inserm.fr	VAN SEUNINGEN, Isabelle/N-6176-2016; Jonckheere, Nicolas/J-6028-2013; Desseyn, Jean-Luc/M-5070-2018	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Jonckheere, Nicolas/0000-0002-0496-0661; Desseyn, Jean-Luc/0000-0001-6876-8049	Institut National du Cancer (INCa); Ligue Nationale contre le Cancer (LNCC); Centre Hospitalier Regional Universitaire (CHRU) de Lille/region Nord-Pas de Calais; Fondation pour la Recherche Medicale (FRM); Universite de Lille 2 and Region Nord-Pas de Calais; la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue, IVS)	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (LNCC)(Ligue nationale contre le cancer); Centre Hospitalier Regional Universitaire (CHRU) de Lille/region Nord-Pas de Calais(Region Hauts-de-France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Universite de Lille 2 and Region Nord-Pas de Calais(Region Hauts-de-France); la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue, IVS)	Dr. Nicolas Jonckheere is a recipient of a postdoctoral fellowship from the Institut National du Cancer (INCa) and Ligue Nationale contre le Cancer (LNCC). Nicolas Skrypek is a recipient of a PhD fellowship of Centre Hospitalier Regional Universitaire (CHRU) de Lille/region Nord-Pas de Calais. Dr Frederic Frenois is a recipient of a postdoctoral fellowship from the Fondation pour la Recherche Medicale (FRM). Johann Merlin is the recipient of a PhD fellowship from the Universite de Lille 2 and Region Nord-Pas de Calais. This work is supported by a grant from la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue 2010, IVS). Isabelle Van Seuningen is the recipient of a "Contrat Hospitalier de Recherche Translationnelle"/CHRT 2010, AVIESAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; BREUSS JM, 1995, J CELL SCI, V108, P2241; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Cheon DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004675; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Desseyn JL, 2002, EUR J BIOCHEM, V269, P3150, DOI 10.1046/j.1432-1033.2002.02988.x; Erkan M., 2010, Experimental Oncology, V32, P128; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; FOGH J, 1980, EXP CELL BIOL, V48, P229; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Jonckheere N, 2004, ONCOGENE, V23, P5729, DOI 10.1038/sj.onc.1207769; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Jonckheere N, 2008, EPITHELIAL MUCINS ST, P17; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kielosto M, 2009, INT J CANCER, V125, P1065, DOI 10.1002/ijc.24391; KIM YW, 1989, PANCREAS, V4, P353, DOI 10.1097/00006676-198906000-00013; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Moniaux N, 2007, BRIT J CANCER, V97, P345, DOI 10.1038/sj.bjc.6603868; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Piessen G, 2007, BIOCHEM J, V402, P81, DOI 10.1042/BJ20061461; Pirollo KF, 2007, CANCER RES, V67, P2938, DOI 10.1158/0008-5472.CAN-06-4535; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; Porchet Nicole, 1999, Journal de la Societe de Biologie, V193, P85; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; Rhodes JM, 2008, BIOCHEM SOC T, V36, P1482, DOI 10.1042/BST0361482; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Theodoropoulos G, 2009, J CELL BIOCHEM, V107, P112, DOI 10.1002/jcb.22106; Tidswell M, 1997, J IMMUNOL, V159, P1497; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Van Seuningen I., 2008, EPITHELIAL MUCINS ST, P233; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh N, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-140; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154	52	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32232	10.1371/journal.pone.0032232	http://dx.doi.org/10.1371/journal.pone.0032232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393391	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500044
J	Kanao, T; Sawada, T; Davies, SA; Ichinose, H; Hasegawa, K; Takahashi, R; Hattori, N; Imai, Y				Kanao, Tomoko; Sawada, Tomoyo; Davies, Shireen-Anne; Ichinose, Hiroshi; Hasegawa, Kazuko; Takahashi, Ryosuke; Hattori, Nobutaka; Imai, Yuzuru			The Nitric Oxide-Cyclic GMP Pathway Regulates FoxO and Alters Dopaminergic Neuron Survival in Drosophila	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; COLON-CANCER CELLS; PARKINSONS-DISEASE; NERVOUS-SYSTEM; CGMP; EXPRESSION; LRRK2; SYNTHASE; PHOSPHORYLATION; LOCALIZATION	Activation of the forkhead box transcription factor FoxO is suggested to be involved in dopaminergic (DA) neurodegeneration in a Drosophila model of Parkinson's disease (PD), in which a PD gene product LRRK2 activates FoxO through phosphorylation. In the current study that combines Drosophila genetics and biochemical analysis, we show that cyclic guanosine monophosphate (cGMP)-dependent kinase II (cGKII) also phosphorylates FoxO at the same residue as LRRK2, and Drosophila orthologues of cGKII and LRRK2, DG2/For and dLRRK, respectively, enhance the neurotoxic activity of FoxO in an additive manner. Biochemical assays using mammalian cGKII and FoxO1 reveal that cGKII enhances the transcriptional activity of FoxO1 through phosphorylation of the FoxO1 S319 site in the same manner as LRRK2. A Drosophila FoxO mutant resistant to phosphorylation by DG2 and dLRRK (dFoxO S259A corresponding to human FoxO1 S319A) suppressed the neurotoxicity and improved motor dysfunction caused by co-expression of FoxO and DG2. Nitric oxide synthase (NOS) and soluble guanylyl cyclase (sGC) also increased FoxO's activity, whereas the administration of a NOS inhibitor L-NAME suppressed the loss of DA neurons in aged flies co-expressing FoxO and DG2. These results strongly suggest that the NO-FoxO axis contributes to DA neurodegeneration in LRRK2-linked PD.	[Kanao, Tomoko] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Imai, Yuzuru] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Sawada, Tomoyo; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Sawada, Tomoyo; Takahashi, Ryosuke; Hattori, Nobutaka] JST, Saitama, Japan; [Davies, Shireen-Anne] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Yokohama, Kanagawa 227, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Natl Hosp Org, Dept Neurol, Sagamihara, Kanagawa, Japan	Juntendo University; Juntendo University; Juntendo University; Kyoto University; University of Glasgow; Tokyo Institute of Technology	Kanao, T (corresponding author), Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan.	yzimai@juntendo.ac.jp	Imai, Yuzuru/AAA-6472-2019; Hattori, Nobutaka/ACR-0069-2022; Sawada, Tomoyo/C-3610-2017; Ichinose, Hiroshi/D-8986-2015	Imai, Yuzuru/0000-0003-2924-5231; Ichinose, Hiroshi/0000-0001-6008-6860	Inamori Foundation; Uehara Memorial Foundation; Dainippon Sumitomo Pharma; Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology; MEXT in Japan; Biotechnology and Biological Sciences Research Council [BB/G020620/1, BB/C000633/1, BB/E011438/1] Funding Source: researchfish; BBSRC [BB/E011438/1, BB/G020620/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [23790973, 23890206, 21500305] Funding Source: KAKEN	Inamori Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology; MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by funding from the Inamori Foundation, the Uehara Memorial Foundation, Dainippon Sumitomo Pharma, and the Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by MEXT in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2008, NEUROCHEM RES, V33, P2416, DOI 10.1007/s11064-008-9697-6; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bicker G, 2007, ARCH INSECT BIOCHEM, V64, P43, DOI 10.1002/arch.20161; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Davies SA, 2000, INSECT BIOCHEM MOLEC, V30, P1123, DOI 10.1016/S0965-1748(00)00118-1; De Vente J, 2001, NEUROSCIENCE, V108, P27, DOI 10.1016/S0306-4522(01)00401-8; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Eve DJ, 1998, MOL BRAIN RES, V63, P62, DOI 10.1016/S0169-328X(98)00259-9; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hong YK, 2009, BIOCHEM BIOPH RES CO, V384, P160, DOI 10.1016/j.bbrc.2009.04.112; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KALDERON D, 1989, J BIOL CHEM, V264, P10738; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kulaksiz H, 2002, AM J PATHOL, V161, P655, DOI 10.1016/S0002-9440(10)64221-6; Kwon IK, 2010, ONCOGENE, V29, P3423, DOI 10.1038/onc.2010.91; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Liberatore GT, 1999, NAT MED, V5, P1403; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; MacPherson MR, 2004, J BIOL CHEM, V279, P40026, DOI 10.1074/jbc.M405619200; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Soh JW, 2008, MOL CARCINOGEN, V47, P519, DOI 10.1002/mc.20409; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tseng KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027187; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang X, 1997, J NEUROCHEM, V68, P443; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00055; Yakubovich N, 2010, CURR BIOL, V20, pR141, DOI 10.1016/j.cub.2009.12.011; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yuasa K, 2000, FEBS LETT, V466, P175, DOI 10.1016/S0014-5793(99)01786-X; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	62	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30958	10.1371/journal.pone.0030958	http://dx.doi.org/10.1371/journal.pone.0030958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393355	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000303003500008
J	Yu, XY; Lu, RJ; Wang, Z; Zhu, N; Wang, W; Julian, D; Chris, B; Lv, JX; Tan, WJ				Yu, Xiaoyan; Lu, Roujian; Wang, Zhong; Zhu, Na; Wang, Wen; Julian, Druce; Chris, Birch; Lv, Jianxin; Tan, Wenjie			Etiology and Clinical Characterization of Respiratory Virus Infections in Adult Patients Attending an Emergency Department in Beijing	PLOS ONE			English	Article							HUMAN CORONAVIRUSES; TRACT INFECTIONS; PCR; DIAGNOSIS; CHILDREN; IDENTIFICATION; ASSAY; HKU1	Background: Acute respiratory tract infections (ARTIs) represent a serious global health burden. To date, few reports have addressed the prevalence of respiratory viruses (RVs) in adults with ARTIs attending an emergency department (ED). Therefore, the potential impact of respiratory virus infections on such patients remains unknown. Methodology/Principal Findings: To determine the epidemiological and clinical profiles of common and recently discovered respiratory viruses in adults with ARTIs attending an ED in Beijing, a 1-year consecutive study was conducted from May, 2010, to April, 2011. Nose and throat swab samples from 416 ARTI patients were checked for 13 respiratory viruses using multiple reverse transcription polymerase chain reaction(RT-PCR) assays for common respiratory viruses, including influenza viruses (Flu) A, B, and adenoviruses (ADVs), picornaviruses (PICs), respiratory syncytial virus (RSV), parainfluenza viruses (PIVs) 1-3, combined with real-time RT-PCR for human metapneumovirus (HMPV) and human coronaviruses (HCoVs, -OC43, -229E, -NL63, and -HKU1). Viral pathogens were detected in 52.88% (220/416) of patient samples, and 7.21% (30/416) of patients tested positive for more than one virus. PICs (17.79%) were the dominant agents detected, followed by FluA (16.11%), HCoVs (11.78%), and ADV (11.30%). HMPV, PIVs, and FluB were also detected (<3%), but not RSV. The total prevalence and the dominant virus infections detected differed significantly between ours and a previous report. Co-infection rates were high for HCoV-229E (12/39, 30.76%), PIC (22/74, 29.73%), ADV (12/47, 25.53%) and FluA (15/67, 22.39%). Different patterns of clinical symptoms were associated with different respiratory viruses. Conclusions: The pattern of RV involvement in adults with ARTIs attending an ED in China differs from that previously reported. The high prevalence of viruses (PIC, FluA, HCoVs and ADV) reported here strongly highlight the need for the development of safe and effective therapeutic approaches for these viruses.	[Yu, Xiaoyan; Lv, Jianxin; Tan, Wenjie] Wenzhou Med Coll, Inst Med Virol, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Yu, Xiaoyan; Lu, Roujian; Zhu, Na; Wang, Wen; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Zhong] CAMS, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Julian, Druce; Chris, Birch] Victorian Infect Dis Reference Lab, Dept Virol, Melbourne, Vic, Australia	Wenzhou Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Victorian Infectious Diseases Reference Laboratory	Yu, XY (corresponding author), Wenzhou Med Coll, Inst Med Virol, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; tanwj28@yahoo.cn		Druce, Julian/0000-0002-3521-3298	China-Australia Health and HIV/AIDSFacility [EID07]; 973 Program of China [2011CB504704]; National Science Foundation [81100062]; 863 Hi-Tech Research and Development Program of China [2007AA02Z463, 2007AA02Z-464]	China-Australia Health and HIV/AIDSFacility; 973 Program of China(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); 863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by a grant provided by the China-Australia Health and HIV/AIDSFacility program (Item no. EID07), 973 Program of China (Grant numbers: 2011CB504704), National Science Foundation Program of China (81100062) and the 863 Hi-Tech Research and Development Program of China (2007AA02Z463,2007AA02Z-464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI [10.2217/fmb.10.48, 10.2217/FMB.10.48]; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Brittain-Long R, 2011, SCAN J INFE IN PRESS; Brittain-Long R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-44; Brittain-Long R, 2010, J CLIN VIROL, V47, P263, DOI 10.1016/j.jcv.2009.12.010; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esposito S, 2006, J MED VIROL, V78, P1609, DOI 10.1002/jmv.20745; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; He J, 2011, J MICROBES INFECT, V6, P90; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mahony JB, 2010, EXPERT REV ANTI-INFE, V8, P1273, DOI [10.1586/eri.10.121, 10.1586/ERI.10.121]; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2011, J CLIN VIROL, V51, P209, DOI 10.1016/j.jcv.2011.05.001; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	27	47	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32174	10.1371/journal.pone.0032174	http://dx.doi.org/10.1371/journal.pone.0032174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389685	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600023
J	Tachikawa, M; Ikeda, S; Fujinawa, J; Hirose, S; Akanuma, S; Hosoya, K				Tachikawa, Masanori; Ikeda, Saori; Fujinawa, Jun; Hirose, Shirou; Akanuma, Shin-ichi; Hosoya, Ken-ichi			gamma-Aminobutyric Acid Transporter 2 Mediates the Hepatic Uptake of Guanidinoacetate, the Creatine Biosynthetic Precursor, in Rats	PLOS ONE			English	Article							METHYLTRANSFERASE DEFICIENCY; MESSENGER-RNAS; INBORN ERROR; BETA-ALANINE; LIVER; BRAIN; HETEROGENEITY; LOCALIZATION; HEPATOCYTES; METABOLISM	Guanidinoacetic acid (GAA) is the biosynthetic precursor of creatine which is involved in storage and transmission of phosphate-bound energy. Hepatocytes readily convert GAA to creatine, raising the possibility that the active uptake of GAA by hepatocytes is a regulatory factor. The purpose of this study is to investigate and identify the transporter responsible for GAA uptake by hepatocytes. The characteristics of [C-14] GAA uptake by hepatocytes were elucidated using the in vivo liver uptake method, freshly isolated rat hepatocytes, an expression system of Xenopus laevis oocytes, gene knockdown, and an immunohistochemical technique. In vivo injection of [C-14] GAA into the rat femoral vein and portal vein results in the rapid uptake of [C-14] GAA by the liver. The uptake was markedly inhibited by c-aminobutyric acid (GABA) and nipecotinic acid, an inhibitor of GABA transporters (GATs). The characteristics of Na+- and Cl--dependent [C-14] GAA uptake by freshly isolated rat hepatocytes were consistent with those of GAT2. The Km value of the GAA uptake (134 mM) was close to that of GAT2-mediated GAA transport (78.9 mM). GABA caused a marked inhibition with an IC50 value of 8.81 mM. The [C-14] GAA uptake exhibited a significant reduction corresponding to the reduction in GAT2 protein expression. GAT2 was localized on the sinusoidal membrane of the hepatocytes predominantly in the periportal region. This distribution pattern was consistent with that of the creatine biosynthetic enzyme, S-adenosylmethionine: guanidinoacetate N-methyltransferase. GAT2 makes a major contribution to the sinusoidal GAA uptake by periportal hepatocytes, thus regulating creatine biosynthesis in the liver.	[Tachikawa, Masanori; Ikeda, Saori; Fujinawa, Jun; Hirose, Shirou; Akanuma, Shin-ichi; Hosoya, Ken-ichi] Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Tachikawa, Masanori] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi 980, Japan	University of Toyama; Tohoku University	Tachikawa, M (corresponding author), Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	hosoyak@pha.u-toyama.ac.jp			Ministry of Education, Science, Sports, and Culture; Japan Society for the Promotion of Science, Japan	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by a Grant-in Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, and the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrue A, 2010, NEUROCHEM RES, V35, P247, DOI 10.1007/s11064-009-0048-z; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Braissant O, 2011, AMINO ACIDS, V40, P1315, DOI 10.1007/s00726-011-0852-z; BURGER HJ, 1989, HEPATOLOGY, V9, P22, DOI 10.1002/hep.1840090105; da Silva RP, 2009, AM J PHYSIOL-ENDOC M, V296, pE256, DOI 10.1152/ajpendo.90547.2008; Fujita M, 2009, AM J PHYSIOL-GASTR L, V297, pG681, DOI 10.1152/ajpgi.00238.2009; GROOTHUIS GMM, 1982, AM J PHYSIOL, V243, pG455, DOI 10.1152/ajpgi.1982.243.6.G455; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Liu MP, 1999, AM J PHYSIOL-GASTR L, V276, pG206, DOI 10.1152/ajpgi.1999.276.1.G206; Madon J, 2000, MOL PHARMACOL, V57, P634, DOI 10.1124/mol.57.3.634; MARESCAU B, 1992, METABOLISM, V41, P526, DOI 10.1016/0026-0495(92)90213-T; MCGUIRE DM, 1986, J HISTOCHEM CYTOCHEM, V34, P429, DOI 10.1177/34.4.3512696; Nasrallah F, 2010, PEDIATR NEUROL, V42, P163, DOI 10.1016/j.pediatrneurol.2009.07.015; NOEL H, 1984, BIOCHEM J, V220, P701, DOI 10.1042/bj2200701; Ohtsuki S, 2002, J CEREBR BLOOD F MET, V22, P1327, DOI 10.1097/01.WCB.0000033966.83623.7D; PARDRIDGE WM, 1979, AM J PHYSIOL, V237, pE367, DOI 10.1152/ajpendo.1979.237.4.E367; PAYNE RM, 1991, BIOCHIM BIOPHYS ACTA, V1089, P352, DOI 10.1016/0167-4781(91)90176-M; PETZINGER E, 1989, AM J PHYSIOL, V256, pG78, DOI 10.1152/ajpgi.1989.256.1.G78; Reichel C, 1999, GASTROENTEROLOGY, V117, P688, DOI 10.1016/S0016-5085(99)70463-4; Schmidt A, 2004, HUM MOL GENET, V13, P905, DOI 10.1093/hmg/ddh112; SORA I, 1994, BIOCHEM BIOPH RES CO, V204, P419, DOI 10.1006/bbrc.1994.2475; Stockler S, 1997, METABOLISM, V46, P1189, DOI 10.1016/S0026-0495(97)90215-8; Stockler S, 1996, AM J HUM GENET, V58, P914; STOLL B, 1991, HEPATOLOGY, V13, P247, DOI 10.1002/hep.1840130208; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Tachikawa M, 2008, J NEUROCHEM, V107, P768, DOI 10.1111/j.1471-4159.2008.05652.x; Tachikawa M, 2009, J NEUROCHEM, V111, P499, DOI 10.1111/j.1471-4159.2009.06332.x; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; ZHANG RW, 1992, DRUG METAB DISPOS, V20, P113	33	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32557	10.1371/journal.pone.0032557	http://dx.doi.org/10.1371/journal.pone.0032557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384273	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500100
J	Toedling, J; Servant, N; Ciaudo, C; Farinelli, L; Voinnet, O; Heard, E; Barillot, E				Toedling, Joern; Servant, Nicolas; Ciaudo, Constance; Farinelli, Laurent; Voinnet, Olivier; Heard, Edith; Barillot, Emmanuel			Deep-Sequencing Protocols Influence the Results Obtained in Small-RNA Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; DATABASE; UPDATE	Second-generation sequencing is a powerful method for identifying and quantifying small-RNA components of cells. However, little attention has been paid to the effects of the choice of sequencing platform and library preparation protocol on the results obtained. We present a thorough comparison of small-RNA sequencing libraries generated from the same embryonic stem cell lines, using different sequencing platforms, which represent the three major second-generation sequencing technologies, and protocols. We have analysed and compared the expression of microRNAs, as well as populations of small RNAs derived from repetitive elements. Despite the fact that different libraries display a good correlation between sequencing platforms, qualitative and quantitative variations in the results were found, depending on the protocol used. Thus, when comparing libraries from different biological samples, it is strongly recommended to use the same sequencing platform and protocol in order to ensure the biological relevance of the comparisons.	[Toedling, Joern; Servant, Nicolas; Ciaudo, Constance; Heard, Edith; Barillot, Emmanuel] Inst Curie, Paris, France; [Toedling, Joern; Servant, Nicolas; Barillot, Emmanuel] INSERM, U900, Paris, France; [Toedling, Joern; Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [Toedling, Joern; Ciaudo, Constance; Heard, Edith] CNRS, UMR3215, Paris, France; [Toedling, Joern; Ciaudo, Constance; Heard, Edith] INSERM, U934, Paris, France; [Ciaudo, Constance; Voinnet, Olivier] Swiss Fed Inst Technol Zurich, Dept Biol, Zurich, Switzerland; [Voinnet, Olivier] Univ Strasbourg, CNRS, UPR2357, Inst Biol Mol Plantes, Strasbourg, France; [Farinelli, Laurent] Fasteris, Plan Les Ouates, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Toedling, J (corresponding author), Inst Curie, Paris, France.	nicolas.servant@curie.fr; cciaudo@ethz.ch	Heard, Edith/D-7197-2017; Ciaudo, Constance/A-2014-2012	Heard, Edith/0000-0001-8052-7117; Ciaudo, Constance/0000-0002-0857-4506; Toedling, Joern/0000-0003-1471-1295; Voinnet, Olivier/0000-0001-6982-9544; BARILLOT, Emmanuel/0000-0003-2724-2002; Servant, Nicolas/0000-0003-1678-7410	Institut Curie, INCa; ANR; European Research Council [ERC 210890]; FEBS: Federation of European Biochemical Societies	Institut Curie, INCa; ANR(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); FEBS: Federation of European Biochemical Societies	This research was funded by Institut Curie, INCa "Gepig", by a grant from the ANR "RNA ES" to both EH and OV, and by a starting grant from the European Research Council "Frontiers of RNAi" ERC 210890 to OV. CC was supported by a post-doctoral fellowship (FEBS: Federation of European Biochemical Societies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; McCormick KP, 2010, SILENCE, V2, P2; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Pfeffer S, 2007, METHOD ENZYMOL, V427, P51, DOI 10.1016/S0076-6879(07)27003-X; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Toedling J, 2010, BIOINFORMATICS, V26, P2902, DOI 10.1093/bioinformatics/btq531; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32724	10.1371/journal.pone.0032724	http://dx.doi.org/10.1371/journal.pone.0032724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384282	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500108
J	Zhang, Y; Zhang, HT; Yao, XG; Shen, H; Chen, J; Li, CJ; Chen, LL; Zheng, MY; Ye, JM; Hu, LH; Shen, X; Jiang, HL				Zhang, Yu; Zhang, Haitao; Yao, Xin-gang; Shen, Hong; Chen, Jing; Li, Chenjing; Chen, Lili; Zheng, Mingyue; Ye, Jiming; Hu, Lihong; Shen, Xu; Jiang, Hualiang			(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; TRANSPORTER EXPRESSION; MUSCLE-CELLS; MECHANISM; ADIPOCYTES; 3T3-L1; GENE; INHIBITION	Glucose transporter 4 (GLUT4) is a principal glucose transporter in response to insulin, and impaired translocation or decreased expression of GLUT4 is believed to be one of the major pathological features of type 2 diabetes mellitus (T2DM). Therefore, induction of GLUT4 translocation or/and expression is a promising strategy for anti-T2DM drug discovery. Here we report that the natural product (+)-Rutamarin (Rut) functions as an efficient dual inducer on both insulin-induced GLUT4 translocation and expression. Rut-treated 3T3-L1 adipocytes exhibit efficiently enhanced insulin-induced glucose uptake, while diet-induced obese (DIO) mice based assays further confirm the Rut-induced improvement of glucose homeostasis and insulin sensitivity in vivo. Subsequent investigation of Rut acting targets indicates that as a specific protein tyrosine phosphatase 1B (PTP1B) inhibitor Rut induces basal GLUT4 translocation to some extent and largely enhances insulin-induced GLUT4 translocation through PI3 kinase-AKT/PKB pathway, while as an agonist of retinoid X receptor alpha (RXR alpha), Rut potently increases GLUT4 expression. Furthermore, by using molecular modeling and crystallographic approaches, the possible binding modes of Rut to these two targets have been also determined at atomic levels. All our results have thus highlighted the potential of Rut as both a valuable lead compound for anti-T2DM drug discovery and a promising chemical probe for GLUT4 associated pathways exploration.	[Zhang, Yu; Zhang, Haitao; Yao, Xin-gang; Shen, Hong; Chen, Jing; Li, Chenjing; Chen, Lili; Zheng, Mingyue; Hu, Lihong; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Ye, Jiming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Royal Melbourne Institute of Technology (RMIT)	Zhang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	simmhulh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn; hljiang@mail.shcnc.ac.cn	Zheng, Mingyue/B-4860-2010; Zhang, Yu/J-5225-2014; Zheng, Mingyue/AAJ-8027-2020; Zhang, Haitao/L-7612-2015; Zhang, Yu/AAV-5722-2021; shen, hong/M-2727-2015; Zheng, Mingyue/HHZ-4062-2022; shen, hong/I-6179-2016; Zheng, Mingyue/Z-3582-2019	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zhang, Haitao/0000-0003-4879-2951; Zhang, Yu/0000-0002-1778-8389; Zheng, Mingyue/0000-0002-3323-3092; 	State Key Program of Basic Research of China [2010CB912501, 2009CB918502]; National Natural Science Foundation of China [90713046, 30890044, 10979072]; Science Foundation of Shanghai [11XD1406100, 11ZR1444500]; Foundation of Chinese Academy of Sciences [KSCX2-EW-Q-3]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the State Key Program of Basic Research of China (grants 2010CB912501, 2009CB918502); the National Natural Science Foundation of China (grants 90713046, 30890044, 10979072); Science Foundation of Shanghai (11XD1406100,11ZR1444500); and Foundation of Chinese Academy of Sciences (grants KSCX2-EW-Q-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Armoni M, 2007, TRENDS ENDOCRIN MET, V18, P100, DOI 10.1016/j.tem.2007.02.001; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROST SC, 1985, J BIOL CHEM, V260, P2646; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lampson MA, 2000, J CELL SCI, V113, P4065; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JO, 2011, J CELL PHYSIOL, V226, P974, DOI 10.1002/jcp.22410; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; Liu F, 2009, BIOCHEM J, V418, P413, DOI 10.1042/BJ20082051; Liu G, 2004, CURR OPIN MOL THER, V6, P331; Montessuit C, 2006, BASIC RES CARDIOL, V101, P27, DOI 10.1007/s00395-005-0567-y; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Navaza J, 1994, ACTA CRYSTALLOGR D, V50, P760; Needham M, 2000, J STEROID BIOCHEM, V72, P35, DOI 10.1016/S0960-0760(00)00027-3; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Pinaire JA, 2007, PPAR RES, V2007, DOI 10.1155/2007/94156; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shen H, 2008, CELL PHYSIOL BIOCHEM, V22, P1, DOI 10.1159/000149779; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; SLEEMAN MW, 1995, MOL CELL ENDOCRINOL, V108, P161, DOI 10.1016/0303-7207(95)03473-K; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Tsiani E, 1998, DIABETES, V47, P1676, DOI 10.2337/diabetes.47.11.1676; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Ye F, 2006, CHEMBIOCHEM, V7, P74, DOI 10.1002/cbic.200500186; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhang YN, 2008, ADV SYNTH CATAL, V350, P2373, DOI 10.1002/adsc.200800396; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	53	18	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31811	10.1371/journal.pone.0031811	http://dx.doi.org/10.1371/journal.pone.0031811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384078	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500039
J	Mimeault, M; Johansson, SL; Batra, SK				Mimeault, Murielle; Johansson, Sonny L.; Batra, Surinder K.			Pathobiological Implications of the Expression of EGFR, pAkt, NF-kappa B and MIC-1 in Prostate Cancer Stem Cells and Their Progenies	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MACROPHAGE INHIBITORY CYTOKINE-1; METASTASIS-INITIATING CELLS; STEM/PROGENITOR CELLS; SIDE POPULATION; ANDROGEN; PROGRESSION; DOCETAXEL; GEFITINIB; ADENOCARCINOMA	The progression of prostate cancers (PCs) to locally invasive, androgen-independent and metastatic disease states is generally associated with treatment resistance and disease relapse. The present study was undertaken to establish the possibility of using a combination of specific oncogenic products, including epidermal growth factor receptor (EGFR), pAkt, nuclear factor-kappaB (NF-kappa B) and macrophage inhibitory cytokine-1 (MIC-1) as biomarkers and therapeutic targets for optimizing the management of patients with localized PC at earlier disease stages. The immunohistochemical and immunofluorescence data have revealed that the expression levels of EGFR, Ser(473)-pAkt, NF-kappa B p65 and MIC-1 proteins were significantly enhanced in the same subset of 76 cases of prostatic adenocarcinoma specimens during the disease progression and these biomarkers were expressed in a small subpopulation of CD133(+) PC cells and the bulk tumor mass of CD133(-) PC cells. Importantly, all of these biomarkers were also overexpressed in 80-100% of 30 PC metastasis bone tissue specimens. Moreover, the results have indicated that the EGF-EGFR signaling pathway can provide critical functions for the self-renewal of side population (SP) cells endowed with stem cell-like features from highly invasive WPE1-NB26 cells. Of therapeutic interest, the targeting of EGFR, pAkt, NF-kappa B or MIC-1 was also effective at suppressing the basal and EGF-promoted prostasphere formation by SP WPE1-NB26 cells, inducing disintegration of SP cell-derived prostaspheres and decreasing the viability of SP and non-SP WPE1-NB26 cell fractions. Also, the targeting of these oncogenic products induced the caspase-dependent apoptosis in chemoresistant SP WPE1-NB26 cells and enhanced their sensibility to the cytotoxic effects induced by docetaxel. These findings suggest that the combined use of EGFR, pAkt, NF-kappa B and/or MIC-1 may represent promising strategies for improving the accuracy of current diagnostic and prognostic methods and efficacy of treatments of PC patients in considering the disease heterogeneity, thereby preventing PC progression to metastatic and lethal disease states.	[Mimeault, Murielle; Batra, Surinder K.] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA; [Johansson, Sonny L.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Mimeault, M (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA.	mmimeault@unmc.edu; sbatra@unmc.edu			National Institutes of Health [R01CA138791]; NATIONAL CANCER INSTITUTE [R01CA138791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors of this work are supported by the National Institutes of Health grant (R01CA138791) for prostate cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Cao DL, 2011, PROSTATE, V71, P700, DOI 10.1002/pros.21286; Chauchereau A, 2011, EXP CELL RES, V317, P262, DOI 10.1016/j.yexcr.2010.10.012; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Dalfior D, 2010, PATHOLOGY, V42, P1, DOI 10.3109/00313020903434447; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Visschere P, 2010, JBR-BTR, V93, P62, DOI 10.5334/jbr-btr.121; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Donovan MJ, 2012, BJU INT, V109, P207, DOI 10.1111/j.1464-410X.2011.10316.x; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Ellem SJ, 2009, AM J PATHOL, V175, P1187, DOI 10.2353/ajpath.2009.081107; Epstein JI, 2004, MODERN PATHOL, V17, P307, DOI 10.1038/modpathol.3800050; Fan X, 2011, UROL ONCOL; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Freedland SJ, 2010, CANCER, V117, P1123; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Graff JN, 2011, CANCER-AM CANCER SOC, V117, P3882, DOI 10.1002/cncr.25986; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Haas GP, 2008, CAN J UROL, V15, P3866; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; HARVEY P., 2009, BMC UROLOGY, V9, P9; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Lakhey M, 2010, Kathmandu Univ Med J (KUMJ), V8, P158; Le Page C, 2005, PROSTATE, V65, P130, DOI 10.1002/pros.20234; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lieberman Ronald, 2004, Am J Ther, V11, P501; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Maitland NJ, 2007, ERNST SCHERING FOUND, V5, P155, DOI 10.1007/2789_2007_050; Merseburger AS, 2006, ONCOL REP, V16, P79; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2006, INT J CANCER, V118, P1022, DOI 10.1002/ijc.21440; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2007, GROWTH FACTORS, V25, P400, DOI 10.1080/08977190801930935; Mimeault M, 2008, ENDOCR REV, V29, P234, DOI 10.1210/er.2007-0040; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Mimeault M, 2007, INT J CANCER, V120, P160, DOI 10.1002/ijc.22268; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Mimeault M, 2011, BBA-REV CANCER, V1816, P25, DOI 10.1016/j.bbcan.2011.03.001; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Mimeault M, 2009, METHODS MOL BIOL, V568, P139, DOI 10.1007/978-1-59745-280-9_8; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Rowehl Rebecca A., 2008, Cancer Genomics & Proteomics, V5, P301; Schafer W, 2006, J UROLOGY, V176, P532, DOI 10.1016/j.juro.2006.03.033; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Shanmugam R, 2006, PROSTATE, V66, P1498, DOI 10.1002/pros.20482; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Torring N, 2003, PROSTATE, V56, P142, DOI 10.1002/pros.10245; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wakchoure S, 2009, PROSTATE, V69, P652, DOI 10.1002/pros.20913; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Xie C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-43; Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901	80	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31919	10.1371/journal.pone.0031919	http://dx.doi.org/10.1371/journal.pone.0031919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384099	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100039
J	Heeg, D; Burns, DA; Cartman, ST; Minton, NP				Heeg, Daniela; Burns, David A.; Cartman, Stephen T.; Minton, Nigel P.			Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile Salts	PLOS ONE			English	Article							BACILLUS-SUBTILIS; INCREASED SPORULATION; TOXIN PRODUCTION; EPIDEMIC; STRAINS; TAUROCHOLATE; INFECTION; PROTEINS; NUTRIENT; SEQUENCE	Clostridium difficile spores play a pivotal role in the transmission of infectious diarrhoea, but in order to cause disease spores must complete germination and return to vegetative cell growth. While the mechanisms of spore germination are well understood in Bacillus, knowledge of C. difficile germination remains limited. Previous studies have shown that bile salts and amino acids play an important role in regulating the germination response of C. difficile spores. Taurocholate, in combination with glycine, can stimulate germination, whereas chenodeoxycholate has been shown to inhibit spore germination in a C. difficile clinical isolate. Our recent studies of C. difficile sporulation characteristics have since pointed to substantial diversity among different clinical isolates. Consequently, in this study we investigated how the germination characteristics of different C. difficile isolates vary in response to bile salts. By analysing 29 isolates, including 16 belonging to the BI/NAP1/027 type, we show that considerable diversity exists in both the rate and extent of C. difficile germination in response to rich medium containing both taurocholate and glycine. Strikingly, we also show that although a potent inhibitor of germination for some isolates, chenodeoxycholate does not inhibit the germination, or outgrowth, of all C. difficile strains. Finally, we provide evidence that components of rich media may induce the germination of C. difficile spores, even in the absence of taurocholate. Taken together, these data suggest that the mechanisms of C. difficile spore germination in response to bile salts are complex and require further study. Furthermore, we stress the importance of studying multiple isolates in the future when analysing the nutrients or chemicals that either stimulate or inhibit C. difficile spore germination.	[Heeg, Daniela; Burns, David A.; Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Sch Mol Med Sci, Clostridia Res Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Heeg, D (corresponding author), Univ Nottingham, Sch Mol Med Sci, Clostridia Res Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England.	nigel.minton@nottingham.ac.uk		Minton, Nigel/0000-0002-9277-1261	UK Medical Research Council [G0601176]; European Community [PEOPLE-ITN-2008-237942, HEALTH-F3-2008-223585]; MRC [G0601176] Funding Source: UKRI; Medical Research Council [G0601176] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results received funding from the UK Medical Research Council (Grant G0601176) and the European Community's Seventh Framework Programmes 'CLOSTNET' (PEOPLE-ITN-2008-237942) and 'HYPERDIFF' (HEALTH-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Broussolle V, 2002, ANAEROBE, V8, P89, DOI 10.1006/anae.2002.0424; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Burns DA, 2010, ANAEROBE, V16, P618, DOI 10.1016/j.anaerobe.2010.10.001; Burns DA, 2010, RES MICROBIOL, V161, P730, DOI 10.1016/j.resmic.2010.09.007; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Cheng VCC, 2011, ENVIRON MODELL SOFTW, P1; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Hudson KD, 2001, J BACTERIOL, V183, P4317, DOI 10.1128/JB.183.14.4317-4322.2001; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; MEKHJIAN HS, 1979, DIGEST DIS SCI, V24, P545, DOI 10.1007/BF01489324; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Moir A, 2002, CELL MOL LIFE SCI, V59, P403, DOI 10.1007/s00018-002-8432-8; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paredes-Sabja D, 2009, J BACTERIOL, V191, P2711, DOI 10.1128/JB.01832-08; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SEKIGUCHI J, 1995, J BACTERIOL, V177, P5582, DOI 10.1128/jb.177.19.5582-5589.1995; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wheeldon LJ, 2008, J APPL MICROBIOL, V105, P2223, DOI 10.1111/j.1365-2672.2008.03965.x; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Xiao YH, 2011, FOOD MICROBIOL, V28, P266, DOI 10.1016/j.fm.2010.03.016	38	88	96	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32381	10.1371/journal.pone.0032381	http://dx.doi.org/10.1371/journal.pone.0032381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384234	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500098
J	Homaira, N; Luby, SP; Petri, WA; Vainionpaa, R; Rahman, M; Hossain, K; Snider, CB; Rahman, M; Alamgir, ASM; Zesmin, F; Alam, M; Gurley, ES; Zaman, RU; Azim, T; Erdman, DD; Fry, AM; Bresee, J; Widdowson, MA; Haque, R; Azziz-Baumgartner, E				Homaira, Nusrat; Luby, Stephen P.; Petri, William A.; Vainionpaa, Raija; Rahman, Mustafizur; Hossain, Kamal; Snider, Cynthia B.; Rahman, Mahmudur; Alamgir, A. S. M.; Zesmin, Farzina; Alam, Masud; Gurley, Emily S.; Zaman, Rashid Uz; Azim, Tasnim; Erdman, Dean D.; Fry, Alicia M.; Bresee, Joseph; Widdowson, Marc-Alain; Haque, Rashidul; Azziz-Baumgartner, Eduardo			Incidence of Respiratory Virus-Associated Pneumonia in Urban Poor Young Children of Dhaka, Bangladesh, 2009-2011	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RISK-FACTORS; INFECTION; EPIDEMIOLOGY; ETIOLOGY; COHORT	Background: Pneumonia is the leading cause of childhood death in Bangladesh. We conducted a longitudinal study to estimate the incidence of virus-associated pneumonia in children aged <2 years in a low-income urban community in Dhaka, Bangladesh. Methods: We followed a cohort of children for two years. We collected nasal washes when children presented with respiratory symptoms. Study physicians diagnosed children with cough and age-specific tachypnea and positive lung findings as pneumonia case-patients. We tested respiratory samples for respiratory syncytial virus (RSV), rhinoviruses, human metapneumovirus (HMPV), influenza viruses, human parainfluenza viruses (HPIV 1, 2, 3), and adenoviruses using real-time reverse transcription polymerase chain reaction assays. Results: Between April 2009-March 2011, we followed 515 children for 730 child-years. We identified a total of 378 pneumonia episodes, 77% of the episodes were associated with a respiratory viral pathogen. The overall incidence of pneumonia associated with a respiratory virus infection was 40/100 child-years. The annual incidence of pneumonia/100 child-years associated with a specific respiratory virus in children aged <2years was 12.5 for RSV, 6 for rhinoviruses, 6 for HMPV, 4 for influenza viruses, 3 for HPIV and 2 for adenoviruses. Conclusion: Young children in Dhaka are at high risk of childhood pneumonia and the majority of these episodes are associated with viral pathogens. Developing effective low-cost strategies for prevention are a high priority.	[Homaira, Nusrat; Luby, Stephen P.; Rahman, Mustafizur; Hossain, Kamal; Zesmin, Farzina; Alam, Masud; Gurley, Emily S.; Zaman, Rashid Uz; Azim, Tasnim; Haque, Rashidul; Azziz-Baumgartner, Eduardo] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Luby, Stephen P.; Erdman, Dean D.; Fry, Alicia M.; Bresee, Joseph; Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Petri, William A.; Snider, Cynthia B.] Univ Virginia, Jack Jouett, VA USA; [Vainionpaa, Raija] Univ Turku, Turku, Finland; [Rahman, Mahmudur; Alamgir, A. S. M.] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; University of Virginia; University of Turku	Homaira, N (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	nhomaira@icddrb.org	Petri, William A./D-3639-2019; Gurley, Emily S/B-7903-2010; rahman, mustafizur/E-6918-2010; Petri, William/AAL-3642-2020; Homaira, Nusrat/U-4526-2019; Zaman, Rashid/AAM-5209-2020	Gurley, Emily S/0000-0002-8648-9403; Petri, William/0000-0002-7268-1218; Homaira, Nusrat/0000-0003-3341-7964; Zaman, Rashid/0000-0002-8556-4993; Widdowson, Marc-Alain/0000-0002-0682-6933	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta [1U01CI000628-01]; University of Virginia (UVA) under the NIH [RO1 AI043596]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U01CI000628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, R01AI043596] Funding Source: NIH RePORTER	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta; University of Virginia (UVA) under the NIH; National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta under the co-operative agreement number 1U01CI000628-01 and University of Virginia (UVA) under the NIH grant RO1 AI043596 to WAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4490; AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Bangladesh Bureau of Statistics, 2009, 2008 STAT YB BANGL; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; BORRERO I, 1990, REV INFECT DIS, V12, pS950; Brooks WA, 2009, PEDIATR INFECT DIS J, V9, P1; Broor S, 2001, Indian Pediatr, V38, P1361; Calegari Tatiany, 2005, Braz J Infect Dis, V9, P156, DOI 10.1590/S1413-86702005000200006; Centers for Disease Control and Prevention (CDC), 2003, SEASONAL FLU; Centers for Disease Control and Prevention (CDC), 2007, SEASONAL FLU; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Darville T, 1998, PEDIAT REV, V19; Ekalaksananan Tipaya, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P513; Forgie IM, 1991, PEDIAT INFECT DIS J, V10; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Huq F, 1990, REV INFECT DIS, V12; ICDDRB, 2009, HLTH SCI B, V7, P1; Jartti T, 2004, J MED VIROLOGY, V72; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; Luby SP, 2009, CLIN INFECT DIS, V48, pS97, DOI 10.1086/596487; Meissner HC, 2005, PEDIATR CLIN N AM, V52, P695, DOI 10.1016/j.pcl.2005.02.010; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; RobertsonI SE, 2004, B WHO, V82; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Savitha MR, 2007, INDIAN J PEDIATR, V74, P477, DOI 10.1007/s12098-007-0081-3; Sinaniotis C A, 2004, Paediatr Respir Rev, V5 Suppl A, pS197, DOI 10.1016/S1526-0542(04)90037-1; Sinaniotis CA, 2005, CURR OPIN PULM MED, V11, P218, DOI 10.1097/01.mcp.0000159831.82529.85; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smyth A, 2002, BRIT MED BULL, V61, P247, DOI 10.1093/bmb/61.1.247; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; VATHANOPHAS K, 1990, REV INFECT DIS, V12, pS957; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; WHO, 2007, WORLD HLTH STAT; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2008, CHILD MORT; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	49	61	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32056	10.1371/journal.pone.0032056	http://dx.doi.org/10.1371/journal.pone.0032056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384139	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500068
J	Toulme, E; Khakh, BS				Toulme, Estelle; Khakh, Baljit S.			Imaging P2X4 Receptor Lateral Mobility in Microglia REGULATION BY CALCIUM AND p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; P2X(4) RECEPTORS; SPINAL MICROGLIA; UP-REGULATION; ATP SENSORS; AMINO-ACIDS; ION-CHANNEL; QUANTUM-DOT; TRAFFICKING; IDENTIFICATION	ATP-gated ionotropic P2X4 receptors are up-regulated in activated microglia and are critical for the development of neuropathic pain, a microglia-associated disorder. However, the nature of how plasma membrane P2X4 receptors are regulated in microglia is not fully understood. We used single-molecule imaging to track quantum dot-labeled P2X4 receptors to explore P2X4 receptor mobility in the processes of resting and activated microglia. We find that plasma membrane P2X4 receptor lateral mobility in resting microglial processes is largely random, consisting of mobile and slowly mobile receptors. Moreover, lateral mobility is P2X subunit-and cell-specific, increased in an ATP activation and calcium-dependent manner, and enhanced in activated microglia by the p38 MAPK pathway that selectively regulates slowly mobile receptors. Thus, our data indicate that P2X4 receptors are dynamically regulated mobile ATP sensors, sampling more of the plasma membrane in response to ATP and during the activated state of microglia that is associated with nervous system dysfunction.	[Toulme, Estelle; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu			National Institutes of Health [NS073980]; Johnson Johnson; Stein-Oppenheimer Foundation; UCLA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Stein-Oppenheimer Foundation; UCLA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS073980. This work was also supported by an award from Johnson & Johnson, a Stein-Oppenheimer Foundation Endowment Award, and unrestricted funds from UCLA (to B. S. K.).	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Alliot F, 1996, DEV BRAIN RES, V95, P140, DOI 10.1016/0165-3806(96)00101-0; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Bowler JW, 2003, BRIT J PHARMACOL, V140, P567, DOI 10.1038/sj.bjp.0705459; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2001, FEBS LETT, V489, P154, DOI 10.1016/S0014-5793(01)02102-0; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Lalo U, 2011, J BIOL CHEM, V286, P30591, DOI 10.1074/jbc.M111.253153; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Murrell-Lagnado R, 2009, J PHYSIOL-LONDON, V587, P2713, DOI 10.1113/jphysiol.2009.174961; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Nakajima K., 2005, NEUROGLIA, V2, P443; Nasu-Tada K, 2006, GLIA, V53, P769, DOI 10.1002/glia.20339; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Richler E, 2011, J NEUROSCI, V31, P16716, DOI 10.1523/JNEUROSCI.3362-11.2011; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2012, J BIOL CHEM, V287, P7594, DOI 10.1074/jbc.M111.322461; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shrivastava AN, 2011, J BIOL CHEM, V286, P14455, DOI 10.1074/jbc.M110.165282; Stokes L, 2009, EUR J IMMUNOL, V39, P986, DOI 10.1002/eji.200838818; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; Young MT, 2008, J BIOL CHEM, V283, P26241, DOI 10.1074/jbc.M804458200	63	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14734	14748		10.1074/jbc.M111.329334	http://dx.doi.org/10.1074/jbc.M111.329334			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393055	hybrid, Green Published			2022-12-25	WOS:000304003200039
J	Sanchez-Gallego, JI; Groeneveld, TWL; Krentz, S; Nilsson, SC; Villoutreix, BO; Blom, AM				Sanchez-Gallego, Jose I.; Groeneveld, Tom W. L.; Krentz, Stefanie; Nilsson, Sara C.; Villoutreix, Bruno O.; Blom, Anna M.			Analysis of Binding Sites on Complement Factor I Using Artificial N-Linked Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; C3B INACTIVATOR; PROTEIN; BIOSYNTHESIS; INHIBITION; CLEAVAGE; PURIFICATION; DEFICIENCY; CONVERTASE; MUTATIONS	Factor I (FI) is a serine protease that inhibits all complement pathways by degrading activated complement components C3b and C4b. FI functions only in the presence of several cofactors, such as factor H, C4b-binding protein, complement receptor 1, and membrane cofactor protein. FI is composed of two chains linked by a disulfide bridge; the light chain comprises only the serine protease (SP) domain, whereas the heavy chain contains the FI membrane attack complex domain (FIMAC), CD5 domain, and low density lipoprotein receptor 1 (LDLr1) and LDLr2 domains. To better understand how FI inhibits complement, we used homology-based three-dimensional models of FI domains in an attempt to identify potential protein-protein interaction sites. Specific amino acids were then mutated to yield 20 recombinant mutants of FI carrying additional surface-exposed N-glycosylation sites that were expected to sterically hinder interactions. The Michaelis constant (K-m) of all FI mutants toward a small substrate was not increased. We found that many mutations in the FIMAC and SP domains nearly abolished the ability of FI to degrade C4b and C3b in the fluid phase and on the surface, irrespective of the cofactor used. On the other hand, only a few alterations in the CD5 and LDLr1/2 domains impaired this activity. In conclusion, all analyzed cofactors form similar trimolecular complexes with FI and C3b/C4b, and the accessibility of FIMAC and SP domains is crucial for the function of FI.	[Sanchez-Gallego, Jose I.; Groeneveld, Tom W. L.; Krentz, Stefanie; Nilsson, Sara C.; Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden; [Villoutreix, Bruno O.] Univ Paris Diderot, INSERM, U973, MTi, F-75013 Paris, France	Lund University; Skane University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blom, AM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009; Villoutreix, Bruno/I-4565-2015; Sánchez Gallego, José Ignacio/M-9369-2017	Blom, Anna/0000-0002-1348-1734; Villoutreix, Bruno/0000-0002-6456-7730; Sánchez Gallego, José Ignacio/0000-0001-7906-9032; Groeneveld, Tom/0000-0002-9095-3280; Groeneveld-Krentz, Stefanie/0000-0002-0612-7913	Swedish Research Council [K2009-68X-14928-06-3]; Soderberg Foundation; Swedish Foundation for Strategic Research; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg	This work was supported Swedish Research Council Grant K2009-68X-14928-06-3, the Soderberg Foundation, the Swedish Foundation for Strategic Research, and the Foundations of Osterlund, Greta and Johan Kock, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg.	Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; CATTERALL CF, 1987, BIOCHEM J, V242, P849, DOI 10.1042/bj2420849; DAHLBACK B, 1983, BLOOD, V62, P218; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; EKDAHL KN, 1990, J IMMUNOL, V144, P4269; FEARON DT, 1977, J IMMUNOL, V119, P1248; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GOLDBERGER G, 1984, J BIOL CHEM, V259, P6492; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; JULEN N, 1992, EUR J IMMUNOL, V22, P213, DOI 10.1002/eji.1830220131; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; MEDOF ME, 1984, J EXP MED, V159, P1669, DOI 10.1084/jem.159.6.1669; Nilsson SC, 2007, MOL IMMUNOL, V44, P1835, DOI 10.1016/j.molimm.2006.10.005; Nilsson SC, 2011, MOL IMMUNOL, V48, P1611, DOI 10.1016/j.molimm.2011.04.004; Nilsson SC, 2010, J BIOL CHEM, V285, P6235, DOI 10.1074/jbc.M109.097212; Nilsson SC, 2010, EUR J IMMUNOL, V40, P172, DOI 10.1002/eji.200939280; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; PERKINS SJ, 1993, BIOCHEM J, V295, P101, DOI 10.1042/bj2950101; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Timar KK, 2007, MOL IMMUNOL, V44, P2943, DOI 10.1016/j.molimm.2007.01.007; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Vyse TJ, 1996, J CLIN INVEST, V97, P925, DOI 10.1172/JCI118515; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1980, J EXP MED, V151, P501, DOI 10.1084/jem.151.3.501; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	33	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13572	13583		10.1074/jbc.M111.326298	http://dx.doi.org/10.1074/jbc.M111.326298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393059	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000303996300014
J	Gu, JM; Liu, XH; Li, Y; Han, WY; Lei, LC; Yang, YJ; Zhao, HL; Gao, Y; Song, J; Lu, R; Sun, CJ; Feng, X				Gu, Jingmin; Liu, Xiaohe; Li, Yue; Han, Wenyu; Lei, Liancheng; Yang, Yongjun; Zhao, Honglei; Gao, Yu; Song, Jun; Lu, Rong; Sun, Changjiang; Feng, Xin			A Method for Generation Phage Cocktail with Great Therapeutic Potential	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; BACTERIOPHAGE THERAPY; STAPHYLOCOCCUS-AUREUS; SMALLER FLEAS; MICE; CIPROFLOXACIN; BACTEREMIA; INFECTION; PATHOGENS; BACTERIAL	Background: Bacteriophage could be an alternative to conventional antibiotic therapy against multidrug-resistant bacteria. However, the emergence of resistant variants after phage treatment limited its therapeutic application. Methodology/Principal Findings: In this study, an approach, named "Step-by-Step" (SBS), has been established. This method takes advantage of the occurrence of phage-resistant bacteria variants and ensures that phages lytic for wild-type strain and its phage-resistant variants are selected. A phage cocktail lytic for Klebsiella pneumoniae was established by the SBS method. This phage cocktail consisted of three phages (GH-K1, GH-K2 and GH-K3) which have different but overlapping host strains. Several phage-resistant variants of Klebsiella pneumoniae were isolated after different phages treatments. The virulence of these variants was much weaker [minimal lethal doses (MLD) > 1.3 x 10(9) cfu/mouse] than that of wild-type K7 countpart (MLD = 2.5 x 10(3) cfu/mouse). Compared with any single phage, the phage cocktail significantly reduced the mutation frequency of Klebsiella pneumoniae and effectively rescued Klebsiella pneumoniae bacteremia in a murine K7 strain challenge model. The minimal protective dose (MPD) of the phage cocktail which was sufficient to protect bacteremic mice from lethal K7 infection was only 3.0 x 10(4) pfu, significantly smaller (p < 0.01) than that of single monophage. Moreover, a delayed administration of this phage cocktail was still effective in protection against K7 challenge. Conclusions/Significance: Our data showed that the phage cocktail was more effective in reducing bacterial mutation frequency and in the rescue of murine bacteremia than monophage suggesting that phage cocktail established by SBS method has great therapeutic potential for multidrug-resistant bacteria infection.	[Gu, Jingmin; Liu, Xiaohe; Li, Yue; Han, Wenyu; Lei, Liancheng; Yang, Yongjun; Zhao, Honglei; Gao, Yu; Song, Jun; Lu, Rong; Sun, Changjiang; Feng, Xin] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China	Jilin University	Gu, JM (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China.	hanwy@jlu.edu.cn	Gu, Jingmin/K-9191-2016; LI, Yue/GRS-8071-2022; SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [31130072]; National Basic Research Program of China (973 Program) [2011CB944404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (Key Program, No. 31130072, http://www.nsfc.gov.cn) and the National Basic Research Program of China (973 Program 2011CB944404, http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; [Anonymous], 1983, LANCET, V2, P1287; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Capparelli R, 2006, CLIN MICROBIOL INFEC, V12, P248, DOI 10.1111/j.1469-0691.2005.01340.x; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capparelli R, 2010, J INFECT DIS, V201, P52, DOI 10.1086/648478; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0; Deresinski S, 2009, CLIN INFECT DIS, V48, P1096, DOI 10.1086/597405; Donovan David M, 2007, Recent Pat Biotechnol, V1, P113, DOI 10.2174/187220807780809463; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Kudva IT, 1999, APPL ENVIRON MICROB, V65, P3767; Lederberg J, 1996, P NATL ACAD SCI USA, V93, P3167, DOI 10.1073/pnas.93.8.3167; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Payne RJH, 2002, J VIROL, V76, P13123, DOI 10.1128/JVI.76.24.13123-13124.2002; Pirisi A, 2000, LANCET, V356, P1418, DOI 10.1016/S0140-6736(05)74059-9; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Sulakvelidze A, 2005, DRUG DISCOV TODAY, V10, P807, DOI 10.1016/S1359-6446(05)03441-0; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Verma V, 2009, J ANTIMICROB CHEMOTH, V64, P1212, DOI 10.1093/jac/dkp360; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; Watanabe R, 2007, ANTIMICROB AGENTS CH, V51, P446, DOI 10.1128/AAC.00635-06; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08; Zhang JY, 2010, FOODBORNE PATHOG DIS, V7, P1415, DOI 10.1089/fpd.2010.0621	36	159	171	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31698	10.1371/journal.pone.0031698	http://dx.doi.org/10.1371/journal.pone.0031698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396736	gold, Green Published, Green Submitted			2022-12-25	WOS:000303005000007
J	Smets, PMY; Lefebvre, HP; Aresu, L; Croubels, S; Haers, H; Piron, K; Meyer, E; Daminet, S				Smets, Pascale M. Y.; Lefebvre, Herve P.; Aresu, Luca; Croubels, Siska; Haers, Hendrik; Piron, Koen; Meyer, Evelyne; Daminet, Sylvie			Renal Function and Morphology in Aged Beagle Dogs Before and after Hydrocortisone Administration	PLOS ONE			English	Article							PITUITARY-DEPENDENT HYPERADRENOCORTICISM; GLOMERULAR-FILTRATION-RATE; RETINOL-BINDING-PROTEIN; CUSHINGS-DISEASE; URINE PROTEIN; EXOGENOUS CREATININE; GEL-ELECTROPHORESIS; ARTERIAL-PRESSURE; KIDNEY-DISEASE; BLOOD-PRESSURE	Objectives of this study were to evaluate glomerular filtration rate (GFR), renal structural changes and proteinuria in aged Beagle dogs before and after hydrocortisone (HC) administration. Eleven Beagle dogs >= 10 years old were treated with either hydrocortisone (HC group, n = 6) or placebo (control group, n = 5). Urinary markers, GFR and kidney biopsies were evaluated before (T0), during (T16 wks) and after discontinuing HC administration (T24 wks). Results indicate that HC administration causes a significant increase in GFR. At all time points except T16 wks, proteinuria was higher in the control group than in the HC group, and there was no significant difference in urinary markers between groups. At T16 wks, proteinuria, urinary albumin-to-creatinine (c) ratio, immunoglobulin G/c and retinol-binding protein/c were higher compared to baseline in the HC group. At T0, rare to mild renal lesions were detected in all HC dogs and rare to moderate changes in all control dogs. Glomerulosclerosis progressed in both groups until T24 wks. Tubular atrophy was detected in three HC dogs at T16 wks and T24 wks, but also in five control dogs throughout the study. At every time point, five HC dogs and all control dogs had rare to moderate interstitial inflammation. Rare to mild interstitial fibrosis was found in up to three HC dogs at T16 wks and T24 wks, and severe fibrosis in one HC dog at T24 wks. Up to four control dogs had rare to mild fibrosis at all time points. These findings indicate that clinically healthy, aged Beagle dogs may have considerable renal lesions and proteinuria, which could have implications for experimental or toxicological studies. Additional research is needed to elucidate glucocorticoid effects on renal structure, but functional changes such as hyperfiltration and proteinuria warrant attention to kidney function of canine patients with Cushing's syndrome or receiving exogenous glucocorticoids.	[Smets, Pascale M. Y.; Piron, Koen; Daminet, Sylvie] Univ Ghent, Fac Vet Med, Dept Small Anim Med & Clin Biol, Salisburylaan, Merelbeke, Belgium; [Lefebvre, Herve P.] Univ Toulouse, INP, Ecole Natl Vet Toulouse, Unite Rech Clin, Toulouse, France; [Lefebvre, Herve P.] Univ Toulouse, INP, Ecole Natl Vet Toulouse, Dept Clin Sci, Toulouse, France; [Aresu, Luca] Univ Padua, Fac Vet Med, Dept Publ Hlth Comparat Pathol & Vet Hyg, Agripolis Legnaro Pd, Italy; [Croubels, Siska; Meyer, Evelyne] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Salisburylaan, Merelbeke, Belgium; [Haers, Hendrik] Univ Ghent, Fac Vet Med, Dept Med Imaging, Salisburylaan, Merelbeke, Belgium	Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; University of Padua; Ghent University; Ghent University	Smets, PMY (corresponding author), Univ Ghent, Fac Vet Med, Dept Small Anim Med & Clin Biol, Salisburylaan, Merelbeke, Belgium.	Pascale.Smets@Ugent.be	; Aresu, Luca/J-9788-2018	Daminet, Sylvie/0000-0001-6733-7925; Croubels, Siska/0000-0001-6357-3517; Aresu, Luca/0000-0002-7893-1740	Fund for Scientific Research Flanders, Belgium [17800]	Fund for Scientific Research Flanders, Belgium(FWO)	This manuscript was supported by the Fund for Scientific Research Flanders, Belgium (grant nr. 17800, www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresu L, 2008, VET REC, V163, P679; BAYLIS C, 1990, SEMIN NEPHROL, V10, P320; CASTAGNARO M, 1987, SCHWEIZ ARCH TIERH, V129, P545; CONNELL JMC, 1987, J HYPERTENS, V5, P425; de Bruin C, 2009, HORM RES, V71, P140, DOI 10.1159/000178058; Esposito C, 2007, J NEPHROL, V20, P617; FINCO DR, 1994, AM J VET RES, V55, P1282; Fuiano G, 2001, KIDNEY INT, V59, P1052; Goy-Thollot I, 2002, J SMALL ANIM PRACT, V43, P489, DOI 10.1111/j.1748-5827.2002.tb00019.x; GRAUER GF, 1985, AM J VET RES, V46, P2116; Groman RP, 2004, VET RADIOL ULTRASOUN, V45, P62, DOI 10.1111/j.1740-8261.2004.04010.x; Haentjens P, 2005, EUR J ENDOCRINOL, V153, P819, DOI 10.1530/eje.1.02040; Haers H, 2011, VET RADIOL ULTRASOUN, V52, P640, DOI 10.1111/j.1740-8261.2011.01843.x; HALL JE, 1980, HYPERTENSION, V2, P139, DOI 10.1161/01.HYP.2.2.139; Heiene R, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-13; Hsieh CK, 2007, CLIN NEPHROL, V67, P109; Hurley KJ, 1998, J AM VET MED ASSOC, V212, P369; IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1; KAPLAN C, 1975, AM J PATHOL, V80, P227; Koh JM, 2000, CLIN ENDOCRINOL, V52, P349; Kubota E, 2001, CLIN EXP NEPHROL, V5, P186, DOI [10.1007/s101570170009, DOI 10.1007/S101570170009]; Le Garreres A, 2007, J FELINE MED SURG, V9, P89, DOI 10.1016/j.jfms.2006.08.003; Lees GE, 2005, J VET INTERN MED, V19, P377, DOI 10.1892/0891-6640(2005)19[377:AAMOPI]2.0.CO;2; Lees GE, 2011, TOP COMPANION ANIM M, V26, P143, DOI 10.1053/j.tcam.2011.04.006; LINDEMAN R D, 1986, Comprehensive Therapy, V12, P43; Maddens B, 2010, J VET INTERN MED, V24, P1263, DOI 10.1111/j.1939-1676.2010.0603.x; Maddens BEJ, 2010, VET IMMUNOL IMMUNOP, V134, P259, DOI 10.1016/j.vetimm.2009.09.003; MANNING RD, 1987, AM J PHYSIOL, V252, pF403, DOI 10.1152/ajprenal.1987.252.3.F403; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Mathieu M, 2006, AM J VET RES, V67, P1236, DOI 10.2460/ajvr.67.7.1236; MCLACHLAN MSF, 1977, J PATHOL, V121, P65, DOI 10.1002/path.1711210202; Nishida E, 1996, EXP ANIM TOKYO, V45, P339, DOI 10.1538/expanim.45.339; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Pomeroy MJ, 2004, TOXICOL PATHOL, V32, P237, DOI 10.1080/01926230490274407; Pugliese A, 2005, VET RES COMMUN, V29, P57, DOI 10.1007/s11259-005-0012-6; Raila J, 2003, AM J VET RES, V64, P874, DOI 10.2460/ajvr.2003.64.874; Raila J, 2010, AM J VET RES, V71, P1387, DOI 10.2460/ajvr.71.11.1387; RIJNBERK A, 1968, J ENDOCRINOL, V41, P397, DOI 10.1677/joe.0.0410397; Schellenberg S, 2008, J VET INTERN MED, V22, P273, DOI 10.1111/j.1939-1676.2007.0039.x; Silva Fred G., 2005, International Urology and Nephrology, V37, P419, DOI 10.1007/s11255-004-0874-5; Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6; Smets PMY, 2010, J VET INTERN MED, V24, P65, DOI 10.1111/j.1939-1676.2009.0426.x; STUART BP, 1975, VET PATHOL, V12, P125, DOI 10.1177/030098587501200205; Stuart S, 2001, AM J KIDNEY DIS, V37, DOI 10.1053/ajkd.2001.22865; TATSUMI T, 1995, INTERNAL MED, V34, P10, DOI 10.2169/internalmedicine.34.10; Torng S, 2001, TRANSPLANTATION, V72, P1453, DOI 10.1097/00007890-200110270-00021; Vaden SL, 2005, CLIN TECH SMALL AN P, V20, P11, DOI 10.1053/j.ctsap.2004.12.003; van Hoek I, 2007, J VET INTERN MED, V21, P950, DOI 10.1892/0891-6640(2007)21[950:CAROPC]2.0.CO;2; VANACKER BAC, 1993, NEPHRON, V65, P254, DOI 10.1159/000187484; Vinge L, 2010, NEPHROL DIAL TRANSPL, V25, P2458, DOI 10.1093/ndt/gfq044; Waters CB, 1997, J VET INTERN MED, V11, P172, DOI 10.1111/j.1939-1676.1997.tb00086.x; Watson ADJ, 2002, J VET INTERN MED, V16, P22, DOI 10.1892/0891-6640(2002)016&lt;0022:PECCTI&gt;2.3.CO;2; Yalcin A, 2004, REV MED VET-TOULOUSE, V155, P104; Zaragoza C, 2003, J COMP PATHOL, V129, P169, DOI 10.1016/S0021-9975(03)00029-X; Zini E, 2004, AM J VET RES, V65, P964, DOI 10.2460/ajvr.2004.65.964	55	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31702	10.1371/journal.pone.0031702	http://dx.doi.org/10.1371/journal.pone.0031702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393368	Green Submitted, gold, Green Published			2022-12-25	WOS:000303003500021
J	Hou, LF; He, SJ; Li, X; Wan, CP; Yang, Y; Zhang, XH; He, PL; Zhou, Y; Zhu, FH; Yang, YF; Li, Y; Tang, W; Zuo, JP				Hou, Li-Fei; He, Shi-Jun; Li, Xin; Wan, Chun-Ping; Yang, Yang; Zhang, Xiao-Hui; He, Pei-Lan; Zhou, Yu; Zhu, Feng-Hua; Yang, Yi-Fu; Li, Ying; Tang, Wei; Zuo, Jian-Ping			SM934 Treated Lupus-Prone NZBxNZW F-1 Mice by Enhancing Macrophage Interleukin-10 Production and Suppressing Pathogenic T Cell Development	PLOS ONE			English	Article							MURINE LUPUS; AUTOANTIBODY PRODUCTION; THERAPEUTIC TARGETS; DISEASE-ACTIVITY; MRL/LPR MICE; ERYTHEMATOSUS; RESPONSES; GAMMA; ARTEMISININ; IL-17	Background: Artemisinin and its derivatives were reported to possess strong regulatory effects on inflammation and autoimmune diseases. This study was designed to examine the therapeutic effects and underlying mechanisms of SM934, a water-soluble artemisinin analogue, on lupus-prone female NZBxNZW F-1 mice. Methodology/Principal Findings: NZB/W F-1 mice were treated orally with SM934 for 3 or 6 months respectively to investigate the effect on clinical manifestations and immunological correlates. To further explore the mechanisms of SM934, ovalbumin (OVA)-immunized or interferon (IFN)-gamma-elicited C57BL/6 mice were used. In vivo, treatment with SM934 for 3 or 6 months significantly delayed the progression of glomerulonephritis and increased the survival rate of NZB/W F1 mice. Clinical improvement was accompanied with decreased Th1-related anti-double-strand DNA (dsDNA) IgG2a and IgG3 Abs, serum interleukin (IL)-17, and increased Th2-related anti-dsDNA IgG1 Ab, serum IL-10 and IL-4. SM934 treatment also suppressed the accumulation of effector/memory T cells, induced the apoptosis of CD4(+) T cells, while enhancing the development of regulatory T cells in NZB/W F-1 mice. In addition, SM934 treatment promoted the IL-10 production of macrophages from NZB/W F-1 mice, OVA-immunized C57BL/6 mice and IFN-gamma-elicited C57BL/6 mice. In vitro, SM934 enhanced IL-10 production from primary macrophages stimulated with IFN-gamma. Conclusions/Significance: The results of this study demonstrated that artemisinin analogue SM934 had therapeutic effects on lupus-prone female NZB/W F-1 mice by inhibiting the pathogenic helper T cell development and enhancing anti-inflammatory cytokine IL-10 production.	[Hou, Li-Fei; He, Shi-Jun; Li, Xin; He, Pei-Lan; Zhou, Yu; Zhu, Feng-Hua; Tang, Wei; Zuo, Jian-Ping] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Wan, Chun-Ping; Yang, Yang; Zhang, Xiao-Hui; Yang, Yi-Fu; Zuo, Jian-Ping] Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai, Peoples R China; [Li, Ying] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Synthet Chem, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Hou, LF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	jpzuo@mail.shcnc.ac.cn		Hou, Lifei/0000-0001-8975-7795	Science & Technology Commission of Shanghai Municipality, China [08XD14053]; National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China [2009ZX09301-001, 2009ZX09102-019]	Science & Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China	This work was supported by the grants of Science & Technology Commission of Shanghai Municipality, China (No. 08XD14053), and National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China (2009ZX09301-001, 2009ZX09102-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 1999, ARTHRITIS RHEUM, V42, P1644, DOI 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Brian LK, 1996, CELL, V85, P303; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Gergely P, 2002, J IMMUNOL, V169, P1092, DOI 10.4049/jimmunol.169.2.1092; Haas C, 1998, J IMMUNOL, V160, P3713; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Hughes GC, 2009, ARTHRITIS RHEUM, V60, P1775, DOI 10.1002/art.24548; Humrich JY, 2010, P NATL ACAD SCI USA, V107, P204, DOI 10.1073/pnas.0903158107; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Jin OY, 2009, CELL MOL IMMUNOL, V6, P461, DOI 10.1038/cmi.2009.58; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Llorente L, 2003, J AUTOIMMUN, V20, P287, DOI 10.1016/S0896-8411(03)00043-X; Lu Lan, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P169; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Monk CR, 2005, ARTHRITIS RHEUM, V52, P1180, DOI 10.1002/art.20976; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Reilly CM, 2002, IMMUNOL RES, V25, P143, DOI 10.1385/IR:25:2:143; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wang JX, 2007, BRIT J PHARMACOL, V150, P652, DOI 10.1038/sj.bjp.0707137; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wu XL, 2010, ACTA BIOCH BIOPH SIN, V42, P916, DOI 10.1093/abbs/gmq101; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Yuan WJ, 2011, ARTHRITIS RHEUM-US, V63, P212, DOI 10.1002/art.30083; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	49	49	59	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32424	10.1371/journal.pone.0032424	http://dx.doi.org/10.1371/journal.pone.0032424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389703	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600041
J	Kategaya, LS; Hilliard, A; Zhang, LY; Asara, JM; Ptacek, LJ; Fu, YH				Kategaya, Lorna S.; Hilliard, Aisha; Zhang, Louying; Asara, John M.; Ptacek, Louis J.; Fu, Ying-Hui			Casein Kinase 1 Proteomics Reveal Prohibitin 2 Function in Molecular Clock	PLOS ONE			English	Article								Throughout the day, clock proteins synchronize changes in animal physiology (e.g., wakefulness and appetite) with external cues (e.g., daylight and food). In vertebrates, both casein kinase 1 delta and epsilon (CK1 delta and CK1 epsilon) regulate these circadian changes by phosphorylating other core clock proteins. In addition, CK1 can regulate circadian-dependent transcription in a non-catalytic manner, however, the mechanism is unknown. Furthermore, the extent of functional redundancy between these closely related kinases is debated. To further advance knowledge about CK1 delta and CK1 epsilon mechanisms of action in the biological clock, we first carried out proteomic analysis of both kinases in human cells. Next, we tested interesting candidates in a cell-based circadian readout which resulted in the discovery of PROHIBITIN 2 (PHB2) as a modulator of period length. Decreasing the expression of PHB2 increases circadian-driven transcription, thus revealing PHB2 acts as an inhibitor in the molecular clock. While stable binding of PHB2 to either kinase was not detected, knocking down CK1 epsilon expression increases PHB2 protein levels and, unexpectedly, knocking down CK1 delta decreases PHB2 transcript levels. Thus, isolating CK1 protein complexes led to the identification of PHB2 as an inhibitor of circadian transcription. Furthermore, we show that CK1 delta and CK1 epsilon differentially regulate the expression of PHB2.	[Kategaya, Lorna S.; Hilliard, Aisha; Zhang, Louying; Ptacek, Louis J.; Fu, Ying-Hui] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Kategaya, LS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ljp@ucsf.edu; ying-hui.fu@ucsf.edu			National Institutes of Health [GM079180, HL059596]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grant GM079180 and HL059596 to LP and YF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Ko CH, 2006, HUM MOL GENET, V89, P184; Koch A, 2010, EUR J CELL BIOL, pR271; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Volkel P, 2010, BIOCHEM SOC T, V38, P883, DOI 10.1042/BST0380883; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	16	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31987	10.1371/journal.pone.0031987	http://dx.doi.org/10.1371/journal.pone.0031987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384121	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500052
J	Reemers, SSN; van Haarlem, DA; Sijts, AJAM; Vervelde, L; Jansen, CA				Reemers, Sylvia S. N.; van Haarlem, Daphne A.; Sijts, Alice J. A. M.; Vervelde, Lonneke; Jansen, Christine A.			Identification of Novel Avian Influenza Virus Derived CD8+T-Cell Epitopes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL RESPONSES; CLASS-I MOLECULE; A VIRUS; INFECTION; CHICKEN; IMMUNITY; MEMORY; MHC; HEMAGGLUTININ	Avian influenza virus (AIV) infection is a continuing threat to both humans and poultry. Influenza virus specific CD8+ T cells are associated with protection against homologous and heterologous influenza strains. In contrast to what has been described for humans and mice, knowledge on epitope-specific CD8+ T cells in chickens is limited. Therefore, we set out to identify AIV-specific CD8+ T-cell epitopes. Epitope predictions based on anchor residues resulted in 33 candidate epitopes. MHC I inbred chickens were infected with a low pathogenic AIV strain and sacrificed at 5, 7, 10 and 14 days post infection (dpi). Lymphocytes isolated from lung, spleen and blood were stimulated ex vivo with AIV-specific pooled or individual peptides and the production of IFN gamma was determined by ELIspot. This resulted in the identification of 12 MHC B12-restricted, 3 B4-restricted and 1 B19-restricted AIV-specific CD8+ T-cell epitopes. In conclusion, we have identified novel AIV-derived CD8+ T-cell epitopes for several inbred chicken strains. This knowledge can be used to study the role of CD8+ T cells against AIV infection in a natural host for influenza, and may be important for vaccine development.	[Reemers, Sylvia S. N.; van Haarlem, Daphne A.; Sijts, Alice J. A. M.; Vervelde, Lonneke; Jansen, Christine A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Reemers, SSN (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	c.a.jansen@uu.nl	Vervelde, Lonneke/C-7707-2013	Vervelde, Lonneke/0000-0003-2241-1743; Sijts, Alice/0000-0003-3815-4788	EU [04220]; Dutch Ministery of Agriculture, Nature and Food Quality	EU(European Commission); Dutch Ministery of Agriculture, Nature and Food Quality	This study was financially supported by the EU sixth framework program Flupath (grant 04220) and Programme "Impulse Veterinary Avian Influenza Research" in The Netherlands, Dutch Ministery of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariaans MP, 2008, DEV COMP IMMUNOL, V32, P1398, DOI 10.1016/j.dci.2008.05.007; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BRILES WE, 1950, GENETICS, V35, P633; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Davison F, 2008, AVIAN IMMUNOLOGY, P1; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Flynn KJ, 1999, P NATL ACAD SCI USA, V96, P8597, DOI 10.1073/pnas.96.15.8597; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GOBEL TWF, 1994, EUR J IMMUNOL, V24, P1685, DOI 10.1002/eji.1830240734; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; GUILLEMOT F, 1988, EMBO J, V7, P2775, DOI 10.1002/j.1460-2075.1988.tb03132.x; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Kapczynski Darrell R, 2011, BMC Proc, V5 Suppl 4, pS13, DOI 10.1186/1753-6561-5-S4-S13; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; PINK JRL, 1985, IMMUNOGENETICS, V21, P293, DOI 10.1007/BF00375381; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Reemers SS, 2010, VACCINE, V28, P6351, DOI 10.1016/j.vaccine.2010.06.099; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; SCHULMAN JL, 1968, J VIROL, V2, P778, DOI 10.1128/JVI.2.8.778-786.1968; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Singh S, 2010, VIROLOGY, V405, P62, DOI 10.1016/j.virol.2010.05.002; Singh S, 2010, VIROLOGY, V399, P231, DOI 10.1016/j.virol.2009.12.029; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; VAINIO O, 1984, IMMUNOGENETICS, V19, P131, DOI 10.1007/BF00387856; VAINIO O, 1988, J IMMUNOL, V140, P2864; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	50	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31953	10.1371/journal.pone.0031953	http://dx.doi.org/10.1371/journal.pone.0031953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384112	Green Published, gold			2022-12-25	WOS:000302916100041
J	Fode, P; Larsen, AR; Feenstra, B; Jespersgaard, C; Skov, RL; Stegger, M; Fowler, VG; Andersen, PS				Fode, Peder; Larsen, Anders Rhod; Feenstra, Bjarke; Jespersgaard, Cathrine; Skov, Robert Leo; Stegger, Marc; Fowler, Vance G., Jr.; Andersen, Paal Skytt		Danish SAB Study Grp Consortium	Genetic Variability in Beta-Defensins Is Not Associated with Susceptibility to Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENOME-WIDE ASSOCIATION; BETA-DEFENSIN-1; PSORIASIS; PEPTIDE; DEFB1; HBD-1	Introduction: Human beta-defensins are key components of human innate immunity to a variety of pathogens, including Staphylococcus aureus. The aim of the present study was to investigate a potential association between gene variations in DEFB1 and DEFB103/DEFB4 and the development of S. aureus bacteremia (SAB) employing a case-control design. Methods: Cases were unique patients with documented SAB, identified with the National S. aureus Bacteremia Register, a comprehensive dataset of all episodes of community associated-SABs (CA-SAB) occurring in children (<= 20 yrs) in Denmark from 1990 to 2006. Controls were age-matched healthy individuals with no history of SAB. DNA obtained from cases and controls using the Danish Newborn Screening Biobank were genotyped for functional polymorphisms of DEFB1 by Sanger sequencing and copy number variation of the DEFB103 and DEFB4 genes using Pyrosequencing-based Paralogue Ratio Test (P-PRT). Results: 193 ethnic Danish SAB cases with 382 age-matched controls were used for this study. S. aureus isolates represented a variety of bacterial (i.e., different spa types) types similar to SAB isolates in general. DEFB1 minor allele frequencies of rs11362 (cases vs. controls 0.47/0.44), rs1800972 (0.21/0.24), and rs1799946 (0.32/0.33) were not significantly different in cases compared with controls. Also, DEFB4/DEFB103 gene copy numbers (means 4.83/4.92) were not significantly different in cases compared with controls. Conclusions: Using a large, unique cohort of pediatric CA-SAB, we found no significant association between DEFB1 genetic variation or DEFB4/DEFB103 gene copy number and susceptibility for SAB.	[Fode, Peder; Larsen, Anders Rhod; Skov, Robert Leo; Stegger, Marc; Andersen, Paal Skytt] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Feenstra, Bjarke] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jespersgaard, Cathrine] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Fowler, Vance G., Jr.] Duke Med Ctr, Dept Infect Dis, Durham, NC USA	Statens Serum Institut; Statens Serum Institut; Statens Serum Institut; Duke University	Fode, P (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	psa@ssi.dk	Andersen, Paal S/H-2087-2015; Skov, Robert/ABB-3105-2020; Fowler, Vance/AAW-2017-2021	Andersen, Paal S/0000-0001-5656-0427; Skov, Robert/0000-0002-6079-5381; Larsen, Anders Rhod/0000-0002-1713-8765; Feenstra, Bjarke/0000-0003-1478-649X; Stegger, Marc/0000-0003-0321-1180	Danish Medical Research Council; Idella Foundation; Lundbeck Foundation; NIH [R01-AI068804]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804] Funding Source: NIH RePORTER	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Idella Foundation; Lundbeck Foundation(Lundbeckfonden); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Danish Medical Research Council; Idella Foundation; and The Lundbeck Foundation. Dr. Fowler was supported by NIH grant R01-AI068804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Chen QX, 2007, GENES IMMUN, V8, P439, DOI 10.1038/sj.gene.6364401; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Skov R, 2008, 2008112 STAT SER I; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32315	10.1371/journal.pone.0032315	http://dx.doi.org/10.1371/journal.pone.0032315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384213	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500094
J	Keum, YS; Kim, HG; Bode, AM; Surh, YJ; Dong, Z				Keum, Y-S; Kim, H-G; Bode, A. M.; Surh, Y-J; Dong, Z.			UVB-induced COX-2 expression requires histone H3 phosphorylation at Ser10 and Ser28	ONCOGENE			English	Article						COX-2; UVB; histone H3; phosphorylation; Cdk9; RNA polymerase II	CHROMATIN MODIFICATIONS; RNA; METHYLATION; CYCLOOXYGENASE-2; ACETYLATION; SERINE-10; HUR	Cyclooxygenase-2 (COX-2) is an inducible enzyme that contributes to the generation of chronic inflammation in response to chemical carcinogens and environmental stresses, including ultraviolet B (UVB) irradiation. Although post-translational histone modifications are believed to have an important role in modulating transcriptional regulation of UVB-induced COX-2, the underlying biochemical mechanisms are completely unknown. Here, we show that UVB activates the p38 MAPK/MSK1 kinase cascade to phosphorylate histone H3 at Ser10 and Ser28, contributing to UVB-induced COX-2 expression. UVB has no effect on the global tri-methylation level of histone H3 (H3K4me3, H3K9me3, and H3K27me3). We observed that selected mammalian 14-3-3 proteins bind to UVB-induced phosphorylated histone H3 (Ser10 and Ser28). In particular, 14-3-3 epsilon is critical for recruiting MSK1 and Cdk9 to the chromatin and subsequently phosphorylating the C-terminal domain of RNA polymerase II in the cox-2 promoter. We propose that histone H3 phosphorylation at Ser10 and Ser28 serve as critical switches to promote cox-2 gene expression by facilitating the recruitment of MSK1 and Cdk9 to the cox-2 promoter, thereby promoting RNA polymerase II phosphorylation. Oncogene (2013) 32, 444-452; doi:10.1038/onc.2012.71; published online 5 March 2012	[Keum, Y-S; Kim, H-G; Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Surh, Y-J; Dong, Z.] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Chem, WCU Program, Seoul, South Korea; [Surh, Y-J; Dong, Z.] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Keum, Y-S] Dongguk Univ, Coll Pharm, Dept Biochem, Goyang, South Korea	University of Minnesota System; Seoul National University (SNU); Seoul National University (SNU); Dongguk University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu			Hormel Foundation; National Institutes of Health [CA120388, R37 CA081064, ES016548]; Korea WCU project of the MEST [R31-2008-000-10103-0]; NRF; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea WCU project of the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation and National Institutes of Health grants CA120388, R37 CA081064, ES016548 and Grant no. R31-2008-000-10103-0 from the Korea WCU project of the MEST and the NRF.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bachelor MA, 2005, MOL CANCER RES, V3, P90, DOI 10.1158/1541-7786.MCR-04-0065; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bode Ann M, 2005, Sci STKE, V2005, pre4, DOI 10.1126/stke.2812005re4; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Rundhaug JE, 2007, MOL CARCINOGEN, V46, P692, DOI 10.1002/mc.20329; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200	32	34	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2013	32	4					444	452		10.1038/onc.2012.71	http://dx.doi.org/10.1038/onc.2012.71			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22391560	Green Accepted			2022-12-25	WOS:000315551300005
J	Patel, VA; Feng, LF; Lee, DJ; Massenburg, D; Pattabiraman, G; Antoni, A; Schwartz, JH; Lieberthal, W; Rauch, J; Ucker, DS; Levine, JS				Patel, Vimal A.; Feng, Lanfei; Lee, Daniel J.; Massenburg, Donald; Pattabiraman, Goutham; Antoni, Angelika; Schwartz, John H.; Lieberthal, Wilfred; Rauch, Joyce; Ucker, David S.; Levine, Jerrold S.			Recognition-dependent Signaling Events in Response to Apoptotic Targets Inhibit Epithelial Cell Viability by Multiple Mechanisms IMPLICATIONS FOR NON-IMMUNE TISSUE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULAR CELLS; NECROTIC CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; T-LYMPHOCYTES; FAS LIGAND; MACROPHAGES; BETA; AKT; ACTIVATION; SURVIVAL	Apoptosis allows for the removal of damaged, aged, and/or excess cells without harm to surrounding tissue. To accomplish this, cells undergoing apoptosis acquire new activities that enable them to modulate the fate and function of nearby cells. We have shown that receptor-mediated recognition of apoptotic versus necrotic target cells by viable kidney proximal tubular epithelial cells (PTEC) modulates the activity of several signaling pathways critically involved in regulation of proliferation and survival. Generally, apoptotic and necrotic targets have opposite effects with apoptotic targets inhibiting and necrotic targets stimulating the activity of these pathways. Here we explore the consequences of these signaling differences. We show that recognition of apoptotic targets induces a profound decrease in PTEC viability through increased responder cell death and decreased proliferation. In contrast, necrotic targets promote viability through decreased death and increased proliferation. Both target types mediate their effects through a network of Akt-dependent and -independent events. Apoptotic targets modulate Akt-dependent viability in part through a reduction in cellular beta-catenin and decreased inactivation of Bad. In contrast, Akt-independent modulation of viability occurs through activation of caspase-8, suggesting that death receptor-dependent pathways are involved. Apoptotic targets also activate p38, which partially protects responders from target-induced death. The response of epithelial cells varies depending on their tissue origin. Some cell lines, like PTEC, demonstrate decreased viability, whereas others (e. g. breast-derived) show increased viability. By acting as sentinels of environmental change, apoptotic targets allow neighboring cells, especially non-migratory epithelial cells, to monitor and potentially adapt to local stresses.	[Patel, Vimal A.; Feng, Lanfei; Lee, Daniel J.; Massenburg, Donald; Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Pattabiraman, Goutham; Ucker, David S.; Levine, Jerrold S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Patel, Vimal A.; Feng, Lanfei; Lee, Daniel J.; Massenburg, Donald; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Schwartz, John H.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA; [Lieberthal, Wilfred] SUNY Stony Brook, Med Ctr, Dept Med, Nephrol Sect, Stony Brook, NY 11794 USA; [Lieberthal, Wilfred] Northport Vet Affairs Hosp, Northport, NY 11768 USA; [Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Dept Med,Div Rheumatol, Montreal, PQ H3G 1A4, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA.	jslevine@uic.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681; Pattabiraman, Goutham/0000-0002-5196-8279	National Institutes of Health [DK071678, AG024234, DK059529]; Genzyme Renal Innovations Program Grant; Veterans Affairs merit award; Dialysis Clinic, Inc. [S-1774, C-3176]; Pennsylvania State System of Higher Education faculty professional development grant; Canadian Institutes of Health Research [MOP-67101, MOP-42391]; Institute of Musculoskeletal Health and Arthritis Priority Announcement [MUS-67101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071678, R01DK059529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Innovations Program Grant; Veterans Affairs merit award(US Department of Veterans Affairs); Dialysis Clinic, Inc.; Pennsylvania State System of Higher Education faculty professional development grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Priority Announcement; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071678 (to V. A. P.), AG024234 (to D. S. U.), and DK059529 (to J. H. S.). This work was also supported by the Genzyme Renal Innovations Program Grant (to J. S. L.), a Veterans Affairs merit award and Dialysis Clinic, Inc. Grants S-1774 and C-3176 (to W. L.), a Pennsylvania State System of Higher Education faculty professional development grant (to A. A.), Canadian Institutes of Health Research Grants MOP-67101 (to J. R.) and MOP-42391 (to J. R.), and Institute of Musculoskeletal Health and Arthritis Priority Announcement MUS-67101 (to J. R.).	Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bellone M, 1997, J IMMUNOL, V159, P5391; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011; Linkermann A, 2011, KIDNEY INT, V79, P169, DOI 10.1038/ki.2010.317; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; MAJNO G, 1995, AM J PATHOL, V146, P3; McDonald PP, 1999, J IMMUNOL, V163, P6164; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Munoz LE, 2010, AUTOIMMUN REV, V9, P425, DOI 10.1016/j.autrev.2009.11.016; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Patel VA, 2009, AUTOIMMUNITY, V42, P317, DOI 10.1080/08916930902832124; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Safirstein RL, 2011, KIDNEY INT, V79, P149, DOI 10.1038/ki.2010.441; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; Skoberne M, 2005, CURR TOP MICROBIOL, V289, P259; Tan KH, 2003, EXP CELL RES, V284, P283, DOI 10.1016/S0014-4827(02)00056-3; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253	34	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13761	13777		10.1074/jbc.M112.350843	http://dx.doi.org/10.1074/jbc.M112.350843			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396534	Green Published, hybrid			2022-12-25	WOS:000303996300032
J	Nag, A; Monine, M; Perelson, AS; Goldstein, B				Nag, Ambarish; Monine, Michael; Perelson, Alan S.; Goldstein, Byron			Modeling and Simulation of Aggregation of Membrane Protein LAT with Molecular Variability in the Number of Binding Sites for Cytosolic Grb2-SOS1-Grb2	PLOS ONE			English	Article							T-CELL-RECEPTOR; FC-EPSILON-RI; ADAPTER PROTEIN; STOCHASTIC SIMULATION; SIGNALING COMPLEXES; DISTAL TYROSINES; ANTIGEN RECEPTOR; SH3 DOMAIN; ACTIVATION; GRB2	The linker for activation of T cells (LAT), the linker for activation of B cells (LAB), and the linker for activation of X cells (LAX) form a family of transmembrane adaptor proteins widely expressed in lymphocytes. These scaffolding proteins have multiple binding motifs that, when phosphorylated, bind the SH2 domain of the cytosolic adaptor Grb2. Thus, the valence of LAT, LAB and LAX for Grb2 is variable, depending on the strength of receptor activation that initiates phosphorylation. During signaling, the LAT population will exhibit a time-varying distribution of Grb2 valences from zero to three. In the cytosol, Grb2 forms 1:1 and 2:1 complexes with the guanine nucleotide exchange factor SOS1. The 2:1 complex can bridge two LAT molecules when each Grb2, through their SH2 domains, binds to a phosphorylated site on a separate LAT. In T cells and mast cells, after receptor engagement, receptor phosphoyrlation is rapidly followed by LAT phosphorylation and aggregation. In mast cells, aggregates containing more than one hundred LAT molecules have been detected. Previously we considered a homogeneous population of trivalent LAT molecules and showed that for a range of Grb2, SOS1 and LAT concentrations, an equilibrium theory for LAT aggregation predicts the formation of a gel-like phase comprising a very large aggregate (superaggregate). We now extend this theory to investigate the effects of a distribution of Grb2 valence in the LAT population on the formation of LAT aggregates and superaggregate and use stochastic simulations to calculate the fraction of the total LAT population in the superaggregate.	[Nag, Ambarish; Monine, Michael; Perelson, Alan S.; Goldstein, Byron] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Monine, Michael] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Nag, A (corresponding author), Natl Renewable Energy Lab, Computat Sci Ctr, Golden, CO USA.	ambarish.nag@nrel.gov	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002; Nag, Ambarish/0000-0001-5174-4673	Department of Energy [W-7405-ENG-36]; National Institutes of Health [R37-GM035556, R37-AI028433, R01-RR006555, P01-AI071195]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028433, P01AI071195, R37AI028433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Department of Energy through contract W-7405-ENG-36, and National Institutes of Health grants R37-GM035556 (BG), R37-AI028433 (ASP), R01-RR006555 (ASP) and P01-AI071195 (ASP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2008, NATURE CELL BIOL, V10, P774; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Cho SW, 2004, EMBO J, V23, P1441, DOI 10.1038/sj.emboj.7600168; Chook YM, 1996, J BIOL CHEM, V271, P30472, DOI 10.1074/jbc.271.48.30472; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDSTEIN B, 1984, BIOPHYS J, V45, P1109, DOI 10.1016/S0006-3495(84)84259-9; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Kambayashi T, 2009, IMMUNOL REV, V232, P99, DOI 10.1111/j.1600-065X.2009.00825.x; Koonpaew S, 2004, J BIOL CHEM, V279, P11229, DOI 10.1074/jbc.M311394200; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; McDonald CB, 2009, BIOCHEMISTRY-US, V48, P4074, DOI 10.1021/bi802291y; METZGER H, 1992, J IMMUNOL, V149, P1477; Monine MI, 2010, BIOPHYS J, V98, P48, DOI 10.1016/j.bpj.2009.09.043; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; SASTRY L, 1995, ONCOGENE, V11, P1107; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Tkaczyk C, 2005, CHEM IMMUNOL ALLERGY, V87, P43, DOI 10.1159/000087570; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wilson BS, 2002, MOL IMMUNOL, V38, P1259, DOI 10.1016/S0161-5890(02)00073-1; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Yang J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031910; Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e28758	10.1371/journal.pone.0028758	http://dx.doi.org/10.1371/journal.pone.0028758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396725	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000002
J	Brush, GS; Najor, NA; Dombkowski, AA; Cukovic, D; Sawarynski, KE				Brush, George S.; Najor, Nicole A.; Dombkowski, Alan A.; Cukovic, Daniela; Sawarynski, Kara E.			Yeast IME2 Functions Early in Meiosis Upstream of Cell Cycle-Regulated SBF and MBF Targets	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; S-PHASE; DNA-REPLICATION; PROTEIN-KINASE; BUDDING YEAST; G1-SPECIFIC TRANSCRIPTION; GENE-EXPRESSION; G1 CYCLINS; PHOSPHORYLATION; INHIBITOR	Background: In Saccharomyces cerevisiae, the G1 cyclin/cyclin-dependent kinase (CDK) complexes Cln1,-2,-3/Cdk1 promote S phase entry during the mitotic cell cycle but do not function during meiosis. It has been proposed that the meiosis-specific protein kinase Ime2, which is required for normal timing of pre-meiotic DNA replication, is equivalent to Cln1,-2/Cdk1. These two CDK complexes directly catalyze phosphorylation of the B-type cyclin/CDK inhibitor Sic1 during the cell cycle to enable its destruction. As a result, Clb5,-6/Cdk1 become activated and facilitate initiation of DNA replication. While Ime2 is required for Sic1 destruction during meiosis, evidence now suggests that Ime2 does not directly catalyze Sic1 phosphorylation to target it for destabilization as Cln1,-2/Cdk1 do during the cell cycle. Methodology/Principal Findings: We demonstrated that Sic1 is eventually degraded in meiotic cells lacking the IME2 gene (ime2 Delta), supporting an indirect role of Ime2 in Sic1 destruction. We further examined global RNA expression comparing wild type and ime2D cells. Analysis of these expression data has provided evidence that Ime2 is required early in meiosis for normal transcription of many genes that are also periodically expressed during late G1 of the cell cycle. Conclusions/Significance: Our results place Ime2 at a position in the early meiotic pathway that lies upstream of the position occupied by Cln1,-2/Cdk1 in the analogous cell cycle pathway. Thus, Ime2 may functionally resemble Cln3/Cdk1 in promoting S phase entry, or it could play a role even further upstream in the corresponding meiotic cascade.	[Brush, George S.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Brush, George S.] Barbara Ann Karmanos Canc Inst, Program Mol Biol & Genet, Detroit, MI USA; [Brush, George S.; Sawarynski, Kara E.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Detroit, MI USA; [Brush, George S.; Najor, Nicole A.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Dombkowski, Alan A.; Cukovic, Daniela] Wayne State Univ, Sch Med, Dept Pediat, Childrens Hosp Michigan,Div Clin Pharmacol & Toxi, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Children's Hospital of Michigan; Wayne State University	Brush, GS (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA.	brushg@karmanos.org	Sawarynski, Kara/AAE-3069-2021	Sawarynski, Kara/0000-0003-3008-0884; Dombkowski, Alan/0000-0002-0312-8750	National Institutes of Health (NIH) [T32CA009531]; NIH Center [P30CA22453]; Perinatology Research Branch of the National Institute of Child Health and Human Development, Wayne State University; NATIONAL CANCER INSTITUTE [T32CA009531, P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of the National Institute of Child Health and Human Development, Wayne State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NAN and KES were supported by the Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant T32CA009531 from the National Institutes of Health (NIH). The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center Grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and by the Perinatology Research Branch of the National Institute of Child Health and Human Development, Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; ANDREWS BJ, 1989, CELL, V57, P21, DOI 10.1016/0092-8674(89)90168-2; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clifford DM, 2004, J BIOL CHEM, V279, P6163, DOI 10.1074/jbc.M306943200; Colomina N, 1999, EMBO J, V18, P320, DOI 10.1093/emboj/18.2.320; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Day A, 2004, CELL CYCLE, V3, P1433, DOI 10.4161/cc.3.11.1205; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Foiani M, 1996, MOL GEN GENET, V253, P278, DOI 10.1007/s004380050323; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Holt LJ, 2007, MOL CELL, V25, P689, DOI 10.1016/j.molcel.2007.02.012; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Mendes ND, 2006, BIOINFORMATICS, V22, P2996, DOI 10.1093/bioinformatics/btl537; MITCHELL AP, 1990, MOL CELL BIOL, V10, P2104, DOI 10.1128/MCB.10.5.2104; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Moore M, 2007, BIOCHEMISTRY-US, V46, P271, DOI 10.1021/bi061858p; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Raithatha SA, 2005, GENETICS, V169, P1329, DOI 10.1534/genetics.104.036103; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Sawarynski KE, 2007, BBA-MOL CELL RES, V1773, P450, DOI 10.1016/j.bbamcr.2006.10.003; Sawarynski KE, 2009, P NATL ACAD SCI USA, V106, P232, DOI 10.1073/pnas.0809731105; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sedgwick C, 2006, BIOCHEM J, V399, P151, DOI 10.1042/BJ20060363; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sopko R, 2002, MOL CELL BIOL, V22, P7024, DOI 10.1128/MCB.22.20.7024-7040.2002; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Valentin G, 2006, J BIOL CHEM, V281, P2828, DOI 10.1074/jbc.M510626200; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	63	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31575	10.1371/journal.pone.0031575	http://dx.doi.org/10.1371/journal.pone.0031575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393365	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500018
J	Chung, MY; Kim, YW; Bae, SM; Kwon, EH; Chaturvedi, PK; Battogtokh, G; Ahn, WS				Chung, Mee Young; Kim, Yong-Wan; Bae, Su Mi; Kwon, Eun Hye; Chaturvedi, Pankaj Kumar; Battogtokh, Gantumur; Ahn, Woong Shick			Development of a Bead-Based Multiplex Genotyping Method for Diagnostic Characterization of HPV Infection	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; POLYMERASE-CHAIN-REACTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FRAGMENT-LENGTH-POLYMORPHISM; LINE PROBE ASSAY; HIGH-RISK HPV; DNA CHIP; CANCER; WOMEN; LESIONS	The accurate genotyping of human papillomavirus (HPV) is clinically important because the oncogenic potential of HPV is dependent on specific genotypes. Here, we described the development of a bead-based multiplex HPV genotyping (MPG) method which is able to detect 20 types of HPV (15 high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 and 5 low-risk HPV types 6, 11, 40, 55, 70) and evaluated its accuracy with sequencing. A total of 890 clinical samples were studied. Among these samples, 484 were HPV positive and 406 were HPV negative by consensus primer (PGMY09/11) directed PCR. The genotyping of 484 HPV positive samples was carried out by the bead-based MPG method. The accuracy was 93.5% (95% CI, 91.0-96.0), 80.1% (95% CI, 72.3-87.9) for single and multiple infections, respectively, while a complete type mismatch was observed only in one sample. The MPG method indiscriminately detected dysplasia of several cytological grades including 71.8% (95% CI, 61.5-82.3) of ASCUS (atypical squamous cells of undetermined significance) and more specific for high grade lesions. For women with HSIL (high grade squamous intraepithelial lesion) and SCC diagnosis, 32 women showed a PPV (positive predictive value) of 77.3% (95% CI, 64.8-89.8). Among women > 40 years of age, 22 women with histological cervical cancer lesions showed a PPV of 88% (95% CI, 75.3-100). Of the highest risk HPV types including HPV-16, 18 and 31 positive women of the same age groups, 34 women with histological cervical cancer lesions showed a PPV of 77.3% (95% CI, 65.0-89.6). Taken together, the bead-based MPG method could successfully detect high-grade lesions and high-risk HPV types with a high degree of accuracy in clinical samples.	[Chung, Mee Young] Catholic Univ Korea, Coll Med, Dept Anesthesiol, Seoul, South Korea; [Kim, Yong-Wan; Bae, Su Mi; Kwon, Eun Hye; Chaturvedi, Pankaj Kumar; Battogtokh, Gantumur] Catholic Univ Korea, Canc Res Inst Med Sci, Seoul, South Korea; [Ahn, Woong Shick] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Chung, MY (corresponding author), Catholic Univ Korea, Coll Med, Dept Anesthesiol, Seoul, South Korea.	ahnlab1@catholic.ac.kr			Small and Medium Business Administration, Seoul, Republic of Korea [2008-22-S1040034]	Small and Medium Business Administration, Seoul, Republic of Korea	The study was supported by a 2008 grant from the Small and Medium Business Administration, Seoul, Republic of Korea (Grant #2008-22-S1040034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bae JH, 2008, J MICROBIOL BIOTECHN, V18, P788; Berkhof J, 2006, CANCER EPIDEM BIOMAR, V15, P1268, DOI 10.1158/1055-9965.EPI-05-0764; Boulet GAV, 2008, CANCER EPIDEM BIOMAR, V17, P810, DOI 10.1158/1055-9965.EPI-07-2865; Brink AATP, 2007, DIS MARKERS, V23, P273, DOI 10.1155/2007/147429; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Carvalho ND, 2010, MEM I OSWALDO CRUZ, V105, P73, DOI 10.1590/S0074-02762010000100011; Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;232::AID-JMV18&gt;3.0.CO;2-7; Choi YD, 2005, GYNECOL ONCOL, V98, P369, DOI 10.1016/j.ygyno.2005.04.044; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Datta NR, 2006, GYNECOL ONCOL, V103, P100, DOI 10.1016/j.ygyno.2006.01.058; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Gasperov NM, 2008, PATHOL ONCOL RES, V14, P355, DOI 10.1007/s12253-008-9084-2; Geraets DT, 2009, J CLIN VIROL, V46, pS21, DOI 10.1016/S1386-6532(09)70297-5; Gharizadeh B, 2001, LAB INVEST, V81, P673, DOI 10.1038/labinvest.3780276; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kim KH, 2006, GYNECOL ONCOL, V100, P38, DOI 10.1016/j.ygyno.2005.08.024; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Lehtinen M, 2001, J CLIN VIROL, V22, P117, DOI 10.1016/S1386-6532(01)00172-X; Liaw KL, 2001, J INFECT DIS, V183, P8, DOI 10.1086/317638; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nobre RJ, 2008, J CLIN VIROL, V42, P13, DOI 10.1016/j.jcv.2007.11.021; Oh Y, 2007, CANCER SCI, V98, P549, DOI 10.1111/j.1349-7006.2007.00427.x; Park JY, 2007, GYNECOL ONCOL, V107, P39, DOI 10.1016/j.ygyno.2007.05.014; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Spinillo A, 2009, VIRUS RES, V142, P154, DOI 10.1016/j.virusres.2009.02.004; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Vernon SD, 2000, J CLIN MICROBIOL, V38, P651, DOI 10.1128/JCM.38.2.651-655.2000; Wallace J, 2005, J MOL DIAGN, V7, P72, DOI 10.1016/S1525-1578(10)60011-6; Wheeler CM, 2006, J INFECT DIS, V194, P1291, DOI 10.1086/507909; Zhao YW, 2008, PATHOL INT, V58, P643, DOI 10.1111/j.1440-1827.2008.02283.x	34	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32259	10.1371/journal.pone.0032259	http://dx.doi.org/10.1371/journal.pone.0032259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393393	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500046
J	Ku, WL; Duggal, G; Li, Y; Girvan, M; Ott, E				Ku, Wai Lim; Duggal, Geet; Li, Yuan; Girvan, Michelle; Ott, Edward			Interpreting Patterns of Gene Expression: Signatures of Coregulation, the Data Processing Inequality, and Triplet Motifs	PLOS ONE			English	Article							REGULATORY NETWORKS; MUTUAL INFORMATION; INFERENCE; ARACNE	Various methods of reconstructing transcriptional regulatory networks infer transcriptional regulatory interactions (TRIs) between strongly coexpressed gene pairs (as determined from microarray experiments measuring mRNA levels). Alternatively, however, the coexpression of two genes might imply that they are coregulated by one or more transcription factors (TFs), and do not necessarily share a direct regulatory interaction. We explore whether and under what circumstances gene pairs with a high degree of coexpression are more likely to indicate TRIs, coregulation or both. Here we use established TRIs in combination with microarray expression data from both Escherichia coli (a prokaryote) and Saccharomyces cerevisiae (a eukaryote) to assess the accuracy of predictions of coregulated gene pairs and TRIs from coexpressed gene pairs. We find that coexpressed gene pairs are more likely to indicate coregulation than TRIs for Saccharomyces cerevisiae, but the incidence of TRIs in highly coexpressed gene pairs is higher for Escherichia coli. The data processing inequality (DPI) has previously been applied for the inference of TRIs. We consider the case where a transcription factor gene is known to regulate two genes (one of which is a transcription factor gene) that are known not to regulate one another. According to the DPI, the non-interacting gene pairs should have the smallest mutual information among all pairs in the triplets. While this is sometimes the case for Escherichia coli, we find that it is almost always not the case for Saccharomyces cerevisiae. This brings into question the usefulness of the DPI sometimes employed to infer TRIs from expression data. Finally, we observe that when a TF gene is known to regulate two other genes, it is rarely the case that one regulatory interaction is positively correlated and the other interaction is negatively correlated. Typically both are either positively or negatively correlated.	[Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Duggal, Geet] Univ Maryland, Inst Adv Comp Studies, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Duggal, Geet] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Li, Yuan] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ku, WL (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	wlku@umd.edu	O, E/F-1630-2015; Girvan, Michelle/E-3982-2016; Ku, Wai Lim/R-7170-2016; Ott, Edward/F-5609-2017	Girvan, Michelle/0000-0003-0299-0784; Ku, Wai Lim/0000-0002-8859-6771; Ott, Edward/0000-0002-9395-5062; Girvan, Michelle/0000-0001-7519-2842	Office of Naval Research (ONR) [N0001H-07-1-0734]	Office of Naval Research (ONR)(Office of Naval Research)	This work was supported by the Office of Naval Research (ONR) grant N0001H-07-1-0734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Alon U, 2007, INTRO SYSTEMS BIOL D; Balaji S, 2008, TRENDS GENET, V24, P319, DOI 10.1016/j.tig.2008.04.006; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; FISHER LD, 1993, BIOSTATISTICS; Gama-Castro S, 2010, NUCL ACIDS RES; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kim DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S9; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Slonim Noam, 2005, ARXIVCS0502017; Veiga DFT, 2007, GENET MOL RES, V6, P730; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31969	10.1371/journal.pone.0031969	http://dx.doi.org/10.1371/journal.pone.0031969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393375	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500028
J	Melcon, ML; Cummins, AJ; Kerosky, SM; Roche, LK; Wiggins, SM; Hildebrand, JA				Melcon, Mariana L.; Cummins, Amanda J.; Kerosky, Sara M.; Roche, Lauren K.; Wiggins, Sean M.; Hildebrand, John A.			Blue Whales Respond to Anthropogenic Noise	PLOS ONE			English	Article							CALIFORNIA	Anthropogenic noise may significantly impact exposed marine mammals. This work studied the vocalization response of endangered blue whales to anthropogenic noise sources in the mid-frequency range using passive acoustic monitoring in the Southern California Bight. Blue whales were less likely to produce calls when mid-frequency active sonar was present. This reduction was more pronounced when the sonar source was closer to the animal, at higher sound levels. The animals were equally likely to stop calling at any time of day, showing no diel pattern in their sensitivity to sonar. Conversely, the likelihood of whales emitting calls increased when ship sounds were nearby. Whales did not show a differential response to ship noise as a function of the time of the day either. These results demonstrate that anthropogenic noise, even at frequencies well above the blue whales' sound production range, has a strong probability of eliciting changes in vocal behavior. The long-term implications of disruption in call production to blue whale foraging and other behaviors are currently not well understood.	[Melcon, Mariana L.; Cummins, Amanda J.; Kerosky, Sara M.; Roche, Lauren K.; Wiggins, Sean M.; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Melcon, ML (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	marumelcon@gmail.com		Debich, Amanda/0000-0003-1848-5651; Guenther, Sara/0000-0002-9964-5823; Hildebrand, John/0000-0002-5418-9799	Naval PostGraduate School; Chief of Naval Operations [N45]; Pacific Fleet; Office of Advanced Cyberinfrastructure (OAC) [0753335] Funding Source: National Science Foundation	Naval PostGraduate School(United States Department of Defense); Chief of Naval Operations; Pacific Fleet; Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The funders (Naval PostGraduate School, the Chief of Naval Operations N45, and the Pacific Fleet) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NRC REP; Berchok CL, 2006, J ACOUST SOC AM, V120, P2340, DOI 10.1121/1.2335676; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; Erbe C, 2002, HEARING ABILITIES BA; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Lombard E, 1911, ANN MALADIES OREILLE, P101; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McKenna MF, 2001, THESIS U CALIFORNIA, P218; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman Robert L., 2007, Journal of Cetacean Research and Management, V9, P151; Richardson W.J., 1995, MARINE MAMMALS NOISE, P449; SCHULKIN M, 1962, J ACOUST SOC AM, V34, P864, DOI 10.1121/1.1918213; Sokal RR, 2001, BIOMETRY, P767; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; Thompson PO, 1996, MAR MAMMAL SCI, V12, P288, DOI 10.1111/j.1748-7692.1996.tb00578.x; Tyack PL, MARINE MAMMAL BIOL, P142; Urick R. J., 1975, PRINCIPLES UNDERWATE; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Wiggins SM, 2007, HIGH FREQUENCY ACOUS, P551	23	69	73	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32681	10.1371/journal.pone.0032681	http://dx.doi.org/10.1371/journal.pone.0032681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393434	Green Published, gold			2022-12-25	WOS:000303003500087
J	Hennessey, PT; Sanford, T; Choudhary, A; Mydlarz, WW; Brown, D; Adai, AT; Ochs, MF; Ahrendt, SA; Mambo, E; Califano, JA				Hennessey, Patrick T.; Sanford, Tiffany; Choudhary, Ashish; Mydlarz, Wojciech W.; Brown, David; Adai, Alex Tamas; Ochs, Michael F.; Ahrendt, Steven A.; Mambo, Elizabeth; Califano, Joseph A.			Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; SIGNATURES; PROGNOSIS; PLASMA	Non small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality world-wide and the majority of cases are diagnosed at late stages of disease. There is currently no cost-effective screening test for NSCLC, and the development of such a test is a public health imperative. Recent studies have suggested that chest computed tomography screening of patients at high risk of lung cancer can increase survival from disease, however, the cost effectiveness of such screening has not been established. In this Phase I/II biomarker study we examined the feasibility of using serum miRNA as biomarkers of NSCLC using RT-qPCR to examine the expression of 180 miRNAs in sera from 30 treatment naive NSCLC patients and 20 healthy controls. Receiver operating characteristic curves (ROC) and area under the curve were used to identify differentially expressed miRNA pairs that could distinguish NSCLC from healthy controls. Selected miRNA candidates were further validated in sera from an additional 55 NSCLC patients and 75 healthy controls. Examination of miRNA expression levels in serum from a multi-institutional cohort of 50 subjects (30 NSCLC patients and 20 healthy controls) identified differentially expressed miRNAs. A combination of two differentially expressed miRNAs miR-15b and miR-27b, was able to discriminate NSCLC from healthy controls with sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 100% in the training set. Upon further testing on additional 130 subjects (55 NSCLC and 75 healthy controls), this miRNA pair predicted NSCLC with a specificity of 84% (95% CI 0.73-0.91), sensitivity of 100% (95% CI; 0.93-1.0), NPV of 100%, and PPV of 82%. These data provide evidence that serum miRNAs have the potential to be sensitive, cost-effective biomarkers for the early detection of NSCLC. Further testing in a Phase III biomarker study in is necessary for validation of these results.	[Hennessey, Patrick T.; Mydlarz, Wojciech W.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Sanford, Tiffany; Choudhary, Ashish; Adai, Alex Tamas; Mambo, Elizabeth] Asuragen Inc, Austin, TX USA; [Brown, David] MiRNA Therapeut Inc, Austin, TX USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Ahrendt, Steven A.] Univ Pittsburgh, Med Ctr, Div Surg Oncol, Pittsburgh, PA USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Asuragen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Greater Baltimore Medical Center	Hennessey, PT (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Ahrendt, Steven/0000-0002-3029-2126	National Institute of Health SBIR [1R43CA141786-01]; National Institute of Health [T32DC000027]; Asuragen, Inc.; NATIONAL CANCER INSTITUTE [R43CA141786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027] Funding Source: NIH RePORTER	National Institute of Health SBIR; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asuragen, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded in part by National Institute of Health SBIR grant #1R43CA141786-01 and by National Institute of Health grant # T32DC000027. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also funded in part by Asuragen, Inc. The researchers at Asuragen, Inc. who participated in this study were not influenced by management or parties outside of their research group and had exclusive control over study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C, 2010, J NATL COMPR CANC NE, V8, P822, DOI 10.6004/jnccn.2010.0059; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bellomi Massimo, 2006, Cancer Imaging, V6, pS9, DOI 10.1102/1470-7330.2006.9001; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Miettinen OS, 2000, CAN MED ASSOC J, V162, P1431; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; New York Early Cancer Action Inv, 2007, RADIOLOGY, V243, P239, DOI 10.1148/radiol.2431060467; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Russi EW, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13185; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	32	147	162	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32307	10.1371/journal.pone.0032307	http://dx.doi.org/10.1371/journal.pone.0032307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389695	gold, Green Published, Green Accepted			2022-12-25	WOS:000302999600033
J	Kota, S; Takahashi, V; Ni, F; Snyder, JK; Strosberg, AD				Kota, Smitha; Takahashi, Virginia; Ni, Feng; Snyder, John K.; Strosberg, A. Donny			Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein	PLOS ONE			English	Article							INFECTION IN-VITRO; CORE PROTEIN; LIPID DROPLETS; CELL-CULTURE; NS3 HELICASE; DIMERIZATION; REPLICATION; ASSAY; EPIDEMIOLOGY; POLYMERASE	Over 130 million people are infected chronically with hepatitis C virus (HCV), which, together with HBV, is the leading cause of liver disease. Novel small molecule inhibitors of Hepatitis C virus (HCV) are needed to complement or replace current treatments based on pegylated interferon and ribavirin, which are only partially successful and plagued with side-effects. Assembly of the virion is initiated by the oligomerization of core, the capsid protein, followed by the interaction with NS5A and other HCV proteins. By screening for inhibitors of core dimerization, we previously discovered peptides and drug-like compounds that disrupt interactions between core and other HCV proteins, NS3 and NS5A, and block HCV production. Here we report that a biotinylated derivative of SL209, a prototype small molecule inhibitor of core dimerization (IC50 of 2.80 mu M) that inhibits HCV production with an EC50 of 3.20 mu M, is capable of penetrating HCV-infected cells and tracking with core. Interaction between the inhibitors, core and other viral proteins was demonstrated by SL209-mediated affinity-isolation of HCV proteins from lysates of infected cells, or of the corresponding recombinant HCV proteins. SL209-like inhibitors of HCV core may form the basis of novel treatments of Hepatitis C in combination with other target-specific HCV drugs such as inhibitors of the NS3 protease, the NS5B polymerase, or the NS5A regulatory protein. More generally, our work supports the hypothesis that inhibitors of viral capsid formation might constitute a new class of potent antiviral agents, as was recently also shown for HIV capsid inhibitors.	[Kota, Smitha; Takahashi, Virginia; Strosberg, A. Donny] Scripps Res Inst, Dept Infectol, Jupiter, FL 33458 USA; [Strosberg, A. Donny] Univ Paris 07, CNRS, Paris, France; [Strosberg, A. Donny] Inst Cochin, INSERM, Paris, France; [Ni, Feng; Snyder, John K.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Boston University	Kota, S (corresponding author), Scripps Res Inst, Dept Infectol, Jupiter, FL 33458 USA.	strosber@scripps.edu			TSRI; Factor Foundation (Florida); NIH [1R21NS066411, RNS073933A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066411] Funding Source: NIH RePORTER	TSRI; Factor Foundation (Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by start-up funds from TSRI, by a donation from The Factor Foundation (Florida), and by NIH grants 1R21NS066411 and RNS073933A (to ADS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Courcambeck J, 2006, ANTIVIR THER, V11, P847; Cristina J, 2007, VIRUS RES, V127, P185, DOI 10.1016/j.virusres.2007.02.023; Curreli F, 2011, BIOORGAN MED CHEM, V19, P77, DOI 10.1016/j.bmc.2010.11.045; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Fader LD, 2011, BIOORG MED CHEM LETT, V21, P398, DOI 10.1016/j.bmcl.2010.10.131; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gentile I, 2010, EXPERT OPIN INV DRUG, V19, P151, DOI 10.1517/13543780903501505; Klein KC, 2005, J VIROL, V79, P6814, DOI 10.1128/JVI.79.11.6814-6826.2005; Kota S, 2009, J GEN VIROL, V90, P1319, DOI 10.1099/vir.0.008565-0; Kota S, 2010, ASSAY DRUG DEV TECHN, V8, P96, DOI 10.1089/adt.2009.0217; Lalezari J, 2013, ANTIVIRAL ACTIVITY P; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Meurs EF, 2007, WORLD J GASTROENTERO, V13, P2446, DOI 10.3748/wjg.v13.i17.2446; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Ni F, 2011, BIOORG MED CHEM LETT, V21, P2198, DOI 10.1016/j.bmcl.2011.03.014; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Peppard J, 2003, J BIOMOL SCREEN, V8, P149, DOI 10.1177/1087057103252308; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prevelige PE, 2011, J MOL BIOL, V410, P634, DOI 10.1016/j.jmb.2011.03.074; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P451, DOI 10.1016/j.bmcl.2008.11.048; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang PY, 2009, J ORG CHEM, V74, P6819, DOI 10.1021/jo901345j; Wei WG, 2009, BIOORG MED CHEM LETT, V19, P6926, DOI 10.1016/j.bmcl.2009.10.070; Zhang HT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-28; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zlotnick A, 2002, J VIROL, V76, P4848, DOI 10.1128/JVI.76.10.4848-4854.2002	45	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32207	10.1371/journal.pone.0032207	http://dx.doi.org/10.1371/journal.pone.0032207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389688	gold, Green Submitted, Green Published			2022-12-25	WOS:000302999600026
J	Sun, J; Liu, SF; Zhang, CS; Yu, LN; Bi, J; Zhu, F; Yang, QL				Sun, Jie; Liu, Shao-fang; Zhang, Chu-shu; Yu, Li-na; Bi, Jie; Zhu, Feng; Yang, Qing-li			Chemical Composition and Antioxidant Activities of Broussonetia papyrifera Fruits	PLOS ONE			English	Article							INHIBITORS; EXTRACTS; CONSTITUENTS; PEPTIDE	Fruits of Broussonetia papyrifera from South China were analyzed for their total chemical composition, and antioxidant activities in ethanol and aqueous extracts. In the fruit of this plant, the crude protein, crude fat and carbohydrates was 7.08%, 3.72% and 64.73% of dry weight, respectively. The crude protein, crude fat and carbohydrates were 15.71%, 20.51% and 36.09% of dry weight, respectively. Fatty acid and amino acid composition of the fruit were analyzed. Unsaturated fatty acid concentration was 70.6% of the total fatty acids. The percentage of the essential amino acids (EAAs) was 40.60% of the total amino acids. Furthermore, B. papyrifera fruit are rich in many mineral elements and vitamins. Total phenolic content was assessed using the Folin-Ciocalteau assay, whereas antioxidant activities were assessed by measuring the ability of the two extracts to scavenge DPPH radicals, inhibit peroxidation, and chelate ferric ions. Their reducing power was also assessed. Results indicated that the aqueous extract of B. papyrifera was a more potent reducing agent and radical-scavenger than the ethanol extract. GC-MS analysis of the ethanol extract showed the presence of some acid-containing compounds. The changes in total phenolic content and antioxidant capacity in B. papyrifera from four different regions grown under normal conditions were assessed. The antioxidant activity of different extracts was positively associated with their total phenolic content. These results suggest that the fruit of B. papyrifera could be used in dietary supplement preparations, or as a food additive, for nutritional gain, or to prevent oxidation in food products.	[Sun, Jie; Liu, Shao-fang; Zhang, Chu-shu; Yu, Li-na; Bi, Jie; Zhu, Feng; Yang, Qing-li] Shandong Peanut Res Inst, Qingdao, Peoples R China		Sun, J (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	rice407@sohu.com			National Natural Science Foundation of China [31100205, 31000728]; China Agriculture Research System [CARS- 14]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Qingdao Municipal Science and Technology Plan Project [11-2-3-26-nsh, 11-2-4-9-(3)-jch]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Natural Science Fund of Shangdong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from the National Natural Science Foundation of China (31100205; 31000728), the China Agriculture Research System (CARS- 14), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), Qingdao Municipal Science and Technology Plan Project (11-2-3-26-nsh; 11-2-4-9-(3)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalbasit AM, 2009, J AM OIL CHEM SOC, V86, P749; Abdalbasit AM, 2009, J AM OIL CHEM SOC, V86, P1181; [Anonymous], 1993, OFF METH REC PRACT; [Anonymous], 1995, OFFICIAL METHODS ANA; BALZ M, 1992, FETT WISS TECHNOL, V94, P209, DOI 10.1002/lipi.19920940604; Chen RM, 2002, BIOORG MED CHEM LETT, V12, P3387, DOI 10.1016/S0960-894X(02)00757-6; Chen XH, 2010, J AGR FOOD CHEM, V58, P6966, DOI 10.1021/jf1011775; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; El-Adawy TA, 2001, FOOD CHEM, V74, P47, DOI 10.1016/S0308-8146(00)00337-X; Emma MM, 1994, FOOD CHEM, V51, P125; Ensminger M.E., 1990, FEEDS NUTR DIGEST, Vsecond; Esenowo G, 2002, J FOOD SCI TECHNOLOG, V39, P435; FAO/WHO, 1990, PROT QUAL EV, P23; Farvin KHS, 2010, FOOD CHEM, V123, P1081, DOI 10.1016/j.foodchem.2010.05.067; Hu XR, 2011, ELECTROCHIM ACTA, V56, P2919, DOI 10.1016/j.electacta.2010.12.086; IRENE D, 2008, FOOD CHEM, V107, P613; Jose M, 2008, PHYTOCHEMISTRY, V69, P451; Ko FN, 1998, FREE RADICAL BIO MED, V25, P160, DOI 10.1016/S0891-5849(98)00031-8; Ko HH, 1997, J NAT PROD, V60, P1008, DOI 10.1021/np970186o; Kumaran A, 2007, FITOTERAPIA, V78, P46, DOI 10.1016/j.fitote.2006.09.031; Lee D, 2001, J NAT PROD, V64, P1286, DOI 10.1021/np010288l; Lin CN, 1996, J NAT PROD, V59, P834, DOI 10.1021/np960376j; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P3365, DOI 10.1016/j.biortech.2007.08.018; Rajapakse N, 2005, FOOD RES INT, V38, P175, DOI 10.1016/j.foodres.2004.10.002; Razali N, 2008, FOOD CHEM, V111, P38, DOI 10.1016/j.foodchem.2008.03.024; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Son KH, 2001, FITOTERAPIA, V72, P456, DOI 10.1016/S0367-326X(00)00329-4; Tuberoso CIG, 2007, FOOD CHEM, V101, P806, DOI 10.1016/j.foodchem.2006.02.039; Tuberoso CIG, 2010, FOOD CHEM, V123, P1242, DOI 10.1016/j.foodchem.2010.05.094; You LJ, 2011, FOOD CHEM, V124, P188, DOI 10.1016/j.foodchem.2010.06.007	31	12	16	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32021	10.1371/journal.pone.0032021	http://dx.doi.org/10.1371/journal.pone.0032021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389678	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600016
J	Victor, KG; Rady, JM; Cross, JV; Templeton, DJ				Victor, Ken G.; Rady, Joshua M.; Cross, Janet V.; Templeton, Dennis J.			Proteomic Profile of Reversible Protein Oxidation Using PROP, Purification of Reversibly Oxidized Proteins	PLOS ONE			English	Article							TYROSINE PHOSPHATASES; HYDROGEN-PEROXIDE; IDENTIFICATION; INACTIVATION; QUANTITATION; ACTIVATION	Signal transduction pathways that are modulated by thiol oxidation events are beginning to be uncovered, but these discoveries are limited by the availability of relatively few analytical methods to examine protein oxidation compared to other signaling events such as protein phosphorylation. We report here the coupling of PROP, a method to purify reversibly oxidized proteins, with the proteomic identification of the purified mixture using mass spectrometry. A gene ontology (GO), KEGG enrichment and Wikipathways analysis of the identified proteins indicated a significant enrichment in proteins associated with both translation and mRNA splicing. This methodology also enabled the identification of some of the specific cysteine residue targets within identified proteins that are reversibly oxidized by hydrogen peroxide treatment of intact cells. From these identifications, we determined a potential consensus sequence motif associated with oxidized cysteine residues. Furthermore, because we identified proteins and specific sites of oxidation from both abundant proteins and from far less abundant signaling proteins (e. g. hepatoma derived growth factor, prostaglandin E synthase 3), the results suggest that the PROP procedure was efficient. Thus, this PROP-proteomics methodology offers a sensitive means to identify biologically relevant redox signaling events that occur within intact cells.	[Victor, Ken G.; Rady, Joshua M.; Cross, Janet V.; Templeton, Dennis J.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Victor, KG (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	kgv7g@virginia.edu; dtempleton@virginia.edu	Cross, Janet V/F-8276-2011; Templeton, Dennis J/F-7695-2011	Rady, Joshua/0000-0002-7806-136X	National Institutes of Health, NCI [CA126101]; NATIONAL CANCER INSTITUTE [R01CA126101] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA126101, part of the Clinical Proteomics Technologies in Cancer program of the NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell J, 2005, NAT BIOTECHNOL, V23, P42, DOI 10.1038/nbt0105-42; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Chu F, 2003, CARCINOGENESIS, V24, P317, DOI 10.1093/carcin/24.2.317; Collier TS, 2010, ANAL CHEM, V82, P8696, DOI 10.1021/ac101978b; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Hagglund P, 2008, J PROTEOME RES, V7, P5270, DOI 10.1021/pr800633y; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lyons CE, 2011, ANAL CHEM, V83, P856, DOI 10.1021/ac102461e; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Sethuraman M, 2004, MOL CELL PROTEOMICS, V3, P273, DOI 10.1074/mcp.T300011-MCP200; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Usaite R, 2008, J PROTEOME RES, V7, P266, DOI 10.1021/pr700580m; Victor KG, 2010, J AM SOC MASS SPECTR, V21, P80, DOI 10.1016/j.jasms.2009.09.007; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamaoka K, 1996, J BIOCHEM-TOKYO, V119, P878; Zander T, 1998, METHOD ENZYMOL, V290, P59, DOI 10.1016/S0076-6879(98)90007-6; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32527	10.1371/journal.pone.0032527	http://dx.doi.org/10.1371/journal.pone.0032527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389707	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600045
J	Cheng, CP; Lee, PF; Liu, WC; Wu, IC; Chin, CY; Chang, TT; Tseng, VS				Cheng, Chun-Pei; Lee, Pei-Fen; Liu, Wen-Chun; Wu, I-Chin; Chin, Chu-Yu; Chang, Ting-Tsung; Tseng, Vincent S.			Analysis of Precore/Core Covariances Associated with Viral Kinetics and Genotypes in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients	PLOS ONE			English	Article							VIRUS CORE GENE; HEPATOCELLULAR-CARCINOMA; MOLECULAR EPIDEMIOLOGY; NATURAL COURSE; LIVER-DISEASE; MUTATIONS; RISK; IMMUNOLOGY; MANAGEMENT; INFECTION	Hepatitis B virus (HBV) is one of the most common DNA viruses that can cause aggressive hepatitis, cirrhosis and hepatocellular carcinoma. Although many people are persistently infected with HBV, the kinetics in serum levels of viral loads and the host immune responses vary from person to person. HBV precore/core open reading frame (ORF) encoding proteins, hepatitis B e antigen (HBeAg) and core antigen (HBcAg), are two indicators of active viral replication. The aim of this study was to discover a variety of amino acid covariances in responses to viral kinetics, seroconversion and genotypes during the course of HBV infection. A one year follow-up study was conducted with a total number of 1,694 clones from 23 HBeAg-positive chronic hepatitis B patients. Serum alanine aminotransferase, HBV DNA and HBeAg levels were measured monthly as criteria for clustering patients into several different subgroups. Monthly derived multiple precore/core ORFs were directly sequenced and translated into amino acid sequences. For each subgroup, time-dependent covariances were identified from their time-varying sequences over the entire follow-up period. The fluctuating, wavering, HBeAg-nonseroconversion and genotype C subgroups showed greater degrees of covariances than the stationary, declining, HBeAg-seroconversion and genotype B. Referring to literature, mutation hotspots within our identified covariances were associated with the infection process. Remarkably, hotspots were predominant in genotype C. Moreover, covariances were also identified at early stage (spanning from baseline to a peak of serum HBV DNA) in order to determine the intersections with aforementioned time-dependent covariances. Preserved covariances, namely representative covariances, of each subgroup are visually presented using a tree-based structure. Our results suggested that identified covariances were strongly associated with viral kinetics, seroconversion and genotypes. Moreover, representative covariances may benefit clinicians to prescribe a suitable treatment for patients even if they have no obvious symptoms at the early stage of HBV infection.	[Cheng, Chun-Pei; Chin, Chu-Yu; Tseng, Vincent S.] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan; [Lee, Pei-Fen; Tseng, Vincent S.] Natl Cheng Kung Univ, Inst Med Informat, Tainan 70101, Taiwan; [Liu, Wen-Chun] Ming Dao Univ, Dept Biotechnol, Changhua, Taiwan; [Wu, I-Chin; Chang, Ting-Tsung] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan; [Wu, I-Chin] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wu, I-Chin; Chang, Ting-Tsung] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; Mingdao University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Cheng, CP (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan.	tsengsm@mail.ncku.edu.tw			National Science Council (NSC) of the Republic of China (Taiwan) [NSC100-2314-B-006-073-]; National Science Council of Taiwan (R.O.C.); Advanced Biomedical ICT Research Center at the National Cheng Kung University	National Science Council (NSC) of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan (R.O.C.)(Ministry of Science and Technology, Taiwan); Advanced Biomedical ICT Research Center at the National Cheng Kung University	The authors would like to thank the National Science Council (NSC, http://web1.nsc.gov.tw/mp.aspx?mp=7) of the Republic of China (Taiwan) for financial support of this research under contract number "NSC100-2314-B-006-073-". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Science Council of Taiwan (R.O.C.) and the Advanced Biomedical ICT Research Center at the National Cheng Kung University. We would also like to thank the collaboration from research fellow Dr. Mi-Hua Tao in the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (R.O.C.).	AKARCA US, 1995, HEPATOLOGY, V22, P50, DOI 10.1002/hep.1840220109; Alexopoulou A, 2009, J MED VIROL, V81, P34, DOI 10.1002/jmv.21337; Asim M, 2010, J MED VIROL, V82, P1115, DOI 10.1002/jmv.21774; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bozkaya H, 1996, HEPATOLOGY, V24, P32, DOI 10.1053/jhep.1996.v24.pm0008707278; Chan HLY, 2009, CLIN GASTROENTEROL H, V7, P1361, DOI 10.1016/j.cgh.2009.08.004; Chan HLY, 2003, J CLIN MICROBIOL, V41, P1277, DOI 10.1128/JCM.41.3.1277-1279.2003; Chang S, 2010, MINING MUTATION CHAI, P473; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; CHUANG WL, 1993, GASTROENTEROLOGY, V104, P263, DOI 10.1016/0016-5085(93)90861-6; Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060; EHATA T, 1992, J CLIN INVEST, V89, P332, DOI 10.1172/JCI115581; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Frenkel-Morgenstern M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S6; GOWANS EJ, 1985, INTERVIROLOGY, V24, P220, DOI 10.1159/000149646; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; HOSONO S, 1995, VIROLOGY, V212, P151, DOI 10.1006/viro.1995.1463; HSU HC, 1987, J HEPATOL, V5, P45, DOI 10.1016/S0168-8278(87)80060-0; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kao JH, 2007, HEPATOL INT, V1, P415, DOI 10.1007/s12072-007-9033-2; Kim H, 2007, J MICROBIOL BIOTECHN, V17, P701; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Krishnan SM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001072; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Liu WC, 2006, J CLIN MICROBIOL, V44, P4491, DOI 10.1128/JCM.01375-06; Liu Z, 2005, J VIRAL HEPATITIS, V12, P146, DOI 10.1111/j.1365-2893.2005.00552.x; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Luciani F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000565; Luo K X, 1994, Zhonghua Nei Ke Za Zhi, V33, P763; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; MISSALE G, 1993, J EXP MED, V177, P751, DOI 10.1084/jem.177.3.751; Mohamadkhani A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-209; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; PENNA A, 1992, ARCH VIROL, P23; Pumpens P, 2002, INTERVIROLOGY, V45, P218, DOI 10.1159/000067915; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Shinkai N, 2007, J CLIN MICROBIOL, V45, P3191, DOI 10.1128/JCM.00411-07; Thakur V, 2003, J MED VIROL, V70, P520, DOI 10.1002/jmv.10426; Tsai Sun-Lung, 1994, Journal of Biomedical Science, V1, P105, DOI 10.1007/BF02257984; Wang Yaoyu E, 2006, Genome Inform, V17, P23; Wu IC, 2007, J MED VIROL, V79, P663, DOI 10.1002/jmv.20822; Xu Z, 2010, J GASTROENTEROL; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yuen MF, 2007, J VIRAL HEPATITIS, V14, P269, DOI 10.1111/j.1365-2893.2006.00799.x	51	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32553	10.1371/journal.pone.0032553	http://dx.doi.org/10.1371/journal.pone.0032553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384271	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500099
J	Ribeiro, PL; Camacho, A; Navas, CA				Ribeiro, Pedro Leite; Camacho, Agustin; Navas, Carlos Arturo			Considerations for Assessing Maximum Critical Temperatures in Small Ectothermic Animals: Insights from Leaf-Cutting Ants	PLOS ONE			English	Article							CRITICAL THERMAL LIMITS; HEAT-SHOCK PROTEINS; CLIMATE-CHANGE; GEOGRAPHIC-VARIATION; SPECIES RESPONSES; TOLERANCE; ACCLIMATION; ADAPTATION; EVOLUTIONARY; DROSOPHILA	The thermal limits of individual animals were originally proposed as a link between animal physiology and thermal ecology. Although this link is valid in theory, the evaluation of physiological tolerances involves some problems that are the focus of this study. One rationale was that heating rates shall influence upper critical limits, so that ecological thermal limits need to consider experimental heating rates. In addition, if thermal limits are not surpassed in experiments, subsequent tests of the same individual should yield similar results or produce evidence of hardening. Finally, several non-controlled variables such as time under experimental conditions and procedures may affect results. To analyze these issues we conducted an integrative study of upper critical temperatures in a single species, the ant Atta sexdens rubropiosa, an animal model providing large numbers of individuals of diverse sizes but similar genetic makeup. Our specific aims were to test the 1) influence of heating rates in the experimental evaluation of upper critical temperature, 2) assumptions of absence of physical damage and reproducibility, and 3) sources of variance often overlooked in the thermal-limits literature; and 4) to introduce some experimental approaches that may help researchers to separate physiological and methodological issues. The upper thermal limits were influenced by both heating rates and body mass. In the latter case, the effect was physiological rather than methodological. The critical temperature decreased during subsequent tests performed on the same individual ants, even one week after the initial test. Accordingly, upper thermal limits may have been overestimated by our (and typical) protocols. Heating rates, body mass, procedures independent of temperature and other variables may affect the estimation of upper critical temperatures. Therefore, based on our data, we offer suggestions to enhance the quality of measurements, and offer recommendations to authors aiming to compile and analyze databases from the literature.	[Ribeiro, Pedro Leite; Camacho, Agustin; Navas, Carlos Arturo] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Ribeiro, PL (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	pedrolribeiro@gmail.com	Navas, Carlos/B-2138-2013; Camacho, Agustín/AAA-7104-2021	Navas, Carlos/0000-0002-9859-0568; Camacho, Agustín/0000-0003-2978-792X	State of Sao Paulo Science Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP) [08/57687-0, 2009/54235-3]	State of Sao Paulo Science Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the State of Sao Paulo Science Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP - 08/57687-0 and 2009/54235-3; URL: http://www.fapesp.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000258; Angilletta MJ, THERMAL ADAPTATION; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; BRATTSTROM BH, 1963, ECOLOGY, V44, P238, DOI 10.2307/1932171; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Cowles Raymond Bridgman, 1944, BULL AMER MUS NAT HIST, V83, P261; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Duarte H, 2011, GLOBAL CHANGE BIOL; Edgerly JS, 2005, FUNCT ECOL, V19, P255, DOI 10.1111/j.1365-2435.2005.00957.x; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Eme J, 2011, J EXP MAR BIOL ECOL, V399, P35, DOI 10.1016/j.jembe.2011.01.009; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Folk DG, 2007, J EXP BIOL, V210, P2649, DOI 10.1242/jeb.003350; Garbuz DG, 2008, MOL ECOL, V17, P4763, DOI 10.1111/j.1365-294X.2008.03947.x; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Gonzalez RA, 2010, J THERM BIOL, V35, P218, DOI 10.1016/j.jtherbio.2010.05.004; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; HEATWOLE H, 1968, COMP BIOCHEM PHYSIOL, V27, P807, DOI 10.1016/0010-406X(68)90620-8; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holldobler B., 1990, pi; Hopkin RS, 2006, J EXP MAR BIOL ECOL, V331, P74, DOI 10.1016/j.jembe.2005.10.007; Huang SP, 2008, J THERM BIOL, V33, P48, DOI 10.1016/j.jtherbio.2007.09.007; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Jumbam KR, 2008, POLAR BIOL, V31, P215, DOI 10.1007/s00300-007-0349-0; Jumbam KR, 2008, J INSECT PHYSIOL, V54, P1008, DOI 10.1016/j.jinsphys.2008.03.011; KIVIVUORI L, 1990, ANN ZOOL FENN, V27, P287; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; Kumlu M, 2010, J THERM BIOL, V35, P305, DOI 10.1016/j.jtherbio.2010.06.009; Lighton JRB, 2004, J EXP BIOL, V207, P1903, DOI 10.1242/jeb.00970; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1553, DOI 10.1139/z97-782; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Manly BFJ, 1997, RANDOMIZATION BOOTST; Marshall DJ, 2010, BIOL LETTERS, V6, P669, DOI 10.1098/rsbl.2010.0233; Martins EG, 2011, GLOBAL CHANGE BIOL, V17, P99, DOI 10.1111/j.1365-2486.2010.02241.x; Mercader RJ, 2008, ECOL ENTOMOL, V33, P537, DOI 10.1111/j.1365-2311.2008.01001.x; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Mora C, 2006, J THERM BIOL, V31, P337, DOI 10.1016/j.jtherbio.2006.01.005; Navas CA, 2007, COMP BIOCHEM PHYS A, V147, P647, DOI 10.1016/j.cbpa.2006.04.035; Nyamukondiwa C, 2010, PHYSIOL ENTOMOL, V35, P255, DOI 10.1111/j.1365-3032.2010.00736.x; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, POLAR BIOL, V29, P688, DOI 10.1007/s00300-005-0106-1; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Rensing L, 1996, CHRONOBIOL INT, V13, P239, DOI 10.3109/07420529609020904; Rensing L, 1997, CHRONOBIOL INT, V14, P481, DOI 10.3109/07420529709001470; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Santos M, 2011, FUNCT ECOL, V25, P1169, DOI 10.1111/j.1365-2435.2011.01908.x; Sarma K, 2010, FISH PHYSIOL BIOCHEM, V36, P85, DOI 10.1007/s10695-008-9293-3; Seebacher F, 2011, J EXP BIOL, V214, P1437, DOI 10.1242/jeb.053124; Sgro CM, 2010, J EVOLUTION BIOL, V23, P2484, DOI 10.1111/j.1420-9101.2010.02110.x; Sherman E, 2003, J THERM BIOL, V28, P373, DOI 10.1016/S0306-4565(03)00014-7; Silva A, 2003, J INSECT PHYSIOL, V49, P307, DOI 10.1016/S0022-1910(03)00004-0; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stenseng E, 2005, BIOL BULL-US, V208, P138, DOI 10.2307/3593122; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Stillman JH, 2005, INT CONGR SER, P267; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2006, AM J TROP MED HYG, V74, P786, DOI 10.4269/ajtmh.2006.74.786; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; WILLHITE C, 1982, COMP BIOCHEM PHYS A, V72, P255, DOI 10.1016/0300-9629(82)90042-1; Yoder JA, 2006, INT J ACAROL, V32, P417, DOI 10.1080/01647950608684490	78	85	86	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32083	10.1371/journal.pone.0032083	http://dx.doi.org/10.1371/journal.pone.0032083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384147	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800023
J	Hunnicutt, BJ; Chaverra, M; George, L; Lefcort, F				Hunnicutt, Barbara J.; Chaverra, Marta; George, Lynn; Lefcort, Frances			IKAP/Elp1 Is Required In Vivo for Neurogenesis and Neuronal Survival, but Not for Neural Crest Migration	PLOS ONE			English	Article							DORSAL ROOT-GANGLIA; FAMILIAL DYSAUTONOMIA; ELONGATOR COMPLEX; MOUSE IKBKAP; DIFFERENTIATION; EXPRESSION; PROTEIN; GENES; CELLS; PROLIFERATION	Familial Dysautonomia (FD; Hereditary Sensory Autonomic Neuropathy; HSAN III) manifests from a failure in development of the peripheral sensory and autonomic nervous systems. The disease results from a point mutation in the IKBKAP gene, which encodes the IKAP protein, whose function is still unresolved in the developing nervous system. Since the neurons most severely depleted in the disease derive from the neural crest, and in light of data identifying a role for IKAP in cell motility and migration, it has been suggested that FD results from a disruption in neural crest migration. To determine the function of IKAP during development of the nervous system, we (1) first determined the spatial-temporal pattern of IKAP expression in the developing peripheral nervous system, from the onset of neural crest migration through the period of programmed cell death in the dorsal root ganglia, and (2) using RNAi, reduced expression of IKBKAP mRNA in the neural crest lineage throughout the process of dorsal root ganglia (DRG) development in chick embryos in ovo. Here we demonstrate that IKAP is not expressed by neural crest cells and instead is expressed as neurons differentiate both in the CNS and PNS, thus the devastation of the PNS in FD could not be due to disruptions in neural crest motility or migration. In addition, we show that alterations in the levels of IKAP, through both gain and loss of function studies, perturbs neuronal polarity, neuronal differentiation and survival. Thus IKAP plays pleiotropic roles in both the peripheral and central nervous systems.	[Hunnicutt, Barbara J.; Chaverra, Marta; George, Lynn; Lefcort, Frances] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Hunnicutt, BJ (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	lefcort@montana.edu		George, Lynn/0000-0002-8125-2319	NIH-NINDS [NS35714]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035714, R29NS035714] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH-NINDS NS35714. This grant paid the salary for every author on this study and for the reagents used for the experiments summarized here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2006, CLIN AUTON RES, V16, P90, DOI 10.1007/s10286-006-0326-7; Boone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015590; CARR VM, 1978, J COMP NEUROL, V182, P727; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Dietrich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027015; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; George L, 2010, J COMP NEUROL, V518, P405, DOI 10.1002/cne.22248; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hapner SJ, 2006, DEV BIOL, V297, P182, DOI 10.1016/j.ydbio.2006.05.007; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Keren H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015884; LAHAT E, 1992, DEV MED CHILD NEUROL, V34, P690; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; Le Douarin N.M., 1982, NEURAL CREST; Le Douarin NM, 1998, NEURAL CREST; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; MAHLOUDJI M, 1970, J NEUROL SCI, V11, P383, DOI 10.1016/0022-510X(70)90083-3; MCKUSICK VA, 1967, ISRAEL J MED SCI, V3, P372; Mezey E, 2003, BRAIN RES, V983, P209, DOI 10.1016/S0006-8993(03)03090-7; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Naumanen T, 2008, CELL ADHES MIGR, V2, P236, DOI 10.4161/cam.2.4.6630; Nelissen H, 2005, P NATL ACAD SCI USA, V102, P7754, DOI 10.1073/pnas.0502600102; Nelson BR, 2004, DEV DYNAM, V229, P618, DOI 10.1002/dvdy.20030; Nguyen L, 2010, TRENDS MOL MED, V16, P1, DOI 10.1016/j.molmed.2009.11.002; Nielsen KM, 2004, MOL CELL NEUROSCI, V25, P629, DOI 10.1016/j.mcn.2003.12.004; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Park KS, 2010, DEVELOPMENT, V137, P2691, DOI 10.1242/dev.050096; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; RILEY C M, 1957, Adv Pediatr, V9, P157; Shafikhani SH, 2008, CELL CYCLE, V7, P2868, DOI 10.4161/cc.7.18.6674; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; TOSNEY KW, 1978, DEV BIOL, V62, P317, DOI 10.1016/0012-1606(78)90219-1; Weston J A, 1970, Adv Morphog, V8, P41	52	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32050	10.1371/journal.pone.0032050	http://dx.doi.org/10.1371/journal.pone.0032050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384137	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100048
J	Kikuchi, O; Kobayashi, M; Amano, K; Sasaki, T; Kitazumi, T; Kim, HJ; Lee, YS; Yokota-Hashimoto, H; Kitamura, YI; Kitamura, T				Kikuchi, Osamu; Kobayashi, Masaki; Amano, Kosuke; Sasaki, Tsutomu; Kitazumi, Tomoya; Kim, Hye-Jin; Lee, Yong-Soo; Yokota-Hashimoto, Hiromi; Kitamura, Yukari-Ido; Kitamura, Tadahiro			FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO1; BETA-CELL GROWTH; INSULIN-RECEPTOR; FACTOR-A; MICE; DIFFERENTIATION; RESISTANCE; PATHWAY; REVASCULARIZATION; VASCULARIZATION	Genetic studies revealed that the ablation of insulin/IGF-1 signaling in the pancreas causes diabetes. FoxO1 is a downstream transcription factor of insulin/IGF-1 signaling. We previously reported that FoxO1 haploinsufficiency restored beta cell mass and rescued diabetes in IRS2 knockout mice. However, it is still unclear whether FoxO1 dysregulation in the pancreas could be the cause of diabetes. To test this hypothesis, we generated transgenic mice overexpressing constitutively active FoxO1 specifically in the pancreas (TG). TG mice had impaired glucose tolerance and some of them indeed developed diabetes due to the reduction of beta cell mass, which is associated with decreased Pdx1 and MafA in beta cells. We also observed increased proliferation of pancreatic duct epithelial cells in TG mice and some mice developed a polycystic pancreas as they aged. Furthermore, TG mice exhibited islet hypervascularities due to increased VEGF-A expression in beta cells. We found FoxO1 binds to the VEGF-A promoter and regulates VEGF-A transcription in beta cells. We propose that dysregulation of FoxO1 activity in the pancreas could account for the development of diabetes and pancreatic cysts.	[Kikuchi, Osamu; Kobayashi, Masaki; Amano, Kosuke; Sasaki, Tsutomu; Kitazumi, Tomoya; Kim, Hye-Jin; Lee, Yong-Soo; Yokota-Hashimoto, Hiromi; Kitamura, Yukari-Ido; Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma 371, Japan	Gunma University	Kikuchi, O (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma 371, Japan.	kitamura@gunma-u.ac.jp	Lee, Yong-Soo/AAI-7059-2020	Sasaki, Tsutomu/0000-0001-8041-1915	Naito Memorial Foundation; Pancreas Research Foundation of Japan; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Naito Memorial Foundation(Naito Memorial Foundation); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research (B) (T.K.), Naito Memorial Foundation (T.K.), Pancreas Research Foundation of Japan (T.K.), The Uehara Memorial Foundation (T.K.), and Global Centers of Excellence program (T.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Elli L, 2006, AM J GASTROENTEROL, V101, P2655, DOI 10.1111/j.1572-0241.2006.00737.x; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawamori D, 2005, J BIOL CHEM; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	31	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32249	10.1371/journal.pone.0032249	http://dx.doi.org/10.1371/journal.pone.0032249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384192	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100062
J	Kim, SU; Kim, JK; Park, YN; Han, KH				Kim, Seung Up; Kim, Ja Kyung; Park, Young Nyun; Han, Kwang-Hyub			Discordance between Liver Biopsy and FibroScan (R) in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY FIBROSCAN; STIFFNESS MEASUREMENT; ACCURACY; VARIABILITY; PERFORMANCE; CIRRHOSIS	Background: Few studies have investigated predictors of discordance between liver biopsy (LB) and liver stiffness measurement (LSM) using FibroScan (R). We assessed predictors of discordance between LB and LSM in chronic hepatitis B (CHB) and investigated the effects of necroinflammatory activity. Methods: In total, 150 patients (107 men, 43 women) were prospectively enrolled. Only LSM with >= 10 valid measurements was considered reliable. Liver fibrosis was evaluated using the Laennec system. LB specimens <15 mm in length were considered ineligible. Reference cutoff LSM values to determine discordance were calculated from our cohort (6.0 kPa for >= F2, 7.5 kPa for >= F3, and 9.4 kPa for F4). Results: A discordance, defined as a discordance of at least two stages between LB and LSM, was identified in 21 (14.0%) patients. In multivariate analyses, fibrosis stages F3-4 and F4 showed independent negative associations with discordance (P = 0.002; hazard ratio [HR], 0.073; 95% confidence interval [CI], 0.014-0.390 for F3-4 and P = 0.014; HR, 0.067; 95% CI, 0.008-0.574 for F4). LSM values were not significantly different between maximal activity grades 1-2 and 3-4 in F1 and F2 fibrosis stages, whereas LSM values were significantly higher in maximal activity grade 3-4 than 1-2 in F3 and F4 fibrosis stage (median 8.6 vs. 11.3 kPa in F3, P = 0.049; median 11.9 vs. 19.2 kPa in F4, P = 0.009). Conclusion: Advanced fibrosis stage (F3-4) or cirrhosis (F4) showed a negative correlation with discordance between LB and LSM in patients with CHB, and maximal activity grade 3-4 significantly influenced LSM values in F3 and F4.	[Kim, Seung Up; Kim, Ja Kyung; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Kim, Ja Kyung; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Ctr Chron Metab Dis, Seoul, South Korea; [Kim, Ja Kyung; Park, Young Nyun; Han, Kwang-Hyub] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Park, Young Nyun; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	young0608@yuhs.ac; gihankhys@yuhs.ac		KIM, JA KYUNG/0000-0001-5025-6846; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Young Nyun/0000-0003-0357-7967; Kim, Seung Up/0000-0002-9658-8050	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A050021]; National Research Foundation [R13-2002-054-03004-0]; Korea government (MOST)	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation; Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This study was supported by the grant of the Good Health R & D Project from the Ministry of Health, Welfare and Family Affairs, Republic of Korea (A050021) and the National Research Foundation grant (R13-2002-054-03004-0) funded by the Korea government (MOST) (to YNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chan HLY, 2009, J VIRAL HEPATITIS, V16, P36, DOI 10.1111/j.1365-2893.2008.01037.x; Cho HJ, 2011, J GASTROEN HEPATOL, V26, P492, DOI 10.1111/j.1440-1746.2010.06419.x; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Fung J, 2010, HEPATOL INT, V4, P716, DOI 10.1007/s12072-010-9189-z; Kim MY, 2011, J HEPATOL, V55, P1004, DOI 10.1016/j.jhep.2011.02.012; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2010, HEPATO-GASTROENTEROL, V57, P832; Kim SU, 2010, MAGN RESON IMAGING, V28, P802, DOI 10.1016/j.mri.2010.03.018; Kim SU, 2008, HEPATOL INT, V2, P471, DOI 10.1007/s12072-008-9091-0; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, LIVER INT, V29, P810, DOI 10.1111/j.1478-3231.2008.01894.x; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Myers RP, 2010, LIVER INT, V30, P1471, DOI 10.1111/j.1478-3231.2010.02331.x; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Wanless IR, 2002, BLOOD, V100, P1566, DOI 10.1182/blood-2002-01-0306; Wright TL, 2006, AM J GASTROENTEROL, V101, pS1, DOI 10.1111/j.1572-0241.2006.00469.x; Yun MH, 2011, J VIRAL HEPATITIS, V18, P631, DOI 10.1111/j.1365-2893.2010.01376.x	27	39	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32233	10.1371/journal.pone.0032233	http://dx.doi.org/10.1371/journal.pone.0032233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384189	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100060
J	Kaiser, TS; Heckel, DG				Kaiser, Tobias S.; Heckel, David G.			Genetic Architecture of Local Adaptation in Lunar and Diurnal Emergence Times of the Marine Midge Clunio marinus (Chironomidae, Diptera)	PLOS ONE			English	Article							DROSOPHILA CIRCADIAN CLOCK; GENOME SIZE; TIMELESS; PROTEIN; TRANSCRIPTION; MELANOGASTER; POPULATIONS; VRILLE; PERIOD; DNA	Circadian rhythms pre-adapt the physiology of most organisms to predictable daily changes in the environment. Some marine organisms also show endogenous circalunar rhythms. The genetic basis of the circalunar clock and its interaction with the circadian clock is unknown. Both clocks can be studied in the marine midge Clunio marinus (Chironomidae, Diptera), as different populations have different local adaptations in their lunar and diurnal rhythms of adult emergence, which can be analyzed by crossing experiments. We investigated the genetic basis of population variation in clock properties by constructing the first genetic linkage map for this species, and performing quantitative trait locus (QTL) analysis on variation in both lunar and diurnal timing. The genome has a genetic length of 167-193 centimorgans based on a linkage map using 344 markers, and a physical size of 95-140 megabases estimated by flow cytometry. Mapping the sex determining locus shows that females are the heterogametic sex, unlike most other Chironomidae. We identified two QTL each for lunar emergence time and diurnal emergence time. The distribution of QTL confirms a previously hypothesized genetic basis to a correlation of lunar and diurnal emergence times in natural populations. Mapping of clock genes and light receptors identified ciliary opsin 2 (cOps2) as a candidate to be involved in both lunar and diurnal timing; cryptochrome 1 (cry1) as a candidate gene for lunar timing; and two timeless (tim2, tim3) genes as candidate genes for diurnal timing. This QTL analysis of lunar rhythmicity, the first in any species, provides a unique entree into the molecular analysis of the lunar clock.	[Kaiser, Tobias S.; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	Max Planck Society	Kaiser, TS (corresponding author), Max F Perutz Labs, Vienna, Austria.	tobias.kaiser@univie.ac.at	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150; Kaiser, Tobias/0000-0002-4126-0533	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	TSK held a scholarship of the International Max Planck Research School. The study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; BASTEN CJ, 2002, QTL CARTOGRAPHER REF; BEERMANN W., 1955, BIOL ZENTRALBL, V74, P525; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fishman L, 2001, GENETICS, V159, P1701; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Gotter AL, 1999, NEURON, V24, P953, DOI 10.1016/S0896-6273(00)81042-9; Gregory TR, 2008, HEREDITY, V101, P228, DOI 10.1038/hdy.2008.49; Hardin PE, 2009, SLEEP BIOL RHYTHMS, V7, P235, DOI 10.1111/j.1479-8425.2009.00412.x; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Huang YM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001107; Kaiser TS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-49; Kaiser TS, 2010, MOL ECOL, V19, P2845, DOI 10.1111/j.1365-294X.2010.04706.x; Kaiser TS, 2009, MOL ECOL RESOUR, V9, P195, DOI 10.1111/j.1755-0998.2008.02340.x; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Korringa P, 1957, MEM GEOL SOC AM, V67, P917; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Markus MA, 2006, DNA CELL BIOL, V25, P457, DOI 10.1089/dna.2006.25.457; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.1093/biomet/80.2.267; MICHAILOVA P, 1980, ZOOL ANZ, V205, P417; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Nardon C, 2005, MOL ECOL, V14, P869, DOI 10.1111/j.1365-294X.2005.02457.x; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; NEUMANN D, 1988, J COMP PHYSIOL A, V163, P671, DOI 10.1007/BF00603851; NEUMANN D, 1967, HELGOLAND WISS MEER, V15, P163, DOI 10.1007/BF01618620; NEUMANN D, 1966, Z VERGL PHYSIOL, V53, P1, DOI 10.1007/BF00343045; NEUMANN D, 1995, NATURWISSENSCHAFTEN, V82, P310, DOI 10.1007/BF01131527; NEUMANN D, 1981, HDB BEHAVIOURAL NEUR, V4, P351; Neumann D, 1990, ATLAS PHASE RESPONSE, P715; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Sugama N, 2008, J PINEAL RES, V45, P133, DOI 10.1111/j.1600-079X.2008.00566.x; THOMPSON PE, 1971, CAN ENTOMOL, V103, P369, DOI 10.4039/Ent103369-3; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Wang S, 2012, WINDOWS QTL CARTOGRA; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	63	13	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32092	10.1371/journal.pone.0032092	http://dx.doi.org/10.1371/journal.pone.0032092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384150	Green Published, gold			2022-12-25	WOS:000302875500075
J	Qi, YC; Ma, MJ; Li, DJ; Chen, MJ; Lu, QB; Li, XJ; Li, JL; Liu, W; Cao, WC				Qi, Ying-Cheng; Ma, Mai-Juan; Li, Dong-Jun; Chen, Mei-Juan; Lu, Qing-Bin; Li, Xiu-Jun; Li, Jun-Lian; Liu, Wei; Cao, Wu-Chun			Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Multi-Ethnic Region, Xinjiang Uygur Autonomous Region, China	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; XDR TUBERCULOSIS; SOUTH-AFRICA; SHANGHAI; TB	Background: The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has emerged as a global threat. Xinjiang is a multi-ethnic region and suffered second highest incidence of TB in China. However, epidemiological information on MDR and XDR TB is scarcely investigated. Methodology/Principal Findings: A prospective study was conducted to analyze the prevalence of MDR and XDR TB and the differences of drug resistance TB between Chinese Han and other nationalities population at Chest Hospital of Xinjiang Uygur Autonomous Region, China. We performed in vitro drug susceptibility testing of Mycobacterium tuberculosis to first- and second-line anti-tuberculosis drugs for all 1893 culture confirmed positive TB cases that were diagnosed between June 2009 and June 2011. Totally 1117 (59.0%, 95% CI, 56.8%-61.2%) clinical isolates were resistant to >= 1 first-line drugs; the prevalence of MDR TB was 13.2% (95% CI, 11.7%-14.7%), of which, 77 (30.8%; 95% CI, 25.0%-36.6%) and 31 (12.8%; 95% CI, 8.6%-17.0%) isolates were pre-XDR and XDR TB respectively. Among the MDR/XDR TB, Chinese Han patients were significantly less likely to be younger with an odds ratio 0.42 for age 20-29 years and 0.52 for age 40-49 years; P-trend = 0.004), and Chinese Han patients has a lower prevalence of XDR TB (9.6%) than all the other nationality (14.9%). Conclusions/Significance: The burden of drug resistance TB cases is sizeable, which highlights an urgent need to reinforce the control, detection and treatment strategies for drug resistance TB. However, the difference of MDR and XDR TB between Chinese Han and other nationalities was not observed.	[Qi, Ying-Cheng; Chen, Mei-Juan; Li, Jun-Lian] Chest Hosp Xinjiang Uygur Autonomous Reg, Dept TB, Urumqi, Peoples R China; [Ma, Mai-Juan; Lu, Qing-Bin; Li, Xiu-Jun; Liu, Wei; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, Dept Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Dong-Jun] Red Cross Aid Ctr Urumqi, Emergency Ctr, Urumqi, Peoples R China; [Lu, Qing-Bin; Li, Xiu-Jun] Shandong Univ, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Shandong University	Qi, YC (corresponding author), Chest Hosp Xinjiang Uygur Autonomous Reg, Dept TB, Urumqi, Peoples R China.	ljunl2007@163.com; liu_weis@sohu.com; caowc@nic.bmi.ac.cn	li, xiu/GXV-1745-2022	Ma, Mai-Juan/0000-0002-8105-462X; Lu, Qing-Bin/0000-0002-2804-0827	National Science Fund for Distinguished Young Scholars [30725032]; Research Funds of academy of military medical sciences [2008ZD006]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Research Funds of academy of military medical sciences	This study was supported by the grants of National Science Fund for Distinguished Young Scholars (30725032) and Innovation Research Funds of academy of military medical sciences (2008ZD006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Blower S, 2007, LANCET INFECT DIS, V7, P443, DOI 10.1016/S1473-3099(07)70143-3; Bureau of Health XUAR, 2011, B HLTH XUAR B; Deng YF, 2011, EMERG INFECT DIS, V17, P495, DOI 10.3201/eid1703.100812; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Health CMo, 2010, NAT BAS SURV DRUG RE; Jin X, 2002, XINJIANG MED J, V32, P25; Lonnroth K, 2000, INT J TUBERC LUNG D, V4, P1052; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Murase Y, 2010, EMERG INFECT DIS, V16, P948, DOI 10.3201/eid1606.091844; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Sun ZG, 2008, J CLIN MICROBIOL, V46, P4075, DOI 10.1128/JCM.00822-08; Tang SJ, 2011, SCAND J INFECT DIS, V43, P280, DOI 10.3109/00365548.2010.548080; Tang SJ, 2011, EMERG INFECT DIS, V17, P558, DOI 10.3201/eid1703.100919; WHO, 2008, ANT DRUG RES WORLD W; WHO, 2004, WHO NEWS, V82, P716; WHO, 2011, GLOB TTUB CONTR 2010; WHO, 2007, WHOHTMTB2007376; WHO, 2006, WORLD HLTH REPORT 20; WHOStopTBPartnership, 2006, WHOHTMSTB200635; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	25	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32103	10.1371/journal.pone.0032103	http://dx.doi.org/10.1371/journal.pone.0032103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384153	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500076
J	Gaur, P; Ranjan, P; Sharma, S; Patel, JR; Bowzard, JB; Rahman, SK; Kumari, R; Gangappa, S; Katz, JM; Cox, NJ; Lal, RB; Sambhara, S; Lal, SK				Gaur, Pratibha; Ranjan, Priya; Sharma, Shipra; Patel, Jenish R.; Bowzard, J. Bradford; Rahman, Shah K.; Kumari, Rashmi; Gangappa, Shivaprakash; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash; Lal, Sunil K.			Influenza A Virus Neuraminidase Protein Enhances Cell Survival through Interaction with Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ADENOCARCINOMA CELLS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; NF-KAPPA-B; KINASE; ACTIVATION; BETA; SRC; OVEREXPRESSION; INFECTIONS; EXPRESSION	The influenza virus neuraminidase (NA) protein primarily aids in the release of progeny virions from infected cells. Here, we demonstrate a novel role for NA in enhancing host cell survival by activating the Src/Akt signaling axis via an interaction with carcinoembryonic antigen-related cell adhesion molecule 6/cluster of differentiation 66c (C6). NA/C6 interaction leads to increased tyrosyl phosphorylation of Src, FAK, Akt, GSK3 beta, and Bcl-2, which affects cell survival, proliferation, migration, differentiation, and apoptosis. siRNA-mediated suppression of C6 resulted inadown-regulation of activated Src, FAK, and Akt, increased apoptosis, and reduced expression of viral proteins and viral titers in influenza virus-infected human lung adenocarcinoma epithelial and normal human bronchial epithelial cells. These findings indicate that influenza NA not only aids in the release of progeny virions, but also cell survival during viral replication.	[Gaur, Pratibha; Sharma, Shipra; Rahman, Shah K.; Kumari, Rashmi; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India; [Ranjan, Priya; Patel, Jenish R.; Bowzard, J. Bradford; Gangappa, Shivaprakash; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30033 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Centers for Disease Control & Prevention - USA	Lal, SK (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	sunillal@icgeb.res.in	Sambhara, Suryaprakash/AAC-4428-2021; Gaur, Pratibha/AGE-6421-2022	Gaur, Pratibha/0000-0002-3155-5944; Rahman, Shah Kamranur/0000-0002-8835-7092; Patel, Jenish/0000-0001-5310-8160	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi; Department of Biotechnology, India; Centers for Disease Control (CDC), Atlanta	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Centers for Disease Control (CDC), Atlanta	This work was supported by internal funds from the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, a research grant from the Department of Biotechnology, India (to S. K. L.), and a training and research grant from the Centers for Disease Control (CDC), Atlanta (to S. K. L.).	Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Autret A, 2008, J VIROL, V82, P3796, DOI 10.1128/JVI.02020-07; Bhatia A, 2007, CELL MOL BIOL LETT, V12, P111, DOI 10.2478/s11658-006-0055-x; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; DUCKER TP, 1992, J LEUKOCYTE BIOL, V52, P11, DOI 10.1002/jlb.52.1.11; Duxbury MS, 2004, ONCOGENE, V23, P5834, DOI 10.1038/sj.onc.1207775; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, J BIOL CHEM, V279, P23176, DOI 10.1074/jbc.M402051200; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Gaur P, 2011, MED SCI MONITOR, V17, pRA148, DOI 10.12659/MSM.881801; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hartshorn KL, 1999, J LEUKOCYTE BIOL, V65, P614, DOI 10.1002/jlb.65.5.614; HOUDE M, 1990, CELL IMMUNOL, V129, P104, DOI 10.1016/0008-8749(90)90190-3; Kasahara K, 2002, NEUROCHEM RES, V27, P823, DOI 10.1023/A:1020265225916; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kumar P, 2007, VIROLOGY, V366, P293, DOI 10.1016/j.virol.2007.04.029; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Miller JL, 2003, J GEN VIROL, V84, P193, DOI 10.1099/vir.0.18590-0; Mizutani T, 2004, VIROLOGY, V327, P169, DOI 10.1016/j.virol.2004.07.005; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Ratra R, 2009, J GEN VIROL, V90, P1359, DOI 10.1099/vir.0.009274-0; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Shih WL, 2003, J BIOL CHEM, V278, P31807, DOI 10.1074/jbc.M302580200; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316	35	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15109	15117		10.1074/jbc.M111.328070	http://dx.doi.org/10.1074/jbc.M111.328070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396546	Green Published, hybrid			2022-12-25	WOS:000304003200072
J	Martin, TD; Mitin, N; Cox, AD; Yeh, JJ; Der, CJ				Martin, Timothy D.; Mitin, Natalia; Cox, Adrienne D.; Yeh, Jen Jen; Der, Channing J.			Phosphorylation by Protein Kinase C alpha Regulates RalB Small GTPase Protein Activation, Subcellular Localization, and Effector Utilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELLS; PLASMA-MEMBRANE; EXOCYST; TRAFFICKING; CANCER; RAIA; RAS; IDENTIFICATION; CYTOKINESIS; EXOCYTOSIS	Ras-like (Ral) small GTPases are regulated downstream of Ras and the noncanonical Ral guanine nucleotide exchange factor (RalGEF) effector pathway. Despite RalA and RalB sharing 82% sequence identity and utilization of shared effector proteins, their roles in normal and neoplastic cell growth have been shown to be highly distinct. Here, we determined that RalB function is regulated by protein kinase C alpha (PKC alpha) phosphorylation. We found that RalB phosphorylation on Ser-198 in the C-terminal membrane targeting sequence resulted in enhanced RalB endomembrane accumulation and decreased RalB association with its effector, the exocyst component Sec5. Additionally, RalB phosphorylation regulated vesicular trafficking and membrane fusion by regulating v-and t-SNARE interactions. RalB phosphorylation regulated vesicular traffic of alpha 5-integrin to the cell surface and cell attachment to fibronectin. In summary, our data suggest that phosphorylation by PKC alpha is critical for RalB-mediated vesicle trafficking and exocytosis.	[Mitin, Natalia; Cox, Adrienne D.; Yeh, Jen Jen; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Martin, Timothy D.; Cox, Adrienne D.; Yeh, Jen Jen; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Mitin, Natalia/E-8043-2012	Cox, Adrienne D./0000-0002-4901-2454; Der, Channing/0000-0002-7751-2747	National Institutes of Health [R01 CA042978, P50 CA106991, R01 CA109550]; NATIONAL CANCER INSTITUTE [R01CA140424, P50CA106991, R01CA109550, R01CA042978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA042978 and P50 CA106991 (to C. J. D.) and R01 CA109550 (to A. D. C.).	Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Brown FC, 2010, MOL MEMBR BIOL, V27, P457, DOI 10.3109/09687688.2010.501765; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200	31	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14827	14836		10.1074/jbc.M112.344986	http://dx.doi.org/10.1074/jbc.M112.344986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393054	hybrid, Green Published			2022-12-25	WOS:000304003200047
J	Braschler, B; Chown, SL; Gaston, KJ				Braschler, Brigitte; Chown, Steven L.; Gaston, Kevin J.			The Fynbos and Succulent Karoo Biomes Do Not Have Exceptional Local Ant Richness	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; INSECT DIVERSITY; LEAFHOPPERS HOMOPTERA; CAPE FYNBOS; GRADIENTS; CLIMATE; ENERGY; SCALE; ASSEMBLAGES	Background: The Fynbos (FB) and Succulent Karoo biomes (SKB) have high regional plant diversity despite relatively low productivity. Local diversity in the region varies but is moderate. For insects, previous work suggests that strict phytophages, but not other taxa, may have high regional richness. However, what has yet to be investigated is whether the local insect species richness of FB and SKB is unusual for a region of this productivity level at this latitude, and whether regional richness is also high. Here we determine whether this is the case for ants. Methodology/Principal Findings: We use species richness data from pitfall traps in the FB and SKB in the Western Cape Province, South Africa and a global dataset of local ant richness extracted from the literature. We then relate the globally derived values of local richness to two energy-related predictors-productive energy (NDVI) and temperature, and to precipitation, and compare the data from the FB and SKB with these relationships. We further compare our local richness estimates with that of similar habitats worldwide, and regional ant richness with estimates derived from other regions. The local ant species richness of the FB and SKB falls within the general global pattern relating ant richness to energy, and is similar to that in comparable habitats elsewhere. At a regional scale, the richness of ants across all of our sites is not exceptional by comparison with other regional estimates from across the globe. Conclusions/Significance: Local richness of ants in the FB and SKB is not exceptional by global standards. Initial analyses suggest that regional diversity is also not exceptional for the group. It seems unlikely that the mechanisms which have contributed to the development of extraordinarily high regional plant diversity in these biomes have had a strong influence on the ants.	[Braschler, Brigitte; Gaston, Kevin J.] Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; [Braschler, Brigitte; Chown, Steven L.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, Matieland, South Africa	University of Sheffield; Stellenbosch University	Braschler, B (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England.	braschle@sun.ac.za	Chown, Steven L/H-3347-2011; Braschler, Brigitte/N-6953-2017; Chown, Steven/ABD-7646-2021	Chown, Steven L/0000-0001-6069-5105; Braschler, Brigitte/0000-0003-0088-3651; Gaston, Kevin J./0000-0002-7235-7928	Department of Science and Technology - National Research Foundation Centre of Excellence for Invasion Biology; UK Darwin Initiative [14-012]; AfriSam; Rand Merchant Bank	Department of Science and Technology - National Research Foundation Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); UK Darwin Initiative; AfriSam; Rand Merchant Bank	This work was financially supported by the Department of Science and Technology - National Research Foundation Centre of Excellence for Invasion Biology. The UK Darwin Initiative (Ref. 14-012/), AfriSam and the Rand Merchant Bank Fund financially contributed to the Iimbovane Outreach Project, which collected data on ant diversity in the Western Cape Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2000, P204; Bestelmeyer BT, 2001, ECOGRAPHY, V24, P381, DOI 10.1034/j.1600-0587.2001.d01-194.x; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; Braschler B, 2010, J INSECT CONSERV, V14, P19, DOI 10.1007/s10841-009-9221-6; Cerda X, 1998, OECOLOGIA, V117, P404, DOI 10.1007/s004420050674; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Colville J, 2002, BIODIVERS CONSERV, V11, P243, DOI 10.1023/A:1014520226989; Cowling R. M., 1998, Diversity and Distributions, V4, P27; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1990, J VEG SCI, V1, P699, DOI 10.2307/3235578; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P31; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P65; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Dunn Robert R., 2007, Myrmecological News, V10, P77; Ellison AM, 2007, ENVIRON ENTOMOL, V36, P766, DOI 10.1603/0046-225X(2007)36[766:RIOTAA]2.0.CO;2; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FORDER JC, 1989, INSECT SOC, V36, P106, DOI 10.1007/BF02225906; French K, 2001, AUSTRAL ECOL, V26, P303, DOI 10.1046/j.1442-9993.2001.01115.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Giliomee JH, 2003, AFR J ECOL, V41, P237, DOI 10.1046/j.1365-2028.2003.00442.x; Goldblatt P., 2000, CAPE PLANTS CONSPECT, V9; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Holldobler B., 1990, pi; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Johnson S.D., 1992, P175; Kaspari M, 2003, AM NAT, V161, P459, DOI 10.1086/367906; Kaspari M, 2004, OECOLOGIA, V140, P407, DOI 10.1007/s00442-004-1607-2; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2000, BIOTROPICA, V32, P703, DOI 10.1646/0006-3606(2000)032[0703:AAAMGI]2.0.CO;2; Keeley JE, 2003, J BIOGEOGR, V30, P1629, DOI 10.1046/j.1365-2699.2003.00950.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lach L, 2010, ANT ECOLOGY, P1; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Majer J.D., 1988, Tasks for Vegetation Science, V19, P197; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mittermeier RA, 2004, HOTSPOTS REVISITED; Mucina L., 2006, STRELITZIA, V19, P616; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; Parr CL, 2003, THESIS U PRETORIA S; Picker MD, 1996, BIODIVERS CONSERV, V5, P591, DOI 10.1007/BF00137611; Proches S, 2006, GLOBAL ECOL BIOGEOGR, V15, P445, DOI 10.1111/j.1566-822x.2006.00239.x; Proches S, 2009, MOL PHYLOGENET EVOL, V51, P94, DOI 10.1016/j.ympev.2008.05.040; Qian H, 2008, J BIOGEOGR, V35, P1362, DOI 10.1111/j.1365-2699.2008.01901.x; Robertson Hamish G., 2000, Journal of Hymenoptera Research, V9, P71; Robertson HG, 1997, AFR ENTOMOL, V5, P1; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Schlick-Steiner BC, 2008, J BIOGEOGR, V35, P2195, DOI 10.1111/j.1365-2699.2008.01968.x; Segev U, 2010, J ARID ENVIRON, V74, P646, DOI 10.1016/j.jaridenv.2009.11.001; Thomas GH, 2008, GLOBAL ECOL BIOGEOGR, V17, P340, DOI 10.1111/j.1466-8238.2008.00384.x; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Wright MG, 1999, BIODIVERS CONSERV, V8, P1089, DOI 10.1023/A:1008880618304	63	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e31463	10.1371/journal.pone.0031463	http://dx.doi.org/10.1371/journal.pone.0031463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396733	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500005
J	Brault, G; Shareck, F; Hurtubise, Y; Lepine, F; Doucet, N				Brault, Guillaume; Shareck, Francois; Hurtubise, Yves; Lepine, Francois; Doucet, Nicolas			Isolation and Characterization of EstC, a New Cold-Active Esterase from Streptomyces coelicolor A3(2)	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; GENOME SEQUENCE; BIOCHEMICAL-CHARACTERIZATION; MICROBIAL LIPASES; ADAPTED LIPASE; GENE CLONING; PURIFICATION; ENZYME; BIOSYNTHESIS; TRIACYLGLYCEROLS	The genome sequence of Streptomyces coelicolor A3(2) contains more than 50 genes coding for putative lipolytic enzymes. Many studies have shown the capacity of this actinomycete to store important reserves of intracellular triacylglycerols in nutrient depletion situations. In the present study, we used genome mining of S. coelicolor to identify genes coding for putative, non-secreted esterases/lipases. Two genes were cloned and successfully overexpressed in E. coli as His-tagged fusion proteins. One of the recombinant enzymes, EstC, showed interesting cold-active esterase activity with a strong potential for the production of valuable esters. The purified enzyme displayed optimal activity at 35 degrees C and was cold-active with retention of 25% relative activity at 10 degrees C. Its optimal pH was 8.5-9 but the enzyme kept more than 75% of its maximal activity between pH 7.5 and 10. EstC also showed remarkable tolerance over a wide range of pH values, retaining almost full residual activity between pH 6-11. The enzyme was active toward short-chain p-nitrophenyl esters (C2-C12), displaying optimal activity with the valerate (C5) ester (k(cat)/K-m = 737 +/- 77 s(-1) mM(-1)). The enzyme was also very active toward short chain triglycerides such as triacetin (C2:0) and tributyrin (C4:0), in addition to showing good primary alcohol and organic solvent tolerance, suggesting it could function as an interesting candidate for organic synthesis of short-chain esters such as flavors.	[Brault, Guillaume; Shareck, Francois; Lepine, Francois; Doucet, Nicolas] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Hurtubise, Yves] Innu Sci Canada Inc, Trois Rivieres, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Brault, G (corresponding author), Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada.	nicolas.doucet@iaf.inrs.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 402623-2011]; Innu-Science Canada; Canadian and Quebec Governments through the BMP; Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); FRQNT Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); FRQS Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Innu-Science Canada; Canadian and Quebec Governments through the BMP; Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); FRQNT Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); FRQS Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant (awarded to Dr. Shareck) and NSERC Discovery grant RGPIN 402623-2011 (awarded to Dr. Doucet), as well as private funding from Innu-Science Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following conflicts: Dr. Hurtubise is the research and development director of the commercial company Innu-Science Canada, Inc. Dr. Brault's salary is provided by a grant from the Canadian and Quebec Governments through the BMP Innovation scholarship program, aimed at fostering the development of university-industry partnerships. Dr. Brault is a PhD student in Dr. Shareck's lab at INRS, and does not commercially benefit from the publication of this manuscript. As grant recipients from the National Sciences and Engineering Research Council of Canada (NSERC), Dr. Shareck and Dr. Doucet are two academic professors involved in collaborative research projects with Dr. Hurtubise's team at Innu-Science. Dr. Shareck and Dr. Doucet are not commercially involved with Innu-Science and neither owns stocks or shares in the company. Dr. Hurtubise and Innu-Science are fully committed to the full disclosure of all results and research materials resulting from the current research. All authors proclaim that this declaration of competing interests does not alter their adherence to all the PLoS ONE policies on sharing data and materials.; The authors would like to thank Jeffrey W. Keillor (University of Ottawa) and Etienne Dube (Innu-Science Canada) for helpful discussions, as well as Innu-Science Canada for technical support. G. B. acknowledges the support of a BMP Innovation scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Fonds de Recherche du Quebec - Nature et Technologies (FRQNT). N.D. acknowledges support from the FRQNT Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO) and the FRQS Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP).	Alquati C, 2002, EUR J BIOCHEM, V269, P3321, DOI 10.1046/j.1432-1033.2002.03012.x; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Alvarez-Macarie E, 2000, J MOL CATAL B-ENZYM, V10, P377, DOI 10.1016/S1381-1177(99)00109-5; Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; ARPIGNY JL, 1993, BIOCHIM BIOPHYS ACTA, V1171, P331, DOI 10.1016/0167-4781(93)90078-R; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bielen A, 2009, BIOCHIMIE, V91, P390, DOI 10.1016/j.biochi.2008.10.018; Choo DW, 1998, APPL ENVIRON MICROB, V64, P486; Cote A, 2008, ENZYME MICROB TECH, V42, P381, DOI 10.1016/j.enzmictec.2008.01.009; De Santi C, 2010, BIOCHIMIE, V92, P949, DOI 10.1016/j.biochi.2010.04.001; Diaz P, 1999, BIOTECHNIQUES, V27, P696, DOI 10.2144/99274bm14; Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3; Gandolfi R, 2000, J APPL MICROBIOL, V89, P870, DOI 10.1046/j.1365-2672.2000.01194.x; Gao B, 2009, J BIOTECHNOL, V139, P169, DOI 10.1016/j.jbiotec.2008.10.004; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jeon JH, 2009, APPL MICROBIOL BIOT, V81, P865, DOI 10.1007/s00253-008-1656-2; Joseph B, 2008, BIOTECHNOL ADV, V26, P457, DOI 10.1016/j.biotechadv.2008.05.003; Kieser T., 2000, PRACTICAL STREPTOMYC, P613; Kim HK, 2004, FEMS MICROBIOL LETT, V235, P349, DOI 10.1016/j.femsle.2004.05.004; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Kulakova L, 2004, BBA-PROTEINS PROTEOM, V1696, P59, DOI 10.1016/j.bbapap.2003.09.008; Large KP, 1999, ENZYME MICROB TECH, V25, P569, DOI 10.1016/S0141-0229(99)00080-0; Lee HK, 2003, J MICROBIOL, V41, P22; Lee MY, 2002, CURR OPIN BIOTECH, V13, P376, DOI 10.1016/S0958-1669(02)00337-3; Lin XZ, 2010, POLAR RES-SWEDEN, V29, P421, DOI 10.1111/j.1751-8369.2010.00189.x; Mayordomo I, 2000, J AGR FOOD CHEM, V48, P105, DOI 10.1021/jf9903354; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; Parra LP, 2008, ENZYME MICROB TECH, V42, P371, DOI 10.1016/j.enzmictec.2007.11.003; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Popova NI, 2005, MICROBIOLOGY+, V74, P624, DOI 10.1007/s11021-005-0114-8; Rashid N, 2001, APPL ENVIRON MICROB, V67, P4064, DOI 10.1128/AEM.67.9.4064-4069.2001; Roh C, 2008, J APPL MICROBIOL, V105, P116, DOI 10.1111/j.1365-2672.2007.03717.x; Ryu HS, 2006, APPL MICROBIOL BIOT, V70, P321, DOI 10.1007/s00253-005-0058-y; Schauner C, 1999, APPL ENVIRON MICROB, V65, P2730; Sharma D, 2011, BIO-TECHNOL, V10, P23, DOI [10.3923/biotech.2011.23.40, DOI 10.3923/BI0TECH.2011.23.40, DOI 10.3923/BIOTECH.2011.23.40]; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Shim MS, 1997, BIOTECHNOL LETT, V19, P221, DOI 10.1023/A:1018345305250; Sommer P, 1997, APPL ENVIRON MICROB, V63, P3553, DOI 10.1128/AEM.63.9.3553-3560.1997; Soror SH, 2007, J IND MICROBIOL BIOT, V34, P525, DOI 10.1007/s10295-007-0224-6; Soror SH, 2009, PROTEIN ENG DES SEL, V22, P333, DOI 10.1093/protein/gzp009; SZTAJER H, 1988, ENZYME MICROB TECH, V10, P492, DOI 10.1016/0141-0229(88)90027-0; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Vujaklija D, 2002, ARCH MICROBIOL, V178, P124, DOI 10.1007/s00203-002-0430-6; Yang XX, 2008, CURR MICROBIOL, V56, P194, DOI 10.1007/s00284-007-9051-2; Zhang J, 2007, J MICROBIOL BIOTECHN, V17, P604; Zhang P, 2006, J MICROBIOL BIOTECHN, V17, P604	53	35	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32041	10.1371/journal.pone.0032041	http://dx.doi.org/10.1371/journal.pone.0032041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396747	Green Submitted, Green Published, gold			2022-12-25	WOS:000303006500011
J	Di Maio, S; Polizzotto, G; Di Gangi, E; Foresta, G; Genna, G; Verzera, A; Scacco, A; Amore, G; Oliva, D				Di Maio, Sabina; Polizzotto, Giuseppe; Di Gangi, Enrico; Foresta, Giusy; Genna, Giuseppe; Verzera, Antonella; Scacco, Antonio; Amore, Gabriele; Oliva, Daniele			Biodiversity of Indigenous Saccharomyces Populations from Old Wineries of South-Eastern Sicily (Italy): Preservation and Economic Potential	PLOS ONE			English	Article							AROMA COMPOUNDS; WHITE WINE; CEREVISIAE STRAINS; YEAST POPULATION; FERMENTATION; GRAPE; IDENTIFICATION; DIVERSITY; AREAS; FLORA	In recent years, the preservation of biodiversity has become an important issue. Despite much public discussion, however, current practices in the food industry seldom take account of its potential economic importance: on the contrary, the introduction of industrialized agriculture practices over large areas has often resulted in a dramatic reduction in biodiversity. In this paper, we report on the remarkable degree of biodiversity in the wine yeast populations naturally present in a small area of Sicily (Italy) where traditional (non-industrial) winery practices are still in place. Out of more than 900 Saccharomyces yeast isolates recovered from late spontaneous fermentations, we detected at least 209 strains. Most interestingly, when evaluated at the fermentation and technological level, a number of isolates were found to be superior to industrial yeast strains. Out of a selected group, isolates from two strains were used for experimental fermentations in a winery environment and the quality of the wines produced was assessed at the technological, quality and sensory levels. Given that the characteristics of the wines produced were found to be industrially appealing, the study demonstrated the economic potential of preserving the patrimony of Sicilian yeast biodiversity and highlighted the importance of maintaining traditional wine making practices.	[Di Maio, Sabina; Polizzotto, Giuseppe; Di Gangi, Enrico; Foresta, Giusy; Genna, Giuseppe; Scacco, Antonio; Amore, Gabriele; Oliva, Daniele] Ist Reg Vite & Vino, Palermo, Italy; [Verzera, Antonella; Scacco, Antonio; Amore, Gabriele] Univ Messina, Dipartimento Chim Organ & Biol, Messina, Italy; [Scacco, Antonio; Amore, Gabriele] Univ Catania, Dipartimento Sci Agr & Alimentari, Catania, Italy; [Amore, Gabriele] Staz Zool Anton Dohrn Napoli, Anim Physiol & Evolut Lab, Naples, Italy	University of Messina; University of Catania; Stazione Zoologica Anton Dohrn di Napoli	Di Maio, S (corresponding author), Ist Reg Vite & Vino, Palermo, Italy.	d.oliva@vitevino.it	Oliva, Daniele/E-8718-2017	Oliva, Daniele/0000-0002-1718-8906; VERZERA, Antonella/0000-0002-6162-9297	IRVV-Palermo Italy	IRVV-Palermo Italy	Support for this study was provided through an intramural funding of the IRVV-Palermo Italy. www.IRVV(www.vitevino.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, 4121 UNI ISO; [Anonymous], 2003, 10957 UNI; [Anonymous], 1977, 3591 ISO; [Anonymous], DIV DAT FING SOFTW U; [Anonymous], 2007, 8589 UNI ISO; Barnett RWP., 2001, PEDIATR DERMATOL, V18, P547, DOI [10.1046/j.1525-1470.2001.1862020a.x, DOI 10.1046/J.1525-1470.2001.1862020A.X]; Capece A, 2010, INT J FOOD MICROBIOL, V144, P187, DOI 10.1016/j.ijfoodmicro.2010.09.009; Caridi A, 2002, J GEN APPL MICROBIOL, V48, P261, DOI 10.2323/jgam.48.261; Cavazza A., 1998, VIGNEVINO, V25, P42; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Clarke R. J., 2004, WINE FLAVOR CHEM; Clavijo A, 2011, ANTON LEEUW INT J G, V99, P727, DOI 10.1007/s10482-010-9514-5; Csoma H, 2010, INT J FOOD MICROBIOL, V140, P239, DOI 10.1016/j.ijfoodmicro.2010.03.024; Csoma H, 2008, FEMS YEAST RES, V8, P328, DOI 10.1111/j.1567-1364.2007.00339.x; Dalby A., 2000, EMPIRE PLEASURES LUX; Di Maio S., 2006, ENOLOGO, V42, P93; EEC 2676, 1990, 2676 EEC; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Ganga MA, 2004, J APPL MICROBIOL, V96, P76, DOI 10.1046/j.1365-2672.2003.02080.x; Giudici P., 1992, VIGNEVINI, V9, P29; Granchi L, 1999, J APPL MICROBIOL, V87, P949, DOI 10.1046/j.1365-2672.1999.00600.x; Gump BH, 2002, AM J ENOL VITICULT, V53, P325; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; International Standard Organization, 1993, 85861 ISO; Josepa S, 2000, FEMS MICROBIOL LETT, V193, P255, DOI 10.1016/S0378-1097(00)00458-4; Kotseridis Y, 1998, AM J ENOL VITICULT, V49, P44; Legras JL, 2003, FEMS MICROBIOL LETT, V221, P249, DOI 10.1016/S0378-1097(03)00205-2; Li H, 2008, EUR FOOD RES TECHNOL, V227, P287, DOI 10.1007/s00217-007-0722-9; Lilly M, 2000, APPL ENVIRON MICROB, V66, P744, DOI 10.1128/AEM.66.2.744-753.2000; Martini A, 1993, J WINE RES, V4, P165, DOI DOI 10.1080/09571269308717966; Meral R., 2008, Trakia Journal of Sciences, V6, P57; Mercado L, 2007, FOOD MICROBIOL, V24, P403, DOI 10.1016/j.fm.2006.06.005; Mndez-Vilas A, 2010, CURRENT RES TECHNOLO; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; NESS F, 1993, J SCI FOOD AGR, V62, P89, DOI 10.1002/jsfa.2740620113; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; Oliva D., 2006, ENOLOGO, V42, P85; Pallmann CL, 2001, AM J ENOL VITICULT, V52, P198; Pastena B, 2009, CULTURE WINE SICILY; Petka J, 2006, J AGR FOOD CHEM, V54, P909, DOI 10.1021/jf0518397; Pino JA, 2011, FOOD CHEM, V125, P1141, DOI 10.1016/j.foodchem.2010.09.056; Pramateftaki PV, 2000, J APPL MICROBIOL, V89, P236, DOI 10.1046/j.1365-2672.2000.01102.x; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Ribereau-Gayon P., 1998, TRAITE OENOLOGIE; Romancino DP, 2008, J APPL MICROBIOL, V105, P2248, DOI 10.1111/j.1365-2672.2008.03894.x; Romano P., 2005, MICROBIOLOGIA VINO, P101; Romano P, 2008, WORLD J MICROB BIOT, V24, P1797, DOI 10.1007/s11274-008-9672-z; ROSI I, 1994, J APPL BACTERIOL, V77, P519, DOI 10.1111/j.1365-2672.1994.tb04396.x; ROSINI G, 1984, J GEN APPL MICROBIOL, V30, P249, DOI 10.2323/jgam.30.249; Ruberto G, 2008, BIORESOURCE TECHNOL, V99, P260, DOI 10.1016/j.biortech.2006.12.025; Santamaria P, 2005, INT J FOOD MICROBIOL, V103, P49, DOI 10.1016/j.ijfoodmicro.2004.11.024; Scacco A, 2010, AM J ENOL VITICULT, V61, P498, DOI 10.5344/ajev.2010.10003; Scacco A, 2010, AM J ENOL VITICULT, V61, P260; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Schuller D, 2004, FEMS MICROBIOL LETT, V231, P19, DOI 10.1016/S0378-1097(03)00928-5; Strauss MLA, 2001, J APPL MICROBIOL, V91, P182, DOI 10.1046/j.1365-2672.2001.01379.x; Torija MJ, 2001, ANTON LEEUW INT J G, V79, P345, DOI 10.1023/A:1012027718701; Valero E, 2005, FEMS YEAST RES, V5, P959, DOI 10.1016/j.femsyr.2005.04.007; VAUGHANMARTINI A, 1995, J IND MICROBIOL, V14, P514, DOI 10.1007/BF01573967; Verzera A, 2008, FOOD ANAL METHOD, V1, P144, DOI 10.1007/s12161-008-9027-2; Yong-Sheng Tao, 2009, Health, V1, P176, DOI 10.4236/health.2009.13028; Zalacain A, 2007, TALANTA, V71, P1610, DOI 10.1016/j.talanta.2006.07.051; ZAMBONELLI C, 1998, MICROBIOLOGIA BIOTEC; [No title captured]	65	37	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30428	10.1371/journal.pone.0030428	http://dx.doi.org/10.1371/journal.pone.0030428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393353	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500006
J	Halasi, M; Gartel, AL				Halasi, Marianna; Gartel, Andrei L.			Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage	PLOS ONE			English	Article							N-TERMINAL KINASE; FORKHEAD BOX M1; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; IONIZING-RADIATION; GAMMA-RADIATION; EXPRESSION; APOPTOSIS; INVASION; RESISTANCE	Irradiation and DNA-damaging chemotherapeutic agents are commonly used in anticancer treatments. Following DNA damage FOXM1 protein levels are often elevated. In this study, we sought to investigate the potential role of FOXM1 in programmed cell death induced by DNA-damage. Human cancer cells after FOXM1 suppression were subjected to doxorubicin or gamma-irradiation treatment. Our findings indicate that FOXM1 downregulation by stable or transient knockdown using RNAi or by treatment with proteasome inhibitors that target FOXM1 strongly sensitized human cancer cells of different origin to DNA-damage-induced apoptosis. We showed that FOXM1 suppresses the activation of pro-apoptotic JNK and positively regulates anti-apoptotic Bcl-2, suggesting that JNK activation and Bcl-2 down-regulation could mediate sensitivity to DNA-damaging agent-induced apoptosis after targeting FOXM1. Since FOXM1 is widely expressed in human cancers, our data further support the fact that it is a valid target for combinatorial anticancer therapy.	[Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Halasi, M (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	agartel@uic.edu			National Institutes of Health (NIH) [1RO1CA1294414, 1R21CA134615]; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants 1RO1CA1294414 and 1R21CA134615 to Dr. Gartel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Burdak-Rothkamm S, 2009, EUR J PHARMACOL, V625, P151, DOI 10.1016/j.ejphar.2009.09.068; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI 10.1517/14728222.12.6.663 ; Halasi M, 2010, CELL CYCLE, V9, P1214, DOI 10.4161/cc.9.6.10955; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kim CH, 2010, BIOCHEM BIOPH RES CO, V391, P1182, DOI 10.1016/j.bbrc.2009.12.012; Kim MJ, 2008, MOL CANCER RES, V6, P1718, DOI 10.1158/1541-7786.MCR-08-0032; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2006, BIOCH BIOPH IN PRESS; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li YR, 2011, CLIN CANCER RES, V17, P4414, DOI 10.1158/1078-0432.CCR-11-0431; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan Senthil K, 2008, Nat Rev Cancer, V8, pc2, DOI 10.1038/nrc2223-c1; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Stevenson HS, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1766; Su ZZ, 2006, ONCOGENE, V25, P2339, DOI 10.1038/sj.onc.1209271; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Teh MT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-45; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wu QF, 2010, ACTA PHARMACOL SIN, V31, P361, DOI 10.1038/aps.2010.4; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	46	64	66	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31761	10.1371/journal.pone.0031761	http://dx.doi.org/10.1371/journal.pone.0031761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393369	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500022
J	Yu, RJ				Yu, Rongjun			Regional White Matter Volumes Correlate with Delay Discounting	PLOS ONE			English	Article							HYPOTHETICAL REWARDS; FUTURE REWARDS; INTERTEMPORAL CHOICE; SUBSTANCE-ABUSERS; NUCLEUS-ACCUMBENS; IMPULSIVE CHOICE; SUBJECTIVE VALUE; DECISION-MAKING; SMOKERS; RATES	A preference for immediate gratification is a central feature in addictive processes. However, the neural structures underlying reward delay tolerance are still unclear. Healthy participants (n = 121) completed a delay discounting questionnaire assessing the extent to which they prefer smaller immediate rewards to larger delayed reward after undergoing magnetic resonance imaging (MRI) scanning. Whole brain voxel-based morphometric analysis shows that delay discounting severity was negatively correlated with right prefrontal subgyral white matter volume and positively correlated with white matter volume in parahippocampus/hippocampus, after whole brain correction. This study might better our understanding of the neural basis of impulsivity and addiction.	[Yu, Rongjun] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] Univ Cambridge, MRC Cognit, Cambridge, England; [Yu, Rongjun] Univ Cambridge, Brain Sci Unit, Cambridge, England	South China Normal University; South China Normal University; University of Cambridge; University of Cambridge	Yu, RJ (corresponding author), S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	rongjun.yu@gmail.com	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524	United Kingdom Medical Research Council	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Bickel WK, 2008, DRUG ALCOHOL DEPEN, V96, P256, DOI 10.1016/j.drugalcdep.2008.03.009; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; Bjork JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011440; Bjork JM, 2009, BIOL PSYCHIAT, V65, P710, DOI 10.1016/j.biopsych.2008.11.023; Bodnar Michael, 2011, Clin Schizophr Relat Psychoses, V4, P217, DOI 10.3371/CSRP.4.4.2; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Epstein LH, 2003, EXP CLIN PSYCHOPHARM, V11, P131, DOI 10.1037/1064-1297.11.2.131; Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Housden CR, 2010, NEUROPSYCHOPHARMACOL, V35, P2155, DOI 10.1038/npp.2010.84; Jaroni JL, 2004, ADDICT BEHAV, V29, P1171, DOI 10.1016/j.addbeh.2004.03.014; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kirby KN, 2005, LEARN INDIVID DIFFER, V15, P213, DOI 10.1016/j.lindif.2005.01.003; Kirby KN, 2009, PSYCHON B REV, V16, P457, DOI 10.3758/PBR.16.3.457; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Madden GJ, 2004, EXP CLIN PSYCHOPHARM, V12, P251, DOI 10.1037/1064-1297.12.4.251; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; Mariano TY, 2009, EUR J NEUROSCI, V30, P472, DOI 10.1111/j.1460-9568.2009.06837.x; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Odum Amy L, 2002, Nicotine Tob Res, V4, P295, DOI 10.1080/14622200210141257; Ohmura Y, 2005, PSYCHOPHARMACOLOGY, V182, P508, DOI 10.1007/s00213-005-0110-8; Ohmura Y, 2006, EXP CLIN PSYCHOPHARM, V14, P318, DOI 10.1037/1064-1297.14.3.318; Olson EA, 2007, PERS INDIV DIFFER, V43, P1886, DOI 10.1016/j.paid.2007.06.016; Olson EA, 2009, J COGNITIVE NEUROSCI, V21, P1406, DOI 10.1162/jocn.2009.21107; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petry NM, 1999, DRUG ALCOHOL DEPEN, V56, P25, DOI 10.1016/S0376-8716(99)00010-1; Petry NM, 2002, PSYCHOPHARMACOLOGY, V162, P425, DOI 10.1007/s00213-002-1115-1; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Reynolds B, 2005, PSYCHOL REC, V55, P439, DOI 10.1007/BF03395520; Reynolds B, 2009, DRUG ALCOHOL DEPEN, V99, P350, DOI 10.1016/j.drugalcdep.2008.07.015; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Walhovd KB, 2004, NEUROLOGY, V63, P1193, DOI 10.1212/01.WNL.0000140489.33249.95; Weatherly JN, 2011, AM INDIAN ALASKA NAT, V17, P43; Wittmann Marc, 2010, J Neurosci Psychol Econ, V3, P15	56	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32595	10.1371/journal.pone.0032595	http://dx.doi.org/10.1371/journal.pone.0032595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393420	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500072
J	Balmaceda-Aguilera, C; Cortes-Campos, C; Cifuentes, M; Peruzzo, B; Mack, L; Tapia, JC; Oyarce, K; Garcia, MA; Nualart, F				Balmaceda-Aguilera, Carolina; Cortes-Campos, Christian; Cifuentes, Manuel; Peruzzo, Bruno; Mack, Lauren; Tapia, Juan Carlos; Oyarce, Karina; Angeles Garcia, Maria; Nualart, Francisco			Glucose Transporter 1 and Monocarboxylate Transporters 1, 2, and 4 Localization within the Glial Cells of Shark Blood-Brain-Barriers	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACILITATIVE GLUCOSE TRANSPORTERS; CHOROID-PLEXUS; ENERGY-METABOLISM; SKELETAL-MUSCLE; RADIAL GLIA; CORTICAL ASTROCYTES; ACID TRANSPORTERS; SQUALUS-ACANTHIAS; GENE-EXPRESSION	Although previous studies showed that glucose is used to support the metabolic activity of the cartilaginous fish brain, the distribution and expression levels of glucose transporter (GLUT) isoforms remained undetermined. Optic/ultrastructural immunohistochemistry approaches were used to determine the expression of GLUT1 in the glial blood-brain barrier (gBBB). GLUT1 was observed solely in glial cells; it was primarily located in end-feet processes of the gBBB. Western blot analysis showed a protein with a molecular mass of 50 kDa, and partial sequencing confirmed GLUT1 identity. Similar approaches were used to demonstrate increased GLUT1 polarization to both apical and basolateral membranes in choroid plexus epithelial cells. To explore monocarboxylate transporter (MCT) involvement in shark brain metabolism, the expression of MCTs was analyzed. MCT1, 2 and 4 were expressed in endothelial cells; however, only MCT1 and MCT4 were present in glial cells. In neurons, MCT2 was localized at the cell membrane whereas MCT1 was detected within mitochondria. Previous studies demonstrated that hypoxia modified GLUT and MCT expression in mammalian brain cells, which was mediated by the transcription factor, hypoxia inducible factor-1. Similarly, we observed that hypoxia modified MCT1 cellular distribution and MCT4 expression in shark telencephalic area and brain stem, confirming the role of these transporters in hypoxia adaptation. Finally, using three-dimensional ultrastructural microscopy, the interaction between glial end-feet and leaky blood vessels of shark brain was assessed in the present study. These data suggested that the brains of shark may take up glucose from blood using a different mechanism than that used by mammalian brains, which may induce astrocyte-neuron lactate shuttling and metabolic coupling as observed in mammalian brain. Our data suggested that the structural conditions and expression patterns of GLUT1, MCT1, MCT2 and MCT4 in shark brain may establish the molecular foundation of metabolic coupling between glia and neurons.	[Balmaceda-Aguilera, Carolina; Mack, Lauren; Oyarce, Karina; Nualart, Francisco] Univ Concepcion, Lab Neurobiol & Stem Cells, Dept Cellular Biol, Concepcion, Chile; [Cortes-Campos, Christian; Angeles Garcia, Maria] Univ Concepcion, Lab Cellular Biol, Dept Cellular Biol, Concepcion, Chile; [Cifuentes, Manuel] Univ Malaga, Dept Cellular Biol Genet & Physiol, Fac Sci, E-29071 Malaga, Spain; [Peruzzo, Bruno] Univ Austral Chile, Anat Histol & Pathol Inst, Fac Med, Valdivia, Chile; [Tapia, Juan Carlos] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Tapia, Juan Carlos] Columbia Univ, Dept Neurosci, New York, NY USA	Universidad de Concepcion; Universidad de Concepcion; Universidad de Malaga; Universidad Austral de Chile; Columbia University; Columbia University	Balmaceda-Aguilera, C (corresponding author), Univ Concepcion, Lab Neurobiol & Stem Cells, Dept Cellular Biol, Concepcion, Chile.	frnualart@udec.cl	Cortes Campos, Christian/Q-4096-2016; Garcia-Robles, Maria/F-4900-2014; Cifuentes, Manuel/I-6922-2018; Nualart, Francisco/AAB-9342-2021	Cortes Campos, Christian/0000-0002-2532-9035; Cifuentes, Manuel/0000-0003-1414-469X; Garcia-Robles, Maria/0000-0001-8482-0361; Oyarce, Karina/0000-0002-9591-3149	Fondo de Ciencia y Tecnologia (FONDECYT) [1100396, 1100705]; Ring of Research (PBCT) [ACT-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	Fondo de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research (PBCT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from Fondo de Ciencia y Tecnologia (FONDECYT 1100396 and 1100705) to FN and MAG, Ring of Research (PBCT ACT-02) to FN and MAG.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; AGNEW WF, 1980, CELL TISSUE RES, V208, P261; Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Ari C, 2008, BRAIN BEHAV EVOLUT, V71, P305, DOI 10.1159/000129654; Aubert A, 2007, GLIA, V55, P1272, DOI 10.1002/glia.20360; Badr GA, 1999, MOL BRAIN RES, V64, P24, DOI 10.1016/S0169-328X(98)00301-5; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Brooks GA, 1999, J APPL PHYSIOL, V87, P1713, DOI 10.1152/jappl.1999.87.5.1713; BUNDGAARD M, 1981, BRAIN RES, V226, P61, DOI 10.1016/0006-8993(81)91083-0; Bundgaard M, 2008, GLIA, V56, P699, DOI 10.1002/glia.20642; Chiba A, 2000, NEUROSCI LETT, V279, P65, DOI 10.1016/S0304-3940(99)00949-0; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; Cortes-Campos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016411; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; DEROOS R, 1985, GEN COMP ENDOCR, V58, P28, DOI 10.1016/0016-6480(85)90133-9; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; FARRELL CL, 1992, J HISTOCHEM CYTOCHEM, V40, P193, DOI 10.1177/40.2.1552163; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; FENSTERMACHER JD, 1980, FED PROC, V39, P3201; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; GRONDONA JM, 1994, MOL BRAIN RES, V26, P299, DOI 10.1016/0169-328X(94)90103-1; HACKER HJ, 1991, HISTOCHEMISTRY, V96, P435, DOI 10.1007/BF00316001; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; Kalman M, 2001, INT J DEV NEUROSCI, V19, P101, DOI 10.1016/S0736-5748(00)00058-7; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Lagana G, 2006, PHYSIOL RES, V55, P675, DOI 10.33549/physiolres.930897; Lazzari M, 2006, ANAT EMBRYOL, V211, P497, DOI 10.1007/s00429-006-0101-5; Lin T, 2005, J TRAUMA, V59, P1191, DOI 10.1097/01.ta.0000188646.86995.9d; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAHER F, 1994, MOL CELL NEUROSCI, V5, P369, DOI 10.1006/mcne.1994.1044; MAHER F, 1991, Molecular and Cellular Neuroscience, V2, P351, DOI 10.1016/1044-7431(91)90066-W; Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8; McVie-Wylie AJ, 2001, GENOMICS, V72, P113, DOI 10.1006/geno.2000.6457; Mobasheri A, 2005, HISTOL HISTOPATHOL, V20, P1327, DOI 10.14670/HH-20.1327; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ngan AK, 2009, COMP BIOCHEM PHYS B, V154, P396, DOI 10.1016/j.cbpb.2009.08.003; Nualart F, 1999, BRAIN RES, V824, P97, DOI 10.1016/S0006-8993(99)01078-1; Nunez-Parra A, 2011, CHEM SENSES; OPPELT WW, 1966, COMP BIOCHEM PHYSIOL, V17, P857, DOI 10.1016/0010-406X(66)90126-5; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Peruzzo B, 2000, EXP BRAIN RES, V132, P10, DOI 10.1007/s002219900289; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Planas JV, 2000, FEBS LETT, V481, P266, DOI 10.1016/S0014-5793(00)02020-2; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Ren BF, 2008, JOINT BONE SPINE, V75, P176, DOI 10.1016/j.jbspin.2007.05.012; Renshaw GMC, 2002, COMP BIOCHEM PHYS B, V131, P133, DOI 10.1016/S1096-4959(01)00484-5; Richards JG, 2003, J COMP PHYSIOL B, V173, P463, DOI 10.1007/s00360-003-0354-8; Segal MB, 2001, MICROSC RES TECHNIQ, V52, P38, DOI 10.1002/1097-0029(20010101)52:1<38::AID-JEMT6>3.3.CO;2-A; Skipor J, 2008, ACTA NEUROBIOL EXP, V68, P414; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; SWANSON RA, 1992, NEUROSCIENCE, V51, P451, DOI 10.1016/0306-4522(92)90329-Z; Teerijoki H, 2000, BBA-GENE STRUCT EXPR, V1494, P290, DOI 10.1016/S0167-4781(00)00216-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; WANG MY, 1994, ARCH BIOCHEM BIOPHYS, V310, P172, DOI 10.1006/abbi.1994.1154; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	84	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32409	10.1371/journal.pone.0032409	http://dx.doi.org/10.1371/journal.pone.0032409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389700	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600038
J	Seto, WK; Lai, CL; Ip, PPC; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF				Seto, Wai-Kay; Lai, Ching-Lung; Ip, Philip P. C.; Fung, James; Wong, Danny Ka-Ho; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Yuen, Man-Fung			A Large Population Histology Study Showing the Lack of Association between ALT Elevation and Significant Fibrosis in Chronic Hepatitis B	PLOS ONE			English	Article							HBV DNA LEVELS; ALANINE AMINOTRANSFERASE LEVELS; PERSISTENTLY NORMAL ALT; LIVER HISTOLOGY; NATURAL-HISTORY; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; PREDICTIVE MODEL; GENOTYPE-C; PREVALENCE	Objective: We determined the association between various clinical parameters and significant liver injury in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients. Methods: From 1994 to 2008, liver biopsy was performed on 319 treatment-naive CHB patients. Histologic assessment was based on the Knodell histologic activity index for necroinflammation and the Ishak fibrosis staging for fibrosis. Results: 211 HBeAg-positive and 108 HBeAg-negative patients were recruited, with a median age of 31 and 46 years respectively. 9 out of 40 (22.5%) HBeAg-positive patients with normal ALT had significant histologic abnormalities (necroinflammation grading >= 7 or fibrosis score >= 3). There was a significant difference in fibrosis scores among HBeAg-positive patients with an ALT level within the Prati criteria (30 U/L for men, 19 U/L for women) and patients with a normal ALT but exceeding the Prati criteria (p = 0.024). Age, aspartate aminotransferase and platelet count were independent predictors of significant fibrosis in HBeAg-positive patients with an elevated ALT by multivariate analysis (p = 0.007, 0.047 and 0.045 respectively). HBV DNA and platelet count were predictors of significant fibrosis in HBeAg-negative disease (p = 0.020 and 0.015 respectively). An elevated ALT was not predictive of significant fibrosis for HBeAg-positive (p = 0.345) and -negative (p = 0.544) disease. There was no significant difference in fibrosis staging among ALT 1-2x upper limit of normal (ULN) and > x2 ULN for both HBeAg-positive (p = 0.098) and -negative (p = 0.838) disease. Conclusion: An elevated ALT does not accurately predict significant liver injury. Decisions on commencing antiviral therapy should not be heavily based on a particular ALT threshold.	[Seto, Wai-Kay; Lai, Ching-Lung; Fung, James; Wong, Danny Ka-Ho; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Ip, Philip P. C.] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching-Lung] Univ Hong Kong, State Key Lab Liver Res, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Seto, WK (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Hung, Ivan FN/ABD-5916-2021; SETO, Wai-Kay/H-4452-2012; Fung, James/AAG-4832-2020; Wong, Danny/H-6819-2016; Wong, Danny/S-6230-2019	Ip, Philip/0000-0002-0493-9838; Hung, Ivan FN/0000-0002-1556-2538; SETO, Wai-Kay/0000-0002-9012-313X; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902				Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Chan HLY, 2002, AM J GASTROENTEROL, V97, P406; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Dufour DR, 2000, CLIN CHEM, V46, P2050; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2008, AM J GASTROENTEROL, V103, P1421, DOI 10.1111/j.1572-0241.2007.01751.x; Huang JF, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.115410; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kumada T, 2007, GUT, V56, P738, DOI 10.1136/gut.2006.118455; Kumada T, 2010, J MED VIROL, V82, P539, DOI 10.1002/jmv.21686; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Park JY, 2008, J VIRAL HEPATITIS, V15, P615, DOI 10.1111/j.1365-2893.2008.00989.x; Peng DD, 2008, J GASTROEN HEPATOL, V23, P1082, DOI 10.1111/j.1440-1746.2008.05478.x; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Shi JP, 2008, J GASTROEN HEPATOL, V23, P1419, DOI 10.1111/j.1440-1746.2008.05531.x; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yuen MF, 2007, J GASTROEN HEPATOL, V22, P973, DOI 10.1111/j.1440-1746.2007.04938.x; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2005, J VIRAL HEPATITIS, V12, P513, DOI 10.1111/j.1365-2893.2005.00629.x; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x; Yuen MF, 2004, AM J GASTROENTEROL, V99, P2032, DOI 10.1111/j.1572-0241.2004.40440.x; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009	40	55	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32622	10.1371/journal.pone.0032622	http://dx.doi.org/10.1371/journal.pone.0032622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389715	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600054
J	Chan, KH; Lee, KM; Wong, KB				Chan, Kwok-Ho; Lee, Ka-Man; Wong, Kam-Bo			Interaction between Hydrogenase Maturation Factors HypA and HypB Is Required for [NiFe]-Hydrogenase Maturation	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; BRADYRHIZOBIUM-JAPONICUM; PROTEINS HYPA; NICKEL; CYANIDE; FE; ISOENZYMES; SUBUNIT; UREASE	The active site of [NiFe]-hydrogenase contains nickel and iron coordinated by cysteine residues, cyanide and carbon monoxide. Metal chaperone proteins HypA and HypB are required for the nickel insertion step of [NiFe]-hydrogenase maturation. How HypA and HypB work together to deliver nickel to the catalytic core remains elusive. Here we demonstrated that HypA and HypB from Archaeoglobus fulgidus form 1: 1 heterodimer in solution and HypA does not interact with HypB dimer preloaded with GMPPNP and Ni. Based on the crystal structure of A. fulgidus HypB, mutants were designed to map the HypA binding site on HypB. Our results showed that two conserved residues, Tyr-4 and Leu-6, of A. fulgidus HypB are required for the interaction with HypA. Consistent with this observation, we demonstrated that the corresponding residues, Leu-78 and Val-80, located at the N-terminus of the GTPase domain of Escherichia coli HypB were required for HypA/HypB interaction. We further showed that L78A and V80A mutants of HypB failed to reactivate hydrogenase in an E. coli Delta hypB strain. Our results suggest that the formation of the HypA/HypB complex is essential to the maturation process of hydrogenase. The HypA binding site is in proximity to the metal binding site of HypB, suggesting that the HypA/HypB interaction may facilitate nickel transfer between the two proteins.	[Chan, Kwok-Ho; Lee, Ka-Man; Wong, Kam-Bo] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, KH (corresponding author), Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Chan, Kwok Ho/0000-0002-6693-2682	CUHK [4610/06M]; Research Grants Council of Hong Kong [HKU1/07C]	CUHK(Chinese University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work is supported by a General Research Fund (CUHK 4610/06M) and a Collaborative Research Fund (HKU1/07C) from Research Grants Council of Hong Kong (http://www.ugc.edu.hk/eng/rgc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova A, 2005, J BACTERIOL, V187, P4689, DOI 10.1128/JB.187.14.4689-4697.2005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Cai F, 2011, J BIOL INORG CHEM, V16, P857, DOI 10.1007/s00775-011-0782-y; Chan K-H, 2011, PLOS ONE IN PRESS; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; WAUGH R, 1986, BIOCHIMIE, V68, P157, DOI 10.1016/S0300-9084(86)81080-X; Winter G, 2005, FEBS LETT, V579, P4292, DOI 10.1016/j.febslet.2005.06.064; Xia W, 2011, J BIOL CHEM; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	36	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32592	10.1371/journal.pone.0032592	http://dx.doi.org/10.1371/journal.pone.0032592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384275	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500102
J	Gabrielsen, M; Beckham, KSH; Feher, VA; Zetterstrom, CE; Wang, D; Muller, S; Elofsson, M; Amaro, RE; Byron, O; Roe, AJ				Gabrielsen, Mads; Beckham, Katherine S. H.; Feher, Victoria A.; Zetterstrom, Caroline E.; Wang, Dai; Mueller, Sylke; Elofsson, Mikael; Amaro, Rommie E.; Byron, Olwyn; Roe, Andrew J.			Structural Characterisation of Tpx from Yersinia pseudotuberculosis Reveals Insights into the Binding of Salicylidene Acylhydrazide Compounds	PLOS ONE			English	Article							X-RAY SOLUTION; THIOL PEROXIDASE; BIOLOGICAL MACROMOLECULES; PROTEIN INTERACTIONS; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PURIFICATION; ASSEMBLIES; INHIBITORS	Thiol peroxidase, Tpx, has been shown to be a target protein of the salicylidene acylhydrazide class of antivirulence compounds. In this study we present the crystal structures of Tpx from Y. pseudotuberculosis (ypTpx) in the oxidised and reduced states, together with the structure of the C61S mutant. The structures solved are consistent with previously solved atypical 2-Cys thiol peroxidases, including that for "forced'' reduced states using the C61S mutant. In addition, by investigating the solution structure of ypTpx using small angle X-ray scattering (SAXS), we have confirmed that reduced state ypTpx in solution is a homodimer. The solution structure also reveals flexibility around the dimer interface. Notably, the conformational changes observed between the redox states at the catalytic triad and at the dimer interface have implications for substrate and inhibitor binding. The structural data were used to model the binding of two salicylidene acylhydrazide compounds to the oxidised structure of ypTpx. Overall, the study provides insights into the binding of the salicylidene acylhydrazides to ypTpx, aiding our long-term strategy to understand the mode of action of this class of compounds.	[Gabrielsen, Mads; Beckham, Katherine S. H.; Wang, Dai; Roe, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Immunol, Glasgow, Lanark, Scotland; [Feher, Victoria A.; Amaro, Rommie E.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Feher, Victoria A.; Amaro, Rommie E.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Feher, Victoria A.; Amaro, Rommie E.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Zetterstrom, Caroline E.; Elofsson, Mikael] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Zetterstrom, Caroline E.; Elofsson, Mikael] Umea Univ, Dept Chem, Umea, Sweden; [Mueller, Sylke] Univ Glasgow, Inst Infect Immun & Immunol, Coll Med Vet & Life Sci, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Byron, Olwyn] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Umea University; Umea University; University of Glasgow; University of Glasgow	Gabrielsen, M (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Immunol, Glasgow, Lanark, Scotland.	Olwyn.Byron@glasgow.ac.uk; Andrew.Roe@glasgow.ac.uk		Gabrielsen, Mads/0000-0002-9848-2276; Byron, Olwyn/0000-0001-7857-4520; Beckham, Kate/0000-0002-4929-6119; Elofsson, Mikael/0000-0002-3219-4669; roe, andrew/0000-0003-3698-6134	Biotechnology and Biological Sciences Research Council [BB/G011389/1]; Medical Research Scotland grant [223 ORG G 0709]; Wellcome Trust; Swedish Research Council; National Institutes of Health (NIH) [1-DP2-OD007237]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237] Funding Source: NIH RePORTER; BBSRC [BB/G011389/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Scotland grant; Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council to AJR and MG (BB/G011389/1) and a Medical Research Scotland grant (ref. 223 ORG G 0709) to AJR and DW. KSHB is supported by a Wellcome Trust studentship. CZ and ME are supported by the Swedish Research Council. This work was supported in part by the National Institutes of Health (NIH) through the NIH Director's New Innovator Award Program, 1-DP2-OD007237 to REA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bricogne G., 2011, BUSTER VERSION 2 8 0; Cao ZB, 2005, STRUCTURE, V13, P1661, DOI 10.1016/j.str.2005.07.021; CHA MK, 1995, J BIOL CHEM, V270, P28635, DOI 10.1074/jbc.270.48.28635; Choi J, 2005, PROTEINS, V61, P1146, DOI 10.1002/prot.20704; Choi JK, 2003, J BIOL CHEM, V278, P49478, DOI 10.1074/jbc.M309015200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gabrielsen M, 2010, ACTA CRYSTALLOGR F, V66, P1606, DOI 10.1107/S1744309110039679; Hall A, 2009, J MOL BIOL, V393, P867, DOI 10.1016/j.jmb.2009.08.040; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Karplus P. Andrew, 2007, V44, P41; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lu J, 2008, BIOCHEM BIOPH RES CO, V373, P414, DOI 10.1016/j.bbrc.2008.06.051; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rho BS, 2006, J MOL BIOL, V361, P850, DOI 10.1016/j.jmb.2006.05.076; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stehr M, 2006, ACTA CRYSTALLOGR D, V62, P563, DOI 10.1107/S0907444906008249; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tao K, 2008, FEMS MICROBIOL LETT, V289, P41, DOI 10.1111/j.1574-6968.2008.01372.x; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wan XY, 1997, FEBS LETT, V407, P32, DOI 10.1016/S0014-5793(97)00302-5; Wang D, 2011, J BIOL CHEM, V286, P29922, DOI 10.1074/jbc.M111.233858; Wang H, 2011, NAT CHEM BIOL, V7, P720, DOI [10.1038/NCHEMBIO.643, 10.1038/nchembio.643]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	53	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32217	10.1371/journal.pone.0032217	http://dx.doi.org/10.1371/journal.pone.0032217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384182	Green Published, Green Accepted, gold			2022-12-25	WOS:000302918500066
J	Ma, Z; Zhang, H; Zheng, JX; Li, Y; Yi, L; Fan, HJ; Lu, CP				Ma, Zhe; Zhang, Hui; Zheng, Junxi; Li, Yue; Yi, Li; Fan, Hongjie; Lu, Chengping			Interaction between M-Like Protein and Macrophage Thioredoxin Facilitates Antiphagocytosis for Streptococcus equi ssp zooepidemicus	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; COMPLEMENT-RESISTANCE MECHANISMS; UP-REGULATED PROTEIN-1; FACTOR-H; SUBSP ZOOEPIDEMICUS; SPLIT-UBIQUITIN; IN-VIVO; PHAGOCYTOSIS; BINDING; ADHERENCE	Streptococcus equi ssp. zooepidemicus (S. zooepidemicus, S.z) is one of the common pathogens that can cause septicemia, meningitis, and mammitis in domesticated species. M-like protein (SzP) is an important virulence factor of S. zooepidemicus and contributes to bacterial infection and antiphagocytosis. The interaction between SzP of S. zooepidemicus and porcine thioredoxin (TRX) was identified by the yeast two-hybrid and further confirmed by co-immunoprecipitation. SzP interacted with both reduced and the oxidized forms of TRX without inhibiting TRX activity. Membrane anchored SzP was able to recruit TRX to the surface, which would facilitate the antiphagocytosis of the bacteria. Further experiments revealed that TRX regulated the alternative complement pathway by inhibiting C3 convertase activity and associating with factor H (FH). TRX alone inhibited C3 cleavage and C3a production, and the inhibitory effect was additive when FH was also present. TRX inhibited C3 deposition on the bacterial surface when it was recruited by SzP. These new findings indicated that S. zooepidemicus used SzP to recruit TRX and regulated the alternative complement pathways to evade the host immune phagocytosis.	[Ma, Zhe; Zhang, Hui; Zheng, Junxi; Li, Yue; Yi, Li; Fan, Hongjie; Lu, Chengping] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Fan, HJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	fhj@njau.edu.cn			National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation of China [31172319]; key Technology R&D Program of Jiangsu [BE2009388]; Fundamental Research Funds for the Central Universities [KYT 201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key Technology R&D Program of Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by Program from the National Basic Research Program (973) of China (2012CB518804), the National Natural Science Foundation of China (31172319), the key Technology R & D Program of Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions	Abbott Y, 2009, J MED MICROBIOL; Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; BARTELT MA, 1978, INFECT IMMUN, V20, P200, DOI 10.1128/IAI.20.1.200-208.1978; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; BISNO AL, 1979, INFECT IMMUN, V26, P1172, DOI 10.1128/IAI.26.3.1172-1176.1979; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; CAMPBELL JR, 1991, INFECT IMMUN, V59, P1978, DOI 10.1128/IAI.59.6.1978-1983.1991; CAMPO RE, 1995, J INFECT DIS, V171, P601, DOI 10.1093/infdis/171.3.601; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Eyre DW, 2010, EUR J CLIN MICROBIOL; Fan HJ, 2009, VACCINE, V27, P56, DOI 10.1016/j.vaccine.2008.10.037; Fan HJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-170; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Johnsson E, 1996, J IMMUNOL, V157, P3021; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849; Kondo N, 2004, J IMMUNOL, V172, P442, DOI 10.4049/jimmunol.172.1.442; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; MOORE BO, 1969, J AM VET MED ASSOC, V155, P416; Nakamura H, 2008, NOVART FDN SYMP, V291, P221; Nakamura H, 2008, NOVART FDN SYMP, V291, P192; Nakamura Hajime, 2008, Novartis Found Symp, V291, P184; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; TIMONEY JF, 1995, INFECT IMMUN, V63, P1440, DOI 10.1128/IAI.63.4.1440-1445.1995; Timoney JF, 1997, INFECT IMMUN, V65, P3600, DOI 10.1128/IAI.65.9.3600-3605.1997; Tiwari R, 2007, VET MICROBIOL, V121, P105, DOI 10.1016/j.vetmic.2006.11.023; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; Wibawan IWT, 1999, RES VET SCI, V67, P131, DOI 10.1053/rvsc.1998.0287	47	16	19	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32099	10.1371/journal.pone.0032099	http://dx.doi.org/10.1371/journal.pone.0032099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384152	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500059
J	Orloff, MS; Zhang, L; Bebek, G; Eng, C				Orloff, Mohammed S.; Zhang, Li; Bebek, Gurkan; Eng, Charis			Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort	PLOS ONE			English	Article							GENETIC PREDISPOSITION; SUSCEPTIBILITY LOCUS; ASSOCIATION; VARIANTS; SMOKING; DISPLAY; BREAST; TOOL	Susceptibility to common cancers is multigenic resulting from low-to-high penetrance predisposition-factors and environmental exposure. Genomic studies suggest germline homozygosity as a novel low-penetrance factor contributing to common cancers. We hypothesized that long homozygous regions (tracts-of-homozygosity [TOH]) harbor tobacco-dependent and independent lung-cancer predisposition (or protection) genes. We performed in silico genome-wide SNP-array-based analysis of lung-cancer patients of European-ancestry from the PLCO screening-trial cohort to identify TOH regions amongst 788 cancer-cases and 830 ancestry-matched controls. Association analyses was then performed between presence of lung cancer and common(c) TOHs (operationally defined as 10 or more subjects sharing >= 100 identical homozygous calls), aTOHs (allelically-matched groups within a cTOH), demographics and tobacco-exposure. Finally, integration of significant c/aTOH with transcriptome was performed to functionally-map lung-cancer risk-genes. After controlling for demographics and smoking, we identified 7 cTOHs and 5 aTOHs associated with lung cancer (adjusted p<0.01). Three cTOHs were over-represented in cases over controls (OR = 1.75-2.06, p = 0.007-0.001), whereas 4 were under-represented (OR = 0.28-0.69, p = 0.006-0.001). Interaction between smoking status and cTOH3/aTOH2 (2p16.3-2p16.1) was observed (adjusted p<0.03). The remaining significant aTOHs have ORs 0.23-0.50 (p = 0.004-0.006) and 2.95-3.97 (p = 0.008-0.001). After integrating significant cTOH/aTOHs with publicly-available lung-cancer transcriptome datasets followed by filtering based on lung cancer and its relevant pathways revealed 9 putative predisposing genes (p<0.0001). In conclusion, differentially-distributed cTOH/aTOH genomic variants between cases and controls harbor sets of plausible differentially-expressed genes accounting for the complexity of lung-cancer predisposition.	[Orloff, Mohammed S.; Zhang, Li; Bebek, Gurkan; Eng, Charis] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA; [Zhang, Li] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA; [Orloff, Mohammed S.; Eng, Charis] Taussig Canc Inst, Cleveland, OH USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Bebek, Gurkan; Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Orloff, MS (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145	Cleveland Clinic; American Cancer Society	Cleveland Clinic; American Cancer Society(American Cancer Society)	CE holds the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic, and the American Cancer Society Clinical Research Professorship. These Chair funds have supported in part some of the authors' FTE to perform this study (including MO and CE's time). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Bacolod MD, 2008, CANCER RES, V68, P2610, DOI 10.1158/0008-5472.CAN-07-5250; Bhattacharya P, 2002, CANCER LETT, V188, P207, DOI 10.1016/S0304-3835(02)00430-5; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank SA, 2004, NAT REV GENET, V5, P764, DOI 10.1038/nrg1450; Fusby JS, 2010, INHAL TOXICOL, V22, P785, DOI 10.3109/08958378.2010.483258; Gao Y, 2009, INT J CANCER, V125, P146, DOI 10.1002/ijc.24283; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; HUANG RTC, 1978, NATURE, V276, P624, DOI 10.1038/276624a0; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Le Roy F, 2007, CELL DEATH DIFFER, V14, P1406, DOI 10.1038/sj.cdd.4402130; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mincey BA, 2003, ONCOLOGIST, V8, P466, DOI 10.1634/theoncologist.8-5-466; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Rudan I, 1999, HUM BIOL, V71, P173; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; SIMPSON JL, 1981, AM J OBSTET GYNECOL, V141, P629, DOI 10.1016/S0002-9378(15)33302-0; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Turnbull C, 2005, CLIN MED, V5, P491, DOI 10.7861/clinmedicine.5-5-491; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31975	10.1371/journal.pone.0031975	http://dx.doi.org/10.1371/journal.pone.0031975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384118	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500051
J	Matulova, M; Stepanova, H; Sisak, F; Havlickova, H; Faldynova, M; Kyrova, K; Volf, J; Rychlik, I				Matulova, Marta; Stepanova, Hana; Sisak, Frantisek; Havlickova, Hana; Faldynova, Marcela; Kyrova, Kamila; Volf, Jiri; Rychlik, Ivan			Cytokine Signaling in Splenic Leukocytes from Vaccinated and Non-Vaccinated Chickens after Intravenous Infection with Salmonella Enteritidis	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; IMMUNE-RESPONSE; PATHOGENICITY ISLANDS; T-CELLS; TYPHIMURIUM; EXPRESSION; RECHALLENGE; CECUM	In order to design a new Salmonella enterica vaccine, one needs to understand how naive and immune chickens interact differently when exposed to S. enterica. In this study we therefore determined the immune response of vaccinated and non-vaccinated chickens after intravenous infection with Salmonella enterica serovar Enteritidis (S. Enteritidis). Using flow cytometry we showed that 4 days post infection (DPI), counts of CD4 and B-lymphocytes did not change, CD8 and gamma delta T-lymphocytes decreased and macrophages and heterophils increased in the spleen. When vaccinated and non-vaccinated chickens were compared, only macrophages and heterophils were found in significantly higher counts in the spleens of the non-vaccinated chickens. The non-vaccinated chickens also expressed higher anti-LPS antibodies than the vaccinated chickens. The expression of interleukin (IL) 1 beta, IL6, IL8, IL18, LITAF, IFN gamma and iNOS did not exhibit any clear pattern in the cells sorted from the spleens of vaccinated or non-vaccinated chickens. Only IL17 and IL22 showed a differential expression in the CD4 T-lymphocytes of the vaccinated and non-vaccinated chickens at 4 DPI, both being expressed at a higher level in the non-vaccinated chickens. Due to a similar IFN gamma expression in the CD4 T-lymphocytes in both the vaccinated and non-vaccinated chickens, and a variable IL17 expression oscillating around IFN gamma expression levels, the IL17: IFN gamma ratio in CD4 T-lymphocytes was found to be central for the outcome of the immune response. When IL17 was expressed at higher levels than IFN gamma in the non-vaccinated chickens, the Th17 immune response with a higher macrophage and heterophil infiltration in the spleen dominated. However, when the expression of IL17 was lower than that of IFN gamma as in the vaccinated chickens, the Th1 response with a higher resistance to S. Enteritidis infection dominated.	[Matulova, Marta; Stepanova, Hana; Sisak, Frantisek; Havlickova, Hana; Faldynova, Marcela; Kyrova, Kamila; Volf, Jiri; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Matulova, M (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022; kyrova, kamila/H-4024-2016; Štěpánová, Hana/GPG-3735-2022; Bendickova, Kamila/D-1544-2017	, Ivan/0000-0001-7995-6483; kyrova, kamila/0000-0001-5627-3305; Bendickova, Kamila/0000-0001-7767-1003	Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006 - ED0006/01/01]; Czech Science Foundation [524/09/0215]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work has been supported by the projects MZE0002716202 of the Czech Ministry of Agriculture, AdmireVet project CZ.1.05/2.1.00/01.0006 - ED0006/01/01 from the Czech Ministry of Education and project 524/09/0215 from the Czech Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Berndt A, 2001, VET IMMUNOL IMMUNOP, V78, P143, DOI 10.1016/S0165-2427(00)00264-6; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Berndt A, 2006, INFECT IMMUN, V74, P3967, DOI 10.1128/IAI.01128-05; Carvajal BG, 2008, VACCINE, V26, P5423, DOI 10.1016/j.vaccine.2008.07.088; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; Kolesarova M, 2011, VET MED-CZECH, V56, P325, DOI 10.17221/1586-VETMED; Matulova M, 2012, VACCINE IN PRESS, DOI [10.1016/j.vaccine.2012.01.050, DOI 10.1016/J.VACCINE.2012.01.050]; Pieper J, 2011, INFECT IMMUN, V79, P822, DOI 10.1128/IAI.00788-10; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Sadeyen JR, 2004, MICROBES INFECT, V6, P1278, DOI 10.1016/j.micinf.2004.07.005; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Van Dijk A, 2009, MOL IMMUNOL, V46, P1517, DOI 10.1016/j.molimm.2008.12.015; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Zuckermann FA, 1999, VET IMMUNOL IMMUNOP, V72, P55, DOI 10.1016/S0165-2427(99)00118-X	16	17	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32346	10.1371/journal.pone.0032346	http://dx.doi.org/10.1371/journal.pone.0032346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384225	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916800037
J	Ruppert, SM; Chehtane, M; Zhang, G; Hu, HY; Li, XM; Khaled, AR				Ruppert, Shannon M.; Chehtane, Mounir; Zhang, Ge; Hu, Haiyan; Li, Xiaoman; Khaled, Annette R.			JunD/AP-1-Mediated Gene Expression Promotes Lymphocyte Growth Dependent on Interleukin-7 Signal Transduction	PLOS ONE			English	Article							T-CELL PROLIFERATION; JUND MESSENGER-RNA; C-JUN; FAMILY-MEMBERS; PROTEIN-KINASE; IL-7; ACTIVATION; RECEPTOR; MOUSE; SURVIVAL	Interleukin-7 (IL-7) is an essential cytokine for lymphocyte growth that has the potential for promoting immune reconstitution. This feature makes IL-7 an ideal candidate for therapeutic development. As with other cytokines, signaling through the IL-7 receptor induces the JAK/STAT pathway. However, the broad scope of IL-7 regulatory targets likely necessitates the use of other signaling components whose identities remain poorly defined. To this end, we used an IL-7 dependent T-cell line to examine how expression of the glycolytic enzyme, Hexokinase II (HXKII) was regulated by IL-7 in a STAT5-independent manner. Our studies revealed that IL-7 promoted the activity of JNK (Jun N-terminal Kinase), and that JNK, in turn, drove the expression of JunD, a component of the Activating Protein 1 (AP-1) transcription factors. Gel shifts showed that the AP-1 complex induced by IL-7 contained JunD but not c-Fos or c-Jun. Inhibition of JNK/JunD blocked glucose uptake and HXKII gene expression, indicating that this pathway was responsible for promoting HXKII expression. Because others had shown that JunD was a negative regulator of cell growth, we performed a bioinformatics analysis to uncover possible JunD-regulated gene targets. Our search revealed that JunD could control the expression of proteins involved in signal transduction, cell survival and metabolism. One of these growth promoters was the oncogene, Pim-1. Pim-1 is an IL-7-induced protein that was inhibited when the activities of JNK or JunD were blocked, showing that in IL-7 dependent T-cells JunD can promote positive signals transduced through Pim-1. This was confirmed when the IL-7-induced proliferation of CD8 T-cells was impaired upon JunD inhibition. These results show that engagement of the IL-7 receptor drives a signal that is more complex than the JAK/STAT pathway, activating JNK and JunD to induce rapid growth stimulation through the expression of metabolic and signaling factors like HXKII and Pim-1.	[Ruppert, Shannon M.; Chehtane, Mounir; Zhang, Ge; Li, Xiaoman; Khaled, Annette R.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Hu, Haiyan] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Ruppert, SM (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	akhaled@mail.ucf.edu			NIH/NCI [CA109524RO1]; NATIONAL CANCER INSTITUTE [R01CA109524] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by an NIH/NCI Grant CA109524RO1 (Khaled) from the National Institutes of Health (NIH) (www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2003, J CLIN INVEST, V112, P1095, DOI 10.1172/JCI200317865; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CASTELLAZZI M, 1991, P NATL ACAD SCI USA, V88, P8890, DOI 10.1073/pnas.88.20.8890; Cen B, 2010, J BIOL CHEM, V285, P29128, DOI 10.1074/jbc.M110.137240; Chehtane M, 2010, AM J PHYSL CELL PHYS; Crawley JB, 1996, EUR J IMMUNOL, V26, P2717, DOI 10.1002/eji.1830261125; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Gao YF, 2005, J IMMUNOL, V175, P5783, DOI 10.4049/jimmunol.175.9.5783; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Heikkinen S, 2000, MAMM GENOME, V11, P91, DOI 10.1007/s003350010019; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Jacobs H, 1999, J EXP MED, V190, P1059, DOI 10.1084/jem.190.8.1059; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kang JS, 2004, J IMMUNOL, V173, P2307, DOI 10.4049/jimmunol.173.4.2307; Khaled AR, 2005, J CELL BIOL, V169, P755, DOI 10.1083/jcb.200409099; Khaled AR, 2003, IMMUNOL REV, V193, P48, DOI 10.1034/j.1600-065X.2003.00050.x; Khaled AR, 2002, IMMUNITY, V17, P561, DOI 10.1016/S1074-7613(02)00450-8; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim K, 2003, J IMMUNOL METHODS, V274, P177, DOI 10.1016/S0022-1759(02)00513-6; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Kittipatarin C, 2010, IMMUNOL LETT, V131, P170, DOI 10.1016/j.imlet.2010.04.007; Kittipatarin C, 2009, J IMMUNOL METHODS, V344, P45, DOI 10.1016/j.jim.2009.03.001; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Li WQ, 2010, MOL CELL BIOL, V30, P590, DOI 10.1128/MCB.01006-09; Li WQ, 2004, J BIOL CHEM, V279, P29160, DOI 10.1074/jbc.M401656200; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morcinek JC, 2002, ONCOGENE, V21, P1668, DOI 10.1038/sj.onc.1205148; Musti AM, 1996, BIOL CHEM, V377, P619, DOI 10.1515/bchm3.1996.377.10.619; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Rahman Z, 2001, IMMUNOL LETT, V75, P199, DOI 10.1016/S0165-2478(00)00322-9; Rajnavolgyi E, IL 7 WITHDRAWAL INDU; Repass JF, 2009, GENESIS; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SAKATA T, 1990, J LEUKOCYTE BIOL, V48, P205, DOI 10.1002/jlb.48.3.205; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; SECKINGER P, 1994, J IMMUNOL, V153, P97; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Short JD, 2002, J BIOL CHEM, V277, P32697, DOI 10.1074/jbc.M204553200; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xiao L, 2007, BIOCHEM J, V403, P573, DOI 10.1042/BJ20061436; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Zou TT, 2010, MOL CELL BIOL, V30, P5021, DOI 10.1128/MCB.00807-10	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32262	10.1371/journal.pone.0032262	http://dx.doi.org/10.1371/journal.pone.0032262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384197	Green Published, gold			2022-12-25	WOS:000302916100064
J	Simmons, T; Appel, B				Simmons, Timothy; Appel, Bruce			Mutation of pescadillo Disrupts Oligodendrocyte Formation in Zebrafish	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; EMBRYONIC-DEVELOPMENT; RIBOSOME BIOGENESIS; CELL-PROLIFERATION; SPECIFICATION; PROTEIN; MIGRATION; GENES; EYE	Background: In vertebrates, the myelin sheath is essential for efficient propagation of action potentials along the axon shaft. Oligodendrocytes are the cells of the central nervous system that create myelin sheaths. During embryogenesis, ventral neural tube precursors give rise to oligodendrocyte progenitor cells, which divide and migrate throughout the central nervous system. This study aimed to investigate mechanisms that regulate oligodendrocyte progenitor cell formation. Methodology/Principal Findings: By conducting a mutagenesis screen in transgenic zebrafish, we identified a mutation, designated vu166, by an apparent reduction in the number of oligodendrocyte progenitor cells in the dorsal spinal cord. We subsequently determined that vu166 is an allele of pescadillo, a gene known to play a role in ribosome biogenesis and cell proliferation. We found that pescadillo function is required for both the proper number of oligodendrocyte progenitors to form, by regulating cell cycle progression, and for normal levels of myelin gene expression. Conclusions/Significance: Our data provide evidence that neural precursors require pes function to progress through the cell cycle and produce oligodendrocyte progenitor cells and for oligodendrocyte differentiation.	[Simmons, Timothy] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Appel, Bruce] Univ Colorado, Dept Pediat, Aurora, CO USA	Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus	Simmons, T (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	Bruce.Appel@UCDenver.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672	NIH [NS046668, NS048154]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668, P30NS048154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by grants NS046668 (B.A) and NS048154 (University of Colorado Denver Zebrafish Core Facility) from the NIH (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Appel lab for discussions. The anti-BrdU antibody, developed by S. J. Kaufman, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA. Confocal microscopy was performed using equipment provided by the Gates Frontiers Fund.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Gessert S, 2007, DEV BIOL, V310, P99, DOI 10.1016/j.ydbio.2007.07.037; Hauptmann G, 2000, METH MOL B, V137, P139; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Maiorana A, 2004, ONCOGENE, V23, P7116, DOI 10.1038/sj.onc.1207916; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sikorski EM, 2006, J BIOL CHEM, V281, P24423, DOI 10.1074/jbc.M602287200; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32317	10.1371/journal.pone.0032317	http://dx.doi.org/10.1371/journal.pone.0032317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384214	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100068
J	Rayson, S; Arciga-Reyes, L; Wootton, L; Zabala, MD; Truman, W; Graham, N; Grant, M; Davies, B				Rayson, Samantha; Arciga-Reyes, Luis; Wootton, Lucie; Zabala, Marta De Torres; Truman, William; Graham, Neil; Grant, Murray; Davies, Brendan			A Role for Nonsense-Mediated mRNA Decay in Plants: Pathogen Responses Are Induced in Arabidopsis thaliana NMD Mutants	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; EXON JUNCTION COMPLEX; SYRINGAE PV. TOMATO; OPEN READING FRAMES; SALICYLIC-ACID; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; CAENORHABDITIS-ELEGANS; DISEASE RESISTANCE; GENE-EXPRESSION	Nonsense-mediated mRNA decay (NMD) is a conserved mechanism that targets aberrant mRNAs for destruction. NMD has also been found to regulate the expression of large numbers of genes in diverse organisms, although the biological role for this is unclear and few evolutionarily conserved targets have been identified. Expression analyses of three Arabidopsis thaliana lines deficient in NMD reveal that the vast majority of NMD-targeted transcripts are associated with response to pathogens. Congruently, NMD mutants, in which these transcripts are elevated, confer partial resistance to Pseudomonas syringae. These findings suggest a biological rationale for the regulation of gene expression by NMD in plants and suggest that manipulation of NMD could offer a new approach for crop protection. Amongst the few non-pathogen responsive NMD-targeted genes, one potential NMD targeted signal, the evolutionarily conserved upstream open reading frame (CuORF), was found to be hugely over-represented, raising the possibility that this feature could be used to target specific physiological mRNAs for control by NMD.	[Rayson, Samantha; Arciga-Reyes, Luis; Wootton, Lucie; Davies, Brendan] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Zabala, Marta De Torres; Truman, William; Grant, Murray] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Graham, Neil] Univ Nottingham, Nottingham Arabidopsis Stock Ctr, Loughborough, Leics, England	University of Leeds; University of Exeter; University of Nottingham	Rayson, S (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England.	b.h.davies@leeds.ac.uk	Graham, Neil/C-5489-2008; Truman, William/D-7823-2015	Graham, Neil/0000-0001-9080-8967; Truman, William/0000-0002-9840-2539; Davies, Brendan/0000-0002-9282-3789	BBSRC; BBSRC [BB/E010334/1, BB/D007046/1, BB/H00775X/1, BB/F005903/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005903/1, BB/D007046/1, BB/E010334/1, BB/H00775X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anders KR, 2003, EMBO J, V22, P641, DOI 10.1093/emboj/cdg056; Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; BENDER CL, 1987, PHYSIOL MOL PLANT P, V30, P273, DOI 10.1016/0885-5765(87)90040-3; Biles CL, 2001, BIOS, V72, P67; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devadas SK, 2002, PLANT J, V30, P467, DOI 10.1046/j.1365-313X.2002.01300.x; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hamid R, 2010, CLIN GENET, V77, P280, DOI 10.1111/j.1399-0004.2009.01311.x; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai A, 2005, PLANT CELL PHYSIOL, V46, pS30; Imai A, 2006, DEVELOPMENT, V133, P3575, DOI 10.1242/dev.02535; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jin JB, 2008, PLANT J, V53, P530, DOI 10.1111/j.1365-313X.2007.03359.x; Jing HC, 2007, J EXP BOT, V58, P3885, DOI 10.1093/jxb/erm237; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kerenyi Z, 2008, EMBO J, V27, P1585, DOI 10.1038/emboj.2008.88; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lamba JK, 2003, HUM MOL GENET, V12, P99, DOI 10.1093/hmg/ddg011; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Li YJ, 2009, PHYSIOL PLANTARUM, V136, P19, DOI 10.1111/j.1399-3054.2009.01209.x; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Malanin SY, 2010, RUSS J PLANT PHYSL+, V57, P267, DOI 10.1134/S1021443710020159; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; McGlincy NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-565; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Mosher S, 2010, PLANT PHYSIOL, V152, P1901, DOI 10.1104/pp.109.152603; Nibbe M, 2002, PLANTA, V216, P120, DOI 10.1007/s00425-002-0907-1; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Riehs N, 2008, J CELL SCI, V121, P2208, DOI 10.1242/jcs.027862; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shashikanth M, 2008, PLANT BIOTECHNOL-NAR, V25, P553, DOI 10.5511/plantbiotechnology.25.553; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Song HR, 2009, PLANT CELL, V21, P1195, DOI 10.1105/tpc.108.064774; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Truman WM, 2010, PLANT PHYSIOL, V152, P1562, DOI 10.1104/pp.109.152173; Venugopal SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000545; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Vincill ED, 2005, PLANT PHYSIOL, V137, P1435, DOI 10.1104/pp.104.051953; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wawrzynska A, 2010, MOL PLANT MICROBE IN, V23, P578, DOI 10.1094/MPMI-23-5-0578; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Yoine M, 2006, PLANT J, V47, P49, DOI 10.1111/j.1365-313X.2006.02771.x; Yoine M, 2006, PLANT CELL PHYSIOL, V47, P572, DOI 10.1093/pcp/pcj035; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720	109	95	96	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31917	10.1371/journal.pone.0031917	http://dx.doi.org/10.1371/journal.pone.0031917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384098	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500052
J	Wang, JR; Nikrad, MP; Travanty, EA; Zhou, B; Phang, T; Gao, BF; Alford, T; Ito, Y; Nahreini, P; Hartshorn, K; Wentworth, D; Dinarello, CA; Mason, RJ				Wang, Jieru; Nikrad, Mrinalini P.; Travanty, Emily A.; Zhou, Bin; Phang, Tzulip; Gao, Bifeng; Alford, Taylor; Ito, Yoko; Nahreini, Piruz; Hartshorn, Kevan; Wentworth, David; Dinarello, Charles A.; Mason, Robert J.			Innate Immune Response of Human Alveolar Macrophages during Influenza A Infection	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; EPITHELIAL-CELLS; LUNG DEFENSE; SERINE PROTEASES; HOST-RESPONSES; H5N1 VIRUSES; SR-AI/II; EXPRESSION; CHEMOKINES; MARCO	Alveolar macrophages (AM) are one of the key cell types for initiating inflammatory and immune responses to influenza virus in the lung. However, the genome-wide changes in response to influenza infection in AM have not been defined. We performed gene profiling of human AM in response to H1N1 influenza A virus PR/8 using Affymetrix HG-U133 Plus 2.0 chips and verified the changes at both mRNA and protein levels by real-time RT-PCR and ELISA. We confirmed the response with a contemporary H3N2 influenza virus A/New York/238/2005 (NY/238). To understand the local cellular response, we also evaluated the impact of paracrine factors on virus-induced chemokine and cytokine secretion. In addition, we investigated the changes in the expression of macrophage receptors and uptake of pathogens after PR/8 infection. Although macrophages fail to release a large amount of infectious virus, we observed a robust induction of type I and type III interferons and several cytokines and chemokines following influenza infection. CXCL9, 10, and 11 were the most highly induced chemokines by influenza infection. UV-inactivation abolished virus-induced cytokine and chemokine response, with the exception of CXCL10. The contemporary influenza virus NY/238 infection of AM induced a similar response as PR/8. Inhibition of TNF and/or IL-1 beta activity significantly decreased the secretion of the proinflammatory chemokines CCL5 and CXCL8 by over 50%. PR/8 infection also significantly decreased mRNA levels of macrophage receptors including C-type lectin domain family 7 member A (CLEC7A), macrophage scavenger receptor 1 (MSR1), and CD36, and reduced uptake of zymosan. In conclusion, influenza infection induced an extensive proinflammatory response in human AM. Targeting local components of innate immune response might provide a strategy for controlling influenza A infection-induced proinflammatory response in vivo.	[Wang, Jieru; Nikrad, Mrinalini P.; Travanty, Emily A.; Alford, Taylor; Ito, Yoko; Nahreini, Piruz; Mason, Robert J.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Zhou, Bin; Wentworth, David] J Craig Venter Inst, Rockville, MD USA; [Phang, Tzulip; Gao, Bifeng] Univ Colorado Denver & Hlth Sci Ctr, Sch Med Canc Ctr, Aurora, CO USA; [Hartshorn, Kevan] Boston Univ, Sch Med, Dept Oncol, Boston, MA 02118 USA; [Dinarello, Charles A.] Univ Colorado Denver & Hlth Sci Ctr, Div Infect Dis, Aurora, CO USA; [Wang, Jieru; Mason, Robert J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Med, Sch Med, Aurora, CO USA	National Jewish Health; J. Craig Venter Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Boston University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Wang, JR (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	wangj@njhealth.org	Zhou, Bin/H-8688-2014; Dinarello, Charles/C-8524-2013	Zhou, Bin/0000-0002-1535-6283; Hartshorn, Kevan/0000-0002-7196-7433; Wentworth, David/0000-0002-5190-980X	National Institutes of Health [AI082982]; ExxonMobil Foundation; Parker B. Francis Foundation; Department of Defense [USAMRMC:W81XWH-07-1-0550]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082982, R03AI101953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ExxonMobil Foundation(Exxon Mobil Corporation); Parker B. Francis Foundation; Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by the grants from National Institutes of Health AI082982, ExxonMobil Foundation, the Parker B. Francis Foundation, and Department of Defense USAMRMC:W81XWH-07-1-0550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bussfeld D, 1998, CELL IMMUNOL, V186, P1, DOI 10.1006/cimm.1998.1295; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Cassel SL, 2009, ADV IMMUNOL, V103, P49, DOI 10.1016/S0065-2776(09)03003-X; Castleman WL, 2010, VET PATHOL; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen YX, 2009, ARCH VIROL, V154, P227, DOI 10.1007/s00705-008-0277-5; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Gordy LE, 2011, J IMMUNOL; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Hamilton NHR, 2004, SCAND J IMMUNOL, V59, P246, DOI 10.1111/j.0300-9475.2004.01391.x; Harvey SAK, 2005, INVEST OPHTH VIS SCI, V46, P3657, DOI 10.1167/iovs.05-0438; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Jankowski M, 2010, ARCH IMMUNOL THER EX, V58, P417, DOI 10.1007/s00005-010-0098-6; Ji R, 2008, AM J PHYSIOL-LUNG C, V294, pL1187, DOI 10.1152/ajplung.00388.2007; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Larrubia JR, 2008, WORLD J GASTROENTERO, V14, P7149, DOI 10.3748/wjg.14.7149; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Lohr CV, 2010, VET PATHOL; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Miura TA, 2007, VIROLOGY, V369, P288, DOI 10.1016/j.virol.2007.07.030; NUGENT KM, 1982, INFECT IMMUN, V38, P1256, DOI 10.1128/IAI.38.3.1256-1262.1982; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Powe JR, 2009, VET PATHOL, V46, P1187, DOI 10.1354/vp.08-VP-0229-P-FL; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; van Riel D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002099; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	63	80	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e29879	10.1371/journal.pone.0029879	http://dx.doi.org/10.1371/journal.pone.0029879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396727	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500002
J	Chai, XQJ; Jacobs, LF				Chai, Xiaoqian J.; Jacobs, Lucia F.			Digit Ratio Predicts Sense of Direction in Women	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; OBJECT LOCATION MEMORY; MENTAL ROTATION PERFORMANCE; MORRIS WATER TASK; SEX-DIFFERENCES; SPATIAL MEMORY; FINGER LENGTH; GENDER-DIFFERENCES; PRENATAL ANDROGENS; MAZE PERFORMANCE	The relative length of the second-to-fourth digits (2D:4D) has been linked with prenatal androgen in humans. The 2D:4D is sexually dimorphic, with lower values in males than females, and appears to correlate with diverse measures of behavior. However, the relationship between digit ratio and cognition, and spatial cognition in particular, has produced mixed results. In the present study, we hypothesized that spatial tasks separating cue conditions that either favored female or male strategies would examine this structure-function correlation with greater precision. Previous work suggests that males are better in the use of directional cues than females. In the present study, participants learned a target location in a virtual landscape environment, in conditions that contained either all directional (i.e., distant or compass bearing) cues, or all positional (i.e., local, small objects) cues. After a short delay, participants navigated back to the target location from a novel starting location. Males had higher accuracy in initial search direction than females in environments with all directional cues. Lower digit ratio was correlated with higher accuracy of initial search direction in females in environments with all directional cues. Mental rotation scores did not correlate with digit ratio in either males or females. These results demonstrate for the first time that a sex difference in the use of directional cues, i.e., the sense of direction, is associated with more male-like digit ratio.	[Chai, Xiaoqian J.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Jacobs, Lucia F.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Chai, XQJ (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	xiaoqian@mit.edu			NSF [ECCS-1028319]; Rennie Epilepsy Fund	NSF(National Science Foundation (NSF)); Rennie Epilepsy Fund	This research was supported by NSF ECCS-1028319, an NSF Graduate Student Fellowship to X.J. Chai and the Rennie Epilepsy Fund grant to L. F. Jacobs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Barkley CL, 2007, BEHAV NEUROSCI, V121, P291, DOI 10.1037/0735-7044.121.2.291; Barkley CL, 2007, ANIM BEHAV, V73, P321, DOI 10.1016/j.anbehav.2006.07.009; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Bettis TJ, 2009, BEHAV PROCESS, V82, P249, DOI 10.1016/j.beproc.2009.07.004; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; Chai XJ, 2010, BEHAV BRAIN RES, V208, P336, DOI 10.1016/j.bbr.2009.11.039; Chai XJ, 2009, BEHAV NEUROSCI, V123, P276, DOI 10.1037/a0014722; Ciumas C, 2009, CEREB CORTEX, V19, P1167, DOI 10.1093/cercor/bhn160; Coolican J, 2003, EVOL HUM BEHAV, V24, P179, DOI 10.1016/S1090-5138(03)00010-2; CSATHO A, 2003, LEARN INDIVID DIFFER, V13, P239; De Goede M, 2008, BRAIN COGNITION, V66, P232, DOI 10.1016/j.bandc.2007.08.004; Epting LK, 1998, BEHAV NEUROSCI, V112, P1304, DOI 10.1037/0735-7044.112.6.1304; Forstmeier W, 2010, P ROY SOC B-BIOL SCI, V277, P3353, DOI 10.1098/rspb.2010.1007; HAMPSON E, 1990, PSYCHONEUROENDOCRINO, V15, P97, DOI 10.1016/0306-4530(90)90018-5; Hampson E, 1998, DEV NEUROPSYCHOL, V14, P299, DOI 10.1080/87565649809540713; Hampson E, 2008, ARCH SEX BEHAV, V37, P133, DOI 10.1007/s10508-007-9263-3; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Hurd PL, 2010, BEHAV GENET; Iachini T, 2005, BRAIN COGNITION, V59, P52, DOI 10.1016/j.bandc.2005.04.004; Jacobs LF, 2003, PSYCHOL REV, V110, P285, DOI 10.1037/0033-295X.110.2.285; James TW, 1997, EVOL HUM BEHAV, V18, P155, DOI 10.1016/S1090-5138(97)00004-4; KELSEY JE, 1988, BEHAV NEUROSCI, V102, P289; Knickmeyer RC, 2011, HORM BEHAV, V60, P256, DOI 10.1016/j.yhbeh.2011.05.009; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; LANGLEY CM, 1994, J COMP PSYCHOL, V108, P3, DOI 10.1037/0735-7036.108.1.3; Levy LJ, 2005, BEHAV NEUROSCI, V119, P853, DOI 10.1037/0735-7044.119.4.853; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Manning JT, 2011, P NATL ACAD SCI USA, V108, P16143, DOI 10.1073/pnas.1113312108; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; McBurney DH, 1997, EVOL HUM BEHAV, V18, P165, DOI 10.1016/S1090-5138(97)00001-9; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Medland SE, 2010, AM J HUM GENET, V86, P519, DOI 10.1016/j.ajhg.2010.02.017; Mueller SC, 2008, PSYCHONEUROENDOCRINO, V33, P973, DOI 10.1016/j.psyneuen.2008.04.005; Nelson E, 2010, AM J PHYS ANTHROPOL, V141, P395, DOI 10.1002/ajpa.21157; New J, 2007, P ROY SOC B-BIOL SCI, V274, P2679, DOI 10.1098/rspb.2007.0826; Nowak NT, 2010, ARCH SEX BEHAV; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Postma A, 1998, BRAIN COGNITION, V36, P334, DOI 10.1006/brcg.1997.0974; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Puts DA, 2010, HORM BEHAV, V58, P282, DOI 10.1016/j.yhbeh.2010.03.005; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; RESNICK SM, 1986, DEV PSYCHOL, V22, P191, DOI 10.1037/0012-1649.22.2.191; ROOF RL, 1993, BEHAV BRAIN RES, V53, P1, DOI 10.1016/S0166-4328(05)80261-X; ROOF RL, 1992, BRAIN RES, V572, P310, DOI 10.1016/0006-8993(92)90491-Q; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Sanders G, 2005, CORTEX, V41, P789, DOI 10.1016/S0010-9452(08)70297-1; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Saucier D, 2007, J INT NEUROPSYCH SOC, V13, P683, DOI 10.1017/S1355617707070865; Silverman I, 1998, SEX DIFFERENCES SPAT, P487; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Tlauka M, 2005, J ENVIRON PSYCHOL, V25, P111, DOI 10.1016/j.jenvp.2004.12.002; van Anders SM, 2005, HORM BEHAV, V47, P92, DOI 10.1016/j.yhbeh.2004.09.003; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; WILLIAMS CL, 1990, BEHAV NEUROSCI, V104, P84, DOI 10.1037/0735-7044.104.1.84; WILLIAMS CL, 1991, PSYCHONEUROENDOCRINO, V16, P155, DOI 10.1016/0306-4530(91)90076-6; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	69	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32816	10.1371/journal.pone.0032816	http://dx.doi.org/10.1371/journal.pone.0032816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393451	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500106
J	Dalmau, J; Codoner, FM; Erkizia, I; Pino, M; Pou, C; Paredes, R; Clotet, B; Martinez-Picado, J; Prado, JG				Dalmau, Judith; Codoner, Francisco M.; Erkizia, Itziar; Pino, Maria; Pou, Christian; Paredes, Roger; Clotet, Bonaventura; Martinez-Picado, Javier; Prado, Julia G.			In-Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; CORECEPTOR USAGE; TYPE-1; ESCAPE; FITNESS; PROGRESSION; MUTATIONS; DIVERSITY; CONSTRAINTS	Background: The use of in vitro models to unravel the phenotypic characteristics of circulating viral variants is key to understanding HIV-1 pathogenesis but limited by the availability of primary viral isolates from biological samples. However, overall in vivo genetic variability of HIV-1 within a subject may not be reflected in the viable viral population obtained after isolation. Although several studies have tried to determine whether viral populations expanded in vitro are representative of in vivo findings, the answer remains unclear due to the reduced number of clonal sequences analyzed or samples compared. In order to overcome previous experimental limitations, here we applied Deep Pyrosequencing (DPS) technology in combination with phenotypic experiments to analyze and compare with unprecedented detail the composition of viral isolates and in vivo quasispecies. Methodology/Principal Findings: We amplified by DPS HIV-1 genomic regions covering gag, protease, integrase and env-V3 to characterize paired isolates from plasma and peripheral blood mononuclear cells and compare them with total plasma viral RNA in four recently HIV-1 infected subjects. Our study demonstrated the presence of unique haplotypes scattered between sample types with conservation of major variants. In addition, no differences in intra- and inter-population encoded protein variability were found between the different types of isolates or when these were compared to plasma viral RNA within subjects. Additionally, in vitro experiments demonstrated phenotypic similarities in terms of replicative capacity and co-receptor usage between viral isolates and plasma viral RNA. Conclusion: This study is the first in-depth comparison and characterization of viral isolates from different sources and plasma circulating quasispecies using DPS in recently HIV-1 infected subjects. Our data supports the use of primary isolates regardless of their plasma or cellular origin to define genetic variability and biological traits of circulating HIV-1 quasispecies.	[Dalmau, Judith; Codoner, Francisco M.; Erkizia, Itziar; Pino, Maria; Pou, Christian; Paredes, Roger; Clotet, Bonaventura; Martinez-Picado, Javier; Prado, Julia G.] Hosp Badalona Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Barcelona, Spain; [Codoner, Francisco M.] Parc Cient Univ Valencia, Lifesequencing SL, Valencia, Spain; [Martinez-Picado, Javier] ICREA, Barcelona, Spain; [Paredes, Roger; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita SIDA, Barcelona, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; Hospital Germans Trias i Pujol	Dalmau, J (corresponding author), Hosp Badalona Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Barcelona, Spain.	jmpicado@irsicaixa.es; jgarciaprado@irsicaixa.es	Dalmau, Judith/I-7065-2016; Pou, Christian/B-2932-2015; Erkizia, Itziar/G-3376-2016; Prado, Julia Garcia/R-7177-2019; Martinez-Picado, Javier/G-5507-2012	Dalmau, Judith/0000-0001-7513-3711; Pou, Christian/0000-0003-3932-788X; Erkizia, Itziar/0000-0003-1244-8972; Prado, Julia Garcia/0000-0002-5439-4645; Martinez-Picado, Javier/0000-0002-4916-2129; Pino Claveria, Maria/0000-0003-4954-5215	Fondo de Investigacion Sanitaria (FIS) [CP09/00279]; "Fondo de Investigacion Sanitaria'' FIS-ISCIII; Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA'' [RD06/0006]; European Community; Anti-HIV-1 Drug Resistance Network (CHAIN) [223131]; "HIV Vacine Catalonian Program'' (HIVACAT Program); Marie Curie European Reintegration [238885]; European Commission; ICREA Funding Source: Custom	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); "Fondo de Investigacion Sanitaria'' FIS-ISCIII(Instituto de Salud Carlos III); Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA''; European Community(European Commission); Anti-HIV-1 Drug Resistance Network (CHAIN); "HIV Vacine Catalonian Program'' (HIVACAT Program); Marie Curie European Reintegration(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA(ICREA)	The project was funded by the Fondo de Investigacion Sanitaria (FIS) (CP09/00279). JGP holds a Miguel Servet contract funded by "Fondo de Investigacion Sanitaria'' FIS-ISCIII. This study was supported by the Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA'' (RD06/0006), the European Community's Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV-1 and Anti-HIV-1 Drug Resistance Network (CHAIN)'' grant agreement number 223131, and the "HIV Vacine Catalonian Program'' (HIVACAT Program). FMC was supported by the Marie Curie European Reintegration Grant number 238885, 'HIV-1 Coevolution', and by the European Commission Framework 7 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Bjorndal A, 1997, J VIROL, V71, P7478; Borderia AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010319; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Honeyborne I, 2010, J VIROL, V84, P11279, DOI 10.1128/JVI.01144-10; Irshad M, 2010, HEPATO-GASTROENTEROL, V57, P1529; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KUSUMI K, 1992, J VIROL, V66, P875, DOI 10.1128/JVI.66.2.875-885.1992; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peyerl FW, 2004, VIRAL IMMUNOL, V17, P144, DOI 10.1089/0882824041310658; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prado JG, 2010, J VIROL, V84, P492, DOI 10.1128/JVI.01743-09; Prado JG, 2009, J VIROL, V83, P1018, DOI 10.1128/JVI.01882-08; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villena C, 2007, J VIROL, V81, P4713, DOI 10.1128/JVI.02135-06; Voronin Y, 2007, J VIROL, V81, P10232, DOI 10.1128/JVI.01035-07; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yuste E, 2005, J VIROL, V79, P5421, DOI 10.1128/JVi.79.9.5421-5427.2005; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	42	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32714	10.1371/journal.pone.0032714	http://dx.doi.org/10.1371/journal.pone.0032714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393441	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500094
J	Dingari, NC; Horowitz, GL; Kang, JW; Dasari, RR; Barman, I				Dingari, Narahara Chari; Horowitz, Gary L.; Kang, Jeon Woong; Dasari, Ramachandra R.; Barman, Ishan			Raman Spectroscopy Provides a Powerful Diagnostic Tool for Accurate Determination of Albumin Glycation	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; NONENZYMATIC GLYCOSYLATION; HEMODIALYSIS-PATIENTS; CALIBRATION MODELS; DIABETIC SUBJECTS; GLYCEMIC CONTROL; PLASMA-GLUCOSE; IN-VIVO; HEMOGLOBIN; FRUCTOSAMINE	We present the first demonstration of glycated albumin detection and quantification using Raman spectroscopy without the addition of reagents. Glycated albumin is an important marker for monitoring the long-term glycemic history of diabetics, especially as its concentrations, in contrast to glycated hemoglobin levels, are unaffected by changes in erythrocyte life times. Clinically, glycated albumin concentrations show a strong correlation with the development of serious diabetes complications including nephropathy and retinopathy. In this article, we propose and evaluate the efficacy of Raman spectroscopy for determination of this important analyte. By utilizing the pre-concentration obtained through drop-coating deposition, we show that glycation of albumin leads to subtle, but consistent, changes in vibrational features, which with the help of multivariate classification techniques can be used to discriminate glycated albumin from the unglycated variant with 100% accuracy. Moreover, we demonstrate that the calibration model developed on the glycated albumin spectral dataset shows high predictive power, even at substantially lower concentrations than those typically encountered in clinical practice. In fact, the limit of detection for glycated albumin measurements is calculated to be approximately four times lower than its minimum physiological concentration. Importantly, in relation to the existing detection methods for glycated albumin, the proposed method is also completely reagent-free, requires barely any sample preparation and has the potential for simultaneous determination of glycated hemoglobin levels as well. Given these key advantages, we believe that the proposed approach can provide a uniquely powerful tool for quantification of glycation status of proteins in biopharmaceutical development as well as for glycemic marker determination in routine clinical diagnostics in the future.	[Dingari, Narahara Chari; Kang, Jeon Woong; Dasari, Ramachandra R.; Barman, Ishan] MIT, Laser Biomed Res Ctr, GR Harrison Spect Lab, Cambridge, MA 02139 USA; [Horowitz, Gary L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Clin Pathol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Dingari, NC (corresponding author), MIT, Laser Biomed Res Ctr, GR Harrison Spect Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ishan@mit.edu			NIH National Center for Research Resources at the MIT Laser Biomedical Research Center [P41-RR02594]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002594] Funding Source: NIH RePORTER	NIH National Center for Research Resources at the MIT Laser Biomedical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors research work is funded by the NIH National Center for Research Resources (http://www.ncrr.nih.gov/) for their grant P41-RR02594, at the MIT Laser Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI E, 1995, LANGMUIR, V11, P1057, DOI 10.1021/la00004a003; ANDERSON DJ, 1989, CLIN CHEM, V35, P2152; [Anonymous], 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004; Arnold MA, 1998, ANAL CHEM, V70, P1773, DOI 10.1021/ac9710801; Barman I, 2011, J BIOMED OPT, V16; Barman I, 2010, ANAL CHEM, V82, P9719, DOI 10.1021/ac101754n; Barman I, 2010, ANAL CHEM, V82, P6104, DOI 10.1021/ac100810e; Barone PW, 2006, ANGEW CHEM INT EDIT, V45, P8138, DOI 10.1002/anie.200603138; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; Brereton R.G., 2003, CHEMOMETRICS DATA AN; Brewster VL, 2011, ANAL CHEM, V83, P6074, DOI 10.1021/ac2012009; Burtis CA, 2001, TIETZ FUNDAMENTALS C; Cameron B D, 1999, Diabetes Technol Ther, V1, P135, DOI 10.1089/152091599317341; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chaiken J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922147; CHEN MC, 1976, J AM CHEM SOC, V98, P990, DOI 10.1021/ja00420a021; Chesne S, 2006, BIOCHIMIE, V88, P1467, DOI 10.1016/j.biochi.2006.05.011; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Crow P, 2005, BRIT J CANCER, V92, P2166, DOI 10.1038/sj.bjc.6602638; Currie LA, 1999, ANAL CHIM ACTA, V391, P103, DOI 10.1016/S0003-2670(99)00103-8; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Davidson J, 1986, CLIN DIABETES MELLIT, P198; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Dingari NC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3611006; Dingari NC, 2011, ANAL BIOANAL CHEM, V400, P2871, DOI 10.1007/s00216-011-5004-5; Esmonde-White KA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130338; Filik J, 2007, ANALYST, V132, P544, DOI 10.1039/b701541k; FITZGIBBONS JF, 1976, J CLIN INVEST, V58, P820, DOI 10.1172/JCI108534; Freedman BI, 2010, PERITON DIALYSIS INT, V30, P72, DOI 10.3747/pdi.2008.00243; GABER BP, 1974, J AM CHEM SOC, V96, P6868, DOI 10.1021/ja00829a010; GARLICK RL, 1983, J BIOL CHEM, V258, P6142; Geddes CD, 2006, TOPICS FLUORESCENCE; Gugliucci Alejandro, 2000, Journal of the American Osteopathic Association, V100, P621; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Hom FG, 1998, ACTA DIABETOL, V35, P48, DOI 10.1007/s005920050100; IBERG N, 1986, J BIOL CHEM, V261, P3542; Ichikawa H, 1996, Nihon Jinzo Gakkai Shi, V38, P305; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Joy MS, 2002, AM J KIDNEY DIS, V39, P297, DOI 10.1053/ajkd.2002.30549; Kang JW, 2011, BIOMED OPT EXPRESS, V2, P2484, DOI 10.1364/BOE.2.002484; Khan MWA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P146, DOI 10.1134/S0006297907020034; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Kocisova E, 2011, J RAMAN SPECTROSC, V42, P1606, DOI 10.1002/jrs.2915; Koga M, 2009, DIABETES RES CLIN PR, V84, P163, DOI 10.1016/j.diabres.2009.01.013; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Kopecky V, 2006, VIB SPECTROSC, V42, P184, DOI 10.1016/j.vibspec.2006.04.019; Kosecki SM, 2005, ANN PHARMACOTHER, V39, P1557, DOI 10.1345/aph.1G010; Kumeda Y, 2008, CLIN ENDOCRINOL, V69, P556, DOI 10.1111/j.1365-2265.2008.03202.x; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; LIN VJC, 1976, BIOPOLYMERS, V15, P203, DOI 10.1002/bip.1976.360150114; Liu W, 1997, BIOCHEM MOL BIOL INT, V42, P277; Matousek P, 2006, APPL SPECTROSC, V60, P758, DOI 10.1366/000370206777886955; OHE Y, 1987, CLIN CHIM ACTA, V169, P229, DOI 10.1016/0009-8981(87)90323-8; Okumura A, 2007, JPN J OPHTHALMOL, V51, P236, DOI 10.1007/s10384-007-0431-8; Ortiz C, 2006, ANAL BIOCHEM, V353, P157, DOI 10.1016/j.ab.2006.03.025; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Peng CS, 2011, J AM CHEM SOC, V133, P15650, DOI 10.1021/ja205636h; PEZOLET M, 1976, BIOCHIM BIOPHYS ACTA, V453, P502, DOI 10.1016/0005-2795(76)90146-X; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Rondeau P, 2010, BBA-PROTEINS PROTEOM, V1804, P789, DOI 10.1016/j.bbapap.2009.12.003; Sacks DB, 2002, CLIN CHEM, V48, P436; Sacks DB, 2001, CARBOHYDRATES; Saha A, 2011, BIOMED OPT EXPRESS, V2, P2792, DOI 10.1364/BOE.2.002792; Saha A, 2010, J BIOPHOTONICS, V3, P670, DOI 10.1002/jbio.201000044; Saha A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3246792; SAKURAI T, 1984, FEBS LETT, V176, P27, DOI 10.1016/0014-5793(84)80905-9; Sardesai V, 2011, INTRO CLIN NUTR, P346; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Shafer-Peltier KE, 2003, J AM CHEM SOC, V125, P588, DOI 10.1021/ja028255v; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stefek M, 1996, ACTA DIABETOL, V33, P35, DOI 10.1007/BF00571938; Tu A.T., 1982, RAMAN SPECTROSCOPY B; VANHAEVERBEEK M, 1994, ACTA DIABETOL, V31, P43, DOI 10.1007/BF00580760; Wang Y, 2007, CLIN CHEM, V53, P1394, DOI 10.1373/clinchem.2006.082917; Wold S, 1983, LECT NOTES MATH; Xu YJ, 2002, CLIN CHIM ACTA, V325, P127, DOI 10.1016/S0009-8981(02)00277-2; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; Zhang DM, 2003, ANAL CHEM, V75, P5703, DOI 10.1021/ac0345087	81	114	121	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32406	10.1371/journal.pone.0032406	http://dx.doi.org/10.1371/journal.pone.0032406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393405	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500058
J	Dong, D; Jin, K; Wu, XL; Zhong, Y				Dong, Dong; Jin, Ke; Wu, Xiaoli; Zhong, Yang			CRDB: Database of Chemosensory Receptor Gene Families in Vertebrate	PLOS ONE			English	Article							LINEAGE-SPECIFIC EXPANSIONS; EVOLUTIONARY DYNAMICS; MAMMALIAN EVOLUTION; GIANT PANDA; REPERTOIRES; SEQUENCE; PROTEIN; MOUSE; COW; PRIMATES	Chemosensory receptors (CR) are crucial for animals to sense the environmental changes and survive on earth. The emergence of whole-genome sequences provides us an opportunity to identify the entire CR gene repertoires. To completely gain more insight into the evolution of CR genes in vertebrates, we identified the nearly all CR genes in 25 vertebrates using homology-based approaches. Among these CR gene repertoires, nearly half of them were identified for the first time in those previously uncharacterized species, such as the guinea pig, giant panda and elephant, etc. Consistent with previous findings, we found that the numbers of CR genes vary extensively among different species, suggesting an extreme form of 'birth-and-death' evolution. For the purpose of facilitating CR gene analysis, we constructed a database with the goals to provide a resource for CR genes annotation and a web tool for exploring their evolutionary patterns. Besides a search engine for the gene extraction from a specific chromosome region, an easy-to-use phylogenetic analysis tool was also provided to facilitate online phylogeny study of CR genes. Our work can provide a rigorous platform for further study on the evolution of CR genes in vertebrates.	[Dong, Dong] E China Normal Univ, iAIR, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Jin, Ke; Wu, Xiaoli; Zhong, Yang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Jin, Ke] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Zhong, Yang] Tibet Univ, Inst Biodivers Sci & Geobiol, Lhasa, Peoples R China	East China Normal University; Fudan University; University of Toronto; Tibet University	Dong, D (corresponding author), E China Normal Univ, iAIR, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	ddong.ecnu@gmail.com			East China Normal University [79633006]	East China Normal University	This work is supported by Key Construction Program of the National '985' project of East China Normal University to Dong Dong, and the funding No. is 79633006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGNETTI E, 1985, EUR J BIOCHEM, V149, P227, DOI 10.1111/j.1432-1033.1985.tb08916.x; BLAZQUEZ NB, 1988, VET REC, V123, P49, DOI 10.1136/vr.123.2.49; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Endo H, 2002, J VET MED SCI, V64, P1153, DOI 10.1292/jvms.64.1153; Fischer A, 2005, MOL BIOL EVOL, V22, P432, DOI 10.1093/molbev/msi027; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 1999, BEHAV NEUROSCI, V113, P840, DOI 10.1037/0735-7044.113.4.840; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KRATZING JE, 1975, CELL TISSUE RES, V156, P239; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; Rouquier S, 1999, MAMM GENOME, V10, P1172, DOI 10.1007/s003359901185; Rouquier S, 1998, HUM MOL GENET, V7, P1337, DOI 10.1093/hmg/7.9.1337; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Steiger SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-446; Yamate J, 2006, J VET MED SCI, V68, P495, DOI 10.1292/jvms.68.495; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	40	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31540	10.1371/journal.pone.0031540	http://dx.doi.org/10.1371/journal.pone.0031540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393364	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500017
J	Weiner, ZP; Boyer, AE; Gallegos-Candela, M; Cardani, AN; Barr, JR; Glomski, IJ				Weiner, Zachary P.; Boyer, Anne E.; Gallegos-Candela, Maribel; Cardani, Amber N.; Barr, John R.; Glomski, Ian J.			Debridement Increases Survival in a Mouse Model of Subcutaneous Anthrax	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; LETHAL TOXIN; EDEMA TOXIN; DENDRITIC CELLS; LYMPH-NODES; INHALATIONAL ANTHRAX; INJECTIONAL ANTHRAX; INFECTION; MACROPHAGES; MANAGEMENT	Anthrax is caused by infection with Bacillus anthracis, a spore-forming Gram-positive bacterium. A major virulence factor for B. anthracis is an immunomodulatory tripartite exotoxin that has been reported to alter immune cell chemotaxis and activation. It has been proposed that B. anthracis infections initiate through entry of spores into the regional draining lymph nodes where they germinate, grow, and disseminate systemically via the efferent lymphatics. If this model holds true, it would be predicted that surgical removal of infected tissues, debridement, would have little effect on the systemic dissemination of bacteria. This model was tested through the development of a mouse debridement model. It was found that removal of the site of subcutaneous infection in the ear increased the likelihood of survival and reduced the quantity of spores in the draining cervical lymph nodes (cLN). At the time of debridement 12 hours post-injection measurable levels of exotoxins were present in the ear, cLN, and serum, yet leukocytes within the cLN were activated; countering the concept that exotoxins inhibit the early inflammatory response to promote bacterial growth. We conclude that the initial entry of spores into the draining lymph node of cutaneous infections alone is not sufficient to cause systemic disease and that debridement should be considered as an adjunct to antibiotic therapy.	[Weiner, Zachary P.; Cardani, Amber N.; Glomski, Ian J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Boyer, Anne E.; Gallegos-Candela, Maribel; Barr, John R.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	University of Virginia; Centers for Disease Control & Prevention - USA	Weiner, ZP (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	iglomski@virginia.edu			University of Virginia School of Medicine; NIH NIAID [1R21AI082046, 5T32AI704634]; Jeffress Memorial Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082046, T32AI007046] Funding Source: NIH RePORTER	University of Virginia School of Medicine; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jeffress Memorial Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this manuscript was funded by The University of Virginia School of Medicine Dean's allocated funds (IJG, ZPW), NIH NIAID grants 1R21AI082046 (IJG, ZPW) and 5T32AI704634 Infectious Diseases Training Program (ZPW), and The Jeffress Memorial Trust Research Award (IJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Beaumont G, 2010, J FORENSIC LEG MED, V17, P443, DOI 10.1016/j.jflm.2010.09.008; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Boyer AE, 2007, ANAL CHEM, V79, P8463, DOI 10.1021/ac701741s; Brookmeyer R, 2002, SCIENCE, V295, P1861, DOI 10.1126/science.1068474; Chand HS, 2009, INFECT IMMUN, V77, P429, DOI 10.1128/IAI.00647-08; Chou PJ, 2008, DNA CELL BIOL, V27, P637, DOI 10.1089/dna.2008.0760; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; Fiole D, 2009, 2009 ASM BAC A UNPUB; Fontes R A Jr, 2000, J Am Acad Orthop Surg, V8, P151; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Glomski IJ, 2007, INFECT IMMUN, V75, P4754, DOI 10.1128/IAI.00575-07; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Glomski IJ, 2011, BACILLUS ANTHRACIS A, P227; Goossens PL, 2009, MOL ASPECTS MED, V30, P467, DOI 10.1016/j.mam.2009.07.005; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Hirsh MI, 2007, LAB INVEST, V87, P182, DOI 10.1038/labinvest.3700505; Hu HJ, 2007, FEMS MICROBIOL LETT, V272, P245, DOI 10.1111/j.1574-6968.2007.00766.x; Jallali N, 2011, J PLAST RECONSTR AES, V64, P276, DOI 10.1016/j.bjps.2010.06.003; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; Maldonado-Arocho FJ, 2009, INFECT IMMUN, V77, P2036, DOI 10.1128/IAI.01329-08; McGovern TW, 2002, NEW ENGL J MED, V346, P943; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Paccani SR, 2007, CELL MICROBIOL, V9, P924, DOI 10.1111/j.1462-5822.2006.00840.x; Ramsay CN, 2010, EURO SURVEILL, V15, P19465; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Ringertz SH, 2000, LANCET, V356, P1574, DOI 10.1016/S0140-6736(00)03133-0; Saadia R, 2000, WORLD J SURG, V24, P1146, DOI 10.1007/s002680010188; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Spencer RC, 2003, J CLIN PATHOL, V56, P182, DOI 10.1136/jcp.56.3.182; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; WELKOS SL, 1993, MICROB PATHOGENESIS, V14, P381, DOI 10.1006/mpat.1993.1037; WHO, 2008, ANTHRAX HUMANS ANIMA; Yang J, 2009, MOL IMMUNOL, V46, P3261, DOI 10.1016/j.molimm.2009.08.005	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30201	10.1371/journal.pone.0030201	http://dx.doi.org/10.1371/journal.pone.0030201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393351	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500004
J	Dan, S; Chen, F; Choy, KW; Jiang, FM; Lin, JR; Xuan, ZL; Wang, W; Chen, SP; Li, XC; Jiang, H; Leung, TY; Lau, TK; Su, Y; Zhang, WY; Zhang, XQ				Dan, Shan; Chen, Fang; Choy, Kwong Wai; Jiang, Fuman; Lin, Jingrong; Xuan, Zhaoling; Wang, Wei; Chen, Shengpei; Li, Xuchao; Jiang, Hui; Leung, Tak Yeung; Lau, Tze Kin; Su, Yue; Zhang, Weiyuan; Zhang, Xiuqing			Prenatal Detection of Aneuploidy and Imbalanced Chromosomal Arrangements by Massively Parallel Sequencing	PLOS ONE			English	Article								Fetal chromosomal abnormalities are the most common reasons for invasive prenatal testing. Currently, G-band karyotyping and several molecular genetic methods have been established for diagnosis of chromosomal abnormalities. Although these testing methods are highly reliable, the major limitation remains restricted resolutions or can only achieve limited coverage on the human genome at one time. The massively parallel sequencing (MPS) technologies which can reach single base pair resolution allows detection of genome-wide intragenic deletions and duplication challenging karyotyping and microarrays as the tool for prenatal diagnosis. Here we reported a novel and robust MPS-based method to detect aneuploidy and imbalanced chromosomal arrangements in amniotic fluid (AF) samples. We sequenced 62 AF samples on Illumina GAIIx platform and with averagely 0.01 x whole genome sequencing data we detected 13 samples with numerical chromosomal abnormalities by z-test. With up to 26 whole genome sequencing data we were able to detect microdeletion/microduplication (ranged from 1.4 Mb to 37.3 Mb of 5 samples from chorionic villus sampling (CVS) using SeqSeq algorithm. Our work demonstrated MPS is a robust and accurate approach to detect aneuploidy and imbalanced chromosomal arrangements in prenatal samples.	[Dan, Shan; Su, Yue; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China; [Chen, Fang; Jiang, Fuman; Lin, Jingrong; Xuan, Zhaoling; Wang, Wei; Chen, Shengpei; Li, Xuchao; Jiang, Hui; Zhang, Xiuqing] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Choy, Kwong Wai; Leung, Tak Yeung; Lau, Tze Kin] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynecol, Fetal Med Unit, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Prince of Wales Hospital	Dan, S (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China.	sd_bao@sina.com; zhangxq@genomics.org.cn	Choy, Richard/AAW-8230-2020	Choy, Richard/0000-0002-3616-6200; Lau, Tze Kin/0000-0002-0242-1410	Beijing Nova Program [2006B08]; Beijing Municipal Science and Technology Commission [Z09090300830909]; Hong Kong General Research Fund (GRF) [463710]; Chinese University [2041573]; Shenzhen City Key Laborabory [CXB200903110066A]	Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Hong Kong General Research Fund (GRF); Chinese University; Shenzhen City Key Laborabory	The study was supported by Beijing Nova Program (2006B08) and Beijing Municipal Science and Technology Commission (Z09090300830909). Choy KW and Lau TK were supported by Hong Kong General Research Fund (GRF) grant project number 463710. Leung TY was supported by Chinese University Direct grant project number 2041573. The study was also supported by Shenzhen City Key Laborabory Project (CXB200903110066A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; HOOK EB, 1981, OBSTET GYNECOL, V58, P282; Irving C, 2011, J MATERN-FETAL NEO M, V24, P137, DOI 10.3109/14767051003758879; Korteweg FJ, 2008, OBSTET GYNECOL, V111, P865, DOI 10.1097/AOG.0b013e31816a4ee3; Leung TY, 2011, ULTRASOUND OBST GYN, V38, P314, DOI 10.1002/uog.8988; Leung TY, 2011, ULTRASOUND OBSTET GY; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Morris JK, 2003, PRENATAL DIAG, V23, P252, DOI 10.1002/pd.568; Vermeesch JR, 2007, EUR J HUM GENET, V15, P1105, DOI 10.1038/sj.ejhg.5201896; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wapner RJ, 2010, CLIN OBSTET GYNECOL, V53, P628, DOI 10.1097/GRF.0b013e3181ee2793; Williams ES, 2011, METHODS MOL BIOL, V735, P113, DOI 10.1007/978-1-61779-092-8_11	15	20	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e27835	10.1371/journal.pone.0027835	http://dx.doi.org/10.1371/journal.pone.0027835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389664	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600001
J	An, S; Chen, LL; Wei, JF; Yang, XN; Ma, DY; Xu, XM; Xu, XQ; He, SH; Lu, J; Laiz, R				An, Su; Chen, Lingling; Wei, Ji-Fu; Yang, Xuening; Ma, Dongying; Xu, Xuemei; Xu, Xueqing; He, Shaoheng; Lu, Jia; Laiz, Ren			Purification and Characterization of Two New Allergens from the Venom of Vespa magnifica	PLOS ONE			English	Article							ANTIGENIC CROSS-REACTIVITY; HORSEFLY SALIVARY-GLANDS; HYMENOPTERA VENOM; WASP VENOM; HONEYBEE VENOM; PROTEIN; HYALURONIDASE; ANAPHYLAXIS; DIPTERA; BIOLOGY	Due to poor diagnostic facilities and a lack of medical alertness, allergy to Vespa wasps may be underestimated. Few allergens have been identified from Vespa wasps. Possible native allergen proteins were purified from the wasp venoms (WV) (Vespa magnifica Smith) by gel filtration, ion exchange chromatography, respectively. Their sequences were determined by Edman degradation and cDNA cloning. Their allergenicities were assayed by enzyme-linked immunosorbent assay inhibition tests (ELISA-IT), immunoblots, and skin prick tests (SPTs). Their cross allergencities with Tab y 2 and Tab y 5 purified from the horsefly (Tabanus yao Macquart) were also determined. Two native allergens were identified from the WV, respectively. They are a 25-KDa antigen 5 protein (Ag5) (Vesp ma 5) and a 35-KDa hyaluronidase (Vesp ma 2). They represented major allergens in Vespa magnifica by immunoblots and SPTs. ELISA inhibition of pooled sera IgE reactivity to both the WV and the horsefly salivary gland extracts (HSGE) using four purified allergens (Vesp ma 2, Vesp ma 5 and previously purified Tab y 2 and Tab y 5) was significant. Their cross allergenicities were confirmed by ELISA-IT, immunoblots, and SPTs. They represented the cross reactive allergens from wasp and horsefly and proved the so called wasp-horsefly syndrome.	[An, Su; Yang, Xuening; Ma, Dongying; Xu, Xueqing; Lu, Jia; Laiz, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China; [An, Su] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Wei, Ji-Fu; He, Shaoheng] Nanjing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Chen, Lingling; Xu, Xuemei] Kunming Med Coll, Affiliated Hosp 1, Clin Lab, Kunming, Yunnan, Peoples R China; [Chen, Lingling; Xu, Xuemei] Kunming Med Coll, Affiliated Hosp 1, Dept Otolaryngol, Kunming, Yunnan, Peoples R China; [An, Su; Yang, Xuening] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University; Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, S (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China.	shaohenghe@hotmail.com; lujia1979@gmail.com; rlai@mail.kiz.ac.cn	Chen, Ling-Ling/AAY-3547-2021; ma, dongying/D-8623-2012		Chinese National Natural Science Foundation [30830021, 30800185, 30972822, 31025025]; Ministry of Science and Technology [2010CB529800, 2009ZX09103-1/091]; Ministry of Agriculture	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by Chinese National Natural Science Foundation (30830021, 30800185, 30972822, 31025025), the Ministry of Science and Technology (2010CB529800, 2009ZX09103-1/091) and the Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2011, ALLERGY, V66, P1420, DOI 10.1111/j.1398-9995.2011.02683.x; de Graaf DC, 2009, J PROTEOMICS, V72, P145, DOI 10.1016/j.jprot.2009.01.017; Freye HB, 1996, ANN ALLERG ASTHMA IM, V76, P270, DOI 10.1016/S1081-1206(10)63440-0; Galvao CES, 2006, J ALLERGY CLIN IMMUN, V117, pS308, DOI 10.1016/j.jaci.2005.12.1216; Han JY, 2008, TOXICON, V51, P914, DOI 10.1016/j.toxicon.2008.01.002; Hemmer W, 1998, J ALLERGY CLIN IMMUN, V101, P134, DOI 10.1016/S0091-6749(98)70208-8; Hoffman DR, 2008, CURR OPIN ALLERGY CL, V8, P338, DOI 10.1097/ACI.0b013e3283036a7d; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109; HOFFMAN DR, 1987, INT ARCH ALLER A IMM, V84, P25, DOI 10.1159/000234394; Jin C, 2010, J ALLERGY CLIN IMMUN, V125, P184, DOI 10.1016/j.jaci.2009.08.037; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; King TP, 1997, J ALLERGY CLIN IMMUN, V99, P630, DOI 10.1016/S0091-6749(97)70025-3; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; LU G, 1993, J IMMUNOL, V150, P2823; Ma D, 2011, ALLERGY, V66, P101, DOI 10.1111/j.1398-9995.2010.02435.x; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Monsalve RI, 1999, PROTEIN EXPRES PURIF, V16, P410, DOI 10.1006/prep.1999.1082; Pantera B, 2003, BBA-GEN SUBJECTS, V1623, P72, DOI 10.1016/j.bbagen.2003.07.001; Peiren N, 2005, BBA-PROTEINS PROTEOM, V1752, P1, DOI 10.1016/j.bbapap.2005.07.017; Peng Z, 2006, ALLERGY, V61, P485, DOI 10.1111/j.1398-9995.2006.00985.x; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4; Quercia O, 2008, EUR ANN ALLERGY CLIN, V40, P61; Seppala U, 2009, MOL IMMUNOL, V46, P2014, DOI 10.1016/j.molimm.2009.03.005; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; SOBOTKA AK, 1976, J ALLERGY CLIN IMMUN, V57, P29, DOI 10.1016/0091-6749(76)90076-2; Suck R, 2000, INT ARCH ALLERGY IMM, V121, P284, DOI 10.1159/000024341; WILBUR RD, 1975, J ALLERGY CLIN IMMUN, V55, P72; Xu XQ, 2006, TOXICON, V47, P249, DOI 10.1016/j.toxicon.2005.10.015; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200; Xu XQ, 2006, PEPTIDES, V27, P3053, DOI 10.1016/j.peptides.2006.09.003; Yang H, 2008, TOXICON, V51, P289, DOI 10.1016/j.toxicon.2007.10.003; Yu HN, 2007, TOXICON, V50, P377, DOI 10.1016/j.toxicon.2007.04.023; Zhou ZH, 2006, BIOCHEM BIOPH RES CO, V347, P1099, DOI 10.1016/j.bbrc.2006.07.024	35	73	81	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31920	10.1371/journal.pone.0031920	http://dx.doi.org/10.1371/journal.pone.0031920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384100	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500046
J	Rong, J; Zhang, W; Wang, XH; Fan, HJ; Lu, CP; Yao, HC				Rong, Jie; Zhang, Wei; Wang, Xiaohui; Fan, Hongjie; Lu, Chengping; Yao, Huochun			Identification of Candidate Susceptibility and Resistance Genes of Mice Infected with Streptococcus suis Type 2	PLOS ONE			English	Article							LONG PENTRAXIN PTX3; MATRIX METALLOPROTEINASES; UP-REGULATION; PROSTAGLANDIN E-2; INNATE IMMUNITY; ACTIVATION; MENINGITIS; PROTEINS; STRAINS; INFLAMMATION	Streptococcus suis type 2 (SS2) is an important swine pathogen and zoonosis agent. A/J mice are significantly more susceptible than C57BL/6 (B6) mice to SS2 infection, but the genetic basis is largely unknown. Here, alterations in gene expression in SS2 (strain HA9801)-infected mice were identified using Illumina mouse BeadChips. Microarray analysis revealed 3,692 genes differentially expressed in peritoneal macrophages between A/J and B6 mice due to SS2 infection. Between SS2-infected A/J and control A/J mice, 2646 genes were differentially expressed (1469 upregulated; 1177 downregulated). Between SS2-infected B6 and control B6 mice, 1449 genes were differentially expressed (778 upregulated; 671 downregulated). These genes were analyzed for significant Gene Ontology (GO) categories and signaling pathways using the Kyoto Encylopedia of Genes and Genomes (KEGG) database to generate a signaling network. Upregulated genes in A/J and B6 mice were related to response to bacteria, immune response, positive regulation of B cell receptor signaling pathway, type I interferon biosynthesis, defense and inflammatory responses. Additionally, upregulated genes in SS2-infected B6 mice were involved in antigen processing and presentation of exogenous peptides, peptide antigen stabilization, lymphocyte differentiation regulation, positive regulation of monocyte differentiation, antigen receptor-mediated signaling pathway and positive regulation of phagocytosis. Downregulated genes in SS2-infected B6 mice played roles in glycolysis, carbohydrate metabolic process, amino acid metabolism, behavior and muscle regulation. Microarray results were verified by quantitative real-time PCR (qRT-PCR) of 14 representative deregulated genes. Four genes differentially expressed between SS2-infected A/J and B6 mice, toll-like receptor 2 (Tlr2), tumor necrosis factor (Tnf), matrix metalloproteinase 9 (Mmp9) and pentraxin 3 (Ptx3), were previously implicated in the response to S. suis infection. This study identified candidate genes that may influence susceptibility or resistance to SS2 infection in A/J and B6 mice, providing further validation of these models and contributing to understanding of S. suis pathogenic mechanisms.	[Rong, Jie; Zhang, Wei; Wang, Xiaohui; Fan, Hongjie; Lu, Chengping; Yao, Huochun] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Rong, J (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	yaohch@njau.edu.cn			Cloning and Identification of the Resistance Genes of Swine Against Major Pathogenic Picroorganism [2009ZX08009-1546]; Foundation of National Natural Science Foundation of China [30671558]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Cloning and Identification of the Resistance Genes of Swine Against Major Pathogenic Picroorganism; Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by Cloning and Identification of the Resistance Genes of Swine Against Major Pathogenic Picroorganism (2009ZX08009-1546), The Foundation of National Natural Science Foundation of China (No. 30671558), and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Numani D, 2003, CLIN EXP IMMUNOL, V133, P67, DOI 10.1046/j.1365-2249.2003.02189.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEAUDOIN M, 1992, FEMS MICROBIOL LETT, V99, P111, DOI 10.1111/j.1574-6968.1992.tb05552.x; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Cotena A, 2007, J IMMUNOL, V179, P6311, DOI 10.4049/jimmunol.179.9.6311; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; KATAOKA Y, 1991, J VET MED SCI, V53, P1043, DOI 10.1292/jvms.53.1043; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Lemay AM, 2005, PHYSIOL GENOMICS, V23, P54, DOI 10.1152/physiolgenomics.00095.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Segura M, 1999, INFECT IMMUN, V67, P4646, DOI 10.1128/IAI.67.9.4646-4654.1999; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Tenenbaum T, 2006, BRAIN RES, V1100, P1, DOI 10.1016/j.brainres.2006.05.041; Vanier G, 2009, MICROB PATHOGENESIS, V46, P13, DOI 10.1016/j.micpath.2008.10.003; Wang KC, 2007, BERL MUNCH TIERARZTL, V120, P207, DOI 10.2376/0005-9366-120-207; WILLIAMS AE, 1988, RES VET SCI, V45, P394, DOI 10.1016/S0034-5288(18)30972-X; Wu ZF, 2010, MICROB PATHOGENESIS, V48, P178, DOI 10.1016/j.micpath.2010.02.007; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294	48	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32150	10.1371/journal.pone.0032150	http://dx.doi.org/10.1371/journal.pone.0032150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384161	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500060
J	Guo, F; Zhou, WJ; Zhang, JC; Xu, Q; Deng, XX				Guo, Fei; Zhou, Wenjing; Zhang, Jiancheng; Xu, Qiang; Deng, Xiuxin			Effect of the Citrus Lycopene beta-Cyclase Transgene on Carotenoid Metabolism in Transgenic Tomato Fruits	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; PHYTOENE SYNTHASE; GENETIC-VARIATION; EPSILON-CYCLASE; POTATO-TUBERS; PLANTS; PATHWAY; ACCUMULATION; MANIPULATION; EXPRESSION	Lycopene beta-cyclase (LYCB) is the key enzyme for the synthesis of beta-carotene, a valuable component of the human diet. In this study, tomato constitutively express Lycb-1 was engineered. The beta-carotene level of transformant increased 4.1 fold, and the total carotenoid content increased by 30% in the fruits. In the transgenic line, the downstream alpha-branch metabolic fluxes were repressed during the three developmental stages while alpha-carotene content increased in the ripe stage. Microarray analysis in the ripe stage revealed that the constitutive expression of Lycb-1 affected a number of pathways including the synthesis of fatty acids, flavonoids and phenylpropanoids, the degradation of limonene and pinene, starch and sucrose metabolism and photosynthesis. This study provided insight into the regulatory effect of Lycb-1 gene on plant carotenoid metabolism and fruit transcriptome.	[Guo, Fei; Zhou, Wenjing; Zhang, Jiancheng; Xu, Qiang; Deng, Xiuxin] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China; [Xu, Qiang; Deng, Xiuxin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Guo, F (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	xxdeng@mail.hzau.edu.cn		Xiuxin, Deng/0000-0003-4490-4514	Ministry of Science and Technology of China [2011CB100601, 2011AA100205]; National Natural Science Foundation of China [30830078]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (Nos.2011CB100601, 2011AA100205) and the National Natural Science Foundation of China (No.30830078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AL, 2011, FEMS MICROBIOL LETT, V318, P76, DOI 10.1111/j.1574-6968.2011.02241.x; Apel W, 2009, PLANT PHYSIOL, V151, P59, DOI 10.1104/pp.109.140533; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bartolozzi F, 1997, J CHROMATOGR A, V758, P99, DOI 10.1016/S0021-9673(96)00709-1; BIRD CR, 1988, PLANT MOL BIOL, V11, P651, DOI 10.1007/BF00017465; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; D'Ambrosio C, 2004, PLANT SCI, V166, P207, DOI 10.1016/j.plantsci.2003.09.015; Davuluri GR, 2004, PLANT J, V40, P344, DOI 10.1111/j.1365-313X.2004.02218.x; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; Fester T, 2002, PLANT CELL PHYSIOL, V43, P256, DOI 10.1093/pcp/pcf029; Forcat S, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-16; Fraser PD, 2007, PLANT CELL, V19, P3194, DOI 10.1105/tpc.106.049817; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Mayne ST, 1996, FASEB J, V10, P690, DOI 10.1096/fasebj.10.7.8635686; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; NAKAJIMA K, 1993, P NATL ACAD SCI USA, V90, P9591, DOI 10.1073/pnas.90.20.9591; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Romer S, 2002, METAB ENG, V4, P263, DOI 10.1006/mben.2002.0234; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Wang F, 2007, BIOTECHNOL ADV, V25, P211, DOI 10.1016/j.biotechadv.2006.12.001; West CE, 2002, J NUTR, V132, p2920S, DOI 10.1093/jn/132.9.2920S; Wurbs D, 2007, PLANT J, V49, P276, DOI 10.1111/j.1365-313X.2006.02960.x; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhou XJ, 2011, PLANT CELL ENVIRON, V34, P1020, DOI 10.1111/j.1365-3040.2011.02301.x	42	21	24	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32221	10.1371/journal.pone.0032221	http://dx.doi.org/10.1371/journal.pone.0032221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384184	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800029
J	Abdouh, M; Chatoo, W; El Hajjar, J; David, J; Ferreira, J; Bernier, G				Abdouh, Mohamed; Chatoo, Wassim; El Hajjar, Jida; David, Jocelyn; Ferreira, Jose; Bernier, Gilbert			Bmi1 Is Down-Regulated in the Aging Brain and Displays Antioxidant and Protective Activities in Neurons	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STAGE ALZHEIMERS-DISEASE; DNA-DAMAGE; OXIDATIVE STRESS; LIFE-SPAN; SUPEROXIDE-DISMUTASE; CELL RENEWAL; IN-VIVO; P53; PROLIFERATION	Aging increases the risk to develop several neurodegenerative diseases, although the underlying mechanisms are poorly understood. Inactivation of the Polycomb group gene Bmi1 in mice results in growth retardation, cerebellar degeneration, and development of a premature aging-like phenotype. This progeroid phenotype is characterized by formation of lens cataracts, apoptosis of cortical neurons, and increase of reactive oxygen species (ROS) concentrations, owing to p53-mediated repression of antioxidant response (AOR) genes. Herein we report that Bmi1 expression progressively declines in the neurons of aging mouse and human brains. In old brains, p53 accumulates at the promoter of AOR genes, correlating with a repressed chromatin state, down-regulation of AOR genes, and increased oxidative damages to lipids and DNA. Comparative gene expression analysis further revealed that aging brains display an up-regulation of the senescence-associated genes IL-6, p19(Arf) and p16(Ink4a), along with the pro-apoptotic gene Noxa, as seen in Bmi1-null mice. Increasing Bmi1 expression in cortical neurons conferred robust protection against DNA damage-induced cell death or mitochondrial poisoning, and resulted in suppression of ROS through activation of AOR genes. These observations unveil that Bmi1 genetic deficiency recapitulates aspects of physiological brain aging and that Bmi1 over-expression is a potential therapeutic modality against neurodegeneration.	[Abdouh, Mohamed; Chatoo, Wassim; El Hajjar, Jida; David, Jocelyn; Bernier, Gilbert] Hop Maison Neuve Rosemont, Dev Biol Lab, Montreal, PQ H1T 2M4, Canada; [Ferreira, Jose] Hop Maison Neuve Rosemont, Dept Pathol, Montreal, PQ H1T 2M4, Canada; [Bernier, Gilbert] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Abdouh, M (corresponding author), Hop Maison Neuve Rosemont, Dev Biol Lab, Montreal, PQ H1T 2M4, Canada.	gbernier.hmr@ssss.gouv.qc.ca		Abdouh, Mohamed/0000-0003-0702-9335	Natural Science and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); Antoine-Turmel Foundation for Macular Degeneration Research	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Antoine-Turmel Foundation for Macular Degeneration Research	This work was supported by grants from the Natural Science and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), and Antoine-Turmel Foundation for Macular Degeneration Research. Dr. Bernier is Chercheur Boursier from the Fonds de Recherche en Sante du Quebec (FRSQ). Dr. Chatoo is a Scholar from the Fonds de Recherche en Ophtalmologie de l'Universite de Montreal (FROUM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2004, DNA REPAIR, V3, P711, DOI 10.1016/j.dnarep.2004.02.010; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Buege J A, 1978, Methods Enzymol, V52, P302; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chatoo W, 2011, ANTIOXID REDOX SIGNA; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dorszewska J, 2004, RESP PHYSIOL NEUROBI, V139, P227, DOI 10.1016/j.resp.2003.10.005; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016615; Kim J, 2009, J BIOL CHEM, V284, P14396, DOI 10.1074/jbc.M808116200; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Markesbery WR, 2006, ANTIOXID REDOX SIGN, V8, P2039, DOI 10.1089/ars.2006.8.2039; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tian F, 2009, REJUV RES, V12, P209, DOI 10.1089/rej.2009.0849; Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiang H, 1998, J NEUROSCI, V18, P1363; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	52	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31870	10.1371/journal.pone.0031870	http://dx.doi.org/10.1371/journal.pone.0031870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384090	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100036
J	Lindorff-Larsen, K; Maragakis, P; Piana, S; Eastwood, MP; Dror, RO; Shaw, DE				Lindorff-Larsen, Kresten; Maragakis, Paul; Piana, Stefano; Eastwood, Michael P.; Dror, Ron O.; Shaw, David E.			Systematic Validation of Protein Force Fields against Experimental Data	PLOS ONE			English	Article							DYNAMICS; MECHANICS; UBIQUITIN; SIMULATIONS; EWALD	Molecular dynamics simulations provide a vehicle for capturing the structures, motions, and interactions of biological macromolecules in full atomic detail. The accuracy of such simulations, however, is critically dependent on the force field-the mathematical model used to approximate the atomic-level forces acting on the simulated molecular system. Here we present a systematic and extensive evaluation of eight different protein force fields based on comparisons of experimental data with molecular dynamics simulations that reach a previously inaccessible timescale. First, through extensive comparisons with experimental NMR data, we examined the force fields' abilities to describe the structure and fluctuations of folded proteins. Second, we quantified potential biases towards different secondary structure types by comparing experimental and simulation data for small peptides that preferentially populate either helical or sheet-like structures. Third, we tested the force fields' abilities to fold two small proteins-one alpha-helical, the other with beta-sheet structure. The results suggest that force fields have improved over time, and that the most recent versions, while not perfect, provide an accurate description of many structural and dynamical properties of proteins.	[Lindorff-Larsen, Kresten; Maragakis, Paul; Piana, Stefano; Eastwood, Michael P.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	D. E. Shaw Research; Columbia University	Lindorff-Larsen, K (corresponding author), DE Shaw Res, New York, NY 10036 USA.	David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Dror, Ron/0000-0002-6418-2793				Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Best RB, 2010, J PHYS CHEM B, V114, P8790, DOI 10.1021/jp102575b; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bowers KJ, 2007, J COMPUT PHYS, V221, P303, DOI 10.1016/j.jcp.2006.06.014; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Dror RO, 2009, P C HIGH PERF COMP N; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Faver JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018868; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Honda S, 2008, J AM CHEM SOC, V130, P15327, DOI 10.1021/ja8030533; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Lei HX, 2007, CURR OPIN STRUC BIOL, V17, P187, DOI 10.1016/j.sbi.2007.03.003; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; NORTHRUP SH, 1980, J CHEM PHYS, V73, P2700, DOI 10.1063/1.440484; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Piana S, 2011, J MOL BIOL, V405, P43, DOI 10.1016/j.jmb.2010.10.023; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; SHALONGO W, 1994, J AM CHEM SOC, V116, P8288, DOI 10.1021/ja00097a039; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Vendruscolo M, 2011, CURR BIOL, V21, pR68, DOI 10.1016/j.cub.2010.11.062; Vogeli B, 2007, J AM CHEM SOC, V129, P9377, DOI 10.1021/ja070324o; Voter AF, 1998, PHYS REV B, V57, P13985, DOI 10.1103/PhysRevB.57.R13985; Wang AC, 1996, J AM CHEM SOC, V118, P2483, DOI 10.1021/ja9535524	42	443	444	4	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32131	10.1371/journal.pone.0032131	http://dx.doi.org/10.1371/journal.pone.0032131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384157	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500077
J	Sun, YL; Senger, K; Baginski, TK; Mazloom, A; Chinn, Y; Pantua, H; Hamidzadeh, K; Ramani, SR; Luis, E; Tom, I; Sebrell, A; Quinones, G; Ma, Y; Mukhyala, K; Sai, T; Ding, JB; Haley, B; Shadnia, H; Kapadia, SB; Gonzalez, LC; Hass, PE; Zarrin, AA				Sun, Yonglian; Senger, Kate; Baginski, Tomasz K.; Mazloom, Anita; Chinn, Yvonne; Pantua, Homer; Hamidzadeh, Kajal; Ramani, Sree Ranjani; Luis, Elizabeth; Tom, Irene; Sebrell, Andrew; Quinones, Gabriel; Ma, Yan; Mukhyala, Kiran; Sai, Tao; Ding, Jiabing; Haley, Benjamin; Shadnia, Hooman; Kapadia, Sharookh B.; Gonzalez, Lino C.; Hass, Philip E.; Zarrin, Ali A.			Evolutionarily Conserved Paired Immunoglobulin-like Receptor alpha (PILR alpha) Domain Mediates Its Interaction with Diverse Sialylated Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 RECEPTOR; INHIBITORY RECEPTOR; SCAVENGER RECEPTOR; GLYCOPROTEIN-B; BINDING-SITE; PROTEIN; CELLS; CD99; RECOGNITION; SIALOADHESIN	Paired immunoglobulin-like receptor (PILR) alpha is an inhibitory receptor that recognizes several ligands, including mouse CD99, PILR-associating neural protein, and Herpes simplex virus-1 glycoprotein B. The physiological function(s) of interactions between PILR alpha and its cellular ligands are not well understood, as are the molecular determinants of PILR alpha/ligand interactions. To address these uncertainties, we sought to identify additional PILR alpha ligands and further define the molecular basis for PILR alpha/ligand interactions. Here, we identify two novel PILR alpha binding partners, neuronal differentiation and proliferation factor-1 (NPDC1), and collectin-12 (COLEC12). We find that sialylated O-glycans on these novel PILR alpha ligands, and on known PILR alpha ligands, are compulsory for PILR alpha binding. Sialylation-dependent ligand recognition is also a property of SIGLEC1, a member of the sialic acid-binding Ig-like lectins. SIGLEC1 Ig domain shares similar to 22% sequence identity with PILR alpha, an identity that includes a conserved arginine localized to position 97 in mouse and human SIGLEC1, position 133 in mouse PILR alpha and position 126 in human PILR alpha. We observe that PILR alpha/ligand interactions require conserved PILR alpha Arg-133 (mouse) and Arg-126 (human), in correspondence with a previously reported requirement for SIGLEC1 Arg-197 in SIGLEC1/ligand interactions. Homology modeling identifies striking similarities between PILR alpha and SIGLEC1 ligand binding pockets as well as at least one set of distinctive interactions in the galactoxyl-binding site. Binding studies suggest that PILR alpha recognizes a complex ligand domain involving both sialic acid and protein motif(s). Thus, PILR alpha is evolved to engage multiple ligands with common molecular determinants to modulate myeloid cell functions in anatomical settings where PILR alpha ligands are expressed.	[Sun, Yonglian; Senger, Kate; Hamidzadeh, Kajal; Ding, Jiabing; Zarrin, Ali A.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Baginski, Tomasz K.] Genentech Inc, Dept Prot Analyt Chem, San Francisco, CA 94080 USA; [Mazloom, Anita; Chinn, Yvonne; Ramani, Sree Ranjani; Luis, Elizabeth; Tom, Irene; Quinones, Gabriel; Haley, Benjamin; Gonzalez, Lino C.; Hass, Philip E.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Sebrell, Andrew; Sai, Tao] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ma, Yan; Mukhyala, Kiran] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Shadnia, Hooman] Chem Comp Grp Inc, Montreal, PQ H3A 2R7, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Chemical Computing Group	Zarrin, AA (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	zarrin.ali@gene.com	Gonzalez, Lino/E-4102-2012	Gonzalez, Lino/0000-0003-3817-6450; Hamidzadeh, Kajal/0000-0002-2949-0774				ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Clark AM, 2007, J CHEM INF MODEL, V47, P1933, DOI 10.1021/ci7001473; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Fan Q, 2010, J VIROL, V84, P8664, DOI 10.1128/JVI.01039-10; Fan Q, 2009, J VIROL, V83, P7384, DOI 10.1128/JVI.00087-09; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; GALIANA E, 1995, P NATL ACAD SCI USA, V92, P1560, DOI 10.1073/pnas.92.5.1560; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keck Rodney G., 2005, V308, P381; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kogure A, 2011, BIOCHEM BIOPH RES CO, V405, P428, DOI 10.1016/j.bbrc.2011.01.047; Masuda K, 1999, MOL IMMUNOL, V36, P993, DOI 10.1016/S0161-5890(99)00131-5; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Olson FJ, 2005, GLYCOBIOLOGY, V15, P177, DOI 10.1093/glycob/cwh158; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Satoh Takeshi, 2008, Virus (Nagoya), V58, P27; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Tabata S, 2008, J BIOL CHEM, V283, P8893, DOI 10.1074/jbc.M709793200; Taylor L S, 2000, Rev Immunogenet, V2, P204; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Wilson MD, 2006, PHYSIOL GENOMICS, V27, P201, DOI 10.1152/physiolgenomics.00284.2005; Wingett D, 1999, CELL IMMUNOL, V193, P17, DOI 10.1006/cimm.1999.1470	40	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15837	15850		10.1074/jbc.M111.286633	http://dx.doi.org/10.1074/jbc.M111.286633			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22396535	Green Published, hybrid			2022-12-25	WOS:000304006300063
J	Kang, J; Park, KH; Kim, JJ; Jo, EK; Han, MK; Kim, UH				Kang, John; Park, Kwang-Hyun; Kim, Jwa-Jin; Jo, Eun-Kyeong; Han, Myung-Kwan; Kim, Uh-Hyun			The Role of CD38 in Fc gamma Receptor (Fc gamma R)-mediated Phagocytosis in Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; INTRACELLULAR FREE CALCIUM; CYTOSOLIC-FREE CALCIUM; MEDIATED PHAGOCYTOSIS; MOBILIZES CA2+; POLYMORPHONUCLEAR LEUKOCYTES; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; ALVEOLAR MACROPHAGES	Phagocytosis is a crucial event in the immune system that allows cells to engulf and eliminate pathogens. This is mediated through the action of immunoglobulin (IgG)-opsonized microbes acting on Fc gamma receptors (Fc(2+)R) on macrophages, which results in sustained levels of intracellular Ca2+ through the mobilization of Ca2+ second messengers. It is known that the ADP-ribosyl cyclase is responsible for the rise in Ca2+ levels after Fc gamma R activation. However, it is unclear whether and how CD38 is involved in Fc gamma R-mediated phagocytosis. Here we show that CD38 is recruited to the forming phagosomes during phagocytosis of IgG-opsonized particles and produces cyclic-ADP-ribose, which acts on ER Ca2+ stores, thus allowing an increase in Fc(2+)R activation-mediated phagocytosis. Ca2+ data show that pretreatment of J774A.1 macrophages with 8-bromo-cADPR, ryanodine, blebbistatin, and various store-operated Ca2+ inhibitors prevented the long-lasting Ca2+ signal, which significantly reduced the number of ingested opsonized particles. Ex vivo data with macrophages extracted from CD38(-/-) mice also shows a reduced Ca2+ signaling and phagocytic index. Furthermore, a significantly reduced phagocytic index of Mycobacterium bovis BCG was shown in macrophages from CD38(-/-) mice in vivo. This study suggests a crucial role of CD38 in Fc gamma R-mediated phagocytosis through its recruitment to the phagosome and mobilization of cADPR-induced intracellular Ca2+ and store-operated extracellular Ca2+ influx.	[Kang, John; Park, Kwang-Hyun; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 561180, South Korea; [Park, Kwang-Hyun; Han, Myung-Kwan; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Med Sci, Jeonju 561180, South Korea; [Kim, Jwa-Jin; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon 301747, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Chungnam National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr		Eun-Kyeong, Jo/0000-0001-7191-0587; Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190	Korea Science and Engineering Foundation (National Research Laboratory) [R0A-2007-000-20121-0]	Korea Science and Engineering Foundation (National Research Laboratory)(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation (National Research Laboratory Grant R0A-2007-000-20121-0) (to U.-H. K.).	ALBERT RK, 1992, AM J RESP CELL MOL, V7, P182, DOI 10.1165/ajrcmb/7.2.182; Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; BENGTSSON T, 1993, EUR J CELL BIOL, V62, P49; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRMELIN M, 1983, EUR J BIOCHEM, V131, P539, DOI 10.1111/j.1432-1033.1983.tb07295.x; BLITZER RD, 1991, BRAIN RES, V542, P293, DOI 10.1016/0006-8993(91)91581-K; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Braun A, 2009, BLOOD, V113, P1097, DOI 10.1182/blood-2008-05-158477; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; De Flora A, 2000, CHEM IMMUNOL, V75, P79; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DIETER P, 1993, BIOL CHEM H-S, V374, P171, DOI 10.1515/bchm3.1993.374.1-6.171; DOWNING JF, 1995, P NATL ACAD SCI USA, V92, P4848, DOI 10.1073/pnas.92.11.4848; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; ELFERINK JGR, 1982, ARZNEIMITTELFORSCH, V32-2, P1417; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Funaro A, 1998, J IMMUNOL, V160, P2238; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; GOLDSTEIN IM, 1974, BIOCHEM BIOPH RES CO, V60, P807, DOI 10.1016/0006-291X(74)90312-X; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff RM, 2003, COMB CHEM HIGH T SCR, V6, P367; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HIRSCH CS, 1994, J IMMUNOL, V152, P743; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; ICHINOSE M, 1995, J NEUROIMMUNOL, V60, P37, DOI 10.1016/0165-5728(95)00050-C; ICHINOSE M, 1995, SCAND J IMMUNOL, V42, P311, DOI 10.1111/j.1365-3083.1995.tb03661.x; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; KIENER PA, 1993, J BIOL CHEM, V268, P24442; KIM E, 1992, INFECT IMMUN, V60, P1244, DOI 10.1128/IAI.60.3.1244-1248.1992; KLEIN JB, 1990, INFLAMMATION, V14, P599, DOI 10.1007/BF00914279; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; Kusner DJ, 1999, J IMMUNOL, V162, P2266; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEW DP, 1985, NATURE, V315, P509, DOI 10.1038/315509a0; LEW PD, 1986, J CELL BIOL, V102, P2197, DOI 10.1083/jcb.102.6.2197; Lieberman LA, 2009, ANTIMICROB AGENTS CH, V53, P756, DOI 10.1128/AAC.00607-08; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu DQ, 2010, ARTERIOSCL THROM VAS, V30, P575, DOI 10.1161/ATVBAHA.109.198374; LUND F, 1995, IMMUNOL TODAY, V16, P469, DOI 10.1016/0167-5699(95)80029-8; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MARKS PW, 1990, CELL CALCIUM, V11, P18, DOI 10.1016/0143-4160(90)90069-7; Matsumura Kazunori, 2006, J Nanobiotechnology, V4, P7, DOI 10.1186/1477-3155-4-7; MCLEISH KR, 1989, INFLAMMATION, V13, P681, DOI 10.1007/BF00914312; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Miyamoto S, 2000, BRIT J PHARMACOL, V130, P650, DOI 10.1038/sj.bjp.0703358; Munoz P, 2008, BLOOD, V111, P3653, DOI 10.1182/blood-2007-07-101600; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Orciani M, 2008, ANTI-CANCER DRUG, V19, P599, DOI 10.1097/CAD.0b013e3282ffd673; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Rakovic S, 1999, J BIOL CHEM, V274, P17820, DOI 10.1074/jbc.274.25.17820; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; ROSALES C, 1991, J IMMUNOL, V146, P3937; SAWYER DW, 1985, SCIENCE, V230, P663, DOI 10.1126/science.4048951; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Song EK, 2008, BIOCHEM BIOPH RES CO, V367, P156, DOI 10.1016/j.bbrc.2007.12.131; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; STENDAHL O, 1994, SCIENCE, V265, P1439, DOI 10.1126/science.8073285; Strzelecka-Kiliszek A, 2002, J IMMUNOL, V169, P6787, DOI 10.4049/jimmunol.169.12.6787; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Trubiani O, 2004, INT J IMMUNOPATH PH, V17, P293, DOI 10.1177/039463200401700309; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; VALERIUS NH, 1981, CELL, V24, P195, DOI 10.1016/0092-8674(81)90515-8; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wilsson A, 1996, J LEUKOCYTE BIOL, V59, P902, DOI 10.1002/jlb.59.6.902; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430; ZABRENETZKY V, 1988, BIOCHEM J, V255, P1037, DOI 10.1042/bj2551037; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	88	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14502	14514		10.1074/jbc.M111.329003	http://dx.doi.org/10.1074/jbc.M111.329003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396532	Green Published, hybrid			2022-12-25	WOS:000304003200017
J	McMillan, DGG; Marritt, SJ; Butt, JN; Jeuken, LJC				McMillan, Duncan G. G.; Marritt, Sophie J.; Butt, Julea N.; Jeuken, Lars J. C.			Menaquinone-7 Is Specific Cofactor in Tetraheme Quinol Dehydrogenase CymA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEWANELLA-ONEIDENSIS MR-1; C-TYPE CYTOCHROMES; UBIQUINONE BINDING-CAPACITY; ESCHERICHIA-COLI; ANAEROBIC RESPIRATION; ELECTRON-TRANSFER; OUTER-MEMBRANE; IRON REDUCTION; Q(O) SITE; REDUCING BACTERIUM	Little is known about enzymatic quinone-quinol interconversions in the lipid membrane when compared with our knowledge of substrate transformations by globular enzymes. Here, the smallest example of a quinol dehydrogenase in nature, CymA, has been studied. CymA is a monotopic membrane tetraheme c-type cytochrome belonging to the NapC/NirT family and central to anaerobic respiration in Shewanella sp. Using protein-film electrochemistry, it is shown that vesicle-bound menaquinone-7 is not only a substrate for this enzyme but is also required as a cofactor when converting other quinones. Here, we propose that the high concentration of quinones in the membrane negates the evolutionary pressure to create a high affinity active site. However, the instability and reactivity of reaction intermediate, semiquinone, might require a cofactor that functions to minimize damaging side reactions.	[McMillan, Duncan G. G.; Jeuken, Lars J. C.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [McMillan, Duncan G. G.; Jeuken, Lars J. C.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [McMillan, Duncan G. G.; Jeuken, Lars J. C.] Univ Leeds, Ctr Mol Nanosci, Leeds LS2 9JT, W Yorkshire, England; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Butt, Julea N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Leeds; University of Leeds; University of Leeds; University of East Anglia; University of East Anglia; University of East Anglia	Jeuken, LJC (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	L.J.C.Jeuken@leeds.ac.uk	Jeuken, Lars J C/A-6234-2008; Butt, Julea/E-2133-2011; McMillan, Duncan/AAT-7415-2021	Jeuken, Lars J C/0000-0001-7810-3964; Butt, Julea/0000-0002-9624-5226; McMillan, Duncan/0000-0001-6614-4494	UK Biotechnology and Biological Sciences Research Council; Engineering and Physical Science Research Council [BB/G009228]; BBSRC [BB/G009228/1, BB/G007519/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007519/1, BB/G009228/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the UK Biotechnology and Biological Sciences Research Council and the Engineering and Physical Science Research Council (BB/G009228).	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Biffinger JC, 2007, BIOSENS BIOELECTRON, V22, P1672, DOI 10.1016/j.bios.2006.07.027; Burns JL, 2009, APPL ENVIRON MICROB, V75, P5209, DOI 10.1128/AEM.00888-09; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; CARTER K, 1985, J BIOL CHEM, V260, P986; Chen XX, 2002, LANGMUIR, V18, P7009, DOI 10.1021/la0204794; Clarke TA, 2008, BIOCHEM SOC T, V36, P1005, DOI 10.1042/BST0361005; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; El Kasmi A, 1998, J AM CHEM SOC, V120, P225, DOI 10.1021/ja973417m; Field SJ, 2000, J BIOL CHEM, V275, P8515, DOI 10.1074/jbc.275.12.8515; Firer-Sherwood M, 2008, J BIOL INORG CHEM, V13, P849, DOI 10.1007/s00775-008-0398-z; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gescher JS, 2008, MOL MICROBIOL, V68, P706, DOI 10.1111/j.1365-2958.2008.06183.x; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P10675, DOI 10.1021/bi012146w; Hirst J, 1998, ANAL CHEM, V70, P5062, DOI 10.1021/ac980557l; Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Kim HJ, 2002, ENZYME MICROB TECH, V30, P145, DOI 10.1016/S0141-0229(01)00478-1; Leopold MC, 2002, LANGMUIR, V18, P2239, DOI 10.1021/la011456c; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; McLean JS, 2010, ENVIRON SCI TECHNOL, V44, P2721, DOI 10.1021/es903043p; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; MYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; MYERS CR, 1994, J APPL BACTERIOL, V76, P253, DOI 10.1111/j.1365-2672.1994.tb01624.x; MYERS CR, 1993, FEMS MICROBIOL LETT, V114, P215, DOI 10.1111/j.1574-6968.1993.tb06576.x; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2006, BIOCHEMISTRY-US, V45, P10492, DOI 10.1021/bi060013a; Pitts KE, 2003, J BIOL CHEM, V278, P27758, DOI 10.1074/jbc.M302582200; Qian YF, 2011, BIOCHEMISTRY-US, V50, P6217, DOI 10.1021/bi2005015; Remy A, 2003, NAT STRUCT BIOL, V10, P637, DOI 10.1038/nsb954; Rodrigues ML, 2008, J MOL BIOL, V381, P341, DOI 10.1016/j.jmb.2008.05.066; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Rumbley JN, 1997, BBA-PROTEIN STRUCT M, V1340, P131, DOI 10.1016/S0167-4838(97)00036-8; Saffarini DA, 2002, J BACTERIOL, V184, P846, DOI 10.1128/JB.184.3.846-848.2002; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Schwalb C, 2002, BIOCHEM SOC T, V30, P658, DOI 10.1042/bst0300658; Sharp RE, 1999, BIOCHEMISTRY-US, V38, P3440, DOI 10.1021/bi982639+; Sharp RE, 1999, BIOCHEMISTRY-US, V38, P14973, DOI 10.1021/bi9914863; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; Shi L, 2005, BIOTECHNIQUES, V38, P297, DOI 10.2144/05382PT01; Stamou D, 1997, LANGMUIR, V13, P2425, DOI 10.1021/la962123w; Viamajala S, 2002, BIOTECHNOL PROGR, V18, P290, DOI 10.1021/bp0202968; Weiss SA, 2009, BIOCHEM J, V417, P555, DOI 10.1042/BJ20081345; Yap LL, 2007, J BIOL CHEM, V282, P8777, DOI 10.1074/jbc.M611595200; Yap LL, 2010, BBA-BIOENERGETICS, V1797, P1924, DOI 10.1016/j.bbabio.2010.04.011; Zargar K, 2009, ARCH MICROBIOL, V191, P797, DOI 10.1007/s00203-009-0511-x; Zhou C, 2004, LANGMUIR, V20, P5870, DOI 10.1021/la036251d	65	69	71	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14215	14225		10.1074/jbc.M112.348813	http://dx.doi.org/10.1074/jbc.M112.348813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393052	Green Published, hybrid			2022-12-25	WOS:000303996300073
J	Pathak, SK; Skold, AE; Mohanram, V; Persson, C; Johansson, U; Spetz, AL				Pathak, Sushil Kumar; Skold, Annette E.; Mohanram, Venkatramanan; Persson, Catrine; Johansson, Ulrika; Spetz, Anna-Lena			Activated Apoptotic Cells Induce Dendritic Cell Maturation via Engagement of Toll-like Receptor 4 (TLR4), Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)grabbing Nonintegrin (DC-SIGN), and beta 2 Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; IMMUNE-RESPONSES; DYING CELLS; PI3 KINASE; TNF-ALPHA; IN-VITRO; RECOGNITION; HMGB1; TOLERANCE	Dendritic cells (DCs) are professional antigen-presenting cells playing a central role in connecting innate and adaptive immunity. Maturation signals are, however, required for DCs to undergo phenotypic and functional changes to acquire a fully competent antigen-presenting capacity. We previously reported that activated apoptotic peripheral lymphocytes (ActApo) provide activation/maturation signals to human monocyte-derived DCs. In this paper, we have characterized the signaling pathways and molecules involved in ActApo-mediated DC maturation. We found that both cellular and supernatant fractions from ActApo are required for DC maturation signaling. ActApoSup-induced CD80 and CD86 expression was significantly blocked in the presence of neutralizing antibodies against tumor necrosis factor-alpha (TNF-alpha). Cell-cell contact-dependent signaling involved beta 2 integrins, dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), and TLR4 because ActApo-induced up-regulation of the maturation markers CD80 and CD86 was significantly inhibited in the presence of neutralizing antibodies against CD18, CD11a, CD11b, and DC-SIGN as well as TLR4. The role of TLR4 was further confirmed by silencing of TLR4 in DCs. In addition, the endogenous adjuvant effect exerted by activated apoptotic splenocytes (ActApoSp) was reduced after immunization with human serum albumin in TLR4(-/-) mice. We detected activation of multiple signaling pathways and transcription factors in DCs upon co-culture with ActApo, including p38, JNK, PI3K-Akt, Src family kinases, NF kappa B p65, and AP1 transcription factor family members c-Jun and c-Fos, demonstrating the complex interactions occurring between ActApo and DCs. These studies provide important mechanistic insight into the responses of DCs during encounter with cells undergoing immunogenic cell death.	[Pathak, Sushil Kumar; Skold, Annette E.; Mohanram, Venkatramanan; Persson, Catrine; Johansson, Ulrika; Spetz, Anna-Lena] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Pathak, SK (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, S-14186 Stockholm, Sweden.	sushil.kumar.pathak@gmt.su.se; anna-lena.spetz@ki.se	Sköld, Annette/P-5718-2015; Mohanram, Venkatramanan/I-3652-2016; Spetz, Anna-Lena/C-3543-2016	Sköld, Annette/0000-0002-5309-8860; Spetz, Anna-Lena/0000-0003-3964-9512	Hedlunds Foundation, ALF-SLL; European Commission [EC-FP6-018953 Auto/AlloCell, EC-FP6-037611 EUROPRISE]; Swedish Foundation for Strategic Research	Hedlunds Foundation, ALF-SLL; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by Hedlunds Foundation, ALF-SLL; European Commission Grant EC-FP6-018953 Auto/AlloCell and Grant EC-FP6-037611 EUROPRISE; and the Swedish Foundation for Strategic Research.	Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Brave A, 2010, VACCINE, V28, P2080, DOI 10.1016/j.vaccine.2009.12.040; Buttiglieri S, 2003, INT J CANCER, V106, P516, DOI 10.1002/ijc.11243; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hedlund S, 2010, HUM IMMUNOL, V71, P535, DOI 10.1016/j.humimm.2010.02.022; Hoffmann TK, 2000, CANCER RES, V60, P3542; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Hu Y, 2008, J LEUKOCYTE BIOL, V84, P1353, DOI 10.1189/jlb.0107040; Ignatius R, 2000, J VIROL, V74, P11329, DOI 10.1128/JVI.74.23.11329-11338.2000; Ishii S, 2003, ANTICANCER RES, V23, P2457; Johansson U, 2007, J IMMUNOL, V179, P1711, DOI 10.4049/jimmunol.179.3.1711; Kabelitz D, 1997, FRONT BIOSCI, V2, P61; Kim JH, 2010, IMMUNOL LETT, V134, P47, DOI 10.1016/j.imlet.2010.08.008; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuka M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011491; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mascanfroni ID, 2010, J BIOL CHEM, V285, P9569, DOI 10.1074/jbc.M109.071241; Mohanram V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021171; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Neves BM, 2010, AM J PATHOL, V177, P2898, DOI 10.2353/ajpath.2010.100367; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Saalbach A, 2007, J IMMUNOL, V178, P4966, DOI 10.4049/jimmunol.178.8.4966; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Singhal E, 2011, INT J BIOCHEM CELL B, V43, P1134, DOI 10.1016/j.biocel.2011.04.006; Spetz AL, 2002, J IMMUNOL, V169, P5771, DOI 10.4049/jimmunol.169.10.5771; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; van Stijn CMW, 2010, MOL IMMUNOL, V47, P1544, DOI 10.1016/j.molimm.2010.01.014; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Voigylander C, 2006, J IMMUNOTHER, V29, P407, DOI 10.1097/01.cji.0000210081.60178.b4; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001	62	29	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13731	13742		10.1074/jbc.M111.336545	http://dx.doi.org/10.1074/jbc.M111.336545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396536	Green Published, hybrid			2022-12-25	WOS:000303996300029
J	Wen, HR; Ostman, J; Bubb, KJ; Panayiotou, C; Priestley, JV; Baker, MD; Ahluwalia, A				Wen, Hairuo; Oestman, Johan; Bubb, Kristen J.; Panayiotou, Catherine; Priestley, John V.; Baker, Mark D.; Ahluwalia, Amrita			20-Hydroxyeicosatetraenoic Acid (20-HETE) Is a Novel Activator of Transient Receptor Potential Vanilloid 1 (TRPV1) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPSAICIN RECEPTOR; MYOGENIC CONSTRICTION; HEK-293 CELLS; PKC-EPSILON; PHOSPHORYLATION; HEAT; AUTOREGULATION; SENSITIZATION; ANTAGONIST	TRPV1 is a member of the transient receptor potential ion channel family and is gated by capsaicin, the pungent component of chili pepper. It is expressed predominantly in small diameter peripheral nerve fibers and is activated by noxious temperatures >42 degrees C. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 4A/4F-derived metabolite of the membrane phospholipid arachidonic acid. It is a powerful vasoconstrictor and has structural similarities with other TRPV1 agonists, e. g. the hydroperoxyeicosatetraenoic acid 12-HPETE, and we hypothesized that it may be an endogenous ligand for TRPV1 in sensory neurons innervating the vasculature. Here, we demonstrate that 20-HETE both activates and sensitizes mouse and human TRPV1, in a kinase-dependent manner, involving the residue Ser(502) in heterologously expressed hTRPV1, at physiologically relevant concentrations.	[Wen, Hairuo; Oestman, Johan; Bubb, Kristen J.; Panayiotou, Catherine; Ahluwalia, Amrita] Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, London EC1M 6BQ, England; [Wen, Hairuo; Oestman, Johan; Priestley, John V.; Baker, Mark D.] Queen Mary Univ London, Barts & London Med Sch, Blizard Inst, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Ahluwalia, A (corresponding author), Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	a.ahluwalia@qmul.ac.uk	Bubb, Kristen/G-7746-2016	AHLUWALIA, Amrita/0000-0001-7626-6399	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust ( to H. W., J. O., K. J. B., and C. P.).	Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Choi JS, 2001, BIOCHEM PHARMACOL, V61, P1029, DOI 10.1016/S0006-2952(01)00556-1; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Elg S, 2007, J COMP NEUROL, V503, P35, DOI 10.1002/cne.21351; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Frisbee JC, 2001, MICROCIRCULATION, V8, P45, DOI 10.1038/sj.mn.7300148; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Huang A, 2005, HYPERTENSION, V46, P607, DOI 10.1161/01.HYP.0000176745.04393.4d; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Jara-Oseguera Andres, 2008, Curr Mol Pharmacol, V1, P255; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Laffer CL, 2004, HYPERTENSION, V43, P388, DOI 10.1161/01.HYP.0000112224.87290.3a; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Scotland RS, 2004, CIRC RES, V95, P1027, DOI 10.1161/01.RES.0000148633.93110.24; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Wang MH, 2001, AM J PHYSIOL-REG I, V280, pR255, DOI 10.1152/ajpregu.2001.280.1.R255; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhao J, 2006, BIOCHEMISTRY-US, V45, P4915, DOI 10.1021/bi052082f; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	33	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13868	13876		10.1074/jbc.M111.334896	http://dx.doi.org/10.1074/jbc.M111.334896			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389490	hybrid, Green Published			2022-12-25	WOS:000303996300042
J	Adams, RA; Snode, ER; Shaw, JB				Adams, Rick A.; Snode, Emily R.; Shaw, Jason B.			Flapping Tail Membrane in Bats Produces Potentially Important Thrust during Horizontal Takeoffs and Very Slow Flight	PLOS ONE			English	Article							KINEMATICS; BIOMECHANICS; PERFORMANCE; UPSTROKE; LIFT	Historically, studies concerning bat flight have focused primarily on the wings. By analyzing high-speed video taken on 48 individuals of five species of vespertilionid bats, we show that the capacity to flap the tail-membrane (uropatagium) in order to generate thrust and lift during takeoffs and minimal-speed flight (< 1 m (s-1)) was largely underestimated. Indeed, bats flapped the tail-membrane by extensive dorso-ventral fanning motions covering as much as 135 degrees of arc consistent with thrust generation by air displacement. The degree of dorsal extension of the tail-membrane, and thus the potential amount of thrust generated during platform launches, was significantly correlated with body mass (P = 0.02). Adduction of the hind limbs during upstrokes collapsed the tail-membrane thereby reducing its surface area and minimizing negative lift forces. Abduction of the hind limbs during the downstroke fully expanded the tail-membrane as it was swept ventrally. The flapping kinematics of the tail-membrane is thus consistent with expectations for an airfoil. Timing offsets between the wings and tail-membrane during downstrokes was as much as 50%, suggesting that the tail-membrane was providing thrust and perhaps lift when the wings were retracting through the upstoke phase of the wing-beat cycle. The extent to which the tail-membrane was used during takeoffs differed significantly among four vespertilionid species (P = 0.01) and aligned with predictions derived from bat ecomorphology. The extensive fanning motion of the tail membrane by vespertilionid bats has not been reported for other flying vertebrates.	[Adams, Rick A.; Snode, Emily R.; Shaw, Jason B.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA	University of Northern Colorado	Adams, RA (corresponding author), Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA.	rick.adams@unco.edu			University of Northern Colorado	University of Northern Colorado	Research was funded by the Provost Research Fund at the University of Northern Colorado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 1997, J ZOOL LONDON, V246, P165; Adams RA, 2008, CELLS TISSUES ORGANS, V187, P13, DOI 10.1159/000109960; ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; [Anonymous], 1999, REV DOLPHIN HYDRODYN; Azuma A., 2006, BIOKINETICS FLYING S; Berg AM, 2010, J EXP BIOL, V213, P1651, DOI 10.1242/jeb.038109; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; Fish FE, 2000, PHYSIOL BIOCHEM ZOOL, V73, P683, DOI 10.1086/318108; Gardiner JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018214; GATESY SM, 1993, J EXP BIOL, V176, P55; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HERMANSON JW, 1983, J MAMMAL, V64, P62, DOI 10.2307/1380751; HERMANSON JW, 1985, J ZOOL, V205, P157, DOI 10.1111/j.1469-7998.1985.tb03526.x; Kojeszewski T, 2007, J EXP BIOL, V210, P2411, DOI 10.1242/jeb.02790; MacAyeal LC, 2011, J EXP BIOL, V214, P786, DOI 10.1242/jeb.050195; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Norberg U., 1990, VERTEBRATE FLIGHT ME; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Rayner J.M.V., 1987, P23; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; Schutt WA, 1997, J EXP BIOL, V200, P3003; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; Swartz SM, 2003, BAT ECOLOGY, P257; Vaughan TA, 1970, BATS, P127; VAUGHAN TERRY A., 1959, UNIV KANSAS PUBL MUS NAT HIST, V12, P1; VIDELER J, 1985, J EXP BIOL, V119, P265	28	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32074	10.1371/journal.pone.0032074	http://dx.doi.org/10.1371/journal.pone.0032074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393378	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500031
J	Parisien, M; Freed, KF; Sosnick, TR				Parisien, Marc; Freed, Karl F.; Sosnick, Tobin R.			On Docking, Scoring and Assessing Protein-DNA Complexes in a Rigid-Body Framework	PLOS ONE			English	Article							BINDING SITES; PREDICTION; RECOGNITION; POTENTIALS; SEQUENCE; ELECTROSTATICS; ENERGIES; INSIGHTS; SURFACE; FOLD	We consider the identification of interacting protein-nucleic acid partners using the rigid body docking method FTdock, which is systematic and exhaustive in the exploration of docking conformations. The accuracy of rigid body docking methods is tested using known protein-DNA complexes for which the docked and undocked structures are both available. Additional tests with large decoy sets probe the efficacy of two published statistically derived scoring functions that contain a huge number of parameters. In contrast, we demonstrate that state-of-the-art machine learning techniques can enormously reduce the number of parameters required, thereby identifying the relevant docking features using a miniscule fraction of the number of parameters in the prior works. The present machine learning study considers a 300 dimensional vector (dependent on only 15 parameters), termed the Chemical Context Profile (CCP), where each dimension reflects a specific type of protein amino acid-nucleic acid base interaction. The CCP is designed to capture the chemical complementarities of the interface and is well suited for machine learning techniques. Our objective function is the Chemical Context Discrepancy (CCD), which is defined as the angle between the native system's CCP vector and the decoy's vector and which serves as a substitute for the more commonly used root mean squared deviation (RMSD). We demonstrate that the CCP provides a useful scoring function when certain dimensions are properly weighted. Finally, we explore how the amino acids on a protein's surface can help guide DNA binding, first through long-range interactions, followed by direct contacts, according to specific preferences for either the major or minor grooves of the DNA.	[Parisien, Marc; Sosnick, Tobin R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Freed, Karl F.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Freed, Karl F.; Sosnick, Tobin R.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Freed, Karl F.] Univ Chicago, James Frank Inst, Chicago, IL 60637 USA; [Sosnick, Tobin R.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Parisien, M (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	trsosnic@uchicago.edu	Freed, Karl F/J-7764-2018	Freed, Karl F/0000-0001-6240-2599; Parisien, Marc/0000-0003-2924-5960	NIH [GM57880]; NSF [CHE-1111918]; United States National Institutes of Health (NIH) [GM57880]; Computation Institute; Biological Sciences Division of the University of Chicago and Argonne National Laboratory [S10 RR029030-01]; National Science Foundation [OCI-1007115]; computing resources of the Open Science Grid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057880, R56GM057880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Computation Institute; Biological Sciences Division of the University of Chicago and Argonne National Laboratory; National Science Foundation(National Science Foundation (NSF)); computing resources of the Open Science Grid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant GM57880 (T. Pan, TRS), NSF grant CHE-1111918 (KF). This work was supported by a United States National Institutes of Health (NIH) grant GM57880 (T. Pan, TRS), NSF grant CHE-1111918 (KF), and the NIH-supported computing resources of the "Beagle'' Cray XE6 system provided by the Computation Institute and the Biological Sciences Division of the University of Chicago and Argonne National Laboratory under grant S10 RR029030-01, and by the National Science Foundation through the NSF-supported ExTENCI project (OCI-1007115) and the computing resources of the Open Science Grid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1258; Andrabi M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-30; Bahadur RP, 2008, NUCLEIC ACIDS RES, V36, P2705, DOI 10.1093/nar/gkn102; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chan SL, 2010, J CHEM INF MODEL, V50, P1724, DOI 10.1021/ci100227h; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P5147, DOI 10.1093/nar/gkh785; Chin K, 1999, NAT STRUCT BIOL, V6, P1055; Chuang GY, 2008, BIOPHYS J, V95, P4217, DOI 10.1529/biophysj.108.135814; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Farwer J, 2006, BIOPOLYMERS, V81, P51, DOI 10.1002/bip.20377; Feliu E, 2010, PROTEINS, V78, P3376, DOI 10.1002/prot.22844; Fitzgerald JE, 2007, PROTEIN SCI, V16, P2123, DOI 10.1110/ps.072939707; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gong HP, 2008, P NATL ACAD SCI USA, V105, P11146, DOI 10.1073/pnas.0804506105; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; KNEGTEL RMA, 1994, J MOL BIOL, V235, P318, DOI 10.1016/S0022-2836(05)80035-X; Kondo J, 2011, NUCL ACIDS RES; Lee D, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-2; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MacCallum JL, 2011, ASSESSMENT PROTEIN S, pn/a; Mereghetti P, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-2; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Nie Y, 2009, CURR GENOMICS, V10, P558, DOI 10.2174/138920209789503923; Ohlendorf D H, 1985, Adv Biophys, V20, P137, DOI 10.1016/0065-227X(85)90034-6; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Perez-Cano L, 2010, BIOCOMPUT-PAC SYM, P293; Poulain P, 2008, J COMPUT CHEM, V29, P2582, DOI 10.1002/jcc.21014; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Romero E, 2008, IEEE T NEURAL NETWOR, V19, P431, DOI 10.1109/TNN.2007.909535; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sternberg MJE, 2000, METH MOL B, V143, P399; Temiz NA, 2009, NUCLEIC ACIDS RES, V37, P4076, DOI 10.1093/nar/gkp289; van Dijk M, 2010, NUCL ACIDS RES; van Dijk M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn386; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; Wilde M, 2011, PARALLEL COMPUT, V37, P633, DOI 10.1016/j.parco.2011.05.005; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Zhao XC, 2010, APPL SOFT COMPUT, V10, P119, DOI 10.1016/j.asoc.2009.06.010	55	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32647	10.1371/journal.pone.0032647	http://dx.doi.org/10.1371/journal.pone.0032647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393431	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500083
J	Morgan, HP; Mertens, HDT; Guariento, M; Schmidt, CQ; Soares, DC; Svergun, DI; Herbert, AP; Barlow, PN; Hannan, JP				Morgan, Hugh P.; Mertens, Haydyn D. T.; Guariento, Mara; Schmidt, Christoph Q.; Soares, Dinesh C.; Svergun, Dmitri I.; Herbert, Andrew P.; Barlow, Paul N.; Hannan, Jonathan P.			Structural Analysis of the C-Terminal Region (Modules 18-20) of Complement Regulator Factor H (FH)	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SMALL-ANGLE SCATTERING; TRANSLATIONAL MINIREVIEW SERIES; POLYANION BINDING-SITE; SYNCHROTRON X-RAY; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; 3-DIMENSIONAL STRUCTURE; HOST RECOGNITION; PROTEIN BETA-1H	Factor H (FH) is a soluble regulator of the human complement system affording protection to host tissues. It selectively inhibits amplification of C3b, the activation-specific fragment of the abundant complement component C3, in fluid phase and on self-surfaces and accelerates the decay of the alternative pathway C3 convertase, C3bBb. We have determined the crystal structure of the three carboxyl-terminal complement control protein (CCP) modules of FH (FH18-20) that bind to C3b, and which additionally recognize polyanionic markers specific to self-surfaces. These CCPs harbour nearly 30 disease-linked missense mutations. We have also deployed small-angle X-ray scattering (SAXS) to investigate FH18-20 flexibility in solution using FH18-20 and FH19-20 constructs. In the crystal lattice FH18-20 adopts a "J"-shape: A similar to 122-degree tilt between the structurally highly similar modules 18 and 19 precedes an extended, linear arrangement of modules 19 and 20 as observed in previously determined structures of these two modules alone. However, under solution conditions FH18-20 adopts multiple conformations mediated by flexibility between CCPs 18 and 19. We also pinpoint the locations of disease-associated missense mutations on the module 18 surface and discuss our data in the context of the C3b: FH interaction.	[Morgan, Hugh P.; Hannan, Jonathan P.] Univ Edinburgh, Inst Struct & Mol Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Mertens, Haydyn D. T.; Svergun, Dmitri I.] Hamburg Outstn, European Mol Biol Lab, Hamburg, Germany; [Guariento, Mara; Schmidt, Christoph Q.; Herbert, Andrew P.; Barlow, Paul N.] Univ Edinburgh, Sch Chem, EaStCHEM, Edinburgh Biomol NMR Unit, Edinburgh, Midlothian, Scotland; [Soares, Dinesh C.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; European Molecular Biology Laboratory (EMBL); University of Edinburgh; University of Edinburgh	Morgan, HP (corresponding author), Univ Edinburgh, Inst Struct & Mol Biol, Sch Biol Sci, Kings Bldg, Edinburgh, Midlothian, Scotland.	Jonathan.Hannan@ucdenver.edu	Herbert, Andrew P/C-4755-2008; Barlow, Paul N/G-2853-2011; Herbert, Andy P/F-6693-2010; Soares, Dinesh C/A-4425-2012	Herbert, Andrew P/0000-0002-4549-6965; Herbert, Andy P/0000-0002-4549-6965; Soares, Dinesh C/0000-0001-7557-0495; Hannan, Jonathan/0000-0003-3318-2341; Svergun, Dmitri/0000-0003-0830-5696; Mertens, Haydyn/0000-0002-5664-744X	School of Biological Sciences at the University of Edinburgh; Wellcome Trust [073131, 088179]; EMBL Interdisciplinary Postdocs programme (EIPOD); Scottish University Life Sciences Alliance; BBSRC; Medical Research Council [G0001089] Funding Source: researchfish; MRC [G0001089] Funding Source: UKRI	School of Biological Sciences at the University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBL Interdisciplinary Postdocs programme (EIPOD); Scottish University Life Sciences Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by start-up funding from the School of Biological Sciences at the University of Edinburgh to JPH, by Wellcome Trust grant 073131 to PNB, and by Wellcome Trust grant 088179 to DCS. HDTM was supported by a fellowship from the EMBL Interdisciplinary Postdocs programme (EIPOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Use of the Protein Production and Biophysical Characterization Facilities at the University of Edinburgh was supported by The Wellcome Trust, the Scottish University Life Sciences Alliance and the BBSRC.	Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GORDON DL, 1995, J IMMUNOL, V155, P348; Guigonis V, 2005, AM J KIDNEY DIS, V45, P588, DOI 10.1053/j.ajkd.2004.12.004; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kirkitadze MD, 1999, BIOCHEMISTRY-US, V38, P7019, DOI 10.1021/bi982453a; Kirkitadze MD, 1999, BIOCHEM J, V344, P167, DOI 10.1042/0264-6021:3440167; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Maleknia SD, 2001, ANAL BIOCHEM, V289, P103, DOI 10.1006/abio.2000.4910; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Morgan HP, 2011, ACTA CRYSTALLOGR D, V67, P593, DOI 10.1107/S0907444911015423; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pechtl IC, 2011, PROTEIN SCI, V12, P2012; Perkins SJ, 2002, J MOL BIOL, V316, P217, DOI 10.1006/jmbi.2001.5337; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ripoche J, 1988, BIOCHEM J, V249, P563; Saunders RE, 2006, HUM MUTAT, V27, P21, DOI 10.1002/humu.20268; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	64	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32187	10.1371/journal.pone.0032187	http://dx.doi.org/10.1371/journal.pone.0032187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389686	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600024
J	Tozer, AJB; Forsythe, ID; Steinert, JR				Tozer, Adam J. B.; Forsythe, Ian D.; Steinert, Joern R.			Nitric Oxide Signalling Augments Neuronal Voltage-Gated L-Type (Ca(V)1) and P/Q-Type (Ca(V)2.1) Channels in the Mouse Medial Nucleus of the Trapezoid Body	PLOS ONE			English	Article							SENSITIVE CALCIUM-CHANNELS; CA2+ CHANNELS; S-NITROSYLATION; INTRINSIC EXCITABILITY; HIPPOCAMPAL-NEURONS; VOLUME TRANSMITTER; HAIR-CELLS; RAT; MODULATION; PATHWAY	Nitric Oxide (NO) is a diffusible second messenger that modulates ion channels, intrinsic excitability and mediates synaptic plasticity. In light of its activity-dependent generation in the principal neurons of the medial nucleus of the trapezoid body (MNTB), we have investigated its potential modulatory effects on native voltage-gated calcium channels (Ca-V) within this nucleus. Whole-cell patch recordings were made from brain slices from P13-15 CBA mice. Slices were incubated with the inhibitor of neuronal nitric oxide synthase (nNOS) 7-nitroindazole (10 mu M) and pharmacological blockers used to isolate Ca2+ current subtypes. Unpaired observations in the presence and absence of the NO-donors sodium nitroprusside (SNP, 100 mu M) or Diethyl-ammonium-nonoate (DEA, 100 mu M) were made to elucidate NO-dependent modulation of the expressed Ca-V subtypes. A differential effect of NO on the calcium channel subtypes was observed: Ca(V)1 and Ca(V)2.1 (L+R- and P/Q+R-type) conductances were potentiated, whereas N+R-type (Ca(V)2.2) and R-type (Ca(V)2.3) current amplitudes were unaffected. L+R-type currents increased from 0.36 +/- 0.04 nA to 0.64 +/- 0.11 nA and P/Q+R-type from 0.55 +/- 0.09 nA to 0.94 +/- 0.05 nA, thereby changing the balance and relative contribution of each subtype to the whole cell calcium current. In addition, N+R-type half-activation voltage was left shifted following NO exposure. NO-dependent modulation of P/Q+R and N+R-type, but not L+R-type, channels was removed by inhibition of soluble guanylyl cyclase (sGC) activity. This data demonstrates a differential effect of NO signalling on voltage-gated calcium entry, by distinct NO-dependent pathways.	[Tozer, Adam J. B.; Forsythe, Ian D.; Steinert, Joern R.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England	University of Leicester	Tozer, AJB (corresponding author), Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England.	js333@le.ac.uk	Steinert, Joern/A-6678-2008; Steinert, Joern R/AAI-2742-2020; Steinert, Joern/ABB-4561-2020	Steinert, Joern/0000-0003-1640-0845; Steinert, Joern R/0000-0003-1640-0845; Forsythe, Ian/0000-0001-8216-0419	Medical Research Council; MRC [MC_U132681855] Funding Source: UKRI; Medical Research Council [MC_U132681855] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (http://www.mrctox.le.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Almanza A, 2007, J NEUROPHYSIOL, V97, P1188, DOI 10.1152/jn.00849.2006; Arroyo G, 2003, EUR J PHARMACOL, V475, P11, DOI 10.1016/S0014-2999(03)02084-3; Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; BLATTER LA, 1994, CELL CALCIUM, V15, P122, DOI 10.1016/0143-4160(94)90051-5; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Chen JG, 2002, FREE RADICAL BIO MED, V32, P638, DOI 10.1016/S0891-5849(02)00748-7; D'Ascenzo M, 2002, J NEUROSCI, V22, P7485; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fessenden JD, 1999, J COMP NEUROL, V404, P52; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jian KH, 2007, BIOCHEM BIOPH RES CO, V359, P481, DOI 10.1016/j.bbrc.2007.05.113; Leao RN, 2004, J PHYSIOL-LONDON, V559, P25, DOI 10.1113/jphysiol.2004.067421; Lewis SJ, 2005, EUR J PHARMACOL, V528, P144, DOI 10.1016/j.ejphar.2005.10.056; Li NZ, 2003, J NEUROSCI, V23, P10302; Lv P, 2010, J NEUROPHYSIOL, V103, P2494, DOI 10.1152/jn.00017.2010; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Petzold GC, 2005, BRAIN RES, V1063, P9, DOI 10.1016/j.brainres.2005.09.048; RANDALL A, 1995, J NEUROSCI, V15, P2995; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Steinert JR, 2010, J PHYSIOL-LONDON, V588, P447, DOI 10.1113/jphysiol.2009.184317; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Willmott NJ, 2000, J NEUROSCI, V20, P1767; Wong AYC, 2003, J NEUROSCI, V23, P4868; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Youssoufian M, 2005, J NEUROPHYSIOL, V94, P3168, DOI 10.1152/jn.00342.2005	36	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32256	10.1371/journal.pone.0032256	http://dx.doi.org/10.1371/journal.pone.0032256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389692	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600030
J	Cruz-Martin, A; Crespo, M; Portera-Cailliau, C				Cruz-Martin, Alberto; Crespo, Michelle; Portera-Cailliau, Carlos			Glutamate Induces the Elongation of Early Dendritic Protrusions via mGluRs in Wild Type Mice, but Not in Fragile X Mice	PLOS ONE			English	Article							CRITICAL PERIOD; BARREL CORTEX; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; IN-VIVO; SPINES; EXPERIENCE; FILOPODIA; MOTILITY; SYNAPTOGENESIS	Fragile X syndrome (FXS), the most common inherited from of autism and mental impairment, is caused by transcriptional silencing of the Fmr1 gene, resulting in the loss of the RNA-binding protein FMRP. Dendritic spines of cortical pyramidal neurons in affected individuals are abnormally immature and in Fmr1 knockout (KO) mice they are also abnormally unstable. This could result in defects in synaptogenesis, because spine dynamics are critical for synapse formation. We have previously shown that the earliest dendritic protrusions, which are highly dynamic and might serve an exploratory role to reach out for axons, elongate in response to glutamate. Here, we tested the hypothesis that this process is mediated by metabotropic glutamate receptors (mGluRs) and that it is defective in Fmr1 KO mice. Using time-lapse imaging with two-photon microscopy in acute brain slices from early postnatal mice, we find that early dendritic protrusions in layer 2/3 neurons become longer in response to application of glutamate or DHPG, a Group 1 mGluR agonist. Blockade of mGluR5 signaling, which reverses some adult phenotypes of KO mice, prevented the glutamate-mediated elongation of early protrusions. In contrast, dendritic protrusions from KO mice failed to respond to glutamate. Thus, absence of FMRP may impair the ability of cortical pyramidal neurons to respond to glutamate released from nearby pre-synaptic terminals, which may be a critical step to initiate synaptogenesis and stabilize spines.	[Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Cruz-Martin, Alberto; Crespo, Michelle; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cruz-Martin, A (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	cpcailliau@mednet.ucla.edu	Cruz Martin, Alberto/ABE-7562-2021; Cruz-Martín, Alberto/AAO-5320-2020	Cruz-Martin, Alberto/0000-0002-3271-7220	NICHD/NIH [5R01HD054453]; Diversity Supplement; University of California; MARC U*STAR NIH/NIGMS; FRAXA; DANA Foundations; Fu-Hsing and Jyu-Yuan Chen Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054453] Funding Source: NIH RePORTER	NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Diversity Supplement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); MARC U*STAR NIH/NIGMS; FRAXA; DANA Foundations; Fu-Hsing and Jyu-Yuan Chen Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NICHD/NIH 5R01HD054453 (CPC) and a Diversity Supplement for that grant(ACM), The University of California President's Postdoctoral Fellowship Program (ACM), MARC U*STAR NIH/NIGMS (MC), and by the FRAXA (www.fraxa.org) and DANA Foundations (www.dana.org)(CPC), as well as by the generous support of the Fu-Hsing and Jyu-Yuan Chen Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; CORNELLBELL AH, 1990, GLIA, V3, P322, DOI 10.1002/glia.440030503; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Dailey ME, 1996, J NEUROSCI, V16, P2983; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; FOX K, 1992, J NEUROSCI, V12, P1826; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pan F, 2010, P NATL ACAD SCI US; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Portera-Cailliau C, 2001, REV NEUROLOGIA, V33, P1158, DOI 10.33588/rn.3312.2001338; Portera-Cailliau C, 2011, NEUROSCIENTIST; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Scotto-Lomassese S, 2011, J NEUROSCI, V31, P2205, DOI 10.1523/JNEUROSCI.5514-10.2011; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SMITH SJ, 1991, NERVE GROWTH CONE, P19; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	46	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32446	10.1371/journal.pone.0032446	http://dx.doi.org/10.1371/journal.pone.0032446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384253	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500091
J	Kaseva, N; Wehkalampi, K; Strang-Karlsson, S; Salonen, M; Pesonen, AK; Raikkonen, K; Tammelin, T; Hovi, P; Lahti, J; Heinonen, K; Jarvenpaa, AL; Andersson, S; Eriksson, JG; Kajantie, E				Kaseva, Nina; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Salonen, Minna; Pesonen, Anu-Katriina; Raikkonen, Katri; Tammelin, Tuija; Hovi, Petteri; Lahti, Jari; Heinonen, Kati; Jarvenpaa, Anna-Liisa; Andersson, Sture; Eriksson, Johan G.; Kajantie, Eero			Lower Conditioning Leisure-Time Physical Activity in Young Adults Born Preterm at Very Low Birth Weight	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIORESPIRATORY FITNESS; RISK-FACTORS; PERSONALITY; HELSINKI; EXERCISE; ADOLESCENCE; PERFORMANCE; COMPENDIUM; CAPACITY	Background: Adults born preterm at very low birth weight (VLBW, <1500 g) have elevated levels of risk factors for cardiovascular diseases and type 2 diabetes. Preliminary observations suggest that this could partly be explained by lower rates of physical activity. The aim of this study was to assess physical activity in healthy young adults born preterm at very low birth weight compared with term-born controls. Methodology/Principal Findings: We studied 94 unimpaired young adults, aged 21-29 years, born at VLBW and 101 age-, sex-, and birth hospital-matched term-born controls from one regional center in Southern Finland. The participants completed a validated 30-item 12-month physical activity questionnaire and the NEO-Personality Inventory based on the Big Five taxonomy, the most commonly used classification of personality traits. Yearly frequency, total time, total volume and energy expenditure of conditioning and non-conditioning leisure-time physical activity (LTPA) and commuting physical activity were compared between VLBW and term-born subjects. A subset of participants underwent dual-energy x-ray absorptiometry for body composition measurement. Data were analyzed by multiple linear regression. Compared with controls, VLBW participants had lower frequency [-38.5% (95% CI; -58.9, -7.7)], total time [-47.4% (95% CI; -71.2, -4.1)], total volume [-44.3% (95% CI; -65.8, -9.2)] and energy expenditure [-55.9% (95% CI; -78.6, -9.4)] of conditioning LTPA when adjusted for age, sex, body mass index, smoking, parental education and personality traits. Adjusting for lean body mass instead of body mass index attenuated the difference. There were no differences in non-conditioning LTPA or commuting physical activity. Conclusions/Significance: Compared with term-born controls, unimpaired VLBW adults undertake less frequent LTPA with lower total time and volume of exercise resulting in lower energy expenditure. Differences in personality that exist between the VLBW and term-born groups do not seem to explain this association.	[Kaseva, Nina; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Salonen, Minna; Hovi, Petteri; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Dept Chron Dis & Diabet Prevent, Helsinki, Finland; [Kaseva, Nina; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Pesonen, Anu-Katriina; Raikkonen, Katri; Lahti, Jari; Heinonen, Kati] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Folkhalsan Research Center	Kaseva, N (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis & Diabet Prevent, Helsinki, Finland.	nina.kaseva@fimnet.fi	PAN, ZEQIANG/X-6341-2018; Kaseva, Nina/O-7918-2019; Lahti, Jari/P-7987-2018; Lahti, Jari/P-2283-2019	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Pesonen, Anu-Katriina/0000-0002-0662-6261; Eriksson, Johan/0000-0002-2516-2060; Raikkonen, Katri/0000-0003-3124-3470; Heinonen, Kati/0000-0002-1262-5599	Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; University of Helsinki; Perklen Foundation; Research Foundation for the Orion Corporation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Waldemar von Frenckell Foundation; Yrjo Jahnsson Foundation; Finnish Medical Foundation; Otto A. Malm Donation Fund; Finska Lakaresallskapet; Emil Aaltonen Foundation	Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; University of Helsinki; Perklen Foundation; Research Foundation for the Orion Corporation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Waldemar von Frenckell Foundation; Yrjo Jahnsson Foundation; Finnish Medical Foundation; Otto A. Malm Donation Fund; Finska Lakaresallskapet; Emil Aaltonen Foundation	The grants previously received are from the following foundations: Vainio Foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, University of Helsinki, the Perklen Foundation, the Research Foundation for the Orion Corporation, the Signe and Ane Gyllenberg Foundation, the Sigrid Juselius Foundation, the Waldemar von Frenckell Foundation, the Yrjo Jahnsson Foundation, the Finnish Medical Foundation, Otto A. Malm Donation Fund, Finska Lakaresallskapet and the Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Burns YR, 2009, DEV MED CHILD NEUROL, V51, P136, DOI 10.1111/j.1469-8749.2008.03118.x; Costa P.T., 1985, NEO PERSONALITY INVE; DEBACKER G, 1981, CARDIOLOGY, V67, P110, DOI 10.1159/000173235; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Evensen KAI, 2009, EUR J PAEDIATR NEURO, V13, P47, DOI 10.1016/j.ejpn.2008.02.009; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hack M, 2007, J PEDIATR-US, V151, P635, DOI 10.1016/j.jpeds.2007.04.063; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kajantie E, 2010, DIABETES CARE; Kajantie E, 2010, J PEDIAT; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Koupil I, 2005, J EPIDEMIOL COMMUN H, V59, P473, DOI 10.1136/jech.2004.026518; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; LAKKA TA, 1992, INT J EPIDEMIOL, V21, P467, DOI 10.1093/ije/21.3.467; LAKKA TA, 1993, J CLIN EPIDEMIOL, V46, P1119, DOI 10.1016/0895-4356(93)90111-D; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Norman M, 2010, SEMIN PERINATOL, V34, P183, DOI 10.1053/j.semperi.2010.02.009; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pesonen AK, 2008, J CHILD PSYCHOL PSYC, V49, P609, DOI 10.1111/j.1469-7610.2007.01874.x; Pianosi PT, 2000, PEDIATR RES, V47, P653, DOI 10.1203/00006450-200005000-00016; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2010, J PEDIAT; Pyhala R, 2009, PEDIATRICS, V123, P731, DOI 10.1542/peds.2008-0277; Rhodes RE, 2006, BRIT J SPORT MED, V40, P958, DOI 10.1136/bjsm.2006.028860; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Schmidt LA, 2008, PEDIATRICS, V122, pE181, DOI 10.1542/peds.2007-3747; Strang-Karlsson S, 2010, CHRONOBIOL INT, V27, P1829, DOI 10.3109/07420528.2010.512689; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC	42	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32430	10.1371/journal.pone.0032430	http://dx.doi.org/10.1371/journal.pone.0032430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384247	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500088
J	Khodja, NI; Chataigneau, T; Auger, C; Schini-Kerth, VB				Khodja, Noureddine Idris; Chataigneau, Thierry; Auger, Cyril; Schini-Kerth, Valerie B.			Grape-Derived Polyphenols Improve Aging-Related Endothelial Dysfunction in Rat Mesenteric Artery: Role of Oxidative Stress and the Angiotensin System	PLOS ONE			English	Article							RED WINE POLYPHENOLS; EDHF-MEDIATED RELAXATIONS; PORCINE CORONARY-ARTERIES; II-INDUCED HYPERTENSION; NITRIC-OXIDE SYNTHASE; HYPERPOLARIZING FACTOR; DEPENDENT RELAXATIONS; SUPEROXIDE-PRODUCTION; REDUCED EXPRESSION; ENZYME-INHIBITION	Aging is characterized by the development of an endothelial dysfunction, which affects both the nitric oxide (NO)- and the endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxations, associated with vascular oxidative stress and the activation of the angiotensin system. This study investigated whether red wine polyphenols (RWPs), antioxidants and potent stimulators of NO-and EDHF-mediated relaxations improve aging-related endothelial dysfunction, and, if so, examined the underlying mechanism. Mesenteric artery reactivity was determined in organ chambers, vascular oxidative stress by dihydroethidine and MitoSOX staining, and expression of target proteins by immunohistochemical staining. Control young rats (16 weeks) received solvent (ethanol, 3% v/v), and middle-aged rats (46 weeks) either solvent or RWPs (100 mg/kg/day) in the drinking water. The acetylcholine-induced endothelium-dependent NO component was slightly reduced whereas the EDHF component was markedly blunted in rings of middle-aged rats compared to young rats. The endothelial dysfunction was associated with oxidative stress, an upregulation of angiotensin II and AT1 receptors and a down-regulation of SKCa, IKCa, and angiotensin converting enzyme. Intake of RWPs for either one or two weeks improved the NO and the EDHF components of the relaxation, and normalized oxidative stress, the expression of SKCa, IKCa and the components of the angiotensin system. The protective effect of the 2-week RWPs treatment persisted for one and two weeks following stopping intake of RWPs. Thus, intake of RWPs caused a persistent improvement of the endothelial function, particularly the EDHF component, in middle-aged rats and this effect seems to involve the normalization of the expression of SKCa, IKCa and the angiotensin system.	[Khodja, Noureddine Idris; Chataigneau, Thierry; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, Fac Pharm, Lab Biophoton & Pharmacol, UMR CNRS 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Khodja, NI (corresponding author), Univ Strasbourg, Fac Pharm, Lab Biophoton & Pharmacol, UMR CNRS 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Auger, Cyril/N-4702-2016		Office National Interprofessionnel des Fruits, des Legumes, des Vins et de l'Horticulture (Action Vin Sante, France)	Office National Interprofessionnel des Fruits, des Legumes, des Vins et de l'Horticulture (Action Vin Sante, France)	This work was supported, in part, by the Office National Interprofessionnel des Fruits, des Legumes, des Vins et de l'Horticulture (Action Vin & Sante, France). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aranda R, 2007, FREE RADICAL RES, V41, P1195, DOI 10.1080/10715760701481461; Armstead WM, 2003, ANESTHESIOLOGY, V98, P1378, DOI 10.1097/00000542-200306000-00012; ATKINSON J, 1994, AM J PHYSIOL, V267, pR136, DOI 10.1152/ajpregu.1994.267.1.R136; Briones A. M., 2005, Autonomic & Autacoid Pharmacology, V25, P155, DOI 10.1111/j.1474-8673.2005.00344.x; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cosentino F, 2001, ARTERIOSCL THROM VAS, V21, P496, DOI 10.1161/01.ATV.21.4.496; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Dal-Ros S, 2011, BIOCHEM BIOPH RES CO, V404, P743, DOI 10.1016/j.bbrc.2010.12.060; Dal-Ros S, 2010, GASTROENTEROLOGY, V138, P1574, DOI 10.1053/j.gastro.2009.10.040; Dal-Ros S, 2009, J PHARMACOL EXP THER, V328, P478, DOI 10.1124/jpet.108.145326; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6; Goto K, 2000, HYPERTENSION, V36, P581, DOI 10.1161/01.HYP.36.4.581; Goto K, 2004, CLIN EXP PHARMACOL P, V31, P650, DOI 10.1111/j.1440-1681.2004.04054.x; Hamilton CA, 2001, HYPERTENSION, V37, P529, DOI 10.1161/01.HYP.37.2.529; Hilgers RHP, 2007, AM J PHYSIOL-HEART C, V292, pH2275, DOI 10.1152/ajpheart.00949.2006; HONGO K, 1988, STROKE, V19, P892, DOI 10.1161/01.STR.19.7.892; Kansui Y, 2002, J HYPERTENS, V20, P439, DOI 10.1097/00004872-200203000-00019; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; KUNG CF, 1995, HYPERTENSION, V25, P194, DOI 10.1161/01.HYP.25.2.194; Lavrentyev EN, 2007, CIRC RES, V101, P455, DOI 10.1161/CIRCRESAHA.107.151852; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; Long DA, 2005, KIDNEY INT, V68, P2154, DOI 10.1111/j.1523-1755.2005.00671.x; Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200; Matz RL, 2000, BRIT J PHARMACOL, V131, P303, DOI 10.1038/sj.bjp.0703568; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Mukai Y, 2002, ARTERIOSCL THROM VAS, V22, P1445, DOI 10.1161/01.ATV.0000029121.63691.CE; NAKASHIMA M, 1993, J CLIN INVEST, V92, P2867, DOI 10.1172/JCI116907; Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774; Ndiaye M, 2003, BIOCHEM BIOPH RES CO, V310, P371, DOI 10.1016/j.bbrc.2003.09.028; Negishi H, 2004, J NUTR, V134, P38, DOI 10.1093/jn/134.1.38; Newaz MA, 2006, J CARDIOVASC PHARM, V48, P88, DOI 10.1097/01.fjc.0000245402.62864.0a; Oudot A, 2006, FREE RADICAL BIO MED, V40, P2214, DOI 10.1016/j.freeradbiomed.2006.02.020; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Urakami-Harasawa L, 1997, J CLIN INVEST, V100, P2793, DOI 10.1172/JCI119826; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Wu SZ, 2007, GERONTOLOGY, V53, P234, DOI 10.1159/000100961; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zhu JH, 2010, ASIAN J ANDROL, V12, P599, DOI 10.1038/aja.2009.97	48	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32039	10.1371/journal.pone.0032039	http://dx.doi.org/10.1371/journal.pone.0032039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384133	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500056
J	Reading, CL; Frincke, JM; White, SK				Reading, Christopher L.; Frincke, James M.; White, Steven K.			Molecular Targets for 17 alpha-Ethynyl-5-Androstene-3 beta,7 beta,17 beta-Triol, an Anti-Inflammatory Agent Derived from the Human Metabolome	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-1; INSULIN-RESISTANCE; RHEUMATOID-ARTHRITIS; SYNTHETIC ANALOG; ORAL TREATMENT; RODENT MODELS; MICE; DISEASE; HE3286; CELLS	HE3286, 17 alpha-ethynyl-5-androstene-3 beta, 7 beta, 17 beta-triol, is a novel synthetic compound related to the endogenous sterol 5-androstene-3 beta, 7 beta, 17 beta-triol (beta-AET), a metabolite of the abundant adrenal steroid dehydroepiandrosterone (DHEA). HE3286 has shown efficacy in clinical studies in impaired glucose tolerance and type 2 diabetes, and in vivo models of types 1 and 2 diabetes, autoimmunity, and inflammation. Proteomic analysis of solid-phase HE3286-bound bead affinity experiments, using extracts from RAW 264.7 mouse macrophage cells, identified 26 binding partners. Network analysis revealed associations of these HE3286 target proteins with nodes in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for type 2 diabetes, insulin, adipokine, and adipocyte signaling. Binding partners included low density lipoprotein receptor-related protein (Lrp1), an endocytic receptor; mitogen activated protein kinases 1 and 3 (Mapk1, Mapk3), protein kinases involved in inflammation signaling pathways; ribosomal protein S6 kinase alpha-3 (Rsp6ka3), an intracellular regulatory protein; sirtuin-2 (Sirt2); and 17 beta-hydroxysteroid dehydrogenase 1 (Hsd17 beta 4), a sterol metabolizing enzyme.	[Reading, Christopher L.; Frincke, James M.] Harbor Biosci, Dept Sci Dev, San Diego, CA USA; [White, Steven K.] Harbor Biosci, Dept Med Chem, San Diego, CA USA		Reading, CL (corresponding author), Harbor Biosci, Dept Sci Dev, San Diego, CA USA.	swhite@harborbiosciences.com			Harbor Biosciences	Harbor Biosciences	The authors have read the journal's policy and have the following conflicts: All authors declare that they are employees of Harbor Biosciences who funded this study. All authors own stock in Harbor Biosciences. Harbor Biosciences owns US patent No. 7,776,845, which is related to HE3286. In addition, Dr. Frincke sits on the Board of Harbor Biosciences. HE3286 is in clinical development, but there is no marketed product to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahlem C, 2009, ANN NY ACAD SCI, V1173, P781, DOI 10.1111/j.1749-6632.2009.04798.x; Ahlem CN, INT J CLIN EXP MED, V4, P119; Ahlem CN, STEROIDS, V76, P669; [Anonymous], BIOGRID DATABASE V 3; Auci D, 2007, ANN NY ACAD SCI, V1110, P630, DOI 10.1196/annals.1423.066; Auci DL, 2010, OBESITY SILVER SPRIN, DOI [10.1038/oby.2010.1204, DOI 10.1038/OBY.2010.1204]; Auci DL, 2010, INT J MOL MED, V25, P625, DOI 10.3892/ijmm_00000385; Auci DL, 2009, AUTOIMMUN REV, V8, P369, DOI 10.1016/j.autrev.2008.11.011; Baitsch D, ARTERIOSCLER THROMB, V31, P1160; Boucher P, BIOCH PHARM, V81, P1; Celec P, 2003, PHYSIOL RES, V52, P397; Ceschin DG, 2009, J CELL BIOCHEM, V106, P372, DOI 10.1002/jcb.22014; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Conrad D, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-52; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; Fleuren WW, NUCL ACIDS RES, V39, pW450; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kosiewicz M, 2011, EUR J PHARM IN PRESS; Kuo LH, 2011, DIABETOLOGIA, V54, P168, DOI 10.1007/s00125-010-1931-5; Lee SJ, 2010, EMBO REP, V11, P226, DOI 10.1038/embor.2010.7; Li JH, 2005, J ORG CHEM, V70, P4393, DOI 10.1021/jo0503310; Loria RM, 1997, PSYCHONEUROENDOCRINO, V22, pS103, DOI 10.1016/S0306-4530(97)00005-X; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Malik AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013566; Mann M, 2009, NAT METHODS, V6, P717, DOI 10.1038/nmeth1009-717; Muller C, 2006, J STEROID BIOCHEM, V99, P215, DOI 10.1016/j.jsbmb.2005.12.001; Offner H, 2002, J NEUROIMMUNOL, V130, P128, DOI 10.1016/S0165-5728(02)00214-X; Offner H, 2009, J PHARMACOL EXP THER, V329, P1100, DOI 10.1124/jpet.108.145086; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Reading C, 2011, OBESITY UNPUB; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Wang TL, 2010, J PHARMACOL EXP THER, V333, P70, DOI 10.1124/jpet.109.161182; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; KEGG PATHWAY	40	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32147	10.1371/journal.pone.0032147	http://dx.doi.org/10.1371/journal.pone.0032147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384159	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916800026
J	Noda, S; Asano, Y; Akamata, K; Aozasa, N; Taniguchi, T; Takahashi, T; Ichimura, Y; Toyama, T; Sumida, H; Yanaba, K; Tada, Y; Sugaya, M; Kadono, T; Sato, S				Noda, Shinji; Asano, Yoshihide; Akamata, Kaname; Aozasa, Naohiko; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Sumida, Hayakazu; Yanaba, Koichi; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi			A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYSTEINE CATHEPSINS; BASEMENT-MEMBRANE; ANGIOGENESIS; ENDOSTATIN; FLI1; DEGRADATION; INHIBITOR; TRANSFORMING-GROWTH-FACTOR-BETA-1; PHOSPHORYLATION	Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease has not been well studied. The aim of this study is to evaluate the roles of CTSB in SSc. Serum pro-CTSB levels were determined by enzyme-linked immunosorbent assay in 55 SSc patients and 19 normal controls. Since the deficiency of transcription factor Fli1 in endothelial cells is potentially associated with the development of SSc vasculopathy, cutaneous CTSB expression was evaluated by immunostaining in Fli1(+/-) and wild type mice as well as in SSc and control subjects. The effects of Fli1 gene silencing and transforming growth factor-beta (TGF-beta) on CTSB expression were determined by real-time PCR in human dermal microvascular endothelial cells (HDMECs) and dermal fibroblasts, respectively. Serum pro-CTSB levels were significantly higher in limited cutaneous SSc (lcSSc) and late-stage diffuse cutaneous SSc (dcSSc) patients than in healthy controls. In dcSSc, patients with increased serum pro-CTSB levels showed a significantly higher frequency of digital ulcers than those with normal levels. CTSB expression in dermal blood vessels was increased in Fli1(+/-) mice compared with wild type mice and in SSc patients compared with healthy controls. Consistently, Fli1 gene silencing increased CTSB expression in HDMECs. In cultured dermal fibroblasts from early dcSSc, CTSB expression was decreased compared with normal fibroblasts and significantly reversed by TGF-beta 1 antisense oligonucleotide. In conclusion, up-regulation of endothelial CTSB due to Fli1 deficiency may contribute to the development of SSc vasculopathy, especially digital ulcers, while reduced expression of CTSB in lesional dermal fibroblasts is likely to be associated with skin sclerosis in early dcSSc.	[Noda, Shinji; Asano, Yoshihide; Akamata, Kaname; Aozasa, Naohiko; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Sumida, Hayakazu; Yanaba, Koichi; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Noda, S (corresponding author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 113, Japan.	yasano-tky@umin.ac.jp	菅谷, 誠/GWC-3786-2022	Sumida, Hayakazu/0000-0003-0531-559X	Japanese Ministry of Education	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant for scientific research from the Japanese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Bujor AM, 2011, ARTHRITIS RHEUM-US, V63, P1729, DOI 10.1002/art.30284; Chang SH, 2009, CANCER RES, V69, P4537, DOI 10.1158/0008-5472.CAN-08-4539; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Distler JHW, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kel295; Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596; Dziadzio M, 2005, RHEUMATOLOGY, V44, P1518, DOI 10.1093/rheumatology/kei088; Dziankowska-Bartkowiak B, 2006, CLIN EXP RHEUMATOL, V24, P508; Dziankowska-Bartkowiak B, 2005, MEDIAT INFLAMM, P144, DOI 10.1155/MI.2005.144; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Hebbar M, 2000, ARTHRITIS RHEUM-US, V43, P889, DOI 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5; Herve-Grepinet V, 2008, FEBS LETT, V582, P1307, DOI 10.1016/j.febslet.2008.03.007; HOYLAND JA, 1993, BRIT J DERMATOL, V129, P384, DOI 10.1111/j.1365-2133.1993.tb03162.x; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Kuroda K, 1997, ARCH DERMATOL RES, V289, P567, DOI 10.1007/s004030050241; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; LEROY EC, 1988, J RHEUMATOL, V15, P202; Malla RR, 2011, CANCER GENE THER, V18, P419, DOI 10.1038/cgt.2011.9; Manetti M, 2010, J CELL MOL MED, V14, P1241, DOI 10.1111/j.1582-4934.2010.01027.x; Moles A, 2009, HEPATOLOGY, V49, P1297, DOI 10.1002/hep.22753; Noda S, 2011, J EUR ACAD DERMATOL; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rhew Elisa Y, 2004, Curr Rheumatol Rep, V6, P129, DOI 10.1007/s11926-004-0057-5; SATO S, 1994, ARTHRITIS RHEUM, V37, P391, DOI 10.1002/art.1780370313; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207	40	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32272	10.1371/journal.pone.0032272	http://dx.doi.org/10.1371/journal.pone.0032272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384200	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100065
J	Tao, M; Xie, P; Chen, J; Qin, BQ; Zhang, DW; Niu, Y; Zhang, M; Wang, Q; Wu, LY				Tao, Min; Xie, Ping; Chen, Jun; Qin, Boqiang; Zhang, Dawen; Niu, Yuan; Zhang, Meng; Wang, Qing; Wu, Laiyan			Use of a Generalized Additive Model to Investigate Key Abiotic Factors Affecting Microcystin Cellular Quotas in Heavy Bloom Areas of Lake Taihu	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS; TOXIC CYANOBACTERIA; MEILIANG BAY; HEPATOTOXIN PRODUCTION; ENVIRONMENTAL-FACTORS; AERUGINOSA; GROWTH; LIGHT; LR; DYNAMICS	Lake Taihu is the third largest freshwater lake in China and is suffering from serious cyanobacterial blooms with the associated drinking water contamination by microcystin (MC) for millions of citizens. So far, most studies on MCs have been limited to two small bays, while systematic research on the whole lake is lacking. To explain the variations in MC concentrations during cyanobacterial bloom, a large-scale survey at 30 sites across the lake was conducted monthly in 2008. The health risks of MC exposure were high, especially in the northern area. Both Microcystis abundance and MC cellular quotas presented positive correlations with MC concentration in the bloom seasons, suggesting that the toxic risks during Microcystis proliferations were affected by variations in both Microcystis density and MC production per Microcystis cell. Use of a powerful predictive modeling tool named generalized additive model (GAM) helped visualize significant effects of abiotic factors related to carbon fixation and proliferation of Microcystis (conductivity, dissolved inorganic carbon (DIC), water temperature and pH) on MC cellular quotas from recruitment period of Microcystis to the bloom seasons, suggesting the possible use of these factors, in addition to Microcystis abundance, as warning signs to predict toxic events in the future. The interesting relationship between macrophytes and MC cellular quotas of Microcystis (i.e., high MC cellular quotas in the presence of macrophytes) needs further investigation.	[Tao, Min; Xie, Ping; Chen, Jun; Zhang, Dawen; Niu, Yuan; Zhang, Meng; Wang, Qing; Wu, Laiyan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China; [Qin, Boqiang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Tao, M (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China.	xieping@ihb.ac.cn	Qin, Boqiang/E-5900-2013; Xie, Ping/AAL-7532-2020		National Basic Research Program of China (973 Program) [2008CB418101]; Chinese Academy of Sciences [KZCX1-YW-14-6-1]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ07]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	This study was jointly supported by the National Basic Research Program of China (973 Program) (2008CB418101), the Knowledge Innovation Project of the Chinese Academy of Sciences (KZCX1-YW-14-6-1) and State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, SAS PROCEDURE GUIDE; Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Casanova MT, 1999, ENVIRON TOXICOL, V14, P97, DOI 10.1002/(SICI)1522-7278(199902)14:1<97::AID-TOX13>3.0.CO;2-3; Chen JZ, 2011, J HAZARD MATER, V190, P240, DOI 10.1016/j.jhazmat.2011.03.030; Chen J, 2009, SCI TOTAL ENVIRON, V407, P3317, DOI 10.1016/j.scitotenv.2009.02.005; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; Dai RH, 2009, J HAZARD MATER, V161, P730, DOI 10.1016/j.jhazmat.2008.04.015; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dong X, 2001, SUGI P; Furukawa K, 2006, J BIOSCI BIOENG, V102, P90, DOI 10.1263/jbb.102.90; Gerard C, 2009, ENVIRON POLLUT, V157, P609, DOI 10.1016/j.envpol.2008.08.017; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Halstvedt CB, 2008, J PLANKTON RES, V30, P607, DOI 10.1093/plankt/fbn025; Haney JF, 2000, 65 NEW HAMPS WAT RES; Hastie TJ., 1990, GEN ADDITIVE MODELS; Havens KE, 2003, ENVIRON POLLUT, V122, P379, DOI 10.1016/S0269-7491(02)00304-4; Hu HJ, FRESHWATER ALGAE CHI; Jahnichen S, 2007, APPL ENVIRON MICROB, V73, P6994, DOI 10.1128/AEM.01253-07; Jahnichen S, 2001, ARCH HYDROBIOL, V150, P177; Jang MH, 2004, AQUAT TOXICOL, V68, P51, DOI 10.1016/j.aquatox.2004.02.002; Jang MH, 2008, TOXICON, V51, P882, DOI 10.1016/j.toxicon.2007.12.015; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Jiang JL, 2011, J HAZARD MATER, V190, P188, DOI 10.1016/j.jhazmat.2011.03.023; John DM., 2002, FRESHWATER ALGAL FLO; Joung SH, 2011, HARMFUL ALGAE, V10, P188, DOI 10.1016/j.hal.2010.09.005; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; KAPLAN A, 1991, PLANT PHYSIOL, V97, P851, DOI 10.1104/pp.97.3.851; Kotak BG, 2000, CAN J FISH AQUAT SCI, V57, P1584, DOI 10.1139/cjfas-57-8-1584; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Lance E, 2010, ENVIRON POLLUT, V158, P674, DOI 10.1016/j.envpol.2009.10.025; LeBlanc S, 2005, ENVIRON TOXICOL, V20, P67, DOI 10.1002/tox.20079; Li S, 2007, B ENVIRON CONTAM TOX, V78, P226, DOI 10.1007/s00128-007-9116-8; Liu YQ, 2008, B ENVIRON CONTAM TOX, V80, P24, DOI 10.1007/s00128-007-9293-5; Ma Ronghua, 2008, Hupo Kexue, V20, P687; MILLER AG, 1984, J BACTERIOL, V159, P100, DOI 10.1128/JB.159.1.100-106.1984; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Ozawa K, 2005, ENVIRON TOXICOL, V20, P270, DOI 10.1002/tox.20117; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; SAS Institute, 2008, SAS STAT US GUID; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3; Shi Limei, 2009, Hupo Kexue, V21, P801; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2658, DOI 10.1128/AEM.56.9.2658-2666.1990; Song Lirong, 1998, Phycological Research, V46, P19, DOI 10.1046/j.1440-1835.1998.00120.x; Te SH, 2011, HARMFUL ALGAE, V10, P319, DOI 10.1016/j.hal.2010.11.006; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; VANDERWESTHUIZEN AJ, 1985, PLANTA, V163, P55, DOI 10.1007/BF00395897; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Wang JX, 2007, ENVIRON RES, V103, P70, DOI 10.1016/j.envres.2006.05.013; Wang Q, 2010, THESCIENTIFICWORLDJO, V10, P1795, DOI 10.1100/tsw.2010.172; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; Wiedner C, 2003, APPL ENVIRON MICROB, V69, P1475, DOI 10.1128/AEM.69.3.1475-1481.2003; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Xie P, HIST DEV CYANOBACTER; Xu Y, 2008, ENVIRON POLLUT, V156, P162, DOI 10.1016/j.envpol.2007.12.027; Yang H, 2006, J FRESHWATER ECOL, V21, P721, DOI 10.1080/02705060.2006.9664136; Ye WJ, 2009, HARMFUL ALGAE, V8, P637, DOI 10.1016/j.hal.2008.10.010; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; Yoshida M, 2007, FEMS MICROBIOL LETT, V266, P49, DOI 10.1111/j.1574-6968.2006.00496.x; Zhang DW, 2009, ECOTOX ENVIRON SAFE, V72, P466, DOI 10.1016/j.ecoenv.2008.05.014; Zhang M, 2011, CHEMOSPHERE, V82, P329, DOI 10.1016/j.chemosphere.2010.10.038; Zhu JY, 2010, AQUAT TOXICOL, V98, P196, DOI 10.1016/j.aquatox.2010.02.011	73	38	42	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32020	10.1371/journal.pone.0032020	http://dx.doi.org/10.1371/journal.pone.0032020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384128	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916100045
J	Jiao, LR; Frampton, AE; Jacob, J; Pellegrino, L; Krell, J; Giamas, G; Tsim, N; Vlavianos, P; Cohen, P; Ahmad, R; Keller, A; Habib, NA; Stebbing, J; Castellano, L				Jiao, Long R.; Frampton, Adam E.; Jacob, Jimmy; Pellegrino, Loredana; Krell, Jonathan; Giamas, Georgios; Tsim, Nicole; Vlavianos, Panagiotis; Cohen, Patrizia; Ahmad, Raida; Keller, Andreas; Habib, Nagy A.; Stebbing, Justin; Castellano, Leandro			MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors	PLOS ONE			English	Article							MUCINOUS CYSTIC NEOPLASMS; DUCTAL ADENOCARCINOMA; CELL-PROLIFERATION; BREAST-CANCER; LUNG-CANCER; EXPRESSION; RAS; LET-7; SUPPRESSOR; KRAS	Background: MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC), but these have not been compared with pre-malignant pancreatic tumors. We wished to compare the miRNA expression signatures in pancreatic benign cystic tumors (BCT) of low and high malignant potential with PDAC, in order to identify miRNAs deregulated during PDAC development. The mechanistic consequences of miRNA dysregulation were further evaluated. Methods: Tissue samples were obtained at a tertiary pancreatic unit from individuals with BCT and PDAC. MiRNA profiling was performed using a custom microarray and results were validated using RT-qPCR prior to evaluation of miRNA targets. Results: Widespread miRNA down-regulation was observed in PDAC compared to low malignant potential BCT. We show that amongst those miRNAs down-regulated, miR-16, miR-126 and let-7d regulate known PDAC oncogenes (targeting BCL2, CRK and KRAS respectively). Notably, miR-126 also directly targets the KRAS transcript at a "seedless" binding site within its 3'UTR. In clinical specimens, miR-126 was strongly down-regulated in PDAC tissues, with an associated elevation in KRAS and CRK proteins. Furthermore, miR-21, a known oncogenic miRNA in pancreatic and other cancers, was not elevated in PDAC compared to serous microcystic adenoma (SMCA), but in both groups it was up-regulated compared to normal pancreas, implicating early up-regulation during malignant change. Conclusions: Expression profiling revealed 21 miRNAs down-regulated in PDAC compared to SMCA, the most benign lesion that rarely progresses to invasive carcinoma. It appears that miR-21 up-regulation is an early event in the transformation from normal pancreatic tissue. MiRNA expression has the potential to distinguish PDAC from normal pancreas and BCT. Mechanistically the down-regulation of miR-16, miR-126 and let-7d promotes PDAC transformation by post-transcriptional up-regulation of crucial PDAC oncogenes. We show that miR-126 is able to directly target KRAS; re-expression has the potential as a therapeutic strategy against PDAC and other KRAS-driven cancers.	[Jiao, Long R.; Frampton, Adam E.; Tsim, Nicole; Habib, Nagy A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Hepatopancreatobiliary Surg Unit, London, England; [Jacob, Jimmy; Pellegrino, Loredana; Krell, Jonathan; Giamas, Georgios; Stebbing, Justin; Castellano, Leandro] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Div Oncol, London, England; [Vlavianos, Panagiotis] Hammersmith Hosp, Imperial Coll NHS Trust, Dept Gastroenterol, London, England; [Cohen, Patrizia; Ahmad, Raida] Hammersmith Hosp, Imperial Coll NHS Trust, Dept Histopathol, London, England; [Keller, Andreas] Univ Saarland, Dept Human Genet, D-6650 Homburg, Saar, Germany	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Saarland University	Jiao, LR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Hepatopancreatobiliary Surg Unit, London, England.	l.castellano@imperial.ac.uk	Keller, Andreas/ABB-6412-2021; Castellano, Leandro/AAE-1366-2021; Giamas, Georgios/AAP-3487-2021	Keller, Andreas/0000-0002-5361-0895; Castellano, Leandro/0000-0002-3059-4829; Giamas, Georgios/0000-0002-4417-2707; Stebbing, Justin/0000-0002-1117-6947	Peel Medical Research Trust; Alliance Family Trust Foundation; MRC [G1100425] Funding Source: UKRI; Cancer Research UK [14549] Funding Source: researchfish; Medical Research Council [G1100425] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish; Worldwide Cancer Research [10-0510] Funding Source: researchfish	Peel Medical Research Trust; Alliance Family Trust Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Worldwide Cancer Research	The Peel Medical Research Trust and The Alliance Family Trust Foundation helped with funding herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, BRIT J CANCER, V89, P2104, DOI 10.1038/sj.bjc.6601391; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Bartsch D, 1998, ANN SURG, V228, P79, DOI 10.1097/00000658-199807000-00012; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Bellizzi AM, 2009, ARCH PATHOL LAB MED, V133, P388, DOI 10.1043/1543-2165-133.3.388; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Brugge WR, 2004, NEW ENGL J MED, V351, P1218, DOI 10.1056/NEJMra031623; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chua YJ, 2005, J CLIN ONCOL, V23, P4532, DOI 10.1200/JCO.2005.17.954; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Crippa S, 2010, CLIN GASTROENTEROL H, V8, P213, DOI 10.1016/j.cgh.2009.10.001; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Galanis C, 2007, J GASTROINTEST SURG, V11, P820, DOI 10.1007/s11605-007-0157-4; Garcea G, 2008, PANCREATOLOGY, V8, P236, DOI 10.1159/000134279; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Hamada S, 2011, MOL CANC RES; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Ishikawa T, 1998, PANCREAS, V16, P40, DOI 10.1097/00006676-199801000-00007; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Klimstra DS, 2009, ARCH PATHOL LAB MED, V133, P454, DOI 10.1043/1543-2165-133.3.454; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mardin WA, 2009, ANN SURG ONCOLOGY; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukherjee S, 2008, CLIN ONCOL-UK, V20, P535, DOI 10.1016/j.clon.2008.02.003; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Ohuchida K, 2011, ANN SURG ONCOL; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Reddy S, 2007, SURG CLIN N AM, V87, P1359, DOI 10.1016/j.suc.2007.08.009; Sahani Dushyant V, 2009, J Am Coll Radiol, V6, P376, DOI 10.1016/j.jacr.2008.10.004; Satoh K, 1991, Nihon Shokakibyo Gakkai Zasshi, V88, P2795; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Seux M, 2009, PANCREATOLOGY, V9, P66, DOI 10.1159/000178876; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sinicrope FA, 1996, CLIN CANCER RES, V2, P2015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Szafranska AE, 2008, CLIN CHEM, V54, P1716, DOI 10.1373/clinchem.2008.109603; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yoshizawa K, 2002, VIRCHOWS ARCH, V441, P437, DOI 10.1007/s00428-002-0645-6; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160	79	103	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32068	10.1371/journal.pone.0032068	http://dx.doi.org/10.1371/journal.pone.0032068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384141	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000302875500070
J	Xiao, Y; Xu, CH; Guan, JX; Ping, YY; Fan, HH; Li, YQ; Zhao, HY; Li, X				Xiao, Yun; Xu, Chaohan; Guan, Jinxia; Ping, Yanyan; Fan, Huihui; Li, Yiqun; Zhao, Hongying; Li, Xia			Discovering Dysfunction of Multiple MicroRNAs Cooperation in Disease by a Conserved MicroRNA Co-Expression Network	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; REGULATORY MODULES; COMBINATORIAL REGULATION; STEM-CELLS; EXPRESSION; CANCER; GENES; DEREGULATION; CLUSTER; FAMILY	MicroRNAs, a new class of key regulators of gene expression, have been shown to be involved in diverse biological processes and linked to many human diseases. To elucidate miRNA function from a global perspective, we constructed a conserved miRNA co-expression network by integrating multiple human and mouse miRNA expression data. We found that these conserved co-expressed miRNA pairs tend to reside in close genomic proximity, belong to common families, share common transcription factors, and regulate common biological processes by targeting common components of those processes based on miRNA targets and miRNA knockout/transfection expression data, suggesting their strong functional associations. We also identified several co-expressed miRNA sub-networks. Our analysis reveals that many miRNAs in the same sub-network are associated with the same diseases. By mapping known disease miRNAs to the network, we identified three cancer-related miRNA sub-networks. Functional analyses based on targets and miRNA knockout/transfection data consistently show that these sub-networks are significantly involved in cancer-related biological processes, such as apoptosis and cell cycle. Our results imply that multiple co-expressed miRNAs can cooperatively regulate a given biological process by targeting common components of that process, and the pathogenesis of disease may be associated with the abnormality of multiple functionally cooperative miRNAs rather than individual miRNAs. In addition, many of these co-expression relationships provide strong evidence for the involvement of new miRNAs in important biological processes, such as apoptosis, differentiation and cell cycle, indicating their potential disease links.	[Xiao, Yun; Xu, Chaohan; Guan, Jinxia; Ping, Yanyan; Fan, Huihui; Li, Yiqun; Zhao, Hongying; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Xiao, Y (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China.	lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013; Fan, Huihui/AGB-0221-2022	Fan, Huihui/0000-0003-4233-5389; Ping, Yanyan/0000-0002-1810-1200	National Natural Science Foundation of China [30871394, 30370798, 30571034]; National High Tech Development Project of China; 863 Program [2007AA02Z329]; National Basic Research Program of China; 973 Program [2008CB517302]; National Science Foundation of Heilongjiang Province [ZJG0501, 1055HG009, GB03C602-4, HCXB2009019, HCXS2010008, BMFH060044, 1155H012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Development Project of China(National High Technology Research and Development Program of China); 863 Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); 973 Program(National Basic Research Program of China); National Science Foundation of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 30871394, 30370798 and 30571034), the National High Tech Development Project of China, the 863 Program (Grant Nos. 2007AA02Z329), the National Basic Research Program of China, the 973 Program (Grant Nos. 2008CB517302) and the National Science Foundation of Heilongjiang Province (Grant Nos. ZJG0501, 1055HG009, GB03C602-4, HCXB2009019, HCXS2010008, BMFH060044 and 1155H012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Dalmasso G, 2011, AM J PHYSIOL-GASTR L, V300, pG52, DOI 10.1152/ajpgi.00394.2010; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Gusev Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S16; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu B, 2010, BIOINFORMATICS, V26, P3105, DOI 10.1093/bioinformatics/btq576; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sengupta D, 2011, MOL BIOSYST; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su NF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-150; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Xu J, 2010, NUCL ACIDS RES; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	53	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32201	10.1371/journal.pone.0032201	http://dx.doi.org/10.1371/journal.pone.0032201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384175	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500084
J	Boll, K; Reiche, K; Kasack, K; Morbt, N; Kretzschmar, AK; Tomm, JM; Verhaegh, G; Schalken, J; von Bergen, M; Horn, F; Hackermuller, J				Boll, K.; Reiche, K.; Kasack, K.; Moerbt, N.; Kretzschmar, A. K.; Tomm, J. M.; Verhaegh, G.; Schalken, J.; von Bergen, M.; Horn, F.; Hackermueller, J.			MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma	ONCOGENE			English	Article						microRNAs; prostate carcinoma; androgen receptor signaling; MAPK pathway; microRNA targets	ANDROGEN RECEPTOR; MICRORNA EXPRESSION; TRANSCRIPTIONAL ACTIVITY; CANCER CELLS; GROWTH; IDENTIFICATION; PROLIFERATION; PROGRESSION; COACTIVATOR; INVASION	With similar to 30 000 deaths annually in the United States, prostate cancer (PCa) is a major oncologic disease. Here we show that the microRNAs miR-130a, miR-203 and miR-205 jointly interfere with the two major oncogenic pathways in prostate carcinoma and are downregulated in cancer tissue. Using transcriptomics we show that the microRNAs repress several gene products known to be overexpressed in this cancer. Argonaute 2 (AGO2) co-immunoprecipitation, reporter assays and western blot analysis demonstrate that the microRNAs directly target several components of the mitogen-activated protein kinase (MAPK) and androgen receptor (AR) signaling pathways, among those several AR coregulators and HRAS (Harvey rat sarcoma viral oncogene homolog), and repress signaling activity. Both pathways are central for the development of the primary tumor and in particular the progression to its incurable castration-resistant form. Reconstitution of the microRNAs in LNCaP PCa cells induce morphological changes, which resemble the effect of androgen deprivation, and jointly impair tumor cell growth by induction of apoptosis and cell cycle arrest. We therefore propose that these microRNAs jointly act as tumor suppressors in prostate carcinoma and might interfere with progression to castration resistance. Oncogene (2013) 32, 277-285; doi:10.1038/onc.2012.55; published online 5 March 2012	[Boll, K.; Reiche, K.; Kasack, K.; Kretzschmar, A. K.; Horn, F.; Hackermueller, J.] Fraunhofer IZI, RNom Grp, Leipzig, Germany; [Boll, K.; Kasack, K.; Horn, F.] Univ Leipzig, Inst Clin Immunol, D-04109 Leipzig, Germany; [Reiche, K.; Kasack, K.; Hackermueller, J.] UFZ Helmholtz Ctr Environm Res, Young Investigators Grp Bioinformat & Transcript, D-04318 Leipzig, Saxony, Germany; [Kasack, K.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Moerbt, N.; Tomm, J. M.; von Bergen, M.; Hackermueller, J.] UFZ Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Saxony, Germany; [Verhaegh, G.; Schalken, J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [von Bergen, M.] UFZ Helmholtz Ctr Environm Res, Dept Metabol, D-04318 Leipzig, Saxony, Germany; [Reiche, K.; Hackermueller, J.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany	Fraunhofer Gesellschaft; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Radboud University Nijmegen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Hackermuller, J (corresponding author), UFZ Helmholtz Ctr Environm Res, Young Investigators Grp Bioinformat & Transcript, Permoserstr 15, D-04318 Leipzig, Saxony, Germany.	joerg.hackermueller@ufz.de	Tomm, Janina M/F-8888-2014; Schalken, Jack A/B-1277-2014; von Bergen, Martin/D-7960-2011; Hackermüller, Jörg/F-2494-2016; Verhaegh, Gerald/L-4708-2015	Tomm, Janina M/0000-0001-8161-1812; Schalken, Jack A/0000-0001-8274-7797; von Bergen, Martin/0000-0003-2732-2977; Hackermüller, Jörg/0000-0003-4920-7072; Verhaegh, Gerald/0000-0003-0227-2280; Reiche, Kristin/0000-0002-4452-4872	Medical Faculty of the University of Leipzig through funding of the Interdisciplinary Center for Clinical Research; grant 'Sequence and functional analysis of non-coding RNA in prostate carcinoma' [formel.1]; European Framework Programme 6 Project SYNLET [043312]; Initiative and Networking Fund one of the Helmholtz Association [VH-NG-738]; LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig; European Social Fund; Free State of Saxony	Medical Faculty of the University of Leipzig through funding of the Interdisciplinary Center for Clinical Research; grant 'Sequence and functional analysis of non-coding RNA in prostate carcinoma'; European Framework Programme 6 Project SYNLET; Initiative and Networking Fund one of the Helmholtz Association; LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig; European Social Fund(European Social Fund (ESF)); Free State of Saxony	We thank Stephan Schreiber, Anne-Sophie Krakovic, Yvonne Kullnick, Sabina Christ, Kathrin Jager, Rudolf Ascherl and Christine Schumann for technical assistance and Catherine Davis for proof-reading. We thank Gunter Meister and colleagues for providing AGO2 antibodies. This work was supported in part by the Medical Faculty of the University of Leipzig through funding of the Interdisciplinary Center for Clinical Research and a formel.1 grant 'Sequence and functional analysis of non-coding RNA in prostate carcinoma', the European Framework Programme 6 Project SYNLET (EC contract number 043312), by the Initiative and Networking Fund one of the Helmholtz Association (VH-NG-738) and by LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, which was funded by means of the European Social Fund and the Free State of Saxony.	Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koochekpour S, 2005, ASIAN J ANDROL, V7, P147, DOI 10.1111/j.1745-7262.2005.00037.x; Koochekpour S, 2007, PROSTATE, V67, P178, DOI 10.1002/pros.20513; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; Lee TJ, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-31; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Papatsoris AG, 2007, MOL CANCER THER, V6, P811, DOI 10.1158/1535-7163.MCT-06-0610; Park JJ, 2000, CANCER RES, V60, P5946; Pitkanen-Arsiola T, 2006, PROSTATE, V66, P1177, DOI 10.1002/pros.20450; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Saeed B, 1997, PROSTATE, V31, P145; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Satoh T, 2009, ENDOCRINOLOGY, V150, P3283, DOI 10.1210/en.2008-1122; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sikand K, 2011, INT J CANCER, V129, P810, DOI 10.1002/ijc.25753; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Truica CI, 2000, CANCER RES, V60, P4709; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang JG, 2006, FASEB J, V20, P2142, DOI 10.1096/fj.06-5900fje; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517	54	181	186	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					277	285		10.1038/onc.2012.55	http://dx.doi.org/10.1038/onc.2012.55			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22391564				2022-12-25	WOS:000314736600002
J	Lv, LH; Wan, YL; Lin, Y; Zhang, W; Yang, M; Li, GL; Lin, HM; Shang, CZ; Chen, YJ; Min, J				Lv, Li-Hong; Wan, Yun-Le; Lin, Yan; Zhang, Wei; Yang, Mei; Li, Guo-Lin; Lin, Hao-Ming; Shang, Chang-Zhen; Chen, Ya-Jin; Min, Jun			Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-DERIVED EXOSOMES; IMMUNE-RESPONSE; K562 CELLS; GRANZYME-B; PHASE-II; MECHANISM; STRESS; CHEMOTHERAPY; IMPAIRMENT; RECEPTORS	Failure of immune surveillance related to inadequate host antitumor immune responses has been suggested as a possible cause of the high incidence of recurrence and poor overall survival outcome of hepatocellular carcinoma. The stress-induced heat shock proteins (HSPs) are known to act as endogenous "danger signals" that can improve tumor immunogenicity and induce natural killer (NK) cell responses. Exosome is a novel secretory pathway for HSPs. In our experiments, the immune regulatory effect of the HSP-bearing exosomes secreted by human hepatocellular carcinoma cells under stress conditions on NK cells was studied. ELISA results showed that the production of HSP60, HSP70, and HSP90 was up-regulated in both cell lines in a stress-specific manner. After exposure to hepatocellular carcinoma cell-resistant or sensitive anticancer drugs (hereafter referred to as "resistant" or "sensitive" anticancer drug), the membrane microvesicles were actively released by hepatocellular carcinoma cells, differing in their ability to present HSPs on the cell surface, which were characterized as exosomes. Acting as a decoy, the HSP-bearing exosomes efficiently stimulated NK cell cytotoxicity and granzyme B production, up-regulated the expression of inhibitory receptor CD94, and down-regulated the expression of activating receptors CD69, NKG2D, and NKp44. Notably, resistant anticancer drugs enhanced exosome release and generated more exosome-carried HSPs, which augmented the activation of the cytotoxic response. In summary, our findings demonstrated that exosomes derived from resistant anticancer drug-treated HepG2 cells conferred superior immunogenicity in inducing HSP-specific NK cell responses, which provided a clue for finding an efficient vaccine for hepatocellular carcinoma immunotherapy.	[Lv, Li-Hong; Wan, Yun-Le; Li, Guo-Lin; Lin, Hao-Ming; Shang, Chang-Zhen; Chen, Ya-Jin; Min, Jun] Sun Yat Sen Univ, Dept Hepatobiliary Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Lin, Yan] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15216 USA; [Zhang, Wei] Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Mei] Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Gen Surg, Guangzhou 510010, Guangdong, Peoples R China	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhejiang University	Chen, YJ (corresponding author), Sun Yat Sen Univ, Dept Hepatobiliary Surg, Sun Yat Sen Mem Hosp, 107W Yanjiang Rd, Guangzhou 510120, Peoples R China.	cyj0509@126.com; drjmin@yahoo.cn			National High Technology Research and Development Program of China (863 Program) [2007AA02Z117]; National Natural Science Foundation of China [30571805, 30672036, 30671987, 81000065]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2007AA02Z117 and National Natural Science Foundation of China Grants 30571805, 30672036, 30671987, and 81000065.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boige V, 2006, EUR J CANCER, V42, P456, DOI 10.1016/j.ejca.2005.09.034; Boozari B, 2010, GUT, V59, P1416, DOI 10.1136/gut.2009.196519; Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012; CARMICHAEL J, 1987, CANCER RES, V47, P936; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Clayton A, 2009, CURR ONCOL, V16, P187; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Dai SM, 2005, CLIN CANCER RES, V11, P7554, DOI 10.1158/1078-0432.CCR-05-0810; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hickman-Miller HD, 2004, TRENDS IMMUNOL, V25, P427, DOI 10.1016/j.it.2004.05.011; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Knight AM, 2008, EUR J IMMUNOL, V38, P1186, DOI 10.1002/eji.200838374; Koga K, 2005, ANTICANCER RES, V25, P3703; Kuang M, 2004, CLIN CANCER RES, V10, P1574, DOI 10.1158/1078-0432.CCR-03-0071; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; RITOSSA P., 1962, RIV 1ST SIEROTERAPITAL, V37, P79; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Savina A, 2002, J CELL SCI, V115, P2505; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yeo W, 2005, JNCI-J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315	48	306	323	2	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15874	15885		10.1074/jbc.M112.340588	http://dx.doi.org/10.1074/jbc.M112.340588			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22396543	hybrid, Green Published			2022-12-25	WOS:000304006300066
J	Qiang, L; Tsuchiya, K; Kim-Muller, JY; Lin, HV; Welch, C; Accili, D				Qiang, Li; Tsuchiya, Kyoichiro; Kim-Muller, Ja-Young; Lin, Hua V.; Welch, Carrie; Accili, Domenico			Increased Atherosclerosis and Endothelial Dysfunction in Mice Bearing Constitutively Deacetylated Alleles of Foxo1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; GLUCOSE CONTROL; DISEASE; MECHANISMS; APOPTOSIS; STRESS; PHOSPHORYLATION; DIFFERENTIATION; ABNORMALITIES	Complications of atherosclerosis are the leading cause of death of patients with type 2 (insulin-resistant) diabetes. Understanding the mechanisms by which insulin resistance and hyperglycemia contribute to atherogenesis in key target tissues (liver, vessel wall, hematopoietic cells) can assist in the design of therapeutic approaches. We have shown that hyperglycemia induces FoxO1 deacetylation and that targeted knock-in of alleles encoding constitutively deacetylated FoxO1 in mice (Foxo1(KR/KR)) improves hepatic lipid metabolism and decreases macrophage inflammation, setting the stage for a potential anti-atherogenic effect of this mutation. Surprisingly, we report here that when Foxo1KR/KR mice are intercrossed with low density lipoprotein receptor knock-out mice (Ldlr(-/-)), they develop larger aortic root atherosclerotic lesions than Ldlr(-/-) controls despite lower plasma cholesterol and triglyceride levels. The phenotype is unaffected by transplanting bone marrow from Ldlr(-/-) mice into Foxo1KR/KR mice, indicating that it is independent of hematopoietic cells and suggesting that the primary lesion in Foxo1KR/KR mice occurs in the vessel wall. Experiments in isolated endothelial cells from Foxo1KR/KR mice indicate that deacetylation favors FoxO1 nuclear accumulation and exerts target gene-specific effects, resulting in higher Icam1 and Tnf alpha expression and increased monocyte adhesion. The data indicate that FoxO1 deacetylation can promote vascular endothelial changes conducive to atherosclerotic plaque formation.	Columbia Univ, Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Qiang, Li/0000-0001-8322-1797; Lin, Hua/0000-0001-5001-5567	National Institutes of Health [HL87123, DK57539, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL87123, DK57539, and DK63608 (to D. A.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Boyle PJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.07.003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1442, DOI 10.1152/ajpcell.2001.281.5.C1442; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Senokuchi T, 2008, DIABETES, V57, P2967, DOI 10.2337/db08-0520; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tanaka J, 2009, DIABETES, V58, P2344, DOI 10.2337/db09-0167; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Tsuchiya K, 2011, ARTERIOSCL THROM VAS, V31, P2920, DOI 10.1161/ATVBAHA.110.219477	38	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13944	13951		10.1074/jbc.M111.332767	http://dx.doi.org/10.1074/jbc.M111.332767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389493	Green Published, hybrid			2022-12-25	WOS:000303996300049
J	Gardali, T; Seavy, NE; DiGaudio, RT; Comrack, LA				Gardali, Thomas; Seavy, Nathaniel E.; DiGaudio, Ryan T.; Comrack, Lyann A.			A Climate Change Vulnerability Assessment of California's At-Risk Birds	PLOS ONE			English	Article							POPULATION CONSEQUENCES; EXTINCTION RISK; HABITAT; FUTURE; BUTTERFLIES; RESILIENCE; FRAMEWORK; RESPONSES; IMPACTS; EVENTS	Conservationists must develop new strategies and adapt existing tools to address the consequences of anthropogenic climate change. To support statewide climate change adaptation, we developed a framework for assessing climate change vulnerability of California's at-risk birds and integrating it into the existing California Bird Species of Special Concern list. We defined climate vulnerability as the amount of evidence that climate change will negatively impact a population. We quantified climate vulnerability by scoring sensitivity (intrinsic characteristics of an organism that make it vulnerable) and exposure (the magnitude of climate change expected) for each taxon. Using the combined sensitivity and exposure scores as an index, we ranked 358 avian taxa, and classified 128 as vulnerable to climate change. Birds associated with wetlands had the largest representation on the list relative to other habitat groups. Of the 29 state or federally listed taxa, 21 were also classified as climate vulnerable, further raising their conservation concern. Integrating climate vulnerability and California's Bird Species of Special Concern list resulted in the addition of five taxa and an increase in priority rank for ten. Our process illustrates a simple, immediate action that can be taken to inform climate change adaptation strategies for wildlife.	[Gardali, Thomas; Seavy, Nathaniel E.] PRBO Conservat Sci, Pacific Coast & Cent Valley Grp, Petaluma, CA USA; [DiGaudio, Ryan T.] PRBO Conservat Sci, Emerging Programs & Partnerships Grp, Petaluma, CA USA; [Comrack, Lyann A.] Calif Dept Fish & Game, Nongame Wildlife Program, Sacramento, CA 95814 USA		Gardali, T (corresponding author), PRBO Conservat Sci, Pacific Coast & Cent Valley Grp, Petaluma, CA USA.	tgardali@prbo.org						[Anonymous], 2011, SCANNING CONSERVATIO; Beissinger SR, 2000, AUK, V117, P549, DOI 10.1642/0004-8038(2000)117[0549:ROTACC]2.0.CO;2; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Bunn D, 2007, CALIFORNIA WILDLIFE; Carter MF, 2000, AUK, V117, P541, DOI 10.1642/0004-8038(2000)117[0541:SCPFLI]2.0.CO;2; Dahl T. E., 1991, STATUS TRENDS WETLAN; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; Heikkinen RK, 2010, BIODIVERS CONSERV, V19, P695, DOI 10.1007/s10531-009-9728-x; HUGHES JM, 1999, BIRDS N AM, V418; IPCC, 2007, CLIM CHANG 2007 PHYS; Isaac Joanne L., 2009, Endangered Species Research, V7, P115, DOI 10.3354/esr00093; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lenihan JM, 2008, CLIMATIC CHANGE, V87, pS215, DOI 10.1007/s10584-007-9362-0; LIGON JD, 1969, AUK, V86, P458, DOI 10.2307/4083408; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Macwirter B, 2002, BIRDS N AM; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Monahan WB, 2008, MAPPING AVIAN RESPON; Natural Resources Defense Council, 2010, CLIM CHANG WAT RISK; North American Bird Conservation Initiative (nabci) U.S. Committee, 2010, STAT BIRDS 2010 REP; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Poole A, BIRDS N AM ONLINE; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; PRBO Conservation Science, 2011, PROJ EFF CLIM CHANG; Richardson T. Will, 2003, Western Birds, V34, P58; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Schneider SH, 2002, WILDLIFE RESPONSES C; Schroeder MA, 1999, BIRDS N AM, V425; SHUFORD WD, 2008, STUDIES W BIRDS, V1, P1; Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2011, METHODS ECOL EVOL, V2, P125, DOI 10.1111/j.2041-210X.2010.00065.x; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; U.S. Environmental Protection Agency, 2009, FRAM CAT REL VULN TH; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Weathers WW, 2001, CONDOR, V103, P678, DOI 10.1650/0010-5422(2001)103[0678:TEAEEO]2.0.CO;2; West JM, 2009, ENVIRON MANAGE, V44, P1001, DOI 10.1007/s00267-009-9345-1; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wolf SG, 2010, GLOBAL CHANGE BIOL, V16, P1923, DOI 10.1111/j.1365-2486.2010.02194.x; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x; Young B., 2010, GUIDELINES USING NAT	55	77	80	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e29507	10.1371/journal.pone.0029507	http://dx.doi.org/10.1371/journal.pone.0029507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396726	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500001
J	Hu, X; Li, JH; Lan, L; Wu, FF; Zhang, EP; Song, ZM; Huang, HC; Luo, FJ; Pan, CW; Tan, F				Hu, Xin; Li, Jiang-Hui; Lan, Lan; Wu, Fei-Fei; Zhang, Er-Peng; Song, Zeng-Mei; Huang, Hui-Cong; Luo, Fang-Jun; Pan, Chang-Wang; Tan, Feng			In Vitro Study of the Effects of Angiostrongylus cantonensis Larvae Extracts on Apoptosis and Dysfunction in the Blood-Brain Barrier (BBB)	PLOS ONE			English	Article							MURINE CEREBRAL MALARIA; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; EOSINOPHILIC MENINGOENCEPHALITIS; MATRIX METALLOPROTEINASES; MONONUCLEAR-CELLS; TISSUE INHIBITORS; MENINGITIS; INFECTION; ASTROCYTES	It has been hypothesized that blood-brain barrier (BBB) dysfunction in Angiostrongylus cantonensis infection might be due to the apoptosis of the hosts' BBB cells. Here, we evaluated this hypothesis through several methods, all based on an in vitro mouse BBB model consisting of primary culture brain microvascular endothelial cells (BMECs) and brain astrocytic cells (BACs). In the present study, a four-hour percolation and HRP permeability experiment showed that A. cantonensis larvae extracts can increase the permeability of the BBB. Apoptosis among BMECs and BACs after exposure to larvae extracts was monitored by TUNEL and annexin-V-FITC/PI double staining. A. cantonensis larvae extracts were found to induce apoptosis in both BMECs and BACs. For this reason, we concluded that the induction of apoptosis might participate in the BBB dysfunction observed during angiostrongyliasis. Improved fundamental understanding of how A. cantonensis induces apoptosis may lead to new approaches to the treatment or prevention of this parasitic disease.	[Hu, Xin] Wenzhou Med Coll, Sch Med Lab Sci, Wenzhou, Zhejiang, Peoples R China; [Hu, Xin] Wenzhou Med Coll, Sch Life Sci, Wenzhou, Zhejiang, Peoples R China; [Li, Jiang-Hui] Wenzhou Med Coll, Inst Hlth & Environm, Wenzhou, Zhejiang, Peoples R China; [Lan, Lan; Wu, Fei-Fei; Zhang, Er-Peng; Song, Zeng-Mei; Huang, Hui-Cong; Pan, Chang-Wang; Tan, Feng] Wenzhou Med Coll, Sch Basic Med Sci, Dept Parasitol, Wenzhou, Zhejiang, Peoples R China; [Luo, Fang-Jun] Zhuji Peoples Hosp, Dept Clin Lab, Zhuji, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Hu, X (corresponding author), Wenzhou Med Coll, Sch Med Lab Sci, Wenzhou, Zhejiang, Peoples R China.	tanfengsong@163.com			Natural Science Foundation of China [30800963, 30972575]; Wenzhou Science and Technology Bureau of China [Y20090001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau of China	This work was supported by Natural Science Foundation of China (No. 30800963, http://www.nsfc.gov.cn) to F. Tan, Natural Science Foundation of China (No. 30972575) to H-C Huang, and grants from Social Development Program of Wenzhou Science and Technology Bureau of China (No. Y20090001, http://www.wzkj.gov.cn/) to C-W Pan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta RE, 2003, J LEUKOCYTE BIOL, V73, P127; Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Balde AT, 2000, PARASITE IMMUNOL, V22, P307, DOI 10.1046/j.1365-3024.2000.00307.x; Brown HC, 2000, NEUROLOGY, V55, P104, DOI 10.1212/WNL.55.1.104; Deininger MH, 2002, EUR CYTOKINE NETW, V13, P173; Dorta-Contreras A, 1998, CLIN DIAGN LAB IMMUN, V5, P452, DOI 10.1128/CDLI.5.4.452-455.1998; El-Kowrany Samy I., 2001, Journal of the Egyptian Society of Parasitology, V31, P245; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Girard M, 2003, INT J PARASITOL, V33, P713, DOI 10.1016/S0020-7519(03)00033-X; Gottfredsson M, 2000, SEMIN NEUROL, V20, P307, DOI 10.1055/s-2000-9394; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Isobe I, 1996, NEUROCHEM INT, V28, P523, DOI 10.1016/0197-0186(95)00142-5; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Li JiangHui, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P894; Medana IM, 1996, GLIA, V16, P51, DOI 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.3.CO;2-2; Medana IM, 1997, GLIA, V19, P91, DOI 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C; Pien F D, 1999, Int J Infect Dis, V3, P161, DOI 10.1016/S1201-9712(99)90039-5; RISAU W, 1990, TRENDS NEUROSCI, V13, P174, DOI 10.1016/0166-2236(90)90043-A; Saikumar P, 1999, AM J MED, V107, P489, DOI 10.1016/S0002-9343(99)00259-4; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Shapiro S, 2003, J NEUROL SCI, V206, P43, DOI 10.1016/S0022-510X(02)00317-9; Stiles JK, 2004, MOL BIOCHEM PARASIT, V133, P229, DOI 10.1016/j.molbiopara.2003.10.011; Stiles JK, 2001, ANN TROP MED PARASIT, V95, P797, DOI 10.1080/00034980120111145; ToureBalde A, 1996, INFECT IMMUN, V64, P744, DOI 10.1128/IAI.64.3.744-750.1996; Tsai HC, 2008, AM J TROP MED HYG, V78, P20, DOI 10.4269/ajtmh.2008.78.20; Tsai HC, 2007, AM J TROP MED HYG, V76, P592, DOI 10.4269/ajtmh.2007.76.592; TUNGKANAK R, 1972, AM J TROP MED HYG, V21, P415, DOI 10.4269/ajtmh.1972.21.415; Weidenfeller C, 2005, BRAIN RES, V1053, P162, DOI 10.1016/j.brainres.2005.06.049; Williams PL, 2002, J INFECT DIS, V186, P1692, DOI 10.1086/345365; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	35	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32161	10.1371/journal.pone.0032161	http://dx.doi.org/10.1371/journal.pone.0032161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393387	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500040
J	Loebbermann, J; Schnoeller, C; Thornton, H; Durant, L; Sweeney, NP; Schuijs, M; O'Garra, A; Johansson, C; Openshaw, PJ				Loebbermann, Jens; Schnoeller, Corinna; Thornton, Hannah; Durant, Lydia; Sweeney, Nathan P.; Schuijs, Martijn; O'Garra, Anne; Johansson, Cecilia; Openshaw, Peter J.			IL-10 Regulates Viral Lung Immunopathology during Acute Respiratory Syncytial Virus Infection in Mice	PLOS ONE			English	Article							EFFECTOR T-CELLS; INTERLEUKIN-10; BRONCHIOLITIS; ASTHMA; INFLAMMATION; DISEASE; ACTIVATION; CHALLENGE; RESPONSES; SUBSETS	Interleukin (IL-) 10 is a pleiotropic cytokine with broad immunosuppressive functions, particularly at mucosal sites such as the intestine and lung. Here we demonstrate that infection of BALB/c mice with respiratory syncytial virus (RSV) induced IL-10 production by CD4(+) and CD8(+) T cells in the airways at later time points (e. g. day 8); a proportion of these cells also co-produced IFN-gamma. Furthermore, RSV infection of IL-10(-/-) mice resulted in more severe disease with enhanced weight loss, delayed recovery and greater cell infiltration of the respiratory tract without affecting viral load. In addition, IL-10(-/-) mice had a pronounced airway neutrophilia and heightened levels of pro-inflammatory cytokines and chemokines in the bronchoalveolar lavage fluid. Notably, the proportion of lung T cells producing IFN-gamma was enhanced, suggesting that IL-10 may act in an autocrine manner to dampen effector T cell responses. Similar findings were made in mice treated with antiIL-10R antibody and infected with RSV. Therefore, IL-10 inhibits disease and inflammation in mice infected with RSV, especially during recovery from infection.	[Loebbermann, Jens; Schnoeller, Corinna; Thornton, Hannah; Durant, Lydia; Sweeney, Nathan P.; Schuijs, Martijn; Johansson, Cecilia; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect MRC, London, England; [Loebbermann, Jens; Schnoeller, Corinna; Thornton, Hannah; Durant, Lydia; Sweeney, Nathan P.; Schuijs, Martijn; Johansson, Cecilia; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr, Natl Heart & Lung Inst, Fac Med, London, England; [O'Garra, Anne] MRC Natl Inst Med Res, Div Immunoregulat, London, England	Imperial College London; Imperial College London; MRC National Institute for Medical Research	Loebbermann, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect MRC, London, England.	p.openshaw@imperial.ac.uk	Loebbermann, Jens/K-8327-2014; Johansson, Cecilia/ABF-6337-2021; Openshaw, Peter/AAL-9442-2020	Johansson, Cecilia/0000-0002-6607-5000; Openshaw, Peter/0000-0002-7220-2555; Durant, Lydia/0000-0002-5068-1479; O'Garra, Anne/0000-0001-9845-6134	Centre of Respiratory Infections (CRI); MRC & Asthma UK Centre in Allergic Mechanisms of Asthma; European Commission [UU-ER/2010/010744]; Wellcome Trust [087805/Z/08/Z]; MRC [G0800311]; Medical Research Council [G0800311, MC_U117565642, G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; MRC [MC_U117565642] Funding Source: UKRI	Centre of Respiratory Infections (CRI); MRC & Asthma UK Centre in Allergic Mechanisms of Asthma(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Centre of Respiratory Infections (CRI), the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, the Erasmus Placement grant (UU-ER/2010/010744, M.S.) from the European Commission Life Long Learning programme, the Wellcome Trust (Programme 087805/Z/08/Z, P.O.) and the MRC career development award (Grant G0800311, C.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bem RA, 2008, PEDIATR RES, V63, P650, DOI 10.1203/PDR.0b013e31816fdc32; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Freymuth F, 2004, REV MAL RESPIR, V21, P35, DOI 10.1016/S0761-8425(04)71233-4; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee DC, 2010, J VIROL; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Murai Hiroki, 2007, Allergol Int, V56, P157, DOI 10.2332/allergolint.O-06-454; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stacey MA, 2011, J IMMUNOL, V187, P2944, DOI 10.4049/jimmunol.1101021; Sun J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002173; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Weiss KA, 2011, J IMMUNOL, V187, P3145, DOI 10.4049/jimmunol.1100764; Zeng RH, 2011, CYTOKINE, V53, P1, DOI 10.1016/j.cyto.2010.09.011	39	92	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32371	10.1371/journal.pone.0032371	http://dx.doi.org/10.1371/journal.pone.0032371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393401	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500054
J	van Beveren, NJM; Buitendijk, GHS; Swagemakers, S; Krab, LC; Roder, C; de Haan, L; van der Spek, P; Elgersma, Y				van Beveren, Nico J. M.; Buitendijk, Gabrielle H. S.; Swagemakers, Sigrid; Krab, Lianne C.; Roder, Christian; de Haan, Lieuwe; van der Spek, Peter; Elgersma, Ype			Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients	PLOS ONE			English	Article							GENE-EXPRESSION; BIPOLAR DISORDER; PREFRONTAL CORTEX; ASSOCIATION; MICROARRAY; HAPLOTYPE; PROFILES; IMMUNE; SAMPLE; RISK	Background: Recent studies have suggested that deregulated AKT1 signaling is associated with schizophrenia. We hypothesized that if this is indeed the case, we should observe both decreased AKT1 expression as well as deregulation of AKT1 regulated pathways in Peripheral Blood Mononuclear Cells (PBMCs) of schizophrenia patients. Objectives: To examine PBMC expression levels of AKT1 in schizophrenia patients versus controls, and to examine whether functional biological processes in which AKT1 plays an important role are deregulated in schizophrenia patients. Methods/Results: A case-control study, investigating whole-genome PBMC gene expression in male, recent onset (, 5 years) schizophrenia patients (N = 41) as compared to controls (N = 29). Genes, differentially expressed between patients and controls were identified using ANOVA with Benjamini-Hochberg correction (false discovery rate (FDR) = 0.05). Functional aspects of the deregulated set of genes were investigated with the Ingenuity Pathway Analysis (IPA) Software Tool. We found significantly decreased PBMC expression of AKT1 (p<0.001, t = -24.25) in the patients. AKT1 expression was decreased in antipsychotic-free or -naive patients (N = 11), in florid psychotic (N = 20) and in remitted (N = 21) patients. A total of 1224 genes were differentially expressed between patients and controls (FDR = 0.05). Functional analysis of the entire deregulated gene set indicated deregulated canonical pathways involved in a large number of cellular processes: immune system, cell adhesion and neuronal guidance, neurotrophins and (neural) growth factors, oxidative stress and glucose metabolism, and apoptosis and cell-cycle regulation. Many of these processes are associated with AKT1. Conclusions: We show significantly decreased PBMC gene expression of AKT1 in male, recent-onset schizophrenia patients. Our observations suggest that decreased PBMC AKT1 expression is a stable trait in recent onset, male schizophrenia patients. We identified several AKT related cellular processes which are potentially affected in these patients, a majority of which play a prominent role in current schizophrenia hypotheses.	[van Beveren, Nico J. M.; Roder, Christian] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [van Beveren, Nico J. M.; Buitendijk, Gabrielle H. S.; Krab, Lianne C.; Elgersma, Ype] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands; [Swagemakers, Sigrid; van der Spek, Peter] Erasmus Univ, Med Ctr, Dept Genet, Dept Bioinformat, Rotterdam, Netherlands; [de Haan, Lieuwe] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Beveren, Nico J. M.] Delta Ctr Mental Hlth Care, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	van Beveren, NJM (corresponding author), Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands.	j.m.vanbeveren@erasmusmc.nl		Elgersma, Ype/0000-0002-3758-1297	AstraZeneca Company (Netherlands)	AstraZeneca Company (Netherlands)	Part of this work has been made possible by an unrestricted personal grant to Nico J. van Beveren by AstraZeneca Company (Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Arguello PA, 2008, J CLIN INVEST, V118, P2018, DOI 10.1172/JCI35931; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Bajestan SN, 2006, AM J MED GENET B, V141B, P383, DOI 10.1002/ajmg.b.30291; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Buckley PF, 2007, SCHIZOPHR RES, V94, P1, DOI 10.1016/j.schres.2007.01.025; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Carter CJ, 2009, SCHIZOPHRENIA BULL, V35, P1163, DOI 10.1093/schbul/sbn054; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Guest PC, 2010, MOL PSYCHIATR, V15, P118, DOI 10.1038/mp.2009.81; Guest PC, 2011, PSYCHONEUROENDOCRINO, V36, P1092, DOI 10.1016/j.psyneuen.2010.12.018; Hanson DR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-7; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Iwamoto K, 2006, NEUROSCIENTIST, V12, P349, DOI 10.1177/1073858406287536; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P9, DOI 10.1111/j.1440-1711.2005.01305.x; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Konradi C, 2005, BRAIN RES REV, V50, P142, DOI 10.1016/j.brainresrev.2005.05.004; Kozlovsky N, 2005, EUR NEUROPSYCHOPHARM, V15, P1, DOI 10.1016/j.euroneuro.2004.02.003; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Liu YC, 2009, J PSYCHOPHARMACOL, V23, P937, DOI 10.1177/0269881108093840; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Muller N, 2006, NEUROTOX RES, V10, P131; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Nadri C, 2002, PSYCHIAT RES, V112, P51, DOI 10.1016/S0165-1781(02)00191-9; Naydenov AV, 2007, ARCH GEN PSYCHIAT, V64, P555, DOI 10.1001/archpsyc.64.5.555; Norton N, 2007, SCHIZOPHR RES, V93, P58, DOI 10.1016/j.schres.2007.02.006; Ohtsuki T, 2004, MOL PSYCHIATR, V9, P981, DOI 10.1038/sj.mp.4001559; Rothermundt M, 2001, BRAIN BEHAV IMMUN, V15, P319, DOI 10.1006/brbi.2001.0648; Salem JE, 1998, CLIN PSYCHOL REV, V18, P795, DOI 10.1016/S0272-7358(98)00008-7; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Turunen JA, 2007, SCHIZOPHR RES, V91, P27, DOI 10.1016/j.schres.2006.11.028; van Beveren NJM, 2006, EUR NEUROPSYCHOPHARM, V16, P469, DOI 10.1016/j.euroneuro.2006.02.001; van Nimwegen LJM, 2008, J CLIN ENDOCR METAB, V93, P572, DOI 10.1210/jc.2007-1167; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Xu MQ, 2007, J CLIN PSYCHIAT, V68, P1358, DOI 10.4088/JCP.v68n0906; Zhong Z, 2006, SCHIZOPHR RES, V84, P1, DOI 10.1016/j.schres.2006.02.009	55	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32618	10.1371/journal.pone.0032618	http://dx.doi.org/10.1371/journal.pone.0032618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393424	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500076
J	van der Helm, JJ; Sabajo, LOA; Grunberg, AW; Morre, SA; Speksnijder, AGCL; de Vries, HJC				van der Helm, Jannie J.; Sabajo, Leslie O. A.; Grunberg, Antoon W.; Morre, Servaas A.; Speksnijder, Arjen G. C. L.; de Vries, Henry J. C.			Point-of-Care Test for Detection of Urogenital Chlamydia in Women Shows Low Sensitivity. A Performance Evaluation Study in Two Clinics in Suriname	PLOS ONE			English	Article							COST-EFFECTIVENESS; TRACHOMATIS INFECTION; NEISSERIA-GONORRHOEAE; RAPID TESTS; DIAGNOSIS; DISEASES; ASSAY	Background: In general, point-of-care (POC) tests for Chlamydia trachomatis (Ct) show disappointing test performance, especially disappointing sensitivity results. However, one study sponsored by the manufacturer (Diagnostics for the Real World) reported over 80% sensitivity with their Chlamydia Rapid Test (CRT). We evaluated the performance of this CRT in a non-manufacturer-sponsored trial. Methods: Between July 2009 and February 2010, we included samples from 912 women in both high-and low-risk clinics for sexually transmitted infections (STIs) in Paramaribo, Suriname. Sensitivity, specificity, positive-and negative predictive values (PPV and NPV) for CRT compared to NAAT (Aptima, Gen-Probe) were determined. Quantitative Ct load and human cell load were determined in all CRT and/or NAAT positive samples. Results: CRT compared to NAAT showed a sensitivity and specificity of 41.2% (95% CI, 31.9%-50.9%) and 96.4% (95% CI, 95.0%-97.5%), respectively. PPV and NPV were 59.2% (95% CI, 47.5%-70.1%) and 92.9% (95% CI, 91.0%-94.5%), respectively. Quantitative Ct bacterial load was 73 times higher in NAAT-positive/CRT-positive samples compared to NAAT-positive/CRT-negative samples (p < 0.001). Human cell load did not differ between true-positive and false-negative CRT results (p = 0.835). Sensitivity of CRT in samples with low Ct load was 12.5% (95% CI, 5.2%-24.2%) and in samples with high Ct load 73.5% (95% CI, 59.9%-84.4%). Conclusions: The sensitivity of CRT for detecting urogenital Ct in this non-manufacturer-sponsored study did not meet the expectations as described previously. The CRT missed samples with a low Ct load. Improved POC are needed as meaningful diagnostic to reduce the disease burden of Ct.	[van der Helm, Jannie J.; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [Sabajo, Leslie O. A.] Minist Hlth, Dermatol Serv, Paramaribo, Suriname; [Grunberg, Antoon W.] Lobi Fdn, Paramaribo, Suriname; [Morre, Servaas A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci, Inst Publ Hlth Genom, Dept Genet & Cell Biol,Res Inst CAPHRI, Maastricht, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci, Inst Publ Hlth Genom, Dept Genet & Cell Biol,Res Inst GROW, Maastricht, Netherlands; [Speksnijder, Arjen G. C. L.] Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Public Health Service Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	van der Helm, JJ (corresponding author), Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands.	h.j.devries@amc.uva.nl	de Vries, Henry/K-5963-2012; Speksnijder, Arjen/M-3406-2017	de Vries, Henry/0000-0001-9784-547X; Speksnijder, Arjen/0000-0002-1966-7265; van der Helm, Jannie/0000-0002-4288-9544	Municipal Health Service of Amsterdam [2369, 2371]; AGIS healthcare insurance [RVVZ] [1417000]	Municipal Health Service of Amsterdam; AGIS healthcare insurance [RVVZ]	This work was supported by the Research and Development fund of the Municipal Health Service of Amsterdam [project no 2369 and 2371] and AGIS healthcare insurance [RVVZ no 1417000]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch L, 2001, LETT APPL MICROBIOL, V33, P296, DOI 10.1046/j.1472-765X.2001.00999.x; Catsburg A, 2006, 11 INT S HUM CHLAM I, P521; Chernesky M, 2006, J CLIN MICROBIOL, V44, P400, DOI 10.1128/JCM.44.2.400-405.2006; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Gift TL, 1999, SEX TRANSM DIS, V26, P232, DOI 10.1097/00007435-199904000-00010; Harding-Esch EM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001234; Hislop J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14290; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Lowe P, 2006, J CLIN MICROBIOL, V44, P2619, DOI 10.1128/JCM.00476-06; Mahilum-Tapay L, 2007, BMJ-BRIT MED J, V335, P1190, DOI 10.1136/bmj.39402.463854.AE; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2006, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro1569; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Pospischil A, 2002, SWISS MED WKLY, V132, P64; Renault CA, 2011, SEX HEALTH, V8, P69, DOI 10.1071/SH10030; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Vickerman P, 2003, SEX TRANSM INFECT, V79, P363, DOI 10.1136/sti.79.5.363; Whyte A, 1998, J INFECTION, V36, P245, DOI 10.1016/S0163-4453(98)80030-3; World Health Organization, 2001, GLOB PREV INC SEL CU	28	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32122	10.1371/journal.pone.0032122	http://dx.doi.org/10.1371/journal.pone.0032122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393383	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500036
J	Becker, N; Jost, H; Ziegler, U; Eiden, M; Hoper, D; Emmerich, P; Fichet-Calvet, E; Ehichioya, DU; Czajka, C; Gabriel, M; Hoffmann, B; Beer, M; Tenner-Racz, K; Racz, P; Gunther, S; Wink, M; Bosch, S; Konrad, A; Pfeffer, M; Groschup, MH; Schmidt-Chanasit, J				Becker, Norbert; Joest, Hanna; Ziegler, Ute; Eiden, Martin; Hoeper, Dirk; Emmerich, Petra; Fichet-Calvet, Elisabeth; Ehichioya, Deborah U.; Czajka, Christina; Gabriel, Martin; Hoffmann, Bernd; Beer, Martin; Tenner-Racz, Klara; Racz, Paul; Guenther, Stephan; Wink, Michael; Bosch, Stefan; Konrad, Armin; Pfeffer, Martin; Groschup, Martin H.; Schmidt-Chanasit, Jonas			Epizootic Emergence of Usutu Virus in Wild and Captive Birds in Germany	PLOS ONE			English	Article							WEST-NILE-VIRUS; SEROLOGICAL EVIDENCE; AUSTRIA	This study aimed to identify the causative agent of mass mortality in wild and captive birds in southwest Germany and to gather insights into the phylogenetic relationship and spatial distribution of the pathogen. Since June 2011, 223 dead birds were collected and tested for the presence of viral pathogens. Usutu virus (USUV) RNA was detected by real-time RT-PCR in 86 birds representing 6 species. The virus was isolated in cell culture from the heart of 18 Blackbirds (Turdus merula). USUV-specific antigen was demonstrated by immunohistochemistry in brain, heart, liver, and lung of infected Blackbirds. The complete polyprotein coding sequence was obtained by deep sequencing of liver and spleen samples of a dead Blackbird from Mannheim (BH65/11-02-03). Phylogenetic analysis of the German USUV strain BH65/11-02-03 revealed a close relationship with strain Vienna that caused mass mortality among birds in Austria in 2001. Wild birds from lowland river valleys in southwest Germany were mainly affected by USUV, but also birds kept in aviaries. Our data suggest that after the initial detection of USUV in German mosquitoes in 2010, the virus spread in 2011 and caused epizootics among wild and captive birds in southwest Germany. The data also indicate an increased risk of USUV infections in humans in Germany.	[Becker, Norbert; Joest, Hanna; Czajka, Christina] German Mosquito Control Assoc KABS, Waldsee, Germany; [Becker, Norbert; Joest, Hanna; Czajka, Christina] Heidelberg Univ, Dept Zool, Heidelberg, Germany; [Joest, Hanna; Emmerich, Petra; Fichet-Calvet, Elisabeth; Ehichioya, Deborah U.; Czajka, Christina; Gabriel, Martin; Guenther, Stephan; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany; [Ziegler, Ute; Eiden, Martin; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Hoeper, Dirk; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Tenner-Racz, Klara; Racz, Paul] Bernhard Nocht Inst Trop Med, Dept Pathol, Hamburg, Germany; [Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Bosch, Stefan] Nat & Biodivers Conservat Union NABU Baden Wurtte, Stuttgart, Germany; [Konrad, Armin] Avifauna Nordbaden De, Ornitholog Gesell Baden Wurttemberg OGBW Nordbade, Heidelberg, Germany; [Pfeffer, Martin] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Fac Vet Med, Leipzig, Germany	Ruprecht Karls University Heidelberg; Bernhard Nocht Institut fur Tropenmedizin; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Bernhard Nocht Institut fur Tropenmedizin; Ruprecht Karls University Heidelberg; Leipzig University	Becker, N (corresponding author), German Mosquito Control Assoc KABS, Waldsee, Germany.	jonassi@gmx.de	Wink, Michael/E-3803-2012; Ehichioya, Deborah/AAR-7295-2020	Wink, Michael/0000-0002-7875-4510; Hoper, Dirk/0000-0001-8408-2274; Ehichioya, Deborah/0000-0002-5777-685X; Schmidt-Chanasit, Jonas/0000-0003-4433-0231; Eiden, Martin/0000-0002-1197-8288; Gunther, Stephan/0000-0002-6562-0230; Jost, Hanna/0000-0001-6947-8334	(European Virus Archive) from the European Community [228292]	(European Virus Archive) from the European Community	The study was supported by grant 228292 (European Virus Archive) from the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2; Bosch Stefan, 2005, Ornithologische Mitteilungen, V57, P192; Bosch Stefan, 2003, Ornithologische Mitteilungen, V55, P308; Brown C.R., 2011, ORNITHOL MONOGR, V71, P1, DOI [DOI 10.1525/0M.2011.71.1.1, 10.1525/om.2011.71.1.1.1, DOI 10.1525/OM.2011.71.1.1.1]; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Cavrini F, 2009, EURO SURVEILL, V14; Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06; Chvala S, 2004, J COMP PATHOL, V131, P176, DOI 10.1016/j.jcpa.2004.03.004; Einstein J, 2011, E COMMUNICATION; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248; Lissak W, E COMMUNICATION; Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023; Pecorari M, 2009, EURO SURVEILL, V14; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubel F, 2008, PREV VET MED, V85, P166, DOI 10.1016/j.prevetmed.2008.01.006; Seidowski D, 2010, VECTOR-BORNE ZOONOT, V10, P639, DOI 10.1089/vbz.2009.0236; Weiss V, 2011, E COMMUNICATION; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Ziegler U, 2012, MONITORING IN PRESS	23	123	125	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32604	10.1371/journal.pone.0032604	http://dx.doi.org/10.1371/journal.pone.0032604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389712	Green Published, gold			2022-12-25	WOS:000302999600051
J	Hurt, JK; Fitzpatrick, BJ; Norris-Drouin, J; Zylka, MJ				Hurt, Julie K.; Fitzpatrick, Brendan J.; Norris-Drouin, Jacqueline; Zylka, Mark J.			Secretion and N-Linked Glycosylation Are Required for Prostatic Acid Phosphatase Catalytic and Antinociceptive Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; 3-DIMENSIONAL STRUCTURE; TYROSINE-PHOSPHATASE; CANCER; PAIN; ECTONUCLEOTIDASE; L(+)-TARTRATE; EXPRESSION; ADENOSINE; COMPLEX	Secretory human prostatic acid phosphatase (hPAP) is glycosylated at three asparagine residues (N62, N188, N301) and has potent antinociceptive effects when administered to mice. Currently, it is unknown if these N-linked residues are required for hPAP protein stability and activity in vitro or in animal models of chronic pain. Here, we expressed wild-type hPAP and a series of Asn to Gln point mutations in the yeast Pichia pastoris X33 then analyzed protein levels and enzyme activity in cell lysates and in conditioned media. Pichia secreted wild-type recombinant (r)-hPAP into the media (6-7 mg protein/L). This protein was as active as native hPAP in biochemical assays and in mouse models of inflammatory pain and neuropathic pain. In contrast, the N62Q and N188Q single mutants and the N62Q, N188Q double mutant were expressed at lower levels and were less active than wild-type r-hPAP. The purified N62Q, N188Q double mutant protein was also 1.9 fold less active in vivo. The N301Q mutant was not expressed, suggesting a critical role for this residue in protein stability. To explicitly test the importance of secretion, a construct lacking the signal peptide of hPAP was expressed in Pichia and assayed. This "cellular'' construct was not expressed at levels detectable by western blotting. Taken together, these data indicate that secretion and post-translational carbohydrate modifications are required for PAP protein stability and catalytic activity. Moreover, our findings indicate that recombinant hPAP can be produced in Pichia-a yeast strain that is used to generate biologics for therapeutic purposes.	[Hurt, Julie K.; Fitzpatrick, Brendan J.; Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Norris-Drouin, Jacqueline] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hurt, JK (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu			NINDS [R01NS060725, R01NS067688]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, R01NS067688] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to MJZ from NINDS (R01NS060725, R01NS067688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter R, 2011, VACCINE, V29, P2272, DOI 10.1016/j.vaccine.2011.01.039; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Gething M-J, 1985, CURRENT COMMUNICATIO; Gutman AB, 1938, J CLIN INVEST, V17, P473, DOI 10.1172/JCI100974; Hassan MI, 2010, EXPERT REV ANTICANC, V10, P1055, DOI 10.1586/ERA.10.46; Jakob CG, 2000, PROSTATE, V42, P211, DOI 10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO;2-U; LaCount MW, 1998, J BIOL CHEM, V273, P30406, DOI 10.1074/jbc.273.46.30406; LEE H, 1991, BIOCHEM J, V277, P759, DOI 10.1042/bj2770759; LINDQVIST Y, 1993, J BIOL CHEM, V268, P20744; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; MORRIS MF, 1989, CLIN CHIM ACTA, V182, P9, DOI 10.1016/0009-8981(89)90145-9; MRSA V, 1987, FEBS LETT, V217, P174, DOI 10.1016/0014-5793(87)80658-0; Murasugi Akira, 2010, Recent Pat Biotechnol, V4, P153; Ortlund E, 2003, BIOCHEMISTRY-US, V42, P383, DOI 10.1021/bi0265067; OSTANIN K, 1994, J BIOL CHEM, V269, P8971; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; RELJIC R, 1992, GLYCOCONJUGATE J, V9, P39, DOI 10.1007/BF00731176; RISLEY JM, 1987, ARCH BIOCHEM BIOPHYS, V258, P404, DOI 10.1016/0003-9861(87)90361-4; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Sowa NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004248; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Tolner B, 2007, EUR J CANCER, V43, P2515, DOI 10.1016/j.ejca.2007.08.027; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; VIHKO P, 1978, CLIN CHEM, V24, P466; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006	34	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32741	10.1371/journal.pone.0032741	http://dx.doi.org/10.1371/journal.pone.0032741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389722	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600061
J	Levinson, P; Choi, RY; Cole, AL; Hirbod, T; Rhedin, S; Payne, B; Guthrie, BL; Bosire, R; Cole, AM; Farquhar, C; Broliden, K				Levinson, Pauline; Choi, Robert Y.; Cole, Amy L.; Hirbod, Taha; Rhedin, Samuel; Payne, Barbara; Guthrie, Brandon L.; Bosire, Rose; Cole, Alexander M.; Farquhar, Carey; Broliden, Kristina			HIV-Neutralizing Activity of Cationic Polypeptides in Cervicovaginal Secretions of Women in HIV-Serodiscordant Relationships	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; EXPOSED SERONEGATIVE INDIVIDUALS; VAGINAL FLUID; SEX WORKERS; ANTIMICROBIAL POLYPEPTIDES; BACTERIAL VAGINOSIS; ALPHA-DEFENSINS; INNATE IMMUNITY; GENITAL-TRACT; MUCOSAL	Background: HIV exposed seronegative (HESN) women represent the population most in need of a prophylactic antiviral strategy. Mucosal cationic polypeptides can potentially be regulated for this purpose and we here aimed to determine their endogenous expression and HIV neutralizing activity in genital secretions of women at risk of HIV infection. Methodology/Principal Findings: Cervicovaginal secretions (CVS) of Kenyan women in HIV-serodiscordant relationships (HESN, n = 164; HIV seropositive, n = 60) and low-risk controls (n = 72) were assessed for the cationic polypeptides HNP1-3, LL-37 and SLPI by ELISA and for HIV neutralizing activity by a PBMC-based assay using an HIV primary isolate. Median levels of HNP1-3 and LL-37 in CVS were similar across study groups. Neither HSV-2 serostatus, nor presence of bacterial vaginosis, correlated with levels of HNP1-3 or LL-37 in the HESN women. However, an association with their partner's viral load was observed. High viral load (>10,000 HIV RNA copies/ml plasma) correlated with higher levels of HNP1-3 and LL-37 (p = 0.04 and 0.03, respectively). SLPI was most abundant in the low-risk group and did not correlate with male partner's viral load in the HESN women. HIV neutralizing activity was found in CVS of all study groups. In experimental studies, selective depletion of cationic polypeptides from CVS rendered the remaining CVS fraction non-neutralizing, whereas the cationic polypeptide fraction retained the activity. Furthermore, recombinant HNP1-3 and LL-37 could induce neutralizing activity when added to CVS lacking intrinsic activity. Conclusions/Significance: These findings show that CVS from HESN, low-risk, and HIV seropositive women contain HIV neutralizing activity. Although several innate immune proteins, including HNP1-3 and LL-37, contribute to this activity these molecules can also have inflammatory properties. This balance is influenced by hormonal and environmental factors and in the present HIV serodiscordant couple cohort study we show that a partner's viral load is associated with levels of such molecules.	[Levinson, Pauline; Hirbod, Taha; Rhedin, Samuel; Broliden, Kristina] Karolinska Inst, Infect Dis Unit, Dept Med, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden; [Choi, Robert Y.; Payne, Barbara; Bosire, Rose] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya; [Choi, Robert Y.; Payne, Barbara; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Payne, Barbara; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Guthrie, Brandon L.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bosire, Rose] Kenya Govt Med Res Ctr, Ctr Publ Hlth Res, Nairobi, Kenya	Karolinska Institutet; Karolinska University Hospital; University of Nairobi; University of Washington; University of Washington Seattle; State University System of Florida; University of Central Florida; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute	Levinson, P (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden.	kristina.broliden@karolinska.se	Arthur Rhedin, Samuel/H-4653-2019	Arthur Rhedin, Samuel/0000-0001-5798-2875	Swedish Research Council; Swedish International Development Cooperation Agency; Swedish Physician against AIDS Foundation; Sven Gard's Foundation; University of Washington Center for AIDS Research (CFAR); National Institute of Health (NIH) [AI052017, AI082623, AI082693, AI NIH/NIAID R01 AI068431, K24 AI087399, K01 TW06080]; US funded program [P30 AI027757]; University of Washington (UW); NIH Fogarty International Center [D43 TW00007]; International Research Scientist Development Award [K01TW008406]; FOGARTY INTERNATIONAL CENTER [D43TW000007, K01TW008406, K01TW006080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082693, R56AI052017, R01AI068431, R01AI052017, P30AI027757, R33AI082693, U19AI082623, K24AI087399, T32AI007140] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Swedish Physician against AIDS Foundation; Sven Gard's Foundation; University of Washington Center for AIDS Research (CFAR); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US funded program; University of Washington (UW)(University of Washington); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Research Scientist Development Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Swedish Research Council (KB), the Swedish International Development Cooperation Agency (KB), the Swedish Physician against AIDS Foundation (PL), and the Sven Gard's Foundation (PL) as well as the University of Washington Center for AIDS Research (CFAR), a National Institute of Health (NIH), US funded program (P30 AI027757). The studies were also funded in part by grants AI052017, AI082623 and AI082693 from the NIH (AMC and ALC) and by the NIH grant AI NIH/NIAID R01 AI068431. CF and BP received support from NIH grants K24 AI087399 (CF) and K01 TW06080 (BP). RB and BLG received training support from the University of Washington (UW) AIDS International Training and Research Program supported by the NIH Fogarty International Center grant D43 TW00007. RYC was supported by the International Research Scientist Development Award (K01TW008406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2007, CURR HIV RES, V5, P410; Broliden K, 2010, J INFECT DIS, V202, pS351, DOI 10.1086/655964; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Guthrie BL, 2011, J ACQUIR IMMUNE DEFI; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Iqbal SM, 2005, J INFECT DIS, V192, P728, DOI 10.1086/432482; Jendrysik MA, 2005, J INFECT DIS, V192, P630, DOI 10.1086/432071; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Macaluso M, 1999, CONTRACEPTION, V59, P195, DOI 10.1016/S0010-7824(99)00013-X; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Pala P, 2009, MUCOSAL IMMUNOL, V2, P300, DOI 10.1038/mi.2009.23; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Shattock RJ, 2011, SCIENCE, V333, P42, DOI 10.1126/science.1206399; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x	29	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31996	10.1371/journal.pone.0031996	http://dx.doi.org/10.1371/journal.pone.0031996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389677	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600015
J	Elferink, MG; Megens, HJ; Vereijken, A; Hu, XX; Crooijmans, RPMA; Groenen, MAM				Elferink, Martin G.; Megens, Hendrik-Jan; Vereijken, Addie; Hu, Xiaoxiang; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.			Signatures of Selection in the Genomes of Commercial and Non-Commercial Chicken Breeds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; BODY-COMPOSITION; ASCITES SYNDROME; GROWTH; EXPRESSION; BIODIVERSITY; ASSOCIATIONS; BROILERS	Identifying genomics regions that are affected by selection is important to understand the domestication and selection history of the domesticated chicken, as well as understanding molecular pathways underlying phenotypic traits and breeding goals. While whole-genome approaches, either high-density SNP chips or massively parallel sequencing, have been successfully applied to identify evidence for selective sweeps in chicken, it has been difficult to distinguish patterns of selection and stochastic and breed specific effects. Here we present a study to identify selective sweeps in a large number of chicken breeds (67 in total) using a high-density (58 K) SNP chip. We analyzed commercial chickens representing all major breeding goals. In addition, we analyzed non-commercial chicken diversity for almost all recognized traditional Dutch breeds and a selection of representative breeds from China. Based on their shared history or breeding goal we in silico grouped the breeds into 14 breed groups. We identified 396 chromosomal regions that show suggestive evidence of selection in at least one breed group with 26 of these regions showing strong evidence of selection. Of these 26 regions, 13 were previously described and 13 yield new candidate genes for performance traits in chicken. Our approach demonstrates the strength of including many different populations with similar, and breed groups with different selection histories to reduce stochastic effects based on single populations.	[Elferink, Martin G.; Megens, Hendrik-Jan; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.] Univ Wageningen & Res Ctr, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Vereijken, Addie] Hendrix Genet, Breeding Res & Technol Ctr, Boxmeer, Netherlands; [Hu, Xiaoxiang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	Wageningen University & Research; China Agricultural University	Elferink, MG (corresponding author), Univ Wageningen & Res Ctr, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	Martin.Elferink@wur.nl	Megens, Hendrik-Jan/M-5300-2019; Megens, Hendrik-Jan/E-9676-2010; Crooijmans, Richard PMA/E-2492-2012; Groenen, Martien/D-8408-2012	Megens, Hendrik-Jan/0000-0002-3619-7533; Megens, Hendrik-Jan/0000-0002-3619-7533; Groenen, Martien/0000-0003-0484-4545	Dutch Technology Foundation (STW) [07106]	Dutch Technology Foundation (STW)(Technologiestichting STW)	Martin Elferink was funded by the Dutch Technology Foundation (STW), project number 07106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amills M, 2003, POULTRY SCI, V82, P1485, DOI 10.1093/ps/82.10.1485; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Baghbanzadeh A, 2008, AVIAN PATHOL, V37, P117, DOI 10.1080/03079450801902062; BAKER CMA, 1968, GENETICS, V58, P211; Balog JM, 2003, AVIAN POULT BIOL REV, V14, P99, DOI 10.3184/147020603783637490; BERRY AJ, 1991, GENETICS, V129, P1111; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; Burt DW, 2005, GENOME RES, V15, P1692, DOI 10.1101/gr.4141805; Crawford R.D, 1990, POULTRY BREEDING GEN; Crooijmans RPMA, 1998, NEDERLANDSE HOENDERR; Dana N, 2010, ANIMAL GENETICS, DOI 10.1111; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Eding H, 2002, GENET SEL EVOL, V34, P613, DOI [10.1186/1297-9686-34-5-613, 10.1051/gse:2002027]; Elferink MG, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-11; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Gao Y, 2009, ANIM GENET, V40, P952, DOI 10.1111/j.1365-2052.2009.01911.x; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hutt F.B., 1949, GENETICS OF THE FOWL; Ikeobi CON, 2004, LIVEST PROD SCI, V87, P143, DOI 10.1016/j.livprodsci.2003.09.020; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; JULIAN RJ, 1993, AVIAN PATHOL, V22, P419, DOI 10.1080/03079459308418934; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Megens HJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-86; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peiris BL, 2011, ANIM GENET, V42, P113, DOI 10.1111/j.1365-2052.2010.02077.x; Plant J, 1986, ORIGIN EVOLUTION H 3; Rabie TSKM, 2005, ANIM GENET, V36, P468, DOI 10.1111/j.1365-2052.2005.01346.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sharman PWA, 2007, CYTOGENET GENOME RES, V117, P296, DOI 10.1159/000103191; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uutela M, 2001, CIRCULATION, V103, P2242; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Whitehead CC, 2000, POULTRY SCI, V79, P1033, DOI 10.1093/ps/79.7.1033; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Zekarias B, 2002, VET RES, V33, P109, DOI 10.1051/vetres:2002001; Zhou H, 2007, POULTRY SCI, V86, P255, DOI 10.3382/ps.2007-00267; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	54	48	51	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32720	10.1371/journal.pone.0032720	http://dx.doi.org/10.1371/journal.pone.0032720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384281	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500107
J	Frenkel, S; Kirzhner, V; Korol, A				Frenkel, Svetlana; Kirzhner, Valery; Korol, Abraham			Organizational Heterogeneity of Vertebrate Genomes	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME MAP; DNA-SEQUENCE; CPG ISLANDS; GC-CONTENT; ULTRACONSERVED ELEMENTS; CHROMOSOME TERRITORIES; RECOMBINATION RATES; MAMMALIAN GENOMES; GENE-EXPRESSION; EVOLUTION	Genomes of higher eukaryotes are mosaics of segments with various structural, functional, and evolutionary properties. The availability of whole-genome sequences allows the investigation of their structure as "texts'' using different statistical and computational methods. One such method, referred to as Compositional Spectra (CS) analysis, is based on scoring the occurrences of fixed-length oligonucleotides (k-mers) in the target DNA sequence. CS analysis allows generating species- or region-specific characteristics of the genome, regardless of their length and the presence of coding DNA. In this study, we consider the heterogeneity of vertebrate genomes as a joint effect of regional variation in sequence organization superimposed on the differences in nucleotide composition. We estimated compositional and organizational heterogeneity of genome and chromosome sequences separately and found that both heterogeneity types vary widely among genomes as well as among chromosomes in all investigated taxonomic groups. The high correspondence of heterogeneity scores obtained on three genome fractions, coding, repetitive, and the remaining part of the noncoding DNA (the genome dark matter - GDM) allows the assumption that CS-heterogeneity may have functional relevance to genome regulation. Of special interest for such interpretation is the fact that natural GDM sequences display the highest deviation from the corresponding reshuffled sequences.	[Frenkel, Svetlana] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Frenkel, S (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	korol@research.haifa.ac.il	Kirzhner, Valery/V-7775-2019		Israel Council for Higher Education; Israeli Ministry of Immigrant Absorption; Israeli Ministry of Absorption; Council for Higher Education	Israel Council for Higher Education; Israeli Ministry of Immigrant Absorption; Israeli Ministry of Absorption; Council for Higher Education	This work was supported by the Scholarship for Excellence in Converging Technologies Program of Israel Council for Higher Education (http://www.che.org.il/template/default_e.aspx?PageId = 286) and the Scholarship Program for Research Students of the Israeli Ministry of Immigrant Absorption (http://www.moia.gov.il/Moia_en/Scientists/ScholarshipProgram.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the anonymous reviewers for their helpful comments and suggestions, Dr. Zeev Frenkel for useful discussions and Alexander Frenkel for help in improving the scripts. This work was supported by the Israeli Ministry of Absorption (S.F. and V.K.). S.F. was also supported by a fellowship for excellence in Converging Technologies Program of The Council for Higher Education.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Azad RK, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031913; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bell SJ, 1999, J THEOR BIOL, V197, P51, DOI 10.1006/jtbi.1998.0857; Bell SJ, 1999, J THEOR BIOL, V197, P63, DOI 10.1006/jtbi.1998.0858; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bingham E, 2006, SOC IND MATH, V124; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carpena P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.032903; Chapus C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-63; Chen LA, 2005, BIOINFORMATICS, V21, P3951, DOI 10.1093/bioinformatics/bti651; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Costantini M, 2007, GENE, V400, P9, DOI 10.1016/j.gene.2007.05.025; Costantini M, 2007, CHROMOSOMA, V116, P29, DOI 10.1007/s00412-006-0078-0; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; De S, 2010, CURR OPIN CELL BIOL, V22, P326, DOI 10.1016/j.ceb.2010.04.004; Deng B, 2007, ARXIV0704219118, P1; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Eory L, 2010, MOL BIOL EVOL, V27, P177, DOI 10.1093/molbev/msp219; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hattori M, 2000, AM J OPHTHALMOL, V130, P383, DOI [10.1016/S0002-9394(00)00695-4, DOI 10.1016/S0002-9394(00)00695-4]; Healy J, 2003, GENOME RES, V13, P2306, DOI 10.1101/gr.1350803; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Jabbari K, 1998, GENE, V224, P123, DOI 10.1016/S0378-1119(98)00474-0; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Katzman S, 2011, GENOME BIOL EVOL, V3, P614, DOI 10.1093/gbe/evr058; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kirzhner V, 2007, J MOL EVOL, V64, P448, DOI 10.1007/s00239-006-0178-8; Kirzhner V, 2005, BIOSYSTEMS, V81, P208, DOI 10.1016/j.biosystems.2005.04.003; Kirzhner V, 2011, INFORM SCIENCES, V181, P1454, DOI 10.1016/j.ins.2010.12.009; Kirzhner VM, 2002, PHYSICA A, V312, P447, DOI 10.1016/S0378-4371(02)00843-9; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Li WT, 2002, GENE, V300, P129, DOI 10.1016/S0378-1119(02)00847-8; Li WT, 1998, GENOME RES, V8, P916, DOI 10.1101/gr.8.9.916; Li WT, 2001, GENE, V276, P57, DOI 10.1016/S0378-1119(01)00672-2; Liao BY, 2004, BIOINFORMATICS, V20, P3156, DOI 10.1093/bioinformatics/bth380; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; McLean C, 2008, GENOME RES, V18, P1743, DOI 10.1101/gr.080184.108; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Melodelima C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-632; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Nussinov R, 1980, NUCLEIC ACIDS RES, V378, DOI [10.1093/nar/gkn942, DOI 10.1093/NAR/GKN942]; Paz A, 2006, MOL BIOL EVOL, V23, P56, DOI 10.1093/molbev/msj007; PIETROKOVSKI S, 1990, J BIOMOL STRUCT DYN, V7, P1251, DOI 10.1080/07391102.1990.10508563; Ponting CP, 2006, HUM MOL GENET, V15, pR170, DOI 10.1093/hmg/ddl182; Porceddu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022855; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schmegner C, 2007, CYTOGENET GENOME RES, V116, P167, DOI 10.1159/000098182; Schmegner C, 2007, GENETICS, V175, P421, DOI 10.1534/genetics.106.064386; Sellis D, 2007, MOL BIOL EVOL, V24, P2385, DOI 10.1093/molbev/msm181; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Sivaraman K, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-20; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Trifonov EN, 1986, GNOMIC DICT GENETIC; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Vinogradov AE, 2005, TRENDS GENET, V21, P639, DOI 10.1016/j.tig.2005.09.002; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Wu H, 2010, BIOSTATISTICS, V11, P499, DOI 10.1093/biostatistics/kxq005; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	90	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32076	10.1371/journal.pone.0032076	http://dx.doi.org/10.1371/journal.pone.0032076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384143	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500058
J	Iglesias, MJ; Reilly, SJ; Emanuelsson, O; Sennblad, B; Najafabadi, MP; Folkersen, L; Malarstig, A; Lagergren, J; Eriksson, P; Hamsten, A; Odeberg, J				Iglesias, Maria Jesus; Reilly, Sarah-Jayne; Emanuelsson, Olof; Sennblad, Bengt; Najafabadi, Mohammad Pirmoradian; Folkersen, Lasse; Malarstig, Anders; Lagergren, Jens; Eriksson, Per; Hamsten, Anders; Odeberg, Jacob			Combined Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within Cytokine Genes in the Macrophage Early Immune Response	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE H3 ACETYLATION; PROMOTER STRUCTURE; TRANSCRIPTION; BINDING; RECRUITMENT; METHYLATION; ELONGATION; DOMAINS; MAPS	Macrophages play a critical role in innate immunity, and the expression of early response genes orchestrate much of the initial response of the immune system. Macrophages undergo extensive transcriptional reprogramming in response to inflammatory stimuli such as Lipopolysaccharide (LPS). To identify gene transcription regulation patterns involved in early innate immune responses, we used two genome-wide approaches - gene expression profiling and chromatin immunoprecipitation-sequencing (ChIP-seq) analysis. We examined the effect of 2 hrs LPS stimulation on early gene expression and its relation to chromatin remodeling (H3 acetylation; H3Ac) and promoter binding of Sp1 and RNA polymerase II phosphorylated at serine 5 (S5P RNAPII), which is a marker for transcriptional initiation. Our results indicate novel and alternative gene regulatory mechanisms for certain proinflammatory genes. We identified two groups of upregulated inflammatory genes with respect to chromatin modification and promoter features. One group, including highly up-regulated genes such as tumor necrosis factor (TNF), was characterized by H3Ac, high CpG content and lack of TATA boxes. The second group, containing inflammatory mediators (interleukins and CCL chemokines), was up-regulated upon LPS stimulation despite lacking H3Ac in their annotated promoters, which were low in CpG content but did contain TATA boxes. Genome-wide analysis showed that few H3Ac peaks were unique to either +/-LPS condition. However, within these, an unpacking/expansion of already existing H3Ac peaks was observed upon LPS stimulation. In contrast, a significant proportion of S5P RNAPII peaks (approx 40%) was unique to either condition. Furthermore, data indicated a large portion of previously unannotated TSSs, particularly in LPS-stimulated macrophages, where only 28% of unique S5P RNAPII peaks overlap annotated promoters. The regulation of the inflammatory response appears to occur in a very specific manner at the chromatin level for specific genes and this study highlights the level of fine-tuning that occurs in the immune response.	[Iglesias, Maria Jesus; Reilly, Sarah-Jayne; Sennblad, Bengt; Folkersen, Lasse; Malarstig, Anders; Eriksson, Per; Hamsten, Anders; Odeberg, Jacob] Karolinska Inst, Ctr Mol Med, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Emanuelsson, Olof; Najafabadi, Mohammad Pirmoradian] KTH Royal Inst Technol, Sch Biotechnol, Div Gene Technol, Sci Life Lab, Stockholm, Sweden; [Lagergren, Jens] KTH Royal Inst Technol, Dept Computat Biol, Stockholm, Sweden; [Hamsten, Anders] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Odeberg, Jacob] Karolinska Univ Hosp Solna, Ctr Hematol, Stockholm, Sweden; [Odeberg, Jacob] KTH Royal Inst Technol, Sch Biotechnol, Div Prote, Sci Life Lab, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Royal Institute of Technology; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Iglesias, MJ (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden.	maria.iglesias@ki.se	Odeberg, Jacob O/O-3336-2014; Odeberg, Jacob/I-8314-2016	Odeberg, Jacob O/0000-0003-0996-1644; Odeberg, Jacob/0000-0003-0996-1644; Eriksson, Per/0000-0002-5635-2692; Folkersen, Lasse/0000-0003-0708-9530; Iglesias Mareque, Maria Jesus/0000-0003-4122-1945; Lagergren, Jens/0000-0002-4552-0240	European Community [LSHM-CT-2007-037273, PIEP-GA-2008-221346]; Swedish Research Council [8691, 80576801, 70374401]; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Torsten and Ragnar Soderberg Foundation; Karolinska Institutet; Stockholm County Council; Foundation for Strategic Research; Uppsala University; Uppsala University Hospital, Science for Life Laboratory - Uppsala	European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten and Ragnar Soderberg Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Foundation for Strategic Research; Uppsala University; Uppsala University Hospital, Science for Life Laboratory - Uppsala	This project was funded by European Community Sixth Framework Program (LSHM-CT-2007-037273), the Swedish Research Council (8691), the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/in_english/), the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, the Strategic Cardiovascular Program of Karolinska Institutet and Stockholm County Council, the Foundation for Strategic Research and Stockholm County Council. The SNP & SEQ Technology Platform in Uppsala is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory - Uppsala and the Swedish Research Council (80576801 and 70374401). MJI is a recipient of a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (PIEP-GA-2008-221346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-544; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kratz A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-257; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; van Heeringen SJ, 2011, GENOME RES, V21, P410, DOI 10.1101/gr.111724.110; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whatling C, 2004, J LIPID RES, V45, P1768, DOI 10.1194/jlr.M400195-JLR200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32306	10.1371/journal.pone.0032306	http://dx.doi.org/10.1371/journal.pone.0032306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384210	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500074
J	Kotzka, J; Knebel, B; Haas, J; Kremer, L; Jacob, S; Hartwig, S; Nitzgen, U; Muller-Wieland, D				Kotzka, Jorg; Knebel, Birgit; Haas, Jutta; Kremer, Lorena; Jacob, Sylvia; Hartwig, Sonja; Nitzgen, Ulrike; Muller-Wieland, Dirk			Preventing Phosphorylation of Sterol Regulatory Element-Binding Protein 1a by MAP-Kinases Protects Mice from Fatty Liver and Visceral Obesity	PLOS ONE			English	Article							SUBSTRATE RECOGNITION; CHOLESTEROL-SYNTHESIS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; HEPATIC STEATOSIS; TRANSGENIC MICE; X-RECEPTOR; SREBP-1; EXPRESSION; IDENTIFICATION	The transcription factor sterol regulatory element binding protein (SREBP)-1a plays a pivotal role in lipid metabolism. Using the SREBP-1a expressing human hepatoma cell line HepG2 we have shown previously that human SREBP-1a is phosphorylated at serine 117 by ERK-mitogen-activated protein kinases (MAPK). Using a combination of cell biology and protein chemistry approach we show that SREBP-1a is also target of other MAPK-families, i.e. c-JUN N-terminal protein kinases (JNK) or p38 stress activated MAP kinases. Serine 117 is also the major phosphorylation site in SREBP-1a for JNK. In contrast to that the major phosphorylation sites of p38 MAPK family are serine 63 and threonine 426. Functional analyses reveal that phosphorylation of SREBP-1a does not alter protein/DNA interaction. The identified phosphorylation sites are specific for both kinase families also in cellular context. To provide direct evidence that phosphorylation of SREBP-1a is a regulatory principle of biological and clinical relevance, we generated transgenic mice expressing mature transcriptionally active N-terminal domain of human SREBP-1a variant lacking all identified phosphorylaton sites designed as alb-SREBP-1a Delta P and wild type SREBP-1a designed as alb-SREBP-1a liver specific under control of the albumin promoter and a liver specific enhancer. In contrast to alb-SREBP-1a mice the phosphorylation-deficient mice develop no enlarged fatty livers under normocaloric conditions. Phenotypical examination reveales a massive accumulation of adipose tissue in alb-SREBP-1a but not in the phosphorylation deficient alb-SREBP-1a Delta P mice. Moreover, preventing phosphorylation of SREBP-1a protects mice also from dyslipidemia. In conclusion, phosphorylation of SREBP-1a by ERK, JNK and p38 MAPK-families resembles a biological principle and plays a significant role, in vivo.	[Kotzka, Jorg; Knebel, Birgit; Kremer, Lorena; Jacob, Sylvia; Hartwig, Sonja; Nitzgen, Ulrike] Univ Dusseldorf, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Haas, Jutta; Muller-Wieland, Dirk] Semmelweis Univ, Dept Gen Internal Med, Fac Med, Inst Diabet Res,Asklepios Clin St Georg, Hamburg, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Asklepios Klinik St. Georg; Semmelweis University	Kotzka, J (corresponding author), Univ Dusseldorf, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Leibniz Ctr Diabet Res, Dusseldorf, Germany.	d.mueller-wieland@asklepios.com		Kotzka, Jorg/0000-0003-1173-9372	Center for Molecular Medicine Cologne (TV1) and Norgenta; Center for Molecular Medicine Cologne (TV1); Norgenta; German Diabetes Center	Center for Molecular Medicine Cologne (TV1) and Norgenta; Center for Molecular Medicine Cologne (TV1); Norgenta; German Diabetes Center	The work was supported by the Center for Molecular Medicine Cologne (TV1) and Norgenta, a non-profit Life Sciences Agency of the federal state government of Hamburg and government of Schleswig-Holstein within the LiDia project and the German Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bruning JC, 2003, J STEROID BIOCHEM, V86, P113, DOI 10.1016/S0960-0760(03)00263-2; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Day YJ, 2004, AM J PHYSIOL-GASTR L, V286, pG285, DOI 10.1152/ajpgi.00348.2003; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harada N, 2008, BIOCHEM BIOPH RES CO, V368, P820, DOI 10.1016/j.bbrc.2008.02.004; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; IZBAN MG, 1989, J BIOL CHEM, V264, P9171; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotzka J, 2000, J LIPID RES, V41, P99; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Kotzka J, 2004, EXPERT OPIN THER TAR, V8, P141, DOI 10.1517/eott.8.2.141.30248; Kotzka J, 2011, ATHEROSCLEROSIS, V218, P134, DOI 10.1016/j.atherosclerosis.2011.05.008; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Lehr S, 2005, BIOCHEMISTRY-US, V44, P5117, DOI 10.1021/bi0479656; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimano H, 2000, TRENDS CARDIOVAS MED, V10, P275, DOI 10.1016/S1050-1738(00)00079-7; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200	54	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32609	10.1371/journal.pone.0032609	http://dx.doi.org/10.1371/journal.pone.0032609			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384276	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500103
J	Dalesman, S; Lukowiak, K				Dalesman, Sarah; Lukowiak, Ken			How Stress Alters Memory in 'Smart' Snails	PLOS ONE			English	Article							LONG-TERM-MEMORY; CENTRAL PATTERN GENERATOR; LYMNAEA-STAGNALIS; ENVIRONMENTAL CALCIUM; POPULATION DIFFERENCES; ANTIPREDATOR BEHAVIOR; PREDATION PRESSURE; LEARNING-ABILITY; LOCAL ADAPTATION; INTERMEDIATE	Cognitive ability varies within species, but whether this variation alters the manner in which memory formation is affected by environmental stress is unclear. The great pond snail, Lymnaea stagnalis, is commonly used as model species in studies of learning and memory. The majority of those studies used a single laboratory strain (i.e. the Dutch strain) originating from a wild population in the Netherlands. However, our recent work has identified natural populations that demonstrate significantly enhanced long-term memory (LTM) formation relative to the Dutch strain following operant conditioning of aerial respiratory behaviour. Here we assess how two populations with enhanced memory formation (i.e. 'smart' snails), one from Canada (Trans Canada 1: TC1) and one from the U. K. (Chilton Moor: CM) respond to ecologically relevant stressors. In control conditions the Dutch strain forms memory lasting 1-3 h following a single 0.5 h training session in our standard calcium pond water (80 mg/l [Ca2+]), whereas the TC1 and CM populations formed LTM lasting 5+ days following this training regime. Exposure to low environmental calcium pond water (20 mg/l [Ca2+]), which blocks LTM in the Dutch strain, reduced LTM retention to 24 h in the TC1 and CM populations. Crowding (20 snails in 100 ml) immediately prior to training blocks LTM in the Dutch strain, and also did so in TC1 and CM populations. Therefore, snails with enhanced cognitive ability respond to these ecologically relevant stressors in a similar manner to the Dutch strain, but are more robust at forming LTM in a low calcium environment. Despite the two populations (CM and TC1) originating from different continents, LTM formation was indistinguishable in both control and stressed conditions. This indicates that the underlying mechanisms controlling cognitive differences among populations may be highly conserved in L. stagnalis.	[Dalesman, Sarah; Lukowiak, Ken] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Dalesman, S (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	sarah.dalesman@ucalgary.ca		Dalesman, Sarah/0000-0001-8548-3096	Alberta Heritage Foundation for Medical Research from Alberta Innovates - Health Solutions, Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Alberta Heritage Foundation for Medical Research from Alberta Innovates - Health Solutions, Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.D. is supported by an Alberta Heritage Foundation for Medical Research postdoctoral fellowship from Alberta Innovates - Health Solutions, Canada (http://www.aihealthsolutions.ca/). K.L. is supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abjornsson K, 2004, ECOLOGY, V85, P1859, DOI 10.1890/03-0074; Andrews JS, 1996, COGNITIVE BRAIN RES, V3, P251, DOI 10.1016/0926-6410(96)00011-0; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Boycott AE, 1936, J ANIM ECOL, V5, P116, DOI 10.2307/1096; Braun MH, 2012, NEUROBIOL LEARN MEM, V97, P173, DOI 10.1016/j.nlm.2011.11.005; Braun MH, 2011, NEUROBIOL LEARN MEM, V96, P403, DOI 10.1016/j.nlm.2011.06.016; Brembs B, 2003, CURR OPIN NEUROBIOL, V13, P710, DOI 10.1016/j.conb.2003.10.002; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Dalesman S, 2006, ANIM BEHAV, V71, P789, DOI 10.1016/j.anbehav.2005.05.028; Dalesman S, 2007, ECOLOGY, V88, P2462, DOI 10.1890/07-0403.1; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Dalesman Sarah, 2011, Communicative & Integrative Biology, V4, P717; Dalesman S, 2011, ANIM BEHAV, V82, P311, DOI 10.1016/j.anbehav.2011.05.005; Dalesman S, 2011, J EXP BIOL, V214, P2528, DOI 10.1242/jeb.058024; Dalesman S, 2011, NEUROBIOL LEARN MEM, V95, P393, DOI 10.1016/j.nlm.2010.11.017; Dalesman S, 2010, FRESHWATER BIOL, V55, P2107, DOI 10.1111/j.1365-2427.2010.02470.x; Dalesman S, 2010, J EXP BIOL, V213, P1471, DOI 10.1242/jeb.040493; Dalesman S, 2010, ANIM BEHAV, V79, P173, DOI 10.1016/j.anbehav.2009.10.024; Dalesman S, 2009, EVOL ECOL, V23, P907, DOI 10.1007/s10682-008-9280-2; Dalesman S, 2009, ANIM BEHAV, V78, P987, DOI 10.1016/j.anbehav.2009.07.018; De Caigny P, 2008, J EXP BIOL, V211, P2678, DOI 10.1242/jeb.020347; Ebanks SC, 2010, J COMP PHYSIOL B, V180, P953, DOI 10.1007/s00360-010-0469-7; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Griffiths SW, 2003, FISH FISH, V4, P256, DOI 10.1046/j.1467-2979.2003.00129.x; Healy SD, 2009, BEHAV PROCESS, V80, P288, DOI 10.1016/j.beproc.2008.10.002; Katsnelson E, 2011, P ROY SOC B-BIOL SCI, V278, P582, DOI 10.1098/rspb.2010.1151; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; KEMENES G, 1989, BRAIN RES, V489, P163, DOI 10.1016/0006-8993(89)90019-X; Knezevic B, 2011, J EXP BIOL, V214, P2118, DOI 10.1242/jeb.054635; Koene JM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-212; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Lukowiak K, 2000, LEARN MEMORY, V7, P140, DOI 10.1101/lm.7.3.140; Lukowiak K, 2003, J EXP BIOL, V206, P2097, DOI 10.1242/jeb.00374; Lukowiak K, 1996, J EXP BIOL, V199, P683; Lukowiak K, 2010, BEHAV BRAIN RES, V214, P18, DOI 10.1016/j.bbr.2010.05.011; MACAN TT, 1950, J ANIM ECOL, V19, P124, DOI 10.2307/1523; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MCKILLOP WB, 1972, CAN J ZOOLOG, V50, P1433, DOI 10.1139/z72-192; Mery F, 2006, CHEM SENSES, V31, pE84; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Munoz A, 2008, BEHAV ECOL SOCIOBIOL, V62, P913, DOI 10.1007/s00265-007-0515-y; Orr M, 2009, J EXP BIOL, V212, P3911, DOI 10.1242/jeb.024281; Orr MV, 2008, J EXP BIOL, V211, P2807, DOI 10.1242/jeb.020172; Orr MV, 2008, J NEUROSCI, V28, P2726, DOI 10.1523/JNEUROSCI.5132-07.2008; Orr MV, 2009, J EXP BIOL, V212, P2237, DOI 10.1242/jeb.031575; Parsons PA, 2003, BIOGERONTOLOGY, V4, P63, DOI 10.1023/A:1023308122587; Parvez K, 2006, CAN J NEUROL SCI, V33, P347, DOI 10.1017/S0317167100005291; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; Sangha S, 2003, J EXP BIOL, V206, P1605, DOI 10.1242/jeb.00301; Scheibenstock A, 2002, J NEUROPHYSIOL, V88, P1584, DOI 10.1152/jn.2002.88.4.1584; SELYE H, 1973, AM SCI, V61, P692; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Skow CD, 2006, BEHAV ECOL, V17, P34, DOI 10.1093/beheco/ari094; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; SYED NI, 1992, ACTA BIOL HUNG, V43, P409; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Tryon R. C., 1940, YEARBOOK NATIONAL SO, V39, P111; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Ward AJW, 2009, BEHAV ECOL, V20, P511, DOI 10.1093/beheco/arp025; WILLIAMS N V, 1970, Malacologia, V10, P153; YOUNG J O, 1975, Proceedings of the Malacological Society of London, V41, P429	69	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32334	10.1371/journal.pone.0032334	http://dx.doi.org/10.1371/journal.pone.0032334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384220	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800036
J	Pourreyron, C; Reilly, L; Proby, C; Panteleyev, A; Fleming, C; McLean, K; South, AP; Foerster, J				Pourreyron, Celine; Reilly, Louise; Proby, Charlotte; Panteleyev, Andrey; Fleming, Colin; McLean, Kathleen; South, Andrew P.; Foerster, John			Wnt5a Is Strongly Expressed at the Leading Edge in Non-Melanoma Skin Cancer, Forming Active Gradients, while Canonical Wnt Signalling Is Repressed	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEINS; BETA-CATENIN; EPIGENETIC INACTIVATION; PROMOTER METHYLATION; INVASION; INHIBITION; PSORIASIS; ADHESION; PATHWAY; FRZA	Wnt5a is one of the so-called non-canonical Wnt ligands which do not act through beta-catenin. In normal development, Wnt5a is secreted and directs the migration of target cells along concentration gradients. The effect of Wnt5a on target cells is regulated by many factors, including the expression level of inhibitors and receptors. Dysregulated Wnt5a signalling facilitates invasion of multiple tumor types into adjacent tissue. However, the expression and distribution of Wnt5a in cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), as well as the effect of Wnt5a on keratinocyte migration has not been studied in detail to date. We here report that Wnt5a is upregulated in SCC and BCC and localised to the leading edge of tumors, as well as tumor-associated fibroblasts. The Wnt5a-triggered bundling of its receptor Fzd3 provides evidence of Wnt5a concentration gradients projecting into the tumor. In vitro migration assays show that Wnt5a concentration gradients determine its effect on keratinoctye migration: While chemotactic migration is inhibited by Wnt5a present in homogenous concentrations, it is enhanced in the presence of a Wnt5a gradient. Expression profiling of the Wnt pathway shows that the upregulation of Wnt5a in SCC is coupled to repression of canonical Wnt signalling. This is confirmed by immunohistochemistry showing lack of nuclear beta-catenin, as well as absent accumulation of Axin2. Since both types of Wnt signalling act mutually antogonistically at multiple levels, the concurrent repression of canonical Wnt signalling suggests hyper-active Wnt5a signal transduction. Significantly, this combination of gene dysregulation is not observed in the benign hyperproliferative inflammatory skin disease psoriasis. Collectively, our data strongly suggest that Wnt5a signalling contributes to tissue invasion by non-melanoma skin cancer.	[Pourreyron, Celine; Reilly, Louise; Proby, Charlotte; Panteleyev, Andrey; South, Andrew P.] Univ Dundee, Coll Med Dent & Nursing, Med Res Inst, Dundee, Scotland; [Proby, Charlotte; Fleming, Colin; Foerster, John] Univ Dundee, Dept Dermatol, Coll Med Dent & Nursing, Dundee, Scotland; [Pourreyron, Celine; Reilly, Louise; Proby, Charlotte; Panteleyev, Andrey; McLean, Kathleen; South, Andrew P.] Univ Dundee, Coll Med Dent & Nursing, Canc Res UK Canc Ctr Dundee, Dundee, Scotland; [Fleming, Colin; Foerster, John] Univ Dundee, Coll Med Dent & Nursing, Educ Div, Dundee, Scotland; [McLean, Kathleen] Univ Dundee, Coll Med Dent & Nursing, Tayside Tissue Bank, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee	Pourreyron, C (corresponding author), Univ Dundee, Coll Med Dent & Nursing, Med Res Inst, Dundee, Scotland.	j.foerster@dundee.ac.uk	Panteleyev, Andrey A/R-9151-2016; Pourreyron, Celine/AAE-7362-2020	Panteleyev, Andrey A/0000-0002-8733-9183; Reilly, Louise/0000-0002-2224-1708	Cancer Research UK; DebRa International (Dystrophic Epidermolysis Bullosa Research Association); European Research Council (ERC); Cancer Research UK [13044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); DebRa International (Dystrophic Epidermolysis Bullosa Research Association); European Research Council (ERC)(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C. Pourreyron, APS). C. Pourreyron was funded by DebRa International (Dystrophic Epidermolysis Bullosa Research Association) and the European Research Council (ERC) (APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Chung MT, 2009, GYNECOL ONCOL, V112, P301, DOI 10.1016/j.ygyno.2008.10.004; Dennis S, 1999, J CELL SCI, V112, P3815; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Doglioni C, 2003, AM J PATHOL, V163, P2277, DOI 10.1016/S0002-9440(10)63585-7; Dufourcq P, 2002, CIRCULATION, V106, P3097, DOI 10.1161/01.CIR.0000039342.85015.5C; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Enomoto M, 2009, ONCOGENE; Galli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kang HY, 2011, J INVEST DERMATOL; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022920; Lin ZH, 2005, J CANCER RES CLIN, V131, P364, DOI 10.1007/s00432-004-0657-5; Matsumoto S, 2010, EMBO J, V29, P1192, DOI 10.1038/emboj.2010.26; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Romanowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005354; Rutberg SE, 2006, J INVEST DERMATOL, V126, P2583, DOI 10.1038/sj.jid.5700454; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Verkaar F, 2010, FEBS LETT, V584, P3850, DOI 10.1016/j.febslet.2010.08.030; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Watt SA, 2011, ONCOGENE; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Xu QH, 1998, DEVELOPMENT, V125, P4767; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90	49	48	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31827	10.1371/journal.pone.0031827	http://dx.doi.org/10.1371/journal.pone.0031827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384081	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500046
J	Qu, XY; Du, J; Zhang, CY; Fu, WJ; Xi, H; Zou, JF; Hou, J				Qu, Xiaoyan; Du, Juan; Zhang, Chunyang; Fu, Weijun; Xi, Hao; Zou, Jianfeng; Hou, Jian			Arsenic Trioxide Exerts Antimyeloma Effects by Inhibiting Activity in the Cytoplasmic Substrates of Histone Deacetylase 6	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; KAPPA-B ACTIVATION; CELL APOPTOSIS; JNK ACTIVATION; HDAC6; PHOSPHORYLATION; GROWTH; CYTOSKELETON; ACETYLATION; P65	Arsenic trioxide (As2O3) has shown remarkable efficacy for the treatment of multiple myeloma (MM). Histone deacetylases (HDAC) play an important role in the control of gene expression, and their dysregulation has been linked to myeloma. Especially, HDAC6, a unique cytoplasmic member of class II, which mainly functions as alpha-tubulin deacetylase and Hsp90 deacetylase, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation. However, the mechanisms of action for As2O3 have not yet been defined. In this study, we investigated the effect of As2O3 on proliferation and apoptosis in human myeloma cell line and primary myeloma cells, and then we studied that As2O3 exerts antimyeloma effects by inhibiting activity in the alpha-tubulin and Hsp90 through western blot analysis and immunoprecipitation. We found that As2O3 acts directly on MM cells at relatively low concentrations of 0.5 similar to 2.5 mu M, which effects survival and apoptosis of MM cells. However, As2O3 inhibited HDAC activity at the relatively high concentration and dose-dependent manner (great than 4 mu M). Subsequently, we found that As2O3 treatment in a dose- and time-dependent fashion markedly increased the level of acetylated alpha-tubulin and acetylated Hsp90, and inhibited the chaperone association with IKK alpha activities and increased degradation of IKK alpha. Importantly, the loss of IKK alpha-associated Hsp90 occurred prior to any detectable loss in the levels of IKK alpha, indicating a novel pathway by which As2O3 down-regulates HDAC6 to destabilize IKK alpha protein via Hsp90 chaperone function. Furthermore, we observed the effect of As2O3 on TNF-alpha-induced NF-kappa B signaling pathway was to significantly reduced phosphorylation of Ser-536 on NF-kappa B p65. Therefore, our studies provide an important insight into the molecular mechanism of anti-myeloma activity of As2O3 in HDAC6-Hsp90-IKK alpha-NF kappa B signaling axis and the rationale for As2O3 can be extended readily using all the HDAC associated diseases.	[Qu, Xiaoyan; Du, Juan; Zhang, Chunyang; Fu, Weijun; Xi, Hao; Zou, Jianfeng; Hou, Jian] Second Mil Med Univ, Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China	Naval Medical University	Qu, XY (corresponding author), Second Mil Med Univ, Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China.	houjian167@sohu.com	qu, xiaoyan/HDN-3134-2022		National Natural Science Foundation of China [NFSC30670884, 30900643]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the National Natural Science Foundation of China (NFSC30670884, 30900643), and no additional external funding was received for the additional part of the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Baysan A, 2007, INT J ONCOL, V30, P313; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; dos Santos GAS, 2012, LEUKEMIA, V26, P451, DOI 10.1038/leu.2011.216; Drobna Z, 2002, FASEB J, V16, P67, DOI 10.1096/fj.02-0287fje; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kajiguchi T, 2006, CANCER SCI, V97, P540, DOI 10.1111/j.1349-7006.2006.00199.x; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lemoine M, 2010, DISCOV MED, V10, P462; Miller WH, 2002, CANCER RES, V62, P3893; Nasr R, 2003, BLOOD, V101, P4576, DOI 10.1182/blood-2002-09-2986; Qazilbash MH, 2008, BIOL BLOOD MARROW TR, V14, P1401, DOI 10.1016/j.bbmt.2008.09.019; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Roussel RR, 2000, ARCH BIOCHEM BIOPHYS, V377, P204, DOI 10.1006/abbi.2000.1770; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Sharma M, 2012, CANCER-AM CANCER SOC, V118, P2507, DOI 10.1002/cncr.26517; Sharma V, 2010, J CELL MOL MED, V14, P2151, DOI 10.1111/j.1582-4934.2009.00844.x; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vey N, 2006, J CLIN ONCOL, V24, P2465, DOI 10.1200/JCO.2005.03.9503; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wu KL, 2006, HAEMATOLOGICA, V91, P1722; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493; Zhou L, 2005, BLOOD, V105, P1198, DOI 10.1182/blood-2003-12-4299	42	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32215	10.1371/journal.pone.0032215	http://dx.doi.org/10.1371/journal.pone.0032215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384180	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500085
J	Zhang, YQ; Wu, LP; Wang, Y; Zhang, MC; Li, LM; Zhu, DH; Li, XH; Gu, HW; Zhang, CY; Zen, K				Zhang, Yaqin; Wu, Linping; Wang, Yang; Zhang, Mingcao; Li, Limin; Zhu, Dihan; Li, Xihan; Gu, Hongwei; Zhang, Chen-Yu; Zen, Ke			Protective Role of Estrogen-induced miRNA-29 Expression in Carbon Tetrachloride-induced Mouse Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELL; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; FIBROSIS; MICRORNAS; ACTIVATION; ESTRADIOL; RISK; SEX; QUANTITATION	Previous studies have indicated that female animals are more resistant to carbon tetrachloride (CCl4)-induced liver fibrosis than male animals, and that estradiol (E-2) treatment can inhibit CCl4-induced animal hepatic fibrosis. The underlying mechanism governing these phenomena, however, has not been fully elucidated. Here we reported the role of estrogen-induced miRNA-29 (miR-29) expression in CCl4-induced mouse liver injury. Hepatic miR-29 levels were differentially regulated in female and male mice during CCl4 treatment. Specifically, the levels of miR-29a and miR-29b expression were significantly decreased in the livers of male, but not female, mice following 4 weeks of CCl4 treatment. The down-regulation of miR-29a and miR-29b in male mouse livers correlated with the early development of liver fibrosis, as indicated by increased expressions of fibrotic markers in male mice relative to female mice. In addition, E-2 was maintained at a higher level in female mice than in male mice. In contrast to TGF-beta 1 that decreased miR-29a/b expression in murine hepatoma IAR20 cells and normal hepatocytes, E-2 enhanced the expression of miR-29a/b through suppression of the nuclear factor-kappa B (NF-kappa B) signal pathway, which negatively regulates miR-29 expression. Furthermore, both E-2 treatment and intravenous injection of the recombinant adenovirus expressing miR-29a/b markedly increased the miR-29a/b level and attenuated the expression of fibrotic markers in mouse livers during CCl4 treatment, supporting the protective role of E-2-induced miR-29 in CCl4-induced hepatic injury. In conclusion, our results collectively demonstrate that estrogen can inhibit CCl4-induced hepatic injury through the induction of hepatic miR-29.	[Zhang, Yaqin; Wu, Linping; Wang, Yang; Li, Limin; Zhu, Dihan; Li, Xihan; Gu, Hongwei; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Zhang, Mingcao] Nanjing Univ, Sch Med, Jingling Hosp, Chinese Peoples Liberat Army,Inst Kidney Dis, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China [2012CB517603, 2011CB504803863]; National Natural Science Foundation of China [30871019, 30890044, 30988003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2012CB517603 and 2011CB504803863 and National Natural Science Foundation of China Grants 30871019, 30890044, and 30988003.	Akiyoshi H, 1999, J HEPATOL, V30, P433, DOI 10.1016/S0168-8278(99)80102-0; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arias M, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; Chen WZ, 2006, J VIROL, V80, P3559, DOI 10.1128/JVI.80.7.3559-3566.2006; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Domenicali M, 2009, J HEPATOL, V51, P991, DOI 10.1016/j.jhep.2009.09.008; EAGON PK, 1991, DIGEST DIS SCI, V36, P1303, DOI 10.1007/BF01307527; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Giannitrapani L, 2006, ANN NY ACAD SCI, V1089, P228, DOI 10.1196/annals.1386.044; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellerbrand C, 2001, DIGEST DIS, V19, P345, DOI 10.1159/000050702; Idogawa M, 2009, CLIN CANCER RES, V15, P3725, DOI 10.1158/1078-0432.CCR-08-2396; Imaoka M, 2009, TOXICOL PATHOL, V37, P218, DOI 10.1177/0192623308329283; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jarvelainen HA, 2001, J HEPATOL, V35, P46, DOI 10.1016/S0168-8278(01)00050-2; Jiang XH, 2010, MOL CELL ENDOCRINOL, V315, P74, DOI 10.1016/j.mce.2009.09.018; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Liu QH, 2004, WORLD J GASTROENTERO, V10, P1315; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muriel P, 2003, J APPL TOXICOL, V23, P103, DOI 10.1002/jat.892; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Pinzani M, 2001, J HEPATOL, V34, P764, DOI 10.1016/S0168-8278(01)00055-1; PORTER LE, 1983, GASTROENTEROLOGY, V84, P704; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VILLA E, 1995, CANCER RES, V55, P498; VILLA E, 1988, CANCER-AM CANCER SOC, V62, P611, DOI 10.1002/1097-0142(19880801)62:3<611::AID-CNCR2820620328>3.0.CO;2-0; Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307	45	77	85	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14851	14862		10.1074/jbc.M111.314922	http://dx.doi.org/10.1074/jbc.M111.314922			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393047	hybrid, Green Published			2022-12-25	WOS:000304003200049
J	Bozkurt, L; Gobl, CS; Tura, A; Chmelik, M; Prikoszovich, T; Kosi, L; Wagner, O; Roden, M; Pacini, G; Gastaldelli, A; Kautzky-Willer, A				Bozkurt, Latife; Goebl, Christian S.; Tura, Andrea; Chmelik, Marek; Prikoszovich, Thomas; Kosi, Lana; Wagner, Oswald; Roden, Michael; Pacini, Giovanni; Gastaldelli, Amalia; Kautzky-Willer, Alexandra			Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes	PLOS ONE			English	Article							INSULIN SENSITIVITY; HEPATIC STEATOSIS; DISEASE; MECHANISMS; RESISTANCE; RISK; PATHOGENESIS; OBESITY; SEX; MEN	Background and Aims: Determinants of fatty liver (FL) might be predictive for further deterioration in insulin resistance (IR) in women with previous gestational diabetes (pGDM). The aim was to evaluate the association between pGDM, FL and future manifestation of type 2 diabetes (T2DM) by a detailed pathophysiological characterization early after pregnancy. Methods: 68 pGDM and 29 healthy controls were included 3-6 months after delivery and underwent specific metabolic assessments: status of IR was determined via oral-and intravenous-glucose-tolerance-tests with analysis of proinflammatory factors and kinetics of free-fatty-acids (FFA). According to the fatty-liver-index (FLI), pGDMs were categorized into three groups with low (FLI <= 20), intermediate (20 <= FLI<60) and high (FLI >= 60) risk for FL to assess differences in metabolic parameters at baseline as well as in the 10-year incidence for T2DM. Accuracy of FLI was proven with 1H-magneticresonance-spectroscopy. Results: FL was strongly associated with IR in pGDM. pGDM with FLI >= 60 showed significantly increased interleukin-6, plasminogen-activator-inhibitor-1, tissue-plasminogen-activator, fibrinogen and increased ultrasensitive-C-reactive-protein compared to the low risk group (FLI <= 20). Analysis of FFA indicated a less pronounced decrease of plasma FFA levels during the oral-glucose-tolerance-test in subjects with FLI >= 60. History of GDM plus FLI >= 60 conferred a high risk for the manifestation of diabetes over 10 years of observation as compared to pGDMs with FLI <= 20 (HR:7.85, Cl:2.02-30.5, p = 0.003). Conclusion: FL is closely linked to GDM, especially to IR and inflammation. Most interestingly, subjects with the highest FLI values showed significant alterations in FFA kinetics and a higher risk to develop T2DM in future.	[Bozkurt, Latife; Goebl, Christian S.; Prikoszovich, Thomas; Kosi, Lana; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Unit Gender Med, Vienna, Austria; [Goebl, Christian S.] Med Univ Vienna, Dept Gyneacol & Obstet, Div Fetomaternal Med, Vienna, Austria; [Tura, Andrea; Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Chmelik, Marek] Med Univ Vienna, High Field Magnet Resonance Ctr Excellence, Vienna, Austria; [Wagner, Oswald] Med Univ Vienna, Clin Inst Med, Chem Lab Diagnost, Vienna, Austria; [Roden, Michael] Univ Dusseldorf, Inst Clin Diabetol, Leibniz Ctr Diabet Res, Dept Metab Dis,German Diabet Ctr, D-40225 Dusseldorf, Germany; [Gastaldelli, Amalia] CNR, Inst Clin Physiol, Cardiometab Risk Unit, Pisa, Italy	Medical University of Vienna; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna; Medical University of Vienna; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Bozkurt, L (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Unit Gender Med, Vienna, Austria.	alexandra.kautzky-willer@meduniwien.ac.at	Gastaldelli, Amalia/H-3319-2014; Roden, Michael/AAD-3843-2019; Chmelik, Marek/AAR-3911-2020	Gastaldelli, Amalia/0000-0003-2594-1651; Chmelik, Marek/0000-0002-9727-9014; Kautzky-Willer, Alexandra/0000-0002-3520-4105	Austrian Science Fund [P14515 MED]	Austrian Science Fund(Austrian Science Fund (FWF))	The study was supported in part by the Austrian Science Fund (P14515 MED) to Dr. Kautsky-Willer. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2003, ARTERIOSCL THROM VAS, V23, P1262, DOI 10.1161/01.ATV.0000077401.36885.BB; Arase Y, 2009, J GASTROENTEROL, V44, P1064, DOI 10.1007/s00535-009-0091-1; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Cigolini M, 1996, THROMB HAEMOSTASIS, V76, P69; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Farhan S, 2006, EUR J CLIN INVEST, V36, P345, DOI 10.1111/j.1365-2362.2006.01630.x; Forbes S, 2011, DIABETOLOGIA, V54, P641, DOI 10.1007/s00125-010-2009-0; Gastaldelli A, 2010, ALIMENT PHARM THER, V32, P769, DOI 10.1111/j.1365-2036.2010.04405.x; Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Kautzky-Willer A, 2003, DIABETES, V52, P244, DOI 10.2337/diabetes.52.2.244; Kautzky-Willer A, 2009, EUR J CLIN INVEST, V39, P631, DOI 10.1111/j.1365-2362.2009.02161.x; Lerchbaum E, 2011, EUR J ENDOCRINOL, V165, P935, DOI 10.1530/EJE-11-0614; Magkos F, 2010, OBESITY, V18, P1510, DOI 10.1038/oby.2010.90; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Metzger BE, 1998, DIABETES CARE, V21, pB161; Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526; Pacini G, 1998, AM J PHYSIOL-ENDOC M, V274, pE592, DOI 10.1152/ajpendo.1998.274.4.E592; Prikoszovich T, 2011, DIABETES CARE, V34, P430, DOI 10.2337/dc10-1002; Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Winzer C, 2004, DIABETES CARE, V27, P1721, DOI 10.2337/diacare.27.7.1721	35	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32710	10.1371/journal.pone.0032710	http://dx.doi.org/10.1371/journal.pone.0032710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393439	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500092
J	Tran, QM; Fong, C; Rothery, RA; Maklashina, E; Cecchini, G; Weiner, JH				Tran, Quang M.; Fong, Carmen; Rothery, Richard A.; Maklashina, Elena; Cecchini, Gary; Weiner, Joel H.			Out of Plane Distortions of the Heme b of Escherichia coli Succinate Dehydrogenase	PLOS ONE			English	Article							QUINONE BINDING-SITE; COMPLEX-II; UBIQUINONE OXIDOREDUCTASE; FUMARATE REDUCTASE; PARACOCCUS-DENITRIFICANS; CYTOCHROMES-C; SUPEROXIDE; PROTEINS; STEREOCHEMISTRY; IDENTIFICATION	The role of the heme b in Escherichia coli succinate dehydrogenase is highly ambiguous and its role in catalysis is questionable. To examine whether heme reduction is an essential step of the catalytic mechanism, we generated a series of site-directed mutations around the heme binding pocket, creating a library of variants with a stepwise decrease in the midpoint potential of the heme from the wild-type value of +20 mV down to -80 mV. This difference in midpoint potential is enough to alter the reactivity of the heme towards succinate and thus its redox state under turnover conditions. Our results show both the steady state succinate oxidase and fumarate reductase catalytic activity of the enzyme are not a function of the redox potential of the heme. As well, lower heme potential did not cause an increase in the rate of superoxide production both in vitro and in vivo. The electron paramagnetic resonance (EPR) spectrum of the heme in the wild-type enzyme is a combination of two distinct signals. We link EPR spectra to structure, showing that one of the signals likely arises from an out-of-plane distortion of the heme, a saddled conformation, while the second signal originates from a more planar orientation of the porphyrin ring.	[Tran, Quang M.; Fong, Carmen; Rothery, Richard A.; Weiner, Joel H.] Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB, Canada; [Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Alberta; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Tran, QM (corresponding author), Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB, Canada.	joel.weiner@ualberta.ca		Rothery, Richard/0000-0003-3265-1783	CIHR [MOP89735]; NIH [GM61606]; Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	CIHR grant MOP89735 and NIH grant GM61606 and the Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KK, 1993, J AM CHEM SOC, V115, P12346, DOI 10.1021/ja00079a015; Berry EA, 2008, J BIOL INORG CHEM, V13, P481, DOI 10.1007/s00775-008-0372-9; Cheng VWT, 2008, BIOCHEMISTRY-US, V47, P9107, DOI 10.1021/bi801008e; COLLINS DM, 1972, J AM CHEM SOC, V94, P2066, DOI 10.1021/ja00761a045; Furlan S, 2007, J PHYS CHEM B, V111, P1157, DOI 10.1021/jp062609d; Hederstedt L, 2002, BBA-BIOENERGETICS, V1553, P74, DOI 10.1016/S0005-2728(01)00231-6; HOBBS JD, 1995, J PROTEIN CHEM, V14, P19, DOI 10.1007/BF01902840; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Jentzen W, 1998, BIOPHYS J, V74, P753, DOI 10.1016/S0006-3495(98)74000-7; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; KITA K, 1989, J BIOL CHEM, V264, P2672; KORSZUN ZR, 1989, BIOCHEMISTRY-US, V28, P1513, DOI 10.1021/bi00430a014; Le Moigne C, 2009, INORG CHEM, V48, P10084, DOI 10.1021/ic9010604; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Markwell M A, 1981, Methods Enzymol, V72, P296; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; MIGITA CT, 1981, J AM CHEM SOC, V103, P4378, DOI 10.1021/ja00405a015; Morgado L, 2007, BIOCHEM BIOPH RES CO, V360, P194, DOI 10.1016/j.bbrc.2007.06.026; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Oyedotun KS, 1999, FEBS LETT, V442, P203, DOI 10.1016/S0014-5793(98)01657-3; PETERSON J, 1994, FEBS LETT, V355, P155, DOI 10.1016/0014-5793(94)01189-3; Ruprecht J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209874; Ruprecht J, 2009, J BIOL CHEM, V284, P29836, DOI 10.1074/jbc.M109.010058; SALERNO JC, 1990, J BIOL CHEM, V265, P4364; Shifman JM, 2000, BIOCHEMISTRY-US, V39, P14813, DOI 10.1021/bi000927b; Shifman JM, 1998, BIOCHEMISTRY-US, V37, P16815, DOI 10.1021/bi9816857; SINGER TP, 1984, METHOD ENZYMOL, V106, P369; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yatsunyk LA, 2003, J AM CHEM SOC, V125, P15986, DOI 10.1021/ja036398r; YU L, 1987, J BIOL CHEM, V262, P1137; Zhao ZW, 2006, BIOCHEM CELL BIOL, V84, P1013, DOI 10.1139/O06-188	37	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32641	10.1371/journal.pone.0032641	http://dx.doi.org/10.1371/journal.pone.0032641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393428	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500080
J	Angrisano, F; Riglar, DT; Sturm, A; Volz, JC; Delves, MJ; Zuccala, ES; Turnbull, L; Dekiwadia, C; Olshina, MA; Marapana, DS; Wong, W; Mollard, V; Bradin, CH; Tonkin, CJ; Gunning, PW; Ralph, SA; Whitchurch, CB; Sinden, RE; Cowman, AF; McFadden, GI; Baum, J				Angrisano, Fiona; Riglar, David T.; Sturm, Angelika; Volz, Jennifer C.; Delves, Michael J.; Zuccala, Elizabeth S.; Turnbull, Lynne; Dekiwadia, Chaitali; Olshina, Maya A.; Marapana, Danushka S.; Wong, Wilson; Mollard, Vanessa; Bradin, Clare H.; Tonkin, Christopher J.; Gunning, Peter W.; Ralph, Stuart A.; Whitchurch, Cynthia B.; Sinden, Robert E.; Cowman, Alan F.; McFadden, Geoffrey I.; Baum, Jake			Spatial Localisation of Actin Filaments across Developmental Stages of the Malaria Parasite	PLOS ONE			English	Article							HOST-CELL INVASION; PLASMODIUM-FALCIPARUM; TOXOPLASMA-GONDII; ERYTHROCYTE INVASION; GLIDING MOTILITY; MOVING JUNCTION; APICOMPLEXAN PARASITES; MAMMALIAN-CELLS; VIRULENCE GENES; PROTEINS	Actin dynamics have been implicated in a variety of developmental processes during the malaria parasite lifecycle. Parasite motility, in particular, is thought to critically depend on an actomyosin motor located in the outer pellicle of the parasite cell. Efforts to understand the diverse roles actin plays have, however, been hampered by an inability to detect microfilaments under native conditions. To visualise the spatial dynamics of actin we generated a parasite-specific actin antibody that shows preferential recognition of filamentous actin and applied this tool to different lifecycle stages (merozoites, sporozoites and ookinetes) of the human and mouse malaria parasite species Plasmodium falciparum and P. berghei along with tachyzoites from the related apicomplexan parasite Toxoplasma gondii. Actin filament distribution was found associated with three core compartments: the nuclear periphery, pellicular membranes of motile or invasive parasite forms and in a ring-like distribution at the tight junction during merozoite invasion of erythrocytes in both human and mouse malaria parasites. Localisation at the nuclear periphery is consistent with an emerging role of actin in facilitating parasite gene regulation. During invasion, we show that the actin ring at the parasite-host cell tight junction is dependent on dynamic filament turnover. Super-resolution imaging places this ring posterior to, and not concentric with, the junction marker rhoptry neck protein 4. This implies motor force relies on the engagement of dynamic microfilaments at zones of traction, though not necessarily directly through receptor-ligand interactions at sites of adhesion during invasion. Combined, these observations extend current understanding of the diverse roles actin plays in malaria parasite development and apicomplexan cell motility, in particular refining understanding on the linkage of the internal parasite gliding motor with the extra-cellular milieu.	[Angrisano, Fiona; Riglar, David T.; Volz, Jennifer C.; Zuccala, Elizabeth S.; Olshina, Maya A.; Marapana, Danushka S.; Wong, Wilson; Bradin, Clare H.; Tonkin, Christopher J.; Cowman, Alan F.; Baum, Jake] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Angrisano, Fiona; Riglar, David T.; Volz, Jennifer C.; Zuccala, Elizabeth S.; Olshina, Maya A.; Tonkin, Christopher J.; Cowman, Alan F.; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Sturm, Angelika; Sinden, Robert E.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Delves, Michael J.; Mollard, Vanessa; McFadden, Geoffrey I.] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London, England; [Turnbull, Lynne; Whitchurch, Cynthia B.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Gunning, Peter W.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Imperial College London; University of Technology Sydney; University of Melbourne; University of New South Wales Sydney	Angrisano, F (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	jake@wehi.edu.au	Zuccala, Elizabeth/HDM-5025-2022; McFadden, Geoffrey McFadden I/F-7667-2014; Tonkin, Christopher/K-6534-2019; Cowman, Alan F/C-7642-2013; Gunning, Peter W/E-9058-2010; Ralph, Stuart/C-8590-2014; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Tonkin, Christopher/0000-0002-7036-6222; Cowman, Alan F/0000-0001-5145-9004; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X; Ralph, Stuart/0000-0003-0114-7808; Delves, Michael/0000-0001-8526-4782; Wong, Wilson/0000-0003-1335-8047; Turnbull, Lynne/0000-0002-9255-9033; Whitchurch, Cynthia/0000-0003-2296-3791; Zuccala, Elizabeth/0000-0002-9189-9810; Gunning, Peter/0000-0003-0833-3128; Riglar, David/0000-0002-5004-4373	National Health and Medical Research Council of Australia (NHMRC [516747, 637341]; Pratt Foundation through the University of Melbourne; HFSP; NHMRC [575523]; University of Technology, Sydney; Australian Research Council (ARC) [FT0990350, FT100100112]	National Health and Medical Research Council of Australia (NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation through the University of Melbourne; HFSP(Human Frontier Science Program); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Technology, Sydney; Australian Research Council (ARC)(Australian Research Council)	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Funding for the research came from the National Health and Medical Research Council of Australia (NHMRC Project Grants 516747 JB & CJT and 637341 JB & GIM). DTR is supported by a Pratt Foundation PhD scholarship through the University of Melbourne; JCV was initially supported by a HFSP long-term fellowship; CJT is supported by an NHMRC Career Development Award (575523); LT is supported by a Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; PWG was a Principal Research Fellow of the NHMRC; SAR is supported by an Australian Research Council (ARC) Future Fellowship (FT0990350); CBW is supported by a Senior Research Fellowship from the NHMRC; AFC is an Australia Fellow of the NHMRC. GIM is an ARC Federation Fellow with support from the NHMRC; JB is supported by an ARC Future Fellowship (FT100100112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Angrisano F, 2012, MOL BIOCHEM PARASIT, V182, P93, DOI 10.1016/j.molbiopara.2011.11.008; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gordon JL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-179; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kudryashev Mikhail, 2010, PMC Biophys, V3, P6, DOI 10.1186/1757-5036-3-6; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Pinder JC, 1998, J CELL SCI, V111, P1831; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schatten H, 2003, MICROSC MICROANAL, V9, P330, DOI 10.1017/S143192760030095; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; Sheiner L, 2010, MOL MICROBIOL; Siden-Kiamos I, 2006, MOL BIOCHEM PARASIT, V150, P308, DOI 10.1016/j.molbiopara.2006.09.003; Siden-Kiamos I, 2012, MOL BIOCHEM PARASIT, V181, P186, DOI 10.1016/j.molbiopara.2011.11.002; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Smythe WA, 2008, CELL MICROBIOL, V10, P452, DOI 10.1111/j.1462-5822.2007.01058.x; Spano F., 1996, Parassitologia (Rome), V38, P559; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Sukow C, 2003, BIOPHYS J, V85, P525, DOI 10.1016/S0006-3495(03)74497-X; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; VARMA M, 1987, EXP CELL RES, V173, P163, DOI 10.1016/0014-4827(87)90342-9; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Vlachou D, 2006, CURR OPIN GENET DEV, V16, P384, DOI 10.1016/j.gde.2006.06.012; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; WHO, 2010, WOR HEALT REP, P1; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	72	53	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32188	10.1371/journal.pone.0032188	http://dx.doi.org/10.1371/journal.pone.0032188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389687	Green Published, gold, Green Accepted			2022-12-25	WOS:000302999600025
J	Girgenti, MJ; LoTurco, JJ; Maher, BJ				Girgenti, Matthew J.; LoTurco, Joseph J.; Maher, Brady J.			ZNF804a Regulates Expression of the Schizophrenia-Associated Genes PRSS16, COMT, PDE4B, and DRD2	PLOS ONE			English	Article							COMMON VARIANTS; RISK	ZNF804a was identified by a genome-wide association study (GWAS) in which a single nucleotide polymorphism (SNP rs1344706) in ZNF804a reached genome-wide statistical significance for association with a combined diagnosis of schizophrenia (SZ) and bipolar disorder. Although the molecular function of ZNF804a is unknown, the amino acid sequence is predicted to contain a C2H2-type zinc-finger domain and suggests ZNF804a plays a role in DNA binding and transcription. Here, we confirm that ZNF804a directly contributes to transcriptional control by regulating the expression of several SZ associated genes and directly interacts with chromatin proximal to the promoter regions of PRSS16 and COMT, the two genes we find upregulated by ZNF804a. Using immunochemistry we establish that ZNF804a is localized to the nucleus of rat neural progenitor cells in culture and in vivo. We demonstrate that expression of ZNF804a results in a significant increase in transcript levels of PRSS16 and COMT, relative to GFP transfected controls, and a statistically significant decrease in transcript levels of PDE4B and DRD2. Furthermore, we show using chromatin immunoprecipitation assays (ChIP) that both epitope-tagged and endogenous ZNF804a directly interacts with the promoter regions of PRSS16 and COMT, suggesting a direct upregulation of transcription by ZNF804a on the expression of these genes. These results are the first to confirm that ZNF804a regulates transcription levels of four SZ associated genes, and binds to chromatin proximal to promoters of two SZ genes. These results suggest a model where ZNF804a may modulate a transcriptional network of SZ associated genes.	[Girgenti, Matthew J.; LoTurco, Joseph J.; Maher, Brady J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Maher, Brady J.] Lieber Inst Brain Dev, Baltimore, MD USA	University of Connecticut	Girgenti, MJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	brady.maher@libd.org	Maher, Brady/GPC-8697-2022; Girgenti, Matthew/ABV-9100-2022; Maher, Brady/L-8314-2016	Maher, Brady/0000-0001-5930-885X	 [K01MH086050];  [R01MH056524]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086050, R01MH056524] Funding Source: NIH RePORTER	; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by K01MH086050 (BJM; www.nih.nimh.gov) and R01MH056524 (JJL; www.nih.nimh.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bowlus CL, 1999, CELL IMMUNOL, V196, P80, DOI 10.1006/cimm.1999.1543; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Hill MJ, 2011, HUM MOL GENET; Hill MJ, 2011, MOL PSYCHIAT; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Sei Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010789; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55; Zhang R, 2011, SCHIZOPHR RES	18	80	85	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32404	10.1371/journal.pone.0032404	http://dx.doi.org/10.1371/journal.pone.0032404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384243	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500086
J	Li, XM; Liao, WJ; Wolfe, LM; Zhang, DY				Li, Xiao-Meng; Liao, Wan-Jin; Wolfe, Lorne M.; Zhang, Da-Yong			No Evolutionary Shift in the Mating System of North American Ambrosia artemisiifolia (Asteraceae) Following Its Introduction to China	PLOS ONE			English	Article							SELF-INCOMPATIBILITY; PROPAGULE PRESSURE; POLLEN LIMITATION; GENETIC-VARIATION; REPRODUCTIVE ASSURANCE; INVASIVE POPULATIONS; COMMON RAGWEED; LIFE-HISTORY; NATIVE RANGE; PLANT	The mating system plays a key role during the process of plant invasion. Contemporary evolution of uniparental reproduction (selfing or asexuality) can relieve the challenges of mate limitation in colonizing populations by providing reproductive assurance. Here we examined aspects of the genetics of colonization in Ambrosia artemisiifolia, a North American native that is invasive in China. This species has been found to possess a strong self-incompatibility system and have high outcrossing rates in North America and we examined whether there has been an evolutionary shift towards the dependence on selfing in the introduced range. Specifically, we estimated outcrossing rates in one native and five invasive populations and compared levels of genetic diversity between North America and China. Based on six microsatellite loci we found that, like the native North American population, all five Chinese populations possessed a completely outcrossing mating system. The estimates of paternity correlations were low, ranging from 0.028-0.122, which suggests that populations possessed similar to 8-36 pollen donor parents contributing to each maternal plant in the invasive populations. High levels of genetic diversity for both native and invasive populations were found with the unbiased estimate of gene diversity ranging from 0.262-0.289 for both geographic ranges based on AFLP markers. Our results demonstrate that there has been no evolutionary shift from outcrossing to selfing during A. artemisiifolia's invasion of China. Furthermore, high levels of genetic variation in North America and China indicate that there has been no erosion of genetic variance due to a bottleneck during the introduction process. We suggest that the successful invasion of A. artemisiifolia into Asia was facilitated by repeated introductions from multiple source populations in the native range creating a diverse gene pool within Chinese populations.	[Li, Xiao-Meng; Liao, Wan-Jin; Zhang, Da-Yong] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Wolfe, Lorne M.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	Beijing Normal University; University System of Georgia; Georgia Southern University	Li, XM (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	liaowj@bnu.edu.cn	Zhang, Da-Yong/B-3078-2011	Zhang, Da-Yong/0000-0003-1056-8735	State Key Basic Research and Development Plan [2009CB119201]; National Natural Science Foundation of China [31121003]; Beijing Normal University; USA National Science Foundation [DEB 0349553]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Normal University; USA National Science Foundation(National Science Foundation (NSF))	This study was financially supported by the State Key Basic Research and Development Plan (2009CB119201), the National Natural Science Foundation of China (31121003), and Beijing Normal University. Dr. Wolfe's research is supported by the USA National Science Foundation (DEB 0349553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Amsellem L, 2001, AM J BOT, V88, P2243, DOI 10.2307/3558386; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barrett S. C. H., 1992, Applied population biology., P91; Barrett SCH, 1997, J HERED, V88, P277, DOI 10.1093/oxfordjournals.jhered.a023105; Barrett Spencer C. H., 1993, Plant Species Biology, V8, P141, DOI 10.1111/j.1442-1984.1993.tb00065.x; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Barrett SCH, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P195; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brown A. H. D, 1981, EVOLUTION TODAY, P351; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Cano L, 2008, AUST J BOT, V56, P539, DOI 10.1071/BT07100; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cheptou PO, 2004, EVOLUTION, V58, P2613; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Colautti RI, 2010, INT J PLANT SCI, V171, P158, DOI 10.1086/649023; Davis HG, 2005, EVOL ECOL, V19, P255, DOI 10.1007/s10682-005-0912-5; Davis HG, 2004, P NATL ACAD SCI USA, V101, P13804, DOI 10.1073/pnas.0405230101; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Eckert C. G., 2006, ECOLOGY EVOLUTION FL, P183; Eckert CG, 1996, EVOLUTION, V50, P1512, DOI [10.1111/j.1558-5646.1996.tb03924.x, 10.2307/2410888]; ECKERT CG, 1994, HEREDITY, V72, P396, DOI 10.1038/hdy.1994.56; Estoup A, 2001, GENETICS, V159, P1671; Foxcroft LC, 2011, PERSPECT PLANT ECOL, V13, P89, DOI 10.1016/j.ppees.2011.03.004; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Lande R., 2003, OXFORD SERIES ECOLOG; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Leung B, 2004, ECOLOGY, V85, P1651, DOI 10.1890/02-0571; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Morgan MT, 2005, AM NAT, V166, P169, DOI 10.1086/431317; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Pannell JR, 1998, EVOLUTION, V52, P657, DOI [10.2307/2411261, 10.1111/j.1558-5646.1998.tb03691.x]; Petanidou T, 2012, PERSPECTIVE IN PRESS; PRICE SC, 1981, OECOLOGIA, V49, P283, DOI 10.1007/BF00349202; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; REINARTZ JA, 1984, J ECOL, V72, P897, DOI 10.2307/2259539; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Taylor CM, 2004, ECOLOGY, V85, P3254, DOI 10.1890/03-0640; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wan FH, 2009, RES BIOL INVASIONS C; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	62	9	11	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31935	10.1371/journal.pone.0031935	http://dx.doi.org/10.1371/journal.pone.0031935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384104	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500053
J	Srinivasan, V; Gertz, RE; Shewmaker, PL; Patrick, S; Chitnis, AS; O'Connell, H; Benowitz, I; Patel, P; Guh, AY; Noble-Wang, J; Turabelidze, G; Beall, B				Srinivasan, Velusamy; Gertz, Robert E., Jr.; Shewmaker, Patricia L.; Patrick, Sarah; Chitnis, Amit S.; O'Connell, Heather; Benowitz, Isaac; Patel, Priti; Guh, Alice Y.; Noble-Wang, Judith; Turabelidze, George; Beall, Bernard			Using PCR-Based Detection and Genotyping to Trace Streptococcus salivarius Meningitis Outbreak Strain to Oral Flora of Radiology Physician Assistant	PLOS ONE			English	Article							IATROGENIC MENINGITIS; SPINAL-ANESTHESIA; MYELOGRAPHY; IDENTIFICATION	We recently investigated three cases of bacterial meningitis that were reported from a midwestern radiology clinic where facemasks were not worn during spinal injection of contrast agent during myelography procedures. Using pulsed field gel electrophoresis we linked a case strain of S. salivarius to an oral specimen of a radiology physician assistant (RPA). We also used a real-time PCR assay to detect S. salivarius DNA within a culture-negative cerebrospinal fluid (CSF) specimen. Here we extend this investigation through using a nested PCR/sequencing strategy to link the culture-negative CSF specimen to the case strain. We also provide validation of the real-time PCR assay used, demonstrating that it is not solely specific for Streptococcus salivarius, but is also highly sensitive for detection of the closely related oral species Streptococcus vestibularis. Through using multilocus sequence typing and 16S rDNA sequencing we further strengthen the link between the CSF case isolate and the RPA carriage isolate. We also demonstrate that the newly characterized strains from this study are distinct from previously characterized S. salivarius strains associated with carriage and meningitis.	[Srinivasan, Velusamy; Gertz, Robert E., Jr.; Shewmaker, Patricia L.; Beall, Bernard] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA; [Patrick, Sarah; Turabelidze, George] Missouri Dept Hlth & Senior Serv, Sect Epidemiol Publ Hlth Practice, Div Community & Publ Hlth, St Louis, MO USA; [Chitnis, Amit S.; O'Connell, Heather; Benowitz, Isaac; Patel, Priti; Guh, Alice Y.; Noble-Wang, Judith] Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Atlanta, GA USA; [Chitnis, Amit S.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Srinivasan, V (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA.	BBEALL@CDC.GOV		Moulton-Meissner, Heather/0000-0002-0728-2552	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GUIDELINE ISOLATION; Baer ET, 2000, CLIN INFECT DIS, V31, P519, DOI 10.1086/313991; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Chapman GH, 1944, J BACTERIOL, V48, P113, DOI 10.1128/JB.48.1.113-114.1944; Chitnis AS, 2011, J AM COLL R IN PRESS; de Fijter S., 2010, Morbidity and Mortality Weekly Report, V59, P65; DEJONG J, 1992, INFECT CONT HOSP EP, V13, P74; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; FRENEY J, 1992, J CLIN MICROBIOL, V30, P2657, DOI 10.1128/JCM.30.10.2657-2661.1992; GELFAND MS, 1995, CLIN INFECT DIS, V20, P582, DOI 10.1093/clinids/20.3.582; Hebl JR, 2006, REGION ANESTH PAIN M, V31, P311, DOI 10.1016/j.rapm.2006.04.004; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Nakanishi H, 2009, FORENSIC SCI INT, V183, P20, DOI 10.1016/j.forsciint.2008.10.003; Rubin L, 2007, INFECT CONT HOSP EP, V28, P1187, DOI 10.1086/520748; SCHLESINGER JJ, 1982, ARCH NEUROL-CHICAGO, V39, P576, DOI 10.1001/archneur.1982.00510210046010; Schneeberger PM, 1996, INFECTION, V24, P29, DOI 10.1007/BF01780647; Seow WK, 2009, INT J PAEDIATR DENT, V19, P406, DOI 10.1111/j.1365-263X.2009.01003.x; Shewmaker PL, 2010, J CLIN MICROBIOL, V48, P2589, DOI 10.1128/JCM.00426-10; VERINGA E, 1995, J HOSP INFECT, V29, P316, DOI 10.1016/0195-6701(95)90283-X; Wilson W, 2011, CLIN MED RES    0804	21	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32169	10.1371/journal.pone.0032169	http://dx.doi.org/10.1371/journal.pone.0032169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384169	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500081
J	Tripathy, AS; Das, R; Rathod, SB; Arankalle, VA				Tripathy, Anuradha S.; Das, Rumki; Rathod, Sanjay B.; Arankalle, Vidya A.			Cytokine Profiles, CTL Response and T Cell Frequencies in the Peripheral Blood of Acute Patients and Individuals Recovered from Hepatitis E Infection	PLOS ONE			English	Article							VIRAL-HEPATITIS; MONONUCLEAR-CELLS; IMMUNE-RESPONSES; VIRUS; SERUM; RNA; DNA	Background: Hepatitis E is a major public health problem in the developing countries. Pathogenesis of hepatitis E virus (HEV) infection is poorly understood. Methods: This case-control study included 124 Hepatitis E patients (46 acute and 78 recovered), 9 with prior exposure to HEV and 71 anti-HEV negative healthy controls. HEV induced CTL response by Elispot, cytokines/chemokines quantitation by Milliplex assay and peripheral CD4+ & CD8+ T cell frequencies by flow cytometry were assessed. Results: Among the patient categories, HEV specific IFN-gamma responses as recorded by Elispot were comparable. Comparisons of cytokines/chemokines revealed significantly high levels of IL-1 alpha and sIL-2R alpha during acute phase. Circulating peripheral CD4/CD8+ T-cell subsets in acute and recovered individuals were comparable compared to controls, while among patient categories CD8+ T cell subset was significantly higher in recovered individuals. Conclusions: Our findings suggest that IL-1 alpha and sIL-2R alpha play a role in the pathogenesis of acute Hepatitis E infection. Lack of robust HEV ORF2-specific CTL response in the peripheral blood of HEV infected patients during the acute and recovered phases of the disease may be associated with involvement of innate immune cells/localization of the immune events at the site of infection.	[Tripathy, Anuradha S.; Das, Rumki; Rathod, Sanjay B.; Arankalle, Vidya A.] Natl Inst Virol, Hepatitis Grp, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Tripathy, AS (corresponding author), Natl Inst Virol, Hepatitis Grp, Pune, Maharashtra, India.	anuradhastripathy@hotmail.com	Rathod, Sanjay/AAT-2556-2021; Rathod, Sanjay/AAQ-6512-2020	Rathod, Sanjay/0000-0003-1755-8222; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This study was funded by the Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Arankalle VA, 2009, VACCINE, V27, P1032, DOI 10.1016/j.vaccine.2008.11.097; BERTOLETTI A, 1991, P NATL ACAD SCI USA, V88, P10445, DOI 10.1073/pnas.88.23.10445; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; FLEISCHER B, 1990, IMMUNOLOGY, V69, P14; Husain MM, 2011, J VIRAL HEPATITIS, V18, pE603, DOI 10.1111/j.1365-2893.2011.01489.x; Ippagunta SK, 2011, J VIRAL HEPATITIS, V18, P668, DOI 10.1111/j.1365-2893.2010.01351.x; Jaiswal SPB, 2001, INT J GYNECOL OBSTET, V72, P103, DOI 10.1016/S0020-7292(00)00264-2; Jilani N, 2007, J GASTROEN HEPATOL, V22, P676, DOI 10.1111/j.1440-1746.2007.04913.x; KHUROO MS, 1993, LANCET, V341, P1355; KOZIEL MJ, 1993, J VIROL, V67, P7522, DOI 10.1128/JVI.67.12.7522-7532.1993; Laskus T, 1999, J VIROL, V73, P1235, DOI 10.1128/JVI.73.2.1235-1238.1999; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Prabhu SB, 2011, J VIRAL HEPATITIS, V18, P587, DOI 10.1111/j.1365-2893.2010.01338.x; Saravanabalaji S, 2009, INTERVIROLOGY, V52, P78, DOI 10.1159/000214862; Schofield DJ, 2000, J VIROL, V74, P5548, DOI 10.1128/JVI.74.12.5548-5555.2000; Srivastava R, 2008, J VIRAL HEPATITIS, V15, P910, DOI 10.1111/j.1365-2893.2008.01036.x; Srivastava R, 2011, J GASTROEN HEPATOL, V26, P306, DOI 10.1111/j.1440-1746.2010.06356.x; TALIANI G, 1995, J MED VIROL, V47, P16, DOI 10.1002/jmv.1890470105; Taneja S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-39; TORRE D, 1994, CLIN INFECT DIS, V18, P194, DOI 10.1093/clinids/18.2.194; TrehanPati N, 2011, J CLIN IMMUNOL, V31, P498, DOI 10.1007/s10875-010-9506-2; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; Tripathy AS, 2011, J VIRAL HEPATITIS, V18, pE415, DOI 10.1111/j.1365-2893.2011.01457.x; Wu T, 2008, INTERVIROLOGY, V51, P322, DOI 10.1159/000172627; YAMAGUCHI S, 1988, HEPATO-GASTROENTEROL, V35, P245	28	29	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31822	10.1371/journal.pone.0031822	http://dx.doi.org/10.1371/journal.pone.0031822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384080	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500045
J	Zhang, WQ; Ji, YL; Meng, J; Wu, XC; Xu, HY				Zhang, Weiqi; Ji, Yinglu; Meng, Jie; Wu, Xiaochun; Xu, Haiyan			Probing the Behaviors of Gold Nanorods in Metastatic Breast Cancer Cells Based on UV-vis-NIR Absorption Spectroscopy	PLOS ONE			English	Article							SURFACE-CHEMISTRY; CELLULAR UPTAKE; PHOTOTHERMAL THERAPY; NANOPARTICLES; MECHANISMS; TOXICITY; DELIVERY	In this work, behaviors of positively-charged AuNRs in a highly metastatic tumor cell line MDA-MB-231 are examined based on UV-vis-NIR absorption spectroscopy in combination with inductively coupled plasma mass spectrometry (ICP-MS), transmission electron microscopy (TEM) and dark-field microscopic observation. It is found that characteristic surface plasmon resonance (SPR) peaks of AuNRs can be detected using spectroscopic method within living cells that have taken up AuNRs. The peak area of transverse SPR band is shown to be proportionally related to the amount of AuNRs in the cells determined with ICP-MS, which suggests a facile and real time quantification method for AuNRs in living cells. The shape of longitudinal SPR band in UV-vis-NIR spectrum reflects the aggregation state of AuNRs in the cells during the incubation period, which is proved by TEM and microscopic observations. Experimental results reveal that AuNRs are internalized by the cells rapidly; the accumulation, distribution and aggregation of AuNRs in the cells compartments are time and dose dependent. The established spectroscopic analysis method can not only monitor the behaviors of AuNRs in living cells but may also be helpful in choosing the optimum laser stimulation wavelength for anti-tumor thermotherapy.	[Zhang, Weiqi; Meng, Jie; Xu, Haiyan] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Weiqi; Meng, Jie; Xu, Haiyan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ji, Yinglu; Wu, Xiaochun] Natl Ctr Nanosci & Technol, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Zhang, WQ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	wuxc@nanoctr.cn; xuhy@pumc.edu.cn	Zhang, Weiqi/J-3974-2019	Zhang, Weiqi/0000-0003-4315-6809	National Key Program of China (973 program) [2011CB933504, 2010CB932802]; Natural Science Foundation of China (NSFC) [81000665]	National Key Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Program of China (973 program 2011CB933504 and 2010CB932802), and Natural Science Foundation of China (NSFC 81000665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Alkilany AM, 2010, LANGMUIR, V26, P9328, DOI 10.1021/la100253k; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Alkilany AM, 2011, ADV DRUG DELIV REV, DOI [10.1016/j.addr.2011.03005, DOI 10.1016/J.ADDR.2011.03005]; Bachmeier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020550; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Bartneck M, 2010, ACS NANO, V4, P3073, DOI 10.1021/nn100262h; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bonoiu AC, 2009, P NATL ACAD SCI USA, V106, P5546, DOI 10.1073/pnas.0901715106; Bright NA, 1997, J CELL SCI, V110, P2027; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Chen KM, 2011, BIOMACROMOLECULES, V12, P2552, DOI 10.1021/bm200374e; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/nnano.2011.58, 10.1038/NNANO.2011.58]; Cho EC, 2010, ANGEW CHEM INT EDIT, V49, P1976, DOI 10.1002/anie.200906584; Errington RJ, 2010, CELL CYCLE, V9, P121, DOI 10.4161/cc.9.1.10246; Feng LL, 2008, CHEM-EUR J, V14, P9764, DOI 10.1002/chem.200800544; Grabinski C, 2011, ACS NANO, V5, P2870, DOI 10.1021/nn103476x; Hauck TS, 2008, SMALL, V4, P153, DOI 10.1002/smll.200700217; Huang HC, 2009, ACS NANO, V3, P2941, DOI 10.1021/nn900947a; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Huff TB, 2007, LANGMUIR, V23, P1596, DOI 10.1021/la062642r; Jain PK, 2006, J PHYS CHEM B, V110, P18243, DOI 10.1021/jp063879z; JORDAN GW, 1978, ANTIMICROB AGENTS CH, V13, P199, DOI 10.1128/AAC.13.2.199; Levy R, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.4889; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nakayama S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2231; Orendorff CJ, 2006, J PHYS CHEM B, V110, P3990, DOI 10.1021/jp0570972; Oyelere AK, 2007, BIOCONJUGATE CHEM, V18, P1490, DOI 10.1021/bc070132i; Pan B, 2012, INT J CANCER, V131, P70, DOI 10.1002/ijc.26341; Parab HJ, 2009, J PHYS CHEM C, V113, P7574, DOI 10.1021/jp9000169; Qiu Y, 2010, BIOMATERIALS, V31, P7606, DOI 10.1016/j.biomaterials.2010.06.051; Rayavarapu RG, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145101; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Sangiuolo Federica, 2002, BMC Med Genet, V3, P8, DOI 10.1186/1471-2350-3-8; Scheffer A, 2008, ANAL BIOANAL CHEM, V390, P249, DOI 10.1007/s00216-007-1576-5; Tong L, 2007, ADV MATER, V19, P3136, DOI 10.1002/adma.200701974; Tong L, 2009, PHOTOCHEM PHOTOBIOL, V85, P21, DOI 10.1111/j.1751-1097.2008.00507.x; Ungureanu C, 2011, NANO LETT, V11, P1887, DOI 10.1021/nl103884b; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang LM, 2011, NANO LETT, V11, P772, DOI 10.1021/nl103992v; Wilson CG, 2009, J MATER CHEM, V19, P6332, DOI 10.1039/b902760b; Yi DK, 2010, BIOCONJUGATE CHEM, V21, P2173, DOI 10.1021/bc100308p; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zhang WQ, 2011, NANOSCALE, V3, P3923, DOI 10.1039/c1nr10573f; Zhou Y, 2010, J MICROSC-OXFORD, V237, P200, DOI 10.1111/j.1365-2818.2009.03324.x	49	22	23	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31957	10.1371/journal.pone.0031957	http://dx.doi.org/10.1371/journal.pone.0031957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384113	Green Submitted, gold, Green Published			2022-12-25	WOS:000302875500058
J	Zhang, XF; Ye, L; Hu, J; Tang, W; Liu, RX; Yang, ML; Hong, J; Wang, WQ; Ning, G; Gu, WQ				Zhang, Xiaofang; Ye, Lei; Hu, Jiong; Tang, Wei; Liu, Ruixin; Yang, Minglan; Hong, Jie; Wang, Weiqing; Ning, Guang; Gu, Weiqiong			Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient	PLOS ONE			English	Article							GENE-EXPRESSION; GRANZYME-A; PROTEIN; TOLERANCE; ALPHA	Objective: Autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) was the first therapeutic approach that can improve beta cell function in type 1 diabetic (T1D) patients. This study was designed to investigate the potential mechanisms involved. Design and methods: We applied AHST to nine T1D patients diagnosed within six months and analyzed the acute responses in peripheral blood for lymphocyte subpopulation as well as for genomic expression profiling at the six-month follow-up. Results: We found six patients obtained insulin free (IF group) and three remained insulin dependent (ID group); C-peptide production was significantly higher in IF group compared to ID group. The acute responses in lymphocytes at six-month follow-up include declined CD3(+)CD4(+), CD3(+)CD8(+) T cell population and recovered B cell, NK cell population in both groups but with no significant differences between the two groups; most immune-related genes and pathways were up-regulated in peripheral blood mononuclear cell (PBMC) of both groups while none of transcription factors for immune regulatory component were significantly changed; the IF group demonstrated more AHST-modified genetic events than the ID group and distinct pattern of top pathways, co-expression network as well as 'hub' genes (eg, TCF7 and GZMA) were associated with each group. Conclusions: AHST could improve the islet function in newly diagnosed T1D patients and elimination of the islet specific autoreactive T cells might be one of the mechanisms involved; T1D patients responded differently to AHST possibly due to the distinct transcriptional events occurring in PBMC.	[Zhang, Xiaofang; Ye, Lei; Liu, Ruixin; Yang, Minglan; Hong, Jie; Wang, Weiqing; Ning, Guang; Gu, Weiqiong] Shanghai Jiao Tong Univ, Ruijin Hosp,Shanghai Key Lab Endocrine Tumors, Sch Med,Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Shanghai E In, Shanghai 200030, Peoples R China; [Ning, Guang] Shanghai Jiao Tong Univ, Chinese Acad Sci, Lab Endocrine & Metab Dis, Inst Hlth Sci,Shanghai Inst Biol Sci,Sch Med, Shanghai 200030, Peoples R China; [Hu, Jiong; Tang, Wei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Hematol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, XF (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp,Shanghai Key Lab Endocrine Tumors, Sch Med,Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Shanghai E In, Shanghai 200030, Peoples R China.	weiqionggu@hotmail.com			National Key Technologies Research and Development Program [2008ZX09312-0191200]; Chinese National Natural Science Foundation [30725037]; Key Project of Shanghai Science and Technology [09DZ1950200]	National Key Technologies Research and Development Program(National Key Technology R&D Program); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Science and Technology	This study was supported by the grants from the National Key Technologies Research and Development Program (2008ZX09312-0191200), the Chinese National Natural Science Foundation (30725037) and the Key Project of Shanghai Science and Technology (09DZ1950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, BLOOD, V113, P214, DOI 10.1182/blood-2008-07-168286; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Beard ME, 2002, DIABETES CARE, V25, P799, DOI 10.2337/diacare.25.4.799; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; Erlich HA, 2009, GENES IMMUN, V10, pS54, DOI 10.1038/gene.2009.92; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HELD W, 1990, P NATL ACAD SCI USA, V87, P2239, DOI 10.1073/pnas.87.6.2239; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Marmont AM, 1997, LUPUS, V6, P545, DOI 10.1177/096120339700600613; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sosenko JM, 2004, DIABETES, V53, pA425; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tsukamoto H, 2011, RHEUMATOLOGY, V50, P944, DOI 10.1093/rheumatology/keq414; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Voltarelli JC, 2008, ANN NY ACAD SCI, V1150, P220, DOI 10.1196/annals.1447.048; Wen YT, 2008, BIOCHEM BIOPH RES CO, V374, P282, DOI 10.1016/j.bbrc.2008.07.016; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	29	5	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31887	10.1371/journal.pone.0031887	http://dx.doi.org/10.1371/journal.pone.0031887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384093	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500050
J	Muramatsu, F; Kidoya, H; Naito, H; Sakimoto, S; Takakura, N				Muramatsu, F.; Kidoya, H.; Naito, H.; Sakimoto, S.; Takakura, N.			microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin	ONCOGENE			English	Article						microRNA; mir125b; angiogenesis; VE-cadherin	VASCULAR MORPHOGENESIS; ENDOTHELIAL-CELLS; IN-VIVO; ANGIOGENESIS; EXPRESSION; RECEPTOR; GROWTH; MICE; STEM; SYSTEM	Angiogenesis is controlled positively or negatively by extrinsic and intrinsic molecular cues in endothelial cells (ECs); in the tumor microenvironment, the action of positive regulators exceeds that of negative regulators. Thus, overinduction of negative regulators may inhibit tumor angiogenesis. MicroRNAs (miRNAs or miRs) are endogenous short noncoding RNAs regulating gene expression either through translational inhibition or destabilization of target mRNA. Here, we show that miR-125b expression is transiently induced in ECs on stimulation with vascular endothelial growth factor or by ischemia. miR-125b inhibits translation of vascular endothelial (VE)-cadherin mRNA and in vitro tube formation by ECs. Injection of miR-125b into the tumor inhibited VE-cadherin expression by ECs and induced nonfunctional blood vessel formation, resulting in inhibition of tumor growth. It has been suggested that pro-angiogenic signals in ECs also upregulate anti-angiogenic molecules simultaneously via negative feedback. Because miR-125b induction in ECs is transient after pro-angiogenic stimulation, prolonged overexpression of miR-125b could result in blood vessel regression. Thus, miR-125b may be useful in cancer therapy by causing the collapse of the lumen of ECs. Oncogene (2013) 32, 414-421; doi:10.1038/onc.2012.68; published online 5 March 2012	[Muramatsu, F.; Kidoya, H.; Naito, H.; Sakimoto, S.; Takakura, N.] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Takakura, N.] CREST, JST, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ntakaku@biken.osaka-u.ac.jp		Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S Fukuhara and N Mochizuki for supplying VE-cadherin expression plasmid, and K Fukuhara and N Fujimoto for technical assistance. This work was partly supported by a grant from the Ministry of Education, Science, Sports, and Culture of Japan.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chen YH, 2003, BIOCHEM BIOPH RES CO, V310, P804, DOI 10.1016/j.bbrc.2003.09.081; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Gotsch U, 1997, J CELL SCI, V110, P583; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nagahama Y, 2010, CANCER RES, V70, P1215, DOI 10.1158/0008-5472.CAN-09-3662; Niola F, 2006, CANCER BIOL THER, V5, P174, DOI 10.4161/cbt.5.2.2317; Okamoto R, 2005, BLOOD, V105, P2757, DOI 10.1182/blood-2004-08-3317; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Takakura N, 2006, CANCER SCI, V97, P568, DOI 10.1111/j.1349-7006.2006.00223.x; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107	36	77	86	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2013	32	4					414	421		10.1038/onc.2012.68	http://dx.doi.org/10.1038/onc.2012.68			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22391569				2022-12-25	WOS:000315551300002
J	van Beijnum, JR; Nowak-Sliwinska, P; van den Boezem, E; Hautvast, P; Buurman, WA; Griffioen, AW				van Beijnum, J. R.; Nowak-Sliwinska, P.; van den Boezem, E.; Hautvast, P.; Buurman, W. A.; Griffioen, A. W.			Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1	ONCOGENE			English	Article						high-mobility group box 1; tumor angiogenesis; chicken embryo chorioallantoic membrane; VEGF; autocrine	END-PRODUCTS RAGE; ENDOTHELIAL-CELLS; NEURITE OUTGROWTH; GENE-EXPRESSION; IN-VIVO; CARDIOVASCULAR-DISEASES; DEPENDENT MECHANISM; SIGNALING PATHWAYS; HMGB1; PROTEIN	The endothelium plays a pivotal role in the progression of solid tumors and is considered a highly relevant target for therapy. However, it emerges that current clinical angiogenesis inhibitors that act through inhibition of tumor-derived growth factors are prone to inducing drug resistance. Therefore, markers of tumor endothelial cells (ECs) themselves provide attractive novel therapeutic targets. In a screen for markers of tumor angiogenesis, we recently identified high-mobility group box 1 (HMGB1), known to act as proinflamnnatory cytokine and chromatin-binding molecule. Here we report on the role of HMGB1 in angiogenesis by showing that its overexpression is associated with an increased angiogenic potential of ECs. HMGB1 stimulates the expression of players in vascular endothelial growth factor and platelet-derived growth factor signaling, both in vitro and in vivo. Importantly, we show that HMGB1 triggers and helps to sustain this proangiogenic gene expression program in ECs, additionally characterized by increased activity of matrix metalloproteinases, integrins and nuclear factor-kappa B. Moreover, we found that HMGB1 is involved in several autocrine and/or paracrine feedback mechanisms resulting in positive enforcement of HMGB1 expression, and that of its receptors, RAGE (receptor for advanced glycation end products) and Toll-like receptor 4 (TLR4). Interference in HMGB1 expression and/or function using knockdown approaches and antibody-mediated targeting to break this vicious circle resulted in inhibited migration and sprouting of ECs. Using different in vivo models, therapeutic efficacy of HMGB1 targeting was confirmed. First, we demonstrated induction of HMGB1 expression in the chicken embryo chorioallantoic membrane (CAM) neovasculature following both photodynannic therapy and tumor challenge. We subsequently showed that anti-HMGB1 antibodies inhibited vessel density in both models, accompanied by a reduced vascular expression of angiogenic growth factor receptors. Collectively, these data identify HMGB1 as an important modulator of tumor angiogenesis and suggest the feasibility of targeting HMGB1 for multi-level cancer treatment. Oncogene (2013) 32, 363-374; doi:10.1038/onc.2012.49; published online 5 March 2012	[van Beijnum, J. R.; Nowak-Sliwinska, P.; Griffioen, A. W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, NL-1081 HV Amsterdam, Netherlands; [van den Boezem, E.; Hautvast, P.] Maastricht Univ, Dept Pathol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Buurman, W. A.] Maastricht Univ, Med Ctr, Dept Surg, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Griffioen, AW (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	aw.griffioen@vumc.nl	Nowak-Sliwinska, Patrycja/T-7663-2018	Nowak-Sliwinska, Patrycja/0000-0002-8299-0444	transnational University Limburg (tUL); GROW-School for Oncology and Developmental Biology; sixth EU Framework Programme (Integrated Project 'Angiotargeting') [504743]; Center for Translational Molecular Medicine (CTMM) [03O-201 MAMMOTH]; EU Framework Programme Integrated Project 'Angiotargeting' [50474]	transnational University Limburg (tUL); GROW-School for Oncology and Developmental Biology; sixth EU Framework Programme (Integrated Project 'Angiotargeting'); Center for Translational Molecular Medicine (CTMM); EU Framework Programme Integrated Project 'Angiotargeting'	This work was supported by grants of the transnational University Limburg (tUL), GROW-School for Oncology and Developmental Biology, the sixth EU Framework Programme (Integrated Project 'Angiotargeting'; contract no. 504743) in the area of 'Life sciences, genomics and biotechnology for health' and Center for Translational Molecular Medicine (CTMM) '03O-201 MAMMOTH'. We are grateful for financial support from J Jacobi Trust, and technical assistance from Dr Roeland Hanemaaijer, Saskia van der Velden, Iris Schulkens, Rajshri Lalai and Maaike van Berkel.; Transnational University Limburg (tUL); EU Framework Programme Integrated Project 'Angiotargeting'; contract no. 50474; Center for Translational Molecular Medicine (CTMM) '03O-201 MAMMOTH'.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Biscetti F, 2010, DIABETES, V59, P1496, DOI 10.2337/db09-1507; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Griffioen AW, 1996, BLOOD, V88, P667, DOI 10.1182/blood.V88.2.667.bloodjournal882667; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Kawahara KI, 2008, CARDIOVASC PATHOL, V17, P129, DOI 10.1016/j.carpath.2007.08.006; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Li W, 2006, CURR OPIN PHARMACOL, V6, P130, DOI 10.1016/j.coph.2005.10.010; Lim SH, 2010, J MED CHEM, V53, P2865, DOI 10.1021/jm901823u; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Liu Y, 2010, EUR J CANCER, V46, P3007, DOI 10.1016/j.ejca.2010.07.016; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Mullins GE, 2004, SCAND J IMMUNOL, V60, P566, DOI 10.1111/j.0300-9475.2004.01518.x; Nowak-Sliwinska P, 2012, J CELL MOL MED, V16, P1553, DOI 10.1111/j.1582-4934.2011.01440.x; Nowak-Sliwinska P, 2011, J MED CHEM, V54, P3895, DOI 10.1021/jm2002074; Nowak-Sliwinska P, 2010, ANGIOGENESIS, V13, P281, DOI 10.1007/s10456-010-9185-x; Nowak-Sliwinska P, 2010, MICROVASC RES, V79, P21, DOI 10.1016/j.mvr.2009.10.004; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Ohmori H, 2011, EXPERT OPIN THER TAR, V15, P183, DOI 10.1517/14728222.2011.546785; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thijssen VLJL, 2007, CURR PHARM DESIGN, V13, P3576, DOI 10.2174/138161207782794121; Thijssen VLJL, 2004, EXP CELL RES, V299, P286, DOI 10.1016/j.yexcr.2004.06.014; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; van Beijnum JR, 2005, BBA-REV CANCER, V1755, P121, DOI 10.1016/j.bbcan.2005.06.001; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang CL, 2008, MED HYPOTHESES, V70, P343, DOI 10.1016/j.mehy.2007.05.024	47	115	116	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					363	374		10.1038/onc.2012.49	http://dx.doi.org/10.1038/onc.2012.49			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22391561				2022-12-25	WOS:000314736600010
J	Wu, ZH; Luo, HY; Thorin, E; Tremblay, J; Peng, JZ; Lavoie, JL; Wang, YJ; Qi, SJ; Wu, T; Wu, JP				Wu, Zenghui; Luo, Hongyu; Thorin, Eric; Tremblay, Johanne; Peng, Junzheng; Lavoie, Julie L.; Wang, Yujia; Qi, Shijie; Wu, Tao; Wu, Jiangping			Possible Role of Efnb1 Protein, a Ligand of Eph Receptor Tyrosine Kinases, in Modulating Blood Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CRE RECOMBINASE; TRANSGENIC MICE; EXPRESSION; EPHRIN-B2; ARTERIAL; CELLS; RHO; NEOVASCULARIZATION; HOMEOSTASIS	Eph kinases constitute the largest receptor tyrosine kinase family, and their ligands, ephrins (Efns), are also cell surface molecules. Although they are ligands, Efns can transduce signals reversely into cells. We have no prior knowledge of the role played by any members of this family of kinases or their ligands in blood pressure (BP) regulation. In the present studies, we investigated the role of Efnb1 in vascular smooth muscle cell (VSMC) contractility and BP regulation. We revealed that reverse signaling through Efnb1 led to a reduction of RhoA activation and VSMC contractility in vitro. Consistent with this finding, ex vivo, there was an increase of RhoA activity accompanied by augmented myosin light chain phosphorylation in mesenteric arteries from mice with smooth muscle-specific conditional Efnb1 gene knock-out (KO). Small interfering RNA knockdown of Grip1, a molecule associated with the Efnb1 intracellular tail, partially eliminated the effect of Efnb1 on VSMC contractility and myosin light chain phosphorylation. In support of these in vitro and ex vivo results, Efnb1 KO mice on a high salt diet showed a statistically significant heightened increment of BP at multiple time points during stress compared with wild type litter-mates. Our results demonstrate that Efnb1 is apreviously unknown negative regulator of VSMC contractility and BP and that it exerts such effects via reverse signaling through Grip1.	[Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Dept Nephrol, Montreal, PQ H2L 4M1, Canada; [Wu, Zenghui; Luo, Hongyu; Tremblay, Johanne; Peng, Junzheng; Lavoie, Julie L.; Wang, Yujia; Qi, Shijie; Wu, Tao; Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ H2L 4M1, Canada; [Thorin, Eric] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Wu, Tao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Universite de Montreal; Universite de Montreal; Universite de Montreal; Zhejiang University	Wu, JP (corresponding author), Notre Dame Hosp, CRCHUM, DeSeve Pavil,Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca	Cossette, Suzanne/I-8008-2016; Thorin, Eric/K-3978-2013; Lavoie, Julie/F-2288-2013; Tremblay, Johanne/E-2154-2013	Thorin, Eric/0000-0001-5827-8935; Lavoie, Julie/0000-0001-6316-2769; 	Canadian Institutes of Health Research [MOP57697, MOP69089, PPP85159, IMH 79565, MOP97829, MOP14496]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation and Export Trade; J.-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	This work was supported in part by Canadian Institutes of Health Research Grants MOP57697, MOP69089, and PPP85159 (to J.W.), IMH 79565 and MOP97829 (to H.L.), and MOP14496 (to E.T.); a Canadian Institutes of Health Research grant (to J.T.); grants from the Heart and Stroke Foundation of Quebec, the Quebec Ministry of Economic Development, Innovation and Export Trade (Grant PSR-SIIRI-069), and the J.-Louis Levesque Foundation (to J.W.); and a group grant from the Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research (to J.W.).	Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Carlson SH, 1998, HYPERTENSION, V32, P46, DOI 10.1161/01.HYP.32.1.46; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Dumas P, 2000, HYPERTENSION, V35, P568, DOI 10.1161/01.HYP.35.2.568; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Han YJ, 2008, AM J HYPERTENS, V21, P860, DOI 10.1038/ajh.2008.199; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Su LF, 2002, J BIOL CHEM, V277, P37037, DOI 10.1074/jbc.M111607200; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	38	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15557	15569		10.1074/jbc.M112.340869	http://dx.doi.org/10.1074/jbc.M112.340869			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393061	hybrid, Green Published			2022-12-25	WOS:000304006300036
J	Moon, SH; Jenkins, CM; Liu, XP; Guan, SP; Mancuso, DJ; Gross, RW				Moon, Sung Ho; Jenkins, Christopher M.; Liu, Xinping; Guan, Shaoping; Mancuso, David J.; Gross, Richard W.			Activation of Mitochondrial Calcium-independent Phospholipase A(2)gamma (iPLA(2)gamma) by Divalent Cations Mediating Arachidonate Release and Production of Downstream Eicosanoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMALOGEN-SELECTIVE PHOSPHOLIPASE-A2; SPONTANEOUSLY HYPERTENSIVE-RATS; ACYL-COA ESTERS; PERMEABILITY TRANSITION; CELL-DEATH; EPOXYEICOSATRIENOIC ACIDS; OXIDATIVE-PHOSPHORYLATION; INTRAMITOCHONDRIAL METABOLISM; PYRUVATE-DEHYDROGENASE; VENTRICULAR MYOCYTES	Calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) (PNPLA8) is the predominant phospholipase activity in mammalian mitochondria. However, the chemical mechanisms that regulate its activity are unknown. Here, we utilize iPLA(2)gamma gain of function and loss of function genetic models to demonstrate the robust activation of iPLA(2)gamma in murine myocardial mitochondria by Ca2+ or Mg2+ ions. Calcium ion stimulated the production of 2-arachidonoyl-lysophosphatidylcholine (2-AA-LPC) from 1-palmitoyl-2-[14C] arachidonoyl- sn-glycero-3-phosphocholine during incubations with wild-type heart mitochondrial homogenates. Furthermore, incubation of mitochondrial homogenates from transgenic myocardium expressing iPLA(2)gamma resulted in 13- and 25-fold increases in the initial rate of radiolabeled 2-AA-LPC and arachidonic acid (AA) production, respectively, in the presence of calcium ion. Mass spectrometric analysis of the products of calcium-activated hydrolysis of endogenous mitochondrial phospholipids in transgenic iPLA(2)gamma mitochondria revealed the robust production of AA, 2-AA-LPC, and 2-docosahexaenoyl-LPC that was over 10-fold greater than wild-type mitochondria. The mechanism- based inhibitor (R)-(E)-6-(bromomethylene)-3-(1-naphthalenyl)- 2H-tetrahydropyran-2-one (BEL) (iPLA(2)gamma selective), but not its enantiomer, (S)-BEL (iPLA(2)gamma selective) or pyrrolidine (cytosolic PLA(2)gamma selective), markedly attenuated Ca2+ -dependent fatty acid release and polyunsaturated LPC production. Moreover, Ca2+-induced iPLA(2)gamma activation was accompanied by the production of downstream eicosanoid metabolites that were nearly completely ablated by (R)-BEL or by genetic ablation of iPLA(2)gamma. Intriguingly, Ca2+ -induced iPLA(2)gamma activation was completely inhibited by long-chain acyl-CoA (IC50 similar to 20 mu M) as well as by a nonhydrolyzable acyl-CoA thioether analog. Collectively, these results demonstrate that mitochondrial iPLA(2)gamma is activated by divalent cations and inhibited by acyl-CoA modulating the generation of biologically active metabolites that regulate mitochondrial bioenergetic and signaling functions.	[Moon, Sung Ho; Jenkins, Christopher M.; Liu, Xinping; Guan, Shaoping; Mancuso, David J.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278, RO1HL41250]; LipoSpectrum and Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LipoSpectrum and Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blum JL, 2011, TOXICOL IN VITRO, V25, P1001, DOI 10.1016/j.tiv.2011.03.014; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Broekemeier KM, 2002, BIOCHEMISTRY-US, V41, P7771, DOI 10.1021/bi020157z; Chen JY, 1999, MOL PHARMACOL, V55, P288, DOI 10.1124/mol.55.2.288; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DAS AM, 1990, AM J PHYSIOL, V259, pH1264, DOI 10.1152/ajpheart.1990.259.4.H1264; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Di Paola M, 2006, FEBS LETT, V580, P775, DOI 10.1016/j.febslet.2005.12.090; DiMarzo V, 1996, BIOCHEM BIOPH RES CO, V227, P281, DOI 10.1006/bbrc.1996.1501; Dransfeld O, 2002, ANN NY ACAD SCI, V967, P208; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fonteriz RI, 2010, CELL CALCIUM, V48, P61, DOI 10.1016/j.ceca.2010.07.001; FORD DA, 1991, J CLIN INVEST, V88, P331, DOI 10.1172/JCI115296; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gaur N, 2011, BIOPHYS J, V100, P2904, DOI 10.1016/j.bpj.2011.05.031; Ghosh M, 2006, J BIOL CHEM, V281, P16615, DOI 10.1074/jbc.M601770200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Gross GJ, 2007, J MOL CELL CARDIOL, V42, P687, DOI 10.1016/j.yjmcc.2006.11.020; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 1996, J AM CHEM SOC, V118, P451, DOI 10.1021/ja952326r; HANSFORD RG, 1985, BIOCHEM J, V227, P129, DOI 10.1042/bj2270129; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Haworth RA, 2010, AM J PHYSIOL-HEART C, V299, pH165, DOI 10.1152/ajpheart.00906.2009; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Katragadda D, 2009, J MOL CELL CARDIOL, V46, P867, DOI 10.1016/j.yjmcc.2009.02.028; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; KOBAYASHI A, 1994, J MOL CELL CARDIOL, V26, P499, DOI 10.1006/jmcc.1994.1060; Korge P, 2003, AM J PHYSIOL-HEART C, V285, pH259, DOI 10.1152/ajpheart.01028.2002; Lee HC, 1999, J PHYSIOL-LONDON, V519, P153, DOI 10.1111/j.1469-7793.1999.0153o.x; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Liu SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1594, DOI 10.1152/ajpcell.00284.2007; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Marinovic J, 2008, AM J PHYSIOL-HEART C, V294, pH1317, DOI 10.1152/ajpheart.00840.2007; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; MCCORMACK JG, 1984, BIOCHEM J, V218, P235, DOI 10.1042/bj2180235; MCCORMACK JG, 1990, P NUTR SOC, V49, P57, DOI 10.1079/PNS19900009; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; MORENOSANCHEZ R, 1985, J BIOL CHEM, V260, P4028; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Nazarewicz RR, 2007, ARCH BIOCHEM BIOPHYS, V468, P114, DOI 10.1016/j.abb.2007.09.018; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pete MJ, 1996, J BIOL CHEM, V271, P18114, DOI 10.1074/jbc.271.30.18114; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; VANSCHAIK RHN, 1993, BIOCHIM BIOPHYS ACTA, V1169, P1, DOI 10.1016/0005-2760(93)90075-K; VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021; WALLUKAT G, 1994, J BIOL CHEM, V269, P29055; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; WOLF RA, 1985, J BIOL CHEM, V260, P7295; Xiao B, 2010, J PHARMACOL EXP THER, V334, P784, DOI 10.1124/jpet.110.167510; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236	86	52	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14880	14895		10.1074/jbc.M111.336776	http://dx.doi.org/10.1074/jbc.M111.336776			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22389508	hybrid, Green Published			2022-12-25	WOS:000304003200052
J	Tan, JHY; Canals, M; Ludeman, JP; Wedderburn, J; Boston, C; Butler, SJ; Carrick, AM; Parody, TR; Taleski, D; Christopoulos, A; Payne, RJ; Stone, MJ				Tan, Joshua H. Y.; Canals, Meritxell; Ludeman, Justin P.; Wedderburn, Jamie; Boston, Christopher; Butler, Stephen J.; Carrick, Ann Marie; Parody, Todd R.; Taleski, Deni; Christopoulos, Arthur; Payne, Richard J.; Stone, Martin J.			Design and Receptor Interactions of Obligate Dimeric Mutant of Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTACTIC PROTEIN-1; CXCR4 SULFOTYROSINE; CCR5 RECEPTOR; BINDING; INTERLEUKIN-8; RECOGNITION; ACTIVATION; NMR; IDENTIFICATION; ANTAGONISM	Chemokine-receptor interactions regulate leukocyte trafficking during inflammation. CC chemokines exist in equilibrium between monomeric and dimeric forms. Although the monomers can activate chemokine receptors, dimerization is required for leukocyte recruitment in vivo, and it remains controversial whether dimeric CC chemokines can bind and activate their receptors. We have developed an obligate dimeric mutant of the chemokine monocyte chemoattractant protein-1 (MCP-1) by substituting Thr10 at the dimer interface with Cys. Biophysical analysis showed that MCP-1(T10C) forms a covalent dimer with similar structure to the wild type MCP-1 dimer. Initial cell-based assays indicated that MCP-1(T10C) could activate chemokine receptor CCR2 with potency reduced 1 to 2 orders of magnitude relative to wild type MCP-1. However, analysis of size exclusion chromatography fractions demonstrated that the observed activity was due to a small proportion of MCP-1(T10C) being monomeric and highly potent, whereas the majority dimeric form could neither bind nor activate CCR2 at concentrations up to 1 mu M. These observations help to reconcile previous conflicting results and indicate that dimeric CC chemokines do not bind to their receptors with affinities approaching those of the corresponding monomeric chemokines.	[Tan, Joshua H. Y.; Ludeman, Justin P.; Wedderburn, Jamie; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Canals, Meritxell; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Boston, Christopher; Carrick, Ann Marie; Parody, Todd R.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Boston, Christopher; Carrick, Ann Marie; Parody, Todd R.] Indiana Univ, Interdisciplinary Program Biochem, Bloomington, IN 47405 USA; [Butler, Stephen J.; Taleski, Deni; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Monash University; Monash University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Sydney	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 76,Wellington Rd, Clayton, Vic 3800, Australia.	martin.stone@monash.edu	Christopoulos, Arthur/B-6207-2013; Butler, Stephen/K-7050-2013; Stone, Martin/C-2492-2012	Christopoulos, Arthur/0000-0003-4442-3294; Butler, Stephen/0000-0001-8109-3330; Canals, Meritxell/0000-0002-7942-5006; Stone, Martin/0000-0002-6468-4427; Payne, Richard/0000-0002-3618-9226	Australian Research Council [DP0881570, LE0989504, DP1094884]; Australian National Health and Medical Research Council [519461]; Monash Medicine, Nursing, and Health Science International Honours Scholarship; American Heart Association; Australia Postgraduate Award	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Medicine, Nursing, and Health Science International Honours Scholarship; American Heart Association(American Heart Association); Australia Postgraduate Award	This work was supported in part by Australian Research Council Grants DP0881570 and LE0989504 (to M. J. S.) and DP1094884 (to R. J. P. and M. J. S.) and by Australian National Health and Medical Research Council Grant 519461 (to A. C.).; Supported by a Monash Medicine, Nursing, and Health Science International Honours Scholarship.; Supported by a predoctoral fellowship from the American Heart Association.; Supported by an Australia Postgraduate Award.	CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLUBB RT, 1994, FEBS LETT, V338, P93, DOI 10.1016/0014-5793(94)80123-1; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Lau E. K., 2004, ADV PROTEIN CHEM, V68, P141; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mayer MR, 2004, FEBS LETT, V571, P166, DOI 10.1016/j.febslet.2004.06.079; Monteclaro FS, 1997, J BIOL CHEM, V272, P23186, DOI 10.1074/jbc.272.37.23186; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Parody TR, 2004, CYTOKINE, V27, P38, DOI 10.1016/j.cyto.2004.03.013; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Taleski D, 2011, CHEM-ASIAN J, V6, P1316, DOI 10.1002/asia.201100232; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Ye JP, 2000, J BIOL CHEM, V275, P27250; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	33	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14692	14702		10.1074/jbc.M111.334201	http://dx.doi.org/10.1074/jbc.M111.334201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396538	Green Published, hybrid			2022-12-25	WOS:000304003200035
J	Stanford, JC; Morris, AJ; Sunkara, M; Popa, GJ; Larson, KL; Ozcan, S				Stanford, Jamie Cantrell; Morris, Andrew J.; Sunkara, Manjula; Popa, Gabriel J.; Larson, Kara L.; Oezcan, Sabire			Sphingosine 1-Phosphate (S1P) Regulates Glucose-stimulated Insulin Secretion in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PHOSPHORYLATION; CERAMIDE SYNTHESIS; MAFA EXPRESSION; SKELETAL-MUSCLE; KINASE-ACTIVITY; INS-1 CELLS; SPHINGOSINE-1-PHOSPHATE; RESISTANCE; ACTIVATION; ISLETS	Recent studies suggest that sphingolipid metabolism is altered during type 2 diabetes. Increased levels of the sphingolipid ceramide are associated with insulin resistance. However, a role for sphingolipids in pancreatic beta cell function, or insulin production, and release remains to be established. Our studies in MIN6 cells and mouse pancreatic islets demonstrate that glucose stimulates an intracellular rise in the sphingolipid, sphingosine 1-phosphate (S1P), whereas the levels of ceramide and sphingomyelin remain unchanged. The increase in S1P levels by glucose is due to activation of sphingosine kinase 2 (SphK2). Interestingly, rises in S1P correlate with increased glucose-stimulated insulin secretion (GSIS). Decreasing S1P levels by treatment of MIN6 cells or primary islets with the sphingosine kinase inhibitor reduces GSIS. Moreover, knockdown of SphK2 alone results in decreased GSIS, whereas knockdown of the S1P phosphatase, Sgpp1, leads to a rise in GSIS. Treatment of mice with the sphingosine kinase inhibitor impairs glucose disposal due to decreased plasma insulin levels. Altogether, our data suggest that glucose activates SphK2 in pancreatic beta cells leading to a rise in S1P levels, which is important for GSIS.	[Stanford, Jamie Cantrell; Popa, Gabriel J.; Larson, Kara L.; Oezcan, Sabire] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Morris, Andrew J.; Sunkara, Manjula] Univ Kentucky, Cardiovasc Res Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Ozcan, S (corresponding author), 741 S Limestone St,BBSRB,B155, Lexington, KY 40536 USA.	sozcan@uky.edu	sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929; Larson, Kara/0000-0002-4678-634X	National Institutes of Health [DK067581, P20RR020171]; American Diabetes Association [1-05-CD-15]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171, S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK067581, R01DK067581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067581 and P20RR020171 (to S. O.). This work was also supported by American Diabetes Association Grant 1-05-CD-15.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Boden G, 2008, DIABETOLOGIA, V51, P1095, DOI 10.1007/s00125-008-1015-y; Buehrer BM, 1996, BBA-LIPID LIPID MET, V1303, P233, DOI 10.1016/0005-2760(96)00092-6; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Guo J, 2010, MOL CELL BIOCHEM, V338, P283, DOI 10.1007/s11010-009-0362-4; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Laychock SG, 2003, DIABETES, V52, P1986, DOI 10.2337/diabetes.52.8.1986; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Ma MM, 2007, DIABETOLOGIA, V50, P891, DOI 10.1007/s00125-006-0589-5; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Major CD, 1999, DIABETES, V48, P1372, DOI 10.2337/diabetes.48.7.1372; Mastrandrea LD, 2010, J LIPID RES, V51, P2171, DOI 10.1194/jlr.M000802; Mastrandrea LD, 2005, DIABETES, V54, P1429, DOI 10.2337/diabetes.54.5.1429; Mathews TP, 2010, J MED CHEM, V53, P2766, DOI 10.1021/jm901860h; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pyne NJ, 2009, ADV ENZYME REGUL, V49, P214, DOI 10.1016/j.advenzreg.2009.01.011; Pyne S, 2009, CELL SIGNAL, V21, P14, DOI 10.1016/j.cellsig.2008.08.008; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Shimizu H, 2000, ENDOCR J, V47, P261, DOI 10.1507/endocrj.47.261; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Straczkowski Marek, 2008, Rev Diabet Stud, V5, P13, DOI 10.1900/RDS.2008.5.13; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Vanderford NL, 2008, ARCH BIOCHEM BIOPHYS, V480, P138, DOI 10.1016/j.abb.2008.10.001; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	40	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13457	13464		10.1074/jbc.M111.268185	http://dx.doi.org/10.1074/jbc.M111.268185			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22389505	Green Published, hybrid			2022-12-25	WOS:000302903700079
J	Dukes, JD; Whitley, P; Chalmers, AD				Dukes, Joseph D.; Whitley, Paul; Chalmers, Andrew D.			The PIKfyve Inhibitor YM201636 Blocks the Continuous Recycling of the Tight Junction Proteins Claudin-1 and Claudin-2 in MDCK cells	PLOS ONE			English	Article							ESCRT MACHINERY; ENDOSOME; KINASE; PTDINS(3,5)P-2; TRAFFICKING; ENDOCYTOSIS; AUTOPHAGY; TRANSPORT; OCCLUDIN; TGN	Tight junctions mediate the intercellular diffusion barrier found in epithelial tissues but they are not static complexes; instead there is rapid movement of individual proteins within the junctions. In addition some tight junction proteins are continuously being endocytosed and recycled back to the plasma membrane. Understanding the dynamic behaviour of tight junctions is important as they are altered in a range of pathological conditions including cancer and inflammatory bowel disease. In this study we investigate the effect of treating epithelial cells with a small molecule inhibitor (YM201636) of the lipid kinase PIKfyve, a protein which is involved in endocytic trafficking. We show that MDCK cells treated with YM201636 accumulate the tight junction protein claudin-1 intracellularly. In contrast YM201636 did not alter the localization of other junction proteins including ZO-1, occludin and E-cadherin. A biochemical trafficking assay was used to show that YM201636 inhibited the endocytic recycling of claudin-1, providing an explanation for the intracellular accumulation. Claudin-2 was also found to constantly recycle in confluent MDCK cells and treatment with YM201636 blocked this recycling and caused accumulation of intracellular claudin-2. However, claudin-4 showed negligible endocytosis and no detectable intracellular accumulation occurred following treatment with YM201636, suggesting that not all claudins show the same rate of endocytic trafficking. Finally, we show that, consistent with the defects in claudin trafficking, incubation with YM201636 delayed formation of the epithelial permeability barrier. Therefore, YM201636 treatment blocks the continuous recycling of claudin-1/claudin-2 and delays epithelial barrier formation.	[Dukes, Joseph D.; Whitley, Paul; Chalmers, Andrew D.] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	University of Bath	Dukes, JD (corresponding author), Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.	P.R.Whitley@bath.ac.uk; ac270@bath.ac.uk	Dukes, Joseph/AAE-2931-2019; Chalmers, Andrew/D-4103-2009	Chalmers, Andrew/0000-0003-4182-6717	Cancer Research UK [C26932/A9548]	Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK project grant (C26932/A9548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Brennan K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460607; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Dupuis-Coronas S, 2011, J BIOL CHEM; Ferguson CJ, 2010, AUTOPHAGY, V6, P170, DOI 10.4161/auto.6.1.10626; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Klaus F, 2009, NEUROCHEM INT, V54, P372, DOI 10.1016/j.neuint.2009.01.002; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rothen-Rutishauser B, 2002, J MEMBRANE BIOL, V188, P151, DOI 10.1007/s00232-001-0182-2; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027	42	38	38	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e28659	10.1371/journal.pone.0028659	http://dx.doi.org/10.1371/journal.pone.0028659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396724	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000001
J	Skodda, S; Gronheit, W; Schlegel, U				Skodda, Sabine; Groenheit, Wenke; Schlegel, Uwe			Impairment of Vowel Articulation as a Possible Marker of Disease Progression in Parkinson's Disease	PLOS ONE			English	Article							SPEECH DISORDERS; SPEAKING RATE; INTELLIGIBILITY; DYSARTHRIA; LEVODOPA; DIADOCHOKINESIS; HYPOKINESIA; PERCEPTION; ACCURACY; SPACE	Purpose: The aim of the current study was to survey if vowel articulation in speakers with Parkinson's disease (PD) shows specific changes in the course of the disease. Method: 67 patients with PD (42 male) and 40 healthy speakers (20 male) were tested and retested after an average time interval of 34 months. Participants had to read a given text as source for subsequent calculation of the triangular vowel space area (tVSA) and vowel articulation index (VAI). Measurement of tVSA and VAI were based upon analysis of the first and second formant of the vowels /alpha/, /i/ and /u/ extracted from defined words within the text. Results: At first visit, VAI values were reduced in male and female PD patients as compared to the control group, and showed a further decrease at the second visit. Only in female Parkinsonian speakers, VAI was correlated to overall speech impairment based upon perceptual impression. VAI and tVSA were correlated to gait impairment, but no correlations were seen between VAI and global motor impairment or overall disease duration. tVSA showed a similar reduction in the PD as compared to the control group and was also found to further decline between first and second examination in female, but not in male speakers with PD. Conclusions: Measurement of VAI seems to be superior to tVSA in the description of impaired vowel articulation and its further decline in the course of the disease in PD. Since impairment of vowel articulation was found to be independent from global motor function but correlated to gait dysfunction, measurement of vowel articulation might have a potential to serve as a marker of axial disease progression.	[Skodda, Sabine; Groenheit, Wenke; Schlegel, Uwe] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Neurol, Bochum, Germany	Ruhr University Bochum	Skodda, S (corresponding author), Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Neurol, Univ Str 150, Bochum, Germany.	sabine.skodda@kk-bochum.de						ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; ACKERMANN H, 1989, FORTSCHR NEUROL PSYC, V57, P149, DOI 10.1055/s-2007-1000756; Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Asgari M, 2010, IEEE ENG MED BIO, P5201, DOI 10.1109/IEMBS.2010.5626104; Blomgren B, 1998, J SPEECH LANG HEAR R, V41, P1042, DOI 10.1044/jslhr.4105.1042; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Bunton K, 2001, J SPEECH LANG HEAR R, V44, P1215, DOI 10.1044/1092-4388(2001/095); BYRD D, 1994, SPEECH COMMUN, V15, P39, DOI 10.1016/0167-6393(94)90039-6; CALIGIURI MP, 1989, BRAIN LANG, V36, P493, DOI 10.1016/0093-934X(89)90080-1; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217, DOI 10.1044/jshd.3003.217; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Ferguson SH, 2004, J ACOUST SOC AM, V116, P2365, DOI 10.1121/1.1788730; FORREST K, 1989, J ACOUST SOC AM, V85, P2608, DOI 10.1121/1.397755; Goberman A, 2002, J COMMUN DISORD, V35, P217, DOI 10.1016/S0021-9924(01)00072-7; Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378; Ho AK, 2008, MOVEMENT DISORD, V23, P574, DOI 10.1002/mds.21899; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUNKER CJ, 1982, NEUROLOGY, V32, P749, DOI 10.1212/WNL.32.7.749; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Kwon HB, 2010, J ADV PROSTHODONT, V2, P71, DOI 10.4047/jap.2010.2.3.71; McRae PA, 2002, J SPEECH LANG HEAR R, V45, P35, DOI 10.1044/1092-4388(2002/003); Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Neel AT, 2008, J SPEECH LANG HEAR R, V51, P574, DOI 10.1044/1092-4388(2008/041); Ramig Lorraine O, 2008, Expert Rev Neurother, V8, P297, DOI 10.1586/14737175.8.2.297; Robertson LT, 1996, J NEUROL NEUROSUR PS, V60, P41, DOI 10.1136/jnnp.60.1.41; Roy N, 2009, J COMMUN DISORD, V42, P124, DOI 10.1016/j.jcomdis.2008.10.001; Sapir S, 2010, J SPEECH LANG HEAR R, V53, P114, DOI 10.1044/1092-4388(2009/08-0184); Sendlmeier WF, FORMATENKARTEN DTSCH; Skodda S, 2011, J VOICE, V25, P467, DOI 10.1016/j.jvoice.2010.01.009; Skodda S, 2011, MOVEMENT DISORD, V26, P59, DOI 10.1002/mds.23382; Skodda S, 2011, J VOICE, V25, P76, DOI 10.1016/j.jvoice.2009.07.005; Skodda S, 2010, J NEURAL TRANSM, V117, P197, DOI 10.1007/s00702-009-0351-5; Skodda S, 2009, MOVEMENT DISORD, V24, P716, DOI 10.1002/mds.22430; Spielman J, 2011, J COMMUN DISORD; Titze IR, 1994, PRINCIPLES VOICE PRO; Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); Tjaden K, 2011, CLIN LINGUIST PHONET, V25, P155, DOI 10.3109/02699206.2010.520185; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; TURNER GS, 1995, J SPEECH HEAR RES, V38, P1001, DOI 10.1044/jshr.3805.1001; Watson PJ, 2008, J ACOUST SOC AM, V124, pEL291, DOI 10.1121/1.2987464; Weenink D., 1996, PRAAT SYSTEM DOING P; Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649	45	110	113	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32132	10.1371/journal.pone.0032132	http://dx.doi.org/10.1371/journal.pone.0032132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928RC	22389682	Green Submitted, Green Published, gold			2022-12-25	WOS:000302999600020
J	Frankle, WG; Cho, RY; Mason, NS; Chen, CM; Himes, M; Walker, C; Lewis, DA; Mathis, CA; Narendran, R				Frankle, W. Gordon; Cho, Raymond Y.; Mason, N. Scott; Chen, Chi-Min; Himes, Michael; Walker, Christopher; Lewis, David A.; Mathis, Chester A.; Narendran, Rajesh			[C-11]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BENZODIAZEPINE-RECEPTORS; HUMAN-BRAIN; GAMMA-OSCILLATIONS; C-11 FLUMAZENIL; IN-VIVO; WORKING-MEMORY; RO 15-1788; HUMANS; NEURONS	Evidence indicates that synchronization of cortical activity at gamma-band frequencies, mediated through GABA-A receptors, is important for perceptual/cognitive processes. To study GABA signaling in vivo, we recently used a novel positron emission tomography (PET) paradigm measuring the change in binding of the benzodiazepine (BDZ) site radiotracer [C-11]flumazenil associated with increases in extracellular GABA induced via GABA membrane transporter (GAT1) blockade with tiagabine. GAT1 blockade resulted in significant increases in [C-11] flumazenil binding potential (BPND) over baseline in the major functional domains of the cortex, consistent with preclinical studies showing that increased GABA levels enhance the affinity of GABA-A receptors for BDZ ligands. In the current study we sought to replicate our previous results and to further validate this approach by demonstrating that the magnitude of increase in [C-11] flumazenil binding observed with PET is directly correlated with tiagabine dose. [C-11] flumazenil distribution volume (VT) was measured in 18 healthy volunteers before and after GAT1 blockade with tiagabine. Two dose groups were studied (n = 9 per group; Group I: tiagabine 0.15 mg/kg; Group II: tiagabine 0.25 mg/kg). GAT1 blockade resulted in increases in mean (+/-SD) [C-11]flumazenil VT in Group II in association cortices (6.8+/-0.8 mL g(-1) vs. 7.3+/-0.4 mL g(-1); p = 0.03), sensory cortices (6.7+/-0.8 mL g(-1) vs. 7.3+/-0.5 mL g(-1); p = 0.02) and limbic regions (5.2+/-0.6 mL g(-1) vs. 5.7+/-0.3 mL g(-1); p = 0.03). No change was observed at the low dose (Group I). Increased orbital frontal cortex binding of [C-11] flumazenil in Group II correlated with the ability to entrain cortical networks (r = 0.67, p = 0.05) measured via EEG during a cognitive control task. These data provide a replication of our previous study demonstrating the ability to measure in vivo, with PET, acute shifts in extracellular GABA.	[Frankle, W. Gordon; Cho, Raymond Y.; Chen, Chi-Min; Himes, Michael; Walker, Christopher; Lewis, David A.; Narendran, Rajesh] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Frankle, W. Gordon; Mason, N. Scott; Mathis, Chester A.; Narendran, Rajesh] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frankle, WG (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	franklewg@upmc.edu	Cho, Raymond/P-3028-2014; Mathis, Chester A/A-8607-2009; Lewis, David A/G-4053-2014	Cho, Raymond/0000-0003-1331-1409; Mathis, Chester A/0000-0001-9811-0950; Lewis, David A/0000-0002-3225-6778; Walker, Christopher P/0000-0002-1042-075X; Frankle, William/0000-0003-0356-4197	Silvio O. Conte Center for the Neuroscience of Mental Disorders [MH51456]; United States National Institutes of Health (NIH)/NCRR; Montefiore University Hospital Clinical and Translational Research Center; GlaxoSmithKline, Inc.; Sunovion Pharmaceuticals, Inc.; Merck; Pfizer; Neuroptix; GE Healthcare; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Silvio O. Conte Center for the Neuroscience of Mental Disorders; United States National Institutes of Health (NIH)/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montefiore University Hospital Clinical and Translational Research Center; GlaxoSmithKline, Inc.(GlaxoSmithKline); Sunovion Pharmaceuticals, Inc.; Merck(Merck & Company); Pfizer(Pfizer); Neuroptix; GE Healthcare(General ElectricGE Healthcare); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	These data were generated with the support of a Silvio O. Conte Center for the Neuroscience of Mental Disorders (MH51456, PI: Lewis) and a United States National Institutes of Health (NIH)/NCRR Grant which funds the Montefiore University Hospital Clinical and Translational Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Frankle serves as a consultant for Sunovion Pharmaceuticals, Inc. and ONO Pharmaceuticals, Inc. Dr. Narendran has received grant support from GlaxoSmithKline, Inc. and Sunovion Pharmaceuticals, Inc. Dr. Mason serves as a consultant for Aposense Inc., Banner Good Samaritan Hospital (Phoenix, AZ), Janssen AI, and The Gollman Group (Dallas, TX). Dr. Lewis has served as a consultant for Bristol Meyer Squibb, Merck, Lilly, and Hoffman-LaRoche and received research grant support from Merck and Pfizer. Dr. Mathis receives royalty payments from the University of Pittsburgh for technology licensed to GE Healthcare and Neuroptix. He serves as a consultant for Elan, Pfizer, Takeda, Amgen, Baxter Scientific, Novartis, and GE Healthcare. He has received grant support from Neuroptix and GE Healthcare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Dr. Cho, Ms. Chen, Mr. Himes and Mr. Walker have no conflict of interest to declare.	ABADIE P, 1992, EUR J PHARMACOL, V213, P107, DOI 10.1016/0014-2999(92)90239-Z; ABI-DARGHAM A, 1994, J NUCL MED, V35, P228; Adkins JC, 1998, DRUGS, V55, P437, DOI 10.2165/00003495-199855030-00013; BARRE L, 1991, APPL RADIAT ISOTOPES, V42, P435; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Belzung C, 2000, PSYCHOPHARMACOLOGY, V148, P24, DOI 10.1007/s002130050021; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; BRAESTRUP C, 1982, SCIENCE, V216, P1241, DOI 10.1126/science.6281892; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; DURING M, 1992, ANN M AM EP SOC SEAT; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; FINKJENSEN A, 1992, EUR J PHARMACOL, V220, P197, DOI 10.1016/0014-2999(92)90748-S; Frankle WG, 2009, NEUROPSYCHOPHARMACOL, V34, P624, DOI 10.1038/npp.2008.104; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gerra G, 2002, ADDICT BIOL, V7, P385, DOI 10.1080/1355621021000005973; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; HALLDIN C, 1988, APPL RADIAT ISOTOPES, V39, P993; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Innis R, 2007, J CEREBRAL BLOOD FLO, V2007; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; KAPCZINSKI F, 1994, PSYCHOPHARMACOLOGY, V114, P187, DOI 10.1007/BF02245463; KOE BK, 1987, EUR J PHARMACOL, V142, P373, DOI 10.1016/0014-2999(87)90076-8; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; LARUELLE M, 1994, J CEREBR BLOOD F MET, V14, P439, DOI 10.1038/jcbfm.1994.55; LASSEN NA, 1995, J CEREBR BLOOD F MET, V15, P152, DOI 10.1038/jcbfm.1995.17; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; LUTZENBERGER W, 1995, NEUROSCI LETT, V183, P39, DOI 10.1016/0304-3940(94)11109-V; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; MILLER LG, 1988, EUR J PHARMACOL, V148, P123, DOI 10.1016/0014-2999(88)90461-X; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; MOHLER H, 1981, NATURE, V294, P763, DOI 10.1038/294763a0; Mohler H, 1977, SCIENCE, V198; PERSSON A, 1985, J PSYCHIAT RES, V19, P609, DOI 10.1016/0022-3956(85)90080-9; PRICE JC, 1993, J CEREBR BLOOD F MET, V13, P656, DOI 10.1038/jcbfm.1993.84; Price RB, 2009, BIOL PSYCHIAT, V65, P792, DOI 10.1016/j.biopsych.2008.10.025; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Richards DA, 1996, NEUROCHEM RES, V21, P135, DOI 10.1007/BF02529130; ROSENBERG HC, 1979, NEUROSCI LETT, V15, P277, DOI 10.1016/0304-3940(79)96126-3; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SYBIRSKA E, 1993, NEUROPHARMACOLOGY, V32, P671, DOI 10.1016/0028-3908(93)90080-M; Talairach I., 1988, COPLANAR STEREOTACTI; TALLMAN JF, 1978, NATURE, V274, P383, DOI 10.1038/274383a0; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Uthman BM, 1998, ARCH NEUROL-CHICAGO, V55, P56, DOI 10.1001/archneur.55.1.56; VANVREESWIJK, 1994, J COMPUT NEUROSCI, V1, P313; Watson CC, 2000, IEEE T NUCL SCI, V47, P1587, DOI 10.1109/23.873020; Weiss M, 2002, NEUROCHEM RES, V27, P1605, DOI 10.1023/A:1021674708556; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; ZEZULA J, 1988, NEUROSCIENCE, V25, P771, DOI 10.1016/0306-4522(88)90036-X; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32443	10.1371/journal.pone.0032443	http://dx.doi.org/10.1371/journal.pone.0032443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384252	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000302918500090
J	Ciborowski, M; Teul, J; Martin-Ventura, JL; Egido, J; Barbas, C				Ciborowski, Michal; Teul, Joanna; Luis Martin-Ventura, Jose; Egido, Jesus; Barbas, Coral			Metabolomics with LC-QTOF-MS Permits the Prediction of Disease Stage in Aortic Abdominal Aneurysm Based on Plasma Metabolic Fingerprint	PLOS ONE			English	Article							PATHOGENESIS; PERFORMANCE; CARNITINE	Abdominal aortic aneurysm (AAA) is a permanent and localized aortic dilation, defined as aortic diameter >= 3 cm. It is an asymptomatic but potentially fatal condition because progressive enlargement of the abdominal aorta is spontaneously evolving towards rupture. Biomarkers may help to explain pathological processes of AAA expansion, and allow us to find novel therapeutic strategies or to determine the efficiency of current therapies. Metabolomics seems to be a good approach to find biomarkers of AAA. In this study, plasma samples of patients with large AAA, small AAA, and controls were fingerprinted with LC-QTOF-MS. Statistical analysis was used to compare metabolic fingerprints and select metabolites that showed a significant change. Results presented here reveal that LC-QTOF-MS based fingerprinting of plasma from AAA patients is a very good technique to distinguish small AAA, large AAA, and controls. With the use of validated PLS-DA models it was possible to classify patients according to the disease stage and predict properly the stage of additional AAA patients. Identified metabolites indicate a role for sphingolipids, lysophospholipids, cholesterol metabolites, and acylcarnitines in the development and progression of AAA. Moreover, guanidinosuccinic acid, which mimics nitric oxide in terms of its vasodilatory action, was found as a strong marker of large AAA.	[Ciborowski, Michal; Teul, Joanna; Barbas, Coral] Univ CEU San Pablo, Fac Farm, CEMBIO Ctr Metabol & Bioanal, Madrid, Spain; [Ciborowski, Michal] Med Univ Bialystok, Dept Phys Chem, Bialystok, Poland; [Teul, Joanna] Med Univ Bialystok, Dept Pharmaceut Anal, Bialystok, Poland; [Luis Martin-Ventura, Jose; Egido, Jesus] IIS Fdn Jimenez Diaz, Vasc Res Lab, Madrid, Spain; [Luis Martin-Ventura, Jose; Egido, Jesus] Univ Autonoma Madrid, Madrid, Spain	San Pablo CEU University; Medical University of Bialystok; Medical University of Bialystok; Fundacion Jimenez Diaz; Autonomous University of Madrid	Ciborowski, M (corresponding author), Univ CEU San Pablo, Fac Farm, CEMBIO Ctr Metabol & Bioanal, Madrid, Spain.	cbarbas@ceu.es	Ciborowski, Michal/E-6728-2015; Barbas, Coral/K-3871-2014; MARTIN-VENTURA, JOSE LUIS/Z-2386-2019	Ciborowski, Michal/0000-0003-3729-0518; Barbas, Coral/0000-0003-4722-491X; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641	Comunidad Autonoma de Madrid (CAM) [S2006/GEN-0247]; European Community [HEALTH F2-2008-200647]; Spanish Ministerio de Ciencia y Tecnologia [SAF2010/21852, CTQ2008-03779]; Ministerio de Sanidad y Consumo; Instituto de Salud Carlos III; Redes Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) [RD06/0014/0035]; European Aeronautic Defence and Space Company - Construcciones Aeronauticas Sociedad Anonima (EADSCASA);  [EUS2008-03565]	Comunidad Autonoma de Madrid (CAM)(Comunidad de Madrid); European Community(European Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Redes Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA); European Aeronautic Defence and Space Company - Construcciones Aeronauticas Sociedad Anonima (EADSCASA); 	The paper has been supported by Comunidad Autonoma de Madrid (CAM) (S2006/GEN-0247), the European Community Fighting Aneurysmal Disease (FAD) project (FP-7, HEALTH F2-2008-200647), the Spanish Ministerio de Ciencia y Tecnologia (SAF2010/21852 and CTQ2008-03779), Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Redes Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) (RD06/0014/0035), European Aeronautic Defence and Space Company - Construcciones Aeronauticas Sociedad Anonima (EADSCASA), and EUS2008-03565. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi K, 2001, KIDNEY INT, V59, pS93, DOI 10.1046/j.1523-1755.2001.59780093.x; Arsenian MA, 1997, PROG CARDIOVASC DIS, V40, P265, DOI 10.1016/S0033-0620(97)80037-0; Ciborowski M, 2011, J PROTEOME RES, V10, P1374, DOI 10.1021/pr101138m; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Gamberi T, 2011, MOL BIOSYST, V7, P2855, DOI 10.1039/c1mb05107e; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Gilmour RS, 2001, EXP BIOL MED, V226, P1; Golledge J, 2011, ATHEROSCLEROSIS, V216, P458, DOI 10.1016/j.atherosclerosis.2011.02.022; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; Hurt-Camejo E, 2001, CIRC RES, V89, P298, DOI 10.1161/hh1601.095598; Klink A, 2011, NAT REV CARDIOL, V8, P338, DOI 10.1038/nrcardio.2011.1; Krishna SM, 2010, ATHEROSCLEROSIS, V212, P16, DOI 10.1016/j.atherosclerosis.2010.02.008; Levin David C, 2009, J Am Coll Radiol, V6, P506, DOI 10.1016/j.jacr.2009.02.003; Martinez-Pinna R, 2011, ARTERIOSCL THROM VAS, V31, P935, DOI 10.1161/ATVBAHA.110.214429; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Milne S, 2006, METHODS, V39, P92, DOI 10.1016/j.ymeth.2006.05.014; Miyake T, 2009, CARDIOVASC RES, V83, P436, DOI 10.1093/cvr/cvp155; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Mosorin Martti, 2008, Interact Cardiovasc Thorac Surg, V7, P578, DOI 10.1510/icvts.2008.178103; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sayed-Ahmed MM, 2001, PHARMACOL RES, V44, P235, DOI 10.1006/phrs.2001.0852; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Shulaev V, 2006, BRIEF BIOINFORM, V7, P128, DOI 10.1093/bib/bbl012; Tosaka M, 2001, STROKE, V32, P2913, DOI 10.1161/hs1201.099525; Touat Z, 2006, AM J PATHOL, V168, P1022, DOI 10.2353/ajpath.2006.050868; Tsuji K, 2009, BIOORG MED CHEM LETT, V19, P1643, DOI 10.1016/j.bmcl.2009.02.004; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Van Veldhoven PP, 2000, CELL SIGNAL, V12, P475, DOI 10.1016/S0898-6568(00)00092-9; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zhang FX, 2009, TALANTA, V79, P836, DOI 10.1016/j.talanta.2009.05.010	31	50	52	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31982	10.1371/journal.pone.0031982	http://dx.doi.org/10.1371/journal.pone.0031982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384120	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800022
J	Valle-Casuso, JC; Gonzalez-Sanchez, A; Medina, JM; Tabernero, A				Carlos Valle-Casuso, Jose; Gonzalez-Sanchez, Ana; Medina, Jose M.; Tabernero, Arantxa			HIF-1 and c-Src Mediate Increased Glucose Uptake Induced by Endothelin-1 and Connexin43 in Astrocytes	PLOS ONE			English	Article							GAP-JUNCTIONAL COMMUNICATION; CULTURED ASTROCYTES; TERMINAL DOMAIN; GROWTH-FACTOR; UP-REGULATION; RAT NEURONS; EXPRESSION; PROTEIN; BRAIN; INHIBITION	In previous work we showed that endothelin-1 (ET-1) increases the rate of glucose uptake in astrocytes, an important aspect of brain function since glucose taken up by astrocytes is used to supply the neurons with metabolic substrates. In the present work we sought to identify the signalling pathway responsible for this process in primary culture of rat astrocytes. Our results show that ET-1 promoted an increase in the transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) in astrocytes, as shown in other cell types. Furthermore, HIF-1 alpha-siRNA experiments revealed that HIF-1 alpha participates in the effects of ET-1 on glucose uptake and on the expression of GLUT-1, GLUT-3, type I and type II hexokinase. We previously reported that these effects of ET-1 are mediated by connexin43 (Cx43), the major gap junction protein in astrocytes. Indeed, our results show that silencing Cx43 increased HIF-1 alpha and reduced the effect of ET-1 on HIF-1 alpha, indicating that the effect of ET-1 on HIF-1 alpha is mediated by Cx43. The activity of oncogenes such as c-Src can up-regulate HIF-1 alpha. Since Cx43 interacts with c-Src, we investigated the participation of c-Src in this pathway. Interestingly, both the treatment with ET-1 and with Cx43-siRNA increased c-Src activity. In addition, when c-Src activity was inhibited neither ET-1 nor silencing Cx43 were able to up-regulate HIF-1 alpha. In conclusion, our results suggest that ET-1 by down-regulating Cx43 activates c-Src, which in turn increases HIF-1 alpha leading to the up-regulation of the machinery required to take up glucose in astrocytes. Cx43 expression can be reduced in response not only to ET-1 but also to various physiological and pathological stimuli. This study contributes to the identification of the signalling pathway evoked after Cx43 down-regulation that results in increased glucose uptake in astrocytes. Interestingly, this is the first evidence linking Cx43 to HIF-1, which is a master regulator of glucose metabolism.	[Carlos Valle-Casuso, Jose; Gonzalez-Sanchez, Ana; Medina, Jose M.; Tabernero, Arantxa] Univ Salamanca, Dept Bioquim & Biol Mol, INCYL, E-37008 Salamanca, Spain	University of Salamanca	Valle-Casuso, JC (corresponding author), Univ Salamanca, Dept Bioquim & Biol Mol, INCYL, E-37008 Salamanca, Spain.	ataber@usal.es	Tabernero, Arantxa/K-5950-2014; Gonzalez-Sanchez, Ana/GWC-6092-2022; Casuso, Jose Carlos Valle/N-2502-2018	Tabernero, Arantxa/0000-0001-6302-6134; Casuso, Jose Carlos Valle/0000-0002-9637-7085	Ministerio de Educacion y Ciencia [BFU2010-22190, BFU2011-27602]; Junta de Castilla y Leon [SA043A09]	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the Ministerio de Educacion y Ciencia, FEDER BFU2010-22190, BFU2011-27602 and the Junta de Castilla y Leon SA043A09. JCVC and AGS were recipient of a fellowship from the Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Blomstrand F, 2006, J NEUROSCI RES, V83, P996, DOI 10.1002/jnr.20801; Blomstrand F, 2004, EUR J NEUROSCI, V19, P1005, DOI 10.1111/j.0953-816X.2004.03197.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Didier N, 2002, NEUROREPORT, V13, P1179, DOI 10.1097/00001756-200207020-00022; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; FUXE K, 1991, NEUROSCI LETT, V123, P107, DOI 10.1016/0304-3940(91)90169-T; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; GIAUME C, 1992, EUR J NEUROSCI, V4, P877, DOI 10.1111/j.1460-9568.1992.tb00198.x; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Giepmans BNG, 2006, ADV CARDIOL, V42, P41, DOI 10.1159/000092561; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hasselblatt M, 2003, GLIA, V42, P390, DOI 10.1002/glia.10224; Herrero-Gonzalez S, 2010, ONCOGENE, V29, P5712, DOI 10.1038/onc.2010.299; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Huang RP, 1998, CANCER RES, V58, P5089; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lee HY, 2011, CARCINOGENESIS, V32, P703, DOI 10.1093/carcin/bgr034; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Nie XJ, 1996, REV NEUROSCIENCE, V7, P177; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Prochnow N, 2008, HISTOCHEM CELL BIOL, V130, P71, DOI 10.1007/s00418-008-0434-7; Pu PY, 2004, CLIN NEUROL NEUROSUR, V107, P49, DOI 10.1016/j.clineuro.2004.03.006; Rosano L, 2010, AM J PHYSIOL-REG I, V299, pR395, DOI 10.1152/ajpregu.00304.2010; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rozyczka J, 2005, J NEUROSCI RES, V79, P303, DOI 10.1002/jnr.20355; Sanchez-Alvarez R, 2004, J NEUROCHEM, V89, P703, DOI 10.1046/j.1471-4159.2004.02398.x; Scemes E, 2008, GLIA, V56, P145, DOI 10.1002/glia.20598; Shinoura N, 1996, J NEUROSURG, V84, P839, DOI 10.3171/jns.1996.84.5.0839; SIMONSON MS, 1993, PHYSIOL REV, V73, P375, DOI 10.1152/physrev.1993.73.2.375; Soroceanu L, 2001, GLIA, V33, P107, DOI 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; SUPATTAPONE S, 1989, BIOCHEM BIOPH RES CO, V165, P1115, DOI 10.1016/0006-291X(89)92718-6; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Tabernero A, 2006, J NEUROCHEM, V96, P973, DOI 10.1111/j.1471-4159.2005.03623.x; Tabernero A, 1996, NEUROSCI RES, V24, P131, DOI 10.1016/0168-0102(95)00981-7; Tabernero A, 1996, GLIA, V16, P187, DOI 10.1002/(SICI)1098-1136(199603)16:3<187::AID-GLIA1>3.0.CO;2-#; Tabernero A, 2001, J NEUROCHEM, V78, P890, DOI 10.1046/j.1471-4159.2001.00476.x; TABERNERO A, 1993, BIOCHEM J, V294, P635, DOI 10.1042/bj2940635; Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x; Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x; Tence M, 2012, CELL SIGNAL, V24, P86, DOI 10.1016/j.cellsig.2011.08.006; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Venance L, 1997, J NEUROSCI, V17, P1981; VICARIO C, 1993, PEDIATR RES, V34, P709, DOI 10.1203/00006450-199312000-00002; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamashita K, 2000, CELL MOL NEUROBIOL, V20, P541, DOI 10.1023/A:1007007710703; YOSHIMOTO S, 1990, BRAIN RES, V508, P283, DOI 10.1016/0006-8993(90)90407-3; ZHANG WW, 1994, J NEUROL SCI, V122, P90, DOI 10.1016/0022-510X(94)90057-4; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	72	35	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32448	10.1371/journal.pone.0032448	http://dx.doi.org/10.1371/journal.pone.0032448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384254	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100083
J	Lee, JS; Kim, YK; Kim, HJ; Hajar, S; Tan, YL; Kang, NY; Ng, SH; Yoon, CN; Chang, YT				Lee, Jun-Seok; Kim, Yun Kyung; Kim, Han Jo; Hajar, Siti; Tan, Yee Ling; Kang, Nam-Young; Ng, Shin Hui; Yoon, Chang No; Chang, Young-Tae			Identification of Cancer Cell-Line Origins Using Fluorescence Image-Based Phenomic Screening	PLOS ONE			English	Article							PHENOTYPES; MOLECULES; PATTERNS; LIBRARY; CONTEXT; PROBE	Universal phenotyping techniques that can discriminate among various states of biological systems have great potential. We applied 557 fluorescent library compounds to NCI's 60 human cancer cell-lines (NCI-60) to generate a systematic fluorescence phenotypic profiling data. By the kinetic fluorescence intensity analysis, we successfully discriminated the organ origin of all the 60 cell-lines.	[Lee, Jun-Seok; Yoon, Chang No] Korea Inst Sci & Technol, Biomol Funct Res Ctr, Seoul, South Korea; [Kim, Yun Kyung] Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul, South Korea; [Kim, Han Jo; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Inst Life Sci, Singapore 117548, Singapore; [Kim, Han Jo; Chang, Young-Tae] Natl Univ Singapore, Med Chem Program, Inst Life Sci, Singapore 117548, Singapore; [Hajar, Siti; Tan, Yee Ling; Kang, Nam-Young; Ng, Shin Hui; Chang, Young-Tae] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Lee, JS (corresponding author), Korea Inst Sci & Technol, Biomol Funct Res Ctr, Seoul, South Korea.	chmcyt@nus.edu.sg	Chang, Young-Tae/B-2780-2010; Lee, Jun-Seok/D-8428-2011	Chang, Young-Tae/0000-0002-1927-3688; Lee, Jun-Seok/0000-0003-3641-1728	Agency for Science, Technology and Research (A*STAR); Singapore Biomedical Research Council; A*STAR SSCC [SSCC10/024]; Ministry of Education, Science and Technology [2010K001410]; T. J. Park Science Fellowship	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR SSCC(Agency for Science Technology & Research (A*STAR)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); T. J. Park Science Fellowship	This work was supported by an intramural funding from Agency for Science, Technology and Research (A*STAR), Singapore Biomedical Research Council and A*STAR SSCC Grant (SSCC10/024). This work was also supported by Converging Research Center Program through the Ministry of Education, Science and Technology (2010K001410). JSL is a recipient of T. J. Park Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2007, J AM CHEM SOC, V129, P4510, DOI 10.1021/ja068230m; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fatrai S, 2011, J BIOL CHEM, V286, P6061, DOI 10.1074/jbc.M110.201848; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Im CN, 2010, ANGEW CHEM INT EDIT, V49, P7497, DOI 10.1002/anie.201002463; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P3616, DOI 10.1002/anie.200604972; Lee JS, 2011, CHEM COMMUN, V47, P2339, DOI 10.1039/c0cc04495d; Lee JS, 2009, J AM CHEM SOC, V131, P10077, DOI 10.1021/ja9011657; Ljosa V, 2008, TRENDS BIOTECHNOL, V26, P527, DOI 10.1016/j.tibtech.2008.06.008; MacKenzie DA, 2007, J BIOL CHEM, V282, P9696, DOI 10.1074/jbc.M604192200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Vounou M, 2010, NEUROIMAGE, V53, P1147, DOI 10.1016/j.neuroimage.2010.07.002; Wagner BK, 2008, J AM CHEM SOC, V130, P4208, DOI 10.1021/ja077656d; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037	26	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32096	10.1371/journal.pone.0032096	http://dx.doi.org/10.1371/journal.pone.0032096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384151	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100052
J	Han, M; Nagele, E; DeMarshall, C; Acharya, N; Nagele, R				Han, Min; Nagele, Eric; DeMarshall, Cassandra; Acharya, Nimish; Nagele, Robert			Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; RATING-SCALE; EPIDEMIOLOGY	Parkinson's disease (PD), hallmarked by a variety of motor disorders and neurological decline, is the second most common neurodegenerative disease worldwide. Currently, no diagnostic test exists to identify sufferers, and physicians must rely on a combination of subjective physical and neurological assessments to make a diagnosis. The discovery of definitive blood-borne biomarkers would be a major step towards early and reliable diagnosis. Despite attention devoted to this search, such biomarkers have remained elusive. In the present study, we used human protein microarrays to reveal serum autoantibodies that are differentially expressed among PD and control subjects. The diagnostic significance of each of these autoantibodies was evaluated, resulting in the selection of 10 autoantibody biomarkers that can effectively differentiate PD sera from control sera with a sensitivity of 93.1% and specificity of 100%. PD sera were also distinguishable from sera obtained from Alzheimer's disease, breast cancer, and multiple sclerosis patients with accuracies of 86.0%, 96.6%, and 100%, respectively. Results demonstrate that serum autoantibodies can be used as highly specific and accurate biomarkers for PD diagnosis throughout the course of the disease.	[Han, Min; DeMarshall, Cassandra; Acharya, Nimish] Univ Med & Dent New Jersey, Sch Osteopath Med, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Han, Min; DeMarshall, Cassandra; Acharya, Nimish; Nagele, Robert] Univ Med & Dent New Jersey, New Jersey Inst Successful Aging, Stratford, NJ USA; [Nagele, Eric; Nagele, Robert] Durin Technol Inc, New Brunswick, NJ USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Han, M (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Grad Sch Biomed Sci, Stratford, NJ 08084 USA.	nagelero@umdnj.edu		Han, Min/0000-0002-8350-687X; Han, Min/0000-0002-7348-9121	Foundation Venture Capital Group, L.L.C.; New Jersey Health Foundation	Foundation Venture Capital Group, L.L.C.; New Jersey Health Foundation	The authors gratefully acknowledge financial support from the Foundation Venture Capital Group, L.L.C., an affiliate of the New Jersey Health Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aarsland D, 2010, BRAIN PATHOL, V20, P633, DOI 10.1111/j.1750-3639.2009.00369.x; Berendse HW, 2011, J NEUROL SC IN PRESS; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Ebersbach G, 2006, J NEUROL, V253, P32, DOI 10.1007/00415-006-4008-0; Gaig C, 2009, MOVEMENT DISORD, V24, pS656, DOI 10.1002/mds.22672; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gerlach M, 2012, J NEURAL TRANSM, V119, P39, DOI 10.1007/s00702-011-0682-x; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Nagele E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023112; NAGELE RG, 2011, J ALZHEIMER IN PRESS; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Stoessl AJ, 2011, NEUROTHERAPEUTICS, V8, P72, DOI 10.1007/s13311-010-0007-z; Strobel G, 2009, J ALZHEIMERS DIS, V18, P625, DOI [10.3233/JAD-2009-1250, 10.3233/JAD-2009-1234]; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tolosa E, 2011, J NEUROL SC IN PRESS; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	28	76	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32383	10.1371/journal.pone.0032383	http://dx.doi.org/10.1371/journal.pone.0032383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384236	Green Published, gold			2022-12-25	WOS:000302875500099
J	Przybycien-Szymanska, MM; Gillespie, RA; Pak, TR				Przybycien-Szymanska, Magdalena M.; Gillespie, Roberta A.; Pak, Toni R.			17 beta-Estradiol Is Required for the Sexually Dimorphic Effects of Repeated Binge-Pattern Alcohol Exposure on the HPA Axis during Adolescence	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING-FACTOR; ARGININE-VASOPRESSIN; MALE RATS; SEX-DIFFERENCES; USE DISORDERS; FEMALE RATS; GENDER-DIFFERENCE; SCHOOL-STUDENTS	Alcohol consumption during adolescence has long-term sexually dimorphic effects on anxiety behavior and mood disorders. We have previously shown that repeated binge-pattern alcohol exposure increased the expression of two critical central regulators of stress and anxiety, corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP), in adolescent male rats. By contrast, there was no effect of alcohol on these same genes in adolescent females. Therefore, we tested the hypothesis that 17 beta-estradiol (E-2), the predominant sex steroid hormone in females, prevents alcohol-induced changes in CRH and AVP gene expression in the paraventricular nucleus (PVN) of the hypothalamus. To test this hypothesis, postnatal day (PND) 26 females were ovariectomized and given E-2 replacement or cholesterol as a control. Next, they were given an alcohol exposure paradigm of 1) saline alone, 2) acute (single dose) or 3) a repeated binge-pattern. Our results showed that acute and repeated binge-pattern alcohol treatment increased plasma ACTH and CORT levels in both E-2- and Ch-treated groups, however habituation to repeated binge-pattern alcohol exposure was evident only in E-2- treated animals. Further, repeated binge-pattern alcohol exposure significantly decreased CRH and AVP mRNA in Ch-, but not E-2- treated animals, which was consistent with our previous observations in gonad intact females. We further tested the effects of E-2 and alcohol treatment on the activity of the wild type CRH promoter in a PVN-derived neuronal cell line. Alcohol increased CRH promoter activity in these cells and concomitant treatment with E-2 completely abolished the effect. Together our data suggest that E-2 regulates the reactivity of the HPA axis to a repeated stressor through modulation of the habituation response and further serves to maintain normal steady state mRNA levels of CRH and AVP in the PVN in response to a repeated alcohol stressor.				tpak@lumc.edu			National Institutes of Health [R21AA018398, T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018398, T32AA013527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Fundings sources: National Institutes of Health R21AA018398 and T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen EQ, 2007, GAC SANIT, V21, P43, DOI 10.1157/13099120; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Bingham B, 2011, PSYCHONEUROENDOCRINO, V36, P249, DOI 10.1016/j.psyneuen.2010.07.015; BURGESS LH, 1993, MOL CELL NEUROSCI, V4, P191, DOI 10.1006/mcne.1993.1023; Cagnacci A, 2007, FERTIL STERIL, V88, P1603, DOI 10.1016/j.fertnstert.2007.01.039; Chen J, 2008, EXP NEUROL, V211, P529, DOI 10.1016/j.expneurol.2008.02.023; Chen J, 2009, J NEUROCHEM, V110, P1310, DOI 10.1111/j.1471-4159.2009.06219.x; Chung WCJ, 2007, J COMP NEUROL, V505, P249, DOI 10.1002/cne.21490; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Epstein EE, 2007, J WOMEN AGING, V19, P31, DOI 10.1300/J074v19n01_03; Field M, 2007, ADDICTION; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; GUENNOUN R, 1995, MOL BRAIN RES, V30, P287, DOI 10.1016/0169-328X(95)00016-L; Handa RJ, 2007, NEUROSCI LETT, V425, P99, DOI 10.1016/j.neulet.2007.08.044; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Lauing K, 2008, ALCOHOL, V42, P649, DOI 10.1016/j.alcohol.2008.08.005; Li ZQ, 2005, MOL CELL NEUROSCI, V29, P345, DOI 10.1016/j.mcn.2005.04.002; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Lund TD, 2006, J NEUROSCI, V26, P1448, DOI 10.1523/JNEUROSCI.3777-05.2006; Lunga P, 2004, J NEUROENDOCRINOL, V16, P776, DOI 10.1111/j.1365-2826.2004.01234.x; Malkoski SP, 1999, MOL ENDOCRINOL, V13, P1629, DOI 10.1210/me.13.10.1629; McCullough LD, 2003, J NEUROSCI, V23, P8701; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Ogilvie KM, 1997, BRAIN RES, V744, P83, DOI 10.1016/S0006-8993(96)01082-7; Ogilvie KM, 1996, ALCOHOL CLIN EXP RES, V20, P255, DOI 10.1111/j.1530-0277.1996.tb01637.x; Ogilvie KM, 1997, BRAIN RES, V766, P19, DOI 10.1016/S0006-8993(97)00525-8; Pak TR, 2007, ENDOCRINOLOGY, V148, P3371, DOI 10.1210/en.2007-0086; Pak TR, 2009, AM J PHYSIOL-ENDOC M, V296, pE1409, DOI 10.1152/ajpendo.00037.2009; Pak TR, 2003, AM J PHYSIOL-ENDOC M, V284, pE206, DOI 10.1152/ajpendo.00352.2002; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; Pietranera L, NEUROSCIENCE, V174, P151; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026647; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Przybycien-Szymanska MM, 2010, AM J PHYSIOL-ENDOC M, V298, pE320, DOI 10.1152/ajpendo.00615.2009; RIVIER C, 1993, ALCOHOL CLIN EXP RES, V17, P854, DOI 10.1111/j.1530-0277.1993.tb00853.x; Saleh TM, 2005, NEUROSCIENCE, V135, P1141, DOI 10.1016/j.neuroscience.2005.06.061; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SENCARCUPOVIC I, 1976, MECH AGEING DEV, V5, P1, DOI 10.1016/0047-6374(76)90002-6; Sierra A, 2003, ENDOCRINE, V21, P43, DOI 10.1385/ENDO:21:1:43; Smith KL, 2008, OBESITY, V16, P2239, DOI 10.1038/oby.2008.366; SODERSTEN P, 1975, HORM BEHAV, V6, P307, DOI 10.1016/0018-506X(75)90001-X; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Tebar M, 1996, BIOL REPROD, V54, P1266, DOI 10.1095/biolreprod54.6.1266; Veiga S, 2005, NEUROREPORT, V16, P1599, DOI 10.1097/01.wnr.0000179081.39659.7d; Walker BM, 2009, PHARMACOL BIOCHEM BE, V91, P560, DOI 10.1016/j.pbb.2008.09.017; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Witt ED, 2007, NEUROTOXICOL TERATOL, V29, P81, DOI 10.1016/j.ntt.2006.10.013; Zilberman ML, 2003, CAN J PSYCHIAT, V48, P5, DOI 10.1177/070674370304800103	52	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32263	10.1371/journal.pone.0032263	http://dx.doi.org/10.1371/journal.pone.0032263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384198	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500091
J	Klokov, D; Leskov, K; Araki, S; Zou, Y; Goetz, EM; Luo, X; Willson, D; Boothman, DA				Klokov, D.; Leskov, K.; Araki, S.; Zou, Y.; Goetz, E. M.; Luo, X.; Willson, D.; Boothman, D. A.			Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGF beta 1 signaling to confer a pro-survival bystander effect	ONCOGENE			English	Article						bystander effects; TGF beta 1; secretory clusterin; insulin-like growth factor-1; low-dose ionizing radiation; p53 suppression	GROWTH-FACTOR-I; CLUSTERIN GENE-EXPRESSION; IONIZING-RADIATION; DNA-DAMAGE; INDUCED SENESCENCE; FACTOR-BETA; CANCER; PROTEIN; APOPTOSIS; ACTIVATION	Inadvertent mammalian tissue exposures to low doses of ionizing radiation (IR) after radiation accidents, remediation of radioactive-contaminated areas, space travel or a dirty bomb represent an interesting trauma to an organism. Possible low-dose IR-induced bystander effects could impact our evaluation of human health effects, as cells within tissue are not equally damaged after doses of IR <= 10 cGy. To understand tissue responses after low IR doses, we generated a reporter system using the human clusterin promoter fused to firefly luciferase (hCLUp-Luc). Secretory clusterin (sCLU), an extracellular molecular chaperone, induced by low doses of cytotoxic agents, clears cell debris. Low-dose IR (>= 2 cGy) exposure induced hCLUp-Luc activity with peak levels at 96 h, consistent with endogenous sCLU levels. As doses increased (>= 1 Gy), sCLU induction amplitudes increased and time-to-peak response decreased. sCLU expression was stimulated by insulin-like growth factor-1, but suppressed by p53. Responses in transgenic hCLUp-Luc reporter mice after low IR doses showed that specific tissues (that is, colon, spleen, mammary, thymus and bone marrow) of female mice induced hCLUp-Luc activity more than male mice after whole body (>= 10 cGy) irradiation. Tissue-specific, non-linear dose- and time-responses of hCLUp-Luc and endogenous sCLU levels were noted. Colon maintained homeostatic balance after 10 cGy. Bone marrow responded with delayed, but prolonged and elevated expression. Intraperitoneal administration of alpha-transforming growth factor (TGF)beta 1 (1D11), but not control (13C4) antibodies, immediately following IR exposure abrogated CLU induction responses. Induction in vivo also correlated with Smad signaling by activated TGF beta 1 after IR. Mechanistically, media with elevated sCLU levels suppressed signaling, blocked apoptosis and increased survival of TGF beta 1-exposed tumor or normal cells. Thus, sCLU is a pro-survival bystander factor that abrogates TGF beta 1 signaling and most likely promotes wound healing. Oncogene (2013) 32, 479-490; doi:10.1038/onc.2012.64; published online 5 March 2012	[Leskov, K.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Araki, S.; Zou, Y.; Goetz, E. M.; Luo, X.; Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Pharmacol,Lab Mol Stress Responses, Dallas, TX 75390 USA; [Araki, S.; Zou, Y.; Goetz, E. M.; Luo, X.; Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Radiat Oncol,Lab Mol Stress Response, Dallas, TX 75390 USA; [Willson, D.] Case Western Reserve Univ, Sch Med, Dept Biomed Engn, Lab Biomed Image Proc, Cleveland, OH USA	Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Pharmacol,Lab Mol Stress Responses, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019; Klokov, Dmitry/AAM-7316-2020; Leskov, Konstantin S/J-2339-2017	Klokov, Dmitry/0000-0003-1629-1431; Leskov, Konstantin S/0000-0001-6201-5660	DOE [DE-FG02-06ER64186]; NASA; DAB; DOD BCRP [W81XWH-06-0748]; DOD PCRP [X8IXWH-09-1-0168]; NATIONAL CANCER INSTITUTE [R01CA139217, R01CA078530, U24CA126608, P30CA142543] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); DAB; DOD BCRP(United States Department of Defense); DOD PCRP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DOE Grant #DE-FG02-06ER64186 to DAB, a pilot grant from NASA to develop BLI imaging of hCLUp-Luc to DW and DAB, a DOD BCRP pre-doctoral fellowship (W81XWH-06-0748) to E.M.G and a DOD PCRP post-doctoral fellowship (X8IXWH-09-1-0168) to XL We thank Ms Lakshmi Sampath and Mr Andrew Bruening for their help with this work. We are also grateful to Dr Mary Helen Barcellos-Hoff for her advice with the animal experiments. We are also grateful to the Robert B. and Virginia Payne Endowment to DAB. This is CSCN 065 and used the Flow Cytometry and Biostatistics Cores, Simmons Cancer Center.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Araki S, 2005, BJR S, V27, P106, DOI [10.1259/bjr/18105113, DOI 10.1259/BJR/18105113]]; Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Arufe MC, 2011, STEM CELLS DEV, V20, P1199, DOI 10.1089/scd.2010.0315; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Chi KN, 2010, J CLIN ONCOL, V28, P4247, DOI 10.1200/JCO.2009.26.8771; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Cornelissen B, 2011, CANCER RES, V71, P4539, DOI 10.1158/0008-5472.CAN-10-4587; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Criswell T, 2003, CANCER BIOL THER, V2, P372, DOI 10.4161/cbt.2.4.430; DASCH JR, 1989, J IMMUNOL, V142, P1536; Davis TW, 1998, CANCER RES, V58, P767; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Garkavtsev I, 2011, P NATL ACAD SCI USA, V108, P11596, DOI 10.1073/pnas.1104225108; Goetz EM, 2011, ONCOGENE, V30, P3745, DOI 10.1038/onc.2011.92; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; He Q, 2003, ONCOGENE, V22, P2674, DOI 10.1038/sj.onc.1206363; Jin G, 1999, EUR J BIOCHEM, V263, P534, DOI 10.1046/j.1432-1327.1999.00533.x; Kirshner J, 2006, CANCER RES, V66, P10861, DOI 10.1158/0008-5472.CAN-06-2565; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Lee TK, 2002, RADIAT RES, V157, P678, DOI 10.1667/0033-7587(2002)157[0678:POMILO]2.0.CO;2; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; Lindholm C, 2010, RADIAT RES, V173, P71, DOI 10.1667/RR1843.1; Nachtrab U, 1998, INT J RADIAT BIOL, V73, P279, DOI 10.1080/095530098142374; Nguyen DH, 2011, CANCER CELL, V19, P640, DOI 10.1016/j.ccr.2011.03.011; Peretz S, 2001, P NATL ACAD SCI USA, V98, P1676, DOI 10.1073/pnas.041416598; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Shahrabani-Gargir L, 2004, ENDOCRINOLOGY, V145, P5679, DOI 10.1210/en.2004-0613; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Snyder AR, 2004, HUM EXP TOXICOL, V23, P87, DOI 10.1191/0960327104ht423oa; Sutton D, 2006, INT J NANOMED, V1, P155, DOI 10.2147/nano.2006.1.2.155; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917	45	22	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2013	32	4					479	490		10.1038/onc.2012.64	http://dx.doi.org/10.1038/onc.2012.64			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22391565	Green Accepted			2022-12-25	WOS:000315551300009
J	Wang, YF; Cufar, K; Eckstein, D; Liang, EY				Wang, Yafeng; Cufar, Katarina; Eckstein, Dieter; Liang, Eryuan			Variation of Maximum Tree Height and Annual Shoot Growth of Smith Fir at Various Elevations in the Sygera Mountains, Southeastern Tibetan Plateau	PLOS ONE			English	Article							PINUS-SYLVESTRIS; PICEA-ABIES; SCOTS PINE; TEMPERATURE; PHOTOSYNTHESIS; TIMBERLINE; INCREMENT; SPRUCE; LIMITS; CONDUCTANCE	Little is known about tree height and height growth (as annual shoot elongation of the apical part of vertical stems) of coniferous trees growing at various altitudes on the Tibetan Plateau, which provides a high-elevation natural platform for assessing tree growth performance in relation to future climate change. We here investigated the variation of maximum tree height and annual height increment of Smith fir (Abies georgei var. smithii) in seven forest plots (30 mx40 m) along two altitudinal transects between 3,800 m and 4,200/4,390 m above sea level (a.s.l.) in the Sygera Mountains, southeastern Tibetan Plateau. Four plots were located on north-facing slopes and three plots on southeast-facing slopes. At each site, annual shoot growth was obtained by measuring the distance between successive terminal bud scars along the main stem of 25 trees that were between 2 and 4 m high. Maximum/mean tree height and mean annual height increment of Smith fir decreased with increasing altitude up to the tree line, indicative of a stress gradient (the dominant temperature gradient) along the altitudinal transect. Above-average mean minimum summer (particularly July) temperatures affected height increment positively, whereas precipitation had no significant effect on shoot growth. The time series of annual height increments of Smith fir can be used for the reconstruction of past climate on the southeastern Tibetan Plateau. In addition, it can be expected that the rising summer temperatures observed in the recent past and anticipated for the future will enhance Smith fir's growth throughout its altitudinal distribution range.	[Wang, Yafeng; Liang, Eryuan] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China; [Cufar, Katarina] Univ Ljubljana, Biotech Fac, Dept Wood Sci & Technol, Ljubljana, Slovenia; [Eckstein, Dieter] Univ Hamburg, Dept Wood Sci, Div Wood Biol, Hamburg, Germany; [Wang, Yafeng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; University of Ljubljana; University of Hamburg; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YF (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China.	liangey@itpcas.ac.cn	Liang, Eryuan/A-1435-2010; Cufar, Katarina/AAE-6288-2020	Liang, Eryuan/0000-0002-8003-4264; Cufar, Katarina/0000-0002-7403-3994	National Basic Research Program of China [2010CB951301]; Chinese Academy of Science [KZCX2-YW-QN111, KZCX2-XB 3-08-02]; National Natural Science Foundation of China [41130529, 40871097]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2010CB951301), the Knowledge Innovation Program and Action Plan for West Development of the Chinese Academy of Science (KZCX2-YW-QN111, KZCX2-XB 3-08-02) and the National Natural Science Foundation of China (41130529, 40871097). The funders had no role in the study design, data collection and analysis, nor in the decision to publish or in the preparation of the manuscript.	[Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Camarero JJ, 2004, CLIMATIC CHANGE, V63, P181, DOI 10.1023/B:CLIM.0000018507.71343.46; Cavaleri MA, 2010, ECOLOGY, V91, P1730, DOI 10.1890/09-1326.1; Cook E.R., 2013, METHODS DENDROCHRONO; DAY TA, 1989, OECOLOGIA, V80, P546, DOI 10.1007/BF00380080; Delucia EH, 1986, TREE PHYSIOL, V2, P143, DOI 10.1093/treephys/2.1-2-3.143; Domec JC, 2008, P NATL ACAD SCI USA, V105, P12069, DOI 10.1073/pnas.0710418105; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Gamache I, 2004, J ECOL, V92, P835, DOI 10.1111/j.0022-0477.2004.00913.x; Girard F, 2011, TREES-STRUCT FUNCT, V25, P311, DOI 10.1007/s00468-010-0507-9; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jalkanen R., 2001, Dendrochronologia, V19, P39; JAMES JC, 1994, J ECOL, V82, P297, DOI 10.2307/2261297; Junttila O, 1986, TREE PHYSIOL, V1, P185, DOI 10.1093/treephys/1.2.185; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; KING DA, 1990, AM NAT, V135, P809, DOI 10.1086/285075; Klinka K, 1996, FOREST CHRON, V72, P193, DOI 10.5558/tfc72193-2; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kong GQ, 2011, THESIS CHINESE ACAD, P1; KOZLOWSKI TT, 1964, BOT REV, V30, P335, DOI 10.1007/BF02858538; Lanner R. M., 1976, Tree physiology and yield improvement - shoot and cambial growth., P223; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Levanic T, 2009, TREES-STRUCT FUNCT, V23, P169, DOI 10.1007/s00468-008-0265-0; Li CY, 2004, TREES-STRUCT FUNCT, V18, P277, DOI 10.1007/s00468-003-0304-9; Li M, 2003, CAN J FOREST RES, V33, P653, DOI [10.1139/x02-202, 10.1139/X02-202]; Li MC, 2007, THESIS CHINESE ACAD, P1; Liang EY, 2009, THEOR APPL CLIMATOL, V98, P9, DOI 10.1007/s00704-008-0085-6; Liang EY, 2011, GLOBAL PLANET CHANGE, V77, P97, DOI 10.1016/j.gloplacha.2011.04.005; Liang EY, 2011, NEW PHYTOL, V190, P760, DOI 10.1111/j.1469-8137.2010.03623.x; Liang EY, 2010, TREES-STRUCT FUNCT, V24, P363, DOI 10.1007/s00468-009-0406-0; Lindholm M, 2011, HOLOCENE, V21, P319, DOI 10.1177/0959683610378875; Lindholm M, 2009, HOLOCENE, V19, P1131, DOI 10.1177/0959683609345078; Liu B, 2011, MT RES DEV, V31, P45, DOI 10.1659/MRD-JOURNAL-D-10-00096.1; Liu XS, 2011, ARCT ANTARCT ALP RES, V43, P229, DOI 10.1657/1938-4246-43.2.229; MAGNANI F, 1995, PLANT CELL ENVIRON, V18, P689, DOI 10.1111/j.1365-3040.1995.tb00570.x; Mayr S., 2007, Trees at their upper limit: treelife limitation at the Alpine timberline, P145; Messaoud Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014691; Morecroft MD, 1996, NEW PHYTOL, V134, P471, DOI 10.1111/j.1469-8137.1996.tb04364.x; Paulsen J, 2000, ARCT ANTARCT ALP RES, V32, P14, DOI 10.2307/1552405; Petit G, 2011, NEW PHYTOL, V189, P241, DOI 10.1111/j.1469-8137.2010.03455.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Rossi S, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008088; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Salminen H, 2007, TREE PHYSIOL, V27, P1347, DOI 10.1093/treephys/27.9.1347; Salminen Hannu, 2004, Dendrochronologia, V21, P79, DOI 10.1078/1125-7865-00039; Seo JW, 2010, BALT FOR, V16, P57; Sierra-Almeida A, 2010, ENVIRON EXP BOT, V69, P273, DOI 10.1016/j.envexpbot.2010.04.015; Sklenar .P, 2011, AUSTR ECOLOGY, V35, P929; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Takahashi K, 2003, ARCT ANTARCT ALP RES, V35, P1, DOI 10.1657/1523-0430(2003)035[0001:EOCCOS]2.0.CO;2; TILMAN D, 1988; Xu FX, 1995, FOREST ECOLOGY RES T; Yao TD, 2004, SCI CHINA SER D, V47, P1065, DOI 10.1360/03yd0256; Zhu HF, 2011, PALAEOGEOGR PALAEOCL, V305, P84, DOI 10.1016/j.palaeo.2011.02.017	57	15	16	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e31725	10.1371/journal.pone.0031725	http://dx.doi.org/10.1371/journal.pone.0031725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396738	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000008
J	Coster, A; Madsen, O; Heuven, HCM; Dibbits, B; Groenen, MAM; van Arendonk, JAM; Bovenhuis, H				Coster, Albart; Madsen, Ole; Heuven, Henri C. M.; Dibbits, Bert; Groenen, Martien A. M.; van Arendonk, Johan A. M.; Bovenhuis, Henk			The Imprinted Gene DIO3 Is a Candidate Gene for Litter Size in Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORIGIN ALLELIC EXPRESSION; MEAT QUALITY; GENOME SCAN; EVOLUTIONARY CONSERVATION; SWINE CHROMOSOME-2; TYPE-3 DEIODINASE; MOUSE-BRAIN; MUSCLE MASS; IGF2 LOCUS	Genomic imprinting is an important epigenetic phenomenon, which on the phenotypic level can be detected by the difference between the two heterozygote classes of a gene. Imprinted genes are important in both the development of the placenta and the embryo, and we hypothesized that imprinted genes might be involved in female fertility traits. We therefore performed an association study for imprinted genes related to female fertility traits in two commercial pig populations. For this purpose, 309 SNPs in fifteen evolutionary conserved imprinted regions were genotyped on 689 and 1050 pigs from the two pig populations. A single SNP association study was used to detect additive, dominant and imprinting effects related to four reproduction traits; total number of piglets born, the number of piglets born alive, the total weight of the piglets born and the total weight of the piglets born alive. Several SNPs showed significant (q-value<0.10) additive and dominant effects and one SNP showed a significant imprinting effect. The SNP with a significant imprinting effect is closely linked to DIO3, a gene involved in thyroid metabolism. The imprinting effect of this SNP explained approximately 1.6% of the phenotypic variance, which corresponded to approximately 15.5% of the additive genetic variance. In the other population, the imprinting effect of this QTL was not significant (q-value>0.10), but had a similar effect as in the first population. The results of this study indicate a possible association between the imprinted gene DIO3 and female fertility traits in pigs.	[Coster, Albart; Madsen, Ole; Heuven, Henri C. M.; Dibbits, Bert; Groenen, Martien A. M.; van Arendonk, Johan A. M.; Bovenhuis, Henk] Wageningen Univ, Anim Breeding & Genom Grp, Wageningen, Netherlands	Wageningen University & Research	Coster, A (corresponding author), Wageningen Univ, Anim Breeding & Genom Grp, Wageningen, Netherlands.	albart@dairyconsult.nl	van Arendonk, Johan/E-2536-2011; Groenen, Martien/D-8408-2012; Bovenhuis, Henk/E-4750-2012; Madsen, Ole/E-3730-2012	van Arendonk, Johan/0000-0003-2592-3947; Groenen, Martien/0000-0003-0484-4545; Madsen, Ole/0000-0001-8082-7881	Technologiestichting STW	Technologiestichting STW(Technologiestichting STW)	The work was financially supported by Technologiestichting STW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S1; Butler MG, 2009, J ASSIST REPROD GEN, V26, P477, DOI 10.1007/s10815-009-9353-3; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Dabney A, 2009, QVALUE Q VALUE ESTIM; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; de Givry S, 2005, P WCB05 WORKSH CONST; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Gilmour AR, 2002, ASREML REFERENCE MAN; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Hager R, 2009, EVOLUTION, V63, P1118, DOI 10.1111/j.1558-5646.2009.00638.x; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Hernandez A, 2005, THYROID, V15, P865, DOI 10.1089/thy.2005.15.865; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Hirooka H, 2001, J ANIM SCI, V79, P2320; Holl JW, 2004, J ANIM SCI, V82, P3421; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Knott SA, 1998, GENETICS, V149, P1069; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Lynch M., 1998, GENETICS ANAL QUANTI; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Munoz M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-23; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Onteru S K, 2009, Soc Reprod Fertil Suppl, V66, P87; Qiao M, 2011, MOL BIOL REP, P1; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Renfree MB, 2008, REPRODUCTION, V136, P523, DOI 10.1530/REP-08-0264; Rohrer GA, 2006, ANIM GENET, V37, P17, DOI 10.1111/j.1365-2052.2005.01368.x; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Sanchez M, 2008, CONSTRAINTS, V13, P130, DOI 10.1007/s10601-007-9029-5; Sandor C, 2008, GENETICS, V180, P1167, DOI 10.1534/genetics.108.092551; Santure AW, 2006, GENETICS, V173, P2297, DOI 10.1534/genetics.105.049494; Stearns TM, 2005, J ANIM SCI, V83, P2471; Stearns TM, 2005, J ANIM SCI, V83, P1481; StGermain DL, 1997, THYROID, V7, P655; Stinckens A, 2010, ANIM GENET; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomsen H, 2004, J ANIM SCI, V82, P2213; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Yang ZL, 2009, AGR SCI CHINA, V8, P613, DOI 10.1016/S1671-2927(08)60253-9; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31825	10.1371/journal.pone.0031825	http://dx.doi.org/10.1371/journal.pone.0031825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393372	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500025
J	Schuller, D; Cardoso, F; Sousa, S; Gomes, P; Gomes, AC; Santos, MAS; Casal, M				Schuller, Dorit; Cardoso, Filipa; Sousa, Susana; Gomes, Paula; Gomes, Ana C.; Santos, Manuel A. S.; Casal, Margarida			Genetic Diversity and Population Structure of Saccharomyces cerevisiae Strains Isolated from Different Grape Varieties and Winemaking Regions	PLOS ONE			English	Article							WINE YEAST POPULATIONS; SPONTANEOUS FERMENTATION; NATURAL FERMENTATION; CONSECUTIVE YEARS; ECOLOGICAL SURVEY; MOLECULAR METHODS; IDENTIFICATION; VINEYARD; AREAS; SPAIN	We herein evaluate intraspecific genetic diversity of fermentative vineyard-associated S. cerevisiae strains and evaluate relationships between grape varieties and geographical location on populational structures. From the musts obtained from 288 grape samples, collected from two wine regions (16 vineyards, nine grape varieties), 94 spontaneous fermentations were concluded and 2820 yeast isolates were obtained that belonged mainly (92%) to the species S. cerevisiae. Isolates were classified in 321 strains by the use of ten microsatellite markers. A high strain diversity (8-43 strains per fermentation) was associated with high percentage (60-100%) of fermenting samples per vineyard, whereas a lower percentage of spontaneous fermentations (0-40%) corresponded to a rather low strain diversity (1-10 strains per fermentation). For the majority of the populations, observed heterozygosity (Ho) was about two to five times lower than the expected heterozygosity (He). The inferred ancestry showed a very high degree of admixture and divergence was observed between both grape variety and geographical region. Analysis of molecular variance showed that 81-93% of the total genetic variation existed within populations, while significant differentiation within the groups could be detected. Results from AMOVA analysis and clustering of allelic frequencies agree in the distinction of genetically more dispersed populations from the larger wine region compared to the less extended region. Our data show that grape variety is a driver of populational structures, because vineyards with distinct varieties harbor genetically more differentiated S. cerevisiae populations. Conversely, S. cerevisiae strains from vineyards in close proximity (5-10 km) that contain the same grape variety tend to be less divergent. Populational similarities did not correlate with the distance between vineyards of the two wine regions. Globally, our results show that populations of S. cerevisiae in vineyards may occur locally due to multi-factorial influences, one of them being the grape variety.	[Schuller, Dorit; Cardoso, Filipa; Casal, Margarida] Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal; [Sousa, Susana; Gomes, Paula; Gomes, Ana C.] Ctr Inovacao Biotecnol, BIOCANT, Cantanhede, Portugal; [Santos, Manuel A. S.] Univ Aveiro, RNA Biol Lab, Dept Biol, P-3800 Aveiro, Portugal	Universidade do Minho; Universidade de Aveiro	Schuller, D (corresponding author), Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal.	dschuller@bio.uminho.pt	Schuller, Dorit/I-6649-2013; Gomes, Ana Catarina/A-2628-2015; Santos, Manuel/E-6704-2010; CASAL, MARGARIDA/B-6386-2009	Gomes, Ana Catarina/0000-0002-4989-6026; Santos, Manuel/0000-0002-0437-1146; CASAL, MARGARIDA/0000-0002-0143-9758; Schuller, Dorit/0000-0001-6030-4602	European Community [232454, 289603]; program FEDER/COMPETE; Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia) [POCI/AGR/56102/2004, PTDC/BIABCM/64745/2006, PTDC/AGR-ALI/103392/2008, PTDC/AGR-ALI/098292/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/64745/2006, PTDC/AGR-ALI/098292/2008, PTDC/AGR-ALI/103392/2008] Funding Source: FCT	European Community(European Commission); program FEDER/COMPETE; Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia); Fundação para a Ciência e a Tecnologia	This study was financially supported by the European Community's Seventh Framework Programme under grant agreements no 232454 and 289603. Funding was also obtained by the program FEDER/COMPETE and the Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia) through the projects POCI/AGR/56102/2004, PTDC/BIABCM/64745/2006, PTDC/AGR-ALI/103392/2008 and PTDC/AGR-ALI/098292/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi M, 2001, YEAST, V18, P1145, DOI 10.1002/yea.767; Ben-Ari G, 2005, HEREDITY, V95, P493, DOI 10.1038/sj.hdy.6800759; Blanco P, 2006, ANTON LEEUW INT J G, V89, P351, DOI 10.1007/s10482-005-9038-6; Cavalieri D, 1998, FOOD TECHNOL BIOTECH, V36, P45; Chavan P, 2009, FOOD MICROBIOL, V26, P801, DOI 10.1016/j.fm.2009.05.005; Comi G, 2000, INT J FOOD MICROBIOL, V58, P117, DOI 10.1016/S0168-1605(00)00287-7; Constanti M, 1997, AM J ENOL VITICULT, V48, P339; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V148, P23, DOI 10.1016/j.ijfoodmicro.2011.04.021; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; Csoma H, 2010, INT J FOOD MICROBIOL, V140, P239, DOI 10.1016/j.ijfoodmicro.2010.03.024; Cubillos FA, 2009, FEMS MICROBIOL ECOL, V67, P162, DOI 10.1111/j.1574-6941.2008.00600.x; Esteve-Zarzoso B, 2000, FOOD MICROBIOL, V17, P553, DOI 10.1006/fmic.2000.0347; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Franco-Duarte R, 2011, ELECTROPHORESIS, V32, P1447, DOI 10.1002/elps.201000640; FREZIER V, 1992, AM J ENOL VITICULT, V43, P375; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gayevskiy V, 2011, ISME J, P1; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Granchi L, 1999, J APPL MICROBIOL, V87, P949, DOI 10.1046/j.1365-2672.1999.00600.x; Greig D, 2009, CURR BIOL, V19, pR886, DOI 10.1016/j.cub.2009.07.037; Gutierrez AR, 1999, LETT APPL MICROBIOL, V29, P411, DOI 10.1046/j.1472-765X.1999.00657.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Khan W., 2000, South African Journal of Enology and Viticulture, V21, P17; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Legras JL, 2005, INT J FOOD MICROBIOL, V102, P73, DOI 10.1016/j.ijfoodmicro.2004.12.007; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LONGO E, 1991, AM J ENOL VITICULT, V42, P141; Lopandic K, 2007, FEMS YEAST RES, V7, P953, DOI 10.1111/j.1567-1364.2007.00240.x; Lopes CA, 2002, J APPL MICROBIOL, V93, P608, DOI 10.1046/j.1365-2672.2002.01738.x; Martini A, 1996, AM J ENOL VITICULT, V47, P435; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Orlic S, 2010, WORLD J MICROB BIOT, V26, P1483, DOI 10.1007/s11274-010-0323-9; PARISH ME, 1985, AM J ENOL VITICULT, V36, P165; Pramateftaki PV, 2000, J APPL MICROBIOL, V89, P236, DOI 10.1046/j.1365-2672.2000.01102.x; Pretorius I. S., 1999, South African Journal of Enology and Viticulture, V20, P61; Rosini G., 1982, VIGNE VINI, V9, P43; Sabate J, 1998, LETT APPL MICROBIOL, V26, P452, DOI 10.1046/j.1472-765X.1998.00369.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SCHNEIDER S, ARLEQUIN VER 2 000 S; Schuller D, 2005, FEMS MICROBIOL ECOL, V51, P167, DOI 10.1016/j.femsec.2004.08.003; Schuller D, 2004, FEMS MICROBIOL LETT, V231, P19, DOI 10.1016/S0378-1097(03)00928-5; Schuller D, 2007, YEAST, V24, P625, DOI 10.1002/yea.1496; Schuller D, 2007, ANTON LEEUW INT J G, V91, P137, DOI 10.1007/s10482-006-9104-8; SCHUTZ M, 1993, J APPL BACTERIOL, V75, P551, DOI 10.1111/j.1365-2672.1993.tb01594.x; Sipiczki M, 2001, ANTON LEEUW INT J G, V79, P97, DOI 10.1023/A:1010249408975; Sun HH, 2009, ANN MICROBIOL, V59, P69, DOI 10.1007/BF03175601; Torija MJ, 2001, ANTON LEEUW INT J G, V79, P345, DOI 10.1023/A:1012027718701; Valero E, 2007, FEMS YEAST RES, V7, P317, DOI 10.1111/j.1567-1364.2006.00161.x; van der Westhuizen T. J., 2000, South African Journal of Enology and Viticulture, V21, P10; van der Westhuizen T. J., 2000, South African Journal of Enology and Viticulture, V21, P3; VERSAVAUD A, 1995, SYST APPL MICROBIOL, V18, P303, DOI 10.1016/S0723-2020(11)80401-7; VERSAVAUD A, 1993, REV FR OENOL, V142, P20; VEZINHET F, 1992, AM J ENOL VITICULT, V43, P83; Wright S., 1978, EVOLUTION GENETICS P	57	65	69	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32507	10.1371/journal.pone.0032507	http://dx.doi.org/10.1371/journal.pone.0032507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393409	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500062
J	Graae, L; Karlsson, R; Paddock, S				Graae, Lisette; Karlsson, Robert; Paddock, Silvia			Significant Association of Estrogen Receptor Binding Site Variation with Bipolar Disorder in Females	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEINS; GENOME-WIDE ASSOCIATION; MENTAL-HEALTH SURVEY; GENE-EXPRESSION; TISSUE TRANSGLUTAMINASE; MAJOR DEPRESSION; SEX-DIFFERENCES; NEURODEGENERATIVE DISORDERS; RESPONSE ELEMENTS; MESSENGER-RNA	Major depression is nearly twice as prevalent in women compared to men. In bipolar disorder, depressive episodes have been reported to be more common amongst female patients. Furthermore, periods of depression often correlate with periods of hormonal fluctuations. A link between hormone signaling and these mood disorders has, therefore, been suggested to exist in many studies. Estrogen, one of the primary female sex hormones, mediates its effect mostly by binding to estrogen receptors (ERs). Nuclear ERs function as transcription factors and regulate gene transcription by binding to specific DNA sequences. A nucleotide change in the binding sequence might alter the binding efficiency, which could affect transcription levels of nearby genes. In order to investigate if variation in ER DNA-binding sequences may be involved in mood disorders, we conducted a genome-wide study of ER DNA-binding in patients diagnosed with major depression or bipolar disorder. Association studies were performed within each gender separately and the results were corrected for multiple testing by the Bonferroni method. In the female bipolar disorder material a significant association result was found for rs6023059 (corrected p-value = 0.023; odds ratio (OR) 0.681, 95% confidence interval (CI) 0.570-0.814), a single nucleotide polymorphism (SNP) placed downstream of the gene coding for transglutaminase 2 (TGM2). Thus, females with a specific genotype at this SNP may be more vulnerable to fluctuating estrogen levels, which may then act as a triggering factor for bipolar disorder.	[Graae, Lisette; Paddock, Silvia] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Karlsson, Robert] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Graae, L (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	graae.lisette@gmail.com		Karlsson, Robert/0000-0002-8949-2587	Swedish Research Council [2005-6929]; Swedish Foundation for Strategic Research [A3 05:207b]; Brain and Behavior Research Foundation; Karolinska Institutet Foundations; Center for Gender Medicine at Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046282, R01MH059567, R01MH059533, R01MH059548, R01MH059553, Z01MH002810, R01MH059545, R01MH059534, R01MH059535, R01MH060068, R01MH059556, U01MH046280, U01MH046274] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Brain and Behavior Research Foundation; Karolinska Institutet Foundations(Karolinska Institutet); Center for Gender Medicine at Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Swedish Research Council (www.vr.se; Dnr. 2005-6929), the Swedish Foundation for Strategic Research (www.stratresearch.se; Dnr. A3 05:207b), a 'Young Investigator Grant' (to SP) from the Brain and Behavior Research Foundation (http://bbrfoundation.org/; formerly NARSAD), Karolinska Institutet Foundations (http://ki.se/ki/jsp/polopoly.jsp;jsessionid=a_3ahrCXd3144UH4Mk?l=en&d=20152), and the Center for Gender Medicine at Karolinska Institutet (http://ki.se/ki/jsp/polopoly.jsp?l=en&d=8993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2008, PSYCHIAT GENET, V18, P1, DOI 10.1097/YPG.0b013e3281ac238e; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Assisi L, 1999, EXP CELL RES, V247, P339, DOI 10.1006/excr.1998.4358; Bauersachs S, 2008, EXP CLIN ENDOCR DIAB, V116, P371, DOI 10.1055/s-2008-1076714; Benes FM, 2006, MOL PSYCHIATR, V11, P241, DOI 10.1038/sj.mp.4001758; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P581, DOI 10.1007/s001270050097; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Bradford M, 2009, AM J MED GENET B, V150B, P335, DOI 10.1002/ajmg.b.30813; Brietzke E, 2011, CNS SPECTRUMS; Campisi A, 2008, J NEUROSCI RES, V86, P1297, DOI 10.1002/jnr.21579; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chiu Chi-Tso, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P461, DOI 10.3969/j.issn.1672-7347.2011.06.001; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; DUBOVSKY SL, 1992, AM J PSYCHIAT, V149, P118; El Khoury A, 2002, PROG NEURO-PSYCHOPH, V26, P1063, DOI 10.1016/S0278-5846(02)00223-3; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Freeman MP, 2002, J CLIN PSYCHIAT, V63, P284, DOI 10.4088/JCP.v63n0403; Fujita K, 2006, NEUROCHEM RES, V31, P1059, DOI 10.1007/s11064-006-9114-y; Gigante AD, 2011, INT J NEUROPSYCHOPH, V14, P1075, DOI 10.1017/S146114571000146X; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Grigoriadis Sophie, 2002, Am J Ther, V9, P503, DOI 10.1097/00045391-200211000-00008; Gupta A, 2011, PHARMACOGENOMICS J; Habauzit D, 2011, J TOXICOL ENV HEAL B, V14, P300, DOI 10.1080/10937404.2011.578554; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Halbreich U, 2001, CNS DRUGS, V15, P797, DOI 10.2165/00023210-200115100-00005; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; Hucho TB, 2006, EUR J NEUROSCI, V24, P527, DOI 10.1111/j.1460-9568.2006.04913.x; Iga J, 2006, NEUROSCI LETT, V400, P203, DOI 10.1016/j.neulet.2006.02.044; Kairouz R, 2005, J CELL PHYSIOL, V203, P85, DOI 10.1002/jcp.20199; Kealey C, 2001, PSYCHIAT GENET, V11, P223, DOI 10.1097/00041444-200112000-00008; Kendler KS, 2006, AM J PSYCHIAT, V163, P109, DOI 10.1176/appi.ajp.163.1.109; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kulakosky PC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290137; Leibenluft E, 1996, AM J PSYCHIAT, V153, P163; Lesort M, 2000, PROG NEUROBIOL, V61, P439, DOI 10.1016/S0301-0082(99)00052-0; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; LI XH, 1995, J NEUROCHEM, V65, P2500; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Mahon PB, 2009, AM J PSYCHIAT, V166, P1229, DOI 10.1176/appi.ajp.2009.09030417; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Middle F, 2003, AM J MED GENET B, V118B, P72, DOI 10.1002/ajmg.b.10021; Osterlund MK, 2005, ENDOCRINE, V28, P235, DOI 10.1385/ENDO:28:3:235; Ostlund H, 2003, ANN NY ACAD SCI, V1007, P54, DOI 10.1196/annals.1286.006; Pae CU, 2009, BIOMED PHARMACOTHER, V63, P228, DOI 10.1016/j.biopha.2008.03.010; Park KC, 2004, BIOCHEM BIOPH RES CO, V323, P1055, DOI 10.1016/j.bbrc.2004.08.204; Payne JL, 2003, INT REV PSYCHIATR, V15, P280, DOI 10.1080/0954026031000136893; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; RUSINOL AE, 1989, J BIOL CHEM, V264, P6612; Samaroo D, 2009, SCHIZOPHR RES; Shadan S, 2008, TRAFFIC, V9, P1743, DOI 10.1111/j.1600-0854.2008.00794.x; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Squassina A, 2008, PHARMACOL RES, V57, P369, DOI 10.1016/j.phrs.2008.03.011; Squassina A, 2008, PSYCHIAT GENET, V18, P128, DOI 10.1097/YPG.0b013e3282fb003d; SULLIVAN PF, 2008, MOL PSYCHIAT; Tenenbaum M, 2007, J ENDOTOXIN RES, V13, P158, DOI 10.1177/0968051907080428; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Viguera AC., 2011, AM J PSYCHIAT; Wasserman MJ, 2004, NEUROPSYCHOPHARMACOL, V29, P759, DOI 10.1038/sj.npp.1300400; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; WILHELM K, 1994, PSYCHOL MED, V24, P97, DOI 10.1017/S0033291700026878; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407	71	7	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32304	10.1371/journal.pone.0032304	http://dx.doi.org/10.1371/journal.pone.0032304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389694	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600032
J	Pinto, P; Wang, QH; Chen, N; Dubovi, EJ; Daniels, JB; Millward, LM; Buonavoglia, C; Martella, V; Saif, LJ				Pinto, Pierfrancesco; Wang, Qiuhong; Chen, Ning; Dubovi, Edward J.; Daniels, Joshua B.; Millward, Laurie M.; Buonavoglia, Canio; Martella, Vito; Saif, Linda J.			Discovery and Genomic Characterization of Noroviruses from a Gastroenteritis Outbreak in Domestic Cats in the US	PLOS ONE			English	Article							NONSTRUCTURAL POLYPROTEIN; MURINE NOROVIRUS; END CDNA; INFECTION; PATHOGENESIS; STRAIN; AMPLIFICATION; ANTIBODY; NORWALK; FECES	Norovirus (NoV) RNA was detected in the stools of 6 out 14 (42.8%) 8-12-week-old cats with enteritis from a feline shelter, in New York State. Upon sequence analysis of the complete capsid, the six NoVs were found to be identical, suggesting the spread of a unique NoV strain in the shelter. The full-length genomic sequence (7839 nt) of one feline NoV, CU081210E/2010/US, was determined. In the capsid protein VP1 region, the virus displayed the highest amino acid identity to animal genogroup IV genotype 2 (GIV.2) NoVs: lion/Pistoia-387/06/IT (97.9%) and dog/Bari-170/07/IT (90.4%). These findings document the discovery of a novel feline calicivirus, different from vesiviruses, and extend the spectrum of NoV host range. Epidemiological studies using feline NoV-specific diagnostic tools and experimental infection of cats are required to understand whether NoVs have a pathogenic role in this species.	[Pinto, Pierfrancesco; Buonavoglia, Canio; Martella, Vito] Univ Bari Aldo Moro, Dept Vet Publ Hlth, Valenzano, Italy; [Wang, Qiuhong; Chen, Ning; Saif, Linda J.] Ohio State Univ, Dept Vet Prevent Med, Wooster, OH USA; [Dubovi, Edward J.] Cornell Univ, Dept Populat Med, Ithaca, NY USA; [Daniels, Joshua B.; Millward, Laurie M.] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA	Universita degli Studi di Bari Aldo Moro; University System of Ohio; Ohio State University; Cornell University; University System of Ohio; Ohio State University	Pinto, P (corresponding author), Univ Bari Aldo Moro, Dept Vet Publ Hlth, Valenzano, Italy.	v.martella@veterinaria.uniba.it	Daniels, Joshua B/D-5200-2019; Martella, Vito/K-3146-2016	Martella, Vito/0000-0002-5740-6947	state and federal funds; Italian Government (Borse di studio a collaborazione internazionale, Regione Puglia e A.DI.S.U. Puglia) [2288/2009]; Italian Ministry of Health, Ricerca corrente; Italian Ministry for Education, University and Research; Scientific and technological collaboration Italy-Usa; Italian Ministry of Foreign Affairs (Mae)	state and federal funds; Italian Government (Borse di studio a collaborazione internazionale, Regione Puglia e A.DI.S.U. Puglia); Italian Ministry of Health, Ricerca corrente(Ministry of Health, Italy); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Scientific and technological collaboration Italy-Usa; Italian Ministry of Foreign Affairs (Mae)(Ministry of Foreign Affairs and International Cooperation (Italy))	Salaries and research support were provided by state and federal funds provided to the Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, US. P. Pinto was supported by the Italian Government (Borse di studio a collaborazione internazionale, Regione Puglia e A.DI.S.U. Puglia, delibera No 2288/2009). V. Martella was supported by the Italian Ministry of Health, Ricerca corrente 2009, project IZS VE 21/09 RC "Definizione di una procedura validata per la selezione di cani per programmi di Interventi Assistiti dagli Animali (IAA)''; by the Italian Ministry for Education, University and Research, grant PRIN 2008 "Calicivirus nei carnivori e nell'uomo: caratterizzazione molecolare, epidemiologia, implicazioni zoonosiche''; and by the grant Scientific and technological collaboration Italy-Usa 2010 by the Italian Ministry of Foreign Affairs (Mae) - "Assessing the impact of GIV-norovirus on human health: a molecular epidemiological investigation on environmental and clinical samples as a basis for the design of novel diagnostic tools for an emerging pathogen''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Di Martino B, 2010, CLIN VACCINE IMMUNOL, V17, P180, DOI 10.1128/CVI.00312-09; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HERBST W, 1987, J VET MED B, V34, P314, DOI 10.1111/j.1439-0450.1987.tb00402.x; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; JOHNSON RP, 1983, CAN VET J, V24, P6; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; KENNEDY FA, 1993, J VET DIAGN INVEST, V5, P273, DOI 10.1177/104063879300500224; Kipar A, 2001, VET PATHOL, V38, P359, DOI 10.1354/vp.38-4-359; Kitajima M, 2009, LETT APPL MICROBIOL, V49, P655, DOI 10.1111/j.1472-765X.2009.02718.x; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; La Rosa G, 2010, ARCH VIROL, V155, P589, DOI 10.1007/s00705-010-0619-y; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lochridge VP, 2007, J VIROL, V81, P12316, DOI 10.1128/JVI.01254-07; LOVE DN, 1972, AUST VET J, V48, P643, DOI 10.1111/j.1751-0813.1972.tb05105.x; MARSHALL JA, 1987, AUST VET J, V64, P100, DOI 10.1111/j.1751-0813.1987.tb09638.x; Martella V, 2011, VET SMALL A IN PRESS; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2007, EMERG INFECT DIS, V13, P1071, DOI 10.3201/eid1307.070268; Martella V, 2009, J VIROL, V83, P11391, DOI 10.1128/JVI.01385-09; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; MOCHIZUKI M, 1992, VET MICROBIOL, V31, P297, DOI 10.1016/0378-1135(92)90087-A; Ntafis V, 2010, J CLIN MICROBIOL, V48, P2605, DOI 10.1128/JCM.02528-09; Povey RC, 1974, J COMP PATHOL, V10, P1307; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; RICE M, 1993, NEW ZEAL VET J, V41, P96, DOI 10.1080/00480169.1993.35743; Scotto-Lavino E, 2006, NAT PROTOC, V1, P3056, DOI 10.1038/nprot.2006.479; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Souza M, 2008, J VIROL, V82, P1777, DOI 10.1128/JVI.01347-07; SPRADBROW PB, 1970, AUST VET J, V46, P105, DOI 10.1111/j.1751-0813.1970.tb15931.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WARDLEY RC, 1977, RES VET SCI, V23, P15, DOI 10.1016/S0034-5288(18)33215-6; Yun SI, 2010, VIRUS RES, V152, P137, DOI 10.1016/j.virusres.2010.06.018; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	39	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32739	10.1371/journal.pone.0032739	http://dx.doi.org/10.1371/journal.pone.0032739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389721	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600060
J	Hartter, J; Stampone, MD; Ryan, SJ; Kirner, K; Chapman, CA; Goldman, A				Hartter, Joel; Stampone, Mary D.; Ryan, Sadie J.; Kirner, Karen; Chapman, Colin A.; Goldman, Abraham			Patterns and Perceptions of Climate Change in a Biodiversity Conservation Hotspot	PLOS ONE			English	Article							EQUATORIAL EAST-AFRICA; HUMAN-POPULATION; RAINFALL VARIABILITY; TEMPORAL PATTERNS; PROTECTED AREAS; FUTURE CLIMATE; CHANGE IMPACTS; FOREST PARK; LAND-USE; UGANDA	Quantifying local people's perceptions to climate change, and their assessments of which changes matter, is fundamental to addressing the dual challenge of land conservation and poverty alleviation in densely populated tropical regions To develop appropriate policies and responses, it will be important not only to anticipate the nature of expected changes, but also how they are perceived, interpreted and adapted to by local residents. The Albertine Rift region in East Africa is one of the world's most threatened biodiversity hotspots due to dense smallholder agriculture, high levels of land and resource pressures, and habitat loss and conversion. Results of three separate household surveys conducted in the vicinity of Kibale National Park during the late 2000s indicate that farmers are concerned with variable precipitation. Many survey respondents reported that conditions are drier and rainfall timing is becoming less predictable. Analysis of daily rainfall data for the climate normal period 1981 to 2010 indicates that total rainfall both within and across seasons has not changed significantly, although the timing and transitions of seasons has been highly variable. Results of rainfall data analysis also indicate significant changes in the intra-seasonal rainfall distribution, including longer dry periods within rainy seasons, which may contribute to the perceived decrease in rainfall and can compromise food security. Our results highlight the need for fine-scale climate information to assist agro-ecological communities in developing effective adaptive management.	[Hartter, Joel; Stampone, Mary D.] Univ New Hampshire, Dept Geog, Durham, NH 03824 USA; [Ryan, Sadie J.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Ryan, Sadie J.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Kirner, Karen] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Goldman, Abraham] Univ Florida, Dept Geog, Gainesville, FL 32611 USA	University System Of New Hampshire; University of New Hampshire; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; State University System of Florida; University of Florida; McGill University; McGill University; Wildlife Conservation Society; State University System of Florida; University of Florida	Hartter, J (corresponding author), Univ New Hampshire, Dept Geog, Durham, NH 03824 USA.	joel.hartter@unh.edu	Ryan, Sadie/H-1595-2012; Chapman, Colin/S-1911-2019; Ryan, Sadie Jane/H-7488-2019	Chapman, Colin/0000-0002-8827-8140; Ryan, Sadie Jane/0000-0002-4308-6321; HARTTER, JOEL/0000-0002-2255-1845	National Science Foundation [0352008, 0624343, EF-0553768]; University of California, Santa Barbara; State of California; Natural Sciences and Engineering Research Council; Canada Research Chair; National Geographic Society	National Science Foundation(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Geographic Society(National Geographic Society)	AG, JH, and KK were funded through National Science Foundation grants (0352008, 0624343). SJR conducted this work while a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by National Science Foundation (EF-0553768), the University of California, Santa Barbara, and the State of California. CAC's research was supported by Natural Sciences and Engineering Research Council, Canada Research Chair, and National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 00849 IFPRI; [Anonymous], [No title captured]; Baird TD, 2009, HUM ECOL, V37, P463, DOI 10.1007/s10745-009-9264-z; Bartlein PJ, 1997, CONSERV BIOL, V11, P782, DOI 10.1046/j.1523-1739.1997.95383.x; BASALIRWA CPK, 1995, INT J CLIMATOL, V15, P1161, DOI 10.1002/joc.3370151008; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Camberlin P, 2009, THEOR APPL CLIMATOL, V98, P237, DOI 10.1007/s00704-009-0113-1; Chapman CA, 2005, J TROP ECOL, V21, P31, DOI 10.1017/S0266467404001993; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chapman CA, 2006, AFR J ECOL, V44, P116, DOI 10.1111/j.1365-2028.2006.00636.x; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Conway D, 2005, PHILOS T ROY SOC A, V363, P49, DOI 10.1098/rsta.2004.1475; Cordeiro NJ, 2007, BIOL CONSERV, V134, P155, DOI 10.1016/j.biocon.2006.08.023; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Edwards CD, 1997, 972 COL STAT U; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; GARBUTT DJ, 1981, ARCH METEOR GEOPHY B, V29, P137, DOI 10.1007/BF02278197; Gbetibouo G.A., 2009, UNDERSTANDING FARMER; Gearheard S, 2010, CLIMATIC CHANGE, V100, P267, DOI 10.1007/s10584-009-9587-1; Goldman A, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P129; Green D, 2010, CLIMATIC CHANGE, V100, P239, DOI 10.1007/s10584-010-9804-y; HANNA LW, 1971, J APPL ECOL, V8, P791, DOI 10.2307/2402684; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hartter J., 2009, Human Dimensions of Wildlife, V14, P433, DOI 10.1080/10871200902911834; Hartter J.N., 2007, LANDSCAPE CHANGE KIB; Hartter J, 2011, LANDSCAPE ECOL, V26, P877, DOI 10.1007/s10980-011-9616-0; Hartter J, 2011, ORYX, V45, P60, DOI 10.1017/S0030605310000141; Hartter J, 2010, LAND USE POLICY, V27, P815, DOI 10.1016/j.landusepol.2009.11.001; Hartter J, 2010, SOC NATUR RESOUR, V23, P207, DOI 10.1080/08941920903360372; Hayes TM, 2006, WORLD DEV, V34, P2064, DOI 10.1016/j.worlddev.2006.03.002; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Houghton J. T., 2001, CLIMATE CHANGE 2001; HUXLEY PA, 1965, EXP AGR, V1, P81, DOI 10.1017/S0014479700018640; Indeje M, 2000, INT J CLIMATOL, V20, P19, DOI [10.1002/(SICI)1097-0088(200001)20:1<19::AID-JOC449>3.0.CO;2-0, 10.1002/(SICI)1097-0088(200001)20:1&lt;19::AID-JOC449&gt;3.0.CO;2-0]; Kirner KE, 2010, AGR VARIATION CHANGE; Lepp A, 2006, SOC NATUR RESOUR, V19, P609, DOI 10.1080/08941920600742377; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Longobardi A, 2010, INT J CLIMATOL, V30, P1538, DOI 10.1002/joc.2001; Maddison DJ, 2007, 4308 WORLD BANK POL; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MANNING HL, 1956, PROC R SOC SER B-BIO, V144, P460, DOI 10.1098/rspb.1956.0004; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; MCKEE TB, 1995, NINTH CONFERENCE ON APPLIED CLIMATOLOGY, P233; McKee TB, 1993, 8 C APPL CLIM 17 JA, V17, P179, DOI DOI 10.1111/J.1467-7717.1988.TB00685; Mertz O, 2009, ENVIRON MANAGE, V43, P804, DOI 10.1007/s00267-008-9197-0; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Moron V, 2007, J CLIMATE, V20, P5244, DOI 10.1175/2007JCLI1623.1; MYERS N, 1991, CLIMATIC CHANGE, V19, P3, DOI 10.1007/BF00142209; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naylor RL, 2007, P NATL ACAD SCI USA, V104, P7752, DOI 10.1073/pnas.0701825104; NICHOLSON SE, 1993, J CLIMATE, V6, P1463, DOI 10.1175/1520-0442(1993)006<1463:AOOARF>2.0.CO;2; Ntale HK, 2003, INT J CLIMATOL, V23, P1335, DOI 10.1002/joc.931; Nyong A., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P787, DOI 10.1007/s11027-007-9099-0; Odekunle TO, 2006, THEOR APPL CLIMATOL, V83, P193, DOI 10.1007/s00704-005-0166-8; OGALLO LJ, 1989, INT J CLIMATOL, V9, P145, DOI 10.1002/joc.3370090204; Ogallo LJ, 1980, STAT CLIMATOLOGY DEV, V13, P255; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Orlove B, 2010, CLIMATIC CHANGE, V100, P243, DOI 10.1007/s10584-009-9586-2; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Phillips J, 2000, INT J CLIMATOL, V20, P171, DOI 10.1002/(SICI)1097-0088(200002)20:2&lt;171::AID-JOC471&gt;3.0.CO;2-O; Plumptre A.J., 2003, BIODIVERSITY ALBERTI; PLUMPTRE AJ, 2002, EXTENT STATUS UNPUB; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Rebetez M, 1996, CLIMATIC CHANGE, V32, P495, DOI 10.1007/BF00140358; Rudnick DA, ISSUES ECOL UNPUB; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Smith K, 2000, WORLD DEV, V28, P1945, DOI 10.1016/S0305-750X(00)00053-X; Speranza CI, 2010, CLIMATIC CHANGE, V100, P295, DOI 10.1007/s10584-009-9713-0; Stampone M. D., 2011, Research Journal of Environmental and Earth Sciences, V3, P14; Terborgh J., 2002, MAKING PARKS WORK ST; Thomas DSG, 2007, CLIMATIC CHANGE, V83, P301, DOI 10.1007/s10584-006-9205-4; Thomas DSG, 2005, GLOBAL ENVIRON CHANG, V15, P115, DOI 10.1016/j.gloenvcha.2004.10.001; Thornton PK, 2009, GLOBAL ENVIRON CHANG, V19, P54, DOI 10.1016/j.gloenvcha.2008.08.005; Twinomugisha B., 2005, CONTENT ANAL REPORTS; Uganda Bureau of Statistics, 2005, 2002 UG POP HOUS CEN; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; Willmott CJ, 2006, INT J GEOGR INF SCI, V20, P89, DOI 10.1080/13658810500286976; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Zahran S, 2006, SOC NATUR RESOUR, V19, P771, DOI 10.1080/08941920600835528	93	68	70	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32408	10.1371/journal.pone.0032408	http://dx.doi.org/10.1371/journal.pone.0032408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22384244	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500087
J	Kumar, AA; Shantha, GPS; Kahan, S; Samson, RJ; Boddu, ND; Cheskin, LJ				Kumar, Anita Ashok; Shantha, Ghanshyam Palamaner Subash; Kahan, Scott; Samson, Rohit Joshua; Boddu, Nelson David; Cheskin, Lawrence Jay			Intentional Weight Loss and Dose Reductions of Anti-Diabetic Medications - A Retrospective Cohort Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; RISK-FACTORS; OBESITY; PREVALENCE; HEALTH	Background and Aim: Intentional weight loss, primarily by improving insulin resistance, is known to decrease the need for anti-diabetic medications. In this study, we assess the magnitude of weight loss that resulted in dose reductions or discontinuation of anti-diabetic medications in overweight or obese patients with type 2 diabetes (DM) undergoing weight loss treatment. Methods: Case records of 50 overweight or obese patients with DM who successfully decreased dosage or discontinued diabetes medications after losing weight via attendance at two University-based, outpatient weight management centers were analyzed. Follow-up visits, weight reduction interventions, and decisions for dose reductions or discontinuation of medications were individualized to patient needs by the treating physician. Results: Mean starting BMI was 35 kg/m(2), mean age 53.4 years, and 58% were male. All 50 used at least one anti-diabetic medication (30 metformin, 39 sulfonylureas, 31 insulin, 21 sitagliptin) to manage blood sugar. Mean duration of follow-up was 30.2 months. Mean weight loss was 10.864.1 kgs (11.1% of initial body weight 64.7%). 22/50 patients (44%) discontinued anti-diabetes medications (14 sulfonylureas [36%], 7 insulin [23%], 4 sitagliptin [19%]). The mean percentage weight loss achieved at the point of successful discontinuation of medication was 11.2% 63.5% (14% for sulphonylureas, 11% for insulin, and 7.1% for sitagliptin). Mean percentage weight loss of 5.6% 62.8% (5.1% for sulphonylureas, 4.3% for insulin, and 7.1% for sitagliptin) was required for initial dose reduction. For every 5% weight loss, predicted dose reductions were sulphonylureas, 39%; insulin, 42%; and any anti-diabetic medications, 49%. Conclusion: Among overweight or obese patients with type 2 diabetes, intentional weight loss of 7-14% was typically required for full discontinuation of at least one anti-diabetic medication. Discontinuation of insulin was achieved at a mean weight reduction of 11% of initial body weight.	[Kumar, Anita Ashok; Shantha, Ghanshyam Palamaner Subash] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kahan, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Kahan, Scott] George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Kahan, Scott; Samson, Rohit Joshua; Boddu, Nelson David; Cheskin, Lawrence Jay] Johns Hopkins Univ, Johns Hopkins Weight Management Ctr, Baltimore, MD USA; [Cheskin, Lawrence Jay] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	lcheskin@jhsph.edu	Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030; Kahan, Scott/0000-0002-3080-0661				Ahamed A, 2008, J INDIAN MED ASSOC, V106, P588; Ahamed Anish, 2008, J Indian Med Assoc, V106, P583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dixon JB, 2009, WORLD J SURG, V33, P2014, DOI 10.1007/s00268-009-0062-y; Espeland M, 2007, DIABETES CARE, V30, P1374; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Greenberg R.S.D.S., 2005, MED EPIDEMIOLOGY, Vfourth; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Ito H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-83; Jeffrey SF, 2005, HARRISONS PRINCIPLES, V1, P422; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Peyrot M, 2011, DIABETES TECHNOL THE, V13, P471, DOI 10.1089/dia.2010.0167; Ray NF, 1998, DIABETES CARE, V21, P296; Redmon JB, 2010, DIABETES CARE, V33, P1153, DOI 10.2337/dc09-2090; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; World Health Organization, 1995, PHYS STAT US INT ANT	23	16	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32395	10.1371/journal.pone.0032395	http://dx.doi.org/10.1371/journal.pone.0032395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384240	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500084
J	Li, CX; Shao, Y; Ng, KTP; Liu, XB; Ling, CC; Ma, YY; Geng, W; Fan, ST; Lo, CM; Man, K				Li, Chang Xian; Shao, Yan; Ng, Kevin T. P.; Liu, Xiao Bing; Ling, Chang Chun; Ma, Yuen Yuen; Geng, Wei; Fan, Sheung Tat; Lo, Chung Mau; Man, Kwan			FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells	PLOS ONE			English	Article							BONE-MARROW; HEPATOCELLULAR-CARCINOMA; ISCHEMIA-REPERFUSION; ANGIOGENIC SWITCH; GRAFT INJURY; CANCER CELLS; STEM-CELLS; FACTOR-I; G-CSF; GROWTH	Background: Surgical procedures such as liver resection and liver transplantation are the first-line treatments for hepatocellular carcinoma (HCC) patients. However, the high incidence of tumor recurrence and metastasis after liver surgery remains a major problem. Recent studies have shown that hepatic ischemia-reperfusion (I/R) injury and endothelial progenitor cells (EPCs) contribute to tumor growth and metastasis. We aim to investigate the mechanism of FTY720, which was originally applied as an immunomodulator, on suppression of liver tumor metastasis after liver resection and partial hepatic I/R injury. Methodology/Principal Findings: An orthotopic liver tumor model in Buffalo rat was established using the hepatocellular carcinoma cell line McA-RH7777. Two weeks after orthotopic liver tumor implantation, the rats underwent liver resection for tumor-bearing lobe and partial hepatic I/R injury. FTY720 (2 mg/kg) was administered through the inferior caval vein before and after I/R injury. Blood samples were taken at days 0, 1, 3, 7, 14, 21 and 28 for detection of circulating EPCs (CD133+CD34+). Our results showed that intrahepatic and lung metastases were significantly inhibited together with less tumor angiogenesis by FTY720 treatment. The number of circulating EPCs was also significantly decreased by FTY720 treatment from day 7 to day 28. Hepatic gene expressions of CXCL10, VEGF, CXCR3, CXCR4 induced by hepatic I/R injury were down-regulated in the treatment group. Conclusions/Significance: FTY720 suppressed liver tumor metastasis after liver resection marred by hepatic I/R injury in a rat liver tumor model by attenuating hepatic I/R injury and reducing circulating EPCs.	[Li, Chang Xian] Univ Hong Kong, Dept Surg, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Li, CX (corresponding author), Univ Hong Kong, Dept Surg, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China.	kwanman@hkucc.hku.hk	Ng, Tak Pan/C-4698-2009; NG, Kevin Tak-Pan/J-1510-2018	NG, Kevin Tak-Pan/0000-0001-9822-1335	Research Grant Council Hong Kong [HKU5/CRF/08, HKU1/CRF10, HKU3/CRF11R]; Centre for Cancer Research-Strategy Research Theme of the University of Hong Kong	Research Grant Council Hong Kong(Hong Kong Research Grants Council); Centre for Cancer Research-Strategy Research Theme of the University of Hong Kong	This study was supported by the Collaborative Research Funds (HKU5/CRF/08, HKU1/CRF10 & HKU3/CRF11R) of the Research Grant Council Hong Kong, Small project funding and Seed funding of Centre for Cancer Research-Strategy Research Theme programme of the University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2002, CANCER RES, V62, P1410; Azuma H, 2003, J UROLOGY, V169, P2372, DOI 10.1097/01.ju.0000064938.32318.91; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Doi K, 2002, J SURG RES, V105, P243, DOI 10.1006/jsre.2002.6356; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ho JWY, 2006, HEPATOLOGY, V44, P836, DOI 10.1002/hep.21353; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kiuchi M, 2000, J MED CHEM, V43, P2946, DOI 10.1021/jm000173z; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Lemoli RM, 2006, STEM CELLS, V24, P2817, DOI 10.1634/stemcells.2006-0333; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Man K, 2005, AM J TRANSPLANT, V5, P40, DOI 10.1111/j.1600-6143.2004.00642.x; Man K, ANN SURG, V251, P1154; Man K, CLIN CANC RES, V16, P967; Man K, 2008, ANN SURG, V247, P1049, DOI 10.1097/SLA.0b013e31816ffab6XXX; Man K, 2007, LIVER TRANSPLANT, V13, P1669, DOI 10.1002/lt.21193; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Ng KT, 2007, INT J ONCOL, V30, P375; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rookmaaker MB, 2002, BLOOD, V99, P1095, DOI 10.1182/blood.V99.3.1095; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sato E, 2007, BRIT J CANCER, V96, P1735, DOI 10.1038/sj.bjc.6603790; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; van der Bilt JDW, 2005, HEPATOLOGY, V42, P165, DOI 10.1002/hep.20739; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yannaki E, 2005, EXP HEMATOL, V33, P108, DOI 10.1016/j.exphem.2004.09.005; Yu DC, 2007, CLIN CANCER RES, V13, P3814, DOI 10.1158/1078-0432.CCR-06-2594; Zhao Y, 2004, AM J TRANSPLANT, V4, P1399, DOI 10.1111/j.1600-6143.2004.00527.x; Zhou C, 2006, CANCER LETT, V233, P36, DOI 10.1016/j.canlet.2005.02.039	39	38	39	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32380	10.1371/journal.pone.0032380	http://dx.doi.org/10.1371/journal.pone.0032380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384233	gold, Green Published			2022-12-25	WOS:000302918500082
J	Zelic, G; Mottet, D; Lagarde, J				Zelic, Gregory; Mottet, Denis; Lagarde, Julien			Behavioral Impact of Unisensory and Multisensory Audio-Tactile Events: Pros and Cons for Interlimb Coordination in Juggling	PLOS ONE			English	Article							MULTIPLE TIME SCALES; OPTICAL INFORMATION; HAPTIC INFORMATION; MOVEMENT; DYNAMICS; INTEGRATION; PHASE; PERCEPTION; PATTERN; HUMANS	Recent behavioral neuroscience research revealed that elementary reactive behavior can be improved in the case of cross-modal sensory interactions thanks to underlying multisensory integration mechanisms. Can this benefit be generalized to an ongoing coordination of movements under severe physical constraints? We choose a juggling task to examine this question. A central issue well-known in juggling lies in establishing and maintaining a specific temporal coordination among balls, hands, eyes and posture. Here, we tested whether providing additional timing information about the balls and hands motions by using external sound and tactile periodic stimulations, the later presented at the wrists, improved the behavior of jugglers. One specific combination of auditory and tactile metronome led to a decrease of the spatiotemporal variability of the juggler's performance: a simple sound associated to left and right tactile cues presented antiphase to each other, which corresponded to the temporal pattern of hands movement in the juggling task. A contrario, no improvements were obtained in the case of other auditory and tactile combinations. We even found a degraded performance when tactile events were presented alone. The nervous system thus appears able to integrate in efficient way environmental information brought by different sensory modalities, but only if the information specified matches specific features of the coordination pattern. We discuss the possible implications of these results for the understanding of the neuronal integration process implied in audio-tactile interaction in the context of complex voluntary movement, and considering the well-known gating effect of movement on vibrotactile perception.	[Zelic, Gregory; Mottet, Denis; Lagarde, Julien] Univ Montpellier I, Montpellier, France	Universite de Montpellier	Zelic, G (corresponding author), Univ Montpellier I, Montpellier, France.	julien.lagarde@univ-montp1.fr	Mottet, Denis/J-3098-2012	Mottet, Denis/0000-0002-7564-5394; Lagarde, Julien/0000-0002-6353-8487	Commission of the European Community [035005]	Commission of the European Community(European Commission)	This research was supported by SKILLS, an Integrated Project (FP6-IST contract #035005) of the Commission of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazeen EL, 2001, ECOL PSYCHOL, V13, P71, DOI 10.1207/S15326969ECO1302_1; Amazeen EL, 1999, J MOTOR BEHAV, V31, P279, DOI 10.1080/00222899909600994; Assisi CG, 2005, BIOL CYBERN, V93, P6, DOI 10.1007/s00422-005-0558-y; Austin HA, 1976, THESIS DEP ELECT ENG; BEEK P J, 1989, Ecological Psychology, V1, P55, DOI 10.1207/s15326969eco0101_4; BEEK PJ, 1992, J EXP PSYCHOL HUMAN, V18, P934, DOI 10.1037/0096-1523.18.4.934; BEEK PJ, 1992, J MOTOR BEHAV, V24, P85, DOI 10.1080/00222895.1992.9941604; Bendat J.S., 2000, RANDOM DATA ANAL MEA; BERNSTEIN IH, 1970, J EXP PSYCHOL, V86, P196, DOI 10.1037/h0029958; Bernstein N.A., 1967, COORDINATION REGULAT; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; CARSON RG, 1995, EXP BRAIN RES, V105, P465; Chapman CE, 2002, BEHAV BRAIN RES, V135, P225, DOI 10.1016/S0166-4328(02)00168-7; Dessing JC, 2007, J MOTOR BEHAV, V39, P433, DOI 10.3200/JMBR.39.5.433-448; Dhamala M, 2007, NEUROIMAGE, V34, P764, DOI 10.1016/j.neuroimage.2006.07.044; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Dunlap K, 1910, PSYCHOL REV, V17, P399, DOI 10.1037/h0074736; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Foxe JJ, 2009, BRAIN TOPOGR, V21, P149, DOI 10.1007/s10548-009-0102-9; Fuchs A, 1996, BIOL CYBERN, V74, P21, DOI 10.1007/BF00199134; FUCHS A, 1994, J EXP PSYCHOL HUMAN, V20, P1088, DOI 10.1037/0096-1523.20.5.1088; Haibach PS, 2004, HUM MOVEMENT SCI, V23, P185, DOI 10.1016/j.humov.2004.07.002; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Huys R, 2004, HUM MOVEMENT SCI, V23, P315, DOI 10.1016/j.humov.2004.08.009; Huys R, 2004, MOTOR CONTROL, V8, P188, DOI 10.1123/mcj.8.2.188; Huys R, 2002, J SPORT SCI, V20, P171, DOI 10.1080/026404102317284745; Jeka JJ, 1997, EXP BRAIN RES, V113, P475, DOI 10.1007/PL00005600; Jirsa VK, 2000, J BIOL PHYS, V26, P85, DOI 10.1023/A:1005208122449; Jirsa VK, 2004, UND COM SYS, P243; Juravle G, 2011, EXP BRAIN RES, V213, P87, DOI 10.1007/s00221-011-2780-2; Juravle G, 2010, BEHAV BRAIN RES, V208, P391, DOI 10.1016/j.bbr.2009.12.009; Kay BA, 2001, BIOL CYBERN, V85, P89, DOI 10.1007/PL00008002; Kelso J. A. S., 1991, RHYTHMS PHYSL SYSTEM, P195; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; KELSO JAS, 1990, ATTENTION PERFORM, P139; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kralemann B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.055201; Lagarde J, 2006, EXP BRAIN RES, V173, P673, DOI 10.1007/s00221-006-0410-1; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; Lagarde J, 2009, SKILLS09 INT C SKILL; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Meredith MA, 2002, COGNITIVE BRAIN RES, V14, P31, DOI 10.1016/S0926-6410(02)00059-9; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; NICKERSON RS, 1973, J EXP PSYCHOL, V98, P36, DOI 10.1037/h0034300; PEPER CE, 1995, HUM MOVEMENT SCI, V14, P217, DOI 10.1016/0167-9457(95)00010-P; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Post AA, 2000, BIOL CYBERN, V82, P143, DOI 10.1007/PL00007966; RAAB DH, 1962, SCIENCE, V135, P42, DOI 10.1126/science.135.3497.42; Rosengren K.S., 2003, DEV MOVEMENT COORDIN, V1st, P56; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Sinnett S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013148; Sperdin HF, 2010, NEUROPSYCHOLOGIA, V48, P3696, DOI 10.1016/j.neuropsychologia.2010.09.001; Sperdin HF, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.009.2010; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Swinnen SP, 2004, NEURO BEHAV DETERMIN; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tass PA, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051909; Todd J.W., 1912, REACTION MULTIPLE ST; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; TULLER B, 1989, EXP BRAIN RES, V75, P306; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; vanSantvoord AAM, 1996, ACTA PSYCHOL, V91, P131, DOI 10.1016/0001-6918(94)00044-1; VANSANTVOORD AAM, 1994, ECOL PSYCHOL, V6, P239, DOI 10.1207/s15326969eco0604_1; Von Holst E, 1973, COLLECTED PAPERS E V; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Voss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002866; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Williams SR, 1998, J NEUROPHYSIOL, V79, P947, DOI 10.1152/jn.1998.79.2.947; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	85	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32308	10.1371/journal.pone.0032308	http://dx.doi.org/10.1371/journal.pone.0032308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22384211	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500075
J	Chen, Q; Xie, LX; Qing, ZR; Li, LJ; Luo, ZY; Lin, M; Zhang, SM; Chen, WZ; Lin, BZ; Lin, QL; Li, H; Chen, WP; Zheng, PY; Mao, LZ; Chen, CY; Yang, C; Zhan, YZ; Liu, XZ; Zheng, JK; Yang, LY				Chen, Qiang; Xie, Long-Xu; Qing, Zhi-Rong; Li, Lie-Jun; Luo, Zhao-Yun; Lin, Min; Zhang, Shi-Ming; Chen, Wen-Zhou; Lin, Bing-Zhong; Lin, Qi-Li; Li, Hui; Chen, Wei-Pian; Zheng, Pei-Yao; Mao, Ling-Zhi; Chen, Chan-Yu; Yang, Chun; Zhan, Yong-Zhong; Liu, Xiang-Zhi; Zheng, Jia-Kun; Yang, Li-Ye			Epidemiologic Characterization of Human Papillomavirus Infection in Rural Chaozhou, Eastern Guangdong Province of China	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; REPUBLIC-OF-CHINA; GENOTYPE DISTRIBUTION; CERVICAL-CANCER; POOLED ANALYSIS; PREVALENCE; WOMEN; DNA; VACCINE	Background: Human papilloma virus (HPV) infection was the main cause of cervical cancer. There were only a few reports and detailed data about epidemiological research of HPV infection in rural population of China. Materials and Methods: The cervical cells of rural Chaozhou women were collected, and multiplex real time PCR was firstly performed to detect high-risk HPV (HR-HPV) infection, which could detect 13 types of HR-HPV (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68). Then, HPV-positive samples were typed by HPV GenoArray test. Results: HR-HPV DNA was detected by multiplex real time-PCR in 3830 of 48559 cases (7.89%). There was a peak incidence in age of 55-60 years group, and a lower incidence in who lived in plain group compared with suburban, mountain and seashore group. 3380 cases of HPV positive sample were genotyped, 11.01% (372/3380) cases could not be classified, among the typed 3008 cases, 101 cases were identified without HR-HPV type infection, 2907 cases were infected with one HR-HPV type at least, the 6 most common HR-HPV types in descending order of infection, were type 52 (33.4%, 16 (20.95%), 58 (15.93%), 33 (9.94%), 68 (9.22%) and 18 (8.36%). The combined prevalence of HPV types 16 and 18 accounted for 28.52% of total infection. However, type 52 plus 58 presented 48.23% of total infection. 2209/2907 cases were infected with a single HPV type and 698/2907 cases were infected with multiple types, and multiple infection constituent ratio increased with age, with a peak incidence in age 55-60 years group. Conclusions: Our findings showed low prevalence of HPV vaccine types (16 and 18) and relatively high prevalence of HPV-52 and -58, support the hypothesis that the second-generation HPV vaccines including HPV-52 and -58 may offer higher protection for women in rural Guangdong Province.	[Chen, Qiang; Luo, Zhao-Yun; Lin, Min; Zhan, Yong-Zhong; Liu, Xiang-Zhi; Zheng, Jia-Kun; Yang, Li-Ye] Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Chen, Qiang] Jilin Univ, Sch Publ Hlth, Dept Radiobiol, Changchun 130023, Peoples R China; [Xie, Long-Xu; Qing, Zhi-Rong; Li, Lie-Jun] Chaozhou Hybribio Ltd Corp, Chaozhou, Guangdong, Peoples R China; [Zhang, Shi-Ming; Chen, Wen-Zhou] Chaozhou Hlth Bur, Chaozhou, Guangdong, Peoples R China; [Lin, Bing-Zhong] Raoping Cty Peoples Hosp, Raoping Cty, Guangdong, Peoples R China; [Lin, Qi-Li] Chaozhou Peoples Hosp, Dept Gynecol & Obstet, Chaozhou, Guangdong, Peoples R China; [Li, Hui] Chaozhou Gynecol & Pediat Hosp, Dept Gynecol & Obstet, Chaozhou, Guangdong, Peoples R China; [Chen, Wei-Pian] Chaoan Cty Gynecol & Pediat Hosp, Chaoan Cty, Guangdong, Peoples R China; [Zheng, Pei-Yao] Fengxi Peoples Hosp, Chaozhou, Guangdong, Peoples R China; [Mao, Ling-Zhi] Guangdong Prov Women & Childrens Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Chen, Chan-Yu; Yang, Chun] Chaozhou Cent Hosp, Dept Gynecol, Chaozhou, Guangdong, Peoples R China	Jilin University	Chen, Q (corresponding author), Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com			Medical Research Funds of Guangdong Province [A2011760]	Medical Research Funds of Guangdong Province	This work was supported by Medical Research Funds of Guangdong Province (A2011760). Reagent discounts and reagent gifts was from Hybribio Biotechnology Limited Corp.. The funders had no role in study design and data analysis, decision to publish, or reparation of the manuscript.	Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; [程娇影 Cheng Jiaoying], 2010, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V28, P113; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Dai M, 2006, BRIT J CANCER, V95, P96, DOI 10.1038/sj.bjc.6603208; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Inoue M, 2006, INT J GYNECOL CANCER, V16, P1007, DOI 10.1111/j.1525-1438.2006.00460.x; Jin Qiong, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P898; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Klintschar M, 2000, J FORENSIC SCI, V45, P669; Li CD, 2010, CANCER EPIDEM BIOMAR, V19, P2655, DOI 10.1158/1055-9965.EPI-10-0212; Li LK, 2006, BRIT J CANCER, V95, P1593, DOI 10.1038/sj.bjc.6603450; Li Q, 2009, CHINESE NEOPLASIA, V18, P315; Lin M, 2008, AUST NZ J OBSTET GYN, V48, P189, DOI 10.1111/j.1479-828X.2008.00844.x; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Liu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Paolini F, 2011, INT J IMMUNOPATH PH, V24, P127, DOI 10.1177/039463201102400115; SOLOMON D, 1989, J REPROD MED, V34, P779; Trottier H, 2009, PUBLIC HEALTH GENOM, V12, P291, DOI 10.1159/000214920; Wu Rui-fang, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P90, DOI 10.3881/j.issn.1000-503X.2010.01.021; Ye J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-66; Yip YC, 2010, J MED VIROL, V82, P1724, DOI 10.1002/jmv.21826; Yoshikawa Hiroyuki, 2009, Virus (Nagoya), V59, P243; Zhao FH, 2010, LANCET ONCOL, V11, P1160, DOI 10.1016/S1470-2045(10)70256-4	31	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32149	10.1371/journal.pone.0032149	http://dx.doi.org/10.1371/journal.pone.0032149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384160	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800027
J	Falanga, A; Tarallo, R; Vitiello, G; Vitiello, M; Perillo, E; Cantisani, M; D'Errico, G; Galdiero, M; Galdiero, S				Falanga, Annarita; Tarallo, Rossella; Vitiello, Giuseppe; Vitiello, Mariateresa; Perillo, Emiliana; Cantisani, Marco; D'Errico, Gerardino; Galdiero, Massimiliano; Galdiero, Stefania			Biophysical Characterization and Membrane Interaction of the Two Fusion Loops of Glycoprotein B from Herpes Simplex Type I Virus	PLOS ONE			English	Article							ELECTRON-SPIN-RESONANCE; CRYSTAL-STRUCTURE; PHOSPHOLIPID-MEMBRANES; FUSOGENIC DOMAINS; PROXIMAL REGION; PEPTIDE; GB; AGGREGATION; ASSOCIATION; VESICLES	The molecular mechanism of entry of herpesviruses requires a multicomponent fusion system. Cell invasion by Herpes simplex virus (HSV) requires four virally encoded glycoproteins: namely gD, gB and gH/gL. The role of gB has remained elusive until recently when the crystal structure of HSV-1 gB became available and the fusion potential of gB was clearly demonstrated. Although much information on gB structure/function relationship has been gathered in recent years, the elucidation of the nature of the fine interactions between gB fusion loops and the membrane bilayer may help to understand the precise molecular mechanism behind herpesvirus-host cell membrane fusion. Here, we report the first biophysical study on the two fusion peptides of gB, with a particular focus on the effects determined by both peptides on lipid bilayers of various compositions. The two fusion loops constitute a structural subdomain wherein key hydrophobic amino acids form a ridge that is supported on both sides by charged residues. When used together the two fusion loops have the ability to significantly destabilize the target membrane bilayer, notwithstanding their low bilayer penetration when used separately. These data support the model of gB fusion loops insertion into cholesterol enriched membranes.	[Falanga, Annarita; Tarallo, Rossella; Perillo, Emiliana; Cantisani, Marco; Galdiero, Stefania] Univ Naples Federico II, Dept Biol Sci, Div Biostruct, Naples, Italy; [Falanga, Annarita; Cantisani, Marco; Galdiero, Massimiliano; Galdiero, Stefania] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, Naples, Italy; [Vitiello, Giuseppe; D'Errico, Gerardino] Univ Naples Federico II, Dept Chem, Naples, Italy; [Vitiello, Mariateresa] CSGI, Consorzio Studio Sistemi Grande Interfase, Naples, Italy; [Galdiero, Massimiliano] Univ Naples 2, Dept Expt Med, Naples, Italy; [Galdiero, Stefania] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Falanga, A (corresponding author), Univ Naples Federico II, Dept Biol Sci, Div Biostruct, Naples, Italy.	massimiliano.galdiero@unina2.it; sgaldier@unina.it	Galdiero, Stefania/M-3225-2019; galdiero, stefania/B-1357-2010; D'Errico, Gerardino/ABC-9579-2020	Galdiero, Stefania/0000-0002-7849-7024; D'Errico, Gerardino/0000-0001-6383-8618; FALANGA, Annarita/0000-0001-6538-8585; Falanga, Anna/0000-0001-6906-9020; Galdiero, Massimiliano/0000-0002-1576-6290; VITIELLO, Giuseppe/0000-0003-3389-6942	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) [FIRB Prot. RBRN07BMCT]	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) (FIRB Prot. RBRN07BMCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Chatterjee PK, 2002, J VIROL, V76, P12712, DOI 10.1128/JVI.76.24.12712-12722.2002; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Cummings JE, 2007, BBA-BIOMEMBRANES, V1768, P1796, DOI 10.1016/j.bbamem.2007.04.016; Curtain C, 1999, EUR BIOPHYS J BIOPHY, V28, P427, DOI 10.1007/s002490050225; D'Errico G, 2008, BIOCHEMISTRY-US, V47, P5317, DOI 10.1021/bi7025062; D'Errico G, 2008, BBA-BIOMEMBRANES, V1778, P2710, DOI 10.1016/j.bbamem.2008.07.014; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; ELLENS H, 1984, BIOCHEMISTRY-US, V23, P1532, DOI 10.1021/bi00302a029; Falanga A, 2011, NANOMED-NANOTECHNOL, V7, P925, DOI 10.1016/j.nano.2011.04.009; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Fiske CH, 1925, J BIOL CHEM, V66, P375; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2012, CURR DRUG METAB, V13, P93, DOI 10.2174/138920012798356961; Galdiero S, 2010, J BIOL CHEM, V285, P17123, DOI 10.1074/jbc.M110.114819; Galdiero S, 2010, BBA-BIOMEMBRANES, V1798, P579, DOI 10.1016/j.bbamem.2010.01.006; Galdiero S, 2009, PROTEIN PEPTIDE LETT, V16, P711, DOI 10.2174/092986609788681797; GORDON LM, 1992, BIOCHIM BIOPHYS ACTA, V1139, P257, DOI 10.1016/0925-4439(92)90099-9; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; KRISHNA YVSR, 1990, BIOCHIM BIOPHYS ACTA, V1024, P89; LANGE A, 1985, BIOCHEMISTRY-US, V24, P4383, DOI 10.1021/bi00337a020; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P688, DOI 10.1016/j.bbamem.2009.12.027; Marsh D, 2008, METHODS, V46, P83, DOI 10.1016/j.ymeth.2008.07.001; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; MOSER M, 1989, BIOPHYS J, V55, P111, DOI 10.1016/S0006-3495(89)82784-5; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8713, DOI 10.1021/bi00489a030; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Spadaccini R, 2010, BBA-BIOMEMBRANES, V1798, P344, DOI 10.1016/j.bbamem.2009.10.018; STANKOWSKI S, 1990, BIOCHIM BIOPHYS ACTA, V1025, P164, DOI 10.1016/0005-2736(90)90094-5; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sun X, 2008, J BIOL CHEM, V283, P6418, DOI 10.1074/jbc.M708955200; SWAMY MJ, 1994, BIOCHEMISTRY-US, V33, P11656, DOI 10.1021/bi00204a030; Tarallo R, 2011, CHEM-EUR J, V17, P12659, DOI 10.1002/chem.201101425; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vitiello G, 2011, BBA-BIOMEMBRANES, V1808, P2517, DOI 10.1016/j.bbamem.2011.07.012; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	67	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32186	10.1371/journal.pone.0032186	http://dx.doi.org/10.1371/journal.pone.0032186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384173	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916100057
J	Yuan, Y; Li, Q; Yu, H; Kong, LF				Yuan, Yang; Li, Qi; Yu, Hong; Kong, Lingfeng			The Complete Mitochondrial Genomes of Six Heterodont Bivalves (Tellinoidea and Solenoidea): Variable Gene Arrangements and Phylogenetic Implications	PLOS ONE			English	Article							TAXONOMIC DIVERSITY GRADIENTS; TRANSFER-RNA GENES; DNA-SEQUENCE; MOLECULAR PHYLOGENY; CONTROL REGION; MOLLUSCA-BIVALVIA; TANDEM REPEATS; COMPLETE MTDNA; MARINE REALM; EVOLUTION	Background: Taxonomy and phylogeny of subclass Heterodonta including Tellinoidea are long-debated issues and a complete agreement has not been reached yet. Mitochondrial (mt) genomes have been proved to be a powerful tool in resolving phylogenetic relationship. However, to date, only ten complete mitochondrial genomes of Heterodonta, which is by far the most diverse major group of Bivalvia, have been determined. In this paper, we newly sequenced the complete mt genomes of six species belonging to Heterodonta in order to resolve some problematical relationships among this subclass. Principal Findings: The complete mt genomes of six species vary in size from 16,352 bp to 18,182. Hairpin-like secondary structures are found in the largest non-coding regions of six freshly sequenced mt genomes, five of which contain tandem repeats. It is noteworthy that two species belonging to the same genus show different gene arrangements with three translocations. The phylogenetic analysis of Heterodonta indicates that Sinonovacula constricta, distant from the Solecurtidae belonging to Tellinoidea, is as a sister group with Solen grandis of family Solenidae. Besides, all five species of Tellinoidea cluster together, while Sanguinolaria diphos has closer relationship with Solecurtus divaricatus, Moerella iridescens and Semele scaba rather than with Sanguinolaria olivacea. Conclusions/Significance: By comparative study of gene order rearrangements and phylogenetic relationships of the five species belonging to Tellinoidea, our results support that comparisons of mt gene order rearrangements, to some extent, are a useful tool for phylogenetic studies. Based on phylogenetic analyses of multiple protein-coding genes, we prefer classifying the genus Sinonovacula within the superfamily Solenoidea and not the superfamily Tellinoidea. Besides, both gene order and sequence data agree that Sanguinolaria (Psammobiidae) is not monophyletic. Nevertheless, more studies based on more mt genomes via combination of gene order and phylogenetic analysis are needed to further understand the phylogenetic relationships in subclass Heterodonta.	[Yuan, Yang; Li, Qi; Yu, Hong; Kong, Lingfeng] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China	Ocean University of China	Yuan, Y (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	973 Program [2010CB126406]; National Natural Science Foundation of China [31072207]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the 973 Program (2010CB126406) and National Natural Science Foundation of China (31072207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, MOL BIOL EVOL, V21, P1492, DOI 10.1093/molbev/msh090; Boore JL, 1999, MOL BIOL EVOL, V16, P410, DOI 10.1093/oxfordjournals.molbev.a026122; BOORE JL, 1994, GENETICS, V138, P423; BOORE JL, 1994, NAUTILUS, V108, P61; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Campbell DC, 2000, GEOL SOC SPEC PUBL, V177, P31, DOI 10.1144/GSL.SP.2000.177.01.03; Canapa A, 2001, MOL PHYLOGENET EVOL, V21, P156, DOI 10.1006/mpev.2001.0992; CANTATORE P, 1987, NATURE, V329, P853, DOI 10.1038/329853a0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHENG S, 1994, NATURE, V369, P684, DOI 10.1038/369684a0; Cope JCW, 1997, PALAEONTOLOGY, V40, P713; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Dreyer H, 2003, ZOOL J LINN SOC-LOND, V139, P229, DOI 10.1046/j.1096-3642.2003.00065.x; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ghosh E., 1920, Records of the Indian Museum, V19; Giribet G, 2003, SM S COMP E, P45; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habe T., 1977, P1; He CB, 2011, MOL BIOL REP, V38, P3401, DOI 10.1007/s11033-010-0449-8; HEBERT PDN, 2002, P ROY SOC LOND B BIO, V270, P313; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kappner I, 2006, MOL PHYLOGENET EVOL, V40, P317, DOI 10.1016/j.ympev.2006.02.006; Keen AM, 1969, TREATISE INVERTEBRAT; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumazawa Y, 1998, GENETICS, V150, P313; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; LAROCHE J, 1990, MOL BIOL EVOL, V7, P45; Lee T, 2003, ZOOL J LINN SOC-LOND, V137, P245, DOI 10.1046/j.1096-3642.2003.00047.x; Lewis TL, 2007, MAR ECOL PROG SER, V329, P131, DOI 10.3354/meps329131; Li Q, 2002, J SHELLFISH RES, V21, P811; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; Mikkelsen PM, 2006, ZOOL J LINN SOC-LOND, V148, P439, DOI 10.1111/j.1096-3642.2006.00262.x; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; NCBI Open Reading Frame Finder, NCBI OP READ FRAM FI; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Podsiadlowski L, 2008, MOL BIOL EVOL, V25, P42, DOI 10.1093/molbev/msm223; POHLO R, 1982, J MOLLUS STUD, V48, P245, DOI 10.1093/oxfordjournals.mollus.a065646; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prezant RS, 1998, MOLLUSCA SO SYNTHESI, V5, P289; Rawlings TA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-440; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Ren JF, 2009, MITOCHONDR DNA, V20, P78, DOI 10.1080/19401730902964425; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simone LRL, 2008, RAFFLES B ZOOL, P151; SMITH MJ, 1993, J MOL EVOL, V36, P545, DOI 10.1007/BF00556359; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; TAYLOR J D, 1973, Palaeontology (Oxford), V16, P519; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; The Basic Local Alignment Search Tool (BLAST), BAS LOC AL SEARCH TO; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trueman E. R., 1966, Proceedings of the Malacological Society of London, V37, P111; Uda K, 2011, GENE, V476, P27, DOI 10.1016/j.gene.2011.01.019; Vokes HE, 1980, GENERA BIVALVIA SYST; von Cosel R, 1990, BIVALVIA; Wang HX, 2010, COMP BIOCHEM PHYS D, V5, P256, DOI 10.1016/j.cbd.2010.07.003; Williams ST, 2004, J MOLLUS STUD, V70, P187, DOI 10.1093/mollus/70.2.187; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu XY, 2010, MOL PHYLOGENET EVOL, V57, P448, DOI 10.1016/j.ympev.2010.05.029; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu KF, 2011, MOL BIOL REP, V38, P3067, DOI 10.1007/s11033-010-9974-8; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; YONGE CM, 1959, J MAR BIOL ASSOC UK, V38, P277, DOI 10.1017/S0025315400006081; YONGE CM, 1949, PHILOS T ROY SOC B, V234, P29, DOI 10.1098/rstb.1949.0006; Yu ZN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-477; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024	96	47	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32353	10.1371/journal.pone.0032353	http://dx.doi.org/10.1371/journal.pone.0032353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384227	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100073
J	Chaves-Perez, A; Mack, B; Maetzel, D; Kremling, H; Eggert, C; Harreus, U; Gires, O				Chaves-Perez, A.; Mack, B.; Maetzel, D.; Kremling, H.; Eggert, C.; Harreus, U.; Gires, O.			EpCAM regulates cell cycle progression via control of cyclin D1 expression	ONCOGENE			English	Article						EpCAM; EpICD; cyclin D1	BREAST-CANCER; EP-CAM; POTENTIAL TARGET; GENE-EXPRESSION; BETA-CATENIN; STEM-CELLS; FHL2; CARCINOMA; PROTEIN; DIFFERENTIATION	The epithelial cell adhesion molecule (EpCAM) is an integral transmembrane protein that is frequently overexpressed in embryonic stem cells, tissue progenitors, carcinomas and cancer-initiating cells. In cancer cells, expression of EpCAM is associated with enhanced proliferation and upregulation of target genes including c-myc. However, the exact molecular mechanisms underlying the observed EpCAM-dependent cell proliferation remained unexplored. Here, we show that EpCAM directly affects cell cycle progression via its capacity to regulate the expression of cyclin D1 at the transcriptional level and depending on the direct interaction partner FHL2 (four-and-a-half LIM domains protein 2). As a result, downstream events such as phosphorylation of the retinoblastoma protein (Rb) and expression of cyclins E and A are similarly affected. In vivo, EpCAM expression strength and pattern are both positively correlated with the proliferation marker Ki67, high expression and nuclear localisation of cyclin D1, and Rb phosphorylation. Thus, EpCAM enhances cell cycle progression via the classical cyclin-regulated pathway. Oncogene (2013) 32, 641-650; doi:10.1038/onc.2012.75; published online 5 March 2012	[Chaves-Perez, A.; Kremling, H.; Eggert, C.; Gires, O.] Univ Munich, Clin Cooperat Grp Mol Oncol, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, D-81377 Munich, Germany; [Chaves-Perez, A.; Kremling, H.; Eggert, C.; Gires, O.] Univ Munich, Head & Neck Res Dept, D-81377 Munich, Germany; [Mack, B.; Harreus, U.; Gires, O.] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-81377 Munich, Germany; [Maetzel, D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; Massachusetts Institute of Technology (MIT); Whitehead Institute	Gires, O (corresponding author), Univ Munich, Dept Otorhinolaryngol, Grosshadern Med Ctr, Marchioninistr 15, D-81377 Munich, Germany.	Olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064				Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Gabriel B, 2006, J SOC GYNECOL INVEST, V13, P69, DOI 10.1016/j.jsgi.2005.10.001; Gabriel B, 2004, ANTICANCER RES, V24, P921; Geng Y, 2001, P NATL ACAD SCI USA, V98, P194, DOI 10.1073/pnas.011522998; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Guo Z, 2010, MOL CARCINOGEN, V49, P826, DOI 10.1002/mc.20659; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; MICHALIDES R, 1995, CANCER RES, V55, P975; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz Markus, 2004, Cancer Genomics Proteomics, V1, P241; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nasr AF, 2003, ONCOGENE, V22, P1668, DOI 10.1038/sj.onc.1206248; Ng CF, 2011, GENE, V481, P41, DOI 10.1016/j.gene.2011.04.005; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; SCHON MP, 1994, J INVEST DERMATOL, V102, P987, DOI 10.1111/1523-1747.ep12384258; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Soucek T, 1997, ONCOGENE, V14, P2251, DOI 10.1038/sj.onc.1201061; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yanamoto S, 2007, ORAL ONCOL, V43, P869, DOI 10.1016/j.oraloncology.2006.10.010	40	80	81	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					641	650		10.1038/onc.2012.75	http://dx.doi.org/10.1038/onc.2012.75			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22391566	Bronze			2022-12-25	WOS:000316164700011
J	Yan, W; Liu, S; Xu, E; Zhang, J; Zhang, Y; Chen, X; Chen, X				Yan, W.; Liu, S.; Xu, E.; Zhang, J.; Zhang, Y.; Chen, X.; Chen, X.			Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8	ONCOGENE			English	Article						p53; mutant p53; HDAC8; HDAC inhibitor; HoxA5; transcription	CLINICAL-IMPLICATIONS; HDAC INHIBITORS; CANCER; EXPRESSION; APOPTOSIS; ACTIVATION; CELLS; GENE; IDENTIFICATION; ACETYLATION	Mutation of the p53 gene is the most common genetic alteration in human cancer and contributes to malignant process by enhancing transformed properties of cells and resistance to anticancer therapy. Mutant p53 is often highly expressed in tumor cells at least, in part, due to its increased half-life. However, whether mutant p53 expression is regulated by other mechanisms in tumors is unclear. Here we found that histone deacetylase (HDAC) inhibitors suppress both wild-type and mutant p53 transcription in time- and dose-dependent manners. Consistent with this, the levels of wild-type and mutant p53 proteins are decreased upon treatment with HDAC inhibitors. Importantly, we found that upon knockdown of each class I HDAC, only HDAC8 knockdown leads to decreased expression of wild-type and mutant p53 proteins and transcripts. Conversely, we found that ectopic expression of wild-type, but not mutant HDAC8, leads to increased transcription of p53. Furthermore, we found that knockdown of HDAC8 results in reduced expression of HoxA5 and consequently, attenuated ability of HoxA5 to activate p53 transcription, which can be rescued by ectopic expression of HoxA5. Because of the fact that HDAC8 is required for expression of both wild-type and mutant p53, we found that targeted disruption of HDAC8 expression remarkably triggers proliferative defect in cells with a mutant but not wild-type, p53. Together, our data uncover a regulatory mechanism of mutant p53 transcription via HDAC8 and suggest that HDAC inhibitors and especially HDAC8-targeting agents might be explored as an adjuvant for tumors carrying a mutant p53. Oncogene (2013) 32, 599-609; doi:10.1038/onc.2012.81; published online 5 March 2012	[Yan, W.; Liu, S.; Xu, E.; Zhang, J.; Zhang, Y.; Chen, X.; Chen, X.] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, X (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	qiao, zhixin/I-3408-2012; liu, shou/C-5406-2015	Zhang, Yi/0000-0002-2789-0811	National Institutes of Health [R01 CA121137]; NATIONAL CANCER INSTITUTE [R01CA076069, R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health Grant R01 CA121137. We thank S Townson (Merck Pharmaceuticals) for SAHA.	Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bertrand P, 2010, EUR J MED CHEM, V45, P2095, DOI 10.1016/j.ejmech.2010.02.030; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dong GE, 2010, AM J PHYSIOL-RENAL, V298, pF293, DOI 10.1152/ajprenal.00410.2009; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Glaser KB, 2003, MOL CANCER THER, V2, P151; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kirschbaum M, 2011, J CLIN ONCOL, V29, P1198, DOI 10.1200/JCO.2010.32.1398; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Noureen N, 2010, CANCER CHEMOTH PHARM, V66, P625, DOI 10.1007/s00280-010-1324-y; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Peart MJ, 2003, CANCER RES, V63, P4460; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Reisman D, 1998, SEMIN CANCER BIOL, V8, P317, DOI 10.1006/scbi.1998.0094; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Sasakawa Y, 2005, BIOCHEM PHARMACOL, V69, P603, DOI 10.1016/j.bcp.2004.11.008; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001	54	113	119	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					599	609		10.1038/onc.2012.81	http://dx.doi.org/10.1038/onc.2012.81			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22391568	Green Accepted			2022-12-25	WOS:000316164700007
J	Martins, TG; Gama, JB; Fraga, AG; Saraiva, M; Silva, MT; Castro, AG; Pedrosa, J				Martins, Teresa G.; Gama, Jose B.; Fraga, Alexandra G.; Saraiva, Margarida; Silva, Manuel T.; Castro, Antonio G.; Pedrosa, Jorge			Local and Regional Re-Establishment of Cellular Immunity during Curative Antibiotherapy of Murine Mycobacterium ulcerans Infection	PLOS ONE			English	Article							BURULI ULCER; RIFAMPIN-STREPTOMYCIN; LATENT TUBERCULOSIS; CLINICAL-EFFICACY; TUBERCLE-BACILLI; INTERFERON-GAMMA; COMBINATION; LESIONS; MYCOLACTONE; DISEASE	Background: Buruli ulcer (BU) is a neglected necrotizing disease of the skin, subcutaneous tissue and bone, caused by Mycobacterium ulcerans. BU pathogenesis is associated with mycolactone, a lipidic exotoxin with cytotoxic and immunosuppressive properties. Since 2004, the World Health Organization recommends the treatment of BU with a combination of rifampicin and streptomycin (RS). Histological analysis of human tissue samples suggests that such antibiotic treatment reverses the mycolactone-induced local immunosuppression, leading to increased inflammatory infiltrations and phagocytosis of bacilli. Methodology/Principal Findings: We used a mouse model of M. ulcerans footpad infection, followed by combined RS treatment. Time-lapsed analyses of macroscopic lesions, bacterial burdens, histology and immunohistochemistry were performed in footpads. We also performed CFU counts, histology and immunohistochemistry in the popliteal draining lymph nodes (DLN). We observed a shift in the cellular infiltrates from a predominantly neutrophilic/macrophagic to a lymphocytic/macrophagic profile in the infected footpads of antibiotic-treated mice. This shift occurred before the elimination of viable M. ulcerans organisms, which were ultimately eradicated as demonstrated by the administration of dexamethasone. This reduction of bacillary loads was accompanied by an increased expression of inducible nitric oxide synthase (NOS2 or iNOS). Predominantly mononuclear infiltrates persisted in the footpads during and after treatment, coincident with the long persistence of non-viable poorly stained acid-fast bacilli (AFB). We additionally observed that antibiotherapy prevented DLN destruction and lymphocyte depletion, which occurs during untreated experimental infections. Conclusions/Significance: Early RS treatment of M. ulcerans mouse footpad infections results in the rapid elimination of viable bacilli with pathogen eradication. However, non-viable AFB persisted for several months after lesion sterilization. This RS regimen prevented DLN destruction, allowing the rapid re-establishment of local and regional cell mediated immune responses associated with macrophage activation. Therefore it is likely that this re-establishment of protective cellular immunity synergizes with antibiotherapy.	[Martins, Teresa G.; Gama, Jose B.; Fraga, Alexandra G.; Saraiva, Margarida; Castro, Antonio G.; Pedrosa, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Martins, Teresa G.; Gama, Jose B.; Fraga, Alexandra G.; Saraiva, Margarida; Castro, Antonio G.; Pedrosa, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Silva, Manuel T.] Inst Mol & Cell Biol, Oporto, Portugal	Universidade do Minho; Universidade do Porto	Martins, TG (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	jpedrosa@ecsaude.uminho.pt	Pedrosa, Jorge/H-4877-2011; Castro, Gil/T-7584-2018; Fraga, Alexandra G./T-5174-2018; Saraiva, Margarida/E-8781-2011	Pedrosa, Jorge/0000-0002-8204-4888; Castro, Gil/0000-0002-4684-4183; Fraga, Alexandra G./0000-0003-2029-1629; Gama, Jose/0000-0002-7011-1502; Saraiva, Margarida/0000-0002-8180-1293	Health Services of Fundaca Calouste Gulbenkian; Portuguese Science and Technology Foundation (FCT) [SFRH/BD/41598/2007, SFRH/BD/33573/2009, SFRH/BPD/68547/2010]	Health Services of Fundaca Calouste Gulbenkian; Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by a grant from the Health Services of Fundaca Calouste Gulbenkian, and the Portuguese Science and Technology Foundation (FCT) fellowships SFRH/BD/41598/2007, SFRH/BD/33573/2009 and SFRH/BPD/68547/2010 to T. G. Martins, J. B. Gama and A. G. Fraga, respectively. M. Saraiva is Ciencia 2007 fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000933; Amofah G, 1998, TROP DOCT, V28, P81, DOI 10.1177/004947559802800208; Asiedu K., 2000, Buruli ulcer: Mycobacterium ulcerans infection.; Bentoucha A, 2001, ANTIMICROB AGENTS CH, V45, P3109, DOI 10.1128/AAC.45.11.3109-3112.2001; Brooks JV, 1999, ANTIMICROB AGENTS CH, V43, P1285, DOI 10.1128/AAC.43.5.1285; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; Dega H, 2000, ANTIMICROB AGENTS CH, V44, P2367, DOI 10.1128/AAC.44.9.2367-2372.2000; Dega H, 2002, ANTIMICROB AGENTS CH, V46, P3193, DOI 10.1128/AAC.46.10.3193-3196.2002; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Fraga AG, 2011, INFECT IMMUN, V79, P421, DOI 10.1128/IAI.00820-10; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Gordon CL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000770; Hong H, 2008, NAT PROD REP, V25, P447, DOI 10.1039/b803101k; Ji BH, 2007, ANTIMICROB AGENTS CH, V51, P3737, DOI 10.1128/AAC.00730-07; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Lefrancois S, 2007, ANTIMICROB AGENTS CH, V51, P645, DOI 10.1128/AAC.00821-06; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Marsollier L, 2003, INT J ANTIMICROB AG, V22, P562, DOI 10.1016/S0924-8579(03)00240-1; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; O'Brien DP, 2009, MED J AUSTRALIA, V191, P564, DOI 10.5694/j.1326-5377.2009.tb03313.x; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Rastogi N, 1996, CURR MICROBIOL, V33, P167, DOI 10.1007/s002849900095; Repique CJ, 2002, INFECT IMMUN, V70, P3318, DOI 10.1128/IAI.70.7.3318-3323.2002; Ruf MT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001252; Sarfo FS, 2009, CLIN VACCINE IMMUNOL, V16, P61, DOI 10.1128/CVI.00235-08; Sarfo FS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001237; Sarfo FS, 2010, ANTIMICROB AGENTS CH, V54, P3678, DOI 10.1128/AAC.00299-10; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Schutte D, 2009, BRIT J DERMATOL, V160, P273, DOI 10.1111/j.1365-2133.2008.08879.x; Schutte D, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000002; Shepard C C, 1968, Int J Lepr Other Mycobact Dis, V36, P78; Silva M T, 1984, Acta Leprol, V2, P281; Silva MT, 2009, LANCET INFECT DIS, V9, P699, DOI 10.1016/S1473-3099(09)70234-8; Sopoh GE, 2010, AM J TROP MED HYG, V83, P307, DOI 10.4269/ajtmh.2010.09-0617; Teelken MA, 2003, ACTA TROP, V88, P51, DOI 10.1016/S0001-706X(03)00170-0; Torrado E, 2007, INFECT IMMUN, V75, P3979, DOI 10.1128/IAI.00290-07; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; Torrado E, 2010, J IMMUNOL, V184, P947, DOI 10.4049/jimmunol.0902717; World Health Organization, 2004, PROV GUID ROL SPEC A, V10, P33; Zhang TY, 2011, ANTIMICROB AGENTS CH, V55, P56, DOI 10.1128/AAC.01260-10	48	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32740	10.1371/journal.pone.0032740	http://dx.doi.org/10.1371/journal.pone.0032740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393444	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500098
J	Ryu, KY; Park, H; Rossi, DJ; Weissman, IL; Kopito, RR				Ryu, Kwon-Yul; Park, Hyejin; Rossi, Derrick J.; Weissman, Irving L.; Kopito, Ron R.			Perturbation of the Hematopoietic System during Embryonic Liver Development Due to Disruption of Polyubiquitin Gene Ubc in Mice	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; STEM-CELLS; DEFICIENCIES; DEGRADATION; PROGRESSION; LACKING	Disruption of the polyubiquitin gene Ubc leads to a defect in fetal liver development, which can be partially rescued by increasing the amount of ubiquitin. However, it is still not known why Ubc is required for fetal liver development and the nature of the defective cell types responsible for embryonic lethality have not been characterized. In this study, we assessed the cause of embryonic lethality with respect to the fetal liver hematopoietic system. We found that Ubc was highly expressed in the embryonic liver, and the proliferation capacity of fetal liver cells was reduced in Ubc(-/-) embryos. Specifically, Ubc was most highly expressed in hematopoietic cells, and the proliferation capacity of hematopoietic cells was significantly impaired in Ubc(-/-) embryos. While hematopoietic cell and hematopoietic stem cell (HSC) frequency was maintained in Ubc(-/-) embryos, the absolute number of these cells was diminished because of reduced total liver cell number in Ubc(-/-) embryos. Transplantations of fetal liver cells into lethally irradiated recipient mice by non-competitive and competitive reconstitution methods indicated that disruption of Ubc does not significantly impair the intrinsic function of fetal liver HSCs. These findings suggest that disruption of Ubc reduces the absolute number of HSCs in embryonic livers, but has no significant effect on the autonomous function of HSCs. Thus, the lethality of Ubc(-/-) embryos is not the result of intrinsic HSC failure.	[Ryu, Kwon-Yul; Park, Hyejin] Univ Seoul, Dept Life Sci, Seoul, South Korea; [Rossi, Derrick J.] Harvard Univ, Sch Med, Immune Dis Inst, Harvard Stem Cell Inst, Boston, MA USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Weissman, Irving L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Seoul; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Stanford University	Ryu, KY (corresponding author), Univ Seoul, Dept Life Sci, Seoul, South Korea.	kyryu@uos.ac.kr		Ryu, Kwon-Yul/0000-0001-6104-8575	National Research Foundation of Korea; Ministry of Education, Science and Technology [20100009065, 20110004618]; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (20100009065 & 20110004618, http://www.nrf.re.kr/html/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Dantuma NP, 2010, CARDIOVASC RES, V85, P263, DOI 10.1093/cvr/cvp255; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ryu KY, 2010, NEUROPATH APPL NEURO, V36, P285, DOI 10.1111/j.1365-2990.2009.01057.x; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2008, MOL CELL BIOL, V28, P1136, DOI 10.1128/MCB.01566-07; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sinnar SA, 2011, MOL REPROD DEV, V78, P415, DOI 10.1002/mrd.21318; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x	24	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32956	10.1371/journal.pone.0032956	http://dx.doi.org/10.1371/journal.pone.0032956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393459	gold, Green Submitted, Green Published			2022-12-25	WOS:000303003500114
J	Selvamani, A; Sathyan, P; Miranda, RC; Sohrabji, F				Selvamani, Amutha; Sathyan, Pratheesh; Miranda, Rajesh C.; Sohrabji, Farida			An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model	PLOS ONE			English	Article							GROWTH-FACTOR-I; CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOCAL ISCHEMIA; SEX-DIFFERENCES; BRAIN-INJURY; IGF-I; MICROGLIAL CELLS; BREAST-CANCER; IFN-GAMMA; EXPRESSION	We previously showed that middle-aged female rats sustain a larger infarct following experimental stroke as compared to younger female rats, and paradoxically, estrogen treatment to the older group is neurotoxic. Plasma and brain insulin-like growth factor-1 (IGF-1) levels decrease with age. However, IGF-1 infusion following stroke, prevents estrogen neurotoxicity in middle-aged female rats. IGF1 is neuroprotective and well tolerated, but also has potentially undesirable side effects. We hypothesized that microRNAs (miRNAs) that target the IGF-1 signaling family for translation repression could be alternatively suppressed to promote IGF-1-like neuroprotection. Here, we report that two conserved IGF pathway regulatory microRNAs, Let7f and miR1, can be inhibited to mimic and even extend the neuroprotection afforded by IGF-1. Anti-mir1 treatment, as late as 4 hours following ischemia, significantly reduced cortical infarct volume in adult female rats, while anti-Let7 robustly reduced both cortical and striatal infarcts, and preserved sensorimotor function and interhemispheric neural integration. No neuroprotection was observed in animals treated with a brain specific miRNA unrelated to IGF-1 (anti-miR124). Remarkably, anti-Let7f was only effective in intact females but not males or ovariectomized females indicating that the gonadal steroid environment critically modifies miRNA action. Let7f is preferentially expressed in microglia in the ischemic hemisphere and confirmed in ex vivo cultures of microglia obtained from the cortex. While IGF-1 was undetectable in microglia harvested from the non-ischemic hemisphere, IGF-1 was expressed by microglia obtained from the ischemic cortex and was further elevated by anti-Let7f treatment. Collectively these data support a novel miRNA-based therapeutic strategy for neuroprotection following stroke.	[Selvamani, Amutha; Sathyan, Pratheesh; Miranda, Rajesh C.; Sohrabji, Farida] Texas A&M Hlth Sci Ctr, Coll Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Selvamani, A (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, College Stn, TX USA.	sohrabji@medicine.tamhsc.edu		Miranda, Rajesh/0000-0002-8359-892X; Sohrabji, Farida/0000-0002-6960-3411	National Institutes of Health [AG027684, AG028303]; NATIONAL INSTITUTE ON AGING [R01AG028303, R01AG027684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants AG027684 and AG028303 to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Biernaskie J, 2001, MAGNET RESON MED, V46, P827, DOI 10.1002/mrm.1263; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Budhu A, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-37; Bushnell CD, 2008, NEUROL CLIN, V26, P1161, DOI 10.1016/j.ncl.2008.05.009; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan J, 2001, J CEREBR BLOOD F MET, V21, P493, DOI 10.1097/00004647-200105000-00003; Hagberg H, 2004, SEMIN PERINATOL, V28, P389, DOI 10.1053/j.semperi.2004.10.006; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hua Y, 2011, J CELL MOL MED; Hutchison ER, 2009, NEUROMOL MED, V11, P153, DOI 10.1007/s12017-009-8086-x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnsen SP, 2005, J CLIN ENDOCR METAB, V90, P5937, DOI 10.1210/jc.2004-2088; Johnson AB, 2005, NEUROBIOL AGING, V26, P1365, DOI 10.1016/j.neurobiolaging.2004.12.006; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Johnston BM, 1996, J CLIN INVEST, V97, P300, DOI 10.1172/JCI118416; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kocerha J, 2009, NEUROMOL MED, V11, P162, DOI 10.1007/s12017-009-8066-1; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2009, J CEREBR BLOOD F MET, V29, P670, DOI 10.1038/jcbfm.2009.3; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Lisabeth LD, 2006, GENDER MED, V3, P270, DOI DOI 10.1016/51550-8579(06)80215-9; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu FD, 2009, STROKE, V40, P1842, DOI 10.1161/STROKEAHA.108.538686; Liu Xin-Feng, 2004, J Stroke Cerebrovasc Dis, V13, P16, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.005; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Donnell SL, 2002, GLIA, V39, P85, DOI 10.1002/glia.10081; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Renolleau S, 2007, DEV MED CHILD NEUROL, V49, P477, DOI 10.1111/j.1469-8749.2007.00477.x; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Schwab S, 1997, STROKE, V28, P1744, DOI 10.1161/01.STR.28.9.1744; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Siegel C, 2010, J NEUROSCI RES, V88, P2765, DOI 10.1002/jnr.22406; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Smith J, 2011, ANN ONCOL, V22, pi50, DOI 10.1093/annonc/mdq666; Smith LEH, 2005, BIOL NEONATE, V88, P237, DOI 10.1159/000087587; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Takane K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-101; Trojan LA, 2002, ACTA BIOCHIM POL, V49, P979; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang JM, 2000, BRAIN RES, V859, P381, DOI 10.1016/S0006-8993(00)02008-4; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Yan YP, 2006, EUR J NEUROSCI, V24, P45, DOI 10.1111/j.1460-9568.2006.04872.x; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Zeng Lili, 2011, Front Biosci (Elite Ed), V3, P1265	79	178	191	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32662	10.1371/journal.pone.0032662	http://dx.doi.org/10.1371/journal.pone.0032662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393433	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500085
J	Yuan, YY; Zhang, X; Huang, SS; Zuo, LJ; Zhang, GZ; Song, YS; Wang, GJ; Wang, HT; Huang, DL; Han, DY; Dai, P				Yuan, Yongyi; Zhang, Xun; Huang, Shasha; Zuo, Lujie; Zhang, Guozheng; Song, Yueshuai; Wang, Guojian; Wang, Hongtian; Huang, Deliang; Han, Dongyi; Dai, Pu			Common Molecular Etiologies Are Rare in Nonsyndromic Tibetan Chinese Patients with Hearing Impairment	PLOS ONE			English	Article							CONNEXIN-26 GJB2 GENE; MUTATION SPECTRUM; OXYGEN-SATURATION; PENDREDS-SYNDROME; HOMEOBOX GENE; DEAFNESS; EAR; POU3F4; MORPHOGENESIS; ADAPTATION	Background: Thirty thousand infants are born every year with congenital hearing impairment in mainland China. Racial and regional factors are important in clinical diagnosis of genetic deafness. However, molecular etiology of hearing impairment in the Tibetan Chinese population living in the Tibetan Plateau has not been investigated. To provide appropriate genetic testing and counseling to Tibetan families, we investigated molecular etiology of nonsyndromic deafness in this population. Methods: A total of 114 unrelated deaf Tibetan children from the Tibet Autonomous Region were enrolled. Five prominent deafness-related genes, GJB2, SLC26A4, GJB6, POU3F4, and mtDNA 12S rRNA, were analyzed. Inner ear development was evaluated by temporal CT. A total of 106 Tibetan hearing normal individuals were included as genetic controls. For radiological comparison, 120 patients, mainly of Han ethnicity, with sensorineural hearing loss were analyzed by temporal CT. Results: None of the Tibetan patients carried diallelic GJB2 or SLC26A4 mutations. Two patients with a history of aminoglycoside usage carried homogeneous mtDNA 12S rRNA A1555G mutation. Two controls were homozygous for 12S rRNA A1555G. There were no mutations in GJB6 or POU3F4. A diagnosis of inner ear malformation was made in 20.18% of the Tibetan patients and 21.67% of the Han deaf group. Enlarged vestibular aqueduct, the most common inner ear deformity, was not found in theTibetan patients, but was seen in 18.33% of the Han patients. Common molecular etiologies, GJB2 and SLC26A4 mutations, were rare in the Tibetan Chinese deaf population. Conclusion: The mutation spectrum of hearing loss differs significantly between Chinese Tibetan patients and Han patients. The incidence of inner ear malformation in Tibetans is almost as high as that in Han deaf patients, but the types of malformation vary greatly. Hypoxia and special environment in plateau may be one cause of developmental inner ear deformity in this population.	[Yuan, Yongyi; Huang, Shasha; Zuo, Lujie; Zhang, Guozheng; Song, Yueshuai; Wang, Guojian; Wang, Hongtian; Huang, Deliang; Han, Dongyi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Zhang, Xun; Zuo, Lujie; Zhang, Guozheng] Hebei Med Univ, Hosp 3, Dept Otolaryngol, Shijiazhuang, Hebei, Peoples R China; [Yuan, Yongyi; Wang, Guojian; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Hebei Medical University; Chinese People's Liberation Army General Hospital	Yuan, YY (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China.	huangdl301@sina.com; hdy301@263.net; daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	Beijing Nova programme [2009B34, 2010B081]; Chinese National Nature Science Foundation [30572015, 30728030, 31071109, 30801285, 81000415]; State 863 High Technology R&D Key Project of China [SQ2010AA0221634001]; Minister of Science and Technology [2012BAI09B02]	Beijing Nova programme(Beijing Municipal Science & Technology Commission); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); Minister of Science and Technology	This work was supported by Chinese National Nature Science Foundation Research Grant (30572015, 30728030, 31071109), State 863 High Technology R&D Key Project of China(SQ2010AA0221634001) and grant from the Minister of Science and Technology (2012BAI09B02) to Dr. Pu Dai, Chinese National Nature Science Foundation Research Grant (30801285) and Beijing Nova programme (2009B34) to Dr. Yongyi Yuan, Chinese National Nature Science Foundation Research Grant (81000415) and Beijing Nova programme (2010B081) to Dr. Guojian Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi O, 2008, GENET TEST, V12, P569, DOI 10.1089/gte.2008.0063; BEALL CM, 1994, AM J PHYS ANTHROPOL, V95, P271, DOI 10.1002/ajpa.1330950303; Beall CM, 1997, HUM BIOL, V69, P597; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bonyadi M, 2009, GENET TEST MOL BIOMA, V13, P689, DOI 10.1089/gtmb.2009.0026; Burton Q, 2004, DEV BIOL, V272, P161, DOI 10.1016/j.ydbio.2004.04.024; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Cohen M. M., 1995, HEREDITARY HEARING L, P9; Dahl HHM, 2006, J MED GENET, V43, P850, DOI 10.1136/jmg.2006.042051; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Fischel-Ghodsian N, 1998, P SOC EXP BIOL MED, V218, P1; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Gualandi F, 2004, ACTA OTO-LARYNGOL, V124, P29, DOI 10.1080/03655230410017166; Han B, 2009, CHINESE MED J-PEKING, V122, P830, DOI 10.3760/cma.j.issn.0366-6999.2009.07.013; Han Dong-yi, 2010, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V45, P265; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Lee HK, 2009, CLIN GENET, V75, P572, DOI 10.1111/j.1399-0004.2009.01181.x; Lench N, 1998, LANCET, V351, P415, DOI 10.1016/S0140-6736(98)24006-2; Li JZ, 2010, J GENET GENOMICS, V37, P787, DOI 10.1016/S1673-8527(09)60096-5; Liu RC, 1982, CHIN J CARDIOL, V10, P241; Mahdieh N, 2011, GENET TEST MOL BIOMA, V15, P489, DOI 10.1089/gtmb.2010.0145; Merlo GR, 2002, DEV BIOL, V248, P157, DOI 10.1006/dbio.2002.0713; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Moraes F, 2005, MECH DEVELOP, V122, P199, DOI 10.1016/j.mod.2004.10.004; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morsli H, 2005, DEVELOPMENT, V126, P2235; Niermeyer S, 2001, HIGH ALTITUDE EXPLOR; Office of the 2ndnationwide survey of the disabled Chinese population, 2007, HDB MAJ DAT 2 NAT SU; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Phippard D, 1998, HEARING RES, V120, P77, DOI 10.1016/S0378-5955(98)00059-8; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; Romand R, 2004, GENE EXPR PATTERNS, V4, P123, DOI 10.1016/j.modgep.2003.09.006; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Ruszymah B H I, 2005, Med J Malaysia, V60, P269; Samanich J, 2007, AM J MED GENET A, V143A, P830, DOI 10.1002/ajmg.a.31668; Shi GZ, 2004, HEARING RES, V197, P19, DOI 10.1016/j.heares.2004.06.012; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Stankovic KM, 2010, ANN OTO RHINOL LARYN, V119, P815, DOI 10.1177/000348941011901205; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Wang J, 2002, TIBETAN SCI TECHNOL, V1, P12, DOI [10.3969/j.issn.1004-3403.2002.01.005, DOI 10.3969/J.ISSN.1004-3403.2002.01.005]; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wu BL, 2002, GENET MED, V4, P279, DOI 10.1097/00125817-200207000-00006; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yong AML, 2001, J CLIN ENDOCR METAB, V86, P3907, DOI 10.1210/jc.86.8.3907; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zlotogora J, 2006, GENET TEST, V10, P40, DOI 10.1089/gte.2006.10.40	59	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30720	10.1371/journal.pone.0030720	http://dx.doi.org/10.1371/journal.pone.0030720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389666	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600003
J	Liu, QH; Zhang, Y; Mao, HP; Chen, W; Luo, N; Zhou, Q; Chen, WF; Yu, XQ				Liu, Qinghua; Zhang, Yu; Mao, Haiping; Chen, Wei; Luo, Ning; Zhou, Qin; Chen, Wenfang; Yu, Xueqing			A Crosstalk between the Smad and JNK Signaling in the TGF-beta-Induced Epithelial-Mesenchymal Transition in Rat Peritoneal Mesothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROTEIN-KINASE PATHWAYS; HEPATIC STELLATE CELLS; HUMAN LUNG FIBROBLASTS; PAI-1 GENE-EXPRESSION; MEDIATED TRANSCRIPTION; INDEPENDENT PATHWAYS; MESANGIAL CELLS; TGF-BETA-1; FIBROSIS	Transforming growth factor beta (TGF-beta) induces the process of epithelial-mesenchymal transition (EMT) through the Smad and JNK signaling. However, it is unclear how these pathways interact in the TGF-beta 1-induced EMT in rat peritoneal mesothelial cells (RPMCs). Here, we show that inhibition of JNK activation by introducing the dominant-negative JNK1 gene attenuates the TGF-beta 1-down-regulated E-cadherin expression, and TGF-beta 1-up-regulated alpha-SMA, Collagen I, and PAI-1 expression, leading to the inhibition of EMT in primarily cultured RPMCs. Furthermore, TGF-beta 1 induces a bimodal JNK activation with peaks at 10 minutes and 12 hours post treatment in RPMCs. In addition, the inhibition of Smad3 activation by introducing a Smad3 mutant mitigates the TGF-beta 1-induced second wave, but not the first wave, of JNK1 activation in RPMCs. Moreover, the inhibition of JNK1 activation prevents the TGF-beta 1-induced Smad3 activation and nuclear translocation, and inhibition of the TGF-gamma 1-induced second wave of JNK activation greatly reduced TGF-beta 1-induced EMT in RPMCs. These data indicate a crosstalk between the JNK1 and Samd3 pathways during the TGF-beta 1-induced EMT and fibrotic process in RPMCs. Therefore, our findings may provide new insights into understanding the regulation of the TGF-beta 1-related JNK and Smad signaling in the development of fibrosis.	[Liu, Qinghua; Zhang, Yu; Mao, Haiping; Chen, Wei; Luo, Ning; Zhou, Qin; Chen, Wenfang; Yu, Xueqing] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liu, QH (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn		Mao, Haiping/0000-0002-3608-3851; Zhou, Qin/0000-0002-7205-082X	Research Fund for the Doctoral Program of Higher Education of China [20100171120067]; Natural Science Foundation of Guangdong Province of China [10451008901005957]; Medical Scientific Research Foundation of Guangdong Province of China [A2010148]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province of China	This study was supported by Research Fund for the Doctoral Program of Higher Education of China (20100171120067), Natural Science Foundation of Guangdong Province of China (10451008901005957) and Medical Scientific Research Foundation of Guangdong Province of China (A2010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Arany PR, 2008, ONCOGENE, V27, P2507, DOI 10.1038/sj.onc.1210889; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Chang Y, 2009, J INT MED RES, V37, P727, DOI 10.1177/147323000903700316; Chang Y, 2010, MOL CELL BIOCHEM, V335, P83, DOI 10.1007/s11010-009-0245-8; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frey RS, 1997, CANCER RES, V57, P628; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Gokal R, 2002, J AM SOC NEPHROL, V13, pS104; Guo BL, 2005, KIDNEY INT, V68, P972, DOI 10.1111/j.1523-1755.2005.00491.x; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Higuchi C, 2005, THER APHER DIAL, V9, P173, DOI 10.1111/j.1774-9987.2005.00232.x; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Hung KY, 2003, NEPHROL DIAL TRANSPL, V18, P670, DOI 10.1093/ndt/gfg141; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kutz SM, 2001, J CELL SCI, V114, P3905; Lindert S, 2005, MATRIX BIOL, V24, P198, DOI 10.1016/j.matbio.2005.03.003; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nie J, 2007, KIDNEY INT, V72, P1336, DOI 10.1038/sj.ki.5002533; Oh KH, 2005, INT J ARTIF ORGANS, V28, P129, DOI 10.1177/039139880502800208; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun YY, 2009, AM J NEPHROL, V30, P84, DOI 10.1159/000203362; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Woodward RN, 2006, ATHEROSCLEROSIS, V186, P92, DOI 10.1016/j.atherosclerosis.2005.07.026; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3	47	50	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32009	10.1371/journal.pone.0032009	http://dx.doi.org/10.1371/journal.pone.0032009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384127	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500053
J	Menezes, MR; Waisertreiger, ISR; Lopez-Bertoni, H; Luo, X; Pavlov, YI				Menezes, Miriam Rose; Waisertreiger, Irina S-R.; Lopez-Bertoni, Hernando; Luo, Xu; Pavlov, Youri I.			Pivotal Role of Inosine Triphosphate Pyrophosphatase in Maintaining Genome Stability and the Prevention of Apoptosis in Human Cells	PLOS ONE			English	Article							BASE ANALOG 6-N-HYDROXYLAMINOPURINE; ADVERSE DRUG-REACTIONS; ESCHERICHIA-COLI; CHROMOSOMAL FRAGMENTATION; MODIFIED PURINES; DNA-DAMAGE; GENE; MUTAGENESIS; REPAIR; SPECIFICITY	Pure nucleotide precursor pools are a prerequisite for high-fidelity DNA replication and the suppression of mutagenesis and carcinogenesis. ITPases are nucleoside triphosphate pyrophosphatases that clean the precursor pools of the non-canonical triphosphates of inosine and xanthine. The precise role of the human ITPase, encoded by the ITPA gene, is not clearly defined. ITPA is clinically important because a widespread polymorphism, 94C>A, leads to null ITPase activity in erythrocytes and is associated with an adverse reaction to thiopurine drugs. We studied the cellular function of ITPA in HeLa cells using the purine analog 6-N hydroxylaminopurine (HAP), whose triphosphate is also a substrate for ITPA. In this study, we demonstrate that ITPA knockdown sensitizes HeLa cells to HAP-induced DNA breaks and apoptosis. The HAP-induced DNA damage and cytotoxicity observed in ITPA knockdown cells are rescued by an overexpression of the yeast ITPase encoded by the HAM1 gene. We further show that ITPA knockdown results in elevated mutagenesis in response to HAP treatment. Our studies reveal the significance of ITPA in preventing base analog-induced apoptosis, DNA damage and mutagenesis in human cells. This implies that individuals with defective ITPase are predisposed to genome damage by impurities in nucleotide pools, which is drastically augmented by therapy with purine analogs. They are also at an elevated risk for degenerative diseases and cancer.	[Menezes, Miriam Rose; Waisertreiger, Irina S-R.; Lopez-Bertoni, Hernando; Luo, Xu; Pavlov, Youri I.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Menezes, MR (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ypavlov@unmc.edu	Lopez, Hernando/AAY-7655-2020; Menezes, Miriam-Rose/I-8002-2019; Pavlov, Youri/T-7532-2017	Lopez, Hernando/0000-0001-6618-1092; Menezes, Miriam-Rose/0000-0001-6478-9600; Pavlov, Youri/0000-0003-1179-5796	Nebraska Department of Health and Human Services [LB506]; University of Nebraska Medical Center Eppley Cancer Center [010107]; National Institute of Cancer [R01 CA129925]; University of Nebraska Medical Center; NATIONAL CANCER INSTITUTE [R01CA129925] Funding Source: NIH RePORTER	Nebraska Department of Health and Human Services; University of Nebraska Medical Center Eppley Cancer Center; National Institute of Cancer; University of Nebraska Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Nebraska Department of Health and Human Services LB506 Grant, by a University of Nebraska Medical Center Eppley Cancer Center 010107 Pilot Grant, and in part by the National Institute of Cancer Grant R01 CA129925 to Youri I. Pavlov. Miriam R. Menezes was supported by a University of Nebraska Medical Center graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULMASIH MT, 1986, J BIOL CHEM, V261, P2020; Abolhassani N, 2010, NUCLEIC ACIDS RES, V38, P2891, DOI 10.1093/nar/gkp1250; AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; Bakker JA, 2011, NUCLEOS NUCLEOT NUCL, V30, P839, DOI 10.1080/15257770.2011.606789; BARRETT JC, 1981, P NATL ACAD SCI-BIOL, V78, P5685, DOI 10.1073/pnas.78.9.5685; Behmanesh M, 2009, CELL DEATH DIFFER, V16, P1315, DOI 10.1038/cdd.2009.53; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; BIESELE JJ, 1963, EXP CELL RES, P525; Bradshaw JS, 2003, MOL MICROBIOL, V48, P1711, DOI 10.1046/j.1365-2958.2003.03540.x; Brem R, 2010, ONCOGENE, V29, P3953, DOI 10.1038/onc.2010.140; Budke B, 2010, MOL MICROBIOL, V75, P230, DOI 10.1111/j.1365-2958.2009.06994.x; Burgis NE, 2003, J BACTERIOL, V185, P3101, DOI 10.1128/JB.185.10.3101-3110.2003; Burgis NE, 2007, J BIOL CHEM, V282, P3531, DOI 10.1074/jbc.M608708200; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Cariani E, 2011, CLIN CHEM LAB MED, V49, P1247, DOI 10.1515/CCLM.2011.618; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; ELMORE E, 1983, CANCER RES, V43, P1650; Fowler RG, 1997, FEMS MICROBIOL REV, V21, P43, DOI 10.1111/j.1574-6976.1997.tb00344.x; FREESE E., 1959, PROC NATL ACAD SCI, V45, P622, DOI 10.1073/pnas.45.4.622; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Kouzminova EA, 2004, P NATL ACAD SCI USA, V101, P16262, DOI 10.1073/pnas.0405943101; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Kozmin SG, 1998, MUTAT RES-FUND MOL M, V402, P41, DOI 10.1016/S0027-5107(97)00280-7; Kozmin SG, 1998, ACTA BIOCHIM POL, V45, P645, DOI 10.18388/abp.1998_4202; Kozmin SG, 2000, J BACTERIOL, V182, P3361, DOI 10.1128/JB.182.12.3361-3367.2000; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Lin SR, 2001, J BIOL CHEM, V276, P18695, DOI 10.1074/jbc.M011084200; Loeb LA, 2010, SEMIN CANCER BIOL, V20, P279, DOI 10.1016/j.semcancer.2010.10.006; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lukas L, 2006, GENETICS, V172, P1359, DOI 10.1534/genetics.105.051144; Marinaki AM, 2004, NUCLEOS NUCLEOT NUCL, V23, P1393, DOI 10.1081/NCN-200027639; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Marsh S, 2004, J HUM GENET, V49, P579, DOI 10.1007/s10038-004-0183-y; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Moe A, 2003, NUCLEIC ACIDS RES, V31, P3893, DOI 10.1093/nar/gkg472; Mullen P, 2004, METH MOLEC MED, V88, P171; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Noskov VN, 1996, YEAST, V12, P17, DOI 10.1002/(SICI)1097-0061(199601)12:1<17::AID-YEA875>3.0.CO;2-I; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; PAVLOV YI, 1986, GENETIKA+, V22, P2235; Pavlov YI, 1996, MUTAT RES-FUND MOL M, V357, P1, DOI 10.1016/0027-5107(96)00060-7; Porta J, 2006, ACTA CRYSTALLOGR F, V62, P1076, DOI 10.1107/S1744309106041790; Qian Y, 1998, MUTAT RES-GEN TOX EN, V418, P61, DOI 10.1016/S1383-5718(98)00108-9; Rotman E, 2007, J BACTERIOL, V189, P6976, DOI 10.1128/JB.00776-07; Sakumi K, 2010, MUTAT RES-GEN TOX EN, V703, P43, DOI 10.1016/j.mrgentox.2010.06.009; Sekiguchi M, 1992, Nucleic Acids Symp Ser, P101; Shcherbakova PV, 1996, MUTAT RES-GENET TOX, V369, P33, DOI 10.1016/S0165-1218(96)90045-2; SHCHERBAKOVA PV, 1993, MUTAGENESIS, V8, P417, DOI 10.1093/mutage/8.5.417; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Stepchenkova EI, 2009, RUSS J GENET+, V45, P409, DOI 10.1134/S1022795409040048; Stepchenkova EI, 2009, J MOL BIOL, V392, P602, DOI 10.1016/j.jmb.2009.07.051; SZMIGIERO L, 1988, ANAL BIOCHEM, V168, P88, DOI 10.1016/0003-2697(88)90014-0; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TSUTSUI T, 1985, MUTAT RES, V148, P107, DOI 10.1016/0027-5107(85)90213-1; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Vallur AC, 2005, DNA REPAIR, V4, P1088, DOI 10.1016/j.dnarep.2005.05.008; VERHOEF VL, 1980, BIOCHEM GENET, V18, P235, DOI 10.1007/BF00484239; Waisertreiger ISR, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/872180; Xiong H, 2010, FUND CLIN PHARMACOL, V24, P393, DOI 10.1111/j.1472-8206.2009.00770.x	68	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32313	10.1371/journal.pone.0032313	http://dx.doi.org/10.1371/journal.pone.0032313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384212	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500076
J	Padhi, AK; Kumar, H; Vasaikar, SV; Jayaram, B; Gomes, J				Padhi, Aditya K.; Kumar, Hirdesh; Vasaikar, Suhas V.; Jayaram, Bhyravabhotla; Gomes, James			Mechanisms of Loss of Functions of Human Angiogenin Variants Implicated in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; PROTEIN-LIGAND COMPLEXES; MOLECULAR-DYNAMICS; HEXANUCLEOTIDE REPEAT; ENDOTHELIAL-CELLS; ANG GENE; ALS-FTD; MUTATIONS; IDENTIFICATION; DOCKING	Background: Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis. Methodology/Principal Findings: MD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99 degrees. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues (RRR33)-R-31 that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies. Conclusions/Significance: Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues (RRR33)-R-31 results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss.	[Padhi, Aditya K.; Kumar, Hirdesh; Vasaikar, Suhas V.; Jayaram, Bhyravabhotla; Gomes, James] Indian Inst Technol, Sch Biol Sci, New Delhi, India; [Jayaram, Bhyravabhotla] Indian Inst Technol, Dept Chem, New Delhi 110016, India; [Jayaram, Bhyravabhotla] Indian Inst Technol, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Padhi, AK (corresponding author), Indian Inst Technol, Sch Biol Sci, New Delhi, India.	jgomes@bioschool.iitd.ac.in	Vasaikar, Suhas/AAJ-5885-2020; Jayaram, B/G-9130-2011; Kumar, Hirdesh/I-6843-2016	Jayaram, B/0000-0002-5495-2213; Kumar, Hirdesh/0000-0002-8488-3001; Padhi, Aditya Kumar/0000-0001-6732-2547; Vasaikar, Suhas/0000-0001-9763-3899	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Programme support to the Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology Delhi from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), Government of India is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bikadi Z, 2007, ARCH BIOCHEM BIOPHYS, V461, P225, DOI 10.1016/j.abb.2007.02.020; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; CURRAN TP, 1993, BIOCHEMISTRY-US, V32, P2307, DOI 10.1021/bi00060a023; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-Santiago R, 2009, J NEUROL, V256, P1337, DOI 10.1007/s00415-009-5124-4; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; HARPER JW, 1988, P NATL ACAD SCI USA, V85, P7139, DOI 10.1073/pnas.85.19.7139; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; Jenkins JL, 2003, BIOCHEMISTRY-US, V42, P6674, DOI 10.1021/bi034164e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Leonidas DD, 1999, J MOL BIOL, V285, P1209, DOI 10.1006/jmbi.1998.2378; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schuyler AD, 2009, J PHYS CHEM B, V113, P6613, DOI 10.1021/jp808736c; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P1726, DOI 10.1021/bi00430a045; Shapiro R, 1998, BIOCHEMISTRY-US, V37, P6847, DOI 10.1021/bi9800146; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Singh T, 2011, J CHEM INF MODEL, V51, P2515, DOI 10.1021/ci200193z; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Ueki M, 2008, CELL BIOCHEM FUNCT, V26, P718, DOI 10.1002/cbf.1498; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5	53	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32479	10.1371/journal.pone.0032479	http://dx.doi.org/10.1371/journal.pone.0032479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384259	Green Published, gold			2022-12-25	WOS:000302918500095
J	Pareja, M; Qvarfordt, E; Webster, B; Mayon, P; Pickett, J; Birkett, M; Glinwood, R				Pareja, Martin; Qvarfordt, Erika; Webster, Ben; Mayon, Patrick; Pickett, John; Birkett, Michael; Glinwood, Robert			Herbivory by a Phloem-Feeding Insect Inhibits Floral Volatile Production	PLOS ONE			English	Article							LEAF HERBIVORY; PLANT DEFENSE; BRASSICA-NAPUS; APHID; ARABIDOPSIS; RESPONSES; ECOLOGY; POLLINATION; SPECIALIST; SALICYLATE	There is extensive knowledge on the effects of insect herbivory on volatile emission from vegetative tissue, but little is known about its impact on floral volatiles. We show that herbivory by phloem-feeding aphids inhibits floral volatile emission in white mustard Sinapis alba measured by gas chromatographic analysis of headspace volatiles. The effect of the Brassica specialist aphid Lipaphis erysimi was stronger than the generalist aphid Myzus persicae and feeding by chewing larvae of the moth Plutella xylostella caused no reduction in floral volatile emission. Field observations showed no effect of L. erysimi-mediated floral volatile emission on the total number of flower visits by pollinators. Olfactory bioassays suggested that although two aphid natural enemies could detect aphid inhibition of floral volatiles, their olfactory orientation to infested plants was not disrupted. This is the first demonstration that phloem-feeding herbivory can affect floral volatile emission, and that the outcome of interaction between herbivory and floral chemistry may differ depending on the herbivore's feeding mode and degree of specialisation. The findings provide new insights into interactions between insect herbivores and plant chemistry.	[Pareja, Martin] Univ Fed Lavras, Dept Entomol, Lavras, Brazil; [Qvarfordt, Erika; Webster, Ben; Glinwood, Robert] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Mayon, Patrick; Pickett, John; Birkett, Michael] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England	Universidade Federal de Lavras; Swedish University of Agricultural Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Pareja, M (corresponding author), Univ Fed Lavras, Dept Entomol, Lavras, Brazil.	robert.glinwood@slu.se	Webster, Ben/K-6860-2012; Pareja, Martin/A-9982-2012	Webster, Ben/0000-0002-0437-9826; Glinwood, Robert/0000-0001-5082-5076; Birkett, Michael/0000-0002-3302-2025	Carl Tryggers Stiftelse; Mistra; Stiftelsen Tornspiran; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/J020281/1, BBS/E/C/00005194] Funding Source: researchfish; BBSRC [BBS/E/C/00005194, BB/J020281/1] Funding Source: UKRI	Carl Tryggers Stiftelse; Mistra; Stiftelsen Tornspiran; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from Carl Tryggers Stiftelse to Martin Pareja and by Mistra through the PlantComMistra program. Funding for equipment from Stiftelsen Tornspiran is acknowledged. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2001, ECOLOGY, V82, P2032, DOI 10.1890/0012-9658(2001)082[2032:DAIEOA]2.0.CO;2; Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Aitchison J, 1986, STAT ANAL COMPOSITIO; Armbruster WS, 1997, ECOLOGY, V78, P1661; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Blande JD, 2007, J CHEM ECOL, V33, P767, DOI 10.1007/s10886-007-9264-7; Blight MM, 1997, J CHEM ECOL, V23, P1715, DOI 10.1023/B:JOEC.0000006446.21160.c1; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Bridges M, 2002, P ROY SOC B-BIOL SCI, V269, P187, DOI 10.1098/rspb.2001.1861; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; CHOU TS, 1984, J CHEM SOC CHEM COMM, P1323, DOI 10.1039/c39840001323; DAWSON GW, 1993, PESTIC SCI, V39, P271, DOI 10.1002/ps.2780390404; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dudareva N, 2006, BIOL FLORAL SCENT; Dudareva N, 2006, BIOLOGY OF FLORAL SCENT, P55; DUKAS R, 1989, OIKOS, V54, P281, DOI 10.2307/3565286; Effmert U, 2008, PLANT PHYSIOL, V146, P1996, DOI 10.1104/pp.107.112326; GAONI Y, 1977, TETRAHEDRON LETT, P947; Girling RD, 2008, J EXP BOT, V59, P3077, DOI 10.1093/jxb/ern163; Glinwood R, 2011, OECOLOGIA, V166, P637, DOI 10.1007/s00442-010-1892-x; Glinwood R, 2009, ARTHROPOD-PLANT INTE, V3, P215, DOI 10.1007/s11829-009-9072-9; Han BY, 2002, J AGR FOOD CHEM, V50, P2571, DOI 10.1021/jf010681x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Heil M, 2008, PROG BOT, P360; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hodek I., 1996, ECOLOGY COCCINELLIDA; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2011, CURR OPIN PLANT BIOL, V14, P429, DOI 10.1016/j.pbi.2011.03.023; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Leopold E.J., 1986, ORG SYNTH, V64, P164, DOI DOI 10.1002/0471264180.0S064.25; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Pettersson J, 2008, APPL ENTOMOL ZOOL, V43, P315, DOI 10.1303/aez.2008.315; Raguso RA, 2008, ENTOMOL EXP APPL, V128, P196, DOI 10.1111/j.1570-7458.2008.00683.x; Raguso RA, 2009, FUNCT ECOL, V23, P837, DOI 10.1111/j.1365-2435.2009.01643.x; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Strauss SY, 1997, ECOLOGY, V78, P1617; Theis N, 2006, J CHEM ECOL, V32, P917, DOI 10.1007/s10886-006-9051-x; Theis N, 2009, AM J BOT, V96, P897, DOI 10.3732/ajb.0800300; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; van Eck L, 2010, PLANT BIOTECHNOL J, V8, P1023, DOI 10.1111/j.1467-7652.2010.00539.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8	54	39	42	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31971	10.1371/journal.pone.0031971	http://dx.doi.org/10.1371/journal.pone.0031971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384116	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000302916100042
J	Ramanadhan, S; Salhi, C; Achille, E; Baril, N; D'Entremont, K; Grullon, M; Judge, C; Oppenheimer, S; Reeves, C; Savage, C; Viswanath, K				Ramanadhan, Shoba; Salhi, Carmel; Achille, Erline; Baril, Nashira; D'Entremont, Kerrie; Grullon, Milagro; Judge, Christine; Oppenheimer, Sarah; Reeves, Chrasandra; Savage, Clara; Viswanath, Kasisomayajula			Addressing Cancer Disparities via Community Network Mobilization and Intersectoral Partnerships: A Social Network Analysis	PLOS ONE			English	Article							HEALTH-PROMOTION; PARTICIPATORY RESEARCH; COLLABORATION; CAPACITY; STRATEGY; COALITIONS; FRAMEWORK	Community mobilization and collaboration among diverse partners are vital components of the effort to reduce and eliminate cancer disparities in the United States. We studied the development and impact of intersectoral connections among the members of the Massachusetts Community Network for Cancer Education, Research, and Training (MassCONECT). As one of the Community Network Program sites funded by the National Cancer Institute, this infrastructure-building initiative utilized principles of Community-based Participatory Research (CBPR) to unite community coalitions, researchers, policymakers, and other important stakeholders to address cancer disparities in three Massachusetts communities: Boston, Lawrence, and Worcester. We conducted a cross-sectional, sociometric network analysis four years after the network was formed. A total of 38 of 55 members participated in the study (69% response rate). Over four years of collaboration, the number of intersectoral connections reported by members (intersectoral out-degree) increased, as did the extent to which such connections were reported reciprocally (intersectoral reciprocity). We assessed relationships between these markers of intersectoral collaboration and three intermediate outcomes in the effort to reduce and eliminate cancer disparities: delivery of community activities, policy engagement, and grants/publications. We found a positive and statistically significant relationship between intersectoral out-degree and community activities and policy engagement (the relationship was borderline significant for grants/publications). We found a positive and statistically significant relationship between intersectoral reciprocity and community activities and grants/publications (the relationship was borderline significant for policy engagement). The study suggests that intersectoral connections may be important drivers of diverse intermediate outcomes in the effort to reduce and eliminate cancer disparities. The findings support investment in infrastructure-building and intersectoral mobilization in addressing disparities and highlight the benefits of using CBPR approaches for such work.	[Ramanadhan, Shoba; Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Salhi, Carmel] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Achille, Erline; Baril, Nashira] Boston Publ Hlth Commiss, New England Ctr Excellence Eliminat Dispar, Boston, MA USA; [D'Entremont, Kerrie; Grullon, Milagro] City Lawrence, Mayors Hlth Task Force, Lawrence, MA USA; [Judge, Christine; Oppenheimer, Sarah] Harvard Univ, Sch Publ Hlth, Div Publ Hlth Practice, Boston, MA 02115 USA; [Reeves, Chrasandra] Boston Alliance Community Hlth, Boston, MA USA; [Savage, Clara] Common Pathways, Worcester, MA USA; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ramanadhan, S (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	shoba_ramanadhan@dfci.harvard.edu			National Cancer Institute [5 U01 CA114644]; NATIONAL CANCER INSTITUTE [U01CA114644] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (Grant#: 5 U01 CA114644, Viswanath, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One co-author, Milagro Grullon, currently works for a commercial enterprise, but was employed by the City of Lawrence Mayor's Health Task Force at the time this work was conducted and the work was not funded or impacted by Lawrence Community Connections.	Borgatti S. P., 2005, UCINET WINDOWS SOFTW; Bracht N., 1990, HEALTH PROMOT INT, V5, P199, DOI [10.1093/heapro/5.3.199, DOI 10.1093/HEAPRO/5.3.199]; Burt R.S., 1992, STRUCTURAL HOLES SOC, DOI DOI 10.1016/J.JET.2007.01.006; Butterfoss FD, 1996, HEALTH EDUC QUART, V23, P65, DOI 10.1177/109019819602300105; Dyer JH, 1998, ACAD MANAGE REV, V23, P660, DOI 10.2307/259056; Emmons KM, 2008, AM J PREV MED, V35, pS204, DOI 10.1016/j.amepre.2008.05.009; FREEMAN H, 1991, J NATL CANCER I, V83, P526, DOI 10.1093/jnci/83.8.526; Giachello AL, 2003, PUBLIC HEALTH REP, V118, P309, DOI 10.1016/S0033-3549(04)50255-8; Goerzen A, 2005, STRATEGIC MANAGE J, V26, P333, DOI 10.1002/smj.447; Griffith DM, 2010, J PRIM PREV, V31, P31, DOI 10.1007/s10935-010-0202-z; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Hansen MT, 1999, ADMIN SCI QUART, V44, P82, DOI 10.2307/2667032; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; KANTER RM, 1994, HARVARD BUS REV, V72, P96; Koelen MA, 2001, J EPIDEMIOL COMMUN H, V55, P257, DOI 10.1136/jech.55.4.257; Koh H, 2009, MASSCONECT YEA UNPUB; Koh HK, 2010, AM J PUBLIC HEALTH, V100, pS72, DOI 10.2105/AJPH.2009.167353; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; Lasker RD, 2001, MILBANK Q, V79, P179, DOI 10.1111/1468-0009.00203; Lavery SH, 2005, AM J PUBLIC HEALTH, V95, P611, DOI 10.2105/AJPH.2004.047704; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Luque JS, 2011, ANN ANTHROPL PRACT, V35, P112, DOI 10.1111/j.2153-9588.2011.01085.x; Luque J, 2010, J COMMUNITY PSYCHOL, V38, P656, DOI 10.1002/jcop.20386; Maibach EW, 2006, PREVENTING CHRONIC D, V3; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Minkler M, 2008, HLTH BEHAV HLTH ED T, P287; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988; Powell WW, 1999, NETWORKS ORG, V16; Provan KG, 2005, PUBLIC ADMIN REV, V65, P603, DOI 10.1111/j.1540-6210.2005.00487.x; Provan KG, 2003, HEALTH EDUC BEHAV, V30, P646, DOI 10.1177/1090198103255366; Ramanadhan S, 2010, AM J HEALTH PROMOT, V25, P12, DOI 10.4278/ajhp.080826-QUAN-163; Ramanadhan S, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-17; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Sandoval JA, 2011, HLTH ED RES; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shults RA, 2009, AM J PREV MED, V37, P360, DOI 10.1016/j.amepre.2009.07.005; Simons-Morton B, 2011, BEHAV THEORY HLTH PR; Tourangeau Roger, 2000, PSYCHOL SURVEY RESPO; Trans-HHS Cancer Health Disparities Progress Review Group, 2004, MAK CANC HLTH UNPUB; Valente T.W., 2005, MODELS METHODS SOCIA, VVolume 28, P98, DOI DOI 10.1017/CBO9780511811395.006; Valente TW, 2007, AM J PUBLIC HEALTH, V97, P880, DOI 10.2105/AJPH.2005.063644; Valente TW, 2010, AM J PUBLIC HEALTH, V100, P1319, DOI 10.2105/AJPH.2009.171116; Valente TW, 2008, EVAL PROGRAM PLANN, V31, P392, DOI 10.1016/j.evalprogplan.2008.06.002; Valente TW, 2010, SOCIAL NETWORKS MODE; Van Duyn MAS, 2006, CANCER, V107, P1945, DOI 10.1002/cncr.22165; Varda D, 2011, AM J PUBLIC HLTH; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Viswanathan M, 2004, Evid Rep Technol Assess (Summ), P1; Wallerstein N, 2010, AM J PUBLIC HEALTH, V100, pS40, DOI 10.2105/AJPH.2009.184036; Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Williams DR, 2008, J PUBLIC HLTH MANA S, V14; Zenk SN, 2005, METHODS COMMUNITY BA	55	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32130	10.1371/journal.pone.0032130	http://dx.doi.org/10.1371/journal.pone.0032130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927NZ	22384156	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100053
J	Kosir, R; Juvan, P; Perse, M; Budefeld, T; Majdic, G; Fink, M; Sassone-Corsi, P; Rozman, D				Kosir, Rok; Juvan, Peter; Perse, Martina; Budefeld, Tomaz; Majdic, Gregor; Fink, Martina; Sassone-Corsi, Paolo; Rozman, Damjana			Novel Insights into the Downstream Pathways and Targets Controlled by Transcription Factors CREM in the Testis	PLOS ONE			English	Article							RESPONSIVE-ELEMENT MODULATOR; LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; CAMP EARLY REPRESSOR; GERM-CELL APOPTOSIS; GENE-EXPRESSION; BINDING PROTEIN; CIRCADIAN-RHYTHMS; MASTER-SWITCH; CYCLIC-AMP; MOUSE	The essential role of the Crem gene in normal sperm development is widely accepted and is confirmed by azoospermia in male mice lacking the Crem gene. The exact number of genes affected by Crem absence is not known, however a large difference has been observed recently between the estimated number of differentially expressed genes found in Crem knock-out (KO) mice compared to the number of gene loci bound by CREM. We therefore re-examined global gene expression in male mice lacking the Crem gene using whole genome transcriptome analysis with Affymetrix microarrays and compared the lists of differentially expressed genes from Crem(-/-) mice to a dataset of genes where binding of CREM was determined by Chip-seq. We determined the global effect of CREM on spermatogenesis as well as distinguished between primary and secondary effects of the CREM absence. We demonstrated that the absence of Crem deregulates over 4700 genes in KO testis. Among them are 101 genes associated with spermatogenesis 41 of which are bound by CREM and are deregulated in Crem KO testis. Absence of several of these genes in mouse models has proven their importance for normal spermatogenesis and male fertility. Our study showed that the absence of Crem plays a more important role on different aspects of spermatogenesis as estimated previously, with its impact ranging from apoptosis induction to deregulation of major circadian clock genes, steroidogenesis and the cell-cell junction dynamics. Several new genes important for normal spermatogenesis and fertility are down-regulated in KO testis and are therefore possible novel targets of CREM.	[Kosir, Rok; Juvan, Peter; Rozman, Damjana] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana 61000, Slovenia; [Perse, Martina] Univ Ljubljana, Fac Med, Inst Pathol, Ctr Med Expt, Ljubljana, Slovenia; [Budefeld, Tomaz; Majdic, Gregor] Univ Ljubljana, Fac Vet, Ctr Anim Genom, Ljubljana, Slovenia; [Fink, Martina] Univ Med Ctr Ljubljana, Dept Haematol, Ljubljana, Slovenia; [Majdic, Gregor] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Kosir, Rok] Diagenomi Ltd, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana; University of Maribor; University of California System; University of California Irvine	Kosir, R (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana 61000, Slovenia.	damjana.rozman@mf.uni-lj.si	Perse, Martina/AAS-2898-2020; Majdic, Gregor/A-7107-2008; Kosir, Rok/AAT-2901-2020	Majdic, Gregor/0000-0001-9620-2683; Kosir, Rok/0000-0002-1197-9627; Juvan, Peter/0000-0003-2873-5247; Rozman, Damjana/0000-0002-6501-2163	Slovenian Research Agency [J1-9438, P1-0527]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by the Slovenian Research Agency Grants J1-9438 and P1-0527. Rok Kosir was supported by the fellowship from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2008, BIOCHEM BIOPH RES CO, V376, P206, DOI 10.1016/j.bbrc.2008.08.126; Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Beardsley A, 2003, BIOL REPROD, V68, P1299, DOI 10.1095/biolreprod.102.009811; Behr R, 2001, INT J ANDROL, V24, P126, DOI 10.1046/j.1365-2605.2001.00277.x; Beissbarth T, 2003, MOL CELL ENDOCRINOL, V212, P29, DOI 10.1016/j.mce.2003.09.023; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Calvel P, 2010, PHILOS T R SOC B, V365, P1481, DOI 10.1098/rstb.2009.0294; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Cheng CY, 2010, PHILOS T R SOC B, V365, P1459, DOI 10.1098/rstb.2010.0024; Cheng CY, 2005, CONTRACEPTION, V72, P251, DOI 10.1016/j.contraception.2005.03.008; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Cos S, 2008, CURR CANCER DRUG TAR, V8, P691, DOI 10.2174/156800908786733469; Cotman M, 2004, ENDOCRINOLOGY, V145, P1419, DOI 10.1210/en.2003-1332; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; Debeljak N, 1999, WHY IS CHOLESTEROGEN; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Frungieri NB, 2005, ENDOCRINOLOGY, V146, P1541, DOI 10.1210/en.2004-0990; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gellersen B, 2002, MOL HUM REPROD, V8, P965, DOI 10.1093/molehr/8.11.965; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Hurst S, 1998, MOL REPROD DEV, V49, P81, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;81::AID-MRD9&gt;3.0.CO;2-K; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Kennaway DJ, 2002, AM J PHYSIOL-REG I, V282, pR358, DOI 10.1152/ajpregu.00360.2001; Kopera IA, 2010, PHILOS T R SOC B, V365, P1593, DOI 10.1098/rstb.2009.0251; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lee NPY, 2009, CURR MED CHEM, V16, P906, DOI 10.2174/092986709787549262; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Manfredini R, 2005, CHRONOBIOL INT, V22, P417, DOI 10.1081/CBI-200062927; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MONACO L, 1995, P NATL ACAD SCI USA, V92, P10673, DOI 10.1073/pnas.92.23.10673; Mongrain V, 2008, GENES CELLS, V13, P1197, DOI 10.1111/j.1365-2443.2008.01237.x; Morales V, 2003, J ENDOCRINOL, V179, P417, DOI 10.1677/joe.0.1790417; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Nantel Francois, 1996, Frontiers in Bioscience (online), V1, pD266; O'Bryan MK, 2006, INT J ANDROL, V29, P76, DOI 10.1111/j.1365-2605.2005.00614.x; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; OLIVA R, 1991, ANN NY ACAD SCI, V637, P289, DOI 10.1111/j.1749-6632.1991.tb27316.x; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pauley SM, 2004, MED HYPOTHESES, V63, P588, DOI 10.1016/j.mehy.2004.03.020; REHFUSS RP, 1991, J BIOL CHEM, V266, P18431; Rozman D, 1999, MOL ENDOCRINOL, V13, P1951, DOI 10.1210/me.13.11.1951; Rozman D, 1998, DRUG METAB DISPOS, V26, P1199; Russell LD, 1993, SERTOLI CELL, P365; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Sassone-Corsi P, 2000, MOL REPROD DEV, V56, P228, DOI 10.1002/(SICI)1098-2795(200006)56:2+<228::AID-MRD2>3.0.CO;2-B; SassoneCorsi P, 1997, CELL, V88, P163, DOI 10.1016/S0092-8674(00)81834-6; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Shiraishi K, 2000, BIOL REPROD, V63, P1538, DOI 10.1095/biolreprod63.5.1538; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Steger K, 1999, J ANDROL, V20, P747; ULISSE S, 1994, ENDOCRINOLOGY, V135, P2479, DOI 10.1210/en.135.6.2479; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Vouk K, 2005, MOL HUM REPROD, V11, P567, DOI 10.1093/molehr/gah209; Walker WH, 1998, MOL CELL ENDOCRINOL, V143, P167, DOI 10.1016/S0303-7207(98)00082-3; Walker WH, 2010, PHILOS T R SOC B, V365, P1557, DOI 10.1098/rstb.2009.0258; Xiao P, 2008, BIOL PHARM BULL, V31, P201, DOI 10.1248/bpb.31.201; Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262	83	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31798	10.1371/journal.pone.0031798	http://dx.doi.org/10.1371/journal.pone.0031798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384077	Green Published, gold			2022-12-25	WOS:000302875500043
J	Brooks, K; Oakes, V; Edwards, B; Ranall, M; Leo, P; Pavey, S; Pinder, A; Beamish, H; Mukhopadhyay, P; Lambie, D; Gabrielli, B				Brooks, K.; Oakes, V.; Edwards, B.; Ranall, M.; Leo, P.; Pavey, S.; Pinder, A.; Beamish, H.; Mukhopadhyay, P.; Lambie, D.; Gabrielli, B.			A potent Chkl inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress	ONCOGENE			English	Article						Chk1; replicative stress; melanoma	DNA-DAMAGE CHECKPOINT; MITOTIC CATASTROPHE; ANTICANCER THERAPY; G(2) CHECKPOINT; CELL-DEATH; KINASE 1; ATR; CANCER; ACCUMULATION; PHOSPHATASE	There are few effective treatments for metastatic melanoma. Checkpoint kinase 1 (Chk1) inhibitors are being trialled for their efficacy in enhancing conventional chemotherapeutic agents, but their effectiveness as single agents is not known. We have examined the effectiveness of two novel Chk1 selective inhibitors, AR323 and AR678, in a panel of melanoma cell lines and normal cell types. We demonstrate that these drugs display single-agent activity, with IC50s in the low nanomolar range. The drugs produce cytotoxic effects in cell lines that are most sensitive to these drugs, whereas normal cells are only sensitive to these drugs at the higher concentrations where they have cytostatic activity. The cytotoxic effect is the consequence of inhibition of S-phase Chk1, which drives cells prematurely from late S phase into an aberrant mitosis and results in either failure of cytokinesis or cell death through an apoptotic mechanism. The sensitivity to the Chk1 inhibitors was correlated with the level of endogenous DNA damage indicating replicative stress. Chk1 inhibitors are viable single-agent therapies that target melanoma cells with high levels of endogenous DNA damage. This sensitivity suggests that Chk1 is a critical component of an adaptation to replicative stress in these cells. It also suggests that markers of DNA damage may be useful in identifying the melanomas and potentially other tumour types that are more likely to be sensitive to Chk1 inhibitors as single agents. Oncogene (2013) 32, 788-796; doi:10.1038/onc.2012.72; published online 5 March 2012	[Brooks, K.; Oakes, V.; Edwards, B.; Ranall, M.; Leo, P.; Pavey, S.; Pinder, A.; Beamish, H.; Mukhopadhyay, P.; Gabrielli, B.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Lambie, D.] Princess Alexandra Hosp, Dept Pathol, Brisbane, Qld 4102, Australia	University of Queensland	Gabrielli, B (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia.	brianG@uq.edu.au	Leo, Paul/R-4464-2019; Gabrielli, Brian G/B-3655-2011; Mukhopadhyay, Pamela/I-6373-2015; Brooks, Kelly M/F-8248-2017; Leo, Paul J/B-3470-2011; Lambie, Duncan/C-1863-2018; Pavey, Sandra/B-3662-2011	Gabrielli, Brian G/0000-0003-3933-1651; Mukhopadhyay, Pamela/0000-0002-5905-1350; Brooks, Kelly M/0000-0002-9751-5961; Leo, Paul J/0000-0001-8325-4134; Lambie, Duncan/0000-0002-0102-6638; Pavey, Sandra/0000-0003-4519-5932	Cancer Council Queensland; National Health and Medical Research Council (NHMRC Australia); Australia Research Council	Cancer Council Queensland(Cancer Council Queensland); National Health and Medical Research Council (NHMRC Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council(Australian Research Council)	We wish to acknowledge Drs Kurt Davies and Cheryl Napier (Array Biopharma), and KeeMing Chia for their technical assistance, A/Professor Grant McArthur and Dr Petranel Ferrao for their helpful comments, Prof. Penny Jeggo (University of Sussex) for her gift of the FO2 cells, and the Australasian Biospecimen Network (Oncology) for the melanoma cell lines. This work was supported by funding from Cancer Council Queensland, the National Health and Medical Research Council (NHMRC Australia) and the Australia Research Council. Brian Gabrielli is an NHMRC senior research fellow.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brown EJ, 2000, GENE DEV, V14, P397; Burgess A, 2004, ONCOGENE, V23, P6693, DOI 10.1038/sj.onc.1207893; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Davies KD, 2011, ONCOL RES, V19, P349, DOI 10.3727/096504011X13079697132961; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli B, 2007, J BIOL CHEM, V282, P6954, DOI 10.1074/jbc.M610104200; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Lainchbury M, 2011, EXPERT OPIN THER PAT, V21, P1191, DOI 10.1517/13543776.2011.586632; Lazzaro F, 2009, DNA REPAIR, V8, P1055, DOI 10.1016/j.dnarep.2009.04.022; Liu QH, 2000, GENE DEV, V14, P1448; Loffler H, 2006, CELL CYCLE, V5, P2543, DOI 10.4161/cc.5.21.3435; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; McDonald ER, 2001, ANN MED, V33, P113, DOI 10.3109/07853890109002066; McNeely S, 2010, CELL CYCLE, V9, P995, DOI 10.4161/cc.9.5.10935; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Myers K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000324; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Ranall MV, 2010, BIOTECHNIQUES, V48, P379, DOI 10.2144/000113410; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XQ, 1996, CANCER RES, V56, P2510; Wasco MJ, 2008, HUM PATHOL, V39, P1614, DOI 10.1016/j.humpath.2008.03.007	41	66	69	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					788	796		10.1038/onc.2012.72	http://dx.doi.org/10.1038/onc.2012.72			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22391562				2022-12-25	WOS:000315746700012
J	Takayama, Y; Clore, GM				Takayama, Yuki; Clore, G. Marius			Interplay between Minor and Major Groove-binding Transcription Factors Sox2 and Oct1 in Translocation on DNA Studied by Paramagnetic and Diamagnetic NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; PROTEIN-PROTEIN ASSOCIATION; RELAXATION ENHANCEMENT; POU DOMAIN; EXCHANGE SPECTROSCOPY; COGNATE SITES; XPLOR-NIH; COMPLEXES; MACROMOLECULES; VISUALIZATION	The pathways whereby Sox2 scans DNA to locate its specific binding site are investigated by NMR in specific and nonspecific Sox2.DNA complexes and in a specific ternary complex with Oct1 on the Hoxb1 regulatory element. Direct transfer of Sox2 between nonspecific sites on different DNA molecules occurs without dissociation into free solution at a rate of similar to 10(6) M-1 s(-1), whereas one-dimensional sliding proceeds with a diffusion constant of >= 0.1 mu m(2).s(-1). Translocation of Sox2 from one specific DNA site to another occurs via jumping, involving complete dissociation into free solution (k(d)similar to 5-6 s(-1)) followed by reassociation (k(a)similar to 5 x 10(8) M-1 s(-1)). In the presence of Oct1 bound to an adjacent specific site, k(d) is reduced by more than 10-fold. Paramagnetic relaxation measurements, however, demonstrate that sparsely populated (<1%), transient states involving nonspecifically bound Sox2 in rapid exchange with specifically bound Sox2 are sampled in both binary Sox2.DNA- and ternary Oct1.Sox2.Hoxb1-DNA-specific complexes. Moreover, Sox2 modulates the mechanism of translocation of Oct1. Both Sox2 and the Oct1 POUHD domain are transiently released from the specific ternary complex by sliding to an adjacent nonspecific site, followed by direct transfer to another DNA molecule, whereas the Oct1 POUS domain is fixed to its specific site through direct interactions with Sox2. Intermolecular translocation of POUHD results in the formation of a bridged intermediate spanning two DNA molecules, enhancing the probability of complete intermolecular translocation of Oct1. By way of contrast, in the specific Oct1.DNA binary complex, POUS undergoes direct intermolecular translocation, whereas POUHD scans the DNA by sliding.	[Takayama, Yuki; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	National Institutes of Health, NIDDK; Office of the Director of the National Institutes of Health; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health, NIDDK, Intramural Program and by the AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G. M. C.).; Supported by a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Clore GM, 2011, J BIOMOL NMR, V51, P209, DOI 10.1007/s10858-011-9555-8; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Rocco G, 2001, J BIOL CHEM, V276, P20506, DOI 10.1074/jbc.M011175200; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Sahu D, 2007, J AM CHEM SOC, V129, P13232, DOI 10.1021/ja074604f; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200	37	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14349	14363		10.1074/jbc.M112.352864	http://dx.doi.org/10.1074/jbc.M112.352864			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396547	Green Published, hybrid			2022-12-25	WOS:000304003200004
J	Kudo, K; Takasaki, J; Manabe, T; Uryu, H; Yamada, R; Kuroda, E; Kobayashi, N; Matsushita, T				Kudo, Koichiro; Takasaki, Jin; Manabe, Toshie; Uryu, Hideko; Yamada, Ritsuko; Kuroda, Emi; Kobayashi, Nobuyuki; Matsushita, Takeji			Systemic Corticosteroids and Early Administration of Antiviral Agents for Pneumonia with Acute Wheezing due to Influenza A(H1N1)pdm09 in Japan	PLOS ONE			English	Article							A H1N1	Background: Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1) pdm09 has been controversial. Applicability of systemic corticosteroid treatment needs to be evaluated. Methods/Principal Findings: We retrospectively reviewed 89 subjects who were diagnosed with influenza A(H1N1) pdm09 and admitted to a national hospital, Tokyo during the pandemic period. The median age of subjects (45 males) was 8 years (range, 0-71). All subjects were treated with antiviral agents and the median time from symptom onset to initiation of antiviral agents was 2 days (range, 0-7). Subjects were classified into four groups: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing. The characteristics of each group was evaluated. A history of asthma was found more frequently in the wheezing illness (55.6%) and pneumonia with wheezing (43.3%) groups than in the other two groups (p = 0.017). Corticosteroid treatment was assessed among subjects with pneumonia. Oxygen saturation was lower in subjects receiving corticosteroids (steroid group) than in subjects not receiving corticosteroids (no-steroid group) (p < 0.001). The steroid group required greater oxygen supply than the no-steroid group (p < 0.001). No significant difference was found by the Kaplan-Meier method between the steroid and the no-steroid groups in hours to fever alleviation from the initiation of antiviral agents and hospitalization days. In logistic regression analysis, wheezing, pneumonia and oxygen saturation were independent factors associated with using systemic corticosteroids. Conclusion: Patients with wheezing and a history of asthma were frequently found in the study subjects. Systemic corticosteroids together with early administration of antiviral agents to pneumonia with wheezing and possibly without wheezing did not result in negative clinical outcomes and may prevent progression to severe pneumonia in this study population.	[Kudo, Koichiro; Takasaki, Jin; Manabe, Toshie; Uryu, Hideko; Yamada, Ritsuko; Kuroda, Emi; Kobayashi, Nobuyuki; Matsushita, Takeji] Natl Ctr Global Hlth & Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Kudo, K (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	kudo@dcc.go.jp			Ministry of Health, Labour and Welfare [H22-emerging infectious diseases and influenza-002]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	The work was supported by the Ministry of Health, Labour and Welfare for the proggram No. H22-emerging infectious diseases and influenza-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Infectious Disease Surveillance Center, 2009, PAND INFL A H1N1 SIT; Jaian S, 2009, NEW ENGL J MED, V302, P1896; Japanese Society of Allergoology, 2009, ASTHM PREV MAN GUIDL, P113; Kil HR, 2011, CRIT CARE, V15, DOI 10.1186/cc10082; Kim SH, 2011, AM J RESP CRIT CARE, V183, P1207, DOI 10.1164/rccm.201101-0110OC; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Riquelme R, 2011, INT J TUBERC LUNG D, V15, P542, DOI 10.5588/ijtld.10.0539; The Global Initiative for Asthma(GINA), 2010, GLOB START ASTHM MAN; The Ministry of Health Labour and Welfare, 2011, TREND PAND H1N1 2009; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2010, WHO GUIDL PHARM MAN	18	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32280	10.1371/journal.pone.0032280	http://dx.doi.org/10.1371/journal.pone.0032280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393395	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500048
J	Maletzki, C; Jahnke, A; Ostwald, C; Klar, E; Prall, F; Linnebacher, M				Maletzki, Claudia; Jahnke, Annika; Ostwald, Christiane; Klar, Ernst; Prall, Friedrich; Linnebacher, Michael			Ex-vivo Clonally Expanded B Lymphocytes Infiltrating Colorectal Carcinoma Are of Mature Immunophenotype and Produce Functional IgG	PLOS ONE			English	Article							T-CELLS; CANCER; ANTIGEN; ANTIBODIES; SURVIVAL; METASTASIS	Background: Tumor infiltrating B cells (TiBc) have not yet been investigated in detail. This may at least in part be due to technical difficulties. Here we describe a straightforward and reproducible method to isolate and culture TiBc from primary colorectal carcinomas (CRC). Methods/Results: TiBc cultures were generated by Epstein-Barr virus (EBV) immortalization. With this method, monoclonal TiBc cultures were obtained for 14/19 CRCs. As assessed by flow cytometry and ELISA, TiBc showed an activated immunophenotype (CD23(+), CD80(+)) and produced immunoglobulin (Ig; IgG secretion in 55% of the cultures). In functional in vitro analysis, most of the IgGs specifically bound to allogeneic CRC target cells. These data suggest that TiBc are antigen-experienced and thus may exhibit functionality in situ. Additionally, mini-cultures generated from 12 further CRCs revealed TiBc outgrowth exclusively in the presence of EBV. Conclusion: In summary, this simple method provides a cellular tool and our data set the stage for analysing the bivalent role of TiBc; being antigen-presenting cells on the one hand and tumor-specific antibody producers on the other. Additionally, the generation of long-term TiBc cultures and their monoclonal Ig may serve to identify novel tumor-specific antigens.	[Maletzki, Claudia; Jahnke, Annika; Klar, Ernst; Linnebacher, Michael] Univ Rostock, Dept Gen Surg, Div Mol Oncol & Immunotherapy, Rostock, Germany; [Ostwald, Christiane; Prall, Friedrich] Univ Rostock, Inst Pathol, Rostock, Germany	University of Rostock; University of Rostock	Maletzki, C (corresponding author), Univ Rostock, Dept Gen Surg, Div Mol Oncol & Immunotherapy, Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402	"Norddeutsche Tumorbank kolorektales Karzinom'' from Deutsche Krebshilfe [108446]	"Norddeutsche Tumorbank kolorektales Karzinom'' from Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was in part supported by the grant "Norddeutsche Tumorbank kolorektales Karzinom'' from Deutsche Krebshilfe (grant number 108446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brandlein S, 2004, HISTOL HISTOPATHOL, V19, P897, DOI 10.14670/HH-19.897; CHIN Y, 1992, ANTICANCER RES, V12, P1463; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Coronella-Wood JA, 2003, CANCER IMMUNOL IMMUN, V52, P715, DOI 10.1007/s00262-003-0409-4; Dechant M, 2001, CRIT REV ONCOL HEMAT, V39, P69, DOI 10.1016/S1040-8428(01)00105-6; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Domschke C, 2009, CANCER RES, V69, P8420, DOI 10.1158/0008-5472.CAN-09-1627; Fraussen J, 2010, J AUTOIMMUN, V35, P130, DOI 10.1016/j.jaut.2010.05.001; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Fujii E, 2008, PATHOL INT, V58, P559, DOI 10.1111/j.1440-1827.2008.02271.x; Greiner J W, 1990, Cancer Treat Res, V51, P413; Hansen MH, 2002, J IMMUNOL, V169, P2701, DOI 10.4049/jimmunol.169.5.2701; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Kanojia D, 2011, AM J PATHOL, V178, P1009, DOI 10.1016/j.ajpath.2010.11.047; Linnebacher M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-362; Mahmoud SM, 2011, BREAST CANC RES 0614; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Naito Y, 1998, CANCER RES, V58, P3491; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Nzula S, 2003, CANCER RES, V63, P3275; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Prall F, 2004, HUM PATHOL, V35, P808, DOI 10.1016/j.humpath.2004.01.022; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Silk AW, 2009, MOL IMMUNOL, V47, P52, DOI 10.1016/j.molimm.2008.12.025; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vollmers HP, 2005, HISTOL HISTOPATHOL, V20, P927, DOI 10.14670/HH-20.927; WALLACE PK, 1994, J LEUKOCYTE BIOL, V55, P816, DOI 10.1002/jlb.55.6.816; Yasuda M, 2002, CANCER RES, V62, P1751; ZHANG H, 1995, CANCER RES, V55, P3584	33	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32639	10.1371/journal.pone.0032639	http://dx.doi.org/10.1371/journal.pone.0032639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393427	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500079
J	Seixas, S; Ivanova, N; Ferreira, Z; Rocha, J; Victor, BL				Seixas, Susana; Ivanova, Nevyana; Ferreira, Zelia; Rocha, Jorge; Victor, Bruno L.			Loss and Gain of Function in SERPINB11: An Example of a Gene under Selection on Standing Variation, with Implications for Host-Pathogen Interactions	PLOS ONE			English	Article							AMINO-ACID SITES; DETECTING POSITIVE SELECTION; INFLAMMATORY-BOWEL-DISEASE; CODON-SUBSTITUTION MODELS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD	Serine protease inhibitors (SERPINs) are crucial in the regulation of diverse biological processes including inflammation and immune response. SERPINB11, located in the 18q21 gene cluster, is a polymorphic gene/pseudogene coding for a non-inhibitory SERPIN. In a genome-wide scan for recent selection, SERPINB11 was identified as a potential candidate gene for adaptive evolution in Yoruba. The present study sought a better understanding of the evolutionary history of SERPINB11, with special focus on evaluating its selective signature. Through the resequencing of coding and noncoding regions of SERPINB11 in 20 Yorubans and analyzing primate orthologous sequences, we identified a full-length SERPINB11 variant encoding a non-inhibitory SERPIN as the putative candidate of selection - probably driven to higher frequencies by an adaptive response using preexisting variation. In addition, we detected contrasting evolutionary features of SERPINB11 in primates: While primate phylogeny as a whole is under purifying selection, the human lineage shows evidence of positive selection in a few codons, all associated with the active SERPINB11. Comparative modeling studies suggest that positively selected codons reduce SERPINB11's ability to undergo the conformational changes typical of inhibitory SERPINs suggesting that it is evolving towards a new non-inhibitory function in humans. Significant correlations between SERPINB11 variants and the environmental variables, pastoralism and pathogen richness, have led us to propose a selective advantage through host-pathogen interactions, possibly linked to an adaptive response combating the emergence of infectious diseases in recent human evolution. This work represents the first description of a resurrected gene in humans, and may well exemplify selection on standing variation triggered by drastic ecological shifts.	[Seixas, Susana; Ivanova, Nevyana; Ferreira, Zelia; Rocha, Jorge] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Ferreira, Zelia; Rocha, Jorge] Univ Porto, Dept Zool & Anthropol, Fac Sci, P-4100 Oporto, Portugal; [Victor, Bruno L.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa	Seixas, S (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	sseixas@ipatimup.pt	Victor, Bruno L./L-2649-2016; Seixas, Susana/I-5084-2013	Victor, Bruno L./0000-0002-6472-5700; Seixas, Susana/0000-0002-7035-7422; rocha, jorge/0000-0001-5460-7615; Worman, Zelia/0000-0002-7619-7466	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-GMG/64043/2006, SFRH/BD/45907/2008, SFRH/BPD/29708/2006]; POPH-QREN - Promotion of scientific employment; Ministry of Science, Technology and Higher Education	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); POPH-QREN - Promotion of scientific employment; Ministry of Science, Technology and Higher Education	This work was supported by the Portuguese Foundation for Science and Technology (FCT), project grant to S. Seixas - PTDC/SAU-GMG/64043/2006. Z. Ferreira and B.L. Victor are supported by fellowships SFRH/BD/45907/2008 and SFRH/BPD/29708/2006, respectively, from FCT, supported by POPH-QREN - Promotion of scientific employment, supported by the European Social Fund and national funds of the Ministry of Science, Technology and Higher Education. S. Seixas is supported by POPH-QREN - Promotion of scientific employment, supported by the European Social Fund and national funds of the Ministry of Science, Technology and Higher Education. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Askew DJ, 2007, J BIOL CHEM, V282, P24948, DOI 10.1074/jbc.M703182200; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; Barnich N, 2007, WORLD J GASTROENTERO, V13, P5571, DOI 10.3748/wjg.v13.i42.5571; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bots M, 2008, J LEUKOCYTE BIOL, V84, P1238, DOI 10.1189/jlb.0208140; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferreira Z, 2011, MOL BIOL EVOL, V28, P2811, DOI 10.1093/molbev/msr106; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fulton KF, 2005, J BIOL CHEM, V280, P8435, DOI 10.1074/jbc.M410206200; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garrigan D, 2005, GENETICS, V170, P1849, DOI 10.1534/genetics.105.041095; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Irving JA, 2007, MOL CELLULAR ASPECTS, P1; Izuhara K, 2008, CELL MOL LIFE SCI, V65, P2541, DOI 10.1007/s00018-008-8049-7; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; Kim HL, 2008, GENETICS, V178, P1505, DOI 10.1534/genetics.107.083691; Knight P, 2008, BRIT MED BULL, V88, P95, DOI 10.1093/bmb/ldn038; Koda Y, 2000, J MOL EVOL, V50, P243, DOI 10.1007/s002399910028; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Nachman MW, 2000, GENETICS, V156, P297; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nielsen R, 1998, GENETICS, V148, P929; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Orr HA, 2001, GENETICS, V157, P875; Patin E, 2006, HUM MUTAT, V27, P720, DOI 10.1002/humu.9438; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pellegrini A, 2004, BBA-GEN SUBJECTS, V1672, P76, DOI 10.1016/j.bbagen.2004.02.010; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Ragg H, 2001, MOL BIOL EVOL, V18, P577, DOI 10.1093/oxfordjournals.molbev.a003838; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheinfeldt LB, 2009, MOL BIOL EVOL, V26, P1357, DOI 10.1093/molbev/msp045; Seixas S, 2007, MOL BIOL EVOL, V24, P587, DOI 10.1093/molbev/msl187; Silva LM, 2010, GLYCOCONJUGATE J, V27, P61, DOI 10.1007/s10719-009-9255-8; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2000, GENETICS, V155, P1865; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	95	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32518	10.1371/journal.pone.0032518	http://dx.doi.org/10.1371/journal.pone.0032518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393410	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500063
J	Wu, YR; Messing, J				Wu, Yongrui; Messing, Joachim			RNA Interference Can Rebalance the Nitrogen Sink of Maize Seeds without Losing Hard Endosperm	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; LOCI	Background: One of the goals of plant breeding is to create crops to provide better nutrition for humans and livestock. Insufficient intake of protein is one of the most severe factors affecting the growth and development of children in developing countries. More than a century ago, in 1896, Hopkins initiated the well-known Illinois long-term selection for maize seed protein concentration, yielding four protein strains. By continuously accumulating QTLs, Illinois High Protein (IHP) reached a protein level 2.5-fold higher than normal maize, with the most increased fraction being the zein protein, which was shown to contain no lysine soon after the long-term selection program initiated. Therefore, IHP is of little value for feeding humans and monogastric animals. Although high-lysine lines of non-vitreous mutants were based on reduced zeins, the kernel soft texture precluded their practical use. Kernel hardness in opaque 2 (o2) could be restored in quality protein maize (QPM) with quantitative trait loci called o2 modifiers (Mo2s), but those did not increase total protein levels. Methods: The most predominant zeins are the 22- and 19-kDa alpha-zeins. To achieve a combination of desired traits, we used RNA interference (RNAi) against both alpha-zeins in IHP and evaluated the silencing effect by SDS-PAGE. Total protein, amino acid composition and kernel texture were analyzed. Conclusions: The alpha-zeins were dramatically reduced, but the high total seed protein level remained unchanged by complementary increase of non-zein proteins. Moreover, the residual zein levels still allowed for a vitreous hard seed. Such dramatic rebalancing of the nitrogen sink could have a major impact in world food supply.	[Wu, Yongrui; Messing, Joachim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Wu, YR (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.	messing@waksman.rutgers.edu		Messing, Joachim/0000-0001-8260-2643				Dudley JW, 2007, CROP SCI, V47, pS20, DOI 10.2135/cropsci2007.04.0003IPBS; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Flint-Garcia SA, 2009, THEOR APPL GENET, V119, P1129, DOI 10.1007/s00122-009-1115-1; Holding DR, 2008, THEOR APPL GENET, V117, P157, DOI 10.1007/s00122-008-0762-y; Holding David R., 2009, V63, P269; Hopkins C.G., 1899, ILL AGR EXP STN B, V55, P205; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; Osborne T B, 1908, Science, V28, P417, DOI 10.1126/science.28.718.417; Osborne TB, 1914, J BIOL CHEM, V18, P1; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; REGGIANI R, 1985, Genetica Agraria, V39, P221; Segal G, 2003, GENETICS, V165, P387; Vasal S. K., 1980, Improvement of quality traits of maize for grain and silage use., P37; Wu YR, 2011, GENETICS, V188, P1019, DOI 10.1534/genetics.111.131078	15	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32850	10.1371/journal.pone.0032850	http://dx.doi.org/10.1371/journal.pone.0032850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393455	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500110
J	Colinet, H; Renault, D; Charoy-Guevel, B; Com, E				Colinet, Herve; Renault, David; Charoy-Guevel, Blandine; Com, Emmanuelle			Metabolic and Proteomic Profiling of Diapause in the Aphid Parasitoid Praon volucre	PLOS ONE			English	Article							NORTHERN HOUSE MOSQUITO; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; FLESH FLY; INSECT DIAPAUSE; COTTON BOLLWORM; COLD TOLERANCE; PIPECOLIC ACID; STRESS; SORBITOL	Background: Diapause, a condition of developmental arrest and metabolic depression exhibited by a wide range of animals is accompanied by complex physiological and biochemical changes that generally enhance environmental stress tolerance and synchronize reproduction. Even though some aspects of diapause have been well characterized, very little is known about the full range of molecular and biochemical modifications underlying diapause in non-model organisms. Methodology/Principal Findings: In this study we focused on the parasitic wasp, Praon volucre that exhibits a pupal diapause in response to environmental signals. System-wide metabolic changes occurring during diapause were investigated using GC-MS metabolic fingerprinting. Moreover, proteomic changes were studied in diapausing versus nondiapausing phenotypes using a combination of two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry. We found a reduction of Krebs cycle intermediates which most likely resulted from the metabolic depression. Glycolysis was galvanized, probably to favor polyols biosynthesis. Diapausing parasitoids accumulated high levels of cryoprotective polyols, especially sorbitol. A large set of proteins were modulated during diapause and these were involved in various functions such as remodeling of cytoskeleton and cuticle, stress tolerance, protein turnover, lipid metabolism and various metabolic enzymes. Conclusions/Significance: The results presented here provide some first clues about the molecular and biochemical events that characterize the diapause syndrome in aphid parasitoids. These data are useful for probing potential commonality of parasitoids diapause with other taxa and they will help creating a general understanding of diapause underpinnings and a background for future interpretations.	[Colinet, Herve; Renault, David] Univ Rennes 1, CNRS, UMR 6553, Rennes, France; [Colinet, Herve] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr BDIV, B-3000 Louvain, Belgium; [Charoy-Guevel, Blandine; Com, Emmanuelle] Univ Rennes 1, Prote Core Facil Biogenouest, IRSET, INSERM,U1085, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Colinet, H (corresponding author), Univ Rennes 1, CNRS, UMR 6553, Bat 14A, Rennes, France.	herve.colinet@uclouvain.be	, Protim/C-4687-2012; Colinet, hervé/B-3677-2019; Com, Emmanuelle/AAD-2312-2020; Com, Emmanuelle/E-8656-2011; colinet, hervé/K-8768-2019	Colinet, hervé/0000-0002-8806-3107; Com, Emmanuelle/0000-0002-7401-817X; Com, Emmanuelle/0000-0002-7401-817X; GUEVEL, Blandine/0000-0002-4592-603X; RENAULT, David/0000-0003-3644-1759	Fonds de la Recherche Scientifique - FNRS in Belgium	Fonds de la Recherche Scientifique - FNRS in Belgium(Fonds de la Recherche Scientifique - FNRS)	This study was supported by Fonds de la Recherche Scientifique - FNRS in Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; AYMESOUTHGATE A, 1989, J CELL BIOL, V108, P521, DOI 10.1083/jcb.108.2.521; Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; Bao B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-224; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Chen LZ, 2010, J INSECT PHYSIOL, V56, P247, DOI 10.1016/j.jinsphys.2009.10.008; ChristiansenWeniger P, 1997, ENTOMOPHAGA, V42, P165, DOI 10.1007/BF02769894; Colinet H, 2010, ANN APPL BIOL, V156, P147, DOI 10.1111/j.1744-7348.2009.00374.x; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Colinet H, 2011, BIOL CONTROL, V58, P83, DOI 10.1016/j.biocontrol.2011.04.014; Colinet H, 2010, PHYSIOL ENTOMOL, V35, P301, DOI 10.1111/j.1365-3032.2010.00743.x; Com E, 2003, MOL CELL PROTEOMICS, V2, P248, DOI 10.1074/mcp.M300010-MCP200; Com E, 2011, METHODS MOL BIOL, V691, P187, DOI 10.1007/978-1-60761-849-2_11; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Courant F, 2009, ANALYST, V134, P1637, DOI 10.1039/b901813a; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Denlinger DL., 2004, COMP MOL INSECT SCI, V3, P615; DENLINGER DL, 2000, CE MO RE ST, V1, P259; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Flannagan RD, 1998, P NATL ACAD SCI USA, V95, P5616, DOI 10.1073/pnas.95.10.5616; GEKKO K, 1981, J BIOCHEM-TOKYO, V90, P1633, DOI 10.1093/oxfordjournals.jbchem.a133638; GOUESBET G, 1994, MICROBIOL-SGM, V140, P2415, DOI 10.1099/13500872-140-9-2415; Gouffi K, 2000, APPL ENVIRON MICROB, V66, P2358, DOI 10.1128/AEM.66.6.2358-2364.2000; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hodkova M, 2004, EUR J ENTOMOL, V101, P445, DOI 10.14411/eje.2004.064; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Langer A, 2000, J INSECT PHYSIOL, V46, P671, DOI 10.1016/S0022-1910(99)00155-9; Lee KY, 1998, J INSECT PHYSIOL, V44, P221, DOI 10.1016/S0022-1910(97)00173-X; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Li AQ, 2009, J MED ENTOMOL, V46, P1382, DOI 10.1603/033.046.0618; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Pavlides SC, 2011, J INSECT PHYSIOL, V57, P635, DOI 10.1016/j.jinsphys.2011.03.022; Pinter M, 1998, INSECT BIOCHEM MOLEC, V28, P91, DOI 10.1016/S0965-1748(97)00095-7; Polgar LA, 2000, ENTOMOL EXP APPL, V97, P21, DOI 10.1023/A:1004004801807; PULLIN AS, 1992, J INSECT PHYSIOL, V38, P319, DOI 10.1016/0022-1910(92)90056-J; Pullin AS, 1996, EUR J ENTOMOL, V93, P121; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Renaut J, 2006, PHYSIOL PLANTARUM, V126, P97, DOI 10.1111/j.1399-3054.2006.00617.x; Reynolds JA, 2009, J EXP BIOL, V212, P2074, DOI 10.1242/jeb.027367; Rinehart JP, 2010, J INSECT PHYSIOL, V56, P603, DOI 10.1016/j.jinsphys.2009.12.007; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Salvucci ME, 2000, J THERM BIOL, V25, P353, DOI 10.1016/S0306-4565(99)00107-2; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Soares-Costa A, 2011, J INSECT PHYSIOL, V57, P462, DOI 10.1016/j.jinsphys.2011.01.006; Storey J. M., 2005, FUNCTIONAL METABOLIS, P473; STOREY KB, 1983, CRYOBIOLOGY, V20, P365, DOI 10.1016/0011-2240(83)90025-1; STORY JM, 1983, J COMP PHYSIOL, V149, P495, DOI 10.1007/BF00690008; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tanaka K, 2007, INSECT BIOCHEM MOLEC, V37, P338, DOI 10.1016/j.ibmb.2006.12.006; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Thiele H, 2008, J PROTEOM BIOINFORM, V1, P485, DOI DOI 10.4172/jpb.1000056; Thiele H, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-141; Waller M, 2007, LC GC N AM, P39; Wolfe GR, 1998, J INSECT PHYSIOL, V44, P597, DOI 10.1016/S0022-1910(98)00035-3; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; YAGINUMA T, 1978, J INSECT PHYSIOL, V24, P347, DOI 10.1016/0022-1910(78)90074-4; Yocum GD, 2005, J INSECT PHYSIOL, V51, P621, DOI 10.1016/j.jinsphys.2004.11.008; Yocum GD, 2009, EUR J ENTOMOL, V106, P471, DOI 10.14411/eje.2009.059; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108; Zhou Q, 2008, MAR BIOTECHNOL, V10, P438, DOI 10.1007/s10126-007-9079-0	82	49	57	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32606	10.1371/journal.pone.0032606	http://dx.doi.org/10.1371/journal.pone.0032606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389713	Green Published, gold			2022-12-25	WOS:000302999600052
J	Shalapour, S; Deiser, K; Kuhl, AA; Glauben, R; Krug, SM; Fischer, A; Sercan, O; Chappaz, S; Bereswill, S; Heimesaat, MM; Loddenkemper, C; Fromm, M; Finke, D; Hammerling, GJ; Arnold, B; Siegmund, B; Schuler, T				Shalapour, Shabnam; Deiser, Katrin; Kuehl, Anja A.; Glauben, Rainer; Krug, Susanne M.; Fischer, Andre; Sercan, Oezen; Chappaz, Stephane; Bereswill, Stefan; Heimesaat, Markus M.; Loddenkemper, Christoph; Fromm, Michael; Finke, Daniela; Haemmerling, Guenter J.; Arnold, Bernd; Siegmund, Britta; Schueler, Thomas			Interleukin-7 Links T Lymphocyte and Intestinal Epithelial Cell Homeostasis	PLOS ONE			English	Article							CHRONIC COLITIS; TRANSGENIC MICE; BETA-CATENIN; IN-VIVO; IL-7; INNATE; INFLAMMATION; RECEPTOR; DIFFERENTIATION; PROLIFERATION	Interleukin-7 (IL-7) is a major survival factor for mature T cells. Therefore, the degree of IL-7 availability determines the size of the peripheral T cell pool and regulates T cell homeostasis. Here we provide evidence that IL-7 also regulates the homeostasis of intestinal epithelial cells (IEC), colon function and the composition of the commensal microflora. In the colon of T cell-deficient, lymphopenic mice, IL-7-producing IEC accumulate. IEC hyperplasia can be blocked by IL-7-consuming T cells or the inactivation of the IL-7/IL-7R signaling pathway. However, the blockade of the IL-7/IL-7R signaling pathway renders T cell-deficient mice more sensitive to chemically-induced IEC damage and subsequent colitis. In summary, our data demonstrate that IL-7 promotes IEC hyperplasia under lymphopenic conditions. Under non-lymphopenic conditions, however, T cells consume IL-7 thereby limiting IEC expansion and survival. Hence, the degree of IL-7 availability regulates both, T cell and IEC homeostasis.	[Shalapour, Shabnam; Deiser, Katrin; Sercan, Oezen; Schueler, Thomas] Charite, Inst Immunol, D-13353 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Res Ctr ImmunoSci, Inst Pathol, D-13353 Berlin, Germany; [Glauben, Rainer; Siegmund, Britta] Charite, Dept Gastroenterol Infectiol & Rheumatol, D-13353 Berlin, Germany; [Krug, Susanne M.; Fromm, Michael] Charite, Inst Clin Physiol, D-13353 Berlin, Germany; [Fischer, Andre; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Sercan, Oezen; Haemmerling, Guenter J.; Arnold, Bernd; Schueler, Thomas] German Canc Res Ctr, Dept Mol Immunol, D-6900 Heidelberg, Germany; [Chappaz, Stephane; Finke, Daniela] Univ Basel, Div Dev Immunol, Dept Biomed, Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Basel	Shalapour, S (corresponding author), Charite, Inst Immunol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	thomas.schueler@charite.de	Fromm, Michael/K-6203-2013; Krug, Susanne M/AAY-6221-2020; Siegmund, Britta/E-6929-2018	Fromm, Michael/0000-0003-4497-7983; Krug, Susanne M/0000-0002-1293-2484; Siegmund, Britta/0000-0002-0055-958X; Kuhl, Anja/0000-0003-2293-5387; Chappaz, Stephane/0000-0003-0574-7544; Heimesaat, Markus/0000-0001-6399-651X; Sercan Alp, Oezen/0000-0001-5150-3618; Shalapour, Shabnam/0000-0002-4743-3706	Deutsche Forschungsgemeinschaft [SFB 405, SFB-TR36/TPB7, SFB633/TPA7/TPB6/TPB15, FOR721]; Swiss National Science Foundation (SNF) [PP00A-116894/1]; European Union [DIAGNOSIS-FP6/WP5]; Fritz-Thyssen-Foundation [Az. 10.05.2.194]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Union(European Commission); Fritz-Thyssen-Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 405, SFB-TR36/TPB7, SFB633/TPA7/TPB6/TPB15, and FOR721), the Swiss National Science Foundation (SNF) (PP00A-116894/1), the European Union (DIAGNOSIS-FP6/WP5), and the Fritz-Thyssen-Foundation (Az. 10.05.2.194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Ponchel F, 2011, CLIN CHIM ACTA, V412, P7, DOI 10.1016/j.cca.2010.09.002; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sportes C, 2009, ANN NY ACAD SCI, V1182, P28, DOI 10.1111/j.1749-6632.2009.05075.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomita T, 2008, J IMMUNOL, V180, P383, DOI 10.4049/jimmunol.180.1.383; Totsuka T, 2007, J IMMUNOL, V178, P4737, DOI 10.4049/jimmunol.178.8.4737; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Watanabe M, 1998, J EXP MED, V187, P389, DOI 10.1084/jem.187.3.389; Watanabe Mamoru, 2003, Current Drug Targets - Inflammation and Allergy, V2, P119, DOI 10.2174/1568010033484269; Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687; Wilcox CM, 2008, GUT, V57, P861, DOI 10.1136/gut.2006.103432; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yamazaki M, 2003, J IMMUNOL, V171, P1556, DOI 10.4049/jimmunol.171.3.1556; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	41	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31939	10.1371/journal.pone.0031939	http://dx.doi.org/10.1371/journal.pone.0031939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384106	Green Published, gold, Green Accepted			2022-12-25	WOS:000302918500048
J	Bouteille, M; Rolland, G; Balsera, C; Loudet, O; Muller, B				Bouteille, Marie; Rolland, Gaelle; Balsera, Crispulo; Loudet, Olivier; Muller, Bertrand			Disentangling the Intertwined Genetic Bases of Root and Shoot Growth in Arabidopsis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; QTL CONTROLLING ROOT; SYSTEM ARCHITECTURE; MAPPING QTLS; NATURAL VARIATION; ELONGATION RATE; EPISTASIS; IDENTIFICATION; AVAILABILITY; DISSECTION	Root growth and architecture are major components of plant nutrient and water use efficiencies and these traits are the matter of extensive genetic analysis in several crop species. Because root growth relies on exported assimilate from the shoot, and changes in assimilate supply are known to alter root architecture, we hypothesized (i) that the genetic bases of root growth could be intertwined with the genetic bases of shoot growth and (ii) that the link could be either positive, with alleles favouring shoot growth also favouring root growth, or negative, because of competition for assimilates. We tested these hypotheses using a quantitative genetics approach in the model species Arabidopsis thaliana and the Bay-0 x Shahdara recombinant inbred lines population. In accordance with our hypothesis, root and shoot growth traits were strongly correlated and most root growth quantitative trait loci (QTLs) colocalized with shoot growth QTLs with positive alleles originating from either the same or the opposite parent. In order to identify regions that could be responsible for root growth independently of the shoot, we generated new variables either based on root to shoot ratios, residuals of root to shoot correlations or coordinates of principal component analysis. These variables showed high heritability allowing genetic analysis. They essentially all yielded similar results pointing towards two regions involved in the root - shoot balance. Using Heterogeneous Inbred Families (a kind of near-isogenic lines), we validated part of the QTLs present in these two regions for different traits. Our study thus highlights the difficulty of disentangling intertwined genetic bases of root and shoot growth and shows that this difficulty can be overcome by using simple statistical tools.	[Bouteille, Marie; Rolland, Gaelle; Balsera, Crispulo; Muller, Bertrand] INRA, Lab Ecophysiol Plantes Stress Environm, UMR759, SupAgro, F-34060 Montpellier, France; [Loudet, Olivier] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Loudet, Olivier] AgroParisTech, Inst Jean Pierre Bourgin, UMR1318, Versailles, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Bouteille, M (corresponding author), INRA, Lab Ecophysiol Plantes Stress Environm, UMR759, SupAgro, F-34060 Montpellier, France.	muller@supagro.inra.fr	Loudet, Olivier/CAF-7559-2022; Muller, Bertrand/AAP-3575-2020; Loudet, Olivier/K-8266-2012	Muller, Bertrand/0000-0001-6387-9460; Loudet, Olivier/0000-0003-3717-0137	ANR (Agence Nationale de la Recherche) [DNV, GPLA 06014G]; ERAPG (ARABRAS) [06-ERAPG-003-01]; Max Planck Institute for developmental biology at Tubingen; French ministry of foreign affairs	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ERAPG (ARABRAS); Max Planck Institute for developmental biology at Tubingen; French ministry of foreign affairs	This study was funded by ANR (Agence Nationale de la Recherche (DNV, GPLA 06014G)) and ERAPG (ARABRAS, 06-ERAPG-003-01 http://www.erapg.org/publicpage.m?key=everyone&trail=/everyone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB thanks D Weigel and the Max Planck Institute for developmental biology at Tubingen for contributing to her PhD fellowship and the French ministry of foreign affairs for EGIDE/PHC - Procope grant for travels. C Granier, D Vile and S Tisne are acknowledged for a critical reading of an earlier draft of the manuscript.	AGUIRREZABAL LAN, 1994, PLANT CELL ENVIRON, V17, P443, DOI 10.1111/j.1365-3040.1994.tb00313.x; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; BINGHAM IJ, 1993, PHYSIOL PLANTARUM, V88, P149, DOI 10.1111/j.1399-3054.1993.tb01772.x; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P361; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chase K, 1997, THEOR APPL GENET, V94, P724, DOI 10.1007/s001220050471; Chevalier F, 2003, PLANT CELL ENVIRON, V26, P1839, DOI 10.1046/j.1365-3040.2003.01100.x; Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Cui KH, 2008, PHYSIOL PLANTARUM, V132, P53, DOI 10.1111/j.1399-3054.2007.00991.x; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; FARRAR JF, 1986, NEW PHYTOL, V102, P513, DOI 10.1111/j.1469-8137.1986.tb00827.x; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; Gerald JNF, 2006, GENETICS, V172, P485, DOI 10.1534/genetics.105.047555; Giuliani S, 2005, J EXP BOT, V56, P3061, DOI 10.1093/jxb/eri303; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hebert Y, 2001, CROP SCI, V41, P363, DOI 10.2135/cropsci2001.412363x; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Huang XQ, 2011, P NATL ACAD SCI USA, V108, P4488, DOI 10.1073/pnas.1100465108; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Hund A, 2004, THEOR APPL GENET, V109, P618, DOI 10.1007/s00122-004-1665-1; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Juenger TE, 2005, GENETICA, V123, P87, DOI 10.1007/s10709-003-2717-1; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Kenis K, 2007, MOL BREEDING, V19, P193, DOI 10.1007/s11032-006-9022-5; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Laperche A, 2006, THEOR APPL GENET, V113, P1131, DOI 10.1007/s00122-006-0373-4; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Li JZ, 2009, J GENET GENOMICS, V36, P173, DOI 10.1016/S1673-8527(08)60104-6; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; MacMillan K, 2006, THEOR APPL GENET, V113, P977, DOI 10.1007/s00122-006-0356-5; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; McConnaughay KDM, 1998, PLANT SOIL, V202, P201, DOI 10.1023/A:1004341731703; MCMICHAEL BL, 1991, ENVIRON EXP BOT, V31, P461, DOI 10.1016/0098-8472(91)90045-P; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Muller B, 1998, PLANT CELL ENVIRON, V21, P149, DOI 10.1046/j.1365-3040.1998.00263.x; Ochoa IE, 2006, CROP SCI, V46, P1609, DOI 10.2135/cropsci2005.12-0446; Ostonen I, 2007, PLANT BIOSYST, V141, P426, DOI 10.1080/11263500701626069; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2005, OECOLOGIA, V142, P360, DOI 10.1007/s00442-004-1705-1; Price AH, 1997, THEOR APPL GENET, V95, P143, DOI 10.1007/s001220050542; Rauh BL, 2002, THEOR APPL GENET, V104, P743, DOI 10.1007/s00122-001-0815-y; REITER RS, 1991, THEOR APPL GENET, V82, P561, DOI 10.1007/BF00226791; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; ROBINSON D, 1986, ANN BOT-LONDON, V58, P841, DOI 10.1093/oxfordjournals.aob.a087266; Roumet C, 2006, NEW PHYTOL, V170, P357, DOI 10.1111/j.1469-8137.2006.01667.x; Rowe HC, 2008, GENETICS, V180, P2237, DOI 10.1534/genetics.108.091439; Ryser P, 2000, AM J BOT, V87, P402, DOI 10.2307/2656636; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Sebastian RL, 2002, THEOR APPL GENET, V104, P601, DOI 10.1007/s001220100743; Sergeeva LI, 2006, P NATL ACAD SCI USA, V103, P2994, DOI 10.1073/pnas.0511015103; SIDDIQUE KHM, 1990, PLANT SOIL, V121, P89, DOI 10.1007/BF00013101; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Thaler P, 1998, PLANT SOIL, V201, P307, DOI 10.1023/A:1004380021699; Thaler P, 1996, PHYSIOL PLANTARUM, V97, P365, DOI 10.1034/j.1399-3054.1996.970222.x; Tisne S, 2010, PLANT CELL ENVIRON, V33, P1875, DOI 10.1111/j.1365-3040.2010.02191.x; Van Rijn CPE, 2000, NEW PHYTOL, V146, P471, DOI 10.1046/j.1469-8137.2000.00670.x; Vlad D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000945; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Zhang WP, 2001, THEOR APPL GENET, V103, P118, DOI 10.1007/s001220100561; Zhu JM, 2006, THEOR APPL GENET, V113, P1, DOI 10.1007/s00122-006-0260-z	75	35	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32319	10.1371/journal.pone.0032319	http://dx.doi.org/10.1371/journal.pone.0032319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384215	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800035
J	Tezuka, A; Matsushima, N; Nemoto, Y; Akashi, HD; Kawata, M; Makino, T				Tezuka, Ayumi; Matsushima, Noe; Nemoto, Yoriko; Akashi, Hiroshi D.; Kawata, Masakado; Makino, Takashi			Comprehensive Primer Design for Analysis of Population Genetics in Non-Sequenced Organisms	PLOS ONE			English	Article							CLIMATE-CHANGE; PHYLOGENETIC ANALYSIS; EMERGING DISEASE; AVIAN GENOME; MARKERS; EVOLUTION; ALIGNMENT; CONSERVATION; FREQUENCY; SELECTION	Nuclear sequence markers are useful tool for the study of the history of populations and adaptation. However, it is not easy to obtain multiple nuclear primers for organisms with poor or no genomic sequence information. Here we used the genomes of organisms that have been fully sequenced to design comprehensive sets of primers to amplify polymorphic genomic fragments of multiple nuclear genes in non-sequenced organisms. First, we identified a large number of candidate polymorphic regions that were flanked on each side by conserved regions in the reference genomes. We then designed primers based on these conserved sequences and examined whether the primers could be used to amplify sequences in target species, montane brown frog (Rana ornativentris), anole lizard (Anolis sagrei), guppy (Poecilia reticulata), and fruit fly (Drosophila melanogaster), for population genetic analysis. We successfully obtained polymorphic markers for all target species studied. In addition, we found that sequence identities of the regions between the primer sites in the reference genomes affected the experimental success of DNA amplification and identification of polymorphic loci in the target genomes, and that exonic primers had a higher success rate than intronic primers in amplifying readable sequences. We conclude that this comparative genomic approach is a time-and cost-effective way to obtain polymorphic markers for non-sequenced organisms, and that it will contribute to the further development of evolutionary ecology and population genetics for non-sequenced organisms, aiding in the understanding of the genetic basis of adaptation.	[Tezuka, Ayumi; Matsushima, Noe; Nemoto, Yoriko; Akashi, Hiroshi D.; Kawata, Masakado; Makino, Takashi] Tohoku Univ, Grad Sch Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan	Tohoku University	Tezuka, A (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan.	kawata@m.tohoku.ac.jp; tamakino@m.tohoku.ac.jp	Kawata, Masakado/E-3962-2012; Makino, Takashi/AAC-5181-2019	Makino, Takashi/0000-0003-4600-9353; Akashi, Hiroshi/0000-0001-5053-3292; Kawata, Masakado/0000-0001-8716-5438	Japan Society for the Promotion of Science [21370007, 23128501]; Ministry of Education, Culture, Sports, Science and Technology of Japan [J03]; Grants-in-Aid for Scientific Research [22657004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MK and TM were supported by a Grant-in-Aid for Scientific Research (21370007 and 23128501, respectively) from the Japan Society for the Promotion of Science, and in part by the Global COE Program "Centre for ecosystem management adapting to global change" (J03) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hartl D., 2007, PRINCIPLES POPULATIO; Hoffmann AA, 2007, ECOL LETT, V10, P63, DOI 10.1111/j.1461-0248.2006.00985.x; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Ouborg NJ, 2007, J ECOL, V95, P8, DOI 10.1111/j.1365-2745.2006.01197.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosenblum EB, 2007, MOL ECOL NOTES, V7, P113, DOI 10.1111/j.1471-8286.2006.01547.x; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storfer A, 2009, BIOSCIENCE, V59, P559, DOI 10.1525/bio.2009.59.7.7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	33	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32314	10.1371/journal.pone.0032314	http://dx.doi.org/10.1371/journal.pone.0032314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22393396	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800034
J	Huang, EY; Bi, Y; Jiang, W; Luo, XJ; Yang, K; Gao, JL; Gao, YH; Luo, Q; Shi, Q; Kim, SH; Liu, X; Li, M; Hu, N; Liu, H; Cui, J; Zhang, WW; Li, RD; Chen, X; Shen, JK; Kong, YH; Zhang, JY; Wang, JH; Luo, JY; He, BC; Wang, HC; Reid, RR; Luu, HH; Haydon, RC; Yang, L; He, TC				Huang, Enyi; Bi, Yang; Jiang, Wei; Luo, Xiaoji; Yang, Ke; Gao, Jian-Li; Gao, Yanhong; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Liu, Xing; Li, Mi; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Chen, Xiang; Shen, Jikun; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; Wang, Huicong; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; Yang, Li; He, Tong-Chuan			Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; MARROW STROMAL CELLS; HEPATIC PROGENITOR CELLS; SUPPRESSES TUMOR-GROWTH; LARGE T-ANTIGEN; OSTEOGENIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; HUMAN OSTEOSARCOMA; RECOMBINANT ADENOVIRUSES	Mesenchymal stem cells (MSCs) are multipotent cells which reside in many tissues and can give rise to multiple lineages including bone, cartilage and adipose. Although MSCs have attracted significant attention for basic and translational research, primary MSCs have limited life span in culture which hampers MSCs' broader applications. Here, we investigate if mouse mesenchymal progenitors can be conditionally immortalized with SV40 large T antigen and maintain long-term cell proliferation without compromising their multipotency. Using the system which expresses SV40 large T antigen flanked with Cre/loxP sites, we demonstrate that mouse embryonic fibroblasts (MEFs) can be efficiently immortalized by SV40 large T antigen. The conditionally immortalized MEFs (iMEFs) exhibit an enhanced proliferative activity and maintain long-term cell proliferation, which can be reversed by Cre recombinase. The iMEFs express most MSC markers and retain multipotency as they can differentiate into osteogenic, chondrogenic and adipogenic lineages under appropriate differentiation conditions in vitro and in vivo. The removal of SV40 large T reduces the differentiation potential of iMEFs possibly due to the decreased progenitor expansion. Furthermore, the iMEFs are apparently not tumorigenic when they are subcutaneously injected into athymic nude mice. Thus, the conditionally immortalized iMEFs not only maintain long-term cell proliferation but also retain the ability to differentiate into multiple lineages. Our results suggest that the reversible immortalization strategy using SV40 large T antigen may be an efficient and safe approach to establishing long-term cell culture of primary mesenchymal progenitors for basic and translational research, as well as for potential clinical applications.	[Huang, Enyi; Wang, Huicong; Yang, Li] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China; [Huang, Enyi; Bi, Yang; Jiang, Wei; Luo, Xiaoji; Yang, Ke; Gao, Jian-Li; Gao, Yanhong; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Liu, Xing; Li, Mi; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Chen, Xiang; Shen, Jikun; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Bi, Yang; Luo, Qing; Liu, Xing; Li, Mi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Key Lab Pediat Codesignated,Chinese Minist Educ, Chongqing, Peoples R China; [Bi, Yang; Luo, Qing; Liu, Xing; Li, Mi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Chongqing Bur Educ, Chongqing, Peoples R China; [Luo, Xiaoji; Shi, Qiong; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med Designated, Chinese Minist Educ, Chongqing, Peoples R China; [Luo, Xiaoji; Shi, Qiong; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Gao, Jian-Li] Zhejiang Chinese Med Univ, Inst Mat Med, Hangzhou, Zhejiang, Peoples R China; [Gao, Yanhong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Chen, Xiang] Fourth Mil Med Univ, Affiliated Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China	Chongqing University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Army Medical University; Zhejiang Chinese Medical University; Shanghai Jiao Tong University; Air Force Military Medical University	Huang, EY (corresponding author), Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China.	yangli@cqu.edu.cn; tche@surgery.bsd.uchicago.edu	GAO, JianLi/J-4997-2017	GAO, JianLi/0000-0002-5977-0021; HUANG, ENYI/0000-0003-1163-5282; Chen, Xiang/0000-0001-7628-516X	American Cancer Society; Orthopaedic Research and Education Foundation; National Institutes of Health; China Scholarship Council	American Cancer Society(American Cancer Society); Orthopaedic Research and Education Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council)	The reported work was supported, in part, by research grants from the American Cancer Society (TCH and HHL), the Orthopaedic Research and Education Foundation (RCH and HHL), and the National Institutes of Health (RCH, TCH and HHL). EH was a recipient of the Predoctoral Fellowship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; GEE CJ, 1979, J CELL SCI, V36, P223; Geserick C, 2006, ONCOGENE, V25, P4310, DOI 10.1038/sj.onc.1209465; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; HOWELL N, 1982, CYTOGENET CELL GENET, V34, P215, DOI 10.1159/000131809; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; KAHN P, 1983, VIROLOGY, V126, P348, DOI 10.1016/0042-6822(83)90484-1; Kang Mo K, 2007, Methods Mol Biol, V371, P151; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Lee MK, 2005, J CELL SCI, V118, P819, DOI 10.1242/jcs.01673; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	71	88	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32428	10.1371/journal.pone.0032428	http://dx.doi.org/10.1371/journal.pone.0032428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384246	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100079
J	Bernardo, GM; Bebek, G; Ginther, CL; Sizemore, ST; Lozada, KL; Miedler, JD; Anderson, LA; Godwin, AK; Abdul-Karim, FW; Slamon, DJ; Keri, RA				Bernardo, G. M.; Bebek, G.; Ginther, C. L.; Sizemore, S. T.; Lozada, K. L.; Miedler, J. D.; Anderson, L. A.; Godwin, A. K.; Abdul-Karim, F. W.; Slamon, D. J.; Keri, R. A.			FOXA1 represses the molecular phenotype of basal breast cancer cells	ONCOGENE			English	Article						FOXA1; luminal; basal; breast cancer	ESTROGEN-RECEPTOR-ALPHA; ANDROGEN RECEPTOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LUMINAL SUBTYPE; GATA-3; MORPHOGENESIS; BINDING; BRCA1; DIFFERENTIATION	Breast cancer is a heterogeneous disease that comprises multiple subtypes. Luminal subtype tumors confer a more favorable patient prognosis, which is, in part, attributed to estrogen receptor (ER)-alpha positivity and antihormone responsiveness. Expression of the forkhead box transcription factor, FOXA1, similarly correlates with the luminal subtype and patient survival, but is also present in a subset of ER-negative tumors. FOXA1 is also consistently expressed in luminal breast cancer cell lines even in the absence of ER. In contrast, breast cancer cell lines representing the basal subtype do not express FOXA1. To delineate an ER-independent role for FOXA1 in maintaining the luminal phenotype, and hence a more favorable prognosis, we performed expression microarray analyses on FOXA1-positive and ER-positive (MCF7, T47D), or FOXA1-positive and ER-negative (MDA-MB-453, SKBR3) luminal cell lines in the presence or absence of transient FOXA1 silencing. This resulted in three FOXA1 transcriptomes: (1) a lumina! signature (consistent across cell lines), (2) an ER-positive signature (restricted to MCF7 and T47D) and (3) an ER-negative signature (restricted to MDA-MB-453 and SKBR3). Gene set enrichment analyses revealed FOXA1 silencing causes a partial transcriptome shift from luminal to basal gene expression signatures. FOXA1 binds to a subset of both luminal and basal genes within luminal breast cancer cells, and loss of FOXA1 increases enhancer RNA transcription for a representative basal gene (CD58). These data suggest FOXA1 directly represses a subset of basal signature genes. Functionally, FOXA1 silencing increases migration and invasion of luminal cancer cells, both of which are characteristics of basal subtype cells. We conclude FOXA1 controls plasticity between basal and luminal breast cancer cells, not only by inducing luminal genes but also by repressing the basal phenotype, and thus aggressiveness. Although it has been proposed that FOXA1-targeting agents may be useful for treating luminal tumors, these data suggest that this approach may promote transitions toward more aggressive cancers. Oncogene (2013) 32, 554-563; doi:10.1038/onc.2012.62; published online 5 March 2012	[Bernardo, G. M.; Sizemore, S. T.; Lozada, K. L.; Keri, R. A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Bebek, G.] Case Western Reserve Univ, Sch Med, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Bebek, G.] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Ginther, C. L.; Anderson, L. A.; Slamon, D. J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Miedler, J. D.; Abdul-Karim, F. W.] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA; [Godwin, A. K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Abdul-Karim, F. W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Keri, R. A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Keri, R. A.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Case Western Reserve University; Case Western Reserve University Hospital; University of Kansas; University of Kansas Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Sizemore, Gina/ABI-7542-2020; Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	Department of Defense [W81XWH-06-1-0712, W81XWH-09-1-0696, W81XWH-08-1-0347]; National Institutes of Health [T32-HD-07104-33, UL1-RR024989, R01 CA090398]; Case Western Reserve University Comprehensive Cancer Center [P30 CA043703]; University Hospitals of Cleveland Pathology Research Associates Grant; Fox Chase Cancer Center [P30 CA006927]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA090398, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University Comprehensive Cancer Center; University Hospitals of Cleveland Pathology Research Associates Grant; Fox Chase Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by the Department of Defense (W81XWH-06-1-0712, GMB; W81XWH-09-1-0696, STS; W81XWH-08-1-0347, RAK), the National Institutes of Health (T32-HD-07104-33, GMB; UL1-RR024989, GB; R01 CA090398, RAK), the Case Western Reserve University Comprehensive Cancer Center (P30 CA043703, GB and RAK), a University Hospitals of Cleveland Pathology Research Associates Grant (FWA and RAK) and a Fox Chase Cancer Center Support Grant (P30 CA006927, AKG).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fu XY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2849; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Nakanishi T, 2010, BRIT J CANCER, V102, P815, DOI 10.1038/sj.bjc.6605553; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Schug J, 2008, CURR PROTOC BIOINFOR, V21, P261, DOI DOI 10.1002/; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Smyth GK, 2005, P 55 SESS INT STAT I; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Williamson EA, 2006, ONCOGENE, V25, P1391, DOI 10.1038/sj.onc.1209170; Wolf I, 2007, INT J CANCER, V120, P1013, DOI 10.1002/ijc.22389; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064	53	102	104	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					554	563		10.1038/onc.2012.62	http://dx.doi.org/10.1038/onc.2012.62			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22391567	Green Accepted			2022-12-25	WOS:000316164700003
J	Funkelstein, L; Lu, WD; Koch, B; Mosier, C; Toneff, T; Taupenot, L; O'Connor, DT; Reinheckel, T; Peters, C; Hook, V				Funkelstein, Lydiane; Lu, W. Douglas; Koch, Britta; Mosier, Charles; Toneff, Thomas; Taupenot, Laurent; O'Connor, Daniel T.; Reinheckel, Thomas; Peters, Christoph; Hook, Vivian			Human Cathepsin V Protease Participates in Production of Enkephalin and NPY Neuropeptide Neurotransmitters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY VESICLES; CHROMAFFIN GRANULES; GENE KNOCKOUT; PEPTIDE NEUROTRANSMITTER; ALZHEIMERS-DISEASE; PROCESSING ENZYME; CYSTEINE PROTEASE; MASS-SPECTROMETRY; EXPRESSION; CELLS	Proteases are required for processing precursors into active neuropeptides that function as neurotransmitters for cell-cell communication. This study demonstrates the novel function of human cathepsin V protease for producing the neuropeptides enkephalin and neuropeptide Y (NPY). Cathepsin V is a human-specific cysteine protease gene. Findings here show that expression of cathepsin V in neuroendocrine PC12 cells and human neuronal SK-N-MC cells results in production of (Met) enkephalin from proenkephalin. Gene silencing of cathepsin V by siRNA in human SK-N-MC cells results in reduction of (Met) enkephalin by more than 80%, illustrating the prominent role of cathepsin V for neuropeptide production. In vitro processing of proenkephalin by cathepsin V occurs at dibasic residue sites to generate enkephalin-containing peptides and an similar to 24-kDa intermediate present in human brain. Cathepsin V is present in human brain cortex and hippocampus where enkephalin and NPY are produced and is present in purified human neuropeptide secretory vesicles. Colocalization of cathepsin V with enkephalin and NPY in secretory vesicles of human neuroblastoma cells was illustrated by confocal microscopy. Furthermore, expression of cathepsin V with proNPY results in NPY production. These findings indicate the unique function of human cathepsin V for producing enkephalin and NPY neuropeptides required for neurotransmission in health and neurological diseases.	[Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Neurosci, La Jolla, CA 92093 USA; [Funkelstein, Lydiane; Lu, W. Douglas; Mosier, Charles; Toneff, Thomas; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA; [Koch, Britta; Reinheckel, Thomas; Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Reinheckel, Thomas; Peters, Christoph] BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Taupenot, Laurent; O'Connor, Daniel T.; Hook, Vivian] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Freiburg; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hook, V (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Neurosci, 9500 Gilman Dr,MC 0744, La Jolla, CA 92093 USA.	vhook@ucsd.edu	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Taupenot, Laurent/0000-0003-2316-3825	National Institutes of Health [R01 DA04271, R01 MH077305, T32 DA07315, P01 HL58120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007315, R01DA004271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA04271, R01 MH077305, and T32 DA07315 (to V. H.), and P01 HL58120 (to D. T. O. and V. H.).	Adachi W, 1998, INVEST OPHTH VIS SCI, V39, P1789; Akil H, 1998, DRUG ALCOHOL DEPEN, V51, P127, DOI 10.1016/S0376-8716(98)00071-4; Baltatzi M, 2008, INT J CLIN PRACT, V62, P1432, DOI 10.1111/j.1742-1241.2008.01823.x; Beinfeld MC, 2009, PEPTIDES, V30, P1882, DOI 10.1016/j.peptides.2009.06.030; Bernard D, 2003, J INVEST DERMATOL, V120, P592, DOI 10.1046/j.1523-1747.2003.12086.x; Biswas N, 2009, ENDOCRINOLOGY, V150, P3547, DOI 10.1210/en.2008-1613; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bromme D., 2004, HDB PROTEOLYTIC ENZY, P1107; Chen NN, 2006, J INVEST DERMATOL, V126, P2345, DOI 10.1038/sj.jid.5700409; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Dozio E, 2008, PEPTIDES, V29, P491, DOI 10.1016/j.peptides.2007.11.001; FOLKESSON R, 1988, MOL BRAIN RES, V3, P147, DOI 10.1016/0169-328X(88)90060-5; Funkelstein L, 2008, J NEUROCHEM, V106, P384, DOI 10.1111/j.1471-4159.2008.05408.x; Funkelstein L, 2008, J BIOL CHEM, V283, P35652, DOI 10.1074/jbc.M709010200; Gehlert DR, 1999, NEUROPEPTIDES, V33, P329, DOI 10.1054/npep.1999.0057; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gupta N, 2010, J PROTEOME RES, V9, P5065, DOI 10.1021/pr100358b; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Holden JE, 2005, AACN ADV CRIT CARE, V16, P291, DOI 10.1097/00044067-200507000-00003; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; HOOK VYH, 1984, FEBS LETT, V172, P212, DOI 10.1016/0014-5793(84)81128-X; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hwang SR, 2007, J BIOL CHEM, V282, P9556, DOI 10.1074/jbc.M605510200; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Hwang SR, 1999, J BIOL CHEM, V274, P1821, DOI 10.1074/jbc.274.3.1821; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; LOH YP, 1984, J BIOL CHEM, V259, P8238; Lu WD, 2009, BIOCHEMISTRY-US, V48, P1604, DOI 10.1021/bi801888j; Magni P, 2000, NEUROPHARMACOLOGY, V39, P1628, DOI 10.1016/S0028-3908(99)00231-2; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Miller R, 2003, NEUROPEPTIDES, V37, P140, DOI 10.1016/S0143-4179(03)00027-1; Minokadeh A, 2010, MOL CELL NEUROSCI, V43, P98, DOI 10.1016/j.mcn.2009.10.001; Munglani R, 1996, DRUGS, V52, P371, DOI 10.2165/00003495-199652030-00004; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Santamaria I, 1998, CANCER RES, V58, P1624; Sato N, 2009, EXPERT OPIN THER PAT, V19, P1401, DOI 10.1517/13543770903251722; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Sevenich L, 2010, BIOCHIMIE, V92, P1674, DOI 10.1016/j.biochi.2010.03.014; Steiner RA, 2001, P NATL ACAD SCI USA, V98, P4184, DOI 10.1073/pnas.061445598; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; VERBEECK MAE, 1990, J BIOL CHEM, V265, P18087; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Wegrzyn J, 2007, J PROTEOME RES, V6, P1652, DOI 10.1021/pr060503p; Wegrzyn JL, 2010, J PROTEOME RES, V9, P5002, DOI 10.1021/pr1003104; Wieland HA, 2000, EXPERT OPIN INV DRUG, V9, P1327, DOI 10.1517/13543784.9.6.1327; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Yasothornsrikul S, 1998, J NEUROCHEM, V70, P153; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200; Zeeuwen PLJM, 2007, J INVEST DERMATOL, V127, P120, DOI 10.1038/sj.jid.5700480; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	53	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15232	15241		10.1074/jbc.M111.310607	http://dx.doi.org/10.1074/jbc.M111.310607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393040	Green Published, hybrid			2022-12-25	WOS:000304006300007
J	Refaie, S; Gagnon, S; Gagnon, H; Desjardins, R; D'Anjou, F; D'Orleans-Juste, P; Zhu, XR; Steiner, DF; Seidah, NG; Lazure, C; Salzet, M; Day, R				Refaie, Sarah; Gagnon, Sandra; Gagnon, Hugo; Desjardins, Roxane; D'Anjou, Francois; D'Orleans-Juste, Pedro; Zhu, Xiaorong; Steiner, Donald F.; Seidah, Nabil G.; Lazure, Claude; Salzet, Michel; Day, Robert			Disruption of Proprotein Convertase 1/3 (PC1/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PERITONEAL-MACROPHAGES; MONOCYTE-DERIVED MACROPHAGES; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; PROHORMONE CONVERTASES; IN-VIVO; IFN-GAMMA; INFLAMMATORY RESPONSES; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION	The proprotein convertase 1/3 is expressed in the regulated secretory pathway of neural and endocrine cells. Its major function is in the post-translational processing and activation of precursor proteins. The PC1/3 knock-out (KO) mouse model has allowed us to elucidate its physiological functions in studies focused primarily on neuroendocrine tissues. However, PC1/3 is also expressed in cells of the immune system, mainly in macrophages. The present study explores the effects of innate immune challenge in the PC1/3 KO mouse. PC1/3 KO mice have an enlarged spleen with marked disorganization of the marginal zone and red pulp. Immunohistochemical studies using various markers demonstrate a depletion of dendritic cells in PC1/3 KO spleens. When challenged with lipopolysaccharide, PC1/3 KO mice are more susceptible to septic shock than wild-type controls or other PC KO mice, such as PC2 and PC7 null mice. Plasma levels of proinflammatory cytokines (IL-6, IL-1 beta, and TNF-alpha) were very significantly elevated in PC1/3 KO mice, consistent with a hypercytokinemia, i.e. indicative of a major systemic uncontrolled inflammatory response or cytokine storm. Peritoneal macrophages isolated from PC1/3 KO mice also demonstrate elevated cytokine secretion when treated with LPS. Electron micrographs show morphological features indicating a prolonged activation of these cells following LPS stimulation. We also present evidence that the proinflammatory Th1 pathway is dominant in the PC1/3 KO mouse model. We conclude that aside from its important role in neuroendocrine functions PC1/3 also has an important role in the regulation of the innate immune system, most likely through the regulation of cytokine secretion in macrophages.	[Day, Robert] Univ Sherbrooke, FMSS, IPS, Sherbrooke, PQ J1H 5N4, Canada; [Zhu, Xiaorong; Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Seidah, Nabil G.; Lazure, Claude] IRCM, Montreal, PQ H2W 1R7, Canada; [Gagnon, Hugo; Salzet, Michel] Univ Lille 1, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA4550, IFR 147, F-59655 Villeneuve Dascq, France	University of Sherbrooke; University of Chicago; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Lille - ISITE; Universite de Lille	Day, R (corresponding author), Univ Sherbrooke, FMSS, IPS, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Robert.day@usherbrooke.ca	Salzet, Michel/A-7675-2011; Seidah, Nabil/I-3596-2013	Salzet, Michel/0000-0003-4318-0817; Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Constam DB, 2000, GENE DEV, V14, P1146; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; D'Anjou F, 2011, TRANSL ONCOL, V4, P157, DOI 10.1593/tlo.10295; Day R, 2002, NEUROENDOCRINOL LETT, V23, P447; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Dey A, 2003, J BIOL CHEM, V278, P15007, DOI 10.1074/jbc.M212128200; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dikeakos JD, 2009, P NATL ACAD SCI USA, V106, P7408, DOI 10.1073/pnas.0809576106; Duitman EH, 2011, EUR J CELL BIOL, V90, P476, DOI 10.1016/j.ejcb.2011.01.010; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0; HARDING CV, 1995, TRENDS CELL BIOL, V5, P105, DOI 10.1016/S0962-8924(00)88959-X; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Isaac BM, 2010, EXP CELL RES, V316, P3406, DOI 10.1016/j.yexcr.2010.06.011; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; Jia T, 2009, SCIENCE, V325, P549, DOI 10.1126/science.1178329; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim R, 2005, CANCER BIOL THER, V4, P924, DOI 10.4161/cbt.4.9.2101; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; LaMendola J, 1997, FEBS LETT, V404, P19, DOI 10.1016/S0014-5793(97)00078-1; Lansac G, 2006, J NEUROIMMUNOL, V171, P57, DOI 10.1016/j.jneuroim.2005.09.019; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marzban L, 2004, DIABETES, V53, P141, DOI 10.2337/diabetes.53.1.141; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MURRAY HW, 1985, J IMMUNOL, V134, P1619; Nacife VP, 2004, CELL STRUCT FUNCT, V29, P27, DOI 10.1247/csf.29.27; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Polati R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-4; Portela-Gomes GM, 2008, REGUL PEPTIDES, V146, P117, DOI 10.1016/j.regpep.2007.09.019; Puddu P, 1997, J IMMUNOL, V159, P3490; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Rholam M, 2009, CELL MOL LIFE SCI, V66, P2075, DOI 10.1007/s00018-009-0007-5; Rittig MG, 1999, MICROBES INFECT, V1, P727, DOI 10.1016/S1286-4579(99)80074-4; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Salzet M, 2000, TRENDS NEUROSCI, V23, P550, DOI 10.1016/S0166-2236(00)01642-8; Salzet M, 2001, NEUROENDOCRINOL LETT, V22, P467; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Straub RH, 2000, J NEUROCHEM, V75, P2464, DOI 10.1046/j.1471-4159.2000.0752464.x; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Ugleholdt R, 2004, ENDOCRINOLOGY, V145, P1349, DOI 10.1210/en.2003-0801; Ugleholdt R, 2006, J BIOL CHEM, V281, P11050, DOI 10.1074/jbc.M601203200; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; VINDROLA O, 1994, NEUROPEPTIDES, V27, P235, DOI 10.1016/0143-4179(94)90004-3; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wardman JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028152; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; You Y, 2011, J IMMUNOL, V186, P2172, DOI 10.4049/jimmunol.1002106; Zanoni Ivan, 2009, Current Immunology Reviews, V5, P311; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	98	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14703	14717		10.1074/jbc.M111.323220	http://dx.doi.org/10.1074/jbc.M111.323220			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396549	Green Published, hybrid			2022-12-25	WOS:000304003200036
J	Hu, W; Wan, DD; Yu, XM; Cao, JG; Guo, PY; Li, HS; Han, JH				Hu, Wen; Wan, Didi; Yu, Xiaoming; Cao, Jinguo; Guo, Peiyi; Li, Hong-sheng; Han, Junhai			Protein G(q) Modulates Termination of Phototransduction and Prevents Retinal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-SENSITIVE CHANNELS; RHODOPSIN IN-VIVO; DROSOPHILA PHOTORECEPTORS; VISUAL TRANSDUCTION; CALMODULIN-BINDING; GENETIC DISSECTION; ARRESTIN; RECEPTOR; KINASE; DEACTIVATION	Appropriate termination of the phototransduction cascade is critical for photoreceptors to achieve high temporal resolution and to prevent excessive Ca2+-induced cell toxicity. Using a genetic screen to identify defective photoresponse mutants in Drosophila, we isolated and identified a novel G alpha(q) mutant allele, which has defects in both activation and deactivation. We revealed that G(q) modulates the termination of the light response and that metarhodopsin/G(q) interaction affects subsequent arrestin-rhodopsin (Arr2-Rh1) binding, which mediates the deactivation of metarhodopsin. We further showed that the G alpha(q) mutant undergoes light-dependent retinal degeneration, which is due to the slow accumulation of stable Arr2-Rh1 complexes. Our study revealed the roles of Gq in mediating photoresponse termination and in preventing retinal degeneration. This pathway may represent a general rapid feedback regulation of G protein-coupled receptor signaling.	[Hu, Wen; Wan, Didi; Cao, Jinguo; Han, Junhai] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Yu, Xiaoming; Han, Junhai] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China; [Guo, Peiyi; Li, Hong-sheng] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	Southeast University - China; Southeast University - China; University of Massachusetts System; University of Massachusetts Worcester	Han, JH (corresponding author), Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	junhaihan@seu.edu.cn	Jinde, Cao/L-2658-2017		National Natural Science Foundation of China [30970663, 31070683]; NATIONAL INSTITUTE ON AGING [R01AG022508] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Natural Science Foundation of China Grants 30970663 and 31070683 (to J. H.).	Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cao JG, 2011, EMBO J, V30, P3701, DOI 10.1038/emboj.2011.254; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Han J, 2007, EMBO J, V26, P4966, DOI 10.1038/sj.emboj.7601929; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; HARDIE RC, 1994, J GEN PHYSIOL, V103, P409, DOI 10.1085/jgp.103.3.409; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Iakhine R, 2004, J NEUROSCI, V24, P2516, DOI 10.1523/JNEUROSCI.5426-03.2004; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Stowers RS, 1999, GENETICS, V152, P1631; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1	46	8	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13911	13918		10.1074/jbc.M112.339895	http://dx.doi.org/10.1074/jbc.M112.339895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389492	Green Published, hybrid			2022-12-25	WOS:000303996300046
J	Sarto-Jackson, I; Milenkovic, I; Smalla, KH; Gundelfinger, ED; Kaehne, T; Herrera-Molina, R; Thomas, S; Kiebler, MA; Sieghart, W				Sarto-Jackson, Isabella; Milenkovic, Ivan; Smalla, Karl-Heinz; Gundelfinger, Eckart D.; Kaehne, Thilo; Herrera-Molina, Rodrigo; Thomas, Sabine; Kiebler, Michael A.; Sieghart, Werner			The Cell Adhesion Molecule Neuroplastin-65 Is a Novel Interaction Partner of gamma-Aminobutyric Acid Type A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC GABA(A) RECEPTORS; LONG-TERM POTENTIATION; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; IMMUNOGLOBULIN SUPERFAMILY; POSTSYNAPTIC DENSITIES; GLUTAMATE RECEPTORS; BETA(3) SUBUNITS; ERM FAMILY; GEPHYRIN	gamma-Aminobutyric acid type A (GABA(A)) receptors are pentameric ligand-gated ion channels that mediate fast inhibition in the central nervous system. Depending on their subunit composition, these receptors exhibit distinct pharmacological properties and differ in their ability to interact with proteins involved in receptor anchoring at synaptic or extra-synaptic sites. Whereas GABA(A) receptors containing alpha 1, alpha 2, or alpha 3 subunits are mainly located synaptically where they interact with the submembranous scaffolding protein gephyrin, receptors containing alpha 5 subunits are predominantly found extra-synaptically and seem to interact with radixin for anchorage. Neuroplastin is a cell adhesion molecule of the immunoglobulin superfamily that is involved in hippocampal synaptic plasticity. Our results reveal that neuroplastin and GABA(A) receptors can be co-purified from rat brain and exhibit a direct physical interaction as demonstrated by co-precipitation and Forster resonance energy transfer (FRET) analysis in a heterologous expression system. The brain-specific isoform neuroplastin-65 co-localizes with GABA(A) receptors as shown in brain sections as well as in neuronal cultures, and such complexes can either contain gephyrin or be devoid of gephyrin. Neuroplastin-65 specifically co-localizes with alpha 1 or alpha 2 but not with alpha 3 subunits at GABAergic synapses. In addition, neuroplastin-65 also co-localizes with GABA(A) receptor alpha 5 subunits at extra-synaptic sites. Down-regulation of neuroplastin-65 by shRNA causes a loss of GABA(A) receptor alpha 2 subunits at GABAergic synapses. These results suggest that neuroplastin-65 can co-localize with a subset of GABA(A) receptor subtypes and might contribute to anchoring and/or confining GABA(A) receptors to particular synaptic or extra-synaptic sites, thus affecting receptor mobility and synaptic strength.	[Sarto-Jackson, Isabella; Milenkovic, Ivan; Sieghart, Werner] Med Univ Vienna, Dept Biochem & Mol Biol Nervous Syst, Ctr Brain Res, A-1090 Vienna, Austria; [Smalla, Karl-Heinz; Gundelfinger, Eckart D.; Herrera-Molina, Rodrigo] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Kaehne, Thilo] Otto Von Guericke Univ, Sch Med, Inst Expt Internal Med, D-39120 Magdeburg, Germany; [Thomas, Sabine; Kiebler, Michael A.] Med Univ Vienna, Dept Neuronal Cell Biol, Ctr Brain Res, A-1090 Vienna, Austria	Medical University of Vienna; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Medical University of Vienna	Sarto-Jackson, I (corresponding author), Med Univ Vienna, Dept Biochem & Mol Biol Nervous Syst, Ctr Brain Res, A-1090 Vienna, Austria.	Isabella.sarto-jackson@meduniwien.ac.at	Smalla, Dr. Karl-Heinz/C-3950-2012; Kaehne, Thilo/E-4858-2012; Sieghart, Werner/A-4877-2013; Herrera-Molina, Rodrigo/GLU-3904-2022	Smalla, Dr. Karl-Heinz/0000-0002-0269-0311; Sieghart, Werner/0000-0002-0443-0302; Kiebler, Michael/0000-0002-8850-6297; Milenkovic, Ivan/0000-0002-2990-0243	Deutsche Forschungsgemeinschaft [SFB 779]; Pakt fur Forschung und Innovation of the Leibniz Society (Wissensgemeinschaft Gottfried Wilhelm Leibniz (WGL)); European Union [2007-2013]; Medical University Vienna, Center for Brain Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pakt fur Forschung und Innovation of the Leibniz Society (Wissensgemeinschaft Gottfried Wilhelm Leibniz (WGL)); European Union(European Commission); Medical University Vienna, Center for Brain Research	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 779 (to T. K. and E. D. G.), the Pakt fur Forschung und Innovation of the Leibniz Society (Wissensgemeinschaft Gottfried Wilhelm Leibniz (WGL)) (to E. D. G.), European Union Structural Funds 2007-2013 (to K. H. S.), and grants from The Medical University Vienna, Center for Brain Research (to I. S.-J., W. S., M. A. K., and S. T.).	Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Craig AM, 1996, J NEUROSCI, V16, P3166; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dahm R, 2008, METHOD CELL BIOL, V85, P293, DOI 10.1016/S0091-679X(08)85013-3; Danglot L, 2003, MOL CELL NEUROSCI, V23, P264, DOI 10.1016/S1044-7431(03)00069-1; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HILL IE, 1988, BRAIN RES, V461, P27, DOI 10.1016/0006-8993(88)90722-6; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Langnaese K, 1997, J BIOL CHEM, V272, P821, DOI 10.1074/jbc.272.2.821; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Li HL, 2009, NEURON, V61, P527, DOI 10.1016/j.neuron.2009.01.010; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Neville D M Jr, 1974, Methods Enzymol, V32, P92; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Owczarek S, 2011, J NEUROCHEM, V117, P984, DOI 10.1111/j.1471-4159.2011.07269.x; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Panzanelli P, 2005, J COMP NEUROL, V484, P121, DOI 10.1002/cne.20440; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sarto I, 2002, J BIOL CHEM, V277, P30656, DOI 10.1074/jbc.M203597200; Sarto-Jackson I, 2007, J BIOL CHEM, V282, P4354, DOI 10.1074/jbc.M609676200; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; Shrivastava AN, 2011, J BIOL CHEM, V286, P14455, DOI 10.1074/jbc.M110.165282; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tretter V, 1997, J NEUROSCI, V17, P2728; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Tretter V, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.007.2008; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Uryu K, 1999, J COMP NEUROL, V405, P216, DOI 10.1002/(SICI)1096-9861(19990308)405:2<216::AID-CNE6>3.0.CO;2-6; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Yoshida S, 2000, EUR J BIOCHEM, V267, P4372, DOI 10.1046/j.1432-1327.2000.01482.x; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	71	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14201	14214		10.1074/jbc.M111.293175	http://dx.doi.org/10.1074/jbc.M111.293175			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389504	Green Published, hybrid			2022-12-25	WOS:000303996300072
J	Ayabe, Y; Ueno, T				Ayabe, Yoshiko; Ueno, Takatoshi			Complex Feeding Tracks of the Sessile Herbivorous Insect Ophiomyia maura as a Function of the Defense against Insect Parasitoids	PLOS ONE			English	Article							LEAF-MINING MOTHS; DISRUPTIVE COLORATION; ADAPTIVE SIGNIFICANCE; DIPTERA-AGROMYZIDAE; LIRIOMYZA-TRIFOLII; FORAGING BEHAVIOR; SPECIES RICHNESS; HOST LEAFMINER; BOTTOM-UP; PATTERN	Because insect herbivores generally suffer from high mortality due to their natural enemies, reducing the risk of being located by natural enemies is of critical importance for them, forcing them to develop a variety of defensive measures. Larvae of leaf-mining insects lead a sedentary life inside a leaf and make conspicuous feeding tracks called mines, exposing themselves to the potential risk of parasitism. We investigated the defense strategy of the linear leafminer Ophiomyia maura Meigen (Diptera: Agromyzidae), by focusing on its mining patterns. We examined whether the leafminer could reduce the risk of being parasitized (1) by making cross structures in the inner area of a leaf to deter parasitoids from tracking the mines due to complex pathways, and (2) by mining along the edge of a leaf to hinder visually searching parasitoids from finding mined leaves due to effective background matching of the mined leaves among intact leaves. We quantified fractal dimension as mine complexity and area of mine in the inner area of the leaf as interior mine density for each sample mine, and analyzed whether these mine traits affected the susceptibility of O. maura to parasitism. Our results have shown that an increase in mine complexity with the development of occupying larvae decreases the probability of being parasitized, while interior mine density has no influence on parasitism. These results suggest that the larval development increases the host defense ability through increasing mine complexity. Thus the feeding pattern of these sessile insects has a defensive function by reducing the risk of parasitism.	[Ayabe, Yoshiko] Natl Inst Basic Biol, Div Theoret Biol, Okazaki, Aichi 444, Japan; [Ueno, Takatoshi] Kyushu Univ, Fac Agr, Inst Biol Control, Fukuoka 812, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyushu University	Ayabe, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Protect, Nagoya, Aichi 4648601, Japan.	ayabe@agr.nagoya-u.ac.jp	Ayabe, Yoshiko/AAR-6201-2021	Ayabe, Yoshiko/0000-0002-9601-8381				Ayabe Y, 2004, ANN ENTOMOL SOC AM, V97, P586, DOI 10.1603/0013-8746(2004)097[0586:DSPOAL]2.0.CO;2; Ayabe Y, 2008, ANIM BEHAV, V76, P1795, DOI 10.1016/j.anbehav.2008.07.026; Ayabe Y, 2008, INSECT SCI, V15, P343, DOI 10.1111/j.1744-7917.2008.00219.x; Ayabe Y, 2010, ANN ENTOMOL SOC AM, V103, P806, DOI 10.1603/AN10049; Bacher S, 1997, J INSECT PHYSIOL, V43, P945, DOI 10.1016/S0022-1910(97)00058-9; Bailey R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000179; BARRETT BA, 1994, BIOL CONTROL, V4, P74, DOI 10.1006/bcon.1994.1013; BRANDL R, 1987, BIOL J LINN SOC, V32, P351, DOI 10.1111/j.1095-8312.1987.tb00436.x; CASAS J, 1989, ECOL ENTOMOL, V14, P257, DOI 10.1111/j.1365-2311.1989.tb00954.x; Connor EF, 1997, OIKOS, V79, P6, DOI 10.2307/3546085; CONNOR EF, 1994, ECOL ENTOMOL, V19, P327, DOI 10.1111/j.1365-2311.1994.tb00249.x; Cornelissen T, 2009, ECOGRAPHY, V32, P459, DOI 10.1111/j.1600-0587.2008.05590.x; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Djemai I, 2004, ANIM BEHAV, V67, P567, DOI 10.1016/j.anbehav.2003.07.006; Djemai I, 2001, P ROY SOC B-BIOL SCI, V268, P2403, DOI 10.1098/rspb.2001.1811; Djemai I, 2000, AM NAT, V156, P257, DOI 10.1086/303388; Eber S, 2004, J ANIM ECOL, V73, P948, DOI 10.1111/j.0021-8790.2004.00867.x; Endler JA, 2006, P R SOC B, V273, P2425, DOI 10.1098/rspb.2006.3650; Evans DL., 1990, INSECT DEFENSES ADAP; FAGOONEE I, 1984, INSECT SCI APPL, V5, P23, DOI 10.1017/S1742758400001387; Falconer J., 2003, FRACTAL GEOMETRY MAT; Fischer S, 2001, J COMP PHYSIOL A, V187, P785, DOI 10.1007/s00359-001-0249-7; Fraser S, 2007, P ROY SOC B-BIOL SCI, V274, P1325, DOI 10.1098/rspb.2007.0153; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GODFRAY HCJ, 1986, ECOL ENTOMOL, V11, P75, DOI 10.1111/j.1365-2311.1986.tb00281.x; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; HAWKINS BA, 1988, J ANIM ECOL, V57, P137, DOI 10.2307/4769; HESPENHEIDE HA, 1991, ANNU REV ENTOMOL, V36, P535, DOI 10.1146/annurev.en.36.010191.002535; HOCHBERG ME, 1992, SCIENCE, V255, P973, DOI 10.1126/science.255.5047.973; HOCHBERG ME, 1993, AM NAT, V142, P671, DOI 10.1086/285563; Jill JT, 1999, ENVIRON ENTOMOL, V28, P1114; KATO M, 1994, OECOLOGIA, V97, P17, DOI 10.1007/BF00317904; KATO M, 1985, RES POPUL ECOL, V27, P265, DOI 10.1007/BF02515465; KIMMERER TW, 1987, OECOLOGIA, V71, P548, DOI 10.1007/BF00379295; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Low C, 2008, BEHAV ECOL, V19, P532, DOI 10.1093/beheco/arm157; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Meyhofer R, 1997, P ROY SOC B-BIOL SCI, V264, P261, DOI 10.1098/rspb.1997.0037; MEYHOFER R, 1994, PHYSIOL ENTOMOL, V19, P349, DOI 10.1111/j.1365-3032.1994.tb01062.x; Mody K, 2011, BASIC APPL ECOL, V12, P456, DOI 10.1016/j.baae.2011.05.005; Patel KJ, 2003, FLA ENTOMOL, V86, P8, DOI 10.1653/0015-4040(2003)086[0008:DDPAHO]2.0.CO;2; REAVEY D, 1991, OIKOS, V61, P19, DOI 10.2307/3545403; Salvo A, 2004, J ANIM ECOL, V73, P494, DOI 10.1111/j.0021-8790.2004.00824.x; SATO H, 1995, ENVIRON ENTOMOL, V24, P879, DOI 10.1093/ee/24.4.879; Scheirs J, 1997, ANN ENTOMOL SOC AM, V90, P646, DOI 10.1093/aesa/90.5.646; Scheirs J, 2001, ECOL ENTOMOL, V26, P509, DOI 10.1046/j.1365-2311.2001.00356.x; StataCorp, 2005, STAT STAT SOFTW REL; Stevens M, 2006, P R SOC B, V273, P2124; Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; SUGIMOTO T, 1977, Applied Entomology and Zoology, V12, P87; SUGIMOTO T, 1988, APPL ENTOMOL ZOOL, V23, P113, DOI 10.1303/aez.23.113; Wajnberg E., 2008, BEHAV ECOLOGY INSECT; Woodcock BA, 2008, INSECT CONSERV DIVER, V1, P180, DOI 10.1111/j.1752-4598.2008.00023.x; Yamazaki K, 2010, OIKOS, V000, P001, DOI [10.1111/j.1600-0706.2010.18300.x., DOI 10.1111/J.1600-0706.2010.18300.X]	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32594	10.1371/journal.pone.0032594	http://dx.doi.org/10.1371/journal.pone.0032594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393419	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500071
J	Longrich, NR; Field, DJ				Longrich, Nicholas R.; Field, Daniel J.			Torosaurus Is Not Triceratops: Ontogeny in Chasmosaurine Ceratopsids as a Case Study in Dinosaur Taxonomy	PLOS ONE			English	Article							BONE-HISTOLOGY; LIFE-HISTORY; GROWTH; SYNONYMY; MATURITY; SUTURES; CLOSURE; FUSION	Background: In horned dinosaurs, taxonomy is complicated by the fact that the cranial ornament that distinguishes species with age. Based on this observation, it has been proposed that the genera Triceratops and Torosaurus are in fact synonymous, with specimens identified as Torosaurus representing the adult form of Triceratops. The hypothesis of synonymy makes three testable predictions: 1) the species in question should have similar geographic and stratigraphic distributions, 2) specimens assigned to Torosaurus should be more mature than those assigned to Triceratops, and 3) intermediates should exist that combine features of Triceratops and Torosaurus. The first condition appears to be met, but it remains unclear whether the other predictions are borne out by the fossil evidence. Methodology/Principal Findings: We assessed the relative maturity of Torosaurus and Triceratops specimens by coding skulls for characters that vary with maturity, and then using a clustering analysis to arrange them into a growth series. We found that a well-defined sequence of changes exists in horned dinosaurs: development of cranial ornament occurs in juveniles, followed by fusion of the skull roof in subadults, and finally, the epoccipitals, epijugals, and rostral fuse to the skull in adults. Using this scheme, we identified mature and immature individuals of both Torosaurus and Triceratops. Furthermore, we describe the ventral depressions on the frill of Triceratops, and show that they differ in shape and position from the parietal fenestrae of Torosaurus. Thus, we conclude that these structures are not intermediates between the solid frill of Triceratops and the fenestrated frill of Torosaurus. Conclusions/Significance: Torosaurus is a distinct genus of horned dinosaur, not the adult of Triceratops. Our method provides a framework for assessing the hypothesis of synonymy through ontogeny in the fossil record.	[Longrich, Nicholas R.; Field, Daniel J.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Yale University	Longrich, NR (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	nicholas.longrich@yale.edu		Longrich, Nicholas/0000-0002-9586-8907; Field, Daniel/0000-0002-1786-0352	Yale Institute for Biospheric Studies; Jurassic Foundation	Yale Institute for Biospheric Studies; Jurassic Foundation	Work was funded by the Yale Institute for Biospheric Studies and the Jurassic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton MJ, 2008, BIOL LETTERS, V4, P729, DOI 10.1098/rsbl.2008.0402; Benton MJ, 2008, PALEOBIOLOGY, V34, P516, DOI 10.1666/06077.1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; BROWN BARNUM, 1933, AMER MUS NOVITATES, V649, P1; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Carpenter Kenneth, 2002, Rocky Mountain Geology, V37, P237, DOI 10.2113/gsrocky.37.2.237; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; COBABE EA, 1987, J PALEONTOL, V61, P148, DOI 10.1017/S0022336000028298; Cope E. D., 1872, P AM PHILOS SOC, V12, P481; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dodson P., 1996, HORNED DINOSAURS, P346; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Farke AA, 2006, CERATOPSIAN ORNITHOP, P235; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Fujiwara Shin-ichi, 2011, Bulletin of Gunma Museum of Natural History, V15, P1; GILMORE C, 1946, US GEOLOGICAL SURV C, P1; Hatcher JB, 1905, AM J SCI, V20, P413; HERRING SW, 1974, ANAT EMBRYOL, V146, P167, DOI 10.1007/BF00315593; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; LAWSON DA, 1976, J PALEONTOL, V50, P158; Longrich NR, 2011, CRETACEOUS RES, V32, P264, DOI 10.1016/j.cretres.2010.12.007; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Lull RS, 1905, AM J SCI, V20, P420; Maisano JA, 2002, J VERTEBR PALEONTOL, V22, P268, DOI 10.1671/0272-4634(2002)022[0268:TFOSEA]2.0.CO;2; Marsh, 1891, AM J SCI, VXLI, P167; Marsh O. C., 1891, American Journal of Science (3), Vxlii, P265; Marsh O. C., 1892, American Journal of Science, V(3), P449; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; Marsh OC, 1877, AM J SCI, P323; Marsh OC, 1898, AM J SCI 3, V4, P6; Marsh OC, 1890, AM J SCI, V39, P422; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; Ostrom J.H., 1986, Zitteliana, V14, P111; Ostrom J.H., 1990, P245, DOI 10.1017/CBO9780511608377.021; Ott Christopher J., 2010, P203; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sanchez-Villagra MR, 2010, J VERTEBR PALEONTOL, V30, P1895, DOI 10.1080/02724634.2010.521218; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Scannella J, 2009, J VERTEBR PALEONTOL, V29, p177A; Scannella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028705; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; SCHLAIKJER ERICH M., 1935, BULL MUS COMP ZOOL, V76, P31; Schott RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021092; Skedros JG, 1996, ANAT RECORD, V246, P47; Sternberg C. M., 1949, Bulletin National Museum of Canada, VNo. 113, P33; Sullivan Robert M., 2010, P169; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P469, DOI 10.1002/ajpa.20481; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517	62	50	50	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32623	10.1371/journal.pone.0032623	http://dx.doi.org/10.1371/journal.pone.0032623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393425	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500077
J	Pirko, I; Cardin, R; Chen, Y; Lohrey, AK; Lindquist, DM; Dunn, RS; Zivadinov, R; Johnson, AJ				Pirko, Istvan; Cardin, Rhonda; Chen, Yi; Lohrey, Anne K.; Lindquist, Diana M.; Dunn, R. Scott; Zivadinov, Robert; Johnson, Aaron J.			CMV Infection Attenuates the Disease Course in a Murine Model of Multiple Sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-CELL RESPONSE; CYTOMEGALOVIRUS-INFECTION; VIRAL-INFECTION; THEILERS VIRUS; INTERFERON; EXPRESSION; MACROPHAGES; DEMYELINATION; INVOLVEMENT	Recent evidence in multiple sclerosis (MS) suggests that active CMV infection may result in more benign clinical disease. The goal of this pilot study was to determine whether underlying murine CMV (MCMV) infection affects the course of the Theiler's murine encephalitis virus (TMEV) induced murine model of MS. A group of eight TMEV-infected mice were co-infected with MCMV at 2 weeks prior to TMEV infection while a second group of TMEV-infected mice received MCMV two weeks post TMEV. We also used 2 control groups, where at the above time points MCMV was replaced with PBS. Outcome measures included (1) monthly monitoring of disability via rotarod for 8 months; (2) in vivo MRI for brain atrophy studies and (3) FACS analysis of brain infiltrating lymphocytes at 8 months post TMEV infection. Co-infection with MCMV influenced the disease course in mice infected prior to TMEV infection. In this group, rotarod detectable motor performance was significantly improved starting 3 months post-infection and beyond (p <= 0.024). In addition, their brain atrophy was close to 30% reduced at 8 months, but this was only present as a trend due to low power (p = 0.19). A significant reduction in the proportion of brain infiltrating CD3+ cells was detected in this group (p = 0.026), while the proportion of CD45+ Mac1+ cells significantly increased (p = 0.003). There was also a strong trend for a reduced proportion of CD4+ cells (p = 0.17) while CD8 and B220+ cell proportion did not change. These findings support an immunomodulatory effect of MCMV infection in this MS model. Future studies in this co-infection model will provide insight into mechanisms which modulate the development of demyelination and may be utilized for the development of novel therapeutic strategies.	[Pirko, Istvan] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Cardin, Rhonda] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Chen, Yi; Lohrey, Anne K.; Johnson, Aaron J.] Mayo Clin, Dept Neurol & Immunol, Rochester, MN USA; [Lindquist, Diana M.; Dunn, R. Scott] Cincinnati Childrens Hosp Med Ctr, Imaging Res Ctr, Cincinnati, OH USA; [Zivadinov, Robert] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; [Zivadinov, Robert] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA	Mayo Clinic; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Mayo Clinic; Cincinnati Children's Hospital Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pirko, I (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	Pirko@mayo.edu	Zivadinov, Robert/Q-2054-2019	Zivadinov, Robert/0000-0002-7799-1485	National MS Society; University of Cincinnati's Waddell Center for Multiple Sclerosis; National Institutes of Heatlh (NINDS) [R01 NS058698]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058698] Funding Source: NIH RePORTER	National MS Society(National Multiple Sclerosis Society); University of Cincinnati's Waddell Center for Multiple Sclerosis; National Institutes of Heatlh (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National MS Society, by intramural funds at the University of Cincinnati's Waddell Center for Multiple Sclerosis, and by the National Institutes of Heatlh (NINDS R01 NS058698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barzilai O, 2007, ANN NY ACAD SCI, V1108, P567, DOI 10.1196/annals.1422.059; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; Benedict CA, 2001, IMMUNITY, V15, P617, DOI 10.1016/S1074-7613(01)00222-9; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; Cardin RD, 2009, J VIROL, V83, P7590, DOI 10.1128/JVI.00386-09; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Fields BN, 2001, FIELDS VIROLOGY, Vxix; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Heise MT, 1998, VIROLOGY, V241, P331, DOI 10.1006/viro.1997.8969; Heise MT, 1998, J EXP MED, V187, P1037, DOI 10.1084/jem.187.7.1037; Jaquiery E, EUR J IMMUNOL, V40, P878; Jilek S, 2008, BRAIN, V131, P1712, DOI 10.1093/brain/awn108; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Kano Y, 2000, J DERMATOL SCI, V22, P196, DOI 10.1016/S0923-1811(99)00085-7; Lyman MA, 2002, J VIROL, V76, P3125, DOI 10.1128/JVI.76.7.3125-3134.2002; Manrique SZ, 2011, J EXP MED, V208, P1485, DOI 10.1084/jem.20100730; McDole J, 2008, HUM IMMUNOL, V69, P805, DOI 10.1016/j.humimm.2008.08.293; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Myhr KM, 1998, J NEUROL NEUROSUR PS, V64, P539, DOI 10.1136/jnnp.64.4.539; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; PERCIVALLE E, 1993, J CLIN INVEST, V92, P663, DOI 10.1172/JCI116635; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; Pirko I, NEUROIMAGE, V54, P802; PIRKO I, 2009, J NEUROL SCI; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Robb RA, 1999, ANNU REV BIOMED ENG, V1, P377, DOI 10.1146/annurev.bioeng.1.1.377; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; Sanders VJ, 1996, J NEUROVIROL, V2, P249, DOI 10.3109/13550289609146888; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Silverman MN, 2004, ENDOCRINOLOGY, V145, P3580, DOI 10.1210/en.2003-1421; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Sweet C, 1999, FEMS MICROBIOL REV, V23, P457, DOI 10.1111/j.1574-6976.1999.tb00408.x; Tsunoda I, 2007, J NEUROIMMUNOL, V188, P22, DOI 10.1016/j.jneuroim.2007.05.012; WROBLEWSKA Z, 1979, INFECT IMMUN, V25, P1008, DOI 10.1128/IAI.25.3.1008-1015.1979; Zivadinov R, 2006, NEUROL RES, V28, P262, DOI 10.1179/016164106X98134; Zuvich RL, 2009, SEMIN IMMUNOL, V21, P328, DOI 10.1016/j.smim.2009.08.003	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32767	10.1371/journal.pone.0032767	http://dx.doi.org/10.1371/journal.pone.0032767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393447	Green Published, gold, Green Submitted			2022-12-25	WOS:000303003500101
J	Nakazono, Y; Hara, K; Kashiwagi, T; Hamada, N; Watanabe, H				Nakazono, Yoko; Hara, Koyu; Kashiwagi, Takahito; Hamada, Nobuyuki; Watanabe, Hiroshi			The RNA Polymerase PB2 Subunit of Influenza A/HongKong/156/1997 (H5N1) Restrict the Replication of Reassortant Ribonucleoprotein Complexes	PLOS ONE			English	Article							N-TERMINAL REGION; VIRUS POLYMERASE; PA SUBUNIT; IN-VITRO; CONSERVED MOTIFS; CAP-BINDING; H1N1 VIRUS; A VIRUSES; NUCLEOPROTEIN; PROTEIN	Background: Genetic reassortment plays a critical role in the generation of pandemic strains of influenza virus. The influenza virus RNA polymerase, composed of PB1, PB2 and PA subunits, has been suggested to influence the efficiency of genetic reassortment. However, the role of the RNA polymerase in the genetic reassortment is not well understood. Methodology/Principal Findings: Here, we reconstituted reassortant ribonucleoprotein (RNP) complexes, and demonstrated that the PB2 subunit of A/HongKong/156/1997 (H5N1) [HK PB2] dramatically reduced the synthesis of mRNA, cRNA and vRNA when introduced into the polymerase of other influenza strains of H1N1 or H3N2. The HK PB2 had no significant effect on the assembly of the polymerase trimeric complex, or on promoter binding activity or replication initiation activity in vitro. However, the HK PB2 was found to remarkably impair the accumulation of RNP. This impaired accumulation and activity of RNP was fully restored when four amino acids at position 108, 508, 524 and 627 of the HK PB2 were mutated. Conclusions/Significance: Overall, we suggest that the PB2 subunit of influenza polymerase might play an important role for the replication of reassortant ribonucleoprotein complexes.	[Nakazono, Yoko; Hara, Koyu; Kashiwagi, Takahito; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Div Infect Dis, Dept Infect Med, Sch Med, Fukuoka, Japan	Kurume University	Nakazono, Y (corresponding author), Kurume Univ, Div Infect Dis, Dept Infect Med, Sch Med, Fukuoka, Japan.	koyu@med.kurume-u.ac.jp			Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan [21791015]; Grants-in-Aid for Scientific Research [24591590] Funding Source: KAKEN	Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ishibashi Foundation for the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 21791015, 2009-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAN WJ, 1984, VIROLOGY, V133, P438, DOI 10.1016/0042-6822(84)90410-0; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Octaviani CP, 2011, J VIROL, V85, P8449, DOI 10.1128/JVI.05054-11; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32634	10.1371/journal.pone.0032634	http://dx.doi.org/10.1371/journal.pone.0032634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389716	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600055
J	Owen, C; Czopek, A; Agouni, A; Grant, L; Judson, R; Lees, EK; Mcilroy, GD; Goransson, O; Welch, A; Bence, KK; Kahn, BB; Neel, BG; Mody, N; Delibegovic, M				Owen, Carl; Czopek, Alicja; Agouni, Abdelali; Grant, Louise; Judson, Robert; Lees, Emma K.; Mcilroy, George D.; Goransson, Olga; Welch, Andy; Bence, Kendra K.; Kahn, Barbara B.; Neel, Benjamin G.; Mody, Nimesh; Delibegovic, Mirela			Adipocyte-Specific Protein Tyrosine Phosphatase 1B Deletion Increases Lipogenesis, Adipocyte Cell Size and Is a Minor Regulator of Glucose Homeostasis	PLOS ONE			English	Article							LIVER-SPECIFIC DELETION; INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM; ENERGY-EXPENDITURE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; PTP1B; EXPRESSION; OBESITY; TRANSPORT	Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin and insulin signaling, is positively correlated with adiposity and contributes to insulin resistance. Global PTP1B deletion improves diet-induced obesity and glucose homeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However, the role of PTP1B in adipocytes is unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose-PTP1B-deficiency on body mass and insulin resistance. To definitively establish the role of adipocyte-PTP1B in body mass regulation and glucose homeostasis, adipocyte-specific-PTP1B knockout mice (adip-crePTP1B(-/-)) were generated using the adiponectin-promoter to drive Cre-recombinase expression. Chow-fed adip-crePTP1B(-/-) mice display enlarged adipocytes, despite having similar body weight/adiposity and glucose homeostasis compared to controls. High-fat diet (HFD)-fed adip-crePTP1B(-/-) mice display no differences in body weight/adiposity but exhibit larger adipocytes, increased circulating glucose and leptin levels, reduced leptin sensitivity and increased basal lipogenesis compared to controls. This is associated with decreased insulin receptor (IR) and Akt/PKB phosphorylation, increased lipogenic gene expression and increased hypoxia-induced factor-1-alpha (Hif-1 alpha) expression. Adipocyte-specific PTP1B deletion does not beneficially manipulate signaling pathways regulating glucose homeostasis, lipid metabolism or adipokine secretion in adipocytes. Moreover, PTP1B does not appear to be the major negative regulator of the IR in adipocytes.	[Owen, Carl; Judson, Robert; Welch, Andy] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Goransson, Olga] Lund Univ, Dept Expt Med Sci, Prot Phosphorylat Unit, Lund, Sweden; [Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Neel, Benjamin G.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Princess Margaret Hosp, Toronto, ON, Canada	University of Aberdeen; Lund University; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Owen, C (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	m.delibegovic@abdn.ac.uk	Mody, Nimesh/J-9602-2019; Agouni, Abdelali/AAP-5298-2020	Mody, Nimesh/0000-0002-2215-7952; Agouni, Abdelali/0000-0002-8363-1582; Delibegovic, Mirela/0000-0001-6193-3152; Mcilroy, George/0000-0003-4230-4355; Lees, Emma/0000-0001-8911-4351; Goransson, Olga/0000-0002-7209-8022; Bence, Kendra/0000-0002-5879-4726	British Heart Foundation [PG/09/048/27675, PG/11/8/28703]; Diabetes UK [BDA/RD08/0003597]; STINT; Swedish Foundation for International Cooperation in Research and Higher Education; BBSRC; Biotechnology and Biological Sciences Research Council [1091530] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043051] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); STINT; Swedish Foundation for International Cooperation in Research and Higher Education; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the British Heart Foundation project grant awarded to MD (PG/09/048/27675 and PG/11/8/28703) and the Diabetes UK project grant awarded to MD. (BDA/RD08/0003597). This work was also supported by a STINT grant awarded to OG; Institutional Grant for Young Researchers, from The Swedish Foundation for International Cooperation in Research and Higher Education. CO is the recipient of a BBSRC postgraduate studentship; NM is the recipient of a British Heart Foundation intermediate basic research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Arya G, 2010, VET MICROBIOL, V141, P332, DOI 10.1016/j.vetmic.2009.09.030; Bai YL, 1996, J BIOL CHEM, V271, P13939, DOI 10.1074/jbc.271.24.13939; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bence Kendra K, 2010, J Clin Metab Diabetes, V1, P27; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dorrestijn J, 1998, ARCH PHYSIOL BIOCHEM, V106, P269, DOI 10.1076/apab.106.4.269.4369; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fine JB, 1997, INT J OBESITY, V21, P764, DOI 10.1038/sj.ijo.0800469; FOLEY JE, 1980, DIABETOLOGIA, V19, P234, DOI 10.1007/BF00275275; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kobayashi K, 2005, CURR DRUG TARGETS, V6, P525, DOI 10.2174/1389450054021972; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lonnqvist F, 1997, J CLIN INVEST, V99, P2398, DOI 10.1172/JCI119422; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; Muthusamy VS, 2008, CHEM-BIOL INTERACT, V174, P69, DOI 10.1016/j.cbi.2008.04.016; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruffolo SC, 2007, J BIOL CHEM, V282, P30423, DOI 10.1074/jbc.M700697200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimizu S, 2003, J BIOL CHEM, V278, P43095, DOI 10.1074/jbc.M306880200; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wang YC, 2006, J NUCL MED, V47, P1891; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Waring JF, 2003, MOL CELL ENDOCRINOL, V203, P155, DOI 10.1016/S0303-7207(03)00008-X; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	56	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32700	10.1371/journal.pone.0032700	http://dx.doi.org/10.1371/journal.pone.0032700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389718	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600057
J	Kim, S; Joo, DH; Lee, JB; Shim, BS; Cheon, IS; Jang, JE; Song, HH; Kim, KH; Song, MK; Chang, J				Kim, Sol; Joo, Dong-Hyun; Lee, Jee-Boong; Shim, Byoung-Shik; Cheon, In Su; Jang, Ji-Eun; Song, Ho-Hyun; Kim, Kyung-Hyo; Song, Man Ki; Chang, Jun			Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant	PLOS ONE			English	Article							ATTACHMENT G GLYCOPROTEIN; G-PROTEIN; PROTECTIVE IMMUNITY; CHOLERA-TOXIN; PULMONARY EOSINOPHILIA; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; RESPONSES; INFECTION; VACCINE	Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease in infancy and early childhood. Despite its importance as a pathogen, there is no licensed vaccine to prevent RSV infection. The G glycoprotein of RSV, a major attachment protein, is a potentially important target for protective antiviral immune responses and has been shown to exhibit chemotactic activity through CX3C mimicry. Here, we show that sublingual or intranasal immunization of a purified G protein fragment of amino acids from 131 to 230, designated Gcf, induces strong serum IgG and mucosal IgA responses. Interestingly, these antibody responses could be elicited by Gcf even in the absence of any adjuvant, indicating a novel self-adjuvanting property of our vaccine candidate. Gcf exhibited potent chemotactic activity in in vitro cell migration assay and cysteine residues are necessary for chemotactic activity and self-adjuvanticity of Gcf in vivo. Mucosal immunization with Gcf also provides protection against RSV challenge without any significant lung eosinophilia or vaccine-induced weight loss. Together, our data demonstrate that mucosal administration of Gcf vaccine elicits beneficial protective immunity and represents a promising vaccine regimen preventing RSV infection.	[Kim, Sol; Lee, Jee-Boong; Chang, Jun] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Joo, Dong-Hyun; Shim, Byoung-Shik; Cheon, In Su; Jang, Ji-Eun; Song, Ho-Hyun; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Kim, Kyung-Hyo] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul, South Korea	Ewha Womans University; International Vaccine Institute; Ewha Womans University	Kim, S (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	songmk@ivi.int; tcell@ewha.ac.kr	kim, sol/I-2198-2019	CHANG, JUN/0000-0002-8423-5987	Korea Health Industry Development Institute; Korean Government [A084555]; Korea Science & Engineering Foundation through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University [R15-2006-020]; government of the Republic of Korea; government of the Republic of Sweden; government of the Republic of Kuwait; Korea Research Institute of Bioscience Biotechnology [KGM3110912]; Ministry of Science Technology	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korean Government(Korean Government); Korea Science & Engineering Foundation through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University; government of the Republic of Korea(Korean Government); government of the Republic of Sweden; government of the Republic of Kuwait; Korea Research Institute of Bioscience Biotechnology; Ministry of Science Technology	This work was supported by the Korea Health Industry Development Institute Grant funded by the Korean Government (A084555), by the grant R15-2006-020 from the National Core Research Center program of the Ministry of Science & Technology and the Korea Science & Engineering Foundation through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University. Man Ki Song was supported by the governments of the Republic of Korea, Sweden, and Kuwait, and by the grant from Korea Research Institute of Bioscience & Biotechnology (KGM3110912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis Mubeccel, 2008, Clin Allergy Immunol, V21, P71; ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Falsey AR, 1998, VACCINE, V16, P1775, DOI 10.1016/S0264-410X(98)00142-X; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Gorman JJ, 1997, PROTEIN SCI, V6, P1308, DOI 10.1002/pro.5560060619; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Huang Y, 2009, J CLIN VIROL, V44, P287, DOI 10.1016/j.jcv.2009.01.009; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Martinez I, 1998, J GEN VIROL, V79, P2215, DOI 10.1099/0022-1317-79-9-2215; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Power UF, 2003, VACCINE, V22, P168, DOI 10.1016/S0264-410X(03)00570-X; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; TAYLOR G, 1984, IMMUNOLOGY, V52, P137; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07; Zhang W, J VIROL, V84, P1148	40	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32226	10.1371/journal.pone.0032226	http://dx.doi.org/10.1371/journal.pone.0032226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384186	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500068
J	Zhu, R; Yang, YT; Tian, Y; Bai, JY; Zhang, X; Li, XH; Peng, ZH; He, YH; Chen, L; Pan, Q; Fang, DC; Chen, WS; Qian, C; Bian, XW; Wang, RQ				Zhu, Rong; Yang, Yongtao; Tian, Yin; Bai, Jianying; Zhang, Xin; Li, Xiaohuan; Peng, Zhihong; He, Yonghong; Chen, Lei; Pan, Qiong; Fang, Dianchun; Chen, Wensheng; Qian, Chen; Bian, Xiuwu; Wang, Rongquan			Ascl2 Knockdown Results in Tumor Growth Arrest by miRNA-302b-Related Inhibition of Colon Cancer Progenitor Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INITIATING CELLS; SELF-RENEWAL; HEMATOPOIETIC STEM; SIGNALING PATHWAYS; TUMORIGENICITY; EXPRESSION; MIR-34; P53	Background: Achaete scute-like 2 (Ascl2), a basic helix-loop-helix (bHLH) transcription factor, controls the fate of intestinal stem cells. However, the role of Ascl2 in colon cancer progenitor cells remains unknown. The cell line HT-29 (47.5-95% of CD133(+) population) and LS174T (0.45% of CD133(+) population) were chosen for functional evaluation of Ascl2 in colon cancer progenitor cells after gene knockdown by RNA interference. Methodology/Principal Findings: Immunohistochemistry demonstrated that Ascl2 was significantly increased in colorectal adenocarcinomas. Downregulation of Ascl2 using RNA interference in cultured colonic adenocarcinoma HT-29 and LS174T cells reduced cellular proliferation, colony-forming ability, invasion and migration in vitro, and resulted in the growth arrest of tumor xenografts in vivo. The Ascl2 protein level in CD133(+) HT-29 cells was significantly higher than in CD133(-) HT-29 cells. Ascl2 blockade via shRNA interference in HT-29 cells (shRNA-Ascl2/HT-29 cells) resulted in 26.2% of cells staining CD133(+) compared with 54.7% in control shRNA-Ctr/HT-29 cells. The levels of 'stemness' associated genes, such as CD133, Sox2, Oct4, Lgr5, Bmi1, and C-myc, were significantly decreased in shRNA-Ascl2/HT-29 and shRNA-Ascl2/LS174T cells in vitro as well as in the corresponding tumor xenograft (CD133 was not performed in shRNA-Ascl2/LS174T cells). The shRNA-Ascl2/HT-29 cells had inhibited abilities to form tumorspheres compared with control. The microRNA (miRNAs) microarrays, identified 26 up-regulated miRNAs and 58 down-regulated miRNAs in shRNA-Ascl2/HT-29 cells. Expression levels of let-7b, miRNA-124, miRNA-125b, miRNA-17, miRNA-20a and miRNA-302b, involved in the regulation of 'stemness', were quantified with qPCR, which confirmed their identities. Restoration of miRNA-302b, via its mimic, led to the restoration of shRNA-Ascl2/HT-29 'stemness' characteristics, including tumorsphere formation and 'stemness' associated genes levels, and the recovery of cellular behaviors, including colony-forming ability, invasion and migration in vitro. Conclusions/Significance: Ascl2 may be a potential target for the inhibition of colon cancer progenitor cells, and functions through a miR-302b-related mechanism.	[Zhu, Rong; Yang, Yongtao; Tian, Yin; Bai, Jianying; Zhang, Xin; Li, Xiaohuan; Peng, Zhihong; He, Yonghong; Chen, Lei; Pan, Qiong; Fang, Dianchun; Chen, Wensheng; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Qian, Chen; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhu, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China.	rongquanw@hotmail.com	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; Wang, Rongquan/0000-0001-5307-0086	State Foundation for the Natural Sciences of the People's Republic of China [81000154]; Natural Science Foundation of CQ CSTC [2008BA5034]	State Foundation for the Natural Sciences of the People's Republic of China; Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by the State Foundation for the Natural Sciences of the People's Republic of China 81000154 (to Y.Y.) and the Natural Science Foundation Project of CQ CSTC 2008BA5034 (to R.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Huang EH, 2008, TRENDS MOL MED, V14, P503, DOI 10.1016/j.molmed.2008.09.005; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Jubb AM, 2010, GUT; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van der Flier LG, 2010, GUT, V59, P1236; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	36	59	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32170	10.1371/journal.pone.0032170	http://dx.doi.org/10.1371/journal.pone.0032170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384170	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100056
J	Falivene, J; Zajac, MPD; Pascutti, MF; Rodriguez, AM; Maeto, C; Perdiguero, B; Gomez, CE; Esteban, M; Calamante, G; Gherardi, MM				Falivene, Juliana; Del Medico Zajac, Maria Paula; Pascutti, Maria Fernanda; Maria Rodriguez, Ana; Maeto, Cynthia; Perdiguero, Beatriz; Gomez, Carmen E.; Esteban, Mariano; Calamante, Gabriela; Magdalena Gherardi, Maria			Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein	PLOS ONE			English	Article							VIRUS ANKARA MVA; IFN-GAMMA PRODUCTION; T-CELL DETERMINANTS; ATTENUATED MVA; SMALLPOX VACCINE; STRAIN MVA; IMMUNOGENICITY; INFECTION; RECEPTOR; MEMORY	Background: Modified Vaccinia Ankara (MVA) is an attenuated strain of Vaccinia virus (VACV) currently employed in many clinical trials against HIV/AIDS and other diseases. MVA still retains genes involved in host immune response evasion, enabling its optimization by removing some of them. The aim of this study was to evaluate cellular immune responses (CIR) induced by an IL-18 binding protein gene (C12L) deleted vector (MVA Delta C12L). Methodology/Principal Findings: BALB/c and C57BL/6 mice were immunized with different doses of MVA Delta C12L or MVA wild type (MVAwt), then CIR to VACV epitopes in immunogenic proteins were evaluated in spleen and draining lymph nodes at acute and memory phases (7 and 40 days post-immunization respectively). Compared with parental MVAwt, MVA Delta C12L immunization induced a significant increase of two to three-fold in CD8(+) and CD4(+) T-cell responses to different VACV epitopes, with increased percentage of anti-VACV cytotoxic CD8(+) T-cells (CD107a/b(+)) during the acute phase of the response. Importantly, the immunogenicity enhancement was also observed after MVA Delta C12L inoculation with different viral doses and by distinct routes (systemic and mucosal). Potentiation of MVA's CIR was also observed during the memory phase, in correlation with a higher protection against an intranasal challenge with VACV WR. Of note, we could also show a significant increase in the CIR against HIV antigens such as Env, Gag, Pol and Nef from different subtypes expressed from two recombinants of MVA Delta C12L during heterologous DNA prime/MVA boost vaccination regimens. Conclusions/Significance: This study demonstrates the relevance of IL-18 bp contribution in the immune response evasion during MVA infection. Our findings clearly show that the deletion of the viral IL-18 bp gene is an effective approach to increase MVA vaccine efficacy, as immunogenicity improvements were observed against vector antigens and more importantly to HIV antigens.	[Falivene, Juliana; Pascutti, Maria Fernanda; Maria Rodriguez, Ana; Maeto, Cynthia; Magdalena Gherardi, Maria] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Del Medico Zajac, Maria Paula; Calamante, Gabriela] CICVyA INTA Castelar, Inst Biotecnol, Buenos Aires, DF, Argentina; [Perdiguero, Beatriz; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Madrid, Spain	University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Falivene, J (corresponding author), Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	mgherardi@fmed.uba.ar	Gomez, Carmen Elena/K-1940-2014; Perdiguero, Beatriz/K-6587-2017; Esteban, Mariano/ABG-5375-2020	Gomez, Carmen Elena/0000-0002-5414-7935; Perdiguero, Beatriz/0000-0001-6276-7766; Esteban, Mariano/0000-0003-0846-2827; Pascutti, Maria Fernanda/0000-0003-3212-780X; Falivene, Juliana/0000-0003-3437-4863	Argentinean Agency for the Promotion of Science and Technology (ANPCYT) [2008-0459]; AECID-PCI of Spain [A/031560/10]; AERG (Area Estrategica de Regursos Geneticos) from National Institute of Agricultural Technology (INTA), Argentina [232152]; Argentinean National Research Council (CONICET)	Argentinean Agency for the Promotion of Science and Technology (ANPCYT)(ANPCyT); AECID-PCI of Spain; AERG (Area Estrategica de Regursos Geneticos) from National Institute of Agricultural Technology (INTA), Argentina; Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been funded by the Argentinean Agency for the Promotion of Science and Technology (ANPCYT, Grant No 2008-0459), the AECID-PCI of Spain (Grant No A/031560/10) and Grant AERG (Area Estrategica de Regursos Geneticos) No 232152 from National Institute of Agricultural Technology (INTA), Argentina. Juliana Falivene and Cynthia Maeto were supported by the Argentinean National Research Council (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008159; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Cox MA, TRENDS IMMUNOL, V32, P180; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Earl PL, 1998, CURRENT PROTOCOLS MO; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Ferrer M. F., 2007, Rev. argent. microbiol., V39, P138; Ferrer MF, VIRAL IMMUNOL, V24, P331; Garcia-Arriaza J, PLOS ONE, V5; Garcia-Arriaza J, PLOS ONE, V6, pe24244; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; Gherardi MM, 1999, J IMMUNOL, V162, P6724; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Gomez CE, CURR GENE THER, V11, P189; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hand TW, P NATL ACAD SCI US, V107, P16601; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Manrique M, 2009, MUCOSAL IMMUNOL, V2, P536, DOI 10.1038/mi.2009.103; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez AM, 2009, VIRUS RES, V146, P1, DOI 10.1016/j.virusres.2009.08.004; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219; Smith CL, 2005, INT J CANCER, V113, P259, DOI 10.1002/ijc.20569; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Wilck MB, J INFECT DIS, V201, P1361; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	60	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32220	10.1371/journal.pone.0032220	http://dx.doi.org/10.1371/journal.pone.0032220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384183	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500087
J	Jachowski, DS; Slotow, R; Millspaugh, JJ				Jachowski, David S.; Slotow, Rob; Millspaugh, Joshua J.			Physiological Stress and Refuge Behavior by African Elephants	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; SEXUAL SEGREGATION; HABITAT SELECTION; GAME RESERVE; CONSERVATION; CORTICOSTERONE; POPULATION; HETEROGENEITY; MOVEMENTS; DOMINANCE	Physiological stress responses allow individuals to adapt to changes in their status or surroundings, but chronic exposure to stressors could have detrimental effects. Increased stress hormone secretion leads to short-term escape behavior; however, no studies have assessed the potential of longer-term escape behavior, when individuals are in a chronic physiological state. Such refuge behavior is likely to take two forms, where an individual or population restricts its space use patterns spatially (spatial refuge hypothesis), or alters its use of space temporally (temporal refuge hypothesis). We tested the spatial and temporal refuge hypotheses by comparing space use patterns among three African elephant populations maintaining different fecal glucocorticoid metabolite (FGM) concentrations. In support of the spatial refuge hypothesis, the elephant population that maintained elevated FGM concentrations (iSimangaliso) used 20% less of its reserve than did an elephant population with lower FGM concentrations (Pilanesberg) in a reserve of similar size, and 43% less than elephants in the smaller Phinda reserve. We found mixed support for the temporal refuge hypothesis; home range sizes in the iSimangaliso population did not differ by day compared to nighttime, but elephants used areas within their home ranges differently between day and night. Elephants in all three reserves generally selected forest and woodland habitats over grasslands, but elephants in iSimangaliso selected exotic forest plantations over native habitat types. Our findings suggest that chronic stress is associated with restricted space use and altered habitat preferences that resemble a facultative refuge behavioral response. Elephants can maintain elevated FGM levels for >= 6 years following translocation, during which they exhibit refuge behavior that is likely a result of human disturbance and habitat conditions. Wildlife managers planning to translocate animals, or to initiate other management activities that could result in chronic stress responses, should consider the potential for, and consequences of, refuge behavior.	[Jachowski, David S.; Millspaugh, Joshua J.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65201 USA; [Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Amarula Elephant Res Programme, Durban, South Africa	University of Missouri System; University of Missouri Columbia; University of Kwazulu Natal	Jachowski, DS (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65201 USA.	djachowski@gmail.com	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	University of Missouri; University of KwaZulu-Natal and Amarula (Distell (PTY) Ltd); Wildlands Conservation Trust; U.S. Fish & Game African Elephant Conservation Fund [98210-2-G419]; National Research Foundation [2053623, FA2006032300024]	University of Missouri; University of KwaZulu-Natal and Amarula (Distell (PTY) Ltd); Wildlands Conservation Trust; U.S. Fish & Game African Elephant Conservation Fund; National Research Foundation	Funding for this research was provided by the University of Missouri, the University of KwaZulu-Natal and Amarula (Distell (PTY) Ltd), Wildlands Conservation Trust, U.S. Fish & Game African Elephant Conservation Fund (98210-2-G419), and National Research Foundation (2053623 and FA2006032300024). D.S. Jachowski was supported by the Brown Fellowship of the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Ahlering MA, 2010, ANIMAL CONSERVATION, V14, P124; Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; ASTHEIMER LB, 1992, ORNIS SCAND, V23, P355, DOI 10.2307/3676661; Barg JJ, 2005, J ANIM ECOL, V74, P139, DOI 10.1111/j.1365-2656.2004.00906.x; Bingham RL, 2004, J WILDLIFE MANAGE, V68, P206, DOI 10.2193/0022-541X(2004)068[0206:COTIER]2.0.CO;2; Bradshaw GA, 2007, ETHOLOGY, V113, P426, DOI 10.1111/j.1439-0310.2007.01333.x; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Breuner CW, 2003, HORM BEHAV, V43, P115, DOI 10.1016/S0018-506X(02)00020-X; Breuner CW, 1998, GEN COMP ENDOCR, V111, P386, DOI 10.1006/gcen.1998.7128; Brockett BH, 1993, WOODY VEGETATION STA; Burke T, 2005, THESIS U KWAZULU NAT; Burke T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002417; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; Elliott JM, 2000, J FISH BIOL, V56, P938, DOI 10.1111/j.1095-8649.2000.tb00883.x; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Garai Marion E., 2004, Pachyderm, V37, P28; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Grant C.C., 2008, P329; Grobler Douw G., 2008, P241; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kerley GIH, 2008, ELEPHANT MANAGEMENT, P84; LAWS RM, 1970, OIKOS, V21, P1, DOI 10.2307/3543832; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Low AB, 1996, VEGETATION S AFRICAN; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Millspaugh JJ, 2000, J WILDLIFE MANAGE, V64, P994, DOI 10.2307/3803209; Millspaugh JJ, 2003, WILDLIFE SOC B, V31, P399; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Millspaugh JSJ, 2004, WILDLIFE SOC B, V32, P148, DOI 10.2193/0091-7648(2004)32[148:COTATT]2.0.CO;2; Mutinda Hamisi, 2011, P246; Ngene SM, 2010, AFR J ECOL, V48, P386, DOI 10.1111/j.1365-2028.2009.01125.x; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Poole Joyce H., 2011, P109; Pretorius Y, 2004, THESIS U NATAL DURBA; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2007, INT J COMP PSYCHOL, V20, P85; Seidel K., 1992, STAT PROPERTIES APPL; Shannon G, 2008, J MAMMAL, V89, P467, DOI 10.1644/07-MAMM-A-132R.1; Shannon G, 2006, AFR ZOOL, V41, P37, DOI 10.3377/1562-7020(2006)41[37:AEHRAH]2.0.CO;2; Shannon G, 2010, AUSTRAL ECOL, V35, P731, DOI 10.1111/j.1442-9993.2009.02080.x; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Slotow R, 2005, S AFR J WILDL RES, V35, P23; Slotow R, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P91, DOI 10.1007/978-1-4614-0902-1_6; Smit IPJ, 2007, DIVERS DISTRIB, V13, P225, DOI 10.1111/j.1472-4642.2007.00318.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; Twine Wayne, 2008, P206; Ultsch GR, 2006, BIOL REV, V81, P339, DOI 10.1017/S1464793106007032; van Winkle W, 1975, J WILDLIFE MANAGE, V54, P322; Vanak AT, 2010, BIOL CONSERV, V143, P2631, DOI 10.1016/j.biocon.2010.07.005; Viijoen JJ, 2008, S AFR J WILDL RES, V38, P146; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wingfield JC, 1997, ARDEA, V85, P155; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Woolley LA, 2009, J WILDLIFE MANAGE, V73, P827, DOI 10.2193/2008-412; Woolley LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003233; Wrege PH, 2010, CONSERV BIOL, V24, P1578, DOI 10.1111/j.1523-1739.2010.01559.x	72	50	50	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31818	10.1371/journal.pone.0031818	http://dx.doi.org/10.1371/journal.pone.0031818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384079	Green Submitted, gold, Green Published			2022-12-25	WOS:000302875500044
J	Zuercher, E; Butticaz, C; Wyniger, J; Martinez, R; Battegay, M; El Amari, EB; Dang, T; Egger, JF; Fehr, J; Mueller-Garamvogyi, E; Parini, A; Schaefer, SC; Schoeni-Affolter, F; Thurnheer, C; Tinguely, M; Telenti, A; Rothenberger, S				Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Battegay, Manuel; El Amari, Emmanuelle Boffi; Thanh Dang; Egger, Jean-Francois; Fehr, Jan; Mueller-Garamvoegyi, Esther; Parini, Andrea; Schaefer, Stephan C.; Schoeni-Affolter, Franziska; Thurnheer, Christine; Tinguely, Marianne; Telenti, Amalio; Rothenberger, Sylvia		Swiss HIV Cohort Study	Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Kb Activation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; KAPPA-B; NASOPHARYNGEAL CARCINOMA; HODGKIN LYMPHOMA; BNLF-1 GENE; WILD-TYPE; SEQUENCE; VARIANTS; MEMBRANE-PROTEIN-1	Epstein-Barr virus (EBV) is associated with several types of cancers including Hodgkin's lymphoma (HL) and nasopharyngeal carcinoma (NPC). EBV-encoded latent membrane protein 1 (LMP1), a multifunctional oncoprotein, is a powerful activator of the transcription factor NF-kappa B, a property that is essential for EBV-transformed lymphoblastoid cell survival. Previous studies reported LMP1 sequence variations and induction of higher NF-kappa B activation levels compared to the prototype B95-8 LMP1 by some variants. Here we used biopsies of EBV-associated cancers and blood of individuals included in the Swiss HIV Cohort Study (SHCS) to analyze LMP1 genetic diversity and impact of sequence variations on LMP1-mediated NF-kappa B activation potential. We found that a number of variants mediate higher NF-kappa B activation levels when compared to B95-8 LMP1 and mapped three single polymorphisms responsible for this phenotype: F106Y, I124V and F144I. F106Y was present in all LMP1 isolated in this study and its effect was variant dependent, suggesting that it was modulated by other polymorphisms. The two polymorphisms I124V and F144I were present in distinct phylogenetic groups and were linked with other specific polymorphisms nearby, I152L and D150A/L151I, respectively. The two sets of polymorphisms, I124V/I152L and F144I/D150A/L151I, which were markers of increased NF-kappa B activation in vitro, were not associated with EBV-associated HL in the SHCS. Taken together these results highlighted the importance of single polymorphisms for the modulation of LMP1 signaling activity and demonstrated that several groups of LMP1 variants, through distinct mutational paths, mediated enhanced NF-kappa B activation levels compared to B95-8 LMP1.	[Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Telenti, Amalio; Rothenberger, Sylvia] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland; [Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Thanh Dang; Schaefer, Stephan C.; Schoeni-Affolter, Franziska; Telenti, Amalio; Rothenberger, Sylvia] Univ Lausanne, Lausanne, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [El Amari, Emmanuelle Boffi] Univ Hosp Geneva, Univ Clin Infect Dis, Geneva, Switzerland; [Thanh Dang] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Egger, Jean-Francois] Lab Viollier Weintraub SA, Pathol, Geneva, Switzerland; [Fehr, Jan; Tinguely, Marianne] Univ Zurich, Zurich, Switzerland; [Fehr, Jan] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Mueller-Garamvoegyi, Esther; Thurnheer, Christine] Univ Bern, Bern, Switzerland; [Mueller-Garamvoegyi, Esther] Univ Hosp Bern, Inst Pathol, CH-3010 Bern, Switzerland; [Parini, Andrea] Osped Regionale, Med Serv, Lugano, Switzerland; [Schaefer, Stephan C.] Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Schoeni-Affolter, Franziska] Univ Lausanne Hosp, Swiss HIV Cohort Study Data Ctr, Lausanne, Switzerland; [Thurnheer, Christine] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Tinguely, Marianne] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Basel; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Zurich; University Zurich Hospital; University of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital	Zuercher, E (corresponding author), Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland.	sylvia.rothenberger-aubert@chuv.ch	Telenti, Amalio/AAY-1674-2021; Pantaleo, Giuseppe/K-6163-2016; Fehr, Jan S/V-7499-2017; Thurnheer, Christine/CAH-0185-2022	Fehr, Jan S/0000-0003-1113-9895; Thurnheer, Christine/0000-0003-1357-0347; Rothenberger, Sylvia/0000-0001-8633-2994	Foundation VELUX; Fondation Emma Muschamp; Fondation Pierre Mercier pour la Science; University of Lausanne; Swiss HIV Cohort Study; Swiss National Science Foundation [FN 3100A0-120250]	Foundation VELUX(Velux Fonden); Fondation Emma Muschamp; Fondation Pierre Mercier pour la Science; University of Lausanne; Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Foundation VELUX, the Fondation Emma Muschamp, the Fondation Pierre Mercier pour la Science, the University of Lausanne, the Swiss HIV Cohort Study and the Swiss National Science Foundation (grant FN 3100A0-120250 to Stefan Kunz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAICHWAL VR, 1988, ONCOGENE, V2, P461; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Blake SMS, 2001, VIROLOGY, V282, P278, DOI 10.1006/viro.2001.0828; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carbone A, 1999, BLOOD, V93, P2319; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Cheung ST, 1998, INT J CANCER, V76, P399, DOI 10.1002/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO;2-6; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Correa RM, 2007, J MED VIROL, V79, P401, DOI 10.1002/jmv.20782; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; Dirmeier U, 2003, CANCER RES, V63, P2982; Dolcetti R, 1997, BLOOD, V89, P1723, DOI 10.1182/blood.V89.5.1723.1723_1723_1731; Dolcetti R, 2001, EUR J CANCER, V37, P1276, DOI 10.1016/S0959-8049(01)00105-8; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Farrell K, 2011, HISTOPATHOLOGY, V58, P15, DOI 10.1111/j.1365-2559.2010.03705.x; Faumont N, 2001, J GEN VIROL, V82, P1169, DOI 10.1099/0022-1317-82-5-1169; FENNEWALD S, 1984, J VIROL, V51, P411, DOI 10.1128/JVI.51.2.411-419.1984; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Gasser O, 2007, PLOS MED, V4, P556, DOI 10.1371/journal.pmed.0040096; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; He ZM, 2000, CANCER RES, V60, P1845; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; HU LF, 1993, ONCOGENE, V8, P1575; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; Jen KY, 2005, VIRUS GENES, V30, P223, DOI 10.1007/s11262-004-5630-5; Johnson RJ, 1998, J VIROL, V72, P4038, DOI 10.1128/JVI.72.5.4038-4048.1998; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KNECHT H, 1995, ONCOGENE, V10, P523; KNECHT H, 1993, BLOOD, V82, P2937; Kuppers Ralf, 2009, Hematology Am Soc Hematol Educ Program, P491, DOI 10.1182/asheducation-2009.1.491; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Miller WE, 1998, ONCOGENE, V16, P1869, DOI 10.1038/sj.onc.1201696; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Nagamine M, 2007, VIRUS GENES, V34, P47, DOI 10.1007/s11262-006-0008-5; Nguyen-Van D, 2008, VIRUS GENES, V37, P273, DOI 10.1007/s11262-008-0262-9; Nicholls J, 2004, J VIROL METHODS, V116, P79, DOI 10.1016/j.jviromet.2003.10.015; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rothenberger S, 2002, CELL MOL LIFE SCI, V59, P171, DOI 10.1007/s00018-002-8413-y; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sandvej K, 1997, BLOOD, V90, P323; Schmitz R, 2009, ANNU REV PATHOL-MECH, V4, P151, DOI 10.1146/annurev.pathol.4.110807.092209; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Spina M, 2011, ADV HEMATOL; Tang YL, 2008, BRAZ J MED BIOL RES, V41, P110, DOI 10.1590/S0100-879X2008000200006; TELENTI A, 1993, EUR J CLIN MICROBIOL, V12, P601, DOI 10.1007/BF01973638; TIRELLI U, 1995, AIDS, V9, P99; Walling DM, 1999, J INFECT DIS, V179, P763, DOI 10.1086/314672; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	60	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32168	10.1371/journal.pone.0032168	http://dx.doi.org/10.1371/journal.pone.0032168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384168	Green Published, Green Accepted, gold			2022-12-25	WOS:000302875500080
J	Kurihara, D; Yamashita, T				Kurihara, Dai; Yamashita, Toshihide			Chondroitin Sulfate Proteoglycans Down-regulate Spine Formation in Cortical Neurons by Targeting Tropomyosin-related Kinase B (TrkB) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; DENDRITIC SPINE; NERVOUS-SYSTEM; VISUAL-CORTEX; FUNCTIONAL RECOVERY; PTP-SIGMA; BRAIN; BDNF; EXPRESSION; PLASTICITY	Chondroitin sulfate proteoglycans (CSPGs) are components of the extracellular matrix that inhibit axonal sprouting and experience-dependent plasticity. Although protein-tyrosine phosphatase sigma (PTP sigma) has been proven to be a receptor for CSPGs, its downstream signaling has remained a mystery. Here, we show that CSPGs target and dephosphorylate tropomyosin-related kinase B, the receptor of brain-derived neurotrophic factor (BDNF), via PTP sigma in embryonic cortical neurons in vitro. Whereas BDNF promoted dendritic spine formation in embryonic cortical neurons, CSPGs abolished the effects of BDNF and eliminated existing dendritic spines when BDNF was present. The latter effect was dependent on the p75 receptor, presumably because BDNF binding to the p75 receptor elicits elimination of dendritic spines. These results suggest that the inhibitory activity of CSPGs on dendritic spine formation operates through the targeting of neurotrophins at the receptor level.	[Kurihara, Dai; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan; [Kurihara, Dai; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018; Kurihara, Dai/0000-0002-0319-3958				Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Egashira Y, 2010, J NEUROSCI RES, V88, P3433, DOI 10.1002/jnr.22505; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Fox K, 2002, SCIENCE, V298, P1187, DOI 10.1126/science.1079224; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Gorba T, 1999, CEREB CORTEX, V9, P864, DOI 10.1093/cercor/9.8.864; Harms KJ, 2007, BRAIN RES, V1184, P65, DOI 10.1016/j.brainres.2006.02.094; Johnson KG, 2001, J NEUROBIOL, V49, P99, DOI 10.1002/neu.1068; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MUNOZCUETO JA, 1990, BRAIN RES, V515, P64; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shimada A, 1998, J NEUROSCI, V18, P8559; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Takei N, 1997, J NEUROCHEM, V68, P370; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	30	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13822	13828		10.1074/jbc.M111.314070	http://dx.doi.org/10.1074/jbc.M111.314070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389491	Green Published, hybrid			2022-12-25	WOS:000303996300037
J	Yu, JX; Zhang, DY; Liu, JY; Li, JX; Yu, YH; Wu, XR; Huang, CS				Yu, Jianxiu; Zhang, Dongyun; Liu, Jinyi; Li, Jingxia; Yu, Yonghui; Wu, Xue-Ru; Huang, Chuanshu			RhoGDI SUMOylation at Lys-138 Increases Its Binding Activity to Rho GTPase and Its Inhibiting Cancer Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED INHIBITOR; GDP DISSOCIATION INHIBITOR; APOPTOSIS PROTEIN XIAP; SUMO; UBIQUITIN; IAPS; PHOSPHORYLATION; CDC42; RAC1	The Rho GDP dissociation inhibitor (RhoGDI) can bind to small GTPases and keep them in a biologically inactive state in cytoplasm, through which it affects actin polymerization and cell motility. However, mechanisms underlying how RhoGDI regulates Rho GTPase complex formation/membrane extraction/GTPase dissociation remain largely unexplored. Our previous studies reported that X-linked inhibitor of apoptosis protein (XIAP) interacted with RhoGDI via its RING domain and negatively modulated RhoGDI SUMOylation and HCT116 cancer cell migration. Here, we identified that RhoGDI SUMOylation specifically occurred at Lys-138, which was inhibited by XIAP domain. We further demonstrated that RhoGDI SUMOylation at Lys-138 was crucial for inhibiting actin polymerization and cytoskeleton formation as well as cancer cell motility. Moreover, SUMO-RhoGDI had a much higher binding affinity to small Rho GTPase compared with the un-SUMOylated form of RhoGDI. Taken together, our study demonstrated a novel modification of RhoGDI, SUMOylation at Lys-138, which played a key role in regulating Rho GTPase activation in cancer cells. The physiological regulation of RhoGDI SUMOylation by the RING domain of XIAP may account for modulation of cancer cell invasion and metastasis by XIAP.	[Yu, Jianxiu; Zhang, Dongyun; Liu, Jinyi; Li, Jingxia; Yu, Yonghui; Huang, Chuanshu] NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Wu, Xue-Ru] NYU, Dept Urol, Sch Med, Tuxedo Pk, NY 10987 USA; [Wu, Xue-Ru] NYU, Dept Pathol, Sch Med, Tuxedo Pk, NY 10987 USA	New York University; New York University; New York University	Huang, CS (corresponding author), NYU, Nelson Inst Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health from NCI [CA112557]; NIEHS [ES000260, ES010344]; National Science Foundation of China [NSFC30928023, NSFC30971516]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, P42ES010344] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112557 from NCI and Grants ES000260, ES010344 from NIEHS. This work was also supported by National Science Foundation of China Grants NSFC30928023 and NSFC30971516.	Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Watts FZ, 2004, SEMIN CELL DEV BIOL, V15, P211, DOI 10.1016/j.semcdb.2003.12.002; Wilson Van G, 2005, Sci STKE, V2005, ppe32, DOI 10.1126/stke.2902005pe32; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238	26	52	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13752	13760		10.1074/jbc.M111.337469	http://dx.doi.org/10.1074/jbc.M111.337469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393046	Green Published, hybrid			2022-12-25	WOS:000303996300031
J	Alama-Bermejo, G; Bron, JE; Raga, JA; Holzer, AS				Alama-Bermejo, Gema; Bron, James Emmanuel; Antonio Raga, Juan; Sibylle Holzer, Astrid			3D Morphology, Ultrastructure and Development of Ceratomyxa puntazzi Stages: First Insights into the Mechanisms of Motility and Budding in the Myxozoa	PLOS ONE			English	Article							BREAM SPARUS-AURATA; N-SP MYXOSPOREA; ELECTRON-MICROSCOPIC DESCRIPTION; CULTURED SEA BASS; DICENTRARCHUS-LABRAX; TETRACAPSULOIDES-BRYOSALMONAE; ENTERIC PARASITE; ACTIN DYNAMICS; CYTOKINESIS; BIVALVULIDA	Free, amoeboid movement of organisms within media as well as substrate-dependent cellular crawling processes of cells and organisms require an actin cytoskeleton. This system is also involved in the cytokinetic processes of all eukaryotic cells. Myxozoan parasites are known for the disease they cause in economical important fishes. Usually, their pathology is related to rapid proliferation in the host. However, the sequences of their development are still poorly understood, especially with regard to pre-sporogonic proliferation mechanisms. The present work employs light microscopy (LM), electron microscopy (SEM, TEM) and confocal laser scanning microscopy (CLSM) in combination with specific stains (Nile Red, DAPI, Phalloidin), to study the three-dimensional morphology, motility, ultrastructure and cellular composition of Ceratomyxa puntazzi, a myxozoan inhabiting the bile of the sharpsnout seabream. Our results demonstrate the occurrence of two C. puntazzi developmental cycles in the bile, i.e. pre-sporogonic proliferation including frequent budding as well as sporogony, resulting in the formation of durable spore stages and we provide unique details on the ultrastructure and the developmental sequence of bile inhabiting myxozoans. The present study describes, for the first time, the cellular components and mechanisms involved in the motility of myxozoan proliferative stages, and reveals how the same elements are implicated in the processes of budding and cytokinesis in the Myxozoa. We demonstrate that F-actin rich cytoskeletal elements polarize at one end of the parasites and in the filopodia which are rapidly de novo created and re-absorbed, thus facilitating unidirectional parasite motility in the bile. We furthermore discover the myxozoan mechanism of budding as an active, polarization process of cytokinesis, which is independent from a contractile ring and thus differs from the mechanism, generally observed in eurkaryotic cells. We hereby demonstrate that CLSM is a powerful tool for myxozoan research with a great potential for exploitation, and we strongly recommend its future use in combination with in vivo stains.	[Alama-Bermejo, Gema; Antonio Raga, Juan; Sibylle Holzer, Astrid] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Zool Deparment, Marine Zool Unit, Valencia, Spain; [Bron, James Emmanuel] Univ Stirling, Inst Aquaculture, Parasitol Grp, Stirling FK9 4LA, Scotland; [Sibylle Holzer, Astrid] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Lab Fish Protistol, CR-37005 Ceske Budejovice, Czech Republic	University of Valencia; University of Stirling; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Alama-Bermejo, G (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Zool Deparment, Marine Zool Unit, Valencia, Spain.	gema.alama@uv.es	Bron, James E/B-6231-2018; Alama-Bermejo, Gema/AAF-8402-2020; Alama-Bermejo, Gema/H-1498-2014; Raga, Juan Antonio/L-7669-2014; Holzer, Astrid Sibylle/E-2531-2011	Bron, James E/0000-0003-3544-0519; Alama-Bermejo, Gema/0000-0002-6452-6154; Raga, Juan Antonio/0000-0003-2687-2539; Holzer, Astrid Sibylle/0000-0002-4916-3172	Conselleria d'Educacio, Direccio General de Politica Cientifica, Generalitat Valenciana, Spain [BFPI/2007/289, BEFPI/2009/013, GV2008-185, PROMETEO/2011/040]; Ministry of Science and Innovation, Spain [MEC JDCI2007-1054-1215]	Conselleria d'Educacio, Direccio General de Politica Cientifica, Generalitat Valenciana, Spain; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was financially supported by the Conselleria d'Educacio, Direccio General de Politica Cientifica, Generalitat Valenciana, Spain. Grant number: BFPI/2007/289, BEFPI/2009/013, GV2008-185 and PROMETEO/2011/040. Ministry of Science and Innovation, Spain. Grant number: MEC JDCI2007-1054-1215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano EA, 2005, DIS AQUAT ORGAN, V64, P229, DOI 10.3354/dao064229; Alama-Bermejo G, 2011, VET PARASITOL, V182, P181, DOI 10.1016/j.vetpar.2011.05.012; Alama-Bermejo G, 2009, J FISH DIS, V32, P335, DOI 10.1111/j.1365-2761.2008.01000.x; ALVAREZPELLITERO P, 1993, J FISH BIOL, V42, P889, DOI 10.1111/j.1095-8649.1993.tb00398.x; Bartholomew JL, 2004, DIS AQUAT ORGAN, V62, P85, DOI 10.3354/dao062085; Bartholomew JL, 1989, FISH DIS LEAFLET F W, V80; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Canning EU, 1999, PARASITOL RES, V85, P910, DOI 10.1007/s004360050657; Casal G, 2007, FOLIA PARASIT, V54, P165, DOI 10.14411/fp.2007.023; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cho JB, 2004, ACTA PROTOZOOL, V43, P241; Cuadrado M, 2007, PARASITOL RES, V101, P403, DOI 10.1007/s00436-007-0484-0; Cuadrado M, 2008, J EUKARYOT MICROBIOL, V55, P178, DOI 10.1111/j.1550-7408.2008.00325.x; Diamant A, 2004, J PARASITOL, V90, P1434, DOI 10.1645/GE-336R; Eszterbauer E, 2009, PARASITOLOGY, V136, P367, DOI 10.1017/S0031182008005398; Feist SW, 2002, J FISH DIS, V25, P451, DOI 10.1046/j.1365-2761.2002.00361.x; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Georgevitch J., 1917, Archives de Zoologie Experimentale Paris, V56; GEORGEVITCH JIVOIN, 1929, ARCH PROTISTENK, V65, P106; Grabner DS, 2010, DIS AQUAT ORGAN, V90, P197, DOI 10.3354/dao02236; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hibi M, 2004, J MUSCLE RES CELL M, V25, P127, DOI 10.1023/B:JURE.0000035842.71415.f3; Hickman CP, 2009, PRINCIPIOS INTEGRALE, P654; Hofer B, 1903, ALLGEMEINE FISCHEREI, V28, P7; Holland JW, 2011, P ROY SOC B-BIOL SCI, V278, P546, DOI 10.1098/rspb.2010.1301; Jimenez-Guri E, 2007, INTEGR COMP BIOL, V47, P752, DOI 10.1093/icb/icm026; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Kallert DM, 2009, DIS AQUAT ORGAN, V84, P123, DOI 10.3354/dao02034; Kudo RR, T AM MICR SOC, V40, P161; Lom J, 1996, FOLIA PARASIT, V43, P189; Maillo-Bellon PA, 2007, ACTA PROTOZOOL, V46, P247; McGurk C, 2005, J FISH DIS, V28, P307, DOI 10.1111/j.1365-2761.2005.00627.x; MEGLITSCH PAUL A., 1960, TRANS ROY SOC NEW ZEALAND, V88, P265; MITCHISON TJ, 1995, PHILOS T ROY SOC B, V349, P299, DOI 10.1098/rstb.1995.0117; Morris DJ, 2008, PARASITOLOGY, V135, P1075, DOI 10.1017/S0031182008004605; Morris DJ, 2010, P ROY SOC B-BIOL SCI, V277, P2565, DOI 10.1098/rspb.2010.0282; Morrison CM, 1996, FOLIA PARASIT, V43, P20; Neujahr R, 1997, J CELL SCI, V110, P123; Noble ER, 1941, J MORPHOL, V69, P455, DOI 10.1002/jmor.1050690304; Palenzuela O, 1997, PARASITOL RES, V83, P539, DOI 10.1007/s004360050295; PARKER J D, 1970, Journal of Wildlife Diseases, V6, P448; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Redondo MJ, 2003, PARASITOL RES, V90, P192, DOI 10.1007/s00436-002-0810-5; Reed CC, 2007, FOLIA PARASIT, V54, P283, DOI 10.14411/fp.2007.037; Sitja-Bobadilla A, 2001, J EUKARYOT MICROBIOL, V48, P627, DOI 10.1111/j.1550-7408.2001.tb00202.x; SitjaBobadilla A, 1996, INT J PARASITOL, V26, P457, DOI 10.1016/0020-7519(96)00015-X; SITJABOBADILLA A, 1992, J PROTOZOOL, V39, P273, DOI 10.1111/j.1550-7408.1992.tb01314.x; SITJABOBADILLA A, 1995, EUR J PROTISTOL, V31, P77, DOI 10.1016/S0932-4739(11)80360-3; SITJABOBADILLA A, 1993, EUR J PROTISTOL, V29, P219, DOI 10.1016/S0932-4739(11)80276-2; SITJABOBADILLA A, 1993, J EUKARYOT MICROBIOL, V40, P755, DOI 10.1111/j.1550-7408.1993.tb04471.x; SITJABOBADILLA A, 1995, J EUKARYOT MICROBIOL, V42, P529, DOI 10.1111/j.1550-7408.1995.tb05901.x; Small JV, 2010, ACTIN-BASED MOTILITY: CELLULAR, MOLECULAR AND PHYSICAL ASPECTS, P3, DOI 10.1007/978-90-481-9301-1_1; SPUDICH JA, 1989, CELL REGUL, V1, P1; Ter Hofte BB, 1984, FISCH UMWELT, V13, P89; Tumova P, 2007, CELL MOTIL CYTOSKEL, V64, P288, DOI 10.1002/cm.20183; Uspenskaya A.V., 2004, Tsitologiya, V46, P748; Uyeda TQP, 2000, MICROSC RES TECHNIQ, V49, P136, DOI 10.1002/(SICI)1097-0029(20000415)49:2<136::AID-JEMT5>3.0.CO;2-F; Uyeda TQP, 2004, CURR OPIN CELL BIOL, V16, P55, DOI 10.1016/j.ceb.2003.11.004; Uyeda TQP, 2000, CELL STRUCT FUNCT, V25, P1	61	18	18	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32679	10.1371/journal.pone.0032679	http://dx.doi.org/10.1371/journal.pone.0032679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22396723	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500086
J	Chagas, AD; da Silva, CLR; Soares, LM; Santos, CS; Silva, CDCM; Athanazio, DA; dos Reis, MG; McBride, FWC; McBride, AJA				Chagas-Junior, Adenizar D.; da Silva, Caroline L. R.; Soares, Luciane Marieta; Santos, Cleiton S.; Silva, Carlos D. C. M.; Athanazio, Daniel A.; dos Reis, Mitermayer G.; Cruz McBride, Flavia W.; McBride, Alan J. A.			Detection and Quantification of Leptospira interrogans in Hamster and Rat Kidney Samples: Immunofluorescent Imprints versus Real-time PCR	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; PROTEIN LIPL32; INFECTION; MODEL; IDENTIFICATION	A major limitation in the clinical management and experimental research of leptospirosis is the poor performance of the available methods for the direct detection of leptospires. In this study, we compared real-time PCR (qPCR), targeting the lipL32 gene, with the immunofluorescent imprint method (IM) for the detection and quantification of leptospires in kidney samples from the rat and hamster experimental models of leptospirosis. Using a virulent strain of Leptospira interrogans serovar Copenhageni, a chronic infection was established in the rat model, which were euthanized 28 days post-infection, while the hamster model simulated an acute infection and the hamsters were euthanized eight days after inoculation. Leptospires in the kidney samples were detected using culture isolation, qPCR and the IM, and quantified using qPCR and the IM. In both the acute and chronic infection models, the correlation between quantification by qPCR and the IM was found to be positive and statistically significant (P<0.05). Therefore, this study demonstrates that the IM is a viable alternative for not only the detection but also the quantification of leptospires, particularly when the use of qPCR is not feasible.	[Chagas-Junior, Adenizar D.; da Silva, Caroline L. R.; Santos, Cleiton S.; Silva, Carlos D. C. M.; Athanazio, Daniel A.; dos Reis, Mitermayer G.; Cruz McBride, Flavia W.; McBride, Alan J. A.] Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Inst, Salvador, BA, Brazil; [Soares, Luciane Marieta; Athanazio, Daniel A.] Univ Fed Bahia, Hlth Sci Inst, Salvador, BA, Brazil; [McBride, Alan J. A.] Univ Fed Pelotas, Ctr Technol Dev, Pelotas, RS, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal de Pelotas	Chagas, AD (corresponding author), Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Inst, Salvador, BA, Brazil.	alan.mcbride@ufpel.edu.br	Athanazio, Daniel/P-6622-2014; McBride, Alan/D-4106-2012	McBride, Alan/0000-0001-9682-540X; Reis, Mitermayer/0000-0002-3051-9060	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [PES-0092/2008, APP0057/2009]; Brazilian National Research Council (CNPq) [314064/2009-5]	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) grants (PES-0092/2008 and APP0057/2009, http://www.fapesb.ba.gov.br/). AJAM received a research scholarship from the Brazilian National Research Council (CNPq, 314064/2009-5, http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P45; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012; Bandeira M, 2011, INFECT IMMUN, V79, P2936, DOI 10.1128/IAI.05099-11; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bonilla-Santiago R., 2011, CURR PROTOC MICROBIO, P1, DOI [10.1002/9780471729259.mc12e03s20, DOI 10.1002/9780471729259.MC12E03S20]; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Chagas-Junior AD, 2009, J MED MICROBIOL, V58, P1632, DOI 10.1099/jmm.0.014050-0; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Santos CS, 2010, J MED MICROBIOL, V59, P1101, DOI 10.1099/jmm.0.021089-0; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236; WHO and ILS, 2003, HUM LEPT GUID DIAGN; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	31	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32712	10.1371/journal.pone.0032712	http://dx.doi.org/10.1371/journal.pone.0032712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393440	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500093
J	Jia, L; Gopinathan, G; Sukumar, JT; Gribben, JG				Jia, Li; Gopinathan, Ganga; Sukumar, Johanna T.; Gribben, John G.			Blocking Autophagy Prevents Bortezomib-Induced NF-kappa B Activation by Reducing I-kappa B alpha Degradation in Lymphoma Cells	PLOS ONE			English	Article							PROTEASOME INHIBITOR PS-341; MULTIPLE-MYELOMA CELLS; CONVENTIONAL CHEMOTHERAPEUTIC-AGENTS; ENDOPLASMIC-RETICULUM STRESS; SELECTIVE AUTOPHAGY; INDUCED APOPTOSIS; DRUG-RESISTANCE; UBIQUITIN; EFFICACY; CANCER	Here we show that bortezomib induces effective proteasome inhibition and accumulation of poly-ubiquitinated proteins in diffuse large B-cell lymphoma (DLBCL) cells. This leads to induction of endoplasmic reticulum (ER) stress as demonstrated by accumulation of the protein CHOP, as well as autophagy, as demonstrated by accumulation of LC3-II proteins. Our data suggest that recruitment of both ubiquitinated proteins and LC3-II by p62 directs ubiquitinated proteins, including I-kappa B alpha, to the autophagosome. Degradation of I-kappa B alpha results in increased NF-kappa B nuclear translocation and transcription activity. Since bortezomib treatment promoted I-kappa B alpha phosphorylation, ubiquitination and degradation, this suggests that the route of I-kappa B alpha degradation was not via the ubiquitin-proteasome degradation system. The autophagy inhibitor chloroquine (CQ) significantly inhibited bortezomib-induced I-kappa B alpha degradation, increased complex formation with NF-kappa B and reduced NF-kappa B nuclear translocation and DNA binding activity. Importantly, the combination of proteasome and autophagy inhibitors showed synergy in killing DLBCL cells. In summary, bortezomib-induced autophagy confers relative DLBCL cell drug resistance by eliminating I-kappa B alpha. Inhibition of both autophagy and the proteasome has great potential to kill apoptosis-resistant lymphoma cells.	[Jia, Li; Gopinathan, Ganga; Sukumar, Johanna T.; Gribben, John G.] Queen Mary Univ London, Ctr Haematooncol, Barts Canc Inst, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Jia, L (corresponding author), Queen Mary Univ London, Ctr Haematooncol, Barts Canc Inst, Barts & London Sch Med & Dent, London, England.	L.jia@qmul.ac.uk		Jia, Li/0000-0002-6076-8455	Cancer Research United Kingdom; National Cancer Institute [P01 CA81538]	Cancer Research United Kingdom(Cancer Research UK); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Research United Kingdom and by funding (to JGG) from the National Cancer Institute (P01 CA81538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Catley L, 2006, BLOOD, V108, P3441, DOI 10.1182/blood-2006-04-016055; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Chauhan D, 2003, CANCER RES, V63, P6174; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Culpin RE, 2010, INT J ONCOL, V37, P367, DOI 10.3892/ijo_00000685; Dasmahapatra G, 2010, BLOOD; David E, 2010, BLOOD, V116, P5285, DOI 10.1182/blood-2010-03-272393; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Dunleavy K, 2009, BLOOD, V113, P6069, DOI 10.1182/blood-2009-01-199679; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Jia L, 1997, BRIT J HAEMATOL, V98, P686, DOI 10.1046/j.1365-2141.1997.2683085.x; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Liu FT, 2008, BLOOD, V112, P3835, DOI 10.1182/blood-2008-04-150227; Liu FT, 2008, BLOOD, V111, P2797, DOI 10.1182/blood-2007-08-110445; Lonial S, 2011, AUTOPHAGY, V7, P448, DOI 10.4161/auto.7.4.14683; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Richardson Paul G, 2003, Cancer Control, V10, P361; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sarosiek KA, 2010, P NATL ACAD SCI USA, V107, P13069, DOI 10.1073/pnas.1002985107; Wehbe-Janek H, 2007, ANTICANCER RES, V27, P3143; Yang DT, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-40; Yang Y, 2004, CANCER SCI, V95, P176, DOI 10.1111/j.1349-7006.2004.tb03200.x	45	75	78	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32584	10.1371/journal.pone.0032584	http://dx.doi.org/10.1371/journal.pone.0032584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393418	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500070
J	Knapp, DG; Pintye, A; Kovacs, GM				Knapp, Daniel G.; Pintye, Alexandra; Kovacs, Gabor M.			The Dark Side Is Not Fastidious - Dark Septate Endophytic Fungi of Native and Invasive Plants of Semiarid Sandy Areas	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL; RHIZOPYCNIS-VAGUM; ROOTS; DIVERSITY; THERMOTOLERANCE; IDENTIFICATION; COLONIZATION; INFORMATION; GRASSLANDS; INFERENCE	Dark septate endophytic (DSE) fungi represent a frequent root-colonizing fungal group common in environments with strong abiotic stress, such as (semi)arid ecosystems. This work aimed to study the DSE fungi colonizing the plants of semiarid sandy grasslands with wood steppe patches on the Great Hungarian Plain. As we may assume that fungi colonizing both invasive and native species are generalists, root associated fungi (RAF) were isolated from eight native and three invasive plant species. The nrDNA sequences of the isolates were used for identification. To confirm that the fungi were endophytes an artificial inoculation system was used to test the isolates: we considered a fungus as DSE if it colonized the roots without causing a negative effect on the plant and formed microsclerotia in the roots. According to the analyses of the ITS sequence of nrDNA the 296 isolates clustered into 41 groups. We found that 14 of these 41 groups were DSE, representing approximately 60% of the isolates. The main DSE groups were generalist and showed no specificity to area or season and colonized both native and invasive species, demonstrating that exotic plants are capable of using the root endophytic fungi of the invaded areas. The DSE community of the region shows high similarity to those found in arid grasslands of North America. Taking into account a previous hypothesis about the common root colonizers of those grasslands and our results reported here, we hypothesize that plants of (semi) arid grasslands share common dominant members of the DSE fungal community on a global scale.	[Knapp, Daniel G.; Pintye, Alexandra; Kovacs, Gabor M.] Eotvos Lorand Univ, Dept Plant Anat, Inst Biol, H-1088 Budapest, Hungary; [Pintye, Alexandra] Hungarian Acad Sci, Inst Plant Protect, Agr Res Ctr, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Kovacs, GM (corresponding author), Eotvos Lorand Univ, Dept Plant Anat, Inst Biol, H-1088 Budapest, Hungary.	gmkovacs@caesar.elte.hu	Knapp, Dániel/C-9481-2013; Kovacs, Gabor/AAF-3542-2020	Knapp, Dániel/0000-0002-7568-238X; Kovacs, Gabor M./0000-0001-9509-4270	Hungarian Research Fund (OTKA) [K72776]	Hungarian Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was supported by the Hungarian Research Fund (OTKA, K72776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy HD, 2005, CAN J BOT, V83, P1, DOI [10.1139/B04-171, 10.1139/b04-171]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armengol J, 2003, PLANT PATHOL, V52, P68, DOI 10.1046/j.1365-3059.2003.00796.x; Bagi I, 2004, BIOL INVAZIOK MAGYAR, P319; Barrow JR, 2001, MYCORRHIZA, V11, P199, DOI 10.1007/s005720100111; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Borhidi A., 1999, VOROS KONYV MAGYAROR; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Farr DF, 1998, MYCOLOGIA, V90, P290, DOI 10.2307/3761305; FEKETE G, 1993, J VEG SCI, V4, P279, DOI 10.2307/3236116; Fekete G, 2002, ACTA ZOOL ACAD SCI H, V48, P137; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Girlanda M, 2002, NEW PHYTOL, V155, P481, DOI 10.1046/j.1469-8137.2002.00474.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrington TC, 2003, MYCOTAXON, V87, P141; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Herrera J, 2010, MYCOLOGIA, V102, P1012, DOI 10.3852/09-264; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakucs E, 2005, MYCORRHIZA, V15, P247, DOI 10.1007/s00572-004-0326-1; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Khidir HH, 2010, J ARID ENVIRON, V74, P35, DOI 10.1016/j.jaridenv.2009.07.014; Kovacs GM, 2008, MYCOLOGIA, V100, P930, DOI 10.3852/08-023; Kovacs GM, 2001, PHYTON-ANN REI BOT A, V41, P161; Kovacs GM, 2002, PHYTON-ANN REI BOT A, V42, P211; Kovacs-Lang E, 2000, PHYTOCOENOLOGIA, V30, P385; Kovacs-Lang E., 2008, KISKUN LTER LONG TER; Mandyam K, 2005, STUD MYCOL, P173; Mandyam K, 2008, MYCORRHIZA, V18, P145, DOI 10.1007/s00572-008-0165-6; Mandyam K, 2012, MYCORRHIZA, V22, P109, DOI 10.1007/s00572-011-0386-y; Mandyam K, 2010, MYCOLOGIA, V102, P813, DOI 10.3852/09-212; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; McLellan CA, 2007, PLANT PHYSIOL, V145, P174, DOI 10.1104/pp.107.101808; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narisawa K, 2004, PHYTOPATHOLOGY, V94, P412, DOI 10.1094/PHYTO.2004.94.5.412; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Paparu P, 2006, ANN APPL BIOL, V149, P1, DOI 10.1111/j.1744-7348.2006.00064.x; Pennisi E., 2003, SCIENCE, V301, P1466, DOI DOI 10.1126/SCIENCE.301.5639.1466A; PHAN HT, 2004, STUD MYCOL, V50, P261; Porras-Alfaro A, 2008, APPL ENVIRON MICROB, V74, P2805, DOI 10.1128/AEM.02769-07; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; READ DJ, 1981, NEW PHYTOL, V88, P341, DOI 10.1111/j.1469-8137.1981.tb01729.x; Reblova M, 2011, STUD MYCOL, P163, DOI 10.3114/sim.2011.68.07; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Marquez SS, 2010, FUNGAL DIVERS, V41, P115, DOI 10.1007/s13225-009-0015-7; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Staden R, 2000, Methods Mol Biol, V132, P115; Szigetvari C, 2004, BIOL INVAZIOK MAGYAR, P337; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udvardy L, 2004, BIOL INVAZIOK MAGYAR, P143; Varallyay G., 1993, FLORA KISKUNSAG NATL, P21; Westphal A, 2011, CROP PROT, V30, P111, DOI 10.1016/j.cropro.2010.11.014; Xu L, 2008, LETT APPL MICROBIOL, V46, P68, DOI 10.1111/j.1472-765X.2007.02264.x; Yu T, 2001, CAN J MICROBIOL, V47, P741, DOI 10.1139/cjm-47-8-741; Zhan JX, 2007, J NAT PROD, V70, P227, DOI 10.1021/np060394t	65	123	129	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32570	10.1371/journal.pone.0032570	http://dx.doi.org/10.1371/journal.pone.0032570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393417	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500069
J	Liu, Y; Zhang, YX; Wen, J; Liu, L; Zhai, XJ; Liu, JB; Pan, SD; Chen, JG; Shen, HB; Hu, ZB				Liu, Yao; Zhang, Yixin; Wen, Juan; Liu, Li; Zhai, Xiangjun; Liu, Jibin; Pan, Shandong; Chen, Jianguo; Shen, Hongbing; Hu, Zhibin			A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER; MICRORNA EXPRESSION; IDENTIFICATION; PROGRESSION; GROWTH; LIVER; SRY	Background: MiR-106b-25 cluster, hosted in intron 13 of MCM7, may play integral roles in diverse processes including immune response and tumorigenesis. A single nucleotide polymorphism (SNP), rs999885, is located in the promoter region of MCM7. Methods: We performed a case-control study including 1300 HBV-positive hepatocellular carcinoma (HCC) cases, 1344 HBV persistent carriers and 1344 subjects with HBV natural clearance to test the association between rs999885 and the risk of HBV persistent infection and HCC. We also investigated the genotype-expression correlation between rs999885 and miR-106b-25 cluster in 25 pairs of HCC and adjacent non-tumor liver tissues. Results: Compared with the HBV natural clearance subjects carrying rs999885 AA genotype, those with AG/GG genotypes had a decreased risk of chronic HBV infection with an adjusted odds ratio (OR) of 0.79 [95% confidence intervals (CIs) = 0.67-0.93]. However, the AG/GG genotypes were significantly associated with an increased HCC risk in HBV persistent carriers (adjusted OR = 1.25, 95% CIs = 1.06-1.47). Expression analysis revealed that the expression level of miR-106b-25 cluster was significantly higher in AG/GG carriers than those in AA carriers in non-tumor liver tissues. Conclusions: These findings indicate that the A to G base change of rs999885 may provide a protective effect against chronic HBV infection but an increased risk for HCC in HBV persistent carriers by altering the expression of the miR-106b-25 cluster.	[Liu, Yao; Wen, Juan; Pan, Shandong; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhang, Yixin; Liu, Li; Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Zhang, Yixin; Liu, Li; Liu, Jibin] Nanjing Med Univ, Affiliated Hosp 2, Inst Digest Endoscopy, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Zhai, Xiangjun] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jianguo] Qidong Liver Canc Res Inst, Qidong, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation [201081]; National Natural Science Foundation of China [30800946, 81072344]; Natural Science Foundation Jiangsu Ministry of Health [H200957]; Program for New Century Excellent Talents in University [NCET-10-0178]; National Major ST Projects [2011ZX10004-902]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Jiangsu Ministry of Health; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Major ST Projects	This work was supported in part by Priority Academic Program Development of Jiangsu Higher Education Institutions, Foundation for the Author of National Excellent Doctoral Dissertation (Grants No.: 201081), National Natural Science Foundation of China (Grants No.: 30800946, 81072344), Natural Science Foundation Jiangsu Ministry of Health (Grant No.: H200957), the Program for New Century Excellent Talents in University (NCET-10-0178) and National Major S&T Projects(Grant No.: 2011ZX10004-902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu L., 2011, HEPATOLOGY; Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kan T, 2009, CURR OPIN PHARMACOL, V9, P727, DOI 10.1016/j.coph.2009.08.009; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Spierings DC, 2011, BLOOD, V117, P5340, DOI 10.1182/blood-2010-10-316034; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhu Zhong-zheng, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P574	30	56	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32230	10.1371/journal.pone.0032230	http://dx.doi.org/10.1371/journal.pone.0032230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393390	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500043
J	Markowitz, J; Cao, YQ; Grossberg, S				Markowitz, Jeffrey; Cao, Yongqiang; Grossberg, Stephen			From Retinal Waves to Activity-Dependent Retinogeniculate Map Development	PLOS ONE			English	Article							VISUAL-SYSTEM DEVELOPMENT; NICOTINIC ACETYLCHOLINE-RECEPTOR; PRENATAL DEVELOPMENT; MAMMALIAN RETINA; MICE LACKING; CIRCUITS; NETWORK; PATHWAY; MODEL; SEGREGATION	A neural model is described of how spontaneous retinal waves are formed in infant mammals, and how these waves organize activity-dependent development of a topographic map in the lateral geniculate nucleus, with connections from each eye segregated into separate anatomical layers. The model simulates the spontaneous behavior of starburst amacrine cells and retinal ganglion cells during the production of retinal waves during the first few weeks of mammalian postnatal development. It proposes how excitatory and inhibitory mechanisms within individual cells, such as Ca2+-activated K+ channels, and cAMP currents and signaling cascades, can modulate the spatiotemporal dynamics of waves, notably by controlling the after-hyperpolarization currents of starburst amacrine cells. Given the critical role of the geniculate map in the development of visual cortex, these results provide a foundation for analyzing the temporal dynamics whereby the visual cortex itself develops.	[Markowitz, Jeffrey; Cao, Yongqiang; Grossberg, Stephen] Boston Univ, Ctr Adapt Syst, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Markowitz, Jeffrey; Cao, Yongqiang; Grossberg, Stephen] Boston Univ, Ctr Excellence Learning Educ Sci & Technol, Boston, MA 02215 USA	Boston University; Boston University	Markowitz, J (corresponding author), Boston Univ, Ctr Adapt Syst, Dept Cognit & Neural Syst, 111 Cummington St, Boston, MA 02215 USA.	steve@bu.edu	Markowitz, Jeffrey/GQP-3708-2022		CELEST (Center of Excellence for Learning in Education, Science and Technology); National Science Foundation Science of Learning Center [SBE-0354379]; DARPA (Defense Advanced Research Projects Agency) [HR0011-09-C-397 0001]	CELEST (Center of Excellence for Learning in Education, Science and Technology)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); DARPA (Defense Advanced Research Projects Agency)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported in part by CELEST (Center of Excellence for Learning in Education, Science and Technology), a National Science Foundation Science of Learning Center (SBE-0354379), and by the SyNAPSE program of DARPA (Defense Advanced Research Projects Agency), HR0011-09-C-397 0001). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2000, J NEUROSCI, V20, P7672; Beggs JM, 2003, J NEUROSCI, V23, P11167; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BURGI PY, 1994, J NEUROSCI, V14, P7426; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; Elliott T, 1999, J NEUROSCI, V19, P7951; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Godfrey KB, 2007, PLOS COMPUT BIOL, V3, P2408, DOI 10.1371/journal.pcbi.0030245; Grossberg S, 1999, VISION RES, V39, P1385, DOI 10.1016/S0042-6989(98)00250-8; Grossberg S, 2003, CEREB CORTEX, V13, P852, DOI 10.1093/cercor/13.8.852; Grossberg S, 2001, CEREB CORTEX, V11, P37, DOI 10.1093/cercor/11.1.37; Haith G. L, 1998, MODELING ACTIVITY DE, DOI [10.5555/927417, DOI 10.5555/927417]; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Mcallister KA, 1996, NEURON, V17, P1057; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sernagor E, 2000, J NEUROSCI, V20, part. no.; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SRETAVAN DW, 1987, J COMP NEUROL, V255, P386, DOI 10.1002/cne.902550306; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou Z J, 2001, Prog Brain Res, V131, P599	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31553	10.1371/journal.pone.0031553	http://dx.doi.org/10.1371/journal.pone.0031553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389669	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600006
J	Marzetti, E; Lees, HA; Manini, TM; Buford, TW; Aranda, JM; Calvani, R; Capuani, G; Marsiske, M; Lott, DJ; Vandenborne, K; Bernabei, R; Pahor, M; Leeuwenburgh, C; Wohlgemuth, SE				Marzetti, Emanuele; Lees, Hazel A.; Manini, Todd M.; Buford, Thomas W.; Aranda, Juan M., Jr.; Calvani, Riccardo; Capuani, Giorgio; Marsiske, Michael; Lott, Donovan J.; Vandenborne, Krista; Bernabei, Roberto; Pahor, Marco; Leeuwenburgh, Christiaan; Wohlgemuth, Stephanie E.			Skeletal Muscle Apoptotic Signaling Predicts Thigh Muscle Volume and Gait Speed in Community-Dwelling Older Persons: An Exploratory Study	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; LOWER-EXTREMITY FUNCTION; PHYSICAL PERFORMANCE; CALORIE RESTRICTION; SARCOPENIA; AGE; CASPASE-3; SUPPLEMENTATION; DYSFUNCTION; ACTIVATION	Background: Preclinical studies strongly suggest that accelerated apoptosis in skeletal myocytes may be involved in the pathogenesis of sarcopenia. However, evidence in humans is sparse. In the present study, we investigated whether apoptotic signaling in the skeletal muscle was associated with indices of muscle mass and function in older persons. Methodology/Principal Findings: Community-dwelling older adults were categorized into high-functioning (HF) or low-functioning (LF) groups according to their short physical performance battery (SPPB) summary score. Participants underwent an isokinetic knee extensor strength test and 3-dimensional magnetic resonance imaging of the thigh. Vastus lateralis muscle samples were obtained by percutaneous needle biopsy and assayed for the expression of a set of apoptotic signaling proteins. Age, sex, number of comorbid conditions and medications as well as knee extensor strength were not different between groups. HF participants displayed greater thigh muscle volume compared with LF persons. Multivariate partial least squares (PLS) regressions showed significant correlations between caspase-dependent apoptotic signaling proteins and the muscular percentage of thigh volume (R-2 = 0.78; Q(2) = 0.61) as well as gait speed (R-2 = 0.81; Q(2) = 0.56). Significant variables in the PLS model of percent muscle volume were active caspase-8, cleaved caspase-3, cytosolic cytochrome c and mitochondrial Bak. The regression model of gait speed was mainly described by cleaved caspase-3 and mitochondrial Bax and Bak. PLS predictive apoptotic variables did not differ between functional groups. No correlation was determined between apoptotic signaling proteins and muscle strength or quality (strength per unit volume). Conclusions/Significance: Data from this exploratory study show for the first time that apoptotic signaling is correlated with indices of muscle mass and function in a cohort of community-dwelling older persons. Future larger-scale studies are needed to corroborate these preliminary findings and determine if down-regulation of apoptotic signaling in skeletal myocytes will provide improvements in the muscle mass and functional status of older persons.	[Marzetti, Emanuele; Lees, Hazel A.; Manini, Todd M.; Buford, Thomas W.; Pahor, Marco; Leeuwenburgh, Christiaan; Wohlgemuth, Stephanie E.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA; [Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Dept Orthoped & Traumatol, Inst Orthoped, I-00168 Rome, Italy; [Aranda, Juan M., Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Calvani, Riccardo] Inst Crystallog, Natl Res Council CNR, Bari, Italy; [Calvani, Riccardo; Bernabei, Roberto] Univ Cattolica Sacro Cuore, Dept Gerontol Geriatr & Physiatr, Inst Internal Med & Geriatr, I-00168 Rome, Italy; [Capuani, Giorgio] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Marsiske, Michael] Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Lott, Donovan J.; Vandenborne, Krista] Univ Florida, Dept Phys Therapy, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA	State University System of Florida; University of Florida; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Marzetti, E (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.	emarzetti@live.com; cleeuwen@ufl.edu	Buford, Thomas W/B-1111-2011; Marzetti, Emanuele/A-9430-2010; Calvani, Riccardo/K-2011-2018; Capuani, Giorgio/B-7738-2015; Bernabei, Roberto/AAB-2704-2019; Capuani, Giorgio/Y-4099-2019	Buford, Thomas W/0000-0002-9541-4358; Marzetti, Emanuele/0000-0001-9567-6983; Calvani, Riccardo/0000-0001-5472-2365; Capuani, Giorgio/0000-0002-6992-2578; Bernabei, Roberto/0000-0002-9197-004X; Capuani, Giorgio/0000-0002-6992-2578; Marsiske, Michael/0000-0001-5973-2116; Leeuwenburgh, Christiaan/0000-0003-0826-4257	University of Florida's Institute on Aging; Claude D. Pepper Older Americans Independence Center [1P30AG028740]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	University of Florida's Institute on Aging; Claude D. Pepper Older Americans Independence Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the University of Florida's Institute on Aging and Claude D. Pepper Older Americans Independence Center (1P30AG028740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; Buford TW, 2012, EXP GERONTOL, V47, P38, DOI 10.1016/j.exger.2011.10.001; Carter CS, 2011, AGE, V33, P167, DOI 10.1007/s11357-010-9196-y; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Galvao DA, 2005, J AM GERIATR SOC, V53, P2090, DOI 10.1111/j.1532-5415.2005.00494.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Malmgren LT, 2001, OTOLARYNG HEAD NECK, V125, P34, DOI 10.1067/mhn.2001.116449; Maly MR, 2005, PHYS THER, V85, P1318, DOI 10.1093/ptj/85.12.1318; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Martens H, 2001, CHEMOMETR INTELL LAB, V58, P151, DOI 10.1016/S0169-7439(01)00157-5; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Marzetti E, 2010, THESCIENTIFICWORLDJO, V10, P340, DOI 10.1100/tsw.2010.27; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Roubenoff R, 2007, NUTR REV, V65, pS208, DOI 10.1111/j.1753-4887.2007.tb00364.x; Ruetten H, 2001, J AM COLL CARDIOL, V38, P2063, DOI 10.1016/S0735-1097(01)01670-9; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; Strasser H, 1999, LANCET, V354, P918, DOI 10.1016/S0140-6736(99)02588-X; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sun YF, 2001, J BIOL CHEM, V276, P16240, DOI 10.1074/jbc.M010419200; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Wohlgemuth SE, 2011, REJUV RES, V14, P315, DOI 10.1089/rej.2010.1132; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430	50	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32829	10.1371/journal.pone.0032829	http://dx.doi.org/10.1371/journal.pone.0032829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389725	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600064
J	Abhold, EL; Kiang, A; Rahimy, E; Kuo, SZ; Wang-Rodriguez, J; Lopez, JP; Blair, KJ; Yu, MA; Haas, M; Brumund, KT; Altuna, X; Patel, A; Weisman, RA; Ongkeko, WM				Abhold, Eric L.; Kiang, Alan; Rahimy, Elham; Kuo, Selena Z.; Wang-Rodriguez, Jessica; Lopez, Jay Patrick; Blair, Katherine J.; Yu, Michael Andrew; Haas, Martin; Brumund, Kevin T.; Altuna, Xabier; Patel, Andrew; Weisman, Robert A.; Ongkeko, Weg M.			EGFR Kinase Promotes Acquisition of Stem Cell-Like Properties: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma Stem Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SELF-RENEWAL; CANCER; RESISTANCE; CHEMOTHERAPY; EXPRESSION; CONFERS; COMMON	Members of the EGFR/ErbB family of tyrosine kinases are found to be highly expressed and deregulated in many cancers, including head and neck squamous cell carcinoma (HNSCC). The ErbB family, including EGFR, has been demonstrated to play key roles in metastasis, tumorigenesis, cell proliferation, and drug resistance. Recently, these characteristics have been linked to a small subpopulation of cells classified as cancer stem cells (CSCs) which are believed to be responsible for tumor initiation and maintenance. In this study, we investigated the possible role of EGFR as a regulator of "stemness" in HNSCC cells. Activation of EGFR by the addition of EGF ligand or ectopic expression of EGFR in two established HNSCC cell lines (UMSCC-22B and HN-1) resulted in the induction of CD44, BMI-1, Oct-4, NANOG, CXCR4, and SDF-1. Activation of EGFR also resulted in increased tumorsphere formation, a characteristic ability of cancer stem cells. Conversely, treatment with the EGFR kinase inhibitor, Gefinitib (Iressa), resulted in decreased expression of the aforementioned genes, and loss of tumorsphere-forming ability. Similar trends were observed in a 99.9% CD44 positive stem cell culture derived from a fresh HNSCC tumor, confirming our findings for the cell lines. Additionally, we found that these putative cancer stem cells, when treated with Gefitinib, possessed a lower capacity to invade and became more sensitive to cisplatin-induced death in vitro. These results suggest that EGFR plays critical roles in the survival, maintenance, and function of cancer stem cells. Drugs that target EGFR, perhaps administered in combination with conventional chemotherapy, might be an effective treatment for HNSCC.	[Abhold, Eric L.; Kiang, Alan; Rahimy, Elham; Kuo, Selena Z.; Lopez, Jay Patrick; Blair, Katherine J.; Yu, Michael Andrew; Brumund, Kevin T.; Patel, Andrew; Weisman, Robert A.; Ongkeko, Weg M.] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Vet Adm Med Ctr, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Haas, Martin] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Altuna, Xabier] Hosp Univ Donostia, San Sebastian, Spain	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego	Abhold, EL (corresponding author), Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA.	wongkeko@ucsd.edu		Rahimy, Elham/0000-0001-7356-3996; Lopez, Jay/0000-0002-7645-1620; ALTUNA, XABIER/0000-0002-3453-5017	AAOHNSF	AAOHNSF	The authors' work was funded by AAOHNSF grant (AAOHNSF.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MALS, 2008, CANCER SCI, V99, P1589, DOI 10.1111/j.1349-7006.2008.00861.x; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; JETTEN AM, 1990, INT J CANCER, V45, P195, DOI 10.1002/ijc.2910450135; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MIYAGUCHI M, 1991, CLIN OTOLARYNGOL, V16, P466, DOI 10.1111/j.1365-2273.1991.tb01041.x; Nemunaitis J, 2002, EXPERT OPIN BIOL TH, V2, P177, DOI 10.1517/14712598.2.2.177; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmidt C, 2008, J NATL CANCER I, V100, P694, DOI 10.1093/jnci/djn168; SCHWACHOFER JHM, 1990, ANTICANCER RES, V10, P805; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Wheeler SE, 2010, ONCOGENE; Yarden Y, 2001, EUR J CANCER, V37, pS3	26	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32459	10.1371/journal.pone.0032459	http://dx.doi.org/10.1371/journal.pone.0032459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384257	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500093
J	Parrilla, M; Lillo, C; Herrero-Turrion, MJ; Arevalo, R; Aijon, J; Lara, JM; Velasco, A				Parrilla, Marta; Lillo, Concepcion; Javier Herrero-Turrion, M.; Arevalo, Rosario; Aijon, Jose; Lara, Juan M.; Velasco, Almudena			Characterization of Pax2 Expression in the Goldfish Optic Nerve Head during Retina Regeneration	PLOS ONE			English	Article							ASTROCYTE PRECURSOR CELLS; GLIAL-CELLS; VISUAL-SYSTEM; MULLER CELLS; GENE; EYE; PROTEINS; FAMILY; AXONS; FISH	The Pax2 transcription factor plays a crucial role in axon-guidance and astrocyte differentiation in the optic nerve head (ONH) during vertebrate visual system development. However, little is known about its function during regeneration. The fish visual system is in continuous growth and can regenerate. Muller cells and astrocytes of the retina and ONH play an important role in these processes. We demonstrate that pax2a in goldfish is highly conserved and at least two pax2a transcripts are expressed in the optic nerve. Moreover, we show two different astrocyte populations in goldfish: Pax2(+) astrocytes located in the ONH and S100(+) astrocytes distributed throughout the retina and the ONH. After peripheral growth zone (PGZ) cryolesion, both Pax2(+) and S100(+) astrocytes have different responses. At 7 days after injury the number of Pax2(+) cells is reduced and coincides with the absence of young axons. In contrast, there is an increase of S100(+) astrocytes in the retina surrounding the ONH and S100(+) processes in the ONH. At 15 days post injury, the PGZ starts to regenerate and the number of S100(+) astrocytes increases in this region. Moreover, the regenerating axons reach the ONH and the pax2a gene expression levels and the number of Pax2(+) cells increase. At the same time, S100(+)/GFAP(+)/GS(+) astrocytes located in the posterior ONH react strongly. In the course of the regeneration, Muller cell vitreal processes surrounding the ONH are primarily disorganized and later increase in number. During the whole regenerative process we detect a source of Pax2(+)/PCNA(+) astrocytes surrounding the posterior ONH. We demonstrate that pax2a expression and the Pax2(+) astrocyte population in the ONH are modified during the PGZ regeneration, suggesting that they could play an important role in this process.	[Parrilla, Marta; Lillo, Concepcion; Javier Herrero-Turrion, M.; Arevalo, Rosario; Aijon, Jose; Lara, Juan M.; Velasco, Almudena] Univ Salamanca, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain	University of Salamanca	Parrilla, M (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain.	malmu@usal.es	Lara, Juan/L-5590-2014; Arévalo, Rosario/L-5649-2014; Lillo, Concepcion/A-6321-2009; Herrero-Turrión, M. Javier/D-9419-2019	Lara, Juan/0000-0001-5389-3592; Arévalo, Rosario/0000-0001-5849-1736; Lillo, Concepcion/0000-0001-5814-9826; Herrero-Turrión, M. Javier/0000-0003-3350-2608; Velasco, Almudena/0000-0002-7442-3255	Ministerio Espanol de Ciencia e Innovacion [BFU-2009-11179]; Grupos de Excelencia de Castilla y Leon [GR-183]	Ministerio Espanol de Ciencia e Innovacion(Spanish Government); Grupos de Excelencia de Castilla y Leon	This work was funded by Ministerio Espanol de Ciencia e Innovacion (BFU-2009-11179) and Grupos de Excelencia de Castilla y Leon (GR-183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balczarek KA, 1997, MOL BIOL EVOL, V14, P829, DOI 10.1093/oxfordjournals.molbev.a025824; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Boije H, 2010, DEV DYNAM, V239, P1858, DOI 10.1002/dvdy.22309; BUNT SM, 1982, J COMP NEUROL, V206, P209, DOI 10.1002/cne.902060302; Busse A, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-36; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Cai Y, 2002, J BIOL CHEM, V277, P1217, DOI 10.1074/jbc.M109663200; Chan-Ling T, 2004, INVEST OPHTH VIS SCI, V45, P2020, DOI 10.1167/iovs.03-1169; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Chun MH, 2000, BRAIN RES, V868, P358, DOI 10.1016/S0006-8993(00)02305-2; Cid E, 2006, PARTICIPACION POBLAC; Clemente D, 2008, ARCH ITAL BIOL, V146, P35; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Dressler GR, 1999, INT J DEV BIOL, V43, P463; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Fu WM, 1998, DEVELOPMENT, V125, P2943; Fujita Y, 2000, TISSUE CELL, V32, P293, DOI 10.1054/tice.2000.0115; Garcia DM, 2009, COMP BIOCHEM PHYS A, V152, P135, DOI 10.1016/j.cbpa.2008.09.026; Goode DK, 2009, DEV DYNAM, V238, P2951, DOI 10.1002/dvdy.22146; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Jimeno D, 1999, BRAIN RES, V816, P175, DOI 10.1016/S0006-8993(98)01170-6; JOHNS PR, 1977, J COMP NEUROL, V176, P331, DOI 10.1002/cne.901760303; Kirsch M, 2010, GLIA, V58, P768, DOI 10.1002/glia.20961; Koriyama Y, 2006, ADV EXP MED BIOL, V572, P333; Lillo C, 2002, J HISTOCHEM CYTOCHEM, V50, P1289, DOI 10.1177/002215540205001002; Lillo C, 2001, J NEUROCYTOL, V30, P475, DOI 10.1023/A:1015684932550; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun K, 1998, DEVELOPMENT, V125, P3049; Macdonald R, 1996, CURR OPIN NEUROBIOL, V6, P49, DOI 10.1016/S0959-4388(96)80008-0; Macdonald R, 1997, DEVELOPMENT, V124, P2397; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Matsukawa T, 2004, BIOL PHARM BULL, V27, P445, DOI 10.1248/bpb.27.445; Meri S, 2001, BIOMOL ENG, V18, P213, DOI 10.1016/S1389-0344(01)00106-X; Mi HY, 1999, J NEUROSCI, V19, P1049; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; MURRAY M, 1982, J COMP NEUROL, V209, P352, DOI 10.1002/cne.902090405; Nagashima M, 2009, NEUROCHEM INT, V54, P229, DOI 10.1016/j.neuint.2008.11.007; Oster SF, 2004, SEMIN CELL DEV BIOL, V15, P125, DOI 10.1016/j.semcdb.2003.09.006; Parrilla M, 2009, BRAIN RES, V1255, P75, DOI 10.1016/j.brainres.2008.12.010; Petrausch B, 2000, MOL CELL NEUROSCI, V16, P350, DOI 10.1006/mcne.2000.0877; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Phelps DE, 1996, J BIOL CHEM, V271, P7978, DOI 10.1074/jbc.271.14.7978; Rodger J, 2006, NEUROSCIENCE, V142, P1043, DOI 10.1016/j.neuroscience.2006.07.057; Sanyanusin P, 1996, GENOMICS, V35, P258, DOI 10.1006/geno.1996.0350; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Soukkarieh C, 2007, DEV BIOL, V303, P800, DOI 10.1016/j.ydbio.2006.11.016; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Stuermer CAO, 2000, PROG NEUROBIOL, V62, P197, DOI 10.1016/S0301-0082(00)00012-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tavassoli K, 1997, HUM GENET, V101, P371, DOI 10.1007/s004390050644; Thanos S, 2004, J NEUROBIOL, V59, P8, DOI 10.1002/neu.20001; Thanos S, 2001, BRAIN RES REV, V35, P205, DOI 10.1016/S0165-0173(01)00049-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres MA, 1996, DEVELOPMENT, V122, P3381; Vecino E, 1997, MICROSC RES TECHNIQ, V36, P17; Velasco A, 1997, BRAIN RES BULL, V43, P327, DOI 10.1016/S0361-9230(97)00014-2; Wehr R, 1996, INT J DEV BIOL, V40, P369; Wohl SG, 2009, EXP NEUROL, V219, P175, DOI 10.1016/j.expneurol.2009.05.008; Ziman MR, 2001, HISTOL HISTOPATHOL, V16, P239, DOI 10.14670/HH-16.239	69	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32348	10.1371/journal.pone.0032348	http://dx.doi.org/10.1371/journal.pone.0032348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384226	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500079
J	Sexton, T; Hitchcook, LJ; Rodgers, DW; Bradley, LH; Hersh, LB				Sexton, Travis; Hitchcook, Lisa J.; Rodgers, David W.; Bradley, Luke H.; Hersh, Louis B.			Active Site Mutations Change the Cleavage Specificity of Neprilysin	PLOS ONE			English	Article							ENDOPEPTIDASE 24.11 ENKEPHALINASE; NEUTRAL ENDOPEPTIDASE; AMYLOID BURDEN; PURIFICATION; DEGRADATION; EXPRESSION; INHIBITOR; PATHOLOGY; MEMBRANE; ENZYME	Neprilysin (NEP), a member of the M13 subgroup of the zinc-dependent endopeptidase family is a membrane bound peptidase capable of cleaving a variety of physiological peptides. We have generated a series of neprilysin variants containing mutations at either one of two active site residues, Phe(563) and Ser(546). Among the mutants studied in detail we observed changes in their activity towards leucine(5)-enkephalin, insulin B chain, and amyloid beta(1-40). For example, NEPF563I displayed an increase in preference towards cleaving leucine(5)-enkephalin relative to insulin B chain, while mutant NEPS546E was less discriminating than neprilysin. Mutants NEPF563L and NEPS546E exhibit different cleavage site preferences than neprilysin with insulin B chain and amyloid beta(1-40) as substrates. These data indicate that it is possible to alter the cleavage site specificity of neprilysin opening the way for the development of substrate specific or substrate exclusive forms of the enzyme with enhanced therapeutic potential.	[Sexton, Travis; Hitchcook, Lisa J.; Rodgers, David W.; Hersh, Louis B.] Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Bradley, Luke H.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Sexton, T (corresponding author), Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	lhersh@uky.edu		Bradley, Luke/0000-0003-1870-0796	Alzheimer's Association; National Institutes of Health [RO1DA02243, T32DA016176, P2ORR020171]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R01DA002243] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from the Alzheimer's Association (DR. Rodgers, Dr. Bradley, Dr. Hersh), and the National Institutes of Health RO1DA02243 (Dr. Hersh), T32DA016176 (Dr. Sexton), and P2ORR020171 (DR. Rodgers, Dr. Bradley, Dr. Hersh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012793; Bradley LH, 2005, PROTEIN ENG DES SEL, V18, P201, DOI 10.1093/protein/gzi020; Bradley LH, 2011, PROTEIN EXPRES PURIF, V75, P186, DOI 10.1016/j.pep.2010.08.007; CAMERON CE, 1994, J BIOL CHEM, V269, P11170; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; ERDOS EG, 1989, FASEB J, V3, P145, DOI 10.1096/fasebj.3.2.2521610; GEE NS, 1985, BIOCHEM J, V228, P119, DOI 10.1042/bj2280119; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; HERSH LB, 1986, J BIOL CHEM, V261, P6433; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Jeffrey JL, 2003, J BIOL CHEM, V278, P18971, DOI 10.1074/jbc.M210113200; KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477; Lee CC, 2005, PLASMID, V54, P80, DOI 10.1016/j.plasmid.2004.12.001; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; LI CW, 1995, METHOD ENZYMOL, V248, P253; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; MALFROY B, 1978, NATURE, V276, P523, DOI 10.1038/276523a0; Marr RA, 2003, J NEUROSCI, V23, P1992; MATSAS R, 1983, P NATL ACAD SCI-BIOL, V80, P3111, DOI 10.1073/pnas.80.10.3111; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; PAINTER RG, 1988, J BIOL CHEM, V263, P9456; Poirier R, 2006, NEUROBIOL DIS, V24, P475, DOI 10.1016/j.nbd.2006.08.003; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Spengler J, 1998, J CHEM SOC PERK T 1, P2091, DOI 10.1039/a801052h; Thanawala V, 2008, CURR DRUG TARGETS, V9, P887, DOI 10.2174/138945008785909356; Thompson MW, 2003, PEPTIDES, V24, P1359, DOI 10.1016/j.peptides.2003.07.012; Turner AJ, 1997, FASEB J, V11, P355, DOI 10.1096/fasebj.11.5.9141502; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; VIJAYARAGHAVAN J, 1990, BIOCHEMISTRY-US, V29, P8052, DOI 10.1021/bi00487a009; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wayman CP, 2010, BRIT J PHARMACOL, V160, P51, DOI 10.1111/j.1476-5381.2010.00691.x; WOLZ RL, 1991, BIOCHEMISTRY-US, V30, P8488, DOI 10.1021/bi00098a029	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32343	10.1371/journal.pone.0032343	http://dx.doi.org/10.1371/journal.pone.0032343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384224	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100072
J	Eva, R; Bouyoucef-Cherchalli, D; Patel, K; Cullen, PJ; Banting, G				Eva, Richard; Bouyoucef-Cherchalli, Dalila; Patel, Kalpana; Cullen, Peter J.; Banting, George			IP3 3-Kinase Opposes NGF Driven Neurite Outgrowth	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE; NERVE GROWTH-FACTOR; B-CELL SELECTION; PC12 CELLS; DENDRITIC SPINES; SIGNALING PATHWAYS; SIGMA-1 RECEPTORS; 1,3,4,5-TETRAKISPHOSPHATE; EXPRESSION; POTENTIATION	The inositol (1,4,5) trisphosphate 3-kinases comprise a family of enzymes (A, B, and C) that phosphorylate the calcium mobilising molecule inositol (1,4,5) trisphosphate (IP3) to generate inositol (1,3,4,5) tetrakisphosphate. This molecule can function as a second messenger, but its roles are not completely understood. The A isoform of inositol (1,4,5) trisphosphate 3-kinase localises to filamentous actin within dendritic spines in the hippocampus and is implicated in the regulation of spine morphology and long term potentiation, however the mechanisms through which it signals in neuronal cells are not completely understood. We have used NGF driven neurite outgrowth from PC12 cells as a platform to examine the impact of signaling via inositol (1,4,5) trisphosphate 3-kinase activity in a neuronal cell. We have found that the catalytic activity of the enzyme opposes neurite outgrowth, whilst pharmacological inhibition of inositol (1,4,5) trisphosphate 3-kinase leads to a significant increase in neurite outgrowth, and we show that the reduction in neurite outgrowth in response to inositol (1,4,5) trisphosphate 3-kinase activity correlates with reduced ERK activity as determined by western blotting using phosphorylation-specific antibodies. Our findings suggest a novel neuronal signaling pathway linking metabolism of IP3 to signaling via ERK.	[Eva, Richard; Bouyoucef-Cherchalli, Dalila; Cullen, Peter J.] Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrated Signalling Labs, Bristol BS8 1TD, Avon, England; [Patel, Kalpana] GlaxoSmithKline Inc, Dept High Throughput Biol Cell Physiol, Harlow, Essex, England	University of Bristol; GlaxoSmithKline	Eva, R (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrated Signalling Labs, Bristol BS8 1TD, Avon, England.	g.banting@bristol.ac.uk	Eva, Richard/J-7865-2017	Eva, Richard/0000-0003-0305-0452; Banting, George/0000-0001-8249-1621; Cullen, Peter/0000-0002-9070-8349	BBSRC; CASE Studentship; GlaxoSmithKline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CASE Studentship; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by funding from the BBSRC and CASE Studentship with GlaxoSmithKline (www.bbsrc.ac.uk, www.gsk.co.uk). The BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GSK contributed to a small percentage of the funding. Kalpana Patel was employed by GSK at the time and contributed to the design of the study. The design of the study on the part of GSK was to investigate the use of fluorescent reporter constructs in PC12 cells for high throughput screening. The decision to pursue investigations of the role of inositol (1,4,5) trisphosphate 3-kinase A in PC12 cell differentiation was not part of the original study design regarding GSK. GSK did not design the study as presented here, however some data was collected and analysed on GSK equipment by Richard Eva. Specifically, neurite outgrowth quantification and analysis was performed on GSK equipment by Richard Eva, who was at the time a PhD student at the University of Bristol. All the data presented in figures 4, 5 and 6 was acquired at the University of Bristol. GSK had no role in the decision to publish or preparation of the manuscript. Kalpana Patel was employed by GSK at the time the data was acquired, but not at the time of the drafting of the manuscript. Cells expressing GFP tagged Inositol (1,4,5) trisphosphate 3-kinase A were sorted for expression levels by Rob Jepras on a FACS machine at GSK. Rob Jepras had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; CONTRERAS ML, 1993, J NEUROCHEM, V61, P1035, DOI 10.1111/j.1471-4159.1993.tb03617.x; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GO M, 1993, NEUROSCI LETT, V158, P135, DOI 10.1016/0304-3940(93)90247-I; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Irvine RF, 1999, CHEM PHYS LIPIDS, V98, P49, DOI 10.1016/S0009-3084(99)00017-1; Irvine RF, 2006, ADV ENZYME REGUL, V46, P314, DOI 10.1016/j.advenzreg.2006.01.009; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Iwashita S, 2007, J BIOL CHEM, V282, P3413, DOI 10.1074/jbc.C600293200; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Jun KS, 1998, LEARN MEMORY, V5, P317; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Marechal Y, 2007, P NATL ACAD SCI USA, V104, P13978, DOI 10.1073/pnas.0704312104; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Miller AT, 2008, CELL CYCLE, V7, P463, DOI 10.4161/cc.7.4.5518; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Miller AT, 2009, J IMMUNOL, V182, P4696, DOI 10.4049/jimmunol.0802850; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Pattni K, 2004, CELL SIGNAL, V16, P643, DOI 10.1016/j.cellsig.2003.10.009; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Rong R, 2003, J BIOL CHEM, V278, P52497, DOI 10.1074/jbc.M306744200; Schell MJ, 2010, CELL MOL LIFE SCI, V67, P1755, DOI 10.1007/s00018-009-0238-5; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Togashi S, 1997, BIOCHEM J, V326, P221, DOI 10.1042/bj3260221; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32386	10.1371/journal.pone.0032386	http://dx.doi.org/10.1371/journal.pone.0032386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384237	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500100
J	Hsu, CJ; Hsieh, WT; Waldman, A; Clarke, F; Huseby, ES; Burkhardt, JK; Baumgart, T				Hsu, Chih-Jung; Hsieh, Wan-Ting; Waldman, Abraham; Clarke, Fiona; Huseby, Eric S.; Burkhardt, Janis K.; Baumgart, Tobias			Ligand Mobility Modulates Immunological Synapse Formation and T Cell Activation	PLOS ONE			English	Article							SUPPORTED LIPID-BILAYERS; FC-EPSILON-RI; RECEPTOR MICROCLUSTERS; IMMUNE SYNAPSE; MEMBRANE DYNAMICS; ANTIGEN RECEPTOR; LATERAL MOBILITY; DENDRITIC CELLS; PROTEIN; ACTIN	T cell receptor (TCR) engagement induces clustering and recruitment to the plasma membrane of many signaling molecules, including the protein tyrosine kinase zeta-chain associated protein of 70 kDa (ZAP70) and the adaptor SH2 domain-containing leukocyte protein of 76 kDa (SLP76). This molecular rearrangement results in formation of the immunological synapse (IS), a dynamic protein array that modulates T cell activation. The current study investigates the effects of apparent long-range ligand mobility on T cell signaling activity and IS formation. We formed stimulatory lipid bilayers on glass surfaces from binary lipid mixtures with varied composition, and characterized these surfaces with respect to diffusion coefficient and fluid connectivity. Stimulatory ligands coupled to these surfaces with similar density and orientation showed differences in their ability to activate T cells. On less mobile membranes, central supramolecular activation cluster (cSMAC) formation was delayed and the overall accumulation of CD3f at the IS was reduced. Analysis of signaling microcluster (MC) dynamics showed that ZAP70 MCs exhibited faster track velocity and longer trajectories as a function of increased ligand mobility, whereas movement of SLP76 MCs was relatively insensitive to this parameter. Actin retrograde flow was observed on all surfaces, but cell spreading and subsequent cytoskeletal contraction were more pronounced on mobile membranes. Finally, increased tyrosine phosphorylation and persistent elevation of intracellular Ca2+ were observed in cells stimulated on fluid membranes. These results point to ligand mobility as an important parameter in modulating T cell responses.	[Hsu, Chih-Jung; Hsieh, Wan-Ting; Waldman, Abraham; Baumgart, Tobias] Univ Penn, Childrens Hosp Philadelphia, Dept Chem, Philadelphia, PA 19104 USA; [Hsu, Chih-Jung; Hsieh, Wan-Ting; Waldman, Abraham; Clarke, Fiona; Burkhardt, Janis K.; Baumgart, Tobias] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Clarke, Fiona; Burkhardt, Janis K.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Massachusetts System; University of Massachusetts Worcester	Hsu, CJ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Chem, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu; baumgart@sas.upenn.edu		Burkhardt, Janis/0000-0002-8176-1375	NIH [R21AI073409, R01GM097552, R01AI065644]; University of Pennsylvania Nano/Bio Interface Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065644, R21AI073409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Nano/Bio Interface Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R21AI073409 and R01GM097552 to TB, NIH grant R01AI065644 to JKB, and an Innovation Award from the University of Pennsylvania Nano/Bio Interface Center to TB and JKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; BERRYMAN JG, 1983, PHYS REV A, V27, P1053, DOI 10.1103/PhysRevA.27.1053; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Carroll-Portillo A, 2010, J IMMUNOL, V184, P1328, DOI 10.4049/jimmunol.0903071; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Forstner MB, 2006, J AM CHEM SOC, V128, P15221, DOI 10.1021/ja064093h; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giocondi MC, 2001, LANGMUIR, V17, P1653, DOI 10.1021/la0012135; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Horton MR, 2007, LANGMUIR, V23, P6263, DOI 10.1021/la063690e; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JACOBS R, 1979, BIOCHEMISTRY-US, V18, P3280, DOI 10.1021/bi00582a013; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; LEE SB, 1990, PHYS REV A, V41, P5338, DOI 10.1103/PhysRevA.41.5338; Lou C, 2007, LANGMUIR, V23, P9752, DOI 10.1021/la701399s; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Purbhoo MA, 2010, SCI SIGNAL, V3, P10; Ratanabanangkoon P, 2002, LANGMUIR, V18, P4270, DOI 10.1021/la025568v; Ratto TV, 2002, BIOPHYS J, V83, P3380, DOI 10.1016/S0006-3495(02)75338-1; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Seantier B, 2004, NANO LETT, V4, P5, DOI [10.1021/nl034590l, 10.1021/nl0345901]; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Spendier K, 2010, BIOPHYS J, V99, P388, DOI 10.1016/j.bpj.2010.04.029; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VAZ WLC, 1989, BIOPHYS J, V56, P869, DOI 10.1016/S0006-3495(89)82733-X; VAZ WLC, 1990, BIOPHYS J, V58, P273, DOI 10.1016/S0006-3495(90)82373-0; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	46	45	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32398	10.1371/journal.pone.0032398	http://dx.doi.org/10.1371/journal.pone.0032398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384241	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500101
J	Schaue, D; Ratikan, JA; Iwamoto, KS				Schaue, Doerthe; Ratikan, Josephine A.; Iwamoto, Keisuke S.			Cellular Autofluorescence following Ionizing Radiation	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; OXIDATIVE PHOSPHORYLATION; CANCER-CELLS; NADH; DNA; SPECTROSCOPY; FIBROBLASTS; RESPONSES; REVEALS; NAD(P)H	Cells often autofluoresce in response to UV radiation excitation and this can reflect critical aspects of cellular metabolism. Here we report that many different human and murine cell types respond to ionizing radiation with a striking rise in autofluorescence that is dependent on dose and time. There was a highly reproducible fluorescent shift at various wavelengths, which was mirrored by an equally reproducible rise in the vital intracellular metabolic co-factors FAD and NADH. It appears that mitochondria, metabolism and Ca2+ homeostasis are important for this to occur as cells without mitochondria or cells unable to alter calcium levels did not behave in this way. We believe these radiation-induced changes are of biological importance and that autofluorescence may even provide us with a tool to monitor radiation responses in the clinic.	[Schaue, Doerthe; Ratikan, Josephine A.; Iwamoto, Keisuke S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schaue, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	dschaue@mednet.ucla.edu			Department of Defense [PC060403, BC094391]; National Institute of Allergy and Infectious Diseases [2U19 AI-67769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Department of Defense PC060403 (DS), the Department of Defense BC094391 (DS), and a National Institute of Allergy and Infectious Diseases Seed grant 2U19 AI-67769 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFANO RR, 1984, IEEE J QUANTUM ELECT, V20, P1507, DOI 10.1109/JQE.1984.1072322; Andersson H, 1998, J MICROSC-OXFORD, V191, P1; Andrews BJ, 2006, J BIOL CHEM, V281, P13596, DOI 10.1074/jbc.M512787200; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Croce AC, 1999, PHOTOCHEM PHOTOBIOL, V69, P364, DOI 10.1562/0031-8655(1999)069<0364:DOFAPO>2.3.CO;2; DaCosta RS, 2005, J CLIN PATHOL, V58, P766, DOI 10.1136/jcp.2004.023804; DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163; Fujibayashi Y, 1997, RADIAT RES, V147, P729, DOI 10.2307/3579487; JAMIESON D, 1966, NATURE, V209, P361, DOI 10.1038/209361a0; KUNZ WS, 1994, ANAL BIOCHEM, V216, P322, DOI 10.1006/abio.1994.1048; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Ohshima Y, BIOCH BIOPHYS ACTA, V1800, P40; ORD MG, 1955, BRIT J RADIOL, V28, P279, DOI 10.1259/0007-1285-28-329-279; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pan MH, 2008, MOL IMAGING BIOL, V10, P325, DOI 10.1007/s11307-008-0158-z; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; ROEDERER M, 1986, CYTOMETRY, V7, P558, DOI 10.1002/cyto.990070610; Shen ZH, 1997, J IMMUNOL, V158, P2723; Silveira L, 2008, J FLUORESC, V18, P35, DOI 10.1007/s10895-007-0232-y; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; THOMSON JF, 1966, RADIAT RES, V29, P121, DOI 10.2307/3572096; VISTICA DT, 1991, CANCER RES, V51, P2515; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	32	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32062	10.1371/journal.pone.0032062	http://dx.doi.org/10.1371/journal.pone.0032062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384140	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500069
J	Barger, JF; Gallo, CA; Tandon, P; Liu, H; Sullivan, A; Grimes, HL; Plas, DR				Barger, J. F.; Gallo, C. A.; Tandon, P.; Liu, H.; Sullivan, A.; Grimes, H. L.; Plas, D. R.			S6K1 determines the metabolic requirements for BCR-ABL survival	ONCOGENE			English	Article						S6K1; glycolysis; fatty-acid oxidation; rapamycin; leukemia; Cpt1c	CHRONIC MYELOID-LEUKEMIA; FACTOR-INDEPENDENT SURVIVAL; GLUCOSE-METABOLISM; CELL-GROWTH; IMATINIB RESISTANCE; POSITIVE CELLS; RAG GTPASES; ACTIVATION; AKT; INHIBITION	In chronic myelogenous leukemia, the constitutive activation of the BCR-ABL kinase transforms cells to an addicted state that requires glucose metabolism for survival. We investigated S6K1, a protein kinase that drives glycolysis in leukemia cells, as a target for counteracting glucose-dependent survival induced by BCR-ABL. BCR-ABL potently activated S6K1-dependent signaling and glycolysis. Although S6K1 knockdown or rapamycin treatment suppressed glycolysis in BCR-ABL-transformed cells, these treatments did not induce cell death. Instead, loss of S6K1 triggered compensatory activation of fatty-acid oxidation, a metabolic program that can support glucose-independent cell survival. Fatty-acid oxidation in response to S6K1 inactivation required the expression of the fatty-acid transporter carnitine palmitoyl transferase 1c, which was recently linked to rapamycin resistance in cancer. Finally, addition of an inhibitor of fatty-acid oxidation significantly enhanced cytotoxicity in response to S6K1 inactivation. These data indicate that S6K1 dictates the metabolic requirements mediating BCR-ABL survival and provide a rationale for combining targeted inhibitors of signal transduction, with strategies to interrupt oncogene-induced metabolism. Oncogene (2013) 32, 453-461; doi:10.1038/onc.2012.70; published online 5 March 2012	[Barger, J. F.; Gallo, C. A.; Tandon, P.; Liu, H.; Sullivan, A.; Plas, D. R.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45208 USA; [Grimes, H. L.] Cincinnati Childrens Hosp, Div Immunobiol, Cincinnati, OH USA; [Grimes, H. L.] Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Plas, DR (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, 3125 Eden Ave, Cincinnati, OH 45208 USA.	plasd@uc.edu	Barger, Jennifer/N-1263-2015	Grimes, H. Leighton/0000-0001-8162-6758	IGERT [0333377]; NIH [CA133164]; American Cancer Society [RSG-08-293-01-CCG]; University of Cincinnati; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA133164] Funding Source: NIH RePORTER	IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Cincinnati; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs George Thomas and Sara Kozma for their advice and access to S6K1 knockout mice. We thank Dr Shane Horman, Jim Phelan and Meghan Brundage for their help with CML models in mice, and Drs Czyzyk-Krzeska and Godar for critique of the manuscript. JFB was supported by an IGERT fellowship #0333377. This work was supported by NIH Grant CA133164, the American Cancer Society RSG-08-293-01-CCG and the University of Cincinnati's Millennium Scholars program.	Barnes K, 2005, ONCOGENE, V24, P3257, DOI 10.1038/sj.onc.1208461; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Chalhoub N, 2006, BRAIN RES, V1100, P32, DOI 10.1016/j.brainres.2006.05.013; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eaton S, 1996, BIOCH J 2, V320, P345; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Mason EF, 2010, CANCER RES, V70, P8066, DOI 10.1158/0008-5472.CAN-10-0608; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Nardella C, 2011, CANCER RES, V71, P3669, DOI 10.1158/0008-5472.CAN-10-3962; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Plas DR, 2009, CURR OPIN CELL BIOL, V21, P230, DOI 10.1016/j.ceb.2008.12.013; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Tandon P, 2011, P NATL ACAD SCI USA, V108, P2361, DOI 10.1073/pnas.1013629108; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vander Heiden MG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001210; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	50	23	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2013	32	4					453	461		10.1038/onc.2012.70	http://dx.doi.org/10.1038/onc.2012.70			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22391570	Green Accepted			2022-12-25	WOS:000315551300006
J	Janfelt, C; Wellner, N; Leger, PL; Kokesch-Himmelreich, J; Hansen, SH; Charriaut-Marlangue, C; Hansen, HS				Janfelt, Christian; Wellner, Niels; Leger, Pierre-Louis; Kokesch-Himmelreich, Julia; Hansen, Steen Honore; Charriaut-Marlangue, Christiane; Hansen, Harald Severin			Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia	FASEB JOURNAL			English	Article						N-palmitoylethanolamine; free fatty acids; sodium/potassium pump; docosahexaenoic acid; arachidonic acid; desorption electrospray ionization	ACYL-ETHANOLAMINE PHOSPHOLIPIDS; FOCAL CEREBRAL-ISCHEMIA; FREE FATTY-ACID; P-31 NMR; ACYLETHANOLAMINES; ACCUMULATION; ANANDAMIDE; 2-ARACHIDONOYLGLYCEROL; PALMITOYLETHANOLAMIDE; NEUROPROTECTION	Spatial synthesis of N-acyl-phosphatidylethanolamines (NAPEs) and N-acylethanolamines (NAEs) during ischemia-reperfusion in neonatal rats has been investigated and compared to the spatial degradation of other phospholipids. Ischemia was induced in anesthetized Wistar P7 rat pups by left middle cerebral artery electrocoagulation combined with a transient and concomitant occlusion of both common carotid arteries. Pups were sacrificed after 24 and 48 h. Sham-treated animals were sacrificed after 48 h. The frozen brains were sliced and subjected to desorption electrospray ionization imaging mass spectrometry. There was a remarkable increase in the levels of many species of NAPEs in the whole injured area at both time points, and a clear but minor increase in selected NAEs. In the ischemic area, the sodium adducts of phosphatidylcholine and of lyso-phosphatidylcholine accumulated and the potassium adduct of phosphatidylcholine disappeared, indicating breakdown of the Na+/K+ pump. Free fatty acids, e. g., arachidonic and docosahexaenoic acids, tended to be more abundant in the periphery than in the center of the ischemic area and showed different spatial distribution. NAPEs are synthesized in the whole ischemic area where the cells seem to be dead and other phospholipids are degraded. Free fatty acids can be found in the periphery of the ischemic area.-Janfelt, C., Wellner, N., Leger, P.-L., Kokesch-Himmelreich, J., Hansen, S. H., Charriaut-Marlangue, C., Hansen, H. S. Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia. FASEB J. 26, 2667-2673 (2012). www.fasebj.org	[Wellner, Niels; Hansen, Harald Severin] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Fac Pharmaceut Sci, DK-2100 Copenhagen O, Denmark; [Janfelt, Christian; Hansen, Steen Honore] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen O, Denmark; [Leger, Pierre-Louis; Charriaut-Marlangue, Christiane] Univ Paris 07, INSERM, U676, Hop Robert Debre, Paris, France; [Kokesch-Himmelreich, Julia] Univ Giessen, Inst Phys Chem, D-6300 Giessen, Germany	University of Copenhagen; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Justus Liebig University Giessen	Hansen, HS (corresponding author), Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Fac Pharmaceut Sci, Univ Pk 2, DK-2100 Copenhagen O, Denmark.	hsh@farma.ku.dk	, CHARRIAUT-MARLANGUE/H-3249-2019	Hansen, Harald S./0000-0001-7360-7418; Janfelt, Christian/0000-0002-4626-3426	Novo Nordisk Foundation; Carlsberg Foundation; Danish Council for Independent Research, Natural Sciences; Novo Nordisk Fonden [NNF11OC1015218] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study has been supported by grants from the Novo Nordisk Foundation (H. S. H.), the Carlsberg Foundation (C. J.), and the Danish Council for Independent Research, Natural Sciences (C. J.).	Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Berger C, 2004, J NEUROCHEM, V88, P1159, DOI 10.1046/j.1471-4159.2003.02244.x; Bonnin P, 2011, J NEUROSCI METH, V198, P103, DOI 10.1016/j.jneumeth.2011.02.030; Chen CT, 2008, J LIPID RES, V49, P147, DOI 10.1194/jlr.M700386-JLR200; Coulon D, 2012, BIOCHIMIE, V94, P75, DOI 10.1016/j.biochi.2011.04.023; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Deutsch J, 1997, NEUROCHEM RES, V22, P759, DOI 10.1023/A:1022030306359; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Franklin A, 2003, J NEUROSCI, V23, P7767; Galan-Rodriguez B, 2009, NEUROPHARMACOLOGY, V56, P653, DOI 10.1016/j.neuropharm.2008.11.006; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Guan XL, 2006, FASEB J, V20, P1152, DOI 10.1096/fj.05-5362com; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hansen HH, 2001, J NEUROCHEM, V76, P39, DOI 10.1046/j.1471-4159.2001.00006.x; Hansen HS, 1997, J NEUROCHEM, V69, P753; Hansen HS, 2002, PHARMACOL THERAPEUT, V95, P119, DOI 10.1016/S0163-7258(02)00251-6; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Kilaru A., 2010, J GLYCOM LIPIDOM, V1, P101; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Manicke NE, 2010, J MASS SPECTROM, V45, P223, DOI 10.1002/jms.1707; Moesgaard B, 1999, J LIPID RES, V40, P515; Moesgaard B, 2000, J LIPID RES, V41, P985; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Murphy RC, 2011, J BIOL CHEM, V286, P25427, DOI 10.1074/jbc.R111.233478; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; NATARAJAN V, 1986, BIOCHIM BIOPHYS ACTA, V878, P32, DOI 10.1016/0005-2760(86)90341-3; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Rodriguez de Fonseca F., 2001, NATURE, V414, P209, DOI DOI 10.1038/35102582; Saito M, 2010, J NEUROCHEM, V115, P168, DOI 10.1111/j.1471-4159.2010.06913.x; Sapirstein A, 2000, NEUROCHEM RES, V25, P745, DOI 10.1023/A:1007583708713; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Sun Y, 2007, BRIT J PHARMACOL, V152, P734, DOI 10.1038/sj.bjp.0707478; Swamy MJ, 2010, CHEM PHYS LIPIDS, V163, P266, DOI 10.1016/j.chemphyslip.2010.01.002; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Terova B, 2005, BBA-BIOMEMBRANES, V1715, P49, DOI 10.1016/j.bbamem.2005.07.004; Thunig J, 2011, ANAL CHEM, V83, P3256, DOI 10.1021/ac2004967; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Wellner N, 2011, BBA-MOL CELL BIOL L, V1811, P508, DOI 10.1016/j.bbalip.2011.06.020; Wiseman JM, 2006, ANGEW CHEM INT EDIT, V45, P7188, DOI 10.1002/anie.200602449	54	48	48	3	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2667	2673		10.1096/fj.11-201152	http://dx.doi.org/10.1096/fj.11-201152			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22389441				2022-12-25	WOS:000305017200042
J	Urzica, EI; Adler, LN; Page, MD; Linster, CL; Arbing, MA; Casero, D; Pellegrini, M; Merchant, SS; Clarke, SG				Urzica, Eugen I.; Adler, Lital N.; Page, M. Dudley; Linster, Carole L.; Arbing, Mark A.; Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.; Clarke, Steven G.			Impact of Oxidative Stress on Ascorbate Biosynthesis in Chlamydomonas via Regulation of the VTC2 Gene Encoding a GDP-L-galactose Phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERT-BUTYL HYDROPEROXIDE; DE-NOVO BIOSYNTHESIS; VITAMIN-C CONTENT; ACID BIOSYNTHESIS; MONODEHYDROASCORBATE REDUCTASE; ARABIDOPSIS-THALIANA; ENHANCED TOLERANCE; HYDROGEN-PEROXIDE; PLANTS; PATHWAY	The L-galactose (Smirnoff-Wheeler) pathway represents the major route to L-ascorbic acid (vitamin C) biosynthesis in higher plants. Arabidopsis thaliana VTC2 and its paralogue VTC5 function as GDP-L-galactose phosphorylases converting GDP-L-galactose to L-galactose-1-P, thus catalyzing the first committed step in the biosynthesis of L-ascorbate. Here we report that the L-galactose pathway of ascorbate biosynthesis described in higher plants is conserved in green algae. The Chlamydomonas reinhardtii genome encodes all the enzymes required for vitamin C biosynthesis via the L-galactose pathway. We have characterized recombinant C. reinhardtii VTC2 as an active GDP-L-galactose phosphorylase. C. reinhardtii cells exposed to oxidative stress show increased VTC2 mRNA and L-ascorbate levels. Genes encoding enzymatic components of the ascorbate-glutathione system (e.g. ascorbate peroxidase, manganese super oxide dismutase, and dehydro ascorbate reductase) are also up-regulated in response to increased oxidative stress. These results indicate that C. reinhardtii VTC2, like its plant homologs, is a highly regulated enzyme in ascorbate biosynthesis in green algae and that, together with the ascorbate recycling system, the L-galactose pathway represents the major route for providing protective levels of ascorbate in oxidatively stressed algal cells.	[Urzica, Eugen I.; Adler, Lital N.; Page, M. Dudley; Linster, Carole L.; Merchant, Sabeeha S.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Casero, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Arbing, Mark A.; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Linster, Carole L.] Catholic Univ Louvain, de Duve Inst, BCHM 7539, B-1200 Brussels, Belgium	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universite Catholique Louvain	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	sabeeha@chem.ucla.edu; clarke@mbi.ucla.edu	Urzica, Eugen Ioan/GXV-9546-2022; Casero, David/E-7365-2010; Urzica, Eugen I/B-7903-2013	Urzica, Eugen Ioan/0000-0002-1028-7442; Casero, David/0000-0002-7347-3330; Linster, Carole/0000-0001-7143-0719; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health [GM026020]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FD02-04ER15529]; Ellison Medical Foundation; UCLA; Department of Energy [DE-FC03-02ER63421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Ellison Medical Foundation(Lawrence Ellison Foundation); UCLA; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020 (to S. G. C.), the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FD02-04ER15529 (to S. S. M.), an Ellison Medical Foundation Senior Scholar Award (to S. G. C.), and UCLA Philip Whitcome and Graduate Division Dissertation Year Fellowships (to L. N. A.). The preparation of recombinant VTC2 enzyme was supported by the Department of Energy Grant DE-FC03-02ER63421 (to David Eisenberg).	Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alia M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Brenner C., 2007, ENCY LIFE SCI, P1; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen Z, 2005, PLANT PHYSIOL, V138, P1673, DOI 10.1104/pp.105.062000; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; CRAIGIE RA, 1982, J CELL SCI, V54, P173; Daskalopoulos R, 2002, GLIA, V39, P124, DOI 10.1002/glia.10099; DIMATTEO A, 2003, COMP BIOCH PHYSL A, V134, pS155; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Drahota Z, 2005, PHYSIOL RES, V54, P67, DOI 10.33549/physiolres.930578; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Filkowski J, 2004, PLANT J, V38, P60, DOI 10.1111/j.1365-313X.2004.02020.x; Fischer BB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-279; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GLASCOTT PA, 1995, MOL PHARMACOL, V48, P80; GRUN M, 1984, PLANTA, V160, P6, DOI 10.1007/BF00392459; Guranowski A, 2010, FEBS LETT, V584, P93, DOI 10.1016/j.febslet.2009.11.003; Hancock RD, 2005, CRIT REV PLANT SCI, V24, P167, DOI 10.1080/07352680591002165; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HELSPER JP, 1982, PLANT PHYSIOL, V69, P465, DOI 10.1104/pp.69.2.465; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Ishikawa Takahiro, 2008, J Biol Chem, V283, P31133, DOI 10.1074/jbc.M803930200; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Ledford HK, 2007, EUKARYOT CELL, V6, P919, DOI 10.1128/EC.00207-06; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Li F, 2010, PHYSIOL PLANTARUM, V139, P421, DOI 10.1111/j.1399-3054.2010.01369.x; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Long JC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1395, DOI 10.1111/j.1751-1097.2008.00451.x; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller-Moule P, 2008, PLANT MOL BIOL, V68, P31, DOI 10.1007/s11103-008-9350-4; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Novoselov SV, 2003, PROTEIN SCI, V12, P372, DOI 10.1110/ps.0226503; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Radzio JA, 2003, PLANT MOL BIOL, V53, P837, DOI 10.1023/B:PLAN.0000023671.99451.1d; RENSTROM B, 1983, PLANT SCI LETT, V28, P299, DOI 10.1016/S0304-4211(83)80022-4; Running JA, 2003, J EXP BOT, V54, P1841, DOI 10.1093/jxb/erg207; Sanmartin M, 2003, PLANTA, V216, P918, DOI 10.1007/s00425-002-0944-9; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; SHIGEOKA S, 1979, J NUTR SCI VITAMINOL, V25, P299; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; Takeda T, 1997, PHYSIOL PLANTARUM, V99, P49, DOI 10.1111/j.1399-3054.1997.tb03429.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang ZN, 2010, J INTEGR PLANT BIOL, V52, P400, DOI 10.1111/j.1744-7909.2010.00921.x; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034; Yabuta Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2598, DOI 10.1271/bbb.80284; Zsigmond L, 2011, PLANT PHYSIOL BIOCH, V49, P809, DOI 10.1016/j.plaphy.2011.04.013	70	76	77	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14234	14245		10.1074/jbc.M112.341982	http://dx.doi.org/10.1074/jbc.M112.341982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393048	Green Published, hybrid			2022-12-25	WOS:000303996300075
J	Islam, KN; Koch, WJ				Islam, Kazi N.; Koch, Walter J.			Involvement of Nuclear Factor kappa B (NF-kappa B) Signaling Pathway in Regulation of Cardiac G Protein-coupled Receptor Kinase 5 (GRK5) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CARDIOMYOCYTE HYPERTROPHY; A GENE-EXPRESSION; HEART-FAILURE; IN-VIVO; ACTIVATION; ALPHA; TRANSCRIPTION; MECHANISMS; OXYGEN; CELLS	G protein-coupled receptor kinase 5 (GRK5) plays a key role in cardiac signaling regulation, and its expression is increased in heart failure. Recently, increased expression of GRK5 in the myocardium of mice has been shown to be detrimental in the setting of pressure-overload hypertrophy. The ubiquitous nuclear transcription factor kappa B (NF-kappa B) is involved in the regulation of numerous genes in various tissues, and activation of NF-kappa B has been shown to be associated with heart disease. Here, we investigated the role of NF-kappa B signaling in the regulation of the GRK5 gene and expression of this kinase in cardiomyocytes. First, in analyzing the 5 '-flanking DNA of GRK5, the presence of a potential NF-kappa B binding site was observed in the promoter region. Phorbol myristate acetate, a known stimulator of NF-kappa B, increased the levels of GRK5 in myocytes whereas treatment of cells with N-acetyl cysteine, a known inhibitor of NF-kappa B, or with SC 514, an inhibitor of I kappa B kinase 2 decreased GRK5. Utilizing EMSA or ChIP assays, we found that both p50 and p65 NF-kappa B could interact with the promoter of GRK5 following myocytes NF-kappa B activation. Importantly, short interfering RNA (siRNA)-mediated loss of p65 in myocytes decreased the stimulated increased levels of GRK5 mRNA and protein. Finally, adenovirus-mediated overexpression of a dominant-negative I kappa B alpha in myocytes inhibited the levels of GRK5. Taken together, our study demonstrates that NF-kappa B plays a critical role in the regulation of GRK5 transcription in myocytes and that this may translate to the significant expression changes seen in heart disease.	[Islam, Kazi N.; Koch, Walter J.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Jefferson University	Islam, KN (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, 3500 N Broad St,904B MERB, Philadelphia, PA 19140 USA.	kazi.islam@temple.edu; walter.koch@temple.edu			National Institute of Heath [P01 HL091799, R37 HL061690, P01 HL075443, R01 HL085503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091799, R01HL085503, P01HL075443, R37HL061690] Funding Source: NIH RePORTER	National Institute of Heath; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Heath Grants P01 HL091799 (Project 1) (to W. J. K), R37 HL061690 (to W. J. K), P01 HL075443 (Project 2) (to W. J. K), R01 HL085503 (to W. J. K.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Grabellus F, 2002, CARDIOVASC RES, V53, P124, DOI 10.1016/S0008-6363(01)00433-3; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee HB, 2004, KIDNEY INT, V65, P1170, DOI 10.1111/j.1523-1755.2004.00491.x; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Patial S, 2011, J CELL PHYSIOL, V226, P1323, DOI 10.1002/jcp.22460; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Peppel K, 2005, CARDIOVASC RES, V65, P674, DOI 10.1016/j.cardiores.2004.10.031; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Vijayan K, 2004, AM J PHYSIOL-HEART C, V287, pH2777, DOI 10.1152/ajpheart.00171.2004; Yi YP, 2002, HYPERTENSION, V39, P1058, DOI 10.1161/01.HYP0000019130.09167.3B; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563	37	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12771	12778		10.1074/jbc.M111.324566	http://dx.doi.org/10.1074/jbc.M111.324566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22389501	Green Published, hybrid			2022-12-25	WOS:000302903700016
J	Mansego, ML; Martinez, F; Martinez-Larrad, MT; Zabena, C; Rojo, G; Morcillo, S; Soriguer, F; Martin-Escudero, JC; Serrano-Rios, M; Redon, J; Chaves, FJ				Luisa Mansego, Maria; Martinez, Fernando; Teresa Martinez-Larrad, Maria; Zabena, Carina; Rojo, Gemma; Morcillo, Sonsoles; Soriguer, Federico; Carlos Martin-Escudero, Juan; Serrano-Rios, Manuel; Redon, Josep; Javier Chaves, Felipe			Common Variants of the Liver Fatty Acid Binding Protein Gene Influence the Risk of Type 2 Diabetes and Insulin Resistance in Spanish Population	PLOS ONE			English	Article							SAMPLE-SIZE REQUIREMENTS; METABOLIC SYNDROME; POLYMORPHISM; ASSOCIATION; IDENTIFICATION; HYPERTENSION; SENSITIVITY; AMERICAN; INSIGHTS; MUTATION	The main objective was to evaluate the association between SNPs and haplotypes of the FABP1-4 genes and type 2 diabetes, as well as its interaction with fat intake, in one general Spanish population. The association was replicated in a second population in which HOMA index was also evaluated. Methods: 1217 unrelated individuals were selected from a population-based study [Hortega study: 605 women; mean age 54 y; 7.8% with type 2 diabetes]. The replication population included 805 subjects from Segovia, a neighboring region of Spain (446 females; mean age 52 y; 10.3% with type 2 diabetes). DM2 mellitus was defined in a similar way in both studies. Fifteen SNPs previously associated with metabolic traits or with potential influence in the gene expression within the FABP1-4 genes were genotyped with SNPlex and tested. Age, sex and BMI were used as covariates in the logistic regression model. Results: One polymorphism (rs2197076) and two haplotypes of the FABP-1 showed a strong association with the risk of DM2 in the original population. This association was further confirmed in the second population as well as in the pooled sample. None of the other analyzed variants in FABP2, FABP3 and FABP4 genes were associated. There was not a formal interaction between rs2197076 and fat intake. A significant association between the rs2197076 and the haplotypes of the FABP1 and HOMA-IR was also present in the replication population. Conclusions: The study supports the role of common variants of the FABP-1 gene in the development of type 2 diabetes in Caucasians.	[Luisa Mansego, Maria; Javier Chaves, Felipe] Fdn Invest Hosp Clin Valencia INCLIVA, Genotyping & Genet Diag Unit, Valencia, Spain; [Martinez, Fernando; Redon, Josep] Univ Valencia, Hosp Clin Univ, Hypertens Clin, Fdn Invest Hosp Clin Valencia INCLIVA, Valencia, Spain; [Teresa Martinez-Larrad, Maria; Zabena, Carina; Serrano-Rios, Manuel] Hosp Clin San Carlos, Dept Internal Med 2, Madrid, Spain; [Rojo, Gemma; Morcillo, Sonsoles; Soriguer, Federico] Carlos Haya Univ Hosp, Endocrinol & Nutr Dept, Malaga, Spain; [Carlos Martin-Escudero, Juan] Univ Valladolid, Hosp Rio Hortega, Dept Internal Med, Valladolid, Spain; [Luisa Mansego, Maria; Javier Chaves, Felipe] Minist Hlth, Inst Hlth Carlos 3, Ctr Invest Biomed Red CIBER Diabet & Enfermedades, Madrid, Spain; [Martinez, Fernando; Redon, Josep] Minist Hlth, Inst Hlth Carlos 3, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Madrid, Spain	University of Valencia; Hospital Clinico San Carlos; Hospital del Rio Hortega; Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Mansego, ML (corresponding author), Fdn Invest Hosp Clin Valencia INCLIVA, Genotyping & Genet Diag Unit, Valencia, Spain.	josep.redon@uv.es	Serrano Ríos, Manuel/E-4625-2019; Chaves-Martinez, Felipe Javier/ABC-3294-2021; Rojo-martínez, Gemma/E-3351-2010; Redon, Josep/L-5997-2019; REDON, JOSEP/E-1719-2019; MartÃnez, Fernando/AAO-5879-2021; MANSEGO, MARIA/A-5687-2011; MORCILLO, SONSOLES/N-9970-2017	Serrano Ríos, Manuel/0000-0002-3214-1444; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Rojo-martínez, Gemma/0000-0003-2179-2134; Redon, Josep/0000-0001-8777-6773; MartÃnez, Fernando/0000-0001-8562-4477; MANSEGO, MARIA/0000-0001-8914-7890; MORCILLO, SONSOLES/0000-0001-6932-5637; Martin-Escudero, Juan Carlos/0000-0002-6209-6509	Interministry Commission of Science and Technology (CICYT) [SAF2005-02883]; Biomedical Research Centers (CIBER) of Physiopathology; Obesity and Nutrition (CIBEROB),; CIBER of Diabetes and Metabolic Diseases (CIBERDEM); Carlos III Health Institute Madrid; Spanish Health Ministry; GRUPOS Valencian Government [03/101, 2005/027]; European Network of Excellence Ingenious Hypercare from the European Commission [EPSS-037093]; National Health Institute Carlos III FEDER (Madrid, Spain) [RD09/0076/00132]	Interministry Commission of Science and Technology (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Biomedical Research Centers (CIBER) of Physiopathology; Obesity and Nutrition (CIBEROB),; CIBER of Diabetes and Metabolic Diseases (CIBERDEM); Carlos III Health Institute Madrid; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); GRUPOS Valencian Government; European Network of Excellence Ingenious Hypercare from the European Commission; National Health Institute Carlos III FEDER (Madrid, Spain)	This study was supported by grants SAF2005-02883 from the Interministry Commission of Science and Technology (CICYT), Biomedical Research Centers (CIBER) of Physiopathology, Obesity and Nutrition (CIBEROB), CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Carlos III Health Institute Madrid, the Spanish Health Ministry; GRUPOS 03/101 and 2005/027 from the Valencian Government and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission; and Bio bank grant from the National Health Institute Carlos III FEDER RD09/0076/00132 (Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brouillette C, 2004, J HUM GENET, V49, P424, DOI 10.1007/s10038-004-0171-2; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Damcott CM, 2004, METABOLISM, V53, P303, DOI 10.1016/j.metabol.2003.10.010; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Galan JJ, 2008, J MED GENET, V45, P420, DOI 10.1136/jmg.2007.056952; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gavin J. R., 2003, DIABETES CARE, V26, pS5; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Lara-Castro C, 2005, J CLIN ENDOCR METAB, V90, P1196, DOI 10.1210/jc.2004-0676; Mansego ML, 2008, J HYPERTENS, V26, P230, DOI 10.1097/HJH.0b013e3282f29865; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; Mena Martin F J, 2003, An Med Interna, V20, P292; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Morcillo S, 2007, AM J CLIN NUTR, V86, P1232, DOI 10.1093/ajcn/86.4.1232; Ordovas JM, 2007, NUTR REV, V65, P130, DOI [10.1301/nr.2007.mar.130-134, 10.1111/j.1753-4887.2007.tb00290.x]; Robitaille J, 2004, MOL GENET METAB, V82, P296, DOI 10.1016/j.ymgme.2004.06.002; Shin Hyoung Doo, 2003, Hum Mutat, V22, P180; Takakura Y, 2005, DIABETES RES CLIN PR, V67, P36, DOI 10.1016/j.diabres.2004.05.002; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Virnaleswaran KS, 2006, METABOLISM, V55, P1222, DOI 10.1016/j.metabol.2006.05.006; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	26	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e31853	10.1371/journal.pone.0031853	http://dx.doi.org/10.1371/journal.pone.0031853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396741	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500009
J	Kielar, C; Sawiak, SJ; Negredo, PN; Tse, DHY; Morton, AJ				Kielar, Catherine; Sawiak, Stephen J.; Negredo, Paloma Navarro; Tse, Desmond H. Y.; Morton, A. Jennifer			Tensor-Based Morphometry and Stereology Reveal Brain Pathology in the Complexin1 Knockout Mouse	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; SYNAPTIC VESICLE FUSION; VOXEL-BASED MORPHOMETRY; NEUROTRANSMITTER RELEASE; HUNTINGTONS-DISEASE; PURKINJE-CELLS; MOTOR COORDINATION; PROTEIN EXPRESSION; THALAMIC LESIONS; MUTANT MOUSE	Complexins (Cplxs) are small, soluble, regulatory proteins that bind reversibly to the SNARE complex and modulate synaptic vesicle release. Cplx1 knockout mice (Cplx1(-/-)) have the earliest known onset of ataxia seen in a mouse model, although hitherto no histopathology has been described in these mice. Nevertheless, the profound neurological phenotype displayed by Cplx1(-/-) mutants suggests that significant functional abnormalities must be present in these animals. In this study, MRI was used to automatically detect regions where structural differences were not obvious when using a traditional histological approach. Tensor-based morphometry of Cplx1(-/-) mouse brains showed selective volume loss from the thalamus and cerebellum. Stereological analysis of Cplx1(-/-) and Cplx1(+/+) mice brain slices confirmed the volume loss in the thalamus as well as loss in some lobules of the cerebellum. Finally, stereology was used to show that there was loss of cerebellar granule cells in Cplx1(-/-) mice when compared to Cplx1(+/+) animals. Our study is the first to describe pathological changes in Cplx1(-/-) mouse brain. We suggest that the ataxia in Cplx1(-/-) mice is likely to be due to pathological changes in both cerebellum and thalamus. Reduced levels of Cplx proteins have been reported in brains of patients with neurodegenerative diseases. Therefore, understanding the effects of Cplx depletion in brains from Cplx1(-/-) mice may also shed light on the mechanisms underlying pathophysiology in disorders in which loss of Cplx1 occurs.	[Kielar, Catherine; Negredo, Paloma Navarro; Tse, Desmond H. Y.; Morton, A. Jennifer] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Sawiak, Stephen J.] Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge, England; [Sawiak, Stephen J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England	University of Cambridge; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Kielar, C (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	ajm41@cam.ac.uk	Sawiak, Stephen J/I-8944-2012; Morton, Jenny/AAT-8642-2020; Tse, Desmond/D-9586-2017	Sawiak, Stephen J/0000-0003-4210-9816; Morton, Jenny/0000-0003-0181-6346; Tse, Desmond/0000-0003-2559-7707	CHDI Fundation Inc. (United States of America)	CHDI Fundation Inc. (United States of America)	This work was supported by the CHDI Fundation Inc. (United States of America, http://www.highqfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CHDI Foundation, Inc. is not a commercial sponsor; it is a not-for-profit foundation.	Altman J, 1997, DEV CEREBELLAR SYSTE; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baader SL, 1998, J NEUROSCI, V18, P1763; Barr AM, 2005, ALCOHOL CLIN EXP RES, V29, P1915, DOI 10.1097/01.alc.0000187806.68957.0a; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Begemann M, 2010, ARCH GEN PSYCHIAT, V67, P879, DOI 10.1001/archgenpsychiatry.2010.107; BergerSweeney J, 1997, BEHAV BRAIN RES, V86, P121, DOI 10.1016/S0166-4328(96)02251-6; Cases O, 1998, J NEUROSCI, V18, P6914; Cho RW, 2010, MOL CELL NEUROSCI, V45, P389, DOI 10.1016/j.mcn.2010.07.012; Drew CJG, 2007, HUM MOL GENET, V16, P2288, DOI 10.1093/hmg/ddm181; Eastwood SL, 2000, MOL PSYCHIATR, V5, P425, DOI 10.1038/sj.mp.4000741; Eastwood SL, 2001, BRAIN RES BULL, V55, P569, DOI 10.1016/S0361-9230(01)00530-5; Eastwood SL, 2001, NEUROSCIENCE, V105, P219, DOI 10.1016/S0306-4522(01)00141-5; Edwardson JM, 2003, J BIOL CHEM, V278, P30849, DOI 10.1074/jbc.M304615200; Evidente VGH, 2000, MAYO CLIN PROC, V75, P475; Freeman W, 2004, BRAIN RES BULL, V63, P45, DOI 10.1016/j.brainresbull.2003.12.004; Freeman W, 2004, BRAIN RES BULL, V63, P33, DOI 10.1016/j.brainresbull.2003.12.003; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; Glynn D, 2005, HUM MOL GENET, V14, P2369, DOI 10.1093/hmg/ddi239; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; Glynn D, 2006, FENS ABSTR, pA458; Glynn D, 2007, BRAIN RES BULL, V72, P108, DOI 10.1016/j.brainresbull.2006.10.017; Glynn D, 2007, NEUROBIOL DIS, V25, P483, DOI 10.1016/j.nbd.2006.10.011; Glynn D, 2010, HUM MOL GENET, V19, P3402, DOI 10.1093/hmg/ddq252; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Harkins Amy B, 2002, Cerebellum, V1, P201, DOI 10.1080/14734220260418420; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HECKROTH JA, 1991, J COMP NEUROL, V312, P641, DOI 10.1002/cne.903120413; Herlenius E, 2001, EARLY HUM DEV, V65, P21, DOI 10.1016/S0378-3782(01)00189-X; HERRUP K, 1982, NEUROSCIENCE, V7, P2185, DOI 10.1016/0306-4522(82)90129-4; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; ITO M, 1984, JPN J PHYSIOL, V34, P781, DOI 10.2170/jjphysiol.34.781; Jeljeli M, 2000, NEUROSCI RES, V38, P155, DOI 10.1016/S0168-0102(00)00152-8; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kamishina H, 2008, BRAIN RES, V1204, P24, DOI 10.1016/j.brainres.2008.01.094; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Krishnakumar SS, 2011, NAT STRUCT MOL BIOL, V18, P934, DOI 10.1038/nsmb.2103; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liu J, 2009, J NEUROSCI, V29, P9148, DOI 10.1523/JNEUROSCI.0660-09.2009; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Matilla-Duenas A, 2010, CEREBELLUM, V9, P148, DOI 10.1007/s12311-009-0144-2; McHugh PC, 2010, J PSYCHOPHARMACOL, V24, P1243, DOI 10.1177/0269881109102786; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; MILLER JW, 1990, BRAIN RES, V508, P297, DOI 10.1016/0006-8993(90)90411-4; Morton AJ, 2001, BRAIN RES BULL, V56, P111, DOI 10.1016/S0361-9230(01)00611-6; NODA H, 1987, J NEUROPHYSIOL, V57, P1247, DOI 10.1152/jn.1987.57.5.1247; Oba D, 2010, ACTA NEUROPATHOL, V119, P513, DOI 10.1007/s00401-010-0639-4; Oz G, 2010, J NEUROSCI, V30, P3831, DOI 10.1523/JNEUROSCI.5612-09.2010; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Purves D., 2001, NEUROSCIENCE; Radyushkin K, 2010, GENES BRAIN BEHAV, V9, P592, DOI 10.1111/j.1601-183X.2010.00590.x; Rantamaki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Ren Y, 2009, J NEUROPHYSIOL, V102, P244, DOI 10.1152/jn.90985.2008; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; ROFFLERTARLOV S, 1981, BRAIN RES, V215, P49, DOI 10.1016/0006-8993(81)90490-X; Rub U, 2005, BRAIN PATHOL, V15, P287; Rub U, 2005, NEUROPATH APPL NEURO, V31, P127, DOI 10.1111/j.1365-2990.2004.00617.x; Rub U, 2003, BRAIN, V126, P2257, DOI 10.1093/brain/awg234; Rub U, 2006, BRAIN PATHOL, V16, P218, DOI 10.1111/j.1750-3639.2006.00022.x; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Sawada K, 2002, MOL PSYCHIATR, V7, P484, DOI 10.1038/sj.mp.4000978; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P12, DOI 10.1016/j.nbd.2008.09.017; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Sewards TV, 2003, BRAIN RES BULL, V61, P25, DOI 10.1016/S0361-9230(03)00069-8; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Shipp S, 2007, CURR BIOL, V17, pR443, DOI 10.1016/j.cub.2007.03.044; SIDMAN RL, 1965, SCIENCE, V150, P513, DOI 10.1126/science.150.3695.513; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2011, CEREBELLUM, V20, P236; Sullivan EV, 2009, ALCOHOL ALCOHOLISM, V44, P155, DOI 10.1093/alcalc/agn103; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tannenberg RK, 2006, NEUROCHEM INT, V49, P631, DOI 10.1016/j.neuint.2006.05.004; Trouillas P, 1997, PROG BRAIN RES, V114, P589; VELASCO F, 1993, ACTA NEUROCHIR, P201; Weigel R, 2004, STEREOT FUNCT NEUROS, V82, P115, DOI 10.1159/000079843; Witzmann FA, 2003, PROTEOMICS, V3, P1335, DOI 10.1002/pmic.200300453; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Yamada M, 1999, NEUROSCIENCE, V93, P7, DOI 10.1016/S0306-4522(99)00104-9; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Zink M, 2009, NEUROTOXICOL TERATOL, V31, P400, DOI 10.1016/j.ntt.2009.08.001	98	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32636	10.1371/journal.pone.0032636	http://dx.doi.org/10.1371/journal.pone.0032636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393426	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500078
J	Tanabe, LM; Martin, C; Dauer, WT				Tanabe, Lauren M.; Martin, Caitlin; Dauer, William T.			Genetic Background Modulates the Phenotype of a Mouse Model of DYT1 Dystonia	PLOS ONE			English	Article							EARLY-ONSET DYSTONIA; TORSION DYSTONIA; IDIOPATHIC DYSTONIA; NUCLEAR-ENVELOPE; PROTEIN; MICE; ABNORMALITIES; PENETRANCE; GENOTYPE; MUTATION	DYT1 dystonia is a debilitating neurological disease characterized by involuntary twisting movements. The disease is caused by an in-frame deletion (GAG, "Delta E") mutation in the TOR1A gene that encodes the torsinA protein. Intriguingly, only 30% of mutation carriers exhibit motor symptoms despite the fact that functional brain imaging studies show abnormal brain metabolism in all carriers. Because genetic modifiers may be a determinant of this reduced penetrance, we examined the genetic contribution of three different inbred strains of mice on the DYT1 mutation in animals that are homozygous (Tor1a(Delta E/Delta E)) or heterozygous (Tor1a(Delta E/+); disease state) for the disease-causing Delta E mutation. We find that the DBA/2J, C57BL/6J, and CD1-ICR contribution of genes significantly alter lifespan in Tor1a(Delta E/Delta E) mice, which die during the first few days of life on the 129S6/SvEvTac (129) background. The C57BL/6J (B6) strain significantly decreases life expectancy of Tor1a(Delta E/Delta E) animals but, like 129S6/SvEvTac Tor1a(Delta E/+) mice, congenic C57BL/6J Tor1a(Delta E/+) mice do not exhibit any motor abnormalities. In contrast, the DBA/2J (D2) strain significantly increases life expectancy. This effect was not present in congenic DBA/2J Tor1a(Delta E/Delta E) mice, indicating that the extended lifespan of F2 129/D2 mice was due to a combination of homozygous and heterozygous allelic effects. Our observations suggest that genetic modifiers may alter the penetrance of the DE mutation, and that mapping these modifiers may provide fresh insight into the torsinA molecular pathway.	[Tanabe, Lauren M.; Dauer, William T.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Martin, Caitlin] Emory Univ, Sch Med, Atlanta, GA USA; [Dauer, William T.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Emory University; University of Michigan System; University of Michigan	Tanabe, LM (corresponding author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.	dauer@med.umich.edu		Dauer, William/0000-0003-1775-7504; Tanabe, Lauren/0000-0003-1760-3468	Dystonia Medical Research Foundation	Dystonia Medical Research Foundation	These experiments were funded by the Dystonia Medical Research Foundation. The link for this foundation can be found at http://www.dystonia-foundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bressman SB, 2007, PARKINSONISM RELAT D, V13, pS347, DOI 10.1016/S1353-8020(08)70029-4; Carbon M, 2004, NEUROLOGY, V62, P1384, DOI 10.1212/01.WNL.0000120541.97467.FE; Clarimon J, 2005, ANN NEUROL, V57, P765, DOI 10.1002/ana.20485; Cookson MR, 2005, NEURON, V48, P875, DOI 10.1016/j.neuron.2005.12.006; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Eidelberg D, 1998, ANN NEUROL, V44, P303, DOI 10.1002/ana.410440304; Giles LM, 2009, J BIOL CHEM, V284, P21765, DOI 10.1074/jbc.M109.004838; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Kamm C, 2006, NEUROLOGY, V67, P1857, DOI 10.1212/01.wnl.0000244423.63406.17; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Nadeau JH, 2005, NEW ENGL J MED, V352, P1598, DOI 10.1056/NEJMe058054; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Niethammer M, 2011, NEUROBIOL DIS, V42, P202, DOI 10.1016/j.nbd.2010.10.010; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Risch NJ, 2007, AM J HUM GENET, V80, P1188, DOI 10.1086/518427; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; Trost M, 2002, ANN NEUROL, V52, P853, DOI 10.1002/ana.10418; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108	31	38	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32245	10.1371/journal.pone.0032245	http://dx.doi.org/10.1371/journal.pone.0032245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393392	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500045
J	Totir, M; Echols, N; Nanao, M; Gee, CL; Moskaleva, A; Gradia, S; Iavarone, AT; Berger, JM; May, AP; Zubieta, C; Alber, T				Totir, Monica; Echols, Nathaniel; Nanao, Max; Gee, Christine L.; Moskaleva, Alisa; Gradia, Scott; Iavarone, Anthony T.; Berger, James M.; May, Andrew P.; Zubieta, Chloe; Alber, Tom			Macro-to-Micro Structural Proteomics: Native Source Proteins for High-Throughput Crystallization	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-REPLACEMENT; PHOSPHOGLUCOSE ISOMERASE; MASS-SPECTROMETRY; REFINEMENT; RESOLUTION; DENSITY; COMPLEX	Structural biology and structural genomics projects routinely rely on recombinantly expressed proteins, but many proteins and complexes are difficult to obtain by this approach. We investigated native source proteins for high-throughput protein crystallography applications. The Escherichia coli proteome was fractionated, purified, crystallized, and structurally characterized. Macro-scale fermentation and fractionation were used to subdivide the soluble proteome into 408 unique fractions of which 295 fractions yielded crystals in microfluidic crystallization chips. Of the 295 crystals, 152 were selected for optimization, diffraction screening, and data collection. Twenty-three structures were determined, four of which were novel. This study demonstrates the utility of native source proteins for high-throughput crystallography.	[Totir, Monica; Echols, Nathaniel; Gee, Christine L.; Moskaleva, Alisa; Berger, James M.; Zubieta, Chloe; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nanao, Max] European Mol Biol Lab, F-38042 Grenoble, France; [Gradia, Scott; Iavarone, Anthony T.] QB3 Inst, Berkeley, CA USA; [May, Andrew P.] Fluidigm Corp, San Francisco, CA USA	University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL)	Totir, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	zubieta@esrf.fr; tom@ucxray.berkeley.edu	Nanao, Max/ABA-9292-2021	Gee, Christine/0000-0002-2632-6418; Nanao, Max/0000-0002-6340-1376; Zubieta, Chloe/0000-0003-4558-9333	University of California Office of the President UC [bio06583]; W.M. Keck Foundation; National Institutes of Health (NIH) [P01 AI068135]; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy (DOE) at Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	University of California Office of the President UC(University of California System); W.M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy (DOE) at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of California Office of the President UC Discovery Grant matched by the Fluidigm Corporation (bio06583; T.A.), a grant from the W.M. Keck Foundation (T.A. and J.M.B.) and National Institutes of Health (NIH) P01 AI068135 (T.A. and J.M.B.). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy (DOE) under Contract No. DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine P., 2005, CCP4 NEWSLETTER, V42; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Babnigg Gyoergy, 2010, Journal of Structural and Functional Genomics, V11, P71, DOI 10.1007/s10969-010-9080-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker MG, 2011, J INFECT; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chen YJ, 1999, RAPID COMMUN MASS SP, V13, P1907, DOI 10.1002/(SICI)1097-0231(19991015)13:19<1907::AID-RCM732>3.0.CO;2-T; Das R, 2009, ACTA CRYSTALLOGR D, V65, P169, DOI 10.1107/S0907444908020039; Davies C, 2002, PROTEINS, V49, P577, DOI 10.1002/prot.10255; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox BG, 2008, NAT METHODS, V5, P129, DOI 10.1038/nmeth0208-129; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; Hansen CL, 2006, J AM CHEM SOC, V128, P3142, DOI 10.1021/ja0576637; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; HUDSON JI, 1993, JAMA-J AM MED ASSOC, V269, P3108, DOI 10.1001/jama.269.24.3108; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin XY, 1999, RAPID COMMUN MASS SP, V13, P2327, DOI 10.1002/(SICI)1097-0231(19991215)13:23<2327::AID-RCM792>3.0.CO;2-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee WH, 2009, MOL CELL ENDOCRINOL, V301, P199, DOI 10.1016/j.mce.2008.09.042; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li L, 2010, ANNU REV BIOPHYS, V39, P139, DOI 10.1146/annurev.biophys.050708.133630; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mujacic M, 2004, MOL MICROBIOL, V51, P849, DOI 10.1046/j.1365-2958.2003.03871.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nanao MH, 2005, ACTA CRYSTALLOGR D, V61, P1227, DOI 10.1107/S0907444905019360; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Ravelli RBG, 2005, J SYNCHROTRON RADIAT, V12, P276, DOI 10.1107/S0909049505003286; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; Shen YF, 2001, J CHROMATOGR A, V914, P257, DOI 10.1016/S0021-9673(01)00579-9; Sigdel Tara K, 2004, J Biomol Tech, V15, P199; Solomons JTG, 2004, J MOL BIOL, V342, P847, DOI 10.1016/j.jmb.2004.07.085; Stokes-Rees I, 2010, P NATL ACAD SCI USA, V107, P21476, DOI 10.1073/pnas.1012095107; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Zwart PH, 2004, ACTA CRYSTALLOGR D, V60, P2230, DOI 10.1107/S0907444904012995	52	24	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32498	10.1371/journal.pone.0032498	http://dx.doi.org/10.1371/journal.pone.0032498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393408	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500061
J	Yuan, Y; Chen, HY; Ma, G; Cao, XF; Liu, ZH				Yuan, Yi; Chen, Hongyan; Ma, Gang; Cao, Xiaofeng; Liu, Zhihua			Reelin Is Involved in Transforming Growth Factor-beta 1-Induced Cell Migration in Esophageal Carcinoma Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; TGF-BETA; BREAST-CANCER; METASTASIS; REPRESSOR; PHOSPHORYLATION; MORPHOGENESIS; PATHWAY	Reelin (RELN), which is a glycoprotein secreted by Cajal-Retzius cells of the developing cerebral cortex, plays an important role in neuronal migration, but its role in cell migration and cancer metastasis is largely unclear. Here, we showed that cell motility was significantly increased in KYSE-510 cells by TGF-beta 1 treatment. Moreover, TGF-beta 1 decreased RELN mRNA expression and overexpression of Reelin at least partly reversed TGF-beta 1-induced cell migration in KYSE-30 cells. Furthermore, this negative regulation of Reelin expression by TGF-beta 1 was through Snail, one transcription factor which was induced by TGF-beta 1 in KYSE-510 cells. RELN promoter activity was reduced in parallel with the induction of Snail after TGF-beta 1 treatment and Snail suppressed both RELN promoter activity and expression through binding to E-box sequences in the RELN promoter region in ESCC cells. Knockdown of RELN induced cell migration in KYSE-510 cells, together with the increase of mesenchymal markers expression. Taken together, Reelin is an essential negative regulator in the TGF-beta 1-induced cell migration process, and is suppressed by TGF-beta pathway at the transcriptional level through Snail regulation. Therefore, the correlation of Reelin and TGF-beta pathway was critical in cancer metastasis, and Reelin could be one potential anti-metastasis target in future clinical practice.	[Yuan, Yi; Chen, Hongyan; Ma, Gang; Liu, Zhihua] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Yuan, Yi; Chen, Hongyan; Ma, Gang; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yuan, Yi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Key Lab Plant Genom, Beijing, Peoples R China; [Yuan, Yi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Plant Gene Res, Beijing, Peoples R China; [Yuan, Yi] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, Y (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	liuzh@cicams.ac.cn			National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81021061]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB504205) and National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Dohi O, 2010, INT J ONCOL, V36, P85, DOI 10.3892/ijo_00000478; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KANDA Y, 1994, INT J CANCER, V58, P291, DOI 10.1002/ijc.2910580224; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okamura Y, 2010, ANN SURG ONCOL; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perrone G, 2007, MODERN PATHOL, V20, P344, DOI 10.1038/modpathol.3800743; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sato N, 2006, GASTROENTEROLOGY, V130, P548, DOI 10.1053/j.gastro.2005.11.008; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Stein T, 2010, AM J PATHOL, V177, P2323, DOI 10.2353/ajpath.2010.100209; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang Q, 2002, CANCER LETT, V179, P71, DOI 10.1016/S0304-3835(01)00846-1; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	47	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31802	10.1371/journal.pone.0031802	http://dx.doi.org/10.1371/journal.pone.0031802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393371	gold, Green Submitted, Green Published			2022-12-25	WOS:000303003500024
J	Bousbia, S; Papazian, L; Saux, P; Forel, JM; Auffray, JP; Martin, C; Raoult, D; La Scola, B				Bousbia, Sabri; Papazian, Laurent; Saux, Pierre; Forel, Jean Marie; Auffray, Jean-Pierre; Martin, Claude; Raoult, Didier; La Scola, Bernard			Repertoire of Intensive Care Unit Pneumonia Microbiota	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; MOLECULAR ANALYSIS; DENTAL PLAQUE; DIAGNOSIS; BACTERIA; CYTOMEGALOVIRUS; IDENTIFICATION; INFECTIONS; PATHOGENS	Despite the considerable number of studies reported to date, the causative agents of pneumonia are not completely identified. We comprehensively applied modern and traditional laboratory diagnostic techniques to identify microbiota in patients who were admitted to or developed pneumonia in intensive care units (ICUs). During a three-year period, we tested the bronchoalveolar lavage (BAL) of patients with ventilator-associated pneumonia, community-acquired pneumonia, non-ventilator ICU pneumonia and aspiration pneumonia, and compared the results with those from patients without pneumonia (controls). Samples were tested by amplification of 16S rDNA, 18S rDNA genes followed by cloning and sequencing and by PCR to target specific pathogens. We also included culture, amoeba co-culture, detection of antibodies to selected agents and urinary antigen tests. Based on molecular testing, we identified a wide repertoire of 160 bacterial species of which 73 have not been previously reported in pneumonia. Moreover, we found 37 putative new bacterial phylotypes with a 16S rDNA gene divergence >= 98% from known phylotypes. We also identified 24 fungal species of which 6 have not been previously reported in pneumonia and 7 viruses. Patients can present up to 16 different microorganisms in a single BAL (mean +/- SD; 3.77 +/- 2.93). Some pathogens considered to be typical for ICU pneumonia such as Pseudomonas aeruginosa and Streptococcus species can be detected as commonly in controls as in pneumonia patients which strikingly highlights the existence of a core pulmonary microbiota. Differences in the microbiota of different forms of pneumonia were documented.	[Bousbia, Sabri; Raoult, Didier; La Scola, Bernard] CNRS IRD UMR 6236, Fac Med, URMITE, Marseille, France; [Papazian, Laurent; Forel, Jean Marie; Auffray, Jean-Pierre] Hop Nord Marseille, Serv Reanimat Med, Marseille, France; [Saux, Pierre] Hop Enfants La Timone, Dept Anesthesie Reanimat, Marseille, France; [Martin, Claude] Hop Nord Marseille, Dept Anesthesie Reanimat, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bousbia, S (corresponding author), CNRS IRD UMR 6236, Fac Med, URMITE, Marseille, France.	bernard.lascola@univmed.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	This work was supported by a grant from the Programme Hospitalier de Recherche Clinique 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; BERDAL BP, 1979, J CLIN MICROBIOL, V9, P575; Berger P, 2006, EMERG INFECT DIS, V12, P248; Bittar F, 2008, EMERG INFECT DIS, V14, P997, DOI 10.3201/eid1406.071236; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bousbia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011298; Bousbia S, 2010, EMERG INFECT DIS, V16, P258, DOI 10.3201/eid1602.090610; Bouza E, 2010, J CRIT CARE; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chiche L, 2009, CRIT CARE MED, V37, P1850, DOI 10.1097/CCM.0b013e31819ffea6; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Drancourt M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000083; DUPONT HT, 1994, CLIN DIAGN LAB IMMUN, V1, P189, DOI 10.1128/CDLI.1.2.189-196.1994; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Esperatti M, 2010, AM J RESP CRIT CARE; Fournier PE, 2002, CLIN DIAGN LAB IMMUN, V9, P795, DOI 10.1128/CDLI.9.4.795-801.2002; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Kawanami T, 2009, J CLIN MICROBIOL, V47, P496, DOI 10.1128/JCM.01429-08; Khlif M, 2009, CLIN MICROBIOL INFEC, V15, P656, DOI 10.1111/j.1469-0691.2009.02762.x; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; La Scola B, 2003, EMERG INFECT DIS, V9, P815, DOI 10.3201/eid0907.030065; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Luyt CE, 2008, CURR OPIN CRIT CARE, V14, P605, DOI 10.1097/MCC.0b013e32830f1e12; Mailman Timothy L, 2005, Can J Infect Dis Med Microbiol, V16, P245; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Murray PR., 2007, MANUAL CLIN MICROBIO, P1004; Papazian L, 1996, ANESTHESIOLOGY, V84, P280, DOI 10.1097/00000542-199602000-00005; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; POTGIETER PD, 1992, CHEST, V101, P199, DOI 10.1378/chest.101.1.199; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Roux D, 2009, CRIT CARE MED, V37, P1062, DOI 10.1097/CCM.0b013e31819629d2; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres A, 2000, CHEST, V117, p198S, DOI 10.1378/chest.117.4_suppl_2.198S; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; ZURAVLEFF JJ, 1983, JAMA-J AM MED ASSOC, V250, P1981, DOI 10.1001/jama.250.15.1981	49	76	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32486	10.1371/journal.pone.0032486	http://dx.doi.org/10.1371/journal.pone.0032486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389704	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600042
J	Jiang, BC; Nie, JH; Zhou, Z; Zhang, J; Tong, J; Cao, Y				Jiang, Bingcheng; Nie, Jihua; Zhou, Zhen; Zhang, Jie; Tong, Jian; Cao, Yi			Adaptive Response in Mice Exposed to 900 MHz Radiofrequency Fields: Primary DNA Damage	PLOS ONE			English	Article							RAT-BRAIN CELLS; HUMAN-LYMPHOCYTES; MICROWAVE-RADIATION; IONIZING-RADIATION; GAMMA-RAYS; VARIABILITY; REPAIR; BREAKS	The phenomenon of adaptive response (AR) in animal and human cells exposed to ionizing radiation is well documented in scientific literature. We have examined whether such AR could be induced in mice exposed to non-ionizing radiofrequency fields (RF) used for wireless communications. Mice were pre-exposed to 900 MHz RF at 120 mu W/cm(2) power density for 4 hours/day for 1, 3, 5, 7 and 14 days and then subjected to an acute dose of 3 Gy gamma-radiation. The primary DNA damage in the form of alkali labile base damage and single strand breaks in the DNA of peripheral blood leukocytes was determined using the alkaline comet assay. The results indicated that the extent of damage in mice which were pre-exposed to RF for 1 day and then subjected to gamma-radiation was similar and not significantly different from those exposed to gamma-radiation alone. However, mice which were pre-exposed to RF for 3, 5, 7 and 14 days showed progressively decreased damage and was significantly different from those exposed to gamma-radiation alone. Thus, the data indicated that RF pre-exposure is capable of inducing AR and suggested that the pre-exposure for more than 4 hours for 1 day is necessary to elicit such AR.	[Jiang, Bingcheng; Nie, Jihua; Zhou, Zhen; Zhang, Jie; Tong, Jian; Cao, Yi] Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Jiang, BC (corresponding author), Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China.	yicao@suda.edu.cn			National Natural Science Foundation of China [81020108028, 81001257]; China Ministry of Science and Technology [2011CB503700]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Ministry of Science and Technology(Ministry of Science and Technology, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research is supported by funding from the National Natural Science Foundation of China (nos. 81020108028 and 81001257), 973 project grant from China Ministry of Science and Technology (2011CB503700) and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in designing the experiments, data collection and analysis, preparation of the manuscript, and decision to publish the results.	BOSI A, 1989, MUTAT RES, V211, P13, DOI 10.1016/0027-5107(89)90102-4; Cao Y, 2011, INT J RADIAT BIOL, V87, P720, DOI 10.3109/09553002.2010.550981; Cao Y, 2010, J TOXICOL ENV HEAL A, V73, P507, DOI 10.1080/15287390903523451; Heynick LN, 2003, BIOELECTROMAGNETICS, pS74, DOI 10.1002/bem.10162; ICNIRP, 2009, EXP HIGH FREQ EL FIE; Ikushima T, 1996, MUTAT RES-FUND MOL M, V358, P193, DOI 10.1016/S0027-5107(96)00120-0; Kim JH, 1996, J RADIAT RES, V37, P161, DOI 10.1269/jrr.37.161; Kleczkowska HE, 1996, MUTAT RES-FUND MOL M, V358, P215, DOI 10.1016/S0027-5107(96)00123-6; Krishnaja AP, 2008, MUTAGENESIS, V23, P77, DOI 10.1093/mutage/gem045; Lai H, 1996, INT J RADIAT BIOL, V69, P513, DOI 10.1080/095530096145814; LAI H, 1995, BIOELECTROMAGNETICS, V16, P207, DOI 10.1002/bem.2250160309; Lai H., 2007, EVIDENCE GENOTOXIC E; Malyapa RS, 1998, RADIAT RES, V149, P637, DOI 10.2307/3579911; Meltz ML, 2003, BIOELECTROMAGNETICS, pS196, DOI 10.1002/bem.10176; Mortazavi SMJ, 2011, IRAN J RADIAT RES, V9, P9; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; Sannino A, 2011, INT J RADIAT BIOL, V87, P1; Sannino A, 2009, RADIAT RES, V171, P735, DOI 10.1667/RR1687.1; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Verschaeve, 2005, TOXICOL APPL PHARM, V207, pS336, DOI 10.1016/j.taap.2005.03.028; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; Vijayalaxmi, 2004, RADIAT RES, V162, P481, DOI 10.1667/RR3252; VIJAYALAXMI, 1995, MUTAT RES LETT, V348, P45, DOI 10.1016/0165-7992(95)90020-9; VIJAYALAXMI, 1989, MUTAGENESIS, V4, P187, DOI 10.1093/mutage/4.3.187; Vijayalaxmi, 2008, RADIAT RES, V169, P561, DOI 10.1667/RR0987.1; WIENCKE JK, 1986, MUTAGENESIS, V1, P375, DOI 10.1093/mutage/1.5.375; YOUNGBLOM JH, 1989, MUTAT RES, V227, P257, DOI 10.1016/0165-7992(89)90107-3; ZHANG LZ, 1995, MUTAT RES-ENVIR MUTA, V334, P33, DOI 10.1016/0165-1161(95)90028-4	28	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32040	10.1371/journal.pone.0032040	http://dx.doi.org/10.1371/journal.pone.0032040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389679	gold, Green Published, Green Submitted			2022-12-25	WOS:000302999600017
J	Kaitu'u-Lino, TJ; Whitehead, CL; Ngian, GL; Permezel, M; Tong, S				Kaitu'u-Lino, Tu'uhevaha J.; Whitehead, Clare L.; Ngian, Gene-Lyn; Permezel, Michael; Tong, Stephen			Serum Concentrations of Soluble Flt-1 Are Decreased among Women with a Viable Fetus and No Symptoms of Miscarriage Destined for Pregnancy Loss	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; EXPRESSION; OXYGEN; RISK; VASCULARIZATION	Miscarriage is the most common complication of pregnancy. Pre-clinical miscarriage has an estimated incidence of 30%, whilst clinical miscarriage has an incidence of 12-15%. Two thirds of pregnancies lost to miscarriage are believed to be attributable to defective placentation, thus a number of studies have sought to identify markers of defective placentation that could be used as clinical biomarkers of miscarriage. Decreased soluble FMS-like tyrosine kinase-1 (sFlt1), placental growth factor (PlGF), and soluble endoglin (sEng) in the maternal circulation during the first trimester have recently been proposed as potential markers of pregnancy loss. However, in these studies clinical samples were only obtained once women had presented with symptoms of miscarriage. In this study we prospectively screened serum samples collected from asymptomatic women with a viable fetus. We assessed maternal serum levels of sFlt1, PlGF and sEng across the first trimester of normal pregnancy and compared levels between women who continued to a live birth, to those who subsequently miscarried. Both sFlt1 and PlGF significantly (p <= 0.05) increased across gestation in normal pregnancy with serum levels rising from 0.65 +/- 0.12 ng/ml at 6 weeks to 1.85 +/- 0.24 ng/ml at 12 weeks for sFlt1, and 57.2 +/- 19.2 pg/ml to 106 +/- 22.7 pg/ml for PlGF. sEng remained unchanged throughout the the first trimester. Importantly we detected a significant (35%, p <= 0.05) decrease in sFlt1 levels between our control and miscarriage cohort, however there was significant overlap between cases and controls, suggesting serum sFlt1 is unlikely to be useful as a clinical biomarker in asymptomatic women. Nevertheless, our data suggests a dysregulation of angiogenic factors may be involved in the pathophysiology of miscarriage.	[Kaitu'u-Lino, Tu'uhevaha J.; Whitehead, Clare L.; Tong, Stephen] Univ Melbourne, Translat Obstet Grp, Mercy Hosp Women, Heidelberg, Vic, Australia; [Kaitu'u-Lino, Tu'uhevaha J.; Whitehead, Clare L.; Ngian, Gene-Lyn; Permezel, Michael; Tong, Stephen] Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Heidelberg, Vic, Australia	University of Melbourne; University of Melbourne	Kaitu'u-Lino, TJ (corresponding author), Univ Melbourne, Translat Obstet Grp, Mercy Hosp Women, Heidelberg, Vic, Australia.	t.klino@unimelb.edu.au		Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586	Victorian Government; National Health and Medical Research Council of Australia [490970, 490995]	Victorian Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Victorian Government's Operational Infrastructure Support Program. The National Health and Medical Research Council of Australia provided salary support (#490970 to S. T.; #490995 to T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Calleja-Agius J, HUM REPROD; Daponte A, 2011, J CLIN ENDOCRINOL ME; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Plaisier M, 2009, HUM REPROD, V24, P185, DOI 10.1093/humrep/den296; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Schiettecatte J, 2001, CLIN BIOCHEM, V43, P768; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tong S, 2008, OBSTET GYNECOL, V111, P710, DOI 10.1097/AOG.0b013e318163747c; Welch PC, 2006, AM J OBSTET GYNECOL, V194, P1625, DOI 10.1016/j.ajog.2006.01.012; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	22	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32509	10.1371/journal.pone.0032509	http://dx.doi.org/10.1371/journal.pone.0032509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389705	Green Published, gold			2022-12-25	WOS:000302999600043
J	Lloyd, AH; Wang, D; Timmis, JN				Lloyd, Andrew H.; Wang, Dong; Timmis, Jeremy N.			Single Molecule PCR Reveals Similar Patterns of Non-Homologous DSB Repair in Tobacco and Arabidopsis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA END; LIGASE-IV; CHLOROPLAST DNA; FLORAL DIP; GENOME; PLANTS; THALIANA; METHYLATION; INTEGRATION	DNA double strand breaks (DSBs) occur constantly in eukaryotes. These potentially lethal DNA lesions are repaired efficiently by two major DSB repair pathways: homologous recombination and non-homologous end joining (NHEJ). We investigated NHEJ in Arabidopsis thaliana and tobacco (Nicotiana tabacum) by introducing DNA double-strand breaks through inducible expression of I-SceI, followed by amplification of individual repair junction sequences by single-molecule PCR. Using this process over 300 NHEJ repair junctions were analysed in each species. In contrast to previously published variation in DSB repair between Arabidopsis and tobacco, the two species displayed similar DSB repair profiles in our experiments. The majority of repair events resulted in no loss of sequence and small (1-20 bp) deletions occurred at a minority (25-45%) of repair junctions. Approximately similar to 1.5% of the observed repair events contained larger deletions (. 20 bp) and a similar percentage contained insertions. Strikingly, insertion events in tobacco were associated with large genomic deletions at the site of the DSB that resulted in increased micro-homology at the sequence junctions suggesting the involvement of a non-classical NHEJ repair pathway. The generation of DSBs through inducible expression of I-SceI, in combination with single molecule PCR, provides an effective and efficient method for analysis of individual repair junctions and will prove a useful tool in the analysis of NHEJ.	[Lloyd, Andrew H.; Wang, Dong; Timmis, Jeremy N.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Adelaide	Lloyd, AH (corresponding author), INRA Ctr Versailles Grignon, INRA AgroParisTech UMR1318, Inst Jean Pierre Bourgin, Versailles, France.	andrew.lloyd@versailles.inra.fr	Wang, Dong/AAF-2406-2020	Wang, Dong/0000-0003-4278-2728; Lloyd, Andrew/0000-0001-7871-6621	Australian Research Council [DP0986973]	Australian Research Council(Australian Research Council)	This research was supported under the Australian Research Council's (www.arc.gov.au) Discovery Projects funding scheme (project number DP0986973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Yehezkel T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn457; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davidson D, 2011, INVEST NEW DRUGS, DOI [10.1007/s10637-10010-19626-10639, DOI 10.1007/S10637-10010-19626-10639]; Della-Maria J, 2011, J BIOL CHEM, DOI [10.1074/jbc.M1111.274159, DOI 10.1074/JBC.M1111.274159]; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Erikson O, 2004, NAT BIOTECHNOL, V22, P455, DOI 10.1038/nbt946; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Friesner J, 2003, PLANT J, V34, P427, DOI 10.1046/j.1365-313X.2003.01738.x; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Hall AE, 2006, GENOME RES, V16, P355, DOI 10.1101/gr.4399206; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Huang CY, 2004, P NATL ACAD SCI USA, V101, P9710, DOI 10.1073/pnas.0400853101; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Kohli A, 2003, PLANT MOL BIOL, V52, P247, DOI 10.1023/A:1023941407376; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lloyd AH, 2011, MOL BIOL EVOL, V28, P2019, DOI 10.1093/molbev/msr021; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; Mathis NL, 1994, PLANT MOL BIOL MAN B, P1; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; OHSHIMA K, 1994, J MOL BIOL, V243, P25, DOI 10.1006/jmbi.1994.1627; Orel N, 2003, PLANT MOL BIOL, V51, P523, DOI 10.1023/A:1022324205661; Pace JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000469; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Rahal EA, 2010, CELL CYCLE, V9, P2866, DOI 10.4161/cc.9.14.12408; Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086; Salter MG, 1998, PLANT J, V16, P127, DOI 10.1046/j.1365-313x.1998.00281.x; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V396, P289, DOI 10.1016/j.bbrc.2010.04.082; Taylor EM, 2010, NUCLEIC ACIDS RES, V38, P441, DOI 10.1093/nar/gkp905; van den Bosch M, 2002, BIOL CHEM, V383, P873; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Windels P, 2003, PLANT PHYSIOL, V133, P2061, DOI 10.1104/pp.103.027532; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YN, 2011, CANCER LETT, V309, P110, DOI 10.1016/j.canlet.2011.05.023	59	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32255	10.1371/journal.pone.0032255	http://dx.doi.org/10.1371/journal.pone.0032255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389691	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600029
J	Lodola, A; Branduardi, D; De Vivo, M; Capoferri, L; Mor, M; Piomelli, D; Cavalli, A				Lodola, Alessio; Branduardi, Davide; De Vivo, Marco; Capoferri, Luigi; Mor, Marco; Piomelli, Daniele; Cavalli, Andrea			A Catalytic Mechanism for Cysteine N-Terminal Nucleophile Hydrolases, as Revealed by Free Energy Simulations	PLOS ONE			English	Article							HYDROLYZING ACID AMIDASE; BILE-SALT HYDROLASE; SCC-DFTB METHOD; MOLECULAR-DYNAMICS SIMULATIONS; HYBRID QM/MM SIMULATIONS; PENICILLIN-V-ACYLASE; CRYSTAL-STRUCTURE; ENZYME CATALYSIS; 20S PROTEASOME; CERAMIDASE	The N-terminal nucleophile (Ntn) hydrolases are a superfamily of enzymes specialized in the hydrolytic cleavage of amide bonds. Even though several members of this family are emerging as innovative drug targets for cancer, inflammation, and pain, the processes through which they catalyze amide hydrolysis remains poorly understood. In particular, the catalytic reactions of cysteine Ntn-hydrolases have never been investigated from a mechanistic point of view. In the present study, we used free energy simulations in the quantum mechanics/molecular mechanics framework to determine the reaction mechanism of amide hydrolysis catalyzed by the prototypical cysteine Ntn-hydrolase, conjugated bile acid hydrolase (CBAH). The computational analyses, which were confirmed in water and using different CBAH mutants, revealed the existence of a chair-like transition state, which might be one of the specific features of the catalytic cycle of Ntn-hydrolases. Our results offer new insights on Ntn-mediated hydrolysis and suggest possible strategies for the creation of therapeutically useful inhibitors.	[Lodola, Alessio; Capoferri, Luigi; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Branduardi, Davide; De Vivo, Marco; Piomelli, Daniele; Cavalli, Andrea] Italian Inst Technol, Genoa, Italy; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of Bologna	Lodola, A (corresponding author), Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy.	andrea.cavalli@iit.it	De Vivo, Marco/A-7525-2012; Lodola, Alessio/H-9078-2013; Branduardi, Davide/B-2473-2010; Mor, Marco/D-2394-2009	De Vivo, Marco/0000-0003-4022-5661; Lodola, Alessio/0000-0002-8675-1002; Mor, Marco/0000-0003-0199-1849; CAVALLI, ANDREA/0000-0002-6370-1176	University of Parma; Univeristy of Bologna; Italian Institute of Technology	University of Parma; Univeristy of Bologna; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	The present work is supported by: University of Parma, Univeristy of Bologna and Italian Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokhove M, 2010, STRUCTURE, V18, P301, DOI 10.1016/j.str.2010.01.005; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Branduardi D, 2011, J CHEM THEORY COMPUT, V7, P539, DOI 10.1021/ct100547a; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Capoferri L, 2011, J MOL MODEL, V17, P2375, DOI 10.1007/s00894-011-0981-z; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavalli A, 2006, CHEM REV, V106, P3497, DOI 10.1021/cr050579p; Crespo A, 2005, J AM CHEM SOC, V127, P6940, DOI 10.1021/ja0452830; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Elstner M, 2006, THEOR CHEM ACC, V116, P316, DOI 10.1007/s00214-005-0066-0; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; GOPALSRIVASTAVA R, 1988, J LIPID RES, V29, P1079; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Harrison MJ, 1997, J AM CHEM SOC, V119, P12285, DOI 10.1021/ja9711472; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ke ZH, 2011, J PHYS CHEM B, V115, P3725, DOI 10.1021/jp200843s; Kumar RS, 2006, J BIOL CHEM, V281, P32516, DOI 10.1074/jbc.M604172200; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee YS, 2000, J BIOL CHEM, V275, P39200, DOI 10.1074/jbc.M002504200; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lonsdale R, 2010, CHEM COMMUN, V46, P2354, DOI 10.1039/b925647d; Ma S, 2007, J AM CHEM SOC, V129, P13633, DOI 10.1021/ja074222+; Mladenovic M, 2008, J AM CHEM SOC, V130, P8696, DOI 10.1021/ja711043x; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Perakyla M, 1996, CHEM-EUR J, V2, P1548, DOI 10.1002/chem.19960021212; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Seabra GD, 2007, J PHYS CHEM A, V111, P5655, DOI 10.1021/jp0700711; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Solorzano C, 2010, J MED CHEM, V53, P5770, DOI 10.1021/jm100582w; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; WARSHEL A, 1972, J AM CHEM SOC, V94, P5612, DOI 10.1021/ja00771a014; Xu Q, 2010, J PHYS CHEM B, V114, P10594, DOI 10.1021/jp102785s; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zhiryakova D, 2009, FEBS J, V276, P2589, DOI 10.1111/j.1742-4658.2009.06987.x	49	51	51	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32397	10.1371/journal.pone.0032397	http://dx.doi.org/10.1371/journal.pone.0032397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389698	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600036
J	Braccini, M; Van Rijn, J; Frick, L				Braccini, Matias; Van Rijn, Jay; Frick, Lorenz			High Post-Capture Survival for Sharks, Rays and Chimaeras Discarded in the Main Shark Fishery of Australia?	PLOS ONE			English	Article							GILL-NET CAPTURE; POSTRELEASE SURVIVORSHIP; MORTALITY; BYCATCH; CAUGHT; CHONDRICHTHYANS; CONSEQUENCES; IMPAIRMENT; MANAGEMENT	Most sharks, rays and chimaeras (chondrichthyans) taken in commercial fisheries are discarded (i.e. returned to the ocean either dead or alive). Quantifying the post-capture survival (PCS) of discarded species is therefore essential for the improved management and conservation of this group. For all chondrichthyans taken in the main shark fishery of Australia, we quantified the immediate PCS of individuals reaching the deck of commercial shark gillnet fishing vessels and applied a risk-based method to semi-quantitatively determine delayed and total PCS. Estimates of immediate, delayed and total PCS were consistent, being very high for the most commonly discarded species (Port Jackson shark, Australian swellshark, and spikey dogfish) and low for the most important commercial species (gummy and school sharks). Increasing gillnet soak time or water temperature significantly decreased PCS. Chondrichthyans with bottom-dwelling habits had the highest PCS whereas those with pelagic habits had the lowest PCS. The risk-based approach can be easily implemented as a standard practice of on-board observing programs, providing a convenient first-step assessment of the PCS of all species taken in commercial fisheries.	[Braccini, Matias] Marine & Freshwater Fisheries Res Inst, Dept Primary Ind Queenscliff Ctr, Queenscliff, Vic, Australia; [Van Rijn, Jay; Frick, Lorenz] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University		Matias.Braccini@fish.wa.gov.au			Australian Fisheries Management Authority [R2006/823]	Australian Fisheries Management Authority	This project was funded through an Australian Fisheries Management Authority grant (R2006/823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CASE STUDIES MANAGEM; Baremore IE, 2007, NOAA TECH MEMO NMFS, V565, P1; Bonfil R., 1994, FAO FISHERIES TECHNI, V341, P119; Braccini J. M., 2009, GHATF SHARK SURVEY P; Braccini JM, 2006, CAN J FISH AQUAT SCI, V63, P2456, DOI 10.1139/F06-141; Branstetter S., 1999, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V378, P109; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Brown IW, 2008, NATL STRATEGY SURVIV; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; Carlson JK, 2004, CRC MAR BIOL SER, P203; Compagno L.J.V., 1984, FAO FISH SYNOP, V125, P250, DOI DOI 10.1071/MF9920109; Compagno LJV., 1984, FAO FISH SYNOP, P20; Davis MW, 2006, FISH RES, V82, P1, DOI 10.1016/j.fishres.2006.09.004; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Davis MW, 2005, J FISH BIOL, V66, P254, DOI 10.1111/j.0022-1112.2005.00602.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Food and Agriculture Organization (FAO), 2000, FISH MANAGE, V4; Francis MP, 1998, MAR FRESHWATER RES, V49, P579, DOI 10.1071/MF97076; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; Frick LH, 2011, COMP BIOC A IN PRESS; Frick LH, 2010, FISH RES, V106, P344, DOI 10.1016/j.fishres.2010.08.016; Frick LH, 2010, J EXP MAR BIOL ECOL, V385, P29, DOI 10.1016/j.jembe.2010.01.013; Frick LH, 2009, N AM J FISH MANAGE, V29, P127, DOI 10.1577/M08-031.1; Gurshin CWD, 2004, J FISH BIOL, V65, P973, DOI 10.1111/j.0022-1112.2004.00501.x; Hight BV, 2007, MAR FRESHWATER RES, V58, P145, DOI 10.1071/MF05260; HILBORN R, 1992; Hobday A.J., 2007, R041072 AUSTR FISH M; HOLDEN M J, 1973, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V164, P360; Hueter R.E., 1994, BYCATCH CATCH RELEAS; Hueter RE, 2006, T AM FISH SOC, V135, P500, DOI 10.1577/T05-065.1; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; KIRKWOOD GP, 1986, AUST J MAR FRESH RES, V37, P689; KOOPMAN M, 2006, INTEGRATED SCI MONIT; Laptikhovsky VV, 2004, FISH B-NOAA, V102, P757; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Mandelman JW, 2007, FISH RES, V83, P238, DOI 10.1016/j.fishres.2006.10.001; Manire C, 2001, T AM FISH SOC, V130, P1038, DOI 10.1577/1548-8659(2001)130&lt;1038:SCAWGN&gt;2.0.CO;2; McAuley RB, 2007, ICES J MAR SCI, V64, P1702, DOI 10.1093/icesjms/fsm136; Mora O, 2006, COL VOL SCI PAP ICCA, V59, P599; Moyes CD, 2006, T AM FISH SOC, V135, P1389, DOI 10.1577/T05-224.1; PAN-Tiburones, 2015, PLAN ACC NAC CONS MA; Revill AS, 2005, FISH RES, V71, P121, DOI 10.1016/j.fishres.2004.07.006; Rulifson RA, 2007, N AM J FISH MANAGE, V27, P279, DOI 10.1577/M06-071.1; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Skomal GB, 2007, FISHERIES MANAG ECOL, V14, P81, DOI 10.1111/j.1365-2400.2007.00528.x; Skomal G, 2010, CRC MAR BIOL SER, P459; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stobutzki IC, 2002, FISH B-NOAA, V100, P800; Van Rijn J, 2009, THESIS MONASH U; Walker Terence I., 2005, Journal of Northwest Atlantic Fishery Science, V35, P505; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017	51	66	68	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32547	10.1371/journal.pone.0032547	http://dx.doi.org/10.1371/journal.pone.0032547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384270	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500098
J	Pichancourt, JB; van Klinken, RD				Pichancourt, Jean-Baptiste; van Klinken, Rieks D.			Phenotypic Plasticity Influences the Size, Shape and Dynamics of the Geographic Distribution of an Invasive Plant	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; SEEDLING SURVIVAL; CLIMATE-CHANGE; EVOLUTION; ECOLOGY; MODELS; SEEDS; ADAPTATION; RESPONSES; SELECTION	Phenotypic plasticity has long been suspected to allow invasive species to expand their geographic range across large-scale environmental gradients. We tested this possibility in Australia using a continental scale survey of the invasive tree Parkinsonia aculeata (Fabaceae) in twenty-three sites distributed across four climate regions and three habitat types. Using tree-level responses, we detected a trade-off between seed mass and seed number across the moisture gradient. Individual trees plastically and reversibly produced many small seeds at dry sites or years, and few big seeds at wet sites and years. Bigger seeds were positively correlated with higher seed and seedling survival rates. The trade-off, the relation between seed mass, seed and seedling survival, and other fitness components of the plant life-cycle were integrated within a matrix population model. The model confirms that the plastic response resulted in average fitness benefits across the life-cycle. Plasticity resulted in average fitness being positively maintained at the wet and dry range margins where extinction risks would otherwise have been high ("Jack-of-all-Trades" strategy JT), and fitness being maximized at the species range centre where extinction risks were already low ("Master-of-Some" strategy MS). The resulting hybrid "Jack-and-Master" strategy (JM) broadened the geographic range and amplified average fitness in the range centre. Our study provides the first empirical evidence for a JM species. It also confirms mechanistically the importance of phenotypic plasticity in determining the size, the shape and the dynamic of a species distribution. The JM allows rapid and reversible phenotypic responses to new or changing moisture conditions at different scales, providing the species with definite advantages over genetic adaptation when invading diverse and variable environments. Furthermore, natural selection pressure acting on phenotypic plasticity is predicted to result in maintenance of the JT and strengthening of the MS, further enhancing the species invasiveness in its range centre.	[Pichancourt, Jean-Baptiste; van Klinken, Rieks D.] CSIRO Ecosyst Sci EcoSci Precinct, Dutton Pk, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Pichancourt, JB (corresponding author), CSIRO Ecosyst Sci EcoSci Precinct, Dutton Pk, Qld, Australia.	jean-baptiste.pichancourt@csiro.au	van Klinken, Rieks D/B-1772-2009; Pichancourt, Jean-Baptiste/J-7715-2016	van Klinken, Rieks D/0000-0002-7578-8977; Pichancourt, Jean-Baptiste/0000-0002-9760-0007; Pichancourt, Jean-Baptiste/0000-0002-9276-8628	Defeating the Weed Menace program	Defeating the Weed Menace program	This study was funded by the Defeating the Weed Menace program (http://lwa.gov.au/programs/defeating-weed-menace). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Angert AL, 2009, P NATL ACAD SCI USA, V106, P19693, DOI 10.1073/pnas.0901652106; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Brzek P, 2011, J EXP BIOL, V214, P2755, DOI 10.1242/jeb.058727; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Callahan HS, 2002, ECOLOGY, V83, P1965, DOI 10.1890/0012-9658(2002)083[1965:SIPAIE]2.0.CO;2; CASWELL H, 1983, AM ZOOL, V23, P35; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Charlesworth B, EVOLUTION AGE STRUCT; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dansereau P, 1957, BIOGEOGRAPHY ECOLOGI, P86; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DeWitt TJ, PHENOTYIC PLASTICIT; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellers J, 2010, EVOL ECOL, V24, P523, DOI 10.1007/s10682-010-9375-4; Fisher R.A., 1930, GENETICAL THEORY NAT; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; Gabriel W, 2005, AM NAT, V166, P339, DOI 10.1086/432558; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Hawkins JA, 2007, NEW PHYTOL, V175, P575, DOI 10.1111/j.1469-8137.2007.02125.x; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Hulme PE, 2008, FUNCT ECOL, V22, P3, DOI 10.1111/j.1365-2435.2007.01369.x; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jongejans E, 2010, EVOL ECOL, V24, P585, DOI 10.1007/s10682-009-9340-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Lloret F, 1999, FUNCT ECOL, V13, P210, DOI 10.1046/j.1365-2435.1999.00309.x; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moles AT, 2004, ECOL LETT, V7, P911, DOI 10.1111/j.1461-0248.2004.00647.x; Mondor EB, 2004, ECOL LETT, V7, P941, DOI 10.1111/j.1461-0248.2004.00650.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nicotra AB, 2010, FUNCT PLANT BIOL, V37, P117, DOI 10.1071/FP09139; Nilsson-Ehle H, 1914, PFLANZENZUECHTUNG, V2, P153; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; Pigliucci M, PHENOTYPIC PLASTICIT; Pohlman CL, 2005, J BIOGEOGR, V32, P341, DOI 10.1111/j.1365-2699.2004.01181.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richards CL, 2010, ESTUAR COAST, V33, P840, DOI 10.1007/s12237-009-9186-4; Sadras VO, 2009, FIELD CROP RES, V110, P242, DOI 10.1016/j.fcr.2008.09.004; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stauffer, 1975, CHARLES DARWINS NATU; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sutherst RW, 1999, CLIMEX PREDICTING EF; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Tuljapurkar S, 2000, ECOL MODEL, V133, P143, DOI 10.1016/S0304-3800(00)00288-X; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van der Werf J, ADAPTATION FITNESS A; van Klinken RD, 2005, WEED SCI, V53, P663, DOI 10.1614/WS-05-008R.1; Van Klinken RD, 2008, ANN BOT-LONDON, V102, P255, DOI 10.1093/aob/mcn087; van Klinken RD, 2009, GLOBAL ECOL BIOGEOGR, V18, P688, DOI 10.1111/j.1466-8238.2009.00483.x; van Klinken Rieks Dekker, 2009, Plant Protection Quarterly, V24, P100	70	53	55	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32323	10.1371/journal.pone.0032323	http://dx.doi.org/10.1371/journal.pone.0032323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384216	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500077
J	Regulski, K; Courtin, P; Meyrand, M; Claes, IJJ; Lebeer, S; Vanderleyden, J; Hols, P; Guillot, A; Chapot-Chartier, MP				Regulski, Krzysztof; Courtin, Pascal; Meyrand, Mickael; Claes, Ingmar J. J.; Lebeer, Sarah; Vanderleyden, Jos; Hols, Pascal; Guillot, Alain; Chapot-Chartier, Marie-Pierre			Analysis of the Peptidoglycan Hydrolase Complement of Lactobacillus casei and Characterization of the Major gamma-D-Glutamyl-L-Lysyl-Endopeptidase	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; BACTERIAL-PEPTIDOGLYCAN; CELL-WALL; TRANSFORMATION; EXPRESSION; PROTEINS; BL23; ELECTROPORATION; IDENTIFICATION; AUTOLYSIN	Peptidoglycan (PG) is the major component of Gram positive bacteria cell wall and is essential for bacterial integrity and shape. Bacteria synthesize PG hydrolases (PGHs) which are able to cleave bonds in their own PG and play major roles in PG remodelling required for bacterial growth and division. Our aim was to identify the main PGHs in Lactobacillus casei BL23, a lactic acid bacterium with probiotic properties. The PGH complement was first identified in silico by amino acid sequence similarity searches of the BL23 genome sequence. Thirteen PGHs were detected with different predicted hydrolytic specificities. Transcription of the genes was confirmed by RT-PCR. A proteomic analysis combining the use of SDS-PAGE and LC-MS/MS revealed the main seven PGHs synthesized during growth of L. casei BL23. Among these PGHs, LCABL_02770 (renamed Lc-p75) was identified as the major one. This protein is the homolog of p75 (Msp1) major secreted protein of Lactobacillus rhamnosus GG, which was shown to promote survival and growth of intestinal epithelial cells. We identified its hydrolytic specificity on PG and showed that it is a gamma-D-glutamyl-L-lysyl-endopeptidase. It has a marked specificity towards PG tetrapeptide chains versus tripeptide chains and for oligomers rather than monomers. Immunofluorescence experiments demonstrated that Lc-p75 localizes at cell septa in agreement with its role in daughter cell separation. It is also secreted under an active form as detected in zymogram. Comparison of the muropeptide profiles of wild type and Lc-p75-negative mutant revealed a decrease of the amount of disaccharide-dipeptide in the mutant PG in agreement with Lc-p75 activity. As a conclusion, Lc-p75 is the major L. casei BL23 PGH with endopeptidase specificity and a key role in daughter cell separation. Further studies will aim at investigating the role of Lc-p75 in the anti-inflammatory potential of L. casei BL23.	[Regulski, Krzysztof; Courtin, Pascal; Meyrand, Mickael; Guillot, Alain; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, Jouy En Josas, France; [Regulski, Krzysztof; Courtin, Pascal; Meyrand, Mickael; Guillot, Alain; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Claes, Ingmar J. J.; Lebeer, Sarah; Vanderleyden, Jos] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Louvain, Belgium; [Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; KU Leuven; Universite Catholique Louvain	Regulski, K (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	Marie-Pierre.Chapot@jouy.inra.fr	Lebeer, Sarah/S-9951-2019; Claes, Ingmar/AAI-1910-2019; Lebeer, Sarah/D-5156-2014	Lebeer, Sarah/0000-0002-9400-6918; Claes, Ingmar/0000-0003-4209-4116; Lebeer, Sarah/0000-0002-9400-6918; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Institut National de la Recherche Agronomique (INRA); Marie Curie FP7 Initial Training Network Cross Talk [21553-2]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Research Department of the Communaute Francaise de Belgique (Concerted Research Action)	Institut National de la Recherche Agronomique (INRA); Marie Curie FP7 Initial Training Network Cross Talk; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Department of the Communaute Francaise de Belgique (Concerted Research Action)	The work of MPCC was supported by Institut National de la Recherche Agronomique (INRA) (Jeune Equipe grant). KR was the recipient of a fellowship from INRA. KR's PhD project received financial support as an associated project from the Marie Curie FP7 Initial Training Network Cross Talk (grant agreement no21553-2, starting date: October, 1st, 2008). IC holds a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). SL is a postdoctoral researcher of the FWO-Vlaanderen. Work of PH was supported by the Research Department of the Communaute Francaise de Belgique (Concerted Research Action), and PH is Research Associate of the National Fund for Scientific Research, Walloon, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asong J, 2009, J BIOL CHEM, V284, P8634, DOI 10.1074/jbc.M806633200; Aukrust T W, 1995, Methods Mol Biol, V47, P201; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Beganovic J, 2010, J PROTEOME RES, V9, P677, DOI 10.1021/pr9000866; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fontaine L, 2010, APPL ENVIRON MICROB, V76, P7870, DOI 10.1128/AEM.01671-10; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Humann J, 2007, J IMMUNOL, V178, P2407, DOI 10.4049/jimmunol.178.4.2407; Humann J, 2009, J INNATE IMMUN, V1, P88, DOI 10.1159/000181181; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; NAGAOKA M, 1990, J BIOCHEM-TOKYO, V108, P568, DOI 10.1093/oxfordjournals.jbchem.a123243; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rochat T, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-22; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Whisstock JC, 1999, TRENDS BIOCHEM SCI, V24, P132, DOI 10.1016/S0968-0004(99)01366-3; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022	41	36	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32301	10.1371/journal.pone.0032301	http://dx.doi.org/10.1371/journal.pone.0032301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384208	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500073
J	Cruceanu, C; Alda, M; Grof, P; Rouleau, GA; Turecki, G				Cruceanu, Cristiana; Alda, Martin; Grof, Paul; Rouleau, Guy A.; Turecki, Gustavo			Synapsin II Is Involved in the Molecular Pathway of Lithium Treatment in Bipolar Disorder	PLOS ONE			English	Article							PROPHYLACTIC TREATMENT; NONNEURONAL CELLS; GENE-EXPRESSION; VALPROIC ACID; SUICIDE RISK; SCHIZOPHRENIA; FAMILY; LYMPHOBLASTS; ASSOCIATION; ILLNESS	Bipolar disorder (BD) is a debilitating psychiatric condition with a prevalence of 1-2% in the general population that is characterized by severe episodic shifts in mood ranging from depressive to manic episodes. One of the most common treatments is lithium (Li), with successful response in 30-60% of patients. Synapsin II (SYN2) is a neuronal phosphoprotein that we have previously identified as a possible candidate gene for the etiology of BD and/or response to Li treatment in a genome-wide linkage study focusing on BD patients characterized for excellent response to Li prophylaxis. In the present study we investigated the role of this gene in BD, particularly as it pertains to Li treatment. We investigated the effect of lithium treatment on the expression of SYN2 in lymphoblastoid cell lines from patients characterized as excellent Li-responders, non-responders, as well as non-psychiatric controls. Finally, we sought to determine if Li has a cell-type-specific effect on gene expression in neuronal-derived cell lines. In both in vitro models, we found SYN2 to be modulated by the presence of Li. By focusing on Li-responsive BD we have identified a potential mechanism for Li response in some patients.	[Cruceanu, Cristiana; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Grof, Paul] Mood Disorders Ctr Ottawa, Ottawa, ON, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Rouleau, Guy A.] Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Montreal, PQ, Canada	McGill University; Dalhousie University; University of Ottawa; Universite de Montreal; Universite de Montreal	Cruceanu, C (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Turecki, Gustavo/K-5100-2015; Cruceanu, Cristiana/AAK-2885-2021; Alda, Martin/F-5812-2010	Cruceanu, Cristiana/0000-0002-7799-5531; Alda, Martin/0000-0001-9544-3944; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research (CIHR) [64410]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (CIHR) grant 64410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2001, J AFFECT DISORDERS, V65, P117, DOI 10.1016/S0165-0327(00)00166-X; Alda M, 2009, ANN MED, V41, P186, DOI 10.1080/07853890802409489; Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187; Baldessarini RJ, 1996, J CLIN PSYCHIAT, V57, P441, DOI 10.4088/JCP.v57n1001; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Benedetti F, 2005, NEUROSCI LETT, V376, P51, DOI 10.1016/j.neulet.2004.11.022; Bhangu PS, 2001, BONE, V29, P16, DOI 10.1016/S8756-3282(01)00482-3; BROWNING MD, 1987, J NEUROSCI, V7, P847; Bustos R, 2001, J CELL SCI, V114, P3695; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chen HM, 2009, INT J NEUROPSYCHOPH, V12, P975, DOI 10.1017/S1461145709000029; Chen Q, 2004, AM J HUM GENET, V75, P873, DOI 10.1086/425588; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Garnham J, 2007, J AFFECT DISORDERS, V104, P185, DOI 10.1016/j.jad.2007.03.003; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; GREBB JA, 1990, ARCH GEN PSYCHIAT, V47, P1149; GROF P, 1994, J AFFECT DISORDERS, V32, P85, DOI 10.1016/0165-0327(94)90066-3; HAYCOCK JW, 1988, J NEUROSCI, V8, P3233; Hurley SL, 2004, BIOCHEM BIOPH RES CO, V317, P16, DOI 10.1016/j.bbrc.2004.03.008; Kile BM, 2010, J NEUROSCI, V30, P9762, DOI 10.1523/JNEUROSCI.2071-09.2010; Lakhan R, SYNAPSE, V64, P403; Lee HJ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-15; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Maienschein V, 1999, GLIA, V26, P233, DOI 10.1002/(SICI)1098-1136(199905)26:3<233::AID-GLIA5>3.0.CO;2-2; Mamdani F, 2008, AM J MED GENET B, V147B, P500, DOI 10.1002/ajmg.b.30617; MATOVCIK LM, 1994, EUR J CELL BIOL, V65, P327; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; MULLEROERLINGHAUSEN B, 1992, J AFFECT DISORDERS, V25, P261, DOI 10.1016/0165-0327(92)90084-J; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rao JS, 2005, NEUROPSYCHOPHARMACOL, V30, P2006, DOI 10.1038/sj.npp.1300740; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Saviouk V, 2007, SCHIZOPHR RES, V96, P100, DOI 10.1016/j.schres.2007.07.031; SCHOU M, 1983, NERVENARZT, V54, P331; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Sun XJ, 2004, NEUROPSYCHOPHARMACOL, V29, P799, DOI 10.1038/sj.npp.1300383; ThiesFlechtner K, 1996, PHARMACOPSYCHIATRY, V29, P103, DOI 10.1055/s-2007-979553; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Wang YB, 2009, PSYCHIAT RES, V169, P167, DOI 10.1016/j.psychres.2008.12.005; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	46	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32680	10.1371/journal.pone.0032680	http://dx.doi.org/10.1371/journal.pone.0032680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384280	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800043
J	Liao, BY; Chang, AYF				Liao, Ben-Yang; Chang, Andrew Ying-Fei			Mammalian Genes Preferentially Co-Retained in Radiation Hybrid Panels Tend to Avoid Coexpression	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; EXPRESSION PROFILES; LINKED GENES; CONSERVATION; NETWORK; MOUSE; ORDER	Coexpression has been frequently used to explore modules of functionally related genes in eukaryotic genomes. However, we found that genetically interacting mammalian genes identified through radiation hybrid (RH) genotypes tend not to be coexpressed across tissues. This pattern remained unchanged after controlling for potential confounding factors, including chromosomal linkage, chromosomal distance, and gene duplication. Because >99.9% of the genetically interacting genes were identified according to the higher co-retention frequencies, our observation implies that coexpression is not necessarily an indication of the need for the co-presence of two genes in the genome, which is a prerequisite for cofunctionality of their coding proteins in the cell. Therefore, coexpression information must be applied cautiously to the exploration of the functional relatedness of genes in a genome.	[Liao, Ben-Yang; Chang, Andrew Ying-Fei] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Liao, BY (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan.	liaoby@nhri.org.tw	Chang, Andrew Ying-Fei/M-5745-2019; Liao, Ben-Yang/AAH-5974-2019; Liao, Ben-Yang/AAX-6318-2021; Liao, Ben-Yang/E-3940-2010; Chang, Andrew Ying-Fei/K-4127-2012	Liao, Ben-Yang/0000-0003-1163-3113; Chang, Andrew Ying-Fei/0000-0001-5949-9836	National Health Research Institutes, Taiwan; National Science Council, Taiwan [NSC 99-2311-B-400-003-MY2]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural funding from the National Health Research Institutes, Taiwan, and research grant (NSC 99-2311-B-400-003-MY2) from the National Science Council, Taiwan, to BYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batada NN, 2007, TRENDS GENET, V23, P480, DOI 10.1016/j.tig.2007.08.003; Bjorklund AK, 2008, PROTEOMICS, V8, P4657, DOI 10.1002/pmic.200800150; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Liao BY, 2008, MOL BIOL EVOL, V25, P1555, DOI 10.1093/molbev/msn101; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lin A, 2010, GENOME RES, V20, P1122, DOI 10.1101/gr.104216.109; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32284	10.1371/journal.pone.0032284	http://dx.doi.org/10.1371/journal.pone.0032284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384204	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800032
J	Dvoriantchikova, G; Ivanov, D; Barakat, D; Grinberg, A; Wen, R; Slepak, VZ; Shestopalov, VI				Dvoriantchikova, Galina; Ivanov, Dmitry; Barakat, David; Grinberg, Alexander; Wen, Rong; Slepak, Vladlen Z.; Shestopalov, Valery I.			Genetic Ablation of Pannexin1 Protects Retinal Neurons from Ischemic Injury	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; CELL-DEATH; GANGLION-CELLS; NITRIC-OXIDE; ATP RELEASE; TNF-ALPHA; INFLAMMASOME; HEMICHANNELS; FAMILY; REPERFUSION	Pannexin1 (Panx1) forms large nonselective membrane channel that is implicated in paracrine and inflammatory signaling. In vitro experiments suggested that Panx1 could play a key role in ischemic death of hippocampal neurons. Since retinal ganglion cells (RGCs) express high levels of Panx1 and are susceptible to ischemic induced injury, we hypothesized that Panx1 contributes to rapid and selective loss of these neurons in ischemia. To test this hypothesis, we induced experimental retinal ischemia followed by reperfusion in live animals with the Panx1 channel genetically ablated either in the entire mouse (Panx1 KO), or only in neurons using the conditional knockout (Panx1 CKO) technology. Here we report that two distinct neurotoxic processes are induced in RGCs by ischemia in the wild type mice but are inactivated in Panx1KO and Panx1 CKO animals. First, the post-ischemic permeation of RGC plasma membranes is suppressed, as assessed by dye transfer and calcium imaging assays ex vivo and in vitro. Second, the inflammasome-mediated activation of caspase-1 and the production of interleukin-1 beta in the Panx1 KO retinas are inhibited. Our findings indicate that post-ischemic neurotoxicity in the retina is mediated by previously uncharacterized pathways, which involve neuronal Panx1 and are intrinsic to RGCs. Thus, our work presents the in vivo evidence for neurotoxicity elicited by neuronal Panx1, and identifies this channel as a new therapeutic target in ischemic pathologies.	[Dvoriantchikova, Galina; Ivanov, Dmitry; Barakat, David; Wen, Rong; Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Ivanov, Dmitry] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Grinberg, Alexander] NICHD, NIH, Bethesda, MD USA; [Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol Pharmacol, Miami, FL 33136 USA; [Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; Russian Academy of Sciences; Vavilov Institute of General Genetics; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Miami; University of Miami	Dvoriantchikova, G (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.	vshestopalov@med.miami.edu	Shestopalov, Valery/AAE-9838-2020	Ivanov, Dmitry/0000-0002-5573-4402; Barakat, David/0000-0001-7057-178X; Shestopalov, Valery/0000-0002-1568-6637	Research to Prevent Blindness Foundation; National Institutes of Health (NIH) [R01EY017991, R21EY020613, RO1EY018666, R01EY018586]; NIH center [P30 EY014801]; NATIONAL EYE INSTITUTE [R21EY017991, R01EY018666, R01EY021517, P30EY014801, R01EY018586, R21EY020613] Funding Source: NIH RePORTER	Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Career Development Award from the Research to Prevent Blindness Foundation (VIS), National Institutes of Health (NIH) grants R01EY017991 (VIS), R21EY020613 (DI), RO1EY018666 (VZS), R01EY018586 (RW), NIH center grant P30 EY014801 and an unrestricted grant from the Research to Prevent Blindness Foundation to the Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Arai J, 2006, JPN J OPHTHALMOL, V50, P417, DOI 10.1007/s10384-006-0352-y; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; BENARI Y, 1990, EUR J NEUROSCI, V2, P62, DOI 10.1111/j.1460-9568.1990.tb00381.x; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bodar EJ, 2009, NETH J MED, V67, P302; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Carlson NG, 1999, J IMMUNOL, V163, P3963; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Daugeliene L, 2000, INVEST OPHTH VIS SCI, V41, P2743; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Dvoriantchikova G, 2011, INVEST OPHTHALMOL VI; Dvoriantchikova G, 2006, MOL VIS, V12, P1417; Dvoriantchikova G, 2010, MOL VIS, V16, P2882; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P886, DOI 10.1016/j.dci.2011.01.008; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Ivanov D, 2006, FEBS LETT, V580, P331, DOI 10.1016/j.febslet.2005.12.017; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P2697; Kawai S, 2001, FASEB J, V15, P1285, DOI 10.1096/fj.00-0666fje; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Macvicar BA, 2009, NON JUNCTION FUNCTIO; Madry C, 2010, BRAIN, V133, P3755, DOI 10.1093/brain/awq284; Maher JJ, 2009, J CLIN INVEST, V119, P246, DOI 10.1172/JCI38178; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Roth S, 1997, CURR EYE RES, V16, P875, DOI 10.1076/ceyr.16.9.875.5045; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trendelenburg G, 2008, J CEREBR BLOOD F MET, V28, P867, DOI 10.1038/sj.jcbfm.9600609; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; WEINBERG JM, 1985, J CLIN INVEST, V76, P1193, DOI 10.1172/JCI112075; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028; Zhang L, 2008, J NEUROSCI RES, V86, P2281, DOI 10.1002/jnr.21675; Zhang X, 2004, EXP EYE RES, V78, P849, DOI 10.1016/j.exer.2003.10.018	71	85	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31991	10.1371/journal.pone.0031991	http://dx.doi.org/10.1371/journal.pone.0031991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384122	Green Published, gold			2022-12-25	WOS:000302916100043
J	Flores, H; van Franeker, JA; Siegel, V; Haraldsson, M; Strass, V; Meesters, EH; Bathmann, U; Wolff, WJ				Flores, Hauke; van Franeker, Jan Andries; Siegel, Volker; Haraldsson, Matilda; Strass, Volker; Meesters, Erik Hubert; Bathmann, Ulrich; Wolff, Willem Jan			The Association of Antarctic Krill Euphausia superba with the Under-Ice Habitat	PLOS ONE			English	Article							NW WEDDELL SEA; PACK-ICE; LAZAREV SEA; TROPHIC RELATIONSHIPS; COMMUNITY STRUCTURE; FORAGING BEHAVIOR; ELEPHANT ISLAND; ENERGY BUDGETS; SOUTH SHETLAND; FATTY-ACIDS	The association of Antarctic krill Euphausia superba with the under-ice habitat was investigated in the Lazarev Sea (Southern Ocean) during austral summer, autumn and winter. Data were obtained using novel Surface and Under Ice Trawls (SUIT), which sampled the 0-2 m surface layer both under sea ice and in open water. Average surface layer densities ranged between 0.8 individuals m(-2) in summer and autumn, and 2.7 individuals m(-2) in winter. In summer, under-ice densities of Antarctic krill were significantly higher than in open waters. In autumn, the opposite pattern was observed. Under winter sea ice, densities were often low, but repeatedly far exceeded summer and autumn maxima. Statistical models showed that during summer high densities of Antarctic krill in the 0-2 m layer were associated with high ice coverage and shallow mixed layer depths, among other factors. In autumn and winter, density was related to hydrographical parameters. Average under-ice densities from the 0-2 m layer were higher than corresponding values from the 0-200 m layer collected with Rectangular Midwater Trawls (RMT) in summer. In winter, under-ice densities far surpassed maximum 0-200 m densities on several occasions. This indicates that the importance of the ice-water interface layer may be under-estimated by the pelagic nets and sonars commonly used to estimate the population size of Antarctic krill for management purposes, due to their limited ability to sample this habitat. Our results provide evidence for an almost year-round association of Antarctic krill with the under-ice habitat, hundreds of kilometres into the ice-covered area of the Lazarev Sea. Local concentrations of postlarval Antarctic krill under winter sea ice suggest that sea ice biota are important for their winter survival. These findings emphasise the susceptibility of an ecological key species to changing sea ice habitats, suggesting potential ramifications on Antarctic ecosystems induced by climate change.	[Flores, Hauke; van Franeker, Jan Andries; Meesters, Erik Hubert] Inst Marine Resources & Ecosyst Studies IMARES, Texel, Netherlands; [Siegel, Volker] Johann Heinrich von Thunen Inst Sea Fisheries, Hamburg, Germany; [Haraldsson, Matilda] Univ Gothenburg, Dept Marine Ecol, Fiskebackskil, Sweden; [Flores, Hauke; Strass, Volker; Bathmann, Ulrich] Alfred Wegener Inst Polar & Marine Res AWI, Bremerhaven, Germany; [Wolff, Willem Jan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands	Wageningen University & Research; Johann Heinrich von Thunen Institute; University of Gothenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Groningen	Flores, H (corresponding author), Alfred Wegener Inst Polar & Marine Res AWI, Bremerhaven, Germany.	hauke.flores@awi.de	Flores, Hauke/ABD-1888-2020	Flores, Hauke/0000-0003-1617-5449; Strass, Volker/0000-0002-7539-1400; Meesters, Erik/0000-0002-3877-1164	Netherlands AntArctic Programme (NAAP) [851.20.011]; Dutch Ministry for Economic Affairs, Agriculture and Innovation [WOT-04-003-002]; German LAKRIS [BMBF MGS 03F046A]	Netherlands AntArctic Programme (NAAP); Dutch Ministry for Economic Affairs, Agriculture and Innovation; German LAKRIS	This study was supported by the Netherlands AntArctic Programme (NAAP Project nr. 851.20.011), the Dutch Ministry for Economic Affairs, Agriculture and Innovation (Statutory Research Tasks Nature and Environment, Project no WOT-04-003-002), and the German LAKRIS project (BMBF MGS 03F046A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINLEY DG, 1986, SCIENCE, V232, P847, DOI 10.1126/science.232.4752.847; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; AINLEY DG, 1992, MAR ECOL PROG SER, V90, P207, DOI 10.3354/meps090207; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2002, LIMNOL OCEANOGR, V47, P953, DOI 10.4319/lo.2002.47.4.0953; Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Brierley AS, 2002, ADV MAR BIOL, V43, P171, DOI 10.1016/S0065-2881(02)43005-2; Cisewski B, 2005, DEEP-SEA RES PT II, V52, P1087, DOI 10.1016/j.dsr2.2005.01.010; Cisewski B, 2011, DEEP-SEA RES PT I, V58, P186, DOI 10.1016/j.dsr.2010.12.001; Cisewski B, 2010, DEEP-SEA RES PT I, V57, P78, DOI 10.1016/j.dsr.2009.10.005; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; Connan M, 2007, MAR BIOL, V152, P95, DOI 10.1007/s00227-007-0664-6; Croxall JP, 2004, ANTARCT SCI, V16, P569, DOI 10.1017/S0954102004002330; Daly KL, 2004, DEEP-SEA RES PT II, V51, P2139, DOI 10.1016/j.dsr2.2004.07.010; de la Mare W., 1994, CCAMLR SCI, V1, P55; Donnelly J, 2006, POLAR BIOL, V29, P280, DOI 10.1007/s00300-005-0051-z; Everson I., 2000, KRILL BIOL ECOLOGY F, P63; Fisher EC, 2004, MAR BIOL, V144, P345, DOI 10.1007/s00227-003-1177-6; Flores H, 2004, POLAR BIOL, V27, P119, DOI 10.1007/s00300-003-0570-4; Flores H, MARINE ECOL IN PRESS; Flores H, 2008, MAR ECOL PROG SER, V367, P271, DOI 10.3354/meps07530; Flores H, 2011, DEEP-SEA RES PT II, V58, P1948, DOI 10.1016/j.dsr2.2011.01.010; GUTT J, 1994, DEEP-SEA RES PT I, V41, P169, DOI 10.1016/0967-0637(94)90031-0; Hamner W.M., 1982, Antarctic Journal of the United States, V17, P165; Hardy A. C., 1935, PLANKTON S GEORGIA W; Hastie T, 1990, GENERALIZED ADDITIVE, P14; Hewitt Roger P., 2000, Reviews in Fisheries Science, V8, P235, DOI 10.1080/10641260091129224; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hunt BPV, 2011, DEEP-SEA RES PT II, V58, P1662, DOI 10.1016/j.dsr2.2010.11.016; Kaufmann RS, 1995, MAR BIOL, V124, P387, DOI 10.1007/BF00363912; Kawaguchi K., 1986, MEMOIRS NATL INSTIT, V44, P67; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Lancraft TM, 2004, DEEP-SEA RES PT II, V51, P2247, DOI 10.1016/j.dsr2.2004.07.004; Lawson GL, 2008, DEEP-SEA RES PT II, V55, P432, DOI 10.1016/j.dsr2.2007.11.014; Lawson GL, 2004, DEEP-SEA RES PT II, V51, P2041, DOI 10.1016/j.dsr2.2004.07.022; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Luque SP, 2007, MAR BIOL, V152, P213, DOI 10.1007/s00227-007-0677-1; Lynnes AS, 2004, POLAR BIOL, V27, P544, DOI 10.1007/s00300-004-0617-1; MARSCHALL HP, 1988, POLAR BIOL, V9, P129, DOI 10.1007/BF00442041; Meyer B, 2002, LIMNOL OCEANOGR, V47, P943, DOI 10.4319/lo.2002.47.4.0943; Meyer B, 2011, POLAR BIOL IN PRESS; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; Meyer B, 2009, LIMNOL OCEANOGR, V54, P1595, DOI 10.4319/lo.2009.54.5.1595; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; NORDHAUSEN W, 1994, MAR ECOL PROG SER, V109, P131, DOI 10.3354/meps109131; O'Brien C, 2011, DEEP-SEA RES PT II, V58, P1211, DOI 10.1016/j.dsr2.2010.11.001; OBRIEN DP, 1987, J CRUSTACEAN BIOL, V7, P437, DOI 10.2307/1548293; Osman LP, 2004, POLAR BIOL, V27, P92, DOI 10.1007/s00300-003-0555-3; Pakhomov EA, 1998, J MARINE SYST, V17, P313, DOI 10.1016/S0924-7963(98)00046-3; Phleger CF, 2002, COMP BIOCHEM PHYS B, V131, P733, DOI 10.1016/S1096-4959(02)00021-0; PIATKOWSKI U, 1985, MEERESFORSCHUNG, V30, P264; QUETIN LB, 1991, AM ZOOL, V31, P49; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P539; ROE HSJ, 1980, MAR BIOL, V56, P247, DOI 10.1007/BF00645349; Ross RM, 1998, J MARINE SYST, V17, P261, DOI 10.1016/S0924-7963(98)00042-6; Schiermeier Q, 2010, NATURE, V467, P15, DOI 10.1038/467015a; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; Schmidt K, DEEP SEA 2 IN PRESS; Schmidt K, 2006, LIMNOL OCEANOGR, V51, P2409, DOI 10.4319/lo.2006.51.5.2409; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Schnack-Schiel S.B., 2003, SEA ICE INTRO ITS PH, P211; Scripps Oceanographic Institution, 2006, GLOB TOP MEAS EST SE; Siegel V, 2005, POLAR BIOL, V29, P1, DOI 10.1007/s00300-005-0058-5; SIEGEL V, 1987, MAR BIOL, V96, P483, DOI 10.1007/BF00397966; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; SIEGEL V, 1990, POLAR BIOL, V10, P549; SIEGEL V, 1992, POLAR BIOL, V12, P15; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STRETCH JJ, 1988, MAR ECOL PROG SER, V44, P131, DOI 10.3354/meps044131; TORRES JJ, 1994, MAR ECOL PROG SER, V113, P221, DOI 10.3354/meps113221; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Van de Putte A, 2006, POLAR BIOL, V29, P1045, DOI 10.1007/s00300-006-0148-z; van Franeker J.A., 2009, THESIS, P181; van Franeker J.A., 2001, MIRRORS ICE; VanFraneker JA, 1997, DEEP-SEA RES PT II, V44, P435, DOI 10.1016/S0967-0645(96)00078-1; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; ZHOU M, 1994, DEEP-SEA RES PT I, V41, P1425, DOI 10.1016/0967-0637(94)90106-6	80	80	87	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31775	10.1371/journal.pone.0031775	http://dx.doi.org/10.1371/journal.pone.0031775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384073	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100034
J	Honeybul, S; Ho, K; Hanlon, SO				Honeybul, Stephen; Ho, Kwok; Hanlon, Susan O'			Access to Reliable Information about Long-Term Prognosis Influences Clinical Opinion on Use of Lifesaving Intervention	PLOS ONE			English	Article							CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; OF-LIFE DECISIONS; DECOMPRESSIVE CRANIECTOMY; SURGICAL DECOMPRESSION; HEMICRANIECTOMY; ATTITUDES; CARE; MULTICENTER; NEUROTRAUMA	Background: Decompressive craniectomy has been traditionally used as a lifesaving rescue treatment in severe traumatic brain injury (TBI). This study assessed whether objective information on long-term prognosis would influence healthcare workers' opinion about using decompressive craniectomy as a lifesaving procedure for patients with severe TBI. Method: A two-part structured interview was used to assess the participants' opinion to perform decompressive craniectomy for three patients who had very severe TBI. Their opinion was assessed before and after knowing the predicted and observed risks of an unfavourable long-term neurological outcome in various scenarios. Results: Five hundred healthcare workers with a wide variety of clinical backgrounds participated. The participants were significantly more likely to recommend decompressive craniectomy for their patients than for themselves (mean difference in visual analogue scale [VAS] -1.5, 95% confidence interval -1.3 to -1.6), especially when the next of kin of the patients requested intervention. Patients' preferences were more similar to patients who had advance directives. The participants' preferences to perform the procedure for themselves and their patients both significantly reduced after knowing the predicted risks of unfavourable outcomes, and the changes in attitude were consistent across different specialties, amount of experience in caring for similar patients, religious backgrounds, and positions in the specialty of the participants. Conclusions: Access to objective information on risk of an unfavourable long-term outcome influenced healthcare workers' decision to recommend decompressive craniectomy, considered as a lifesaving procedure, for patients with very severe TBI.	[Honeybul, Stephen; Hanlon, Susan O'] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004				Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Barbour KA, 2006, CHEST, V129, P1367, DOI 10.1378/chest.129.5.1367; Burns JP, 2001, CRIT CARE MED, V29, P658, DOI 10.1097/00003246-200103000-00036; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Granja C, 2001, INTENS CARE MED, V27, P555, DOI 10.1007/s001340100852; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2005, INTENS CARE MED, V31, P668, DOI 10.1007/s00134-005-2613-5; Ho KM, 2004, ANAESTH INTENS CARE, V32, P781, DOI 10.1177/0310057X0403200609; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2011, ACTA NEUROCHIR, V153, P1105, DOI 10.1007/s00701-011-0974-9; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kelly AG, 2010, NEUROLOGY, V75, P682, DOI 10.1212/WNL.0b013e3181eee273; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pugh EJ, 2009, PALLIATIVE MED, V23, P158, DOI 10.1177/0269216308100248; Pusic A, 2007, OTOLARYNG HEAD NECK, V136, P525, DOI 10.1016/j.otohns.2006.12.006; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sanoff HK, 2007, CLIN COLORECTAL CANC, V6, P700, DOI 10.3816/CCC.2007.n.039; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	36	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32375	10.1371/journal.pone.0032375	http://dx.doi.org/10.1371/journal.pone.0032375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384231	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100075
J	Molloy, TJ; Roepman, P; Naume, B; van't Veer, LJ				Molloy, Timothy J.; Roepman, Paul; Naume, Bjorn; van't Veer, Laura J.			A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients	PLOS ONE			English	Article							BONE-MARROW MICROMETASTASIS; MARKER GENES; SURVIVAL; SIGNATURE; RECOMMENDATIONS; CARCINOMAS; RECURRENCE; TAMOXIFEN; SUBTYPES	The detection of circulating tumor cells (CTCs) in the peripheral blood and microarray gene expression profiling of the primary tumor are two promising new technologies able to provide valuable prognostic data for patients with breast cancer. Meta-analyses of several established prognostic breast cancer gene expression profiles in large patient cohorts have demonstrated that despite sharing few genes, their delineation of patients into "good prognosis" or "poor prognosis" are frequently very highly correlated, and combining prognostic profiles does not increase prognostic power. In the current study, we aimed to develop a novel profile which provided independent prognostic data by building a signature predictive of CTC status rather than outcome. Microarray gene expression data from an initial training cohort of 72 breast cancer patients for which CTC status had been determined in a previous study using a multimarker QPCR-based assay was used to develop a CTC-predictive profile. The generated profile was validated in two independent datasets of 49 and 123 patients and confirmed to be both predictive of CTC status, and independently prognostic. Importantly, the "CTC profile" also provided prognostic information independent of the well-established and powerful '70-gene' prognostic breast cancer signature. This profile therefore has the potential to not only add prognostic information to currently-available microarray tests but in some circumstances even replace blood-based prognostic CTC tests at time of diagnosis for those patients already undergoing testing by multigene assays.	[Molloy, Timothy J.; van't Veer, Laura J.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Roepman, Paul; van't Veer, Laura J.] Agendia BV, Amsterdam, Netherlands; [Naume, Bjorn] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Netherlands Cancer Institute; Agendia; University of Oslo	Molloy, TJ (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.vt.veer@nki.nl			European Commission [LSHC-CT-2005-018911]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Sixth Framework Program of the European Commission as part of the international DISMAL collaboration for research into disseminated epithelial malignancies (Project LSHC-CT-2005-018911). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosma AJ, 2002, CLIN CANCER RES, V8, P1871; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Molloy TJ, 2008, BREAST CANCER RES TR, V112, P297, DOI 10.1007/s10549-007-9872-5; Molloy TJ, 2011, BRIT J CANC; Molloy TJ, 2011, BREAST CANC IN PRESS; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Reyal F, 2011, ANN ONCOL, V22, P1458, DOI 10.1093/annonc/mdr144; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2003, BRIT J CANCER, V88, P1091, DOI 10.1038/sj.bjc.6600868; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Wiedswang G, 2006, INT J CANCER, V118, P2013, DOI 10.1002/ijc.21576; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497	30	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32426	10.1371/journal.pone.0032426	http://dx.doi.org/10.1371/journal.pone.0032426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384245	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100078
J	Gregory, JM; Barros, TP; Meehan, S; Dobson, CM; Luheshi, LM				Gregory, Jenna M.; Barros, Teresa P.; Meehan, Sarah; Dobson, Christopher M.; Luheshi, Leila M.			The Aggregation and Neurotoxicity of TDP-43 and Its ALS-Associated 25 kDa Fragment Are Differentially Affected by Molecular Chaperones in Drosophila	PLOS ONE			English	Article							HSP90 INHIBITOR; PROTEIN; MODEL; NEURODEGENERATION; DEGENERATION; NUCLEAR; DETERMINANTS; INCLUSIONS; EXPRESSION; INDUCTION	Almost all cases of sporadic amyotrophic lateral sclerosis (ALS), and some cases of the familial form, are characterised by the deposition of TDP-43, a member of a family of heteronuclear ribonucleoproteins (hnRNP). Although protein misfolding and deposition is thought to be a causative feature of many of the most prevalent neurodegenerative diseases, a link between TDP-43 aggregation and the dysfunction of motor neurons has yet to be established, despite many correlative neuropathological studies. We have investigated this relationship in the present study by probing the effect of altering TDP-43 aggregation behaviour in vivo by modulating the levels of molecular chaperones in a Drosophila model. More specifically, we quantify the effect of either pharmacological upregulation of the heat shock response or specific genetic upregulation of a small heat shock protein, CG14207, on the neurotoxicity of both TDP-43 and of its disease associated 25 kDa fragment (TDP-25) in a Drosophila model. Inhibition of the aggregation of TDP-43 by either method results in a partial reduction of its neurotoxic effects on both photoreceptor and motor neurons, whereas inhibition of the aggregation of TDP-25 results not only in a complete suppression of its toxicity but also its clearance from the brain in both neuronal subtypes studied. The results demonstrate, therefore, that aggregation plays a crucial role in mediating the neurotoxic effects of both full length and truncated TDP-43, and furthermore reveal that the in vivo propensity of these two proteins to aggregate and their susceptibility to molecular chaperone mediated clearance are quite distinct.	[Gregory, Jenna M.; Barros, Teresa P.; Meehan, Sarah; Dobson, Christopher M.; Luheshi, Leila M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Gregory, Jenna M.; Barros, Teresa P.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge	Gregory, JM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	lml25@cam.ac.uk	Barros, Teresa/F-7706-2013	Barros, Teresa/0000-0003-4889-1597; Gregory, Jenna/0000-0003-3337-4079	International Journal of Experimental Pathology; James Baird Fund; Royal Society; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0700990, MC_G1000734] Funding Source: researchfish; MRC [G0700990, MC_G1000734] Funding Source: UKRI	International Journal of Experimental Pathology; James Baird Fund; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the International Journal of Experimental Pathology (JMG), which is a non-profit-making institution; the James Baird Fund (JMG); the Royal Society (SM); and the Biotechnology and Biological Sciences Research Council (LML, TPB, and CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Hostein I, 2001, CANCER RES, V61, P4003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	40	43	44	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31899	10.1371/journal.pone.0031899	http://dx.doi.org/10.1371/journal.pone.0031899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384095	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500051
J	Olivry, T; Linder, KE; Wang, P; Bizikova, P; Bernstein, JA; Dunston, SM; Paps, JS; Casal, ML				Olivry, Thierry; Linder, Keith E.; Wang, Ping; Bizikova, Petra; Bernstein, Joseph A.; Dunston, Stanley M.; Paps, Judy S.; Casal, Margret L.			Deficient Plakophilin-1 Expression Due to a Mutation in PKP1 Causes Ectodermal Dysplasia-Skin Fragility Syndrome in Chesapeake Bay Retriever Dogs	PLOS ONE			English	Article							DESMOSOMAL PROTEIN PLAKOPHILIN-1; SPLICE-SITE MUTATIONS; EPIDERMOLYSIS-BULLOSA; GENE; FAMILIES; ADHESION	In humans, congenital and hereditary skin diseases associated with epidermal cell-cell separation (acantholysis) are very rare, and spontaneous animal models of these diseases are exceptional. Our objectives are to report a novel congenital acantholytic dermatosis that developed in Chesapeake Bay retriever dogs. Nine affected puppies in four different litters were born to eight closely related clinically normal dogs. The disease transmission was consistent with an autosomal recessive mode of inheritance. Clinical signs occurred immediately after birth with superficial epidermal layers sloughing upon pressure. At three month of age, dogs exhibited recurrent superficial skin sloughing and erosions at areas of friction and mucocutaneous junctions; their coat was also finer than normal and there were patches of partial hair loss. At birth, histopathology revealed severe suprabasal acantholysis, which became less severe with ageing. Electron microscopy demonstrated a reduced number of partially formed desmosomes with detached and aggregated keratin intermediate filaments. Immunostaining for desmosomal adhesion molecules revealed a complete lack of staining for plakophilin-1 and anomalies in the distribution of desmoplakin and keratins 10 and 14. Sequencing revealed a homozygous splice donor site mutation within the first intron of PKP1 resulting in a premature stop codon, thereby explaining the inability to detect plakophilin-1 in the skin. Altogether, the clinical and pathological findings, along with the PKP1 mutation, were consistent with the diagnosis of ectodermal dysplasia-skin fragility syndrome with plakophilin-1 deficiency. This is the first occurrence of ectodermal dysplasia-skin fragility syndrome in an animal species. Controlled mating of carrier dogs would yield puppies that could, in theory, be tested for gene therapy of this rare but severe skin disease of children.	[Olivry, Thierry; Bizikova, Petra; Dunston, Stanley M.; Paps, Judy S.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27607 USA; [Olivry, Thierry] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Linder, Keith E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Wang, Ping; Casal, Margret L.] Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA; [Bernstein, Joseph A.] Long Green Anim Dermatol Ctr, Baldwin, MD USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Pennsylvania	Olivry, T (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27607 USA.	tolivry@ncsu.edu	Olivry, Thierry/AAV-7869-2021; Olivry, Thierry/E-3289-2013	Olivry, Thierry/0000-0003-1399-0034; 	National Institutes of Health (NIH)-National Center for Research Resources [RR02512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was in part provided by the National Institutes of Health (NIH)-National Center for Research Resources (RR02512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from NIH was used for the genetic part of the study. Otherwise, no additional external funding was received for this study.	Bergman R, 2005, AM J DERMATOPATH, V27, P333, DOI 10.1097/01.dad.0000157451.46657.a6; Bizikova P, 2011, VET DERMATOL, V22, P132, DOI 10.1111/j.1365-3164.2010.00924.x; Ersoy-Evans S, 2006, J AM ACAD DERMATOL, V55, P157, DOI 10.1016/j.jaad.2005.10.002; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Hamada T, 2002, EXP DERMATOL, V11, P107, DOI 10.1034/j.1600-0625.2002.110202.x; Hartmann L, 2008, FRONT BIOSCI-LANDMRK, V13, P3252; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JOLLY RD, 1973, VET PATHOL, V10, P473, DOI 10.1177/030098587301000601; McGrath JA, 1999, BRIT J DERMATOL, V140, P297; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McGrath JA, 2010, DERMATOL CLIN, V28, P131, DOI 10.1016/j.det.2009.10.015; McGrath JA, 2010, DERMATOL CLIN, V28, P125, DOI 10.1016/j.det.2009.10.014; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Nel S, 2011, VET PATHOL, V48, P276, DOI 10.1177/0300985810374843; Olivry T, 2009, VET DERMATOL, V20, P313, DOI 10.1111/j.1365-3164.2009.00821.x; RIETCORREA F, 1994, VET PATHOL, V31, P450, DOI 10.1177/030098589403100407; Sprecher E, 2004, J INVEST DERMATOL, V122, P647, DOI 10.1111/j.0022-202X.2004.22335.x; Steijlen PM, 2004, J INVEST DERMATOL, V122, P1321, DOI 10.1111/j.0022-202X.2003.22302.x; Tanaka A, 2009, BRIT J DERMATOL, V160, P692, DOI 10.1111/j.1365-2133.2008.08900.x; Wessagowit V, 2005, ACTA DERM-VENEREOL, V85, P386, DOI 10.1080/00015550510011763; Whittock NV, 2000, J INVEST DERMATOL, V115, P368, DOI 10.1046/j.1523-1747.2000.00082.x	22	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32072	10.1371/journal.pone.0032072	http://dx.doi.org/10.1371/journal.pone.0032072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384142	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500071
J	Thomas, CM; Hong, T; van Pijkeren, JP; Hemarajata, P; Trinh, DV; Hu, WD; Britton, RA; Kalkum, M; Versalovic, J				Thomas, Carissa M.; Hong, Teresa; van Pijkeren, Jan Peter; Hemarajata, Peera; Trinh, Dan V.; Hu, Weidong; Britton, Robert A.; Kalkum, Markus; Versalovic, James			Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK Signaling	PLOS ONE			English	Article							NF-KAPPA-B; GASTROINTESTINAL-TRACT; GENE-EXPRESSION; DENDRITIC CELL; T-CELL; IDENTIFICATION; H-2-RECEPTOR; MAPK; MATURATION; RESPONSES	Beneficial microbes and probiotic species, such as Lactobacillus reuteri, produce biologically active compounds that can modulate host mucosal immunity. Previously, immunomodulatory factors secreted by L. reuteri ATCC PTA 6475 were unknown. A combined metabolomics and bacterial genetics strategy was utilized to identify small compound(s) produced by L. reuteri that were TNF-inhibitory. Hydrophilic interaction liquid chromatography-high performance liquid chromatography (HILIC-HPLC) separation isolated TNF-inhibitory compounds, and HILIC-HPLC fraction composition was determined by NMR and mass spectrometry analyses. Histamine was identified and quantified in TNF-inhibitory HILIC-HPLC fractions. Histamine is produced from L-histidine via histidine decarboxylase by some fermentative bacteria including lactobacilli. Targeted mutagenesis of each gene present in the histidine decarboxylase gene cluster in L. reuteri 6475 demonstrated the involvement of histidine decarboxylase pyruvoyl type A (hdcA), histidine/histamine antiporter (hdcP), and hdcB in production of the TNF-inhibitory factor. The mechanism of TNF inhibition by L. reuteri-derived histamine was investigated using Toll-like receptor 2 (TLR2)-activated human monocytoid cells. Bacterial histamine suppressed TNF production via activation of the H-2 receptor. Histamine from L. reuteri 6475 stimulated increased levels of cAMP, which inhibited downstream MEK/ERK MAPK signaling via protein kinase A (PKA) and resulted in suppression of TNF production by transcriptional regulation. In summary, a component of the gut microbiome, L. reuteri, is able to convert a dietary component, L-histidine, into an immunoregulatory signal, histamine, which suppresses pro-inflammatory TNF production. The identification of bacterial bioactive metabolites and their corresponding mechanisms of action with respect to immunomodulation may lead to improved anti-inflammatory strategies for chronic immune-mediated diseases.	[Thomas, Carissa M.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Hong, Teresa; Trinh, Dan V.; Hu, Weidong; Kalkum, Markus] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [van Pijkeren, Jan Peter; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Hemarajata, Peera] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; City of Hope; Beckman Research Institute of City of Hope; Michigan State University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Thomas, CM (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA.	jamesv@bcm.edu	Hemarajata, Peera/F-8268-2018; van Pijkeren, Jan-Peter/H-5333-2019	Hemarajata, Peera/0000-0001-6182-9136; Kalkum, Markus/0000-0002-9506-671X; Thomas, Carissa/0000-0003-0765-5731	National Institutes of Health; National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) [R01 DK065075, P30 DK56338]; National Center for Complementary and Alternative Medicine (NCCAM) [R01 AT004326]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK065075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health including the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) (R01 DK065075) and the National Center for Complementary and Alternative Medicine (NCCAM) (R01 AT004326). The Texas Medical Center Digestive Disease Center receives support from NIDDK (P30 DK56338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlFaleh K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005496.pub2, 10.1097/AOG.0b013e3181726f2f]; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Andou A, 2009, GASTROENTEROLOGY, V136, P564, DOI 10.1053/j.gastro.2008.09.062; Aschenbach JR, 2009, INFLAMM RES, V58, P269, DOI 10.1007/s00011-008-8091-9; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Clarke MB, 2005, AM J PHYSIOL-GASTR L, V288, pG1105, DOI 10.1152/ajpgi.00572.2004; Coeffier M, 2010, INFLAMM BOWEL DIS, V16, P518, DOI 10.1002/ibd.21017; Corthier G, 1998, APPL ENVIRON MICROB, V64, P2721; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOHLSTEN M, 1988, SCAND J IMMUNOL, V27, P527, DOI 10.1111/j.1365-3083.1988.tb02379.x; Drouault S, 2002, APPL ENVIRON MICROB, V68, P938, DOI 10.1128/AEM.68.2.938-941.2002; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Fuller MF, 1998, ANNU REV NUTR, V18, P385, DOI 10.1146/annurev.nutr.18.1.385; Funaki C, 2010, INVEST OPHTH VIS SCI, V51, P6321, DOI 10.1167/iovs.10-5690; Gionchetti P, 2007, DIS COLON RECTUM, V50, P2075, DOI 10.1007/s10350-007-9068-4; Gosetti F, 2007, J CHROMATOGR A, V1149, P151, DOI 10.1016/j.chroma.2007.02.097; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Handley SA, 2006, P NATL ACAD SCI USA, V103, P9268, DOI 10.1073/pnas.0510414103; Hotel A.C.P., 2001, HLTH NUTR PROP PROB, V5, P1, DOI DOI 10.1201/9781420009613.CH16; Hungerford JM, 2010, TOXICON, V56, P231, DOI 10.1016/j.toxicon.2010.02.006; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Koyama J, 2011, ANAL BIOANAL CHEM, V401, P1385, DOI 10.1007/s00216-011-5200-3; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Lucas PM, 2005, APPL ENVIRON MICROB, V71, P1417, DOI 10.1128/AEM.71.3.1417-1424.2005; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Martin MC, 2005, MICROBIOL-SGM, V151, P1219, DOI 10.1099/mic.0.27459-0; Masaki T, 2005, FASEB J, V19, P1245, DOI 10.1096/fj.04-3195com; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Murzyn A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012050; Nakamura T, 1997, EUR J PHARMACOL, V322, P83, DOI 10.1016/S0014-2999(96)00987-9; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nuutinen S, 2010, ADV EXP MED BIOL, V709, P95; Pena JA, 2009, INFLAMM BOWEL DIS, V15, P248, DOI 10.1002/ibd.20744; Pena JA, 2005, INFECT IMMUN, V73, P912, DOI 10.1128/IAI.73.2.912-920.2005; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Singh SK, 2011, MICROB CELL FACT, V10, DOI [10.1186/1475-2859-10-114, 10.1186/1475-2859-10-55]; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Son DO, 2005, FEBS LETT, V579, P4671, DOI 10.1016/j.febslet.2005.07.038; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; TAFFET SM, 1989, CELL IMMUNOL, V120, P291, DOI 10.1016/0008-8749(89)90198-6; Takahasi HK, 2003, CLIN IMMUNOL, V108, P274, DOI 10.1016/S1521-6616(03)00140-2; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Trip H, 2011, MOL MICROBIOL, V79, P861, DOI 10.1111/j.1365-2958.2010.07492.x; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; VANNIER E, 1991, J EXP MED, V174, P281, DOI 10.1084/jem.174.1.281; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Walter J, 2003, APPL ENVIRON MICROB, V69, P2044, DOI 10.1128/AEM.69.4.2044-2051.2003; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wang L, 1996, AM J PHYSIOL-GASTR L, V271, pG613, DOI 10.1152/ajpgi.1996.271.4.G613; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Xia JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-507; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; ZHU G, 1990, J MAGN RESON, V90, P405, DOI 10.1016/0022-2364(90)90150-8	76	262	291	9	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31951	10.1371/journal.pone.0031951	http://dx.doi.org/10.1371/journal.pone.0031951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384111	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500057
J	Ji, YW; Sun, SY; Xu, AM; Bhargava, P; Yang, L; Lam, KSL; Gao, B; Lee, CH; Kersten, S; Qi, L				Ji, Yewei; Sun, Shengyi; Xu, Aimin; Bhargava, Prerna; Yang, Liu; Lam, Karen S. L.; Gao, Bin; Lee, Chih-Hao; Kersten, Sander; Qi, Ling			Activation of Natural Killer T Cells Promotes M2 Macrophage Polarization in Adipose Tissue and Improves Systemic Glucose Tolerance via Interleukin-4 (IL-4)/STAT6 Protein Signaling Axis in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVARIANT NKT CELLS; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; LIPID ANTIGEN; INFLAMMATION; RECEPTOR; MICE; FAT; RECOGNITION; MODULATION	Natural killer T (NKT) cells are important therapeutic targets in various disease models and are under clinical trials for cancer patients. However, their function in obesity and type 2 diabetes remains unclear. Our data show that adipose tissues of both mice and humans contain a population of type 1 NKT cells, whose abundance decreases with increased adiposity and insulin resistance. Although loss-of-function of NKT cells had no effect on glucose tolerance in animals with prolonged high fat diet feeding, activation of NKT cells by lipid agonist alpha-galactosylceramide enhances alternative macrophage polarization in adipose tissue and improves glucose homeostasis in animals at different stages of obesity. Furthermore, the effect of NKT cells is largely mediated by the IL-4/STAT6 signaling axis in obese adipose tissue. Thus, our data identify a novel therapeutic target for the treatment of obesity-associated inflammation and type 2 diabetes.	[Ji, Yewei; Kersten, Sander; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Sun, Shengyi; Yang, Liu; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Bhargava, Prerna; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Bhargava, Prerna; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Complex Dis & Nutr, Boston, MA 02115 USA; [Gao, Bin] NIAAA, Lab Liver Dis, Rockville, MD 20852 USA; [Kersten, Sander] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 EV Wageningen, Netherlands	Cornell University; Cornell University; University of Hong Kong; University of Hong Kong; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Wageningen University & Research	Qi, L (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	lq35@cornell.edu	Ji, Yewei/F-5040-2014; Xu, Aimin/D-3291-2013; Kersten, Sander/A-1116-2011; /C-4315-2009	Ji, Yewei/0000-0002-4249-6812; Xu, Aimin/0000-0002-0668-033X; Kersten, Sander/0000-0003-4488-7734; Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902; /0000-0001-5757-541X	National Institutes of Health from NIDDK [R01DK075046]; NIDDK [R01DK082582, R01DK082582-S1]; Hong Kong Collaborative Research Fund Grant [HKU4/CRF/10]; Netherlands Nutrigenomics Centre; Cornell startup package; American Diabetes Association [7-08-JF-47, 1-12-CD-04]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046, R01DK082582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hong Kong Collaborative Research Fund Grant; Netherlands Nutrigenomics Centre; Cornell startup package; American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK075046 from NIDDK (to C. H. L.) and Grants R01DK082582 and R01DK082582-S1 from NIDDK (to L. Q.). This work was also supported by Hong Kong Collaborative Research Fund Grant HKU4/CRF/10 (to A. X. and K. S. L. L.), Netherlands Nutrigenomics Centre (to S. K.), Cornell startup package, and American Diabetes Association Grants 7-08-JF-47 and 1-12-CD-04.; Supported by the International Student Research Fellowship from Howard Hughes Medical Institute.	Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kis J, 2007, J LEUKOCYTE BIOL, V81, P654, DOI 10.1189/jlb.1106654; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	57	155	162	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13561	13571		10.1074/jbc.M112.350066	http://dx.doi.org/10.1074/jbc.M112.350066			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396530	Green Published, hybrid			2022-12-25	WOS:000303996300013
J	Zhang, Q; Hou, SP; Jiang, ZX; Du, LP; Li, FZ; Xiao, X; Kijlstra, A; Yang, PZ				Zhang, Qi; Hou, Shengping; Jiang, Zhengxuan; Du, Liping; Li, Fuzhen; Xiao, Xiang; Kijlstra, Aize; Yang, Peizeng			No Association of PTPN22 Polymorphisms with Susceptibility to Ocular Behcet's Disease in Two Chinese Han Populations	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE PTPN22; GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; SILK ROAD; IL23R-IL12RB2; VARIANT; IL10	Background: Behcet's disease is known as a recurrent, multisystem inflammation and immune-related disease. Protein tyrosine phosphatase non-receptor 22 (PTPN22) is a key negative regulator of T lymphocytes and polymorphisms of the PTPN22 gene have been shown to be associated with various immune-related diseases. The present study was performed to assess the association between PTPN22 polymorphisms and Behcet's disease in two Chinese Han populations. Methodology/Principal Findings: A total of 516 patients with ocular Behcet's disease and 690 healthy controls from two Chinese Han populations were genotyped by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method for three single nucleotide polymorphisms (SNPs). Hardy-Weinberg equilibrium was tested using the chi(2) test. Genotype frequencies were estimated through direct counting. Allele and genotype frequencies were compared between patients and controls using logistic regression analysis. The results revealed that there was no association between the tested three PTPN22 SNPs (rs2488457, rs1310182 and rs3789604) and ocular Behcet's disease (p>05). Categorization analysis according to the clinical features did not show any association of these three polymorphisms with these parameters (p>.05). Conclusions/Significance: The investigated PTPN22 gene polymorphisms (rs2488457, rs1310182 and rs3789604) were not associated with ocular Behcet's disease in two Chinese Han populations, and showed that it may be different from other classical autoimmune diseases. More studies are needed to confirm these findings for Behcet's disease in other ethnic backgrounds.	[Zhang, Qi; Hou, Shengping; Jiang, Zhengxuan; Du, Liping; Li, Fuzhen; Xiao, Xiang; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Zhang, Qi; Hou, Shengping; Jiang, Zhengxuan; Du, Liping; Li, Fuzhen; Xiao, Xiang; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013; Du, Liping/M-9495-2019; Hou, Shengping/E-5250-2013		Natural Science Foundation [30910103912]; National Natural Science Foundation of China [81070723, 81070722]; Health Bureau of Chongqing [2009-2-390]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Hundred Outstanding S&T Leaders of Chongqing Municipality; PAR-EU	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Hundred Outstanding S&T Leaders of Chongqing Municipality; PAR-EU	This work was supported by Natural Science Foundation Major International (Regional) Joint Research Project (30910103912) (http://www.nsfc.gov.cn/Portal0/default152.htm), General Program of National Natural Science Foundation of China (81070723) (http://www.nsfc.gov.cn/Portal0/default152.htm), General Program of National Natural Science Foundation of China (81070722) (http://www.nsfc.gov.cn/Portal0/default152.htm), General Program of Health Bureau of Chongqing (2009-2-390) (http://www.cqwsj.gov.cn/), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003) (http://www.cstc.gov.cn/Index.aspx), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality (http://cqkjdj.cstc.gov.cn/) and Fund for PAR-EU Scholars Program (http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranathan V, 2007, ANN RHEUM DIS, V66, P1531, DOI 10.1136/ard.2007.073866; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Behrens TW, 2011, NAT GENET, V43, P821, DOI 10.1038/ng.914; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Direskeneli H, 2006, RHEUMATOLOGY, V45, P1461, DOI 10.1093/rheumatology/kel329; Du L, 2009, BRIT J OPHTHALMOL, V93, P1378, DOI 10.1136/bjo.2008.156919; Feng X, 2010, TISSUE ANTIGENS, V76, P297, DOI 10.1111/j.1399-0039.2010.01521.x; Gregersen PK, 2005, NAT GENET, V37, P1300, DOI 10.1038/ng1205-1300; Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894; Hou SP, 2008, CLIN IMMUNOL, V129, P170, DOI 10.1016/j.clim.2008.06.006; Huang JJ, 2010, RHEUMATOLOGY INT; Ichimura M, 2008, THYROID, V18, P625, DOI 10.1089/thy.2007.0353; Japan BsDRCo, 2003, REV CRIT MAN TREATM, P11; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Karasneh J, 2005, ARTHRITIS RHEUM-US, V52, P1836, DOI 10.1002/art.21060; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Keino H, 2007, BRIT J OPHTHALMOL, V91, P1573, DOI 10.1136/bjo.2007.124875; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Martin TM, 2009, MOL VIS, V15, P208; Matesanz F, 2005, J NEUROL, V252, P994, DOI 10.1007/s00415-005-0795-y; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Piga M, 2011, RHEUMATOLOGY, V50, P299, DOI 10.1093/rheumatology/keq331; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sahin N, 2007, TISSUE ANTIGENS, V70, P432, DOI 10.1111/j.1399-0039.2007.00928.x; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Taniyama M, 2010, HUM IMMUNOL, V71, P795, DOI 10.1016/j.humimm.2010.05.016; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Wagenleiter SEN, 2005, INT J IMMUNOGENET, V32, P323, DOI 10.1111/j.1744-313X.2005.00534.x; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang ZH, 2008, INT J IMMUNOGENET, V35, P433, DOI 10.1111/j.1744-313X.2008.00803.x	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e31230	10.1371/journal.pone.0031230	http://dx.doi.org/10.1371/journal.pone.0031230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396730	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500004
J	Authie, CN; Mestre, DR				Authie, Colas N.; Mestre, Daniel R.			Path Curvature Discrimination: Dependence on Gaze Direction and Optical Flow Speed	PLOS ONE			English	Article							EYE-MOVEMENTS; SELF-MOTION; OCULAR RESPONSES; PERCEPTION; COORDINATION; INFORMATION; LOCOMOTION; VISION	Many experimental approaches to the control of steering rely on the tangent point (TP) as major source of information. The TP is a good candidate to control self-motion. It corresponds to a singular and salient point in the subject's visual field, and its location depends on the road geometry, the direction of self-motion relative to the road and the position of the driver on the road. However, the particular status of the TP in the optical flow, as a local minimum of flow speed, has often been left aside. We therefore assume that the TP is actually an optimal location in the dynamic optical array to perceive a change in the trajectory curvature. In this study, we evaluated the ability of human observers to detect variations in their path curvature from optical flow patterns, as a function of their gaze direction in a virtual environment. We simulated curvilinear self-motion parallel to a ground plane. Using random-dot optic flow stimuli of brief duration and a two-alternative forced-choice adaptive procedure, we determined path curvature discrimination thresholds, as a function of gaze direction. The discrimination thresholds are minimal for a gaze directed toward a local minimum of optical flow speed. A model based on Weber fraction of the foveal velocities (Delta V/V) correctly predicts the relationship between experimental thresholds and local flow velocities. This model was also tested for an optical flow computation integrating larger circular areas in central vision. Averaging the flow over five degrees leads to an even better fit of the model to experimental thresholds. We also found that the minimal optical flow speed direction corresponds to a maximal sensitivity of the visual system, as predicted by our model. The spontaneous gazing strategies observed during driving might thus correspond to an optimal selection of relevant information in the optical flow field.	[Authie, Colas N.; Mestre, Daniel R.] Aix Marseille Univ, Inst Sci Mouvement, UMR 7287, Marseille, France; [Authie, Colas N.; Mestre, Daniel R.] CNRS, Inst Sci Mouvement, UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Authie, CN (corresponding author), Aix Marseille Univ, Inst Sci Mouvement, UMR 7287, Marseille, France.	colas.authie@gmail.com	Mestre, Daniel R/J-9526-2015	Mestre, Daniel R/0000-0002-0399-4747; Colas Nils, Authie/0000-0002-5017-9614	French Ministere de l'Enseignement Superieur et de la Recherche	French Ministere de l'Enseignement Superieur et de la Recherche	This work was funded by a grant from the French Ministere de l'Enseignement Superieur et de la Recherche (C.N. Authie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authie CN, 2011, VISION RES, V51, P1791, DOI 10.1016/j.visres.2011.06.010; Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Chattington M, 2007, EXP BRAIN RES, V180, P1, DOI 10.1007/s00221-006-0839-2; Coutton Jean C, 2009, BEHAVIOUR, V12, P483; CROWELL J A, 1990, Investigative Ophthalmology and Visual Science, V31, P522; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Cutting J.E., 1986, PERCEPTION EYE MOTIO, VVolume 1; Gibson J, 1950, PERCEPTION VISUAL WO, V2; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; GIBSON JJ, 1954, PSYCHOL REV, V61, P304, DOI 10.1037/h0061885; GODTHELP H, 1986, HUM FACTORS, V28, P211, DOI 10.1177/001872088602800209; GORDON DA, 1966, PUBLIC ROADS, V34, P53; Holst E. von, 1950, Naturwissenschaften Berlin, V37, P464; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Land M, VISUAL CONTROL STEER, P163; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappe M, 1998, J NEUROPHYSIOL, V79, P1461, DOI 10.1152/jn.1998.79.3.1461; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Lee D. N., 1978, MODES PERCEIVING PRO, P159; MacDougall HG, 2005, OPTOMETRY VISION SCI, V82, P706, DOI 10.1097/01.opx.0000175623.86611.03; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; Mestre DR, 1997, VISION RES, V37, P1627, DOI 10.1016/S0042-6989(96)00314-8; Miles FA, 1998, EUR J NEUROSCI, V10, P811, DOI 10.1046/j.1460-9568.1998.00112.x; MILES FA, 2004, OPTIC FLOW, P79; Niemann T, 1999, VISION RES, V39, P1359, DOI 10.1016/S0042-6989(98)00236-3; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; Rushton SK, 2001, TRENDS COGN SCI, V5, P6, DOI 10.1016/S1364-6613(00)01562-X; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; VANDENBERG AV, 1993, NATURE, V365, P497, DOI 10.1038/365497a0; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1992, PERCEPT PSYCHOPHYS, V51, P443, DOI 10.3758/BF03211640; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WARREN WH, 1991, J EXP PSYCHOL HUMAN, V17, P28, DOI 10.1037/0096-1523.17.1.28; Weber E, HANDWORTERBUCH PHY 2, V3, P481; Wilkie R, 2003, J EXP PSYCHOL HUMAN, V29, P363, DOI 10.1037/0096-1523.29.2.363; Wilkie RM, 2006, J EXP PSYCHOL HUMAN, V32, P88, DOI 10.1037/0096-1523.32.1.88; Wilson M, 2007, EXP BRAIN RES, V176, P397, DOI 10.1007/s00221-006-0623-3	41	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31479	10.1371/journal.pone.0031479	http://dx.doi.org/10.1371/journal.pone.0031479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393363	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500016
J	Hyslop, L; Prathalingam, N; Nowak, L; Fenwick, J; Harbottle, S; Byerley, S; Rhodes, J; Watson, B; Henderson, R; Murdoch, A; Herbert, M				Hyslop, Louise; Prathalingam, Nilendran; Nowak, Lynne; Fenwick, Jeanette; Harbottle, Steve; Byerley, Samantha; Rhodes, John; Watson, Bruce; Henderson, Robin; Murdoch, Alison; Herbert, Mary			A Novel Isolator-Based System Promotes Viability of Human Embryos during Laboratory Processing	PLOS ONE			English	Article							INTRACELLULAR PH REGULATION; IN-VITRO FERTILIZATION; OXYGEN CONCENTRATION; MOUSE EMBRYOS; HUMAN OOCYTE; DIRECTED DIFFERENTIATION; BLASTOCYST YIELD; SIBLING OOCYTES; BOVINE EMBRYOS; STEM-CELLS	In vitro fertilisation (IVF) and related technologies are arguably the most challenging of all cell culture applications. The starting material is a single cell from which one aims to produce an embryo capable of establishing a pregnancy eventually leading to a live birth. Laboratory processing during IVF treatment requires open manipulations of gametes and embryos, which typically involves exposure to ambient conditions. To reduce the risk of cellular stress, we have developed a totally enclosed system of interlinked isolator-based workstations designed to maintain oocytes and embryos in a physiological environment throughout the IVF process. Comparison of clinical and laboratory data before and after the introduction of the new system revealed that significantly more embryos developed to the blastocyst stage in the enclosed isolator-based system compared with conventional open-fronted laminar flow hoods. Moreover, blastocysts produced in the isolator-based system contained significantly more cells and their development was accelerated. Consistent with this, the introduction of the enclosed system was accompanied by a significant increase in the clinical pregnancy rate and in the proportion of embryos implanting following transfer to the uterus. The data indicate that protection from ambient conditions promotes improved development of human embryos. Importantly, we found that it was entirely feasible to conduct all IVF-related procedures in the isolator-based workstations.	[Hyslop, Louise; Nowak, Lynne; Fenwick, Jeanette; Harbottle, Steve; Byerley, Samantha; Murdoch, Alison; Herbert, Mary] Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Prathalingam, Nilendran; Herbert, Mary] Newcastle Univ, Ctr Life, Newcastle Fertil Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rhodes, John] Univ Hosp N Tees, Stockton Qual Control Lab, Stockton On Tees, England; [Watson, Bruce] Northumbria Univ, Sch Design, Ctr Design Res, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Henderson, Robin] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University Hospital of North Tees; Northumbria University; Newcastle University - UK	Hyslop, L (corresponding author), Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	mary.herbert@ncl.ac.uk	Hyslop, Louise/AAJ-2583-2021	Herbert, Mary/0000-0002-8488-2770	Medical Research Council [G0601157, GO400232]; One North East; RegeNer8; MRC [G0601157] Funding Source: UKRI; Medical Research Council [G0400232] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); One North East; RegeNer8; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding received from the Medical Research Council (G0601157 and GO400232), One North East, and RegeNer8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PA, 1995, ZYGOTE, V3, P357, DOI 10.1017/S0967199400002793; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BOWMAN P, 1970, J EMBRYOL EXP MORPH, V24, P203; BRINSTER RL, 1965, J EXP ZOOL, V158, P49, DOI 10.1002/jez.1401580105; BUSTER JE, 1985, AM J OBSTET GYNECOL, V153, P211, DOI 10.1016/0002-9378(85)90116-4; Caprino L, 1998, ENVIRON HEALTH PERSP, V106, P115, DOI 10.2307/3434312; Ciray HN, 2009, FERTIL STERIL, V91, P1459, DOI 10.1016/j.fertnstert.2008.07.1707; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Cohen J, 1997, HUM REPROD, V12, P1742, DOI 10.1093/humrep/12.8.1742; Coleman CA, 2003, TOXICOL LETT, V142, P133, DOI 10.1016/S0378-4274(03)00020-1; Dale B, 1998, HUM REPROD, V13, P964, DOI 10.1093/humrep/13.4.964; DAVIDSON A, 1988, FERTIL STERIL, V49, P516; Dumoulin JCM, 1999, HUM REPROD, V14, P465, DOI 10.1093/humrep/14.2.465; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Sobrinho DBG, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-143; Griffiths TA, 2000, HUM REPROD, V15, P1592, DOI 10.1093/humrep/15.7.1592; Hall J, 1998, HUM REPROD, V13, P146, DOI 10.1093/humrep/13.suppl_4.146; Harton GL, 2011, HUM REPROD, V26, P41, DOI 10.1093/humrep/deq265; JOHN DP, 1988, FERTIL STERIL, V49, P150; Karagenc L, 2004, REPROD BIOMED ONLINE, V9, P409, DOI 10.1016/S1472-6483(10)61276-X; Kea B, 2007, FERTIL STERIL, V87, P213, DOI 10.1016/j.fertnstert.2006.05.066; Kovacic B, 2008, REPROD BIOMED ONLINE, V17, P229, DOI 10.1016/S1472-6483(10)60199-X; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Lane M, 1999, MOL REPROD DEV, V54, P396, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;396::AID-MRD10&gt;3.0.CO;2-6; Lane M, 1999, BIOL REPROD, V61, P452, DOI 10.1095/biolreprod61.2.452; Leese HJ, 1998, HUM REPROD, V13, P184, DOI 10.1093/humrep/13.suppl_4.184; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; Mantzouratou A, 2011, CYTOGENET GENOME RES, V133, P141, DOI 10.1159/000323794; Midcalf B, 2004, PHARM ISOLATORS; Molhave L., 1991, INDOOR AIR, V1, P357, DOI DOI 10.1111/J.1600-0668.1991.00001.X; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Phillips KP, 1999, DEV BIOL, V208, P392, DOI 10.1006/dbio.1999.9199; Phillips KP, 2000, HUM REPROD, V15, P896, DOI 10.1093/humrep/15.4.896; PICKERING SJ, 1990, FERTIL STERIL, V54, P102; PLANTE L, 1994, J ASSIST REPROD GEN, V11, P515, DOI 10.1007/BF02216032; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Swain JE, 2010, REPROD BIOMED ONLINE, V21, P6, DOI 10.1016/j.rbmo.2010.03.012; Tillett L, 1999, AM J HEALTH-SYST PH, V56, P1433, DOI 10.1093/ajhp/56.14.1433; Veraitch FS, 2008, BIOTECHNOL BIOENG, V99, P1216, DOI 10.1002/bit.21673; Wang WH, 2001, HUM REPROD, V16, P2374, DOI 10.1093/humrep/16.11.2374; Xie Y, 2008, MOL REPROD DEV, V75, P689, DOI 10.1002/mrd.20787; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31010	10.1371/journal.pone.0031010	http://dx.doi.org/10.1371/journal.pone.0031010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393356	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000303003500009
J	Imamovic, L; Muniesa, M				Imamovic, Lejla; Muniesa, Maite			Characterizing RecA-Independent Induction of Shiga toxin2-Encoding Phages by EDTA Treatment	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; TOXIN 2-ENCODING BACTERIOPHAGE; ETHYLENEDIAMINETETRAACETIC ACID; CONVERTING BACTERIOPHAGES; GENE; STRAINS; EXPRESSION; TRANSDUCTION; PROPHAGES; VIRULENCE	Background: The bacteriophage life cycle has an important role in Shiga toxin (Stx) expression. The induction of Shiga toxin-encoding phages (Stx phages) increases toxin production as a result of replication of the phage genome, and phage lysis of the host cell also provides a means of Stx toxin to exit the cell. Previous studies suggested that prophage induction might also occur in the absence of SOS response, independently of RecA. Methodology/Principal Findings: The influence of EDTA on RecA-independent Stx2 phage induction was assessed, in laboratory lysogens and in EHEC strains carrying Stx2 phages in their genome, by Real-Time PCR. RecA-independent mechanisms described for phage lambda induction (RcsA and DsrA) were not involved in Stx2 phage induction. In addition, mutations in the pathway for the stress response of the bacterial envelope to EDTA did not contribute to Stx2 phage induction. The effect of EDTA on Stx phage induction is due to its chelating properties, which was also confirmed by the use of citrate, another chelating agent. Our results indicate that EDTA affects Stx2 phage induction by disruption of the bacterial outer membrane due to chelation of Mg2+. In all the conditions evaluated, the pH value had a decisive role in Stx2 phage induction. Conclusions/Significance: Chelating agents, such as EDTA and citrate, induce Stx phages, which raises concerns due to their frequent use in food and pharmaceutical products. This study contributes to our understanding of the phenomenon of induction and release of Stx phages as an important factor in the pathogenicity of Shiga toxin-producing Escherichia coli (STEC) and in the emergence of new pathogenic strains.	[Imamovic, Lejla; Muniesa, Maite] Univ Barcelona, Dept Microbiol, Barcelona, Spain	University of Barcelona	Imamovic, L (corresponding author), Univ Barcelona, Dept Microbiol, Barcelona, Spain.	mmuniesa@ub.edu	Muniesa, Maite/K-4577-2014; Imamovic, Lejla/C-2612-2015; Imamovic, Lejla/ABB-7301-2021	Muniesa, Maite/0000-0001-5549-1394; Imamovic, Lejla/0000-0003-1662-9447; 	Generalitat de Catalunya [2009SGR1043]; Spanish Ministry of Education and Science [AGL2009-07576, FPI 20060054361]; Xarxa de Referencia en Biotecnologia (XeRBa)	Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education and Science(Spanish Government); Xarxa de Referencia en Biotecnologia (XeRBa)	This study was supported by the Generalitat de Catalunya (grant 2009SGR1043), by the Spanish Ministry of Education and Science (grant AGL2009-07576), and by the Xarxa de Referencia en Biotecnologia (XeRBa). L. Imamovic is a recipient of a grant from the Spanish Ministry of Education and Science (grant FPI 20060054361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Acheson DWK, 1998, INFECT IMMUN, V66, P4496; Aertsen A, 2005, APPL ENVIRON MICROB, V71, P1155, DOI 10.1128/AEM.71.3.1155-1162.2005; Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Blanusa M, 2005, CURR MED CHEM, V12, P2771, DOI 10.2174/092986705774462987; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Boland JS, 2003, J FOOD PROTECT, V66, P1783, DOI 10.4315/0362-028X-66.10.1783; Branen JK, 2004, INT J FOOD MICROBIOL, V90, P63, DOI 10.1016/S0168-1605(03)00172-7; Bucheli-Witschel M, 2001, FEMS MICROBIOL REV, V25, P69, DOI 10.1111/j.1574-6976.2001.tb00572.x; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Crane JK, 2011, INFECT IMMUN, V79, P1696, DOI 10.1128/IAI.01099-10; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuchs S, 1999, MICROB PATHOGENESIS, V27, P13, DOI 10.1006/mpat.1999.0279; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; HEINDORFF K, 1983, MUTAT RES, V115, P149, DOI 10.1016/0165-1110(83)90001-5; Imamovic L, 2010, APPL ENVIRON MICROB, V76, P5693, DOI 10.1128/AEM.00107-10; James CE, 2001, APPL ENVIRON MICROB, V67, P4335, DOI 10.1128/AEM.67.9.4335-4337.2001; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Koudelka AP, 2004, J BACTERIOL, V186, P7659, DOI 10.1128/JB.186.22.7659-7669.2004; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Livny J, 2004, MOL MICROBIOL, V51, P1691, DOI 10.1111/j.1365-2958.2003.03934.x; Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006; Los M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-13; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Muhldorfer I, 1996, INFECT IMMUN, V64, P495; Muniesa M, 2004, MICROBIOL-SGM, V150, P2959, DOI 10.1099/mic.0.27188-0; Muniesa M, 1998, APPL ENVIRON MICROB, V64, P2443; Muniesa M, 2004, ENVIRON MICROBIOL, V6, P716, DOI 10.1111/j.1462-2920.2004.00604.x; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Mustard JA, 2000, J BACTERIOL, V182, P1659, DOI 10.1128/JB.182.6.1659-1670.2000; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Ritchie JM, 2003, APPL ENVIRON MICROB, V69, P1059, DOI 10.1128/AEM.69.2.1059-1066.2003; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt H, 1999, APPL ENVIRON MICROB, V65, P3855; Serra-Moreno R, 2008, J BACTERIOL, V190, P4722, DOI 10.1128/JB.00069-08; Serra-Moreno R, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-31; Shimizu T, 2009, INFECT IMMUN, V77, P2813, DOI 10.1128/IAI.00060-09; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; Toth I, 2003, APPL ENVIRON MICROB, V69, P7242, DOI 10.1128/AEM.69.12.7242-7247.2003; Tyler JS, 2004, J BACTERIOL, V186, P7670, DOI 10.1128/JB.186.22.7670-7679.2004; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wagner PL, 1999, INFECT IMMUN, V67, P6710; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001	59	56	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32393	10.1371/journal.pone.0032393	http://dx.doi.org/10.1371/journal.pone.0032393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393404	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500057
J	Rukke, BA; Birkemoe, T; Soleng, A; Lindstedt, HH; Ottesen, P				Rukke, Bjorn Arne; Birkemoe, Tone; Soleng, Arnulf; Lindstedt, Heidi Heggen; Ottesen, Preben			Head Lice in Norwegian Households: Actions Taken, Costs and Knowledge	PLOS ONE			English	Article							PEDICULUS-HUMANUS-CAPITIS; PREVALENCE; DIAGNOSIS; SCHOOLCHILDREN; INFESTATIONS; INSPECTION; COMB	Introduction: Head lice infestations cause distress in many families. A well-founded strategy to reduce head lice prevalence must shorten the infectious period of individual hosts. To develop such a strategy, information about the actions taken (inspection, treatment and informing others about own infestations), level of knowledge and costs is needed. The present study is the first to consider all these elements combined. Materials and Methods: A questionnaire was answered by 6203 households from five geographically separated municipalities in Norway. Results: 94% of the households treated members with pediculicides when head lice were discovered. Nearly half of the households checked biannually or not at all. Previous occurrence of head lice and multiple children in a household improved both checking frequency and method. More than 90% of the households informed close contacts about their own pediculosis. Direct costs of pediculosis were low (less than (sic)6.25 yearly) for 70% of the households, but the ability to pay for pediculicides decreased with the number of head lice infestations experienced. One in three households kept children from school because of pediculosis. Other widespread misconceptions, such as that excessive cleaning is necessary to fight head lice, may also add unnecessary burden to households. School affiliation had a significant effect on checking frequency and method, knowledge and willingness to inform others about own pediculosis. Conclusions: Increased checking frequencies appear to be the most important element to reduce head lice prevalence in Norway and should be a primary focus of future strategies. National campaigns directed through schools to individual households, might be an important tool to achieve this goal. In addition to improving actions taken, such campaigns should also provide accurate information to reduce costs and enhance the level of knowledge about head lice in households.	[Rukke, Bjorn Arne; Birkemoe, Tone; Soleng, Arnulf; Lindstedt, Heidi Heggen; Ottesen, Preben] Norwegian Inst Publ Hlth, Dept Pest Control, Oslo, Norway; [Birkemoe, Tone] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway	Norwegian Institute of Public Health (NIPH); Norwegian University of Life Sciences	Rukke, BA (corresponding author), Norwegian Inst Publ Hlth, Dept Pest Control, Oslo, Norway.	bjorn.arne.rukke@fhi.no		Soleng, Arnulf/0000-0002-3777-497X				[Anonymous], 2011, DRUG CONSUMPTION NOR; Balcioglu C, 2008, EPIDEMIOL INFECT, V136, P1425, DOI 10.1017/S0950268807000118; Bauer E, 2009, PARASITOL RES, V104, P677, DOI 10.1007/s00436-008-1245-4; Begon M, 2009, PRINCETON GUIDE ECOL, P220; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; Burgess IE, 2004, ANNU REV ENTOMOL, V49, P457, DOI 10.1146/annurev.ento.49.061802.123253; Canyon D., 2010, MANAGEMENT CONTROL H, P34; Counahan M, 2004, J PAEDIATR CHILD H, V40, P616, DOI 10.1111/j.1440-1754.2004.00486.x; Counahan M L, 2007, Rural Remote Health, V7, P687; Counahan ML, 2005, MED J AUSTRALIA, V182, P137, DOI 10.5694/j.1326-5377.2005.tb06620.x; De Maeseneer J, 2000, BRIT MED J, V321, P1187, DOI 10.1136/bmj.321.7270.1187; Downs AMR, 2005, ARCH DERMATOL, V141, P1318, DOI 10.1001/archderm.141.10.1318-a; Eaker S, 1998, AM J EPIDEMIOL, V147, P74; Laguna MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021848; Falagas ME, 2008, EMERG INFECT DIS, V14, P1493, DOI 10.3201/eid1409.080368; GRATZ NG, 1997, WHOCTDWHOPES978; Hansen RC, 2004, CLIN PEDIATR, V43, P523, DOI 10.1177/000992280404300603; Hensel P, 2000, PUBLIC HEALTH NURS, V17, P300, DOI 10.1046/j.1525-1446.2000.00300.x; Heukelbach J, 2010, MANAGEMENT CONTROL H, P143; Heukelbach J, 2010, MANAGEMENTS CONTROL, P43; Heukelbach J, 2011, J INFECT DEV COUNTR, V5, P652, DOI 10.3855/jidc.1746; Ibarra J, 2007, J CLIN NURS, V16, P1955, DOI 10.1111/j.1365-2702.2007.01795.x; Ibarra J, 2009, PERSPECT PUBLIC HEAL, V129, P165, DOI 10.1177/1466424008094804; Jahnke C, 2009, ARCH DERMATOL, V145, P309, DOI 10.1001/archdermatol.2008.587; Kristensen M, 2006, J MED ENTOMOL, V43, P533, DOI 10.1603/0022-2585(2006)43[533:SOPAMR]2.0.CO;2; Leung Alexander K C, 2005, J Pediatr Health Care, V19, P369, DOI 10.1016/j.pedhc.2005.07.002; MAUNDER B, 1985, J ROY SOC HEALTH, V105, P61, DOI 10.1177/146642408510500206; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mumcuoglu Kosta Y, 2007, J Drugs Dermatol, V6, P409; Mumcuoglu KY, 2001, PEDIATR DERMATOL, V18, P9, DOI 10.1046/j.1525-1470.2001.018001009.x; Nutanson I, 2008, ACTA DERMATOVEN ALP, V17, P147; Parison JC, 2008, OPEN DERMATOL J, V2, P9; Parison JC, 2010, MANAGEMENT CONTROL H, P103; Pollack RJ, 2000, PEDIATR INFECT DIS J, V19, P689, DOI 10.1097/00006454-200008000-00003; Roberts RJ, 2002, NEW ENGL J MED, V346, P1645, DOI 10.1056/NEJMcp012640; Rukke BA, 2011, PARASITOLOGY, V138, P1296, DOI 10.1017/S0031182011001004; Soultana V, 2009, PEDIATR DERMATOL, V26, P701, DOI 10.1111/j.1525-1470.2009.01016.x; StataCorp LP, 2009, STAT VERS 11; Stone P, 2008, J MATH BIOL, V56, P743, DOI 10.1007/s00285-007-0136-0; Tebruegge M, 2011, ARCH DIS CHILDHOOD-E, V96, P2, DOI 10.1136/adc.2009.178038; Toloza A, 2009, PARASITOL RES, V104, P1295, DOI 10.1007/s00436-008-1324-6; Willems S, 2005, EUR J DERMATOL, V15, P387	42	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32686	10.1371/journal.pone.0032686	http://dx.doi.org/10.1371/journal.pone.0032686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393437	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500090
J	Shehzad, W; McCarthy, TM; Pompanon, F; Purevjav, L; Coissac, E; Riaz, T; Taberlet, P				Shehzad, Wasim; McCarthy, Thomas Michael; Pompanon, Francois; Purevjav, Lkhagvajav; Coissac, Eric; Riaz, Tiayyba; Taberlet, Pierre			Prey Preference of Snow Leopard (Panthera uncia) in South Gobi, Mongolia	PLOS ONE			English	Article							ARGALI OVIS-AMMON; SCAT-DETECTION DOGS; LARGE CARNIVORES; DNA; CONSERVATION; LIVESTOCK; CONFLICT; DIET; IDENTIFICATION; PREDATORS	Accurate information about the diet of large carnivores that are elusive and inhabit inaccessible terrain, is required to properly design conservation strategies. Predation on livestock and retaliatory killing of predators have become serious issues throughout the range of the snow leopard. Several feeding ecology studies of snow leopards have been conducted using classical approaches. These techniques have inherent limitations in their ability to properly identify both snow leopard feces and prey taxa. To examine the frequency of livestock prey and nearly-threatened argali in the diet of the snow leopard, we employed the recently developed DNA-based diet approach to study a snow leopard population located in the Tost Mountains, South Gobi, Mongolia. After DNA was extracted from the feces, a region of similar to 100 bp long from mitochondrial 12S rRNA gene was amplified, making use of universal primers for vertebrates and a blocking oligonucleotide specific to snow leopard DNA. The amplicons were then sequenced using a next-generation sequencing platform. We observed a total of five different prey items from 81 fecal samples. Siberian ibex predominated the diet (in 70.4% of the feces), followed by domestic goat (17.3%) and argali sheep (8.6%). The major part of the diet was comprised of large ungulates (in 98.8% of the feces) including wild ungulates (79%) and domestic livestock (19.7%). The findings of the present study will help to understand the feeding ecology of the snow leopard, as well as to address the conservation and management issues pertaining to this wild cat.	[Shehzad, Wasim; Pompanon, Francois; Coissac, Eric; Riaz, Tiayyba; Taberlet, Pierre] Univ Grenoble 1, CNRS, Lab Ecol Alpine, Unite Mixte Rech 5553, Grenoble, France; [Purevjav, Lkhagvajav] Snow Leopard Conservat Fund, Ulaanbaatar, Mongolia; [McCarthy, Thomas Michael] Panthera, Snow Leopard Program, New York, NY USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Shehzad, W (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, Unite Mixte Rech 5553, Grenoble, France.	pierre.taberlet@ujf-grenoble.fr	Pompanon, François/D-3459-2009; Taberlet, Pierre/D-1178-2010; Coissac, Éric/AAE-8735-2019	Pompanon, François/0000-0003-4600-0172; Taberlet, Pierre/0000-0002-3554-5954; Coissac, Éric/0000-0001-7507-6729	Laboratoire d'Ecologie Alpine, Centre National de la Recherche Scientifique, France [UMR 5553]; Snow Leopard Conservation Grant Program; Higher Education Commission (HEC) of Pakistan	Laboratoire d'Ecologie Alpine, Centre National de la Recherche Scientifique, France; Snow Leopard Conservation Grant Program; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	This work was funded by Laboratoire d'Ecologie Alpine, UMR 5553, Centre National de la Recherche Scientifique, France. Partial funding was provided by Snow Leopard Conservation Grant Program for 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; We thank Rana Bayrakci for a critical review of the manuscript and for providing numerous helpful suggestions. We also extend our thanks to Alice Valentini, Christian Miquel, Carole Poillot, Delphine Rioux and Ludovic Gielly for their valuable comments and suggestions throughout the course of this study. Wasim Shehzad and Tiayyba Riaz are supported by the Higher Education Commission (HEC) of Pakistan.	Allen P, 2002, CONSERVATION PANTHER; Anwar MB, 2011, EUR J WILDLIFE RES, V57, P1077, DOI 10.1007/s10344-011-0521-2; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Chundawat RS, 1994, INT SNOW LEOPARD TRU, P127; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fox J, 1994, P 7 INT SNOW LEOP S, P3; Fox J.L, 1989, REV STATUS ECOLOGY S; Gronberg E, 2011, MOVEMENT PATTERNS SN; Hansen MM, 1999, J ZOOL, V247, P177, DOI 10.1111/j.1469-7998.1999.tb00981.x; Hussain S, 2003, ORYX, V37, P26, DOI 10.1017/S0030605303000085; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jackson RM, THESIS U LONDON; Jackson Rodney, 2001, Endangered Species Update, V18, P138; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jackson Rodney M., 2010, P417; JALANKA HH, 1989, J ZOO WILDLIFE MED, V20, P154; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Khatoon R, THESIS ARID AGR U PA; Long RA, 2007, J WILDLIFE MANAGE, V71, P2007, DOI 10.2193/2006-230; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Macdonald David W., 2010, P3; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Maroney RL, 2005, BIOL CONSERV, V121, P231, DOI 10.1016/j.biocon.2004.04.024; McCarthy T, THESIS U MASSACHUSET; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy Tom, 2010, Cat News, V53, P15; Mishra C, 2006, ORYX, V40, P29, DOI 10.1017/S0030605306000032; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Namgail T, 2004, J ZOOL, V262, P57, DOI 10.1017/S0952836903004394; Namgail T, 2007, ENVIRON MANAGE, V39, P490, DOI 10.1007/s00267-005-0178-2; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; OLI MK, 1993, J ZOOL, V231, P71, DOI 10.1111/j.1469-7998.1993.tb05354.x; OLI MK, 1993, J ZOOL, V231, P365, DOI 10.1111/j.1469-7998.1993.tb01924.x; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Reading RP, 1997, ORYX, V31, P285, DOI 10.1046/j.1365-3008.1997.d01-17.x; Reading RP, 1999, BIODIVERS CONSERV, V8, P1115, DOI 10.1023/A:1008900427566; Rege JEO, 2000, P 3 INT C YAK PROD C, P69; Riaz T, 2011, NUCLEIC ACIDS RES, V39, P11; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Shrestha R, 2006, RANGELAND ECOL MANAG, V59, P512, DOI 10.2111/06-022R2.1; Spiering PA, 2009, CONSERV GENET, V10, P2005, DOI 10.1007/s10592-009-9880-6; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x	53	77	85	1	174	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32104	10.1371/journal.pone.0032104	http://dx.doi.org/10.1371/journal.pone.0032104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393381	Green Published, gold			2022-12-25	WOS:000303003500034
J	Doyle, ME; Perley, JP; Skalak, TC				Doyle, Megan E.; Perley, Jeffrey P.; Skalak, Thomas C.			Bone Marrow-Derived Progenitor Cells Augment Venous Remodeling in a Mouse Dorsal Skinfold Chamber Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; COLLATERAL PERFUSION; INTERFERON-GAMMA; STROMAL CELLS; BLOOD-FLOW; RAT MODEL; ANGIOGENESIS; PROLIFERATION	The delivery of bone marrow-derived cells (BMDCs) has been widely used to stimulate angiogenesis and arteriogenesis. We identified a progenitor-enriched subpopulation of BMDCs that is able to augment venular remodeling, a generally unexplored area in microvascular research. Two populations of BMDCs, whole bone marrow (WBM) and Lin(-)/Sca-1(+) progenitor cells, were encapsulated in sodium alginate and delivered to a mouse dorsal skinfold chamber model. Upon observation that encapsulated Sca-1(+) progenitor cells enhance venular remodeling, the cells and tissue were analyzed on structural and molecular levels. Venule walls were thickened and contained more nuclei after Sca-1(+) progenitor cell delivery. In addition, progenitors expressed mRNA transcript levels of chemokine (C-X-C motif) ligand 2 (CXCL2) and interferon gamma (IFN gamma) that are over 5-fold higher compared to WBM. Tissues that received progenitors expressed significantly higher protein levels of vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), and platelet derived growth factor-BB (PDGF-BB) compared to tissues that received an alginate control construct. Nine days following cell delivery, tissue from progenitor recipients contained 39% more CD45(+) leukocytes, suggesting that these cells may enhance venular remodeling through the modulation of the local immune environment. Results show that different BMDC populations elicit different microvascular responses. In this model, Sca-1(+) progenitor cell-derived CXCL2 and IFN gamma may mediate venule enlargement via modulation of the local inflammatory environment.	[Doyle, Megan E.; Perley, Jeffrey P.; Skalak, Thomas C.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA	University of Virginia	Doyle, ME (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	meg6u@virginia.edu			National Institutes of Health [HL-065958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this work was provided by the National Institutes of Health (HL-065958). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2006, J VASC SURG, V44, P863, DOI 10.1016/j.jvs.2006.05.043; ADAIR TH, 1995, AM J PHYSIOL-HEART C, V269, pH717, DOI 10.1152/ajpheart.1995.269.2.H717; Al-Khaldi A, 2003, ANN THORAC SURG, V75, P204, DOI 10.1016/S0003-4975(02)04291-1; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Aranguren XL, 2008, J CLIN INVEST, V118, P505, DOI [10.1172/JC131153, 10.1172/JCI31153]; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Baggiolini M, 1995, Clin Exp Immunol, V101 Suppl 1, P5; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Dorfmuller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goodell MA, 2001, ANN NY ACAD SCI, V938, P208; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Ichioka S, 2005, BRIT J PLAST SURG, V58, P1124, DOI 10.1016/j.bjps.2005.04.054; Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Komai Y, 2005, CLIN HEMORHEOL MICRO, V32, P247; Kwei S, 2004, AM J PATHOL, V164, P81, DOI 10.1016/S0002-9440(10)63099-4; Laham RJ, 2003, ANN VASC SURG, V17, P245, DOI 10.1007/s10016-001-0299-x; Lamb DJ, 2004, ATHEROSCLEROSIS, V176, P21, DOI 10.1016/j.atherosclerosis.2004.04.012; Li ZS, 2008, J BIOMED MATER RES A, V86A, P552, DOI 10.1002/jbm.a.31596; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Morris CE, 2007, J APPL PHYSIOL, V103, P629, DOI 10.1152/japplphysiol.01133.2006; NAGAOKA I, 1992, COMP BIOCHEM PHYS B, V103, P349, DOI 10.1016/0305-0491(92)90303-9; Nickerson MM, 2006, FASEB J, V20, pA709; Nugent HM, 2007, J VASC SURG, V46, P548, DOI 10.1016/j.jvs.2007.04.074; Price RJ, 1996, AM J PHYSIOL-HEART C, V271, pH752, DOI 10.1152/ajpheart.1996.271.2.H752; PRICE RJ, 1994, MICROVASC RES, V47, P188, DOI 10.1006/mvre.1994.1015; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Schatteman GC, 2006, STEM CELLS, V24, P717, DOI 10.1634/stemcells.2005-0214; SCHREIBER RD, 1986, ANN INST PASTEUR IMM, VC137, P203, DOI 10.1016/S0771-050X(86)80028-6; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072; Van Huyen JPD, 2008, MODERN PATHOL, V21, P837, DOI 10.1038/modpathol.2008.48; Van Overstraeten-Schloegel N, 2006, EUR J HAEMATOL, V76, P488, DOI 10.1111/j.1600-0609.2006.00633.x; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Wragg A, 2008, J MOL MED, V86, P1221, DOI 10.1007/s00109-008-0390-7; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhang Hong-kun, 2005, Zhonghua Wai Ke Za Zhi, V43, P1275; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	56	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32815	10.1371/journal.pone.0032815	http://dx.doi.org/10.1371/journal.pone.0032815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389724	Green Submitted, gold, Green Published			2022-12-25	WOS:000302999600063
J	Fritah, A; Steel, JH; Parker, N; Nikolopoulou, E; Christian, M; Carling, D; Parker, MG				Fritah, Asmaa; Steel, Jennifer H.; Parker, Nadeene; Nikolopoulou, Evanthia; Christian, Mark; Carling, David; Parker, Malcolm G.			Absence of RIP140 Reveals a Pathway Regulating glut4-Dependent Glucose Uptake in Oxidative Skeletal Muscle through UCP1-Mediated Activation of AMPK	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR RIP140; RECEPTOR-INTERACTING PROTEIN-140; BROWN ADIPOSE-TISSUE; NUCLEAR RECEPTOR; GENE-EXPRESSION; SIGNALING PATHWAYS; INSULIN-RESISTANCE; ENERGY-METABOLISM; WHITE ADIPOCYTES; KINASE	Skeletal muscle constitutes the major site of glucose uptake leading to increased removal of glucose from the circulation in response to insulin. Type 2 diabetes and obesity are often associated with insulin resistance that can be counteracted by exercise or the use of drugs increasing the relative proportion of oxidative fibers. RIP140 is a transcriptional coregulator with a central role in metabolic tissues and we tested the effect of modulating its level of expression on muscle glucose and lipid metabolism in two mice models. Here, we show that although RIP140 protein is expressed at the same level in both oxidative and glycolytic muscles, it inhibits both fatty acid and glucose utilization in a fiber-type dependent manner. In RIP140-null mice, fatty acid utilization increases in the extensor digitorum longus and this is associated with elevated expression of genes implicated in fatty acid binding and transport. In the RIP140-null soleus, depletion of RIP140 leads to increased GLUT4 trafficking and glucose uptake with no change in Akt activity. AMPK phosphorylation/activity is inhibited in the soleus of RIP140 transgenic mice and increased in RIP140-null soleus. This is associated with increased UCP1 expression and mitochondrial uncoupling revealing the existence of a signaling pathway controlling insulin-independent glucose uptake in the soleus of RIP140-null mice. In conclusion, our findings reinforce the participation of RIP140 in the maintenance of energy homeostasis by acting as an inhibitor of energy production and particularly point to RIP140 as a promising therapeutic target in the treatment of insulin resistance.	[Fritah, Asmaa; Steel, Jennifer H.; Nikolopoulou, Evanthia; Christian, Mark; Parker, Malcolm G.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Parker, Nadeene] UCL, Dept Cell & Dev Biol, London, England; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Fac Med, Med Res Councils Clin Sci Ctr, London, England	Imperial College London; University of London; University College London; Imperial College London	Fritah, A (corresponding author), Ecole Normale Super Lyon, Lab Biol Mol Cellule, F-69364 Lyon, France.	asmaa.fritah@ens-lyon.fr	Parker, Nadeene/C-1562-2008; Steel, Jennifer/B-4737-2013; Carling, David/F-1943-2014	Steel, Jennifer/0000-0003-4439-0090; Carling, David/0000-0002-2316-1830; Christian, Mark/0000-0002-1616-4179	Wellcome Trust [079200/Z/06/Z]; Medical Research Council [MC_U120027537] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust, Reference 079200/Z/06/Z (AF and JHS). http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carroll AM, 2004, BIOCHEM SOC T, V32, P1066, DOI 10.1042/BST0321066; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010; Fritah A, 2010, CARDIOVASC RES, V86, P443, DOI 10.1093/cvr/cvp418; Fritah A, 2009, APPL PHYSIOL NUTR ME, V34, P362, DOI 10.1139/H09-026; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; LARSSON L, 1991, AM J PHYSIOL, V261, pC93, DOI 10.1152/ajpcell.1991.261.1.C93; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LHorset F, 1996, MOL CELL BIOL, V16, P6029; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nautiyal J, 2010, ENDOCRINOLOGY, V151, P2923, DOI 10.1210/en.2010-0081; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Wu H, 2003, J MUSCLE RES CELL M, V24, P587, DOI 10.1023/B:JURE.0000009968.60331.86; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699	61	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32520	10.1371/journal.pone.0032520	http://dx.doi.org/10.1371/journal.pone.0032520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389706	Green Published, gold, Green Submitted			2022-12-25	WOS:000302999600044
J	Froeschke, G; Sommer, S				Froeschke, Goetz; Sommer, Simone			Insights into the Complex Associations Between MHC Class II DRB Polymorphism and Multiple Gastrointestinal Parasite Infestations in the Striped Mouse	PLOS ONE			English	Article							GENETIC DIVERSITY; HELMINTH-PARASITES; SELECTION; POPULATION; RESISTANCE; ALLELES; MICE; INFECTION; LOAD; MICROSATELLITES	Differences in host susceptibility to different parasite types are largely based on the degree of matching between immune genes and parasite antigens. Specifically the variable genes of the major histocompatibility complex (MHC) play a major role in the defence of parasites. However, underlying genetic mechanisms in wild populations are still not well understood because there is a lack of studies which deal with multiple parasite infections and their competition within. To gain insights into these complex associations, we implemented the full record of gastrointestinal nematodes from 439 genotyped individuals of the striped mouse, Rhabdomys pumilio. We used two different multivariate approaches to test for associations between MHC class II DRB genotype and multiple nematodes with regard to the main pathogen-driven selection hypotheses maintaining MHC diversity and parasite species-specific co-evolutionary effects. The former includes investigations of a `heterozygote advantage', or its specific form a `divergent-allele advantage' caused by highly dissimilar alleles as well as possible effects of specific MHC-alleles selected by a `rare allele advantage' (= negative `frequency-dependent selection'). A combination of generalized linear mixed models (GLMMs) and co-inertia (COIA) analyses made it possible to consider multiple parasite species despite the risk of type I errors on the population and on the individual level. We could not find any evidence for a `heterozygote' advantage but support for `divergent-allele' advantage and infection intensity. In addition, both approaches demonstrated high concordance of positive as well as negative associations between specific MHC alleles and certain parasite species. Furthermore, certain MHC alleles were associated with more than one parasite species, suggesting a many-to-many gene-parasite co-evolution. The most frequent allele Rhpu-DRB*38 revealed a pleiotropic effect, involving three nematode species. Our study demonstrates the co-existence of specialist and generalist MHC alleles in terms of parasite detection which may be an important feature in the maintenance of MHC polymorphism.	[Froeschke, Goetz; Sommer, Simone] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung	Froeschke, G (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.	sommer@izw-berlin.de			Hansische Universitatsstiftung; German Academic Exchange Service (DAAD); Stellenbosch University; Leibniz-Institute for Zoo and Wildlife Research/Berlin	Hansische Universitatsstiftung; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Stellenbosch University; Leibniz-Institute for Zoo and Wildlife Research/Berlin	The study was financed by the Hansische Universitatsstiftung, the German Academic Exchange Service (DAAD), the Stellenbosch University and the Leibniz-Institute for Zoo and Wildlife Research/Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P3842, DOI 10.1111/j.1365-294X.2010.04772.x; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Apps P., 2000, SMITHERS MAMMALS SO; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI [10.1139/f02-066, 10.1139/F02-066]; Axtner J, 2011, INFECT GENET EVOL, V11, P2063, DOI 10.1016/j.meegid.2011.09.020; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; BEHNKE J.M., 2001, PARASITOLOGY, V122, P39; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; BEHNKE JM, 1973, PARASITOLOGY, V67, P157, DOI 10.1017/S0031182000046382; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brooks DR, 2006, J PARASITOL, V92, P426, DOI 10.1645/GE-711R.1; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cattadori IM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P349, DOI 10.1007/978-4-431-36025-4_18; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Crawley M.J., 2007, R BOOK; de Bellocq JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/j.1420-9101.2008.01538.x; De Graaf G., 1981, RODENTS SO AFRICA; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deter J, 2008, INFECT GENET EVOL, V8, P450, DOI 10.1016/j.meegid.2007.07.003; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; Doherty P C, 1975, Nature, V256, P50; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evans ML, 2009, MOL ECOL, V18, P4716, DOI 10.1111/j.1365-294X.2009.04374.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Froeschke G, 2010, OIKOS, V119, P1029, DOI 10.1111/j.1600-0706.2009.18124.x; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Goncalves L, 1998, MEM I OSWALDO CRUZ, V93, P121, DOI 10.1590/S0074-02761998000100023; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GREGORY RD, 1990, J ANIM ECOL, V59, P363, DOI 10.2307/5178; Harf R, 2005, MOL ECOL, V14, P85, DOI 10.1111/j.1365-294X.2004.02402.x; HAYUNGA EG, 1991, J PARASITOL, V77, P865, DOI 10.2307/3282734; HUGHEE AL, 1992, GENETICS, V132, P863; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; KLEIN J, 1986, NATURAL HIST MAJOR H; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-269; Loiseau C, 2008, ECOL LETT, V11, P258, DOI 10.1111/j.1461-0248.2007.01141.x; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Meyer-Lucht Y, 2009, EVOL ECOL RES, V11, P1085; Meyer-Lucht Y, 2010, CONSERV GENET, V11, P2001, DOI 10.1007/s10592-010-0093-9; Michels C, 2006, INFECT IMMUN, V74, P5926, DOI 10.1128/IAI.00207-06; Nwosu CO, 2007, VET PARASITOL, V144, P118, DOI 10.1016/j.vetpar.2006.09.004; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Pearce Edward J., 2002, P39; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; R Core Team, 2021, R LANG ENV STAT COMP; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; Schwensow N, 2011, INFECT GENET EVOL, V11, P23, DOI 10.1016/j.meegid.2010.10.017; Schwensow N, 2010, INFECT GENET EVOL, V10, P662, DOI 10.1016/j.meegid.2010.03.012; SINGLETON GR, 1985, AUST WILDLIFE RES, V12, P437; Skorping A, 2004, TRENDS ECOL EVOL, V19, P219, DOI 10.1016/j.tree.2004.02.006; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stear MJ, 1997, NATURE, V389, P27, DOI 10.1038/37895; Summers K, 2003, BIOL REV, V78, P639, DOI 10.1017/S146479310300616X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tellier A, 2007, P R SOC B, V274, P809, DOI 10.1098/rspb.2006.0281; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Venables W.N., 2002, MODERN APPL STAT S, V4th, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; WAKELAND EK, 1990, IMMUNOL RES, V9, P115, DOI 10.1007/BF02918202; Wegner KM, 2008, J FISH BIOL, V73, P2110, DOI 10.1111/j.1095-8649.2008.02051.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Weil ZM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P443, DOI 10.1007/978-4-431-36025-4_21; Wilson K., 2001, ECOLOGY WILDLIFE DIS, P6; Zuur Alain F., 2009, P1	84	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31820	10.1371/journal.pone.0031820	http://dx.doi.org/10.1371/journal.pone.0031820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389675	Green Submitted, Green Published, gold			2022-12-25	WOS:000302999600013
J	Gulati, AS; Shanahan, MT; Arthur, JC; Grossniklaus, E; von Furstenberg, RJ; Kreuk, L; Henning, SJ; Jobin, C; Sartor, RB				Gulati, Ajay S.; Shanahan, Michael T.; Arthur, Janelle C.; Grossniklaus, Emily; von Furstenberg, Richard J.; Kreuk, Lieselotte; Henning, Susan J.; Jobin, Christian; Sartor, R. Balfour			Mouse Background Strain Profoundly Influences Paneth Cell Function and Intestinal Microbial Composition	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INNATE IMMUNITY; CROHNS-DISEASE; INTERLEUKIN-10-DEFICIENT MICE; BACTERICIDAL LECTIN; ALPHA-DEFENSINS; EPITHELIUM; EXPRESSION; COLITIS; SOX9	Background: Increasing evidence supports the central role of Paneth cells in maintaining intestinal host-microbial homeostasis. However, the direct impact of host genotype on Paneth cell function remains unclear. Here, we characterize key differences in Paneth cell function and intestinal microbial composition in two widely utilized, genetically distinct mouse strains (C57BL/6 and 129/SvEv). In doing so, we demonstrate critical influences of host genotype on Paneth cell activity and the enteric microbiota. Methodology and Principal Findings: Paneth cell numbers were determined by flow cytometry. Antimicrobial peptide (AMP) expression was evaluated using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR), acid urea-polyacrylamide gel electrophoresis, and mass spectrometry. Effects of mouse background on microbial composition were assessed by reciprocal colonization of germ-free mice from both background strains, followed by compositional analysis of resultant gut bacterial communities using terminal restriction fragment length polymorphism analysis and 16 S qPCR. Our results revealed that 129/SvEv mice possessed fewer Paneth cells and a divergent AMP profile relative to C57BL/6 counterparts. Novel 129/SvEv a-defensin peptides were identified, including Defa2/18v, Defa11, Defa16, and Defa18. Host genotype profoundly affected the global profile of the intestinal microbiota, while both source and host factors were found to influence specific bacterial groups. Interestingly, ileal a-defensins from 129/SvEv mice displayed attenuated antimicrobial activity against pro-inflammatory E. coli strains, a bacterial species found to be expanded in these animals. Conclusions and Significance: This work establishes the important impact of host genotype on Paneth cell function and the composition of the intestinal microbiota. It further identifies specific AMP and microbial alterations in two commonly used inbred mouse strains that have varying susceptibilities to a variety of disorders, ranging from obesity to intestinal inflammation. This will be critical for future studies utilizing these murine backgrounds to study the effects of Paneth cells and the intestinal microbiota on host health and disease.	[Gulati, Ajay S.; Shanahan, Michael T.; Arthur, Janelle C.; Grossniklaus, Emily; von Furstenberg, Richard J.; Kreuk, Lieselotte; Henning, Susan J.; Jobin, Christian; Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Gulati, Ajay S.] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Pediat, Chapel Hill, NC USA; [Shanahan, Michael T.; Arthur, Janelle C.; Grossniklaus, Emily; von Furstenberg, Richard J.; Kreuk, Lieselotte; Henning, Susan J.; Jobin, Christian; Sartor, R. Balfour] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Henning, Susan J.] Univ N Carolina, Dept Cellular & Mol Physiol, Chapel Hill, NC USA; [Jobin, Christian] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gulati, AS (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	agulati@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022	Arthur, Janelle/0000-0002-4796-0207	United States National Institutes of Health (NIH) [KL2 RR025746]; NASPGHAN Foundation/Crohn's and Colitis Foundation of America; Global Probiotics Council; NIH [R01 DK53347, P40 RR018603, T32 DK007737, U01 DK085547, P30 DK34987]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603, KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, T32DK007737, R01DK053347, U01DK085547] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASPGHAN Foundation/Crohn's and Colitis Foundation of America; Global Probiotics Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by grants United States National Institutes of Health (NIH) KL2 RR025746 (Marshall S. Runge, PI), a Career Development Award from the NASPGHAN Foundation/Crohn's and Colitis Foundation of America (ASG), a Young Investigator Award from the Global Probiotics Council (ASG), NIH R01 DK53347 (RBS), NIH P40 RR018603 (RBS), NIH T32 DK007737 (RBS), NIH U01 DK085547 (SJH), and NIH P30 DK34987 (Robert S. Sandler, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Esworthy RS, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/986046; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Keshav S, 2006, J LEUKOCYTE BIOL, V80, P500, DOI 10.1189/jlb.1005556; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Pena JA, 2009, INFLAMM BOWEL DIS, V15, P248, DOI 10.1002/ibd.20744; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	45	58	62	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32403	10.1371/journal.pone.0032403	http://dx.doi.org/10.1371/journal.pone.0032403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384242	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500085
J	Iserbyt, A; Van Gossum, H; Stoks, R				Iserbyt, Arne; Van Gossum, Hans; Stoks, Robby			Biogeographical Survey Identifies Consistent Alternative Physiological Optima and a Minor Role for Environmental Drivers in Maintaining a Polymorphism	PLOS ONE			English	Article							FEMALE COLOR POLYMORPHISM; FREQUENCY-DEPENDENT SELECTION; MORPH FREQUENCIES; IMMUNE FUNCTION; LIFE-HISTORY; EVOLUTIONARY DYNAMICS; NEHALENNIA-IRENE; CLINAL VARIATION; CORRELATIONAL SELECTION; GEOGRAPHIC-VARIATION	The contribution of adaptive mechanisms in maintaining genetic polymorphisms is still debated in many systems. To understand the contribution of selective factors in maintaining polymorphism, we investigated large-scale (>1000 km) geographic variation in morph frequencies and fitness-related physiological traits in the damselfly Nehalennia irene. As fitness-related physiological traits, we investigated investment in immune function (phenoloxidase activity), energy storage and fecundity (abdomen protein and lipid content), and flight muscles (thorax protein content). In the first part of the study, our aim was to identify selective agents maintaining the large-scale spatial variation in morph frequencies. Morph frequencies varied considerably among populations, but, in contrast to expectation, in a geographically unstructured way. Furthermore, frequencies co-varied only weakly with the numerous investigated ecological parameters. This suggests that spatial frequency patterns are driven by stochastic processes, or alternatively, are consequence of highly variable and currently unidentified ecological conditions. In line with this, the investigated ecological parameters did not affect the fitness-related physiological traits differently in both morphs. In the second part of the study, we aimed at identifying tradeoffs between fitness-related physiological traits that may contribute to the local maintenance of both colour morphs by defining alternative phenotypic optima, and test the spatial consistency of such trade-off patterns. The female morph with higher levels of phenoloxidase activity had a lower thorax protein content, and vice versa, suggesting a trade-off between investments in immune function and in flight muscles. This physiological trade-off was consistent across the geographical scale studied and supports widespread correlational selection, possibly driven by male harassment, favouring alternative trait combinations in both female morphs.	[Iserbyt, Arne; Van Gossum, Hans] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Stoks, Robby] Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium	University of Antwerp; KU Leuven	Iserbyt, A (corresponding author), Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium.	arne.iserbyt@ua.ac.de	Stoks, Robby/AAK-1227-2020	Iserbyt, Arne/0000-0002-6414-6688; Stoks, Robby/0000-0003-4130-0459	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); University of Antwerp (BOF-NOI) [2401]; Fund for Scientific Research Flanders (FWO); University of Leuven	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University of Antwerp (BOF-NOI); Fund for Scientific Research Flanders (FWO)(FWO); University of Leuven(KU Leuven)	This study was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen research grant to AI: http://www.iwt.be), research grants from the University of Antwerp (BOF-NOI, project number: 2401 to HVG: http://www.ua.ac.be), and the Fund for Scientific Research Flanders (FWO: http://www.fwo.be) and the University of Leuven (http://www.kuleuven.be) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andres JA, 2000, EVOLUTION, V54, P2156, DOI 10.1111/j.0014-3820.2000.tb01258.x; Andres JA, 2002, ANIM BEHAV, V63, P677, DOI 10.1006/anbe.2001.1948; Antoniazza S, 2010, EVOLUTION, V64, P1944, DOI 10.1111/j.1558-5646.2010.00969.x; Berwaerts K, 2004, OECOLOGIA, V141, P536, DOI 10.1007/s00442-004-1661-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bots J, 2008, PHYSIOL ENTOMOL, V33, P138, DOI 10.1111/j.1365-3032.2008.00616.x; Bots J, 2009, BIOL J LINN SOC, V97, P545, DOI 10.1111/j.1095-8312.2009.01238.x; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Bouton N, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.11201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calsbeek B, 2010, J EVOLUTION BIOL, V23, P1138, DOI 10.1111/j.1420-9101.2010.01978.x; Calsbeek R, 2008, J ANIM ECOL, V77, P103, DOI 10.1111/j.1365-2656.2007.01320.x; Calsbeek R, 2010, EVOLUTION, V64, P116, DOI 10.1111/j.1558-5646.2009.00808.x; Conrad KF, 2002, ECOGRAPHY, V25, P439, DOI 10.1034/j.1600-0587.2002.250406.x; Cooper IA, 2010, AM NAT, V176, P566, DOI 10.1086/656491; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordero Rivera A, 1998, ETOLOGIA, V6, P71; Cordoba-Aguilar A, 2009, BEHAV ECOL SOCIOBIOL, V63, P751, DOI 10.1007/s00265-009-0709-6; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; De Block M, 2008, ECOL ENTOMOL, V33, P796, DOI 10.1111/j.1365-2311.2008.01024.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Fielding DJ, 2008, PHYSIOL ENTOMOL, V33, P264, DOI 10.1111/j.1365-3032.2008.00619.x; Fincke OM, 2004, ANIM BEHAV, V67, P833, DOI 10.1016/j.anbehav.2003.04.017; Forbes MR, 1997, CAN J ZOOL, V75, P253, DOI 10.1139/z97-032; FORBES MRL, 1995, ECOSCIENCE, V2, P28, DOI 10.1080/11956860.1995.11682265; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gosden TP, 2011, BIOL J LINN SOC, V102, P775, DOI 10.1111/j.1095-8312.2011.01619.x; Gosden TP, 2009, AM NAT, V173, P709, DOI 10.1086/598491; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Hammers M, 2008, ANIM BEHAV, V76, P1403, DOI 10.1016/j.anbehav.2008.06.021; HINNEKINT BON, 1987, HYDROBIOLOGIA, V146, P3, DOI 10.1007/BF00007574; Hoffman EA, 2000, BIOL J LINN SOC, V70, P633, DOI 10.1006/bijl.1999.0421; HOLM S, 1979, SCAND J STAT, V6, P65; Hubert M, 2003, J CHEMOMETR, V17, P537, DOI 10.1002/cem.822; Iserbyt A, 2010, J ZOOL, V282, P256, DOI 10.1111/j.1469-7998.2010.00735.x; Iserbyt A, 2012, THESIS ANTWERP U ANT; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Iserbyt A, 2009, ANIM BEHAV, V78, P1463, DOI 10.1016/j.anbehav.2009.09.031; Iserbyt A, 2009, ANIM BIOL, V59, P313, DOI 10.1163/157075609X454944; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; Joop G, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-19; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; King EG, 2011, J EVOLUTION BIOL, V24, P256, DOI 10.1111/j.1420-9101.2010.02160.x; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kunte K, 2009, ANIM BEHAV, V78, P1029, DOI 10.1016/j.anbehav.2009.08.013; Lam E., 2004, DAMSELFLIES NE GUIDE; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lease HM, 2011, PHYSIOL ENTOMOL, V36, P29, DOI 10.1111/j.1365-3032.2010.00767.x; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li BB, 2002, CHEMOMETR INTELL LAB, V64, P79, DOI 10.1016/S0169-7439(02)00051-5; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Locklin JL, 2010, PARASITOL RES, V107, P75, DOI 10.1007/s00436-010-1836-8; Magurran AE, 2005, EVOLUTIONARY ECOLOGY, P224; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Millstein RL, 2002, BIOL PHILOS, V17, P33, DOI 10.1023/A:1012990800358; Mucklow PT, 2004, P ROY SOC B-BIOL SCI, V271, P1175, DOI 10.1098/rspb.2004.2707; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Nakamoto A, 2011, POPUL ECOL, V53, P241, DOI 10.1007/s10144-010-0214-9; Nosil P, 2006, AM NAT, V167, pE66, DOI 10.1086/499383; Ohsaki N, 2005, J ANIM ECOL, V74, P728, DOI 10.1111/j.1365-2656.2005.00972.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Parkash R, 2009, J INSECT PHYSIOL, V55, P358, DOI 10.1016/j.jinsphys.2009.01.008; Phifer-Rixey M, 2008, J EVOLUTION BIOL, V21, P966, DOI 10.1111/j.1420-9101.2008.01549.x; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Punzalan D, 2010, CURR BIOL, V20, pR972, DOI 10.1016/j.cub.2010.09.067; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; Rolff J, 2004, P ROY SOC B-BIOL SCI, V271, P2157, DOI 10.1098/rspb.2004.2859; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Sanchez-Guillen RA, 2011, HEREDITY, V107, P513, DOI 10.1038/hdy.2011.36; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; SLATKIN M, 1973, GENETICS, V75, P733; Stapley J, 2011, J HERED, V102, P118, DOI 10.1093/jhered/esq104; Stearns S.C., 2000, EVOLUTION INTRO; Stoks R, 2006, ECOLOGY, V87, P809, DOI 10.1890/0012-9658(2006)87[809:TCMPPI]2.0.CO;2; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Svensson E, 2001, P NATL ACAD SCI USA, V98, P12561, DOI 10.1073/pnas.211071298; Svensson EI, 2005, J EVOLUTION BIOL, V18, P1503, DOI 10.1111/j.1420-9101.2005.00946.x; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; Svensson EI, 2009, EVOL ECOL, V23, P93, DOI 10.1007/s10682-007-9208-2; Takahashi Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-256; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Van Gossum H, 2008, CAN J ZOOL, V86, P1131, DOI 10.1139/Z08-091; Van Gossum H, 2001, BEHAV ECOL SOCIOBIOL, V51, P69; Van Gossum H, 2008, ECOL MODEL, V210, P212, DOI 10.1016/j.ecolmodel.2007.07.023; Van Gossum H, 2007, BIOL J LINN SOC, V90, P501, DOI 10.1111/j.1095-8312.2007.00740.x; Van Gossum Hans, 2008, P219; WESTFALL MJ, 1996, DAMSELFLIES N AM; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Wong A, 2003, MOL ECOL, V12, P3505, DOI 10.1046/j.1365-294X.2003.02002.x; Xu MZ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1215, DOI 10.1007/s00265-010-1134-6; Zhao Z, 2006, J INSECT PHYSIOL, V52, P646, DOI 10.1016/j.jinsphys.2006.03.003; Zheng HF, 2009, AGR ECOSYST ENVIRON, V132, P98, DOI 10.1016/j.agee.2009.03.004; Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014	113	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32648	10.1371/journal.pone.0032648	http://dx.doi.org/10.1371/journal.pone.0032648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384278	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500105
J	Falsafi, SK; Deli, A; Hoger, H; Pollak, A; Lubec, G				Falsafi, Soheil Keihan; Deli, Alev; Hoeger, Harald; Pollak, Arnold; Lubec, Gert			Scopolamine Administration Modulates Muscarinic, Nicotinic and NMDA Receptor Systems	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC SYSTEM; WATER MAZE; INHIBITORY AVOIDANCE; SYNAPTIC PLASTICITY; BINDING-PROPERTIES; CEREBRAL-CORTEX; MESSENGER-RNAS; WORKING-MEMORY	Studies on the effect of scopolamine on memory are abundant but so far only regulation of the muscarinic receptor (M1) has been reported. We hypothesized that levels of other cholinergic brain receptors as the nicotinic receptors and the N-methyl-D-aspartate (NMDA) receptor, known to be involved in memory formation, would be modified by scopolamine administration. C57BL/6J mice were used for the experiments and divided into four groups. Two groups were given scopolamine 1 mg/kg i.p. (the first group was trained and the second group untrained) in the multiple T-maze (MTM), a paradigm for evaluation of spatial memory. Likewise, vehicle-treated mice were trained or untrained thus serving as controls. Hippocampal levels of M1, nicotinic receptor alpha 4 (Nic4) and 7 (Nic7) and subunit NR1containing complexes were determined by immunoblotting on blue native gel electrophoresis. Vehicle-treated trained mice learned the task and showed memory retrieval on day 8, while scopolamine-treatment led to significant impairment of performance in the MTM. At the day of retrieval, hippocampal levels for M1, Nic7 and NR1 were higher in the scopolamine treated groups than in vehicle-treated groups. The concerted action, i.e. the pattern of four brain receptor complexes regulated by the anticholinergic compound scopolamine, is shown. Insight into probable action mechanisms of scopolamine at the brain receptor complex level in the hippocampus is provided. Scopolamine treatment is a standard approach to test cognitive enhancers and other psychoactive compounds in pharmacological studies and therefore knowledge on mechanisms is of pivotal interest.	[Falsafi, Soheil Keihan; Deli, Alev; Pollak, Arnold; Lubec, Gert] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Falsafi, SK (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	gert.lubec@meduniwien.ac.at		Lubec, Gert/0000-0002-6333-9461				Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Barak S, 2009, INT J NEUROPSYCHOPH, V12, P227, DOI 10.1017/S1461145708009176; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BERMUDEZRATTONI F, 1987, PHARMACOL BIOCHEM BE, V26, P553, DOI 10.1016/0091-3057(87)90165-1; BLOKLAND A, 1992, PSYCHOPHARMACOLOGY, V109, P373, DOI 10.1007/BF02245886; BODDEKE EWGM, 1992, EUR J PHARMACOL, V222, P21, DOI 10.1016/0014-2999(92)90457-F; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOREN JJ, 1959, J EXP ANAL BEHAV, V2, P107, DOI 10.1901/jeab.1959.2-107; BRITO GNO, 1983, PSYCHOPHARMACOLOGY, V81, P315, DOI 10.1007/BF00427569; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Buccafusco JJ, 2008, PSYCHOPHARMACOLOGY, V199, P481, DOI 10.1007/s00213-007-0887-8; BUCKLEY NJ, 1988, J NEUROSCI, V8, P4646; BURESOVA O, 1986, BEHAV NEUROSCI, V100, P476, DOI 10.1037/0735-7044.100.4.476; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; Cain DP, 1998, NEUROSCI BIOBEHAV R, V22, P181, DOI 10.1016/S0149-7634(97)00005-5; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; CARLTON PL, 1963, PSYCHOL REV, V70, P19, DOI 10.1037/h0045063; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Chen P, 2006, J NEUROCHEM, V98, P1126, DOI 10.1111/j.1471-4159.2006.03934.x; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; Cunha GMA, 2008, EXP NEUROL, V210, P776, DOI 10.1016/j.expneurol.2007.11.013; DECKER MW, 1990, BRAIN RES, V513, P81, DOI 10.1016/0006-8993(90)91091-T; Doralp S, 2008, NEUROBIOL LEARN MEM, V90, P382, DOI 10.1016/j.nlm.2008.05.013; ECKERMAN DA, 1980, PHARMACOL BIOCHEM BE, V12, P595, DOI 10.1016/0091-3057(80)90194-X; Fornari RV, 2000, LEARN MEMORY, V7, P287, DOI 10.1101/lm.34900; Ghafari M, 2011, BRAIN STRUC IN PRESS, DOI [10.1007/s00429-00011-00335-00428, DOI 10.1007/S00429-00011-00335-00428]; Ghafari M, 2011, BEHAV BRAIN RES, V221, P142, DOI 10.1016/j.bbr.2011.02.042; GODDING PR, 1982, PHARMACOL BIOCHEM BE, V16, P919, DOI 10.1016/0091-3057(82)90045-4; Harrison FE, 2009, BEHAV BRAIN RES, V205, P550, DOI 10.1016/j.bbr.2009.08.017; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; HEARST E, 1959, J PHARMACOL EXP THER, V126, P349; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; HULME EC, 1978, MOL PHARMACOL, V14, P737; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; JONES SVP, 1993, LIFE SCI, V52, P457, DOI 10.1016/0024-3205(93)90302-J; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kang SU, 2008, J PROTEOME RES, V7, P3498, DOI 10.1021/pr800236u; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kimura Y, 1999, BRAIN RES, V834, P6, DOI 10.1016/S0006-8993(99)01526-7; Klinkenberg I, 2011, PSYCHOPHARMACOLOGY, V215, P549, DOI 10.1007/s00213-011-2171-1; Soares JCK, 2006, NEUROBIOL LEARN MEM, V86, P188, DOI 10.1016/j.nlm.2006.02.006; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lena C, 1998, J PHYSIOL-PARIS, V92, P63, DOI 10.1016/S0928-4257(98)80140-X; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Li HB, 1996, BRAIN RES, V725, P268, DOI 10.1016/0006-8993(96)00404-0; Lieben CKJ, 2005, NEUROPSYCHOPHARMACOL, V30, P2169, DOI 10.1038/sj.npp.1300777; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; Loiseau F, 2008, PSYCHOPHARMACOLOGY, V196, P93, DOI 10.1007/s00213-007-0934-5; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKS MJ, 1982, MOL PHARMACOL, V22, P554; McGehee DS, 1999, ANN NY ACAD SCI, V868, P565, DOI 10.1111/j.1749-6632.1999.tb11330.x; MESSER WS, 1987, BRAIN RES, V407, P37, DOI 10.1016/0006-8993(87)91217-0; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; Ohno M, 1996, EUR J PHARMACOL, V318, P267, DOI 10.1016/S0014-2999(96)00907-7; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Park SJ, 2010, FOOD CHEM TOXICOL, V48, P1671, DOI 10.1016/j.fct.2010.03.042; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Renner UD, 2005, THER DRUG MONIT, V27, P655, DOI 10.1097/01.ftd.0000168293.48226.57; RIEKKINEN P, 1990, BEHAV NEURAL BIOL, V54, P204, DOI 10.1016/0163-1047(90)91436-F; Robinson L, 2004, BEHAV BRAIN RES, V151, P277, DOI 10.1016/j.bbr.2003.09.001; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Roldan G, 1997, NEUROSCI LETT, V230, P93, DOI 10.1016/S0304-3940(97)00489-8; Rush R, 2002, MOL PHARMACOL, V61, P1416, DOI 10.1124/mol.61.6.1416; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Salminen O, 2007, MOL PHARMACOL, V71, P1563, DOI 10.1124/mol.106.031492; Sase A, 2011, AMINO ACIDS IN PRESS, DOI [10.1007/s00726-00011-01130-00729, DOI 10.1007/S00726-00011-01130-00729]; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; SCHMELLER T, 1995, PHARMAZIE, V50, P493; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Thouvarecq R, 2007, PHYSIOL BEHAV, V90, P155, DOI 10.1016/j.physbeh.2006.09.024; Thouvarecq R, 2001, BEHAV BRAIN RES, V118, P209, DOI 10.1016/S0166-4328(00)00330-2; Vaisman N, 2009, PROG NEURO-PSYCHOPH, V33, P952, DOI 10.1016/j.pnpbp.2009.04.021; Volpicelli LA, 2004, PROG BRAIN RES, V145, P59, DOI 10.1016/S0079-6123(03)45003-6; WATTS J, 1981, PHYSIOL BEHAV, V26, P845, DOI 10.1016/0031-9384(81)90108-6; WEI J, 1994, J NEUROCHEM, V63, P815; WEINER DM, 1990, P NATL ACAD SCI USA, V87, P7050, DOI 10.1073/pnas.87.18.7050; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wezenberg E, 2005, PSYCHOPHARMACOLOGY, V181, P582, DOI 10.1007/s00213-005-0083-7; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; WIENER NI, 1973, BEHAV BIOL, V9, P227, DOI 10.1016/S0091-6773(73)80157-9; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	90	69	70	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32082	10.1371/journal.pone.0032082	http://dx.doi.org/10.1371/journal.pone.0032082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384146	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100050
J	Christensen, B; Lundby, C; Jessen, N; Nielsen, TS; Vestergaard, PF; Moller, N; Pilegaard, H; Pedersen, SB; Kopchick, JJ; Jorgensen, JOL				Christensen, Britt; Lundby, Carsten; Jessen, Niels; Nielsen, Thomas S.; Vestergaard, Poul F.; Moller, Niels; Pilegaard, Henriette; Pedersen, Steen B.; Kopchick, John J.; Jorgensen, Jens Otto L.			Evaluation of Functional Erythropoietin Receptor Status in Skeletal Muscle In Vivo: Acute and Prolonged Studies in Healthy Human Subjects	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; KINASE LYN; ACTIVATION; PHOSPHORYLATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; ANTIBODIES; TISSUE	Background: Erythropoietin receptors have been identified in human skeletal muscle tissue, but downstream signal transduction has not been investigated. We therefore studied in vivo effects of systemic erythropoietin exposure in human skeletal muscle. Methodology/Principal Findings: The protocols involved 1) acute effects of a single bolus injection of erythropoietin followed by consecutive muscle biopsies for 1-10 hours, and 2) a separate study with prolonged administration for 16 days with biopsies obtained before and after. The presence of erythropoietin receptors in muscle tissue as well as activation of Epo signalling pathways (STAT5, MAPK, Akt, IKK) were analysed by western blotting. Changes in muscle protein profiles after prolonged erythropoietin treatment were evaluated by 2D gel-electrophoresis and mass spectrometry. The presence of the erythropoietin receptor in skeletal muscle was confirmed, by the M20 but not the C20 antibody. However, no significant changes in phosphorylation of the Epo-R, STAT5, MAPK, Akt, Lyn, IKK, and p70S6K after erythropoietin administration were detected. The level of 8 protein spots were significantly altered after 16 days of rHuEpo treatment; one isoform of myosin light chain 3 and one of desmin/actin were decreased, while three isoforms of creatine kinase and two of glyceraldehyd-3-phosphate dehydrogenase were increased. Conclusions/Significance: Acute exposure to recombinant human erythropoietin is not associated by detectable activation of the Epo-R or downstream signalling targets in human skeletal muscle in the resting situation, whereas more prolonged exposure induces significant changes in the skeletal muscle proteome. The absence of functional Epo receptor activity in human skeletal muscle indicates that the long-term effects are indirect and probably related to an increased oxidative capacity in this tissue.	[Christensen, Britt; Vestergaard, Poul F.; Moller, Niels; Pedersen, Steen B.; Jorgensen, Jens Otto L.] Aarhus Univ Hosp, NBG THG, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Lundby, Carsten] Univ Zurich, Inst Physiol, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jessen, Niels] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Kopchick, John J.] Ohio Univ, Dept Biomed Sci, Edison Biotechnol Inst, Athens, OH 45701 USA; [Christensen, Britt; Jessen, Niels; Nielsen, Thomas S.; Vestergaard, Poul F.; Moller, Niels] Univ Aarhus, Med Res Labs, Aarhus, Denmark; [Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark; [Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen Muscle Res Ctr, Copenhagen, Denmark	Aarhus University; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Aarhus University; University System of Ohio; Ohio University; Aarhus University; University of Copenhagen; University of Copenhagen	Christensen, B (corresponding author), Aarhus Univ Hosp, NBG THG, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark.	britt.christensen@ki.au.dk	Pilegaard, Henriette/M-2315-2014; Pedersen, Steen B./AAB-3331-2019; Jorgensen, Jens Otto Lunde/O-8003-2019; Moller, Niels/E-5091-2011; Jessen, Niels/E-1731-2011	Pilegaard, Henriette/0000-0002-1071-0327; Pedersen, Steen B./0000-0002-7838-8063; Moller, Niels/0000-0001-5627-7322; Jorgensen, Jens Otto Lunde/0000-0001-7408-1526; Jessen, Niels/0000-0001-5613-7274; Nielsen, Thomas Svava/0000-0002-9457-8000	Danish Council of Independent Research in Medical Sciences, Denmark [271-08-0647]	Danish Council of Independent Research in Medical Sciences, Denmark	This study was supported by The Danish Council of Independent Research in Medical Sciences (271-08-0647), Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittorf T, 2001, CELL SIGNAL, V13, P673, DOI 10.1016/S0898-6568(01)00189-9; Boudot C, 2003, BIOCHEM BIOPH RES CO, V300, P437, DOI 10.1016/S0006-291X(02)02866-8; Cayla JL, 2008, INT J SPORTS MED, V29, P460, DOI 10.1055/s-2007-965359; Chin H, 1998, BLOOD, V91, P3734; Chong Zhao Zhong, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P141, DOI 10.2174/1568006033481483; Christensen B, 2011, J APPL PHYSIOL, V110, P149, DOI 10.1152/japplphysiol.00665.2010; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Erbayraktar Serhat, 2003, Curr Hematol Rep, V2, P465; Feng QP, 2006, CARDIOVASC RES, V71, P615, DOI 10.1016/j.cardiores.2006.07.001; Fisher JW, 2003, EXP BIOL MED, V228, P1; Hagstrom L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/137817; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Jegalian AG, 2002, J INTERF CYTOK RES, V22, P853, DOI 10.1089/107999002760274863; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Jorgensen JOL, 2006, AM J PHYSIOL-ENDOC M, V291, pE899, DOI 10.1152/ajpendo.00024.2006; Juel C, 2007, EUR J APPL PHYSIOL, V102, P41, DOI 10.1007/s00421-007-0567-8; Kirkeby A, 2007, J NEUROSCI METH, V164, P50, DOI 10.1016/j.jneumeth.2007.03.026; Lappin TR, 2002, STEM CELLS, V20, P485, DOI 10.1634/stemcells.20-6-485; Launay T, 2010, CELL PROLIFERAT, V43, P1, DOI 10.1111/j.1365-2184.2009.00648.x; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lundby C, 2008, J APPL PHYSIOL, V104, P1154, DOI 10.1152/japplphysiol.01211.2007; Lundby C, 2011, J PHYSIOL-LONDON, V589, P1265, DOI 10.1113/jphysiol.2010.195917; Marzo F, 2008, J THROMB THROMBOLYS, V26, P183, DOI 10.1007/s11239-008-0212-3; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Okumura N, 2005, PROTEOMICS, V5, P2896, DOI 10.1002/pmic.200401181; Ramakrishnan R, 2004, J CLIN PHARMACOL, V44, P991, DOI 10.1177/0091270004268411; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Rotter R, 2008, J ORTHOP RES, V26, P1618, DOI 10.1002/jor.20692; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; Shi ZZ, 2010, MOL CANCER RES, V8, P615, DOI 10.1158/1541-7786.MCR-09-0264; STARON RS, 1993, COMP BIOCHEM PHYS B, V106, P463, DOI 10.1016/0305-0491(93)90120-T; Tilbrook PA, 2001, ARCH BIOCHEM BIOPHYS, V396, P128, DOI 10.1006/abbi.2001.2577; Tilbrook PA, 1999, INT J BIOCHEM CELL B, V31, P1001, DOI 10.1016/S1357-2725(99)00071-0; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31857	10.1371/journal.pone.0031857	http://dx.doi.org/10.1371/journal.pone.0031857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384088	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000302875500049
J	Castro, LFC; Monroig, O; Leaver, MJ; Wilson, J; Cunha, I; Tocher, DR				Costa Castro, Luis Filipe; Monroig, Oscar; Leaver, Michael J.; Wilson, Jonathan; Cunha, Isabel; Tocher, Douglas R.			Functional Desaturase Fads1 (Delta 5) and Fads2 (Delta 6) Orthologues Evolved before the Origin of Jawed Vertebrates	PLOS ONE			English	Article							FATTY-ACID DESATURASE; ALPHA-LINOLENIC ACID; TELEOST FISH; CAENORHABDITIS-ELEGANS; ACYL DESATURASES; ATLANTIC SALMON; MARINE FISH; FRESH-WATER; EVOLUTION; METABOLISM	Long-chain polyunsaturated fatty acids (LC-PUFAs) such as arachidonic (ARA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are essential components of biomembranes, particularly in neural tissues. Endogenous synthesis of ARA, EPA and DHA occurs from precursor dietary essential fatty acids such as linoleic and alpha-linolenic acid through elongation and Delta 5 and Delta 6 desaturations. With respect to desaturation activities some noteworthy differences have been noted in vertebrate classes. In mammals, the Delta 5 activity is allocated to the Fads1 gene, while Fads2 is a Delta 6 desaturase. In contrast, teleosts show distinct combinations of desaturase activities (e.g. bifunctional or separate Delta 5 and Delta 6 desaturases) apparently allocated to Fads2-type genes. To determine the timing of Fads1-Delta 5 and Fads2-Delta 6 evolution in vertebrates we used a combination of comparative and functional genomics with the analysis of key phylogenetic species. Our data show that Fads1 and Fads2 genes with Delta 5 and Delta 6 activities respectively, evolved before gnathostome radiation, since the catshark Scyliorhinus canicula has functional orthologues of both gene families. Consequently, the loss of Fads1 in teleosts is a secondary episode, while the existence of D5 activities in the same group most likely occurred through independent mutations into Fads2 type genes. Unexpectedly, we also establish that events of Fads1 gene expansion have taken place in birds and reptiles. Finally, a fourth Fads gene (Fads4) was found with an exclusive occurrence in mammalian genomes. Our findings enlighten the history of a crucially important gene family in vertebrate fatty acid metabolism and physiology and provide an explanation of how observed lineage-specific gene duplications, losses and diversifications might be linked to habitat-specific food web structures in different environments and over geological timescales.	[Costa Castro, Luis Filipe; Wilson, Jonathan; Cunha, Isabel] Univ Porto, CIMAR Associate Lab, CIIMAR Interdisciplinary Ctr Marine & Environm Re, P-4100 Oporto, Portugal; [Monroig, Oscar] CSIC, IATS, Castellon de La Plana, Spain; [Leaver, Michael J.; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland	Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Stirling	Castro, LFC (corresponding author), Univ Porto, CIMAR Associate Lab, CIIMAR Interdisciplinary Ctr Marine & Environm Re, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	filipe.castro@ciimar.up.pt	Castro, Filipe/AAA-2197-2022; Tocher, Douglas R/C-5652-2011; Wilson, Jonathan/I-6071-2012; Monroig, Oscar/K-9117-2014; Wilson, Jonathan Mark/AAG-6481-2019; Leaver, Michael/B-5518-2012	Castro, Filipe/0000-0001-7697-386X; Tocher, Douglas R/0000-0002-8603-9410; Wilson, Jonathan/0000-0003-3681-1166; Monroig, Oscar/0000-0001-8712-0440; Wilson, Jonathan Mark/0000-0003-3681-1166; Leaver, Michael/0000-0002-3155-0844; Cunha, Isabel/0000-0002-6149-9840	Fundacao para a Ciencia e a Tecnologia; European Community [PERG08-GA-2010-276916]; Ministerio de Ciencia e Innovacion, Spanish Government;  [PTDC/MAR/68885/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); Ministerio de Ciencia e Innovacion, Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This research was financed by the Fundacao para a Ciencia e a Tecnologia Plurianual Program and partially by the Project PTDC/MAR/68885/2006. OM was supported by a Marie Curie Reintegration Grant within the 7th European Community Framework Programme (PERG08-GA-2010-276916, LONGFA) and a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion, Spanish Government. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agaba M, 2004, MAR BIOTECHNOL, V6, P251, DOI 10.1007/s10126-003-0029-1; Alonso DL, 2003, BIOCHEM SYST ECOL, V31, P1111, DOI 10.1016/S0305-1978(03)00041-3; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Castro LFC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-132; Cook HW, BIOCH LIPIDS LIPOPRO, P181; Evans H, 2008, PHYSIOL GENOMICS, V35, P18, DOI 10.1152/physiolgenomics.90266.2008; GILLAN FT, 1984, PHYTOCHEMISTRY, V23, P2817, DOI 10.1016/0031-9422(84)83021-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knoll HA, 2007, EVOLUTION PRIMARY PR; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Michaelson LV, 1998, FEBS LETT, V439, P215, DOI 10.1016/S0014-5793(98)01385-4; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Napier JA, 1998, BIOCHEM J, V330, P611; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RIVERS JPW, 1975, NATURE, V258, P171, DOI 10.1038/258171a0; Sargent J.R., 1995, Journal of Marine Biotechnology, V3, P26; Sargent JR, 1989, FISH NUTR, Vsecond, P153; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; SINCLAIR AJ, 1981, BRIT J NUTR, V46, P93, DOI 10.1079/BJN19810012; SINCLAIR AJ, 1979, LIPIDS, V14, P932, DOI 10.1007/BF02533508; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vanhercke T, 2011, J BIOL CHEM, V286, P12860, DOI 10.1074/jbc.M110.191098; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	44	99	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31950	10.1371/journal.pone.0031950	http://dx.doi.org/10.1371/journal.pone.0031950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384110	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500056
J	Mohebbi, I; Saadat, S; Aghassi, M; Shekari, M; Matinkhah, M; Sehat, S				Mohebbi, Iraj; Saadat, Soheil; Aghassi, Mohammadreza; Shekari, Mahsa; Matinkhah, Maghsuod; Sehat, Shadi			Prevalence of Metabolic Syndrome in Iranian Professional Drivers: Results from a Population Based Study of 12,138 Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; WAIST CIRCUMFERENCE; CIGARETTE-SMOKING; UNITED-STATES; MORTALITY; HEALTH; IMPACT; EAST	Background: It is evident that professional driving is associated with substantial changes in lifestyle habits. Professional drivers are prone to metabolic syndrome (MetS) and its complications because their working environment is characterized by numerous stress factors such as lack of physical activity due to working in a fixed position, disruption in diet, and irregular sleep habits. The aim of the present study was to estimate the prevalence of MetS among long distance drivers residing in West Azerbaijan province in Iran. Materials: To assess the prevalence of metabolic syndrome among professional long distance drivers, 12138 participants were enrolled in this cross sectional study. The MetS was defined using International Diabetes Federation criteria. Results: Among 12138 participants, 3697 subjects found to be MetS. The crude and age-adjusted rates of MetS were 30.5% and 32.4% respectively. Based on Body mass index (BMI), 5027 subjects (41.4%) were overweight (BMI >= 25.01-30 kg/m2), and 2592 (21.3%) were obese (BMI >= 30.01 kg/m2). The presence of central obesity was more common than other components. The associations of MetS with BMI, pack-year smoking, age, weekly driving duration and driving experiences were significant in the logistic regression. By increasing BMI, pack-year smoking, age, weekly driving duration and driving experiences, odds ratio of MetS was increased. Conclusion: The study suggests that MetS has become a noteworthy health problem among Iranian long distance drivers. This might be due to the following facts: sitting in a fixed position for long hours while working, cigarette smoking, job stress, unhealthy diet and lack of physical activity. Educational programs should be established for promoting healthy lifestyle and also for early detection and appropriate interventions	[Mohebbi, Iraj; Shekari, Mahsa; Matinkhah, Maghsuod; Sehat, Shadi] Urmia Univ Med Sci, Occupat Med Ctr, Orumiyeh, Iran; [Saadat, Soheil] Med Sci Univ Tehran, Sina Hosp, Sina Trauma Res Ctr, Tehran, Iran; [Aghassi, Mohammadreza] Urmia Univ Med Sci, Dept Endocrinol, Orumiyeh, Iran	Urmia University of Medical Sciences; Tehran University of Medical Sciences; Urmia University of Medical Sciences	Mohebbi, I (corresponding author), Urmia Univ Med Sci, Occupat Med Ctr, Orumiyeh, Iran.	irajmohebbi@umsu.ac.ir	Brunner, Paul H/A-9690-2013; ONeill, Susan/B-1761-2010; De Robbio, Antonella/G-6496-2010; Mohebbi, Iraj/G-1494-2017; Saadat, Soheil/J-1595-2014	Brunner, Paul H/0000-0003-0091-8236; De Robbio, Antonella/0000-0001-6617-444X; Saadat, Soheil/0000-0002-2744-7983; Mohebbi, Iraj/0000-0001-9158-5742				Ahmad OB, 2001, WHO DISCUSSION PAPER; [Anonymous], INT DIAB FED IDF CON; Azizi F, 2003, DIABETES RES CLIN PR, V61, P29, DOI 10.1016/S0168-8227(03)00066-4; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Branth S, 2007, NUTR METAB CARDIOVAS, V17, P427, DOI 10.1016/j.numecd.2006.03.001; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Eapen D, 2009, VASC HEALTH RISK MAN, V5, P731; Eberly LE, 2006, DIABETES CARE, V29, P123, DOI 10.2337/diacare.29.01.06.dc05-1320; Emdad R, 1998, PSYCHOTHER PSYCHOSOM, V67, P226, DOI 10.1159/000012285; Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; FRENCH SA, 1994, INT J OBESITY, V18, P145; HARTVIG P, 1983, INT ARCH OCC ENV HEA, V52, P353, DOI 10.1007/BF02226900; Kompier M.A.J., 1996, BUS DRIVERS OCCUPATI; Kurosaka K, 2000, IND HEALTH, V38, P15, DOI 10.2486/indhealth.38.15; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Miyatake N, 2006, INTERNAL MED, V45, P1039, DOI 10.2169/internalmedicine.45.1850; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; MORRIS JN, 1953, LANCET, V265, P1053; MORRIS JN, 1953, LANCET, V265, P1111; Nakamura K, 1998, OCCUP MED-OXFORD, V48, P169, DOI 10.1093/occmed/48.3.169; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Saberi HR, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-8; Sharifi F, 2009, EXP DIABETES RES, DOI 10.1155/2009/136501; Wang PD, 2001, PUBLIC HEALTH, V115, P261, DOI 10.1016/S0033-3506(01)00456-5; Zabetian A, 2007, DIABETES RES CLIN PR, V77, P251, DOI 10.1016/j.diabres.2006.12.001	34	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31790	10.1371/journal.pone.0031790	http://dx.doi.org/10.1371/journal.pone.0031790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384075	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500041
J	Winder, VL; Emslie, SD				Winder, Virginia L.; Emslie, Steven D.			Mercury in Nelson's Sparrow Subspecies at Breeding Sites	PLOS ONE			English	Article							SWALLOWS TACHYCINETA-BICOLOR; NORTHEASTERN UNITED-STATES; SHARP-TAILED SPARROWS; SALT-MARSH SPARROWS; REPRODUCTIVE SUCCESS; EXPOSURE; PATTERNS; CAUDACUTUS; BLOOD	Background: Mercury is a persistent, biomagnifying contaminant that can cause negative effects on ecosystems. Marshes are often areas of relatively high mercury methylation and bioaccumulation. Nelson's Sparrows (Ammodramus nelsoni) use marsh habitats year-round and have been documented to exhibit tissue mercury concentrations that exceed negative effects thresholds. We sought to further characterize the potential risk of Nelson's Sparrows to mercury exposure by sampling individuals from sites within the range of each of its subspecies. Methodology/Principal Findings: From 2009 to 2011, we captured adult Nelson's Sparrows at sites within the breeding range of each subspecies (A. n. nelsoni: Grand Forks and Upham, North Dakota; A. n. alterus: Moosonee, Ontario; and A. n. subvirgatus: Grand Manan Island, New Brunswick) and sampled breast feathers, the first primary feather (P1), and blood for total mercury analysis. Mean blood mercury in nelsoni individuals captured near Grand Forks ranged from 0.84 +/- 0.37 to 1.65 +/- 1.02 SD ppm among years, between 2.0 and 4.9 times as high as concentrations at the other sites (P<0.01). Breast feather mercury did not vary among sites within a given sampling year (site means ranged from 0.98 +/- 0.69 to 2.71 +/- 2.93 ppm). Mean P1 mercury in alterus (2.96 +/- 1.84 ppm fw) was significantly lower than in any other sampled population (5.25 +/- 2.24-6.77 +/- 3.51 ppm; P <= 0.03). Conclusions/Significance: Our study further characterized mercury in Nelson's Sparrows near Grand Forks; we documented localized and potentially harmful mercury concentrations, indicating that this area may represent a biological mercury hotspot. This finding warrants further research to determine if wildlife populations of conservation or recreational interest in this area may be experiencing negative effects due to mercury exposure. We present preliminary conclusions about the risk of each sampled population to mercury exposure.	[Winder, Virginia L.; Emslie, Steven D.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Winder, VL (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	vlw3056@uncw.edu			National Oceanic and Atmospheric Administration (NOAA); Ralph Brauer Fellowship, Sigma Xi; Eastern Bird Banding Association; North Carolina SeaGrant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Ralph Brauer Fellowship, Sigma Xi; Eastern Bird Banding Association; North Carolina SeaGrant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	Funding and support for this project were provided by National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship (http://www.nerrs.noaa.gov/), Ralph Brauer Fellowship, Sigma Xi Grants in Aid of Research (http://www.sigmaxi.org/), Eastern Bird Banding Association (http://www.frontiernet.net/similar to bpbird/index.htm), North Carolina SeaGrant (http://www.ncseagrant.org/), the James and Francis Parnell Fellowship, and the Department of Biology and Marine Biology at the University of North Carolina Wilmington (http://www.uncw.edu/bio/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayard TS, 2011, AUK, V128, P393, DOI 10.1525/auk.2011.10178; Bearhop S, 2000, ENVIRON TOXICOL CHEM, V19, P1638, DOI [10.1002/etc.5620190622, 10.1897/1551-5028(2000)019&lt;1638:DOMIBA&gt;2.3.CO;2]; Bechard MJ, 2009, B ENVIRON CONTAM TOX, V83, P698, DOI 10.1007/s00128-009-9848-8; Bodaly RA, 2004, ENVIRON SCI TECHNOL, V38, p346A, DOI 10.1021/es040614u; Brasso RL, 2008, ECOTOXICOLOGY, V17, P133, DOI 10.1007/s10646-007-0163-z; Brigham ME, 2002, WATER AIR SOIL POLL, V138, P61, DOI 10.1023/A:1015573621474; Burger J, 1996, AUK, V113, P339; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Cristol DA, 2008, SCIENCE, V320, P335, DOI 10.1126/science.1154082; Cristol DA, 2011, ECOTOXICOLOGY, V20, P1773, DOI 10.1007/s10646-011-0710-5; Custer TW, 2008, ENVIRON POLLUT, V155, P217, DOI 10.1016/j.envpol.2007.12.003; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Evers DC, 2011, ECOTOXICOLOGY, V20, P1487, DOI 10.1007/s10646-011-0784-0; Evers DC, 2005, ECOTOXICOLOGY, V14, P193, DOI 10.1007/s10646-004-6269-7; Evers DC, 2004, ASSESSING IMPACTS ME, P69; Greenlaw JS, 2007, WILSON J ORNITHOL, V119, P361, DOI 10.1676/05-152.1; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Kahle S, 1999, CHEMOSPHERE, V39, P2451, DOI 10.1016/S0045-6535(99)00154-X; Lane OP, 2011, ECOTOXICOLOGY, V20, P1984, DOI 10.1007/s10646-011-0740-z; Lane OP, 2006, METHYLMERCURY AVAILA, P27; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; RICH TD, 2004, PARTNERS FLIGHT N AM; Sando SK, 2007, 20075219 US GEOL SUR, P66; Shriver W. Gregory, 2006, Environmental Bioindicators, V1, P129, DOI 10.1080/15555270600695734; Snodgrass JW, 2000, CAN J FISH AQUAT SCI, V57, P171, DOI 10.1139/cjfas-57-1-171; U.S. EPA, 2007, 7473 US EPA; *US FISH WILDL SER, 2002, BIRDS CONS CONC 2002; WILLIAMS TP, 1994, MAR POLLUT BULL, V28, P277, DOI 10.1016/0025-326X(94)90152-X; Winder VL, 2011, ECOTOXICOLOGY, V20, P218, DOI 10.1007/s10646-010-0573-1; Winder VL, 2011, ECOTOXICOLO IN PRESS; WOLFE MF, 2003, ECOSYSTEM RESPONSES, P123	33	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32257	10.1371/journal.pone.0032257	http://dx.doi.org/10.1371/journal.pone.0032257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384194	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500090
J	Kahali, S; Sarcar, B; Prabhu, A; Seto, E; Chinnaiyan, P				Kahali, Soumen; Sarcar, Bhaswati; Prabhu, Antony; Seto, Edward; Chinnaiyan, Prakash			Class I histone deacetylases localize to the endoplasmic reticulum and modulate the unfolded protein response	FASEB JOURNAL			English	Article						HDAC inhibitor; GRP78; acetylation	CHAPERONE FUNCTION; CANCER CELLS; ER STRESS; ACETYLATION; ACTIVATION; INHIBITORS; EXPRESSION; GROWTH; DOMAIN; ATF6	Post-translational modification through protein acetylation is emerging as an important mode of cellular regulation. We have previously demonstrated the role that glucose-regulated protein 78 kDa (GRP78) acetylation and subsequent activation of the unfolded protein response (UPR) play in the antitumor activity of class I histone deacetylase (HDAC) inhibitors, which primarily target class I HDACs. In this study, we explored the contributory role these class I HDACs may play in UPR regulation. Binding studies were performed using immunoprecipitation/immunoblotting following dual-transfection with HA-tagged GRP78 and FLAG-tagged HDACs. Subcellular localization was performed using Western blot of fractionated cell lysates and confocal microscopy. Individual HDACs were inhibited using RNA interference. We identified the potential of HDACs 1, 2, and 3 to bind to GRP78. These HDACs colocalized with GRP78 in the endoplasmic reticulum (ER). Inhibition of individual HDACs resulted in GRP78 acetylation and selective activation of the UPR. Although traditionally viewed as nuclear enzymes, we demonstrate that Class I HDACs localize to the ER, bind to GRP78, and selectively activate the UPR, representing a novel mode of UPR regulation and mechanism of action of HDAC inhibitors.-Kahali, S., Sarcar, B., Prabhu, A., Seto, E., Chinnaiyan, P. Class I histone deacetylases localize to the endoplasmic reticulum and modulate the unfolded protein response. FASEB J. 26, 2437-2445 (2012). www.fasebj.org	[Kahali, Soumen; Sarcar, Bhaswati; Prabhu, Antony; Chinnaiyan, Prakash] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA; [Kahali, Soumen; Sarcar, Bhaswati; Prabhu, Antony; Chinnaiyan, Prakash] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA; [Seto, Edward] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chinnaiyan, P (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol & Expt Therapeut, SRB3,12902 Magnolia Dr, Tampa, FL 33612 USA.	prakash.chinnaiyan@moffitt.org	Dayalan, Antony Herold Prabhu Packiam/J-8625-2019	Dayalan, Antony Herold Prabhu Packiam/0000-0003-2401-0118	American Cancer Society [RSG-11-029-01-CSM]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge Joseph Johnson (Moffitt Imaging Core Facility, H. Lee Moffitt Cancer Center) for assistance with confocal microscopy. This work was funded by the American Cancer Society (RSG-11-029-01-CSM).	Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dangond F, 2001, INT J ONCOL, V19, P773; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Kahali S, 2011, METHOD ENZYMOL, V490, P159, DOI 10.1016/B978-0-12-385114-7.00010-6; Kahali S, 2010, NEOPLASIA, V12, P80, DOI 10.1593/neo.91422; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; MacDonald VE, 2009, EPIGENETICS-US, V4, P139, DOI 10.4161/epi.4.3.8484; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Park JJ, 2007, J GEN VIROL, V88, P3214, DOI 10.1099/vir.0.83171-0; Rao R, 2010, MOL CANCER THER, V9, P942, DOI 10.1158/1535-7163.MCT-09-0988; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu XD, 2002, J NATL CANCER I, V94, P504; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	35	34	34	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2437	2445		10.1096/fj.11-193706	http://dx.doi.org/10.1096/fj.11-193706			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22389438	Green Published			2022-12-25	WOS:000305017200021
J	Zheng, M; Kim, SK; Joe, Y; Back, SH; Cho, HR; Kim, HP; Ignarro, LJ; Chung, HT				Zheng, Min; Kim, Seul-Ki; Joe, Yeonsoo; Back, Sung Hoon; Cho, Hong R.; Kim, Hong Pyo; Ignarro, Louis J.; Chung, Hun-Taeg			Sensing endoplasmic reticulum stress by protein kinase RNA-like endoplasmic reticulum kinase promotes adaptive mitochondrial DNA biogenesis and cell survival via heme oxygenase-1/carbon monoxide activity	FASEB JOURNAL			English	Article						unfolded protein response; nuclear factor E2-related factor2; Nrf2; nuclear respiratory factor-1; NRF-1; mitochondrial transcription factor A; TFAM	NITRIC-OXIDE; MUSCLE-CELLS; DIFFERENTIATION; APOPTOSIS; INDUCTION	Endoplasmic reticulum (ER) stress activates the adaptive unfolded protein response, allowing cells to recover folding capacity in the organelle. However, the overwhelming response to severe damage results in apoptotic cell death. Because of the physical proximity between ER and mitochondria, a functional interrelationship between these two organelles, including mitochondrial ATP production and apoptosis, has been suggested. The adaptive response to ER stress includes the maintenance of cellular energetics, which eventually determines cell fate. We previously demonstrated that heme oxygenase-1 (HO-1) activity protects cells against ER stress in a protein kinase RNA-like endoplasmic reticulum kinase (PERK)-dependent pathway. Here, we provide evidence that PERK-mediated induction of HO-1 in murine macrophages, RAW264.7, relays ER stress to mitochondrial DNA (mtDNA) replication and function. ER stress induced by thapsigargin treatments (10-100 nM) resulted in a 2-fold increase in mtDNA contents compared with that in the untreated control. HO-1 activity on ER stress is proven to be critical for mitochondrial integrity because chemical inhibition (zinc protoporphyrin, 5-20 mu M) and genetic depletion of HO-1 by small interference RNA transfection suppress the activation of transcription factors for mitochondrial biogenesis. Carbon monoxide (CO), an enzymatic by-product of HO-1 activity is responsible for the function of HO-1. Limited bioavailability of CO by hemoglobin treatment triggers cell death with a concomitant decline in ATP production. Approximately 78.1% of RAW264.7 cells were damaged in the presence of hemoglobin compared with the percentage of injured cells (26.9%) under ER stress alone. Mitochondrial generation of ATP levels significantly declined when CO availability was limited under prolonged ER stress. Taken together, these results suggest that the cellular HO-1/CO system conveys ER stress to cell survival signals from mitochondria via both the activation of transcriptional factors and functional integrity of mtDNA.-Zheng, M., Kim, S.-K., Joe, Y., Back, S. H., Cho, H. R., Kim, H. P., Ignarro, L. J., Chung, H.-T. Sensing endoplasmic reticulum stress by protein kinase RNA-like endoplasmic reticulum kinase promotes adaptive mitochondrial DNA biogenesis and cell survival via heme oxygenase-1/carbon monoxide activity. FASEB J. 26, 2558-2568 (2012). www.fasebj.org	[Zheng, Min; Cho, Hong R.] Univ Ulsan, Dept Surg, Ulsan Univ Hosp, World Class Univ, Ulsan 680749, South Korea; [Zheng, Min; Cho, Hong R.] Univ Ulsan, Sch Med, World Class Univ, Ulsan 680749, South Korea; [Kim, Seul-Ki; Joe, Yeonsoo; Back, Sung Hoon; Kim, Hong Pyo; Chung, Hun-Taeg] Univ Ulsan, Sch Biol Sci, World Class Univ, Ulsan 680749, South Korea; [Ignarro, Louis J.] Konkuk Univ, Sch Med, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; University of Ulsan; Konkuk University; Konkuk University Medical Center	Zheng, M (corresponding author), Univ Ulsan, Dept Surg, Ulsan Univ Hosp, World Class Univ, Ulsan 680749, South Korea.	chung@ulsan.ac.kr			Korea Research Foundation; Korean Government (MOEHRD) [BRL-2010-0001199]	Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Research Foundation, funded by the Korean Government (MOEHRD; BRL-2010-0001199). Author contributions: H. P. K., L. J. I., and H.-T. C. designed research; M. Z., S.-K. K., and Y. J. performed research; S. H. B. and H. R. C. analyzed data; and H. P. K., L. J. I., and H. T. C. wrote the article.	Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Burgess A, 2010, HYPERTENSION, V56, P1124, DOI 10.1161/HYPERTENSIONAHA.110.151423; Choi BM, 2004, BIOCHEM BIOPH RES CO, V321, P132, DOI 10.1016/j.bbrc.2004.06.120; Choumar A, 2011, ANTIOXID REDOX SIGN, V15, P2837, DOI 10.1089/ars.2010.3713; Chung J, 2011, MOL IMMUNOL, V48, P1793, DOI 10.1016/j.molimm.2011.05.014; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Jahnke VE, 2009, AM J PHYSIOL-CELL PH, V296, pC1185, DOI 10.1152/ajpcell.00377.2008; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; Kim HP, 2011, BIOCHEM BIOPH RES CO, V404, P1, DOI 10.1016/j.bbrc.2010.11.067; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Park YC, 1996, IMMUNOLOGY, V87, P296, DOI 10.1046/j.1365-2567.1996.456544.x; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	28	33	34	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2558	2568		10.1096/fj.11-199604	http://dx.doi.org/10.1096/fj.11-199604			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22391129				2022-12-25	WOS:000305017200032
J	Hall, KL; Volk-Draper, LD; Flister, MJ; Ran, S				Hall, Kelly L.; Volk-Draper, Lisa D.; Flister, Michael J.; Ran, Sophia			New Model of Macrophage Acquisition of the Lymphatic Endothelial Phenotype	PLOS ONE			English	Article							GROWTH-FACTOR-C; NF-KAPPA-B; EMBRYONIC STEM-CELLS; FACTOR RECEPTOR-3; VEGF-C; TIE2-EXPRESSING MONOCYTES; INDUCED LYMPHANGIOGENESIS; TUMOR LYMPHANGIOGENESIS; PROGENITOR CELLS; VESSEL FORMATION	Background: Macrophage-derived lymphatic endothelial cell progenitors (M-LECPs) contribute to new lymphatic vessel formation, but the mechanisms regulating their differentiation, recruitment, and function are poorly understood. Detailed characterization of M-LECPs is limited by low frequency in vivo and lack of model systems allowing in-depth molecular analyses in vitro. Our goal was to establish a cell culture model to characterize inflammation-induced macrophage-to-LECP differentiation under controlled conditions. Methodology/Principal Findings: Time-course analysis of diaphragms from lipopolysaccharide (LPS)-treated mice revealed rapid mobilization of bone marrow-derived and peritoneal macrophages to the proximity of lymphatic vessels followed by widespread (similar to 50%) incorporation of M-LECPs into the inflamed lymphatic vasculature. A differentiation shift toward the lymphatic phenotype was found in three LPS-induced subsets of activated macrophages that were positive for VEGFR-3 and many other lymphatic-specific markers. VEGFR-3 was strongly elevated in the early stage of macrophage transition to LECPs but undetectable in M-LECPs prior to vascular integration. Similar transient pattern of VEGFR-3 expression was found in RAW264.7 macrophages activated by LPS in vitro. Activated RAW264.7 cells co-expressed VEGF-C that induced an autocrine signaling loop as indicated by VEGFR-3 phosphorylation inhibited by a soluble receptor. LPS-activated RAW264.7 macrophages also showed a 68% overlap with endogenous CD11b(+)/VEGFR-3(+) LECPs in the expression of lymphatic-specific genes. Moreover, when injected into LPS- but not saline-treated mice, GFP-tagged RAW264.7 cells massively infiltrated the inflamed diaphragm followed by integration into 18% of lymphatic vessels. Conclusions/Significance: We present a new model for macrophage-LECP differentiation based on LPS activation of cultured RAW264.7 cells. This system designated here as the "RAW model" mimics fundamental features of endogenous M-LECPs. Unlike native LECPs, this model is unrestricted by cell numbers, heterogeneity of population, and ability to change genetic composition for experimental purposes. As such, this model can provide a valuable tool for understanding the LECP and lymphatic biology.	[Hall, Kelly L.; Volk-Draper, Lisa D.; Flister, Michael J.; Ran, Sophia] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Hall, KL (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA.	sran@siumed.edu			National Institutes of Health [2R01-CA140732]; Illinois William E. McElroy Foundation; NATIONAL CANCER INSTITUTE [R01CA140732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois William E. McElroy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by grants from the National Institutes of Health (2R01-CA140732) and Illinois William E. McElroy Foundation, awarded to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bogos K, 2009, CLIN CANCER RES, V15, P1741, DOI 10.1158/1078-0432.CCR-08-1372; Buttler K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-43; Cimato T, 2009, CIRCULATION, V119, P2170, DOI 10.1161/CIRCULATIONAHA.109.849596; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Conrad C, 2009, CIRCULATION, V119, P281, DOI 10.1161/CIRCULATIONAHA.108.793208; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Flister MJ, 2011, MICROCIRCULATION, V18, P85, DOI 10.1111/j.1549-8719.2010.00057.x; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Ganta VC, 2010, INFLAMM BOWEL DIS, V16, P1029, DOI 10.1002/ibd.21150; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Henno A, 2009, BRIT J DERMATOL, V160, P581, DOI 10.1111/j.1365-2133.2008.08889.x; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Jeon BH, 2008, CANCER RES, V68, P1100, DOI 10.1158/0008-5472.CAN-07-2572; Jiang SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003812; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kim KE, 2009, AM J PATHOL, V175, P1733, DOI 10.2353/ajpath.2009.090133; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kono T, 2006, ARTERIOSCL THROM VAS, V26, P2070, DOI 10.1161/01.ATV.0000225770.57219.b0; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Lin FJ, 2010, J CLIN INVEST, V120, P1694, DOI 10.1172/JCI40101; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Mouta Carla, 2003, Lymphat Res Biol, V1, P201, DOI 10.1089/153968503768330247; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Olszewski Waldemar L, 2003, Lymphat Res Biol, V1, P11, DOI 10.1089/15396850360495655; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; RALPH P, 1977, J IMMUNOL, V119, P950; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shin WS, 2008, ANN NY ACAD SCI, V1131, P50, DOI 10.1196/annals.1413.005; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Suzuki H, 2005, BLOOD, V105, P2372, DOI 10.1182/blood-2004-07-2547; Trompezinski S, 2004, EXP DERMATOL, V13, P98, DOI 10.1111/j.0906-6705.2004.00137.x; TSO P, 1985, AM J PHYSIOL, V249, pG21, DOI 10.1152/ajpgi.1985.249.1.G21; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Young PP, 2011, CANCER MICROENVIRON, V4, P1, DOI 10.1007/s12307-010-0045-4; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	63	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e31794	10.1371/journal.pone.0031794	http://dx.doi.org/10.1371/journal.pone.0031794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396739	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500008
J	Chen, WF; Liu, CH; Nakabayashi, K				Chen, Wenfeng; Liu, Chang Hong; Nakabayashi, Kazuyo			Beauty Hinders Attention Switch in Change Detection: The Role of Facial Attractiveness and Distinctiveness	PLOS ONE			English	Article							HIGH-LEVEL POP; FACES; PERCEPTION; ADVANTAGE; CROWD	Background: Recent research has shown that the presence of a task-irrelevant attractive face can induce a transient diversion of attention from a perceptual task that requires covert deployment of attention to one of the two locations. However, it is not known whether this spontaneous appraisal for facial beauty also modulates attention in change detection among multiple locations, where a slower, and more controlled search process is simultaneously affected by the magnitude of a change and the facial distinctiveness. Using the flicker paradigm, this study examines how spontaneous appraisal for facial beauty affects the detection of identity change among multiple faces. Methodology/Principal Findings: Participants viewed a display consisting of two alternating frames of four faces separated by a blank frame. In half of the trials, one of the faces (target face) changed to a different person. The task of the participant was to indicate whether a change of face identity had occurred. The results showed that (1) observers were less efficient at detecting identity change among multiple attractive faces relative to unattractive faces when the target and distractor faces were not highly distinctive from one another; and (2) it is difficult to detect a change if the new face is similar to the old. Conclusions/Significance: The findings suggest that attractive faces may interfere with the attention-switch process in change detection. The results also show that attention in change detection was strongly modulated by physical similarity between the alternating faces. Although facial beauty is a powerful stimulus that has well-demonstrated priority, its influence on change detection is easily superseded by low-level image similarity. The visual system appears to take a different approach to facial beauty when a task requires resource-demanding feature comparisons.	[Chen, Wenfeng] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Liu, Chang Hong; Nakabayashi, Kazuyo] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Hull	Chen, WF (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	c.h.liu@hull.ac.uk	Chen, Wenfeng/H-2424-2012	Chen, Wenfeng/0000-0002-4271-8366	Royal Society; Chinese Ministry of Science and Technology [2011CB302201]	Royal Society(Royal Society of London); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This study was sponsored by grants from the Royal Society and the 973 program (2011CB302201) of the Chinese Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website: http://royalsociety.org/http://www.973.gov.cn/	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hein E, 2006, VIS COGN, V13, P29, DOI 10.1080/13506280500143524; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Light L.L., 1981, PERSONALITY SOCIAL P, V7, P269, DOI [10.1177/014616728172014, DOI 10.1177/014616728172014]; Maner JK, 2007, EVOL HUM BEHAV, V28, P28, DOI 10.1016/j.evolhumbehav.2006.05.006; Mitroff SR, 2002, J EXP PSYCHOL HUMAN, V28, P798, DOI 10.1037//0096-1523.28.4.798; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Olson IR, 2005, EMOTION, V5, P498, DOI 10.1037/1528-3542.5.4.498; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Peskin M, 2004, PERCEPTION, V33, P147, DOI 10.1068/p5028; Pinkham AE, 2010, EMOTION, V10, P141, DOI 10.1037/a0017387; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rensink RA, 2000, VIS COGN, V7, P345, DOI 10.1080/135062800394847; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Ryu JJ, 2007, PERCEPTION, V36, P1057, DOI 10.1068/p5751; Smilek D, 2000, J EXP PSYCHOL HUMAN, V26, P480, DOI 10.1037/0096-1523.26.2.480; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; Sui J, 2009, PSYCHON B REV, V16, P276, DOI 10.3758/PBR.16.2.276; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; VanRullen R, 2006, VISION RES, V46, P3017, DOI 10.1016/j.visres.2005.07.009; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wickham LHV, 2003, AM J PSYCHOL, V116, P455, DOI 10.2307/1423503; Yang CT, 2009, VIS COGN, V17, P484, DOI 10.1080/13506280701822991	26	15	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32897	10.1371/journal.pone.0032897	http://dx.doi.org/10.1371/journal.pone.0032897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393457	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500112
J	De la Fuente, IM; Cortes, JM				De la Fuente, Ildefonso M.; Cortes, Jesus M.			Quantitative Analysis of the Effective Functional Structure in Yeast Glycolysis	PLOS ONE			English	Article							CHAOS; INFORMATION; OSCILLATIONS; ORGANIZATION; SUBSTRATE; PATHWAYS; DYNAMICS; EXTRACTS; ROUTE; MODEL	The understanding of the effective functionality that governs the enzymatic self-organized processes in cellular conditions is a crucial topic in the post-genomic era. In recent studies, Transfer Entropy has been proposed as a rigorous, robust and self-consistent method for the causal quantification of the functional information flow among nonlinear processes. Here, in order to quantify the functional connectivity for the glycolytic enzymes in dissipative conditions we have analyzed different catalytic patterns using the technique of Transfer Entropy. The data were obtained by means of a yeast glycolytic model formed by three delay differential equations where the enzymatic rate equations of the irreversible stages have been explicitly considered. These enzymatic activity functions were previously modeled and tested experimentally by other different groups. The results show the emergence of a new kind of dynamical functional structure, characterized by changing connectivity flows and a metabolic invariant that constrains the activity of the irreversible enzymes. In addition to the classical topological structure characterized by the specific location of enzymes, substrates, products and feedback-regulatory metabolites, an effective functional structure emerges in the modeled glycolytic system, which is dynamical and characterized by notable variations of the functional interactions. The dynamical structure also exhibits a metabolic invariant which constrains the functional attributes of the enzymes. Finally, in accordance with the classical biochemical studies, our numerical analysis reveals in a quantitative manner that the enzyme phosphofructokinase is the key-core of the metabolic system, behaving for all conditions as the main source of the effective causal flows in yeast glycolysis.	[De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.] Inst Invest Sanitarias Biocruces, Baracaldo, Spain; [Cortes, Jesus M.] Univ Granada, DECSAI Dept Ciencias Comp & Inteligencia Artifici, Granada, Spain; [Cortes, Jesus M.] Univ Granada, CITIC, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; University of Granada	De la Fuente, IM (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mtpmadei@ehu.es	Cortes, Jesus/D-9949-2012; , Ivan/D-6804-2012	Cortes, Jesus/0000-0002-9059-8194; De la Fuente, Ildefonso/0000-0001-6548-7583; , Ivan/0000-0002-3108-058X	Consejo Superior Investigaciones Cientificas (CSIC) [201020I026]; Ministerio de Ciencia e Innovacion (MICINN), CEI BioTIC GENIL [PYR-2010-14]; Ministerio de Ciencia e Innovacion (MICINN); Junta de Andalucia [P09-FQM-4682, P07-FQM-02725]	Consejo Superior Investigaciones Cientificas (CSIC); Ministerio de Ciencia e Innovacion (MICINN), CEI BioTIC GENIL(Ministry of Science and Innovation, Spain (MICINN)); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	Consejo Superior Investigaciones Cientificas (CSIC), Ref. 201020I026. Ministerio de Ciencia e Innovacion (MICINN), CEI BioTIC GENIL, Ref. PYR-2010-14. Ministerio de Ciencia e Innovacion (MICINN), programa Ramon y Cajal. Junta de Andalucia, Refs. P09-FQM-4682 and P07-FQM-02725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; BOITEUX A, 1975, P NATL ACAD SCI USA, V72, P3829, DOI 10.1073/pnas.72.10.3829; CHANCE B, 1964, BIOCHEM BIOPH RES CO, V16, P182, DOI 10.1016/0006-291X(64)90358-4; Colussi C, 2006, FASEB J, V14; Cover TM, 1991, ELEMENTS INFORM THEO; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; De la Fuente IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027224; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DUYSENS LNM, 1957, BIOCHIM BIOPHYS ACTA, V24, P19, DOI 10.1016/0006-3002(57)90141-5; Ebeling W, 1986, SELFORGANIZATION NON; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fujita A, 2007, BIOINFORMATICS, V23, P1623, DOI 10.1093/bioinformatics/btm151; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; GOLDBETT.A, 1973, P NATL ACAD SCI USA, V70, P3255, DOI 10.1073/pnas.70.11.3255; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; KAUFFMAN SA, 1991, J THEOR BIOL, V149, P467, DOI 10.1016/S0022-5193(05)80094-3; MARKUS M, 1985, BER BUNSEN PHYS CHEM, V89, P651, DOI 10.1002/bbpc.19850890617; MARKUS M, 1984, FEBS LETT, V172, P235, DOI 10.1016/0014-5793(84)81132-1; MARKUS M, 1980, BIOCHEM J, V189, P421, DOI 10.1042/bj1890421; MARKUS M, 1985, BIOPHYS CHEM, V22, P95, DOI 10.1016/0301-4622(85)80030-2; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Nicolis G., 1977, SELF ORG NONEQUILIBR; Olsen L, 2009, BIOPHYS J, V96; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; PRIGOGINE I, 1977, P NATL ACAD SCI USA, V74, P4152, DOI 10.1073/pnas.74.10.4152; RUELLE D, 1971, COMMUN MATH PHYS, V20, P167, DOI 10.1007/BF01646553; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Serrano G, 1989, YEASTS; Sorensen P, 2005, FEBS J, V272; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Termonia Y, 1981, P NATL ACAD SCI USA, V78; VIOLA RE, 1982, BIOCHEMISTRY-US, V21, P1295, DOI 10.1021/bi00535a029; Vlassenkoa A, 2010, P NATL ACAD SCI US; Wolf J, 2000, BIOPHYS J, V78, P1145, DOI 10.1016/S0006-3495(00)76672-0	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30162	10.1371/journal.pone.0030162	http://dx.doi.org/10.1371/journal.pone.0030162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393350	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500003
J	Hulsmans, M; Van Dooren, E; Mathieu, C; Holvoet, P				Hulsmans, Maarten; Van Dooren, Els; Mathieu, Chantal; Holvoet, Paul			Decrease of miR-146b-5p in Monocytes during Obesity Is Associated with Loss of the Anti-Inflammatory but Not Insulin Signaling Action of Adiponectin	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; GLOBULAR ADIPONECTIN; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; KAPPA-B; MICRORNAS; INFLAMMATION; EXPRESSION; GENERATION; RESISTANCE	Background: Low adiponectin, a well-recognized antidiabetic adipokine, has been associated with obesity-related inflammation, oxidative stress and insulin resistance. Globular adiponectin is an important regulator of the interleukin-1 receptor-associated kinase (IRAK)/NF kappa B pathway in monocytes of obese subjects. It protects against inflammation and oxidative stress by inducing IRAK3. microRNA (miR)-146b-5p inhibits NF kappa B-mediated inflammation by targeted repression of IRAK1 and TNF receptor-associated factor-6 (TRAF6). Therefore, we measured the expression of miR-146b-5p in monocytes of obese subjects. Because it was low we determined the involvement of this miR in the anti-inflammatory, antioxidative and insulin signaling action of globular adiponectin. Methods: miR-146b-5p expression in monocytes of obese subjects was determined by qRT-PCR. The effect of miR-146b-5p silencing on molecular markers of inflammation, oxidative stress and insulin signaling and the association with globular adiponectin was assessed in human THP-1 monocytes. Results: miR-146b-5p was downregulated in monocytes of obese persons. Low globular adiponectin decreased miR-146b5p and IRAK3 in THP-1 monocytes, associated with increased mitochondrial reactive oxygen species (ROS). Intracellular ROS and insulin receptor substrate-1 (IRS1) protein were unchanged. Silencing of miR-146b-5p with an antisense inhibitor resulted in increased expression of IRAK1 and TRAF6 leading to more NF kappa B p65 DNA binding activity and TNF alpha. As a response IRAK3 and IRS1 protein increased. Mitochondrial and intracellular ROS production did not increase despite more inflammation. In addition, exposure of miR-146b-5p-depleted THP-1 monocytes to high levels of globular adiponectin resulted in an increased production of TNF alpha and intracellular ROS. Still, they did not lose their potential to increase IRAK3 and IRS1 protein and to decrease mitochondrial ROS. Conclusion: miR-146b-5p, decreased in monocytes during obesity, is a major mediator of the anti-inflammatory action of globular adiponectin. It appears not to be involved in insulin signaling possibly by protective response of IRAK3 and lack of mitochondrial ROS production.	[Hulsmans, Maarten; Van Dooren, Els; Holvoet, Paul] Katholieke Univ Leuven, Dept Cardiovasc Sci, Atherosclerosis & Metab Unit, Louvain, Belgium; [Mathieu, Chantal] Katholieke Univ Leuven, Dept Clin & Expt Med, Clin & Expt Endocrinol Unit, Louvain, Belgium	KU Leuven; KU Leuven	Hulsmans, M (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Atherosclerosis & Metab Unit, Louvain, Belgium.	paul.holvoet@med.kuleuven.be	Hulsmans, Maarten/AAI-9547-2020; Xie, Huangming/B-2260-2012; HOLVOET, PAUL/T-8434-2017; mathieu, chantal/ABD-5505-2021	Hulsmans, Maarten/0000-0003-1009-658X; HOLVOET, PAUL/0000-0001-9201-0772; mathieu, chantal/0000-0002-4055-5233	Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven [PF/10/014]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G0846.11]; Vascular Biology Network	Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven(KU Leuven); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Vascular Biology Network	Funding was provided by the Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven (PF/10/014) and by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G0846.11, and Vascular Biology Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Cardellini M, 2011, DIABETES, V60, P3265, DOI 10.2337/db11-0162; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Haugen F, 2007, ENDOCRINOLOGY, V148, P5478, DOI 10.1210/en.2007-0370; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Holvoet P, 2006, ARTERIOSCL THROM VAS, V26, P1558, DOI 10.1161/01.ATV.0000226553.01555.02; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030414; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Johnsen SH, 2005, STROKE, V36, P715, DOI 10.1161/01.STR.0000158909.07634.83; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Patino R, 2000, AM J CARDIOL, V85, P1288, DOI 10.1016/S0002-9149(00)00757-8; Pickl WF, 1996, J IMMUNOL, V157, P3850; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rovin BH, 2006, CLIN IMMUNOL, V120, P99, DOI 10.1016/j.clim.2006.01.010; Salio M, 2000, EUR J IMMUNOL, V30, P705, DOI 10.1002/1521-4141(200002)30:2<705::AID-IMMU705>3.0.CO;2-P; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vickers Kasey C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P150, DOI 10.1097/MED.0b013e32833727a1; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zhang P, 2009, ARTERIOSCL THROM VAS, V29, P67, DOI 10.1161/ATVBAHA.108.178061	44	67	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32794	10.1371/journal.pone.0032794	http://dx.doi.org/10.1371/journal.pone.0032794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393448	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500102
J	Lemons, D; Pare, A; McGinnis, W				Lemons, Derek; Pare, Adam; McGinnis, William			Three Drosophila Hox Complex microRNAs Do Not Have Major Effects on Expression of Evolutionarily Conserved Hox Gene Targets during Embryogenesis	PLOS ONE			English	Article							MESSENGER-RNAS; ABDOMINAL-B; POSTTRANSCRIPTIONAL REGULATION; BITHORAX-COMPLEX; TRANSCRIPTION; SPECIFICITY; PREDICTION; MIR-196; IMPACT; IDENTIFICATION	The discovery of microRNAs has resulted in a major expansion of the number of molecules known to be involved in gene regulation. Elucidating the functions of animal microRNAs has posed a significant challenge as their target interactions with messenger RNAs do not adhere to simple rules. Of the thousands of known animal microRNAs, relatively few microRNA: messenger RNA regulatory interactions have been biologically validated in an normal organismal context. Here we present evidence that three microRNAs from the Hox complex in Drosophila (miR-10-5p, miR-10-3p, miR-iab-4-5p) do not have significant effects during embryogenesis on the expression of Hox genes that contain high confidence microRNAs target sites in the 39 untranslated regions of their messenger RNAs. This is significant, in that it suggests that many predicted microRNA-target interactions may not be biologically relevant, or that the outcomes of these interactions may be so subtle that mutants may only show phenotypes in specific contexts, such as in environmental stress conditions, or in combinations with other microRNA mutations.	[Lemons, Derek; Pare, Adam; McGinnis, William] Univ Calif San Diego, Div Biol Sci, Sect Cellular & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lemons, D (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cellular & Dev Biol, La Jolla, CA 92093 USA.	wmcginnis@ucsd.edu			NIH [HD28315, T32GM007240]; family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH Grant HD28315 (to W.M.), National Institutes of Health Training Grant T32GM007240 (to D.L. and A.P.), and funds from the family of Herbert Stern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 1999, DEVELOPMENT, V126, P1121; Akbari OS, 2006, DEV BIOL, V293, P294, DOI 10.1016/j.ydbio.2006.02.015; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; BERGSON C, 1990, EMBO J, V9, P4287, DOI 10.1002/j.1460-2075.1990.tb07877.x; BERMINGHAM JR, 1990, DEVELOPMENT, V109, P553; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; DELORENZI M, 1990, DEVELOPMENT, V108, P323; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Ho MCW, 2009, INT J DEV BIOL, V53, P459, DOI 10.1387/ijdb.082647mh; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIORA MA, 1988, EMBO J, V7, P3233, DOI 10.1002/j.1460-2075.1988.tb03190.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 1998, DEVELOPMENT, V125, P4077; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; PATTATUCCI AM, 1991, GENETICS, V129, P423; Pederson JD, 1996, DEV BIOL, V180, P131, DOI 10.1006/dbio.1996.0290; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Thomsen S, 2010, DEVELOPMENT, V137, P2951, DOI 10.1242/dev.047324; TIONG S, 1985, MOL GEN GENET, V200, P335, DOI 10.1007/BF00425445; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Z, 2010, PLOS GENET, V6, P9; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	80	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31365	10.1371/journal.pone.0031365	http://dx.doi.org/10.1371/journal.pone.0031365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393361	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500014
J	Miranda, MR; Saye, M; Bouvier, LA; Camara, MD; Montserrat, J; Pereira, CA				Miranda, Mariana R.; Saye, Melisa; Bouvier, Leon A.; de los Milagros Camara, Maria; Montserrat, Javier; Pereira, Claudio A.			Cationic Amino Acid Uptake Constitutes a Metabolic Regulation Mechanism and Occurs in the Flagellar Pocket of Trypanosoma cruzi	PLOS ONE			English	Article							PROTOZOAN PARASITES; LEISHMANIA-DONOVANI; ARGININE KINASE; TRANSPORT; BRUCEI; EXPRESSION; AFFINITY; FAMILY	Trypanosomatids' amino acid permeases are key proteins in parasite metabolism since they participate in the adaptation of parasites to different environments. Here, we report that TcAAP3, a member of a Trypanosoma cruzi multigene family of permeases, is a bona fide arginine transporter. Most higher eukaryotic cells incorporate cationic amino acids through a single transporter. In contrast, T. cruzi can recognize and transport cationic amino acids by mono-specific permeases since a 100-fold molar excess of lysine could not affect the arginine transport in parasites that over-express the arginine permease (TcAAP3 epimastigotes). In order to test if the permease activity regulates downstream processes of the arginine metabolism, the expression of the single T. cruzi enzyme that uses arginine as substrate, arginine kinase, was evaluated in TcAAP3 epimastigotes. In this parasite model, intracellular arginine concentration increases 4-folds and ATP level remains constant until cultures reach the stationary phase of growth, with decreases of about 6-folds in respect to the controls. Interestingly, Western Blot analysis demonstrated that arginine kinase is significantly down-regulated during the stationary phase of growth in TcAAP3 epimastigotes. This decrease could represent a compensatory mechanism for the increase in ATP consumption as a consequence of the displacement of the reaction equilibrium of arginine kinase, when the intracellular arginine concentration augments and the glucose from the medium is exhausted. Using immunofluorescence techniques we also determined that TcAAP3 and the specific lysine transporter TcAAP7 co-localize in a specialized region of the plasma membrane named flagellar pocket, staining a single locus close to the flagellar pocket collar. Taken together these data suggest that arginine transport is closely related to arginine metabolism and cell energy balance. The clinical relevance of studying trypanosomatids' permeases relies on the possibility of using these molecules as a route of entry of therapeutic drugs.	[Miranda, Mariana R.; Saye, Melisa; Bouvier, Leon A.; de los Milagros Camara, Maria; Pereira, Claudio A.] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina; [Miranda, Mariana R.; Saye, Melisa; Bouvier, Leon A.; de los Milagros Camara, Maria; Pereira, Claudio A.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Montserrat, Javier] Inst Invest Ingn Genet & Biol Mol INGEBI, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Miranda, MR (corresponding author), Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina.	cpereira@retina.ar	Pereira, Claudio A/F-5382-2012	Pereira, Claudio A/0000-0001-7874-1894; SAYE, MELISA/0000-0003-0246-1356; Miranda, Mariana/0000-0002-0692-5675; Montserrat, Javier/0000-0002-1879-8044; MONTSERRAT, Josep Maria/0000-0003-3098-4605	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0685]; Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT) [PICT 2008-1209, PICT 2008-2194, PICT 2010-0289]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT)(ANPCyTFONCyT)	This study was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 0685), and Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT 2008-1209, PICT 2008-2194 and PICT 2010-0289). CAP and MRM are members of the career of scientific investigator of CONICET (Argentina); LAB and MMC are research fellows from the same institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman M, 2004, BIOCHEM BIOPH RES CO, V325, P353, DOI 10.1016/j.bbrc.2004.09.212; Alonso GD, 2001, FEBS LETT, V498, P22, DOI 10.1016/S0014-5793(01)02473-5; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bouvier LA, 2004, BIOCHEM BIOPH RES CO, V321, P547, DOI 10.1016/j.bbrc.2004.07.002; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carrillo C, 2010, FEMS MICROBIOL LETT, V306, P97, DOI 10.1111/j.1574-6968.2010.01936.x; Chollet C, 2009, BIOORGAN MED CHEM, V17, P2512, DOI 10.1016/j.bmc.2009.01.058; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Inbar E, 2010, AMINO ACIDS; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Pereira CA, 2002, FEBS LETT, V526, P111, DOI 10.1016/S0014-5793(02)03157-5; Pereira CA, 2008, MEDICINA-BUENOS AIRE, V68, P398; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	25	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32760	10.1371/journal.pone.0032760	http://dx.doi.org/10.1371/journal.pone.0032760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393446	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500100
J	Rao, RK; Riffel, P; Meyer, M; Kettnaker, PJ; Lemke, A; Haneder, S; Schoenberg, SO; Michaely, HJ				Rao, Raghuram K.; Riffel, Philipp; Meyer, Mathias; Kettnaker, Paul J.; Lemke, Andreas; Haneder, Stefan; Schoenberg, Stefan O.; Michaely, Henrik J.			Implementation of Dual-Source RF Excitation in 3 T MR-Scanners Allows for Nearly Identical ADC Values Compared to 1.5 T MR Scanners in the Abdomen	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; RENAL LESIONS CHARACTERIZATION; CARCINOMA; CHEMOTHERAPY; DESIGN; LIVER; FIELD	Background: To retrospectively and prospectively compare abdominal apparent diffusion coefficient (ADC) values obtained within in a 1.5 T system and 3 T systems with and without dual-source parallel RF excitation techniques. Methodology/Principal Findings: After IRB approval, diffusion-weighted (DW) images of the abdomen were obtained on three different MR systems (1.5 T, a first generation 3 T, and a second generation 3 T which incorporates dual-source parallel RF excitation) on 150 patients retrospectively and 19 volunteers (57 examinations total) prospectively. Seven regions of interest (ROI) were throughout the abdomen were selected to measure the ADC. Statistical analysis included independent two-sided t-tests, Mann-Whitney U tests and correlation analysis. In the DW images of the abdomen, mean ADC values were nearly identical with nonsignificant differences when comparing the 1.5 T and second generation 3 T systems in all seven anatomical regions in the patient population and six of the seven in the volunteer population (p > 0.05 in all distributions). The strength of correlation measured in the volunteer population between the two scanners in the kidneys ranged from r = 0.64-0.88 and in the remaining regions (besides the spleen), r > 0.85. In the patient population the first generation 3 T scanner had different mean ADC values with significant differences (p < 0.05) compared to the other two scanners in each of the seven distributions. In the volunteer population, the kidneys shared similar ADC mean values in comparison to the other two scanners with nonsignificant differences. Conclusions/Significance: A second generation 3 T scanner with dual-source parallel RF excitation provides nearly identical ADC values compared with the 1.5 T imaging system in abdominal imaging.	[Rao, Raghuram K.; Riffel, Philipp; Meyer, Mathias; Kettnaker, Paul J.; Haneder, Stefan; Schoenberg, Stefan O.; Michaely, Henrik J.] Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany; [Rao, Raghuram K.] Univ Texas Galveston, Med Branch, Dept Radiol, Galveston, TX 77550 USA; [Lemke, Andreas] Heidelberg Univ, Dept Comp Assisted Clin Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Medical Branch Galveston; Ruprecht Karls University Heidelberg	Rao, RK (corresponding author), Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany.	henrik.michaely@umm.de			Deutsche Forschungsgemeinschaft (DFG) [SCHO 710/2-2]; Siemens	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Siemens(Siemens AG)	This study was in part sponsored by the "Deutsche Forschungsgemeinschaft (DFG)"(SCHO 710/2-2). No additional external funding received for this study. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; H. Michaely and S. Schoenberg received travel grants (HM, SS) and speaker's honoraria (HM) from Siemens. The Institute of Clinical Radiology and Nuclear Medicine has a master research agreement with Siemens. Siemens played no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. No further disclosures exist for any of the other authors of this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; Dale BM, 2010, INVEST RADIOL, V45, P104, DOI 10.1097/RLI.0b013e3181c8ceac; Doganay S, 2011, CLIN RADIOL, V66, P420, DOI 10.1016/j.crad.2010.11.013; Harry VN, 2008, GYNECOL ONCOL, V111, P213, DOI 10.1016/j.ygyno.2008.07.048; Kamel IR, 2007, J VASC INTERV RADIOL, V18, P49, DOI 10.1016/j.jvir.2006.10.005; Kim S, 2009, RADIOLOGY, V251, P796, DOI 10.1148/radiol.2513080724; Koh DM, 2009, EUR RADIOL, V19, P2728, DOI 10.1007/s00330-009-1469-4; Kukuk GM, 2011, RADIOLOGY, V259, P421, DOI 10.1148/radiol.11101429; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Li Y, 2011, EUROPEAN J RADIOLOGY; Lowenthal D, 2011, EUR RADIOL, V21, P832, DOI 10.1007/s00330-010-1977-2; Manenti G, 2008, RADIOL MED, V113, P199, DOI 10.1007/s11547-008-0246-9; Razek AAKA, 2011, J COMPUT ASSIST TOMO, V35, P332, DOI 10.1097/RCT.0b013e318219fe76; Rosenkrantz AB, 2011, J MAGN RESON IMAGING, V33, P128, DOI 10.1002/jmri.22395; Sandrasegaran K, 2010, AM J ROENTGENOL, V194, P438, DOI 10.2214/AJR.09.3024; Saremi F, 2009, RADIOGRAPHICS, V29, P1295, DOI 10.1148/rg.295095003; Schick F, 2005, EUR RADIOL, V15, P946, DOI 10.1007/s00330-005-2678-0; Schmitz BL, 2005, AM J NEURORADIOL, V26, P2229; Shah B, 2011, RADIOGRAPHICS, V31, P867, DOI 10.1148/rg.313105155; Sun YS, 2010, RADIOLOGY, V254, P170, DOI 10.1148/radiol.2541082230; Tang L, 2011, RADIOLOGY, V258, P729, DOI 10.1148/radiol.10100402; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Taouli B, 2009, RADIOLOGY, V251, P398, DOI 10.1148/radiol.2512080880; Tofts PS, 1997, MAGN RESON IMAGING, V15, P69, DOI 10.1016/S0730-725X(96)00220-2; Wang HY, 2010, RADIOLOGY, V257, P135, DOI 10.1148/radiol.10092396; Willinek WA, 2010, RADIOLOGY, V256, P966, DOI 10.1148/radiol.10092127; Zhang JL, 2010, RADIOLOGY, V254, P783, DOI 10.1148/radiol.09090891	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32613	10.1371/journal.pone.0032613	http://dx.doi.org/10.1371/journal.pone.0032613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393422	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500074
J	Ahmadpour, F; Ghirlando, R; De Jong, AT; Gloyd, M; Shin, JA; Guarne, A				Ahmadpour, Faraz; Ghirlando, Rodolfo; De Jong, Antonia T.; Gloyd, Melanie; Shin, Jumi A.; Guarne, Alba			Crystal Structure of the Minimalist Max-E47 Protein Chimera	PLOS ONE			English	Article							DOMAIN-DNA COMPLEX; ANALYTICAL ULTRACENTRIFUGATION; INDUCED-DIFFERENTIATION; SEDIMENTATION-VELOCITY; COGNATE DNA; C-MYC; TRANSCRIPTION; BINDING; MAX; HELIX	Max-E47 is a protein chimera generated from the fusion of the DNA-binding basic region of Max and the dimerization region of E47, both members of the basic region/helix-loop-helix (bHLH) superfamily of transcription factors. Like native Max, Max-E47 binds with high affinity and specificity to the E-box site, 5'-CACGTG, both in vivo and in vitro. We have determined the crystal structure of Max-E47 at 1.7 angstrom resolution, and found that it associates to form a well-structured dimer even in the absence of its cognate DNA. Analytical ultracentrifugation confirms that Max-E47 is dimeric even at low micromolar concentrations, indicating that the Max-E47 dimer is stable in the absence of DNA. Circular dichroism analysis demonstrates that both non-specific DNA and the E-box site induce similar levels of helical secondary structure in Max-E47. These results suggest that Max-E47 may bind to the E-box following the two-step mechanism proposed for other bHLH proteins. In this mechanism, a rapid step where protein binds to DNA without sequence specificity is followed by a slow step where specific protein: DNA interactions are fine-tuned, leading to sequence-specific recognition. Collectively, these results show that the designed Max-E47 protein chimera behaves both structurally and functionally like its native counterparts.	[Ahmadpour, Faraz; Gloyd, Melanie; Guarne, Alba] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [De Jong, Antonia T.; Shin, Jumi A.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada	McMaster University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Toronto; University Toronto Mississauga	Ahmadpour, F (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	guarnea@mcmaster.ca		Ahmadpour, Faraz/0000-0002-3861-1224	National Sciences and Engineering Research Council; Canadian Institutes of Health Research [MOP-67189]; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Discovery Grants from the National Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/) to JAS and AG, by an Operating Grant (MOP-67189) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) to AG and by the intramural research program of the National Institutes of Health to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balbo A., 2005, PROTEIN PROTEIN INTE; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Bird GH, 2002, ANAL CHEM, V74, P219, DOI 10.1021/ac010683g; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Cave JW, 2000, PROTEIN SCI, V9, P2354, DOI 10.1110/ps.9.12.2354; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Fairman R, 1997, PROTEIN SCI, V6, P175; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Kunne AGE, 1998, BIOCHEMISTRY-US, V37, P4217, DOI 10.1021/bi9725374; Larsson LG, 1997, ONCOGENE, V15, P737, DOI 10.1038/sj.onc.1201390; LARSSON LG, 1994, ONCOGENE, V9, P1247; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Longo A, 2008, BIOCHEMISTRY-US, V47, P218, DOI 10.1021/bi701527r; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luscher B, 2001, GENE, V277, P1, DOI 10.1016/S0378-1119(01)00697-7; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEIERHANS D, 1995, BIOCHEMISTRY-US, V34, P11026, DOI 10.1021/bi00035a008; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Sauve S, 2007, J MOL BIOL, V365, P1163, DOI 10.1016/j.jmb.2006.10.044; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHA M, 1995, J BIOL CHEM, V270, P19325, DOI 10.1074/jbc.270.33.19325; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wendt H, 1998, J BIOL CHEM, V273, P5735, DOI 10.1074/jbc.273.10.5735; Xu J, 2009, J AM CHEM SOC, V131, P7839, DOI 10.1021/ja901306q	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32136	10.1371/journal.pone.0032136	http://dx.doi.org/10.1371/journal.pone.0032136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389683	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600021
J	Maan, NS; Maan, S; Belaganahalli, MN; Ostlund, EN; Johnson, DJ; Nomikou, K; Mertens, PPC				Maan, Narender S.; Maan, Sushila; Belaganahalli, Manjunatha N.; Ostlund, Eileen N.; Johnson, Donna J.; Nomikou, Kyriaki; Mertens, Peter P. C.			Identification and Differentiation of the Twenty Six Bluetongue Virus Serotypes by RT-PCR Amplification of the Serotype-Specific Genome Segment 2	PLOS ONE			English	Article							COMPLETE SEQUENCE; UNITED-STATES; EPIDEMIOLOGY; ORBIVIRUS; EUROPE; NEUTRALIZATION; CATTLE; SHEEP; VP2; EMERGENCE	Bluetongue (BT) is an arthropod-borne viral disease, which primarily affects ruminants in tropical and temperate regions of the world. Twenty six bluetongue virus (BTV) serotypes have been recognised worldwide, including nine from Europe and fifteen in the United States. Identification of BTV serotype is important for vaccination programmes and for BTV epidemiology studies. Traditional typing methods (virus isolation and serum or virus neutralisation tests (SNT or VNT)) are slow (taking weeks, depend on availability of reference virus-strains or antisera) and can be inconclusive. Nucleotide sequence analyses and phylogenetic comparisons of genome segment 2 (Seg-2) encoding BTV outer-capsid protein VP2 (the primary determinant of virus serotype) were completed for reference strains of BTV-1 to 26, as well as multiple additional isolates from different geographic and temporal origins. The resulting Seg-2 database has been used to develop rapid (within 24 h) and reliable RT-PCR-based typing assays for each BTV type. Multiple primer-pairs (at least three designed for each serotype) were widely tested, providing an initial identification of serotype by amplification of a cDNA product of the expected size. Serotype was confirmed by sequencing of the cDNA amplicons and phylogenetic comparisons to previously characterised reference strains. The results from RT-PCR and sequencing were in perfect agreement with VNT for reference strains of all 26 BTV serotypes, as well as the field isolates tested. The serotype-specific primers showed no cross-amplification with reference strains of the remaining 25 serotypes, or multiple other isolates of the more closely related heterologous BTV types. The primers and RT-PCR assays developed in this study provide a rapid, sensitive and reliable method for the identification and differentiation of the twenty-six BTV serotypes, and will be updated periodically to maintain their relevance to current BTV distribution and epidemiology (http://www.reoviridae.org/dsRNA_virus_proteins/ReoID/rt-pcr-primers.htm).	[Maan, Narender S.; Maan, Sushila; Belaganahalli, Manjunatha N.; Nomikou, Kyriaki; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Viral Dis Programme, Arbovirus Mol Res Grp, Woking, Surrey, England; [Ostlund, Eileen N.; Johnson, Donna J.] Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Vet Serv, USDA, Ames, IA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; United States Department of Agriculture (USDA)	Maan, NS (corresponding author), LLR Univ Vet & Anim Sci, Dept Anim Biotechnol, Hisar, Haryana, India.	peter.mertens@iah.ac.uk	Nomikou, Kyriaki/Q-5555-2016; Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/P-1840-2018	Nomikou, Kyriaki/0000-0002-7013-1853; Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV; Commonwealth Scholarship Commission; U.S. Department of Agriculture	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV; Commonwealth Scholarship Commission; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was partly funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the European Union (EU) (SANCO/940/2002) awarded to NSM and PM. This work was also partly funded by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM; KN was involved in this study and is funded by a Wellcome BTV Programme grant (http://www.wellcome.ac.uk/). For some of this work, MB was funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), and EO and DJ were funded by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Batten CA, 2008, VET MICROBIOL, V129, P80, DOI 10.1016/j.vetmic.2007.11.005; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Brenner J, 2010, EMERG INFECT DIS, V16, P2003, DOI 10.3201/eid1612.100239; Cetre-Sossah C, 2010, RES VET SCI; DAVIES FG, 1992, VET MICROBIOL, V31, P25, DOI 10.1016/0378-1135(92)90138-J; De Clercq K, 2009, TRANSBOUND EMERG DIS, V56, P355, DOI 10.1111/j.1865-1682.2009.01092.x; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; Erasmus B. J., 1990, Virus infections of ruminants., P227; Eschbaumer M, 2011, VACCINE; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; GARD GP, 1985, AUST VET J, V62, P203, DOI 10.1111/j.1751-0813.1985.tb07302.x; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Hamblin C, 2004, Vet Ital, V40, P538; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWELL P G, 1970, Onderstepoort Journal of Veterinary Research, V37, P59; JEGGO MH, 1986, RES VET SCI, V40, P386, DOI 10.1016/S0034-5288(18)30556-3; JEGGO MH, 1983, RES VET SCI, V34, P205, DOI 10.1016/S0034-5288(18)32261-6; Johnson DJ, 2007, P ANN C AM ASS VET L; Listes E, 2009, VET MICROBIOL, V138, P92, DOI 10.1016/j.vetmic.2009.03.011; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2009, BIOL ANIM INFECT, P135, DOI 10.1016/B978-012369368-6.50011-3; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2007, VIRUS RES, V129, P236, DOI 10.1016/j.virusres.2007.07.009; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; MCCOLL KA, 1991, VIRUS RES, V21, P19, DOI 10.1016/0168-1702(91)90069-8; Mellor PS, 2009, BIOL ANIM INFECT, P235, DOI 10.1016/B978-012369368-6.50015-0; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1987, VIROLOGY, V161, P438, DOI 10.1016/0042-6822(87)90137-1; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 2011, RNAS PROTEINS DSRNA; NAMP, 2009, NAT ARB MON PROGR NA; OIE, 2008, 6964 OIE; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; PIERCE CM, 1995, VIROLOGY, V209, P263, DOI 10.1006/viro.1995.1253; Planzer J, 2011, RES VET SCI; Prasad G., 1999, Indian Journal of Experimental Biology, V37, P1255; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Roy P, 1990, FEMS Microbiol Immunol, V2, P223; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; STGEORGE TD, 1978, AUST VET J, V54, P153, DOI 10.1111/j.1751-0813.1978.tb05539.x; STGEORGE TD, 1980, AUST VET J, V56, P562, DOI 10.1111/j.1751-0813.1980.tb02598.x; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; WILSON WC, 1993, J VIROL METHODS, V45, P39, DOI 10.1016/0166-0934(93)90138-H; World Organization for Animal Health (OIE), 2000, MAN STAND DIAGN TEST, P178; YAMAGUCHI S, 1988, NUCLEIC ACIDS RES, V16, P2725, DOI 10.1093/nar/16.6.2725; YAMAGUCHI S, 1988, VIRUS RES, V11, P49, DOI 10.1016/0168-1702(88)90066-4; Zientara S, 2010, EXPERT REV VACCINES, V9, P989, DOI 10.1586/ERV.10.97	62	111	131	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32601	10.1371/journal.pone.0032601	http://dx.doi.org/10.1371/journal.pone.0032601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389711	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000302999600050
J	Mudge, JF; Baker, LF; Edge, CB; Houlahan, JE				Mudge, Joseph F.; Baker, Leanne F.; Edge, Christopher B.; Houlahan, Jeff E.			Setting an Optimal alpha That Minimizes Errors in Null Hypothesis Significance Tests	PLOS ONE			English	Article							STATISTICAL SIGNIFICANCE; EFFECT SIZE; INSIGNIFICANCE	Null hypothesis significance testing has been under attack in recent years, partly owing to the arbitrary nature of setting alpha (the decision-making threshold and probability of Type I error) at a constant value, usually 0.05. If the goal of null hypothesis testing is to present conclusions in which we have the highest possible confidence, then the only logical decision-making threshold is the value that minimizes the probability (or occasionally, cost) of making errors. Setting alpha to minimize the combination of Type I and Type II error at a critical effect size can easily be accomplished for traditional statistical tests by calculating the alpha associated with the minimum average of alpha and beta at the critical effect size. This technique also has the flexibility to incorporate prior probabilities of null and alternate hypotheses and/or relative costs of Type I and Type II errors, if known. Using an optimal alpha results in stronger scientific inferences because it estimates and minimizes both Type I errors and relevant Type II errors for a test. It also results in greater transparency concerning assumptions about relevant effect size(s) and the relative costs of Type I and II errors. By contrast, the use of alpha = 0.05 results in arbitrary decisions about what effect sizes will likely be considered significant, if real, and results in arbitrary amounts of Type II error for meaningful potential effect sizes. We cannot identify a rationale for continuing to arbitrarily use alpha = 0.05 for null hypothesis significance tests in any field, when it is possible to determine an optimal alpha.	[Mudge, Joseph F.; Baker, Leanne F.; Edge, Christopher B.; Houlahan, Jeff E.] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada	University of New Brunswick	Mudge, JF (corresponding author), Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.	joe.mudge@unb.ca	Edge, Christopher/E-8003-2012; Baker, Leanne F./D-2694-2012; Mudge, Joseph/B-9706-2012	Mudge, Joseph/0000-0001-6091-2966; Baker, Leanne/0000-0003-3339-7123; Edge, Christopher/0000-0002-4713-0035	NSERC; Canadian Rivers Institute at the University of New Brunswick Saint John; Canadian Department of Defence; Natural Resources Canada-Canadian Forest Services; Environment Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Rivers Institute at the University of New Brunswick Saint John; Canadian Department of Defence; Natural Resources Canada-Canadian Forest Services(Natural Resources CanadaCanadian Forest Service); Environment Canada(CGIAR)	The authors are supported by an NSERC Strategic Grant, the Canadian Rivers Institute at the University of New Brunswick Saint John, the Canadian Department of Defence, Natural Resources Canada-Canadian Forest Services, and Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; CARVER RP, 1993, J EXP EDUC, V61, P287, DOI 10.1080/00220973.1993.10806591; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crawley MJ., 2007, R BOOK; Dupont P., 1977, REND SEM MAT U POLIT, V36, P125; Field SA, 2004, ECOL LETT, V7, P669, DOI 10.1111/j.1461-0248.2004.00625.x; Gill J, 1999, POLIT RES QUART, V52, P647, DOI 10.1177/106591299905200309; Huberty CJ, 2002, EDUC PSYCHOL MEAS, V62, P227, DOI 10.1177/0013164402062002002; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munkittrick KR, 2009, ENVIRON TOXICOL CHEM, V28, P1361, DOI 10.1897/08-376.1; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; POWER M, 1995, ENVIRON MANAGE, V19, P629, DOI 10.1007/BF02471945; ROYALL RM, 1986, AM STAT, V40, P313, DOI 10.2307/2684616; Shrader-Frechette K. S., 1991, RISK RATIONALITY PHI; Steidl RJ, 1997, J WILDLIFE MANAGE, V61, P270, DOI 10.2307/3802582; Suter GW, 1996, HUM ECOL RISK ASSESS, V2, P331, DOI 10.1080/10807039609383611; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101	18	97	100	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32734	10.1371/journal.pone.0032734	http://dx.doi.org/10.1371/journal.pone.0032734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389720	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600059
J	Cui, W; Zhang, J; Lian, HY; Wang, HL; Miao, DQ; Zhang, CX; Luo, MJ; Tan, JH				Cui, Wei; Zhang, Jie; Lian, Hua-Yu; Wang, Hui-Li; Miao, De-Qiang; Zhang, Chuan-Xin; Luo, Ming-Jiu; Tan, Jing-He			Roles of MAPK and Spindle Assembly Checkpoint in Spontaneous Activation and MIII Arrest of Rat Oocytes	PLOS ONE			English	Article							METAPHASE-II ARREST; PROTEIN-KINASE-II; MOUSE OOCYTES; MEIOTIC MATURATION; NUCLEAR-TRANSFER; VERTEBRATE EGGS; CYCLIN B1; IN-VITRO; PARTHENOGENETIC ACTIVATION; MICROTUBULE ORGANIZATION	Rat oocytes are well known to undergo spontaneous activation (SA) after leaving the oviduct, but the SA is abortive with oocytes being arrested in metaphase III (MIII) instead of forming pronuclei. This study was designed to investigate the mechanism causing SA and MIII arrest. Whereas few oocytes collected from SD rats at 13 h after hCG injection that showed 100% of mitogen-activated protein kinase (MAPK) activities activated spontaneously, all oocytes recovered 19 h post hCG with MAPK decreased to below 75% underwent SA during in vitro culture. During SA, MAPK first declined to below 45% and then increased again to 80%; the maturation-promoting factor (MPF) activity fluctuated similarly but always began to change ahead of the MAPK activity. In SA oocytes with 75% of MAPK activities, microtubules were disturbed with irregularly pulled chromosomes dispersed over the spindle and the spindle assembly checkpoint (SAC) was activated. When MAPK decreased to 45%, the spindle disintegrated and chromosomes surrounded by microtubules were scattered in the ooplasm. SA oocytes entered MIII and formed several spindle-like structures by 6 h of culture when the MAPK activity re-increased to above 80%. While SA oocytes showed one Ca2+ rise, Sr2+-activated oocytes showed several. Together, the results suggested that SA stimuli triggered SA in rat oocytes by inducing a premature MAPK inactivation, which led to disturbance of spindle microtubules. The microtubule disturbance impaired pulling of chromosomes to the spindle poles, caused spindle disintegration and activated SAC. The increased SAC activity reactivated MPF and thus MAPK, leading to MIII arrest.	[Cui, Wei; Zhang, Jie; Lian, Hua-Yu; Wang, Hui-Li; Miao, De-Qiang; Zhang, Chuan-Xin; Luo, Ming-Jiu; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Cui, W (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	wang, hui/GRS-4730-2022; Miao, Deqiang/F-1226-2015; Cui, Wei/F-2192-2016; Luo, Mingjiu/AAU-8570-2021; wang, huimin/HDM-8421-2022	Miao, Deqiang/0000-0001-9731-9322; Cui, Wei/0000-0001-7281-3471; 	National Basic Research Program of China [2012CB944403, 2007CB947403]; China National Natural Science Foundation [30972096, 30771556]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2007CB947403) and the China National Natural Science Foundation (Nos. 30972096 and 30771556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; Chaube SK, 2007, CLONING STEM CELLS, V9, P608, DOI 10.1089/clo.2007.0001; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Goto S, 2002, MOL REPROD DEV, V63, P388, DOI 10.1002/mrd.90022; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Hatch KR, 2001, MOL REPROD DEV, V58, P69, DOI 10.1002/1098-2795(200101)58:1&lt;69::AID-MRD10&gt;3.0.CO;2-O; Hayes E, 2001, PHYSIOL GENOMICS, V5, P193, DOI 10.1152/physiolgenomics.2001.5.4.193; Hirabayashi M, 2003, CLONING STEM CELLS, V5, P35, DOI 10.1089/153623003321512148; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Iannaccone P, 2001, ZYGOTE, V9, P135, DOI 10.1017/S0967199401001149; Ito J, 2005, REPRODUCTION, V129, P171, DOI 10.1530/rep.1.00431; Ito J, 2007, THERIOGENOLOGY, V67, P475, DOI 10.1016/j.theriogenology.2006.08.012; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; Josefsberg LBY, 2003, BIOL REPROD, V68, P1282, DOI 10.1095/biolreprod.102.006882; Kalab P, 1996, DEVELOPMENT, V122, P1957; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; KUBIAK JZ, 1989, DEV BIOL, V136, P537, DOI 10.1016/0012-1606(89)90279-0; Lee J, 2000, ZYGOTE, V8, P119, DOI 10.1017/S0967199400000897; Li JJ, 2012, ZYGOTE, V20, P291, DOI 10.1017/S0967199411000219; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Markoulaki S, 2004, DEV BIOL, V272, P15, DOI 10.1016/j.ydbio.2004.04.008; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Miyoshi K, 1997, BIOL REPROD, V56, P180, DOI 10.1095/biolreprod56.1.180; Nixon VL, 2002, CURR BIOL, V12, P746, DOI 10.1016/S0960-9822(02)00811-4; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Paronetto MP, 2004, EMBO J, V23, P4649, DOI 10.1038/sj.emboj.7600448; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Ross PJ, 2006, CLONING STEM CELLS, V8, P275, DOI 10.1089/clo.2006.8.275; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sterthaus O, 2009, CLONING STEM CELLS, V11, P463, DOI 10.1089/clo.2009.0014; Sun SC, 2008, MOL REPROD DEV, V75, P1542, DOI 10.1002/mrd.20891; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Tong C, 2003, CELL RES, V13, P375, DOI 10.1038/sj.cr.7290183; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Verlhac MH, 1996, DEVELOPMENT, V122, P815; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Yin S, 2006, CELL CYCLE, V5, P2130, DOI 10.4161/cc.5.18.3170; Yoo JG, 2007, BIOCHEM BIOPH RES CO, V359, P854, DOI 10.1016/j.bbrc.2007.05.181; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; ZERNICKAGOETZ M, 1991, MOL REPROD DEV, V28, P169, DOI 10.1002/mrd.1080280210; ZERNICKAGOETZ M, 1993, MOL REPROD DEV, V35, P165, DOI 10.1002/mrd.1080350210	55	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32044	10.1371/journal.pone.0032044	http://dx.doi.org/10.1371/journal.pone.0032044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384134	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500057
J	Marin, RM; Vanicek, J				Marin, Ray M.; Vanicek, Jiri			Optimal Use of Conservation and Accessibility Filters in MicroRNA Target Prediction	PLOS ONE			English	Article							SITE ACCESSIBILITY; PROTEIN; IDENTIFICATION; POPULATION; IMPACT; GENES	It is generally accepted that filtering microRNA (miRNA) target predictions by conservation or by accessibility can reduce the false discovery rate. However, these two strategies are usually not exploited in a combined and flexible manner. Here, we introduce PACCMIT, a flexible method that filters miRNA binding sites by their conservation, accessibility, or both. The improvement in performance obtained with each of these three filters is demonstrated on the prediction of targets for both i) highly and ii) weakly conserved miRNAs, i.e., in two scenarios in which the miRNA-target interactions are subjected to different evolutionary pressures. We show that in the first scenario conservation is a better filter than accessibility (as both sensitivity and precision are higher among the top predictions) and that the combined filter improves performance of PACCMIT even further. In the second scenario, on the other hand, the accessibility filter performs better than both the conservation and combined filters, suggesting that the site conservation is not equally effective in rejecting false positive predictions for all miRNAs. Regarding the quality of the ranking criterion proposed by Robins and Press and used in PACCMIT, it is shown that top ranking interactions correspond to more downregulated proteins than do the lower ranking interactions. Comparison with several other target prediction algorithms shows that the ranking of predictions provided by PACCMIT is at least as good as the ranking generated by other conservation-based methods and considerably better than the energy-based ranking used in other accessibility-based methods.	[Marin, Ray M.; Vanicek, Jiri] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lab Theoret Phys Chem, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Marin, RM (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lab Theoret Phys Chem, Lausanne, Switzerland.	jiri.vanicek@epfl.ch	Marin, Ray/C-5515-2013; Vanicek, Jiri/I-6479-2013	Marin, Ray/0000-0002-5648-0731; Vanicek, Jiri/0000-0002-2080-4378	Ecole Polytechnique Federale de Lausanne	Ecole Polytechnique Federale de Lausanne	This research was supported by Ecole Polytechnique Federale de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005681; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-476; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Orom UA, 2010, GENE, V451, P1, DOI 10.1016/j.gene.2009.11.008; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wen JY, 2011, RNA, V17, P820, DOI 10.1261/rna.2387911; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	43	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32208	10.1371/journal.pone.0032208	http://dx.doi.org/10.1371/journal.pone.0032208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384176	Green Published, gold			2022-12-25	WOS:000302918500064
J	Sakai, A; Takasu, K; Sawada, M; Suzuki, H				Sakai, Atsushi; Takasu, Kumiko; Sawada, Makoto; Suzuki, Hidenori			Hemokinin-1 Gene Expression Is Upregulated in Microglia Activated by Lipopolysaccharide through NF-kappa B and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							MAMMALIAN TACHYKININ PEPTIDE; SUBSTANCE-P; RAT/MOUSE HEMOKININ-1; SUPRASPINAL LEVEL; MESSENGER-RNA; NK1 RECEPTOR; KINASE; CELLS; PAIN; MICE	The mammalian tachykinins, substance P (SP) and hemokinin-1 (HK-1), are widely distributed throughout the nervous system and/or peripheral organs, and function as neurotransmitters or chemical modulators by activating their cognate receptor NK1. The TAC1 gene encoding SP is highly expressed in the nervous system, while the TAC4 gene encoding HK-1 is uniformly expressed throughout the body, including a variety of peripheral immune cells. Since TAC4 mRNA is also expressed in microglia, the resident immune cells in the central nervous system, HK-1 may be involved in the inflammatory processes mediated by these cells. In the present study, we found that TAC4, rather than TAC1, was the predominant tachykinin gene expressed in primary cultured microglia. TAC4 mRNA expression was upregulated in the microglia upon their activation by lipopolysaccharide, a well-characterized Toll-like receptor 4 agonist, while TAC1 mRNA expression was downregulated. Furthermore, both nuclear factor-kappa B and p38 mitogen-activated protein kinase intracellular signaling pathways were required for the upregulation of TAC4 mRNA expression, but not for the downregulation of TAC1 mRNA expression. These findings suggest that HK-1, rather than SP, plays dominant roles in the pathological conditions associated with microglial activation, such as neurodegenerative and neuroinflammatory disorders.	[Sakai, Atsushi; Takasu, Kumiko; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	Nippon Medical School; Nagoya University	Sakai, A (corresponding author), Nippon Med Sch, Dept Pharmacol, 1-1-5 Sendagi, Tokyo 113, Japan.	hsuzuki@nms.ac.jp		Sakai, Atsushi/0000-0002-3996-8022	Japan Society for the Promotion of Science [22791457]; Ministry of Education, Culture, Sports, Science and Technology, Japan [S0801035]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Encouragement of Young Scientists (B) (22791457 to AS) from the Japan Society for the Promotion of Science and a grant (S0801035 to HS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2007, J NEUROIMMUNOL, V187, P83, DOI 10.1016/j.jneuroim.2007.04.019; Berger A, 2010, BLOOD, V116, P3792, DOI 10.1182/blood-2010-06-291062; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Duffy RA, 2003, NEUROPHARMACOLOGY, V45, P242, DOI 10.1016/S0028-3908(03)00150-3; Endo D, 2006, NEUROSCI LETT, V392, P114, DOI 10.1016/j.neulet.2005.09.005; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fu CY, 2007, BEHAV BRAIN RES, V184, P39, DOI 10.1016/j.bbr.2007.06.019; Fu CY, 2006, BEHAV BRAIN RES, V170, P293, DOI 10.1016/j.bbr.2006.03.007; Grassin-Delyle S, 2011, PEPTIDES, V32, P1027, DOI 10.1016/j.peptides.2011.02.012; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Klassert TE, 2008, J NEUROIMMUNOL, V196, P27, DOI 10.1016/j.jneuroim.2008.02.010; Kurtz MM, 2002, GENE, V296, P205, DOI 10.1016/S0378-1119(02)00861-2; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liu L, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2011.01685.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Matsumura T, 2008, BRIT J PHARMACOL, V155, P767, DOI 10.1038/bjp.2008.301; Metwali A, 2004, J IMMUNOL, V172, P6528, DOI 10.4049/jimmunol.172.11.6528; Naono-Nakayama R, 2010, NEUROPEPTIDES, V44, P57, DOI 10.1016/j.npep.2009.10.002; Nelson DA, 2004, J NEUROIMMUNOL, V155, P94, DOI 10.1016/j.jneuroim.2004.06.005; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Page NM, 2004, CELL MOL LIFE SCI, V61, P1652, DOI 10.1007/s00018-004-4035-x; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Sunakawa N, 2010, NEUROPEPTIDES, V44, P273, DOI 10.1016/j.npep.2010.01.003; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tran AH, 2009, NEUROPEPTIDES, V43, P1, DOI 10.1016/j.npep.2008.10.002; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Wang W, 2010, J IMMUNOL, V184, P3590, DOI 10.4049/jimmunol.0901278; Watanabe C, 2010, PEPTIDES, V31, P1613, DOI 10.1016/j.peptides.2010.04.025; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	37	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32268	10.1371/journal.pone.0032268	http://dx.doi.org/10.1371/journal.pone.0032268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384199	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500070
J	Xue, FZ; Li, SX; Luan, JA; Yuan, ZS; Luben, RN; Khaw, KT; Wareham, NJ; Loos, RJF; Zhao, JH				Xue, Fuzhong; Li, Shengxu; Luan, Jian'an; Yuan, Zhongshang; Luben, Robert N.; Khaw, Kay-Tee; Wareham, Nicholas J.; Loos, Ruth J. F.; Zhao, Jing Hua			A Latent Variable Partial Least Squares Path Modeling Approach to Regional Association and Polygenic Effect with Applications to a Human Obesity Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; DISEASE; RISK; GENE; MARKERS; SUSCEPTIBILITY; POPULATION; PARTICIPANTS; REGRESSION	Genetic association studies are now routinely used to identify single nucleotide polymorphisms (SNPs) linked with human diseases or traits through single SNP-single trait tests. Here we introduced partial least squares path modeling (PLSPM) for association between single or multiple SNPs and a latent trait that can involve single or multiple correlated measurement(s). Furthermore, the framework naturally provides estimators of polygenic effect by appropriately weighting trait-attributing alleles. We conducted computer simulations to assess the performance via multiple SNPs and human obesity-related traits as measured by body mass index (BMI), waist and hip circumferences. Our results showed that the associate statistics had type I error rates close to nominal level and were powerful for a range of effect and sample sizes. When applied to 12 candidate regions in data (N = 2,417) from the European Prospective Investigation of Cancer (EPIC)-Norfolk study, a region in FTO was found to have stronger association (rs7204609 similar to rs9939881 at the first intron P = 4.29 x 10(-7)) than single SNP analysis (all with P>10(-4)) and a latent quantitative phenotype was obtained using a subset sample of EPIC-Norfolk(N = 12,559). We believe our method is appropriate for assessment of regional association and polygenic effect on a single or multiple traits.	[Xue, Fuzhong; Yuan, Zhongshang] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Xue, Fuzhong; Luan, Jian'an; Wareham, Nicholas J.; Loos, Ruth J. F.; Zhao, Jing Hua] MRC Epidemiol Unit, Cambridge, England; [Xue, Fuzhong; Luan, Jian'an; Wareham, Nicholas J.; Loos, Ruth J. F.; Zhao, Jing Hua] Inst Metab Sci, Cambridge, England; [Li, Shengxu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Luben, Robert N.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England	Shandong University; University of Cambridge; Tulane University; University of Cambridge; University of Cambridge	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	jinghua.zhao@mrc-epid.cam.ac.uk	Loos, Ruth J F/Q-2862-2016; Li, Shengxu/D-8915-2012; Yuan, Zhongshang/GVT-8351-2022; Xue, Fuzhong/AAG-4808-2020; Khaw, Kay-Tee/AAZ-3209-2021; Loos, Ruth/GON-5877-2022; Luben, Robert N/H-5519-2015	Loos, Ruth J F/0000-0002-8532-5087; Luben, Robert N/0000-0002-5088-6343; Xue, Fuzhong/0000-0003-0378-7956	Cancer Research UK; Medical Research Council; National Natural Science Foundation of China [30171155]; China Scholarship Council; Medical Research Council [G1000143, MC_U106179471, G0401527] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The EPIC-Norfolk study is supported by research programme grant funding from Cancer Research UK and the Medical Research Council. FX was supported by grants from National Natural Science Foundation of China (30171155) and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Chun HH, 2011, GENET EPIDEMIOL, V35, P479, DOI 10.1002/gepi.20596; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Day N, 1999, BRIT J CANCER, V80, P95; Efron B., 1994, INTRO BOOTSTRAP; Esposito VV, 2010, HDB PARTIAL LEAST SQ; Glaz J, 2008, SCAN STAT METHODS ST; Harlaar N, 2005, J CHILD PSYCHOL PSYC, V46, P1097, DOI 10.1111/j.1469-7610.2005.01515.x; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoh J, 2000, P NATL ACAD SCI USA, V97, P9615, DOI 10.1073/pnas.170179197; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Jones, 2017, J S CAROLINA WATER R, V4, P21, DOI [10.34068/JSCWR.04.03, DOI 10.34068/JSCWR.04.03]; Kao CH, 1999, GENETICS, V152, P1203; Khoury MJ, 2004, GENET MED, V6, P38, DOI 10.1097/01.GIM.0000105751.71430.79; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Li HZ, 2010, BIOSTATISTICS, V11, P139, DOI 10.1093/biostatistics/kxp043; Li J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-44; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lin JD, 2002, J CLIN EPIDEMIOL, V55, P757, DOI 10.1016/S0895-4356(02)00433-X; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Peng QQ, 2010, EUR J HUM GENET, V18, P582, DOI 10.1038/ejhg.2009.223; Peng QQ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-6; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; RIMM AA, 1988, J CLIN EPIDEMIOL, V41, P459, DOI 10.1016/0895-4356(88)90047-9; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Sun YV, 2009, COMPUT STAT DATA AN, V53, P1794, DOI 10.1016/j.csda.2008.04.013; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Walsh Patty, 2004, Diabetes Forecast, V57, P73; WALTON C, 1995, AM J MED, V99, P459, DOI 10.1016/S0002-9343(99)80220-4; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang HC, 2009, BMC P S7, V3, pS135; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; ZENG ZB, 1994, GENETICS, V136, P1457	44	10	12	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31927	10.1371/journal.pone.0031927	http://dx.doi.org/10.1371/journal.pone.0031927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384102	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500047
J	Dakin, SG; Werling, D; Hibbert, A; Abayasekara, DRE; Young, NJ; Smith, RKW; Dudhia, J				Dakin, Stephanie Georgina; Werling, Dirk; Hibbert, Andrew; Abayasekara, Dilkush Robert Ephrem; Young, Natalie Jayne; Smith, Roger Kenneth Whealands; Dudhia, Jayesh			Macrophage Sub-Populations and the Lipoxin A(4) Receptor Implicate Active Inflammation during Equine Tendon Repair	PLOS ONE			English	Article							ACHILLES-TENDON; LIPID MEDIATORS; ALTERNATIVE ACTIVATION; FLEXOR TENDINITIS; ASPIRIN TREATMENT; HUMAN-LEUKOCYTES; GENE-EXPRESSION; IN-VIVO; TENDINOPATHY; RESOLUTION	Macrophages (M phi) orchestrate inflammatory and reparatory processes in injured connective tissues but their role during different phases of tendon healing is not known. We investigated the contribution of different M phi subsets in an equine model of naturally occurring tendon injury. Post mortem tissues were harvested from normal (uninjured), sub-acute (3-6 weeks post injury) and chronically injured (>3 months post injury) superficial digital flexor tendons. To determine if inflammation was present in injured tendons, M phi sub-populations were quantified based on surface antigen expression of CD172a (pan M phi), CD14(high) CD206(low) (pro-inflammatory M1M phi), and CD206(high) (anti-inflammatory M2M phi) to assess potential polarised phenotypes. In addition, the Lipoxin A(4) receptor (FPR2/ALX) was used as marker for resolving inflammation. Normal tendons were negative for both M phi and FPR2/ALX. In contrast, M1M phi predominated in sub-acute injury, whereas a potential phenotype-switch to M2M phi polarity was seen in chronic injury. Furthermore, FPR2/ALX expression by tenocytes was significantly upregulated in sub-acute but not chronic injury. Expression of the FPR2/ALX ligand Annexin A1 was also significantly increased in sub-acute and chronic injuries in contrast to low level expression in normal tendons. The combination of reduced FPR2/ALX expression and persistence of the M2M phi phenotype in chronic injury suggests a potential mechanism for incomplete resolution of inflammation after tendon injury. To investigate the effect of pro-inflammatory mediators on lipoxin A(4) (LXA(4)) production and FPR2/ALX expression in vitro, normal tendon explants were stimulated with interleukin-1 beta and prostaglandin E-2. Stimulation with either mediator induced LXA(4) release and maximal upregulation of FPR2/ALX expression after 72 hours. Taken together, our data suggests that although tenocytes are capable of mounting a protective mechanism to counteract inflammatory stimuli, this appears to be of insufficient duration and magnitude in natural tendon injury, which may potentiate chronic inflammation and fibrotic repair, as indicated by the presence of M2M phi.	[Dakin, Stephanie Georgina; Smith, Roger Kenneth Whealands; Dudhia, Jayesh] Univ London, Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [Werling, Dirk] Univ London, Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Hibbert, Andrew; Abayasekara, Dilkush Robert Ephrem] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Young, Natalie Jayne] Natl Inst Biol Stand & Controls, Dept Biotherapeut, S Mimms, Herts, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; National Institute for Biological Standards & Control	Dakin, SG (corresponding author), Univ London, Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England.	sdakin@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Dudhia, Jayesh/0000-0002-2503-697X; Dakin, Stephanie Georgina/0000-0003-2470-1031	Biotechnology and Biological Sciences Research Council (BBSRC) UK; Ceva (France) [BB/F018258/1]; Biotechnology and Biological Sciences Research Council [BB/D524883/1] Funding Source: researchfish; BBSRC [BB/D524883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ceva (France); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research article was funded by Biotechnology and Biological Sciences Research Council (BBSRC) UK and Ceva (France) grant number BB/F018258/1. The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Alfredson H, 2002, CURR DRUG TARGETS, V3, P43, DOI 10.2174/1389450023348028; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dahlgren LA, 2002, J ORTHOP RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Gavins FNE, 2005, PROSTAG LEUKOTR ESS, V73, P211, DOI 10.1016/j.plefa.2005.05.008; Gilroy DW, 2010, INT J BIOCHEM CELL B, V42, P524, DOI 10.1016/j.biocel.2009.12.013; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Herrmann-Hoesing LM, 2010, VET PATHOL, V47, P518, DOI 10.1177/0300985809359605; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; JOZSA L, 1990, ARCH ORTHOP TRAUM SU, V110, P15, DOI 10.1007/BF00431359; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Ker RF, 2000, J EXP BIOL, V203, P1317; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Leibovich S J, 1988, Prog Clin Biol Res, V266, P131; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Magra M, 2006, CLIN J SPORT MED, V16, P1, DOI 10.1097/01.jsm.0000194764.27819.5d; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Moller A, 1996, ACTA ORTHOP SCAND, V67, P479, DOI 10.3109/17453679608996672; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Nagaoka T, 2000, AM J PATHOL, V157, P237, DOI 10.1016/S0002-9440(10)64534-8; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; RAIFE TJ, 1994, AM J CLIN PATHOL, V101, P296, DOI 10.1093/ajcp/101.3.296; Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211; Satoh N, 2010, DIABETES CARE, V33, pe7; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan Charles N, 2002, ScientificWorldJournal, V2, P169; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, AM J RESP CRIT CARE, V161, pS95, DOI 10.1164/ajrccm.161.supplement_1.ltta-19; Silver I A, 1983, Equine Vet J Suppl, P1; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; Smeekens SP, 2011, EUR J IMMUNOL, V41, P2915, DOI 10.1002/eji.201141418; Smith R, 2003, IN PRACTICE, V25, P529; Smith RKW, 2008, VET CLIN N AM-EQUINE, V24, P37, DOI 10.1016/j.cveq.2007.11.005; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Thampatty BP, 2007, GENE, V386, P154, DOI 10.1016/j.gene.2006.08.027; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; WELSH RP, 1980, CAN MED ASSOC J, V122, P193; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WILLIAMS IF, 1984, RES VET SCI, V36, P326, DOI 10.1016/S0034-5288(18)31954-4; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Yang GG, 2005, GENE, V363, P166, DOI 10.1016/j.gene.2005.08.006; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	82	57	59	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32333	10.1371/journal.pone.0032333	http://dx.doi.org/10.1371/journal.pone.0032333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384219	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500096
J	Mizuguchi, Y; Specht, S; Lunz, JG; Isse, K; Corbitt, N; Takizawa, T; Demetris, AJ				Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G., III; Isse, Kumiko; Corbitt, Natasha; Takizawa, Toshihiro; Demetris, Anthony J.			Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; DOWN-REGULATION; MIR-200 FAMILY; CANCER-CELLS; E-CADHERIN; PROTEIN; EXPRESSION; ZEB1; CBP	Epithelial to mesenchymal transition (EMT) not only occurs during embryonic development and in response to injury, but is an important element in cancer progression. EMT and its reverse process, mesenchymal to epithelial transition (MET) is controlled by a network of transcriptional regulators and can be influenced by posttranscriptional and posttranslational modifications. EMT/MET involves many effectors that can activate and repress these transitions, often yielding a spectrum of cell phenotypes. Recent studies have shown that the miR-200 family and the transcriptional suppressor ZEB1 are important contributors to EMT. Our previous data showed that forced expression of SPRR2a was a powerful inducer of EMT and supports the findings by others that SPRR gene members are highly upregulated during epithelial remodeling in a variety of organs. Here, using SPRR2a cells, we characterize the role of acetyltransferases on the microRNA-200c/141 promoter and their effect on the epithelial/mesenchymal status of the cells. We show that the deacetylase inhibitor TSA as well as P300 and PCAF can cause a shift towards epithelial characteristics in HUCCT-1-SPRR2a cells. We demonstrate that both P300 and PCAF act as cofactors for ZEB1, forming a P300/PCAF/ZEB1 complex on the miR200c/141 promoter. This binding results in lysine acetylation of ZEB1 and a release of ZEB1 suppression on miR-200c/141 transcription. Furthermore, disruption of P300 and PCAF interactions dramatically down regulates miR-200c/141 promoter activity, indicating a PCAF/P300 cooperative function in regulating the transcriptional suppressor/activator role of ZEB1. These data demonstrate a novel mechanism of miRNA regulation in mediating cell phenotype.	[Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G., III; Isse, Kumiko; Corbitt, Natasha; Demetris, Anthony J.] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G., III; Isse, Kumiko; Corbitt, Natasha; Demetris, Anthony J.] Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA USA; [Lunz, John G., III] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA; [Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Anat & Med, Tokyo 113, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nippon Medical School	Mizuguchi, Y (corresponding author), Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA.	demetrisaj@upmc.edu			Thomas E. Starzl Professor of Pathology Endowment Fund; Ministry of Education, Science, Sports, and Culture of Japan	Thomas E. Starzl Professor of Pathology Endowment Fund; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Thomas E. Starzl Professor of Pathology Endowment Fund. It was also supported by the Ministry of Education, Science, Sports, and Culture of Japan and Grants-in-Aid for Scientific Research, Research Fellowships for young scientists and the Core Research Project for Private University: matching fund subsidy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chan HM, 2001, J CELL SCI, V114, P2363; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Demetris AJ, 2008, J HEPATOL, V48, P276, DOI 10.1016/j.jhep.2007.09.019; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han C, 2004, J BIOL CHEM, V279, P44344, DOI 10.1074/jbc.M404852200; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Neves R, BMC RES NOTES, V3, P219; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	32	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32449	10.1371/journal.pone.0032449	http://dx.doi.org/10.1371/journal.pone.0032449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384255	Green Accepted, Green Published, gold			2022-12-25	WOS:000302875500102
J	Watmuff, B; Pouton, CW; Haynes, JM				Watmuff, Bradley; Pouton, Colin W.; Haynes, John M.			In Vitro Maturation of Dopaminergic Neurons Derived from Mouse Embryonic Stem Cells: Implications for Transplantation	PLOS ONE			English	Article							INTRACELLULAR CHLORIDE; PARKINSONS-DISEASE; GABAERGIC NEURONS; PROGENITOR CELLS; CA2+ REGULATION; DRUG DISCOVERY; RAT MODEL; GABA; MIDBRAIN; SURVIVAL	The obvious motor symptoms of Parkinson's disease result from a loss of dopaminergic neurons from the substantia nigra. Embryonic stem cell-derived neural progenitor or precursor cells, adult neurons and fetal midbrain tissue have all been used to replace dying dopaminergic neurons. Transplanted cell survival is compromised by factors relating to the new environment, for example; hypoxia, mechanical trauma and excitatory amino acid toxicity. In this study we investigate, using live-cell fluorescence Ca2+ and Cl- imaging, the functional properties of catecholaminergic neurons as they mature. We also investigate whether GABA has the capacity to act as a neurotoxin early in the development of these neurons. From day 13 to day 21 of differentiation [Cl-](i) progressively dropped in tyrosine hydroxylase positive (TH+) neurons from 56.0 ( 95% confidence interval, 55.1, 56.9) mM to 6.9 (6.8, 7.1) mM. At days 13 and 15 TH+ neurons responded to GABA (30 mu M) with reductions in intracellular Cl- ([Cl-](i)); from day 21 the majority of neurons responded to GABA (30 mu M) with elevations of [Cl-](i). As [Cl-](i) reduced, the ability of GABA (30 mu M) to elevate intracellular Ca2+ ([Ca2+](i)) did also. At day 13 of differentiation a three hour exposure to GABA (30 mu M) or L-glutamate (30 mu M) increased the number of midbrain dopaminergic (TH+ and Pitx3(+)) neurons labeled with the membrane-impermeable nuclear dye TOPRO-3. By day 23 cultures were resistant to the effects of both GABA and L-glutamate. We believe that neuronal susceptibility to amino acid excitotoxicity is dependent upon neuronal maturity, and this should be considered when isolating cells for transplantation studies.	[Watmuff, Bradley; Pouton, Colin W.; Haynes, John M.] Monash Univ, Monash Inst Pharmaceut Sci, Stem Cell Biol Grp, Parkville, Vic, Australia	Monash University	Watmuff, B (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Stem Cell Biol Grp, Parkville, Vic, Australia.	colin.pouton@monash.edu; john.haynes@monash.edu	Pouton, Colin W/M-2049-2016	Pouton, Colin W/0000-0003-0224-3308; , john/0000-0003-3075-1553	Australian Research Council [LP0455327]; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	This work was funded by the Australian Research Council (LP0455327). BW was the recipient of an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett LE, 1997, CELL TRANSPLANT, V6, P557, DOI 10.1016/S0963-6897(97)00079-1; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cai J, 2009, STEM CELLS DEV; Cordero-Erausquin M, 2005, J NEUROSCI, V25, P9613, DOI 10.1523/JNEUROSCI.1488-05.2005; Cucchiaroni ML, 2011, EUR J NEUROSCI; Dayanithi G, 2006, CELL CALCIUM, V39, P237, DOI 10.1016/j.ceca.2005.10.011; DIPORZIO U, 1993, EXP NEUROL, V120, P202, DOI 10.1006/exnr.1993.1055; Gaillard A, 2011, TRENDS NEUROSCI; Goren MZ, 2001, NEUROL SCI, V22, P297, DOI 10.1007/s10072-001-8171-x; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Gruol DL, 2005, CEREBELLUM, V4, P128, DOI 10.1080/14734220510007969; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hahn M, 2009, J NEUROSCI RES, V87, P2006, DOI 10.1002/jnr.22031; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; He J, 2005, CELL PHYSIOL BIOCHEM, V16, P69, DOI 10.1159/000087733; Ibanez-Sandoval O, 2007, J NEUROPHYSIOL, V98, P2311, DOI 10.1152/jn.00620.2007; Inglefield JR, 1999, METHODS, V18, P197, DOI 10.1006/meth.1999.0772; Jonsson ME, 2009, EXP NEUROL, V219, P341, DOI 10.1016/j.expneurol.2009.06.006; Khaira SK, 2011, NEUROCHEM INT, V59, P413, DOI 10.1016/j.neuint.2011.02.016; Khaira SK, 2009, BRIT J PHARMACOL, V158, P1922, DOI 10.1111/j.1476-5381.2009.00479.x; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Lang RJ, 2004, EUR J NEUROSCI, V20, P3209, DOI 10.1111/j.1460-9568.2004.03782.x; Liu Jia, 2007, Neurosci Bull, V23, P377, DOI 10.1007/s12264-007-0056-4; Lobb CJ, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00025; Lobb CJ, 2011, J NEUROPHYSIOL, V105, P2501, DOI 10.1152/jn.01076.2010; Malmersjo S, 2010, STEM CELLS DEV, V19, P1355, DOI 10.1089/scd.2009.0436; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; Meredith GE, 2009, EXP NEUROL, V219, P334, DOI 10.1016/j.expneurol.2009.06.005; Morizane A, 2008, CELL TISSUE RES, V331, P323, DOI 10.1007/s00441-007-0541-0; Nishimura F, 2003, STEM CELLS, V21, P171, DOI 10.1634/stemcells.21-2-171; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Nunez JL, 2003, EXP NEUROL, V181, P258, DOI 10.1016/S0014-4886(03)00053-0; Owens DF, 1996, J NEUROSCI, V16, P6414; Pignatelli A, 2009, PFLUG ARCH EUR J PHY, V457, P899, DOI 10.1007/s00424-008-0535-0; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Preston A, 2003, BRIT J PHARMACOL, V138, P218, DOI 10.1038/sj.bjp.0705021; Raye WS, 2007, EUR J NEUROSCI, V25, P1961, DOI 10.1111/j.1460-9568.2007.05489.x; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Steiner B, 2008, J NEUROSCI METH, V169, P128, DOI 10.1016/j.jneumeth.2007.11.032; Storch A, 2003, J CHEM NEUROANAT, V26, P133, DOI 10.1016/S0891-0618(03)00067-X; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	51	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31999	10.1371/journal.pone.0031999	http://dx.doi.org/10.1371/journal.pone.0031999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384125	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500065
J	Zhou, X; Hao, Q; Liao, J; Zhang, Q; Lu, H				Zhou, X.; Hao, Q.; Liao, J.; Zhang, Q.; Lu, H.			Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress	ONCOGENE			English	Article						RPS14; p53; MDM2; RPS19; ribosomal stress	DIAMOND-BLACKFAN ANEMIA; N-TERMINAL DOMAIN; P53 ACTIVATION; NUCLEOLAR PROTEIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CELL-PROLIFERATION; ONCOPROTEIN MDM2; UBIQUITIN LIGASE; C-TERMINUS	The MDM2-p53 feedback loop is crucially important for restricting p53 level and activity during normal cell growth and proliferation, and is thus subjected to dynamic regulation in order for cells to activate p53 upon various stress signals. Several ribosomal proteins, such as RPL11, RPL5, RPL23, RPL26 or RPS7, have been shown to have a role in regulation of this feedback loop in response to ribosomal stress. Here, we identify another ribosomal protein S14, which is highly associated with 5q-syndrome, as a novel activator of p53 by inhibiting MDM2 activity. We found that RPS14, but not RPS19, binds to the central acidic domain of MDM2, similar to RPL5 and RPL23, and inhibits its E3 ubiquitin ligase activity toward p53. This RPS14-MDM2 binding was induced upon ribosomal stress caused by actinomycin D or mycophenolic acid. Overexpression of RPS14, but not RPS19, elevated p53 level and activity, leading to G1 or G2 arrest. Conversely, knockdown of RPS14 alleviated p53 induction by these two reagents. Interestingly, knockdown of either RPS14 or RPS19 caused a ribosomal stress that led to p53 activation, which was impaired by further knocking down the level of RPL11 or RPL5. Together, our results demonstrate that RPS14 and RPS19 have distinct roles in regulating the MDM2-p53 feedback loop in response to ribosomal stress. Oncogene (2013) 32, 388-396; doi:10.1038/onc.2012.63; published online 5 March 2012	[Zhou, X.; Hao, Q.; Liao, J.; Zhang, Q.; Lu, H.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Zhou, X.; Hao, Q.; Liao, J.; Zhang, Q.; Lu, H.] Indiana Univ Sch Med, Ctr Canc, Indianapolis, IN USA; [Zhou, X.; Hao, Q.; Liao, J.; Zhang, Q.; Lu, H.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Zhou, X.; Hao, Q.; Liao, J.; Zhang, Q.; Lu, H.] Tulane Univ, Sch Med, Ctr Canc, New Orleans, LA 70112 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tulane University; Tulane University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Zhou, Xiang/J-5046-2017	Zhou, Xiang/0000-0002-1172-7948	NIH-NCI [CA095441, CA 079721, CA129828]; NATIONAL CANCER INSTITUTE [R01CA079721, R01CA095441, R01CA129828] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Steven Ellis for reagents and discussion. This work was supported in part by NIH-NCI Grants CA095441, CA 079721 and CA129828 to HL.	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JUVEN T, 1993, ONCOGENE, V8, P3411; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; LUNA RMD, 1995, NATURE, V378, P203; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yu WS, 2011, NUCLEIC ACIDS RES, V39, P2234, DOI 10.1093/nar/gkq1117; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	60	110	113	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 17	2013	32	3					388	396		10.1038/onc.2012.63	http://dx.doi.org/10.1038/onc.2012.63			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22391559	Green Accepted			2022-12-25	WOS:000314736600012
J	Queiroz, N; Humphries, NE; Noble, LR; Santos, AM; Sims, DW				Queiroz, Nuno; Humphries, Nicolas E.; Noble, Leslie R.; Santos, Antonio M.; Sims, David W.			Spatial Dynamics and Expanded Vertical Niche of Blue Sharks in Oceanographic Fronts Reveal Habitat Targets for Conservation	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; TUNA THUNNUS-THYNNUS; PELAGIC SHARKS; PRIONACE-GLAUCA; SEASONAL MOVEMENTS; DIVING BEHAVIOR; XIPHIAS-GLADIUS; BASKING SHARKS; PACIFIC-OCEAN; MIGRATION	Dramatic population declines among species of pelagic shark as a result of overfishing have been reported, with some species now at a fraction of their historical biomass. Advanced telemetry techniques enable tracking of spatial dynamics and behaviour, providing fundamental information on habitat preferences of threatened species to aid conservation. We tracked movements of the highest pelagic fisheries by-catch species, the blue shark Prionace glauca, in the North-east Atlantic using pop-off satellite-linked archival tags to determine the degree of space use linked to habitat and to examine vertical niche. Overall, blue sharks moved south-west of tagging sites (English Channel; southern Portugal), exhibiting pronounced site fidelity correlated with localized productive frontal areas, with estimated space-use patterns being significantly different from that of random walks. Tracked female sharks displayed behavioural variability in diel depth preferences, both within and between individuals. Diel depth use ranged from normal DVM (nDVM; dawn descent, dusk ascent), to reverse DVM (rDVM; dawn ascent, dusk descent), to behavioural patterns where no diel differences were apparent. Results showed that blue sharks occupy some of the most productive marine zones for extended periods and structure diel activity patterns across multiple spatio-temporal scales in response to particular habitat types. In so doing, sharks occupied an extraordinarily broad vertical depth range for their size (1.0-2.0 m fork length), from the surface into the bathypelagic realm (max. dive depth, 1160 m). The space-use patterns of blue sharks indicated they spend much of the time in areas where pelagic longlining activities are often highest, and in depth zones where these fisheries particularly target other species, which could account for the rapid declines recently reported for blue sharks in many parts of the world's oceans. Our results provide habitat targets for blue shark conservation that may also be relevant to other pelagic species.	[Queiroz, Nuno; Humphries, Nicolas E.; Sims, David W.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Queiroz, Nuno; Santos, Antonio M.] Ctr Invest Biodiversidade & Recursos Genet, CIBIO UP, Vairao, Portugal; [Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Humphries, Nicolas E.] Univ Plymouth, Sch Marine Sci & Engn, Inst Marine, Plymouth PL4 8AA, Devon, England; [Sims, David W.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Sims, David W.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England	Marine Biological Association United Kingdom; Universidade do Porto; University of Aberdeen; University of Plymouth; NERC National Oceanography Centre; University of Southampton; University of Southampton	Queiroz, N (corresponding author), Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Humphries, Nick/AAE-7170-2019; Santos, António M/M-3515-2013; Queiroz, Nuno/G-3850-2010	Humphries, Nick/0000-0003-3741-1594; Santos, António M/0000-0002-0417-8813; Queiroz, Nuno/0000-0002-3860-7356; Noble, leslie/0000-0003-3076-0759; Sims, David/0000-0002-0916-7363	Save Our Seas Foundation; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/MAR/100345/2008, SFRH/BPD/70070/2010]; UK Natural Environment Research Council (NERC); NERC [mba010004] Funding Source: UKRI; Natural Environment Research Council [mba010004] Funding Source: researchfish	Save Our Seas Foundation; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was received from the Save Our Seas Foundation (www.saveourseas.org), Fundacao para a Ciencia e a Tecnologia (FCT) Grant PTDC/MAR/100345/2008 and Scholarship SFRH/BPD/70070/2010 (www.fct.pt), and the UK Natural Environment Research Council (NERC) Oceans 2025 Strategic Research Programme (Theme 6, Science for Sustainable Marine Resources) (www.oceans2025.org) through grant awards to DWS and NQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bigelow K, 2006, FISH RES, V77, P173, DOI 10.1016/j.fishres.2005.10.010; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bolle LJ, 2005, ICES J MAR SCI, V62, P236, DOI 10.1016/j.icesjms.2004.11.010; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Buencuerpo V, 1998, FISH B-NOAA, V96, P667; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; Dupont N, 2009, LIMNOL OCEANOGR, V54, P1765, DOI 10.4319/lo.2009.54.5.1765; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Fitzmaurice P., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1171; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2009, J EXP MAR BIOL ECOL, V370, P134, DOI 10.1016/j.jembe.2008.12.009; Horodysky AZ, 2007, FISH OCEANOGR, V16, P240, DOI 10.1111/j.1365-2419.2007.00419.x; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Kaartvedt S, 2007, LIMNOL OCEANOGR, V52, P975, DOI 10.4319/lo.2007.52.3.0975; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Labat JP, 2009, DEEP-SEA RES PT I, V56, P1742, DOI 10.1016/j.dsr.2009.05.013; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Litvinov F.F, 2006, J ICHTHYOL, V46, P613, DOI DOI 10.1134/S0032945206080091; Lopez-Mendilaharsu M, 2009, J EXP MAR BIOL ECOL, V378, P31, DOI 10.1016/j.jembe.2009.07.010; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Manly BFJ, 1997, RANDOMIZATION BOOTST, P455; Marchesiello P, 2009, INT J EARTH SCI, V98, P299, DOI 10.1007/s00531-007-0235-6; Markaida U, 2005, FISH B-NOAA, V103, P219; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Neat FC, 2006, MAR BIOL, V148, P643, DOI 10.1007/s00227-005-0110-6; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Pade NG, 2009, J EXP MAR BIOL ECOL, V370, P64, DOI 10.1016/j.jembe.2008.12.002; PODESTA GP, 1993, CONT SHELF RES, V13, P253, DOI 10.1016/0278-4343(93)90109-B; Queiroz N, 2005, J MAR BIOL ASSOC UK, V85, P1107, DOI 10.1017/S0025315405012154; Queiroz N, 2010, MAR ECOL PROG SER, V406, P265, DOI 10.3354/meps08500; RINGELBERG J, 1995, J MAR BIOL ASSOC UK, V75, P15, DOI 10.1017/S0025315400015162; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Sedberry GR, 2001, MAR BIOL, V139, P355; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Simpfendorfer CA, 2002, FISH RES, V55, P175; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2003, J MAR BIOL ASSOC UK, V83, P643, DOI 10.1017/S0025315403007598h; STEVENS JD, 1976, J MAR BIOL ASSOC UK, V56, P929, DOI 10.1017/S002531540002097X; STEVENS JD, 1990, J MAR BIOL ASSOC UK, V70, P707, DOI 10.1017/S0025315400058999; STEVENS JD, 1973, J MAR BIOL ASSOC UK, V53, P357, DOI 10.1017/S0025315400022323; Turchin Peter, 1998; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Ward P, 2005, CAN J FISH AQUAT SCI, V62, P1130, DOI 10.1139/F05-021; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Weng KC, 2009, J FISH BIOL, V74, P1434, DOI 10.1111/j.1095-8649.2009.02209.x; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; WOLANSKI E, 1988, SCIENCE, V241, P177, DOI 10.1126/science.241.4862.177; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	68	59	59	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32374	10.1371/journal.pone.0032374	http://dx.doi.org/10.1371/journal.pone.0032374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393403	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000303003500056
J	Sala, E; Ballesteros, E; Dendrinos, P; Di Franco, A; Ferretti, F; Foley, D; Fraschetti, S; Friedlander, A; Garrabou, J; Guclusoy, H; Guidetti, P; Halpern, BS; Hereu, B; Karamanlidis, AA; Kizilkaya, Z; Macpherson, E; Mangialajo, L; Mariani, S; Micheli, F; Pais, A; Riser, K; Rosenberg, AA; Sales, M; Selkoe, KA; Starr, R; Tomas, F; Zabala, M				Sala, Enric; Ballesteros, Enric; Dendrinos, Panagiotis; Di Franco, Antonio; Ferretti, Francesco; Foley, David; Fraschetti, Simonetta; Friedlander, Alan; Garrabou, Joaquim; Guclusoy, Harun; Guidetti, Paolo; Halpern, Benjamin S.; Hereu, Bernat; Karamanlidis, Alexandros A.; Kizilkaya, Zafer; Macpherson, Enrique; Mangialajo, Luisa; Mariani, Simone; Micheli, Fiorenza; Pais, Antonio; Riser, Kristin; Rosenberg, Andrew A.; Sales, Marta; Selkoe, Kimberly A.; Starr, Rick; Tomas, Fiona; Zabala, Mikel			The Structure of Mediterranean Rocky Reef Ecosystems across Environmental and Human Gradients, and Conservation Implications	PLOS ONE			English	Article							MARINE PROTECTED AREAS; URCHIN PARACENTROTUS-LIVIDUS; ALGAL ASSEMBLAGES; CYSTOSEIRA SPP.; SEA-URCHINS; MONK SEAL; FISH; COMMUNITY; HABITATS; NORTHWESTERN	Historical exploitation of the Mediterranean Sea and the absence of rigorous baselines makes it difficult to evaluate the current health of the marine ecosystems and the efficacy of conservation actions at the ecosystem level. Here we establish the first current baseline and gradient of ecosystem structure of nearshore rocky reefs at the Mediterranean scale. We conducted underwater surveys in 14 marine protected areas and 18 open access sites across the Mediterranean, and across a 31-fold range of fish biomass (from 3.8 to 118 g m(-2)). Our data showed remarkable variation in the structure of rocky reef ecosystems. Multivariate analysis showed three alternative community states: (1) large fish biomass and reefs dominated by non-canopy algae, (2) lower fish biomass but abundant native algal canopies and suspension feeders, and (3) low fish biomass and extensive barrens, with areas covered by turf algae. Our results suggest that the healthiest shallow rocky reef ecosystems in the Mediterranean have both large fish and algal biomass. Protection level and primary production were the only variables significantly correlated to community biomass structure. Fish biomass was significantly larger in well-enforced no-take marine reserves, but there were no significant differences between multi-use marine protected areas (which allow some fishing) and open access areas at the regional scale. The gradients reported here represent a trajectory of degradation that can be used to assess the health of any similar habitat in the Mediterranean, and to evaluate the efficacy of marine protected areas.	[Sala, Enric] Natl Geog Soc, Washington, DC USA; [Sala, Enric; Ballesteros, Enric; Macpherson, Enrique; Mariani, Simone; Tomas, Fiona] CSIC, CEAB, Blanes, Spain; [Dendrinos, Panagiotis; Karamanlidis, Alexandros A.] MOm Hellen Soc Study & Protect Monk Seal, Athens, Greece; [Di Franco, Antonio; Fraschetti, Simonetta; Guidetti, Paolo] Univ Salento, DiSTeBA, Lecce, Italy; [Ferretti, Francesco; Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Foley, David] NOAA, SW Fisheries Sci Ctr, Pacific Grove, CA USA; [Foley, David] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Friedlander, Alan] US Geol Survey, Hawaii Cooperat Fishery Res Unit, Honolulu, HI USA; [Friedlander, Alan] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Garrabou, Joaquim] CSIC, ICM, Ctr Mediterrani Invest Marines & Ambientals, Barcelona, Spain; [Guclusoy, Harun] Dokuz Eylul Univ, Inst Marine Sci & Technol, Izmir, Turkey; [Guclusoy, Harun; Kizilkaya, Zafer] EKOG, SAD, Ankara, Turkey; [Halpern, Benjamin S.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Hereu, Bernat; Zabala, Mikel] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain; [Mangialajo, Luisa] Univ Nice Sophia Antipolis, Nice, France; [Pais, Antonio] Univ Sassari, Dipartimento Sci Zootecn, I-07100 Sassari, Italy; [Riser, Kristin; Starr, Rick] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Rosenberg, Andrew A.] Conservat Int, Arlington, VA USA; [Sales, Marta] Ctr Oceanog Balears, IEO, Estacio Invest Jaume Ferrer, Mao, Spain; [Starr, Rick] Moss Landing Marine Labs, Moss Landing, CA 95039 USA	National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Salento; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; United States Department of the Interior; United States Geological Survey; University of Hawaii System; University of Hawaii Manoa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Dokuz Eylul University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Barcelona; UDICE-French Research Universities; Universite Cote d'Azur; University of Sassari; University of California System; University of California San Diego; Scripps Institution of Oceanography; Conservation International; Spanish Institute of Oceanography; Moss Landing Marine Laboratories	Sala, E (corresponding author), Natl Geog Soc, Washington, DC USA.	esala@ngs.org	Karamanlidis, Alexandros/S-8239-2017; Ballesteros, Enric/K-6497-2012; Pais, Antonio/D-2209-2012; Macpherson, Enrique/J-8982-2012; Hereu, Bernat/K-9150-2015; Fraschetti, Simonetta/R-8716-2019; Ferretti, Francesco/AAR-2545-2020; Guclusoy, Harun/P-2094-2019; Tomas, Fiona/G-3713-2010; Di Franco, Antonio/A-8796-2010	Karamanlidis, Alexandros/0000-0003-0943-1619; Pais, Antonio/0000-0003-4370-8423; Macpherson, Enrique/0000-0003-4849-4532; Hereu, Bernat/0000-0001-6247-7638; Fraschetti, Simonetta/0000-0002-1780-1651; Ferretti, Francesco/0000-0001-9510-3552; Guclusoy, Harun/0000-0002-4147-2587; Tomas, Fiona/0000-0001-8682-2504; Guidetti, Paolo/0000-0002-7983-8775; Mariani, Simone/0000-0003-0903-8657; Mangialajo, Luisa/0000-0002-0225-8625; Micheli, Fiorenza/0000-0002-6865-1438; Di Franco, Antonio/0000-0003-3411-7015	Oak Foundation; Pew Charitable Trusts; Spain's National Council for Scientific Research (CSIC); Lenfest Ocean Program	Oak Foundation; Pew Charitable Trusts; Spain's National Council for Scientific Research (CSIC); Lenfest Ocean Program	This study was funded by the Oak Foundation, the Pew Charitable Trusts, Spain's National Council for Scientific Research (CSIC) and the Lenfest Ocean Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alcoverro T., 2002, TRAVAUX SCIENTIFIQUE, V60, P95; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azzurro E, 2007, J MAR BIOL ASSOC UK, V87, P991, DOI 10.1017/S0025315407056342; Ballesteros, 1989, SCI MAR, V53, P3; BALLESTEROS E, 1989, Scientia Marina, V53, P357; Ballesteros E, 2008, MONITORING MARINE PR; Ballesteros E., 1992, ELS VEGETALS ZONACIO; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Braak CT, 2002, SECTION PERMUTATION; Bulleri F, 2007, ENVIRON CONSERV, V34, P181, DOI 10.1017/S0376892907004201; Cardona L, 2007, ESTUAR COAST SHELF S, V72, P273, DOI 10.1016/j.ecss.2006.10.023; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dendrinos P, 2007, MAR MAMMAL SCI, V23, P615, DOI 10.1111/j.1748-7692.2007.00121.x; Dendrinos Panagiotis, 2008, Aquatic Mammals, V34, P355, DOI 10.1578/AM.34.3.2008.355; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; FRANCOUR P, 1994, OCEANOL ACTA, V17, P309; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; GARCIA-RUBIES A, 1990, Scientia Marina, V54, P317; Guclusoy H., 2004, EGE UNIVESITY J FISH, V21, P201; Guidetti P, 2005, J MAR BIOL ASSOC UK, V85, P247, DOI 10.1017/S0025315405011124h; Guidetti P, 2003, MAR BIOL, V143, P1135, DOI 10.1007/s00227-003-1163-z; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2011, FRONT ECOL ENVIRON, V9, P374, DOI 10.1890/11.WB.019; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hereu B, 2004, MAR BIOL, V144, P1011, DOI 10.1007/s00227-003-1266-6; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Jackson JBC, 2001, SCI MAR, V65, P273, DOI 10.3989/scimar.2001.65s2273; Johnson W, 2006, MONK SEAL FACT FILES; Jongman R, DATA ANAL COMMUNITY; Klein J, 2005, MAR ECOL PROG SER, V290, P79, DOI 10.3354/meps290079; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Mangialajo L, 2011, J EXPT MARI IN PRESS; Mangialajo L, 2007, MAR POLLUT BULL, V55, P30, DOI 10.1016/j.marpolbul.2006.08.022; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; MOm, 2009, STAT MED MONK SEAL M; Morey G, 2003, FISH RES, V62, P89, DOI 10.1016/S0165-7836(02)00250-3; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Occhipinti-Ambrogi A., 2010, ADV OCEANOGR LIMNOL, V1, P199, DOI [10.1080/19475721003743876, DOI 10.1080/19475721003743876]; Pais A, 2007, ESTUAR COAST SHELF S, V73, P589, DOI 10.1016/j.ecss.2007.02.011; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Pierce GJ, 2011, AQUAT MAMM, V37, P284, DOI 10.1578/AM.37.3.2011.284; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Ribera M.A., 1995, PROGR PHYCOLOGICAL R, V11, P187; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017356; Sales M, 2011, ESTUAR COAST SHELF S, V92, P347, DOI 10.1016/j.ecss.2011.01.008; Sales M, 2010, EUR J PHYCOL, V45, P404, DOI 10.1080/09670262.2010.498585; Sales M, 2009, ESTUAR COAST SHELF S, V84, P476, DOI 10.1016/j.ecss.2009.07.013; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Tomas F, 2004, MAR ECOL PROG SER, V282, P173, DOI 10.3354/meps282173; Tomas F, 2011, ESTUAR COAST SHELF S, V92, P27, DOI 10.1016/j.ecss.2010.12.004; Verges A, 2009, MAR ECOL PROG SER, V375, P1, DOI 10.3354/meps07778; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	84	220	222	3	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32742	10.1371/journal.pone.0032742	http://dx.doi.org/10.1371/journal.pone.0032742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393445	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500099
J	Ehrentraut, H; Westrich, JA; Eltzschig, HK; Clambey, ET				Ehrentraut, Heidi; Westrich, Joseph A.; Eltzschig, Holger K.; Clambey, Eric T.			Adora2b Adenosine Receptor Engagement Enhances Regulatory T Cell Abundance during Endotoxin-Induced Pulmonary Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; CUTTING EDGE; DEAMINASE DEFICIENCY; AIRWAY INFLAMMATION; DEPENDENT INDUCTION; IMMUNE-RESPONSE; DENDRITIC CELLS; HYPOXIA; PROTECTION; MICE	Anti-inflammatory signals play an essential role in constraining the magnitude of an inflammatory response. Extracellular adenosine is a critical tissue-protective factor, limiting the extent of inflammation. Given the potent anti-inflammatory effects of extracellular adenosine, we sought to investigate how extracellular adenosine regulates T cell activation and differentiation. Adenosine receptor activation by a pan adenosine-receptor agonist enhanced the abundance of murine regulatory T cells (Tregs), a cell type critical in constraining inflammation. Gene expression studies in both naive CD4 T cells and Tregs revealed that these cells expressed multiple adenosine receptors. Based on recent studies implicating the Adora2b in endogenous anti-inflammatory responses during acute inflammation, we used a pharmacologic approach to specifically activate Adora2b. Indeed, these studies revealed robust enhancement of Treg differentiation in wild-type mice, but not in Adora2b(-/-) T cells. Finally, when we subjected Adora2b-deficient mice to endotoxin-induced pulmonary inflammation, we found that these mice experienced more severe inflammation, characterized by increased cell recruitment and increased fluid leakage into the airways. Notably, Adora2b-deficient mice failed to induce Tregs after endotoxin-induced inflammation and instead had an enhanced recruitment of pro-inflammatory effector T cells. In total, these data indicate that the Adora2b adenosine receptor serves a potent anti-inflammatory role, functioning at least in part through the enhancement of Tregs, to limit inflammation.	[Ehrentraut, Heidi; Westrich, Joseph A.; Eltzschig, Holger K.; Clambey, Eric T.] Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ehrentraut, H (corresponding author), Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol, Aurora, CO 80045 USA.	eric.clambey@ucdenver.edu		Westrich, Joseph/0000-0003-2406-6891	National Institutes of Health [R01-HL0921, R01-DK083385, R01HL098294]; Crohn's and Colitis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by National Institutes of Health grants R01-HL0921, R01-DK083385, R01HL098294, and by a Crohn's and Colitis Foundation grant to HKE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2011, GUT             0803; Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Du GJ, 2009, CANCER RES, V69, P3205, DOI 10.1158/0008-5472.CAN-08-3393; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Joetham A, 2009, J IMMUNOL, V183, P1821, DOI 10.4049/jimmunol.0900303; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Mustafa SJ, 2007, J PHARMACOL EXP THER, V320, P1246, DOI 10.1124/jpet.106.112250; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nakatsukasa H, 2011, BIOCHEM BIOPH RES CO, V409, P114, DOI 10.1016/j.bbrc.2011.04.125; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Sitkovsky MV, 2008, CLIN CANCER RES, V14, P5947, DOI 10.1158/1078-0432.CCR-08-0229; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zaynagetdinov R, 2010, AM J RESP CELL MOL, V42, P564, DOI 10.1165/rcmb.2008-0391OC; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	60	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32416	10.1371/journal.pone.0032416	http://dx.doi.org/10.1371/journal.pone.0032416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389701	Green Published, Green Submitted, gold			2022-12-25	WOS:000302999600039
J	Bigini, P; Diana, V; Barbera, S; Fumagalli, E; Micotti, E; Sitia, L; Paladini, A; Bisighini, C; De Grada, L; Coloca, L; Colombo, L; Manca, P; Bossolasco, P; Malvestiti, F; Fiordaliso, F; Forloni, G; Morbidelli, M; Salmona, M; Giardino, D; Mennini, T; Moscatelli, D; Silani, V; Cova, L				Bigini, Paolo; Diana, Valentina; Barbera, Sara; Fumagalli, Elena; Micotti, Edoardo; Sitia, Leopoldo; Paladini, Alessandra; Bisighini, Cinzia; De Grada, Laura; Coloca, Laura; Colombo, Laura; Manca, Pina; Bossolasco, Patrizia; Malvestiti, Francesca; Fiordaliso, Fabio; Forloni, Gianluigi; Morbidelli, Massimo; Salmona, Mario; Giardino, Daniela; Mennini, Tiziana; Moscatelli, Davide; Silani, Vincenzo; Cova, Lidia			Longitudinal Tracking of Human Fetal Cells Labeled with Super Paramagnetic Iron Oxide Nanoparticles in the Brain of Mice with Motor Neuron Disease	PLOS ONE			English	Article							STEM-CELLS; TRANSFECTION AGENT; MOUSE MODEL; IN-VIVO; SCLEROSIS; CORD; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION	Stem Cell (SC) therapy is one of the most promising approaches for the treatment of Amyotrophic Lateral Sclerosis (ALS). Here we employed Super Paramagnetic Iron Oxide nanoparticles (SPIOn) and Hoechst 33258 to track human Amniotic Fluid Cells (hAFCs) after transplantation in the lateral ventricles of wobbler (a murine model of ALS) and healthy mice. By in vitro, in vivo and ex vivo approaches we found that: 1) the main physical parameters of SPIOn were maintained over time; 2) hAFCs efficiently internalized SPIOn into the cytoplasm while Hoechst 33258 labeled nuclei; 3) SPIOn internalization did not alter survival, cell cycle, proliferation, metabolism and phenotype of hAFCs; 4) after transplantation hAFCs rapidly spread to the whole ventricular system, but did not migrate into the brain parenchyma; 5) hAFCs survived for a long time in the ventricles of both wobbler and healthy mice; 6) the transplantation of double-labeled hAFCs did not influence mice survival.	[Bigini, Paolo; Barbera, Sara; Fumagalli, Elena; Micotti, Edoardo; Sitia, Leopoldo; Paladini, Alessandra; Bisighini, Cinzia; Colombo, Laura; Fiordaliso, Fabio; Forloni, Gianluigi; Salmona, Mario; Mennini, Tiziana] Mario Negri Inst Pharmacol Res, Milan, Italy; [De Grada, Laura; Coloca, Laura; Manca, Pina; Malvestiti, Francesca; Giardino, Daniela] ISCCR Ist Auxol Italiano, Lab Citogenet, Cusano Milanino, Italy; [Bossolasco, Patrizia] Univ Milan, Dipartimento Farmacol Chemioterapia & Tossicol Me, Fdn Matarelli, Milan, Italy; [Morbidelli, Massimo] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Moscatelli, Davide] Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20133 Milan, Italy; [Silani, Vincenzo] Univ Milan, Dept Neurol, Ctr Dino Ferrari, IRCCS Ist Auxol Italiano, Milan, Italy; [Silani, Vincenzo] Univ Milan, Neurosci Lab, Ctr Dino Ferrari, IRCCS Ist Auxol Italiano, Milan, Italy; [Diana, Valentina; Silani, Vincenzo; Cova, Lidia] IRCCS Ist Auxol Italiano, Neurosci Lab, Cusano Milanino, Italy; [Diana, Valentina; Silani, Vincenzo; Cova, Lidia] IRCCS Ist Auxol Italiano, Dept Neurol, Cusano Milanino, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Auxologico Italiano; University of Milan; Swiss Federal Institutes of Technology Domain; ETH Zurich; Polytechnic University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Bigini, P (corresponding author), Mario Negri Inst Pharmacol Res, Milan, Italy.	l.cova@auxologico.it	Silani, Vincenzo/P-4421-2017; Micotti, Edoardo/J-9359-2018; Bossolasco, Patrizia/AAA-5275-2020; Cova, Lidia/K-6459-2016; colombo, laura/AAA-6716-2020; DE GRADA, LAURA/AAA-5224-2020; salmona, mario/AAA-7116-2020; Forloni, Gianluigi/AAB-2115-2020; moscatelli, davide/G-8795-2013; salmona, mario/ABI-4066-2020; Sitia, Leopoldo/K-4017-2016; Bigini, Paolo/AAB-2901-2020; Fiordaliso, Fabio/AAA-7161-2020	Silani, Vincenzo/0000-0002-7698-3854; Micotti, Edoardo/0000-0002-5995-2992; Bossolasco, Patrizia/0000-0002-1596-7818; Cova, Lidia/0000-0002-1504-1556; colombo, laura/0000-0002-3243-0270; DE GRADA, LAURA/0000-0001-6662-0999; salmona, mario/0000-0002-9098-9873; Forloni, Gianluigi/0000-0001-5374-3914; moscatelli, davide/0000-0003-2759-9781; Sitia, Leopoldo/0000-0002-7268-4056; Bigini, Paolo/0000-0002-0239-9532; Fiordaliso, Fabio/0000-0002-0172-4030; Morbidelli, Massimo/0000-0002-0112-414X; Giardino, Daniela/0000-0003-2615-0026				Albani D, 2009, J NEUROCHEM, V110, P1445, DOI 10.1111/j.1471-4159.2009.06228.x; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2003, TRANSPLANTATION, V76, P1123, DOI 10.1097/01.TP.0000089237.39220.83; Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140; Bigini P, 2011, REJUVENATIO IN PRESS; Bigini P, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-71; Bigini P, 2007, NEUROSCI LETT, V426, P106, DOI 10.1016/j.neulet.2007.08.057; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cova L, 2010, STEM CELLS CLONING, V3, P145, DOI 10.2147/SCCAA.S8662; Diana V, 2010, EXP NEUROL, V225, P163, DOI 10.1016/j.expneurol.2010.06.008; DUCHEN LW, 1968, J NEUROL NEUROSUR PS, V31, P535, DOI 10.1136/jnnp.31.6.535; Flexman JA, 2011, MOL IMAGING BIOL, V13, P104, DOI 10.1007/s11307-010-0311-3; Focke A, 2008, MAGN RESON MED, V60, P1321, DOI 10.1002/mrm.21745; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hedlund E, 2007, EUR J NEUROSCI, V26, P1721, DOI 10.1111/j.1460-9568.2007.05780.x; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Lohrke J, 2008, NANOMEDICINE-UK, V3, P437, DOI 10.2217/17435889.3.4.437; Magnitsky S, 2005, NEUROIMAGE, V26, P744, DOI 10.1016/j.neuroimage.2005.02.029; Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mazzini L, 2011, CYTOTHERAPY; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mohorko N, 2005, HUM EXP TOXICOL, V24, P573, DOI 10.1191/0960327105ht570oa; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Paxinos G., MOUSE BRAIN STEREOTA; Pioro EP, 1998, NEUROREPORT, V9, P3041, DOI 10.1097/00001756-199809140-00023; Rathke-Hartlieb S, 1999, NEUROREPORT, V10, P3411, DOI 10.1097/00001756-199911080-00028; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Silani V, 2010, CNS NEUROL DISORD-DR, V9, P314, DOI 10.2174/187152710791292666; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang C, 2009, CYTOTHERAPY, V11, P299, DOI 10.1080/14653240902806986	37	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32326	10.1371/journal.pone.0032326	http://dx.doi.org/10.1371/journal.pone.0032326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384217	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500078
J	Zichel, R; Chearwae, W; Pandey, GS; Golding, B; Sauna, ZE				Zichel, Ran; Chearwae, Wanida; Pandey, Gouri Shankar; Golding, Basil; Sauna, Zuben E.			Aptamers as a Sensitive Tool to Detect Subtle Modifications in Therapeutic Proteins	PLOS ONE			English	Article							FACTOR-VIII; HUMAN THROMBIN; BIOSIMILARS; COMPARABILITY; INHIBITORS; AGENTS	Therapeutic proteins are derived from complex expression/production systems, which can result in minor conformational changes due to preferential codon usage in different organisms, post-translational modifications, etc. Subtle conformational differences are often undetectable by bioanalytical methods but can sometimes profoundly impact the safety, efficacy and stability of products. Numerous bioanalytical methods exist to characterize the primary structure of proteins, post translational modifications; protein-substrate/protein/protein interactions and functional bioassays are available for most proteins that are developed as products. There are however few analytical techniques to detect changes in the tertiary structure of proteins suitable for use during drug development and quality control. For example, x-ray crystallography and NMR are impractical for routine use and do not capture the heterogeneity of the product. Conformation-sensitive antibodies can be used to map proteins. However the development of antibodies to represent sufficient epitopes can be challenging. Other limitations of antibodies include limited supply, high costs, heterogeneity and batch to batch variations in titer. Here we provide proof-of-principle that DNA aptamers to thrombin can be used as surrogate antibodies to characterize conformational changes. We show that aptamers can be used in assays using either an ELISA or a label-free platform to characterize different thrombin products. In addition we replicated a heat-treatment procedure that has previously been shown to not affect protein activity but can result in conformational changes that have serious adverse consequences. We demonstrate that a panel of aptamers (but not an antibody) can detect changes in the proteins even when specific activity is unaffected. Our results indicate a novel approach to monitor even small changes in the conformation of proteins which can be used in a routine drug-development and quality control setting. The technique can provide an early warning of structural changes during the manufacturing process that could have consequential outcomes downstream.	[Zichel, Ran; Chearwae, Wanida; Pandey, Gouri Shankar; Sauna, Zuben E.] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Hemostasis, Bethesda, MD 20014 USA; [Golding, Basil] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Plasma Derivat, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Zichel, R (corresponding author), Israel Inst Biol Res, Dept Biotechnol, IL-70450 Ness Ziona, Israel.	zuben.sauna@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019		Laboratory of Hemostasis; Center for Biologics Evaluation and Research, Food and Drug Administration's Modernization of Science	Laboratory of Hemostasis; Center for Biologics Evaluation and Research, Food and Drug Administration's Modernization of Science	This work was supported by funds from the Laboratory of Hemostasis and the Center for Biologics Evaluation and Research, Food and Drug Administration's Modernization of Science program (ZES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, REC PACK INS; [Anonymous], 2007, EV PACK INS; [Anonymous], 2007, THROMB JMI PACK INS; [Anonymous], 2006, GUIDELINE SIMILAR BI; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Belsey MJ, 2006, NAT REV DRUG DISCOV, V5, P535, DOI 10.1038/nrd2093; Byeon JY, 2010, LANGMUIR, V26, P15430, DOI 10.1021/la1021824; Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; Chapman WC, 2007, J AM COLL SURGEONS, V205, P252, DOI 10.1016/j.jamcollsurg.2007.03.020; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; DAWES J, 1984, THROMB RES, V36, P397, DOI 10.1016/0049-3848(84)90296-2; Dichtelmuller H, 1996, BIOLOGICALS, V24, P125, DOI 10.1006/biol.1996.0016; Doria C, 2008, CURR MED RES OPIN, V24, P785, DOI 10.1185/030079908X273426; Famulok M, 2005, CURR OPIN MOL THER, V7, P137; Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w; Jhaveri S, 2000, NAT BIOTECHNOL, V18, P1293, DOI 10.1038/82414; Kessler CM, 2009, THROMB HAEMOSTASIS, V102, P15, DOI 10.1160/TH09-01-0034; Kozlowski S, 2011, NEW ENGL J MED, V365, P385, DOI 10.1056/NEJMp1107285; Lomax C, 2009, PHARMACOTHERAPY, V29, p8S, DOI 10.1592/phco.29.pt2.8S; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Modesti PA, 2009, ANESTHESIOLOGY, V111, P844, DOI 10.1097/ALN.0b013e3181b1607f; Peerlinck K, 1997, THROMB HAEMOSTASIS, V77, P80; PIZZI E, 1995, BIOPOLYMERS, V36, P675, DOI 10.1002/bip.360360513; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P698, DOI 10.1016/j.tibtech.2009.09.004; Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26; Raut S, 1998, THROMB HAEMOSTASIS, V80, P624; Rentmeister A, 2007, NUCLEIC ACIDS RES, V35, P3713, DOI 10.1093/nar/gkm300; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Roger SD, 2010, EXPERT OPIN BIOL TH, V10, P1011, DOI 10.1517/14712591003796553; Ruigrok VJB, 2011, BIOCHEM J, V436, P1, DOI 10.1042/BJ20101860; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schellekens H, 2004, TRENDS BIOTECHNOL, V22, P406, DOI 10.1016/j.tibtech.2004.06.003; Schellekens H, 2010, NAT BIOTECHNOL, V28, P28, DOI 10.1038/nbt0110-28; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Schoenecker JG, 2003, J AM COLL SURGEONS, V197, P580, DOI 10.1016/S1072-7515(03)00670-7; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Soukup GA, 1999, TRENDS BIOTECHNOL, V17, P469, DOI 10.1016/S0167-7799(99)01383-9; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tombelli S, 2009, CURR OPIN MOL THER, V11, P179; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/NCHEMBIO.609, 10.1038/nchembio.609]	42	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31948	10.1371/journal.pone.0031948	http://dx.doi.org/10.1371/journal.pone.0031948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384109	Green Published			2022-12-25	WOS:000302918500050
J	Kiselev, Y; Eriksen, TE; Forsdahl, S; Lan, HTN; Mikkola, I				Kiselev, Yury; Eriksen, Tonje Engevik; Forsdahl, Siri; Lan Huong Thi Nguyen; Mikkola, Ingvild			3T3 Cell Lines Stably Expressing Pax6 or Pax6(5a) - A New Tool Used for Identification of Common and Isoform Specific Target Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PAX6; CELL-ADHESION MOLECULE; TISSUE GROWTH-FACTOR; PAIRED DOMAIN; DNA-BINDING; LENS; SEQUENCE; ROLES; ANIRIDIA; FAMILY	Pax6 and Pax6(5a) are two isoforms of the evolutionary conserved Pax6 gene often co-expressed in specific stochiometric relationship in the brain and the eye during development. The Pax6(5a) protein differs from Pax6 by having a 14 amino acid insert in the paired domain, causing the two proteins to have different DNA binding specificities. Difference in functions during development is proven by the fact that mutations in the 14 amino acid insertion for Pax6(5a) give a slightly different eye phenotype than the one described for Pax6. Whereas quite many Pax6 target genes have been published during the last years, few Pax6(5a) specific target genes have been reported on. However, target genes identified by Pax6 knockout studies can probably be Pax6(5a) targets as well, since this isoform also will be affected by the knockout. In order to identify new Pax6 target genes, and to try to distinguish between genes regulated by Pax6 and Pax6(5a), we generated FlpIn-3T3 cell lines stably expressing Pax6 or Pax6(5a). RNA was harvested from these cell lines and used in gene expression microarrays where we identified a number of genes differentially regulated by Pax6 and Pax6(5a). A majority of these were associated with the extracellular region. By qPCR we verified that Ncam1, Ngef, Sphk1, Dkk3 and Crtap are Pax6(5a) specific target genes, while Tgfbi, Vegfa, EphB2, Klk8 and Edn1 were confirmed as Pax6 specific target genes. Nbl1, Ngfb and seven genes encoding different glycosyl transferases appeared to be regulated by both. Direct binding to the promoters of Crtap, Ctgf, Edn1, Dkk3, Pdgfb and Ngef was verified by ChIP. Furthermore, a change in morphology of the stably transfected Pax6 and Pax6(5a) cells was observed, and the Pax6 expressing cells were shown to have increased proliferation and migration capacities.	[Kiselev, Yury; Eriksen, Tonje Engevik; Forsdahl, Siri; Lan Huong Thi Nguyen; Mikkola, Ingvild] Univ Tromso, Dept Pharm, Res Grp Pharmacol, Tromso, Norway	UiT The Arctic University of Tromso	Kiselev, Y (corresponding author), Univ Tromso, Dept Pharm, Res Grp Pharmacol, Tromso, Norway.	ingvild.mikkola@uit.no		Mikkola, Ingvild/0000-0001-6442-7626; Kiselev, Yury/0000-0002-6753-8572	Norwegian Research Council [160293]; Research School for Molecular and Structural Biology, University of Tromso; University of Tromso	Norwegian Research Council(Research Council of NorwayEuropean Commission); Research School for Molecular and Structural Biology, University of Tromso; University of Tromso	This work was supported by the Norwegian Research Council, grant # 160293 for I. M., and by the Research School for Molecular and Structural Biology, University of Tromso, with a Ph.D grant for Y.K. S. F. has a Ph.D grant from the University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Caric D, 1997, DEVELOPMENT, V124, P5087; Cartier L, 2006, J NEUROBIOL, V66, P421, DOI 10.1002/neu.20225; CHALEPAKIS G, 1994, DNA CELL BIOL, V13, P891, DOI 10.1089/dna.1994.13.891; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2002, GENES CELLS, V7, P1267, DOI 10.1046/j.1365-2443.2002.00602.x; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duncan MK, 2000, J CELL SCI, V113, P3173; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Faber SC, 2002, DEVELOPMENT, V129, P3727; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; Gerlach-Bank LM, 2002, DEV DYNAM, V224, P109, DOI 10.1002/dvdy.10079; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Holst BD, 1997, P NATL ACAD SCI USA, V94, P1465, DOI 10.1073/pnas.94.4.1465; Huang DW, 2008, BIOINFORMATION, V2, P428; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kim AS, 2003, DEV BRAIN RES, V145, P159, DOI 10.1016/S0165-3806(03)00213-X; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kucerova R, 2006, INVEST OPHTH VIS SCI, V47, P5276, DOI 10.1167/iovs.06-0581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Martin CC, 2004, J BIOL CHEM, V279, P34277, DOI 10.1074/jbc.M404830200; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Nagase T, 2001, DEV GROWTH DIFFER, V43, P683; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Numayama-Tsuruta K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-6; Olakowski M, 2009, FOLIA HISTOCHEM CYTO, V47, P249, DOI 10.2478/v10042-009-0031-1; OsumiYamashita N, 1997, DEV GROWTH DIFFER, V39, P53; OZAKI T, 1994, CANCER RES, V54, P646; Petros TJ, 2010, DEV NEUROBIOL, V70, P781, DOI 10.1002/dneu.20821; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; Pinson J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-13; Pinson J, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-25; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; PRITCHARD DJ, 1974, EXP EYE RES, V19, P335, DOI 10.1016/0014-4835(74)90018-9; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Rodrigues NR, 2000, GENOMICS, V65, P53, DOI 10.1006/geno.2000.6138; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shimizu N, 2009, BIOL PHARM BULL, V32, P999, DOI 10.1248/bpb.32.999; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Sivak JM, 2000, DEV BIOL, V222, P41, DOI 10.1006/dbio.2000.9694; Skala-Rubinson H, 2002, J BIOL CHEM, V277, P47190, DOI 10.1074/jbc.M209349200; Sugioka K, 2010, TOHOKU J EXP MED, V222, P45, DOI 10.1620/tjem.222.45; Takahashi Hiroshi, 2006, Birth Defects Research, V78, P256, DOI 10.1002/bdrc.20077; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Talamillo A, 2003, DEV BIOL, V255, P151, DOI 10.1016/S0012-1606(02)00046-5; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Yao JG, 2008, DEV BIOL, V315, P535, DOI 10.1016/j.ydbio.2007.12.037; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhang WY, 2001, MOL VIS, V7, P1; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhou YH, 2003, CLIN CANCER RES, V9, P3369; Zhou YH, 2010, J NEURO-ONCOL, V96, P191, DOI 10.1007/s11060-009-9963-8	83	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31915	10.1371/journal.pone.0031915	http://dx.doi.org/10.1371/journal.pone.0031915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384097	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100038
J	Rest, JS; Bullaughey, K; Morris, GP; Li, WH				Rest, Joshua S.; Bullaughey, Kevin; Morris, Geoffrey P.; Li, Wen-Hsiung			Contribution of Transcription Factor Binding Site Motif Variants to Condition-Specific Gene Expression Patterns in Budding Yeast	PLOS ONE			English	Article							DNA-BINDING; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROTEIN; SEQUENCES; GENOME; CIS; EVOLUTION; ELEMENT; INFERENCE	It is now experimentally well known that variant sequences of a cis transcription factor binding site motif can contribute to differential regulation of genes. We characterize the relationship between motif variants and gene expression by analyzing expression microarray data and binding site predictions. To accomplish this, we statistically detect motif variants with effects that differ among environments. Such environmental specificity may be due to either affinity differences between variants or, more likely, differential interactions of TFs bound to these variants with cofactors, and with differential presence of cofactors across environments. We examine conservation of functional variants across four Saccharomyces species, and find that about a third of transcription factors have target genes that are differentially expressed in a condition-specific manner that is correlated with the nucleotide at variant motif positions. We find good correspondence between our results and some cases in the experimental literature (Reb1, Sum1, Mcm1, and Rap1). These results and growing consensus in the literature indicates that motif variants may often be functionally distinct, that this may be observed in genomic data, and that variants play an important role in condition-specific gene regulation.	[Rest, Joshua S.; Bullaughey, Kevin; Morris, Geoffrey P.; Li, Wen-Hsiung] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Rest, JS (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	Joshua.Rest@StonyBrook.edu; whli@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456; Rest, Joshua/0000-0002-9582-1041; Morris, Geoffrey Preston/0000-0002-3067-3359	National Institutes of Health [GM30998, GM081724]; International Balzan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030998, R01GM081724, R01GM030998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Balzan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (www.nih.gov) grants (GM30998 and GM081724) and the International Balzan Foundation (www.balzan.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton TB, 1997, MOL CELL BIOL, V17, P1881, DOI 10.1128/MCB.17.4.1881; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Chan SK, 1997, DEVELOPMENT, V124, P2007; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dos Santos C, 2009, DIABETES, V58, P489, DOI 10.2337/db08-0587; Erb I, 2006, IEEE P 1 INT C COMP; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fuchs J, 2009, NEUROBIOL AGING, V30, P731, DOI 10.1016/j.neurobiolaging.2007.08.014; Gaudet J, 2004, PLOS BIOL, V2, P1828, DOI 10.1371/journal.pbio.0020352; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Giordano M, 2006, MOL CELL ENDOCRINOL, V249, P51, DOI 10.1016/j.mce.2006.01.006; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kristensen VN, 2006, P NATL ACAD SCI USA, V103, P7735, DOI 10.1073/pnas.0601893103; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; Lim FL, 2003, MOL CELL BIOL, V23, P450, DOI 10.1128/MCB.23.2.450-461.2003; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Michal L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000018; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Papatsenko D, 2005, P NATL ACAD SCI USA, V102, P4966, DOI 10.1073/pnas.0409414102; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Ren YQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000523; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P1975, DOI 10.1021/bi802068s; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STRUHL K, 1986, MOL CELL BIOL, V6, P3847, DOI 10.1128/MCB.6.11.3847; Swamy KBS, 2009, NUCLEIC ACIDS RES, V37, P6991, DOI 10.1093/nar/gkp743; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tanay A, 2004, GENOME RES, V14, P829, DOI 10.1101/gr.2064404; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; WEFALD FC, 1990, NATURE, V344, P260, DOI 10.1038/344260a0; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; WYNNE J, 1992, NUCLEIC ACIDS RES, V20, P3297, DOI 10.1093/nar/20.13.3297; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934; Zhong HL, 1999, GENOME RES, V9, P1040, DOI 10.1101/gr.9.11.1040; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	71	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32274	10.1371/journal.pone.0032274	http://dx.doi.org/10.1371/journal.pone.0032274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384202	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100066
J	Bertrand, Y; Topel, M; Elvang, A; Melik, W; Johansson, M				Bertrand, Yann; Topel, Mats; Elvang, Annelie; Melik, Wessam; Johansson, Magnus			First Dating of a Recombination Event in Mammalian Tick-Borne Flaviviruses	PLOS ONE			English	Article							LOUPING ILL VIRUS; PHYLOGENETIC TREE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; ENCEPHALITIS-VIRUS; RNA VIRUSES; POPULATION-DYNAMICS; PURIFYING SELECTION; MOLECULAR CLOCK; DENGUE VIRUS; DNA VIRUSES	The mammalian tick-borne flavivirus group (MTBFG) contains viruses associated with important human and animal diseases such as encephalitis and hemorrhagic fever. In contrast to mosquito-borne flaviviruses where recombination events are frequent, the evolutionary dynamic within the MTBFG was believed to be essentially clonal. This assumption was challenged with the recent report of several homologous recombinations within the Tick-borne encephalitis virus (TBEV). We performed a thorough analysis of publicly available genomes in this group and found no compelling evidence for the previously identified recombinations. However, our results show for the first time that demonstrable recombination (i.e., with large statistical support and strong phylogenetic evidences) has occurred in the MTBFG, more specifically within the Louping ill virus lineage. Putative parents, recombinant strains and breakpoints were further tested for statistical significance using phylogenetic methods. We investigated the time of divergence between the recombinant and parental strains in a Bayesian framework. The recombination was estimated to have occurred during a window of 282 to 76 years before the present. By unravelling the temporal setting of the event, we adduce hypotheses about the ecological conditions that could account for the observed recombination.	[Bertrand, Yann; Topel, Mats] Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden; [Elvang, Annelie; Melik, Wessam; Johansson, Magnus] Sodertorn Univ, Sch Life Sci, Huddinge, Sweden; [Melik, Wessam] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	University of Gothenburg; Sodertorn University; Stockholm University	Bertrand, Y (corresponding author), Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden.	yann.bertrand@sh.se	Bertrand, Yann/R-5850-2018	Bertrand, Yann/0000-0001-6593-6959; Topel, Mats/0000-0001-7989-696X	Foundation for Baltic and East European studies	Foundation for Baltic and East European studies	This work was supported by grants to MJ by the Foundation for Baltic and East European studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Dzhioev YP, 2011, VOP VIRUSOL+, V56, P14; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elvang A, 2011, VECTOR-BORNE ZOONOT, V11, P649, DOI 10.1089/vbz.2010.0105; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Gao GF, 1997, ACTA VIROL, V41, P259; GAO GF, 1993, J GEN VIROL, V74, P109, DOI 10.1099/0022-1317-74-1-109; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; GONZALEZ L, 1987, VET REC, V121, P12, DOI 10.1136/vr.121.1.12; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Heinz F. X., 1990, Archives of Virology, Supplementum, P125; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, GENE, V404, P117, DOI 10.1016/j.gene.2007.09.013; Hughes AL, 2010, INFECT GENET EVOL, V10, P50, DOI 10.1016/j.meegid.2009.10.001; Jensen Per M, 2004, Ugeskr Laeger, V166, P2563; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; MARIN MS, 1995, RES VET SCI, V58, P11, DOI 10.1016/0034-5288(95)90081-0; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McGuire K, 1998, J GEN VIROL, V79, P981, DOI 10.1099/0022-1317-79-5-981; Nylander J.A.A., 2004, MRAIC PL; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Skarphedinsson S, 2005, EMERG INFECT DIS, V11, P1055, DOI 10.3201/eid1107.041265; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2007, GENES GENET SYST, V82, P187, DOI 10.1266/ggs.82.187; Swofford DL, 2002, PHYLOGENETIC ANAL US; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Yang ZH, 2000, GENETICS, V155, P431; Yun S-M, VIRUS GENES, V42, P307; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zlobin V. I., 2001, Voprosy Virusologii, V46, P17	61	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31981	10.1371/journal.pone.0031981	http://dx.doi.org/10.1371/journal.pone.0031981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384119	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500062
J	Peters, JL; Roberts, TE; Winker, K; McCracken, KG				Peters, Jeffrey L.; Roberts, Trina E.; Winker, Kevin; McCracken, Kevin G.			Heterogeneity in Genetic Diversity among Non-Coding Loci Fails to Fit Neutral Coalescent Models of Population History	PLOS ONE			English	Article							MULTILOCUS PHYLOGEOGRAPHY; DEMOGRAPHIC HISTORY; LINKAGE DISEQUILIBRIUM; CONTRASTING PATTERNS; STATISTICAL-METHOD; NATURAL-SELECTION; NORTH-AMERICA; MULTIPLE LOCI; DNA; DIVERGENCE	Inferring aspects of the population histories of species using coalescent analyses of non-coding nuclear DNA has grown in popularity. These inferences, such as divergence, gene flow, and changes in population size, assume that genetic data reflect simple population histories and neutral evolutionary processes. However, violating model assumptions can result in a poor fit between empirical data and the models. We sampled 22 nuclear intron sequences from at least 19 different chromosomes (a genomic transect) to test for deviations from selective neutrality in the gadwall (Anas strepera), a Holarctic duck. Nucleotide diversity among these loci varied by nearly two orders of magnitude (from 0.0004 to 0.029), and this heterogeneity could not be explained by differences in substitution rates alone. Using two different coalescent methods to infer models of population history and then simulating neutral genetic diversity under these models, we found that the observed among-locus heterogeneity in nucleotide diversity was significantly higher than expected for these simple models. Defining more complex models of population history demonstrated that a pre-divergence bottleneck was also unlikely to explain this heterogeneity. However, both selection and interspecific hybridization could account for the heterogeneity observed among loci. Regardless of the cause of the deviation, our results illustrate that violating key assumptions of coalescent models can mislead inferences of population history.	[Peters, Jeffrey L.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Roberts, Trina E.] Univ Iowa, Museum Nat Hist, Iowa City, IA USA; [Winker, Kevin; McCracken, Kevin G.] Univ Alaska Fairbanks, Univ Alaska Museum, Fairbanks, AK USA; [McCracken, Kevin G.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA	University System of Ohio; Wright State University Dayton; University of Iowa; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Peters, JL (corresponding author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.	jeffrey.peters@wright.edu	Winker, Kevin/M-2042-2014; Peters, Jeffrey/I-5116-2012	Winker, Kevin/0000-0002-8985-8104; Peters, Jeffrey/0000-0002-5920-7976	NSF [DEB-0926162]; Alaska EPSCoR (NSF) [EPS-0346770]; Institute of Arctic Biology, University of Alaska Fairbanks; Department of Biological Sciences, Wright State University; Division Of Environmental Biology [0926162] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alaska EPSCoR (NSF)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Institute of Arctic Biology, University of Alaska Fairbanks; Department of Biological Sciences, Wright State University; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants provided by NSF (DEB-0926162), Alaska EPSCoR (NSF EPS-0346770), the Institute of Arctic Biology, University of Alaska Fairbanks, and the Department of Biological Sciences, Wright State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Bachtrog D, 2006, GENETICS, V174, P2045, DOI 10.1534/genetics.106.062760; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensch S, 2006, MOL ECOL, V15, P161, DOI 10.1111/j.1365-294X.2005.02766.x; BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.immunol.7.1.579; Borge T, 2005, GENETICS, V171, P1861, DOI 10.1534/genetics.105.045120; Burt DW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S5; Carling MD, 2008, GENETICS, V178, P363, DOI 10.1534/genetics.107.076422; Carneiro M, 2010, EVOLUTION, V64, P3443, DOI 10.1111/j.1558-5646.2010.01092.x; Casillas S, 2007, MOL BIOL EVOL, V24, P2222, DOI 10.1093/molbev/msm150; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2000, EVOLUTION, V54, P1839; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fain MG, 2004, EVOLUTION, V58, P2558; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Galtier N, 2000, GENETICS, V155, P981; Gillespie JH, 2000, GENETICS, V155, P909; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; Harlin-Cognato AD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-131; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; JOHNSGARD PAUL A., 1960, CONDOR, V62, P25, DOI 10.2307/1365656; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Luhtala M, 1998, POULTRY SCI, V77, P1858, DOI 10.1093/ps/77.12.1858; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; McCracken KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023173; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; McCracken KG, 2005, SYST BIOL, V54, P35, DOI 10.1080/10635150590910249; MENG XL, 1994, ANN STAT, V22, P1142, DOI 10.1214/aos/1176325622; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; Ometto L, 2006, BIOL LETT-UK, V2, P604, DOI 10.1098/rsbl.2006.0521; Peters JL, 2008, EVOLUTION, V62, P1469, DOI 10.1111/j.1558-5646.2008.00372.x; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Peters JL, 2007, AUK, V124, P444, DOI 10.1642/0004-8038(2007)124[444:PSAMPI]2.0.CO;2; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pritchard JK, 2000, GENETICS, V155, P945; R Development Team, 2009, R LANG ENV STAT COMP; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sonsthagen SA, 2011, J BIOGEOGR, V38, P1368, DOI 10.1111/j.1365-2699.2011.02492.x; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2008, EVOLUTION, V62, P1936, DOI 10.1111/j.1558-5646.2008.00415.x; Strasburg JL, 2011, MOL ECOL, V20, P2353, DOI 10.1111/j.1365-294X.2011.05048.x; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; VEILLETTE A, 1991, EUR J IMMUNOL, V21, P397, DOI 10.1002/eji.1830210222; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; Wall JD, 2000, GENETICS, V155, P1865; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; WRIGHT S., 1938, Science (Washington), V87, P430; Wright SI, 2008, ANNU REV ECOL EVOL S, V39, P193, DOI 10.1146/annurev.ecolsys.39.110707.173342; Yuri T, 2008, MOL BIOL EVOL, V25, P352, DOI 10.1093/molbev/msm260	93	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31972	10.1371/journal.pone.0031972	http://dx.doi.org/10.1371/journal.pone.0031972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384117	Green Published, gold			2022-12-25	WOS:000302875500061
J	Hu, YC; Li, YP; Lin, HF; Yang, ZH; Cheng, LX				Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao; Cheng, Liangxi			Integrating Various Resources for Gene Name Normalization	PLOS ONE			English	Article							KNOWLEDGE	The recognition and normalization of gene mentions in biomedical literature are crucial steps in biomedical text mining. We present a system for extracting gene names from biomedical literature and normalizing them to gene identifiers in databases. The system consists of four major components: gene name recognition, entity mapping, disambiguation and filtering. The first component is a gene name recognizer based on dictionary matching and semi-supervised learning, which utilizes the co-occurrence information of a large amount of unlabeled MEDLINE abstracts to enhance feature representation of gene named entities. In the stage of entity mapping, we combine the strategies of exact match and approximate match to establish linkage between gene names in the context and the EntrezGene database. For the gene names that map to more than one database identifiers, we develop a disambiguation method based on semantic similarity derived from the Gene Ontology and MEDLINE abstracts. To remove the noise produced in the previous steps, we design a filtering method based on the confidence scores in the dictionary used for NER. The system is able to adjust the trade-off between precision and recall based on the result of filtering. It achieves an F-measure of 83% (precision: 82.5% recall: 83.5%) on BioCreative II Gene Normalization (GN) dataset, which is comparable to the current state-of-the-art.	[Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Cheng, Liangxi] Dalian Univ Technol, Dept Biomed Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian University of Technology	Hu, YC (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	huyuncui@mail.dlut.edu.cn			Natural Science Foundation of China [60673039, 61070098]; National High Tech Research and Development Plan of China [2006AA01Z151]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work was supported by grant from the Natural Science Foundation of China (No. 60673039 and 61070098)(http://www.nsfc.gov.cn/Portal0/default124.htm), the National High Tech Research and Development Plan of China (No. 2006AA01Z151)(http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando RK, 2007, P 2 BIOCREATIVE CHAL, V23, P101; Carpenter B, 2004, P 13 ANN TEXT RETR C; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cohen AM, 2007, P 2 BIOCREATIVE CHAL, P169; Fang H. R., 2006, P BIONLP WORKSH LINK, P41; Fluck J., 2007, P 2 BIOCREATIVE CHAL, P149; Fundel K, 2007, P 2 BIOCREATIVE CHAL, P153; Ganchev K., 2007, P 2 BIOCREATIVE CHAL, P119; Gonzalez G, 2007, P 2 BIOCREATIVE CHAL, P227; Grover C., 2007, P 2 BIOCREATIVE CHAL, P273; Hakenberg J, 2011, BIOINFORMATICS; Hakenberg J., 2007, P 2 BIOCREATIVE CHAL, P141; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Huang HS, 2007, P 2 BIOCREATIVE CHAL, P109; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Klinger R., 2007, P 2 BIOCREATIVE CHAL, P89; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL, P105; Lau W, 2007, P 2 BIOCR CHALL EV W, P165; Li YP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-223; Luong T, 2007, P 2 BIOCREATIVE CHAL, P145; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Nakov P, 2007, P 2 BIOCR CHALL EV W, P297; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Schuemie M.J., 2007, P 2 BIOCREATIVE CHAL, P131; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Smith L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S2; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Xu H, 2007, BIOINFORMATICS, V23, P1015, DOI 10.1093/bioinformatics/btm056	33	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43558	10.1371/journal.pone.0043558	http://dx.doi.org/10.1371/journal.pone.0043558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22384115	Green Published, gold			2022-12-25	WOS:000308738500017
J	Wang, X; Zhang, AX; Liu, Y; Chen, S; Feng, ZQ; Shang, WB; Maziarz, M; Radtke, J; Hampe, CS				Wang, Xin; Zhang, Aixia; Liu, Yu; Chen, Shi; Feng, Zhenqing; Shang, Wenbin; Maziarz, Marlena; Radtke, Jared; Hampe, Christiane S.			Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIRIBOSOMAL P AUTOANTIBODIES; ANTIGEN-PRESENTING CELLS; ACID DECARBOXYLASE GAD; GRAVES-DISEASE; DNA ANTIBODIES; B-LYMPHOCYTES; MONOCLONAL-ANTIBODIES; IDIOTYPIC ANTIBODIES; NETWORK THEORY	Overt autoantibodies to the smaller isoform of glutamate decarboxylase (GAD65Ab) are a characteristic in patients with Type 1 diabetes (T1D). Anti-idiotypic antibodies (anti-Id) directed to GAD65Ab effectively prevent the binding of GAD65 to GAD65Ab in healthy individuals. Levels of GAD65Ab-specific anti-Id are significantly lower in patients with T1D, leading to overt GAD65Ab in these patients. To determine the possible protective role of GAD65Ab-specific anti-Id in T1D pathogenesis, we developed the monoclonal anti-Id MAb 8E6G4 specifically targeting human monoclonal GAD65Ab b96.11. MAb 8E6G4 was demonstrated as a specific anti-Id directed to the antigen binding site of b96.11. MAb 8E6G4 recognized human antibodies in sera from healthy individuals, T2D patients, and T1D patients as established by ELISA. We confirmed these MAb 8E6G4-bound human antibodies to contain GAD65Ab by testing the eluted antibodies for binding to GAD65 in radioligand binding assays. These findings confirm that GAD65Ab are present in sera of individuals, who test GAD65Ab-negative in conventional detection assays. To test our hypothesis that GAD65Ab-specific anti-Id have an immune modulatory role in T1D, we injected young Non Obese Diabetic (NOD) mice with MAb 8E6G4. The animals were carefully monitored for development of T1D for 40 weeks. Infiltration of pancreatic islets by mononuclear cells (insulitis) was determined to establish the extent of an autoimmune attack on the pancreatic islets. Administration of MAb 8E6G4 significantly reduced the cumulative incidence rate of T1D and delayed the time of onset. Insulitis was significantly less severe in animals that received MAb 8E6G4 as compared to control animals. These results support our hypothesis that anti-Id specific to GAD65Ab have a protective role in T1D.	[Wang, Xin; Chen, Shi] Jiangsu Prov Hosp TCM, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Zhang, Aixia] Nanjing Med Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China; [Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130023, Jilin, Peoples R China; [Feng, Zhenqing] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Technol, Nanjing, Jiangsu, Peoples R China; [Shang, Wenbin] Nanjing Univ Chinese Med, Coll Clin Med 1, Med Res Ctr, Nanjing, Jiangsu, Peoples R China; [Maziarz, Marlena; Radtke, Jared; Hampe, Christiane S.] Univ Washington, Seattle, WA 98195 USA	Nanjing University of Chinese Medicine; Nanjing Medical University; Jilin University; Nanjing Medical University; Nanjing University of Chinese Medicine; University of Washington; University of Washington Seattle	Wang, X (corresponding author), Jiangsu Prov Hosp TCM, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	drwangxin@gmail.com; champe@u.washington.edu	Maziarz, Marlena/F-1746-2019; Maziarz, Marlena/AAL-3798-2021; Hampe, Christiane Susanne/GSD-7679-2022; Maziarz, Marlena/N-4255-2018; Shang, Wenbin/E-6682-2011; Wallinga, Jacco/C-4382-2018	Maziarz, Marlena/0000-0003-1417-6050; Maziarz, Marlena/0000-0003-1417-6050; Maziarz, Marlena/0000-0003-1417-6050; Shang, Wenbin/0000-0002-0317-5928; Bogaert, Debby/0000-0003-2651-7000; Trzcinski, Krzysztof/0000-0002-5433-8846; Wallinga, Jacco/0000-0003-1725-5627; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK26190, DK17047, DK53456]; American Diabetes Association [1-09-RA-64]; Ministry of Science and Technology of China [2006BAI04A03]; Natural Science Foundation of China [NSF-C 81100555/H0707]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Institutes of Health (www2.niddk.nih.gov/) (grant numbers DK26190, DK17047, and DK53456), a basic science grant from the American Diabetes Association (www.diabetes.org)/(1-09-RA-64 to CSH), grant 2006BAI04A03 of the Ministry of Science and Technology of China (www.most.cn/eng/), and a grant from the Natural Science Foundation of China (www.nsfc.gov.cn/Portal0/default106.htm) NSF-C 81100555/H0707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU NI, 1989, J CLIN IMMUNOL, V9, P16, DOI 10.1007/BF00917123; ABDOU NI, 1981, J CLIN INVEST, V67, P1297, DOI 10.1172/JCI110158; Aly Theresa, 2005, Am J Ther, V12, P481, DOI 10.1097/01.mjt.0000178782.97413.79; Anderson CJ, 1998, ARTHRITIS RHEUM, V41, P33, DOI 10.1002/1529-0131(199801)41:1<33::AID-ART5>3.0.CO;2-5; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bach JF, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar554; Brooks-Worrell B, 2012, CLIN EXP IMMUNOL, V167, P40, DOI 10.1111/j.1365-2249.2011.04501.x; DWYER DS, 1983, NATURE, V301, P611, DOI 10.1038/301611a0; ERTL HCJ, 1988, VACCINE, V6, P80, DOI 10.1016/S0264-410X(88)80003-3; Falcone M, 1998, J IMMUNOL, V161, P1163; Goudy KS, 2005, INT REV IMMUNOL, V24, P307, DOI 10.1080/08830180500379721; Hall TR, 2008, IMMUNOLOGY, V123, P547, DOI 10.1111/j.1365-2567.2007.02724.x; Hampe CS, 2000, J CLIN ENDOCR METAB, V85, P4671, DOI 10.1210/jc.85.12.4671; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; O'Neill SK, 2009, CURR OPIN ENDOCRINOL, V16, P293, DOI 10.1097/MED.0b013e32832e06a7; Oak S, 2008, P NATL ACAD SCI USA, V105, P5471, DOI 10.1073/pnas.0800578105; Padoa CJ, 2003, DIABETES, V52, P2689, DOI 10.2337/diabetes.52.11.2689; Pan ZJ, 1998, J CLIN INVEST, V102, P215, DOI 10.1172/JCI1969; PASCHKE R, 1990, J AUTOIMMUN, V3, P441, DOI 10.1016/S0896-8411(05)80011-3; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Quinn A, 1996, J AUTOIMMUN, V9, P365, DOI 10.1006/jaut.1996.0049; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Routsias JG, 2003, J AUTOIMMUN, V21, P17, DOI 10.1016/S0896-8411(03)00063-5; Sanjeevi CB, 1996, DIABETES NUTR METAB, V9, P167; Sapir T, 2005, CLIN REV ALLERG IMMU, V29, P185, DOI 10.1385/CRIAI:29:3:185; Serreze DV, 1998, J IMMUNOL, V161, P3912; SIKORSKA HM, 1986, J IMMUNOL, V137, P3786; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; SILVESTRIS F, 1984, ARTHRITIS RHEUM, V27, P1387, DOI 10.1002/art.1780271209; STAFFORD HA, 1995, J IMMUNOL, V155, P2754; Tada H, 2001, ENDOCR J, V48, P703, DOI 10.1507/endocrj.48.703; TANIGUCHI O, 1984, J RHEUMATOL, V11, P291; Tremble J, 1997, J CLIN ENDOCR METAB, V82, P2664, DOI 10.1210/jc.82.8.2664; Usuki S, 2010, J NEUROSCI RES, V88, P1651, DOI 10.1002/jnr.22330; VALDERRAMA R, 1988, J NEUROIMMUNOL, V20, P269, DOI 10.1016/0165-5728(88)90174-9; WILLIAMS RC, 1995, J RHEUMATOL, V22, P1075; Williams WM, 1998, LUPUS, V7, P164, DOI 10.1191/096120398678919958; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; ZOUALI M, 1983, CELL IMMUNOL, V76, P137, DOI 10.1016/0008-8749(83)90356-8	44	78	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32515	10.1371/journal.pone.0032515	http://dx.doi.org/10.1371/journal.pone.0032515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	23189192	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916800042
J	Sharaf, MR; Aldawood, AS				Sharaf, Mostafa R.; Aldawood, Abdulrahman S.			Ants of the Genus Solenopsis Westwood 1840 (Hymenoptera: Formicidae) in the Arabian Peninsula with Description of a New Species, Solenopsis elhawagryi	PLOS ONE			English	Article								Ants of the genus Solenopsis Westwood in the Arabian Peninsula are revised. Six species are treated: Solenopsis elhawagryi Sharaf & Aldawood sp. n., S. geminata (Fabricius, 1804), S. omana Collingwood & Agosti, 1996, S. saudiensis Sharaf & Aldawood, 2011, S. sumara Collingwood & Agosti, 1996, and S. zingibara Collingwood & Agosti, 1996. Solenopsis elhawagryi is described from Beljorashi Governorate, Al Baha Province, Saudi Arabia, based on worker castes and the queen with notes on this species biology and ecology. Solenopsis sumara workers are redescribed and illustrated for the first time and a lectotype is designated. An identification key to the Arabian and Egyptian species is provided with scanning electron micrographs to facilitate species recognition.	[Sharaf, Mostafa R.; Aldawood, Abdulrahman S.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia.	antsharaf@gmail.com	Aldawood, Abdulrahman Saad/M-3657-2019	Aldawood, Abdulrahman Saad/0000-0003-0721-6632	NPST program (King Saud University) [11-BIO1974-02]	NPST program (King Saud University)(King Saud University)	Funding for the research was provided by NPST program (King Saud University) Project No. 11-BIO1974-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton B., 1987, Bulletin of the British Museum (Natural History) Entomology, V54, P263; Bolton B., 1994, Identification guide to the ant genera of the world.; BOLTON B., 2007, BOLTONS CATALOGUE AN; Brown William L. Jr, 2000, P45; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Collingwood Cedric A., 1996, Fauna of Saudi Arabia, V15, P300; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Creighton WS, 1930, P AM ACAD ARTS SCI, V66, P39, DOI 10.2307/20026320; ETTERSHANK G., 1966, AUSTRALIAN J ZOOL, V14, P73, DOI 10.1071/ZO9660073; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Mayr G., 1863, VERHANDLUNGEN KAISER, V13, P385; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Pacheco JA, 2006, THESIS U TEXAS EL PA, P543; Sharaf MR, 2011, ANN SOC ENTOMOL FR, V47, P474, DOI 10.1080/00379271.2011.10697738; Sharaf MR, 2011, T AM ENTOMOL SOC, V137, P203, DOI 10.3157/061.137.0113; Sharaf MR, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2004.1.4; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; West-Wood J. O., 1840, ANN MAGAZINE NATURAL, V6, P81, DOI [10.1080/03745484009443610, DOI 10.1080/03745484009443610]; Wetterer JK, 2011, MYRMECOL NEWS, V14, P21	19	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49485	10.1371/journal.pone.0049485	http://dx.doi.org/10.1371/journal.pone.0049485			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226211	Green Published, Green Submitted, gold			2022-12-25	WOS:000312376100020
J	Hu, Y; Duan, JH; Zhan, QM; Wang, FD; Lu, X; Yang, XD				Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da			Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; EXPRESSION; DESIGN; ACID	Chemotherapy is a primary treatment for cancer, but its efficacy is often limited by the adverse effects of cytotoxic agents. Targeted drug delivery may reduce the non-specific toxicity of chemotherapy by selectively directing anticancer drugs to tumor cells. MUC1 protein is an attractive target for tumor-specific drug delivery owning to its overexpression in most adenocarcinomas. In this study, a novel MUC1 aptamer is exploited as the targeting ligand for carrying doxorubicin (Dox) to cancer cells. We developed an 86-base DNA aptamer (MA3) that bound to a peptide epitope of MUC1 with a K-d of 38.3 nM and minimal cross reactivity to albumin. Using A549 lung cancer and MCF-7 breast cancer cells as MUC1-expressing models, MA3 was found to preferentially bind to MUC1-positive but not MUC1-negative cells. An aptamer-doxorubicin complex (Apt-Dox) was formulated by intercalating doxorubicin into the DNA structure of MA3. Apt-Dox was found capable of carrying doxorubicin into MUC1-positive tumor cells, while significantly reducing the drug intake by MUC1-negative cells. Moreover, Apt-Dox retained the efficacy of doxorubicin against MUC1-positive tumor cells, but lowered the toxicity to MUC1-negative cells (P<0.01). The results suggest that the MUC1 aptamer may have potential utility as a targeting ligand for selective delivery of cytotoxic agent to MUC1-expressing tumors.	[Hu, Yan; Duan, Jinhong; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wang, Fengdan; Lu, Xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Hu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ayangmd@gmail.com			Chinese Ministry of Science and Technology [2011CB933504, 2011CB911004, 2011CB911003]; Natural Science Foundation of China [81071870]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Chinese Ministry of Science and Technology (2011CB933504, 2011CB911004, 2011CB911003) and the Natural Science Foundation of China (81071870).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cao Y, 1999, VIRCHOWS ARCH, V434, P503, DOI 10.1007/s004280050375; Croce MV, 2001, BREAST CANCER RES TR, V69, P1, DOI 10.1023/A:1012220902991; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2006, EXPERT OPIN DRUG DEL, V3, P311, DOI 10.1517/17425247.3.3.311; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Haj HTB, 2003, CHEM-BIOL INTERACT, V145, P349, DOI 10.1016/S0009-2797(03)00061-9; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Murray A, 1998, J PEPT RES, V52, P375; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren LF, 1997, CHEM-BIOL INTERACT, V104, P55, DOI 10.1016/S0009-2797(97)03767-8; SENTER PD, 1995, BIOCONJUGATE CHEM, V6, P389, DOI 10.1021/bc00034a008; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Vasir JK, 2005, TECHNOL CANCER RES T, V4, P363, DOI 10.1177/153303460500400405; Vogel CL, 2009, J CLIN ONCOL, V27; Ye Xin, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P206	28	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31970	10.1371/journal.pone.0031970	http://dx.doi.org/10.1371/journal.pone.0031970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384115	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500060
J	Park, HK; Ha, MH; Park, SG; Kim, MN; Kim, BJ; Kim, W				Park, Hee Kuk; Ha, Myung-Ho; Park, Sang-Gue; Kim, Myeung Nam; Kim, Beom Joon; Kim, Wonyong			Characterization of the Fungal Microbiota (Mycobiome) in Healthy and Dandruff-Afflicted Human Scalps	PLOS ONE			English	Article							HUMAN SKIN; DERMATITIS; ETIOLOGY; YEAST	The human scalp harbors a vast community of microbial mutualists, the composition of which is difficult to elucidate as many of the microorganisms are not culturable using current culture techniques. Dandruff, a common scalp disorder, is known as a causative factor of a mild seborrheic dermatitis as well as pityriasis versicolor, seborrheic dermatitis, and atopic dermatitis. Lipophilic yeast Malassezia is widely accepted to play a role in dandruff, but relatively few comprehensive studies have been reported. In order to investigate fungal biota and genetic resources of dandruff, we amplified the 26S rRNA gene from samples of healthy scalps and dandruff-afflicted scalps. The sequences were analyzed by a high throughput method using a GS-FLX 454 pyrosequencer. Of the 74,811 total sequence reads, Basidiomycota (Filobasidium spp.) was the most common phylum associated with dandruff. In contrast, Ascomycota (Acremonium spp.) was common in the healthy scalps. Our results elucidate the distribution of fungal communities associated with dandruff and provide new avenues for the potential prevention and treatment of dandruff.	[Park, Hee Kuk; Kim, Wonyong] Chung Ang Univ, Dept Microbiol, Seoul 156756, South Korea; [Kim, Myeung Nam; Kim, Beom Joon] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul 156756, South Korea; [Ha, Myung-Ho; Park, Sang-Gue] Chung Ang Univ, Dept Appl Stat, Fac Business & Econ, Seoul 156756, South Korea	Chung Ang University; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Park, HK (corresponding author), Chung Ang Univ, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Park, Heekuk/Y-2097-2019; PARK, Sang-Gue/V-7768-2019; Park, Heekuk/G-5292-2016	Park, Heekuk/0000-0001-5815-9717; Park, Heekuk/0000-0001-5815-9717; FERKO, Boris/0000-0001-5340-4437; Kim, Beom Joon/0000-0003-2320-7621	Ministry for Health & Welfare, Republic of Korea [A085138]	Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare Technology Research & Development Project, Ministry for Health & Welfare, Republic of Korea (A085138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Das S, 2010, MYCOPATHOLOGIA, V170, P361, DOI 10.1007/s11046-010-9334-1; Erchiga VC, 2002, CURR OPIN INFECT DIS, V15, P133, DOI 10.1097/00001432-200204000-00006; Geyer AS, 2006, J AM ACAD DERMATOL, V55, P1095, DOI 10.1016/j.jaad.2006.08.001; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gueho E, 1998, MED MYCOL, V36, P220; Gupta AK, 2004, DERMATOLOGY, V208, P89, DOI 10.1159/000076478; Gupta AK, 2001, MED MYCOL, V39, P199, DOI 10.1080/mmy.39.2.199.206; Gupta M, 2007, INDIAN J DERMATOL VE, V73, P389; Jo JH, 2005, CONTACT DERMATITIS, V52, P142, DOI 10.1111/j.0105-1873.2005.00528.x; 박주희, 2009, [Korean Journal of Dermatology, 대한피부과학회지], V47, P875; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LEYDEN JJ, 1976, ARCH DERMATOL, V112, P333, DOI 10.1001/archderm.112.3.333; MCGINLEY KJ, 1975, J INVEST DERMATOL, V64, P401, DOI 10.1111/1523-1747.ep12512335; Miyazaki J, 1996, J FERMENT BIOENG, V81, P315, DOI 10.1016/0922-338X(96)80583-6; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; PERFECT JR, 2006, FUNGAL PATHOGENESIS, P3; Pierard G E, 1995, Skin Res Technol, V1, P137, DOI 10.1111/j.1600-0846.1995.tb00033.x; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Pierard-Franchimont C, 2000, DERMATOLOGY, V200, P93, DOI 10.1159/000018337; Prohic Asja, 2003, Acta Dermatovenerol Croat, V11, P10; Ranganathan S, 2010, Indian J Dermatol, V55, P130, DOI 10.4103/0019-5154.62734; Ro BI, 2005, J INVEST DERM SYMP P, V10, P194, DOI 10.1111/j.1087-0024.2005.10104.x; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002	27	255	268	7	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32847	10.1371/journal.pone.0032847	http://dx.doi.org/10.1371/journal.pone.0032847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22761928	Green Published, Green Submitted, gold			2022-12-25	WOS:000303003500109
J	Song, XF; Ren, H; Andreasen, A; Thomsen, JS; Zhai, XY				Song, Xiao-Feng; Ren, Hao; Andreasen, Arne; Thomsen, Jesper Skovhus; Zhai, Xiao-Yue			Expression of Bcl-2 and Bax in Mouse Renal Tubules during Kidney Development	PLOS ONE			English	Article							CYTOCHROME-C; PROXIMAL TUBULE; APOPTOSIS; DEATH; FAMILY; CELLS; MITOCHONDRIA; PROTEINS; RELEASE; MEMBERS	Bcl-2 and Bax play an important role in apoptosis regulation, as well as in cell adhesion and migration during kidney morphogenesis, which is structurally and functionally related to mitochondria. In order to elucidate the role of Bcl-2 and Bax during kidney development, it is essential to establish the exact location of their expression in the kidney. The present study localized their expression during kidney development. Kidneys from embryonic (E) 16-, 17-, 18-day-old mouse fetuses, and postnatal (P) 1-, 3-, 5-, 7-, 14-, 21-day-old pups were embedded in Epon. Semi-thin serial sections from two E17 kidneys underwent computer assisted 3D tubule tracing. The tracing was combined with a newly developed immunohistochemical technique, which enables immunohistochemistry on glutaraldehyde fixated plastic embedded sections. Thereby, the microstructure could be described in detail, and the immunochemistry can be performed using exactly the same sections. The study showed that Bcl-2 and Bax were strongly expressed in mature proximal convoluted tubules at all time points, less strongly expressed in proximal straight tubules, and only weakly in immature proximal tubules and distal tubules. No expression was detected in ureteric bud and other earlier developing structures, such as comma bodies, S shaped bodies, glomeruli, etc. Tubules expressing Bcl-2 only were occasionally observed. The present study showed that, during kidney development, Bcl-2 and Bax are expressed differently in the proximal and distal tubules, although these two tubule segments are almost equally equipped with mitochondria. The functional significance of the different expression of Bcl-2 and Bax in proximal and distal tubules is unknown. However, the findings of the present study suggest that the mitochondrial function differs between mature proximal tubules and in the rest of the tubules. The function of Bcl-2 and Bax during tubulogenesis still needs to be investigated.	[Song, Xiao-Feng; Ren, Hao; Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Liao Ning, Peoples R China; [Andreasen, Arne; Thomsen, Jesper Skovhus] Aarhus Univ, Dept Anat, Dept Biomed, Aarhus, Denmark; [Song, Xiao-Feng] Liao Ning Med Coll, Dept Histol & Embryol, Jin Zhou, Liao Ning, Peoples R China; [Zhai, Xiao-Yue] China Med Univ, Inst Nephropathol, Shenyang, Liao Ning, Peoples R China	China Medical University; Aarhus University; China Medical University	Song, XF (corresponding author), China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Liao Ning, Peoples R China.	zhaixy@mail.cmu.edu.cn		Thomsen, Jesper Skovhus/0000-0001-9386-6679	National Natural Science Foundation of China [30871313, 31171400]; China Postdoctoral Science Special Foundation [200801399]; Research Fund for the Doctoral Program of Higher Education of China [200801590016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported mainly by grants of National Natural Science Foundation of China (contract no. 30871313 and 31171400, http://isisn.nsfc.gov.cn/egrantweb), in part by China Postdoctoral Science Special Foundation (contract no. 200801399) and Research Fund for the Doctoral Program of Higher Education of China (contract no. 200801590016). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen A, 2003, J NEUROSCI METH, V122, P157, DOI 10.1016/S0165-0270(02)00317-5; Arany I, 2008, KIDNEY INT, V74, P261, DOI 10.1038/ki.2008.221; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Basile DP, 1997, AM J PHYSIOL-RENAL, V272, pF640, DOI 10.1152/ajprenal.1997.272.5.F640; Carev D, 2006, PEDIATR NEPHROL, V21, P627, DOI 10.1007/s00467-006-0057-y; CHEN BY, 1994, TERATOLOGY, V50, P1, DOI 10.1002/tera.1420500102; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Fedorov LM, 2006, MECH AGEING DEV, V127, P600, DOI 10.1016/j.mad.2006.02.009; Foley JGD, 2002, J ANAT, V201, P477, DOI 10.1046/j.1469-7580.2002.00114.x; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hammerman MR, 1998, CURR OPIN NEPHROL HY, V7, P419, DOI 10.1097/00041552-199807000-00012; Hayashi M, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_9.8; KELLENBERGER E, 1987, J HISTOCHEM CYTOCHEM, V35, P959, DOI 10.1177/35.9.3302020; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Messaris E, 2008, SURG INFECT, V9, P377, DOI 10.1089/sur.2006.018; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; NOVACK DV, 1994, AM J PATHOL, V145, P61; Patschan D, 2007, KIDNEY INT, V71, P744, DOI 10.1038/sj.ki.5002102; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; RUEGG CE, 1990, AM J PHYSIOL, V259, pF176, DOI 10.1152/ajprenal.1990.259.1.F176; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Sheibani N, 2007, J CELL PHYSIOL, V210, P616, DOI 10.1002/jcp.20858; Sorenson CM, 2004, BBA-MOL CELL RES, V1644, P169, DOI 10.1016/j.bbamcr.2003.08.010; Torchinsky A, 1995, TERATOGEN CARCIN MUT, V15, P179, DOI 10.1002/tcm.1770150404; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhai XY, 2007, KIDNEY INT, V72, P731, DOI 10.1038/sj.ki.5002403; Zhai XY, 2006, J AM SOC NEPHROL, V17, P77, DOI 10.1681/ASN.2005080796; Ziehr J, 2004, AM J PHYSIOL-RENAL, V287, pF1154, DOI 10.1152/ajprenal.00129.2004	39	28	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32771	10.1371/journal.pone.0032771	http://dx.doi.org/10.1371/journal.pone.0032771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389723	gold, Green Published			2022-12-25	WOS:000302999600062
J	Sharaf, MR; Aldawood, AS; Taylor, B				Sharaf, Mostafa R.; Aldawood, Abdulrahman S.; Taylor, Brian			A New Ant Species of the Genus Tetramorium Mayr, 1855 (Hymenoptera: Formicidae) from Saudi Arabia, with a Revised Key to the Arabian Species	PLOS ONE			English	Article							COMPLEX HYMENOPTERA; REGION; FOREST; FAUNA; USSR	Tetramorium amalae sp. n. is described and illustrated from Saudi Arabia based on two worker caste specimens collected in Al Bahah region. The new species belongs to the T. shilohense group and appears to be closely related to T. dysderke Bolton from Nigeria. T. amalae is distinguished by having well-developed frontal carinae, smaller eyes, greater head length and width, greater pronotal width, and the petiole node is longer than broad. Tetramorium latinode Collingwood & Agosti is recorded for the first time from Saudi Arabia and for only the second time since the original description. The worker caste of T. latinode is redescribed and illustrated using scanning electron micrographs to facilitate recognition and the gyne is described for the first time with observations given on species relationships, biology and habitat. A revised key to the nineteen Tetramorium species recorded from Arabian Peninsula based on worker castes is provided. Tetramorium bicarinatum (Nylander) is recorded for the first time from Saudi Arabia. It is suggested that T. amalae and T. latinode are endemic to the Arabian Peninsula.	[Sharaf, Mostafa R.; Aldawood, Abdulrahman S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	antsharaf@yahoo.com; aldawood88@yahoo.com	Aldawood, Abdulrahman Saad/M-3657-2019	Aldawood, Abdulrahman Saad/0000-0003-0721-6632	King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center	King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center	This project was supported by King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center. The authors express their debt and gratitude to Mr. Barry Bolton and Dr. Brian Fisher for useful and valuable comments, which much improved the manuscript. Actually, without their continuous help this study could not have been completed. Special thanks are due to Prof. Boris Kondratieff for critical reading of the manuscript. We are indebted to Dr. Stephen Judd, Director of the World Museum Liverpool and Mr. Guy Knight, Head of Zoology and Curator of Invertebrates, for allowing the senior author to examine Tetramorium material. Thanks go to Dr. Richard Pyle for providing the first Formicidae LSID for the new species. We are grateful for two anonymous reviewers for their comments which greatly improved the manuscript. We also thank Mr. Hassan Badri for technical assistance and Dr. Omer Hamed for taking SEM images. Special thanks go to Prof. Magdi Elhawagry and Mr. Mohammed Metwally for help in expedition to Baha region and Mr. Mohammed Sallam for helping with the photography of T. latinode. The senior author expresses his gratitude to his wife Amal El Saadany, for her joyful assistance and appreciated help with specimens mounting, to Mr. Cedric Collingwood, for his continuous encouragements and wonderful hospitality, and to Tony van Harten, Mr. Salah Montaser (the Egyptian Journalist, Al Ahram Newspaper), Prof. Hoda Farid (Ain Shams University), Dr. Mahmoud Eldera'a and Mr. Ismail Fareed for their encouragement.	Arnold G., 1926, Annals of the South African Museum, V23, P191; Bodenheimer FS, 1937, P LINN SOC LONDON, V148, P47; BOLTON B, 1995, J NAT HIST, V29, P1037, DOI 10.1080/00222939500770411; Bolton B., 1979, Bulletin of the British Museum (Natural History) Entomology, V38, P129; BOLTON B, 1985, J NAT HIST, V19, P243, DOI 10.1080/00222938500770191; Bolton B., 1977, Bulletin Br Mus nat Hist (Ent), V36, P67; Bolton B., 1976, Bulletin of the British Museum (Natural History), Entomology, V34, P281; Bolton B., 1980, Bulletin of the British Museum (Natural History) Entomology, V40, P193; Bolton B., 1994, IDENTIFICATION GUIDE; Brown WL, 2000, BIOL DIVERSITY HDB S; Collingwood C.A., 1985, Fauna of Saudi Arabia, V7, P230; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Collingwood Cedric A., 2005, Zoology in the Middle East, V35, P73; Collingwood Cedric A., 1996, Fauna of Saudi Arabia, V15, P300; Collingwood Cedric A., 2004, V20, P473; Csosz S, 2007, ZOOTAXA, P1; Csosz S, 2010, ZOOTAXA, P1; Garcia FH, 2010, ZOOTAXA, P1; Garcia FH, 2011, ZOOTAXA, P1; Garcia Francisco Hita, 2010, Bonn Zoological Bulletin, V57, P359; Garcia FH, 2010, MYRMECOL NEWS, V13, P141; Nayman J, 1972, ATLAS WILDLIFE; RADCHENKO AG, 1992, ZOOL ZH, V71, P39; RADCHENKO AG, 1992, ZOOL ZH, V71, P50; Taylor B., 1980, COCOA RES I NIGERIA, V7, P1; Yamane Seiki, 2011, Insecta Matsumurana, V67, P61	26	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30811	10.1371/journal.pone.0030811	http://dx.doi.org/10.1371/journal.pone.0030811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	23226211	Green Published, gold			2022-12-25	WOS:000302999600004
J	Chen, F; Zhang, W; Liang, Y; Huang, JL; Li, K; Green, CD; Liu, JC; Zhang, GJ; Zhou, B; Yi, X; Wang, W; Liu, H; Xu, XH; Shen, F; Qu, N; Wang, YD; Gao, GY; San, A; JiangBai, LS; Sang, H; Fang, XD; Kristiansen, K; Yang, HM; Wang, J; Han, JDJ; Wang, J				Chen, Fang; Zhang, Wei; Liang, Yu; Huang, Jialiang; Li, Kui; Green, Christopher D.; Liu, Jiancheng; Zhang, Guojie; Zhou, Bing; Yi, Xin; Wang, Wei; Liu, Hang; Xu, Xiaohong; Shen, Feng; Qu, Ning; Wang, Yading; Gao, Guoyi; San, A.; JiangBai, LuoSang; Sang, Hua; Fang, Xiangdong; Kristiansen, Karsten; Yang, Huanming; Wang, Jun; Han, Jing-Dong J.; Wang, Jian			Transcriptome and Network Changes in Climbers at Extreme Altitudes	PLOS ONE			English	Article							EXPRESSION DATA; STEM-CELLS; HYPOXIA; ADAPTATION; EVEREST; ILLNESS; PROTEIN; OCT4	Extreme altitude can induce a range of cellular and systemic responses. Although it is known that hypoxia underlies the major changes and that the physiological responses include hemodynamic changes and erythropoiesis, the molecular mechanisms and signaling pathways mediating such changes are largely unknown. To obtain a more complete picture of the transcriptional regulatory landscape and networks involved in extreme altitude response, we followed four climbers on an expedition up Mount Xixiabangma (8,012 m), and collected blood samples at four stages during the climb for mRNA and miRNA expression assays. By analyzing dynamic changes of gene networks in response to extreme altitudes, we uncovered a highly modular network with 7 modules of various functions that changed in response to extreme altitudes. The erythrocyte differentiation module is the most prominently up-regulated, reflecting increased erythrocyte differentiation from hematopoietic stem cells, probably at the expense of differentiation into other cell lineages. These changes are accompanied by coordinated down-regulation of general translation. Network topology and flow analyses also uncovered regulators known to modulate hypoxia responses and erythrocyte development, as well as unknown regulators, such as the OCT4 gene, an important regulator in stem cells and assumed to only function in stem cells. We predicted computationally and validated experimentally that increased OCT4 expression at extreme altitude can directly elevate the expression of hemoglobin genes. Our approach established a new framework for analyzing the transcriptional regulatory network from a very limited number of samples.	[Chen, Fang; Zhang, Guojie; Yi, Xin; Wang, Wei; Liu, Hang; Xu, Xiaohong; Shen, Feng; Qu, Ning; Wang, Yading; San, A.; JiangBai, LuoSang; Sang, Hua; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Wei; Huang, Jialiang; Green, Christopher D.; Liu, Jiancheng; Zhou, Bing; Han, Jing-Dong J.] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Chen, Fang; Liang, Yu; Li, Kui; Yi, Xin; San, A.; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Zhang, Wei; Huang, Jialiang; Liu, Jiancheng; Zhou, Bing] Chinese Acad Sci, Ctr Mol Syst Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Chen, Fang; Zhang, Wei; Liang, Yu; Huang, Jialiang; Li, Kui; Liu, Jiancheng; Zhou, Bing; Yi, Xin; San, A.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities Autonomous, Jinghong, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen	Chen, F (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn; jdhan@picb.ac.cn; wangjian@genomics.org.cn	Zhou, Bing/J-3281-2015; Kristiansen, Karsten/J-5148-2014; Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Wang, Jun/A-7261-2013; Zhang, Wei/K-4276-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kristiansen, Karsten/0000-0002-6024-0917; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Zhang, Wei/0000-0002-0942-1245; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Wang, Dao Wen/0000-0002-9774-3980; , Chen/0000-0001-5080-9383	China National Science Foundation [30890033, 30588001, 30620120433]; Chinese Ministry of Science and Technology [2006CB910700, 2006CB504103]; Chinese Academy of Sciences [KSCX1-YW-R-40, KSCX2-YW-R-76]; Science and Technology Plan of the Tibet Autonomous Region [2007-2-18]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Plan of the Tibet Autonomous Region	This work was supported by grants from the China National Science Foundation (Grant # 30890033, # 30588001 and # 30620120433), Chinese Ministry of Science and Technology (973 program, Grant # 2006CB910700, # 2006CB504103) and Chinese Academy of Sciences (# KSCX1-YW-R-40, # KSCX2-YW-R-76), Science and Technology Plan of the Tibet Autonomous Region (# 2007-2-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; BERGLUND B, 1992, SPORTS MED, V14, P289, DOI 10.2165/00007256-199214050-00002; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Clerici C, 2009, AM J PHYSIOL-LUNG C, V296, pL267, DOI 10.1152/ajplung.90528.2008; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Hochachka PW, 2003, BIOESSAYS, V25, P515, DOI 10.1002/bies.10261; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Koeppen M, 2011, CURR OPIN ANESTHESIO, V24, P363, DOI 10.1097/ACO.0b013e32834873fd; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEEHAN RT, 1987, ANN EMERG MED, V16, P974, DOI 10.1016/S0196-0644(87)80743-6; Michael P, 2000, HIGH ALTITUDE MED PH; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Torkamani A, 2009, BIOINFORMATICS, V25, P2222, DOI 10.1093/bioinformatics/btp388; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145; Xia K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-508; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	32	127	132	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31645	10.1371/journal.pone.0031645	http://dx.doi.org/10.1371/journal.pone.0031645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393366	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500019
